Citrus Sinensis ID: 013016
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 451 | 2.2.26 [Sep-21-2011] | |||||||
| O64682 | 438 | Protein kinase PINOID OS= | yes | no | 0.953 | 0.981 | 0.698 | 1e-174 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | yes | no | 0.851 | 0.793 | 0.581 | 1e-130 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.895 | 0.769 | 0.465 | 1e-105 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.838 | 0.641 | 0.472 | 1e-103 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.838 | 0.641 | 0.469 | 1e-102 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.791 | 0.586 | 0.496 | 1e-102 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.818 | 0.395 | 0.491 | 1e-101 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.809 | 0.631 | 0.488 | 1e-96 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.809 | 0.740 | 0.472 | 1e-96 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.762 | 0.379 | 0.445 | 3e-87 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 311/445 (69%), Positives = 351/445 (78%), Gaps = 15/445 (3%)
Query: 11 SDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPEN--LSLKPHRSSDFAYSAIRS 68
SD +T + S +ESCSSFSRLSF+ P S E LSLKPHRSSDFAY+ IR
Sbjct: 5 SDGEMSLGTTNSPISSGTESCSSFSRLSFDAPPSTIPEEESFLSLKPHRSSDFAYAEIRR 64
Query: 69 ATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE 128
+K GLTFRDF L RRIGAGDIGTVYLC L + R +AMKVV+KE L
Sbjct: 65 R---KKQGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESR----SSYFAMKVVDKEALA 117
Query: 129 KKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF 188
KKK+HRAEMEK ILKMLDHPFLPTLYAEFEAS+FSCIVME+CSGGDLHSLRH+QPH+RF
Sbjct: 118 LKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRF 177
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
SL+SARFYAAEVLVALEYLHMLGIIYRDLKPEN+LVRSDGHIMLSDFDLSLCS++I AVE
Sbjct: 178 SLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSDSIAAVE 237
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
S +SSPE RS R++ TRL+R R SKK+QTL P RLFVAEPV ARS SFVG
Sbjct: 238 SSSSSPENQQLRS---PRRF-TRLARLFQRVLRSKKVQTLEPTRLFVAEPVTARSGSFVG 293
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ 368
THEYV+PEVASGGSHGNAVDWWAFG+F+YEMIYG+TPF AP+N+ LRNIVK+ L+FPT
Sbjct: 294 THEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTD 353
Query: 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGM 428
SP++M E HAR+LISGLLNKDP RLGS+RGAA+VK HPFFKGLNFALIR+LTPPEIP
Sbjct: 354 SPATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALIRTLTPPEIPSS 413
Query: 429 RRQKTMPFPDQKIKSQS--TAFDYF 451
+K M +S + AFDYF
Sbjct: 414 VVKKPMKSATFSGRSSNKPAAFDYF 438
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1192), Expect = e-130, Method: Compositional matrix adjust.
Identities = 238/409 (58%), Positives = 294/409 (71%), Gaps = 25/409 (6%)
Query: 31 CSSFSRLSFEL---------PTSKSSPE-NLSLKPHRSSDFAYSAIRSATFGRKTGLTFR 80
CSS SRLSF+ TS S P ++ L+PHRS D A++AIR+A+ L R
Sbjct: 50 CSSLSRLSFDCSPSAAVAAAATSCSPPRASVLLRPHRSGDVAWAAIRAASTTSAAPLGPR 109
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF L RRIG GDIGTVYLC L R E C+YAMKVV++ + +K+K+ RA EK
Sbjct: 110 DFKLVRRIGGGDIGTVYLCRL----RSSPERESPCMYAMKVVDRRAVARKQKLGRAAAEK 165
Query: 141 KILKMLDHPFLPTLYAEFEAS-NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+IL+ LDHPFLPTL+A+F+A+ +FSC VMEFC GGDLHSLRH+ P +RF L SARFYAAE
Sbjct: 166 RILRQLDHPFLPTLFADFDATPHFSCAVMEFCPGGDLHSLRHRMPSRRFPLPSARFYAAE 225
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
VL+A+EYLHM+GI+YRDLKPENVL+R+DGHIML+DFDLSL S P+++ + + AS
Sbjct: 226 VLLAIEYLHMMGIVYRDLKPENVLIRADGHIMLTDFDLSLQSTTSPSLDGDTDTDDEASG 285
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+ + L RF R + P FVAEPV ARSCSFVGTHEYV+PEVAS
Sbjct: 286 GASCFPDH----LLRFKRR-----RNAVAAPRPRFVAEPVDARSCSFVGTHEYVAPEVAS 336
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS-SMSEYHA 378
GG+HG AVDWWA+G+F+YE+IYGRTPFA +NE TLRNIV++PL FP+ S S ++ A
Sbjct: 337 GGAHGAAVDWWAYGVFLYELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADA 396
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427
RDLI+ LL KDP RLGS+RGAADVK+HPFFK LN AL+RS PP +PG
Sbjct: 397 RDLIARLLAKDPAARLGSRRGAADVKSHPFFKSLNLALLRSSRPPVVPG 445
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-105, Method: Compositional matrix adjust.
Identities = 228/490 (46%), Positives = 294/490 (60%), Gaps = 86/490 (17%)
Query: 4 DSDFEPPSDA--TTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDF 61
+SD+E + ++R TS +SS +S SCSS S LS S + KPH+++
Sbjct: 12 ESDYESSTVGPDSSRRTSWLSSSFTASPSCSSISHLSNHGLNSYNQS-----KPHKANQV 66
Query: 62 AYSAIRSA--TFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAM 119
A+ A+ GR GL F L +R+G+GDIG+VYLC Q RG YAM
Sbjct: 67 AWEAMARLRRCCGRAVGL--EHFRLLKRLGSGDIGSVYLC-------QIRGSPETAFYAM 117
Query: 120 KVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL 179
KVV+KE + KKK+ RAEMEKKIL MLDHPF PTLYA FEAS++S +VME+C GGDL+++
Sbjct: 118 KVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAV 177
Query: 180 RHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239
R +QP KRF+++S RFYAAE LVALEYLHM+GI+YRDLKPENVL+R DGH+MLSDFDLS
Sbjct: 178 RLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSF 237
Query: 240 ------------------------------CS---------NAIPAVESPASSPE----- 255
CS N + + SP SS
Sbjct: 238 KCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTPSCTTTPLNPVISCFSPTSSRRRKKNV 297
Query: 256 ------------AASPRSQTYTRQYS---TRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300
+ S +S +R +S + SR N G + I P+ AEP+
Sbjct: 298 VTTTIHENAAGTSDSVKSNDVSRTFSRSPSSCSRVSN---GLRDISGGCPS--IFAEPIN 352
Query: 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK 360
ARS SFVGTHEY++PEV SG HG+AVDWW +GIF+YEMI+GRTPF +NE TL NI+K
Sbjct: 353 ARSKSFVGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILK 412
Query: 361 KPLTFPTQSPSSMSEY----HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416
PLTFP +S EY +A+DLI LL K+P RLGS +G+ ++K H FF+G+N+AL
Sbjct: 413 APLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWAL 472
Query: 417 IRSLTPPEIP 426
IRS+ PP +P
Sbjct: 473 IRSIKPPWVP 482
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-103, Method: Compositional matrix adjust.
Identities = 203/430 (47%), Positives = 262/430 (60%), Gaps = 52/430 (12%)
Query: 21 ANSSSMSSES-CSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTF 79
+ SS +S ES CSS S ++ KPH+++D + AI+ R L
Sbjct: 149 STSSDVSDESACSSISSVT---------------KPHKANDSRWEAIQ-MIRTRDGILGL 192
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
F L +++G GDIG+VYL LN +AMKV++K L +KK+ RA+ E
Sbjct: 193 SHFKLLKKLGCGDIGSVYLSELNGTKS---------YFAMKVMDKASLASRKKLLRAQTE 243
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
K+IL+ LDHPFLPTLY FE FSC+VMEFC GGDLH+LR +Q K F + +FY AE
Sbjct: 244 KEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAE 303
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL-CSNAIPAVESPASSPEAAS 258
+L+A+EYLHMLGIIYRDLKPENVLVR DGHIMLSDFDLSL C+ + + S EA
Sbjct: 304 ILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALR 363
Query: 259 PRSQTYTRQ-------------YSTRLSRFLNRFFGSKK---------IQTLTPNRLFVA 296
+Q Y Q +T + F RFF K + ++P +A
Sbjct: 364 KNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIA 423
Query: 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
EP ARS SFVGTHEY++PE+ G HG+AVDWW FGIF+YE+++G+TPF N TL
Sbjct: 424 EPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 483
Query: 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416
N++ +PL FP S S ARDLI GLL K+P RLG KRGA ++K HPFF+G+N+AL
Sbjct: 484 NVIGQPLRFPEYPVVSFS---ARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWAL 540
Query: 417 IRSLTPPEIP 426
IR +PPE+P
Sbjct: 541 IRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 372 bits (956), Expect = e-102, Method: Compositional matrix adjust.
Identities = 202/430 (46%), Positives = 262/430 (60%), Gaps = 52/430 (12%)
Query: 21 ANSSSMSSES-CSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTF 79
+ SS +S ES CSS S ++ KPH+++D + AI+ R L
Sbjct: 149 STSSDVSDESACSSISSVT---------------KPHKANDSRWEAIQ-MIRTRDGILGL 192
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
F L +++G GDIG+VYL L+ +AMKV++K L +KK+ RA+ E
Sbjct: 193 SHFKLLKKLGCGDIGSVYLSELSGTKS---------YFAMKVMDKASLASRKKLLRAQTE 243
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
K+IL+ LDHPFLPTLY FE FSC+VMEFC GGDLH+LR +Q K F + +FY AE
Sbjct: 244 KEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAE 303
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL-CSNAIPAVESPASSPEAAS 258
+L+A+EYLHMLGIIYRDLKPENVLVR DGHIMLSDFDLSL C+ + + S EA
Sbjct: 304 ILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALR 363
Query: 259 PRSQTYTRQ-------------YSTRLSRFLNRFFGSKK---------IQTLTPNRLFVA 296
+Q Y Q +T + F RFF K + ++P +A
Sbjct: 364 KNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIA 423
Query: 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
EP ARS SFVGTHEY++PE+ G HG+AVDWW FGIF+YE+++G+TPF N TL
Sbjct: 424 EPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 483
Query: 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416
N++ +PL FP S S ARDLI GLL K+P RLG KRGA ++K HPFF+G+N+AL
Sbjct: 484 NVIGQPLRFPEYPVVSFS---ARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWAL 540
Query: 417 IRSLTPPEIP 426
IR +PPE+P
Sbjct: 541 IRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 371 bits (952), Expect = e-102, Method: Compositional matrix adjust.
Identities = 197/397 (49%), Positives = 251/397 (63%), Gaps = 40/397 (10%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KPH+++D + AI+ A R L R F L +++G GDIG+VYL L+
Sbjct: 202 KPHKANDIRWEAIQ-AVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTS------ 254
Query: 114 CCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
+AMKV+NK L +KK+ RA+ E++IL+ LDHPFLPTLY FE FSC+VMEFC G
Sbjct: 255 ---FAMKVMNKTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPG 311
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDLH+LR +QP K FS + RFY AEVL++LEYLHMLGIIYRDLKPENVLVR DGHIMLS
Sbjct: 312 GDLHALRQRQPGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLS 371
Query: 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYS------------TRLSRFLNRFFG 281
DFDLSL + P + S +S Y Q S + S F RF
Sbjct: 372 DFDLSLRCSVSPTL---VKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLS 428
Query: 282 SKKI------------QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDW 329
K +TP +AEP ARS SFVGTHEY++PE+ G HG+AVDW
Sbjct: 429 GKSKKDKKSKPKNDMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDW 488
Query: 330 WAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389
W FGIF+YE+++GRTPF +N TL N++ +PL FP +SP+ + ARDLI GLL K+
Sbjct: 489 WTFGIFLYELLFGRTPFKGSANRATLFNVIGQPLRFP-ESPT--VSFAARDLIRGLLVKE 545
Query: 390 PCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
P +RL +RGA ++K HPFF+ +N+ALIR TPPE+P
Sbjct: 546 PQHRLAYRRGATEIKQHPFFQNVNWALIRCATPPEVP 582
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 205/417 (49%), Positives = 262/417 (62%), Gaps = 48/417 (11%)
Query: 43 TSKSSPENLSL-----KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVY 97
TS S NLS KPH S D + AI+ + L R F+L +++G GDIGTVY
Sbjct: 495 TSISEESNLSRFSCGNKPHMSMDVRWEAIKHIKV-QYGSLGLRHFNLLKKLGCGDIGTVY 553
Query: 98 LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157
L L CL+A+KV++ E L ++KK RA+ E++ILKMLDHPFLPTLYA+
Sbjct: 554 LAELIGTN---------CLFAIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQ 604
Query: 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDL 217
F + N SC+VME+C GGDLH LR KQ + F +ARFY AE+L+ALEYLHMLGIIYRDL
Sbjct: 605 FTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDL 664
Query: 218 KPENVLVRSDGHIMLSDFDLSL-C--------SNAIPAVESPA--SSPEAASPRSQTY-T 265
KPEN+LVR DGHIML+DFDLSL C SN+ P + PA S P S Q +
Sbjct: 665 KPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNSPPG-KDPARISGPYNTSNCIQPFCI 723
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNR----------------LFVAEPVAARSCSFVGT 309
+ S ++S F R S + Q P R VAEP ARS SFVGT
Sbjct: 724 TEPSCQVSCFSPRL-SSNQQQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGT 782
Query: 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS 369
HEY++PE+ G HG AVDWW FG+ +YE++YG+TPF +N+ TL N+V + L FP
Sbjct: 783 HEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPD-- 840
Query: 370 PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
S + + A+DLI GLL K+P NRLGS++G+ ++K HPFF+GLN+ALIR PPE+P
Sbjct: 841 -SPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELP 896
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 194/397 (48%), Positives = 249/397 (62%), Gaps = 32/397 (8%)
Query: 50 NLSLKPHR-SSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQD 108
N + KPHR ++D + AI+ + L +DF L +++G GDIG VYL L
Sbjct: 149 NAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGT---- 204
Query: 109 RGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVM 168
+A+KV+ K + +KK+ RA+ EK+IL+ LDHPFLPTLY+ FE SC+VM
Sbjct: 205 -----GVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVM 259
Query: 169 EFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
EFC GGDLHSLR KQ K F +ARFY AEVL+A+EYLHMLGIIYRDLKPENVLVR DG
Sbjct: 260 EFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDG 319
Query: 229 HIMLSDFDLSLCSNAIP--------AVESPASS-------PEAASPRSQTYTRQYSTRLS 273
HIMLSDFDLSL P +ES +SS + +S Q Q
Sbjct: 320 HIMLSDFDLSLRCAVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTP 379
Query: 274 RFLNRFFGSKKIQTLT----PNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDW 329
RFL++ KK ++ P +AEP +ARS SFVGTHEY++PE+ G HG+AVDW
Sbjct: 380 RFLSKGKHRKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDW 439
Query: 330 WAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389
W FGIF+YE+++G TPF N TL N+V +PL FP S + ARDLI GLL K+
Sbjct: 440 WTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVS---FAARDLIRGLLVKE 496
Query: 390 PCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
P +RL +RGA ++K HPFF+ +N+ALIR +PP+IP
Sbjct: 497 PQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIP 533
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 191/404 (47%), Positives = 252/404 (62%), Gaps = 39/404 (9%)
Query: 54 KPHRSSDFAYSAIRSATFGR-KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHE 112
KPH+++ + AIR G + GL F L RR+G+GD+G VYLC L +
Sbjct: 53 KPHKANQAEWEAIRRLRAGAGRVGL--EHFRLVRRLGSGDLGNVYLCRLREPWSSSSMTT 110
Query: 113 PC--CLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEF 170
CLYAMKVV+K+ L +KK+ RAE+E+ IL+ LDHPFLPTLYA+FEAS+++C+VMEF
Sbjct: 111 TAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLVMEF 170
Query: 171 CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230
C GGDLH R +QP +RF+++S RFY AE ++ALEYLHM+G++YRDLKPENVLVR DGHI
Sbjct: 171 CPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGDGHI 230
Query: 231 MLSDFDLSLCSNAI-----PAVESPASSPEAASPRSQTYTRQYSTRLS---RFLNRFFGS 282
MLSDFDLSL + + PA + A P S LS R +++ +
Sbjct: 231 MLSDFDLSLKCDVVPKLLRPARSAAAGGKPPLPPPSSCVPPTIQPVLSCIFRGVHKCHHA 290
Query: 283 KKIQTLTPNRLFVAEPVAA---------------------RSCSFVGTHEYVSPEVASGG 321
K+ + RS SFVGTHEY++PEV SG
Sbjct: 291 KECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYLAPEVISGQ 350
Query: 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP-TQSPSSMSEYH--- 377
HG+AVDWW G+F+YEM+YGRTPF SNE TL NI+K+P+TFP ++ E+
Sbjct: 351 GHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAAAGEWEEMK 410
Query: 378 -ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420
A+DL+ LL K+P RLGS G+A+VK HPFFKG+N+AL+RS+
Sbjct: 411 TAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVRSV 454
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 176/395 (44%), Positives = 243/395 (61%), Gaps = 51/395 (12%)
Query: 40 ELPTSKSSPENL--------SLKPHRSSDFAYSAIRSAT-FGRKTGLTFRDFDLHRRIGA 90
ELP + PE+L S KPH+ ++ ++ AI AT G K GL + F + +G
Sbjct: 527 ELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEKATNLGEKIGL--KHFKPVKPLGC 584
Query: 91 GDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF 150
GD G+V+L L Q G L+AMK ++K V+ + KVHRA +E++I +LDHPF
Sbjct: 585 GDTGSVHLVEL-----QGSGE----LFAMKAMDKSVMLNRNKVHRACIEREIYALLDHPF 635
Query: 151 LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML 210
LPTLY F+ C++ +FC GG+L ++ +QP K F ARFYAAEV++ LEYLH L
Sbjct: 636 LPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAAEVVIGLEYLHCL 695
Query: 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYST 270
GIIYRDLKPEN+L+++DGHI+L+DFDLS + + P V + ST
Sbjct: 696 GIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHV------------------IKNST 737
Query: 271 RLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWW 330
L R ++ F L P FV+EP + S SFVGT EY++PEV +G H +A+DWW
Sbjct: 738 SLKRRRSQEF-------LPPT--FVSEP-STPSNSFVGTEEYIAPEVITGAGHTSAIDWW 787
Query: 331 AFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390
A GI +YEM+YGRTPF + + T NI+ K LTFP+ P S++ A+ LI GLL +DP
Sbjct: 788 ALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLA---AKQLIHGLLQRDP 844
Query: 391 CNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425
NR+GS GA D+K H FF+ +N+ LIR ++PPE+
Sbjct: 845 SNRIGSNAGANDIKQHSFFQDINWPLIRCMSPPEL 879
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 451 | ||||||
| 255571312 | 465 | serine/threonine protein kinase, putativ | 0.917 | 0.890 | 0.776 | 0.0 | |
| 356549120 | 442 | PREDICTED: protein kinase PINOID-like [G | 0.951 | 0.970 | 0.733 | 1e-180 | |
| 449435508 | 474 | PREDICTED: protein kinase PINOID-like [C | 0.913 | 0.869 | 0.729 | 1e-179 | |
| 15226800 | 438 | protein kinase-like protein [Arabidopsis | 0.953 | 0.981 | 0.698 | 1e-172 | |
| 225443982 | 451 | PREDICTED: protein kinase PINOID [Vitis | 0.895 | 0.895 | 0.727 | 1e-172 | |
| 357519467 | 456 | Protein kinase G11A [Medicago truncatula | 0.873 | 0.864 | 0.741 | 1e-171 | |
| 297826931 | 441 | hypothetical protein ARALYDRAFT_321182 [ | 0.949 | 0.970 | 0.688 | 1e-170 | |
| 1935918 | 439 | putative serine/threonine protein kinase | 0.951 | 0.977 | 0.683 | 1e-170 | |
| 356528424 | 460 | PREDICTED: protein kinase PINOID-like [G | 0.911 | 0.893 | 0.711 | 1e-166 | |
| 45271576 | 445 | serine/threonine protein kinase [Pisum s | 0.944 | 0.957 | 0.688 | 1e-165 |
| >gi|255571312|ref|XP_002526605.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223534045|gb|EEF35764.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/429 (77%), Positives = 370/429 (86%), Gaps = 15/429 (3%)
Query: 36 RLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGT 95
RLSFEL T++SSPENL+LKPHRSSD AYSAIRSATF RKTGLTFRDF L RRIG+GDIGT
Sbjct: 39 RLSFELLTARSSPENLTLKPHRSSDSAYSAIRSATFRRKTGLTFRDFRLIRRIGSGDIGT 98
Query: 96 VYLCSLNNKYRQDRGHE------------PCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
VYLC L K+ + C YAMKVV+KE L+ KKKVHRAEME+KIL
Sbjct: 99 VYLCRLTRKHNNQEEDDDFEDDHDDDDDEKLCFYAMKVVDKEALQVKKKVHRAEMERKIL 158
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
KMLDHPFLP+LYAEFEAS+FSCIVME+CSGGDL SLRHKQP+KRFSL+SARFYAAEVLVA
Sbjct: 159 KMLDHPFLPSLYAEFEASHFSCIVMEYCSGGDLLSLRHKQPYKRFSLSSARFYAAEVLVA 218
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS+AIPAVESP+ SP++ SP S
Sbjct: 219 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSDAIPAVESPSLSPDSTSPSSLP 278
Query: 264 YTRQYSTR-LSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322
Y R +S++ S LNR F SKKIQTL PNRLFVAEPV+ARSCSFVGTHEYV+PEVASGGS
Sbjct: 279 YARSHSSKTFSCLLNRLFRSKKIQTLCPNRLFVAEPVSARSCSFVGTHEYVAPEVASGGS 338
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382
HGNAVDWWAFGIFIYE++YGRTPFAAPSNE TLRNIVKKPL+FPT SPSS E HAR+LI
Sbjct: 339 HGNAVDWWAFGIFIYELMYGRTPFAAPSNEQTLRNIVKKPLSFPTHSPSSSLESHARNLI 398
Query: 383 SGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIK 442
SGLLNKDP +RLG+KRG+ADVKTHPFFKGLNFALIR++TPP++PG+RRQ+T PF + K
Sbjct: 399 SGLLNKDPNSRLGTKRGSADVKTHPFFKGLNFALIRTVTPPQVPGLRRQRTTPFYQGQPK 458
Query: 443 SQSTAFDYF 451
STAFDYF
Sbjct: 459 --STAFDYF 465
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549120|ref|XP_003542945.1| PREDICTED: protein kinase PINOID-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1641), Expect = e-180, Method: Compositional matrix adjust.
Identities = 322/439 (73%), Positives = 354/439 (80%), Gaps = 10/439 (2%)
Query: 19 STANSSSMSSES-CS-SFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTG 76
S+ +SMS+ES CS SFSRLSF+LP SSPE L +KPHRSSDFAYSAI RK+
Sbjct: 8 SSTQRTSMSNESVCSTSFSRLSFDLPPPSSSPETLFVKPHRSSDFAYSAI----LRRKSA 63
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
LTFRDF L RRIGAGDIGTVYLC L + + E C YAMKVV+KE + KKK RA
Sbjct: 64 LTFRDFHLLRRIGAGDIGTVYLCRLRHDAGDEDDDEDPCFYAMKVVDKEAVALKKKAQRA 123
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
EME+KILKM+DHPFLPTLYAEFEASNFSCIVME+CSGGDLHSL+H P+ RFSL+SARFY
Sbjct: 124 EMERKILKMVDHPFLPTLYAEFEASNFSCIVMEYCSGGDLHSLQHNHPNNRFSLSSARFY 183
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS+AIPAVESP S +
Sbjct: 184 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSDAIPAVESPDCSLDP 243
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
A + YTRQYST S NR F S+K+QTL PNRLFVAEPV ARSCSFVGTHEYVSPE
Sbjct: 244 AFAPALRYTRQYSTPFSCLSNRVFRSRKVQTLQPNRLFVAEPVGARSCSFVGTHEYVSPE 303
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
VASG SHGNAVDWW+FGIFIYEM+YGRTPFA SNE TLR+I+KKPL FPT +PSS E
Sbjct: 304 VASGNSHGNAVDWWSFGIFIYEMVYGRTPFAGSSNEATLRSIIKKPLAFPTSTPSSTLEM 363
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPF 436
HARDLISGLLNKDP RLGSKRG+ADVK HPFF GLN ALIR++TPPE+P +RR KT PF
Sbjct: 364 HARDLISGLLNKDPNRRLGSKRGSADVKKHPFFAGLNLALIRTVTPPEVPSLRRHKTTPF 423
Query: 437 ----PDQKIKSQSTAFDYF 451
+ Q TAFDYF
Sbjct: 424 YYPANVNNSRQQLTAFDYF 442
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435508|ref|XP_004135537.1| PREDICTED: protein kinase PINOID-like [Cucumis sativus] gi|449531119|ref|XP_004172535.1| PREDICTED: protein kinase PINOID-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1635), Expect = e-179, Method: Compositional matrix adjust.
Identities = 327/448 (72%), Positives = 353/448 (78%), Gaps = 36/448 (8%)
Query: 36 RLSFE----LPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAG 91
RLSF+ LPTS+SSP +L LKPHRSSDFAYSAIR RK+ LTFRDF L RRIGAG
Sbjct: 31 RLSFDAAIDLPTSRSSPASLHLKPHRSSDFAYSAIRR----RKSKLTFRDFRLLRRIGAG 86
Query: 92 DIGTVYLCSLNNKYR-----------------QDRGHEPCCLYAMKVVNKEVLEKKKKVH 134
DIGTVYLC L N + D + CLYAMKVV+K+ LE KKKV
Sbjct: 87 DIGTVYLCQLRNLSKGCCYEDEDDEDDDVDDEDDDDDDVSCLYAMKVVDKDALELKKKVQ 146
Query: 135 RAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
RAEME+KILKMLDHPFLPTLYAEFEAS+FSCIVMEFCSGGDLHSLRHKQP KRFSLTSAR
Sbjct: 147 RAEMERKILKMLDHPFLPTLYAEFEASHFSCIVMEFCSGGDLHSLRHKQPRKRFSLTSAR 206
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS+A PAVESP SSP
Sbjct: 207 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSDATPAVESPNSSP 266
Query: 255 EAASPRSQTYTRQYSTR-------LSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
A S Y + S NR F S+K+QTL+PN LFVAEPV+ARSCSFV
Sbjct: 267 NTAFHESTAYPKTNVAVSAASAAPFSCLYNRLFRSRKVQTLSPNWLFVAEPVSARSCSFV 326
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
GTHEYVSPEVA+GGSHGNAVDWWAFGIF+YE+IYGRTPFAA SNETTLR+I+KKPLTFPT
Sbjct: 327 GTHEYVSPEVAAGGSHGNAVDWWAFGIFLYELIYGRTPFAASSNETTLRSIIKKPLTFPT 386
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427
PS E+HARDLISGLLNKDP RLGSKRG+AD+K HPFFKGLNFALIRSLTPPEIPG
Sbjct: 387 AVPSGALEHHARDLISGLLNKDPTRRLGSKRGSADIKKHPFFKGLNFALIRSLTPPEIPG 446
Query: 428 MRRQKTMPFPDQKIK----SQSTAFDYF 451
+RR+K P P K K QST FDYF
Sbjct: 447 VRRRKATPAPVAKTKDQKSGQSTGFDYF 474
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15226800|ref|NP_181012.1| protein kinase-like protein [Arabidopsis thaliana] gi|75219833|sp|O64682.1|PID_ARATH RecName: Full=Protein kinase PINOID; AltName: Full=Protein kinase ABRUPTUS gi|3128224|gb|AAC26704.1| putative protein kinase [Arabidopsis thaliana] gi|7208442|gb|AAF40202.1| protein kinase PINOID [Arabidopsis thaliana] gi|330253909|gb|AEC09003.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 311/445 (69%), Positives = 351/445 (78%), Gaps = 15/445 (3%)
Query: 11 SDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPEN--LSLKPHRSSDFAYSAIRS 68
SD +T + S +ESCSSFSRLSF+ P S E LSLKPHRSSDFAY+ IR
Sbjct: 5 SDGEMSLGTTNSPISSGTESCSSFSRLSFDAPPSTIPEEESFLSLKPHRSSDFAYAEIRR 64
Query: 69 ATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE 128
+K GLTFRDF L RRIGAGDIGTVYLC L + R +AMKVV+KE L
Sbjct: 65 R---KKQGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESR----SSYFAMKVVDKEALA 117
Query: 129 KKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF 188
KKK+HRAEMEK ILKMLDHPFLPTLYAEFEAS+FSCIVME+CSGGDLHSLRH+QPH+RF
Sbjct: 118 LKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRF 177
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
SL+SARFYAAEVLVALEYLHMLGIIYRDLKPEN+LVRSDGHIMLSDFDLSLCS++I AVE
Sbjct: 178 SLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSDSIAAVE 237
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
S +SSPE RS R++ TRL+R R SKK+QTL P RLFVAEPV ARS SFVG
Sbjct: 238 SSSSSPENQQLRS---PRRF-TRLARLFQRVLRSKKVQTLEPTRLFVAEPVTARSGSFVG 293
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ 368
THEYV+PEVASGGSHGNAVDWWAFG+F+YEMIYG+TPF AP+N+ LRNIVK+ L+FPT
Sbjct: 294 THEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTD 353
Query: 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGM 428
SP++M E HAR+LISGLLNKDP RLGS+RGAA+VK HPFFKGLNFALIR+LTPPEIP
Sbjct: 354 SPATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALIRTLTPPEIPSS 413
Query: 429 RRQKTMPFPDQKIKSQS--TAFDYF 451
+K M +S + AFDYF
Sbjct: 414 VVKKPMKSATFSGRSSNKPAAFDYF 438
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443982|ref|XP_002274153.1| PREDICTED: protein kinase PINOID [Vitis vinifera] gi|147828664|emb|CAN62073.1| hypothetical protein VITISV_032865 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 317/436 (72%), Positives = 350/436 (80%), Gaps = 32/436 (7%)
Query: 33 SFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGD 92
SFSRLSFE SPENL+LKPHRSSD AY AIRSA F RK+GL+FRDF L RRIG+GD
Sbjct: 31 SFSRLSFE-----HSPENLTLKPHRSSDSAYEAIRSAAFSRKSGLSFRDFKLVRRIGSGD 85
Query: 93 IGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP 152
IGTVYLC L + D C YAMKVV+KE L KKK+ RAEMEK+ILKMLDHPFLP
Sbjct: 86 IGTVYLCRLRSSSDDD-----GCFYAMKVVDKETLAMKKKIQRAEMEKRILKMLDHPFLP 140
Query: 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGI 212
TLYAEFEAS+FS IVME+CSGGDLHSL+HKQP KRFSL+SARFYAAEVLVALEYLHMLGI
Sbjct: 141 TLYAEFEASHFSGIVMEYCSGGDLHSLKHKQPQKRFSLSSARFYAAEVLVALEYLHMLGI 200
Query: 213 IYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRL 272
IYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP SP++ SP S R S
Sbjct: 201 IYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPDFSPDSPSPASPPNCRTPSP-- 258
Query: 273 SRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAF 332
+ F S+K+QTL+ NRLFVAEPV+A+SCSFVGTHEYVSPEVASG SHGN VDWWA
Sbjct: 259 ---FSCLFRSRKVQTLSINRLFVAEPVSAKSCSFVGTHEYVSPEVASGRSHGNGVDWWAL 315
Query: 333 GIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392
GIFIYEM+YG TPFA +NE TLRNIVKKPL+FPT++P+S+SE HARDL+SGLL KDP +
Sbjct: 316 GIFIYEMVYGATPFAGATNEATLRNIVKKPLSFPTETPASVSEMHARDLMSGLLVKDPAS 375
Query: 393 RLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPF-PDQKIKSQ------- 444
RLGSKRGAADVKTHPFFKGLNFAL+RSLTPPEIPG+RR KT F PD ++
Sbjct: 376 RLGSKRGAADVKTHPFFKGLNFALVRSLTPPEIPGLRRHKTPSFRPDSANSNKGRYHHQQ 435
Query: 445 ---------STAFDYF 451
STAFDYF
Sbjct: 436 QQQQQQQQQSTAFDYF 451
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357519467|ref|XP_003630022.1| Protein kinase G11A [Medicago truncatula] gi|355524044|gb|AET04498.1| Protein kinase G11A [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1562), Expect = e-171, Method: Compositional matrix adjust.
Identities = 304/410 (74%), Positives = 343/410 (83%), Gaps = 16/410 (3%)
Query: 32 SSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAG 91
+SFSRLSF+L SPE+LSLKPHRSSDFAYSAIR RK+ LTFRDF L RRIGAG
Sbjct: 32 TSFSRLSFDL--LPPSPESLSLKPHRSSDFAYSAIR-----RKSALTFRDFHLLRRIGAG 84
Query: 92 DIGTVYLCSL---NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH 148
DIGTVYLC L N+K++ + + CLYAMKVV+K+V+ KKK HRAEME+KILKMLDH
Sbjct: 85 DIGTVYLCRLRNGNDKFKNEEDN--TCLYAMKVVDKDVVALKKKSHRAEMERKILKMLDH 142
Query: 149 PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH 208
PFLPTLYAEFEAS+FSCIVMEFCSGGDLHS+RHK PH R L SARFYAA+VLVALEYLH
Sbjct: 143 PFLPTLYAEFEASHFSCIVMEFCSGGDLHSIRHKHPHNRLPLISARFYAAQVLVALEYLH 202
Query: 209 MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQ---TYT 265
MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES + ++++ S T +
Sbjct: 203 MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESSDNLQDSSTFSSTLPYTRS 262
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
R + T + F NR F S+K+QT+ PNRLFVAEPV+ARSCSFVGTHEYVSPEVA+G SHGN
Sbjct: 263 RSFPTPFTCFSNRLFKSRKVQTVQPNRLFVAEPVSARSCSFVGTHEYVSPEVAAGNSHGN 322
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385
AVDWW+FGIFIYE++YGRTPFAAPSN+ TLRNI+KKPLTFPT + SS E HARDLISGL
Sbjct: 323 AVDWWSFGIFIYELVYGRTPFAAPSNKETLRNILKKPLTFPTPTASSALELHARDLISGL 382
Query: 386 LNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI-PGMRRQKTM 434
LNKDP RLGSKRG+ADVK H FFKG+N ALIR LTPPE+ PG R+ KTM
Sbjct: 383 LNKDPTQRLGSKRGSADVKQHSFFKGINLALIRMLTPPEVPPGSRKPKTM 432
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297826931|ref|XP_002881348.1| hypothetical protein ARALYDRAFT_321182 [Arabidopsis lyrata subsp. lyrata] gi|297327187|gb|EFH57607.1| hypothetical protein ARALYDRAFT_321182 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-170, Method: Compositional matrix adjust.
Identities = 310/450 (68%), Positives = 353/450 (78%), Gaps = 22/450 (4%)
Query: 11 SDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSS--PEN---LSLKPHRSSDFAYSA 65
SD +T + S +ESCSSFSRLSF+ P S ++ PE LSLKPHRSSDFAY+
Sbjct: 5 SDGEMSLGTTNSPISSGTESCSSFSRLSFDAPPSTTAIIPEEESFLSLKPHRSSDFAYAE 64
Query: 66 IRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE 125
IR +K GLTFRDF L RRIGAGDIGTVYLC L + R +AMKVV+KE
Sbjct: 65 IRRR---KKHGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESR----SSYFAMKVVDKE 117
Query: 126 VLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH 185
L KKK+HRAEMEK ILKMLDHPFLPTLYAEFEAS+FSCIVME+CSGGDLHSLRH+QP
Sbjct: 118 ALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPT 177
Query: 186 KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+RFSL+SARFYAAEVLVALEYLHMLGIIYRDLKPEN+LVRSDGHIMLSDFDLSLCS++I
Sbjct: 178 RRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSLCSDSIA 237
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
AVES +SSPE RS + TRL+R +R SKK+QTL PNRLFVAEPV ARS S
Sbjct: 238 AVESTSSSPENHQLRSP----RRLTRLARLFHRVMRSKKVQTLEPNRLFVAEPVTARSGS 293
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF 365
FVGTHEYV+PEVASGGSHGNAVDWWAFG+F+YEMIYG+TPF AP+N+ LRNIVK+ L+F
Sbjct: 294 FVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNIVKRQLSF 353
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425
PT SP++M E HAR+LISGLL KDP RLGS+RGAA+VK HPFFKGLNFALIR+LTPPEI
Sbjct: 354 PTDSPATMFELHARNLISGLLTKDPTKRLGSRRGAAEVKVHPFFKGLNFALIRTLTPPEI 413
Query: 426 PGMRRQKTMPFPDQKIKSQST----AFDYF 451
P +K P + +S+ AFDYF
Sbjct: 414 PSSVVKK--PMKSARFGGRSSNKPAAFDYF 441
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1935918|gb|AAB54117.1| putative serine/threonine protein kinase [Brassica rapa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1559), Expect = e-170, Method: Compositional matrix adjust.
Identities = 315/461 (68%), Positives = 364/461 (78%), Gaps = 32/461 (6%)
Query: 1 MLIDSDFEPPSDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSS--PEN---LSLKP 55
ML++SD E + TT++ SS +ESCSSFSRLSF+ P S ++ PE LSLKP
Sbjct: 1 MLLESDGE----MSLETTNSPISSG--TESCSSFSRLSFDAPPSTTAIIPEEESCLSLKP 54
Query: 56 HRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCC 115
HRSSDFAY+ I RK LTFRDF L RRIGAGDIGTVYLC L + R
Sbjct: 55 HRSSDFAYAEILRR---RKHSLTFRDFRLMRRIGAGDIGTVYLCRLAGDQEESRS----S 107
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGD 175
+AMKVV+ E L KKK+HRAEMEKKILKMLDHPFLP+LYAEFEAS+FSCIVME+CSGGD
Sbjct: 108 YFAMKVVDNEALAMKKKMHRAEMEKKILKMLDHPFLPSLYAEFEASHFSCIVMEYCSGGD 167
Query: 176 LHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
LHSLRH+QP RFSL+SARFYAAEVLVALEYLHMLGIIYRDLKPEN+LVRSDGHIMLSDF
Sbjct: 168 LHSLRHRQPQHRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDF 227
Query: 236 DLSLCSNAIPAVESPASSPEA---ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNR 292
DLSLCS++I AVES +S+PE +SPR T RL++ NR SKK+QTL PNR
Sbjct: 228 DLSLCSDSIAAVESSSSTPENYPHSSPRRLT-------RLAKLFNRVLRSKKVQTLEPNR 280
Query: 293 LFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE 352
LFVAEPV ARS SFVGTHEYV+PEVASGGSHGNAVDWWAFG+F+YE+IYGRTPFAAP+N+
Sbjct: 281 LFVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEIIYGRTPFAAPTND 340
Query: 353 TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
LRNIVK+PL+FPT SP++M E HAR LISGLLNKDP RLGS+RGAA+VK HPFFKGL
Sbjct: 341 VILRNIVKRPLSFPTDSPATMFELHARSLISGLLNKDPSTRLGSRRGAAEVKVHPFFKGL 400
Query: 413 NFALIRSLTPPEIPG-MRR-QKTMPFPDQKIKSQSTAFDYF 451
NFALIR++TPPE+P +RR +K+ F + S+ AFD+F
Sbjct: 401 NFALIRTMTPPEVPSDVRRPKKSATFGGR--SSKPAAFDFF 439
|
Source: Brassica rapa Species: Brassica rapa Genus: Brassica Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528424|ref|XP_003532803.1| PREDICTED: protein kinase PINOID-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 310/436 (71%), Positives = 344/436 (78%), Gaps = 25/436 (5%)
Query: 32 SSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAG 91
+SFSRLSF+L SPE LS+KPHRSSDFAYSA F RK LTFRDF L RRIGAG
Sbjct: 33 TSFSRLSFDL--LPPSPETLSIKPHRSSDFAYSA----AFRRKAALTFRDFHLLRRIGAG 86
Query: 92 DIGTVYLCSLNNKYR---QDRGHEPC-CLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
DIGTVYLC L+N + QD E CLYAMKVV+K+ + KKK RAEMEKKILKMLD
Sbjct: 87 DIGTVYLCRLHNSNQLKNQDEDEEDVSCLYAMKVVDKDAVALKKKSQRAEMEKKILKMLD 146
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPFLPTLYAEFEAS+FSCIVMEFCSGGDLHSLR K PH RF L+SARFYAAEVLVALEYL
Sbjct: 147 HPFLPTLYAEFEASHFSCIVMEFCSGGDLHSLRFKHPHNRFPLSSARFYAAEVLVALEYL 206
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES-PASSPEA-ASPRSQTYT 265
HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL S AIPAVES P S P + A P YT
Sbjct: 207 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLYSEAIPAVESSPDSLPSSNALPLPYAYT 266
Query: 266 RQYS--TRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH 323
R +S + S F NR S++++T+ PNRLFVAEPV+ARSCSFVGTHEYVSPEVASG SH
Sbjct: 267 RSHSFMSPFSCFSNR---SREVRTIEPNRLFVAEPVSARSCSFVGTHEYVSPEVASGRSH 323
Query: 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383
GNAVDWW+FG+FIYE+IYGRTP+A PS E TLRNIVKKPL FPT +P+S E HARDLIS
Sbjct: 324 GNAVDWWSFGVFIYELIYGRTPYAGPSKEATLRNIVKKPLAFPTATPTSNLELHARDLIS 383
Query: 384 GLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRR--QKTMPFP---- 437
GLLNKDP RLGSKRGAADVK HPFFKGLN ALIR TPPE+PG RR + T +P
Sbjct: 384 GLLNKDPARRLGSKRGAADVKKHPFFKGLNLALIRMQTPPEVPGSRRRTKTTSLYPVKGN 443
Query: 438 --DQKIKSQSTAFDYF 451
+ + Q+ +FD++
Sbjct: 444 GNNNHKQQQTASFDFY 459
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|45271576|gb|AAS57526.1| serine/threonine protein kinase [Pisum sativum] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 312/453 (68%), Positives = 346/453 (76%), Gaps = 27/453 (5%)
Query: 13 ATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFG 72
+ T T+ SS+ S +SFSRLSFEL S S E+LS+KPHRSSDFAYSAIR
Sbjct: 6 VNSNTQRTSLSSATESICSTSFSRLSFELLPSSSP-ESLSIKPHRSSDFAYSAIR----- 59
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNN---KYRQDRGHEPCCLYAMKVVNKEVLEK 129
K+GLTFRDF L RRIG+GDIGTVYLC L + Y D + YAMKVV+K+ +
Sbjct: 60 -KSGLTFRDFHLLRRIGSGDIGTVYLCRLRDSSVNYINDE--DSSFYYAMKVVDKDAVAL 116
Query: 130 KKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFS 189
KKK HRAEME+KILKMLDHPFLP+LYAEFEASNFSCIVMEFCSGGDLHSLRH+ P RFS
Sbjct: 117 KKKSHRAEMERKILKMLDHPFLPSLYAEFEASNFSCIVMEFCSGGDLHSLRHRHPRNRFS 176
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
L+SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS+AIPAVE
Sbjct: 177 LSSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSHAIPAVEL 236
Query: 250 PASSPEAASPRSQTYTRQYSTR--LSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
P P + TR +S R F S+K+QT NRLFVAEPV ARSCSFV
Sbjct: 237 SPDDP----PLDVSCTRPHSISSPFKCLSKRLFRSRKVQTFQSNRLFVAEPVEARSCSFV 292
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
GTHEYVSPEVASG SHGNAVDWW+FGIFIYEM+YGRTPFA PSNE TLRNI+KKPL+FPT
Sbjct: 293 GTHEYVSPEVASGNSHGNAVDWWSFGIFIYEMVYGRTPFAGPSNEATLRNIIKKPLSFPT 352
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427
+PSS E HARDLISGLLNKDP RLG KRGAADVK HPFF GLN ALIR +TPPE+PG
Sbjct: 353 ATPSSTLEMHARDLISGLLNKDPNRRLGLKRGAADVKMHPFFVGLNLALIRMVTPPEVPG 412
Query: 428 MRRQKTMPFPDQK---------IKSQSTAFDYF 451
+RR KT PF K + +++FDYF
Sbjct: 413 LRRNKTTPFVSGKDSNGNRSSSKQHPASSFDYF 445
|
Source: Pisum sativum Species: Pisum sativum Genus: Pisum Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 451 | ||||||
| TAIR|locus:2062268 | 438 | PID "PINOID" [Arabidopsis thal | 0.891 | 0.917 | 0.671 | 7e-141 | |
| UNIPROTKB|Q2QM77 | 484 | PID "Protein kinase PINOID" [O | 0.824 | 0.768 | 0.572 | 1.9e-108 | |
| UNIPROTKB|A6MW92 | 491 | bif2 "Barren inflorescence2" [ | 0.818 | 0.751 | 0.543 | 1.6e-104 | |
| TAIR|locus:2043813 | 525 | PID2 "PINOID2" [Arabidopsis th | 0.390 | 0.335 | 0.561 | 1e-92 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.394 | 0.357 | 0.550 | 1.1e-91 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.394 | 0.254 | 0.550 | 3e-91 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.392 | 0.349 | 0.552 | 3.8e-91 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.414 | 0.319 | 0.527 | 2.1e-90 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.394 | 0.232 | 0.544 | 5.2e-89 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.798 | 0.721 | 0.484 | 3.2e-88 |
| TAIR|locus:2062268 PID "PINOID" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
Identities = 280/417 (67%), Positives = 314/417 (75%)
Query: 39 FELPTSKSSPEN--LSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTV 96
F+ P S E LSLKPHRSSDFAY+ IR +K GLTFRDF L RRIGAGDIGTV
Sbjct: 33 FDAPPSTIPEEESFLSLKPHRSSDFAYAEIRRR---KKQGLTFRDFRLMRRIGAGDIGTV 89
Query: 97 YLCSLNNKYRQDRGHEPCCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYA 156
YLC L + R +AM HRAEMEK ILKMLDHPFLPTLYA
Sbjct: 90 YLCRLAGDEEESRSS----YFAMKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYA 145
Query: 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
EFEAS+FSCIVME+CSGGDLHSLRH+QPH+RFSL+SARFYAAEVLVALEYLHMLGIIYRD
Sbjct: 146 EFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRD 205
Query: 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIXXXXXXXXXXXXXXXRSQTYTRQYSTRLSRFL 276
LKPEN+LVRSDGHIMLSDFDLSLCS++I RS R++ TRL+R
Sbjct: 206 LKPENILVRSDGHIMLSDFDLSLCSDSIAAVESSSSSPENQQLRSP---RRF-TRLARLF 261
Query: 277 NRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFI 336
R SKK+QTL P RLFVAEPV ARS SFVGTHEYV+PEVASGGSHGNAVDWWAFG+F+
Sbjct: 262 QRVLRSKKVQTLEPTRLFVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFL 321
Query: 337 YEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396
YEMIYG+TPF AP+N+ LRNIVK+ L+FPT SP++M E HAR+LISGLLNKDP RLGS
Sbjct: 322 YEMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLGS 381
Query: 397 KRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKSQS--TAFDYF 451
+RGAA+VK HPFFKGLNFALIR+LTPPEIP +K M +S + AFDYF
Sbjct: 382 RRGAAEVKVHPFFKGLNFALIRTLTPPEIPSSVVKKPMKSATFSGRSSNKPAAFDYF 438
|
|
| UNIPROTKB|Q2QM77 PID "Protein kinase PINOID" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
Identities = 222/388 (57%), Positives = 266/388 (68%)
Query: 43 TSKSSPE-NLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSL 101
TS S P ++ L+PHRS D A++AIR+A+ L RDF L RRIG GDIGTVYLC L
Sbjct: 71 TSCSPPRASVLLRPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRL 130
Query: 102 NNKYRQDRGHEPCCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEAS 161
R E C+YAM RA EK+IL+ LDHPFLPTL+A+F+A+
Sbjct: 131 ----RSSPERESPCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDAT 186
Query: 162 -NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220
+FSC VMEFC GGDLHSLRH+ P +RF L SARFYAAEVL+A+EYLHM+GI+YRDLKPE
Sbjct: 187 PHFSCAVMEFCPGGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPE 246
Query: 221 NVLVRSDGHIMLSDFDLSLCSNAIXXXXXXXXXXXXXXXRSQTYTRQYSTRLSRFLNRFF 280
NVL+R+DGHIML+DFDLSL S + + L RF R
Sbjct: 247 NVLIRADGHIMLTDFDLSLQSTTSPSLDGDTDTDDEASGGASCFP----DHLLRFKRR-- 300
Query: 281 GSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI 340
+ P FVAEPV ARSCSFVGTHEYV+PEVASGG+HG AVDWWA+G+F+YE+I
Sbjct: 301 ---RNAVAAPRPRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYGVFLYELI 357
Query: 341 YGRTPFAAPSNETTLRNIVKKPLTFPTQSPS-SMSEYHARDLISGLLNKDPCNRLGSKRG 399
YGRTPFA +NE TLRNIV++PL FP+ S S ++ ARDLI+ LL KDP RLGS+RG
Sbjct: 358 YGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLAKDPAARLGSRRG 417
Query: 400 AADVKTHPFFKGLNFALIRSLTPPEIPG 427
AADVK+HPFFK LN AL+RS PP +PG
Sbjct: 418 AADVKSHPFFKSLNLALLRSSRPPVVPG 445
|
|
| UNIPROTKB|A6MW92 bif2 "Barren inflorescence2" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 211/388 (54%), Positives = 261/388 (67%)
Query: 46 SSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKY 105
SSP +PHR+ D A++AIR+A+ L RDF L RR+G GD+GTVYLC L
Sbjct: 90 SSPAPAPARPHRAGDAAWAAIRAASASAAAPLGPRDFRLLRRVGGGDVGTVYLCRL---- 145
Query: 106 RQDRGHEP-CCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEAS-NF 163
R P CCLYAM A E++IL+ LDHPFLPTL+A+F+A+ +F
Sbjct: 146 RAPPAPAPVCCLYAMKVVDRRVAAAKKKLEHAAAERRILRALDHPFLPTLFADFDAAPHF 205
Query: 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223
SC+V EFC GGDLHSLRH+ P++RF L SARFYAAEVL+ALEYLHM+GI+YRDLKPENVL
Sbjct: 206 SCVVTEFCPGGDLHSLRHRMPNRRFPLPSARFYAAEVLLALEYLHMMGIVYRDLKPENVL 265
Query: 224 VRSDGHIMLSDFDLSL-CSNAIXXXXXXXXXXXXXXXRSQTYTRQYSTRLSRFLNRFFGS 282
+R+DGHIML+DFDLSL C++ R+ RL R + +
Sbjct: 266 IRADGHIMLTDFDLSLQCTSTPSLEPCAAPEAAAASCFPDHLFRRRRARLRRAAS----A 321
Query: 283 KKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYG 342
++ P VAEPV ARSCSFVGTHEYV+PEVA GG HG AVDWWA G+F+YE+++G
Sbjct: 322 RR-----PPTTLVAEPVEARSCSFVGTHEYVAPEVARGGPHGAAVDWWALGVFLYELLHG 376
Query: 343 RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAAD 402
RTPFA NE TLRNI ++PL+FP + + ARDLI+ LL KDP +RLGS+RGAAD
Sbjct: 377 RTPFAGADNEATLRNIARRPLSFPA---AGAGDADARDLIARLLAKDPRHRLGSRRGAAD 433
Query: 403 VKTHPFFKGLNFALIRSLTPPEIPGMRR 430
VK HPFF+GLNFAL+RS PP +P R
Sbjct: 434 VKAHPFFRGLNFALLRSSRPPVVPAASR 461
|
|
| TAIR|locus:2043813 PID2 "PINOID2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 1.0e-92, Sum P(2) = 1.0e-92
Identities = 105/187 (56%), Positives = 130/187 (69%)
Query: 54 KPHRSSDFAYSAIRSAT--FGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGH 111
KPH+++ A+ A+ GR GL F L +R+G+GDIG+VYLC + RG
Sbjct: 59 KPHKANQVAWEAMARLRRCCGRAVGL--EHFRLLKRLGSGDIGSVYLCQI-------RGS 109
Query: 112 EPCCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFC 171
YAM RAEMEKKIL MLDHPF PTLYA FEAS++S +VME+C
Sbjct: 110 PETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYC 169
Query: 172 SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231
GGDL+++R +QP KRF+++S RFYAAE LVALEYLHM+GI+YRDLKPENVL+R DGH+M
Sbjct: 170 PGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVM 229
Query: 232 LSDFDLS 238
LSDFDLS
Sbjct: 230 LSDFDLS 236
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
Identities = 104/189 (55%), Positives = 129/189 (68%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KPH+++D + AI+ A + GL F L +R+G GDIGTV+L LN
Sbjct: 82 KPHKANDVRWEAIQ-AVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGTR-------- 132
Query: 114 CCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
C +AM RA+ E++IL+ LDHPFLPTLY+ FE FSC+VMEFC G
Sbjct: 133 -CYFAMKVMDKTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPG 191
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDLH+LR +QP KRF+ +A+FY AEVL+A+EYLHMLGIIYRDLKPENVLVR DGH+MLS
Sbjct: 192 GDLHTLRQRQPGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLS 251
Query: 234 DFDLSL-CS 241
DFDLSL C+
Sbjct: 252 DFDLSLRCT 260
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 3.0e-91, Sum P(2) = 3.0e-91
Identities = 104/189 (55%), Positives = 126/189 (66%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KPH+ +D + AI A R L F L +R+G GDIG+VYL L+
Sbjct: 281 KPHKGNDPRWKAIL-AIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTR-------- 331
Query: 114 CCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
C +AM RA+ E++IL++LDHPFLPTLY FE FSC+VME+C G
Sbjct: 332 -CYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPG 390
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDLH+LR +QP K FS +ARFYAAEVL+ALEYLHMLG++YRDLKPENVLVR DGHIMLS
Sbjct: 391 GDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLS 450
Query: 234 DFDLSL-CS 241
DFDLSL C+
Sbjct: 451 DFDLSLRCA 459
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 3.8e-91, Sum P(2) = 3.8e-91
Identities = 105/190 (55%), Positives = 129/190 (67%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTG-LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHE 112
KPH+++D + AI++ K G L F L +R+G GDIGTV+L L H
Sbjct: 96 KPHKANDVRWEAIQAVR--TKHGVLGLNHFRLLKRLGCGDIGTVHLAEL---------HG 144
Query: 113 PCCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCS 172
C +AM RA+ E++IL+ LDHPFLPTLY+ FE FSC+VMEFC
Sbjct: 145 TRCFFAMKVMDKGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCP 204
Query: 173 GGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232
GGDLH+LR +QP KRFS +A+FY AEVL+A+EYLHMLGIIYRDLKPENVLVR DGH+ML
Sbjct: 205 GGDLHTLRQRQPGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVML 264
Query: 233 SDFDLSL-CS 241
SDFDLSL C+
Sbjct: 265 SDFDLSLRCT 274
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 2.1e-90, Sum P(2) = 2.1e-90
Identities = 104/197 (52%), Positives = 129/197 (65%)
Query: 43 TSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLN 102
+S SS + KPH+++D + AI++ R L F L +R+G GDIG+VYL L+
Sbjct: 153 SSCSSFSSTVNKPHKANDLRWEAIQAVRV-RDGLLGLSHFRLLKRLGCGDIGSVYLSELS 211
Query: 103 NKYRQDRGHEPCCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASN 162
G + C +AM RA+ E++IL+ LDHPFLPTLY FE
Sbjct: 212 -------GTK--CYFAMKVMDKTSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 262
Query: 163 FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222
FSC+VMEFC GGDLH+LR +QP K FS + +FY AE L+ALEYLHMLGI+YRDLKPENV
Sbjct: 263 FSCLVMEFCPGGDLHTLRQRQPGKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENV 322
Query: 223 LVRSDGHIMLSDFDLSL 239
LVR DGHIMLSDFDLSL
Sbjct: 323 LVREDGHIMLSDFDLSL 339
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 489 (177.2 bits), Expect = 5.2e-89, Sum P(2) = 5.2e-89
Identities = 103/189 (54%), Positives = 127/189 (67%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KPH+ +D ++AI A R L F L +R+G GDIG+VYL L+
Sbjct: 336 KPHKGNDPWWNAIL-AIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGTR-------- 386
Query: 114 CCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
C +A+ +RA+ E+ IL++LDHPFLPTLY FE FSC+VME+C G
Sbjct: 387 -CHFAVKVMDKASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPG 445
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDLH+LR +QP K FS +ARFYAAEVL+ALEYLHMLG++YRDLKPENVLVR DGHIMLS
Sbjct: 446 GDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLS 505
Query: 234 DFDLSL-CS 241
DFDLSL C+
Sbjct: 506 DFDLSLRCA 514
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 3.2e-88, P = 3.2e-88
Identities = 188/388 (48%), Positives = 239/388 (61%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KPH+ +D + AI++ + L F L +++G GDIG+VYL L ++ G
Sbjct: 86 KPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAEL-----REMG--- 137
Query: 114 CCLYAMXXXXXXXXXXXXXXHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
C +AM RA+ E++IL +LDHPFLPTLY+ FE FSC++MEFCSG
Sbjct: 138 -CFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSG 196
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDLH LR KQP K FS +ARFYA+EVL+ALEYLHM+G++YRDLKPENV+VR DGHIMLS
Sbjct: 197 GDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLS 256
Query: 234 DFDLSLCS--NAIXXXXXXXXXXXXXXXRSQTYTRQYSTRL-------SRFLNRFFGSKK 284
DFDLSL S + Q S +L S F RF +K
Sbjct: 257 DFDLSLQSFVSPTLIQSTSQPSCHIASYCIQPPCIDPSCKLPVACIQPSCFKPRFLNNKP 316
Query: 285 IQTLTPNR------LFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYE 338
+ T + +AEP AARS SFVGTHEY++PE+ G HG++VDWW FGIF+YE
Sbjct: 317 RKAKTEKAGSDSLPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLYE 376
Query: 339 MIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398
++ G+TPF N TL N+V +PL FP S S + A+DLI GLL KDP RLG K+
Sbjct: 377 LLTGKTPFKGNGNRETLFNVVGQPLKFPEGSIS----FAAKDLIRGLLTKDPKKRLGFKK 432
Query: 399 GAADVKTHPFFKGLNFALIRSLTPPEIP 426
GA ++K HPFF +N+ALIRS TPPEIP
Sbjct: 433 GATEIKQHPFFNNVNWALIRSTTPPEIP 460
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QM77 | PID_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5819 | 0.8514 | 0.7933 | yes | no |
| O64682 | PID_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6988 | 0.9534 | 0.9817 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 451 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-156 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-96 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-85 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-81 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-73 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-71 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-65 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-64 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-63 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-62 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-59 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-58 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-57 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-56 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-56 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-56 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-55 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-54 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-53 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-53 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-52 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-51 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-51 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-51 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-51 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-50 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-49 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-49 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-49 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-48 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-48 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-47 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-46 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-45 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-45 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-45 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-44 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-44 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-43 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-43 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-42 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-41 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-40 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-40 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-40 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-39 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-39 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-39 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-38 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-37 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-31 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-28 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-25 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 4e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 4e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.001 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.002 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.003 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.004 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 444 bits (1143), Expect = e-156
Identities = 164/347 (47%), Positives = 211/347 (60%), Gaps = 38/347 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ F + +G GD+G V+L + +G L+A+KV++K+ + K+ KV R E
Sbjct: 1 KHFKKIKLLGKGDVGRVFLV-------RLKGTGK--LFALKVLDKKEMIKRNKVKRVLTE 51
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++IL LDHPFLPTLYA F+ + C+VM++C GG+L L +QP K S ARFYAAE
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE 111
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
VL+ALEYLH+LGI+YRDLKPEN+L+ GHIMLSDFDLS S+ P S A +
Sbjct: 112 VLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+ +E + RS SFVGT EY++PEV S
Sbjct: 172 SVNSIP--------------------------SETFSEEPSFRSNSFVGTEEYIAPEVIS 205
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
G HG+AVDWW GI +YEM+YG TPF + + T NI+KK +TFP P S S AR
Sbjct: 206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSS---AR 262
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
DLI LL KDP RLGSKRGAA++K HPFF+G+N+ALIR TPP IP
Sbjct: 263 DLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIP 309
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 1e-96
Identities = 125/322 (38%), Positives = 166/322 (51%), Gaps = 72/322 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V L + + LYAMKV+ K+ + K+K+V E+ IL ++
Sbjct: 1 LGKGSFGKVLLV----RKKDTGK-----LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPF+ L+ F+ +V+E+ GG+L S H RFS ARFYAAE+++ALEYL
Sbjct: 52 HPFIVKLHYAFQTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAAEIVLALEYL 109
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H LGIIYRDLKPEN+L+ +DGHI L+DF L + E +S S+T T
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGL---------------AKELSSEGSRTNT-- 152
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
F GT EY++PEV G +G AV
Sbjct: 153 --------------------------------------FCGTPEYLAPEVLLGKGYGKAV 174
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
DWW+ G+ +YEM+ G+ PF A + I+K PL F P +S ARDLISGLL
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF----PEFLSP-EARDLISGLLQ 229
Query: 388 KDPCNRLGSKRGAADVKTHPFF 409
KDP RLGS GA ++K HPFF
Sbjct: 230 KDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 3e-85
Identities = 119/351 (33%), Positives = 170/351 (48%), Gaps = 79/351 (22%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
DF+ + +G G G V L + YA+K+++K + K K+V E
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK---------YYALKILSKAKIVKLKQVEHVLNE 51
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
K+IL+ + HPFL LY F+ + +VME+ GG+L S K RF ARFYAA+
Sbjct: 52 KRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQ 109
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
V++ALEYLH L I+YRDLKPEN+L+ SDG+I ++D
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITD------------------------- 144
Query: 260 RSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
FG +K+++ R+ + GT EY++PE+
Sbjct: 145 --------------------FGFAKRVKG--------------RTYTLCGTPEYLAPEII 170
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378
+G AVDWWA GI IYEM+ G PF + I++ + F PS S A
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF----PSFFSP-DA 225
Query: 379 RDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF-ALI-RSLTPPEIP 426
+DLI LL D RLG+ K G D+K HP+F G+++ AL+ R + P IP
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 260 bits (668), Expect = 4e-85
Identities = 110/328 (33%), Positives = 149/328 (45%), Gaps = 74/328 (22%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+++ ++G G G VYL R + L A+KV+ K+ + KK R E K
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKK--KIKKDRERILREIK 49
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
ILK L HP + LY FE + +VME+C GGDL L K R S ARFY ++L
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEARFYLRQIL 107
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
ALEYLH GI++RDLKPEN+L+ DGH+ L+DF
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG------------------------- 142
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321
L+R L+ + +FVGT EY++PEV G
Sbjct: 143 ----------LARQLDP---------------------GEKLTTFVGTPEYMAPEVLLGK 171
Query: 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381
+G AVD W+ G+ +YE++ G+ PF L + KP +S A+DL
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP-EAKDL 230
Query: 382 ISGLLNKDPCNRLGSKRGAADVKTHPFF 409
I LL KDP RL A + HPFF
Sbjct: 231 IRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 2e-81
Identities = 111/334 (33%), Positives = 156/334 (46%), Gaps = 60/334 (17%)
Query: 81 DFDLHRRIGAGDIGTVYLCSL--NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
DF + IG G TV L NK YA+K+++K L K+KKV ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKE-----------YAIKILDKRQLIKEKKVKYVKI 50
Query: 139 EKKILKMLD-HPFLPTLYAEFEASNFSCI--VMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
EK++L L+ HP + LY F+ + V+E+ G+L K + RF
Sbjct: 51 EKEVLTRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRF 106
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
YAAE+L+ALEYLH GII+RDLKPEN+L+ D HI ++DF + + SP S+
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG---TAKVLDPNSSPESNKG 163
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
A+ + R SFVGT EYVSP
Sbjct: 164 DATNIDSQIEKNR--------------------------------RRFASFVGTAEYVSP 191
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
E+ + G + D WA G IY+M+ G+ PF + T + I+K +F P +
Sbjct: 192 ELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF----PPNFPP 247
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
A+DLI LL DP +RLG G ++K HPFF
Sbjct: 248 -DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 5e-73
Identities = 119/348 (34%), Positives = 175/348 (50%), Gaps = 46/348 (13%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF++ + IG G G V+L +D G +YAMKV+ K + K+ ++ E+
Sbjct: 2 DFEVIKVIGRGAFGEVWLV-----RDKDTGQ----VYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
IL D P++ LY F+ +VME+ GGDL +L + F +ARFY AE+
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAEL 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
++AL+ +H LG I+RD+KP+N+L+ +DGHI L+DF LC A +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADF--GLCKKMNKAKDRE---------- 158
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
Y L R Q R+ S VGT +Y++PEV G
Sbjct: 159 --YYLNDSHNLLFRDNVLVRRRDHKQRRV------------RANSTVGTPDYIAPEVLRG 204
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSMSEYHA 378
+G DWW+ G+ +YEM+YG PF + + + T I+ K+ L FP P S A
Sbjct: 205 TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSP---EA 261
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
DLI LL DP +RLGS ++K+HPFFKG+++ +R PP +P
Sbjct: 262 IDLICRLL-CDPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-71
Identities = 105/326 (32%), Positives = 147/326 (45%), Gaps = 62/326 (19%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
I G G V+L K D +YA+KV+ K + +K +V + E+ IL
Sbjct: 1 ISKGAYGRVFLAK--KKSTGD-------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
P++ LY F+ +VME+ GGDL SL AR Y AE+++ALEYL
Sbjct: 52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYL 109
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H GII+RDLKP+N+L+ S+GH+ L+DF LS
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLS----------------------------- 140
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
G + Q + VGT +Y++PEV G H V
Sbjct: 141 -----------KVGLVRRQINLNDD-------EKEDKRIVGTPDYIAPEVILGQGHSKTV 182
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
DWW+ G +YE + G PF + E +NI+ + +P S A DLIS LL
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVS---DEAIDLISKLLV 239
Query: 388 KDPCNRLGSKRGAADVKTHPFFKGLN 413
DP RLG+K ++K HPFFKG++
Sbjct: 240 PDPEKRLGAK-SIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 5e-65
Identities = 106/351 (30%), Positives = 168/351 (47%), Gaps = 75/351 (21%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G G G V L L LYA+KV+ K+V+ + V EK++L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDE---------LYAVKVLKKDVILQDDDVECTMTEKRVLAL 51
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
HPFL L++ F+ + VME+ +GGDL + H Q RF ARFYAAE+++ L
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
++LH GIIYRDLK +NVL+ S+GHI ++DF + E T
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM---------------CKEGILGGVTTS 154
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
T F G TP+ Y++PE+ S +G
Sbjct: 155 T-------------FCG-------TPD--------------------YIAPEILSYQPYG 174
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
AVDWWA G+ +YEM+ G++PF + ++I++ + +P +S+ A+ ++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSK-EAKSILKS 229
Query: 385 LLNKDPCNRLGSKR-GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432
L K+P RLG G D+K HPFF+ +++ + + + PP P ++ +
Sbjct: 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRF 280
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 3e-64
Identities = 114/352 (32%), Positives = 180/352 (51%), Gaps = 70/352 (19%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK-EVLEKKKKVHRAEME 139
+F+L R +G G G V+L R+ GH+ LYAMKV+ K +++K K E
Sbjct: 1 NFELLRVLGTGAYGKVFLV------RKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE 54
Query: 140 KKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+++L+ + PFL TL+ F+ +++++ +GG+L + H + F+ + R Y A
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFT--HLYQREHFTESEVRVYIA 112
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
E+++AL++LH LGIIYRD+K EN+L+ S+GH++L+DF LS
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------- 152
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
+ F+AE R+ SF GT EY++PEV
Sbjct: 153 ---------------------------------KEFLAEE-EERAYSFCGTIEYMAPEVI 178
Query: 319 SGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
GGS H AVDWW+ G+ +E++ G +PF + + I ++ L P +MS
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA- 237
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
ARD I LL KDP RLG+ GA ++K HPFF+G+++ + + + P P
Sbjct: 238 EARDFIQKLLEKDPKKRLGAN-GADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 1e-63
Identities = 99/333 (29%), Positives = 147/333 (44%), Gaps = 78/333 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEMEK 140
++L R++G+G GTVY + A+K++ K KK + R E+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---------GKIVAVKILKKRSEKSKKDQTARREI-- 49
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+IL+ L HP + L FE + +VME+C GGDL + S A+ A ++
Sbjct: 50 RILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQI 107
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L LEYLH GII+RDLKPEN+L+ +G + ++D
Sbjct: 108 LRGLEYLHSNGIIHRDLKPENILLDENGVVKIAD-------------------------- 141
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG K + +FVGT Y++PEV G
Sbjct: 142 -------------------FGLAKKLL-KSSSSL---------TTFVGTPWYMAPEVLLG 172
Query: 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNET---TLRNIVKKPLTFPTQSPSSMSEY 376
G+ +G VD W+ G+ +YE++ G+ PF+ + +R I+ PL F SS SE
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
A+DLI LNKDP R A ++ HP+F
Sbjct: 233 -AKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 99/332 (29%), Positives = 153/332 (46%), Gaps = 77/332 (23%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V L + +K R +A+K V K + + + EK+IL+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNR---------TFALKCVKKRHIVETGQQEHIFSEKEILEECN 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPF+ LY F+ + ++ME+C GG+L ++ F +ARFY A V++A EYL
Sbjct: 52 HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYL 109
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H GIIYRDLKPEN+L+ S+G++ L DF
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGF------------------------------ 139
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
+KK++ ++ +F GT EYV+PE+ + +V
Sbjct: 140 --------------AKKLK------------SGQKTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNE--TTLRNIVK--KPLTFPTQSPSSMSEYHARDLIS 383
D+W+ GI +YE++ GR PF + +I+K L FP + A+DLI
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKA-----AKDLIK 228
Query: 384 GLLNKDPCNRLG-SKRGAADVKTHPFFKGLNF 414
LL ++P RLG K G D+K H +F G ++
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 3e-59
Identities = 104/342 (30%), Positives = 150/342 (43%), Gaps = 69/342 (20%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V C + + +YA K ++K+ L+K+K A EKKIL+ +
Sbjct: 1 LGKGGFGEVCACQVKATGK---------MYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
F+ +L FE + C+VM +GGDL + F A FYAA+++ LE+L
Sbjct: 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H I+YRDLKPENVL+ G++ +SD L AVE +
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGL--------AVELKGGKK----------IKG 153
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
GT Y++PEV G + +V
Sbjct: 154 R--------------------------------------AGTPGYMAPEVLQGEVYDFSV 175
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
DW+A G +YEMI GR+PF + + ++ L + P S A+DL LL
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSP-EAKDLCEALLQ 234
Query: 388 KDPCNRLGSK-RGAADVKTHPFFKGLNFALIRS--LTPPEIP 426
KDP RLG + A +V+ HP FK LN+ + + L PP IP
Sbjct: 235 KDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-58
Identities = 115/343 (33%), Positives = 157/343 (45%), Gaps = 76/343 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KML 146
IG G G V L K++ D YA+KV+ K+ + KKK+ E+ +L K +
Sbjct: 3 IGKGSFGKVLLA----KHKADGK-----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HPFL L+ F+ ++ V+++ +GG+L H Q + F ARFYAAE+ AL Y
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFF--HLQRERSFPEPRARFYAAEIASALGY 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH L IIYRDLKPEN+L+ S GH++L+DF LC E T T
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDF--GLCK-------------EGIEHSKTTST- 155
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
F GT EY++PEV +
Sbjct: 156 ---------------------------------------FCGTPEYLAPEVLRKQPYDRT 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ-SPSSMSEYHARDLISGL 385
VDWW G +YEM+YG PF + NI+ KPL S S AR L+ GL
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVS------ARHLLEGL 230
Query: 386 LNKDPCNRLGSKRGAADVKTHPFFKGLNFA--LIRSLTPPEIP 426
L KD RLG+K ++K H FF +N+ + + +TPP P
Sbjct: 231 LQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 8e-57
Identities = 115/370 (31%), Positives = 180/370 (48%), Gaps = 67/370 (18%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ + I G G VYL ++++ R +AMK +NK+ L + ++ + +E+
Sbjct: 2 DFETIKLISNGAYGAVYLV----RHKETRQR-----FAMKKINKQNLILRNQIQQVFVER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARFYAAE 199
IL ++PF+ +++ FE C+VME+ GGD +L ++ + AR Y AE
Sbjct: 53 DILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA---LPVDMARMYFAE 109
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
++ALEYLH GI++RDLKP+N+L+ S GHI L+DF LS
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG------------------ 151
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+S N + G + T R F+ + V GT EY++PEV
Sbjct: 152 -----------LMSLTTNLYEGHIEKDT----REFLDKQVC-------GTPEYIAPEVIL 189
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
+G VDWWA GI +YE + G PF + E ++ + +P + ++ A+
Sbjct: 190 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPAD--AQ 247
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQ 439
DLIS LL ++P RLG+ GA +VK H FF GL++ G+ RQK P
Sbjct: 248 DLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWN-----------GLLRQKAEFIPQL 295
Query: 440 KIKSQSTAFD 449
+ + ++ FD
Sbjct: 296 ESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 117/357 (32%), Positives = 185/357 (51%), Gaps = 69/357 (19%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK-VHRAEME 139
+F+L + +G G G V+L R+ GH+ LYAMKV+ K L +K K V E
Sbjct: 1 NFELLKVLGTGAYGKVFLV------RKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE 54
Query: 140 KKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+ +L+ + PFL TL+ F+ +++++ SGG++ + +++ + FS RFY+
Sbjct: 55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSG 112
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
E+++ALE+LH LGI+YRD+K EN+L+ S+GH++L+DF LS
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS-------------------- 152
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
F +K +T + F GT EY++PE+
Sbjct: 153 ------------------KEFLSEEKERTYS----------------FCGTIEYMAPEII 178
Query: 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
G G HG AVDWW+ GI I+E++ G +PF T + ++ L PS +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG-PE 237
Query: 378 ARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431
A+DL+ LL KDP RLG+ +GA+++K HPFFKGL++ + R + PP P +R +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNE 294
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-56
Identities = 113/362 (31%), Positives = 164/362 (45%), Gaps = 76/362 (20%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V L R+ + YAMK++ KEV+ K +V E ++L+
Sbjct: 3 LGKGTFGKVILV------REKATGK---YYAMKILKKEVIIAKDEVAHTLTESRVLQNTR 53
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPFL L F+ + C VME+ +GG+L H + FS ARFY AE++ AL YL
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H ++YRDLK EN+++ DGHI ++DF LC I +
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDF--GLCKEGI------------------SDGAT 151
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
T F GT EY++PEV +G AV
Sbjct: 152 MKT-----------------------------------FCGTPEYLAPEVLEDNDYGRAV 176
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP-TQSPSSMSEYHARDLISGLL 386
DWW G+ +YEM+ GR PF +E I+ + + FP T SP A+ L++GLL
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE------AKSLLAGLL 230
Query: 387 NKDPCNRL-GSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKS 443
KDP RL G A ++ H FF +N+ + + L PP P + + + D++ +
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTA 290
Query: 444 QS 445
QS
Sbjct: 291 QS 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 5e-56
Identities = 121/352 (34%), Positives = 182/352 (51%), Gaps = 43/352 (12%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK-EVLEKKKKVH-RAEM 138
DF+ + IG G G V L ++D GH +YAMK + K E+LEK++ H RAE
Sbjct: 2 DFESIKVIGRGAFGEVRLVQ-----KKDTGH----IYAMKKLRKSEMLEKEQVAHVRAE- 51
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+ IL D+P++ LY F+ N+ ++ME+ GGD+ +L K+ F+ RFY A
Sbjct: 52 -RDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIA 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS--LCSNAIPAVESPASSPEA 256
E ++A++ +H LG I+RD+KP+N+L+ + GHI LSDF L L + S
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
++ S R K +T NR +A S VGT +Y++PE
Sbjct: 169 SNFLDFISKPMSSKR------------KAETWKRNRRALAY-------STVGTPDYIAPE 209
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSMS 374
V + DWW+ G+ +YEM+ G PF + + + T R I+ K+ L FP + P S
Sbjct: 210 VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPE 269
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
A+DLI L + RLG+ G ++K+HPFFKG+++ IR P IP
Sbjct: 270 ---AKDLIKRLCC-EAERRLGNN-GVNEIKSHPFFKGVDWEHIRERPAPIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 7e-55
Identities = 105/352 (29%), Positives = 156/352 (44%), Gaps = 86/352 (24%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V L LYA+K + K + + +V EK+I + +
Sbjct: 7 LGRGHFGKVLLAEYKKTGE---------LYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 148 ---HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
HPFL L+A F+ + C VME+ +GGDL + H FS A FYAA V++ L
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIH-TDVFSEPRAVFYAACVVLGL 114
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
+YLH I+YRDLK +N+L+ ++G + ++DF LC E +T
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADF--GLCK-------------EGMGFGDRTS 159
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
T F GT E+++PEV + S+
Sbjct: 160 T----------------------------------------FCGTPEFLAPEVLTETSYT 179
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI----VKKPLTFPTQSPSSMSEYHARD 380
AVDWW G+ IYEM+ G +PF E +I V+ P ++ S M
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR----- 234
Query: 381 LISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFA--LIRSLTPPEIPGMR 429
LL ++P RLGS ++ A DVK PFF+ +N+ L R + PP +P ++
Sbjct: 235 ----LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIK 282
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 1e-54
Identities = 114/358 (31%), Positives = 182/358 (50%), Gaps = 40/358 (11%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF + IG G G V L ++D G +YAMK + K + KK ++ + E+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQ-----KKDTGK----IYAMKTLLKSEMFKKDQLAHVKAER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L D P++ +LY F+ + + ++MEF GGDL ++ K + FS RFY AE
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAEC 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS-----LCSNA--IPAVESPASS 253
++A+E +H LG I+RD+KP+N+L+ GHI LSDF LS +A ++ ++
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ S T S+ +I T NR +A S VGT +Y+
Sbjct: 171 NRIDNRNSVAVDSINLTMSSK--------DQIATWKKNRRLMAY-------STVGTPDYI 215
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPS 371
+PE+ +G DWW+ G ++E + G PF + ++ T R I+ ++ L FP
Sbjct: 216 APEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHL 275
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMR 429
S A DLI L+ + NRLG + GA ++K+HPFF+G+++ IR + P IP ++
Sbjct: 276 S---VEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLK 328
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-53
Identities = 110/347 (31%), Positives = 168/347 (48%), Gaps = 74/347 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V+L R+ G + LYAMKV+ K L+ + +V R +ME+ IL ++
Sbjct: 4 LGQGSFGKVFLV------RKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVN 56
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPF+ L+ F+ ++++F GGDL + K+ F+ +FY AE+ +AL++L
Sbjct: 57 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHL 114
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H LGIIYRDLKPEN+L+ +GHI L+DF L S E+ + Y
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGL---------------SKESIDHEKKAY--- 156
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
SF GT EY++PEV + H +
Sbjct: 157 -------------------------------------SFCGTVEYMAPEVVNRRGHTQSA 179
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-QSPSSMSEYHARDLISGLL 386
DWW+FG+ ++EM+ G PF + T+ I+K L P SP A+ L+ L
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSP------EAQSLLRALF 233
Query: 387 NKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430
++P NRLG+ G ++K HPFF +++ + R + PP P + R
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGR 280
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-53
Identities = 113/364 (31%), Positives = 178/364 (48%), Gaps = 72/364 (19%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK-EVLEKKKKVHRAEMEKKILK 144
+ +G G G V+ R+ G + ++AMKV+ K ++ +K + E+ IL+
Sbjct: 2 KVLGKGGYGKVFQV------RKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE 55
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+ HPF+ L F+ +++E+ SGG+L H + F +A FY +E+ +AL
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLAL 113
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
E+LH GIIYRDLKPEN+L+ + GH+ L+DF LC E+ + T+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDF--GLCK-------------ESIHEGTVTH 158
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
T F GT EY++PE+ HG
Sbjct: 159 T----------------------------------------FCGTIEYMAPEILMRSGHG 178
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
AVDWW+ G +Y+M+ G PF A + + T+ I+K L P P E ARDL+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP---PYLTPE--ARDLLKK 233
Query: 385 LLNKDPCNRLGSKRG-AADVKTHPFFKGLNF--ALIRSLTPPEIPGMRRQKTMPFPDQKI 441
LL ++P +RLG+ G AA+V++HPFF+ +N+ L R + PP P ++ ++ + D K
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKF 293
Query: 442 KSQS 445
Q+
Sbjct: 294 TRQT 297
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 7e-52
Identities = 106/339 (31%), Positives = 169/339 (49%), Gaps = 68/339 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEME 139
+F+L + +G G G V+L R+ GH+ LYAMKV+ K +++K K E
Sbjct: 1 NFELLKVLGTGAYGKVFLV------RKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTE 54
Query: 140 KKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+++L+ + PFL TL+ F+ +++++ +GG+L + H +RF + Y+
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQIYSG 112
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
E+++ALE+LH LGIIYRD+K EN+L+ S+GH++L+D
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD------------------------ 148
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
FG K F + V R+ SF GT EY++P++
Sbjct: 149 ---------------------FGLSK--------EFHEDEVE-RAYSFCGTIEYMAPDIV 178
Query: 319 SGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
GG H AVDWW+ G+ +YE++ G +PF + + I ++ L P MS
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 377 HARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF 414
A+D+I LL KDP RLG A ++K HPFF+ +N+
Sbjct: 239 -AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 100/345 (28%), Positives = 157/345 (45%), Gaps = 77/345 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM-L 146
+G G G V L L +A+K + K+V+ + V +E+++L +
Sbjct: 3 LGKGSFGKVMLAELKGTNE---------FFAIKALKKDVVLEDDDVECTMVERRVLALAW 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
+HPFL L+ F+ VME+ +GGDL + H Q RF ARFYAAE++ L++
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQF 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH GIIYRDLK +NVL+ DGHI ++D
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGHIKIAD-------------------------------- 139
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
FG K + + +F GT +Y++PE+ G + +
Sbjct: 140 -------------FGMCKENMNGEGK----------ASTFCGTPDYIAPEILKGQKYNES 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VDWW+FG+ +YEM+ G++PF + +I+ FP A+D +S L
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR-----WISKEAKDCLSKLF 231
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429
+DP RLG D++ HPFF+G+++ + R + PP P ++
Sbjct: 232 ERDPTKRLGVD---GDIRQHPFFRGIDWERLEKREIPPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 107/333 (32%), Positives = 155/333 (46%), Gaps = 67/333 (20%)
Query: 117 YAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL 176
YAMK++ KEV+ K +V E ++L+ HPFL L F+ + C VME+ +GG+L
Sbjct: 23 YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL 82
Query: 177 HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236
H + F+ ARFY AE++ ALEYLH ++YRD+K EN+++ DGHI ++DF
Sbjct: 83 --FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF- 139
Query: 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVA 296
LC I S A + F
Sbjct: 140 -GLCKEGI--------SDGATM---------------------------------KTFCG 157
Query: 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
P EY++PEV +G AVDWW G+ +YEM+ GR PF +E
Sbjct: 158 TP------------EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 205
Query: 357 NIVKKPLTFP-TQSPSSMSEYHARDLISGLLNKDPCNRL-GSKRGAADVKTHPFFKGLNF 414
I+ + + FP T SP A+ L++GLL KDP RL G A +V H FF +N+
Sbjct: 206 LILMEEIRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259
Query: 415 --ALIRSLTPPEIPGMRRQKTMPFPDQKIKSQS 445
+ + L PP P + + + D + +QS
Sbjct: 260 QDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQS 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 109/345 (31%), Positives = 162/345 (46%), Gaps = 76/345 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK--- 144
IG G G VY + R +YAMKV++K+ + KK+V E+ IL
Sbjct: 1 IGKGTFGQVYQVRKKDTRR---------IYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+ + PF+ L F+ + +V ++ SGG+L H Q RFS A+FY AE+++AL
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
E+LH I+YRDLKPEN+L+ + GHI L D
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCD------------------------------ 139
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA-SGGSH 323
FG K LT N+ + +F GT EY++PEV +
Sbjct: 140 ---------------FGLSK-ANLTDNKT---------TNTFCGTTEYLAPEVLLDEKGY 174
Query: 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383
VD+W+ G+ ++EM G +PF A + RNI + FP S R +
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD----EGRQFVK 230
Query: 384 GLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
GLLN++P +RLG+ R A ++K HPFF +++ L+ + +TPP P
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 5e-51
Identities = 110/360 (30%), Positives = 171/360 (47%), Gaps = 84/360 (23%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+DFD+ +G G G V + + K D +YAMKV+ K VL ++ V E E
Sbjct: 1 KDFDVKSLVGRGHFGEVQV--VREKATGD-------IYAMKVMKKSVLLAQETVSFFEEE 51
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFYA 197
+ IL + + P++P L F+ + +VME+ GGDL SL R++ F A+FY
Sbjct: 52 RDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYL 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
AE+++A+ +H +G ++RD+KPENVL+ GHI L+DF
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG--------------------- 147
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
+ RL+ +K + + P VGT +Y++PEV
Sbjct: 148 ----------SAARLTA-------NKMVNSKLP----------------VGTPDYIAPEV 174
Query: 318 ------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQS 369
G++G DWW+ G+ YEMIYGR+PF ++ T NI+ ++ L FP
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED- 233
Query: 370 PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMR 429
P S++ DLI LL RLG + + HPFF +++ IR+ PP +P ++
Sbjct: 234 PKVSSDF--LDLIQSLLC-GQKERLGYEG----LCCHPFFSKIDWNNIRNSLPPFVPTLK 286
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 110/351 (31%), Positives = 166/351 (47%), Gaps = 77/351 (21%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R IG G V L L R +YAMKV+ KE++ + + + EK + +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRR---------IYAMKVIKKELVNDDEDIDWVQTEKHVFET 51
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+HPFL L++ F+ + V+EF SGGDL + H Q ++ ARFY+AE+ +AL
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLAL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
+LH GIIYRDLK +NVL+ ++GHI L+ D +C E P T
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAEGHIKLT--DYGMCK-------------EGIRPGDTTS 154
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
T F GT Y++PE+ G +G
Sbjct: 155 T----------------------------------------FCGTPNYIAPEILRGEDYG 174
Query: 325 NAVDWWAFGIFIYEMIYGRTPF-----AAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
+VDWWA G+ ++EM+ GR+PF + ++ T + + L + P S+S A
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS-VKAS 233
Query: 380 DLISGLLNKDPCNRLGSKR--GAADVKTHPFFKGLNFALI--RSLTPPEIP 426
++ G LNKDP RLG G D+K+HPFF+ +++ L+ + + PP P
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 105/356 (29%), Positives = 174/356 (48%), Gaps = 75/356 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ +G G G V L + +G + LYA+K++ K+V+ + V +EK
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-------ERKGTDE--LYAIKILKKDVIIQDDDVECTMVEK 51
Query: 141 KILKMLDHP-FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++L + P FL L++ F+ + VME+ +GGDL + H Q +F A FYAAE
Sbjct: 52 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAE 109
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
+ + L +LH GIIYRDLK +NV++ ++GHI ++DF +C I
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADF--GMCKENI--------------- 152
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
FG K +T F GT +Y++PE+ +
Sbjct: 153 --------------------FGGKTTRT------------------FCGTPDYIAPEIIA 174
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
+G +VDWWAFG+ +YEM+ G+ PF + ++I++ +++ P S+S+ A
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY----PKSLSK-EAV 229
Query: 380 DLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432
+ GLL K P RLG G D++ H FF+ +++ + R + PP P ++ ++
Sbjct: 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRR 285
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-49
Identities = 94/330 (28%), Positives = 146/330 (44%), Gaps = 77/330 (23%)
Query: 88 IGAGDIGTVYLCS--LNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
I G G+VYL Y +A+KV+ K + K +V + E+ I+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY-----------FAIKVLKKSDMIAKNQVTNVKAERAIMMI 52
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+ P++ LY F++ ++ +VME+ +GGD SL A+ Y AEV++ +
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGV 110
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
E LH GII+RD+KPEN+L+ GH+ L+DF LS
Sbjct: 111 EDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS-------------------------- 144
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
R +F G TP+ Y++PE G
Sbjct: 145 ------RNGLENKKFVG-------TPD--------------------YLAPETILGVGDD 171
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
DWW+ G I+E ++G PF A + + NI+ + + +P + S A DLI+
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP-EAVDLINR 230
Query: 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414
LL DP RLG+ G ++K+HPFFK +N+
Sbjct: 231 LLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-49
Identities = 107/352 (30%), Positives = 153/352 (43%), Gaps = 72/352 (20%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
TFR +R +G G G V C + + +YA K + K+ ++K+K A
Sbjct: 1 TFR---HYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMAL 48
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
EK+IL+ ++ F+ +L +E + C+V+ +GGDL + + F A FYA
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
AE+ LE LH I+YRDLKPEN+L+ GHI +SD L AVE P
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL--------AVEIPEG----- 155
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
E + R VGT Y++PEV
Sbjct: 156 ---------------------------------------ETIRGR----VGTVGYMAPEV 172
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ + DWW G IYEMI G++PF + + ++ + SE
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA- 231
Query: 378 ARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFKGLNFALIRS--LTPPEIP 426
AR + LL KDP RLG + GA +VK HPFF+ NF + + L PP P
Sbjct: 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 7e-49
Identities = 116/345 (33%), Positives = 159/345 (46%), Gaps = 74/345 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KML 146
IG G G V L K + D YA+KV+ K+ + KKK+ + E+ +L K L
Sbjct: 3 IGKGSFGKVLLA----KRKSDGS-----FYAVKVLQKKTILKKKEQNHIMAERNVLLKNL 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HPFL L+ F+ + V+++ +GG+L H Q + F ARFYAAEV A+ Y
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGY 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH L IIYRDLKPEN+L+ S GH++L+DF LC E P T T
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDF--GLCK-------------EGVEPEETTST- 155
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
F GT EY++PEV +
Sbjct: 156 ---------------------------------------FCGTPEYLAPEVLRKEPYDRT 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VDWW G +YEM+YG PF + NI+ KPL P + A DL+ GLL
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA-----ACDLLVGLL 231
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429
+KD RLG+K ++K H FF +N+ + + +TPP P +
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVA 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 7e-49
Identities = 106/343 (30%), Positives = 159/343 (46%), Gaps = 74/343 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IG G G V Q R + +YA+K + K + + +V E+ +L ++
Sbjct: 1 IGKGSFGKVM---------QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
PF+ L F++ +V+ F +GG+L H Q RF L+ ARFY AE+L ALE L
Sbjct: 52 CPFIVPLKFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTAELLCALENL 109
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
H +IYRDLKPEN+L+ GH ++LC
Sbjct: 110 HKFNVIYRDLKPENILLDYQGH-------IALCD-------------------------- 136
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
FG K+ ++ + +F GT EY++PE+ G + AV
Sbjct: 137 ------------FGLCKLNMKDDDK----------TNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
DWW G+ +YEM+ G PF + R I+++PL FP A+DL+ GLL+
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD-----AKDLLIGLLS 229
Query: 388 KDPCNRLGSKRGAADVKTHPFFKGLNFA--LIRSLTPPEIPGM 428
+DP RLG GA ++K HPFF L++ L++ + PP P +
Sbjct: 230 RDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAV 271
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 107/332 (32%), Positives = 159/332 (47%), Gaps = 65/332 (19%)
Query: 117 YAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL 176
YAMK++ KEV+ K +V E ++LK HPFL +L F+ + C VME+ +GG+L
Sbjct: 23 YAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL 82
Query: 177 HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236
H + FS RFY AE++ AL+YLH I+YRDLK EN+++ DGHI ++DF
Sbjct: 83 --FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDF- 139
Query: 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVA 296
LC I +AA+ ++
Sbjct: 140 -GLCKEGI---------TDAATMKT----------------------------------- 154
Query: 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
F GT EY++PEV +G AVDWW G+ +YEM+ GR PF +E
Sbjct: 155 ---------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
Query: 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL-GSKRGAADVKTHPFFKGLNFA 415
I+ + + FP + A+ L+SGLL KDP RL G A ++ H FF G+N+
Sbjct: 206 LILMEDIKFPRTLSAD-----AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260
Query: 416 LI--RSLTPPEIPGMRRQKTMPFPDQKIKSQS 445
+ + L PP P + + + D++ +Q+
Sbjct: 261 DVYDKKLVPPFKPQVTSETDTRYFDEEFTAQT 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 7e-48
Identities = 112/360 (31%), Positives = 164/360 (45%), Gaps = 57/360 (15%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ IG G G V L + LYAMK + K + + + + E+ IL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNA---------LYAMKTLRKADVLMRNQAAHVKAERDILAE 57
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
D+ ++ LY F+ + VM++ GGD+ SL + F ARFY AE+ A+E
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIE 115
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC-------------SNAIPAVESPAS 252
+H +G I+RD+KP+N+L+ DGHI L+DF LC +S
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDF--GLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
S E + +++ L R + A S VGT Y
Sbjct: 174 SEEWSEI---------------------DRCRLKPLERRRKRQHQRCLAH--SLVGTPNY 210
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNI-VKKPLTFPTQSP 370
++PEV + DWW+ G+ +YEM+ G+ PF A + ET L+ I + L P+Q+
Sbjct: 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK 270
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA-LIRSLTPPEIPGMR 429
S A DLI L +RLG K GA ++K HPFFKG++FA LIR P IP +
Sbjct: 271 LSRE---ASDLILRLC-CGAEDRLG-KNGADEIKAHPFFKGIDFASLIRRQKAPYIPKIT 325
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 9e-47
Identities = 112/344 (32%), Positives = 160/344 (46%), Gaps = 74/344 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEMEKKILKML 146
IG G G V L +++ + YA+KV+ K+ +L+KK++ H +LK +
Sbjct: 3 IGKGSFGKVLLA----RHKAEEK-----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HPFL L+ F+ ++ V+++ +GG+L H Q + F ARFYAAE+ AL Y
Sbjct: 54 KHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGY 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH L I+YRDLKPEN+L+ S GHI+L+DF LC I T T
Sbjct: 112 LHSLNIVYRDLKPENILLDSQGHIVLTDF--GLCKENI-------------EHNGTTST- 155
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
F GT EY++PEV +
Sbjct: 156 ---------------------------------------FCGTPEYLAPEVLHKQPYDRT 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VDWW G +YEM+YG PF + + NI+ KPL +S AR L+ GLL
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS-----ARHLLEGLL 231
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNF--ALIRSLTPPEIPGM 428
KD RLG+K ++K H FF +N+ + + +TPP P +
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNV 275
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 108/349 (30%), Positives = 169/349 (48%), Gaps = 75/349 (21%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R IG G V L L + +YAMKVV KE++ + + + EK + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQ---------IYAMKVVKKELVHDDEDIDWVQTEKHVFEQ 51
Query: 146 LD-HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+PFL L++ F+ ++ +V+E+ +GGDL + H Q ++ ARFYAAE+ +AL
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIAL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
+LH GIIYRDLK +NVL+ +DGHI L+D+ +C E P T
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDADGHIKLTDY--GMCK-------------EGLGPGDTTS 154
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
T F GT Y++PE+ G +G
Sbjct: 155 T----------------------------------------FCGTPNYIAPEILRGEEYG 174
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN---IVKKPLTFPTQSPSSMSEYHARDL 381
+VDWWA G+ ++EM+ GR+PF ++ + + + L P + P +S A +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS-VKASHV 233
Query: 382 ISGLLNKDPCNRLGSK--RGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
+ G LNKDP RLG + G +D+K+H FF+ +++ L+ + +TPP P
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKP 282
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 105/352 (29%), Positives = 156/352 (44%), Gaps = 72/352 (20%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
TFR + R +G G G V C + + +YA K + K+ ++K+K A
Sbjct: 1 TFRQY---RVLGKGGFGEVCACQVRATGK---------MYACKRLEKKRIKKRKGESMAL 48
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
EK+IL+ ++ F+ L +E + C+V+ +GGDL + + F A FYA
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYA 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
AE+L LE LH +YRDLKPEN+L+ GHI +SD L++ PE
Sbjct: 109 AEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV------------KIPEGE 156
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
S R + VGT Y++PEV
Sbjct: 157 SIRGR--------------------------------------------VGTVGYMAPEV 172
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ + + D+W G IYEMI G++PF E R V + + + S+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG-RKEKVKREEVDRRVLETEEVYSAKFSEE 231
Query: 378 ARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFKGLNFALIRS--LTPPEIP 426
A+ + LL KDP RLG + GA +VK HPFF+ +NF + + L PP +P
Sbjct: 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 105/366 (28%), Positives = 163/366 (44%), Gaps = 77/366 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML- 146
+G G G V L L K +A+K + K+V+ V +EK++L +
Sbjct: 3 LGKGSFGKVLLAELKGKGE---------YFAVKALKKDVVLIDDDVECTMVEKRVLALAW 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
++PFL LY F+ VMEF +GGDL + H Q RF L A FYAAE++ L++
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQF 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH GIIYRDLK +NV++ DGHI ++DF +C +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADF--GMCKENV---------------------- 147
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
FG + T F GT +Y++PE+ G + +
Sbjct: 148 -------------FGDNRAST------------------FCGTPDYIAPEILQGLKYTFS 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VDWW+FG+ +YEM+ G++PF + +I +P ++D++ L
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE-----SKDILEKLF 231
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQ 444
+DP RLG +++ HPFFK +N+ + R L PP P ++ D++ S+
Sbjct: 232 ERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSE 288
Query: 445 STAFDY 450
Y
Sbjct: 289 KPRLSY 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-45
Identities = 115/349 (32%), Positives = 182/349 (52%), Gaps = 41/349 (11%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ + IG G G V L ++D GH +YAMK++ K + +K++V E+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQ-----KKDTGH----IYAMKILRKADMLEKEQVAHIRAER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
IL D ++ ++ F+ ++MEF GGD+ +L K+ S + +FY AE
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAET 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
++A++ +H LG I+RD+KP+N+L+ + GH+ LSDF LC+ A R
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDF--GLCTGLKKA------------HR 156
Query: 261 SQTYTRQYSTRLSRFLNRFFGSK-KIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
++ Y S F + SK K +T NR +A S VGT +Y++PEV
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY-------STVGTPDYIAPEVFM 209
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSMSEYH 377
+ DWW+ G+ +YEM+ G PF + + + T R ++ K+ L FP + P +SE
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP--ISE-K 266
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
A+DLI D NR+GS G ++K+HPFF+G+++ IR P IP
Sbjct: 267 AKDLILRFCT-DSENRIGSN-GVEEIKSHPFFEGVDWGHIRE-RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 111/353 (31%), Positives = 172/353 (48%), Gaps = 77/353 (21%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R IG G V L L + +R +YAMKVV KE++ + + + EK + +
Sbjct: 1 RVIGRGSYAKVLLVRLK---KTER------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 51
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+HPFL L++ F+ + V+E+ +GGDL + H Q ++ ARFY+AE+ +AL
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLAL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
YLH GIIYRDLK +NVL+ S+GHI L+D+ +C E P T
Sbjct: 110 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDY--GMCK-------------EGLRPGDTT- 153
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
+ F G TPN Y++PE+ G +G
Sbjct: 154 ------------STFCG-------TPN--------------------YIAPEILRGEDYG 174
Query: 325 NAVDWWAFGIFIYEMIYGRTPF-----AAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
+VDWWA G+ ++EM+ GR+PF + ++ T + + L + P S+S A
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS-VKAA 233
Query: 380 DLISGLLNKDPCNRLG--SKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGM 428
++ LNKDP RLG + G AD++ HPFF+ +++ L+ + + PP P +
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNI 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 104/351 (29%), Positives = 165/351 (47%), Gaps = 77/351 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM-L 146
+G G G V L L +YA+KV+ K+V+ + V EK+IL +
Sbjct: 3 LGKGSFGKVMLAELKGTDE---------VYAIKVLKKDVILQDDDVDCTMTEKRILALAA 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HPFL L+ F+ + VME+ +GGDL + Q ++F +RFYAAEV +AL +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH G+IYRDLK +N+L+ ++GH L+DF +C E T T
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADF--GMCK-------------EGILNGVTTTT- 155
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
F G TP+ Y++PE+ +G +
Sbjct: 156 ------------FCG-------TPD--------------------YIAPEILQELEYGPS 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VDWWA G+ +YEM+ G+ PF A + + +I+ + +P +S+ A ++ +
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW----LSK-EAVSILKAFM 231
Query: 387 NKDPCNRLG---SKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432
K+P RLG S+ G +K HPFFK +++ L+ R + PP P ++ ++
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKR 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 110/363 (30%), Positives = 164/363 (45%), Gaps = 77/363 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V L + G YAMK++ KEV+ K +V E ++L+
Sbjct: 3 LGKGTFGKVILVK-----EKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 53
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HPFL L F+ + C VME+ +GG+L H + FS ARFY AE++ AL+YL
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 208 HM-LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
H ++YRDLK EN+++ DGHI ++DF LC I + A+ ++ T
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDF--GLCKEGI---------KDGATMKTFCGTP 160
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
+Y ++PEV +G A
Sbjct: 161 EY--------------------------------------------LAPEVLEDNDYGRA 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP-TQSPSSMSEYHARDLISGL 385
VDWW G+ +YEM+ GR PF +E I+ + + FP T SP A+ L+SGL
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP------EAKSLLSGL 230
Query: 386 LNKDPCNRL-GSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIK 442
L KDP RL G A ++ H FF G+ + + + L PP P + + + D++
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFT 290
Query: 443 SQS 445
+Q
Sbjct: 291 AQM 293
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 102/344 (29%), Positives = 156/344 (45%), Gaps = 70/344 (20%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G V C + + LYA K +NK+ L+K+K A +EK+IL +
Sbjct: 1 LGKGGFGEVSACQMRATGK---------LYACKKLNKKRLKKRKGYEGAMVEKRILAKVH 51
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDL--HSLRHKQPHKRFSLTSARFYAAEVLVALE 205
F+ +L F+ C+VM +GGDL H + + F A FY A+++ LE
Sbjct: 52 SRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE 111
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
+LH IIYRDLKPENVL+ +DG++ +SD L AVE Q+ T
Sbjct: 112 HLHQRRIIYRDLKPENVLLDNDGNVRISDLGL--------AVELKD---------GQSKT 154
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
+ Y+ GT +++PE+ G +
Sbjct: 155 KGYA--------------------------------------GTPGFMAPELLQGEEYDF 176
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385
+VD++A G+ +YEMI R PF A + + + ++ L P S ++ L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSP-ASKSFCEAL 235
Query: 386 LNKDPCNRLGSKRGAAD-VKTHPFFKGLNFALIRS--LTPPEIP 426
L KDP RLG + G D ++THP F+ LN+ + + L PP +P
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 98/347 (28%), Positives = 161/347 (46%), Gaps = 77/347 (22%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G G G V+L L + +A+K + K+V+ V +EK++L +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSL 51
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+HPFL LY F+ VME+ +GGDL + H Q +F L A FYAAE++ L
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
++LH GI+YRDLK +N+L+ +DGHI ++DF +C +
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADF--GMCKENM-------------------- 147
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
G K T F P +Y++PE+ G +
Sbjct: 148 ---------------LGDAKTCT------FCGTP------------DYIAPEILLGQKYN 174
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
+VDWW+FG+ +YEM+ G++PF E ++I +P A+D++
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP-----RWLTREAKDILVK 229
Query: 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429
L ++P RLG K D++ HPFF+ ++++ + R + PP P ++
Sbjct: 230 LFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIEPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 85/323 (26%), Positives = 120/323 (37%), Gaps = 111/323 (34%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G GTVYL ++ A+K++ KE + + E +ILK L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKK---------VAIKIIKKE--DSSSLLEELLREIEILKKLN 49
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HP + LY FE N +VME+C GG L L K+ + S ++L LEYL
Sbjct: 50 HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL-LKENEGKLSEDEILRILLQILEGLEYL 108
Query: 208 HMLGIIYRDLKPENVLVRSD-GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
H GII+RDLKPEN+L+ SD G + L+DF LS
Sbjct: 109 HSNGIIHRDLKPENILLDSDNGKVKLADFGLS---------------------------- 140
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG-GSHGN 325
+ S K + VGT Y++PEV G G +
Sbjct: 141 -----------KLLTSDKSLL----------------KTIVGTPAYMAPEVLLGKGYYSE 173
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385
D W+ G+ +YE+ +DLI +
Sbjct: 174 KSDIWSLGVILYEL------------------------------------PELKDLIRKM 197
Query: 386 LNKDPCNRLGSKR-GAADVKTHP 407
L KDP KR A ++ H
Sbjct: 198 LQKDP-----EKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 107/348 (30%), Positives = 157/348 (45%), Gaps = 76/348 (21%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-LEKKKKVHRAEMEKKILKML 146
IG G G V L R+ G YA+KV+ K++ L +K++ H +LK +
Sbjct: 3 IGKGSFGKVLLAK-----RKLDGK----CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HPFL L+ F+ + V++F +GG+L H Q + F ARFYAAE+ AL Y
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGY 111
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH + I+YRDLKPEN+L+ S GH++L+DF LC I ++ +
Sbjct: 112 LHSINIVYRDLKPENILLDSQGHVVLTDF--GLCKEGIAQSDTTTT-------------- 155
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
F P EY++PEV + N
Sbjct: 156 ---------------------------FCGTP------------EYLAPEVIRKQPYDNT 176
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-PTQSPSSMSEYHARDLISGL 385
VDWW G +YEM+YG PF NI+ KPL P S ++ S ++ L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS------ILEEL 230
Query: 386 LNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431
L KD RLG+K +++ HPFF+ L++ + + + PP P +
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGP 278
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 115/374 (30%), Positives = 188/374 (50%), Gaps = 44/374 (11%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ + IG G G V L ++D GH +YAMK++ K + +K++V E+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQ-----KKDTGH----VYAMKILRKADMLEKEQVGHIRAER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
IL D ++ ++ F+ ++MEF GGD+ +L K+ + +FY AE
Sbjct: 53 DILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAET 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
++A++ +H LG I+RD+KP+N+L+ S GH+ LSDF LC+ A R
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDF--GLCTGLKKA------------HR 156
Query: 261 SQTYTRQYSTRLSRFLNRFFGSK-KIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
++ Y + S F + SK K +T NR +A S VGT +Y++PEV
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLA-------FSTVGTPDYIAPEVFM 209
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSMSEYH 377
+ DWW+ G+ +YEM+ G PF + + + T + ++ K+ L FP + P S
Sbjct: 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEK--- 266
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIR---SLTPPEIPGMRRQKTM 434
A+DLI + +R+G+ G ++KT+PFF+G+++ IR + P EI +
Sbjct: 267 AKDLILRFCCEWE-HRIGAP-GVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNF 324
Query: 435 -PFPDQKIKSQSTA 447
FPD I + A
Sbjct: 325 DEFPDSDILKPTVA 338
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-40
Identities = 107/352 (30%), Positives = 153/352 (43%), Gaps = 72/352 (20%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
TFR + R +G G G V C + + +YA K + K+ ++K+K A
Sbjct: 1 TFRHY---RVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMAL 48
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
EK+IL+ ++ F+ +L +E + C+V+ +GGDL + + F A FYA
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
AE+ LE L I+YRDLKPEN+L+ GHI +SD L AV+ P
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL--------AVQIPE------ 154
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
E V R VGT Y++PEV
Sbjct: 155 --------------------------------------GETVRGR----VGTVGYMAPEV 172
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ + + DWW G IYEMI G++PF E R V + + + S
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRK-RKERVKREEVDRRVKEDQEEYSEKFSED 231
Query: 378 ARDLISGLLNKDPCNRLGSK-RGAADVKTHPFFKGLNFALIRS--LTPPEIP 426
A+ + LL K+P RLG + GAA VK HP FK +NF + + L PP P
Sbjct: 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 66/317 (20%)
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGD 175
+YA K ++K+ L+KK A +EK+IL+ ++ PF+ L FE+ C+VM +GGD
Sbjct: 20 MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79
Query: 176 LHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
L + + + Y+A++ + +LH + I+YRD+KPENVL+ G+ LSD
Sbjct: 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDL 139
Query: 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295
L AVE
Sbjct: 140 GL--------AVELKD-------------------------------------------- 147
Query: 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPF----AAPSN 351
+ + R+ GT+ Y++PE+ + VDW+A G IYEM+ GRTPF +
Sbjct: 148 GKTITQRA----GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
Query: 352 ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
E R ++ + F Q+ + ++D+ L K P +RLGS+ D + H FFK
Sbjct: 204 EELKRRTLEDEVKFEHQNFTE----ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259
Query: 412 LNFALIRS--LTPPEIP 426
+NF + + + PP +P
Sbjct: 260 INFPRLEAGLIPPPFVP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 106/352 (30%), Positives = 151/352 (42%), Gaps = 72/352 (20%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
TFR + R +G G G V C + + +YA K + K+ ++K+K A
Sbjct: 1 TFRQY---RVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGESMAL 48
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
EK+IL+ ++ F+ +L +E + C+V+ +GGDL + F A FYA
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
AE+ LE LH I+YRDLKPEN+L+ GHI +S DL L +
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGHIRIS--DLGLAVHV-------------- 152
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
P QT + R VGT Y++PEV
Sbjct: 153 -PEGQT-----------------------------------IKGR----VGTVGYMAPEV 172
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ + DWWA G +YEMI G++PF + + + + S
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSP-D 231
Query: 378 ARDLISGLLNKDPCNRLGSK-RGAADVKTHPFFKGLNFALIRS--LTPPEIP 426
AR L LL KDP RLG + GA +VK HP FK +NF + + L PP P
Sbjct: 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 103/346 (29%), Positives = 161/346 (46%), Gaps = 77/346 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML- 146
IG G G VY C + D G +YAMK ++K+ ++ K+ A E+ +L ++
Sbjct: 2 IGRGGFGEVYGCR-----KADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVS 52
Query: 147 --DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
D PF+ + F + +++ +GGDLH H H FS RFYAAE+++ L
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLSQHGVFSEAEMRFYAAEIILGL 110
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
E++H ++YRDLKP N+L+ GH+ +S DL L +
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRIS--DLGLACD---------------------- 146
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV-ASGGSH 323
F KK P A+ VGTH Y++PEV G ++
Sbjct: 147 ---------------FSKKK-------------PHAS-----VGTHGYMAPEVLQKGVAY 173
Query: 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383
++ DW++ G +++++ G +PF + I + LT + P S S R L+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP-ELRSLLE 231
Query: 384 GLLNKDPCNRLGSK-RGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
GLL +D RLG RGA +VK HPFF+ L++ ++ + PP IP
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 109/353 (30%), Positives = 168/353 (47%), Gaps = 75/353 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF++ + IG G G V + L N + ++AMK++NK + K+ + E+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L D+ ++ TL+ F+ N +VM++ GGDL +L K R ARFY AE+
Sbjct: 53 DVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEM 111
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
++A++ +H L ++RD+KP+N+L+ +GHI L+D
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD-------------------------- 145
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FGS L + E +S VGT +Y+SPE+
Sbjct: 146 -------------------FGSC---------LKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 321 -----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSM 373
G +G DWW+ G+ +YEM+YG TPF A S T I+ K+ FP Q + +
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV-TDV 236
Query: 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
SE A+DLI L+ +RLG + G D K HPFF G+++ IR+ P IP
Sbjct: 237 SE-DAKDLIRRLICSRE-HRLG-QNGIEDFKQHPFFTGIDWDNIRNCEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 105/357 (29%), Positives = 157/357 (43%), Gaps = 85/357 (23%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DFD+ + IG G G V L R + +YAMK+++K + K+ E+
Sbjct: 44 DFDVIKVIGRGAFGEVQLV------RHKSSKQ---VYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFYAA 198
I+ + ++ L+ F+ + +VME+ GGDL +L + P K ARFY A
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-----ARFYTA 149
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS--SPEA 256
EV++AL+ +H +G I+RD+KP+N+L+ GH+ L+DF + +A V + +P+
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 257 ASP---RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
SP +SQ Y R C
Sbjct: 210 ISPEVLKSQGGDGYY--------------------------------GREC--------- 228
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPS 371
DWW+ G+F+YEM+ G TPF A S T I+ K LTFP
Sbjct: 229 --------------DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--I 272
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG--LNFALIRSLTPPEIP 426
+S+ A+DLI L RLG + G ++K+HPFFK F IR P +P
Sbjct: 273 EISK-QAKDLICAFLTDRE-VRLG-RNGVDEIKSHPFFKNDQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 105/320 (32%), Positives = 163/320 (50%), Gaps = 30/320 (9%)
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGD 175
LYAMK + K+ + + +V + E+ IL D+ ++ LY F+ + VM++ GGD
Sbjct: 28 LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87
Query: 176 LHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+ SL + + F ARFY AE+ +A+E +H +G I+RD+KP+N+L+ DGHI L+DF
Sbjct: 88 MMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDF 145
Query: 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295
LC+ + + + ++ RQ S S + + +RL
Sbjct: 146 --GLCTGF-------RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR-----CGDRLKT 191
Query: 296 AEPVAARS---C---SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP 349
E A + C S VGT Y++PEV + DWW+ G+ ++EM+ G+ PF AP
Sbjct: 192 LEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251
Query: 350 S-NETTLRNI-VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407
+ ET L+ I + L P Q S A DLI+ L RLG + GA D+K HP
Sbjct: 252 TPTETQLKVINWENTLHIPPQVKLSP---EAVDLITKLCCSAE-ERLG-RNGADDIKAHP 306
Query: 408 FFKGLNFAL-IRSLTPPEIP 426
FF ++F+ IR+ P +P
Sbjct: 307 FFSEVDFSSDIRTQPAPYVP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 108/320 (33%), Positives = 164/320 (51%), Gaps = 30/320 (9%)
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGD 175
LYAMK + K+ + + +V + E+ IL D+ ++ LY F+ + VM++ GGD
Sbjct: 28 LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 87
Query: 176 LHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+ SL + F ARFY AE+ A+E +H +G I+RD+KP+N+L+ DGHI L+DF
Sbjct: 88 MMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 145
Query: 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295
LC+ + ++ +S + RQ S S N + + +RL
Sbjct: 146 --GLCTGF-------RWTHDSKYYQSGDHVRQDSMDFS---NEWGDPANCR--CGDRLKP 191
Query: 296 AEPVAARS---C---SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP 349
E AAR C S VGT Y++PEV + DWW+ G+ +YEM+ G+ PF A
Sbjct: 192 LERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251
Query: 350 SNETTLRNIVK--KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407
+ T ++ L P Q+ S A DLI L + P +RLG K GA ++K HP
Sbjct: 252 TPLETQMKVINWQTSLHIPPQAKLSP---EASDLIIKLC-RGPEDRLG-KNGADEIKAHP 306
Query: 408 FFKGLNFAL-IRSLTPPEIP 426
FFK ++F+ +R + P IP
Sbjct: 307 FFKTIDFSSDLRQQSAPYIP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 86/330 (26%), Positives = 127/330 (38%), Gaps = 81/330 (24%)
Query: 86 RRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-EMEKKIL 143
+G G G+VYL + L A+K V E+ ++ A E E +IL
Sbjct: 6 ELLGRGSFGSVYLALDKDTG----------ELMAVKSV--ELSGDSEEELEALEREIRIL 53
Query: 144 KMLDHPFLPT-LYAEF-EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
L HP + +E E N I +E+ SGG L SL K + R Y ++L
Sbjct: 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQIL 111
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
L YLH GI++RD+K N+LV SDG + L+DF
Sbjct: 112 EGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC------------------------ 147
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321
+K++ + S GT +++PEV G
Sbjct: 148 --------------------AKRLGDIETGEGTG---------SVRGTPYWMAPEVIRGE 178
Query: 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN-IVKKPLTFPTQSPSSMSEYHARD 380
+G A D W+ G + EM G+ P++ N I P + P +SE A+D
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPEHLSE-EAKD 235
Query: 381 LISGLLNKDPCNRLGSKRG-AADVKTHPFF 409
+ L +DP KR A ++ HPF
Sbjct: 236 FLRKCLRRDP-----KKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 141 bits (354), Expect = 1e-37
Identities = 103/385 (26%), Positives = 147/385 (38%), Gaps = 81/385 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + R++G G G VYL A+KV+ K++ K K+V R E
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLV------------ALKVLAKKLESKSKEVERFLREI 48
Query: 141 KILKMLDHP-FLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARFYAA 198
+IL L+HP + LY F+ +VME+ GG L L + S + A F A
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGH-IMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L ALEYLH GII+RD+KPEN+L+ DG + L DF L+
Sbjct: 109 QILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA------------------- 149
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
+ S + VGT Y++PEV
Sbjct: 150 --------KLLPDPGSTSSIPAL----------------------PSTSVGTPGYMAPEV 179
Query: 318 ASGGSHGN---AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT------- 367
G S + D W+ GI +YE++ G PF N + +K L PT
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 368 -QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIR--SLTPPE 424
S + A DL+ LL KDP NRL S + +H L L P+
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSS----SSDLSHDLLAHLKLKESDLSDLLKPD 295
Query: 425 IPGMRRQKTMPFPDQKIKSQSTAFD 449
R P + I S ++
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAI 320
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 89/330 (26%), Positives = 129/330 (39%), Gaps = 79/330 (23%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
F++ +IG G G VY K R R + A+KV+ E EKK+K+ E
Sbjct: 1 LFEILEKIGKGGFGEVY------KARHKRTGK---EVAIKVIKLESKEKKEKIIN---EI 48
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+ILK HP + Y + + IVMEFCSGG L L + + + E+
Sbjct: 49 QILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKEL 107
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L LEYLH GII+RD+K N+L+ SDG + L D
Sbjct: 108 LKGLEYLHSNGIIHRDIKAANILLTSDGEVKLID-------------------------- 141
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG + T R + VGT +++PEV +G
Sbjct: 142 -------------------FGLSAQLSDTKARN-----------TMVGTPYWMAPEVING 171
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-QSPSSMSEYHAR 379
+ D W+ GI E+ G+ P++ L I P ++P S+ +
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSD-EFK 228
Query: 380 DLISGLLNKDPCNRLGSKR-GAADVKTHPF 408
D + L K+P KR A + HPF
Sbjct: 229 DFLKKCLQKNP-----EKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 102/346 (29%), Positives = 160/346 (46%), Gaps = 77/346 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML- 146
IG G G VY C + D G +YAMK ++K+ ++ K+ A E+ +L ++
Sbjct: 2 IGRGGFGEVYGCR-----KADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVS 52
Query: 147 --DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
D PF+ + F + C +++ +GGDLH H H FS RFYA E+++ L
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY--HLSQHGVFSEKEMRFYATEIILGL 110
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
E++H ++YRDLKP N+L+ GH+ +S DL L +
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRIS--DLGLACD---------------------- 146
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV-ASGGSH 323
F KK P A+ VGTH Y++PEV G ++
Sbjct: 147 ---------------FSKKK-------------PHAS-----VGTHGYMAPEVLQKGTAY 173
Query: 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383
++ DW++ G +++++ G +PF + I + LT + P S S + L+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSP-ELKSLLE 231
Query: 384 GLLNKDPCNRLGSK-RGAADVKTHPFFKGLNF--ALIRSLTPPEIP 426
GLL +D RLG RGA +VK H FFKG+++ ++ PP IP
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 61/157 (38%), Positives = 92/157 (58%), Gaps = 15/157 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN-KEVLEKKKKVHRAEME 139
D + + +G G G V+L + R + YA+KV+ EV+ K++ H E
Sbjct: 2 DLERIKTVGTGTFGRVHLV----RDRISEHY-----YALKVMAIPEVIRLKQEQH-VHNE 51
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
K++LK + HPF+ L+ F ++ME+ GG+L S LR+ RFS ++ FYA+
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYAS 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
E++ ALEYLH I+YRDLKPEN+L+ +GHI L+DF
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 86/338 (25%), Positives = 129/338 (38%), Gaps = 85/338 (25%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP-CCLYAMKVVNKEVLEKKKKVHRAEME 139
D + + +G G G VY H+P +YA+K ++ V ++ + E
Sbjct: 2 DLERVKVLGQGSSGVVYKVR----------HKPTGKIYALKKIH--VDGDEEFRKQLLRE 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
K L+ + P++ Y F IV+E+ GG L L + + + A +
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQ 107
Query: 200 VLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
+L L+YLH II+RD+KP N+L+ S G + ++D
Sbjct: 108 ILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIAD------------------------ 143
Query: 259 PRSQTYTRQYSTRLSRFLNRFFG-SKKI-QTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
FG SK + TL +FVGT Y+SPE
Sbjct: 144 ---------------------FGISKVLENTLDQCN------------TFVGTVTYMSPE 170
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---TTLRNIVKKPLTFPTQSPSSM 373
G S+ A D W+ G+ + E G+ PF P ++ I P P+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP--PSLPAEEF 228
Query: 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
S RD IS L KDP R AA++ HPF K
Sbjct: 229 SP-EFRDFISACLQKDPKKR----PSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 89/333 (26%), Positives = 125/333 (37%), Gaps = 85/333 (25%)
Query: 86 RRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK--KKVHRAEMEKKI 142
+IG G G VY +L+ L A+K + + + K K++ E K+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTG----------ELMAVKEIRIQDNDPKTIKEIAD---EMKV 52
Query: 143 LKMLDHPFLPTLYA-EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF-SLTSARFYAAEV 200
L++L HP L Y E I ME+CSGG L L H R R Y ++
Sbjct: 53 LELLKHPNLVKYYGVEVHREKV-YIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQL 108
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L L YLH GI++RD+KP N+ + +G I L D
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGD-------------------------- 142
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG L N + E V S GT Y++PEV +G
Sbjct: 143 -------------------FGCAVK--LKNNTTTMGEEVQ----SLAGTPAYMAPEVITG 177
Query: 321 GS---HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTFPTQSPSSMSE 375
G HG A D W+ G + EM G+ P++ NE + V P S
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE- 236
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
+D + L DP R A+++ HPF
Sbjct: 237 --GKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 13/179 (7%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF + ++G G G V+L ++ E A+K + K +L K +V E+
Sbjct: 2 DFQILTQVGQGGYGQVFLA------KKKDTGEIV---ALKRMKKSLLFKLNEVRHVLTER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
IL +L L F+ + + ME+ GGD +L + S ARFY AE+
Sbjct: 53 DILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEM 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
A++ LH LG I+RDLKPEN L+ + GHI L+DF LS + S SP+ +P
Sbjct: 111 FEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAP 167
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 57/157 (36%), Positives = 84/157 (53%), Gaps = 15/157 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSL--NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
DF++ +G G G V + +Y YA+K + K + K K+V
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEY-----------YAIKCLKKREILKMKQVQHVAQ 67
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
EK IL L HPF+ + F+ N ++EF GG+L + H + RF A+FY A
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT--HLRKAGRFPNDVAKFYHA 125
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
E+++A EYLH IIYRDLKPEN+L+ + GH+ ++DF
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 13/158 (8%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F+L R IG G G V + ++ ++AMK +NK+ +K V E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKR-DTKK--------MFAMKYMNKQKCVEKGSVRNVLNERR 52
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLR-HKQPHKRFSLTSARFYAAEV 200
IL+ L+HPFL L+ F+ +V++ GGDL R H +FS +F+ E+
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL---RYHLSQKVKFSEEQVKFWICEI 109
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ALEYLH GII+RD+KP+N+L+ GH+ ++DF+++
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 68/160 (42%), Positives = 89/160 (55%), Gaps = 14/160 (8%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R +G G G V L L R LYA+KV+ K+V+ + V EK+IL +
Sbjct: 1 RVLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSL 51
Query: 146 L-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+HPFL LY F+ + VMEF +GGDL + H Q +RF ARFYAAE+ AL
Sbjct: 52 ARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSAL 109
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244
+LH GIIYRDLK +NVL+ +GH L+DF +C I
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADF--GMCKEGI 147
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 54/133 (40%), Positives = 69/133 (51%), Gaps = 7/133 (5%)
Query: 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355
A+ V R+ + GT EY++PEV HG AVDWW G+ +YE I G PF +
Sbjct: 165 AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224
Query: 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF 414
I+ L FP + + ARDL+ GLL D RLG+ K G ADVK HP+F G N+
Sbjct: 225 EKILAGRLKFP-----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279
Query: 415 -ALIRSLTPPEIP 426
L P IP
Sbjct: 280 DKLYARYYPAPIP 292
|
Length = 329 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 54/161 (33%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN-KEVLEKKKKVHRAEME 139
+++ ++IG G G VYL K LY +K ++ + EK+++ A E
Sbjct: 1 KYEIIKQIGKGSFGKVYLVR--RKSDGK-------LYVLKEIDLSNMSEKERE--DALNE 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFYA 197
KILK L+HP + Y FE CIVME+ GGDL + K+ K F +
Sbjct: 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF 109
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ +AL+YLH I++RD+KP+N+ + S+G + L DF +S
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 62/161 (38%), Positives = 91/161 (56%), Gaps = 11/161 (6%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
+ +F + + I G G VYL N + LYA+KVV K + K VH+ +
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSK---------LYAVKVVKKADMINKNMVHQVQ 52
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E+ L + PF+ LY +++N +VME+ GGD+ SL H + F A Y
Sbjct: 53 AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYI 110
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+EV +AL+YLH GII+RDLKP+N+L+ ++GHI L+DF LS
Sbjct: 111 SEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 77/319 (24%), Positives = 120/319 (37%), Gaps = 81/319 (25%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM-- 138
DF++ +IG G G V+ R+ +YAMK ++ L K + R E
Sbjct: 1 DFEILNKIGKGSFGVVF-----KVVRKADKR----VYAMKQID---LSKMNRREREEAID 48
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA-RFYA 197
E ++L LD ++ Y F IVME+ GDLH L Q + RF+
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF- 107
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L+ L +LH I++RD+K N+ + + ++ + D
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD----------------------- 144
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
G K+ L+ N F A + VGT Y+SPE+
Sbjct: 145 ----------------------LGVAKL--LSDNTNF------AN--TIVGTPYYLSPEL 172
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK---KPLTFPTQSPSSMS 374
+ D WA G+ +YE G+ PF A + + I++ P+ S M
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV-------SQMY 225
Query: 375 EYHARDLISGLLNKDPCNR 393
LI L KD R
Sbjct: 226 SQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 81/324 (25%), Positives = 126/324 (38%), Gaps = 72/324 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRAEMEKKILKM 145
+G G G VYLC Y D G E A+K V + E KK+V+ E E ++LK
Sbjct: 10 LGQGAFGRVYLC-----YDVDTGRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKN 60
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L H + Y I ME+ GG + + + + T R Y ++L +E
Sbjct: 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKD--QLKAYGALTETVTRKYTRQILEGVE 118
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
YLH I++RD+K N+L S G++ L DF
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFG----------------------------- 149
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
SK++QT+ + + S GT ++SPEV SG +G
Sbjct: 150 ---------------ASKRLQTICSSGTGMK--------SVTGTPYWMSPEVISGEGYGR 186
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385
D W+ G + EM+ + P+A + I +P Q PS +S AR+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSP-DARNFLRRT 243
Query: 386 LNKDPCNRLGSKRGAADVKTHPFF 409
++ + A ++ H F
Sbjct: 244 FVEN----AKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/190 (33%), Positives = 99/190 (52%), Gaps = 16/190 (8%)
Query: 49 ENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQD 108
+NL L + SD + RK + + DF+ R +G G G V L + N+
Sbjct: 5 KNLQLHKKKDSD------STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNE---- 54
Query: 109 RGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVM 168
P A+K K + K+K+V E+KIL ++HPF LY F+ ++ +V+
Sbjct: 55 -DFPPV---AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110
Query: 169 EFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
EF GG+ + + +KRF FYAA++++ EYL L I+YRDLKPEN+L+ DG
Sbjct: 111 EFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
Query: 229 HIMLSDFDLS 238
I ++DF +
Sbjct: 169 FIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 79/324 (24%), Positives = 129/324 (39%), Gaps = 77/324 (23%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI--LKM 145
+G+G G+VY LN D G +A+K V+ + + ++E++I L
Sbjct: 8 LGSGSFGSVYE-GLNL----DDGD----FFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L HP + + I +E GG L L K + F R Y ++L+ LE
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLE 116
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
YLH ++RD+K N+LV ++G + L+DF +
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGVVKLADFGM---------------------------- 148
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV-ASGGSHG 324
+K++ A+S F G+ +++PEV A G +G
Sbjct: 149 ----------------AKQVVEF----------SFAKS--FKGSPYWMAPEVIAQQGGYG 180
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
A D W+ G + EM G+ P++ + I + P P +S+ A+D I
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI--PDHLSD-EAKDFILK 237
Query: 385 LLNKDPCNRLGSKRGAADVKTHPF 408
L +DP R AA++ HPF
Sbjct: 238 CLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 52/132 (39%), Positives = 72/132 (54%), Gaps = 11/132 (8%)
Query: 302 RSCSFVGTHEYVSPEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
+S VGT +Y+SPE+ G +G DWW+ G+ +YEM+YG TPF A S T
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 357 NIV--KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414
I+ K+ FP E A+DLI L+ P RLG + G D K HPFF+G+++
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEE--AKDLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDW 274
Query: 415 ALIRSLTPPEIP 426
IR+ T P +P
Sbjct: 275 DNIRNSTAPYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 53/134 (39%), Positives = 74/134 (55%), Gaps = 8/134 (5%)
Query: 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355
A+ + R+ + GT EY++PEV H AVDWWA GI IYEM+ G PF +
Sbjct: 148 AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF----FDDNP 203
Query: 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF 414
I +K L + P + + +A+DLI LL D RLG+ K GA DVK H +FK +++
Sbjct: 204 FGIYEKILAGKLEFPRHL-DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262
Query: 415 ALI--RSLTPPEIP 426
+ R L PP +P
Sbjct: 263 DDVPQRKLKPPIVP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 72/325 (22%), Positives = 132/325 (40%), Gaps = 89/325 (27%)
Query: 84 LHRR---IGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
L++R IG G G VY + + A+K++N + + +++
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGR-----------VVALKIINLDTPDDDV----SDI 46
Query: 139 EKKI-----LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTS 192
++++ L+ P + Y + I+ME+ GG + +L P +++
Sbjct: 47 QREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI 106
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
R EVLVAL+Y+H +G+I+RD+K N+LV + G++ L DF +
Sbjct: 107 IR----EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGV--------------- 147
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
AA + R +FVGT +
Sbjct: 148 ---AALLNQNSSKRS-------------------------------------TFVGTPYW 167
Query: 313 VSPEVASGGSHGNA-VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
++PEV + G + + D W+ GI IYEM G P+ S+ R ++ P + P +
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLED 224
Query: 372 SMSEYHARDLISGLLNKDPCNRLGS 396
+ R+ ++ L+++P RL +
Sbjct: 225 NGYSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 60/158 (37%), Positives = 91/158 (57%), Gaps = 12/158 (7%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ +G G G V L +G + LYA+K++ K+V+ + V +EK
Sbjct: 1 DFNFLMVLGKGSFGKVMLAER-------KGTDE--LYAIKILKKDVVIQDDDVECTMVEK 51
Query: 141 KILKMLDHP-FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++L + D P FL L++ F+ + VME+ +GGDL + H Q +F A FYAAE
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAE 109
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237
+ V L +LH GIIYRDLK +NV++ S+GHI ++DF +
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 82/335 (24%), Positives = 123/335 (36%), Gaps = 75/335 (22%)
Query: 81 DFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAE 137
D++L IG G VY +C NN E A+K ++ LEK + V
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNN--------EKV---AIKRID---LEKCQTSVDELR 47
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARFY 196
E + + +HP + Y F + +VM + SGG L + + P
Sbjct: 48 KEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
EVL LEYLH G I+RD+K N+L+ DG + ++DF +S
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---------------- 151
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
TR R +FVGT +++PE
Sbjct: 152 ------LADGGDRTRKVRK-----------------------------TFVGTPCWMAPE 176
Query: 317 V-ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMS 374
V + D W+FGI E+ G P++ P + + + P + T +
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
R +IS L KDP R A ++ H FF
Sbjct: 237 SKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 3e-23
Identities = 83/360 (23%), Positives = 125/360 (34%), Gaps = 120/360 (33%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK------ 140
++G G G VY + G + A+K + R + E+
Sbjct: 6 KLGEGTYGVVYKA-----RDKKTGE----IVALKKI------------RLDNEEEGIPST 44
Query: 141 -----KILKMLDHPFLPTLYAEFEASNFSC-IVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
+LK L HP + L + + +V E+C DL K+P S +
Sbjct: 45 ALREISLLKELKHPNIVKLL-DVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIK 101
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
++L L Y H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA---------------- 145
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
R FG ++T T V T Y +
Sbjct: 146 -----------------------RAFGI-PLRTYTHE---------------VVTLWYRA 166
Query: 315 PEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNI 358
PE+ G H AVD W+ G EMI G+ F S E + +
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226
Query: 359 VKKP---LTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
K P TFP P + + DL+S +L +P R+ +K A HP+F
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE-ALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 72/314 (22%), Positives = 113/314 (35%), Gaps = 72/314 (22%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKK 141
L +++G G G VY +L K G A+K + ++ E+ E E +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGK-----GDGKEVEVAVKTLKEDASEQ----QIEEFLREAR 53
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
I++ LDHP + L IVME+ GGDL K K SL+ +A ++
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
+EYL I+RDL N LV + + +SDF LS R
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---------------------RD 152
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321
Y + + P+ +++PE G
Sbjct: 153 LYDDDYYKVKGGKL----------------------PIR-----------WMAPESLKEG 179
Query: 322 SHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHAR 379
+ D W+FG+ ++E+ G P+ SN L + K L P P +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL-----Y 234
Query: 380 DLISGLLNKDPCNR 393
L+ +DP +R
Sbjct: 235 KLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 46/126 (36%), Positives = 70/126 (55%), Gaps = 9/126 (7%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKP 362
S VG+ +Y++PEV G + VD+W+ G +YE + G PF+ + T N+ K+
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 363 LTFP--TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420
L P ++S+ A DLI+ L+N DP R GS D+K HPFFK +++ +R L
Sbjct: 217 LQRPVYDDPRFNLSD-EAWDLITKLIN-DPSRRFGSLE---DIKNHPFFKEVDWNELREL 271
Query: 421 TPPEIP 426
PP +P
Sbjct: 272 KPPFVP 277
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 83/321 (25%), Positives = 124/321 (38%), Gaps = 75/321 (23%)
Query: 80 RDFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
+F + ++IG G VY +C L+ + + A+K V + K
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGR-----------VVALKKVQIFEMMDAKARQDCL 50
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKR-FSLTSARF 195
E +LK LDHP + A F +N IV+E GDL ++H + KR +
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y ++ ALE++H I++RD+KP NV + + G + L D L
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG----------------- 153
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
RFF SK AA S VGT Y+SP
Sbjct: 154 ----------------------RFFSSKTT--------------AAH--SLVGTPYYMSP 175
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
E + D W+ G +YEM ++PF ++ L ++ KK + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKK-IEKCDYPPLPADH 232
Query: 376 YHA--RDLISGLLNKDPCNRL 394
Y RDL+S +N DP R
Sbjct: 233 YSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 58/158 (36%), Positives = 90/158 (56%), Gaps = 12/158 (7%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ +G G G V L + +G + LYA+K++ K+V+ + V +EK
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-------ERKGTDE--LYAIKILKKDVVIQDDDVECTMVEK 51
Query: 141 KILKMLDHP-FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++L + P FL L++ F+ + VME+ +GGDL + Q RF A FYAAE
Sbjct: 52 RVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAE 109
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237
+ + L +LH GIIYRDLK +NV++ S+GHI ++DF +
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 78/319 (24%), Positives = 121/319 (37%), Gaps = 83/319 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM-E 139
++ L IG G G VY LN + G A+K ++ E + K++ ++ M E
Sbjct: 1 NYQLGDLIGRGAFGVVYK-GLN----LETGD----FVAIKQISLE--KIKEEALKSIMQE 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+LK L HP + E S+ I++E+ G L + K F + Y +
Sbjct: 50 IDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQ 107
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
VL L YLH G+I+RD+K N+L DG + L+DF +
Sbjct: 108 VLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGV---------------------- 145
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+T+L+ V+ S VGT +++PEV
Sbjct: 146 ---------ATKLND------------------------VSKDDASVVGTPYWMAPEVIE 172
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFA--APSNETTLRNIVKK---PLTFPTQSPSSMS 374
A D W+ G + E++ G P+ P L IV+ PL P +S
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRIVQDDHPPL------PEGIS 224
Query: 375 EYHARDLISGLLNKDPCNR 393
+D + KDP R
Sbjct: 225 P-ELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 60/181 (33%), Positives = 99/181 (54%), Gaps = 12/181 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF++ + IG G G V + + N + +YAMK++NK + K+ + E+
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQ---------VYAMKILNKWEMLKRAETACFREER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L D ++ L+ F+ N +VM++ GGDL +L K R ARFY AE+
Sbjct: 53 DVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEM 111
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS--SPEAAS 258
++A++ +H LG ++RD+KP+NVL+ +GHI L+DF L A V+S + +P+ S
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 259 P 259
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 80/330 (24%), Positives = 124/330 (37%), Gaps = 78/330 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F L IG G G VY +++ + Q + A+KV++ E E + ++ + E +
Sbjct: 3 FTLLECIGKGSFGEVYK-AIDKRTNQ--------VVAIKVIDLE--EAEDEIEDIQQEIQ 51
Query: 142 ILKMLDHPFLPTLYAEFEASNFSC-IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
L P++ Y F I+ME+C GG S + T F EV
Sbjct: 52 FLSQCRSPYITKYYGSF-LKGSKLWIIMEYCGGG---SCLDLLKPGKLDETYIAFILREV 107
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L+ LEYLH G I+RD+K N+L+ +G + L+DF +
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGV----------------------- 144
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
S +L+ T++ FV GT +++PEV
Sbjct: 145 --------SGQLT------------STMSKRNTFV------------GTPFWMAPEVIKQ 172
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+ D W+ GI E+ G P + L I K P + +D
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKD 229
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+S LNKDP R +K ++ H F K
Sbjct: 230 FVSLCLNKDPKERPSAK----ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 69/301 (22%), Positives = 103/301 (34%), Gaps = 94/301 (31%)
Query: 139 EKKILKMLDHPFLPTLYAEF-EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E K L+ HP++ L F S F +VME+ DL + + + Y
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFV-LVMEYM-PSDLSEVLRDEERP-LPEAQVKSYM 105
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
+L + Y+H GI++RDLKP N+L+ +DG + ++DF L+ S E
Sbjct: 106 RMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLA----------RLFSEEEP- 154
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
R YS + V T Y +PE+
Sbjct: 155 --------RLYSHQ-----------------------------------VATRWYRAPEL 171
Query: 318 ASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
G VD WA G E++ G F ++ L + + T T + +
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR---TLGTPNEETWPGL 228
Query: 377 H----------------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
A DL+ GLL DP RL AA+ HP+
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL----SAAEALRHPY 284
Query: 409 F 409
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 60/181 (33%), Positives = 99/181 (54%), Gaps = 12/181 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF++ + IG G G V + + + R +YAMK++NK + K+ + E+
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTER---------IYAMKILNKWEMLKRAETACFREER 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L D ++ TL+ F+ N+ +VM++ GGDL +L K R ARFY AE+
Sbjct: 53 NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEM 111
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS--SPEAAS 258
++A+ +H L ++RD+KP+NVL+ +GHI L+DF L N V+S + +P+ S
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 259 P 259
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 70/317 (22%), Positives = 104/317 (32%), Gaps = 78/317 (24%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKK 141
L +++G G G VY +L G A+K + E + R E E
Sbjct: 3 LGKKLGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLK----EGASEEEREEFLEEAS 53
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YAA 198
I+K L HP + L IV E+ GGDL LR LT A
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK----LTLKDLLQMAL 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ +EYL ++RDL N LV + + +S D L
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKIS--DFGLS------------------ 149
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
R Y R L P+ +++PE
Sbjct: 150 -RDIYEDDYYRKRGGGKL---------------------PIK-----------WMAPESL 176
Query: 319 SGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEY 376
G + D W+FG+ ++E+ G P+ SNE L + L P P +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL--- 233
Query: 377 HARDLISGLLNKDPCNR 393
+L+ DP +R
Sbjct: 234 --YELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 42/128 (32%), Positives = 67/128 (52%), Gaps = 9/128 (7%)
Query: 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP 362
+ +F GT +Y++PE+ +G +VDWWA G+ +YEM+ G PF A + + I+
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212
Query: 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS--KRGAADVKTHPFFKGLNFALI--R 418
+ +PT A D++ + K+P RLGS G + HPFFK L++ + R
Sbjct: 213 VVYPT-----WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR 267
Query: 419 SLTPPEIP 426
+ PP P
Sbjct: 268 QIEPPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 81/329 (24%), Positives = 131/329 (39%), Gaps = 77/329 (23%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L +R+G G GTVYL ++R L +K + L + V A E ++L
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEER------LKVLKEIPVGELNPNETVQ-ANQEAQLL 56
Query: 144 KMLDHPFLPTLYAEF-EASNFSCIVMEFCSGGDLH-SLRH-KQPHKRFSLTSARFYAAEV 200
LDHP + +A F E F CI+ E+C G DL L K K S + ++
Sbjct: 57 SKLDHPAIVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L+ + Y+H I++RDLK +N+ ++++ + + DF
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFG------------------------ 150
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+SR L GS + T +F GT Y+SPE
Sbjct: 151 -----------VSRLL---MGSCDLAT-----------------TFTGTPYYMSPEALKH 179
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHAR 379
+ + D W+ G +YEM F + + + IV+ P + P ++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS---- 235
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPF 408
++ +LNKDP R AA++ +PF
Sbjct: 236 -IMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 75/352 (21%), Positives = 119/352 (33%), Gaps = 101/352 (28%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+IG G G VY + A+K + + A E K+LK
Sbjct: 5 GKIGEGTYGVVYKARDKLTGE---------IVAIKKIKLRFESEGIPK-TALREIKLLKE 54
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L+HP + L F +V EF ++ +Q + + Y ++L L
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLA 112
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
+ H GI++RDLKPEN+L+ ++G + L+DF L+ + + YT
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLA----------------RSFGSPVRPYT 156
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG-GSHG 324
TR Y +PE+ G +
Sbjct: 157 HYVVTRW---------------------------------------YRAPELLLGDKGYS 177
Query: 325 NAVDWWAFGIFIYEMIYGRTPF----------------AAPSNE------TTLRNIV--- 359
VD W+ G E++ R F P E + RN
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 360 --KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
K + P P++ + A DL+S +L+ DP R+ A HP+F
Sbjct: 238 PKKAGMPLPKLFPNASPQ--ALDLLSQMLHYDPHKRI----TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 75/277 (27%), Positives = 111/277 (40%), Gaps = 64/277 (23%)
Query: 121 VVNKEV--LEKKKKVHRAEM-EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLH 177
VV KEV +K R + E IL +L HP + Y F N I ME+ +GG L+
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87
Query: 178 SLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237
+Q + F +Y +++ A+ Y+H GI++RD+K N+ + G I L DF +
Sbjct: 88 DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAE 297
SK + + E
Sbjct: 148 --------------------------------------------SKILGS---------E 154
Query: 298 PVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN 357
A + VGT Y+SPE+ G + D WA G +YE++ + F A +N L
Sbjct: 155 YSMAETV--VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVV 211
Query: 358 -IVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
IV+ T P S S SE + L+ LL +DP R
Sbjct: 212 KIVQGNYT-PVVSVYS-SELIS--LVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 18/191 (9%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
RK + D+D+ + IG G G V L + +K Q +YAMK+++K + K+
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQL--VRHKSSQK-------VYAMKLLSKFEMIKRSD 86
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSL 190
E+ I+ + P++ L+ F+ + +VME+ GGDL +L + P K
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW--- 143
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD--LSLCSNAIPAVE 248
A+FY AEV++AL+ +H +G+I+RD+KP+N+L+ GH+ L+DF + + + +
Sbjct: 144 --AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 249 SPASSPEAASP 259
+ +P+ SP
Sbjct: 202 TAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 74/317 (23%), Positives = 118/317 (37%), Gaps = 79/317 (24%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKK 141
L +++G G G VY L K + A+K + ++ E+ E E +
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGK--GGKKKVEV---AVKTLKEDASEQ----QIEEFLREAR 53
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YAA 198
I++ LDHP + L IVME+ GGDL S LR +P L+ + +A
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFAL 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ +EYL I+RDL N LV + + +SDF L S +
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLY------------- 153
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
Y R+ +L P+ +++PE
Sbjct: 154 --DDDYYRKRGGKL-------------------------PIR-----------WMAPESL 175
Query: 319 SGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEY 376
G + D W+FG+ ++E+ G P+ SNE L + L P P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL--- 232
Query: 377 HARDLISGLLNKDPCNR 393
DL+ +DP +R
Sbjct: 233 --YDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 80/312 (25%), Positives = 123/312 (39%), Gaps = 77/312 (24%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R +G G G V+LC R L +K + E + K ++ A+ E ++LK+
Sbjct: 6 RVVGRGAFGIVHLC---------RRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKL 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L HP + Y F IVME+ GG L K+ + + + ++L+AL
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIM---LSDFDLSLCSNAIPAVESPASSPEAASPRSQ 262
++H I++RDLK +N+L+ D H M + DF +S + S +S+
Sbjct: 116 HVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGIS----------------KILSSKSK 157
Query: 263 TYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322
YT VGT Y+SPE+ G
Sbjct: 158 AYT----------------------------------------VVGTPCYISPELCEGKP 177
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP-SSMSEYHARDL 381
+ D WA G +YE+ + F A + L +V K + T +P S R L
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN----LPALVLK-IMSGTFAPISDRYSPDLRQL 232
Query: 382 ISGLLNKDPCNR 393
I +LN DP R
Sbjct: 233 ILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 93/365 (25%), Positives = 157/365 (43%), Gaps = 81/365 (22%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
R + D+++ + IG G G V L + +K + +YAMK+++K + K+
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQL--VRHKSTRK-------VYAMKLLSKFEMIKRSD 86
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSL 190
E+ I+ + P++ L+ F+ + +VME+ GGDL +L + P K
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW--- 143
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD--LSLCSNAIPAVE 248
ARFY AEV++AL+ +H +G I+RD+KP+N+L+ GH+ L+DF + + + +
Sbjct: 144 --ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201
Query: 249 SPASSPEAASP---RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
+ +P+ SP +SQ Y + F + + TP F A+ S
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP---FYAD-------S 251
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF 365
VGT+ + +H N+ LTF
Sbjct: 252 LVGTYSKIM-------NHKNS------------------------------------LTF 268
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL--IRSLTPP 423
P + S A++LI L D RLG + G ++K H FFK +A +R P
Sbjct: 269 PDDNDISKE---AKNLICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWETLRDTVAP 323
Query: 424 EIPGM 428
+P +
Sbjct: 324 VVPDL 328
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 51/130 (39%), Positives = 72/130 (55%), Gaps = 17/130 (13%)
Query: 307 VGTHEYVSPEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361
VGT +Y+SPE+ G +G DWW+ G+ +YEM+YG TPF A S T I+
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
Query: 362 PLTFPTQSPSSMSEY--HARDLISGLLNKDPCN---RLGSKRGAADVKTHPFFKGLNFAL 416
F Q PS +++ A+DLI L+ C+ RLG + G D K H FF+G+++
Sbjct: 224 EERF--QFPSHITDVSEEAKDLIQRLI----CSRERRLG-QNGIEDFKKHAFFEGIDWEN 276
Query: 417 IRSLTPPEIP 426
IR+L P IP
Sbjct: 277 IRNLEAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 42/125 (33%), Positives = 72/125 (57%), Gaps = 8/125 (6%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+F GT +Y++PE+ + +G +VDWWAFG+ +YEM+ G+ PF + ++I++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLG-SKRGAADVKTHPFFKGLNFALI--RSLT 421
+ P SMS+ A + GL+ K P RLG G D+K H FF+ +++ + + +
Sbjct: 220 Y----PKSMSK-EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQ 274
Query: 422 PPEIP 426
PP P
Sbjct: 275 PPYKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 74/329 (22%), Positives = 114/329 (34%), Gaps = 101/329 (30%)
Query: 120 KVVNKEVLEKKKKVHRAEM--------EKKILKMLDHPFLPTLY---AEFEASNFSCIVM 168
K + V KK ++ + E K+L+ L HP + L + +V
Sbjct: 21 KKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY-MVF 79
Query: 169 EFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
E+ DL L P +F+ + + Y ++L L+YLH GI++RD+K N+L+ +DG
Sbjct: 80 EYMDH-DLTGL-LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG 137
Query: 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTL 288
+ L+DF L+ R + +
Sbjct: 138 VLKLADFGLA---------------------------------------RPYTKRNSADY 158
Query: 289 TPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFA 347
T NR V T Y PE+ G +G VD W+ G + E+ G+ F
Sbjct: 159 T-NR--------------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203
Query: 348 APSNETTLRNI--------------VKKPLTF----PTQS-PSSMSEY-------HARDL 381
+ L I V K F P + + E+ A DL
Sbjct: 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDL 263
Query: 382 ISGLLNKDPCNRLGSKRG-AADVKTHPFF 409
+ LL DP KR A H +F
Sbjct: 264 LDKLLTLDP-----KKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 12/109 (11%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---LRNIVKK 361
S GT Y++PEV + AVDWW+ G+ YE + G+ P+ S
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217
Query: 362 PLTFP-TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
+ +P T S ++ D I+ LL +DP RLG D+K HP+F
Sbjct: 218 DVLYPATWSTEAI------DAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 40/125 (32%), Positives = 73/125 (58%), Gaps = 8/125 (6%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+F GT +Y++PE+ + +G +VDWWA+G+ +YEM+ G+ PF + ++I++ ++
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLG-SKRGAADVKTHPFFKGLNFALI--RSLT 421
+ P S+S+ A + GL+ K P RLG G D++ H FF+ +++ + R +
Sbjct: 220 Y----PKSLSK-EAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQ 274
Query: 422 PPEIP 426
PP P
Sbjct: 275 PPFKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 73/316 (23%), Positives = 123/316 (38%), Gaps = 76/316 (24%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+++ R +G G G L N ++ YAMK + V + E
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQK---------YAMKEIRLPK--SSSAVEDSRKEA 49
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L + HP + FEA IVME+C GGDL Q K F + + ++
Sbjct: 50 VLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ ++++H +++RD+K +N+ + +G + L D
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGD-------------------------- 143
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FGS ++ + P A +C++VGT YV PE+
Sbjct: 144 -------------------FGSARL---------LTSPGAY-ACTYVGTPYYVPPEIWEN 174
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK---KPLTFPTQSPSSMSEYH 377
+ N D W+ G +YE+ + PF A S + + + + KPL PS S Y
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL------PSHYS-YE 227
Query: 378 ARDLISGLLNKDPCNR 393
R LI + ++P +R
Sbjct: 228 LRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 76/325 (23%), Positives = 120/325 (36%), Gaps = 84/325 (25%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM-- 138
D+++ IG G GTV K R+ + + K ++ + +K+K +
Sbjct: 1 DYEVLETIGKGSFGTVR------KVRRKSDGK---ILVWKEIDYGNMTEKEK----QQLV 47
Query: 139 -EKKILKMLDHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSA 193
E IL+ L HP + Y ++ IVME+C GGDL L + K+ K
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 194 RFYAAEVLVALEYLHMLG-----IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
++L+AL H +++RDLKP N+ + ++ ++ L D
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD-------------- 153
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
FG KI L + F ++VG
Sbjct: 154 -------------------------------FGLAKI--LGHDSSFAK--------TYVG 172
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ 368
T Y+SPE + S+ D W+ G IYE+ PF A + I + F
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FRR- 229
Query: 369 SPSSMSEYHARDLISGLLNKDPCNR 393
P S ++I +LN DP R
Sbjct: 230 IPYRYSS-ELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 72/308 (23%), Positives = 121/308 (39%), Gaps = 69/308 (22%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
++IG G G L +Q Y +K +N + K++ + E +L
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQ---------YVIKEINISKMSPKER-EESRKEVAVLSN 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
+ HP + FE + IVM++C GGDL+ + Q F + ++ +AL+
Sbjct: 56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
++H I++RD+K +N+ + DG I L DF
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFG----------------------------- 146
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
++R LN T+ R + P Y+SPE+ + N
Sbjct: 147 ------IARVLN--------STVELARTCIGTPY------------YLSPEICENRPYNN 180
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385
D WA G +YEM + F A + ++N+V K + SS Y R+L+S L
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 386 LNKDPCNR 393
++P +R
Sbjct: 237 FKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 51/128 (39%), Positives = 67/128 (52%), Gaps = 13/128 (10%)
Query: 307 VGTHEYVSPEV----ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--K 360
VGT +Y+SPEV G +G DWW+ G+F++EM+ G TPF A S T I+ K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG--LNFALIR 418
L FP S HA++LI L D RLG + G ++K HPFFK N+ IR
Sbjct: 264 NSLNFPEDVEISK---HAKNLICAFLT-DREVRLG-RNGVEEIKQHPFFKNDQWNWDNIR 318
Query: 419 SLTPPEIP 426
P +P
Sbjct: 319 ETAAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 50/160 (31%), Positives = 69/160 (43%), Gaps = 15/160 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCL-YAMKVVNKEVLEKKKKVHRAEME 139
D + +GAG+ G V H P A+K + E+ E +K + E
Sbjct: 2 DLEYLGELGAGNSGVVSKVL----------HRPTGKIMAVKTIRLEINEAIQK--QILRE 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
IL + P++ Y F + I ME+ GG L + K+ R A
Sbjct: 50 LDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVA 108
Query: 200 VLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
VL L YLH II+RD+KP N+LV S G I L DF +S
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 59/267 (22%), Positives = 96/267 (35%), Gaps = 85/267 (31%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
+V E DL + K P + + ++L +++LH I++RDLKP+N+LV
Sbjct: 83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141
Query: 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI 285
SDG + ++DF L ++ Y+ + +
Sbjct: 142 SDGQVKIADFGL-----------------------ARIYSFEMA---------------- 162
Query: 286 QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP 345
LT V T Y +PEV S+ VD W+ G E+ + R P
Sbjct: 163 --LTS---------------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRP 204
Query: 346 -FAAPSNETTL----------------RNIVKKPLTFPTQSPSSMSEY------HARDLI 382
F S L RN+ +FP+ +P S + DL+
Sbjct: 205 LFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLL 264
Query: 383 SGLLNKDPCNRLGSKRGAADVKTHPFF 409
+L +P R+ A + HP+F
Sbjct: 265 KKMLTFNPHKRI----SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 42/120 (35%), Positives = 66/120 (55%), Gaps = 6/120 (5%)
Query: 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355
A+ V R+ + GT EY++PE+ HG A DWW GIFIYE++ G PF A
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF 414
+ I++ + FP + + + L+ LL+ D R G+ K+GA +VK HP+F +++
Sbjct: 238 QKILEGIIYFP-----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 84/361 (23%), Positives = 129/361 (35%), Gaps = 111/361 (30%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE--ME 139
+ + +++G G G+VYL L A+K + KKK + E M
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGE---------LVAIKKM-------KKKFYSWEECMN 44
Query: 140 ----KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
K + K+ +HP + L F ++ V E+ G +L+ L + K FS + R
Sbjct: 45 LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRS 103
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
++L L ++H G +RDLKPEN+LV + ++DF L A E + P
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPP- 154
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
YT STR Y +P
Sbjct: 155 --------YTDYVSTRW---------------------------------------YRAP 167
Query: 316 EV--ASGGSHGNAVDWWAFGIFIYEMIYGRTPFA----------------APSNETTLRN 357
E+ S S+ + VD WA G + E+ R F P+ +
Sbjct: 168 EILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 358 IV---KKPLTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
K FP +P+S+ + A DLI +L DP R A+ HP+
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP----TASQALQHPY 282
Query: 409 F 409
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 88/359 (24%), Positives = 122/359 (33%), Gaps = 116/359 (32%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKV-HRAEM-------- 138
+G G VY K R K + V KK K+ R E
Sbjct: 8 LGEGTYAVVY------KARD------------KETGRIVAIKKIKLGERKEAKDGINFTA 49
Query: 139 --EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E K+L+ L HP + L F + +V EF DL + K + + Y
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI-KDKSIVLTPADIKSY 107
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
L LEYLH I++RDLKP N+L+ SDG + L+DF L+
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA------------------ 149
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
R FGS PNR + V T Y +PE
Sbjct: 150 ---------------------RSFGS-------PNRKMTHQ---------VVTRWYRAPE 172
Query: 317 VASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNI--------------VK 360
+ G H G VD W+ G E++ R PF ++ L I V
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 361 K---PLTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ F P+ + + A DL+ LL +P R+ A HP+F
Sbjct: 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI----TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF + +++G G G+VY + + YA+K V+ + +K++ A E
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDLGSMSQKER-EDAVNEI 50
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF--YAA 198
+IL ++HP + + F N CIVME+ GDL K+ KR +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++L L+ LH I++RDLK N+L+ ++ + + D +S
Sbjct: 111 QLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 87/324 (26%), Positives = 130/324 (40%), Gaps = 73/324 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKV-VNKEVLEKKKKVHRAEMEKKILKML 146
+G G G VYLC Y D G E L A +V + E E K+V E E ++LK L
Sbjct: 10 LGQGAFGRVYLC-----YDVDTGRE---LAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 147 DHPFLPTLYAEFE--ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
H + Y A I ME+ GG + + + + + R Y ++L +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGM 119
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
YLH I++RD+K N+L S G++ L DF
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFG---------------------------- 151
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
SK++QT+ RS + GT ++SPEV SG +G
Sbjct: 152 ----------------ASKRLQTI------CMSGTGIRSVT--GTPYWMSPEVISGEGYG 187
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
D W+ G + EM+ + P+A + I +P T P Q PS +SE HARD +
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNP-QLPSHISE-HARDFLGC 244
Query: 385 LLNKDPCNRLGSKRGAADVKTHPF 408
+ + + A ++ HPF
Sbjct: 245 IFVEAR-----HRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 93/367 (25%), Positives = 148/367 (40%), Gaps = 90/367 (24%)
Query: 51 LSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRG 110
L L P SS + S+ ++ + + + RIG+G GTVY K
Sbjct: 45 LPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVY------KVI---- 94
Query: 111 HEPCC-LYAMKVV--NKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167
H P LYA+KV+ N E ++++ R E +IL+ ++HP + + F+ + ++
Sbjct: 95 HRPTGRLYALKVIYGNHED-TVRRQICR---EIEILRDVNHPNVVKCHDMFDHNGEIQVL 150
Query: 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227
+EF GG L ++F AR ++L + YLH I++RD+KP N+L+ S
Sbjct: 151 LEFMDGGSLEG--THIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSA 204
Query: 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQT 287
++ ++DF +SR L QT
Sbjct: 205 KNVKIADFG-----------------------------------VSRILA--------QT 221
Query: 288 LTPNRLFVAEPVAARSC-SFVGTHEYVSPE-----VASGGSHGNAVDWWAFGIFIYEMIY 341
+ P C S VGT Y+SPE + G G A D W+ G+ I E
Sbjct: 222 MDP-------------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 342 GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401
GR PF + ++ P ++P++ S R IS L ++P R A
Sbjct: 269 GRFPFGVGRQGDWASLMCAICMSQPPEAPATASR-EFRHFISCCLQREPAKR----WSAM 323
Query: 402 DVKTHPF 408
+ HPF
Sbjct: 324 QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK--KIL 143
+++G G G VY L K A+K + ++ E+++K + K +++
Sbjct: 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERK----DFLKEARVM 50
Query: 144 KMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF----SLTSARF-- 195
K L HP + L E +V+E+ GGDL LR +P +L+
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPL-YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+A ++ +EYL ++RDL N LV D + +SDF LS
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 18/151 (11%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G G VY R G E A+K + L K+ K E I+K
Sbjct: 26 KIGEGASGEVYKA----TDRAT-GKE----VAIKKMR---LRKQNK-ELIINEILIMKDC 72
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR--FYAAEVLVAL 204
HP + Y + + +VME+ GG L + + + + EVL L
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGL 129
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
EYLH +I+RD+K +N+L+ DG + L+DF
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 83/321 (25%), Positives = 129/321 (40%), Gaps = 79/321 (24%)
Query: 81 DFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+F + ++IG G VY C L+ P L +++ ++++ K RA+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLD--------GVPVALKKVQIF--DLMDAKA---RADC 49
Query: 139 EKKI--LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARF 195
K+I LK L+HP + YA F N IV+E GDL + +H + KR +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109
Query: 196 -YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
Y ++ ALE++H +++RD+KP NV + + G + L D L
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG---------------- 153
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
RFF SK AA S VGT Y+S
Sbjct: 154 -----------------------RFFSSKT--------------TAAH--SLVGTPYYMS 174
Query: 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--PLTFPTQSPSS 372
PE + D W+ G +YEM ++PF ++ L ++ KK +P PS
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPL-PSD 231
Query: 373 MSEYHARDLISGLLNKDPCNR 393
R L++ +N DP R
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 77/319 (24%), Positives = 125/319 (39%), Gaps = 75/319 (23%)
Query: 81 DFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+F + ++IG G VY C L+ K P L +++ E+++ K +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRK--------PVALKKVQIF--EMMDAKAR-QDCVK 51
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARF-Y 196
E +LK L+HP + F N IV+E GDL + ++ + KR + Y
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
++ A+E++H +++RD+KP NV + + G + L D L
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG------------------ 153
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
RFF SK AA S VGT Y+SPE
Sbjct: 154 ---------------------RFFSSKT--------------TAAH--SLVGTPYYMSPE 176
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--PLTFPTQSPSSMS 374
+ D W+ G +YEM ++PF ++ L ++ +K +P S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 375 EYHARDLISGLLNKDPCNR 393
E R+L+S + DP R
Sbjct: 235 E-KLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 33/167 (19%)
Query: 81 DFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVV--NKEVLEKKKKVHRA 136
FD+ ++G G G+VY + + A+KVV +++ E K
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQV-----------VAIKVVPVEEDLQEIIK----- 47
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGG---DLHSLRHKQPHKRFSLTSA 193
E ILK D P++ Y + + IVME+C G D+ + +K +LT
Sbjct: 48 --EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK------TLTEE 99
Query: 194 RFYA--AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A + L LEYLH I+RD+K N+L+ +G L+DF +S
Sbjct: 100 EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 80/327 (24%), Positives = 132/327 (40%), Gaps = 82/327 (25%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G GTVY G E A+K +N L+++ K E +++
Sbjct: 26 KIGQGASGTVYTAI-----DVATGQE----VAIKQMN---LQQQPKKELIINEILVMREN 73
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
HP + + + +VME+ +GG L + + + + E L ALE+
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEF 130
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH +I+RD+K +N+L+ DG + L+DF C+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDF--GFCA------------------------- 163
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
+TP + ++ + VGT +++PEV + ++G
Sbjct: 164 --------------------QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI--VKKPLTFPTQSPSSMSEYHARDLISG 384
VD W+ GI EM+ G P+ NE LR + + T Q+P +S RD ++
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIF-RDFLNR 251
Query: 385 LLNKDPCNRLGSKRGAA-DVKTHPFFK 410
L D KRG+A ++ HPF K
Sbjct: 252 CLEMDV-----EKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 77/302 (25%), Positives = 117/302 (38%), Gaps = 70/302 (23%)
Query: 115 CLYAMKVVNKEVLEKK---KKVHRAEM---EKKILKMLDHPFLPTLYAEFEASNFSCIVM 168
C+ K K+V KK +K R E+ E I++ H + +Y + + +VM
Sbjct: 39 CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98
Query: 169 EFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
EF GG L + H R + VL AL YLH G+I+RD+K +++L+ SDG
Sbjct: 99 EFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155
Query: 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTL 288
I LS D C+
Sbjct: 156 RIKLS--DFGFCAQ---------------------------------------------- 167
Query: 289 TPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA 348
V++ V R S VGT +++PEV S +G VD W+ GI + EMI G P+
Sbjct: 168 ------VSKEVPKRK-SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF- 219
Query: 349 PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
NE L+ + + P P + ++ G L+ + A ++ HPF
Sbjct: 220 --NEPPLQAMRRIRDNLP---PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274
Query: 409 FK 410
K
Sbjct: 275 LK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 81/331 (24%), Positives = 127/331 (38%), Gaps = 88/331 (26%)
Query: 115 CLYAMKVVNKEVLEKK---KKVHRAEM---EKKILKMLDHPFLPTLYAEFEASNFSCIVM 168
C+ +K K V KK +K R E+ E I++ H + +Y + + +VM
Sbjct: 37 CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96
Query: 169 EFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
EF GG L + H R + VL AL LH G+I+RD+K +++L+ DG
Sbjct: 97 EFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG 153
Query: 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTL 288
+ LSDF C+ SK++
Sbjct: 154 RVKLSDF--GFCAQV--------------------------------------SKEVP-- 171
Query: 289 TPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA 348
R S VGT +++PE+ S +G VD W+ GI + EM+ G P+
Sbjct: 172 -------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF- 217
Query: 349 PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN----KDPCNRLGSKRGAADVK 404
NE L+ + P P + + + G L+ +DP R AA++
Sbjct: 218 --NEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELL 268
Query: 405 THPFFKGLNFALIRSLTPPE--IPGMRRQKT 433
HPF + PP +P MR+ +
Sbjct: 269 KHPF--------LAKAGPPSCIVPLMRQNRM 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 68/311 (21%), Positives = 101/311 (32%), Gaps = 89/311 (28%)
Query: 128 EKKKKVHRAEM-EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK 186
E + V + + E K+L+ L H + L F +V E+ L L P
Sbjct: 38 EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASP-G 95
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
+ R Y ++L A+ Y H II+RD+KPEN+LV G + L DF +
Sbjct: 96 GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA-------- 147
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
R ++ LT +
Sbjct: 148 -------------------------------RALRARPASPLT---------------DY 161
Query: 307 VGTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-------------- 351
V T Y +PE+ G ++G VD WA G + E++ G F S+
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221
Query: 352 -----ETTLRNIVKKPLTFPTQS--------PSSMSEYHARDLISGLLNKDPCNRLGSKR 398
E N + FP S A D + L DP RL
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL---- 277
Query: 399 GAADVKTHPFF 409
++ HP+F
Sbjct: 278 TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 78/336 (23%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G G V + + RQ A+K+++ L K+++ E I++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQ---------VAVKMMD---LRKQQRRELLFNEVVIMRDY 75
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
H + +Y + ++MEF GG L + + R + VL AL Y
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCY 132
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH G+I+RD+K +++L+ DG + LS D C+
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLS--DFGFCA------------------------- 165
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
+I P R S VGT +++PEV S +G
Sbjct: 166 -----------------QISKDVPKRK-----------SLVGTPYWMAPEVISRTPYGTE 197
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
VD W+ GI + EM+ G P+ + S ++ + P P + RD + +L
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP--PKLKNAHKISPVLRDFLERML 255
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422
++P R A ++ HPF L L L P
Sbjct: 256 TREPQER----ATAQELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 8e-15
Identities = 89/346 (25%), Positives = 139/346 (40%), Gaps = 84/346 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + + +IG G GTV+ G E A+K +N L+K+ K E
Sbjct: 19 KKYTRYEKIGQGASGTVFTAI-----DVATGQE----VAIKQIN---LQKQPKKELIINE 66
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++K L +P + F + +VME+ +GG L + + + + E
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRE 123
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
L ALE+LH +I+RD+K +NVL+ DG + L+DF C+ P S
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDF--GFCAQITP----------EQSK 171
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
RS + VGT +++PEV +
Sbjct: 172 RS-------------------------------------------TMVGTPYWMAPEVVT 188
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN--IVKKPLTFPTQSPSSMSEYH 377
++G VD W+ GI EM+ G P+ NE LR ++ T Q+P +S
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSPIF 245
Query: 378 ARDLISGLLNKDPCNRLGSKRGAA-DVKTHPFFKGLNFALIRSLTP 422
RD ++ L D KRG+A ++ HPF K + SLTP
Sbjct: 246 -RDFLNRCLEMDV-----EKRGSAKELLQHPFLKLAK--PLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 52/158 (32%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D++L +RIG+G G VY K R E L A+KV+ LE + E
Sbjct: 4 DYELIQRIGSGTYGDVY------KARDIATGE---LVAIKVIK---LEPGDDFEIIQQEI 51
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+LK HP + + + + IVME+C GG L + L A + E
Sbjct: 52 SMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA-YVCRET 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L L YLH G I+RD+K N+L+ DG + L+DF +S
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 86/335 (25%), Positives = 132/335 (39%), Gaps = 87/335 (25%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV---NKEVLEKKKKVHRAEMEKKILK 144
+G G G VY + + E L A KV+ ++E LE + E+E IL
Sbjct: 20 LGDGAFGKVY---------KAKNKETGALAAAKVIETKSEEELED----YMVEIE--ILA 64
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+HP++ L F I++EFC GG + ++ + + + + ++L AL
Sbjct: 65 TCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEAL 123
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
+YLH + II+RDLK NVL+ DG I L+DF +S
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS-------------------------- 157
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
+K ++TL R SF+GT +++PEV +
Sbjct: 158 -----------------AKNVKTLQ------------RRDSFIGTPYWMAPEVVMCETMK 188
Query: 325 NA-----VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHA 378
+ D W+ GI + EM P + L I K +P T S SM E+
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM-EFR- 246
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
D + L+K P R AA + HPF +
Sbjct: 247 -DFLKTALDKHPETR----PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN-KEVLEKKKKVHRAEMEKKILK 144
R+G G G+V C L N ++A+K + + +K++ R E +I K
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGM---------IFALKTITTDPNPDLQKQILR---ELEINK 54
Query: 145 MLDHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY---AAE 199
P++ Y F E+S+ I ME+C GG L S+ +K+ KR + A
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSI-YKKVKKRGGRIGEKVLGKIAES 113
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
VL L YLH II+RD+KP N+L+ G + L DF +S
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 82/328 (25%), Positives = 129/328 (39%), Gaps = 76/328 (23%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMK-VVNKEVLEKKKKVHRA-----EMEKK 141
IG+G G+VYL +N + L A+K V V K R+ E
Sbjct: 8 IGSGSFGSVYL-GMNASSGE--------LMAVKQVELPSVSASSKDRKRSMLDALAREIA 58
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
+LK L H + ++ I +E+ GG + +L + + F T R + ++L
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQIL 116
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
L YLH GII+RD+K N+LV + G I +SDF +
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGI------------------------ 152
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQ-TLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
SKK++ + A P S G+ +++PEV
Sbjct: 153 --------------------SKKLEANSLSTKTNGARP------SLQGSVFWMAPEVVKQ 186
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
S+ D W+ G + EM+ G+ PF + T L+ I K + PS++S A D
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPEIPSNISS-EAID 242
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPF 408
+ D N+ + AA++ HPF
Sbjct: 243 FLEKTFEID-HNK---RPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 41/120 (34%), Positives = 70/120 (58%), Gaps = 6/120 (5%)
Query: 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
+GT +Y++PE+ G HG AVDWWA G+ ++E + G PF + + +NI+ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
+ +S +A++ I LL DP R G K ++K HP F G+++ +++ T P IP
Sbjct: 601 -EGEEKLSV-NAQNAIEILLTMDPTKRAGLK----ELKQHPLFHGVDWENLQNQTMPFIP 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 86/344 (25%), Positives = 128/344 (37%), Gaps = 92/344 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
F+L IG G G VY + + K Q L A+K+++ E++ + E
Sbjct: 7 IFELVEVIGEGTYGKVYK-ARHKKTGQ--------LVAIKIMDIIEDEEE----EIKEEY 53
Query: 141 KILKML-DHPFLPTLYAEFEASNFSC------IVMEFCSGG---DLHSLRHKQPHKRFSL 190
IL+ +HP + T Y F N +VME C GG DL K+ KR
Sbjct: 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKE 112
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
+ E L L YLH +I+RD+K +N+L+ + + L DF +S
Sbjct: 113 EWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS------------ 160
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
Q + L R N F G TP
Sbjct: 161 ---------------AQLDSTLGR-RNTFIG-------TPY------------------- 178
Query: 311 EYVSPEVAS-----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF 365
+++PEV + S+ D W+ GI E+ G+ P L I + P
Sbjct: 179 -WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-- 235
Query: 366 PT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
PT +SP + S+ D IS L K+ R + ++ HPF
Sbjct: 236 PTLKSPENWSKKF-NDFISECLIKNYEQRPFME----ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
R +++G G G V LC + D E A+K +N E+ HR++
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPL--GDNTGE---QVAVKSLNHSGEEQ----HRSDF 53
Query: 139 EKKI--LKMLDHPFLPTL--YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
E++I L+ LDH + E ++ME+ G SLR R + R
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG---SLRDYLQRHRDQINLKR 110
Query: 195 F--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+++++ ++YL I+RDL N+LV S+ + +SDF L+
Sbjct: 111 LLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 78/306 (25%), Positives = 120/306 (39%), Gaps = 70/306 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV--NKEVLEKKKKVHRAEM 138
++ L + +G G G VYLC Y D G E A+K V + E E K+V+ E
Sbjct: 3 NWRLGKLLGQGAFGRVYLC-----YDADTGRE----LAVKQVQFDPESPETSKEVNALEC 53
Query: 139 EKKILKMLDHPFLPTLYAEFE--ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ++LK L H + Y I ME GG + + + + R Y
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKY 111
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
++L + YLH I++RD+K N+L S G++ L DF
Sbjct: 112 TRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG-------------------- 151
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
SK++QT+ + + S GT ++SPE
Sbjct: 152 ------------------------ASKRLQTICLSGTGMK--------SVTGTPYWMSPE 179
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V SG +G D W+ G + EM+ + P+A + I +P T P P +S+
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-TNP-VLPPHVSD- 236
Query: 377 HARDLI 382
H RD +
Sbjct: 237 HCRDFL 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 85/375 (22%), Positives = 133/375 (35%), Gaps = 121/375 (32%)
Query: 82 FDLH------RRIGAGDIGTVYLCS-LNNKYRQDRGHEPCCLYAMKVVNK--EVLEKKKK 132
FD+ IG+G G V CS ++ + + A+K + +V K+
Sbjct: 1 FDVGSRYKPIENIGSGAYGVV--CSAIDTRSGKK--------VAIKKIPHAFDVPTLAKR 50
Query: 133 VHRAEMEKKILKMLDHP--------FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH-KQ 183
R E KIL+ H P A+F+ +ME DLH + H Q
Sbjct: 51 TLR---ELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLME----SDLHHIIHSDQ 102
Query: 184 PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
P + R++ ++L L+Y+H +I+RDLKP N+LV D + + DF ++
Sbjct: 103 P---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL-- 157
Query: 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303
+SSP + + +Y
Sbjct: 158 -------SSSPT----EHKYFMTEY----------------------------------- 171
Query: 304 CSFVGTHEYVSPEVA-SGGSHGNAVDWWAFGIFIYEMIYGRTPF---------------- 346
V T Y +PE+ S + A+D W+ G EM+ R F
Sbjct: 172 ---VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 347 AAPSNETTLR---NIVKKPLT-FPTQSPSSMSEY------HARDLISGLLNKDPCNRLGS 396
+PS E R + V+K + P + P S+ A DL+S +L DP R+
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-- 286
Query: 397 KRGAADVKTHPFFKG 411
HPF
Sbjct: 287 --TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 72/292 (24%)
Query: 109 RGHEPCCLYAMKVVNKEV-LEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167
RG +P KVV K V L +++ A E L DH + + +F++ + ++
Sbjct: 88 RGSDP----KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 168 MEFCSGGDLHS-----LRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222
ME+ SGGDL+ L+ P + + + FY ++++AL+ +H +++RDLK N+
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEV-GLLFY--QIVLALDEVHSRKMMHRDLKSANI 200
Query: 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGS 282
+ G I L DF S +QYS +S
Sbjct: 201 FLMPTGIIKLGDFGFS---------------------------KQYSDSVS--------- 224
Query: 283 KKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYG 342
L VA SF GT Y++PE+ + D W+ G+ +YE++
Sbjct: 225 ----------LDVAS-------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 343 RTPFAAPSNETTLRNIV-KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
PF PS ++ ++ K FP S M + L+ LL+K+P R
Sbjct: 268 HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM-----KALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 79/327 (24%), Positives = 119/327 (36%), Gaps = 81/327 (24%)
Query: 88 IGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KM 145
+G G G VY L+ + R + KE+ E+ + + E+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVR--------------IAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARFYAAEVLVAL 204
L H + + F I ME GG L +L R K + + + FY ++L L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 205 EYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
+YLH I++RD+K +NVLV + G + +SDF
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT-------------------------- 155
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-- 321
SK++ + P E +F GT +Y++PEV G
Sbjct: 156 ------------------SKRLAGINP----CTE-------TFTGTLQYMAPEVIDKGPR 186
Query: 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381
+G D W+ G I EM G+ PF V P + P S+S A++
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-EIPESLSA-EAKNF 244
Query: 382 ISGLLNKDPCNRLGSKRGAADVKTHPF 408
I DP R A D+ PF
Sbjct: 245 ILRCFEPDPDKR----ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 63/196 (32%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV--NKEVLEKKK-------KVHRAEM 138
IG G G VYL LN G + A+K V + + K R+E+
Sbjct: 9 IGKGTYGRVYLA-LN----VTTGE----MMAVKQVELPATIAGRHDSRQKDMVKALRSEI 59
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFS-CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E LK LDH + Y FE + I +E+ GG + S + RF RF+
Sbjct: 60 E--TLKDLDHLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFT 114
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS----- 252
+VL L YLH GI++RDLK +N+LV +DG +SDF +S S+ I + S
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 253 ---SPEAASPRSQTYT 265
+PE SQ Y+
Sbjct: 175 FWMAPEVIHSYSQGYS 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 18/183 (9%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+++ ++IG G G +YL K + D H V KE+ K V E KK
Sbjct: 2 YEIIKKIGEGSFGKIYLA----KAKSDSEH---------CVIKEIDLTKMPVKEKEASKK 48
Query: 142 ---ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+L + HP + T +A F+ + IVME+C GGDL ++Q FS +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS-LCSNAIPAVESPASSPEA 256
++ + L+++H I++RD+K +N+ + +G + L DF ++ ++++ + +P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYY 168
Query: 257 ASP 259
SP
Sbjct: 169 LSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 85/378 (22%), Positives = 131/378 (34%), Gaps = 131/378 (34%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK--EVLEKKKKVHRAEME 139
++L + IG+G G V + G + A+K ++ + L K++ R E
Sbjct: 2 YELLKPIGSGAYGVVCSA-----VDKRTGRK----VAIKKISNVFDDLIDAKRILR---E 49
Query: 140 KKILKMLDHP--------FLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSL 190
K+L+ L H P +F IV E DLH ++ QP L
Sbjct: 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVY---IVTEL-METDLHKVIKSPQP-----L 100
Query: 191 TSA--RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
T +++ ++L L+YLH +I+RDLKP N+LV S + DL +C
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS-------NCDLKICD------- 146
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFV 307
FG ++ + + F+ E V R
Sbjct: 147 -------------------------------FGLARGVDPDEDEKGFLTEYVVTRW---- 171
Query: 308 GTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV------- 359
Y +PE+ S A+D W+ G E++ + F L IV
Sbjct: 172 ----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 360 -----------------------KKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRL 394
KKPL+ FP SP A DL+ +L DP R+
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE------AIDLLEKMLVFDPKKRI 281
Query: 395 GSKRGAADVKTHPFFKGL 412
A + HP+ L
Sbjct: 282 ----TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+L +RIG+G G VY K R E L A+KV+ LE + + E
Sbjct: 10 DFELIQRIGSGTYGDVY------KARNVNTGE---LAAIKVIK---LEPGEDFAVVQQEI 57
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++K H + + + + I MEFC GG L + H S + + + E
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRET 115
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L L YLH G ++RD+K N+L+ +GH+ L+DF +S
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 62/275 (22%)
Query: 139 EKKILKMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E +++ L+HP + + A E S+F+ + +E+ +GG + L K + F Y
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFN-LFVEWMAGGSVSHLLSK--YGAFKEAVIINYT 109
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLSLCSNAIPAVESPASSPEA 256
++L L YLH II+RD+K N+L+ S G + ++DF A
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFG------------------AA 151
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
A ++ T F + G T +++PE
Sbjct: 152 ARLAAKG------TGAGEFQGQLLG---------------------------TIAFMAPE 178
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSE 375
V G +G + D W+ G I EM + P+ A + L I K T P +S
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
RD+ L P +R S+ ++ HP F+
Sbjct: 239 -GLRDVTLRCLELQPEDRPPSR----ELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 81/335 (24%), Positives = 120/335 (35%), Gaps = 112/335 (33%)
Query: 147 DHPFLPTLYAEFEASNFSCIVMEF-CSGGDLHS-LRH---KQPHKRFSLTSARFYAAEVL 201
DHP + L +A N I + F DLH+ +R + HKR+ Y ++L
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYI-----MY--QLL 117
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
AL+Y+H +I+RDLKP N+L+ SD + L+DF
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG------------------------- 152
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321
L+R L+ + + LT +V T Y +PE+ G
Sbjct: 153 ----------LARSLSELEENPENPVLT---------------DYVATRWYRAPEILLGS 187
Query: 322 SHGN-AVDWWAFGIFIYEMIYGRTPFA----------------APSNE-----------T 353
+ VD W+ G + EM+ G+ F PS E T
Sbjct: 188 TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAAT 247
Query: 354 TLRNIV---KKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
L ++ +KPL P S A DL+ LL +P RL A + HP+
Sbjct: 248 MLDSLPSRPRKPLDELLPKASDD------ALDLLKKLLVFNPNKRL----TAEEALEHPY 297
Query: 409 FKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKS 443
F P + P + T+P D S
Sbjct: 298 VA--QFH-----NPSDEPVLPYPITIPLDDNVKLS 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 8e-13
Identities = 83/338 (24%), Positives = 138/338 (40%), Gaps = 82/338 (24%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G GTVY +++ Q+ A+K +N L+++ K E +++
Sbjct: 26 KIGQGASGTVY-TAIDIATGQE--------VAIKQMN---LQQQPKKELIINEILVMREN 73
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
+P + + + +VME+ +GG L + + + + E L AL++
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDF 130
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH +I+RD+K +N+L+ DG + L+DF C+ P S RS
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDF--GFCAQITP----------EQSKRS----- 173
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
+ VGT +++PEV + ++G
Sbjct: 174 --------------------------------------TMVGTPYWMAPEVVTRKAYGPK 195
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRN--IVKKPLTFPTQSPSSMSEYHARDLISG 384
VD W+ GI EM+ G P+ NE LR ++ T Q+P +S RD ++
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPERLSAVF-RDFLNR 251
Query: 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422
L D +R GS A ++ HPF K + SLTP
Sbjct: 252 CLEMD-VDRRGS---AKELLQHPFLKLAK--PLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (166), Expect = 1e-12
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+ VGT Y+SPE+ + D W+ G +YE+ + PF + I+K
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP 221
Query: 365 -FPTQSPSSMSEYHARDLISGLLNKDPCNR 393
P+Q S + R+L+S LL KDP R
Sbjct: 222 PIPSQYSSEL-----RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 88/349 (25%), Positives = 127/349 (36%), Gaps = 97/349 (27%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G G VY K R E + A+K + + E + A E +LK L
Sbjct: 7 KIGEGTYGVVY------KARNKLTGE---VVALKKIRLD-TETEGVPSTAIREISLLKEL 56
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
+HP + L N +V EF DL P L + Y ++L L +
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
H +++RDLKP+N+L+ ++G I L+DF L+
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLA---------------------------- 147
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS-HGN 325
R FG P R + E V T Y +PE+ G +
Sbjct: 148 -----------RAFG-------VPVRTYTHEVV---------TLWYRAPEILLGCKYYST 180
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-------------------KPLTFP 366
AVD W+ G EM+ R F S L I + KP +FP
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-SFP 239
Query: 367 TQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
+ S+ RDL+S +L+ DP R+ +K A HPFF
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 69/260 (26%), Positives = 105/260 (40%), Gaps = 72/260 (27%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
+VME+ +GG L + + + + E L ALE+LH +I+RD+K +N+L+
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI 285
DG + L+DF C+ P S RS
Sbjct: 151 MDGSVKLTDF--GFCAQITP----------EQSKRST----------------------- 175
Query: 286 QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP 345
VGT +++PEV + ++G VD W+ GI EMI G P
Sbjct: 176 --------------------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 346 FAAPSNETTLRN--IVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA-D 402
+ NE LR ++ T Q+P +S RD ++ L+ D KRG+A +
Sbjct: 216 YL---NENPLRALYLIATNGTPELQNPEKLSAIF-RDFLNRCLDMDV-----EKRGSAKE 266
Query: 403 VKTHPFFKGLNFALIRSLTP 422
+ H F K + SLTP
Sbjct: 267 LLQHQFLKIAK--PLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 81/341 (23%), Positives = 122/341 (35%), Gaps = 98/341 (28%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAE 137
D +IG G G V C+ K ++V KK +K R E
Sbjct: 20 YLDNFVKIGEGSTGIV------------------CIATDKSTGRQVAVKKMDLRKQQRRE 61
Query: 138 M---EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
+ E I++ HP + +Y+ + + +VMEF GG +L H R +
Sbjct: 62 LLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG---ALTDIVTHTRMNEEQIA 118
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
VL AL +LH G+I+RD ++SD I+L
Sbjct: 119 TVCLAVLKALSFLHAQGVIHRD-------IKSDS-ILL---------------------- 148
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
T +LS F F V++ V R S VGT +++
Sbjct: 149 ----------TSDGRVKLSDF--GFCAQ------------VSKEVPRRK-SLVGTPYWMA 183
Query: 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS 374
PEV S +G VD W+ GI + EM+ G P+ ++ I P +
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-------PPKLK 236
Query: 375 EYHA-----RDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
H R + +L +DP R AA++ HPF
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRA----TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 71/287 (24%), Positives = 113/287 (39%), Gaps = 69/287 (24%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV--NKEVLEKKKKVHRAEM 138
++ L + +G G G VYLC Y D G E A+K V + + E K+V+ E
Sbjct: 3 NWRLGKLLGRGAFGEVYLC-----YDADTGRE----LAVKQVPFDPDSQETSKEVNALEC 53
Query: 139 EKKILKMLDHPFLPTLYA---EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
E ++LK L H + Y + E S I +E+ GG + + + + R
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLS-IFVEYMPGGSIKD--QLKAYGALTENVTRR 110
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y ++L + YLH I++RD+K N+L S G++ L DF
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG------------------- 151
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
SK+IQT+ + + S GT ++SP
Sbjct: 152 -------------------------ASKRIQTICMSGTGIK--------SVTGTPYWMSP 178
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP 362
EV SG +G D W+ + EM+ + P+A + I +P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G VY + E A K++ +E ++++ +E IL
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECK 60
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HP + LY + N I++EFC GG L S+ + + R+ ++L AL +L
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFL 119
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
H +I+RDLK N+L+ DG + L+DF +S
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 92/370 (24%), Positives = 138/370 (37%), Gaps = 120/370 (32%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
++L + +G G G V CS N + E + K+ N V KK RA E K
Sbjct: 2 YELIKELGQGAYGIV--CSARNAETSE--EETVAI--KKITN--VFSKKILAKRALRELK 53
Query: 142 ILKML-DHPFLPTLYAE--FEASNFSCI-----VMEFCSGGDLHS-LRHKQPHKRFSLTS 192
+L+ H + LY NF+ + +ME DLH +R QP LT
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQP-----LTD 104
Query: 193 ARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
A F + ++L L+Y+H +++RDLKP N+LV +D + + DF L+ + P +
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
F+ E VA R
Sbjct: 165 -------------------------------------------FMTEYVATRW------- 174
Query: 311 EYVSPEVA-SGGSHGNAVDWWAFGIFIYEMIYGRTPF-----------------AAPSNE 352
Y +PE+ S S+ A+D W+ G + E+ GR P P E
Sbjct: 175 -YRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 353 T--------------TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398
T +L NI KKP F + P++ A DL+ LL DP R+ +
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKP--FESIFPNANPL--ALDLLEKLLAFDPTKRISVE- 287
Query: 399 GAADVKTHPF 408
+ HP+
Sbjct: 288 ---EALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 85/365 (23%), Positives = 128/365 (35%), Gaps = 115/365 (31%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL---EKKKKVHRAEMEKKIL 143
+IG G G V+ +K + V K+VL EK+ A E KIL
Sbjct: 19 KIGQGTFGEVF--KARHKKTKQ-----------IVALKKVLMENEKEGFPITALREIKIL 65
Query: 144 KMLDHP----------FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
++L H T Y ++ S + +V EFC DL L + +F+L+
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DLAGLL-SNKNVKFTLSEI 121
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+ +L L Y+H I++RD+K N+L+ DG + L+DF L+ S
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA----------RAFSL 171
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ + P +R+ NR V T Y
Sbjct: 172 SKNSKP-------------NRYTNR----------------------------VVTLWYR 190
Query: 314 SPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNE-------TTLR--------- 356
PE+ G G +D W G + EM + R+P + E + L
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEM-WTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249
Query: 357 NIVKKPLTFPTQSPSS------------MSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404
+ K L + P + + HA DLI LL DP R+ A
Sbjct: 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI----DADTAL 305
Query: 405 THPFF 409
H FF
Sbjct: 306 NHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 9e-12
Identities = 52/224 (23%), Positives = 79/224 (35%), Gaps = 54/224 (24%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E I+ LDH L LY +V E G L K F +++ YA
Sbjct: 46 EAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ + YL I+RDL N+L+ SD + + DF L A+P E
Sbjct: 105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGL---MRALPQNE---------- 151
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
Y + ++ P A + +PE
Sbjct: 152 ---DHYVMEEHLKV-------------------------PFA-----------WCAPESL 172
Query: 319 SGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKK 361
+ +A D W FG+ ++EM YG P+A S L+ I K+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 67/259 (25%), Positives = 100/259 (38%), Gaps = 74/259 (28%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G+ GTVY Y + A+KV+ ++ + +K +E+E IL D
Sbjct: 9 LGHGNGGTVY-----KAYHLLTRR----ILAVKVIPLDITVELQKQIMSELE--ILYKCD 57
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
P++ Y F N I EF GG L R H R A V+ L YL
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH-----VLGRI-AVAVVKGLTYL 111
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
L I++RD+KP N+LV + G + LC +
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQ-------VKLCDFGV----------------------- 141
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
ST+L V + + ++VGT+ Y++PE SG +G
Sbjct: 142 -STQL--------------------------VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 328 DWWAFGIFIYEMIYGRTPF 346
D W+ GI E+ GR P+
Sbjct: 175 DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R +G G G V L ++R D Y +K +N ++++ AE E ++L
Sbjct: 6 RVVGKGSYGEVSLV----RHRTDGKQ-----YVIKKLNLRNASRRER-KAAEQEAQLLSQ 55
Query: 146 LDHPFLPTLYAEFEASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
L HP + +E + IVM FC GGDL+ +Q K + ++ +AL
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL-----SLCSNAIPAVESP-ASSPEAAS 258
+YLH I++RDLK +NV + I + D + + C A + +P SPE S
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 259 PRSQTY 264
+ Y
Sbjct: 176 NKPYNY 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 68/296 (22%), Positives = 102/296 (34%), Gaps = 85/296 (28%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +LK L+HP + L + N +V EF DL P + Y
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++L + Y H +++RDLKP+N+L+ +G + L+DF L+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA-------------------- 146
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
R FG P R + E V T Y +PE+
Sbjct: 147 -------------------RAFG-------VPVRTYTHEVV---------TLWYRAPEIL 171
Query: 319 SGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNIVKKP 362
G VD W+ G EM+ R F S +E + P
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231
Query: 363 ---LTFPTQSPSSMS------EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
TFP + +S + DL+S +L DP R+ +K HP+F
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ----HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
RIG G G V+ ++N+ +Q + A+K+++ E E + ++ + E +L
Sbjct: 11 RIGKGSFGEVFK-GIDNRTQQ--------VVAIKIIDLE--EAEDEIEDIQQEITVLSQC 59
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
D P++ Y + I+ME+ GG L P F + + E+L L+Y
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM---LKEILKGLDY 116
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
LH I+RD+K NVL+ G + L+DF ++
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 79/333 (23%), Positives = 120/333 (36%), Gaps = 81/333 (24%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPC-CLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+G G+ G+VY K H P AMK + E+ E K ++ ME IL
Sbjct: 9 LGKGNYGSVY------KVL----HRPTGVTMAMKEIRLELDESK--FNQIIMELDILHKA 56
Query: 147 DHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSLR-HKQPHKRFSLTSARFYAAEVLVA 203
P++ Y F E + + C ME+ G L L + R V+
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114
Query: 204 LEYL-HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQ 262
L++L II+RD+KP NVLV +G + L DF +S + A+ ++
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-------------GNLVASLAKTN 161
Query: 263 TYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322
+ Y + P R+ P + + V +V
Sbjct: 162 IGCQSY-------------------MAPERIKSGGPNQNPTYT-------VQSDV----- 190
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---LRNIVKKPLTFPTQSPSSMSEYHAR 379
W+ G+ I EM GR P+ + L IV P PS S+ A+
Sbjct: 191 -------WSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---PPTLPSGYSD-DAQ 239
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
D ++ LNK P R A + HP+
Sbjct: 240 DFVAKCLNKIPNRR----PTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 50/153 (32%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G VY + + E L A KV++ + ++++ +E IL D
Sbjct: 13 LGDGAFGKVY---------KAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD 60
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGG--DLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
HP + L F N I++EFC+GG D L ++P + R + L AL
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALN 117
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
YLH II+RDLK N+L DG I L+DF +S
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 71/308 (23%), Positives = 119/308 (38%), Gaps = 81/308 (26%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
RIG G G VY ++N+ ++ + A+K+++ E E + ++ + E +L
Sbjct: 11 RIGKGSFGEVYK-GIDNRTKE--------VVAIKIIDLE--EAEDEIEDIQQEITVLSQC 59
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALE 205
D P++ Y + I+ME+ GG L P + + T R E+L L+
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLD 115
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
YLH I+RD+K NVL+ G + L+DF ++
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVA--------------------------G 149
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
+ T++ R N F G TP F P EV ++
Sbjct: 150 QLTDTQIKR--NTFVG-------TP---FWMAP-----------------EVIKQSAYDF 180
Query: 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA---RDLI 382
D W+ GI E+ G P S+ +R + P SP ++ ++ ++ +
Sbjct: 181 KADIWSLGITAIELAKGEPPN---SDLHPMRVL----FLIPKNSPPTLEGQYSKPFKEFV 233
Query: 383 SGLLNKDP 390
LNKDP
Sbjct: 234 EACLNKDP 241
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 78/327 (23%), Positives = 125/327 (38%), Gaps = 85/327 (25%)
Query: 77 LTFRD-----FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
L F++ F R IG G G VY R R +E + M K+ EK +
Sbjct: 17 LFFKEDPEKLFTDLREIGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQ 70
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFC--SGGDLHSLRHKQPHKRFS 189
+ + E K L+ + HP + + + +VME+C S DL + HK+P +
Sbjct: 71 DIIK---EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVE 126
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
+ + A L L YLH +I+RD+K N+L+ G + L+DF + ++ S
Sbjct: 127 IAAITHGA---LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA-------SIAS 176
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
PA+S FVGT
Sbjct: 177 PANS----------------------------------------------------FVGT 184
Query: 310 HEYVSPEV---ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
+++PEV G + VD W+ GI E+ + P + + L +I + P
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESP 242
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNR 393
T + S+Y R+ + L K P +R
Sbjct: 243 TLQSNEWSDYF-RNFVDSCLQKIPQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 85/374 (22%), Positives = 126/374 (33%), Gaps = 114/374 (30%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR---- 135
RD+++ ++G G G VY K RQ + L KK +H
Sbjct: 8 RDYEILGKLGEGTFGEVY------KARQIKTGRVVAL------------KKILMHNEKDG 49
Query: 136 ----AEMEKKILKMLDHP-FLPTLYAEFEASNFS-----CIVMEF---CSGGDLHSLRHK 182
A E KILK L HP +P + E + S + M DL L
Sbjct: 50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--DLSGLLE- 106
Query: 183 QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSN 242
P + + + + Y ++L + YLH I++RD+K N+L+ + G + ++DF L
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL----- 161
Query: 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302
A P P + ++ YT
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYT------------------------------------- 184
Query: 303 SCSFVGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFA-------------- 347
+ V T Y PE+ G + AVD W G EM R
Sbjct: 185 --NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242
Query: 348 -APSNETTLRNIVKKP-----LTFPTQSPSSMSEYHAR------DLISGLLNKDPCNRLG 395
E T P +F P ++ E + DL+S LL+ DP RL
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERFGKLGPEGLDLLSKLLSLDPYKRL- 300
Query: 396 SKRGAADVKTHPFF 409
A+D HP+F
Sbjct: 301 ---TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 73/313 (23%), Positives = 115/313 (36%), Gaps = 80/313 (25%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R IG G G VY R R E + M K+ EK + + + E + L+
Sbjct: 21 REIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQK 71
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFC--SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
L HP + + + +VME+C S DL + HK+P + + + A L
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGA---LQG 127
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
L YLH +I+RD+K N+L+ G + L DF + ++ +PA+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANX---------- 170
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV---ASG 320
FVGT +++PEV
Sbjct: 171 ------------------------------------------FVGTPYWMAPEVILAMDE 188
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
G + VD W+ GI E+ + P + + L +I + P SEY R+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYF-RN 245
Query: 381 LISGLLNKDPCNR 393
+ L K P +R
Sbjct: 246 FVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 12/112 (10%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-----LRNIV 359
+FVGT Y++PE G + D W+ G+ + E+ GR P+ ++ L+ IV
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217
Query: 360 KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
+P P + PS +D ++ L KDP R K + HPF K
Sbjct: 218 NEP---PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE----LLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 79/354 (22%), Positives = 120/354 (33%), Gaps = 94/354 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D+ +IG G G VY K R + + + AMK + E E++ A E
Sbjct: 1 DYTKIEKIGEGTYGVVY------KGRNKKTGQ---IVAMKKIRLES-EEEGVPSTAIREI 50
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+LK L HP + L + ++ EF S L + + Y ++
Sbjct: 51 SLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L + + H +++RDLKP+N+L+ + G I L+DF L+
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA---------------------- 148
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
R FG P R++ E V T Y +PEV G
Sbjct: 149 -----------------RAFG-------IPVRVYTHEVV---------TLWYRAPEVLLG 175
Query: 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNIVKKP-- 362
+ VD W+ G EM + F S E + P
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 363 -LTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
TFP S+ DL+ +L DP R+ +K HP+F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK----KALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 61/236 (25%), Positives = 87/236 (36%), Gaps = 59/236 (25%)
Query: 128 EKKKKVHRAEM-EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK 186
E K V + M E ++LK L H L L F +V EF L L P+
Sbjct: 38 EDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNG 96
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
+ Y ++L +E+ H II+RD+KPEN+LV G + L DF +
Sbjct: 97 LDESRVRK-YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA-------- 147
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
+ A+ E YT +TR
Sbjct: 148 -RTLAAPGEV-------YTDYVATRW---------------------------------- 165
Query: 307 VGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361
Y +PE+ G +G AVD WA G + EM+ G F S+ L +I+K
Sbjct: 166 -----YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 12/107 (11%)
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET----TLRNIVKKPL 363
GT +Y SPE G ++ + DWWA G+ YE++ G+ PF +E +L +K L
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
F ++S +A D + +L + RL + ++ HPF K
Sbjct: 228 PF----IKNVS-KNANDFVQSMLKYNINYRLTNYN---EIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R IG G G VY R R +E + M K+ EK + + + E + L+
Sbjct: 21 REIGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQQ 71
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFC--SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
L HP + + + +VME+C S D+ + HK+P + + + L
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEV-HKKPLQEVEIAAI---CHGALQG 127
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF-DLSLCSNAIPAVESP 250
L YLH I+RD+K N+L+ G + L+DF SL S A V +P
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTP 175
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 40/119 (33%), Positives = 59/119 (49%), Gaps = 12/119 (10%)
Query: 130 KKKVH---RAEMEKKILKMLD--H----PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLR 180
KK VH ++ + K+IL+ L H P++ + Y F N C+ MEF G L +
Sbjct: 35 KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY 94
Query: 181 HKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
K + A V+ L YL+ + I++RD+KP N+LV S G I L DF +S
Sbjct: 95 KKGGPIPVEILGK--IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 70/336 (20%), Positives = 127/336 (37%), Gaps = 81/336 (24%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCC--LYAMKVVNKEVLEKKKKVHRAEME 139
+D+ R IG G +G VYL ++P C A+K + +++ E R E
Sbjct: 4 YDIIRLIGKGGMGEVYL-----------AYDPVCSRRVALKKIREDLSENPLLKKRFLRE 52
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH---------KQPHKRFSL 190
KI L HP + +Y+ + M + G L SL K+ ++ S+
Sbjct: 53 AKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
+ ++ +EY+H G+++RDLKP+N+L+ G +++ D+ ++
Sbjct: 113 GAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLT-PNRLFVAEPVAARSCSFVGT 309
E S +T P ++ VGT
Sbjct: 173 IDVDERNICYSS-------------------------MTIPGKI-------------VGT 194
Query: 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ- 368
+Y++PE G + D +A G+ +Y+M+ P+ R + +++
Sbjct: 195 PDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---------RRKKGRKISYRDVI 245
Query: 369 -SPSSMSEYHARDLISGL-------LNKDPCNRLGS 396
SP ++ Y R++ L L DP R S
Sbjct: 246 LSPIEVAPY--REIPPFLSQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 65/314 (20%), Positives = 121/314 (38%), Gaps = 79/314 (25%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+IG G G V+ ++N+ ++ + A+K+++ E E + ++ + E +L
Sbjct: 11 KIGKGSFGEVFK-GIDNRTQK--------VVAIKIIDLE--EAEDEIEDIQQEITVLSQC 59
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
D P++ Y + I+ME+ GG L P + + E+L L+Y
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI---LREILKGLDY 116
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
LH I+RD+K NVL+ G + L+DF ++ +
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA--------------------------GQ 150
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
T++ R N F G T +++PEV ++ +
Sbjct: 151 LTDTQIKR--NTFVG---------------------------TPFWMAPEVIKQSAYDSK 181
Query: 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL---IS 383
D W+ GI E+ G P + + +K P +P ++ +++ L +
Sbjct: 182 ADIWSLGITAIELAKGEPPHSE-------LHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234
Query: 384 GLLNKDPCNRLGSK 397
LNK+P R +K
Sbjct: 235 ACLNKEPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 47/150 (31%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMK-VVNKEVLEKKKKVHRAEMEKKILKM 145
+IG G G V+ C R E + A+K V E KK+ A E ++LK
Sbjct: 8 KIGEGSYGVVFKC---------RNRETGQIVAIKKFVESEDDPVIKKI--ALREIRMLKQ 56
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L HP L L F +V E+C L+ L K P + + L A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL-EKNPRGVPEHLIKKI-IWQTLQAVN 114
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+ H I+RD+KPEN+L+ G I L DF
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 93/407 (22%), Positives = 142/407 (34%), Gaps = 108/407 (26%)
Query: 38 SFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVY 97
FE+ K E S + D + R + + L IG G G VY
Sbjct: 27 KFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPN---KSYKLGNIIGNGSFGVVY 83
Query: 98 LCSLNNKYRQDRGHEPCCL-YAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY- 155
E C+ + KV K+VL+ + +R + K L ++ FL Y
Sbjct: 84 --------------EAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 156 ----AEFEASNFSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYAAEVLVALEYLHML 210
+ E + F +VMEF ++H + + L + Y+ ++ AL Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYST 270
I +RDLKP+N+L+ + H L LC
Sbjct: 190 FICHRDLKPQNLLIDPNTHT------LKLCD----------------------------- 214
Query: 271 RLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS-HGNAVDW 329
FGS K N L RS S++ + Y +PE+ G + + +D
Sbjct: 215 ---------FGSAK------NLL-----AGQRSVSYICSRFYRAPELMLGATNYTTHIDL 254
Query: 330 WAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-----------------KPLTFPTQSPSS 372
W+ G I EMI G F+ S+ L I++ + FP P
Sbjct: 255 WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD 314
Query: 373 MSEY-------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ + A + IS L +P RL AD PFF L
Sbjct: 315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD----PFFDDL 357
|
Length = 440 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 20/104 (19%)
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRT-----PFAAPSNETTLRNIVKKPLTFP 366
Y +PEV A DWW+ G ++E++ G+T P + + TTL
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP-SGINTHTTL----------- 195
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFF 409
P +SE AR L+ LL +P RLG+ G D+K+HPFF
Sbjct: 196 -NIPEWVSE-EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
D++L +R+G+G G VY K R E L A+K++ LE + E
Sbjct: 9 HDYELIQRVGSGTYGDVY------KARNLHTGE---LAAVKIIK---LEPGDDFSLIQQE 56
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYAA 198
++K H + + + + I ME+C GG L + H P + +
Sbjct: 57 IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA---YVCR 113
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
E L L YLH G ++RD+K N+L+ +G + L+DF ++
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 76/350 (21%), Positives = 123/350 (35%), Gaps = 99/350 (28%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
++G G TVY + R + A+K ++ + E A E ++K L
Sbjct: 7 KLGEGTYATVY---------KGRNRTTGEIVALKEIHLDAEEGTPST--AIREISLMKEL 55
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKR-FSLTSARFYAAEVLVALE 205
H + L+ N +V E+ DL + + + + ++L +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
+ H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLA--------------------------- 147
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-SHG 324
R FG P F E V T Y +P+V G ++
Sbjct: 148 ------------RAFG-------IPVNTFSNEVV---------TLWYRAPDVLLGSRTYS 179
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-------------------KPLTF 365
++D W+ G + EMI GR F +NE L I + KP TF
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP-TF 238
Query: 366 PTQSPSSMSEYHAR------DLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
P P + + DL+ LL +P R+ A D HP+F
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI----SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 37/115 (32%), Positives = 52/115 (45%), Gaps = 17/115 (14%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---------- 354
+FVGT Y+SPE GG + D W+ GI I E+ G+ PFA + +
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 355 -LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
L+ IV++P P + PSS RD + L KDP R ++ PF
Sbjct: 221 LLQQIVQEP---PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ---LCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 15/155 (9%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKKIL 143
+ +G G+ G+V + Y G E A+K + +E + KK E E ++
Sbjct: 1 KELGHGNFGSV----VKGVYLMKSGKEVEV--AVKTLKQEHIAAGKK----EFLREASVM 50
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
LDHP + L + +VME G L K+ ++ + A +V +
Sbjct: 51 AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE--IPVSDLKELAHQVAMG 107
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ YL ++RDL NVL+ + +SDF +S
Sbjct: 108 MAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 91/369 (24%), Positives = 131/369 (35%), Gaps = 118/369 (31%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCL-YAMKVVNKEVL-EKKKKVHRAEM 138
DF+ +GAG+ G V H P L A K+++ E+ + ++ R
Sbjct: 2 DFEKLGELGAGNGGVVTKVL----------HRPSGLIMARKLIHLEIKPAIRNQIIR--- 48
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ---PHKRFSLTSARF 195
E K+L + P++ Y F + I ME GG L + K P S
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS--- 105
Query: 196 YAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLS--LCSNAIPAVESPAS 252
A VL L YL I++RD+KP N+LV S G I L DF +S L ++S A+
Sbjct: 106 IA--VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMAN 156
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
S TR Y ++P RL GTH
Sbjct: 157 SFVG--------TRSY-------------------MSPERL-------------QGTHYT 176
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP------------FAAPSNETTLRNIVK 360
V D W+ G+ + EM GR P F P +E + +
Sbjct: 177 VQS------------DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 361 KPLTFPTQSPSSMSEYHARDLI---------SGLLNKDPCN-------RLGSKRGAADVK 404
P SP M+ + D I SG + + + + +R AD+K
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER--ADLK 282
Query: 405 ---THPFFK 410
HPF K
Sbjct: 283 ELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN-------KEVLEKKKKVH 134
+ + +G+G G VY K R+ L A+K +N K+ E+ K +
Sbjct: 2 YAVLEHLGSGAFGCVY------KVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIG 53
Query: 135 RAEMEKKILK-MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL--HSLRHKQPHKRFSLT 191
E I+K L HP + Y F ++ IVM+ G L H K+ +RF T
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRF--T 111
Query: 192 SARFYA--AEVLVALEYLHMLG-IIYRDLKPENVLVRSDGHIMLSDFDLS 238
R + ++++AL YLH I++RDL P N+++ D + ++DF L+
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
+V++ GG L S K + +AAE++VAL+ LH GI+ RDL P N+L+
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKR--WAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 226 SDGHIML------SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRF 279
GHI L S+ + S AVE+ +PE +T + +
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGE---AVENMYCAPEVGGISEETEACDWWS--------- 167
Query: 280 FGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
G+ + LT L P + + + E+VS E S
Sbjct: 168 LGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARS 207
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 78/350 (22%), Positives = 117/350 (33%), Gaps = 97/350 (27%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IG G GTVY K R L +++V E V + K+ L+ D
Sbjct: 8 IGVGAYGTVY------KARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR-LEAFD 60
Query: 148 HPFLPTLY-----AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV 202
HP + L + + +V E DL + K P + + + L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 203 ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQ 262
L++LH I++RDLKPEN+LV S G + L+DF L+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA------------------------ 155
Query: 263 TYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322
R YS +++ LTP V T Y +PEV +
Sbjct: 156 ---RIYSCQMA--------------LTP---------------VVVTLWYRAPEVLLQST 183
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPF-----------------AAPSNETTLRNIVKKPLTF 365
+ VD W+ G EM + R P P + R++ F
Sbjct: 184 YATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242
Query: 366 PTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
+ P + L+ +L +P R+ A HPFF
Sbjct: 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI----SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 74/332 (22%), Positives = 138/332 (41%), Gaps = 91/332 (27%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ R +G+G GTV LC+ ++ EP +A+KVV+ E + + K +RA+ E L
Sbjct: 36 ISRVLGSGATGTV-LCA-----KRVSDGEP---FAVKVVDMEGMSEADK-NRAQAEVCCL 85
Query: 144 KMLDHPFLPTLYAEF--------EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
D + + +F E +V+++ + GDL +Q K + T+ F
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTF 140
Query: 196 YAAE-------VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
E VL+A+ ++H +I+RD+K N+L+ S+G + L DF
Sbjct: 141 REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG------------ 188
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
+++ Y+ +S + R +F G
Sbjct: 189 ---------------FSKMYAATVSDDVGR--------------------------TFCG 207
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--FP 366
T YV+PE+ + D ++ G+ +YE++ + PF + + ++ K L +
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYD 263
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398
PS E +++++ LL+ DP R S +
Sbjct: 264 PLPPSISPE--MQEIVTALLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK--EVLEKKKKVHRAEMEKKILKM 145
+G+G G V CS + + A+K +++ + K+ +R E ++LK
Sbjct: 23 VGSGAYGQV--CSAFDTKTGRK-------VAIKKLSRPFQSAIHAKRTYR---ELRLLKH 70
Query: 146 LDHPFLPTLYAEF----EASNFSCI--VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+DH + L F +F + V G DL+++ Q + S +F +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVKCQ---KLSDDHIQFLVYQ 126
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+L L+Y+H GII+RDLKP N+ V D + + DF L+
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 60/296 (20%), Positives = 104/296 (35%), Gaps = 72/296 (24%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E KI+ + H + L + +F +VM+ + DL + ++ R + + +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRK--IRLTESQVKCILL 126
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++L L LH ++RDL P N+ + S G ++DF L+
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY--------------GYP 172
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
P S T ++ +T+ ++ V T Y +PE+
Sbjct: 173 PYSDTLSKD------------------ETMQRREEMTSKVV---------TLWYRAPELL 205
Query: 319 SGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNIVKKP 362
G + AVD W+ G E++ G+ F + NE K P
Sbjct: 206 MGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLP 265
Query: 363 LTFP--TQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
L + P + A DL+ LL +P R+ A + H +FK
Sbjct: 266 LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI----SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 69/275 (25%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKKILKM 145
IG G+ G V L + A+K + +K+ R + E I+
Sbjct: 12 IGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQ----RLDFLTEASIMGQ 61
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVAL 204
DHP + L S I+ E+ G L LR +F++ + +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGM 119
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
+YL + ++RDL N+LV S+ +SDF LS +E ++
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------RRLEDSEAT----------- 162
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
Y+T+ KI P R + +PE +
Sbjct: 163 ---YTTK----------GGKI----PIR-------------------WTAPEAIAYRKFT 186
Query: 325 NAVDWWAFGIFIYE-MIYGRTPFAAPSNETTLRNI 358
+A D W+FGI ++E M YG P+ SN+ ++ +
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 21/172 (12%)
Query: 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI 142
LH IG G G VY + +E + M K+ EK + + + E K
Sbjct: 25 GLHE-IGHGSFGAVYFAT------NSHTNEVVAVKKMSYSGKQTNEKWQDIIK---EVKF 74
Query: 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLR-HKQPHKRFSLTSARFYAAEVL 201
L+ L HP + + + +VME+C G L HK+P + + + A L
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGA---L 131
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
L YLH +I+RD+K N+L+ G + L+DF + + SPA+S
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA-------SKSSPANS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 73/325 (22%), Positives = 118/325 (36%), Gaps = 108/325 (33%)
Query: 127 LEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF------EASNFSCIVMEFCSGGDLHSLR 180
+ + RA E +LK ++H + +L F E +VME +
Sbjct: 58 FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117
Query: 181 HKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240
+ H+R S + ++L +++LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 118 MELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-- 170
Query: 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300
T + F+ +TP
Sbjct: 171 ----------------------------RTACTNFM-----------MTP---------- 181
Query: 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPF-------------- 346
+V T Y +PEV G + VD W+ G + E++ G F
Sbjct: 182 -----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236
Query: 347 --AAPSNE------TTLRNIVK-KP-------------LTFPTQSP-SSMSEYHARDLIS 383
PS E T+RN V+ +P FP++S + ARDL+S
Sbjct: 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLS 296
Query: 384 GLLNKDPCNRLGSKRGAADVKTHPF 408
+L DP R+ + HP+
Sbjct: 297 KMLVIDPDKRI----SVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 71/276 (25%), Positives = 108/276 (39%), Gaps = 62/276 (22%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ + IGAG+ G V CS K R E A+K + EK+++ +E I+
Sbjct: 8 IEKVIGAGEFGEV--CSGRLKLPGKR--EIPV--AIKTLKAGYTEKQRRDFLSE--ASIM 59
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
DHP + L S IV E+ G L + K +F++ +
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASG 118
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
++YL +G ++RDL N+LV S+ +SDF LS PEAA
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS---------RVLEDDPEAA------ 163
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH 323
Y+TR G K P R E +A R +
Sbjct: 164 ----YTTR---------GGK-----IPIRWTAPEAIAYRKFT------------------ 187
Query: 324 GNAVDWWAFGIFIYE-MIYGRTPFAAPSNETTLRNI 358
+A D W++GI ++E M YG P+ SN+ ++ I
Sbjct: 188 -SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 18/168 (10%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE--M 138
L R +G G G VY + + +V K V E R E
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPE--------TRVAIKTVNENASMRERIEFLN 58
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-----SLTS 192
E ++K + + L + +VME + GDL S LR ++P T
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 193 ARFY--AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+F AAE+ + YL ++RDL N +V D + + DF ++
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 71 FGRKTGLTFRDFDLHRRIGAGDIGTVYLCS---LNNKYRQDRGHEPCCLYAMKVVNKEVL 127
F RK LTF++ ++G G G V+LC + +D + + V K +
Sbjct: 2 FPRKR-LTFKE-----KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR 55
Query: 128 EKKKKVHRAEM--EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQ 183
E K R + E KI+ L P + L A S+ C++ E+ GDL+ RH+
Sbjct: 56 EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEP 115
Query: 184 PH-------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236
S ++ F A ++ ++YL L ++RDL N LV + I ++DF
Sbjct: 116 QEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFG 175
Query: 237 LS 238
+S
Sbjct: 176 MS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 54/263 (20%), Positives = 96/263 (36%), Gaps = 77/263 (29%)
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
+E +L+ ++HP + + + +C+V+ S DL++ K+ + + A
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIE 163
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L L YLH II+RD+K EN+ + + + D
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL---------------------- 201
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
G+ + + P L +A GT E +PEV
Sbjct: 202 -----------------------GAAQFPVVAPAFLGLA-----------GTVETNAPEV 227
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ + + D W+ GI ++EM+ A PS I + P + P + H
Sbjct: 228 LARDKYNSKADIWSAGIVLFEML------AYPS------TIFEDPPSTP-EEYVKSCHSH 274
Query: 378 ARDLISGL------LNKDPCNRL 394
+IS L +DP +RL
Sbjct: 275 LLKIISTLKVHPEEFPRDPGSRL 297
|
Length = 357 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 14/110 (12%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN---IVKK 361
S VGT +++PEV +G VD W+ GI EM G P+ E LR I K
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL---REPPLRALFLITTK 231
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA-DVKTHPFFK 410
+ P ++P S +D ++ L KDP KR +A ++ HPF K
Sbjct: 232 GIP-PLKNPEKWSP-EFKDFLNKCLVKDP-----EKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 89/361 (24%), Positives = 143/361 (39%), Gaps = 88/361 (24%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++++ ++IG G G V+L + R E C A+ + EK + V +E
Sbjct: 14 EYEVIKKIGNGRFGEVFLV------KHKRTQEFFCWKAISYRGLKEREKSQLV----IEV 63
Query: 141 KILKMLDHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY-- 196
+++ L H + F +A+ I+MEFC GDL S ++ +K F
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVD 122
Query: 197 -AAEVLVALEYLHMLG-------IIYRDLKPENVL----VRSDGHIMLSDFDLSLCSNAI 244
++L AL Y H L +++RDLKP+N+ +R G I +L N
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL----NGR 178
Query: 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304
P + + F SK I + A SC
Sbjct: 179 PIAK---------------------------IGDFGLSKNIGIES----------MAHSC 201
Query: 305 SFVGTHEYVSPEVA--SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP 362
VGT Y SPE+ S+ + D WA G IYE+ G+TPF +N + L + +K+
Sbjct: 202 --VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259
Query: 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422
P + S LI LLN L +K + ++ L + +I+++ P
Sbjct: 260 PDLPIKGKSK----ELNILIKNLLN------LSAKERPSALQC------LGYQIIKNVGP 303
Query: 423 P 423
P
Sbjct: 304 P 304
|
Length = 1021 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 68/298 (22%), Positives = 104/298 (34%), Gaps = 102/298 (34%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
IVME ++ + H+R S + ++L +++LH GII+RDLKP N++V+
Sbjct: 106 IVMELMDANLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160
Query: 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI 285
SD + + DF L+ R G+
Sbjct: 161 SDCTLKILDFGLA---------------------------------------RTAGTS-- 179
Query: 286 QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP 345
F+ P +V T Y +PEV G + VD W+ G + EMI G
Sbjct: 180 --------FMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 224
Query: 346 F----------------AAPSNE------TTLRNIVK-KP-------------LTFPTQS 369
F P E T+R V+ +P + FP S
Sbjct: 225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS 284
Query: 370 P-SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
+ + ARDL+S +L D R+ + HP+ PP+IP
Sbjct: 285 EHNKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINVWYDPSEAEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 19/132 (14%)
Query: 122 VNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS--------------CIV 167
V K VL + V A E KI++ LDH + +Y S IV
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227
E DL ++ + P S AR + ++L L+Y+H +++RDLKP NV + ++
Sbjct: 95 QE-YMETDLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE 150
Query: 228 GHIM-LSDFDLS 238
++ + DF L+
Sbjct: 151 DLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 89/374 (23%), Positives = 133/374 (35%), Gaps = 117/374 (31%)
Query: 71 FGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK 130
FG +T R DL + +G G G V CS Q G MK + VL K
Sbjct: 2 FGTVFEITNRYVDL-QPVGMGAFGLV--CS---ARDQLTGQNVAIKKIMKPFSTPVLAK- 54
Query: 131 KKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP-HKRFS 189
R E K+LK L H + +L F + + G DLH L +P K+F
Sbjct: 55 ----RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF- 109
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
+++ ++L L+Y+H G+++RDLKP N+L+ + DL +C
Sbjct: 110 ---IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-------CDLKICD-------- 151
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
FG +IQ +P + +V T
Sbjct: 152 ------------------------------FGLARIQ----------DP---QMTGYVST 168
Query: 310 HEYVSPEVA-SGGSHGNAVDWWAFGIFIYEMIYGRTPF----------------AAPS-- 350
Y +PE+ + + VD W+ G EM+ G+ F P
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 351 ------NETTLRNIV------KKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396
+E TLR + P + F PS A DL+ +L DP R+
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPS------AIDLLEKMLVFDPQKRI-- 280
Query: 397 KRGAADVKTHPFFK 410
AA+ HP+
Sbjct: 281 --SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 15/153 (9%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G+G G V+L K A+K++ + + + + E K++
Sbjct: 10 KELGSGQFGVVHLGKWRGKID----------VAIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L HP L LY IV E+ + G L + ++ K ++V A+E
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAME 114
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
YL G I+RDL N LV D + +SDF L+
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 85/369 (23%), Positives = 140/369 (37%), Gaps = 112/369 (30%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ + IG G G V CS + + ++ A+K +N +V E R E K
Sbjct: 2 YKIQEVIGKGSYGVV--CSAIDTHTGEK-------VAIKKIN-DVFEHVSDATRILREIK 51
Query: 142 ILKMLDHP--------FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
+L++L HP LP EF+ +ME DLH + + + +
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME----SDLHQV--IKANDDLTPEHH 105
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+F+ ++L AL+Y+H + +RDLKP+N+L +D + + DF L+ +
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA------------ 153
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
F + TP +F + VA R Y
Sbjct: 154 ---------------------FND-----------TPTAIFWTDYVATRW--------YR 173
Query: 314 SPEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPF----------------AAPSNETT- 354
+PE+ + A+D W+ G E++ G+ F PS ET
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 355 -LRNI----------VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADV 403
+RN K+P+ F + P+ ++ A L+ LL DP +R A +
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPN--ADPLALRLLERLLAFDPKDR----PTAEEA 287
Query: 404 KTHPFFKGL 412
P+FKGL
Sbjct: 288 LADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 58/249 (23%), Positives = 89/249 (35%), Gaps = 86/249 (34%)
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
S+ + R + ++L L Y H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 101 SMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA---------- 150
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
A S S+TY+ + T R P+ L +G
Sbjct: 151 ------RAKSVPSKTYSNEVVTLWYR--------------PPDVL-------------LG 177
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPF-----------------AAPSN 351
+ EY + +D W G YEM GR F P+
Sbjct: 178 STEYSTS-----------LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE 226
Query: 352 ET---TLRNIVKKPLTFPTQSPSSMSEY--------HARDLISGLLNKDPCNRLGSKRGA 400
ET N KP +FP P + + H +L L +P R+ A
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI----SA 282
Query: 401 ADVKTHPFF 409
A+ HP+F
Sbjct: 283 AEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 62/275 (22%), Positives = 96/275 (34%), Gaps = 95/275 (34%)
Query: 166 IVMEFCSGGDLHSL--RHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223
+VME+ DL SL KQP F + + ++L + +LH I++RDLK N+L
Sbjct: 83 MVMEYVEH-DLKSLMETMKQP---FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138
Query: 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSK 283
+ + G + + DF L+ R+Y + L +
Sbjct: 139 LNNRGILKICDFGLA---------------------------REYGSPLKPY-------- 163
Query: 284 KIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYG 342
T V T Y +PE+ G A+D W+ G E++
Sbjct: 164 -----TQL---------------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
Query: 343 RTPFAAPSNETTLRNIVK-------------------KPLTFPTQSPS---------SMS 374
+ F S L I K K TF + S+S
Sbjct: 204 KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLS 263
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
+ + DL++ LL DP R+ A D HP+F
Sbjct: 264 D-NGFDLLNRLLTYDPAKRI----SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 50/252 (19%), Positives = 95/252 (37%), Gaps = 68/252 (26%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E IL+ ++HP + L F + F+C+++ DL+ + + ++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYC--YLAAKRNIAICDILAIER 189
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
VL A++YLH II+RD+K EN+ + G + L DF + I A
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA------------ 237
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
N+++G + GT +PE+
Sbjct: 238 ------------------NKYYG------------------------WAGTIATNAPELL 255
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPF-------AAPSNETTLRNIVKK----PLTFPT 367
+ +G AVD W+ GI ++EM ++ ++ I+++ P FP
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 368 QSPSSMSEYHAR 379
+ +++ E +
Sbjct: 316 DAQANLDEIYIG 327
|
Length = 391 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 82/355 (23%), Positives = 126/355 (35%), Gaps = 105/355 (29%)
Query: 86 RRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
++G G TVY + +N G L A+KV++ + E A E +L
Sbjct: 11 EKLGEGSYATVYKGISRIN-------GQ----LVALKVISMKTEEGVP--FTAIREASLL 57
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
K L H + L+ V E+ DL + P + R + ++L
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRLFMFQLLRG 115
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
L Y+H I++RDLKP+N+L+ G + L+DF L+ + +IP SQT
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIP---------------SQT 159
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS- 322
Y+ + V T Y P+V G +
Sbjct: 160 YSSE---------------------------------------VVTLWYRPPDVLLGATD 180
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSN----------------ETTLRNIVK----KP 362
+ +A+D W G EM+ G+ F S+ E T + K KP
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 363 LTFPTQSPSSMSE--------YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
F P + A DL S +L P +R+ A D HP+F
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI----SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV---NKEVLEKKKKVHRAEMEKKILK 144
+G G GTVY C L N+ + L A+K V VL +K+ + + E +LK
Sbjct: 8 LGKGAYGTVY-CGLTNQGQ---------LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF-SLTSARF--YAAEVL 201
L H + N I MEF GG + S+ RF L F Y ++L
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQIL 112
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+ YLH +++RD+K NV++ +G I L DF
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 61/276 (22%), Positives = 95/276 (34%), Gaps = 78/276 (28%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F+L +G G G VY K R + + + M V E E K++++ +
Sbjct: 8 FELVELVGNGTYGQVY------KGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK---- 57
Query: 142 ILKMLDHPFLPTLYAEFEASNFS------CIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
K H + T Y F N +VMEFC G + L +
Sbjct: 58 --KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
E+L L +LH +I+RD+K +NVL+ + + L DF +
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV------------------ 157
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
S +L R R +F+GT +++P
Sbjct: 158 -------------SAQLDR------------------------TVGRRNTFIGTPYWMAP 180
Query: 316 EVASGGSHGNAV-----DWWAFGIFIYEMIYGRTPF 346
EV + + +A D W+ GI EM G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 34/102 (33%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF--Y 196
E I++ DHP + L N IVME G+L R ++SL A Y
Sbjct: 57 EAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGEL---RSYLQVNKYSLDLASLILY 112
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ AL YL ++RD+ NVLV S + L DF LS
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 62/296 (20%), Positives = 105/296 (35%), Gaps = 85/296 (28%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +LK L H + TL+ +V E+ L + S+ + + +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG--NLMSMHNVKIFMF 110
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++L L Y H I++RDLKP+N+L+ G + L+DF L+ A S
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA----------------RAKS 154
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
++TY+ + T R P+ L +G+ EY +P
Sbjct: 155 VPTKTYSNEVVTLWYR--------------PPDVL-------------LGSTEYSTP--- 184
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK------------------ 360
+D W G +YEM GR F + + L I +
Sbjct: 185 --------IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236
Query: 361 -KPLTFPTQSPSSMSEYHAR------DLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
+ FP + + R DL+S LL + +R+ ++ H +F
Sbjct: 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL----RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 50/250 (20%), Positives = 86/250 (34%), Gaps = 85/250 (34%)
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
++ + + + ++L L Y H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA---------- 151
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
A S ++TY+ + V
Sbjct: 152 ------RAKSIPTKTYSNE---------------------------------------VV 166
Query: 309 THEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK------- 360
T Y P++ G + + +D W G YEM GR F + E L I +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 361 ------------KPLTFPTQSPSSMSEYHAR------DLISGLLNKDPCNRLGSKRGAAD 402
K +P + + R +L+S LL + R+ A +
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI----SAEE 282
Query: 403 VKTHPFFKGL 412
HP+F L
Sbjct: 283 AMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 82/356 (23%), Positives = 122/356 (34%), Gaps = 103/356 (28%)
Query: 87 RIGAGDIGTVYL--CSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK 144
++G G TVY +N K L A+KV+ + E++ A E +LK
Sbjct: 12 KLGEGSYATVYKGKSKVNGK-----------LVALKVIRLQ--EEEGTPFTAIREASLLK 58
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
L H + L+ +V E+ DL K P + + + ++L L
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGG-LHPENVKLFLFQLLRGL 116
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
Y+H I++RDLKP+N+L+ G + L+DF L+ A S S TY
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLA----------------RAKSVPSHTY 160
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
+ + T R + GS + T
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYST------------------------------------- 183
Query: 325 NAVDWWAFGIFIYEMIYGRTPFA----------------APSNETTLRNIVK----KPLT 364
+D W G EMI G F NE T + KP
Sbjct: 184 -CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242
Query: 365 FPTQSPSSMSEY--------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
F SP ++ + HA DL S LL P NRL ++ +H +F L
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL----SHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 65/274 (23%), Positives = 98/274 (35%), Gaps = 79/274 (28%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCL-YAMKVVNKEVLEKKKKVHRAEME 139
DF+ +GAG+ G V+ S H+P L A K+++ E+ K ++ E
Sbjct: 6 DFEKISELGAGNGGVVFKVS----------HKPSGLIMARKLIHLEI--KPAIRNQIIRE 53
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ---PHKRFSLTSARFY 196
++L + P++ Y F + I ME GG L + K P + S
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--- 110
Query: 197 AAEVLVALEYL-HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
V+ L YL I++RD+KP N+LV S G I L DF +S
Sbjct: 111 --AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------- 151
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+ N F G++ Y+SP
Sbjct: 152 -------------GQLIDSMANSFVGTR---------------------------SYMSP 171
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP 349
E G + D W+ G+ + EM GR P P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 17/155 (10%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEMEKKILK 144
+IG G+ G VY L A+K + K+K + E +ILK
Sbjct: 1 EKIGKGNFGDVYKGVLKGN----------TEVAVKTCRSTLPPDLKRKFLQ---EAEILK 47
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVA 203
DHP + L IVME GG L + LR K+ R ++ + +
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAG 105
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+EYL I+RDL N LV + + +SDF +S
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 18/163 (11%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F+L +G G G VY K R + + + M V E E K +++ M KK
Sbjct: 18 FELVEVVGNGTYGQVY------KGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN---MLKK 68
Query: 142 ILKMLDHPFLPTLYAEFEASNFS------CIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
H + T Y F + +VMEFC G + L +
Sbjct: 69 YSH---HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
E+L L +LH +I+RD+K +NVL+ + + L DF +S
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 19/114 (16%)
Query: 135 RAEMEKKILKMLDHP--------FLP-TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ-P 184
RA E ++K+++H F P EF+ +VME +L +
Sbjct: 61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY---LVMELMDA-NLCQVIQMDLD 116
Query: 185 HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
H+R S + ++L +++LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 117 HERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 44/162 (27%), Positives = 64/162 (39%), Gaps = 21/162 (12%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
++ L IG G+ G V L + KV K + + E
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQ---------------KVAVKCLKDDSTAAQAFLAE 50
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARF--Y 196
++ L HP L L N IV E+ + G L LR + R +T A+ +
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGF 107
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A +V +EYL ++RDL NVLV D +SDF L+
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 67/308 (21%), Positives = 108/308 (35%), Gaps = 79/308 (25%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G VY L + A+K + + K ++ R E E ++ L
Sbjct: 13 LGEGAFGKVYKGELTGPNERL----SATSVAIKTLKENAEPKVQQEFRQEAE--LMSDLQ 66
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHK-----------RFSLTSARF 195
HP + L +C++ E+ + GDLH L PH + SL + F
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 196 Y--AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
A ++ +EYL ++RDL N LV + +SDF LS
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS--------------- 171
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
Y+ Y S+ +L P R ++
Sbjct: 172 -------RDIYSADYYRVQSK------------SLLPVR-------------------WM 193
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTL-----RNIVKKPLTFPT 367
PE G D W+FG+ ++E+ YG P+ SN+ + R ++ P P
Sbjct: 194 PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPA 253
Query: 368 QSPSSMSE 375
+ + M E
Sbjct: 254 RVYALMIE 261
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 3/95 (3%)
Query: 145 MLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
M D+P LY ++M++ GDL L K+ + S + +++ AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEAL 122
Query: 205 EYLHMLGIIYRDLKPENVL-VRSDGHIMLSDFDLS 238
LH II+ D+K ENVL R+ I L D+ L
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 49/243 (20%), Positives = 87/243 (35%), Gaps = 69/243 (28%)
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHK--------- 186
+ E ++ L HP + L C++ E+ + GDLH L + PH
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 187 ---RFSLTSARFY--AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
+ SL F A ++ +EYL +++DL N+L+ H+ +SD LS
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS--- 171
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
+ Y+ Y + +L P R
Sbjct: 172 -------------------REIYSADYYRVQPK------------SLLPIR--------- 191
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK 360
++ PE G + D W+FG+ ++E+ +G P+ SN+ + + K
Sbjct: 192 ----------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
Query: 361 KPL 363
+ L
Sbjct: 242 RQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 13/151 (8%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G+ G V+ +L +K A+K KE L ++ K+ + E +ILK D
Sbjct: 3 LGKGNFGEVFKGTLKDKTP----------VAVKTC-KEDLPQELKI-KFLSEARILKQYD 50
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HP + L IVME GGD S K+ + + +F A + + YL
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYL 109
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
I+RDL N LV + + +SDF +S
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 63/265 (23%), Positives = 91/265 (34%), Gaps = 88/265 (33%)
Query: 175 DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234
DLH + S + + ++L L+YLH GI++RD+KP N+LV S+ + + D
Sbjct: 89 DLHKIIVSPQP--LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146
Query: 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLF 294
F L+ VE P S +Q QY
Sbjct: 147 FGLA-------RVEEPDESKHM----TQEVVTQY-------------------------- 169
Query: 295 VAEPVAARSCSFVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA----- 348
Y +PE+ G H +AVD W+ G E++ R F A
Sbjct: 170 -----------------YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
Query: 349 -----------PSNET-----------TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386
PS E LR K P + SS + + A L+ +L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKG 411
DP R+ AAD HP+
Sbjct: 273 VFDPDKRI----SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 62/272 (22%), Positives = 96/272 (35%), Gaps = 89/272 (32%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
+VME+C DL SL P FS + + ++L L+YLH II+RDLK N+L+
Sbjct: 85 LVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142
Query: 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI 285
G + ++DF L+ R +G
Sbjct: 143 DKGCLKIADFGLA---------------------------------------RTYGL-PA 162
Query: 286 QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRT 344
+ +TP V T Y +PE+ G ++ A+D WA G + E++ +
Sbjct: 163 KPMTPK---------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207
Query: 345 PFAAPS---------------NETTLRNIVKKPL----TFPTQSPSSMSEYH-------A 378
S NE+ PL T P Q P + ++
Sbjct: 208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ-PYNNLKHKFPWLSEAG 266
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
L++ LL DP R A + +FK
Sbjct: 267 LRLLNFLLMYDPKKRA----TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 78/358 (21%), Positives = 126/358 (35%), Gaps = 115/358 (32%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKV-HRAEMEKKILKM 145
+IG G GTV+ K + HE + A+K V + + + V A E +LK
Sbjct: 7 KIGEGTYGTVF------KAKNRETHE---IVALKRVRLD--DDDEGVPSSALREICLLKE 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF--------SLTSARFYA 197
L H + LY + +V E+C Q K++ + +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCD----------QDLKKYFDSCNGDIDPEIVKSFM 105
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L L + H +++RDLKP+N+L+ +G + L+DF L+
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------------------- 146
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
R FG P R + AE V T Y P+V
Sbjct: 147 --------------------RAFG-------IPVRCYSAEVV---------TLWYRPPDV 170
Query: 318 ASGGS-HGNAVDWWAFGIFIYEMIYGRTP-FAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
G + ++D W+ G E+ P F + L+ I + T +S +S+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 376 ---------YHA---------------RDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
Y A RDL+ LL +P R+ A + HP+F
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI----SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 30/143 (20%), Positives = 54/143 (37%), Gaps = 12/143 (8%)
Query: 93 IGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP 152
I + N A+K +N + K+ + + E + L HP +
Sbjct: 15 IVHLAKHKPTNTL-----------VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGI 212
F + +V + G L + + F +VL AL+Y+H G
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 213 IYRDLKPENVLVRSDGHIMLSDF 235
I+R +K ++L+ DG ++LS
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 137 EMEKKILKML-DHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHK--QPHKRF 188
E E ILK L DHP + Y + + +V+E C+GG + L + +R
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ E L+ L++LH+ I+RD+K N+L+ ++G + L DF +S
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 184 PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD--LSLCS 241
P + + + +VL L LH +GI++RD+KPEN+LV DG + + DF + +C+
Sbjct: 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361
Query: 242 ----NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRF 279
N + + P SP Q+ R + ++ L+ F
Sbjct: 362 GINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPF 403
|
Length = 507 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 135 RAEMEKKILKMLDHP----FLPTLYAEFEASNFS--CIVMEFCSGGDLHSLRHKQPHKRF 188
RA E ++LK + H L + F +VM F G DL L H++
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKL---MKHEKL 115
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
S +F ++L L+Y+H GII+RDLKP N+ V D + + DF L+
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 63/303 (20%), Positives = 101/303 (33%), Gaps = 64/303 (21%)
Query: 118 AMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS-NFSCIVMEFCSGGDL 176
A+K++ + E++ + R E + L HP + L EA V E+ G L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 177 HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIMLS 233
+ T +VL AL H GI++RDLKP+N++V G H +
Sbjct: 67 REVLAADGALPAGETGR--LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293
DF + TL P
Sbjct: 125 DFGIG------------------------------------------------TLLPGVR 136
Query: 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET 353
R+ +GT Y +PE G D +A+G+ E + G+ S
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS--- 193
Query: 354 TLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ I+ + L+ P ++ + ++ LNKDP R S A+ F+ L
Sbjct: 194 -VAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAER-----FRAL 247
Query: 413 NFA 415
Sbjct: 248 ELC 250
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 38/184 (20%)
Query: 88 IGAGDIGTVYLCSLNNKYR--QDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK--KIL 143
+G G+ G+V LC +Y QD E VV + L+ H + E+ +IL
Sbjct: 12 LGKGNFGSVELC----RYDPLQDNTGE--------VVAVKKLQHSTAEHLRDFEREIEIL 59
Query: 144 KMLDHPFLPTLYAEFEASNFSC------IVMEFCSGGDLHSL----RHKQPHKRFSLTSA 193
K L H + +++ +S +VME+ G L R + H++ L
Sbjct: 60 KSLQHDNI----VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL--- 112
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL---CSNAIPAVESP 250
YA+++ +EYL ++RDL N+LV S+ + + DF L+ V P
Sbjct: 113 --YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170
Query: 251 ASSP 254
SP
Sbjct: 171 GESP 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 13/158 (8%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F L R++G+G G V+ N+ R A+K++ + L K++ + E
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVR----------VAIKILKSDDLLKQQDF---QKEV 53
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+ LK L H L +L+A I+ E G L + + + S A +V
Sbjct: 54 QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV 113
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ YL I+RDL N+LV D ++DF L+
Sbjct: 114 AEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G+G G V+L + + A+K +N+ + ++ + E K++
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK----------VAIKAINEGAMSEEDFIE----EAKVMMK 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFYAAEVLVAL 204
L HP L LY IV EF G L + LR +Q S +V +
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGM 113
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
EYL I+RDL N LV S G + +SDF ++
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVM-EFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E ++L+ L HP + L +C+V+ ++ S DL++ + + L A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARL-RPLGLAQVTAVA 266
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
++L A++Y+H GII+RD+K ENVLV I L DF
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 53/260 (20%), Positives = 91/260 (35%), Gaps = 101/260 (38%)
Query: 181 HKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240
K+P + Y ++L +L+++H GI +RD+KPEN+L++ D + L+DF
Sbjct: 93 RKRP---LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADF----- 143
Query: 241 SNAIPAVESPASSPEAASPRS----QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVA 296
S R YT STR
Sbjct: 144 ----------------GSCRGIYSKPPYTEYISTRW------------------------ 163
Query: 297 EPVAARSCSFVGTHEYVSPE-VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE--- 352
Y +PE + + G +G +D WA G +E++ F +NE
Sbjct: 164 ---------------YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG-TNELDQ 207
Query: 353 -TTLRNIV----------KKPLT-----FPTQSPS-------SMSEYHARDLISGLLNKD 389
+ +++ + FP++ + + S DL+ LL D
Sbjct: 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAE-GLDLLKKLLAYD 266
Query: 390 PCNRLGSKRGAADVKTHPFF 409
P R+ +K+ HP+F
Sbjct: 267 PDERITAKQAL----RHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 73/334 (21%), Positives = 118/334 (35%), Gaps = 82/334 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKY-RQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
RD L +G G G V+L +N QD+ L A+K + KE E ++ + E
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDK-----MLVAVKAL-KEASESARQDFQREA 58
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKR---------- 187
E +L +L H + Y +V E+ GDL+ LR P +
Sbjct: 59 E--LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 188 --FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+L A+++ + YL L ++RDL N LV + + DF +S
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS------- 169
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
YST R R T+ P R E + R +
Sbjct: 170 -------------------RDIYSTDYYRVGGR--------TMLPIRWMPPESILYRKFT 202
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPL 363
D W+FG+ ++E+ YG+ P+ SN + I + + L
Sbjct: 203 -------------------TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397
P P + ++ G ++P R+ K
Sbjct: 244 ERPRTCPPEVY-----AIMQGCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 67/285 (23%), Positives = 104/285 (36%), Gaps = 74/285 (25%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCL-YAMKVVNKEVLEKKKKVHRAEME 139
DF+ +GAG+ G V K + H+P L A K+++ E+ K ++ E
Sbjct: 6 DFERISELGAGNGGVVT------KVQ----HKPSGLIMARKLIHLEI--KPAIRNQIIRE 53
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++L + P++ Y F + I ME GG L + + KR +
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIA 111
Query: 200 VLVALEYL-HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
VL L YL I++RD+KP N+LV S G I L DF +S
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS-------------------- 151
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
+ N F G++ Y+SPE
Sbjct: 152 ----------GQLIDSMANSFVGTR---------------------------SYMSPERL 174
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL 363
G + D W+ G+ + E+ GR P P + L I +P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI-PPPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 70/331 (21%), Positives = 113/331 (34%), Gaps = 82/331 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK--KKKVHRAE 137
L R +G G G V+L + ++ L A+K + KE +K R
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPEND----KELVAVKTL-KETASNDARKDFER-- 57
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RH----------KQPH 185
E ++L H + Y + +V E+ GDL+ H P
Sbjct: 58 -EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116
Query: 186 KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+L+ A ++ + YL ++RDL N LV D + + DF +S
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------- 169
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
YT Y R G T+ P R
Sbjct: 170 ---------------RDVYTTDYY--------RVGGH----TMLPIR------------- 189
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPL 363
++ PE D W+FG+ ++E+ YG+ P+ SNE + I + + L
Sbjct: 190 ------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394
P PS + D++ G +DP R+
Sbjct: 244 QRPRTCPSEV-----YDIMLGCWKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 47/154 (30%), Positives = 64/154 (41%), Gaps = 16/154 (10%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
RIG G+ G V+ + + R D A+K +E L K + E +ILK
Sbjct: 2 RIGRGNFGEVF----SGRLRADN-----TPVAVKSC-RETLPPDLKA-KFLQEARILKQY 50
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-SLTSARFYAAEVLVAL 204
HP + L IVME GGD + LR + P + L AA +
Sbjct: 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAA---AGM 107
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
EYL I+RDL N LV + +SDF +S
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 19/171 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYR------QDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
L ++G G G V+LC + +P L A+K++ +V + + E
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPV-LVAVKMLRADVTKTARNDFLKE 67
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-------- 188
+ KI+ L +P + L + + C++ E+ GDL+ L ++ F
Sbjct: 68 I--KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 189 -SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
S+ + + A ++ ++YL L ++RDL N LV + I ++DF +S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 14/153 (9%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+++GAG G V++ NN + KV K + V E ++K
Sbjct: 12 KKLGAGQFGEVWMGYYNN--------------STKVAVKTLKPGTMSVQAFLEEANLMKT 57
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L H L LYA I+ E+ + G L + L ++A++ +
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
Y+ I+RDL+ NVLV ++DF L+
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 12/125 (9%)
Query: 118 AMKVVNKEVLEKKKKVHRAEM--EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGD 175
A+KV+ E +K R EM E +I+ LD+P++ + EA +VME SGG
Sbjct: 26 AIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGP 80
Query: 176 LHSLRHKQPHKRFSLTSARFYAA--EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
L+ K+ +T + +V + ++YL ++RDL NVL+ + + +S
Sbjct: 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKIS 137
Query: 234 DFDLS 238
DF LS
Sbjct: 138 DFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 32/118 (27%), Positives = 58/118 (49%), Gaps = 11/118 (9%)
Query: 127 LEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF------EASNFSCIVMEFCSGGDLHSLR 180
+ + RA E ++K ++H + +L F E +VME ++
Sbjct: 54 FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 181 HKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ H+R S + ++L +++LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 114 MELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 17/163 (10%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCC-LYAMKVVNKEVLEKKKKVHRAEMEKKILK 144
R +G G G V L Y D ++ + A+K + +E ++ + E+ ILK
Sbjct: 10 RVLGEGHFGKVSL------YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEI--NILK 61
Query: 145 MLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV 202
L H + + ++ME+ L SLR P + +L +A ++
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLLLFAQQICE 118
Query: 203 ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+ YLH I+RDL NVL+ +D + + DF L + A+P
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL---AKAVP 158
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 38/179 (21%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRG-----HEPCCLYAMKVVNKEV-LEKKKKVHRAEME 139
R IG G G V+ Q R +EP + A+K++ +E + + R E
Sbjct: 11 RDIGQGAFGRVF---------QARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---E 58
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSL----TSAR 194
++ DHP + L C++ E+ + GDL+ LRH+ P + SL +SAR
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 195 FY---------------AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A +V + YL ++RDL N LV + + ++DF LS
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 66/272 (24%), Positives = 103/272 (37%), Gaps = 60/272 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IGAG+ G V L +++ A+K + EK+++ +E I+ D
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSE--ASIMGQFD 63
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HP + L S I+ EF G L S +Q +F++ + ++YL
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
+ ++RDL N+LV S+ +SDF LS +E S P TYT
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLS------RFLEDDTSDP--------TYTSS 168
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
G K P R E +A R + +A
Sbjct: 169 ------------LGGK-----IPIRWTAPEAIAYRKFT-------------------SAS 192
Query: 328 DWWAFGIFIYE-MIYGRTPFAAPSNETTLRNI 358
D W++GI ++E M YG P+ SN+ + I
Sbjct: 193 DVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 84/365 (23%), Positives = 126/365 (34%), Gaps = 116/365 (31%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR--------AEM 138
+IG G G VY K R +V N+ + KK ++ + A
Sbjct: 9 KIGEGTYGVVY------KARD------------RVTNETIALKKIRLEQEDEGVPSTAIR 50
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFS--LTSARFY 196
E +LK + H + L + +V E+ DL +H F+ + Y
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLV-RSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
++L + Y H +++RDLKP+N+L+ R + L+DF L+
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA----------------- 150
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
R FG P R F E V T Y +P
Sbjct: 151 ----------------------RAFG-------IPVRTFTHEVV---------TLWYRAP 172
Query: 316 EVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNIV 359
E+ G H VD W+ G EM+ + F S NE T +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 360 KKP---LTFPTQSPSSMS------EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P FP P ++ E DL+S +L DP R+ + R A + H +FK
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-TARAALE---HEYFK 288
Query: 411 GLNFA 415
L A
Sbjct: 289 DLGDA 293
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 39/174 (22%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN--KEVLEKKKKVHRAEME 139
+++ IG G G VY + NK + L A+K+++ +V E+ E E
Sbjct: 24 WEIIETIGKGTYGKVY--KVTNK-------KDGSLAAVKILDPISDVDEE------IEAE 68
Query: 140 KKILKML-DHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSL---------RHKQP 184
IL+ L +HP + Y F ++ +V+E C+GG + L R +
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 185 HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ L A L+ L++LH II+RD+K N+L+ ++G + L DF +S
Sbjct: 129 MISYILYGA-------LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 56/257 (21%), Positives = 82/257 (31%), Gaps = 92/257 (35%)
Query: 182 KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
+ P + + + + ++L + + H G+++RDLKP+N +L D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN---------LLVDKQKGLL- 150
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
KI L R F PV +
Sbjct: 151 ------------------------------------------KIADLGLGRAFSI-PVKS 167
Query: 302 RSCSFVGTHE-----YVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355
THE Y +PEV G +H VD W+ G EM + F S L
Sbjct: 168 Y------THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221
Query: 356 RNIVKKPLT-----------------FPTQSPSSMS------EYHARDLISGLLNKDPCN 392
+I K T FP P +S DL+ +L DP
Sbjct: 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK 281
Query: 393 RLGSKRGAADVKTHPFF 409
R+ +K THP+F
Sbjct: 282 RISAK----AALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 1/43 (2%)
Query: 197 AAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A ++ ALEYLH L +I+RD+KP NVL+ +G + L DF +S
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
+GT Y++PEV G + D W+ G +YEM PF A S + LR V++
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DLRYKVQR----- 215
Query: 367 TQSPSSMSEYHARDL---ISGLLNKDPCNRLG 395
+ P Y ++DL I +L P R
Sbjct: 216 GKYPPIPPIY-SQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+D + +G G G V KY + RG A+K++ + + + + + E
Sbjct: 4 KDLTFLKELGTGQFGVV-------KYGKWRGQYDV---AIKMIKEGSMSEDEFIE----E 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFYAA 198
K++ L H L LY IV E+ S G L + LR KRF +
Sbjct: 50 AKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCK 107
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V + YL I+RDL N LV G + +SDF LS
Sbjct: 108 DVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKKILKM 145
+G+G+ GTV Y+ + + A+K++ + + K E+ E +++
Sbjct: 3 LGSGNFGTV----KKGMYKMKKSEKTV---AVKILKNDNNDPALK---DELLREANVMQQ 52
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVAL 204
LD+P++ + EA ++ +VME G L+ K H ++T +V + +
Sbjct: 53 LDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGM 108
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+YL ++RDL NVL+ + + +SDF LS
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 42/156 (26%), Positives = 62/156 (39%), Gaps = 16/156 (10%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L R++GAG G V++ + N KV K + E +I+
Sbjct: 10 LERKLGAGQFGEVWMGTWNG--------------TTKVAVKTLKPGTMSPEAFLQEAQIM 55
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
K L H L LYA IV E+ S G L K+ L AA++
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS 238
+ YL I+RDL N+LV + + ++DF L+
Sbjct: 116 MAYLESRNYIHRDLAARNILV-GENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 51/250 (20%), Positives = 86/250 (34%), Gaps = 85/250 (34%)
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
S+ + + + ++L L Y H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 102 SMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA---------- 151
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
A S ++TY+ + V
Sbjct: 152 ------RAKSVPTKTYSNE---------------------------------------VV 166
Query: 309 THEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK------- 360
T Y P+V G S + +D W G +EM GR F + E L I +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 361 ------------KPLTFPTQSPSSMSEYHAR------DLISGLLNKDPCNRLGSKRGAAD 402
K FP P + + R +L++ L + R+ A +
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI----SAEE 282
Query: 403 VKTHPFFKGL 412
H +F+ L
Sbjct: 283 AMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 15/137 (10%)
Query: 114 CCLYAMKVVNKEVLEKKKK-----VH--RAEMEKKILKMLDHPFLPTLYAEFEAS----N 162
C Y ++ K ++K + +H R E ++LK + H + L F + N
Sbjct: 32 CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91
Query: 163 FSCI-VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221
F+ + ++ G DL+++ Q + S +F ++L L+Y+H GII+RDLKP N
Sbjct: 92 FNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSN 148
Query: 222 VLVRSDGHIMLSDFDLS 238
V V D + + DF L+
Sbjct: 149 VAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 35/169 (20%)
Query: 83 DLHR--RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV----NKEVLEKKKKVHRA 136
DL IG+G G VY ++++ GH + A+K + NKE E K R
Sbjct: 16 DLENLGEIGSGTCGQVYKM----RFKKT-GH----VMAVKQMRRTGNKE--ENK----RI 60
Query: 137 EMEKKI-LKMLDHPFLPTLYAEF--EASNFSCI-VMEFCSGGDLHSLRHKQPHKRFSLTS 192
M+ + LK D P++ Y F ++ F C+ +M C D R + P L
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCL--DKLLKRIQGPIPEDILGK 118
Query: 193 ARFYAAEVLVALEYL---HMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ AL YL H G+I+RD+KP N+L+ + G++ L DF +S
Sbjct: 119 M---TVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 25/159 (15%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGH-----EPCCLYAMKVVNKEVLEKKKKVHRAEM--EK 140
+G+G GTVY +G E + V K + E+ E+ E
Sbjct: 15 LGSGAFGTVY-----------KGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEA 60
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYAAE 199
++ +DHP + L +S ++ + G L L + + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQ 117
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ + YL +++RDL NVLV++ H+ ++DF L+
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 45/155 (29%), Positives = 63/155 (40%), Gaps = 14/155 (9%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L R++GAG G V+ NN P A+K + ++ K + A+ I+
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNT-------TPV---AVKTLKPGTMDPKDFLAEAQ----IM 55
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
K L HP L LYA IV E G L + L AA+V
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ YL I+RDL NVLV + ++DF L+
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 70/335 (20%), Positives = 117/335 (34%), Gaps = 83/335 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNN-KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
RD L R +G G G V+L N +D+ L A+K + L +K R
Sbjct: 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDK-----MLVAVKALKDPTLAARKDFQR--- 56
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--------------RHKQP 184
E ++L L H + Y + +V E+ GDL+ + +Q
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 185 HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244
L+ A+++ + YL ++RDL N LV ++ + + DF +S
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------ 170
Query: 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304
Y+ Y R G T+ P R E + R
Sbjct: 171 ----------------RDVYSTDYY--------RVGG----HTMLPIRWMPPESIMYRKF 202
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KP 362
+ D W+FG+ ++E+ YG+ P+ SN + I + +
Sbjct: 203 T-------------------TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243
Query: 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397
L P P + D++ G ++P RL K
Sbjct: 244 LERPRVCPKEVY-----DIMLGCWQREPQQRLNIK 273
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 23/64 (35%), Positives = 37/64 (57%)
Query: 175 DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234
DL + K P + + ++L L++LH +++RDLKP+N+LV S G I L+D
Sbjct: 94 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153
Query: 235 FDLS 238
F L+
Sbjct: 154 FGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 38/169 (22%), Positives = 70/169 (41%), Gaps = 18/169 (10%)
Query: 86 RRIGAGDIGTVYLCSLNN-------KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
++G G G V+LC + + ++ + L A+KV+ + + ++ E+
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFYA 197
KIL L P + L C++ME+ GDL L+ +++ +
Sbjct: 71 --KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 198 AEVLV--------ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L+ + YL L ++RDL N LV + I ++DF +S
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 34/155 (21%), Positives = 62/155 (40%), Gaps = 24/155 (15%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ + G VYL ++ Y +K+ EK R E IL++
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-----------YVLKINPSR--EKGADRER---EVAILQL 47
Query: 146 LDH--PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
L +P + A E+ +S ++ME+ G L + ++ AE+L
Sbjct: 48 LARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEK------EDIAEQLAELLAK 101
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L L +L + + DL P N+LV + + D++ +
Sbjct: 102 LHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IG G G V CS N ++ A+K + + + R E K+L+ LD
Sbjct: 13 IGRGAYGIV--CSAKNSETNEK-------VAIKKIAN-AFDNRIDAKRTLREIKLLRHLD 62
Query: 148 HPFLPTLY-----AEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTS--ARFYAAE 199
H + + EA N IV E DLH +R Q L+ +++ +
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQT-----LSDDHCQYFLYQ 116
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
+L L+Y+H +++RDLKP N+L+ ++ + + DF L+ ++
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE--VLEKKKKVHRAEMEKKIL 143
R +G G G V LC + D E + ++K + + + KK++ IL
Sbjct: 10 RDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIE-------IL 60
Query: 144 KMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
+ L H + + N ++MEF G L + +K +L YA ++
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQIC 119
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++YL ++RDL NVLV S+ + + DF L+
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 30/178 (16%)
Query: 87 RIGAGDIGTVYLCSLNNK---------YRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
++G G G V+LC + N + +G L A+K++ + + + E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRP--LLVAVKILRPDANKNARNDFLKE 69
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL------HSLRHKQ-------- 183
+ KIL L P + L + C++ E+ GDL H L K+
Sbjct: 70 V--KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 184 ---PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
S +S A ++ ++YL L ++RDL N LV + I ++DF +S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 41/151 (27%), Positives = 59/151 (39%), Gaps = 15/151 (9%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IG+G G V+L K KV K + E E +++ L
Sbjct: 12 IGSGQFGLVWLGYWLEK--------------RKVAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
HP L LY + C+V EF G L Q K FS + +V + YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYL 116
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+I+RDL N LV + + +SDF ++
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 27/172 (15%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
L + +G G+ G+V L+ QD G + +KV K + K +E+E+
Sbjct: 1 LKLGKILGEGEFGSVMEGQLS----QDDGSQ------LKVAVKTM--KLDIHTYSEIEEF 48
Query: 142 I-----LKMLDHPFLPTLYA-EFEASNFS-----CIVMEFCSGGDLHSL----RHKQPHK 186
+ +K DHP + L FEAS+ +++ F GDLHS R +
Sbjct: 49 LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ L + + ++ + +EYL I+RDL N ++R D + ++DF LS
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 5/101 (4%)
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF---SLTSARFYAAE 199
+ L+HP + + S +V+EFC GDL + LR + R A E
Sbjct: 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACE 108
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240
V L +LH I+ DL N + +D + + D+ L+L
Sbjct: 109 VASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 15/155 (9%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L +++GAG G V++ N KV K + + E ++
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHT--------------KVAIKSLKQGSMSPEAFLAEANLM 55
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
K L HP L LYA I+ E+ G L + ++ AA++
Sbjct: 56 KQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ I+RDL+ N+LV ++DF L+
Sbjct: 115 MAFIERKNYIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 20/56 (35%), Positives = 33/56 (58%)
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
S ++ ++L L+Y+H GII+RDLKP N+ V D + + DF L+ ++A
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 19/157 (12%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPC-CLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
IG G GTV NK H+P + A+K + V EK++K +++ +++
Sbjct: 12 IGRGAFGTV------NKML----HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV-VMRSS 60
Query: 147 DHPFLPTLY-AEFEASNFSC-IVMEF--CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV 202
D P++ Y A F + C I ME S + ++ A +
Sbjct: 61 DCPYIVKFYGALFREGD--CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 203 ALEYL-HMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
AL YL L II+RD+KP N+L+ +G+I L DF +S
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 46/196 (23%), Positives = 69/196 (35%), Gaps = 65/196 (33%)
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF----DLSLCSNAIPAVES 249
R Y +++ A+ + H I++RD+KPEN+L+ + + L DF +LS SNA
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA------ 156
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
YT +TR
Sbjct: 157 -------------NYTEYVATRW------------------------------------- 166
Query: 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS 369
Y SPE+ G +G AVD W+ G + E+ G+ F S L I K P
Sbjct: 167 --YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP--- 221
Query: 370 PSSMSEYHARDLISGL 385
M +++ GL
Sbjct: 222 AEQMKLFYSNPRFHGL 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 13/117 (11%)
Query: 125 EVLEKKKKVHRAEMEKKIL---KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH 181
L+++ + R E +I+ + +P +Y + NF IVME+ G L L +
Sbjct: 35 PELDERIRRERTRREARIMSRARKAGVN-VPAVY-FVDPENFI-IVMEYIEGEPLKDLIN 91
Query: 182 KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ L LV LH GII+ DL N+++ S G I L DF L+
Sbjct: 92 SNGMEELEL----SREIGRLVGK--LHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 18/111 (16%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+ +GT +++PEV + N D W+ GI EM G+ P+ S+ +R I
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIF----M 210
Query: 365 FPTQSPSSMSEYHA-----RDLISGLLNKDPCNRLGSKRGAA-DVKTHPFF 409
P + P ++S+ D + L KDP +R +A + HPF
Sbjct: 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDP-----EERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 22/66 (33%), Positives = 37/66 (56%), Gaps = 3/66 (4%)
Query: 173 GGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232
G DL+++ Q + + +F ++L L+Y+H II+RDLKP N+ V D + +
Sbjct: 105 GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161
Query: 233 SDFDLS 238
DF L+
Sbjct: 162 LDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 66/321 (20%), Positives = 110/321 (34%), Gaps = 75/321 (23%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+G+G G VY + + G A+K + K +++KK E ++
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRV---AVKTLRKGATDQEKKEFLKEAH--LMSN 55
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLR----HKQPHKRFSLTSARFYAAEV 200
+HP + L + I+ME GGDL LR + +L +V
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGH-----IMLSDFDLSLCSNAIPAVESPASSPE 255
YL + I+RDL N LV G+ + + DF L
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL------------------ 157
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
A Y R K+ + L P R +++P
Sbjct: 158 ARDIYKSDYYR----------------KEGEGLLPVR-------------------WMAP 182
Query: 316 EVASGGSHGNAVDWWAFGIFIYE-MIYGRTPFAAPSNETTLRNIVKK-PLTFPTQSPSSM 373
E G D W+FG+ ++E + G+ P+ A +N+ L+++ L P P +
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKI 242
Query: 374 SEYHARDLISGLLNKDPCNRL 394
L++ +DP R
Sbjct: 243 -----YQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D + ++G G G VY + KY A+K + ++ +E V E
Sbjct: 7 DITMKHKLGGGQYGEVYE-GVWKKYS--------LTVAVKTLKEDTME----VEEFLKEA 53
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR--FYAA 198
++K + HP L L I+ EF + G+L L + + R + + + A
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL--LDYLRECNRQEVNAVVLLYMAT 111
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ A+EYL I+RDL N LV + + ++DF LS
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 57/307 (18%), Positives = 103/307 (33%), Gaps = 80/307 (26%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVH-----RAEMEKKI 142
+G G+ G V+L +V + L+K K + R E++ +
Sbjct: 13 LGRGEFGEVFLAKAKG---------IEEEGGETLVLVKALQKTKDENLQSEFRRELD--M 61
Query: 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLH-----SLRHKQPHKRFSLTSARFYA 197
+ L H + L + +++E+ GDL + + K L++ + A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 198 --AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
++ + +++L ++RDL N LV S + +S LSL +
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS--LLSLSKD------------- 166
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
Y +Y K L P R +++P
Sbjct: 167 -------VYNSEY-------------YKLRNALIPLR-------------------WLAP 187
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPL--TFPTQSPSS 372
E D W+FG+ ++E+ G PF S+E L + L P PS
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR 247
Query: 373 MSEYHAR 379
+ + R
Sbjct: 248 LYKLMTR 254
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 64/325 (19%), Positives = 107/325 (32%), Gaps = 84/325 (25%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKY-RQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI 142
L R +G G G V+L N QD+ L A+K + +K HR E ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDK-----ILVAVKTLKDASDNARKDFHR---EAEL 60
Query: 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-----------LRHKQPHKRFSLT 191
L L H + Y + +V E+ GDL+ + + +
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
A ++ + YL ++RDL N LV + + + DF +S
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS------------- 167
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
Y+ Y R G T+ P R E + R +
Sbjct: 168 ---------RDVYSTDYY--------RVGG----HTMLPIRWMPPESIMYRKFT------ 200
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLR-----NIVKKPLTF 365
D W+ G+ ++E+ YG+ P+ SN + ++++P T
Sbjct: 201 -------------TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247
Query: 366 PTQSPSSM-----SEYHARDLISGL 385
P + M E H R I +
Sbjct: 248 PKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
FD+ +IG G G VY K R E L +++ N EK+ A E K
Sbjct: 9 FDIIGQIGEGTYGQVY------KARDKDTGELVALKKVRLDN----EKEGFPITAIREIK 58
Query: 142 ILKMLDHPFLPTLY---------AEF--EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSL 190
IL+ L+H + L +F + F +V E+ + L H FS
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY-LVFEYMDHDLMGLLESGLVH--FSE 115
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
+ + ++L L Y H ++RD+K N+L+ + G I L+DF L+ N+
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+ +GT Y+SPE+ S + D WA G +YEM + F A + + I++ L
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL- 219
Query: 365 FPTQSPSSMSEYHAR--DLISGLLNKDPCNR 393
P +Y +LI+ +L+K P R
Sbjct: 220 -----PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 38/168 (22%), Positives = 60/168 (35%), Gaps = 37/168 (22%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKV---------VNKEVLEKKKKVHR- 135
+IG G VYL D P L ++ ++ L +K
Sbjct: 21 NQIGVGKESDVYLA-------LDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWL 73
Query: 136 ------AEMEKKILKML-DHPF-LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKR 187
A+ E LK L + F +P N +VME+ G +L+ +R +
Sbjct: 74 YLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVLED--- 126
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
E+L + + GII+ DL N+LV D I + D+
Sbjct: 127 -----PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 24/73 (32%), Positives = 38/73 (52%)
Query: 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
IVME S G+L + + S+ ++ +V +EYL +++RDL N+LV
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 226 SDGHIMLSDFDLS 238
DG +SDF L+
Sbjct: 135 EDGVAKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 52/227 (22%), Positives = 81/227 (35%), Gaps = 52/227 (22%)
Query: 48 PENLSLK--PHRSSDFAYSAIRSATFG---RKTG------LTFRDFD---LHR------- 86
P L K + Y R R+T LTF +D LH
Sbjct: 33 PLELIKKRARMDEEELLYRLKRLDKLKLVSRRTISYEGYQLTFSGYDALALHALVKRGIV 92
Query: 87 -----RIGAGDIGTVYLCSLNNKYRQ----DRGHEPCCLYAMKVVNKEVLEKKKK----- 132
+IG G VY+ + R + N++ L K+
Sbjct: 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKR--NRDYLADKEHGSWLY 150
Query: 133 VHR--AEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLR--HKQPHKRF 188
V R AE E + L+ L +P + A N +VME+ G +L+ LR + P +
Sbjct: 151 VSRLAAEREFEALQRL-YPEGVKVPKPI-AWNRHAVVMEYIEGVELYRLRLDVENPDEIL 208
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+L + + GI++ DL N+LV DG I++ D+
Sbjct: 209 DK---------ILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 1/100 (1%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +++K L H L LYA IV E+ S G L + K L AA
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ + Y+ + ++RDL+ N+LV + ++DF L+
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 1/100 (1%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +I+K L H L LYA IV EF G L + K L AA
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ + Y+ + I+RDL+ N+LV + ++DF L+
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 1/100 (1%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +I+K L H L LYA IV E+ S G L + L + AA
Sbjct: 51 EAQIMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V + Y+ + I+RDL+ N+LV ++DF L+
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 1/81 (1%)
Query: 306 FVGTHEYVSPEVASGGSHGN-AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+V T Y +PE+ H N VD W+ G + E++ GRT F + L+ I++ T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 365 FPTQSPSSMSEYHARDLISGL 385
+ +S AR+ I L
Sbjct: 237 PGAELLKKISSESARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 15/155 (9%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L +++GAG G V++ + N KV K + V E ++
Sbjct: 10 LEKKLGAGQFGEVWMATYNKH--------------TKVAVKTMKPGSMSVEAFLAEANVM 55
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
K L H L L+A I+ EF + G L + L ++A++
Sbjct: 56 KTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ I+RDL+ N+LV + ++DF L+
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 3/99 (3%)
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ILK + H + L + + C+VM + P L A
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP---LPLEQAITI 190
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
+L AL YLH GII+RD+K EN+ + + +L DF
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ IG G G V CS +K + A+K + E + R E
Sbjct: 6 RYQNLSYIGEGAYGMV--CSATHKPTGVK-------VAIKKI--SPFEHQTFCQRTLREI 54
Query: 141 KILKMLDHPFLPTLYA-----EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
KIL+ H + + FE+ N IV E DL+ L Q S ++
Sbjct: 55 KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---LSNDHIQY 110
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++L L+Y+H +++RDLKP N+L+ ++ + + DF L+
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 29/92 (31%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP---SNETTLRNIVKK 361
S VGT Y PE+ +G D WAFG +Y+M + PF + S T + V +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
PL P M D+I+ L D R
Sbjct: 232 PL------PEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNI 358
+ +PE AS G+ D W+FGI +YEM YG+ P+ +N I
Sbjct: 170 WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 66/291 (22%), Positives = 104/291 (35%), Gaps = 65/291 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
IGAG+ G V+ L R++ A+K + EK+++ +E I+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVA------VAIKTLKPGYTEKQRQDFLSE--ASIMGQFS 64
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALEY 206
H + L + I+ E+ G L LR FS + ++Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKY 122
Query: 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTR 266
L + ++RDL N+LV S+ +SDF LS PE TYT
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLS---------RVLEDDPEG------TYTT 167
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
G K P R + +PE + +A
Sbjct: 168 S-------------GGK-----IPIR-------------------WTAPEAIAYRKFTSA 190
Query: 327 VDWWAFGIFIYE-MIYGRTPFAAPSNETTLRNIVKK-PLTFPTQSPSSMSE 375
D W+FGI ++E M +G P+ SN ++ I L P PS++ +
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 34/123 (27%), Positives = 47/123 (38%), Gaps = 13/123 (10%)
Query: 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-- 354
E V + + +F GT Y++PE G + D W+ G+ + E+ R PF
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213
Query: 355 ---LRNIVKKPLTFPTQSPS---SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
L IV P P SE +D I L KDP R D+ HP+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSE-EFKDFIKQCLEKDPTRRPTPW----DMLEHPW 268
Query: 409 FKG 411
K
Sbjct: 269 IKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK 360
A +C VGT Y+SPE+ + N D W+ G +YE+ + PF + + I +
Sbjct: 159 AYTC--VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
F SP+ + + LIS L P +R
Sbjct: 217 G--YFAPISPNFSRDLRS--LISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 40/140 (28%), Positives = 58/140 (41%), Gaps = 41/140 (29%)
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPF----------------AAP 349
+V T Y +PEV G + VD W+ G + EM+ + F P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 350 SNE------TTLRNIVK-KP----LTFPTQSPSSM----SEYH------ARDLISGLLNK 388
E T+RN V+ +P LTFP P S+ SE++ ARDL+S +L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 389 DPCNRLGSKRGAADVKTHPF 408
DP R+ + HP+
Sbjct: 298 DPAKRI----SVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 27/95 (28%), Positives = 45/95 (47%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E + K+ +HP + A F A N +V F + G L S + +
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
VL AL+Y+H +G ++R +K ++L+ DG + LS
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 68/303 (22%), Positives = 103/303 (33%), Gaps = 75/303 (24%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM--EKKIL 143
R +G G G VY + EP A+K VN E R E E ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKD----EPETRVAIKTVN----EAASMRERIEFLNEASVM 63
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFS-------LTSARF 195
K + + L + ++ME + GDL S LR +P + L
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
A E+ + YL+ ++RDL N +V D + + DF +
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 165
Query: 256 AASPRSQTYTRQ-YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
TR Y T R K + L P R ++S
Sbjct: 166 ---------TRDIYETDYYR--------KGGKGLLPVR-------------------WMS 189
Query: 315 PEVASGGSHGNAVDWWAFGIFIYEM-IYGRTPFAAPSNETTLRNIVKKP-LTFPTQSPSS 372
PE G D W+FG+ ++E+ P+ SNE LR +++ L P P
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM 249
Query: 373 MSE 375
+ E
Sbjct: 250 LFE 252
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+FVGT +++PEV ++ + D W+ GI E+ G P + L I K
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-- 217
Query: 365 FPTQSPSSMSEY--HARDLISGLLNKDPCNRLGSK 397
P+ E+ ++ I LNKDP R +K
Sbjct: 218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 11/151 (7%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+++ IG G G VY N + + YA+K + + A E
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKN-GKDGK------EYAIKKFKGDKEQYTGISQSACREIA 54
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVM--EFCSGGDLHSLRHKQPHKRFSLTSARFYAA- 198
+L+ L H + +L F + + ++ ++ + KR S+ + +
Sbjct: 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114
Query: 199 -EVLVALEYLHMLGIIYRDLKPENVLVRSDG 228
++L + YLH +++RDLKP N+LV +G
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 11/128 (8%)
Query: 118 AMKVVNKEVLEKKKKVHRAEMEK-----KILKML-DHPFLPTLYAEFEASNFSCIVMEFC 171
MKV K + K H +E E KI+ L +H + L ++ E+C
Sbjct: 65 VMKVAVKML---KPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121
Query: 172 SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231
GDL + ++ +L ++ +V + +L I+RDL NVL+ + G I+
Sbjct: 122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL-THGKIV 180
Query: 232 -LSDFDLS 238
+ DF L+
Sbjct: 181 KICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 16/88 (18%)
Query: 166 IVMEFCSGGDLHS-LRHKQP-------------HKRFSLTSARFYAAEVLVALEYLHMLG 211
+V+E+ + G+L LR ++P + + +A +V +E+L
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK 152
Query: 212 IIYRDLKPENVLVRSDGHIM-LSDFDLS 238
I+RDL NVLV ++ H+M ++DF L+
Sbjct: 153 CIHRDLAARNVLV-TEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI- 142
L + +G G+ G+V LN QD +KV K + K R+EME +
Sbjct: 3 LGKTLGEGEFGSVMEGQLN----QDD-------SILKVAVKTM--KIAICTRSEMEDFLS 49
Query: 143 ----LKMLDHPFLPTLY------AEFEASNFSCIVMEFCSGGDLHSLR-----HKQPHKR 187
+K DHP + L E E +++ F GDLHS P
Sbjct: 50 EAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL 109
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ +F ++ +EYL I+RDL N ++ + ++ ++DF LS
Sbjct: 110 PTQMLVKF-MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 17/39 (43%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 203 ALEYLHMLGIIYRDL-KPENVLVRSDGHIMLSDFDLSLC 240
AL LH GI + DL KP+N L+ DG + DF L+
Sbjct: 123 ALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161
|
Length = 365 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 16/46 (34%), Positives = 25/46 (54%), Gaps = 1/46 (2%)
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNI 358
+PE A+ G D W+FGI + E++ YGR P+ +N L +
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 1/49 (2%)
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNI 358
++ +PE + GS D W+FGI + E++ YGR P+ SN +R +
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
L R ++L A+EY+H +I+RD+K EN+ + DG I+L DF
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDF 311
|
Length = 501 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 451 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.04 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.82 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.69 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.43 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.31 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.15 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.15 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.87 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.5 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.48 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.48 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.46 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.43 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.88 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.54 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-64 Score=471.13 Aligned_cols=364 Identities=57% Similarity=0.944 Sum_probs=298.2
Q ss_pred CCCCCCCCCchhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH
Q 013016 51 LSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK 130 (451)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~ 130 (451)
....|+...+..+..+..........+.++.|+++++||.|.-|+||+|.++++.. ++|+||+.+......
T Consensus 48 ~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~---------~fAmKVmdK~~l~~r 118 (459)
T KOG0610|consen 48 SGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNC---------LFAMKVMDKESLASR 118 (459)
T ss_pred ccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCc---------eEEEEEecHHHHhhh
Confidence 34556666666554444444344556677899999999999999999999988764 699999999999999
Q ss_pred HHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 013016 131 KKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML 210 (451)
Q Consensus 131 ~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~ 210 (451)
+...+.+.|.+||..++||.++.||+.|+.+++.|+|||||+||+|..++++++++.|++..++.++.+++.||+|||-.
T Consensus 119 kKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml 198 (459)
T KOG0610|consen 119 KKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML 198 (459)
T ss_pred hHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhcc-ccCCcc----c
Q 013016 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNR-FFGSKK----I 285 (451)
Q Consensus 211 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~ 285 (451)
|||+|||||+||||.++|.+.|+||.++......+...............+... . ...-+..+ ....++ .
T Consensus 199 GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~-~----~~s~f~~r~~~~~~~~~k~~ 273 (459)
T KOG0610|consen 199 GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRS-R----QPSCFSPRCLSSSKKRKKKD 273 (459)
T ss_pred ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccc-c----cccccccchhcccccccccc
Confidence 999999999999999999999999999976633333322211111111111111 0 01111111 111110 0
Q ss_pred ccc-CCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Q 013016 286 QTL-TPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364 (451)
Q Consensus 286 ~~~-~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 364 (451)
... ........++...++.+++||..|.|||++.|...+.++|.|+||++|||||.|..||.+.++.+.+.+|+...+.
T Consensus 274 ~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~ 353 (459)
T KOG0610|consen 274 ESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK 353 (459)
T ss_pred ccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc
Confidence 000 2223345677888999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 365 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
+|... ..+..+++||+++|.+||.+|...+++|.||.+||||++++|++++...||.||.+...
T Consensus 354 Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 354 FPEEP---EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred CCCCC---cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 98765 23338999999999999999999999999999999999999999999999999988754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=455.17 Aligned_cols=289 Identities=39% Similarity=0.659 Sum_probs=260.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|.+++.||+|+|++|++|+.+.+.++ |||||+.++.....+.+..+.+|..+|.+| .||.|++|+..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~ke---------YAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKE---------YAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCce---------eeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 37899999999999999999999988775 999999999999999999999999999999 89999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
|.+...+|+|+||+++|+|.++|+.. +.|++..++.++.||+.||+|||++|||||||||+|||++.||++||+|||.
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999999999999999999987 6799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|+.+.........+... ........+|+||..|++||+
T Consensus 221 AK~l~~~~~~~~~~~~~------------------------------------------~~a~s~~~SFVGTAeYVSPEl 258 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDP------------------------------------------NQASSRRSSFVGTAEYVSPEL 258 (604)
T ss_pred cccCChhhccccCccCc------------------------------------------ccccCcccceeeeecccCHHH
Confidence 98766443322211000 001112357899999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+..+..+..+|||+||||||+|+.|++||.+.++...+++|+.....++...++ .+++||+++|..||.+|+|
T Consensus 259 L~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~-----~a~dLv~KLLv~dp~~Rlt-- 331 (604)
T KOG0592|consen 259 LNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPE-----DARDLIKKLLVRDPSDRLT-- 331 (604)
T ss_pred hcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCH-----HHHHHHHHHHccCcccccc--
Confidence 999999999999999999999999999999999999999999999988877654 8999999999999999999
Q ss_pred CChHHHHcCCCcCCCCcccccccCCCCC-CCCC
Q 013016 398 RGAADVKTHPFFKGLNFALIRSLTPPEI-PGMR 429 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~~~~~~~~~-p~~~ 429 (451)
+++|.+||||.+++|..++.+.||.| |..+
T Consensus 332 --~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p 362 (604)
T KOG0592|consen 332 --SQQIKAHPFFEGVDWENLWQQTPPKLQPYKP 362 (604)
T ss_pred --HHHHhhCcccccCChhhhhhcCCCcccCCCC
Confidence 99999999999999999999999998 5544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-59 Score=438.95 Aligned_cols=283 Identities=39% Similarity=0.724 Sum_probs=254.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||+||.++.+++++ .||+|++++..............|..||..++||.||.++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~k---------iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGK---------IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCc---------eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3789999999999999999999887665 6999999999988888888899999999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
++.+++|||+||+.||.|..+|++. +.|++..++.++.+|+.||.|||++|||||||||+|||++.+|.++|+|||+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999999999988875 66999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+... .....+.++|||+.|||||++
T Consensus 173 k~~~-------------------------------------------------------~~~~~t~tfcGT~eYmAPEil 197 (357)
T KOG0598|consen 173 KEDL-------------------------------------------------------KDGDATRTFCGTPEYMAPEIL 197 (357)
T ss_pred hhcc-------------------------------------------------------cCCCccccccCCccccChHHH
Confidence 5321 122334468999999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+.+|+.++|.||||+++|||++|.+||.+.+...+.++|..++...+... .+.++++||+++|..||++|.....
T Consensus 198 ~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~----ls~~ardll~~LL~rdp~~RLg~~~ 273 (357)
T KOG0598|consen 198 LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY----LSEEARDLLKKLLKRDPRQRLGGPG 273 (357)
T ss_pred hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc----CCHHHHHHHHHHhccCHHHhcCCCC
Confidence 999999999999999999999999999999999999999999984444332 2238999999999999999986555
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
++.+|.+||||..++|..+ +++.||+.|...+.
T Consensus 274 d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 274 DAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred ChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence 6999999999999999854 88999999998875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=441.53 Aligned_cols=327 Identities=36% Similarity=0.647 Sum_probs=266.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|+++..||+|+||.||+|+.+.++. +||+|++++.......++..+..|..+|....+++||++|
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~---------iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGE---------IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCc---------EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 4567899999999999999999999888776 6999999999998899999999999999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
-.|++..++||||||++||++..+|.+. +.|++..++.++.+++.|++-||+.|+|||||||+|+||+..|++||+||
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 9999999999999999999999998875 66999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccC----CCcc--------cccccccccc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLT----PNRL--------FVAEPVAARS 303 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--------~~~~~~~~~~ 303 (451)
|+|.-........... .....+.........+.. +.+. ..........
T Consensus 286 GLs~gl~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a 345 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYR--------------------LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA 345 (550)
T ss_pred cccchhhhhhhhhhhc--------------------chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence 9985433221111000 000000000000000000 0000 0011223334
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~l 381 (451)
.+++|||-|||||++.+..|+..+|.|||||||||||.|.+||.+....+...+|++.. +.+|.... .. .++++|
T Consensus 346 ~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--~s-~eA~DL 422 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--LS-DEAKDL 422 (550)
T ss_pred hcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--cc-HHHHHH
Confidence 45799999999999999999999999999999999999999999999999999999876 44444333 22 499999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCCCCCCCC
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 438 (451)
|.+||. ||++|.. ..+++||.+||||++++|..++...+|++|.+.++-.-++++
T Consensus 423 I~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 423 ITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFD 477 (550)
T ss_pred HHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccc
Confidence 999999 9999998 677999999999999999999999999999999875555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-59 Score=437.75 Aligned_cols=263 Identities=30% Similarity=0.470 Sum_probs=231.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH----HHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK----KKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
+.|.+.+.||+|+||.|-+|..+.+++ .||||+++++.... ......+.+|+++|++|+|||||+++
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk---------~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGK---------QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCc---------EEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 569999999999999999999988876 49999999887654 22445567899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEE
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIML 232 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl 232 (451)
++|+..+..||||||+.||+|.+.+-.+ +.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999999988765 568899999999999999999999999999999999999866 68999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||+|+..+ ......++|||+.|
T Consensus 321 tDFGlAK~~g--------------------------------------------------------~~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 321 TDFGLAKVSG--------------------------------------------------------EGSFMKTLCGTPSY 344 (475)
T ss_pred cccchhhccc--------------------------------------------------------cceehhhhcCCccc
Confidence 9999996432 12334468999999
Q ss_pred cCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 313 VSPEVASGGSH---GNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 313 ~aPE~~~~~~~---~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
.|||++.+..+ ..++||||+|||||-+|+|.+||.+..... ...+|.++...+-...|..+.+ ++++||++||..
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise-ea~dlI~~mL~V 423 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE-EALDLINWMLVV 423 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH-HHHHHHHHhhEe
Confidence 99999988653 458899999999999999999999877776 7888999988887777776666 899999999999
Q ss_pred CcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
||++||+ ++|+|+||||+-.+.
T Consensus 424 dP~~R~s----~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 424 DPENRPS----ADEALNHPWFKDAPC 445 (475)
T ss_pred CcccCcC----HHHHhcChhhhcccc
Confidence 9999999 999999999997663
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=411.18 Aligned_cols=291 Identities=39% Similarity=0.695 Sum_probs=263.1
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..+++|++++.||.|+||+|.+++.+.++. .||+|++.++....-++++...+|..+|+.+.||.++++++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~---------yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~ 111 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGN---------YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYG 111 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCc---------eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEE
Confidence 456899999999999999999999988765 59999999999999999999999999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
.|.+.+++||||||++||.|..++++. ++|++..++.++.||+.||+|||+++|++|||||+|||++.+|.+||+|||
T Consensus 112 t~~d~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 112 TFKDNSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred eeccCCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999999999999886 679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|+.. ..++.++||||.|+|||
T Consensus 190 FAK~v----------------------------------------------------------~~rT~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 190 FAKRV----------------------------------------------------------SGRTWTLCGTPEYLAPE 211 (355)
T ss_pred ceEEe----------------------------------------------------------cCcEEEecCCccccChH
Confidence 98632 23455789999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc-CC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR-LG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R-pt 395 (451)
++...+|+.++|.||||+++|||+.|.+||...+...++.+|+.+.+.+|....+ ++++||+++|++|-.+| -+
T Consensus 212 ii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~-----~~kdLl~~LL~vD~t~R~gn 286 (355)
T KOG0616|consen 212 IIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSS-----DAKDLLKKLLQVDLTKRFGN 286 (355)
T ss_pred HhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCH-----HHHHHHHHHHhhhhHhhhcC
Confidence 9999999999999999999999999999999999999999999999999987665 89999999999999999 44
Q ss_pred CCCChHHHHcCCCcCCCCccc--ccccCCCCCC-CCCCCCCCCCCCCcc
Q 013016 396 SKRGAADVKTHPFFKGLNFAL--IRSLTPPEIP-GMRRQKTMPFPDQKI 441 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~--~~~~~~~~~p-~~~~~~~~~~~~~~~ 441 (451)
.+.+.++|..||||++++|.. .+...+|..| ....+-....++.+-
T Consensus 287 lknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~ 335 (355)
T KOG0616|consen 287 LKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYE 335 (355)
T ss_pred cCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccc
Confidence 566899999999999999974 4888888887 444444444444443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-57 Score=449.67 Aligned_cols=303 Identities=37% Similarity=0.691 Sum_probs=272.7
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~ 153 (451)
..+.+++|.++++||+|+||+|+++..+.+.+ +||||+++|.....++.++....|..|+.... ||.++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e---------~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNE---------YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCc---------EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEee
Confidence 35567899999999999999999999998876 69999999998888888888889999988775 999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
++.+|++.+++|+||||+.||++..+++. ..|++..++.++..|+.||.|||++||||||||.+|||+|.+|.+||+
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEec
Confidence 99999999999999999999995544433 569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+... ....++.++|||+.||
T Consensus 511 DFGlcKe~m-------------------------------------------------------~~g~~TsTfCGTpey~ 535 (694)
T KOG0694|consen 511 DFGLCKEGM-------------------------------------------------------GQGDRTSTFCGTPEFL 535 (694)
T ss_pred ccccccccC-------------------------------------------------------CCCCccccccCChhhc
Confidence 999996311 1234667899999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|||++.+..|+.++|.|||||+|||||.|+.||.+.++++.+..|+...+.+|..... ++.++++++|.+||++|
T Consensus 536 aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~-----ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 536 APEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK-----EAIAIMRRLLRKNPEKR 610 (694)
T ss_pred ChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH-----HHHHHHHHHhccCcccc
Confidence 9999999999999999999999999999999999999999999999999998887654 89999999999999999
Q ss_pred CCC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCccccCC
Q 013016 394 LGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQSTAFD 449 (451)
Q Consensus 394 pt~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 449 (451)
..+ ..++++|..||||++|+|..+ +...||++|..+++....++++.-.+..-+++
T Consensus 611 LG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 611 LGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALT 669 (694)
T ss_pred cCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccC
Confidence 996 456899999999999999854 99999999999999988888887776655554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=439.95 Aligned_cols=257 Identities=32% Similarity=0.558 Sum_probs=237.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|...+.||+|||++||.+++..+++ .||+|++.+.........+++.+|++|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge---------~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE---------VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc---------EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 459999999999999999999977765 49999999999888889999999999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.++.|||.|+|..++|..++++. +.+++.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 999999999999999999998854 679999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
... ....+..++||||.|.|||++.
T Consensus 167 ~le-------------------------------------------------------~~~Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 167 QLE-------------------------------------------------------YDGERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred eec-------------------------------------------------------CcccccceecCCCcccChhHhc
Confidence 332 1234455789999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
...++..+||||+|||||-||.|++||....-.+.+.+|.......|..... ++++||..||+.||.+|||
T Consensus 192 k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~-----~A~dLI~~lL~~~P~~Rps---- 262 (592)
T KOG0575|consen 192 KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSA-----EAKDLIRKLLRPNPSERPS---- 262 (592)
T ss_pred cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCH-----HHHHHHHHHhcCCcccCCC----
Confidence 9999999999999999999999999999999999999999999888874433 8999999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
+++||.|+||+.
T Consensus 263 l~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 263 LDEVLDHPFFKS 274 (592)
T ss_pred HHHHhcCHhhhC
Confidence 999999999944
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-56 Score=414.04 Aligned_cols=262 Identities=31% Similarity=0.489 Sum_probs=228.2
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.+++..+.+..+.||+|..|+||+|.++.+.+ ++|+|++... .+....+.+.+|+++++..+||+||.+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~---------i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ 142 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGK---------IYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGF 142 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCe---------EEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeE
Confidence 34555788889999999999999999998776 6999999543 344556778889999999999999999
Q ss_pred eEEEEeCC-eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEE
Q 013016 155 YAEFEASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 155 ~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl 232 (451)
||+|..++ .++|+||||.||||.+++... +++++.....|+.++++||.|||+ .+||||||||+|||++..|+|||
T Consensus 143 ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 143 YGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred eEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEe
Confidence 99999999 499999999999999998876 679999999999999999999995 99999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
||||.+..+. .+...+++||..|
T Consensus 221 cDFGVS~~lv---------------------------------------------------------nS~a~tfvGT~~Y 243 (364)
T KOG0581|consen 221 CDFGVSGILV---------------------------------------------------------NSIANTFVGTSAY 243 (364)
T ss_pred ccccccHHhh---------------------------------------------------------hhhcccccccccc
Confidence 9999984321 1234568999999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcCCCC-CCCCCCCCcChHHHHHHHHHhc
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP-----SNETTLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ll~~~L 386 (451)
||||.+.+..|+.++||||||++|+||.+|+.||... ...+.+..|+.+..+ +|.. .++.++++||..||
T Consensus 244 MsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~----~fS~ef~~FV~~CL 319 (364)
T KOG0581|consen 244 MSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG----EFSPEFRSFVSCCL 319 (364)
T ss_pred cChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc----cCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999875 556778888876432 3332 45559999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.+||.+||+ +.|++.|||+++...
T Consensus 320 ~Kdp~~R~s----~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 320 RKDPSERPS----AKQLLQHPFIKKFED 343 (364)
T ss_pred cCCcccCCC----HHHHhcCHHHhhccc
Confidence 999999999 999999999998444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=398.34 Aligned_cols=262 Identities=30% Similarity=0.518 Sum_probs=227.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||.|+||+||+|+++.++.. ||||.+.+... ..+..+.+..|+.+|+.++|||||.++++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~---------VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~ 77 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTE---------VAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDC 77 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCce---------EEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEE
Confidence 347899999999999999999999988764 99999988754 45667778889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC------CCEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD------GHIM 231 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~------~~~k 231 (451)
+..++++|||||||.||+|.+|++.. +.+++..++.++.||+.||++||+++||||||||+|||++.. -.+|
T Consensus 78 ~~~~~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 78 IEDDDFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EecCCeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 99999999999999999999999986 469999999999999999999999999999999999999865 3589
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||+|+.+.. .....+.||++.
T Consensus 156 IADFGfAR~L~~--------------------------------------------------------~~~a~tlcGSpl 179 (429)
T KOG0595|consen 156 IADFGFARFLQP--------------------------------------------------------GSMAETLCGSPL 179 (429)
T ss_pred ecccchhhhCCc--------------------------------------------------------hhHHHHhhCCcc
Confidence 999999965431 122235699999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|||||++..+.|+.|+|+||+|+|||+|++|+.||...+..+.+..+..+.-..+... ...+..+.+|+...|..+|.
T Consensus 180 YMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~--~~~s~~~~~Ll~~ll~~~~~ 257 (429)
T KOG0595|consen 180 YMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP--AELSNPLRELLISLLQRNPK 257 (429)
T ss_pred ccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh--hhccCchhhhhhHHHhcCcc
Confidence 9999999999999999999999999999999999999999999888777654333221 11222567999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCCC
Q 013016 392 NRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
.|.+ ..+-+.|+++....
T Consensus 258 ~~~~----~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 258 DRIS----FEDFFDHPFLAANP 275 (429)
T ss_pred ccCc----hHHhhhhhhcccCc
Confidence 9999 89999999998854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-53 Score=382.54 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=212.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|+.+.++|+|+||+||+|+++++++ .||||.+.... .+....+-..+|+++|++++|+|+|.++++|.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq---------IVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr 71 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ---------IVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFR 71 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCccc---------EEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHH
Confidence 568889999999999999999988776 69999996432 23344455678999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
....++||+|||...-| +-+...++ .++.+.++.++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+
T Consensus 72 rkrklhLVFE~~dhTvL-~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 72 RKRKLHLVFEYCDHTVL-HELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred hcceeEEEeeecchHHH-HHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhH
Confidence 99999999999966444 44555544 48999999999999999999999999999999999999999999999999995
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.+..+ ...-..++.|++|+|||++.
T Consensus 150 ~L~~p-------------------------------------------------------gd~YTDYVATRWYRaPELLv 174 (396)
T KOG0593|consen 150 TLSAP-------------------------------------------------------GDNYTDYVATRWYRAPELLV 174 (396)
T ss_pred hhcCC-------------------------------------------------------cchhhhhhhhhhccChhhhc
Confidence 43211 01111357899999999999
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------------------CCCCCC--------CC
Q 013016 320 G-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-------------------TFPTQS--------PS 371 (451)
Q Consensus 320 ~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------------~~~~~~--------~~ 371 (451)
| ..|+.++||||+||++.||++|.+.|.+.++.+.+..|..... .+|... .+
T Consensus 175 GDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p 254 (396)
T KOG0593|consen 175 GDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP 254 (396)
T ss_pred ccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcc
Confidence 9 6799999999999999999999999999988877666654111 111111 11
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.+.. -+.+|++.||..||.+|++ .+++|.|+||.+
T Consensus 255 ~~s~-~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~ 289 (396)
T KOG0593|consen 255 KISN-VLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDG 289 (396)
T ss_pred cchH-HHHHHHHHHhcCCcccccc----HHHHhcChHHHH
Confidence 1222 5789999999999999999 999999999966
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=400.22 Aligned_cols=260 Identities=29% Similarity=0.412 Sum_probs=220.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~ 157 (451)
.++|.++++||.|+||.||+|..+.+++ +||||.+++.... .+... -.+|+..|++|+ |||||++.++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~---------~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGE---------LVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCc---------eeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHH
Confidence 3789999999999999999999887765 5999999876543 22222 346999999998 9999999999
Q ss_pred EEeCC-eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 158 FEASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 158 ~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
+.+++ ++|+||||| ..+|+++++.+ +..|++..++.|+.||+.||+|+|.+|++||||||+|||+..+..+||+|||
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence 99888 999999999 88999999887 7889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|+.....+.-. .++.|++|+|||
T Consensus 156 LARev~SkpPYT--------------------------------------------------------eYVSTRWYRAPE 179 (538)
T KOG0661|consen 156 LAREVRSKPPYT--------------------------------------------------------EYVSTRWYRAPE 179 (538)
T ss_pred cccccccCCCcc--------------------------------------------------------hhhhcccccchH
Confidence 997554332211 247899999999
Q ss_pred cccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC-----------------------
Q 013016 317 VASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS----------------------- 372 (451)
Q Consensus 317 ~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------- 372 (451)
+++. ..|+.++||||+|||++|+++-++.|.+.++.+.+.+|......+....++.
T Consensus 180 vLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L 259 (538)
T KOG0661|consen 180 VLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDL 259 (538)
T ss_pred HhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHh
Confidence 9876 5589999999999999999999999999998888887766333222221111
Q ss_pred --cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 373 --MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 373 --~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
..+.++.++|.+||.|||.+||| |.|+|+||||+.
T Consensus 260 ~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~ 296 (538)
T KOG0661|consen 260 LPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQV 296 (538)
T ss_pred CcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCccccc
Confidence 12338899999999999999999 999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=404.31 Aligned_cols=261 Identities=33% Similarity=0.561 Sum_probs=229.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH--HHHHHHHHHHHHHHHCC-CCCccce
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK--KKVHRAEMEKKILKMLD-HPFLPTL 154 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~nIv~l 154 (451)
..+.|.+.+.||+|+||+|++|.+..++. .||+|++++...... .....+.+|+.+++++. ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~---------~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGE---------KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCC---------eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 34789999999999999999999887765 399998887532211 23455667999999998 9999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEEe
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIMLS 233 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~ 233 (451)
++++....++|+|||||.||+|.+++.. .+++.+..++.+++||+.||+|||++||+||||||+|||++.+ +++||+
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEe
Confidence 9999999999999999999999999988 3679999999999999999999999999999999999999999 999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++.... .......+++||+.|+
T Consensus 164 DFG~s~~~~-------------------------------------------------------~~~~~l~t~cGsp~Y~ 188 (370)
T KOG0583|consen 164 DFGLSAISP-------------------------------------------------------GEDGLLKTFCGSPAYA 188 (370)
T ss_pred ccccccccC-------------------------------------------------------CCCCcccCCCCCcccC
Confidence 999985321 0112223569999999
Q ss_pred CcccccCCC-C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 314 SPEVASGGS-H-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 314 aPE~~~~~~-~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|||++.+.. | +.++||||+|++||.|++|+.||...+....+..|..+...+|.... +.++++|+.+||..||.
T Consensus 189 aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~----S~~~~~Li~~mL~~~P~ 264 (370)
T KOG0583|consen 189 APEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL----SPEARSLIEKMLVPDPS 264 (370)
T ss_pred CHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC----CHHHHHHHHHHcCCCcc
Confidence 999999977 7 58999999999999999999999998888899999999888887653 33899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCC
Q 013016 392 NRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~ 412 (451)
+|++ +.+++.||||+..
T Consensus 265 ~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 265 TRIT----LLEILEHPWFQKE 281 (370)
T ss_pred cCCC----HHHHhhChhhccC
Confidence 9999 9999999999983
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=408.97 Aligned_cols=260 Identities=26% Similarity=0.500 Sum_probs=233.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.+-|++.+-||.|+.|.|-+|++..+++ +.|||++.+...........+++|+.||+.+.||||+++|+++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGq---------laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw 81 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQ---------LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW 81 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccc---------eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence 3669999999999999999999887766 6999999988555556667788999999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
++..++|+|.||++||.|.+++-.. +++++.++.++++||+.|+.|+|..+||||||||+|+|++..+++||+|||+|
T Consensus 82 e~~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 82 ENKQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred ccCceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeecccee
Confidence 9999999999999999999998775 77999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
-.... ...-.+.||.+.|.|||++
T Consensus 160 sLe~~--------------------------------------------------------gklLeTSCGSPHYA~PEIV 183 (786)
T KOG0588|consen 160 SLEVP--------------------------------------------------------GKLLETSCGSPHYAAPEIV 183 (786)
T ss_pred ecccC--------------------------------------------------------CccccccCCCcccCCchhh
Confidence 42211 0111134999999999999
Q ss_pred cCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.|.+| +.++||||+|||||.||||+.||.+.+....+.++.+|.+..|..... ++++||++||.+||++|.|
T Consensus 184 ~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~-----eaQdLLr~ml~VDp~~RiT-- 256 (786)
T KOG0588|consen 184 SGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISS-----EAQDLLRRMLDVDPSTRIT-- 256 (786)
T ss_pred cCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCH-----HHHHHHHHHhccCcccccc--
Confidence 99998 889999999999999999999999999999999999999888865544 9999999999999999999
Q ss_pred CChHHHHcCCCcCCCCc
Q 013016 398 RGAADVKTHPFFKGLNF 414 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~ 414 (451)
.+||++|||+++-.-
T Consensus 257 --~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 257 --TEEILKHPFLSGYTS 271 (786)
T ss_pred --HHHHhhCchhhcCCC
Confidence 999999999999433
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-51 Score=398.52 Aligned_cols=281 Identities=38% Similarity=0.692 Sum_probs=238.3
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
...+++|.+.+.||+|+||.||+|.++.+++ .||+|++.+...........+..|+.++++++||||++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGE---------YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3445889999999999999999999987765 4999999877555555667788899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++..++..|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999999988765 46899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .....+||+.|+||
T Consensus 163 g~~~~~~~----------------------------------------------------------~~~~~~gt~~y~aP 184 (329)
T PTZ00263 163 GFAKKVPD----------------------------------------------------------RTFTLCGTPEYLAP 184 (329)
T ss_pred cCceEcCC----------------------------------------------------------CcceecCChhhcCH
Confidence 99742210 01124789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||......+....+..+...++.. .+..+++||.+||+.||.+|++
T Consensus 185 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW-----FDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred HHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC-----CCHHHHHHHHHHhhcCHHHcCC
Confidence 99999889999999999999999999999999888888888888776655543 3348999999999999999997
Q ss_pred C-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 396 S-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 396 ~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
. ...+++|+.||||++.+|... +...+|..|....
T Consensus 260 ~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T PTZ00263 260 TLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKS 297 (329)
T ss_pred CCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCC
Confidence 3 334799999999999988754 4445555454433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=398.52 Aligned_cols=278 Identities=37% Similarity=0.679 Sum_probs=231.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||+|.++.+++ .||||++.+...........+..|+.++++++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK---------YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 369999999999999887665 49999998776555555667778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-- 147 (323)
T cd05571 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-- 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--
Confidence 999999999999988764 5689999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
.......++||+.|+|||++.+..++.
T Consensus 148 -----------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05571 148 -----------------------------------------------------DGATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred -----------------------------------------------------CCCcccceecCccccChhhhcCCCCCc
Confidence 001112357999999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC-ChHHHH
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~-~~~ell 404 (451)
++|||||||++|||++|+.||...........+..+...++.. .+.++.+||.+||+.||++||+... .+.+++
T Consensus 175 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred cccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 9999999999999999999999888888888887776655543 2338999999999999999992100 199999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRRQKTM 434 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~ 434 (451)
+||||++++|... ....+|..|........
T Consensus 250 ~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05571 250 EHRFFASINWQDVVQKKLEPPFKPQVTSETDT 281 (323)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 9999999999755 45566666666654333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-51 Score=392.15 Aligned_cols=277 Identities=39% Similarity=0.683 Sum_probs=235.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.++.+++ .||+|++.............+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEH---------YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC---------EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 469999999999999999999887655 49999998665444455667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+++|+||||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 999999999999999999998765 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .....+|++.|+|||++.
T Consensus 150 ~~~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~ 171 (291)
T cd05612 150 KLRD----------------------------------------------------------RTWTLCGTPEYLAPEVIQ 171 (291)
T ss_pred hccC----------------------------------------------------------CcccccCChhhcCHHHHc
Confidence 2210 011246899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~ 398 (451)
+..++.++|||||||++|+|++|+.||......+....+..+...++... +..+++||++||+.||.+|++. +.
T Consensus 172 ~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~li~~~l~~dp~~R~~~~~~ 246 (291)
T cd05612 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL-----DLYAKDLIKKLLVVDRTRRLGNMKN 246 (291)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccC-----CHHHHHHHHHHcCCCHHHccCCccC
Confidence 98899999999999999999999999999888888888888776655433 3389999999999999999942 33
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
.++++++||||+.++|... ....++..|....
T Consensus 247 ~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~ 280 (291)
T cd05612 247 GADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSH 280 (291)
T ss_pred CHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCC
Confidence 3999999999999999753 4555666666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=397.31 Aligned_cols=282 Identities=35% Similarity=0.695 Sum_probs=239.1
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+.+++|.+.+.||.|+||.||+|.++.... ..||+|++.+...........+..|+.+++.++||||++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 97 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDF--------PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCC--------eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence 3455889999999999999999998765432 14999999876555555667788899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+++++|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 98 GSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecC
Confidence 9999999999999999999999998765 45899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .....+||+.||||
T Consensus 176 G~a~~~~~----------------------------------------------------------~~~~~~gt~~y~aP 197 (340)
T PTZ00426 176 GFAKVVDT----------------------------------------------------------RTYTLCGTPEYIAP 197 (340)
T ss_pred CCCeecCC----------------------------------------------------------CcceecCChhhcCH
Confidence 99742210 01134799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|..||...........+..+...++... +.++.++|++||+.||++|++
T Consensus 198 E~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL-----DNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred HHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHHHcccCHHHcCC
Confidence 999998899999999999999999999999999888888888888776555432 338999999999999999962
Q ss_pred C-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 396 S-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 396 ~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
. ...++++++||||++++|... ....+|..|....
T Consensus 273 ~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 273 NLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 1 122999999999999998754 5667777787654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=384.23 Aligned_cols=270 Identities=29% Similarity=0.408 Sum_probs=231.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++...||.|..++||+|+...... +||||+++-+..... .+.+.+|+..++.++||||++++..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e---------~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNE---------VVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCC---------EEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEE
Confidence 33789999999999999999999887664 699999998865443 7888899999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
|..+..+|+||.||.+||+.++++......|++..+..|++++++||.|||++|-||||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999988777799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+.++...- .....+..+++||+.|||||+
T Consensus 173 sa~l~~~G---------------------------------------------------~R~~~rf~tfvgtp~wmAPEv 201 (516)
T KOG0582|consen 173 SASLFDSG---------------------------------------------------DRQVTRFNTFVGTPCWMAPEV 201 (516)
T ss_pred eeeecccC---------------------------------------------------ceeeEeeccccCcccccChHH
Confidence 85543210 000111146799999999999
Q ss_pred ccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-----CCCCCcChHHHHHHHHHhcccCc
Q 013016 318 ASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-----QSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 318 ~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
+.. ..|+.|+||||||++..||.+|..||.......++..-+++.++.+. .......+..++.+|..||.+||
T Consensus 202 l~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 202 LMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred hhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 654 45899999999999999999999999998888888777777665332 11122233478999999999999
Q ss_pred CCcCCCCCChHHHHcCCCcCCCC
Q 013016 391 CNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
.+||| +.++|+|+||+...
T Consensus 282 ~kRpt----AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 282 SKRPT----ASKLLKHAFFKKAK 300 (516)
T ss_pred ccCCC----HHHHhccHHHhhcc
Confidence 99999 99999999999943
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=402.41 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=228.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|+.+.+.+ +||+|.+.+... ..+..+.+.+|++|++.++|||||.++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~---------~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfE 71 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ---------VVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFE 71 (808)
T ss_pred cchhHHHHhcCCccceeeeccccccee---------EEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhc
Confidence 578889999999999999999887765 699999987753 3455678889999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
...++|+|.|||.| +|..++... +.++++.+..++.|++.||.|||+++|.|||+||.|||+...|.+|+||||+|+
T Consensus 72 t~~~~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 72 TSAHLWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred ccceEEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhh
Confidence 99999999999965 999999886 569999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ...-.++.|||.|||||++.
T Consensus 149 ~m~~~-------------------------------------------------------t~vltsikGtPlYmAPElv~ 173 (808)
T KOG0597|consen 149 AMSTN-------------------------------------------------------TSVLTSIKGTPLYMAPELVE 173 (808)
T ss_pred hcccC-------------------------------------------------------ceeeeeccCcccccCHHHHc
Confidence 44321 11222468999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+++|+..+|+||||||+|||++|++||...+.......|......+|..... .+++|+..+|.+||..|.+
T Consensus 174 e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~-----~f~nfl~gLL~kdP~~Rlt---- 244 (808)
T KOG0597|consen 174 EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASS-----SFVNFLQGLLIKDPAQRLT---- 244 (808)
T ss_pred CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccH-----HHHHHHHHHhhcChhhccc----
Confidence 9999999999999999999999999999988888999999988777764433 8999999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
..+++.|||+++
T Consensus 245 W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 245 WTDLLGHPFWKG 256 (808)
T ss_pred HHHHhcChHHhh
Confidence 999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=373.92 Aligned_cols=273 Identities=26% Similarity=0.318 Sum_probs=225.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|+.+.+|++|+||.||+|+++.+.+ +||+|.++.+. .....--...+|+.+|.+++|||||.+-++
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~e---------IVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEV 143 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDE---------IVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEV 143 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcce---------eEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence 45789999999999999999999988765 69999998664 222222335679999999999999999998
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
.... +.+||||||| .-+|..++...+ .+|...+++.+..|++.||+|||.++|+|||||++|+|++..|.+||+||
T Consensus 144 VvG~~~d~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 144 VVGSNMDKIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred EeccccceeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 7644 5799999999 568999888875 67999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|+....+. ..+ ...+-|.+|+||
T Consensus 222 GLAR~ygsp~----------------------------------------k~~---------------T~lVVTLWYRaP 246 (419)
T KOG0663|consen 222 GLAREYGSPL----------------------------------------KPY---------------TPLVVTLWYRAP 246 (419)
T ss_pred chhhhhcCCc----------------------------------------ccC---------------cceEEEeeecCH
Confidence 9996443220 111 124779999999
Q ss_pred ccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCc---------------------
Q 013016 316 EVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM--------------------- 373 (451)
Q Consensus 316 E~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--------------------- 373 (451)
|+++|.. |+.++|+||+|||+.||+++++.|.+.+..+.+.+|.+....+....|+..
T Consensus 247 ELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~ 326 (419)
T KOG0663|consen 247 ELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRK 326 (419)
T ss_pred HHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhh
Confidence 9999965 899999999999999999999999999999888888874433332222211
Q ss_pred ------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccC
Q 013016 374 ------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLT 421 (451)
Q Consensus 374 ------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~ 421 (451)
.+....+|++.+|.+||.+|.| |.|.|+|+||.+.+.+..+...
T Consensus 327 kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 327 KFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETPLPIDPSMF 376 (419)
T ss_pred hccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCCCCCChhhc
Confidence 1235679999999999999999 9999999999998877655443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=384.93 Aligned_cols=270 Identities=34% Similarity=0.580 Sum_probs=225.6
Q ss_pred CCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-----------HHHHHHHHHHH
Q 013016 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-----------KVHRAEMEKKI 142 (451)
Q Consensus 74 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~ 142 (451)
.....+++|++.+.||.|.||.|-+|++...++ +||||++.+....... ..+++.+|+.+
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~---------l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGK---------LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI 161 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCc---------EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence 334567899999999999999999999887766 6999999876543221 23567889999
Q ss_pred HHHCCCCCccceeEEEEeC--CeEEEEEeeccCCchhhhhhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 143 LKMLDHPFLPTLYAEFEAS--NFSCIVMEFCSGGDLHSLRHKQPHKR-FSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
|++++|||||+|+++..+. +++|||+|||..|.+...-.. ++ +++.++++++++++.||+|||.+|||||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP 238 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP 238 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 9999999999999999765 599999999999888654322 34 89999999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+|+||+++|++||+|||.+......... +..
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~-------------------------------------------------~~d 269 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDE-------------------------------------------------GSD 269 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCcc-------------------------------------------------ccH
Confidence 9999999999999999998543211000 000
Q ss_pred cccccccccCCCccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcCh
Q 013016 300 AARSCSFVGTHEYVSPEVASGGS----HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 375 (451)
... ...+|||.|||||.+.++. .+.+.||||+||+||.|+.|+.||.+....+.+.+|++..+.+|... .+.+
T Consensus 270 ~~L-~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p--e~~e 346 (576)
T KOG0585|consen 270 DQL-SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP--EINE 346 (576)
T ss_pred HHH-hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc--cccH
Confidence 000 0138999999999998733 37899999999999999999999999999999999999999888764 2233
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.+++||++||++||+.|.+ +.+|..|||...-
T Consensus 347 -~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 347 -DLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTRD 378 (576)
T ss_pred -HHHHHHHHHhhcChhheee----hhhheecceeccC
Confidence 8999999999999999999 9999999999883
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.87 Aligned_cols=280 Identities=33% Similarity=0.555 Sum_probs=237.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.+..+++ .||||++.+...........+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGE---------IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 469999999999999999999887655 49999998776555555667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++.|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 999999999999999999999764 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .....+||+.|+|||++.
T Consensus 150 ~~~~----------------------------------------------------------~~~~~~gt~~y~aPE~~~ 171 (333)
T cd05600 150 GIVT----------------------------------------------------------YANSVVGSPDYMAPEVLR 171 (333)
T ss_pred cccc----------------------------------------------------------ccCCcccCccccChhHhc
Confidence 2210 111347999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC---CcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS---SMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+..++.++|||||||++|||++|..||...+..+.+..+............. ...+.++.+||.+||..+|.+||+
T Consensus 172 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s- 250 (333)
T cd05600 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS- 250 (333)
T ss_pred CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC-
Confidence 9899999999999999999999999999887777776665433221111111 122448999999999999999999
Q ss_pred CCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCC
Q 013016 397 KRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~ 432 (451)
+.++++||||.++++.......+|++|......
T Consensus 251 ---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (333)
T cd05600 251 ---LEDIKNHPFFKEVDWNELRELKPPFVPELESEI 283 (333)
T ss_pred ---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcc
Confidence 999999999999999888888888888766543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=360.42 Aligned_cols=266 Identities=27% Similarity=0.386 Sum_probs=223.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|...++||+|.||.||+|++..+++. ||||.++..... +.......+|++.|+.++|+||+.++++|.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~---------VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~ 71 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKR---------VAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFP 71 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcE---------EEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhcc
Confidence 4688899999999999999999888764 999999865322 222345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+.||+||+ ..+|...++.. ...++..+++.++.++++||+|||+++|+||||||+|+||+.+|.+||+|||+|+
T Consensus 72 ~~~~l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 72 HKSNLSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred CCCceEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchh
Confidence 999999999999 67898888765 4569999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... ... .-+-|.+|+|||++.
T Consensus 150 ~f~~p~~-----------------------------------------------------~~~--~~V~TRWYRAPELLf 174 (318)
T KOG0659|consen 150 FFGSPNR-----------------------------------------------------IQT--HQVVTRWYRAPELLF 174 (318)
T ss_pred ccCCCCc-----------------------------------------------------ccc--cceeeeeccChHHhc
Confidence 4332111 111 116789999999999
Q ss_pred CCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcC-----------------------h
Q 013016 320 GGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS-----------------------E 375 (451)
Q Consensus 320 ~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----------------------~ 375 (451)
|.. |+..+||||.|||+.||+-|.+.|.+.++-+.+..|.+....+....|+++. +
T Consensus 175 Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas 254 (318)
T KOG0659|consen 175 GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAAS 254 (318)
T ss_pred cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccccc
Confidence 954 8999999999999999999999999999999888888755444333333221 2
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
.++.+|+.+||..||.+|++ +.|+|+|+||+..+.+.
T Consensus 255 ~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 255 SDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSLPLPT 291 (318)
T ss_pred HHHHHHHHhhhccCchhccc----HHHHhcchhhhcCCCCC
Confidence 26789999999999999999 99999999999865544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=384.03 Aligned_cols=276 Identities=35% Similarity=0.576 Sum_probs=225.5
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.+.||+|+||+||+|.+..+++ .||+|++.+...........+..|+.++++++|+||+++++++.+.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCc---------eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 7889999999999999999887765 4999999876554444445667899999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 99999999999999998876655556999999999999999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
... .......||..|+|||++.+.
T Consensus 153 ~~~--------------------------------------------------------~~~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05631 153 PEG--------------------------------------------------------ETVRGRVGTVGYMAPEVINNE 176 (285)
T ss_pred CCC--------------------------------------------------------CeecCCCCCCCccCHhhhcCC
Confidence 100 000123689999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.++.++|||||||++|+|++|+.||........ ...+......++. ..+.++.+|+++||+.||.+||+.+
T Consensus 177 ~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE-----KFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc-----cCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 999999999999999999999999987554322 2222222222222 2334899999999999999999742
Q ss_pred -CChHHHHcCCCcCCCCcccc--cccCCCCCCC
Q 013016 398 -RGAADVKTHPFFKGLNFALI--RSLTPPEIPG 427 (451)
Q Consensus 398 -~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~ 427 (451)
..++++++||||+++++..+ +.+.+|+.|-
T Consensus 252 ~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 252 GNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred CCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 23899999999999999866 5557777774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=393.91 Aligned_cols=309 Identities=29% Similarity=0.490 Sum_probs=231.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+..|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGH---------VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 479999999999999999999887655 49999998766555556677788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+.+||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 999999999999999999998764 569999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
................ .....+........... . .............+||+.|+|||++.
T Consensus 150 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 150 GLKKAHRTEFYRNLNH--------------SLPSDFTFQNMNSKRKA-----E-TWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred cccccccccccccccc--------------ccccccccccccccccc-----c-hhhhccccccccccCCccccCHHHHc
Confidence 4321110000000000 00000000000000000 0 00000111123458999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--CCCCCCCCCcChHHHHHHHHHhcccCcCC---cC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL--TFPTQSPSSMSEYHARDLISGLLNKDPCN---RL 394 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP~~---Rp 394 (451)
+..++.++|||||||++|||++|+.||.+....+.+.++..... .++.. .. .+.++++||.+|+. +|.+ ||
T Consensus 210 ~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~-~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 210 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE--VP-ISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc--CC-CCHHHHHHHHHHcC-ChhhcCCCC
Confidence 99999999999999999999999999998888888888876432 23321 12 23489999999775 5554 57
Q ss_pred CCCCChHHHHcCCCcCCCCcccccccCCCCCCC
Q 013016 395 GSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~ 427 (451)
+ ++||++||||++++|.......++..+.
T Consensus 286 ~----~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (363)
T cd05628 286 G----VEEIKTNPFFEGVDWEHIRERPAAIPIE 314 (363)
T ss_pred C----HHHHhCCCCCCCCCHHHHHhCCCCCCcc
Confidence 8 9999999999999998876554444333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=389.33 Aligned_cols=288 Identities=37% Similarity=0.669 Sum_probs=237.3
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||+|.++.+++ .||+|++.+...........+..|+.+++.++||||++++++|...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 369999999999999877665 49999998776555555666778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~- 148 (323)
T cd05595 72 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 148 (323)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-
Confidence 999999999999888764 46899999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
........||+.|+|||++.+..++.
T Consensus 149 ------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05595 149 ------------------------------------------------------GATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred ------------------------------------------------------CCccccccCCcCcCCcccccCCCCCc
Confidence 00011247999999999999989999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~ell 404 (451)
++|||||||++|+|++|+.||...........+......++.. .+.++.+||.+||+.||.+|++. ...+.+++
T Consensus 175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l 249 (323)
T cd05595 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 249 (323)
T ss_pred hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHH
Confidence 9999999999999999999999888888888877766655543 23489999999999999999821 01199999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCc
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQ 444 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~ 444 (451)
+|+||.+++|... ..+.+|..|...++....+.+...+.+
T Consensus 250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (323)
T cd05595 250 EHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 291 (323)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccC
Confidence 9999999988643 556677777777665555555544444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=367.58 Aligned_cols=259 Identities=28% Similarity=0.523 Sum_probs=232.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|.|+.||+|.+..++++ +|+|+++-..+... ..+.+.+|+.|.+.|+|||||++.+...
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~---------fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLE---------FAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHH---------HHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 6799999999999999999998887765 99999987766544 6788899999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEEecc
Q 013016 160 ASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIMLSDF 235 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Df 235 (451)
+.++.|||+|++.|++|.. +..+ ..+++..+-++++||++||.|+|.+||||||+||.|+|+.+. --+||+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeeccc
Confidence 9999999999999999975 3343 347899999999999999999999999999999999999754 36999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|+..+. ......++|||+||||
T Consensus 158 GvAi~l~~--------------------------------------------------------g~~~~G~~GtP~fmaP 181 (355)
T KOG0033|consen 158 GLAIEVND--------------------------------------------------------GEAWHGFAGTPGYLSP 181 (355)
T ss_pred ceEEEeCC--------------------------------------------------------ccccccccCCCcccCH
Confidence 99964431 1122246899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++...+|+..+|||+.|+|||-||.|.+||.+.+....+..|+.+...++...++.+.+ ++++||++||..||.+|.|
T Consensus 182 Evvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~-~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 182 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP-EAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred HHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH-HHHHHHHHHhccChhhhcc
Confidence 999999999999999999999999999999999999999999999999999888888777 9999999999999999999
Q ss_pred CCCChHHHHcCCCcCCC
Q 013016 396 SKRGAADVKTHPFFKGL 412 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~ 412 (451)
+.|.|+|||+.+.
T Consensus 261 ----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 261 ----ADEALKHPWICNR 273 (355)
T ss_pred ----HHHHhCCchhcch
Confidence 9999999999983
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=398.68 Aligned_cols=325 Identities=31% Similarity=0.531 Sum_probs=238.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++.+...........+..|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGK---------IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 479999999999999999999887765 49999998765545556677888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+++||||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999999998764 558999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCC--CCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 240 CSNAIPAVESPA--SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 240 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
............ .......... ..+ ....+.............. .............+||+.|+|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~gt~~y~aPE~ 219 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRI--DNR-NSVAVDSINLTMSSKDQIA-------TWKKNRRLMAYSTVGTPDYIAPEI 219 (377)
T ss_pred cccccccccccccccccccccccc--ccc-cccccccccccccchhhhh-------hhhhcccccccccCCCccccCHHH
Confidence 332111000000 0000000000 000 0000000000000000000 000000011123579999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc---C
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR---L 394 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R---p 394 (451)
+.+..++.++|||||||++|||++|..||......+.+..+............ ...+.++.+||.+||. +|.+| +
T Consensus 220 ~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDD-IHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred HccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCC-CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99989999999999999999999999999988777777777653322221111 1234489999999998 77776 4
Q ss_pred CCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 395 GSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
+ +.|++.||||++++|...+...+|.+|.....
T Consensus 298 ~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 330 (377)
T cd05629 298 G----AHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSI 330 (377)
T ss_pred C----HHHHhcCCCcCCCCHHHHccCCCCcccCCCCc
Confidence 8 99999999999999998889999999887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=395.99 Aligned_cols=320 Identities=33% Similarity=0.573 Sum_probs=240.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||+||+|.++.+++ .||||++.+...........+..|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGH---------IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 479999999999999999999887665 49999998765545555667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 999999999999999999998764 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhcc-ccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNR-FFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
.................... ........ ........ .............+||+.|+|||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPS-----------NFLDFISKPMSSKRKAE-------TWKRNRRALAYSTVGTPDYIAPEVF 211 (364)
T ss_pred eccccccccccccccccccc-----------ccccccccccccccccc-------chhhcccccccccccCccccCHHHH
Confidence 43211110000000000000 00000000 00000000 0000001112235899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|||||||++|+|++|..||......+....+......+...... ..+.++.+||.+||. +|.+|++. .
T Consensus 212 ~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~~~~~li~~ll~-~p~~R~~~-~ 288 (364)
T cd05599 212 LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV-PLSPEAKDLIKRLCC-EAERRLGN-N 288 (364)
T ss_pred cCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCC-CCCHHHHHHHHHHcc-CHhhcCCC-C
Confidence 99899999999999999999999999999888887777776654332221111 234489999999997 99999863 3
Q ss_pred ChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
.+.+++.||||++++|.......+|.+|.....
T Consensus 289 ~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (364)
T cd05599 289 GVNEIKSHPFFKGVDWEHIRERPAPIIPELKSI 321 (364)
T ss_pred CHHHHhcCCCcCCCCHHHHhhcCCCCCCCCCCc
Confidence 399999999999999988877888888876654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.00 Aligned_cols=285 Identities=38% Similarity=0.683 Sum_probs=234.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||+|.++.+++ .||+|++.+...........+.+|+.+++.++||||+++++++...+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGK---------YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 369999999999999877665 49999998776555556677788999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 72 lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~- 148 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD- 148 (328)
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-
Confidence 999999999999888664 45899999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
.......+||+.|+|||++.+..++.
T Consensus 149 ------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (328)
T cd05593 149 ------------------------------------------------------AATMKTFCGTPEYLAPEVLEDNDYGR 174 (328)
T ss_pred ------------------------------------------------------ccccccccCCcCccChhhhcCCCCCc
Confidence 00111347999999999999988999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~ell 404 (451)
++|||||||++|+|++|+.||......+....+......++.. .+.++.+||.+||..||.+|++. ...+.+++
T Consensus 175 ~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT-----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred cCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCC-----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999999887777777777666555443 23489999999999999999721 01199999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCcc
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKI 441 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~ 441 (451)
+||||.+.+|... ....+|..|...++...++.+...
T Consensus 250 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (328)
T cd05593 250 RHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEF 288 (328)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCccc
Confidence 9999999988644 455666667766655555444433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=372.56 Aligned_cols=304 Identities=37% Similarity=0.683 Sum_probs=272.1
Q ss_pred CCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccc
Q 013016 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 74 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
+...+.++|..+++||+|.||+|-+|+.+.+++ +||+|+++++.......+..-..|-.+|+..+||.+..
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k---------~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~ 232 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGK---------LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTS 232 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCc---------eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHH
Confidence 444566899999999999999999999888776 69999999998877777777778999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+.-.|+..+++|+||||+.||.|.-++.+. ..|++...+.+...|+.||.|||+++||+||||.+|+|++.||.+||+
T Consensus 233 LKYsFQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 233 LKYSFQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred hhhhhccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEee
Confidence 999999999999999999999998777664 569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+..- ....++.++||||.|.
T Consensus 311 DFGLCKE~I-------------------------------------------------------~~g~t~kTFCGTPEYL 335 (516)
T KOG0690|consen 311 DFGLCKEEI-------------------------------------------------------KYGDTTKTFCGTPEYL 335 (516)
T ss_pred ecccchhcc-------------------------------------------------------cccceeccccCChhhc
Confidence 999985210 1234556899999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|||++....|+.++|.|.+|||||||++|+.||...+.+..+..|+.+.+.+|....+ +++.|+..+|.+||.+|
T Consensus 336 APEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~-----eAktLLsGLL~kdP~kR 410 (516)
T KOG0690|consen 336 APEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP-----EAKTLLSGLLKKDPKKR 410 (516)
T ss_pred CchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH-----HHHHHHHHHhhcChHhh
Confidence 9999999999999999999999999999999999999999999999999888876554 89999999999999999
Q ss_pred CCC-CCChHHHHcCCCcCCCCccc--ccccCCCCCCCCCCCCCCCCCCCccCCccccC
Q 013016 394 LGS-KRGAADVKTHPFFKGLNFAL--IRSLTPPEIPGMRRQKTMPFPDQKIKSQSTAF 448 (451)
Q Consensus 394 pt~-~~~~~ell~hp~~~~~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 448 (451)
... ...+.||..|+||..++|.. ..++.||+.|.+.+...-.|+++....|+-.+
T Consensus 411 LGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~l 468 (516)
T KOG0690|consen 411 LGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTL 468 (516)
T ss_pred cCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEe
Confidence 985 45589999999999999974 58999999999999988888888877776443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=356.61 Aligned_cols=262 Identities=33% Similarity=0.567 Sum_probs=239.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+.+++|++.+.||.|-||.||+|+.+.+.- .||+||+.+.........+.+.+|++|...|+||||+++|
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~---------IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLF---------IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCc---------EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence 3456899999999999999999999887765 5999999998887777788889999999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++|-+....||++||..+|+|.+.+...+...+++.....++.|++.||.|+|.++|+||||||+|+|++.+|.+||+||
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999999999999888888999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|-+.... ..+..++|||..|.+|
T Consensus 169 GwsV~~p---------------------------------------------------------~~kR~tlcgt~dyl~p 191 (281)
T KOG0580|consen 169 GWSVHAP---------------------------------------------------------SNKRKTLCGTLDYLPP 191 (281)
T ss_pred CceeecC---------------------------------------------------------CCCceeeecccccCCH
Confidence 9974211 2233467999999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|...+..++..+|+|++|++.||++.|.+||...+..+.+++|......+|..... ++.++|.+||.++|.+|.+
T Consensus 192 Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~-----~a~dlI~~ll~~~p~~r~~ 266 (281)
T KOG0580|consen 192 EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISG-----GAADLISRLLVKNPIERLA 266 (281)
T ss_pred hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccCh-----hHHHHHHHHhccCcccccc
Confidence 99999999999999999999999999999999999999999999998888854433 8999999999999999999
Q ss_pred CCCChHHHHcCCCcCCC
Q 013016 396 SKRGAADVKTHPFFKGL 412 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~ 412 (451)
..|++.|||....
T Consensus 267 ----l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 267 ----LTEVMDHPWIVAN 279 (281)
T ss_pred ----HHHHhhhHHHHhc
Confidence 9999999998764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=395.87 Aligned_cols=323 Identities=30% Similarity=0.482 Sum_probs=236.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA---------LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC---------EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 369999999999999999999887655 49999998765545555667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999999999998764 458999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
................. ... . .................................++||+.|||||++.
T Consensus 150 ~~~~~~~~~~~~~~~~~-~~~----~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 217 (376)
T cd05598 150 GFRWTHDSKYYQKGDHH-RQD----S-------MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217 (376)
T ss_pred ccccccccccccccccc-ccc----c-------ccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc
Confidence 33211110000000000 000 0 00000000000000000000000000111223468999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC---CC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL---GS 396 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp---t~ 396 (451)
+..++.++|||||||++|+|++|+.||......+....+.............. .+.++.++|.+|+ .+|.+|+ +
T Consensus 218 ~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~l~-~~p~~R~~~~t- 294 (376)
T cd05598 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-LSREASDLILRLC-CGAEDRLGKNG- 294 (376)
T ss_pred CCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCC-CCHHHHHHHHHHh-cCHhhcCCCCC-
Confidence 99999999999999999999999999998877776666655433332222222 3348899999976 5999999 7
Q ss_pred CCChHHHHcCCCcCCCCcccc-cccCCCCCCCCCCC
Q 013016 397 KRGAADVKTHPFFKGLNFALI-RSLTPPEIPGMRRQ 431 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~~~~-~~~~~~~~p~~~~~ 431 (451)
+.++++||||+++++... ....+|.+|....+
T Consensus 295 ---~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (376)
T cd05598 295 ---ADEIKAHPFFKGIDFASLIRRQKAPYIPKITHP 327 (376)
T ss_pred ---HHHHhCCCCcCCCCHHHHhhcCCCCCCCcCCCc
Confidence 999999999999999866 56667777776543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=384.32 Aligned_cols=279 Identities=34% Similarity=0.677 Sum_probs=231.8
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC-CccceeEEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP-FLPTLYAEFE 159 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-nIv~l~~~~~ 159 (451)
+|.+.+.||+|+||.||+|.++.+.+ .||||++.+...........+..|+.++..+.|+ +|+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58999999999999999999887665 4999999877554445566677889999999765 5888999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence 999999999999999999988764 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ........+||+.|+|||++.
T Consensus 150 ~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 150 ENIF-------------------------------------------------------GGKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred ecCC-------------------------------------------------------CCCceeeecCCccccChhhhc
Confidence 2100 000111347999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC-C
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK-R 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~-~ 398 (451)
+..++.++|||||||++|+|++|+.||......+.+..+......++.. .+.++.+++.+||+.||.+|++.+ .
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~~l~~~P~~R~~~~~~ 249 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS-----LSKEAVSICKGLLTKHPAKRLGCGPT 249 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 9899999999999999999999999999988888888888776655543 233899999999999999999842 2
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
..+++++||||++++|... +...+|..|..++
T Consensus 250 ~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (324)
T cd05587 250 GERDIREHAFFRRIDWEKLERREIQPPFKPKVKG 283 (324)
T ss_pred CHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCC
Confidence 2489999999999999654 3445555565544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=385.55 Aligned_cols=275 Identities=39% Similarity=0.716 Sum_probs=230.0
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||||++.+...........+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC---------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 369999999999999887665 4999999877554455566677788888876 699999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~- 148 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF- 148 (320)
T ss_pred EEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-
Confidence 9999999999999888765 4599999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.........||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 149 ------------------------------------------------------NGKTTSTFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred ------------------------------------------------------CCCcccccccCccccCHHHHcCCCCC
Confidence 00011234799999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC--CChHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK--RGAAD 402 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~--~~~~e 402 (451)
.++|||||||++|+|++|+.||......+.+..+......++.. .+.++.+||.+||+.||.+|+++. ...++
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 249 (320)
T cd05590 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-----LSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249 (320)
T ss_pred CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHcccCHHHCCCCCCCCCHHH
Confidence 99999999999999999999999988888888888776655443 334899999999999999999921 11289
Q ss_pred HHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 403 VKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 403 ll~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
+++||||++++|... +...+|..|+..+.
T Consensus 250 ~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 280 (320)
T cd05590 250 ILRHPFFKELDWEKLNRRQIEPPFRPRIKSR 280 (320)
T ss_pred HHcCCCcCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 999999999998754 56677777877653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=384.69 Aligned_cols=279 Identities=36% Similarity=0.678 Sum_probs=230.9
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHH---HHCCCCCccceeEEE
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL---KMLDHPFLPTLYAEF 158 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~nIv~l~~~~ 158 (451)
|.+.+.||+|+||.||+|.++.+++ .||||++.+...........+..|+.++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGE---------LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 7889999999999999999887665 4999999876544444455666666655 456799999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...++.|+||||++|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC 148 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCC
Confidence 999999999999999999887754 45999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... .......++|++.|+|||++
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~g~~~y~aPE~~ 173 (324)
T cd05589 149 KEGMG-------------------------------------------------------FGDRTSTFCGTPEFLAPEVL 173 (324)
T ss_pred ccCCC-------------------------------------------------------CCCcccccccCccccCHhHh
Confidence 42110 00111235799999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|||||||++|+|++|+.||......+.+..+......++.. .+..+.+||.+||+.||.+||++++
T Consensus 174 ~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF-----LSREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 99889999999999999999999999999988888888887776655433 2348999999999999999995422
Q ss_pred -ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCC
Q 013016 399 -GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432 (451)
Q Consensus 399 -~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~ 432 (451)
.+.++++||||+.+++... ....+|.+|......
T Consensus 249 ~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (324)
T cd05589 249 KDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPE 285 (324)
T ss_pred CCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcc
Confidence 3999999999999888653 556677777765543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=388.20 Aligned_cols=283 Identities=35% Similarity=0.610 Sum_probs=236.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||+|++.+...........+..|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGD---------IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 479999999999999999999887665 49999999776555556667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.++.|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 9999999999999999999987753 459999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... ........||+.|+|||++.
T Consensus 151 ~~~~~~------------------------------------------------------~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 151 RLTANK------------------------------------------------------MVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred ECCCCC------------------------------------------------------ceeeecccCCccccCHHHhc
Confidence 321100 00111236899999999986
Q ss_pred ------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 320 ------GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 320 ------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
+..++.++|||||||++|+|++|+.||........+.++............ ...+.++.+||.+||. ||.+|
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~li~~ll~-~p~~R 254 (330)
T cd05601 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED-PKVSSDFLDLIQSLLC-GQKER 254 (330)
T ss_pred cccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC-CCCCHHHHHHHHHHcc-ChhhC
Confidence 456789999999999999999999999988877777777664322211111 1234489999999998 99999
Q ss_pred CCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCC
Q 013016 394 LGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~ 432 (451)
|+ +.+++.||||++++|.......+|..|...+..
T Consensus 255 ~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (330)
T cd05601 255 LG----YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDD 289 (330)
T ss_pred CC----HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcc
Confidence 99 999999999999999988888888888776644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=392.79 Aligned_cols=327 Identities=30% Similarity=0.494 Sum_probs=234.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|.++++||+|+||+||+|.++.+++ .||||++.+...........+..|+.+++.++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHA---------LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58999999999999999999887765 499999987765555666778889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+++|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999999999999998765 4589999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
................................... + .....+... ...........+++||+.|+|||++.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~--~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC-----G-DRLKTLEQR--ATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred cccccccccccccccccccccCccccccccccccc-----c-cccchhhcc--ccccccccccccccCCccccCHHHHcC
Confidence 32111100000000000000000000000000000 0 000000000 000001112235689999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc--cCcCCcCCCCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN--KDPCNRLGSKR 398 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~--~dP~~Rpt~~~ 398 (451)
..++.++|||||||++|||++|+.||......+....+.............. .+.++.+||.+|+. .++..|++
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~dli~~ll~~~~~~~~R~~--- 298 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK-LSPEAVDLITKLCCSAEERLGRNG--- 298 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCC-CCHHHHHHHHHHccCcccccCCCC---
Confidence 8899999999999999999999999998777666666654322222111112 33489999999664 45556999
Q ss_pred ChHHHHcCCCcCCCCccc-ccccCCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFAL-IRSLTPPEIPGMRRQ 431 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~-~~~~~~~~~p~~~~~ 431 (451)
+.+|+.||||++++|.. .+..++|.+|....+
T Consensus 299 -~~~~l~hp~f~~~~~~~~~~~~~~~~~p~~~~~ 331 (381)
T cd05626 299 -ADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHP 331 (381)
T ss_pred -HHHHhcCcccCCCChhHHhhcCCCCccCcCCCc
Confidence 99999999999998864 456666777776543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=383.08 Aligned_cols=270 Identities=37% Similarity=0.722 Sum_probs=226.5
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||+|+||.||+|.++.+++ .||+|++.+...........+..|+.++++++||||+++++++...+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR---------IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999999887665 4999999876554555566777899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---- 145 (312)
T cd05585 72 LAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK---- 145 (312)
T ss_pred EcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc----
Confidence 9999999999988764 4699999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
........+||+.|+|||++.+..++.++
T Consensus 146 ---------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 174 (312)
T cd05585 146 ---------------------------------------------------DDDKTNTFCGTPEYLAPELLLGHGYTKAV 174 (312)
T ss_pred ---------------------------------------------------CCCccccccCCcccCCHHHHcCCCCCCcc
Confidence 00111234799999999999998999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCC
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp 407 (451)
|||||||++|+|++|+.||......+.+..+......++... +.++.+||.+||+.||.+||+... +.|++.||
T Consensus 175 DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~L~~dp~~R~~~~~-~~e~l~hp 248 (312)
T cd05585 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF-----DRDAKDLLIGLLSRDPTRRLGYNG-AQEIKNHP 248 (312)
T ss_pred ceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcC-----CHHHHHHHHHHcCCCHHHcCCCCC-HHHHHcCC
Confidence 999999999999999999998888888888887766655432 338999999999999999985321 89999999
Q ss_pred CcCCCCcccc--cccCCCCCCCCC
Q 013016 408 FFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 408 ~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
||.+.++... ....++..|...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~ 272 (312)
T cd05585 249 FFSQLSWKKLLMKGIQPPFKPAVS 272 (312)
T ss_pred CcCCCCHHHHHhCCCCCCcCCCCC
Confidence 9999877543 344455555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=379.21 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=213.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|...+.||+|+||.||++.++.+++ .+|||.+..... ...+.+++|+.+|.+++|||||+.+|...
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~---------~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~ 84 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGE---------LMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSS 84 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCc---------ceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccc
Confidence 457888899999999999999987544 499999986521 11566788999999999999999999754
Q ss_pred eCC--eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccC
Q 013016 160 ASN--FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFD 236 (451)
Q Consensus 160 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg 236 (451)
... .+++.|||++||+|.+++....+ .+++..++.+++||++||+|||++||||+||||+|||++. ++.+||+|||
T Consensus 85 ~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 85 SRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred cccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCc
Confidence 443 79999999999999999998865 7999999999999999999999999999999999999999 7999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++...... ........+.||+.|||||
T Consensus 164 ~a~~~~~~~----------------------------------------------------~~~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 164 LAKKLESKG----------------------------------------------------TKSDSELSVQGTPNYMAPE 191 (313)
T ss_pred ccccccccc----------------------------------------------------ccccccccccCCccccCch
Confidence 985432100 0011122458999999999
Q ss_pred cccCCC-CCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 317 VASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 317 ~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
++..+. ...++|||||||++.||+||+.||.. ......+..+.... ..| ..++. .+.++++||.+||.+||++||
T Consensus 192 vi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~-ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 192 VIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDS-LSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred hhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcc-cCHHHHHHHHHHhhcCcccCc
Confidence 999633 34599999999999999999999987 34444444444443 222 22333 344999999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCc
Q 013016 395 GSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~ 414 (451)
| |.++|+|||.++...
T Consensus 269 t----a~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 269 T----AEELLEHPFLKQNSI 284 (313)
T ss_pred C----HHHHhhChhhhcccc
Confidence 9 999999999998444
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=386.76 Aligned_cols=284 Identities=37% Similarity=0.680 Sum_probs=234.6
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||+||+|.++.+++ .||+|++.+...........+..|+.+++.++|+||+++++++...+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 369999999999999877655 49999998776555555566778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
+||||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus 72 lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~ 149 (325)
T cd05594 72 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149 (325)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence 999999999999888664 458999999999999999999997 89999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........||+.|+|||++.+..++
T Consensus 150 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05594 150 -------------------------------------------------------GATMKTFCGTPEYLAPEVLEDNDYG 174 (325)
T ss_pred -------------------------------------------------------CcccccccCCcccCCHHHHccCCCC
Confidence 0011124799999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC-----CCCCC
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL-----GSKRG 399 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp-----t~~~~ 399 (451)
.++|||||||++|+|++|+.||...........+......++.. .+.++.+||.+||+.||++|+ +
T Consensus 175 ~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~---- 245 (325)
T cd05594 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT-----LSPEAKSLLSGLLKKDPKQRLGGGPDD---- 245 (325)
T ss_pred CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHhhcCHHHhCCCCCCC----
Confidence 99999999999999999999999888877777777766655543 233899999999999999997 7
Q ss_pred hHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCc
Q 013016 400 AADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQ 444 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~ 444 (451)
+.++++||||.++.|... ....+|..|.........+.++....+
T Consensus 246 ~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (325)
T cd05594 246 AKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQ 292 (325)
T ss_pred HHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcC
Confidence 999999999999888644 455566667666554444555544443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=392.82 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=220.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|....+||+|+.|.||.|....+.+. ||||.+...... ..+.+.+|+.+|+..+|+|||.+++.|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~---------VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Syl 340 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQE---------VAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYL 340 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCce---------EEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhc
Confidence 4588899999999999999998887764 999999876443 3456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+++||||++||+|.+++... .+++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|.
T Consensus 341 v~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 341 VGDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ccceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeee
Confidence 999999999999999999988764 49999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ...+..+++||+.|||||++.
T Consensus 418 qi~~-------------------------------------------------------~~~KR~TmVGTPYWMAPEVvt 442 (550)
T KOG0578|consen 418 QISE-------------------------------------------------------EQSKRSTMVGTPYWMAPEVVT 442 (550)
T ss_pred cccc-------------------------------------------------------ccCccccccCCCCccchhhhh
Confidence 2211 122445679999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
...|+.++||||||++++||+.|++||-..+....+..|... ..+.......+.+ .+++||.+||+.|+++|++
T Consensus 443 rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~-~~kdFL~~cL~~dv~~Ras---- 516 (550)
T KOG0578|consen 443 RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSP-ELKDFLDRCLVVDVEQRAS---- 516 (550)
T ss_pred hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCH-HHHHHHHHHhhcchhcCCC----
Confidence 999999999999999999999999999976666666655443 2333333334444 9999999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
|.|||+||||+.
T Consensus 517 A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 517 AKELLEHPFLKM 528 (550)
T ss_pred HHHHhcChhhhh
Confidence 999999999965
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=391.54 Aligned_cols=324 Identities=31% Similarity=0.530 Sum_probs=238.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.++++||+|+||+||+|.++.+++ .||+|++.+...........+..|+.+++.++|+||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKA---------LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCC---------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58999999999999999999887665 499999987655555666778889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
++++|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999999999999988764 4589999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccc-c---ccCC-CcccccccccccccccccCCCccCc
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI-Q---TLTP-NRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~-~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
............ ....... ...+... ++.... . ...+ ..............+++||+.|+||
T Consensus 151 ~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (382)
T cd05625 151 FRWTHDSKYYQS-GDHVRQD-----------SMDFSNE-WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217 (382)
T ss_pred cccccccccccc-ccccccc-----------ccccccc-ccccccccccccccchhhhhccccccccccccccCcccCCH
Confidence 321111000000 0000000 0000000 000000 0 0000 0000000011122346899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|||++|+.||......+....+.............. .+.++.++|.+|+ .||.+|++
T Consensus 218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~-~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAK-LSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCccc-CCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999999999999999999999999998887777777765433322222222 3348999999976 59999986
Q ss_pred CCCChHHHHcCCCcCCCCccc-ccccCCCCCCCCCCC
Q 013016 396 SKRGAADVKTHPFFKGLNFAL-IRSLTPPEIPGMRRQ 431 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~-~~~~~~~~~p~~~~~ 431 (451)
. ..++++++||||+++++.. ..+..+|.+|....+
T Consensus 296 ~-~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 331 (382)
T cd05625 296 K-NGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHP 331 (382)
T ss_pred C-CCHHHHhcCCCcCCcChHHHHhcCCCCccCcCCCc
Confidence 2 3389999999999999875 466677777877654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=382.16 Aligned_cols=274 Identities=35% Similarity=0.697 Sum_probs=227.3
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
++||+|+||.||+|.++.+++ .||||++.+...........+..|..++..+ +||||+++++++..++.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE---------VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 369999999999999887655 4999999877554455556667788888866 799999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 72 ~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN 149 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence 9999999999999888764 45899999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.......+||+.|+|||++.+..++
T Consensus 150 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05591 150 -------------------------------------------------------GVTTTTFCGTPDYIAPEILQELEYG 174 (321)
T ss_pred -------------------------------------------------------CccccccccCccccCHHHHcCCCCC
Confidence 0011134789999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC---ChH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR---GAA 401 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~---~~~ 401 (451)
.++|||||||++|+|++|+.||...+..+.+..+......++.. .+.++.+||.+||+.||++|++... .+.
T Consensus 175 ~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~ 249 (321)
T cd05591 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW-----LSKEAVSILKAFMTKNPNKRLGCVASQGGED 249 (321)
T ss_pred CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHH
Confidence 99999999999999999999999988888888888876655433 3348999999999999999993211 299
Q ss_pred HHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 402 DVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 402 ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
++++||||.+++|... ....+|..|....
T Consensus 250 ~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (321)
T cd05591 250 AIKQHPFFKEIDWVLLEQRKIKPPFKPKIKT 280 (321)
T ss_pred HHhcCCccCCCCHHHHHhCCCCCCCCCCCCC
Confidence 9999999999999754 4445555555543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-51 Score=366.74 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=213.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE-
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA- 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~- 156 (451)
++.+|++.++||.|+||+||++....++. ++|.|-+..... +.+..+.+..|+.+|++|+|||||++++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~---------l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~ 86 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGK---------LVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAH 86 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcc---------hhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHH
Confidence 34679999999999999999999887765 599999986544 3455567788999999999999999998
Q ss_pred EEEeCCe-EEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeccCCCCcEEEccCCC
Q 013016 157 EFEASNF-SCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHM--LG--IIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 157 ~~~~~~~-~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~--~g--ivH~Dlkp~NIll~~~~~ 229 (451)
.|.+++. ++||||||.+|+|.++++..+ .+.+++..+++++.|++.||.++|. .. |+||||||.||+++.+|.
T Consensus 87 ~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 87 SFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred hhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 5544444 999999999999999987543 4569999999999999999999998 44 999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||+++.+... ..-+.+++||
T Consensus 167 vKLGDfGL~r~l~s~-------------------------------------------------------~tfA~S~VGT 191 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSK-------------------------------------------------------TTFAHSLVGT 191 (375)
T ss_pred eeeccchhHhHhcch-------------------------------------------------------hHHHHhhcCC
Confidence 999999998654321 1222357999
Q ss_pred CCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 310 ~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|.||+||.+.+.+|+.++||||+||++|||..-+.||.+.+-.+.-.+|.++..+. .+...++.++..||..|+.+|
T Consensus 192 PyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~---~p~~~YS~~l~~li~~ci~vd 268 (375)
T KOG0591|consen 192 PYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP---LPDEHYSTDLRELINMCIAVD 268 (375)
T ss_pred CcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC---CcHHHhhhHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999998888888888885431 122445568999999999999
Q ss_pred cCCcCC
Q 013016 390 PCNRLG 395 (451)
Q Consensus 390 P~~Rpt 395 (451)
|+.||+
T Consensus 269 ~~~RP~ 274 (375)
T KOG0591|consen 269 PEQRPD 274 (375)
T ss_pred cccCCC
Confidence 999998
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=379.62 Aligned_cols=271 Identities=35% Similarity=0.750 Sum_probs=223.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH-CCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM-LDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||.||+|.++.+++ .||||++.+..............|..++.. .+||||+++++++..++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNE---------FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 369999999999999887665 499999987654444444555566777765 4899999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 72 ~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence 9999999999999988764 45999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.......+||+.|+|||++.+..++
T Consensus 150 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05592 150 -------------------------------------------------------EGKASTFCGTPDYIAPEILKGQKYN 174 (316)
T ss_pred -------------------------------------------------------CCccccccCCccccCHHHHcCCCCC
Confidence 0111234799999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh-HHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA-ADV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~-~el 403 (451)
.++|||||||++|+|++|+.||.+.+..+.+..+......++.. .+.++.+||.+||+.||.+||+ + .++
T Consensus 175 ~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~ll~~~l~~~P~~R~~----~~~~l 245 (316)
T cd05592 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW-----ISKEAKDCLSKLFERDPTKRLG----VDGDI 245 (316)
T ss_pred CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHccCCHHHcCC----ChHHH
Confidence 99999999999999999999999988888888777655444432 3448999999999999999998 5 488
Q ss_pred HcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 404 KTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 404 l~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
++||||.+++|... +...++..|....+
T Consensus 246 ~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (316)
T cd05592 246 RQHPFFRGIDWERLEKREIPPPFKPKVKSP 275 (316)
T ss_pred HcCcccCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999998654 44555666665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=381.23 Aligned_cols=275 Identities=38% Similarity=0.693 Sum_probs=227.5
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHH-HHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK-ILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||||++.+...........+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGK---------FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 369999999999999887665 49999998765444444444445544 56779999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~- 148 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE- 148 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-
Confidence 9999999999999888764 5689999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (323)
T cd05575 149 ------------------------------------------------------HSKTTSTFCGTPEYLAPEVLRKQPYD 174 (323)
T ss_pred ------------------------------------------------------CCCccccccCChhhcChhhhcCCCCC
Confidence 00011234799999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++|||||||++|+|++|+.||...+..+.+..+.......+... +..+.+||.+||+.||.+||+.+..+.+++
T Consensus 175 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNI-----SVSARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 999999999999999999999999888888888887765544322 348999999999999999999766678999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
+||||..++|..+ ....+|..|....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05575 250 NHVFFSSINWDDLVNKKITPPFNPNVSGP 278 (323)
T ss_pred cCCCcCCCCHHHHhhccCCCCcCCCCCCc
Confidence 9999999988654 45566666766554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.82 Aligned_cols=268 Identities=27% Similarity=0.359 Sum_probs=220.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..+.|+.+++||+|+||.||+|++..+++ +||+|.++.... .........+||.||++|.||||++|.+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgk---------ivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGK---------IVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCc---------EEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 34569999999999999999999988776 699999986642 23445566789999999999999999998
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
..+. +.+|||+|||+ -+|.-++.. +.-.|++.+++.+++||+.||+|+|.+||+|||||.+||||+.+|.+||+||
T Consensus 185 vt~~~~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 185 VTSKLSGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred EEecCCceEEEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccc
Confidence 8776 69999999994 477766654 3456999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|.+... ..-..+ ...+-|.+|+||
T Consensus 263 GLAr~y~~---------------------------------------~~~~~~---------------T~rVvTLWYRpP 288 (560)
T KOG0600|consen 263 GLARFYTP---------------------------------------SGSAPY---------------TSRVVTLWYRPP 288 (560)
T ss_pred cceeeccC---------------------------------------CCCccc---------------ccceEEeeccCh
Confidence 99853221 111111 123779999999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC-----------------------
Q 013016 316 EVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS----------------------- 371 (451)
Q Consensus 316 E~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------- 371 (451)
|+++|. .|+.++|+||+||||.||++|++.|.+..+.+.+..|..--..+....|+
T Consensus 289 ELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~ 368 (560)
T KOG0600|consen 289 ELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET 368 (560)
T ss_pred HHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH
Confidence 999995 49999999999999999999999999999999888887644333333332
Q ss_pred -CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 372 -SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 372 -~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
...+..+.+|+..||+.||.+|.| |.++|+++||...+.+
T Consensus 369 ~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 369 FKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTTEPLP 409 (560)
T ss_pred hccCCHHHHHHHHHHhccCcccccc----HHHHhcCcccccCCCC
Confidence 011226789999999999999999 9999999999664443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=386.73 Aligned_cols=309 Identities=36% Similarity=0.650 Sum_probs=242.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++.+...........+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ---------VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCC---------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 479999999999999999999887655 49999998776555455667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 999999999999999999998875 569999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.................. .... .. ..................||+.|+|||++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~---------~~~~-------------~~----~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 150 KMNKAKDREYYLNDSHNL---------LFRD-------------NV----LVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred cCcccCcccccccccccc---------cccc-------------cc----cccccccccccccccccccCccccCHHHHc
Confidence 443221000000000000 0000 00 000000000111222457999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--CCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK--KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+..++.++|||||||++|+|++|+.||...........+.. ....++... . .+.++.+||.+||. ||.+|++.
T Consensus 204 ~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~-~~~~~~~li~~ll~-dp~~R~~s- 278 (350)
T cd05573 204 GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP--P-VSPEAIDLICRLLC-DPEDRLGS- 278 (350)
T ss_pred CCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCC--C-CCHHHHHHHHHHcc-ChhhcCCC-
Confidence 99999999999999999999999999999887777777776 333333322 1 34489999999998 99999985
Q ss_pred CChHHHHcCCCcCCCCcccccccCCCCCCCCCCCC
Q 013016 398 RGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~ 432 (451)
+.++++||||++++|.......+|..|....+.
T Consensus 279 --~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (350)
T cd05573 279 --FEEIKSHPFFKGIDWENLRETKPPFVPELSSPL 311 (350)
T ss_pred --HHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCch
Confidence 789999999999999888888888888877643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=386.12 Aligned_cols=285 Identities=33% Similarity=0.565 Sum_probs=233.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|++.++||+|+||.||+|.++.+++ .||+|++.+...........+..|+.+++.++||||++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~ 109 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 3455789999999999999999999887665 4999999876544444455677799999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+++++|+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEec
Confidence 9999999999999999999999988653 4889999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... ........+||+.|+||
T Consensus 187 G~~~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aP 212 (370)
T cd05596 187 GTCMKMDAN------------------------------------------------------GMVRCDTAVGTPDYISP 212 (370)
T ss_pred cceeeccCC------------------------------------------------------CcccCCCCCCCcCeECH
Confidence 997432100 00011134799999999
Q ss_pred ccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 316 EVASGG----SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 316 E~~~~~----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|++.+. .++.++|||||||++|||++|+.||...+....+..+............. ..+.++++||.+||+.+|.
T Consensus 213 E~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~~~~~li~~~L~~~p~ 291 (370)
T cd05596 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI-EISKQAKDLICAFLTDREV 291 (370)
T ss_pred HHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC-CCCHHHHHHHHHHccChhh
Confidence 998753 37889999999999999999999999988888888887654322211111 2344899999999999998
Q ss_pred C--cCCCCCChHHHHcCCCcCCCCcc--cccccCCCCCCCCCCC
Q 013016 392 N--RLGSKRGAADVKTHPFFKGLNFA--LIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 392 ~--Rpt~~~~~~ell~hp~~~~~~~~--~~~~~~~~~~p~~~~~ 431 (451)
+ |++ ++|+++||||++.+|. ..+...+|.+|...+.
T Consensus 292 r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~ 331 (370)
T cd05596 292 RLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSD 331 (370)
T ss_pred ccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCcCCCc
Confidence 8 999 9999999999998775 3456666777765543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=378.32 Aligned_cols=271 Identities=36% Similarity=0.715 Sum_probs=223.5
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||.||+|.++.+++ .||+|++.+..............|..++... +|+||+++++++.+.+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGE---------YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 469999999999999887665 4999999876543333445556677777754 899999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||+.||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 148 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF- 148 (316)
T ss_pred EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-
Confidence 9999999999999888764 5589999999999999999999999999999999999999999999999998731100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 149 ------------------------------------------------------GDNRASTFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred ------------------------------------------------------CCCceeccCCCcCccCHHHHcCCCCC
Confidence 00011234799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh-HHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA-ADV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~-~el 403 (451)
.++|||||||++|+|++|+.||...+..+.+..+......++.. .+.++.+||.+||+.||++|++ + +++
T Consensus 175 ~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dP~~R~~----~~~~~ 245 (316)
T cd05620 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW-----ITKESKDILEKLFERDPTRRLG----VVGNI 245 (316)
T ss_pred cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHccCCHHHcCC----ChHHH
Confidence 99999999999999999999999888877777776655444432 3448999999999999999999 7 589
Q ss_pred HcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 404 KTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 404 l~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
++||||+.++|... ....+|..|....+
T Consensus 246 ~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 275 (316)
T cd05620 246 RGHPFFKTINWTALEKRELDPPFKPKVKSP 275 (316)
T ss_pred HcCCCcCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999998753 45556666666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.15 Aligned_cols=264 Identities=36% Similarity=0.604 Sum_probs=239.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
..|++.+.||.|.||.||+|..+.+++. +|+|++.+...........+.+|+.+|+++. |||||.++++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~---------~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKE---------VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCce---------eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 5699999999999999999999987664 9999999987766666678888999999998 99999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC----CCEEEec
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD----GHIMLSD 234 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~----~~~kl~D 234 (451)
++...+++|||+|.||.|.+.+... .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999999988776 29999999999999999999999999999999999999743 4799999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++..... ..+...++||+.|+|
T Consensus 183 FGla~~~~~--------------------------------------------------------~~~~~~~~Gtp~y~A 206 (382)
T KOG0032|consen 183 FGLAKFIKP--------------------------------------------------------GERLHTIVGTPEYVA 206 (382)
T ss_pred CCCceEccC--------------------------------------------------------CceEeeecCCccccC
Confidence 999853321 122335699999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++.+..|+..+||||+|+++|.|++|..||.+......+.++..+...+....++.+.. .+++||++||..||.+|+
T Consensus 207 PEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~-~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 207 PEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE-SAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred chhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH-HHHHHHHHhcccCcccCC
Confidence 9999989999999999999999999999999999999999999999999999999988866 999999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCccc
Q 013016 395 GSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~ 416 (451)
| +.++|+|||+++.....
T Consensus 286 t----a~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 286 T----AAQALQHPWIKSIGEAT 303 (382)
T ss_pred C----HHHHhcCccccCCcccc
Confidence 9 99999999999865554
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=378.01 Aligned_cols=270 Identities=36% Similarity=0.721 Sum_probs=227.3
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||||++.+...........+..|..+++.+ +|+||+++++++...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE---------LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 369999999999999887655 4999999987655555566677788898887 699999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~- 148 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL- 148 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-
Confidence 9999999999999888764 4699999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+|++.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 149 ------------------------------------------------------GGVTTSTFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred ------------------------------------------------------CCCcccceecCccccCHHHhcCCCCC
Confidence 00011134789999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh----
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA---- 400 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~---- 400 (451)
.++|||||||++|+|++|+.||...+.......+......++.. .+..+.+||.+||..||.+||+ +
T Consensus 175 ~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~~l~~dP~~R~s----~~~~~ 245 (318)
T cd05570 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW-----LSKEAKSILKSFLTKNPEKRLG----CLPTG 245 (318)
T ss_pred cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc-----CCHHHHHHHHHHccCCHHHcCC----CCCCC
Confidence 99999999999999999999999888888888887766555432 3348999999999999999999 7
Q ss_pred -HHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 401 -ADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 401 -~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
.+++.||||+.++|... ....+|..|....
T Consensus 246 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05570 246 EQDIKGHPFFREIDWDKLERKEIKPPFKPKIKG 278 (318)
T ss_pred HHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 99999999999988643 4555666666654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=386.66 Aligned_cols=306 Identities=31% Similarity=0.557 Sum_probs=231.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+..|+.++..++|+||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGH---------IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 469999999999999999999887665 49999998765555556677888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+++|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999999999999999999998764 458999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCc--ccccccccccccccccCCCccCccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNR--LFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
............. ........+. ........ ..............+||+.|+|||+
T Consensus 150 ~~~~~~~~~~~~~--------------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 207 (360)
T cd05627 150 GLKKAHRTEFYRN--------------LTHNPPSDFS--------FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207 (360)
T ss_pred ccccccccccccc--------------cccCCccccc--------ccccccccccccccccccccccccCCCccccCHHH
Confidence 4321110000000 0000000000 00000000 0000011122234689999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--CCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL--TFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++|||||||++|||++|+.||........+..+..... .++.. ...+.++++||.+|+ .||.+|++
T Consensus 208 ~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~ 283 (360)
T cd05627 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIG 283 (360)
T ss_pred HcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCC
Confidence 9999999999999999999999999999998888888777775432 22221 113348999999987 49999996
Q ss_pred CCCChHHHHcCCCcCCCCcccccccCCC
Q 013016 396 SKRGAADVKTHPFFKGLNFALIRSLTPP 423 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~~~~~~~~ 423 (451)
.. .+.|+++||||++++|........+
T Consensus 284 ~~-~~~ei~~hp~f~~~~~~~~~~~~~~ 310 (360)
T cd05627 284 SN-GVEEIKSHPFFEGVDWGHIRERPAA 310 (360)
T ss_pred CC-CHHHHhcCCCCCCCCHHHHhcCCCC
Confidence 21 2899999999999999877554433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=385.45 Aligned_cols=284 Identities=32% Similarity=0.590 Sum_probs=231.2
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
...++|++.++||+|+||.||+|.++.+++ .||+|++.+...........+..|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344789999999999999999999987665 49999998755444444556778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++.+++++|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999999999999988653 48999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+.+||+.|||||
T Consensus 188 ~a~~~~~~------------------------------------------------------~~~~~~~~~gt~~Y~aPE 213 (370)
T cd05621 188 TCMKMDET------------------------------------------------------GMVRCDTAVGTPDYISPE 213 (370)
T ss_pred cceecccC------------------------------------------------------CceecccCCCCcccCCHH
Confidence 98532110 000112347999999999
Q ss_pred cccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 317 VASGGS----HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 317 ~~~~~~----~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
++.+.. ++.++|||||||++|+|++|+.||...+....+..+......+..... ...+..+++++.+||..++.+
T Consensus 214 ~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~~L~~~~~r 292 (370)
T cd05621 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED-VEISKHAKNLICAFLTDREVR 292 (370)
T ss_pred HHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc-ccCCHHHHHHHHHHccCchhc
Confidence 997643 788999999999999999999999998888888888765432222111 123448999999999865544
Q ss_pred --cCCCCCChHHHHcCCCcCCCCc--ccccccCCCCCCCCCCC
Q 013016 393 --RLGSKRGAADVKTHPFFKGLNF--ALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 393 --Rpt~~~~~~ell~hp~~~~~~~--~~~~~~~~~~~p~~~~~ 431 (451)
|++ +.|+++||||++..| ...+...+|.+|.....
T Consensus 293 ~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~ 331 (370)
T cd05621 293 LGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSD 331 (370)
T ss_pred cCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCc
Confidence 889 999999999998655 34566777888877654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=379.24 Aligned_cols=278 Identities=34% Similarity=0.664 Sum_probs=231.7
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFE 159 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~ 159 (451)
+|.+.+.||+|+||.||+|.++.+++ .||||++.+..............|..++..+ +|++|+.+++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 58899999999999999999887665 4999999877554444555566678888777 5899999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~ 149 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence 999999999999999999888764 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ........+||+.|+|||++.
T Consensus 150 ~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 150 ENMW-------------------------------------------------------DGVTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred ecCC-------------------------------------------------------CCCccccCCCChhhcCHHHhc
Confidence 2110 000112347999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC-C
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK-R 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~-~ 398 (451)
+..++.++|||||||++|+|++|+.||........+..+......++.. .+.++.+|+.+||+.||.+|++.. .
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS-----MSKEAVAICKGLMTKHPGKRLGCGPE 249 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-----CCHHHHHHHHHHcccCHHhcCCCCCC
Confidence 9999999999999999999999999999988888888888876665543 233899999999999999999842 2
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
...++++||||+.++|... +...+|..|..+
T Consensus 250 ~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (323)
T cd05616 250 GERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC 282 (323)
T ss_pred CHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC
Confidence 3589999999999999754 445555555543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=372.77 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=231.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|++.+.||.|.||+|-+|+.+..++ .||||.|++....+.+..-.+.+|++||..|+||||+.+|++|+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR---------~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGR---------EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCc---------EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 569999999999999999999877766 49999999999888888888999999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+.|||||..+|.|++|+... +.+++..++++++||+.|+.|+|.++++|||||.+|||++.++++||+|||++.
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999999999999886 669999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ++ .-.+|||++.|.+||++.
T Consensus 202 ly~~---------------------------------------~k-----------------fLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 202 LYAD---------------------------------------KK-----------------FLQTFCGSPLYASPEIVN 225 (668)
T ss_pred hhcc---------------------------------------cc-----------------HHHHhcCCcccCCccccC
Confidence 3221 11 112579999999999999
Q ss_pred CCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
|.+| +..+|-||||++||-|+.|..||.+.+...++++|.++....|.... ++.-||+.||-+||++|.|
T Consensus 226 G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PS------dA~gLIRwmLmVNP~RRAT--- 296 (668)
T KOG0611|consen 226 GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPS------DASGLIRWMLMVNPERRAT--- 296 (668)
T ss_pred CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCc------hHHHHHHHHHhcCcccchh---
Confidence 9998 78999999999999999999999999999999999998776665432 7889999999999999999
Q ss_pred ChHHHHcCCCcCC
Q 013016 399 GAADVKTHPFFKG 411 (451)
Q Consensus 399 ~~~ell~hp~~~~ 411 (451)
+.+|..|-|++=
T Consensus 297 -ieDiAsHWWvNw 308 (668)
T KOG0611|consen 297 -IEDIASHWWVNW 308 (668)
T ss_pred -HHHHhhhheeec
Confidence 999999988754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=379.71 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=212.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+..+.+.||.|+||+||+|.+++... ||+|++......... ...+.+|+.+|.+++|||||.++|++.
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~----------vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDV----------VAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCcee----------EEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456667779999999999999988753 999999877554444 678899999999999999999999999
Q ss_pred eCC-eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeccCCCCcEEEccCC-CEEEeccC
Q 013016 160 ASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG-IIYRDLKPENVLVRSDG-HIMLSDFD 236 (451)
Q Consensus 160 ~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivH~Dlkp~NIll~~~~-~~kl~Dfg 236 (451)
++. .++|||||+++|+|.++++......+++..+..|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 887 7999999999999999998855577999999999999999999999999 99999999999999998 99999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++...... .......||+.|||||
T Consensus 190 lsr~~~~~~-------------------------------------------------------~~~~~~~GT~~wMAPE 214 (362)
T KOG0192|consen 190 LSREKVISK-------------------------------------------------------TSMTSVAGTYRWMAPE 214 (362)
T ss_pred cceeecccc-------------------------------------------------------ccccCCCCCccccChh
Confidence 985432110 0111247999999999
Q ss_pred ccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 317 VAS--GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 317 ~~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
++. ...|+.++||||||++||||+||+.||...........+.......+.... .+..+..|+.+||..||..||
T Consensus 215 v~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~---~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 215 VLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE---CPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred hhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc---CCHHHHHHHHHhCCCCCCcCC
Confidence 999 568999999999999999999999999998887766666644433322211 344899999999999999999
Q ss_pred CCCCChHHHH
Q 013016 395 GSKRGAADVK 404 (451)
Q Consensus 395 t~~~~~~ell 404 (451)
+ +.+++
T Consensus 292 ~----f~ei~ 297 (362)
T KOG0192|consen 292 S----FLEIV 297 (362)
T ss_pred C----HHHHH
Confidence 9 66665
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=376.38 Aligned_cols=272 Identities=35% Similarity=0.744 Sum_probs=225.4
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH-CCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM-LDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||||++.+..............|..++.. ++||||+++++++.+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999999887665 499999987654333444555667777776 4899999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 148 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML- 148 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-
Confidence 9999999999999988764 4589999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.........||..|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05619 149 ------------------------------------------------------GDAKTCTFCGTPDYIAPEILLGQKYN 174 (316)
T ss_pred ------------------------------------------------------CCCceeeecCCccccCHHHHcCCCCC
Confidence 00011234789999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChH-HH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA-DV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~-el 403 (451)
.++|||||||++|+|++|+.||......+.+..+......++. ..+.++.+||.+||+.||.+|++ +. ++
T Consensus 175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~----~~~~l 245 (316)
T cd05619 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR-----WLTREAKDILVKLFVREPERRLG----VKGDI 245 (316)
T ss_pred chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----cCCHHHHHHHHHHhccCHhhcCC----ChHHH
Confidence 9999999999999999999999988877777777655444332 23348999999999999999999 75 89
Q ss_pred HcCCCcCCCCcccc--cccCCCCCCCCCCCC
Q 013016 404 KTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432 (451)
Q Consensus 404 l~hp~~~~~~~~~~--~~~~~~~~p~~~~~~ 432 (451)
+.||||++++|... +...+|..|....+.
T Consensus 246 ~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05619 246 RQHPFFREIDWSALEEREIEPPFKPKVKSAN 276 (316)
T ss_pred HcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 99999999999754 556677777776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=378.42 Aligned_cols=274 Identities=37% Similarity=0.732 Sum_probs=221.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||.||+|.++.+++ .||||++.+...........+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR---------IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 369999999999999887765 4999999877655555566677899999888 799999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 148 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR- 148 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-
Confidence 9999999999999888654 5699999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.......++||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 149 ------------------------------------------------------PGDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred ------------------------------------------------------CCCccccccCCccccCHHHHcCCCCC
Confidence 00111235799999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPS---------NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
.++|||||||++|+|++|+.||.... .......+.......|.. .+.++.++|++||+.||.+|++
T Consensus 175 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS-----LSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhccCHHHcCC
Confidence 99999999999999999999996311 122344455554444432 2338999999999999999997
Q ss_pred CC--CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 396 SK--RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 396 ~~--~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
.. ..++++++||||..++|... ....+|..|....
T Consensus 250 ~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (329)
T cd05588 250 CHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIES 288 (329)
T ss_pred CCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCC
Confidence 32 23789999999999998754 3344455555544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.50 Aligned_cols=280 Identities=34% Similarity=0.673 Sum_probs=233.3
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFE 159 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~ 159 (451)
+|++.+.||+|+||+||+|.++.+++ .||+|++.+...........+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDE---------LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47889999999999999999887665 49999998765544455566777888888885 577888999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence 999999999999999999988764 459999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 150 ~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 150 EHMVD-------------------------------------------------------GVTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred ccCCC-------------------------------------------------------CccccCccCCccccCHHHHc
Confidence 21100 00111346899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC-C
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK-R 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~-~ 398 (451)
+..++.++|||||||++|+|++|+.||...........+......++... +.++.+++.+||+.||.+|++.. .
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~-----~~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05615 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL-----SKEAVSICKGLMTKHPSKRLGCGPE 249 (323)
T ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC-----CHHHHHHHHHHcccCHhhCCCCCCC
Confidence 98899999999999999999999999999888888888887766555432 33899999999999999999842 2
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
...++++||||++++|... +...+|..|..+..
T Consensus 250 ~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 284 (323)
T cd05615 250 GERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK 284 (323)
T ss_pred CHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC
Confidence 3679999999999999755 44566777765553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.96 Aligned_cols=284 Identities=36% Similarity=0.598 Sum_probs=230.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.++.+++ .||+|++.+...........+..|+.++..++|+||+.+++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQ---------VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 479999999999999999999887665 49999998755444555566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|+||||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 999999999999999999998764 3458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........+||+.|+|||++.
T Consensus 151 ~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 151 RLLAD------------------------------------------------------GTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred ecCCC------------------------------------------------------CCccccceeccccccCHHHHh
Confidence 32110 000011236899999999986
Q ss_pred C-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC--
Q 013016 320 G-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN-- 392 (451)
Q Consensus 320 ~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~-- 392 (451)
+ ..++.++|||||||++|+|++|+.||......+.+..+......+.........+..+++||++||..++.+
T Consensus 177 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~ 256 (331)
T cd05597 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLG 256 (331)
T ss_pred hccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccC
Confidence 3 347889999999999999999999999887777777776544322221111224448999999999765443
Q ss_pred cCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
|++ ++++++||||.+++|.......+|.+|...+.
T Consensus 257 r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
T cd05597 257 RNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSP 291 (331)
T ss_pred CCC----HHHHhcCCCCCCCCHHHHhhCCCCccCcCCCc
Confidence 778 99999999999999988877777777766553
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=378.26 Aligned_cols=276 Identities=37% Similarity=0.711 Sum_probs=221.0
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||+|++.+...........+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTER---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 469999999999999887765 4999999877554445556677788888776 799999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 72 ~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence 9999999999998887664 45999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
......++||+.|+|||++.+..++
T Consensus 150 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 150 -------------------------------------------------------GDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred -------------------------------------------------------CCccccccCCccccCHHHHcCCCCC
Confidence 0011234799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAP---------SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
.++|||||||++|+|++|+.||... ........+......+|.. .+..+.+||.+||+.||.+|++
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHhcCCHHHcCC
Confidence 9999999999999999999999521 1122334444554444432 2338999999999999999998
Q ss_pred CC--CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCC
Q 013016 396 SK--RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432 (451)
Q Consensus 396 ~~--~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~ 432 (451)
.. ..+.++++||||++++|... +...+|..|...+..
T Consensus 250 ~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05618 250 CHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEF 290 (329)
T ss_pred CCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcc
Confidence 32 22579999999999998644 445566666655443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=372.68 Aligned_cols=312 Identities=53% Similarity=0.906 Sum_probs=248.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|++|.||+|.+..+++ .||+|.+.............+..|+++++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK---------LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCc---------EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 369999999999999999999887554 49999998765444445667888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+.|++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 99999999999999999999987666779999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
............... .+.... . .+. ......+........+.|+..|+|||++.
T Consensus 152 ~~~~~~~~~~~~~~~---------~~~~~~--~---------~~~------~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 205 (316)
T cd05574 152 QSDVEPPPVSKALRK---------GSRRSS--V---------NSI------PSETFSEEPSFRSNSFVGTEEYIAPEVIS 205 (316)
T ss_pred ccccccccccccccc---------cccccc--c---------ccc------chhhhcccccCCCCCCcCccCCcCHHHHc
Confidence 432211100000000 000000 0 000 00001111122233568999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|+|++|+.||........+.++......++.... .+..+.+||.+||..||++||+.+..
T Consensus 206 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~ 282 (316)
T cd05574 206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPP---VSSSARDLIRKLLVKDPSKRLGSKRG 282 (316)
T ss_pred CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccc---cCHHHHHHHHHHccCCHhHCCCchhh
Confidence 988999999999999999999999999988888888777766555443221 34589999999999999999999888
Q ss_pred hHHHHcCCCcCCCCcccccccCCCCCCCCC
Q 013016 400 AADVKTHPFFKGLNFALIRSLTPPEIPGMR 429 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~~~~~~~~~~~p~~~ 429 (451)
++|+|.||||++.+|+..+...+|.+|.+-
T Consensus 283 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 283 AAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 999999999999999999999888887653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=376.49 Aligned_cols=284 Identities=35% Similarity=0.588 Sum_probs=233.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.++.+.+ .||+|++.+...........+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC---------EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 479999999999999999999887665 49999998755444455556778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+++|+||||++||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 9999999999999999999997642 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........+||+.|+|||++.
T Consensus 151 ~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 151 KLMED------------------------------------------------------GTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred ecccC------------------------------------------------------CcceecccccCccccCHHHHh
Confidence 22100 000111247999999999986
Q ss_pred C-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC--
Q 013016 320 G-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN-- 392 (451)
Q Consensus 320 ~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~-- 392 (451)
+ ..++.++|||||||++|||++|+.||...+..+.+..+.......+........+.++++||++||..++.+
T Consensus 177 ~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~ 256 (332)
T cd05623 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLG 256 (332)
T ss_pred ccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcC
Confidence 3 457889999999999999999999999988888888887654333221111223448999999999765554
Q ss_pred cCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
|++ +.|+++||||++++|...+....|.+|...++
T Consensus 257 r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05623 257 QNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSP 291 (332)
T ss_pred CCC----HHHHhCCCCcCCCCHHHHhhCCCCccCCCCCC
Confidence 678 99999999999999998888888888876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=369.01 Aligned_cols=268 Identities=34% Similarity=0.553 Sum_probs=218.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|++.++||+|+||+||+|.+..+.+ .||+|++.............+.+|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCc---------eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 48899999999999999999876654 499999986654444444556679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+++|+||||+++|+|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999999999999888765556699999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... ......+|+..|+|||++.+
T Consensus 152 ~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 152 IPEG--------------------------------------------------------ETIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred cCCC--------------------------------------------------------CccccccCCCCccCcHHhcC
Confidence 2100 00012368899999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC-----C
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL-----G 395 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp-----t 395 (451)
..++.++|||||||++|+|++|+.||.+.........+.......+.... ...+..+.+||.+||..||++|| +
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 254 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS-EKFSEAARSICRQLLTKDPGFRLGCRGEG 254 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC-cccCHHHHHHHHHHccCCHHHhcCCCCCC
Confidence 88999999999999999999999999876554333332221111111111 12344899999999999999999 7
Q ss_pred CCCChHHHHcCCCcCCCCccccc
Q 013016 396 SKRGAADVKTHPFFKGLNFALIR 418 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~~~ 418 (451)
++++++||||...+|+...
T Consensus 255 ----~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05605 255 ----AEEVKAHPFFRTANFKRLE 273 (285)
T ss_pred ----HHHHhcCcCccCCCHHHHh
Confidence 9999999999999998663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=368.62 Aligned_cols=261 Identities=34% Similarity=0.598 Sum_probs=212.0
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||+|+||+||+|.++.+++ .||+|++.+...........+..|+.+++.++|+||+++++++...++.|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATGK---------LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCCc---------EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 6999999999999887665 4999999876555444556677899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 168 MEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
|||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~- 150 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG- 150 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC-
Confidence 9999999998877542 2356899999999999999999999999999999999999999999999999997432110
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
........||+.|+|||++.+..++.
T Consensus 151 ------------------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~ 176 (280)
T cd05608 151 ------------------------------------------------------QSKTKGYAGTPGFMAPELLQGEEYDF 176 (280)
T ss_pred ------------------------------------------------------CccccccCCCcCccCHHHhcCCCCCc
Confidence 00011246899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC-Ch
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNE----TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GA 400 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~-~~ 400 (451)
++|||||||++|+|++|+.||...... .....+......++. ..+.++.+++.+||+.||++||+.+. .+
T Consensus 177 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 251 (280)
T cd05608 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD-----KFSPASKSFCEALLAKDPEKRLGFRDGNC 251 (280)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc-----cCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 999999999999999999999865432 223333333222222 23448999999999999999994311 28
Q ss_pred HHHHcCCCcCCCCcccc
Q 013016 401 ADVKTHPFFKGLNFALI 417 (451)
Q Consensus 401 ~ell~hp~~~~~~~~~~ 417 (451)
+++++||||++++|..+
T Consensus 252 ~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 252 DGLRTHPLFRDLNWRQL 268 (280)
T ss_pred HHHhcChhhhcCCHhHH
Confidence 99999999999988755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=376.80 Aligned_cols=274 Identities=36% Similarity=0.679 Sum_probs=225.2
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHH-HHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK-ILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||+|++.+...........+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGK---------CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 369999999999999877655 49999998765444444445555554 46778999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~- 148 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA- 148 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-
Confidence 9999999999999887654 5699999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05604 149 ------------------------------------------------------QSDTTTTFCGTPEYLAPEVIRKQPYD 174 (325)
T ss_pred ------------------------------------------------------CCCCcccccCChhhCCHHHHcCCCCC
Confidence 00011234799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++|||||||++|+|++|+.||......+.+..+.......+.. .+..+.++|.+||+.||.+||+.+..+.+++
T Consensus 175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG-----ASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCC-----CCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 99999999999999999999999888888888887765544322 2338899999999999999999777788999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
+||||..++|... ....+|..|....
T Consensus 250 ~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T cd05604 250 EHPFFESLSWTDLEQKKIPPPFNPNVEG 277 (325)
T ss_pred cCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 9999999888654 3445566665544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=379.77 Aligned_cols=284 Identities=32% Similarity=0.576 Sum_probs=230.2
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
...++|++.+.||+|+||.||+|.++.+.+ .||+|++.+...........+..|+.+++.++||||+++++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~---------~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCc---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 344789999999999999999999987765 49999998755444445556778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++..++++|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 111 AFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999999988653 48999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ........+||+.|||||
T Consensus 188 ~a~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE 213 (371)
T cd05622 188 TCMKMNKE------------------------------------------------------GMVRCDTAVGTPDYISPE 213 (371)
T ss_pred ceeEcCcC------------------------------------------------------CcccccCcccCccccCHH
Confidence 98432110 000112347999999999
Q ss_pred cccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 317 VASGGS----HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 317 ~~~~~~----~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
++.+.. ++.++|||||||++|+|++|+.||...+....+..+......+....... .+..+++||.+||..++.+
T Consensus 214 ~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~~~~r 292 (371)
T cd05622 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND-ISKEAKNLICAFLTDREVR 292 (371)
T ss_pred HHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC-CCHHHHHHHHHHcCChhhh
Confidence 987643 78899999999999999999999999888888888876543322222222 3448999999999844433
Q ss_pred --cCCCCCChHHHHcCCCcCCCCc--ccccccCCCCCCCCCCC
Q 013016 393 --RLGSKRGAADVKTHPFFKGLNF--ALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 393 --Rpt~~~~~~ell~hp~~~~~~~--~~~~~~~~~~~p~~~~~ 431 (451)
|++ ++|+++|+||++..+ ...+...+|.+|...+.
T Consensus 293 ~~r~~----~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (371)
T cd05622 293 LGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSD 331 (371)
T ss_pred cCCCC----HHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCc
Confidence 678 999999999999655 45567777777765543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=373.78 Aligned_cols=276 Identities=36% Similarity=0.682 Sum_probs=222.6
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
++||+|+||.||+|.+.... ..+..||||++.+..... ......+..|+.+++.++||||+++++++..++.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 57999999999999865321 123359999998754322 23345567799999999999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 152 (323)
T cd05584 76 YLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH- 152 (323)
T ss_pred EEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-
Confidence 9999999999999988764 4588999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+||+.|+|||++.+..++
T Consensus 153 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 178 (323)
T cd05584 153 ------------------------------------------------------EGTVTHTFCGTIEYMAPEILMRSGHG 178 (323)
T ss_pred ------------------------------------------------------CCCcccccCCCccccChhhccCCCCC
Confidence 00011134799999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~el 403 (451)
.++|||||||++|||++|+.||........+..+..+....+... +.++.+||.+||+.||++||+. ...++++
T Consensus 179 ~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYL-----TPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 999999999999999999999999888888888887766554432 3389999999999999999921 1119999
Q ss_pred HcCCCcCCCCcccc--cccCCCCCCCCC
Q 013016 404 KTHPFFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 404 l~hp~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
+.||||....|... ....+|..|...
T Consensus 254 ~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (323)
T cd05584 254 QSHPFFRHVNWDDLLARKVEPPFKPLLQ 281 (323)
T ss_pred hcCCCcCCCCHHHHhcCCCCCCcCCCCC
Confidence 99999999877544 333344444443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=373.28 Aligned_cols=274 Identities=39% Similarity=0.685 Sum_probs=224.9
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHH-HHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK-ILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.+..+++ .||+|++.+...........+..|.. +++.++|+||+++++++...+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 369999999999999877655 49999998765544444444555554 57889999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 72 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence 9999999999998887654 55899999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.......+||+.|+|||++.+..++
T Consensus 150 -------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05603 150 -------------------------------------------------------EETTSTFCGTPEYLAPEVLRKEPYD 174 (321)
T ss_pred -------------------------------------------------------CCccccccCCcccCCHHHhcCCCCC
Confidence 0011234789999999999998899
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++|||||||++|+|++|+.||...+.......+......++.. .+..+.++|.+||+.||.+|++....+.+++
T Consensus 175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGG-----KTVAACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 99999999999999999999999888778888887776554432 2338999999999999999999766678999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
+|+||..++|... ....+|..|....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T cd05603 250 NHVFFSPINWDDLYHKRITPPYNPNVAG 277 (321)
T ss_pred CCCCcCCCCHHHHhcCCCCCCcCCCCCC
Confidence 9999999988653 4455555555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=387.41 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=216.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-C-----CCccce
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-H-----PFLPTL 154 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~nIv~l 154 (451)
+|.+.+.||+|+||.|-+|.+..+++ .||||+++... ........|+.+|..|+ | -|||++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e---------~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE---------IVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc---------EEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 58999999999999999999998876 59999998653 34455566999999986 4 479999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC--CEEE
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG--HIML 232 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl 232 (451)
+++|...+|+|||+|++ ..+|+++++.+...+|+...++.|+.||+.||.+||+.||||+||||+||||...+ .+||
T Consensus 254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred eeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeE
Confidence 99999999999999999 89999999999888899999999999999999999999999999999999998654 7999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||.|.... .+..+.+-++.|
T Consensus 333 IDFGSSc~~~----------------------------------------------------------q~vytYiQSRfY 354 (586)
T KOG0667|consen 333 IDFGSSCFES----------------------------------------------------------QRVYTYIQSRFY 354 (586)
T ss_pred EecccccccC----------------------------------------------------------Ccceeeeecccc
Confidence 9999985322 111134677889
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC------------------------
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ------------------------ 368 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------ 368 (451)
+|||+++|.+|+.+.||||||||++||++|.+.|.+.+..+.+..|+.....++..
T Consensus 355 RAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~ 434 (586)
T KOG0667|consen 355 RAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVE 434 (586)
T ss_pred ccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeee
Confidence 99999999999999999999999999999999999999998888887511111000
Q ss_pred ------------------------CC----------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 369 ------------------------SP----------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 369 ------------------------~~----------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.+ .......+.+||++||.+||.+|+| +.++|+||||.+.
T Consensus 435 ~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 435 TSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----PAQALNHPFLTGT 508 (586)
T ss_pred ecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----HHHHhcCcccccc
Confidence 00 0012226789999999999999999 9999999999973
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=375.03 Aligned_cols=284 Identities=36% Similarity=0.602 Sum_probs=232.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.++.+.+ .||+|++.+...........+..|+.++..++|+||+.+++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTER---------IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 479999999999999999999887665 49999998754444445556777899999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.++.|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 9999999999999999999997642 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........+||+.|+|||++.
T Consensus 151 ~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 151 KMNQD------------------------------------------------------GTVQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred eccCC------------------------------------------------------CceeeccccCCcccCCHHHHh
Confidence 32110 000111247999999999987
Q ss_pred C-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC--
Q 013016 320 G-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN-- 392 (451)
Q Consensus 320 ~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~-- 392 (451)
+ ..++.++|||||||++|+|++|+.||...+..+.+..+......++........+.++++||.+||..++.+
T Consensus 177 ~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~ 256 (331)
T cd05624 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLG 256 (331)
T ss_pred ccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcC
Confidence 6 457889999999999999999999999888777777776644322211111122348999999999976654
Q ss_pred cCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
|++ ++++++||||+.++|...+...+|.+|....+
T Consensus 257 ~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~ 291 (331)
T cd05624 257 QNG----IEDFKKHAFFEGIDWENIRNLEAPYIPDVSSP 291 (331)
T ss_pred CCC----HHHHhcCCCcCCCCHHHHhhCCCCccCCCCCc
Confidence 456 99999999999999998888888888876554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=355.24 Aligned_cols=271 Identities=26% Similarity=0.469 Sum_probs=234.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----HHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----KKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
..|...+.||.|..++|-+|..+.++++ +|+|++.-.... .....+.-..|+.||+++ .||+|++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e---------~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKE---------FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccc---------eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 6788899999999999999999988775 999998643221 122344455689999998 6999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+.++|+.+..+++|+|+|+.|.|.|++... -.+++...+.|++|+++|++|||.++||||||||+|||++++.++||+
T Consensus 88 l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 88 LQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred eeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence 999999999999999999999999999875 448999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..+.. ..+-...||||+|.
T Consensus 166 DFGFa~~l~~--------------------------------------------------------GekLrelCGTPgYL 189 (411)
T KOG0599|consen 166 DFGFACQLEP--------------------------------------------------------GEKLRELCGTPGYL 189 (411)
T ss_pred ccceeeccCC--------------------------------------------------------chhHHHhcCCCccc
Confidence 9999864321 11112359999999
Q ss_pred CcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 314 SPEVASG------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 314 aPE~~~~------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|||.+.. ..|+..+|+|++|+|||.||.|.+||.......+++.|+.++..+....|.++.. ..++||.+||+
T Consensus 190 APEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~-~~KdLIsrlLq 268 (411)
T KOG0599|consen 190 APETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA-TVKDLISRLLQ 268 (411)
T ss_pred ChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc-cHHHHHHHHHe
Confidence 9999854 3478899999999999999999999999888889999999999998888877766 89999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCCcccccccCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~ 422 (451)
.||.+|.| ++|+|.||||.++-+...+.+.|
T Consensus 269 Vdp~~Rit----ake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 269 VDPTKRIT----AKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred eCchhccc----HHHHhcChHHHHHHHhcccccCC
Confidence 99999999 99999999999876666666555
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=376.74 Aligned_cols=273 Identities=38% Similarity=0.680 Sum_probs=223.7
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeEEEEeCCeE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~~ 164 (451)
||+|+||+||+|.++.+++ .||||++.+..............|..++... .||||+.+++++...+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR---------IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECCCCC---------EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999999887665 4999999876554444444555567777655 699999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~- 148 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT- 148 (330)
T ss_pred EEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-
Confidence 9999999999999888764 5699999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC-CC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-SH 323 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 323 (451)
........+||+.|+|||++.+. .+
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (330)
T cd05586 149 ------------------------------------------------------DNKTTNTFCGTTEYLAPEVLLDEKGY 174 (330)
T ss_pred ------------------------------------------------------CCCCccCccCCccccCHHHHcCCCCC
Confidence 00011234799999999998764 47
Q ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHH
Q 013016 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADV 403 (451)
Q Consensus 324 ~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~el 403 (451)
+.++|||||||++|+|++|+.||......+.+..+..+...++.. ..+.++.+||.+||+.||.+||+.+..+.++
T Consensus 175 ~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l 250 (330)
T cd05586 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL 250 (330)
T ss_pred CCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence 999999999999999999999999888888888887776655532 2334899999999999999999766669999
Q ss_pred HcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 404 KTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 404 l~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
++||||...++... ....+|..|....
T Consensus 251 l~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (330)
T cd05586 251 KEHPFFADIDWDLLSKKQITPPFKPIVDS 279 (330)
T ss_pred hcCccccCCCHHHHHhCCCCCCccCCCCC
Confidence 99999999888754 3444555555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=373.31 Aligned_cols=274 Identities=37% Similarity=0.726 Sum_probs=221.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+.+ .||+|++.+...........+..|+.++.++ +|+||+.+++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQ---------IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 469999999999999887765 4999999987665556667778899998888 699999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~- 148 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG- 148 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC-
Confidence 9999999999999887664 4599999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
........+||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 149 ------------------------------------------------------PGDTTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred ------------------------------------------------------CCCceecccCCcccCCHHHHCCCCCC
Confidence 00011234799999999999999999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCC------C-hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAP------S-NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~------~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.++|||||||++|+|++|+.||... . .......+......++.. .+..+.++|.+||+.||.+|++..
T Consensus 175 ~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-----LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHhccCHHHcCCCC
Confidence 9999999999999999999999642 1 223344444444444332 233899999999999999999831
Q ss_pred --CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 398 --RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 398 --~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
..+.++++||||++++|... ....+|..|....
T Consensus 250 ~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 286 (327)
T cd05617 250 PQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITD 286 (327)
T ss_pred CCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCC
Confidence 23579999999999999865 4445555565543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=374.24 Aligned_cols=281 Identities=40% Similarity=0.737 Sum_probs=218.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+|++.++||+|+||+||+|.+.... ..+..||+|++.+..... ......+..|+.+++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 5899999999999999999875321 123369999998654332 23445677799999999 599999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999999999988764 45899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... .......++||+.|+|||++
T Consensus 153 ~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 153 KEFLSE------------------------------------------------------EKERTYSFCGTIEYMAPEII 178 (332)
T ss_pred cccccc------------------------------------------------------CCCccccccCCccccCHHHh
Confidence 422100 00111235799999999999
Q ss_pred cCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 319 SGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 319 ~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
.+.. ++.++|||||||++|+|++|+.||.... .......+......++.. .+..+.+||.+||+.||++|
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~R 253 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF-----IGPEAQDLLHKLLRKDPKKR 253 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCC-----CCHHHHHHHHHHcCCCHHHc
Confidence 8754 7889999999999999999999996432 223334444444333322 33489999999999999999
Q ss_pred CCC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCC
Q 013016 394 LGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGM 428 (451)
Q Consensus 394 pt~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~ 428 (451)
|++ ...++++++||||++.+|... ....+|..|..
T Consensus 254 ~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 254 LGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 942 112889999999999887543 33444444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=372.18 Aligned_cols=273 Identities=38% Similarity=0.689 Sum_probs=222.2
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHH-HHHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK-KILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||+||+|.++.+++ .||+|++.+...........+..|. .+++.++|+||+++++++...+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEK---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCC---------EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 369999999999999887655 4999999876543333333444444 456788999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~- 148 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 148 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-
Confidence 9999999999999988764 4588999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.......++||+.|+|||++.+..++
T Consensus 149 ------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05602 149 ------------------------------------------------------HNGTTSTFCGTPEYLAPEVLHKQPYD 174 (325)
T ss_pred ------------------------------------------------------CCCCcccccCCccccCHHHHcCCCCC
Confidence 00011234799999999999998999
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++|||||||++|+|++|+.||......+.+..+......++.. .+..+.++|.+||+.||.+|++.+..+.+++
T Consensus 175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN-----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCC-----CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 99999999999999999999999888888888887765443322 2338999999999999999999777788999
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
+|+||..++|..+ ....+|..|...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T cd05602 250 NHIFFSPINWDDLINKKITPPFNPNVS 276 (325)
T ss_pred cCcccCCCCHHHHHhCCCCcCcCCCCC
Confidence 9999999988644 333444444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=364.59 Aligned_cols=262 Identities=32% Similarity=0.557 Sum_probs=212.8
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||+|+||.||++.++.+++ .||+|.+................|++++++++||||+++++++..+.+.|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK---------MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccCCc---------EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999999887665 4999999765443333334455699999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||++|++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--- 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--- 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---
Confidence 99999999998887665556899999999999999999999999999999999999999999999999997432110
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
.......|+..|+|||++.+..++.++
T Consensus 149 -----------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 175 (277)
T cd05607 149 -----------------------------------------------------KTITQRAGTNGYMAPEILKEEPYSYPV 175 (277)
T ss_pred -----------------------------------------------------ceeeccCCCCCccCHHHHccCCCCCch
Confidence 000113688899999999998899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHH
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPSN----ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADV 403 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~el 403 (451)
|||||||++|+|++|+.||..... .+.............. ...+.++++||.+||+.||++||++++...++
T Consensus 176 DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 999999999999999999976433 2233333333322221 12344899999999999999999965555889
Q ss_pred HcCCCcCCCCccccc
Q 013016 404 KTHPFFKGLNFALIR 418 (451)
Q Consensus 404 l~hp~~~~~~~~~~~ 418 (451)
+.|+||+++++....
T Consensus 252 ~~h~~f~~~~~~~~~ 266 (277)
T cd05607 252 RKHEFFKTINFPRLE 266 (277)
T ss_pred hcChhhcCCCHHHHh
Confidence 999999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=368.59 Aligned_cols=285 Identities=36% Similarity=0.614 Sum_probs=246.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.++.+.|...++||.|+||.||-|+-+.+++ .||.|.+.+.+...........+|..||.+++.+.||.+-
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGK---------MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGK---------MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchh---------hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 4556789999999999999999999888876 5999999999888777777888899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
-+|++.+.+|||+..|+||+|.-+|.+..+..|++..++.++.+|+.||++||+.+||+|||||+|||+|+.|+++|.|+
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999998888877778999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|........ ....+||.+||||
T Consensus 332 GLAvei~~g~~--------------------------------------------------------~~~rvGT~GYMAP 355 (591)
T KOG0986|consen 332 GLAVEIPEGKP--------------------------------------------------------IRGRVGTVGYMAP 355 (591)
T ss_pred ceEEecCCCCc--------------------------------------------------------cccccCcccccCH
Confidence 99853321111 1123899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE----TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|++.+..|+...|.|||||+||||+.|+.||...... +.-+.+......++.. .+.++++|++.+|++||+
T Consensus 356 Evl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~k-----FS~eakslc~~LL~Kdp~ 430 (591)
T KOG0986|consen 356 EVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDK-----FSEEAKSLCEGLLTKDPE 430 (591)
T ss_pred HHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccc-----cCHHHHHHHHHHHccCHH
Confidence 9999999999999999999999999999999864433 3444444444444433 344999999999999999
Q ss_pred CcCCCC-CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 392 NRLGSK-RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 392 ~Rpt~~-~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
+|.... .+++++.+||||+.++|..+ ..+.||++|.+.-
T Consensus 431 ~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 431 KRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred HhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 999974 77999999999999999865 8899999987653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=367.04 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=207.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|.+.++||.|+||+||+|.++.+++ .||+|++..... ......+.+|+.++++++|+||+++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 72 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTEN---------LVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDII 72 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCC---------EEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3789999999999999999999887665 499999865421 12234556799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 73 HTERCLTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred cCCCeEEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence 99999999999995 5898887654 245899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......|++.|+|||++
T Consensus 151 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~ 175 (288)
T cd07871 151 RAKSVPT-------------------------------------------------------KTYSNEVVTLWYRPPDVL 175 (288)
T ss_pred eeccCCC-------------------------------------------------------ccccCceecccccChHHh
Confidence 4321000 000123678899999998
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC-------------------------CC
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP-------------------------SS 372 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~ 372 (451)
.+ ..++.++|||||||++|+|++|+.||......+.+..+.......+...+ ..
T Consensus 176 ~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (288)
T cd07871 176 LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAP 255 (288)
T ss_pred cCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCC
Confidence 76 45899999999999999999999999887776665555432111100000 01
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+.++++||++||++||.+||| ++|+|+||||
T Consensus 256 ~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 256 RLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred CCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 12347899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=360.82 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=216.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|...+.||.|+||.|+.|.++.+++. ||||.+... +......++..+|+++|+.++|+||+.+++++.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~---------VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEK---------VAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCE---------eehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 4577789999999999999999988764 999998743 345566778889999999999999999999986
Q ss_pred e-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 A-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
. -+.+|+|+|+| +.+|.++++.. +.++...++.++.||+.||+|+|+.||+||||||.|+|++.+..+||||
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 5 35789999999 88999999885 4499999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|+..... ........++-|.+|+|
T Consensus 169 FGLAR~~~~~-----------------------------------------------------~~~~~mTeYVaTRWYRA 195 (359)
T KOG0660|consen 169 FGLARYLDKF-----------------------------------------------------FEDGFMTEYVATRWYRA 195 (359)
T ss_pred ccceeecccc-----------------------------------------------------CcccchhcceeeeeecC
Confidence 9999643211 00111123578999999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----------------------CCCCC-
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-----------------------FPTQS- 369 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----------------------~~~~~- 369 (451)
||++.. ..|+.++||||+|||+.||++|++.|.+.+....+..|+.-... .+...
T Consensus 196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f 275 (359)
T KOG0660|consen 196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF 275 (359)
T ss_pred HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence 999865 56999999999999999999999999987665555554432111 11111
Q ss_pred ---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 ---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.+.. +..+.+|+.+||.+||.+|+| ++|+|.||||.+...+
T Consensus 276 ~~~fp~a-~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 276 SSIFPNA-NPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHcCCC-CHHHHHHHHHHhccCccccCC----HHHHhcChhhhhhcCC
Confidence 1122 238899999999999999999 9999999999995544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=372.62 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=203.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
...+++|++.++||.|+||+||+|.++.+++ .||||++.... .......+.+|+++++.++|+||++++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 138 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGR---------LYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCH 138 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCC---------EEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceee
Confidence 3345789999999999999999999876655 49999986542 223345677899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+.+++||||+.+++|.+. ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 139 ~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 139 DMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred eEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 999999999999999999998653 23567888999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .......+||..|+||
T Consensus 213 G~~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aP 237 (353)
T PLN00034 213 GVSRILAQT-------------------------------------------------------MDPCNSSVGTIAYMSP 237 (353)
T ss_pred ccceecccc-------------------------------------------------------cccccccccCccccCc
Confidence 997432110 0001123789999999
Q ss_pred ccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 316 EVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET---TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 316 E~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|++.. ...+.++|||||||++|||++|+.||......+ ....+.... ..... ...+.++.+||.+||+
T Consensus 238 E~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~~l~ 313 (353)
T PLN00034 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---PPEAP-ATASREFRHFISCCLQ 313 (353)
T ss_pred cccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC---CCCCC-CccCHHHHHHHHHHcc
Confidence 98743 234578999999999999999999997533222 222222111 11111 2234489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.||++||+ +.||++||||.+.
T Consensus 314 ~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 314 REPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred CChhhCcC----HHHHhcCcccccC
Confidence 99999999 9999999999994
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=386.71 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=200.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC------CCCcc
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD------HPFLP 152 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~nIv 152 (451)
.++|.+.++||+|+||+||+|.+...++ .||||+++... ........|+.+++.+. |.+|+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~---------~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKE---------YCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCe---------EEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCccee
Confidence 3789999999999999999999876654 49999996432 11223344666766664 44588
Q ss_pred ceeEEEEeC-CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCC--
Q 013016 153 TLYAEFEAS-NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDG-- 228 (451)
Q Consensus 153 ~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~-- 228 (451)
+++++|..+ +++|+|||++ |++|.+++... +.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence 899988754 5899999998 88998888764 569999999999999999999997 6999999999999998765
Q ss_pred --------------CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccc
Q 013016 229 --------------HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLF 294 (451)
Q Consensus 229 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (451)
.+||+|||.+....
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---------------------------------------------------- 299 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER---------------------------------------------------- 299 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc----------------------------------------------------
Confidence 49999999863110
Q ss_pred ccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC------
Q 013016 295 VAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ------ 368 (451)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------ 368 (451)
.....++||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+.+..+......++..
T Consensus 300 ------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~ 373 (467)
T PTZ00284 300 ------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCG 373 (467)
T ss_pred ------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhcc
Confidence 01113579999999999999999999999999999999999999998877665544443321111100
Q ss_pred -------------------------------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 369 -------------------------------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 369 -------------------------------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
......+..+.+||.+||.+||++||| ++|+|+||||++.
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 374 TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPYVLKY 444 (467)
T ss_pred chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHhcCcccccc
Confidence 000112336789999999999999999 9999999999983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=357.33 Aligned_cols=267 Identities=29% Similarity=0.388 Sum_probs=220.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~ 158 (451)
..|..+++||+|+||+||+|+.+.+++ .||+|.++-.... +..-....+|+.+++.++|+| ||.+++++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~---------~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~ 80 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGK---------FVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVI 80 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCC---------EEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence 568888899999999999999988775 5999999865321 223445567999999999999 99999999
Q ss_pred EeCC------eEEEEEeeccCCchhhhhhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EASN------FSCIVMEFCSGGDLHSLRHKQPH--KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~~------~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
...+ .++|||||+ .-+|.+++..... ..++...++.+++||+.||+|||++||+||||||+||||+.+|.+
T Consensus 81 ~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 81 HTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred eecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcE
Confidence 8877 899999999 7899999988753 368889999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||+|.....+-. . ...-++|.
T Consensus 160 KlaDFGlAra~~ip~~----------------------------------------------~---------yt~evvTl 184 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMR----------------------------------------------T---------YTPEVVTL 184 (323)
T ss_pred eeeccchHHHhcCCcc----------------------------------------------c---------ccccEEEe
Confidence 9999999853221000 0 01227899
Q ss_pred CccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcC---------------
Q 013016 311 EYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS--------------- 374 (451)
Q Consensus 311 ~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--------------- 374 (451)
.|+|||++.|. .|+..+||||+|||++||++++..|.+.++.+.+..|.+.........|+...
T Consensus 185 WYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~ 264 (323)
T KOG0594|consen 185 WYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGP 264 (323)
T ss_pred eccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCc
Confidence 99999999997 58999999999999999999999999999988888887643333222222110
Q ss_pred ----------hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 375 ----------EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 375 ----------~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
..+..+++.+||+.+|.+|.+ ++.+|.||||++++...
T Consensus 265 ~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 265 KDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELPEKS 312 (323)
T ss_pred cchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccccch
Confidence 126789999999999999999 99999999999976543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=366.32 Aligned_cols=263 Identities=28% Similarity=0.381 Sum_probs=206.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.++.+++ .||||++..... ......+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGK---------LVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIH 73 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCC---------EEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEe
Confidence 689999999999999999999886655 499999975422 122334567999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.....|+||||+ +++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 74 TKETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred cCCeEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 999999999999 568877776543 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|++.|+|||++.
T Consensus 152 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 176 (303)
T cd07869 152 AKSVPS-------------------------------------------------------HTYSNEVVTLWYRPPDVLL 176 (303)
T ss_pred eccCCC-------------------------------------------------------ccCCCCcccCCCCChHHHc
Confidence 211000 0001236889999999987
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCC-----------CCC--------CC--------
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTF-----------PTQ--------SP-------- 370 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~-----------~~~--------~~-------- 370 (451)
+. .++.++|||||||++|+|++|..||.+..+. +.+..+....... +.. ..
T Consensus 177 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (303)
T cd07869 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWN 256 (303)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhh
Confidence 64 5789999999999999999999999875432 2333322110000 000 00
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
......++.+||.+||++||++||| +.|+|+||||++++.
T Consensus 257 ~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~ 296 (303)
T cd07869 257 KLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPP 296 (303)
T ss_pred ccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCCh
Confidence 0012237889999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=362.75 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=207.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|+++.+++ .||+|++..... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKE---------IVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFR 70 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCc---------EEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEe
Confidence 469999999999999999999987665 499999975422 2233456677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||++++.|..+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 71 RRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 99999999999988777655433 2458999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... ........|++.|+|||++.
T Consensus 149 ~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 174 (287)
T cd07848 149 NLSEGS------------------------------------------------------NANYTEYVATRWYRSPELLL 174 (287)
T ss_pred cccccc------------------------------------------------------cccccccccccccCCcHHHc
Confidence 321100 00011246899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC--------CC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQSP--------SS 372 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~~--------~~ 372 (451)
+..++.++|||||||++|+|++|+.||...+..+.+..+...... .+.... ..
T Consensus 175 ~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07848 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLG 254 (287)
T ss_pred CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhc
Confidence 988999999999999999999999999887665544433321111 010000 01
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+.++.+||++||++||++||| ++++|+||||
T Consensus 255 ~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 255 ILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred ccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 13447999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=369.11 Aligned_cols=274 Identities=38% Similarity=0.711 Sum_probs=223.2
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||++.+.... ..+..||+|++.+..... .....+..|++++++++|+||+++++++..++.+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP------DAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC------CCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence 57999999999999864221 122359999998764332 23345667999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~- 151 (318)
T cd05582 75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 151 (318)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-
Confidence 999999999999988664 45899999999999999999999999999999999999999999999999997422100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
........|++.|+|||++.+..++.
T Consensus 152 ------------------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~ 177 (318)
T cd05582 152 ------------------------------------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQ 177 (318)
T ss_pred ------------------------------------------------------CCceecccCChhhcCHHHHcCCCCCC
Confidence 00112347899999999999888999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC-ChHHHH
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~-~~~ell 404 (451)
++|||||||++|+|++|+.||......+.+..+.......+.. .+.++.+||++||+.||.+||++.+ .+.+++
T Consensus 178 ~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-----LSPEAQSLLRALFKRNPANRLGAGPDGVEEIK 252 (318)
T ss_pred ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 9999999999999999999999888888888887766655433 2338999999999999999999532 367899
Q ss_pred cCCCcCCCCcccc--cccCCCCCCCC
Q 013016 405 THPFFKGLNFALI--RSLTPPEIPGM 428 (451)
Q Consensus 405 ~hp~~~~~~~~~~--~~~~~~~~p~~ 428 (451)
.||||+.++|... ....+|..|..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05582 253 RHPFFSTIDWNKLYRREIKPPFKPAV 278 (318)
T ss_pred CCCCcCCCCHHHHHhcCCCCCcCCCC
Confidence 9999999988654 33444444544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=357.28 Aligned_cols=284 Identities=39% Similarity=0.706 Sum_probs=237.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|++|.||+|.+...++ .||+|++.............+..|++++++++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK---------YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 479999999999999999999887655 49999998765555556677888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 999999999999999999998775 569999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... .....|++.|+|||.+.
T Consensus 150 ~~~~~----------------------------------------------------------~~~~~~~~~y~aPE~~~ 171 (290)
T cd05580 150 RVKGR----------------------------------------------------------TYTLCGTPEYLAPEIIL 171 (290)
T ss_pred ccCCC----------------------------------------------------------CCCCCCCccccChhhhc
Confidence 22100 11236888999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~ 398 (451)
+..++.++||||||+++|+|++|+.||...........+..+...++... +..+.++|.+||+.||.+|++. ..
T Consensus 172 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~R~~~~~~ 246 (290)
T cd05580 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF-----SPDAKDLIRNLLQVDLTKRLGNLKN 246 (290)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccC-----CHHHHHHHHHHccCCHHHccCcccC
Confidence 88889999999999999999999999988777777777776665554332 3489999999999999999921 12
Q ss_pred ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCC
Q 013016 399 GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFP 437 (451)
Q Consensus 399 ~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~ 437 (451)
.++|+++||||+.++|..+ ..+..|..|....+...+++
T Consensus 247 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (290)
T cd05580 247 GVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287 (290)
T ss_pred CHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccc
Confidence 2999999999999998654 55566666666554444433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=356.25 Aligned_cols=280 Identities=34% Similarity=0.569 Sum_probs=225.7
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|+..+.||+|+||+||+|.+..+.+ .||+|++.+...........+..|++++++++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGK---------MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCc---------EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 7788999999999999999887665 4999999876544444445567799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..|+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 99999999999999998887655557999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
... .......|+..|+|||++.+.
T Consensus 153 ~~~--------------------------------------------------------~~~~~~~g~~~~~aPE~~~~~ 176 (285)
T cd05632 153 PEG--------------------------------------------------------ESIRGRVGTVGYMAPEVLNNQ 176 (285)
T ss_pred CCC--------------------------------------------------------CcccCCCCCcCccChHHhcCC
Confidence 100 000123689999999999988
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC-CCh
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK-RGA 400 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~-~~~ 400 (451)
.++.++|||||||++|+|++|..||...........+.............. .+.++.+|+.+||+.||++||+.. ..+
T Consensus 177 ~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~P~~R~~~~~~~~ 255 (285)
T cd05632 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK-FSEEAKSICKMLLTKDPKQRLGCQEEGA 255 (285)
T ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc-CCHHHHHHHHHHccCCHhHcCCCcccCh
Confidence 899999999999999999999999987665544333332221111111222 333889999999999999999963 347
Q ss_pred HHHHcCCCcCCCCcccc--cccCCCCCCC
Q 013016 401 ADVKTHPFFKGLNFALI--RSLTPPEIPG 427 (451)
Q Consensus 401 ~ell~hp~~~~~~~~~~--~~~~~~~~p~ 427 (451)
.+++.|+||+.+++... ....+|..|.
T Consensus 256 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 256 GEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 89999999999988743 5555666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=365.86 Aligned_cols=264 Identities=27% Similarity=0.469 Sum_probs=232.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+-|.+.+.||+|.|+.|-+|++-.++.. ||||++.+.....-.. ..+..|+..|+..+|||||++|++..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGek---------VAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEK---------VAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccce---------eEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 4599999999999999999998887764 9999999887654433 44556999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a 238 (451)
....+|||+|+-.+|+|++|+-... ..+.+..++++++||+.|+.|+|+..+|||||||+||.+.+ -|-|||+|||++
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeecccc
Confidence 9999999999999999999998764 44999999999999999999999999999999999998875 589999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..+. .. .+-.++||+..|.|||++
T Consensus 167 Nkf~--------------------------------------PG------------------~kL~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 167 NKFQ--------------------------------------PG------------------KKLTTSCGSLAYSAPEIL 190 (864)
T ss_pred ccCC--------------------------------------Cc------------------chhhcccchhhccCchhh
Confidence 3221 11 122356999999999999
Q ss_pred cCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHG-NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~-~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+|..|+ +++||||||||||.|++|+.||...++.+.+-.|+..+...|..... ++++||..||..||.+|.+
T Consensus 191 LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~-----eCrdLI~sMLvRdPkkRAs-- 263 (864)
T KOG4717|consen 191 LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSK-----ECRDLIQSMLVRDPKKRAS-- 263 (864)
T ss_pred hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhH-----HHHHHHHHHHhcCchhhcc--
Confidence 999884 68999999999999999999999999999999999999888876443 9999999999999999999
Q ss_pred CChHHHHcCCCcCCCCcccccc
Q 013016 398 RGAADVKTHPFFKGLNFALIRS 419 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~~~ 419 (451)
++||..|+|++.++......
T Consensus 264 --lEeI~s~~Wlq~~D~~~sT~ 283 (864)
T KOG4717|consen 264 --LEEIVSTSWLQAGDRGLSTA 283 (864)
T ss_pred --HHHHhccccccCCCCCcccc
Confidence 99999999999988876653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=360.75 Aligned_cols=298 Identities=33% Similarity=0.635 Sum_probs=254.6
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~ 156 (451)
...+|..+..||.|+||+|.+|..+++.+ +||||++++........++--..|.++|.... -|.++.+..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdE---------LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDE---------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcch---------hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 34689999999999999999998877765 79999999987766666677777888888774 678999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
+|+.-+.+|+||||+.||+|--.+++. ++|.+..+..++.+|+-||-|||++|||+||||.+|||++.+|.+||+|||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecc
Confidence 999999999999999999997666664 679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++..- ....++.++|||+.|+|||
T Consensus 496 mcKEni-------------------------------------------------------~~~~TTkTFCGTPdYiAPE 520 (683)
T KOG0696|consen 496 MCKENI-------------------------------------------------------FDGVTTKTFCGTPDYIAPE 520 (683)
T ss_pred cccccc-------------------------------------------------------cCCcceeeecCCCcccccc
Confidence 985210 0223455789999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++...+|+.++|.||+|++|||||.|++||.+.+.++.+..|......+|..... ++.++++.+|.+.|.+|...
T Consensus 521 Ii~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSk-----EAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 521 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSK-----EAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred eEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccH-----HHHHHHHHHhhcCCccccCC
Confidence 9999999999999999999999999999999999999999999999988876543 89999999999999999986
Q ss_pred -CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCccc
Q 013016 397 -KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQST 446 (451)
Q Consensus 397 -~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 446 (451)
..+-++|..||||+.|+|..+ +.+.||+.|..+--+.-.+++.......+
T Consensus 596 g~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~ 648 (683)
T KOG0696|consen 596 GPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPT 648 (683)
T ss_pred CCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCC
Confidence 344578999999999999754 89999999998543333334443333333
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=363.15 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=212.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||.|+||.||+|.++.++. .||+|++.... .......+.+|+++++.++|+||+++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGL---------IMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCc---------EEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 3789999999999999999999887665 49999997542 223445678899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
...+..++||||++|++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 73 YSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EECCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 9999999999999999999998765 4589999999999999999999986 699999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+..... .......|++.|+|||+
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~~g~~~y~aPE~ 173 (331)
T cd06649 151 SGQLID---------------------------------------------------------SMANSFVGTRSYMSPER 173 (331)
T ss_pred cccccc---------------------------------------------------------cccccCCCCcCcCCHhH
Confidence 742210 00112468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC----------------------------------
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL---------------------------------- 363 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------------------------------- 363 (451)
+.+..++.++|||||||++|+|++|+.||......+....+ ....
T Consensus 174 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T cd06649 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF-GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA 252 (331)
T ss_pred hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-cccccccccCCccccCcccccccccccccccccccchh
Confidence 99988999999999999999999999999766544432221 1100
Q ss_pred ----------CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 364 ----------TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 364 ----------~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
...........+.++++||.+||.+||++||| ++||++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~ 308 (331)
T cd06649 253 IFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhcc
Confidence 00000111123458999999999999999999 99999999998843
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=371.49 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=204.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
++..++|.+.++||+|+||.||+|.+..+.+ .||+|.... ..+.+|+.++++++||||++++
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~---------~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~ 149 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCE---------HVVIKAGQR---------GGTATEAHILRAINHPSIIQLK 149 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCC---------EEEEechhh---------hhhHHHHHHHHhCCCCCCCCEe
Confidence 3455789999999999999999999987766 399997542 2345699999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++|..+.+.|+|||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 150 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 150 GTFTYNKFTCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEEECCeeEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 9999999999999999 67888887664 45899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... ........+||+.|+||
T Consensus 227 G~a~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 227 GAACFPVDI------------------------------------------------------NANKYYGWAGTIATNAP 252 (391)
T ss_pred Ccccccccc------------------------------------------------------cccccccccCccCCCCh
Confidence 997421100 00011234799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCCCCCC--------------------
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-------NETTLRNIVKKPLTFPTQ-------------------- 368 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~-------------------- 368 (451)
|++.+..++.++|||||||++|+|++|+.||.... ....+..++......+..
T Consensus 253 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 332 (391)
T PHA03212 253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS 332 (391)
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhcc
Confidence 99999899999999999999999999998875321 112222222211110000
Q ss_pred ------C--CC--CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 369 ------S--PS--SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 369 ------~--~~--~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
. +. ...+.++.+||.+||++||.+||| +.|+|+||||+++.
T Consensus 333 ~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~~ 383 (391)
T PHA03212 333 SRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDIP 383 (391)
T ss_pred CCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccCC
Confidence 0 00 011337889999999999999999 99999999998854
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=357.95 Aligned_cols=276 Identities=37% Similarity=0.590 Sum_probs=220.4
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.+.||+|+||.||+|.+..+++ .||+|.+.+...........+..|+.++++++|+||+.+++.+...
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCc---------eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence 7788899999999999999988765 4999999765443333345566799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
++.|+||||++|++|.+++.......+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 99999999999999999887655556999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
... .......|+..|+|||++.+.
T Consensus 153 ~~~--------------------------------------------------------~~~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05630 153 PEG--------------------------------------------------------QTIKGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred CCC--------------------------------------------------------ccccCCCCCccccChHHHcCC
Confidence 100 000123689999999999998
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-C
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-K 397 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~ 397 (451)
.++.++|||||||++|+|++|+.||...... +....+..... ... ....+.++.+|+.+||+.||++|||. +
T Consensus 177 ~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEY-SEKFSPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---hhc-CccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence 8999999999999999999999999864332 22222222111 111 12234489999999999999999983 1
Q ss_pred CChHHHHcCCCcCCCCcccccc--cCCCCCC
Q 013016 398 RGAADVKTHPFFKGLNFALIRS--LTPPEIP 426 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~~~--~~~~~~p 426 (451)
-.+.|+++||||+++++..... ..||..|
T Consensus 253 ~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05630 253 GGAREVKEHPLFKQINFKRLEAGMLEPPFKP 283 (285)
T ss_pred CchHHHHcChhhhccCHHHHhcCCCCCCCCC
Confidence 2368999999999998886533 4455555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=358.75 Aligned_cols=260 Identities=26% Similarity=0.344 Sum_probs=204.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~ 156 (451)
++|++.+.||+|+||+||+|.+..... ..||+|++....... .......+|+.+++.+ .||||+++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~--------~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~ 71 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGG--------RFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFD 71 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCC--------eEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEE
Confidence 369999999999999999998754321 149999987543211 1223344566666665 6999999999
Q ss_pred EEE-----eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 157 EFE-----ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 157 ~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
++. ....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~k 150 (290)
T cd07862 72 VCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 150 (290)
T ss_pred EEecccCCCCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEE
Confidence 885 345799999999 57999998876666799999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++...... .......||+.
T Consensus 151 l~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~ 174 (290)
T cd07862 151 LADFGLARIYSFQ--------------------------------------------------------MALTSVVVTLW 174 (290)
T ss_pred EccccceEeccCC--------------------------------------------------------ccccccccccc
Confidence 9999997422100 01112468999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC---------------------
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP--------------------- 370 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------------------- 370 (451)
|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+...........+
T Consensus 175 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T cd07862 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 254 (290)
T ss_pred ccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHH
Confidence 99999999888999999999999999999999999998877777766543211100000
Q ss_pred -CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 371 -SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 371 -~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
....+..+.+|+.+||+.||++||| +.|+|+||||
T Consensus 255 ~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 255 FVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred HccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 0112337889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=395.91 Aligned_cols=287 Identities=38% Similarity=0.687 Sum_probs=249.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
....++|.+++.||.|+||.|.+++.+.+.+ +||+|++++-..........|..|..+|..-+.+-|+.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~---------VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEK---------VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeecccc---------chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 3445889999999999999999999988876 6999999986665555666777899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
-+|.++.++|+||||++||+|..++.... ++++..+++++..|+.||.-||+.|+|||||||+|||++..|++||+||
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999999998874 7999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|.|..+.. +...+...-+|||-|.+|
T Consensus 220 GsClkm~~------------------------------------------------------dG~V~s~~aVGTPDYISP 245 (1317)
T KOG0612|consen 220 GSCLKMDA------------------------------------------------------DGTVRSSVAVGTPDYISP 245 (1317)
T ss_pred hhHHhcCC------------------------------------------------------CCcEEeccccCCCCccCH
Confidence 99853321 122233345999999999
Q ss_pred ccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 316 EVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--PLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 316 E~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
|++.. +.|+..+|.||+||++|||+.|..||...+-.+.+.+|++- .+.+|... . .+.++++||.++++
T Consensus 246 EvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~--~-VSeeakdLI~~ll~- 321 (1317)
T KOG0612|consen 246 EVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET--D-VSEEAKDLIEALLC- 321 (1317)
T ss_pred HHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc--c-cCHHHHHHHHHHhc-
Confidence 99853 56899999999999999999999999999999999999986 56666222 2 34499999999886
Q ss_pred CcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCC
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~ 432 (451)
+|+.|.. ..+++++..||||.+++|..+|...||.+|-+.++.
T Consensus 322 ~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~ 364 (1317)
T KOG0612|consen 322 DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDD 364 (1317)
T ss_pred Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCC
Confidence 5667766 555999999999999999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=365.80 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=206.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||+|+||.||+|.++.+++ .||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 70 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGE---------KVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLP 70 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCC---------EEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEec
Confidence 58999999999999999999887665 499999874322 12233456789999999999999999998854
Q ss_pred C-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 161 S-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 161 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
. ..+|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 71 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 71 PSRREFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred cCCCCCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccC
Confidence 3 3589999999 67898888764 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ ........+||+.|+||
T Consensus 148 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 148 GLARVAFNDTP----------------------------------------------------TAIFWTDYVATRWYRAP 175 (338)
T ss_pred ccccccccccC----------------------------------------------------ccccccCCCCCCCcCCH
Confidence 99843210000 00001124789999999
Q ss_pred ccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------------------CCCCC-
Q 013016 316 EVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--------------------------PLTFP- 366 (451)
Q Consensus 316 E~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~--------------------------~~~~~- 366 (451)
|++.+ ..++.++|||||||++|+|++|+.||.+......+..+... ....+
T Consensus 176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 255 (338)
T cd07859 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF 255 (338)
T ss_pred HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence 99876 56899999999999999999999999876543332221110 00000
Q ss_pred CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 367 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
....+. .+..+.++|.+||+.||++||+ ++|+|+||||+++....
T Consensus 256 ~~~~~~-~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 256 SQKFPN-ADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKVE 300 (338)
T ss_pred HHhcCC-CChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCccc
Confidence 000111 2337899999999999999999 99999999999866643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=368.54 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=219.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|....+||.|+||.||+|.+..+++ .||+|++.-+. .....+.++.|+.+|..++++||.++|+.+.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k---------~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKK---------VVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred cccccchhccccccceeeeeeeccccc---------eEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 347777999999999999999998887 49999998763 4456678888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..++++||||.||++.++++.. ..+.+..+.-++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+.
T Consensus 82 ~g~~LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 82 KGTKLWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ecccHHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceee
Confidence 999999999999999999998874 335888999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ...+..+++||+.|||||++.
T Consensus 160 ql~~-------------------------------------------------------~~~rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 160 QLTN-------------------------------------------------------TVKRRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred eeec-------------------------------------------------------hhhccccccccccccchhhhc
Confidence 3211 122335789999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..|+.++||||||++.+||.+|.+|+........+..|-+..++... ..++..+++||..||++||+.||+
T Consensus 185 ~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~Rps---- 256 (467)
T KOG0201|consen 185 QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPS---- 256 (467)
T ss_pred cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc----cccCHHHHHHHHHHhhcCcccCcC----
Confidence 889999999999999999999999999987774444333333222111 134447999999999999999999
Q ss_pred hHHHHcCCCcCCC
Q 013016 400 AADVKTHPFFKGL 412 (451)
Q Consensus 400 ~~ell~hp~~~~~ 412 (451)
|.+||+|+|++..
T Consensus 257 A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 257 AKELLKHKFIKRA 269 (467)
T ss_pred HHHHhhhHHHHhc
Confidence 9999999999983
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=369.19 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=230.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|..++++|.|+||.+++++++...+ .|++|.++-........ .....|+.++++++|||||.+.+.|+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~---------~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~ 73 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDK---------LYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFE 73 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCc---------eEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchh
Confidence 679999999999999999999887766 49999998776544433 35677999999999999999999999
Q ss_pred eCCe-EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNF-SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~-~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+++. +||||+||+||+|.+.+...++..|+++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGla 153 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLA 153 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhh
Confidence 9887 999999999999999999888888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+..+... ....+.+||+.||+||++
T Consensus 154 K~l~~~~-------------------------------------------------------~~a~tvvGTp~YmcPEil 178 (426)
T KOG0589|consen 154 KILNPED-------------------------------------------------------SLASTVVGTPYYMCPEIL 178 (426)
T ss_pred hhcCCch-------------------------------------------------------hhhheecCCCcccCHHHh
Confidence 7654321 233456999999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+.+|+.++|||||||++|||++-+.+|...+......+|.+...... +..++.+++.+|..||..+|..||+
T Consensus 179 ~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl----p~~ys~el~~lv~~~l~~~P~~RPs--- 251 (426)
T KOG0589|consen 179 SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL----PSMYSSELRSLVKSMLRKNPEHRPS--- 251 (426)
T ss_pred CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC----CccccHHHHHHHHHHhhcCCccCCC---
Confidence 999999999999999999999999999999999999999998874322 2234458999999999999999999
Q ss_pred ChHHHHcCCCcCC
Q 013016 399 GAADVKTHPFFKG 411 (451)
Q Consensus 399 ~~~ell~hp~~~~ 411 (451)
+.+||.+|.++.
T Consensus 252 -a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 252 -ALELLRRPHLLR 263 (426)
T ss_pred -HHHHhhChhhhh
Confidence 999999999885
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=356.42 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=210.4
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|...+++|.|+||.||.|....+.+ .||||.+-.+. .. -.+|+++|+++.|||||++..+|..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~---------~vAIKKv~~d~----r~---knrEl~im~~l~HpNIV~L~~~f~~ 88 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEE---------EVAIKKVLQDK----RY---KNRELQIMRKLDHPNIVRLLYFFSS 88 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCc---------eeEEEEecCCC----Cc---CcHHHHHHHhcCCcCeeeEEEEEEe
Confidence 48889999999999999999988754 49999885432 22 2249999999999999999998854
Q ss_pred CC-----eEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEE
Q 013016 161 SN-----FSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIML 232 (451)
Q Consensus 161 ~~-----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl 232 (451)
.. +..+||||+ ..+|.++++.. .+..++.-.++-+..||++||.|||+.|||||||||+|||+|.+ |.+||
T Consensus 89 ~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 89 STESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred cCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEe
Confidence 32 678999999 67898888742 34668999999999999999999999999999999999999976 99999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
||||.|+...... ...++..|+.|
T Consensus 168 cDFGSAK~L~~~e--------------------------------------------------------pniSYicSRyY 191 (364)
T KOG0658|consen 168 CDFGSAKVLVKGE--------------------------------------------------------PNISYICSRYY 191 (364)
T ss_pred ccCCcceeeccCC--------------------------------------------------------CceeEEEeccc
Confidence 9999997543211 11245778899
Q ss_pred cCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----------------C---CCC--
Q 013016 313 VSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-----------------P---TQS-- 369 (451)
Q Consensus 313 ~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-----------------~---~~~-- 369 (451)
+|||++.|.. |+.++||||.|||+.||+-|++.|.+.+..+.+..|.+-...+ + ...
T Consensus 192 RaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~ 271 (364)
T KOG0658|consen 192 RAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWH 271 (364)
T ss_pred cCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccce
Confidence 9999999954 8999999999999999999999999998888877776521111 0 111
Q ss_pred --CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 --PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 --~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.....+.++.+|+.++|..+|.+|.+ +.|+|.||||.++..+
T Consensus 272 ~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 272 KVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELRDP 315 (364)
T ss_pred eecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhhCc
Confidence 11223448999999999999999999 9999999999996554
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=353.08 Aligned_cols=300 Identities=34% Similarity=0.594 Sum_probs=238.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||.||+|.++...+ .||+|.+.............+..|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQ---------RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCc---------EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 469999999999999999999887765 39999998765444445567778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++++|+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 999999999999999999998765 458999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
............ . ...............|+..|+|||.+.
T Consensus 150 ~~~~~~~~~~~~-~---------------------------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~ 189 (305)
T cd05609 150 IGLMSLTTNLYE-G---------------------------------------HIEKDTREFLDKQVCGTPEYIAPEVIL 189 (305)
T ss_pred ccCcCccccccc-c---------------------------------------ccccchhhccccCCccCccccCchhcc
Confidence 321100000000 0 000000000111246788999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|..||.+....+.+..+.......+.... ..+.++.+||.+||+.||++||+...
T Consensus 190 ~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~- 266 (305)
T cd05609 190 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE--ALPADAQDLISRLLRQNPLERLGTGG- 266 (305)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc--cCCHHHHHHHHHHhccChhhccCccC-
Confidence 888999999999999999999999999988777777777766554443322 34448999999999999999998532
Q ss_pred hHHHHcCCCcCCCCcccccccCCCCCCCCCCCCC
Q 013016 400 AADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKT 433 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~~ 433 (451)
+.++|+||||.+.+++.......+.+|....+..
T Consensus 267 ~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (305)
T cd05609 267 AFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDD 300 (305)
T ss_pred HHHHHhCccccCCCHHHHhhcCCCCCCCCCCccc
Confidence 7899999999999998776665666777755443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.63 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=208.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.+.||.|+||.||+|...+... +..||+|.+... ....+|+.++++++|+||+++++++.
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~-------~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQ-------RKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCcc-------ceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 579999999999999999998654321 224999988643 12346999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 157 ~~~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 157 WKSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred eCCEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 999999999999 57888888443 569999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......+.||+.|+|||++.
T Consensus 234 ~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 260 (392)
T PHA03207 234 KLDAHP-----------------------------------------------------DTPQCYGWSGTLETNSPELLA 260 (392)
T ss_pred ccCccc-----------------------------------------------------ccccccccccccCccCHhHhc
Confidence 321100 001112347999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcC----CCCCCC-------------------------
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---ETTLRNIVKK----PLTFPT------------------------- 367 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~----~~~~~~------------------------- 367 (451)
+..++.++|||||||++|||++|+.||.+... ...+..+... ...++.
T Consensus 261 ~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (392)
T PHA03207 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPP 340 (392)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccc
Confidence 98999999999999999999999999976432 2222222221 111110
Q ss_pred CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccc
Q 013016 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRS 419 (451)
Q Consensus 368 ~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~ 419 (451)
.......+.++.+||.+||..||.+||+ +.|+|.||||++.++..++.
T Consensus 341 ~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 341 VIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred hhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhcC
Confidence 0001122347889999999999999999 99999999999988776543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=365.25 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=212.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.+.++++||+|.||.||+|.+++..+ ||+|.+.... ...+.+.+|+++|++|+|+|||+++++|.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~----------vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTK----------VAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCc----------ccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 447788999999999999999998875 9999997542 23355668999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++.+|||||||+.|+|.++|....+..+...+.+.++.||++|++||+++++|||||.+.||||+++..+||+|||+|+
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 98899999999999999999998667789999999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.......... ..-.-...|.|||.+.
T Consensus 352 ~~~d~~Y~~~------------------------------------------------------~~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 352 LIGDDEYTAS------------------------------------------------------EGGKFPIKWTAPEALN 377 (468)
T ss_pred ccCCCceeec------------------------------------------------------CCCCCCceecCHHHHh
Confidence 3221111000 0001245699999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+.++.++||||||++||||+| |+.||...++.+.+..+.++..-+.. ...+.++-++++.||..+|++|||
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P----~~CP~~vY~lM~~CW~~~P~~RPt--- 450 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP----EGCPDEVYELMKSCWHEDPEDRPT--- 450 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC----CCCCHHHHHHHHHHhhCCcccCCC---
Confidence 9999999999999999999999 99999999999999999988543222 224448999999999999999999
Q ss_pred ChHHHH
Q 013016 399 GAADVK 404 (451)
Q Consensus 399 ~~~ell 404 (451)
++.+.
T Consensus 451 -F~~L~ 455 (468)
T KOG0197|consen 451 -FETLR 455 (468)
T ss_pred -HHHHH
Confidence 66543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=365.55 Aligned_cols=294 Identities=35% Similarity=0.624 Sum_probs=262.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
...+.+++++..||-|+||.|=++..+.... .+|+|++++....+.++.+.+..|..||...+.|.||++|
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~---------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLY 486 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKA---------TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLY 486 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccch---------HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHH
Confidence 4456788889999999999999998876653 2899999999888888888889999999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
-.|.++++.|+.||-|-||.|+.++... +.|....++.++..+++|++|||++|||+|||||+|++++.+|.+||.||
T Consensus 487 rTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 487 RTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred HHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeeh
Confidence 9999999999999999999999998876 66999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|+... ...++.+||||+.|.||
T Consensus 565 GFAKki~--------------------------------------------------------~g~KTwTFcGTpEYVAP 588 (732)
T KOG0614|consen 565 GFAKKIG--------------------------------------------------------SGRKTWTFCGTPEYVAP 588 (732)
T ss_pred hhHHHhc--------------------------------------------------------cCCceeeecCCcccccc
Confidence 9996432 23456689999999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|++++...+.++|.||||+++||||+|.+||.+.+....+..|+++. ..+|..... .+.+||+++..-+|.+|
T Consensus 589 EIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k-----~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 589 EIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITK-----TATDLIKKLCRDNPTER 663 (732)
T ss_pred hhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccch-----hHHHHHHHHHhcCcHhh
Confidence 99999999999999999999999999999999999999999999874 344443333 78999999999999999
Q ss_pred CCC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCcc
Q 013016 394 LGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKI 441 (451)
Q Consensus 394 pt~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~ 441 (451)
... +.++.+|.+|.||.+++|..+ +.++||.+|.+..+..-.+++...
T Consensus 664 LG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p 714 (732)
T KOG0614|consen 664 LGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP 714 (732)
T ss_pred hccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence 986 677999999999999999865 789999999999887766666543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.63 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=208.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|+++.+.+ .||+|++..... ......+.+|+.++++++|+||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 74 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTEN---------LVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVH 74 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCC---------eEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEe
Confidence 679999999999999999999876655 499999875422 122234567999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+++.|+||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 75 TDKSLTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred eCCeEEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccce
Confidence 9999999999995 5888877654 2458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|+..|+|||++.
T Consensus 153 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 177 (309)
T cd07872 153 AKSVPT-------------------------------------------------------KTYSNEVVTLWYRPPDVLL 177 (309)
T ss_pred ecCCCc-------------------------------------------------------cccccccccccccCCHHHh
Confidence 221100 0001125788999999987
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC------CCc
Q 013016 320 G-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQSP------SSM 373 (451)
Q Consensus 320 ~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~~------~~~ 373 (451)
+ ..++.++|||||||++|+|++|+.||...+..+.+..+...... ++.... ...
T Consensus 178 ~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (309)
T cd07872 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPR 257 (309)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccC
Confidence 6 45789999999999999999999999887665554444332110 111000 011
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
.+.++++||.+||+.||.+||| +.|+|+||||+.+.
T Consensus 258 ~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~~ 293 (309)
T cd07872 258 LDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSLG 293 (309)
T ss_pred CCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhcc
Confidence 2347899999999999999999 99999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=361.89 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=206.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+....+. ||||++..... .......+.+|+.+++.++|+||+++++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~---------vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERN---------VAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcE---------EEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 37899999999999999999998776653 99999975422 223345566799999999999999999987
Q ss_pred EeC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EAS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
... ...|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 167 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167 (364)
T ss_pred cccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEE
Confidence 543 36799999994 577776643 3889999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||..|
T Consensus 168 ~DfG~a~~~~~~--------------------------------------------------------~~~~~~~~t~~y 191 (364)
T cd07875 168 LDFGLARTAGTS--------------------------------------------------------FMMTPYVVTRYY 191 (364)
T ss_pred EeCCCccccCCC--------------------------------------------------------CcccCCcccCCc
Confidence 999998432110 001123688999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC----------------------CC---
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF----------------------PT--- 367 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----------------------~~--- 367 (451)
+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..++...... ..
T Consensus 192 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (364)
T cd07875 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 271 (364)
T ss_pred CCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCCh
Confidence 99999999999999999999999999999999998877666555554321110 00
Q ss_pred ------------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 368 ------------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 368 ------------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.......+.++++||.+||+.||.+||| +.|+|+||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~~ 324 (364)
T cd07875 272 EKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVW 324 (364)
T ss_pred HhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCcccccc
Confidence 0001112347899999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=360.56 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=203.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.+..+++ .||||++..... .......+.+|+.+++.++|+||+++++++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGI---------NVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCc---------eeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 3789999999999999999999877655 499999975422 223345667799999999999999999998
Q ss_pred EeCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
...+ ..|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl 164 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164 (359)
T ss_pred ccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE
Confidence 6543 5799999995 566665543 3889999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||+.|
T Consensus 165 ~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~~t~~y 188 (359)
T cd07876 165 LDFGLARTACTN--------------------------------------------------------FMMTPYVVTRYY 188 (359)
T ss_pred ecCCCccccccC--------------------------------------------------------ccCCCCcccCCC
Confidence 999997421100 001123688999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----------------------CCCCCCC--
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK----------------------PLTFPTQ-- 368 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~----------------------~~~~~~~-- 368 (451)
+|||++.+..++.++|||||||++|+|++|+.||...+....+..+... ....+..
T Consensus 189 ~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (359)
T cd07876 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISF 268 (359)
T ss_pred CCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcch
Confidence 9999999999999999999999999999999999876554433222211 1111000
Q ss_pred -------------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 369 -------------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 369 -------------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
......+.++++||.+||+.||++||| +.|+|+||||+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 269 EELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred hhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 001122347899999999999999999 999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=364.85 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=218.8
Q ss_pred CCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccc
Q 013016 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 74 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
.+.+.+++..+...||+|.||+||+|.|.++ ||||+++-.... .++.+.|.+|+.++++-+|.||+-
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlL 452 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILL 452 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhhee
Confidence 3445567888999999999999999999987 999999876544 458899999999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+.|+|..+++ .||+-+|+|.+|+.+++... .+|.....+.|++||+.|+.|||.++|||||||..||++.++++|||+
T Consensus 453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred eehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEe
Confidence 9999999887 99999999999999998775 569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..-. + +.+ ...-..-.|...||
T Consensus 531 DFGLatvk~-----------------------~------------w~g------------------~~q~~qp~gsilwm 557 (678)
T KOG0193|consen 531 DFGLATVKT-----------------------R------------WSG------------------EQQLEQPHGSLLWM 557 (678)
T ss_pred cccceeeee-----------------------e------------ecc------------------ccccCCCccchhhh
Confidence 999973210 0 000 00011225778899
Q ss_pred CcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aPE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|||+++. .+|+..+||||||||+|||++|..||...+.+.++-.+-++.+...........+.++++|+..||.+++
T Consensus 558 APEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 558 APEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDR 637 (678)
T ss_pred cHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCc
Confidence 9999864 5689999999999999999999999997777777766666655554444455566689999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
++||. +.+||.
T Consensus 638 ~eRP~----F~~il~ 648 (678)
T KOG0193|consen 638 EERPL----FPQLLS 648 (678)
T ss_pred ccCcc----HHHHHH
Confidence 99999 777774
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.09 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=203.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.+..+++ .||||++.... ....+|+.+++.++|+||+++++++.
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~---------~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSE---------KVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCC---------EEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 679999999999999999999877655 49999886431 12235899999999999999998874
Q ss_pred eC--------CeEEEEEeeccCCchhhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-
Q 013016 160 AS--------NFSCIVMEFCSGGDLHSLRHK--QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG- 228 (451)
Q Consensus 160 ~~--------~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~- 228 (451)
.. .++++||||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC
Confidence 32 25789999995 577776653 2345699999999999999999999999999999999999999665
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||+|..... ........|
T Consensus 209 ~vkL~DFGla~~~~~--------------------------------------------------------~~~~~~~~~ 232 (440)
T PTZ00036 209 TLKLCDFGSAKNLLA--------------------------------------------------------GQRSVSYIC 232 (440)
T ss_pred ceeeeccccchhccC--------------------------------------------------------CCCcccCCC
Confidence 799999999853210 001112468
Q ss_pred CCCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----------------CCCCC-
Q 013016 309 THEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-----------------FPTQS- 369 (451)
Q Consensus 309 t~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----------------~~~~~- 369 (451)
|+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+..+...... ++...
T Consensus 233 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 312 (440)
T PTZ00036 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKP 312 (440)
T ss_pred CcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCc
Confidence 9999999998774 5899999999999999999999999988776666655432111 11100
Q ss_pred ------CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 ------PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.+...+.++++||.+||++||.+||| +.|+|.||||+++...
T Consensus 313 ~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 313 KDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDP 360 (440)
T ss_pred hhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcc
Confidence 01112348999999999999999999 9999999999986553
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=368.86 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=224.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
-|.|+..||.|+||+||+|..+.+. .+-|.|+|.-. .....+.+..|++||..+.||+||++++.|..
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~---------~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~ 100 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETK---------LLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYF 100 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccch---------hhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc
Confidence 4899999999999999999877554 35788888643 45667888889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
++.++|+.|||.||-+..++-.. +..+.+.++.-+++|++.||.|||+++|||||||..|||++.+|.++|+|||.+-.
T Consensus 101 enkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 101 ENKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred cCceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999999999998876655 35599999999999999999999999999999999999999999999999998621
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
......+..+|.|||.|||||++..
T Consensus 180 -------------------------------------------------------n~~t~qkRDsFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 180 -------------------------------------------------------NKSTRQKRDSFIGTPYWMAPEVVMC 204 (1187)
T ss_pred -------------------------------------------------------chhHHhhhccccCCcccccchheee
Confidence 1122344557899999999999754
Q ss_pred -----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 321 -----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 321 -----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
.+|+.++||||||++|.||..+.+|-...+...++.+|....+ |....+..++..+.+|+++||.+||..||+
T Consensus 205 ET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP--PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 205 ETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PTLLQPSHWSRSFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred ccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC--CcccCcchhhhHHHHHHHHHHhcCCccCCC
Confidence 5789999999999999999999999999999888888877643 344445556669999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCCc
Q 013016 396 SKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~ 414 (451)
+.+||+||||++++.
T Consensus 283 ----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 283 ----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred ----HHHHhhCcccccCCc
Confidence 999999999997654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=357.07 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=208.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||.|+||.||+|.++.++. .+|+|++.... .......+.+|+++++.++|+||++++++|.
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGL---------IMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCc---------EEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 789999999999999999999886655 49999887542 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+++|+||||++|++|.+++... +.+++..+..++.||+.||.|||++ +|+|+||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 999999999999999999998764 4589999999999999999999975 7999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... .......|+..|+|||++
T Consensus 152 ~~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE~~ 174 (333)
T cd06650 152 GQLID---------------------------------------------------------SMANSFVGTRSYMSPERL 174 (333)
T ss_pred hhhhh---------------------------------------------------------hccccCCCCccccCHHHh
Confidence 42110 001123688999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CCC--------------------------------
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK---KPL-------------------------------- 363 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~---~~~-------------------------------- 363 (451)
.+..++.++|||||||++|+|++|+.||...........+.. +..
T Consensus 175 ~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (333)
T cd06650 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFEL 254 (333)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHH
Confidence 998899999999999999999999999986544332211100 000
Q ss_pred ------CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 364 ------TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 364 ------~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
..+........+.++++||.+||++||++||| +.|++.||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 255 LDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred HHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 00000011123447899999999999999999 9999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.39 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=203.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+....+ .||||++..... .......+.+|+.+++.++|+||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCc---------eEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 3789999999999999999999876655 399999875422 223345566799999999999999999988
Q ss_pred EeC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EAS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
... ...|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred eccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEE
Confidence 643 35799999995 567666643 3889999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||+.|
T Consensus 161 ~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y 184 (355)
T cd07874 161 LDFGLARTAGTS--------------------------------------------------------FMMTPYVVTRYY 184 (355)
T ss_pred eeCcccccCCCc--------------------------------------------------------cccCCccccCCc
Confidence 999998422110 001123689999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC----------------------CC-----C
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP----------------------LT-----F 365 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~----------------------~~-----~ 365 (451)
+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+.... .. +
T Consensus 185 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (355)
T cd07874 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264 (355)
T ss_pred cCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccc
Confidence 99999999889999999999999999999999998766544333322210 00 0
Q ss_pred CC----------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 366 PT----------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 366 ~~----------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
+. .......+.++++||.+||..||++||| +.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~~ 317 (355)
T cd07874 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINVW 317 (355)
T ss_pred hhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhcc
Confidence 00 0011112347899999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=356.14 Aligned_cols=260 Identities=18% Similarity=0.285 Sum_probs=201.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|++.++||.|+||.||+|.+....+. ..+..||||++.... .......+..|+.++..+ +||||++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKK----SSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCc----ccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 36899999999999999999986433211 122359999997542 223345677899999999 89999999998
Q ss_pred EEeC-CeEEEEEeeccCCchhhhhhhCC----------------------------------------------------
Q 013016 158 FEAS-NFSCIVMEFCSGGDLHSLRHKQP---------------------------------------------------- 184 (451)
Q Consensus 158 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 184 (451)
+... +.+++||||++||+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 46899999999999999887532
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCC
Q 013016 185 --------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256 (451)
Q Consensus 185 --------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 256 (451)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~----------- 228 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP----------- 228 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-----------
Confidence 1347888999999999999999999999999999999999999999999999984321000
Q ss_pred CCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHH
Q 013016 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFI 336 (451)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il 336 (451)
.........++..|+|||++.+..++.++|||||||++
T Consensus 229 ------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 266 (338)
T cd05102 229 ------------------------------------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 266 (338)
T ss_pred ------------------------------------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHH
Confidence 00011123466789999999998899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHH-HHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 337 YEMIY-GRTPFAAPSNETTL-RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 337 ~ellt-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
|||++ |..||......+.+ ..+..+.... .+...+..+.+|+.+||+.||.+||+ +.||++
T Consensus 267 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs----~~el~~ 329 (338)
T cd05102 267 WEIFSLGASPYPGVQINEEFCQRLKDGTRMR----APENATPEIYRIMLACWQGDPKERPT----FSALVE 329 (338)
T ss_pred HHHHhCCCCCCCCCCccHHHHHHHhcCCCCC----CCCCCCHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 99997 99999876544433 3333332211 11223448999999999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.25 Aligned_cols=257 Identities=28% Similarity=0.382 Sum_probs=201.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYAE 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~ 157 (451)
+|++.+.||+|+||+||+|.++.+++ .||+|++...... .........|+.+++.+ +|+||++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~---------~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~ 70 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGH---------FVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCc---------EEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence 48999999999999999999987765 4999998754211 11112233466666554 79999999998
Q ss_pred EEe-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 158 FEA-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 158 ~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
+.. ....++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 71 CATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 864 346899999995 58988887765566999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||..|
T Consensus 150 ~dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 173 (288)
T cd07863 150 ADFGLARIYSCQ--------------------------------------------------------MALTPVVVTLWY 173 (288)
T ss_pred CccCccccccCc--------------------------------------------------------ccCCCccccccc
Confidence 999997432110 000123678899
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----CCC------------------CC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-----FPT------------------QS 369 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----~~~------------------~~ 369 (451)
+|||++.+..++.++|||||||++|+|++|++||......+.+.++...... ++. ..
T Consensus 174 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07863 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSV 253 (288)
T ss_pred cCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHh
Confidence 9999999988999999999999999999999999887766655555431100 000 00
Q ss_pred CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 370 PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 370 ~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.+ ..+..+.+||.+||++||++||| +.|++.||||
T Consensus 254 ~~-~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 254 VP-EIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred Cc-CcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01 12337899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=370.95 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=215.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccc-cccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNK-YRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..|.+.+.||.|++|.||+|....+ .+ .||+|.+.... ......+..|+.+++.++|||||++++++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~---------~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~ 134 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKE---------KVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDF 134 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCe---------EEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4599999999999999999987665 32 38888775432 23334566799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
..++++||||||++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 135 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 135 KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 9999999999999999999887642 23568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++....... .......++||+.|+|||
T Consensus 215 la~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~aPE 241 (478)
T PTZ00267 215 FSKQYSDSV-----------------------------------------------------SLDVASSFCGTPYYLAPE 241 (478)
T ss_pred CceecCCcc-----------------------------------------------------ccccccccCCCccccCHh
Confidence 985321100 001122357999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++|||||||++|+|++|+.||......+.+..+..+..... +...+.++.+||.+||+.||++||+
T Consensus 242 ~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps- 316 (478)
T PTZ00267 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF----PCPVSSGMKALLDPLLSKNPALRPT- 316 (478)
T ss_pred HhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CccCCHHHHHHHHHHhccChhhCcC-
Confidence 99998899999999999999999999999998888887877776544311 1123348999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.+++.|+|++.
T Consensus 317 ---~~~~l~~~~~~~ 328 (478)
T PTZ00267 317 ---TQQLLHTEFLKY 328 (478)
T ss_pred ---HHHHHhCHHHHH
Confidence 999999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.33 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=207.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||+|+||.||+|.+..+++ .||||++.... ........+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 70 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGK---------RVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQP 70 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCC---------EEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecC
Confidence 47889999999999999999876655 39999986432 122334567789999999999999999999987
Q ss_pred CC-----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 161 SN-----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 161 ~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
.+ +.|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 71 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 71 PHIDPFEEIYVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred CCccccceEEEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccc
Confidence 76 899999999 46788777553 56999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++....... ........|++.|+||
T Consensus 148 g~a~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aP 173 (372)
T cd07853 148 GLARVEEPDE------------------------------------------------------SKHMTQEVVTQYYRAP 173 (372)
T ss_pred cceeecccCc------------------------------------------------------cccCCCCCcCCCcCCH
Confidence 9984321100 0001123678899999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----------------------CCCCCCC---
Q 013016 316 EVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK-----------------------PLTFPTQ--- 368 (451)
Q Consensus 316 E~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-----------------------~~~~~~~--- 368 (451)
|++.+. .++.++|||||||++|||++|+.||.+.+....+..+... ....+..
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (372)
T cd07853 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL 253 (372)
T ss_pred HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh
Confidence 999874 4789999999999999999999999887666554444321 1111100
Q ss_pred -CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 369 -SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 369 -~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
......+.++.+||.+||+.||.+||| +.|+|+||||++..+
T Consensus 254 ~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~ 296 (372)
T cd07853 254 YTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRL 296 (372)
T ss_pred cccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcc
Confidence 001112448899999999999999999 999999999998543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=347.81 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=208.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|.+.++||.|+||.||+|.++.+.+ .||+|.+..... ......+..|+.+++.++|+||+++++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~ 73 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDN---------LVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDII 73 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCc---------EEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEE
Confidence 4789999999999999999999876655 499999864421 12233456799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 74 HTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred ecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 99999999999995 6898887654 345899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......+++.|+|||++
T Consensus 152 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~~ 176 (301)
T cd07873 152 RAKSIPT-------------------------------------------------------KTYSNEVVTLWYRPPDIL 176 (301)
T ss_pred hccCCCC-------------------------------------------------------CcccccceeecccCcHHH
Confidence 4221000 000112567889999998
Q ss_pred cCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCC------CCC
Q 013016 319 SGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQS------PSS 372 (451)
Q Consensus 319 ~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~------~~~ 372 (451)
.+. .++.++|||||||++|+|++|+.||...+..+.+..+...... .+... ...
T Consensus 177 ~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (301)
T cd07873 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAP 256 (301)
T ss_pred hCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcC
Confidence 764 4788999999999999999999999887665554443321111 01000 001
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
..+.++.+||.+||+.||.+||| +.|+|+||||+.+..
T Consensus 257 ~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~~ 294 (301)
T cd07873 257 RLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLGE 294 (301)
T ss_pred CCCHHHHHHHHHHhcCCcccCcC----HHHHhcCcccccccc
Confidence 22347899999999999999999 999999999998663
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=343.22 Aligned_cols=273 Identities=37% Similarity=0.615 Sum_probs=215.9
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||+|+||+||+|.++.+++ .||+|++.+...........+..|++++++++|+||+++++.+...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKATGK---------MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCCCc---------EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6999999999999887665 4999999876544444455566799999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--- 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--- 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---
Confidence 99999999999988765557999999999999999999999999999999999999999999999999987422100
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
.......|+..|+|||.+.+..++.++
T Consensus 149 -----------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~ 175 (277)
T cd05577 149 -----------------------------------------------------KKIKGRAGTPGYMAPEVLQGEVYDFSV 175 (277)
T ss_pred -----------------------------------------------------CccccccCCCCcCCHHHhcCCCCCchh
Confidence 000112577789999999888899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC-ChHHHHcC
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GAADVKTH 406 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~-~~~ell~h 406 (451)
|||||||++|+|++|+.||...........+.......+...... .+.++.++|.+||+.||.+||+.++ .+.+++.|
T Consensus 176 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK-FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred hhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCcc-CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 999999999999999999987544222222222222222222222 3448999999999999999995433 49999999
Q ss_pred CCcCCCCcccc--cccCCCCCC
Q 013016 407 PFFKGLNFALI--RSLTPPEIP 426 (451)
Q Consensus 407 p~~~~~~~~~~--~~~~~~~~p 426 (451)
|||..++|... ....+|++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 255 PLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred hhhhcCChhhhhcCCCCCCCCC
Confidence 99999999755 333444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=378.14 Aligned_cols=152 Identities=41% Similarity=0.660 Sum_probs=137.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|.+.++||+|+||+||+|.+...++ .||||++.............+..|+.+++.++|+||+++++++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 73 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSK---------LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence 4789999999999999999999886655 4999999865544445556778899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+++||||||+.|++|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 74 ~~~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 74 QSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EECCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 9999999999999999999998764 45899999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q 013016 239 LCS 241 (451)
Q Consensus 239 ~~~ 241 (451)
+..
T Consensus 152 ~~~ 154 (669)
T cd05610 152 KVT 154 (669)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.95 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=199.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|.+.+.||.|+||.||+|.+....+ .||||.... ..+.+|+.++++++|+|||++++++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~---------~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~ 230 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQ---------RVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRV 230 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCC---------EEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 469999999999999999999887665 399996432 22346999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+|||++ .++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 231 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 231 VGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred ECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 999999999999 578888876543 369999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......+.||..|+|||++.
T Consensus 309 ~~~~~~-----------------------------------------------------~~~~~~~~~GT~~Y~APE~~~ 335 (461)
T PHA03211 309 FARGSW-----------------------------------------------------STPFHYGIAGTVDTNAPEVLA 335 (461)
T ss_pred eccccc-----------------------------------------------------ccccccccCCCcCCcCHHHHc
Confidence 321100 000111347999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHhcCCC---CCCC---------------------
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS--------NETTLRNIVKKPL---TFPT--------------------- 367 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~---~~~~--------------------- 367 (451)
+..++.++|||||||+||||++|..++.... .......+..... .++.
T Consensus 336 ~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 415 (461)
T PHA03211 336 GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA 415 (461)
T ss_pred CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence 9999999999999999999999876553321 1222222222111 0110
Q ss_pred ---CCCC--CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 368 ---QSPS--SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 368 ---~~~~--~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
..+. ...+.++.+||.+||++||.+||| +.|||+||||+.
T Consensus 416 ~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 416 YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred cCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 0000 011237899999999999999999 999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=354.32 Aligned_cols=253 Identities=21% Similarity=0.379 Sum_probs=197.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.+.||+|+||.||+|.+....+ .||+|+..+.. ...|+.++++++|+||+++++++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPD---------PVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCc---------eEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEE
Confidence 569999999999999999999887655 39999865331 234889999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+|||++ .++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 128 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 128 SGAITCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred eCCeeEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 999999999999 67888887654 3569999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... .......||..|+|||++.
T Consensus 206 ~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~ 229 (357)
T PHA03209 206 FPVVA--------------------------------------------------------PAFLGLAGTVETNAPEVLA 229 (357)
T ss_pred ccccC--------------------------------------------------------cccccccccccccCCeecC
Confidence 21100 0011246899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCC-CCCCCh---------HHHHHHHhcCCCCCCCCCC-------------------
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTP-FAAPSN---------ETTLRNIVKKPLTFPTQSP------------------- 370 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~---------~~~~~~i~~~~~~~~~~~~------------------- 370 (451)
+..++.++|||||||++|||+++..+ |..... ...+..++......+....
T Consensus 230 ~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (357)
T PHA03209 230 RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLER 309 (357)
T ss_pred CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCC
Confidence 98999999999999999999985444 443211 1122222221110000000
Q ss_pred ----------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 371 ----------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 371 ----------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
....+.++.+||.+||++||.+||| +.|||+||||+++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 310 QPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred CcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 0012236678999999999999999 9999999999874
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.68 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=216.4
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||+|++|.||+|.++.+++ .|++|.+...... ......+..|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKR---------VYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLD 70 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCc---------EEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeecc
Confidence 58899999999999999999887665 3999998754322 3344567789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..|+||||++|++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence 99999999999999999999876566799999999999999999999999999999999999999999999999998743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... .......|+..|+|||++.+
T Consensus 151 ~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08529 151 LSDNT-------------------------------------------------------NFANTIVGTPYYLSPELCED 175 (256)
T ss_pred ccCcc-------------------------------------------------------chhhccccCccccCHHHhcC
Confidence 22100 00112367888999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++|||||||++|+|++|+.||...........+..+....... ..+..+.+++.+||+.+|++||+ +
T Consensus 176 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~----~ 247 (256)
T cd08529 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ----MYSQQLAQLIDQCLTKDYRQRPD----T 247 (256)
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc----ccCHHHHHHHHHHccCCcccCcC----H
Confidence 889999999999999999999999999888777777766654322211 23448999999999999999999 9
Q ss_pred HHHHcCCCc
Q 013016 401 ADVKTHPFF 409 (451)
Q Consensus 401 ~ell~hp~~ 409 (451)
.++++|||+
T Consensus 248 ~~ll~~~~~ 256 (256)
T cd08529 248 FQLLRNPSL 256 (256)
T ss_pred HHHhhCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=355.12 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=205.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||+||+|.+..+++ .||||++..... .......+.+|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQ---------KVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCC---------EEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 679999999999999999999877665 499999975432 2233455667999999999999999999885
Q ss_pred eC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
.. ...|+++|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEc
Confidence 43 4679999998 8899887754 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......||+.|+
T Consensus 161 Dfg~~~~~~~----------------------------------------------------------~~~~~~~t~~y~ 182 (343)
T cd07878 161 DFGLARQADD----------------------------------------------------------EMTGYVATRWYR 182 (343)
T ss_pred CCccceecCC----------------------------------------------------------CcCCcccccccc
Confidence 9999742210 011236899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----------------------CCCC
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-----------------------PTQS 369 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~~~ 369 (451)
|||++.+ ..++.++|||||||++|+|++|+.||......+.+..+....... +...
T Consensus 183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (343)
T cd07878 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQD 262 (343)
T ss_pred CchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchh
Confidence 9999977 468999999999999999999999998766555444443211100 0000
Q ss_pred ----CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 370 ----PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 370 ----~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
... .+..+.+||.+||..||.+||| +.|+|.||||.+...
T Consensus 263 ~~~~~~~-~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~~~ 306 (343)
T cd07878 263 LKKIFRG-ANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQYHD 306 (343)
T ss_pred HHHhccC-CCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhccCC
Confidence 001 1236789999999999999999 999999999998443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=369.37 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=215.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||++..... .......+..|+.++..++|+||+++++.+.
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~---------~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGE---------PFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCC---------EEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 689999999999999999999877665 499999975532 2234456777999999999999999988775
Q ss_pred eCC--------eEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC
Q 013016 160 ASN--------FSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 160 ~~~--------~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~ 229 (451)
..+ .+++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence 432 478999999999999988653 2356899999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||+++...... ........+||
T Consensus 182 vkL~DFGls~~~~~~~-----------------------------------------------------~~~~~~~~~Gt 208 (496)
T PTZ00283 182 VKLGDFGFSKMYAATV-----------------------------------------------------SDDVGRTFCGT 208 (496)
T ss_pred EEEEecccCeeccccc-----------------------------------------------------cccccccccCC
Confidence 9999999985321100 00111235799
Q ss_pred CCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 310 ~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+..+..... + ...+.++.+|+.+||+.|
T Consensus 209 ~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~-~~~~~~l~~li~~~L~~d 284 (496)
T PTZ00283 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL---P-PSISPEMQEIVTALLSSD 284 (496)
T ss_pred cceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC---C-CCCCHHHHHHHHHHcccC
Confidence 999999999998999999999999999999999999998887777777776543221 1 123348999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCC
Q 013016 390 PCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~ 411 (451)
|.+||+ +.++++|||++.
T Consensus 285 P~~RPs----~~ell~~p~~~~ 302 (496)
T PTZ00283 285 PKRRPS----SSKLLNMPICKL 302 (496)
T ss_pred hhhCcC----HHHHHhCHHHHH
Confidence 999999 999999999886
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.11 Aligned_cols=317 Identities=32% Similarity=0.504 Sum_probs=244.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
-|..++.||-|+||.|.+++..++.. +||+|.+++.......++..+..|..||..-..+-||+||-.|.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~---------lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRA---------LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhh---------HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 38889999999999999999777644 799999999988888888888889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+.+|+||+|++||++-.+|-+. +-|++..++.++.++..|+++.|..|+|||||||+|||||.+|.+||+|||+|.=
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence 99999999999999998877664 6699999999999999999999999999999999999999999999999999842
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccc--hhhhhhhccccCCccccccCCCcccc-----cccccccccccccCCCcc
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYS--TRLSRFLNRFFGSKKIQTLTPNRLFV-----AEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~gt~~y~ 313 (451)
+. ++-.++.|....+ ....+.... ..+..++.... ..-.....-..+||+.|+
T Consensus 779 fR--------------WTHdskYYq~gdH~RqDSmep~~e------~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 779 FR--------------WTHDSKYYQEGDHHRQDSMEPSPE------WADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred ce--------------eccccccccCCCccccccCCCchh------hccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 21 1111111110000 000111111 11111110000 001122233569999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|||++....|+..+|.||.|||||||+.|+.||......+.-.++++-.-.+-....-. .+.++.++|.++. -+++.|
T Consensus 839 apevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~-ls~e~~~li~kLc-~sad~R 916 (1034)
T KOG0608|consen 839 APEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGN-LSKEALDLIQKLC-CSADSR 916 (1034)
T ss_pred ChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccc-cCHHHHHHHHHHh-cChhhh
Confidence 99999999999999999999999999999999998777666555554332222222222 3338888888754 477888
Q ss_pred CCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCC
Q 013016 394 LGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~ 431 (451)
+. +.++++|..||||++|||..++++..|-||+..-+
T Consensus 917 LG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHp 953 (1034)
T KOG0608|consen 917 LG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHP 953 (1034)
T ss_pred hc-ccchhhhhcCccccccchHhhhhccCCcCccccCC
Confidence 87 55688999999999999999999999999998854
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=328.12 Aligned_cols=301 Identities=36% Similarity=0.682 Sum_probs=253.1
Q ss_pred CCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCc
Q 013016 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFL 151 (451)
Q Consensus 73 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nI 151 (451)
.++++.+++|.+++.||.|+|++|.+++++.+.+ .||+|+++++.....+...+++.|..+..+- +||.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~q---------iyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQ---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccce---------eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 3556778999999999999999999999998876 5999999999988888888888888888765 79999
Q ss_pred cceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 152 PTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
|-+..+|..+..+++|.||++||+|-=.++++ .+++++.++.+...|+.||.|||++|||+||||.+|+|++..|.+|
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCcee
Confidence 99999999999999999999999996555554 5699999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|+|.++.-- .....+.++|||+.
T Consensus 392 ltdygmcke~l-------------------------------------------------------~~gd~tstfcgtpn 416 (593)
T KOG0695|consen 392 LTDYGMCKEGL-------------------------------------------------------GPGDTTSTFCGTPN 416 (593)
T ss_pred ecccchhhcCC-------------------------------------------------------CCCcccccccCCCc
Confidence 99999985211 01234567899999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-------CChHH-HHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-------PSNET-TLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~-------~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
|.|||++.|..|+..+|.|+||++|+||+.|+.||.- .+.++ .+.-|+...+.+|....- .+..+++
T Consensus 417 yiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv-----kas~vlk 491 (593)
T KOG0695|consen 417 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV-----KASHVLK 491 (593)
T ss_pred ccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh-----hhHHHHH
Confidence 9999999999999999999999999999999999963 22333 455566666666654332 6778999
Q ss_pred HhcccCcCCcCCC--CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCc
Q 013016 384 GLLNKDPCNRLGS--KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQ 444 (451)
Q Consensus 384 ~~L~~dP~~Rpt~--~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~ 444 (451)
..|++||.+|... .-++.++..|+||+.++|..+ ....||+.|...+.-....++-+..++
T Consensus 492 gflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e 556 (593)
T KOG0695|consen 492 GFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSE 556 (593)
T ss_pred HhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccC
Confidence 9999999999875 335789999999999999754 788899999998765555555444443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=341.47 Aligned_cols=256 Identities=35% Similarity=0.613 Sum_probs=208.8
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.+.||+|+||+||+|.+..+.+. ||+|++......... ......|+.++++++|+||+++++++...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~---------~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQK---------VAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDD 70 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEE---------EEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEES
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeE---------EEEEEeccccccccc-cchhhhhhhcccccccccccccccccccc
Confidence 78999999999999999999988754 999999877544333 22334599999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
...++|||++.+++|.+++... ..+++..+..++.||+.||++||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 71 ~~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 71 NYLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp SEEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999833 55899999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc-C
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS-G 320 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~ 320 (451)
. ..........|+..|+|||++. +
T Consensus 149 ~-------------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~ 173 (260)
T PF00069_consen 149 S-------------------------------------------------------ENNENFNPFVGTPEYMAPEVLQQG 173 (260)
T ss_dssp T-------------------------------------------------------STTSEBSSSSSSGGGSCHHHHTTT
T ss_pred c-------------------------------------------------------cccccccccccccccccccccccc
Confidence 0 0011112347888999999998 7
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
..++.++||||||+++|+|++|..||..... ...+................ .....+.++|.+||+.||++||+
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~R~~-- 250 (260)
T PF00069_consen 174 KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR-EKSEELRDLIKKMLSKDPEQRPS-- 250 (260)
T ss_dssp SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT-TSHHHHHHHHHHHSSSSGGGSTT--
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc-hhHHHHHHHHHHHccCChhHCcC--
Confidence 7889999999999999999999999998732 33333333322221111111 11248999999999999999999
Q ss_pred CChHHHHcCCCc
Q 013016 398 RGAADVKTHPFF 409 (451)
Q Consensus 398 ~~~~ell~hp~~ 409 (451)
+.++++||||
T Consensus 251 --~~~l~~~~~~ 260 (260)
T PF00069_consen 251 --AEELLKHPWF 260 (260)
T ss_dssp --HHHHHTSGGG
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=334.81 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=212.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
++|.+.+.||+|++|.||+|.+..+++ .||+|++...... .......+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGR---------ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCc---------EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 579999999999999999999876655 3999998654221 22334567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+..++..++||||++|++|.+++... +.+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 99999999999999999999988765 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .........|+..|+|||+
T Consensus 151 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 151 SKRLQTICS----------------------------------------------------SGTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred ceecccccc----------------------------------------------------ccccccCCCcCccccCcce
Confidence 743211000 0000012367888999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++||||||+++|+|++|+.||...........+........ . +...+..+.++|.+||..+|.+|||
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~li~~~l~~~p~~Rpt-- 253 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--L-PSHVSPDARNFLRRTFVENAKKRPS-- 253 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--C-CccCCHHHHHHHHHHhhcCcccCCC--
Confidence 9998899999999999999999999999988766665555544332211 1 1223448999999999999999999
Q ss_pred CChHHHHcCCCc
Q 013016 398 RGAADVKTHPFF 409 (451)
Q Consensus 398 ~~~~ell~hp~~ 409 (451)
+.++++|+||
T Consensus 254 --~~~ll~~~~~ 263 (263)
T cd06625 254 --AEELLRHFFV 263 (263)
T ss_pred --HHHHhhCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.91 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=212.7
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|++|.||+|.++.+++ .||+|.+...... ......+..|++++++++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK---------QYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc---------EEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence 48999999999999999999877655 3999998754322 2334556779999999999999999998764
Q ss_pred -CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 161 -SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+.+|+||||+++++|.+++.......+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceE
Confidence 4578999999999999999987666679999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|++.|+|||++.
T Consensus 151 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 175 (257)
T cd08223 151 VLENQC-------------------------------------------------------DMASTLIGTPYYMSPELFS 175 (257)
T ss_pred EecccC-------------------------------------------------------CccccccCCcCccChhHhc
Confidence 321100 0011236888999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+..+..... +...+.++.+|+.+||+.||.+||+
T Consensus 176 ~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~---- 247 (257)
T cd08223 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM----PKDYSPELGELIATMLSKRPEKRPS---- 247 (257)
T ss_pred CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC----ccccCHHHHHHHHHHhccCcccCCC----
Confidence 98899999999999999999999999988776666666666543221 1223448999999999999999999
Q ss_pred hHHHHcCCCc
Q 013016 400 AADVKTHPFF 409 (451)
Q Consensus 400 ~~ell~hp~~ 409 (451)
+.++++||||
T Consensus 248 ~~~~l~~~~~ 257 (257)
T cd08223 248 VKSILRQPYI 257 (257)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=341.91 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=209.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-C-C----Ccc
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-H-P----FLP 152 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----nIv 152 (451)
-++|.+..+||+|.||.|-.|.++.... .|||||++.- .+..+....|++++.++. + | -+|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~---------~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKE---------HVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCc---------eehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 3779999999999999999999988754 4999999754 233445556899999983 2 2 288
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc------
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS------ 226 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~------ 226 (451)
.+.+||+..+|.|||+|.+ |-|+.+++..+...+++...++.|+.||+++++|||+++++|.||||+|||+.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 9999999999999999999 889999999988889999999999999999999999999999999999999953
Q ss_pred --------------CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCc
Q 013016 227 --------------DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNR 292 (451)
Q Consensus 227 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (451)
+..++|+|||.|....
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~-------------------------------------------------- 263 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDH-------------------------------------------------- 263 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceec--------------------------------------------------
Confidence 2357899999874321
Q ss_pred ccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC
Q 013016 293 LFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372 (451)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 372 (451)
....+++.|..|+|||+++|-+|+.++||||+||||+||+||...|....+.+.+..+..-..++|..+...
T Consensus 264 --------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r 335 (415)
T KOG0671|consen 264 --------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKK 335 (415)
T ss_pred --------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhh
Confidence 122356889999999999999999999999999999999999999998777664322222111222111110
Q ss_pred c-----------------------------------------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 373 M-----------------------------------------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 373 ~-----------------------------------------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
. .-.++.+||++||.+||.+|+| +.|+|.||||+.
T Consensus 336 ~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT----l~EAL~HpFF~~ 411 (415)
T KOG0671|consen 336 TRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT----LREALSHPFFAR 411 (415)
T ss_pred hhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc----HHHHhcCHHhhc
Confidence 0 0116789999999999999999 999999999997
Q ss_pred C
Q 013016 412 L 412 (451)
Q Consensus 412 ~ 412 (451)
.
T Consensus 412 ~ 412 (415)
T KOG0671|consen 412 L 412 (415)
T ss_pred C
Confidence 4
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.78 Aligned_cols=269 Identities=32% Similarity=0.617 Sum_probs=204.0
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHH---HHHCCCCCccceeEEEEeCCe
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI---LKMLDHPFLPTLYAEFEASNF 163 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~nIv~l~~~~~~~~~ 163 (451)
.||+|+||.||+|.+..+++ .+|+|++.+..............|..+ +....|+||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCc---------EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999999876655 499999976533222222222334333 334579999999999999999
Q ss_pred EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCC
Q 013016 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243 (451)
Q Consensus 164 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 243 (451)
.|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence 99999999999999888764 4599999999999999999999999999999999999999999999999998732110
Q ss_pred CCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC-CC
Q 013016 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG-GS 322 (451)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~ 322 (451)
. ......|+..|+|||.+.+ ..
T Consensus 150 ~---------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 172 (279)
T cd05633 150 K---------------------------------------------------------KPHASVGTHGYMAPEVLQKGTA 172 (279)
T ss_pred c---------------------------------------------------------CccCcCCCcCccCHHHhcCCCC
Confidence 0 0011268899999999864 55
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCC
Q 013016 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSN--ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRG 399 (451)
Q Consensus 323 ~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~ 399 (451)
++.++|||||||++|+|++|..||..... ......... ......+. ..+.++.++|.+||..||.+|++. ...
T Consensus 173 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~~~ 248 (279)
T cd05633 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TVNVELPD-SFSPELKSLLEGLLQRDVSKRLGCLGRG 248 (279)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cCCcCCcc-ccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence 78999999999999999999999975322 222222211 11111222 233489999999999999999921 111
Q ss_pred hHHHHcCCCcCCCCcccc--cccCCCCCCC
Q 013016 400 AADVKTHPFFKGLNFALI--RSLTPPEIPG 427 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~~~--~~~~~~~~p~ 427 (451)
+.|+++||||+++++... ...++|.+|+
T Consensus 249 ~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 278 (279)
T cd05633 249 AQEVKEHVFFKGIDWQQVYLQKYPPPLIPP 278 (279)
T ss_pred HHHHHhCccccCCCHhHHhcCCCCCCCCCC
Confidence 999999999999998754 5556666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.69 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=207.4
Q ss_pred EEeeeccC--CeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 84 LHRRIGAG--DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 84 ~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
+.++||+| +|++||+|.++.+++ .||+|++...... ......+..|+.+++.++||||+++++++..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~---------~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 71 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGE---------YVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 71 (327)
T ss_pred hhhhccccccceEEEEEEeecccCc---------EEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence 46789999 789999999987765 4999999765332 23445677799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999999999999987655556999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC-
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG- 320 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 320 (451)
........ ..........++..|+|||++.+
T Consensus 152 ~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~ 183 (327)
T cd08227 152 INHGQRLR------------------------------------------------VVHDFPKYSVKVLPWLSPEVLQQN 183 (327)
T ss_pred cccccccc------------------------------------------------ccccccccccceecccChHHhhcc
Confidence 10000000 00000011256778999999976
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC--------------------------------
Q 013016 321 -GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-------------------------------- 367 (451)
Q Consensus 321 -~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------------------------- 367 (451)
..++.++|||||||++|+|++|+.||..............+......
T Consensus 184 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (327)
T cd08227 184 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263 (327)
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCc
Confidence 35889999999999999999999999876555444443332211000
Q ss_pred ---------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 368 ---------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 368 ---------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
.......+.++.+||.+||+.||++||| ++||++||||+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 264 RPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred CccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0001112347899999999999999999 99999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=347.90 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=189.6
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe--CC
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA--SN 162 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~ 162 (451)
.++||+|+||+||+|.++.... +..||+|++.... ......+|+.++++++||||+++++++.. +.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~-------~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADR 73 (317)
T ss_pred ccccccCCCeEEEEEEEccCCC-------CceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc
Confidence 4579999999999999764321 1249999986432 12335569999999999999999999854 45
Q ss_pred eEEEEEeeccCCchhhhhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc----cCCCEE
Q 013016 163 FSCIVMEFCSGGDLHSLRHKQ-------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR----SDGHIM 231 (451)
Q Consensus 163 ~~~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~----~~~~~k 231 (451)
+.|+||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 74 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 74 KVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEE
Confidence 789999999 66888876532 123589999999999999999999999999999999999994 557899
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ .........||+.
T Consensus 153 l~DfG~a~~~~~~~~----------------------------------------------------~~~~~~~~~~t~~ 180 (317)
T cd07868 153 IADMGFARLFNSPLK----------------------------------------------------PLADLDPVVVTFW 180 (317)
T ss_pred EeecCceeccCCCCc----------------------------------------------------cccccCCcccccc
Confidence 999999853321000 0001113478999
Q ss_pred ccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHhcCCCCCCCC-------------
Q 013016 312 YVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---------TTLRNIVKKPLTFPTQ------------- 368 (451)
Q Consensus 312 y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~---------~~~~~i~~~~~~~~~~------------- 368 (451)
|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+..+..........
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07868 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 260 (317)
T ss_pred ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhh
Confidence 9999999874 5899999999999999999999999753321 1222222110000000
Q ss_pred --------------------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 369 --------------------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 369 --------------------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
......+.++.+||.+||++||.+||| ++|+|+||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 261 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred hhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 000011236889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=340.45 Aligned_cols=264 Identities=29% Similarity=0.431 Sum_probs=215.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|++.++||.|+||.||+|.+..+.+ .||+|++.... ......+..|+.+++.++|+||+++++.+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~---------~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGA---------LAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCc---------eEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 569999999999999999999887665 49999987542 334556677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++.+|+||||++|++|..++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999988775543 458999999999999999999999999999999999999999999999999873
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||++.
T Consensus 159 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 159 KNVKT-------------------------------------------------------LQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred ecccc-------------------------------------------------------ccccceecCCccccCceeec
Confidence 21100 00111236788899999985
Q ss_pred C-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 320 G-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 320 ~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
+ ..++.++|||||||++|+|++|..||........+.++...... ....+...+.++.+||.+||..||++||
T Consensus 184 ~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (292)
T cd06644 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRP 261 (292)
T ss_pred cccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence 3 34688999999999999999999999887666666555443321 1111222344899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCcccc
Q 013016 395 GSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~~ 417 (451)
+ +.++++||||..+++...
T Consensus 262 ~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 262 S----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred C----HHHHhcCccccccccchh
Confidence 9 999999999999888654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=338.84 Aligned_cols=259 Identities=27% Similarity=0.356 Sum_probs=203.4
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||+|++|.||+|.++.++. .||+|++..... .......+..|+.+++.+.|+||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ---------IVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ 70 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc---------EEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence 58999999999999999999876654 499999865421 12233556679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++..|+||||++ ++|.+++.... +..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECccccee
Confidence 999999999996 68888876543 3568999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......+++.|+|||++.
T Consensus 150 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 174 (285)
T cd07861 150 AFGIPV-------------------------------------------------------RVYTHEVVTLWYRAPEVLL 174 (285)
T ss_pred ecCCCc-------------------------------------------------------ccccCCcccccccChHHhc
Confidence 321100 0000125678899999987
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC------------------C------CCCCCcC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP------------------T------QSPSSMS 374 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------------~------~~~~~~~ 374 (451)
+. .++.++|||||||++|+|++|+.||...........+........ . .......
T Consensus 175 ~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T cd07861 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNL 254 (285)
T ss_pred CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCC
Confidence 64 468899999999999999999999987665443333222110000 0 0001113
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
+.++.+||.+||+.||.+||| +.+|+.||||
T Consensus 255 ~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 255 DEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred CHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 448889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=340.47 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=208.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.+..++. .+|+|.+.... .......+..|++++++++||||+++++++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 69 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGL---------IMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFY 69 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCe---------EEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 369999999999999999999877654 49999886442 2233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.++++|+||||++|++|.+++... +.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++
T Consensus 70 ~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 70 SDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred eCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence 999999999999999999998765 558999999999999999999997 69999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... .......|+..|+|||++
T Consensus 148 ~~~~~---------------------------------------------------------~~~~~~~~~~~~~aPE~~ 170 (308)
T cd06615 148 GQLID---------------------------------------------------------SMANSFVGTRSYMSPERL 170 (308)
T ss_pred ccccc---------------------------------------------------------cccccCCCCcCccChhHh
Confidence 32110 001124688899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---------------------------------
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF--------------------------------- 365 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------------------------------- 365 (451)
.+..++.++|||||||++|+|++|+.||...........+.......
T Consensus 171 ~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (308)
T cd06615 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP 250 (308)
T ss_pred cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC
Confidence 88889999999999999999999999997654333222111110000
Q ss_pred CCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 366 ~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
+...+....+.++.+|+.+||..||++||+ +.+|++||||.+.
T Consensus 251 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~ 293 (308)
T cd06615 251 PPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKRA 293 (308)
T ss_pred CccCcCcccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhhc
Confidence 000111123447999999999999999999 9999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=338.14 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=221.7
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
-|.++.+||+|+||.||+|.+++.+. ++|||.+.-+ ...+.+..|+.|++++..+++|++||.+..
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~---------v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK 99 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGH---------VLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK 99 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCc---------EEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhcc
Confidence 38999999999999999999887765 6999998643 345677789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
+..+++|||||.-|++.++++.. ++.+++..+..+++..+.||+|||...-||||||..|||++.+|.+||+|||.|-.
T Consensus 100 ~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 100 HSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred CCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch
Confidence 99999999999999999988765 46799999999999999999999999999999999999999999999999999731
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..+...+.+++.||+.|||||++..
T Consensus 179 -------------------------------------------------------LTDTMAKRNTVIGTPFWMAPEVI~E 203 (502)
T KOG0574|consen 179 -------------------------------------------------------LTDTMAKRNTVIGTPFWMAPEVIEE 203 (502)
T ss_pred -------------------------------------------------------hhhhHHhhCccccCcccccHHHHHH
Confidence 1224455667899999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
-.|+.++||||||++..||..|++||.+......+-.|-.. +.|....+..++.++.+||+.||-++|++|.| +
T Consensus 204 IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~--PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T----A 277 (502)
T KOG0574|consen 204 IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK--PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT----A 277 (502)
T ss_pred hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH----H
Confidence 99999999999999999999999999986665444333332 23444445566669999999999999999999 9
Q ss_pred HHHHcCCCcCCC
Q 013016 401 ADVKTHPFFKGL 412 (451)
Q Consensus 401 ~ell~hp~~~~~ 412 (451)
-+|++|||.++.
T Consensus 278 ~~L~~H~FiknA 289 (502)
T KOG0574|consen 278 LRLCEHTFIKNA 289 (502)
T ss_pred HHHhhhhhhcCC
Confidence 999999999983
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=337.37 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=205.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+..|+.++++++|+||+++++.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 69 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRR---------ILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFF 69 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCc---------EEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 368889999999999999999876655 49999987542 2233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 70 VENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred ECCEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 99999999999999998654 237889999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ......+|+..|+|||++.
T Consensus 144 ~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 166 (279)
T cd06619 144 QLVN---------------------------------------------------------SIAKTYVGTNAYMAPERIS 166 (279)
T ss_pred eccc---------------------------------------------------------ccccCCCCChhhcCceeec
Confidence 2210 0011247889999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-------TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+..++.++|||||||++|+|++|+.||...... .....+...... .......+.++.+|+.+||..||++
T Consensus 167 ~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~ 243 (279)
T cd06619 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP---VLPVGQFSEKFVHFITQCMRKQPKE 243 (279)
T ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC---CCCCCcCCHHHHHHHHHHhhCChhh
Confidence 988999999999999999999999999653211 222222222111 1111223348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||+ ++|+++||||+..+..
T Consensus 244 Rp~----~~eil~~~~~~~~~~~ 262 (279)
T cd06619 244 RPA----PENLMDHPFIVQYNDG 262 (279)
T ss_pred CCC----HHHHhcCcccccccCc
Confidence 999 9999999999986543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=317.83 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=214.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l 154 (451)
....++.+++..||.|+.|.||+++.+.++. ++|||.+++. .+.+..+++...+.++.+.+ +|+||+.
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~---------iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGH---------IIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccce---------EEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeee
Confidence 3445678888999999999999999987654 6999999876 44555667777777777665 9999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEe
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+|+|..+...++.||.| ..-+..++.+.+ +++++..+-++...++.||.||.+ +||+||||||+|||+++.|++|||
T Consensus 157 ~GyFi~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eeEEeeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEee
Confidence 99999999999999998 666777777654 569999999999999999999995 689999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++-.+-+..+. ..-.|.+.||
T Consensus 235 DFGIsGrlvdSkAh--------------------------------------------------------trsAGC~~YM 258 (391)
T KOG0983|consen 235 DFGISGRLVDSKAH--------------------------------------------------------TRSAGCAAYM 258 (391)
T ss_pred cccccceeeccccc--------------------------------------------------------ccccCCcccc
Confidence 99998433211111 0126889999
Q ss_pred CcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 314 SPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 314 aPE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|||-+.- ..|+.++||||||+.++||.||+.||.+.+ +.+++-.+++..++ ......-.+.++++|+..||++|
T Consensus 259 aPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP--~L~~~~gFSp~F~~fv~~CL~kd 336 (391)
T KOG0983|consen 259 APERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP--LLPGHMGFSPDFQSFVKDCLTKD 336 (391)
T ss_pred CccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC--CCCcccCcCHHHHHHHHHHhhcC
Confidence 9999864 358999999999999999999999999854 56777777775442 22222226669999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCC
Q 013016 390 PCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+.+||. ..+||+|||...
T Consensus 337 ~r~RP~----Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 337 HRKRPK----YNKLLEHPFIKR 354 (391)
T ss_pred cccCcc----hHHHhcCcceee
Confidence 999999 999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.67 Aligned_cols=267 Identities=26% Similarity=0.339 Sum_probs=209.4
Q ss_pred CCCchhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHH
Q 013016 57 RSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136 (451)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ 136 (451)
....|++.+++.|| ++|.-.++||+|+||.||+|...++. .||||.+....... ..+|
T Consensus 61 ~~~~fs~~el~~AT---------~~Fs~~~~ig~Ggfg~VYkG~l~~~~----------~vAVK~~~~~~~~~---~~eF 118 (361)
T KOG1187|consen 61 PLRSFSYDELRKAT---------NNFSESNLIGEGGFGTVYKGVLSDGT----------VVAVKRLSSNSGQG---EREF 118 (361)
T ss_pred CcceeeHHHHHHHH---------hCCchhcceecCCCeEEEEEEECCCC----------EEEEEEecCCCCcc---hhHH
Confidence 45669999999999 99999999999999999999998763 39999887543221 3458
Q ss_pred HHHHHHHHHCCCCCccceeEEEEeCC-eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Q 013016 137 EMEKKILKMLDHPFLPTLYAEFEASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG---I 212 (451)
Q Consensus 137 ~~e~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---i 212 (451)
..|+.++.+++|+|+|+++|||.+.+ +.+|||||+++|+|.++++......++|..+.+|+.+++.||+|||+.. |
T Consensus 119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i 198 (361)
T KOG1187|consen 119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPI 198 (361)
T ss_pred HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence 88999999999999999999999998 5999999999999999998765437999999999999999999999754 9
Q ss_pred eeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCc
Q 013016 213 IYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNR 292 (451)
Q Consensus 213 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (451)
||||||++|||+|+++++||+|||+|+.....
T Consensus 199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~------------------------------------------------ 230 (361)
T KOG1187|consen 199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG------------------------------------------------ 230 (361)
T ss_pred ecCCCCHHHeeECCCCCEEccCccCcccCCcc------------------------------------------------
Confidence 99999999999999999999999998432210
Q ss_pred cccccccccccccc-ccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hH----HHHH-HHhcCCCC
Q 013016 293 LFVAEPVAARSCSF-VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS--NE----TTLR-NIVKKPLT 364 (451)
Q Consensus 293 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~--~~----~~~~-~i~~~~~~ 364 (451)
.....+. .||.+|+|||++..+..+.++||||||++|+||+||+.+..... .. +... .+..+...
T Consensus 231 -------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ 303 (361)
T KOG1187|consen 231 -------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLR 303 (361)
T ss_pred -------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchh
Confidence 0000011 69999999999998889999999999999999999998887532 11 1111 11121111
Q ss_pred -CCCCC-C-CCcC----hHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 365 -FPTQS-P-SSMS----EYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 365 -~~~~~-~-~~~~----~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
+.+.. . .... -..+..+..+|++.+|.+||+ +.||+
T Consensus 304 eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~----m~~Vv 346 (361)
T KOG1187|consen 304 EIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPT----MSQVV 346 (361)
T ss_pred heeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcC----HHHHH
Confidence 11100 0 1111 114678999999999999999 66653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.20 Aligned_cols=277 Identities=22% Similarity=0.295 Sum_probs=198.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCC------CCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRG------HEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
++|+++++||+|+||+||+|..+........ ...+...+.|++.+...........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 6899999999999999999987543321000 0000011112222222222334456778999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQP---HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
+++++...+..|+|+|++ +++|.+++.... ........++.|+.||+.||+|||++||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999 667777665432 1224466788899999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... ........+||.
T Consensus 307 kL~DFGla~~~~~~------------------------------------------------------~~~~~~~~~gt~ 332 (501)
T PHA03210 307 VLGDFGTAMPFEKE------------------------------------------------------REAFDYGWVGTV 332 (501)
T ss_pred EEEeCCCceecCcc------------------------------------------------------cccccccccCCc
Confidence 99999998532110 001112347999
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHHhcCCC----CCCC----------------
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP-FAAP--SNETTLRNIVKKPL----TFPT---------------- 367 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~--~~~~~~~~i~~~~~----~~~~---------------- 367 (451)
.|+|||++.+..++.++|||||||+||||++|..+ |... .....+.+++.... .++.
T Consensus 333 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~ 412 (501)
T PHA03210 333 ATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDH 412 (501)
T ss_pred CCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhccc
Confidence 99999999999999999999999999999998764 4332 22233333322111 0110
Q ss_pred -------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 368 -------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 368 -------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.......+.++.++|.+||++||.+||| +.|+|.||||.+....
T Consensus 413 ~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~ 463 (501)
T PHA03210 413 AGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEE 463 (501)
T ss_pred CccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCch
Confidence 0000112336788899999999999999 9999999999986554
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=332.08 Aligned_cols=258 Identities=35% Similarity=0.651 Sum_probs=210.9
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHH-HHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||.|+||.||+|.+...++ .||+|++.+...........+..|..++ ...+|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD---------YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC---------eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 468999999999999877655 3999999765443333333444454443 455899999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence 9999999999999998765 4589999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.....|+..|+|||.+.+..++
T Consensus 150 ----------------------------------------------------------~~~~~~~~~y~~pe~~~~~~~~ 171 (260)
T cd05611 150 ----------------------------------------------------------NKKFVGTPDYLAPETILGVGDD 171 (260)
T ss_pred ----------------------------------------------------------cccCCCCcCccChhhhcCCCCc
Confidence 1123678889999999888889
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++||||||+++|+|++|..||........+..+.......+...... .+.++.++|.+||+.||++||++.. +.|++
T Consensus 172 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~p~~R~~~~~-~~~~l 249 (260)
T cd05611 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF-CSPEAVDLINRLLCMDPAKRLGANG-YQEIK 249 (260)
T ss_pred chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccccc-CCHHHHHHHHHHccCCHHHccCCCc-HHHHH
Confidence 999999999999999999999998887777777766655444333322 3448999999999999999996211 68999
Q ss_pred cCCCcCCCCcc
Q 013016 405 THPFFKGLNFA 415 (451)
Q Consensus 405 ~hp~~~~~~~~ 415 (451)
.||||+.++|.
T Consensus 250 ~~~~~~~~~~~ 260 (260)
T cd05611 250 SHPFFKSINWD 260 (260)
T ss_pred cChHhhcCCCC
Confidence 99999998773
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.49 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=205.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+.|.+.+.||.|+||.||+|.+....+ .||+|++.... .....+..|+.+++++ +|+||+++++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAF 72 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCc---------EEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 679999999999999999999877665 49999986432 2224556688899988 699999999998
Q ss_pred EeC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EAS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
... ..+|+||||+++++|.+++.......+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred eecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEE
Confidence 753 47899999999999999988765567999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ........|+..|
T Consensus 153 ~Dfg~~~~~~~~-------------------------------------------------------~~~~~~~~g~~~y 177 (272)
T cd06637 153 VDFGVSAQLDRT-------------------------------------------------------VGRRNTFIGTPYW 177 (272)
T ss_pred ccCCCceecccc-------------------------------------------------------cccCCcccccccc
Confidence 999997432110 0011134688999
Q ss_pred cCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 313 VSPEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 313 ~aPE~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ......+.++.+|+.+||.
T Consensus 178 ~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~ 254 (272)
T cd06637 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR---LKSKKWSKKFQSFIESCLV 254 (272)
T ss_pred cCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC---CCCCCcCHHHHHHHHHHcC
Confidence 99999863 357889999999999999999999998765544444333322111 1122234589999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCc
Q 013016 388 KDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.||.+||+ +.++++||||
T Consensus 255 ~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 255 KNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred CChhhCCC----HHHHhhCCCC
Confidence 99999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=374.70 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=210.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|.++++||+|+||+||+|.++.... .||+|++...... ......+..|+.+++.++|||||+++++|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~---------~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQE---------FFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCe---------EEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 4789999999999999999999887654 5999998754322 23345677899999999999999999988
Q ss_pred Ee--CCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeccCCCCcEEEccC
Q 013016 159 EA--SNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHML-------GIIYRDLKPENVLVRSD 227 (451)
Q Consensus 159 ~~--~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~-------givH~Dlkp~NIll~~~ 227 (451)
.. ...+||||||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 54 457999999999999999887532 35699999999999999999999985 49999999999999642
Q ss_pred -----------------CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCC
Q 013016 228 -----------------GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTP 290 (451)
Q Consensus 228 -----------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (451)
+.+||+|||++......
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---------------------------------------------- 195 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---------------------------------------------- 195 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccc----------------------------------------------
Confidence 35899999998432100
Q ss_pred CcccccccccccccccccCCCccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC
Q 013016 291 NRLFVAEPVAARSCSFVGTHEYVSPEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ 368 (451)
Q Consensus 291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 368 (451)
......+||+.|+|||++.+ ..++.++||||||||||+|++|+.||........+...+.....++..
T Consensus 196 ----------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~ 265 (1021)
T PTZ00266 196 ----------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIK 265 (1021)
T ss_pred ----------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcC
Confidence 00112479999999999865 347899999999999999999999998766555544444433333221
Q ss_pred CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 369 ~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
..+.++.+||..||..+|.+||+ +.|+|.|+|++.+..+
T Consensus 266 ----~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 266 ----GKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGPP 304 (1021)
T ss_pred ----CCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCCC
Confidence 22348999999999999999999 9999999999986554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=332.02 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=215.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||+||+|.+..++. .+|+|++....... ....+..|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNE---------KVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFV 69 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCc---------EEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEe
Confidence 479999999999999999999876554 49999987543222 4566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+..++|||+++|++|.+++..... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 70 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999999999876533 56899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .........|+..|+|||.+
T Consensus 150 ~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~~Pe~~ 178 (267)
T cd06610 150 ASLADGGDR---------------------------------------------------TRKVRKTFVGTPCWMAPEVM 178 (267)
T ss_pred HHhccCccc---------------------------------------------------cccccccccCChhhcChHHH
Confidence 533211000 00011234688899999998
Q ss_pred cCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-CCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 SGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 ~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
... .++.++|+|||||++|+|++|+.||........+..+...... ++........+..+.+++.+||..||++||+
T Consensus 179 ~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~- 257 (267)
T cd06610 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT- 257 (267)
T ss_pred ccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC-
Confidence 876 6899999999999999999999999887776666666554322 2111111233448899999999999999999
Q ss_pred CCChHHHHcCCCc
Q 013016 397 KRGAADVKTHPFF 409 (451)
Q Consensus 397 ~~~~~ell~hp~~ 409 (451)
+.+|++||||
T Consensus 258 ---~~~ll~~p~~ 267 (267)
T cd06610 258 ---AEELLKHKFF 267 (267)
T ss_pred ---HHHHhhCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.73 Aligned_cols=250 Identities=29% Similarity=0.487 Sum_probs=207.5
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
-+||+|.||+||-|+++.+..+ +|||-+.-+ .....+-+..|+.+.+.|+|.|||+++|.+.+++++-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvr---------IaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~k 648 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVR---------IAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFK 648 (1226)
T ss_pred EEeecCceeEEEeeccccceeE---------EEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEE
Confidence 4699999999999999988764 999998754 3345566777999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc-cCCCEEEeccCcccccC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRF--SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-SDGHIMLSDFDLSLCSN 242 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~ 242 (451)
|.||.++||||.+++... -+++ .+..+..+.+||++||.|||++.|||||||.+|+||+ -.|.+||.|||.++.+.
T Consensus 649 IFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 649 IFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred EEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999999999998764 3556 7889999999999999999999999999999999998 46899999999986432
Q ss_pred CCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCC
Q 013016 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322 (451)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 322 (451)
. ...-+-+|.||..|||||++..++
T Consensus 728 g-------------------------------------------------------inP~TETFTGTLQYMAPEvIDqG~ 752 (1226)
T KOG4279|consen 728 G-------------------------------------------------------INPCTETFTGTLQYMAPEVIDQGP 752 (1226)
T ss_pred c-------------------------------------------------------CCccccccccchhhhChHhhccCC
Confidence 1 111233678999999999997654
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH--hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 323 --HGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNI--VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 323 --~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i--~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
|+.++|||||||++.||.||++||.....-. .+-++ .+..+++|.. + +.+++.||.+|+.+||.+||+
T Consensus 753 RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPee----l-saeak~FilrcFepd~~~R~s-- 825 (1226)
T KOG4279|consen 753 RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEE----L-SAEAKNFILRCFEPDPCDRPS-- 825 (1226)
T ss_pred cCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHH----H-HHHHHHHHHHHcCCCcccCcc--
Confidence 8999999999999999999999998754333 22222 2223333332 2 238999999999999999999
Q ss_pred CChHHHHcCCCcCCC
Q 013016 398 RGAADVKTHPFFKGL 412 (451)
Q Consensus 398 ~~~~ell~hp~~~~~ 412 (451)
|.++|.+||++-.
T Consensus 826 --A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 826 --AKDLLQDPFLQHN 838 (1226)
T ss_pred --HHHhccCcccccC
Confidence 9999999999985
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=339.89 Aligned_cols=275 Identities=27% Similarity=0.342 Sum_probs=213.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||.|+||.||+|.++.+++ .||+|++...... .........|+.++++++|+||+++++++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~---------~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGE---------IVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVV 75 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCc---------EEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEE
Confidence 4789999999999999999999887655 4999998744221 12223345699999999999999999998
Q ss_pred EeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
... +.+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 76 VGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred ecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccc
Confidence 755 57899999995 58888877643 568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++........ ......++..|+|||
T Consensus 154 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~aPE 178 (309)
T cd07845 154 LARTYGLPAK-------------------------------------------------------PMTPKVVTLWYRAPE 178 (309)
T ss_pred eeeecCCccC-------------------------------------------------------CCCcccccccccChh
Confidence 9853221000 000114567899999
Q ss_pred cccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-------------------CCCCCC-----
Q 013016 317 VASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-------------------PTQSPS----- 371 (451)
Q Consensus 317 ~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-------------------~~~~~~----- 371 (451)
.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+....... +.....
T Consensus 179 ~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07845 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258 (309)
T ss_pred hhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh
Confidence 9876 457899999999999999999999999887777666655421110 000000
Q ss_pred -CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCC
Q 013016 372 -SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGM 428 (451)
Q Consensus 372 -~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~ 428 (451)
...+.++.+||.+||++||++||| +.+++.||||++...+.. +++.|+.
T Consensus 259 ~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~~~~~~~----~~~~~~~ 308 (309)
T cd07845 259 FPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKEKPLPCE----PEMMPTF 308 (309)
T ss_pred ccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccCCCCCC----CCcCCCC
Confidence 112447899999999999999999 999999999998555432 5555654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.00 Aligned_cols=269 Identities=21% Similarity=0.291 Sum_probs=212.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.++||.|+||.||+|..+...+. ..+..||+|.+..... ......+..|+.+++.++|+||+++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKG----EAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCC----CcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 37899999999999999999987643211 1223599999864421 22234566799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQP--------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
...+..|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999999999999987532 1335677889999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+|+|||++........ ........++.
T Consensus 159 ~L~Dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 185 (288)
T cd05061 159 KIGDFGMTRDIYETDY-----------------------------------------------------YRKGGKGLLPV 185 (288)
T ss_pred EECcCCcccccccccc-----------------------------------------------------ccccCCCcccc
Confidence 9999999743211000 00001124567
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
.|+|||.+.+..++.++|||||||++|||++ |..||......+....+..+..... +...+..+.+++.+||+.|
T Consensus 186 ~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~ 261 (288)
T cd05061 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ----PDNCPERVTDLMRMCWQFN 261 (288)
T ss_pred cccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCC
Confidence 7999999998889999999999999999998 8999988777777666655432211 1122348999999999999
Q ss_pred cCCcCCCCCChHHHHc------CCCcCCCCc
Q 013016 390 PCNRLGSKRGAADVKT------HPFFKGLNF 414 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~------hp~~~~~~~ 414 (451)
|.+||+ +.++++ ||||.+++|
T Consensus 262 p~~Rps----~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 262 PKMRPT----FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred hhHCcC----HHHHHHHHHhhcCCCCCCCCC
Confidence 999999 778776 999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.94 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=206.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
..|+++++||.||.+.||++..-+.+ .||+|.+.... .+.....-+..|+.+|.+|+ |.+||.+|++-
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~----------iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ----------IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc----------chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 55999999999999999999865444 37887775443 34566777889999999995 99999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++++||||||= ..+|..+|...... ++.-.++.+..||+.|+.++|+.||||.||||.|+|+- .|.+||+|||+|
T Consensus 430 v~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 430 VTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred ccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence 9999999999965 77899999876443 33338999999999999999999999999999999997 789999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ...-...+-+||+.||+||.+
T Consensus 507 ~aI~~D-----------------------------------------------------TTsI~kdsQvGT~NYMsPEAl 533 (677)
T KOG0596|consen 507 NAIQPD-----------------------------------------------------TTSIVKDSQVGTVNYMSPEAL 533 (677)
T ss_pred cccCcc-----------------------------------------------------ccceeeccccCcccccCHHHH
Confidence 643211 111112234899999999998
Q ss_pred cCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCC--CCCCCCCCCcChHHHHHHHHH
Q 013016 319 SGGS-----------HGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKKPL--TFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 319 ~~~~-----------~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~ll~~ 384 (451)
.... .++++||||||||||+|+.|+.||.... ...-+..|..-.. ++|..... .++.++++.
T Consensus 534 ~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~----~~li~~mK~ 609 (677)
T KOG0596|consen 534 TDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN----DELIDVMKC 609 (677)
T ss_pred hhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCc----hHHHHHHHH
Confidence 5432 4678999999999999999999998744 3344555544322 33332222 149999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
||.+||.+||+ +.|||+|||++.+.-
T Consensus 610 CL~rdPkkR~s----i~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 610 CLARDPKKRWS----IPELLQHPFLQIQPI 635 (677)
T ss_pred HHhcCcccCCC----cHHHhcCcccccccc
Confidence 99999999999 999999999998443
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=334.34 Aligned_cols=256 Identities=30% Similarity=0.440 Sum_probs=207.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+..+++ .||+|++..... .....+..|+.+++.++|+||+++++.+.
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~ 76 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGE---------LAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCc---------EEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 579999999999999999999877665 499999875421 22345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 77 RRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 999999999999999999988764 469999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||++.
T Consensus 155 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 155 QITAT-------------------------------------------------------IAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred EccCc-------------------------------------------------------ccccccccCcccccChhhhc
Confidence 22100 00011236889999999974
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 ---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
...++.++|||||||++|+|++|..||...........+.......+........+..+.+++.+||+.||++||+
T Consensus 180 ~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~- 258 (267)
T cd06645 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT- 258 (267)
T ss_pred cccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC-
Confidence 4457889999999999999999999997655544444433333322221111123447999999999999999999
Q ss_pred CCChHHHHcCCC
Q 013016 397 KRGAADVKTHPF 408 (451)
Q Consensus 397 ~~~~~ell~hp~ 408 (451)
+++|++|||
T Consensus 259 ---~~~ll~~~~ 267 (267)
T cd06645 259 ---AEKLLQHPF 267 (267)
T ss_pred ---HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=329.16 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=214.9
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||.|+||.||++....+++ .||+|.+...... ......+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGK---------QYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEE 70 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCC---------EEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence 58999999999999999999877655 3999998754322 2234567789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.++.|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 99999999999999999988776555689999999999999999999999999999999999999999999999999742
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... ........|+..|+|||++.+
T Consensus 151 ~~~~-------------------------------------------------------~~~~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 151 LNST-------------------------------------------------------VELARTCIGTPYYLSPEICEN 175 (256)
T ss_pred cCcc-------------------------------------------------------hhhhhhccCCccccCHHHhCC
Confidence 2110 000012357888999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++|||||||++|+|++|+.||......+....+..+..... +...+.++.++|.+||+.+|.+||+ +
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~----~ 247 (256)
T cd08218 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV----SSHYSYDLRNLVSQLFKRNPRDRPS----V 247 (256)
T ss_pred CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC----cccCCHHHHHHHHHHhhCChhhCcC----H
Confidence 8899999999999999999999999988777777777766543221 1123348999999999999999999 9
Q ss_pred HHHHcCCCc
Q 013016 401 ADVKTHPFF 409 (451)
Q Consensus 401 ~ell~hp~~ 409 (451)
.+|++||||
T Consensus 248 ~~vl~~~~~ 256 (256)
T cd08218 248 NSILEKNFI 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=333.94 Aligned_cols=260 Identities=29% Similarity=0.439 Sum_probs=215.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|++|.||+|.+..+++ .||+|++.... .......+..|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQ---------VVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFL 69 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCe---------EEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEE
Confidence 368899999999999999999887655 49999987542 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++..+|+|+||+++++|.+++... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 70 KGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred ECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 999999999999999999998764 68999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|+..|+|||.+.
T Consensus 147 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~~~ 171 (274)
T cd06609 147 QLTSTM-------------------------------------------------------SKRNTFVGTPFWMAPEVIK 171 (274)
T ss_pred eecccc-------------------------------------------------------cccccccCCccccChhhhc
Confidence 332110 0111236788899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+......... ....+..+.+++.+||..||++||+
T Consensus 172 ~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~l~~~p~~Rpt---- 244 (274)
T cd06609 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNKFSKPFKDFVSLCLNKDPKERPS---- 244 (274)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc---ccccCHHHHHHHHHHhhCChhhCcC----
Confidence 988999999999999999999999999877666555555544322211 1113448999999999999999999
Q ss_pred hHHHHcCCCcCCCCcc
Q 013016 400 AADVKTHPFFKGLNFA 415 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~ 415 (451)
++++++||||++....
T Consensus 245 ~~~il~~~~~~~~~~~ 260 (274)
T cd06609 245 AKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhChhhcCCCcc
Confidence 9999999999985543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=330.65 Aligned_cols=256 Identities=38% Similarity=0.710 Sum_probs=213.9
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||.|++|.||+|.+....+ .||+|++.+...........+..|+.+++.++|+||+++++.+.+++..|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNR---------TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECCCCc---------EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6999999999999876554 4999999876544445556788899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||+++++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~--- 146 (262)
T cd05572 72 MEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--- 146 (262)
T ss_pred EecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---
Confidence 9999999999998765 44899999999999999999999999999999999999999999999999997432110
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
.......|+..|++||.+.+..++.++
T Consensus 147 -----------------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~ 173 (262)
T cd05572 147 -----------------------------------------------------QKTWTFCGTPEYVAPEIILNKGYDFSV 173 (262)
T ss_pred -----------------------------------------------------cccccccCCcCccChhHhcCCCCCChh
Confidence 011123678889999999888899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhc--CCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHH
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPS--NETTLRNIVK--KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAAD 402 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~e 402 (451)
|+||||+++|+|++|..||.... ....+..+.. ....++... +.++.++|.+||+.||++||++ +..++|
T Consensus 174 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~i~~~l~~~p~~R~~~~~~~~~~ 248 (262)
T cd05572 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI-----DKAAKDLIKQLLRRNPEERLGNLKGGIKD 248 (262)
T ss_pred hhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCccc-----CHHHHHHHHHHccCChhhCcCCcccCHHH
Confidence 99999999999999999998766 5556666663 223333222 3489999999999999999994 444899
Q ss_pred HHcCCCcCCCCcc
Q 013016 403 VKTHPFFKGLNFA 415 (451)
Q Consensus 403 ll~hp~~~~~~~~ 415 (451)
+++||||++.+|.
T Consensus 249 l~~~~~~~~~~~~ 261 (262)
T cd05572 249 IKKHKWFNGFDWE 261 (262)
T ss_pred HhcChhhhCCCCC
Confidence 9999999987764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.12 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=211.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+|.+.+.||+|++|.||+|.+..+++ .||+|.+...... ....+..|+.+++.+.|+||+++++.+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCc---------EEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3689999999999999999999876655 3999998754322 235566799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
....+.|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 87 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999999998865 34889999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ........|++.|+|||.+
T Consensus 164 ~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 188 (296)
T cd06654 164 AQITPE-------------------------------------------------------QSKRSTMVGTPYWMAPEVV 188 (296)
T ss_pred hhcccc-------------------------------------------------------ccccCcccCCccccCHHHH
Confidence 421100 0000123688899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|||||||++|+|++|+.||...........+..... .+..... ..+..+.+|+.+||..||++||+
T Consensus 189 ~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt--- 263 (296)
T cd06654 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPE-KLSAIFRDFLNRCLDMDVEKRGS--- 263 (296)
T ss_pred cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCcc-ccCHHHHHHHHHHCcCCcccCcC---
Confidence 988889999999999999999999999987766544443333221 1111122 23347999999999999999999
Q ss_pred ChHHHHcCCCcCCCC
Q 013016 399 GAADVKTHPFFKGLN 413 (451)
Q Consensus 399 ~~~ell~hp~~~~~~ 413 (451)
+.++++||||...+
T Consensus 264 -~~eil~~~~~~~~~ 277 (296)
T cd06654 264 -AKELLQHQFLKIAK 277 (296)
T ss_pred -HHHHhhChhhhccC
Confidence 99999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=332.90 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=206.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.++.+++ .||+|++..... .....+..|+.++++++|+||+++++++.
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~ 76 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGE---------LAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYL 76 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCe---------EEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence 679999999999999999999876655 499999874421 22345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 77 SREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999999988754 468999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||.+.
T Consensus 155 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 155 KITAT-------------------------------------------------------IAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred eeccc-------------------------------------------------------ccccCccccCccccCHhHcc
Confidence 22100 00011236888999999985
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 ---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
...++.++|||||||++|+|++|+.||...........+.......+........+..+.+||++||+.||++||+
T Consensus 180 ~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~- 258 (267)
T cd06646 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT- 258 (267)
T ss_pred cccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC-
Confidence 3447889999999999999999999997655444433333333222222111223448999999999999999999
Q ss_pred CCChHHHHcCCC
Q 013016 397 KRGAADVKTHPF 408 (451)
Q Consensus 397 ~~~~~ell~hp~ 408 (451)
+++|++|+|
T Consensus 259 ---~~~il~~l~ 267 (267)
T cd06646 259 ---AERLLTHLF 267 (267)
T ss_pred ---HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.26 Aligned_cols=266 Identities=21% Similarity=0.280 Sum_probs=203.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccC-------CCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQD-------RGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv 152 (451)
++|.+.++||+|+||.||+|.+....... .....+..||+|++.... .......+.+|+.++.+++|+||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 67999999999999999999876543210 112233469999997542 223345677899999999999999
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP-----------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYR 215 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~ 215 (451)
++++++...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999886532 1246888999999999999999999999999
Q ss_pred cCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccc
Q 013016 216 DLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295 (451)
Q Consensus 216 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (451)
||||+|||++.++.+||+|||++.......
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------------------------------- 192 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------------------------------- 192 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCc--------------------------------------------------
Confidence 999999999999999999999974221100
Q ss_pred cccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhc---CCCCCCCCCC
Q 013016 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY--GRTPFAAPSNETTLRNIVK---KPLTFPTQSP 370 (451)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~ 370 (451)
.........++..|+|||++.+..++.++|||||||++|+|++ +..||......+.+..+.. ..........
T Consensus 193 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (304)
T cd05096 193 ---YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFR 269 (304)
T ss_pred ---eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccC
Confidence 0001112356778999999988889999999999999999987 6778887666655444322 1111000111
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
+...+..+.+|+.+||+.||++||| +.+|.
T Consensus 270 ~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~ 299 (304)
T cd05096 270 PPPCPQGLYELMLQCWSRDCRERPS----FSDIH 299 (304)
T ss_pred CCCCCHHHHHHHHHHccCCchhCcC----HHHHH
Confidence 1223448999999999999999999 88884
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=331.03 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=210.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH------HHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE------KKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
+|.+...||.|++|.||+|.+....+ .||+|.+...... .......+..|+.++++++|+||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGE---------LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCc---------EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 37788899999999999999876654 3999988643221 22344667789999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++...++.++||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecc
Confidence 99999999999999999999999999765 4589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||.+......... .........+.|+..|+|
T Consensus 150 fg~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~y~~ 180 (267)
T cd06628 150 FGISKKLEANSLS-------------------------------------------------TKTNGARPSLQGSVFWMA 180 (267)
T ss_pred cCCCccccccccc-------------------------------------------------CCccccccccCCCcCccC
Confidence 9997533210000 000001113468889999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||.+.+..++.++|||||||++|+|++|+.||........+.++..... ..+ ...+.++.++|.+||+.||.+|
T Consensus 181 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R 255 (267)
T cd06628 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP-----SNISSEAIDFLEKTFEIDHNKR 255 (267)
T ss_pred hhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC-----cccCHHHHHHHHHHccCCchhC
Confidence 9999988899999999999999999999999988766555555444321 111 1233489999999999999999
Q ss_pred CCCCCChHHHHcCCCc
Q 013016 394 LGSKRGAADVKTHPFF 409 (451)
Q Consensus 394 pt~~~~~~ell~hp~~ 409 (451)
|+ +.++++||||
T Consensus 256 p~----~~~il~~~~~ 267 (267)
T cd06628 256 PT----AAELLKHPFL 267 (267)
T ss_pred cC----HHHHhhCCCC
Confidence 99 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=331.73 Aligned_cols=253 Identities=34% Similarity=0.636 Sum_probs=212.1
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|+||.||+|.+..+++ .||+|++.+...........+..|++++++++||||+++++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKK---------MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCc---------EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 48999999999999999999876655 399999987655444566788889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
+++.|+|+||+.|++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 99999999999999999998765 4689999999999999999999999999999999999999999999999998742
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... ......|+..|+|||.+.+
T Consensus 150 ~~~~~--------------------------------------------------------~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 150 VTPDT--------------------------------------------------------LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred cCCCc--------------------------------------------------------cccccCCChhhcCHHHHcc
Confidence 21100 0012357788999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
..++.++|+||||+++|+|++|+.||..... ..............+. ..+.++.++|.+||+.||.+||+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~~p~~R~~-- 246 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA-----TWSTEAIDAINKLLERDPQKRLG-- 246 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcc-----cCcHHHHHHHHHHccCChhHcCC--
Confidence 8899999999999999999999999987664 3333222222222222 23348999999999999999999
Q ss_pred CCh--HHHHcCCCc
Q 013016 398 RGA--ADVKTHPFF 409 (451)
Q Consensus 398 ~~~--~ell~hp~~ 409 (451)
+ .|+++||||
T Consensus 247 --~~~~~l~~~~~~ 258 (258)
T cd05578 247 --DNLKDLKNHPYF 258 (258)
T ss_pred --ccHHHHhcCCCC
Confidence 7 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=335.29 Aligned_cols=242 Identities=17% Similarity=0.214 Sum_probs=201.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe----C
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA----S 161 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~ 161 (451)
..||+|++|.||+|.+.+. .||||++...........+.+.+|+.++++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNK-----------EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEECCE-----------EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5789999999999998543 399999986544344445677889999999999999999999876 4
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
..+++||||++||+|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 5789999999999999998765 458999999999999999999998 5999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... .....|+..|+|||++.+
T Consensus 173 ~~~~----------------------------------------------------------~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 173 LSSP----------------------------------------------------------PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred hccc----------------------------------------------------------cccccCcccccCHHHhhh
Confidence 2110 001267889999999976
Q ss_pred --CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 321 --GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 321 --~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
..++.++|||||||++|||++|+.||......+....+......++.. ...+..+.+|+.+||+.||++|||
T Consensus 195 ~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps--- 268 (283)
T PHA02988 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP---LDCPLEIKCIVEACTSHDSIKRPN--- 268 (283)
T ss_pred ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC---CcCcHHHHHHHHHHhcCCcccCcC---
Confidence 678999999999999999999999999888777777776554333321 123448999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.||++
T Consensus 269 -~~ell~ 274 (283)
T PHA02988 269 -IKEILY 274 (283)
T ss_pred -HHHHHH
Confidence 888874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=351.02 Aligned_cols=264 Identities=17% Similarity=0.272 Sum_probs=205.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
....++|++.+.||+|+||.||+|.+...+.. .....||+|++..... ......+..|+.+++.+ +|+||+++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKE----DNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcc----cccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeE
Confidence 33446799999999999999999997654432 1223599999975432 22345677899999999 89999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC--------------------------------------------------
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP-------------------------------------------------- 184 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------------------------------------------- 184 (451)
+++|...+..|+|||||++|+|.+++....
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 999999999999999999999999875421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCC
Q 013016 185 ------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 185 ------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 246 (451)
..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~- 266 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS- 266 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc-
Confidence 1347889999999999999999999999999999999999999999999999974321100
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 326 (451)
.........++..|||||++.+..++.+
T Consensus 267 ----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 294 (374)
T cd05106 267 ----------------------------------------------------NYVVKGNARLPVKWMAPESIFDCVYTVQ 294 (374)
T ss_pred ----------------------------------------------------ceeeccCCCCccceeCHHHhcCCCCCcc
Confidence 0000011235667999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 327 VDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 327 ~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+|||||||++|+|++ |+.||........+..+......... +...+.++.+++.+||+.||.+||+ +.+|++
T Consensus 295 ~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs----~~~l~~ 367 (374)
T cd05106 295 SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR---PDFAPPEIYSIMKMCWNLEPTERPT----FSQISQ 367 (374)
T ss_pred ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC---CCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999997 99999876555444444443222111 1123348999999999999999999 888864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.30 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=222.5
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.-++.||.|+||-||.|++..+.. +||||.+...-....+..+++..|+.+|+++.|||++.+.|+|..+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~e---------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre 98 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE 98 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccc---------eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence 7788899999999999999987765 5999999876666677888999999999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
...||||||| -||-.|++.-.+ +++.+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|..
T Consensus 99 ~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi- 175 (948)
T KOG0577|consen 99 HTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI- 175 (948)
T ss_pred chHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh-
Confidence 9999999999 788888887664 5699999999999999999999999999999999999999999999999998732
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC-
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG- 320 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 320 (451)
..-.++|+|||.|||||+|+.
T Consensus 176 ----------------------------------------------------------~~PAnsFvGTPywMAPEVILAM 197 (948)
T KOG0577|consen 176 ----------------------------------------------------------MAPANSFVGTPYWMAPEVILAM 197 (948)
T ss_pred ----------------------------------------------------------cCchhcccCCccccchhHheec
Confidence 223346899999999999864
Q ss_pred --CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 321 --GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 321 --~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.|+-++||||||++..||...++|+..++....+..|.... +.++ .+.++..++.||..||.+-|.+|||
T Consensus 198 DEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq----s~eWS~~F~~Fvd~CLqKipqeRpt-- 271 (948)
T KOG0577|consen 198 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPT-- 271 (948)
T ss_pred cccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC----CchhHHHHHHHHHHHHhhCcccCCc--
Confidence 679999999999999999999999999988888877776654 3333 2334458999999999999999999
Q ss_pred CChHHHHcCCCcCC
Q 013016 398 RGAADVKTHPFFKG 411 (451)
Q Consensus 398 ~~~~ell~hp~~~~ 411 (451)
.+++|+|+|...
T Consensus 272 --se~ll~H~fv~R 283 (948)
T KOG0577|consen 272 --SEELLKHRFVLR 283 (948)
T ss_pred --HHHHhhcchhcc
Confidence 999999999987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.54 Aligned_cols=257 Identities=31% Similarity=0.436 Sum_probs=211.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||.||+|.+..+.+ .+|+|++..... .....+..|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 70 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGE---------LVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYL 70 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCC---------EEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEE
Confidence 679999999999999999999876654 399999975532 24466778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.+|++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 71 RRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999999999887642 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||.+.
T Consensus 150 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~~Pe~~~ 174 (262)
T cd06613 150 QLTAT-------------------------------------------------------IAKRKSFIGTPYWMAPEVAA 174 (262)
T ss_pred hhhhh-------------------------------------------------------hhccccccCCccccCchhhc
Confidence 22100 00111236788899999998
Q ss_pred CC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 GG---SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+. .++.++|||||||++|+|++|+.||...........+.......+........+.++.+|+.+||..||..||+
T Consensus 175 ~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt- 253 (262)
T cd06613 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT- 253 (262)
T ss_pred ccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC-
Confidence 76 78899999999999999999999998877666555554443322221122223447899999999999999999
Q ss_pred CCChHHHHcCCC
Q 013016 397 KRGAADVKTHPF 408 (451)
Q Consensus 397 ~~~~~ell~hp~ 408 (451)
+.+++.|+|
T Consensus 254 ---~~~il~~~~ 262 (262)
T cd06613 254 ---ATKLLQHPF 262 (262)
T ss_pred ---HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.42 Aligned_cols=254 Identities=32% Similarity=0.612 Sum_probs=199.9
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHH---HHHHHHCCCCCccceeEEEEeCCe
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME---KKILKMLDHPFLPTLYAEFEASNF 163 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~nIv~l~~~~~~~~~ 163 (451)
.||+|+||.||+|.+..+++ .||+|++.+..............| +.+++...|+||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCC---------EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 38999999999999876655 499999876533222211122223 344555689999999999999999
Q ss_pred EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCC
Q 013016 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243 (451)
Q Consensus 164 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 243 (451)
.|+||||+.|++|.+++... +.+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 149 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence 99999999999999888654 5699999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC-C
Q 013016 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-S 322 (451)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 322 (451)
.......|+..|+|||.+.++ .
T Consensus 150 ---------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 172 (278)
T cd05606 150 ---------------------------------------------------------KKPHASVGTHGYMAPEVLQKGVA 172 (278)
T ss_pred ---------------------------------------------------------cCCcCcCCCcCCcCcHHhcCCCC
Confidence 000123688999999999754 5
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC-----
Q 013016 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPS---NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL----- 394 (451)
Q Consensus 323 ~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp----- 394 (451)
++.++||||+||++|+|++|+.||.... .......+.......+. ..+.++.+++.+||..||.+|+
T Consensus 173 ~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~li~~~l~~~p~~R~~~~~~ 247 (278)
T cd05606 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD-----SFSPELRSLLEGLLQRDVNRRLGCLGR 247 (278)
T ss_pred CCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC-----cCCHHHHHHHHHHhhcCHHhccCCCCC
Confidence 8999999999999999999999998652 22222222222222222 2244899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCcccc
Q 013016 395 GSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~~ 417 (451)
+ +.++++||||+.++|...
T Consensus 248 ~----~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 248 G----AQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred C----HHHHHhCccccCCCchHh
Confidence 8 999999999999988765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=321.79 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=217.8
Q ss_pred CCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 80 RDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
++|.+. ++||-|-.|.|-.|..+.++++ +|+|++... .+..+|+++.... .|+|||.++++
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ek---------fALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidV 123 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEK---------FALKVLLDS--------PKARREVELHWMASGHPHIVSIIDV 123 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhh---------hHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehh
Confidence 678775 4699999999999999988875 999998633 2223466665444 69999999999
Q ss_pred EEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CCCE
Q 013016 158 FEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHI 230 (451)
Q Consensus 158 ~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~~~ 230 (451)
|+. ...+.+|||.++||.|..-+.......|++.++..|++||..|+.|||+.+|.||||||+|+|.+. |-.+
T Consensus 124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred hhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence 864 357889999999999999999988888999999999999999999999999999999999999985 4479
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||+|+..... ..-.+-|-|+
T Consensus 204 KLtDfGFAK~t~~~--------------------------------------------------------~~L~TPc~TP 227 (400)
T KOG0604|consen 204 KLTDFGFAKETQEP--------------------------------------------------------GDLMTPCFTP 227 (400)
T ss_pred EecccccccccCCC--------------------------------------------------------ccccCCcccc
Confidence 99999999643210 0111237899
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
.|.|||++....|+...|+||+||+||-||+|.+||.... .-.+..+|..+...+|...|+.+++ .++++|+.+|
T Consensus 228 yYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe-~aKdlIR~LL 306 (400)
T KOG0604|consen 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE-AAKDLIRKLL 306 (400)
T ss_pred cccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH-HHHHHHHHHh
Confidence 9999999998899999999999999999999999998754 3457788999999999998888777 8999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
..+|.+|.| +.++++|||+.+
T Consensus 307 kt~PteRlT----I~~~m~hpwi~~ 327 (400)
T KOG0604|consen 307 KTEPTERLT----IEEVMDHPWINQ 327 (400)
T ss_pred cCCchhhee----HHHhhcCchhcc
Confidence 999999999 999999999998
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.39 Aligned_cols=258 Identities=27% Similarity=0.382 Sum_probs=212.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|++.+.||.|++|.||+|.+..+++ .||+|.+..... .....+..|+.+++.++|+||+++++++.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQ---------EVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFL 86 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCc---------EEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence 579999999999999999999876665 399999875422 23455677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 99999999999999999998865 348999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||.+.
T Consensus 164 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 164 QITPE-------------------------------------------------------QSKRSTMVGTPYWMAPEVVT 188 (296)
T ss_pred hcccc-------------------------------------------------------cccCCCcCCCccccCcchhc
Confidence 22100 00011236888999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||........+..+....... ... +...+..+.+||.+||..||.+||+
T Consensus 189 ~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~li~~~l~~dp~~Rpt---- 262 (296)
T cd06655 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQN-PEKLSPIFRDFLNRCLEMDVEKRGS---- 262 (296)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCC-cccCCHHHHHHHHHHhhcChhhCCC----
Confidence 8889999999999999999999999998877666555554332111 111 1223348999999999999999999
Q ss_pred hHHHHcCCCcCCCC
Q 013016 400 AADVKTHPFFKGLN 413 (451)
Q Consensus 400 ~~ell~hp~~~~~~ 413 (451)
+.+++.||||+...
T Consensus 263 ~~~il~~~~~~~~~ 276 (296)
T cd06655 263 AKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhChHhhhcc
Confidence 99999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=334.70 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=214.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||.|+||.||+|.+..+.. .+|+|++.... ......+..|+.++++++|+||+++++.+.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGL---------FAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYF 72 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCc---------EEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEe
Confidence 679999999999999999999876554 49999987442 233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 73 YENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred cCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999999999887642 459999999999999999999999999999999999999999999999999863
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .........|+..|+|||++.
T Consensus 152 ~~~~-------------------------------------------------------~~~~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 152 KNKS-------------------------------------------------------TLQKRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred hhcc-------------------------------------------------------cccccceeecchhhcCHHHHh
Confidence 2110 000111246888999999975
Q ss_pred -----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 320 -----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 320 -----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
+..++.++|||||||++|+|++|+.||........+..+....... ...+...+.++.++|.+||..||.+||
T Consensus 177 ~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred hcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC--cCCcccCCHHHHHHHHHHhccChhhCc
Confidence 3446789999999999999999999998877777666665543221 111223344899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCC
Q 013016 395 GSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~ 413 (451)
+ +.++++||||.+..
T Consensus 255 s----~~~il~~~~~~~~~ 269 (280)
T cd06611 255 T----AAELLKHPFVSDQS 269 (280)
T ss_pred C----HHHHhcChhhcccc
Confidence 9 99999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=324.44 Aligned_cols=267 Identities=30% Similarity=0.447 Sum_probs=219.8
Q ss_pred ceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEE
Q 013016 82 FDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFE 159 (451)
Q Consensus 82 y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~ 159 (451)
|++. +.||+|+|+.|-.|....++.+ ||||++.+.... ...++.+|++++.+.+ |+||+.++++|+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~E---------YAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKE---------YAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchh---------hhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 5553 4699999999999998877765 999999987332 3356677999999985 999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl~Dfg 236 (451)
++..+|||||.|.||+|...+... +.|++..+.+++++|+.||.|||.+||.||||||+|||-.... -+|||||.
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999999988876 4599999999999999999999999999999999999998665 48999998
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+..-..... .-....+| .-.+.+|+..|||||
T Consensus 225 LgSg~k~~~-------------------------------------~~spastP-----------~L~tPvGSAEfMAPE 256 (463)
T KOG0607|consen 225 LGSGIKLNN-------------------------------------DCSPASTP-----------ELLTPVGSAEFMAPE 256 (463)
T ss_pred cccccccCC-------------------------------------CCCCCCCc-----------cccCcccchhhcchh
Confidence 862110000 00000000 011348999999999
Q ss_pred ccc---C--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHhcCCCCCCCCCCCCcChH
Q 013016 317 VAS---G--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETTLRNIVKKPLTFPTQSPSSMSEY 376 (451)
Q Consensus 317 ~~~---~--~~~~~~~DIwSlG~il~elltg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~ 376 (451)
++. + ..|+.+.|.||||+|||-||.|.+||.+.- ....+..|..+...+|...|--+.+
T Consensus 257 VVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~- 335 (463)
T KOG0607|consen 257 VVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS- 335 (463)
T ss_pred HHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH-
Confidence 863 2 347999999999999999999999997531 3467899999999999998877766
Q ss_pred HHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 377 ~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
++++++..+|-.|+..|.+ +.++++|||++..-..
T Consensus 336 eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 336 EAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHhccHHhhhh----hhhccCCccccccchh
Confidence 8999999999999999999 9999999999995443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=329.87 Aligned_cols=265 Identities=38% Similarity=0.678 Sum_probs=217.7
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||.|+||.||+|.+..+++ .+|+|++.............+..|+.++++++|+||+++++.+...+..|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD---------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCCC---------EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999999886554 4999999876555556667788899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence 99999999999988753 6899999999999999999999999999999999999999999999999997432111000
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
.. ...........++..|+|||.+.+..++.++
T Consensus 150 ~~-----------------------------------------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~ 182 (265)
T cd05579 150 NL-----------------------------------------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182 (265)
T ss_pred cc-----------------------------------------------ccccccccCcccCccccCHHHhcCCCCCcch
Confidence 00 0000111224678889999999888889999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCC
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp 407 (451)
||||||+++|+|++|..||......+.+..+..+...++.... .+..+.+|+.+||+.+|.+|||+.. +.++|+||
T Consensus 183 Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~-~~~~l~~~ 258 (265)
T cd05579 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE---VSDEAIDLISKLLVPDPEKRLGAKS-IEEIKNHP 258 (265)
T ss_pred hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcccc---CCHHHHHHHHHHhcCCHhhcCCCcc-HHHHhcCc
Confidence 9999999999999999999988888888777765554443221 2448999999999999999999111 29999999
Q ss_pred CcCCCCc
Q 013016 408 FFKGLNF 414 (451)
Q Consensus 408 ~~~~~~~ 414 (451)
||++++|
T Consensus 259 ~~~~~~~ 265 (265)
T cd05579 259 FFKGIDW 265 (265)
T ss_pred cccCCCC
Confidence 9999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.14 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=208.8
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH---HHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV---LEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
+|.+.+.||.|+||.||+|....+. .+|+|++.... .........+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~----------~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQ----------LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCC----------eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999999764322 39999886432 1223344567889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+.+..|+||||++|++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchh
Confidence 99999999999999999999998764 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........... .........|+..|+|||+
T Consensus 149 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~~~pe~ 179 (265)
T cd06631 149 ARRLAWVGLHGT-------------------------------------------------HSNMLKSMHGTPYWMAPEV 179 (265)
T ss_pred hHhhhhcccccc-------------------------------------------------ccccccccCCCccccChhh
Confidence 743211000000 0000112368889999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||...........+.......+. .+...+..+.+++.+||..+|.+||+
T Consensus 180 ~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~-- 255 (265)
T cd06631 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR--LPDSFSAAAIDFVTSCLTRDQHERPS-- 255 (265)
T ss_pred hcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC--CCCCCCHHHHHHHHHHhcCCcccCCC--
Confidence 99888999999999999999999999999876655544444433221111 11224448999999999999999999
Q ss_pred CChHHHHcCCCc
Q 013016 398 RGAADVKTHPFF 409 (451)
Q Consensus 398 ~~~~ell~hp~~ 409 (451)
+.+++.||||
T Consensus 256 --~~~~l~~~~~ 265 (265)
T cd06631 256 --ALQLLRHDFL 265 (265)
T ss_pred --HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.38 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=205.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+.|++.+.||.|+||.||+|.+....+ .+|+|++.... .....+..|+.+++++ +|+||+++++++
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCc---------EEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 789999999999999999999876654 49999986542 2234566788889888 699999999998
Q ss_pred E------eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 E------ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
. ...+.|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 5 3468899999999999999998766667899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ........|+..|
T Consensus 163 ~dfg~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y 187 (282)
T cd06636 163 VDFGVSAQLDRT-------------------------------------------------------VGRRNTFIGTPYW 187 (282)
T ss_pred eeCcchhhhhcc-------------------------------------------------------ccCCCcccccccc
Confidence 999997422100 0011124688899
Q ss_pred cCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 313 VSPEVAS-----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 313 ~aPE~~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+|||.+. +..++.++|||||||++|+|++|..||...........+..... ........+.++.+||.+||+
T Consensus 188 ~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~ 264 (282)
T cd06636 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP---PKLKSKKWSKKFIDFIEGCLV 264 (282)
T ss_pred cCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC---CCCcccccCHHHHHHHHHHhC
Confidence 9999986 34578899999999999999999999987655444433332211 111122234489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCc
Q 013016 388 KDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.||.+||+ +.|||+||||
T Consensus 265 ~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 265 KNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred CChhhCcC----HHHHhcCCCC
Confidence 99999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=334.31 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=211.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+...... .....||+|.+.... .......+.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNER----LSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCC----cceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 447899999999999999999998765421 122359999987442 22334567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPH--------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
+...+..|++|||+++++|.+++..... ..+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9999999999999999999999876421 45889999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.++|+|||++....... .....
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~-----------------------------------------------------~~~~~ 183 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSAD-----------------------------------------------------YYRVQ 183 (283)
T ss_pred EcCCCcEEECCCcceeeccccc-----------------------------------------------------ccccc
Confidence 9999999999999974221100 00011
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..+..... +...+.++.+|+
T Consensus 184 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~l~ 259 (283)
T cd05048 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC----PEDCPARVYALM 259 (283)
T ss_pred CCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC----cccCCHHHHHHH
Confidence 12256788999999988889999999999999999998 9999998887777777665543221 223345899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHcC
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+||+.||.+||+ +.||+++
T Consensus 260 ~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 260 IECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred HHHccCChhhCcC----HHHHHHH
Confidence 9999999999999 9998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=324.79 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=216.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|+||.||.+....+.+ .+++|.+...... ......+..|+.++++++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 70 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDS---------LVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMD 70 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCc---------EEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence 58999999999999999999877655 3999988654322 2334566789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+.+++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 99999999999999999999876556789999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... .......|++.|+|||.+.+
T Consensus 151 ~~~~~-------------------------------------------------------~~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 151 LGSEY-------------------------------------------------------SMAETVVGTPYYMSPELCQG 175 (256)
T ss_pred ccccc-------------------------------------------------------ccccccCCCccccCHhhcCC
Confidence 21100 00112368889999999998
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++||||||+++|+|++|..||......+....+..+...... ...+.++.+++.+||..+|.+||+ +
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~s----~ 247 (256)
T cd08221 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV----SVYSSELISLVHSLLQQDPEKRPT----A 247 (256)
T ss_pred CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc----cccCHHHHHHHHHHcccCcccCCC----H
Confidence 88899999999999999999999999987777777777765443222 223448999999999999999999 9
Q ss_pred HHHHcCCCc
Q 013016 401 ADVKTHPFF 409 (451)
Q Consensus 401 ~ell~hp~~ 409 (451)
.++++|+|+
T Consensus 248 ~~ll~~~~l 256 (256)
T cd08221 248 DEVLDQPLL 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.53 Aligned_cols=266 Identities=27% Similarity=0.353 Sum_probs=210.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+|.+.+.||.|++|.||+|.+..+++ .||||.+...... .......+..|+.+++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCc---------EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 48889999999999999999877655 3999999765432 122334556789999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~ 149 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA 149 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceee
Confidence 9999999999999 999999987653 36999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......++..|+|||.+
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 150 RSFGSPN-------------------------------------------------------RKMTHQVVTRWYRAPELL 174 (298)
T ss_pred eeccCCC-------------------------------------------------------ccccccccceeeeCHHHH
Confidence 5322110 000112457789999998
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-----------------------CCCCCcC
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-----------------------QSPSSMS 374 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~~ 374 (451)
.+ ..++.++|||||||++|+|++|..+|......+.+..+......... .......
T Consensus 175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T cd07841 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAA 254 (298)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccc
Confidence 65 45789999999999999999998888876665555444332110000 0000112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
+..+.+||.+||.+||.+||+ +.|++.|+||++...+.
T Consensus 255 ~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 255 SDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSNDPAPT 292 (298)
T ss_pred cHHHHHHHHHHhcCCcccCcC----HHHHhhCccccCCCCCC
Confidence 347899999999999999999 99999999999955543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.95 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=207.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH---HHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL---EKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
+|+..+.||+|++|.||+|.+..+++ .||+|++..... ........+..|+.++++++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGT---------LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCc---------EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999999876655 399999975431 112345677889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEeccC
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFD 236 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg 236 (451)
+.+.++.++||||++|++|.+++... +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 99999999999999999999998764 4689999999999999999999999999999999999998776 59999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
.+......... .........|+..|+|||
T Consensus 150 ~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~~~~PE 178 (268)
T cd06630 150 AAARLAAKGTG---------------------------------------------------AGEFQGQLLGTIAFMAPE 178 (268)
T ss_pred ccccccccccc---------------------------------------------------CCccccccccccceeCHh
Confidence 97433211000 000112346888999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.+.+..++.++|||||||++|+|++|..||...........+............+...+.++.+++.+||..||.+||+
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~- 257 (268)
T cd06630 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP- 257 (268)
T ss_pred HhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC-
Confidence 9988889999999999999999999999997544322222222111001111111223348999999999999999999
Q ss_pred CCChHHHHcCCCcC
Q 013016 397 KRGAADVKTHPFFK 410 (451)
Q Consensus 397 ~~~~~ell~hp~~~ 410 (451)
+.++++||||+
T Consensus 258 ---~~~ll~~~~~~ 268 (268)
T cd06630 258 ---SRELLKHPVFR 268 (268)
T ss_pred ---HHHHhcCcccC
Confidence 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=331.67 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=205.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|.+.+.||+|+||.||+|.++.+++ .+|+|++.... .....+..|+.+++++ +|+||+++++++
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~---------~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGS---------LAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCC---------EEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 789999999999999999999877665 39999986432 1224456688899988 799999999998
Q ss_pred EeC-----CeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 159 EAS-----NFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 159 ~~~-----~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
... +..|+||||++|++|.++++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence 754 3689999999999999988642 345689999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++....... .......|+..
T Consensus 169 l~dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 193 (291)
T cd06639 169 LVDFGVSAQLTSTR-------------------------------------------------------LRRNTSVGTPF 193 (291)
T ss_pred Eeecccchhccccc-------------------------------------------------------ccccCccCCcc
Confidence 99999974321000 00012357888
Q ss_pred ccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 312 YVSPEVASGG-----SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 312 y~aPE~~~~~-----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
|+|||.+... .++.++|||||||++|+|++|+.||........+..+........ ..... ....+.+||.+||
T Consensus 194 y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~l~~li~~~l 271 (291)
T cd06639 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-LHPEK-WCRSFNHFISQCL 271 (291)
T ss_pred ccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-Ccccc-cCHHHHHHHHHHh
Confidence 9999998643 267899999999999999999999988766666666554432211 11112 2337999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcC
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~ 410 (451)
+.||++||+ +.|++.||||+
T Consensus 272 ~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 272 IKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred hcChhhCcC----HHHHhcCcccC
Confidence 999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.84 Aligned_cols=258 Identities=28% Similarity=0.399 Sum_probs=210.9
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|++.+.||.|+||.||+|.+...+. .+|+|.+.... ......+..|+++++.++|+||+++++++..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 73 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGV---------LAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYY 73 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCe---------EEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee
Confidence 37888999999999999999887654 48999986542 2334566779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..|+||||+++++|..++... ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..
T Consensus 74 ~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 74 ENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred CCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999999998877653 24689999999999999999999999999999999999999999999999999742
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc-
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS- 319 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~- 319 (451)
.... ........|+..|+|||++.
T Consensus 153 ~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 177 (282)
T cd06643 153 NTRT-------------------------------------------------------IQRRDSFIGTPYWMAPEVVMC 177 (282)
T ss_pred cccc-------------------------------------------------------ccccccccccccccCHhhccc
Confidence 1100 00111246888999999984
Q ss_pred ----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 320 ----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 320 ----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+..++.++|||||||++|+|++|+.||......+....+........ ..+...+.++.+||.+||+.||.+||+
T Consensus 178 ~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~ 255 (282)
T cd06643 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWT 255 (282)
T ss_pred cCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC--CCccccCHHHHHHHHHHccCChhhCcC
Confidence 34578899999999999999999999988777666666655432211 112223448999999999999999999
Q ss_pred CCCChHHHHcCCCcCCC
Q 013016 396 SKRGAADVKTHPFFKGL 412 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~ 412 (451)
+.++++||||+..
T Consensus 256 ----~~~il~~~~~~~~ 268 (282)
T cd06643 256 ----TTQLLQHPFVTVN 268 (282)
T ss_pred ----HHHHhcCCCEecc
Confidence 9999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.52 Aligned_cols=259 Identities=29% Similarity=0.400 Sum_probs=206.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|++|.||+|.++.+++ .||||.+..... .......+..|++++++++|+||+++++++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 70 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE---------VVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHT 70 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC---------EEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhccc
Confidence 48899999999999999999876655 499999875432 22233567779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..++||||+ .++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 71 ~~~~~~v~e~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 71 ENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred CCcEEEEeecc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999 46899888776667799999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... .......++..|+|||++.+
T Consensus 150 ~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 150 FGVPV-------------------------------------------------------RTYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred cccCc-------------------------------------------------------cccccccccccccCCeEEec
Confidence 21100 00001246778999999877
Q ss_pred CC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC------------------CC------CCcCh
Q 013016 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ------------------SP------SSMSE 375 (451)
Q Consensus 321 ~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------~~------~~~~~ 375 (451)
.. ++.++|||||||++|+|+||+.||...+....+.++.......... .. ....+
T Consensus 175 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (284)
T cd07860 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLD 254 (284)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCC
Confidence 54 5889999999999999999999998876655544443321111000 00 01123
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.+++++|.+||+.||.+||| ++++++||||
T Consensus 255 ~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 255 EDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 37889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.80 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=201.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|++.+.||.|++|.||+|.++.+++ .||||.+..... ......+.+|+.++++++|+||+++++++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQ---------LVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDII 72 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCc---------EEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEE
Confidence 3789999999999999999999876554 499999875421 11223355699999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+.++.|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 73 HTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred ecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccc
Confidence 99999999999996 58998887654 36899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......++..|+|||++
T Consensus 151 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~aPE~~ 175 (291)
T cd07844 151 RAKSVPS-------------------------------------------------------KTYSNEVVTLWYRPPDVL 175 (291)
T ss_pred cccCCCC-------------------------------------------------------ccccccccccccCCcHHh
Confidence 4211000 000012467789999998
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCCC-------------------CCC-------CC
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKKPLTF-------------------PTQ-------SP 370 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~-------------------~~~-------~~ 370 (451)
.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.+..... ... ..
T Consensus 176 ~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd07844 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA 255 (291)
T ss_pred hcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC
Confidence 76 457899999999999999999999997654 233333222110000 000 00
Q ss_pred CCcC-hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 371 SSMS-EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 371 ~~~~-~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+. ..++.+++.+||+.||.+||+ +.|++.||||
T Consensus 256 ~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 256 PRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred cCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 0111 137889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=334.57 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=208.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||.||+|.+...+. .||+|.+.... .......+.+|+.++++++|+||+++++.+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGV---------TMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFF 69 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCc---------EEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhhee
Confidence 368999999999999999999876654 49999886542 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
..+.+|+||||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred cCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 9999999999999999998887632 2368999999999999999999996 5999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ......|+..|+|||.
T Consensus 150 ~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~ 172 (286)
T cd06622 150 SGNLVAS---------------------------------------------------------LAKTNIGCQSYMAPER 172 (286)
T ss_pred cccccCC---------------------------------------------------------ccccCCCccCccCcch
Confidence 7422100 0012257788999999
Q ss_pred ccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 318 ASGGS------HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 318 ~~~~~------~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+.+.. ++.++|||||||++|+|++|+.||...........+.......+...... .+.++.+||.+||+.+|+
T Consensus 173 ~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred hcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc-cCHHHHHHHHHHcccCcc
Confidence 86543 47899999999999999999999976554443333222111111111222 344899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCCCc
Q 013016 392 NRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+||+ +++++.||||.....
T Consensus 252 ~Rp~----~~~l~~~~~~~~~~~ 270 (286)
T cd06622 252 RRPT----YAQLLEHPWLVKYKN 270 (286)
T ss_pred cCCC----HHHHhcChhhhhccC
Confidence 9999 999999999988543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.48 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=209.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+...++ .||+|.+...... ..+.+..|+.+++.++|+||+++++++.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 86 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQ---------EVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYL 86 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCC---------EEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 789999999999999999999876655 3999998754322 2345667899999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++.|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999999998865 348899999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|++.|+|||.+.
T Consensus 164 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 188 (297)
T cd06656 164 QITPEQ-------------------------------------------------------SKRSTMVGTPYWMAPEVVT 188 (297)
T ss_pred EccCCc-------------------------------------------------------cCcCcccCCccccCHHHHc
Confidence 221000 0001235788899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+.... .+....+...+..+.+|+.+||..||++||+
T Consensus 189 ~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---- 262 (297)
T cd06656 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG--TPELQNPERLSAVFRDFLNRCLEMDVDRRGS---- 262 (297)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC--CCCCCCccccCHHHHHHHHHHccCChhhCcC----
Confidence 8889999999999999999999999998765544333222221 1111112223447899999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
+.++++||||+.
T Consensus 263 ~~~il~~~~~~~ 274 (297)
T cd06656 263 AKELLQHPFLKL 274 (297)
T ss_pred HHHHhcCchhcc
Confidence 999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.60 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=203.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||.||+|.++..++ .+|+|++.... .....+..|+.+++.+ +|+||+++++++
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGS---------KAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCc---------eeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 889999999999999999999877655 39999886432 1224456688999998 699999999988
Q ss_pred E-----eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 159 E-----ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 159 ~-----~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
. .++.+++||||++|++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence 4 446799999999999999987642 235689999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++....... .......|+..
T Consensus 165 l~dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 189 (286)
T cd06638 165 LVDFGVSAQLTSTR-------------------------------------------------------LRRNTSVGTPF 189 (286)
T ss_pred EccCCceeecccCC-------------------------------------------------------CccccccCCCc
Confidence 99999974321100 00112368899
Q ss_pred ccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 312 YVSPEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 312 y~aPE~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
|+|||++.+ ..++.++|||||||++|+|++|+.||........+..+..... +....+...+.++.+|+.+||
T Consensus 190 y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd06638 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP--PTLHQPELWSNEFNDFIRKCL 267 (286)
T ss_pred ccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC--CcccCCCCcCHHHHHHHHHHc
Confidence 999999753 4478899999999999999999999987665554444333221 111122233448999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
+.||++||+ +.||++|+||
T Consensus 268 ~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 268 TKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred cCCcccCCC----HHHHhhcccC
Confidence 999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.80 Aligned_cols=256 Identities=19% Similarity=0.241 Sum_probs=206.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.++...+ .+..||+|++..... ......+..|+.++++++||||+++++++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~------~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSK------RELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCC------ceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 3679999999999999999998764321 123599999976522 23345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+++.|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999987643 46899999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... ........++..|+|||.+
T Consensus 155 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 180 (266)
T cd05064 155 QEDKSEA------------------------------------------------------IYTTMSGKSPVLWAAPEAI 180 (266)
T ss_pred ccccccc------------------------------------------------------hhcccCCCCceeecCHHHH
Confidence 3210000 0000012456789999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |+.||......+.+..+..+... +. +...+..+.+++.+||+.+|.+||+
T Consensus 181 ~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~li~~c~~~~p~~RP~-- 254 (266)
T cd05064 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL-PA---PRNCPNLLHQLMLDCWQKERGERPR-- 254 (266)
T ss_pred hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-CC---CCCCCHHHHHHHHHHcCCCchhCCC--
Confidence 99899999999999999999775 99999988877777776655322 11 2234448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+++|++
T Consensus 255 --~~~i~~ 260 (266)
T cd05064 255 --FSQIHS 260 (266)
T ss_pred --HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=347.01 Aligned_cols=253 Identities=31% Similarity=0.473 Sum_probs=224.3
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeE
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
.+.||+|.||+||-|.++.+++. ||||+|.+.++...+ ...+..|++||+.++||.||.+-..|+..+..
T Consensus 569 devLGSGQFG~VYgg~hRktGrd---------VAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRD---------VAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred HhhccCCcceeeecceecccCce---------eeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 56899999999999999888775 999999988776544 36777899999999999999999999999999
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEEeccCccccc
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIMLSDFDLSLCS 241 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~ 241 (451)
|+|||.+ +|++.+++-....+++++...+.++.||+.||.|||.+||+|+||||+|||+.+. -++||||||+|+..
T Consensus 639 FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 639 FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 9999999 6777777766667889999999999999999999999999999999999999854 37999999998543
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
.+. +-..+++||+.|.|||+++.+
T Consensus 718 gEk--------------------------------------------------------sFRrsVVGTPAYLaPEVLrnk 741 (888)
T KOG4236|consen 718 GEK--------------------------------------------------------SFRRSVVGTPAYLAPEVLRNK 741 (888)
T ss_pred chh--------------------------------------------------------hhhhhhcCCccccCHHHHhhc
Confidence 211 112256999999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChH
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ 401 (451)
.|+...|+||+|+|+|--|.|..||.. ++++-.+|.+..+-+|...|..+.+ ++.+||+.+|++.-.+|.+ ++
T Consensus 742 GyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~-~AidlIn~LLqVkm~kRys----vd 814 (888)
T KOG4236|consen 742 GYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP-EAIDLINNLLQVKMRKRYS----VD 814 (888)
T ss_pred cccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH-HHHHHHHHHHHHHHHHhcc----hH
Confidence 999999999999999999999999985 4566778888888889888888877 8999999999999999999 99
Q ss_pred HHHcCCCcCC
Q 013016 402 DVKTHPFFKG 411 (451)
Q Consensus 402 ell~hp~~~~ 411 (451)
..|.|||+|+
T Consensus 815 k~lsh~Wlq~ 824 (888)
T KOG4236|consen 815 KSLSHPWLQD 824 (888)
T ss_pred hhccchhhhc
Confidence 9999999998
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=335.44 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=200.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||.|+||.||+|.++.+++ .||+|++..... .......+..|+.++++++|+||+++++++.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~---------~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 70 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHS 70 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCc---------EEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence 48899999999999999999887665 499999875421 12223456679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..|+|+||+. ++|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 71 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 71 DKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 999999999995 6888777654 24599999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... .......++..|+|||++.+
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 149 FGIPV-------------------------------------------------------RCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred cCCCC-------------------------------------------------------CCcCCCccccCCcChHHHhC
Confidence 21100 00011256788999999877
Q ss_pred CC-CCcchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCC-----------------CCCCCC-------CCCcC
Q 013016 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFA-APSNETTLRNIVKKPL-----------------TFPTQS-------PSSMS 374 (451)
Q Consensus 321 ~~-~~~~~DIwSlG~il~elltg~~pf~-~~~~~~~~~~i~~~~~-----------------~~~~~~-------~~~~~ 374 (451)
.. ++.++|||||||++|+|++|..|+. ..+..+.+..+..... .++... .....
T Consensus 174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07839 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL 253 (284)
T ss_pred CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence 54 6899999999999999999988854 3443444333322110 000000 00112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
+.++.+||.+||+.||.+||| ++++++||||
T Consensus 254 ~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 254 NSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred CHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 348899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=324.37 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=212.9
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|+||.||+|.+..+.+ .+|+|.+...... ......+..|+.+++.++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQK---------LVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLE 70 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCc---------EEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence 58999999999999999999876655 4999998754322 2345667789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 239 (451)
.+..++||||++|++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 99999999999999999999876556689999999999999999999999999999999999998654 68999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... .......|+..|+|||.+.
T Consensus 151 ~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 151 ILSSK--------------------------------------------------------SKAYTVVGTPCYISPELCE 174 (256)
T ss_pred ecCCC--------------------------------------------------------ccccccccCCcccCchhcc
Confidence 32110 0011236788999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|+|++|+.||...........+......... ...+.++.+++.+||..||.+|||
T Consensus 175 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt---- 246 (256)
T cd08220 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS----DRYSPDLRQLILSMLNLDPSKRPQ---- 246 (256)
T ss_pred CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCC----CCcCHHHHHHHHHHccCChhhCCC----
Confidence 888899999999999999999999999887777666666654332111 113338999999999999999999
Q ss_pred hHHHHcCCCc
Q 013016 400 AADVKTHPFF 409 (451)
Q Consensus 400 ~~ell~hp~~ 409 (451)
+.|++.||||
T Consensus 247 ~~~ll~~p~~ 256 (256)
T cd08220 247 LSQIMAQPIC 256 (256)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.31 Aligned_cols=254 Identities=29% Similarity=0.421 Sum_probs=210.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||.|+||.||+|.++.+.+ .||+|.+..... ...+..|+.++++++|+||+++++.+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~ 68 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYF 68 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCc---------EEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeee
Confidence 679999999999999999999887544 499999975422 467778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
...+.|+++||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 69 KNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred cCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccch
Confidence 9999999999999999999986543 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|+..|+|||++.
T Consensus 148 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~~~ 172 (256)
T cd06612 148 QLTDTM-------------------------------------------------------AKRNTVIGTPFWMAPEVIQ 172 (256)
T ss_pred hcccCc-------------------------------------------------------cccccccCCccccCHHHHh
Confidence 321100 0011235788899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|+|++|+.||...........+...... ....+...+.++.+++.+||+.||.+||+
T Consensus 173 ~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---- 246 (256)
T cd06612 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPS---- 246 (256)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcC----
Confidence 888999999999999999999999999876655544443332211 11112223448999999999999999999
Q ss_pred hHHHHcCCCc
Q 013016 400 AADVKTHPFF 409 (451)
Q Consensus 400 ~~ell~hp~~ 409 (451)
+.|+|.||||
T Consensus 247 ~~~il~~~~~ 256 (256)
T cd06612 247 AIQLLQHPFI 256 (256)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.77 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=188.6
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe--CC
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA--SN 162 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~ 162 (451)
..+||+|+||+||+|.++.... +..||+|.+.... ....+.+|+.+++.++||||+++++++.. +.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~-------~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDR 73 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCc-------cceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC
Confidence 3579999999999999765321 1249999986432 12345679999999999999999998853 56
Q ss_pred eEEEEEeeccCCchhhhhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE----ccCCCEE
Q 013016 163 FSCIVMEFCSGGDLHSLRHKQ-------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV----RSDGHIM 231 (451)
Q Consensus 163 ~~~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll----~~~~~~k 231 (451)
.+|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 74 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07867 74 KVWLLFDYA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred eEEEEEeee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEE
Confidence 889999999 56787776432 12358899999999999999999999999999999999999 4567999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ .........||+.
T Consensus 153 l~DfG~a~~~~~~~~----------------------------------------------------~~~~~~~~~~t~~ 180 (317)
T cd07867 153 IADMGFARLFNSPLK----------------------------------------------------PLADLDPVVVTFW 180 (317)
T ss_pred EeeccceeccCCCcc----------------------------------------------------cccccCcceeccc
Confidence 999999853321100 0001113478999
Q ss_pred ccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHhcCCCC--------------CCC
Q 013016 312 YVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---------TTLRNIVKKPLT--------------FPT 367 (451)
Q Consensus 312 y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~---------~~~~~i~~~~~~--------------~~~ 367 (451)
|+|||++.+. .++.++|||||||++|||+||+.||.....+ ..+..+...... ++.
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPT 260 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchh
Confidence 9999999774 4799999999999999999999999753321 111111110000 000
Q ss_pred -------------------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 368 -------------------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 368 -------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.......+..+.+||.+||+.||.+||| +.|+|+||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 261 LQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 0000112236889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.25 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=231.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
...|.+.+.||+|.|++|.+|++..++.+ ||||++.+...... ....+.+|+++|+.++|||||+++.+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~---------VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTE---------VAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCce---------EEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 37799999999999999999999988775 99999988765433 334478899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+....+|+||||+.+|.+++++... +.+.+..+..++.|++.|++|||+++|||||||++|||++.+.++||+|||++
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccc
Confidence 9999999999999999999999886 56788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..+.. ...-.++||++.|.|||+.
T Consensus 203 ~~~~~--------------------------------------------------------~~~lqt~cgsppyAaPEl~ 226 (596)
T KOG0586|consen 203 TFFDY--------------------------------------------------------GLMLQTFCGSPPYAAPELF 226 (596)
T ss_pred eeecc--------------------------------------------------------cccccccCCCCCccChHhh
Confidence 53321 1122357999999999999
Q ss_pred cCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.|..| +..+|+||+|++||.|+.|..||.+.+-.+.-.+.+.+...++..+.. ++.++|+++|.++|.+|++
T Consensus 227 ~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~-----dce~lLrk~lvl~Pskr~~-- 299 (596)
T KOG0586|consen 227 NGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSC-----DCEDLLRKFLVLNPSKRGP-- 299 (596)
T ss_pred cCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeec-----hhHHHHHHhhccCccccCC--
Confidence 99887 789999999999999999999999998888888888888888776655 8999999999999999999
Q ss_pred CChHHHHcCCCcCCCCcc
Q 013016 398 RGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~ 415 (451)
++++.+|.|.......
T Consensus 300 --~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 300 --CDQIMKDRWRNDLLEA 315 (596)
T ss_pred --HHHhhhhcccchhhhh
Confidence 9999999999874443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.79 Aligned_cols=261 Identities=16% Similarity=0.283 Sum_probs=203.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|++.+.||+|+||+||+|.+....+ .+.+..||||++..... ......+.+|+.+++.+ +||||++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~----~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFK----SDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecccc----CccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3679999999999999999998643221 12233599999974422 22335677799999999 89999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC-----------------------------------------------------
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP----------------------------------------------------- 184 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 184 (451)
+...+..++|||||+||+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999886432
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 185 --------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 185 --------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999999999999999999999999999999998432110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
.. ........++..|+|||++.+..++
T Consensus 268 ~~-----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 294 (375)
T cd05104 268 SN-----------------------------------------------------YVVKGNARLPVKWMAPESIFNCVYT 294 (375)
T ss_pred cc-----------------------------------------------------ccccCCCCCCcceeChhHhcCCCCC
Confidence 00 0000112456679999999999999
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHH
Q 013016 325 NAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~el 403 (451)
.++|||||||++|+|++ |..||........+..++........ +...+.++.+|+.+||+.||++||+ +.||
T Consensus 295 ~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs----~~ei 367 (375)
T cd05104 295 FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS---PECAPSEMYDIMKSCWDADPLKRPT----FKQI 367 (375)
T ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC---CCCCCHHHHHHHHHHccCChhHCcC----HHHH
Confidence 99999999999999998 99999876555444444443221111 1223448999999999999999999 9998
Q ss_pred Hc
Q 013016 404 KT 405 (451)
Q Consensus 404 l~ 405 (451)
++
T Consensus 368 l~ 369 (375)
T cd05104 368 VQ 369 (375)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=328.97 Aligned_cols=146 Identities=31% Similarity=0.469 Sum_probs=123.3
Q ss_pred hhhccCCCCCcccC--CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHH
Q 013016 67 RSATFGRKTGLTFR--DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK 144 (451)
Q Consensus 67 ~~~~~~~~~~~~~~--~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~ 144 (451)
+.+......|..|+ +|.+.++||||.|++||+|.+....+ .||+||.+.. ....+....||.+|+
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r---------~VAlKVvKSA----qhYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKR---------YVALKVVKSA----QHYTEAALDEIKLLQ 129 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCe---------EEEEEEEehh----hHHHHHHHHHHHHHH
Confidence 34444555666555 69999999999999999999988776 5999999854 334455666999999
Q ss_pred HCC-----C---CCccceeEEEEeC----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q 013016 145 MLD-----H---PFLPTLYAEFEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLG 211 (451)
Q Consensus 145 ~l~-----h---~nIv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~g 211 (451)
++. | .+||+|++.|... .|+|||+|++ |.+|..+|.....+.++...+++|++|||.||.||| ++|
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 872 3 4699999999754 4999999999 999999999888888999999999999999999999 579
Q ss_pred CeeccCCCCcEEEcc
Q 013016 212 IIYRDLKPENVLVRS 226 (451)
Q Consensus 212 ivH~Dlkp~NIll~~ 226 (451)
|||.||||+|||+..
T Consensus 209 IIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 209 IIHTDLKPENVLLCS 223 (590)
T ss_pred ccccCCCcceeeeec
Confidence 999999999999953
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.41 Aligned_cols=275 Identities=39% Similarity=0.625 Sum_probs=221.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
++|.+.+.||.|+||.||+|.+..++. .||+|++.+...........+..|+.+++++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNK---------EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCC---------EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 479999999999999999999876655 49999998765544455567778999999998 99999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..++|||++++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~ 149 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTA 149 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccc
Confidence 9999999999999999999998875 36999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
................ . . .-............+.|+..|+|||.+
T Consensus 150 ~~~~~~~~~~~~~~~~----------~----------------------~---~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 194 (280)
T cd05581 150 KVLDPNSSPESNKGDA----------T----------------------N---IDSQIEKNRRRFASFVGTAEYVSPELL 194 (280)
T ss_pred cccCCccccccCCCCC----------c----------------------c---ccccccccccccccccCCccccCHHHh
Confidence 5433211100000000 0 0 000000011222345788999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++||||||+++++|++|+.||........+..+......++... +..+.+||.+||+.||.+||+
T Consensus 195 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~~--- 266 (280)
T cd05581 195 NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNF-----PPDAKDLIEKLLVLDPQDRLG--- 266 (280)
T ss_pred CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCcc-----CHHHHHHHHHHhcCCHhhCCC---
Confidence 888889999999999999999999999998887777777765554444333 338999999999999999999
Q ss_pred Ch----HHHHcCCCc
Q 013016 399 GA----ADVKTHPFF 409 (451)
Q Consensus 399 ~~----~ell~hp~~ 409 (451)
+ +++++||||
T Consensus 267 -~~~~~~~ll~~~~~ 280 (280)
T cd05581 267 -VNEGYDELKAHPFF 280 (280)
T ss_pred -cccCHHHHhcCCCC
Confidence 8 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=324.43 Aligned_cols=252 Identities=26% Similarity=0.454 Sum_probs=210.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||.|+||.||+|.++.+.+ .||+|.++.... ....+.+..|+.+++.++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 69 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQ---------KYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA 69 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCc---------eEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence 58999999999999999999887665 399999864422 2344566779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+++|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+..
T Consensus 70 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 99999999999999999988776666789999999999999999999999999999999999999999999999998742
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... ........|+..|+|||++.+
T Consensus 150 ~~~~-------------------------------------------------------~~~~~~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 150 LTSP-------------------------------------------------------GAYACTYVGTPYYVPPEIWEN 174 (255)
T ss_pred eccc-------------------------------------------------------ccccccccCCccccCHHHHcc
Confidence 2100 000112468889999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++||||||+++|+|++|..||...+.......+..+...... ...+..+.+||.+||+.||++||+ +
T Consensus 175 ~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~----~ 246 (255)
T cd08219 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP----SHYSYELRSLIKQMFKRNPRSRPS----A 246 (255)
T ss_pred CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC----cccCHHHHHHHHHHHhCCcccCCC----H
Confidence 88999999999999999999999999987766666666555432211 123348999999999999999999 9
Q ss_pred HHHHcC
Q 013016 401 ADVKTH 406 (451)
Q Consensus 401 ~ell~h 406 (451)
.+|+.-
T Consensus 247 ~~il~~ 252 (255)
T cd08219 247 TTILSR 252 (255)
T ss_pred HHHhhc
Confidence 999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=327.75 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=207.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||.|++|.||+|.++...+ .+++|++..... ....+..|+.+++++ .|+||+++++++
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQ---------LVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAF 72 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCc---------EEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEE
Confidence 789999999999999999999876654 499999875432 235567799999998 699999999999
Q ss_pred EeCC------eEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EASN------FSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~~------~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
.... .+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred EecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeE
Confidence 7644 5899999999999999887643 4679999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+|+|||++...... ........|+.
T Consensus 153 ~l~d~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 177 (275)
T cd06608 153 KLVDFGVSAQLDST-------------------------------------------------------LGRRNTFIGTP 177 (275)
T ss_pred EECCCccceecccc-------------------------------------------------------hhhhcCccccc
Confidence 99999987422100 00011236888
Q ss_pred CccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 311 EYVSPEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 311 ~y~aPE~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+....... .......+..+.+||.+|
T Consensus 178 ~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~ 255 (275)
T cd06608 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT--LKSPENWSKKFNDFISEC 255 (275)
T ss_pred cccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC--CCchhhcCHHHHHHHHHH
Confidence 9999998754 236789999999999999999999998766666666655543211 111122344899999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCc
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
|..||++||| +.+|++|||+
T Consensus 256 l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 256 LIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred hhcChhhCcC----HHHHhcCCCC
Confidence 9999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=329.61 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=204.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|++|.||+|.++.+++ .||+|++..... .......+..|+.++++++|+||+++++++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 70 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ---------IVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFR 70 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCc---------EEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEe
Confidence 469999999999999999999886655 499999864321 1122344567999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.....++||||++++.|..++... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 71 RKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred eCCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccce
Confidence 999999999999998888776543 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... ......++..|+|||.+.
T Consensus 149 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~aPE~~~ 173 (286)
T cd07847 149 ILTGPGD-------------------------------------------------------DYTDYVATRWYRAPELLV 173 (286)
T ss_pred ecCCCcc-------------------------------------------------------cccCcccccccCCHHHHh
Confidence 3211000 001235778899999987
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------------------CCCCCC--C-----CC
Q 013016 320 G-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-------------------TFPTQS--P-----SS 372 (451)
Q Consensus 320 ~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------------~~~~~~--~-----~~ 372 (451)
+ ..++.++|||||||++|+|++|+.||.+....+....+..... ..+... . ..
T Consensus 174 ~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd07847 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFP 253 (286)
T ss_pred CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhc
Confidence 6 4578999999999999999999999988766554443322100 000000 0 01
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+..+.+|+.+||+.||++||+ +.|++.||||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 254 NISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred cCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 12347899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=330.87 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=208.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||.|++|.||+|.++.+++ .||+|.+..... .......+..|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNE---------TIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVH 71 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCc---------EEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEe
Confidence 689999999999999999999876655 399999865422 1223345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a 238 (451)
..++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++
T Consensus 72 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 72 SEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cCCeEEEEEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 999999999999 568888776655555789999999999999999999999999999999999985 457999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......|++.|+|||++
T Consensus 151 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 151 RAFGIPV-------------------------------------------------------RTFTHEVVTLWYRAPEIL 175 (294)
T ss_pred cccCCCc-------------------------------------------------------cccccCceeecccCHHHH
Confidence 4321100 000112567889999998
Q ss_pred cCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC------------------------CCCc
Q 013016 319 SGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS------------------------PSSM 373 (451)
Q Consensus 319 ~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~ 373 (451)
.+. .++.++|||||||++|+|+||+.||......+.+.++........... ....
T Consensus 176 ~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PLN00009 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT 255 (294)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcC
Confidence 764 578999999999999999999999988766655555432111100000 0011
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.+..+.++|.+||+.||++||+ +.+++.||||.+++.
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 256 LEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLGD 292 (294)
T ss_pred CChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHhc
Confidence 2347899999999999999999 999999999998664
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=329.46 Aligned_cols=259 Identities=21% Similarity=0.322 Sum_probs=210.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+...... ..+..||+|++..... ......+.+|+++++.+.|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPE----NDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCc----CCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 6799999999999999999987654211 1123599999875422 223467778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
..+..++||||++|++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 9999999999999999999987542 2447899999999999999999999999999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+.++|+|||++........ ........
T Consensus 159 ~~~kl~d~g~~~~~~~~~~-----------------------------------------------------~~~~~~~~ 185 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDY-----------------------------------------------------YRVGGHTM 185 (280)
T ss_pred CeEEECCcccceecccCcc-----------------------------------------------------eecCCCCc
Confidence 9999999999742110000 00001124
Q ss_pred cCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..+....+.. ..+..+.+++.+||
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l 261 (280)
T cd05049 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPR----TCPSEVYDIMLGCW 261 (280)
T ss_pred ccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHc
Confidence 5678999999999899999999999999999998 999998888887777777655433321 23448999999999
Q ss_pred ccCcCCcCCCCCChHHHHc
Q 013016 387 NKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~ 405 (451)
+.||++||+ +.|+++
T Consensus 262 ~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 262 KRDPQQRIN----IKDIHE 276 (280)
T ss_pred CCCcccCCC----HHHHHH
Confidence 999999999 999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=329.32 Aligned_cols=260 Identities=29% Similarity=0.449 Sum_probs=208.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.+..+++ .||+|++...... ......+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGE---------TVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPH 70 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCc---------eEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 58999999999999999999877655 3999999765321 2334567789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 71 ~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 71 GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 99999999999 999999887653 5699999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
...... .......|+..|+|||.+.+
T Consensus 149 ~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 149 FSEEEP------------------------------------------------------RLYSHQVATRWYRAPELLYG 174 (286)
T ss_pred ccCCCC------------------------------------------------------CccccccCcccccCceeeec
Confidence 221000 00011268889999999876
Q ss_pred CC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC------CCcC
Q 013016 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQSP------SSMS 374 (451)
Q Consensus 321 ~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~~------~~~~ 374 (451)
.. ++.++|||||||++|+|++|.++|........+..+...... ++.... ....
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07832 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA 254 (286)
T ss_pred cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence 44 689999999999999999999999877665555544432110 000000 0112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcC
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~ 410 (451)
+..+.+||.+||..||.+||+ +++++.||||.
T Consensus 255 ~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 255 SPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred cHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 348899999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=323.43 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=205.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.++... .+|+|.+..... ....+..|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~----------~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQI----------KVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVC 68 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCc----------eEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEE
Confidence 367999999999999999999886543 299998864422 124566799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+
T Consensus 69 ~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 69 TQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 99999999999999999999887543 35899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... ........++..|+|||++
T Consensus 148 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 173 (256)
T cd05114 148 RYVLDDE------------------------------------------------------YTSSSGAKFPVKWSPPEVF 173 (256)
T ss_pred cccCCCc------------------------------------------------------eeccCCCCCchhhCChhhc
Confidence 4221000 0000112355679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++||||||+++|+|++ |+.||......+.+..+..+..... +...+..+.+++.+||..||.+||+
T Consensus 174 ~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~li~~c~~~~p~~Rps-- 247 (256)
T cd05114 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLASMTVYEVMYSCWHEKPEGRPT-- 247 (256)
T ss_pred ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----CCCCCHHHHHHHHHHccCCcccCcC--
Confidence 98889999999999999999999 9999998888888777776543221 1223448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.++++
T Consensus 248 --~~~l~~ 253 (256)
T cd05114 248 --FAELLR 253 (256)
T ss_pred --HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=325.11 Aligned_cols=260 Identities=30% Similarity=0.440 Sum_probs=206.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH--HHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+|.+.+.||+|+||.||+|.+..+++ .||+|++..... ........+..|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGR---------ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCc---------EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 479999999999999999999877655 499998864321 122345667789999999999999999998
Q ss_pred EEe--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEA--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+.. .+.++++|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 875 36889999999999999988764 45899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... ........|+..|+||
T Consensus 151 g~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~aP 178 (266)
T cd06651 151 GASKRLQTICMS----------------------------------------------------GTGIRSVTGTPYWMSP 178 (266)
T ss_pred CCcccccccccc----------------------------------------------------CCccccCCccccccCH
Confidence 997432110000 0000123578889999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||...........+...... + .. +...+..+.+++ +||..+|++||+
T Consensus 179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~-~~-~~~~~~~~~~li-~~~~~~p~~Rp~ 254 (266)
T cd06651 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-P-QL-PSHISEHARDFL-GCIFVEARHRPS 254 (266)
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-C-CC-chhcCHHHHHHH-HHhcCChhhCcC
Confidence 9999888999999999999999999999999876655555444332211 1 11 122333788888 677789999999
Q ss_pred CCCChHHHHcCCCcC
Q 013016 396 SKRGAADVKTHPFFK 410 (451)
Q Consensus 396 ~~~~~~ell~hp~~~ 410 (451)
++||++||||+
T Consensus 255 ----~~eil~hp~~~ 265 (266)
T cd06651 255 ----AEELLRHPFAQ 265 (266)
T ss_pred ----HHHHhcCcccc
Confidence 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=341.41 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=203.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++. ||||++.+... .......+.+|+.++++++|+||++++++|.
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~---------vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQN---------VAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFT 85 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCE---------EEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeec
Confidence 7899999999999999999998876653 99999864321 2233345667999999999999999999886
Q ss_pred eC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
.. .+.|+||||+ .++|.+.+... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 86 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 86 PQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred cCCCccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 44 3679999999 56888877543 8999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... .......|+..|+
T Consensus 161 Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ 184 (353)
T cd07850 161 DFGLARTAGTS--------------------------------------------------------FMMTPYVVTRYYR 184 (353)
T ss_pred cCccceeCCCC--------------------------------------------------------CCCCCCccccccc
Confidence 99997432110 0011235788899
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC----------------------------
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF---------------------------- 365 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---------------------------- 365 (451)
|||++.+..++.++|||||||++|+|++|+.||...+....+..+.......
T Consensus 185 aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (353)
T cd07850 185 APEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFE 264 (353)
T ss_pred CHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchh
Confidence 9999999999999999999999999999999998766544443332211000
Q ss_pred --------CC--CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 366 --------PT--QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 366 --------~~--~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+. .......+..+++||.+||+.||++||| +.|+|.||||+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYINV 316 (353)
T ss_pred hhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHhh
Confidence 00 0001123446899999999999999999 999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=322.60 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=212.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|+||.||+|.++..+.. +|+|.+...... ......+..|+.+++.++|+||+++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~---------~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~ 70 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEH---------CVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQE 70 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCce---------EEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence 588999999999999999999876653 999999765322 2234556779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 239 (451)
.+..|+|+||+++++|.+++.......+++..++.++.||+.||.|||+++++|+||||+||+++.++ .++|+|||.+.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence 99999999999999999998876555689999999999999999999999999999999999999886 46999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|++.|+|||++.
T Consensus 151 ~~~~~~-------------------------------------------------------~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 151 QLNDSM-------------------------------------------------------ELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred hccCCc-------------------------------------------------------ccccccCCCccccCHHHHc
Confidence 321100 0001135788899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|+|++|..||......+....+........ . ...+.++.++|.+||..+|++|||
T Consensus 176 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~i~~~l~~~p~~Rpt---- 247 (257)
T cd08225 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---S-PNFSRDLRSLISQLFKVSPRDRPS---- 247 (257)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---C-CCCCHHHHHHHHHHhccChhhCcC----
Confidence 88899999999999999999999999988776666666655433211 1 123348999999999999999999
Q ss_pred hHHHHcCCCc
Q 013016 400 AADVKTHPFF 409 (451)
Q Consensus 400 ~~ell~hp~~ 409 (451)
+.|+++||||
T Consensus 248 ~~~ll~~~~~ 257 (257)
T cd08225 248 ITSILKRPFL 257 (257)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=344.61 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=204.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~ 155 (451)
...++|.+.++||.|+||.||+|.+....+. .++..||||++.... .....+.+.+|+.+++++. ||||++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~----~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRS----QPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCC----CCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 3347899999999999999999987544321 223359999997542 2233456788999999996 99999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCC---------------------------------------------------
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------------------------------------------- 184 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------- 184 (451)
+++.+.+..|||||||++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999998876431
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 185 -------------------------------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 185 -------------------------------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 1247888899999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++....... ...
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~-----------------------------------------------------~~~ 294 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDS-----------------------------------------------------NYV 294 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccc-----------------------------------------------------ccc
Confidence 999999999999999974321100 000
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||........+...+......+. +...+.++.+
T Consensus 295 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 371 (400)
T cd05105 295 SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK---PDHATQEVYD 371 (400)
T ss_pred ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCC---CccCCHHHHH
Confidence 1112356788999999999889999999999999999997 99999876554444333333222221 1223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHc
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
++.+||+.||++||+ +.+|.+
T Consensus 372 li~~cl~~dP~~RPt----~~~l~~ 392 (400)
T cd05105 372 IMVKCWNSEPEKRPS----FLHLSD 392 (400)
T ss_pred HHHHHCccCHhHCcC----HHHHHH
Confidence 999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=323.88 Aligned_cols=253 Identities=20% Similarity=0.294 Sum_probs=207.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
...+|.+.++||.|+||.||+|.++...+. ||+|++.... .....+..|+.+++.++|+||++++++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~---------~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLT---------VAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 70 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCce---------EEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEE
Confidence 346799999999999999999998876553 9999987432 223456779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+.+++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred EcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999999999999998776556689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .......++..|+|||.
T Consensus 151 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~ 176 (263)
T cd05052 151 SRLMTGDTY------------------------------------------------------TAHAGAKFPIKWTAPES 176 (263)
T ss_pred cccccccee------------------------------------------------------eccCCCCCccccCCHHH
Confidence 743211000 00001134567999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|+|++ |..||.+....+....+...... .. +...+.++.+++.+||+.||++||+
T Consensus 177 ~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~li~~cl~~~p~~Rp~- 251 (263)
T cd05052 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ER-PEGCPPKVYELMRACWQWNPSDRPS- 251 (263)
T ss_pred hccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---CC-CCCCCHHHHHHHHHHccCCcccCCC-
Confidence 998889999999999999999998 99999887777766666554211 11 1223348999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.++++
T Consensus 252 ---~~~l~~ 257 (263)
T cd05052 252 ---FAEIHQ 257 (263)
T ss_pred ---HHHHHH
Confidence 888864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=327.49 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=206.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.+++..+. ..+..||+|++..... ......+..|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~----~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKD----EPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCC----CceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7899999999999999999987653221 1223599999864321 123345677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPH--------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
.++..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999999875321 2367888999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ ........++..
T Consensus 160 l~dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 186 (277)
T cd05062 160 IGDFGMTRDIYETDY-----------------------------------------------------YRKGGKGLLPVR 186 (277)
T ss_pred ECCCCCccccCCcce-----------------------------------------------------eecCCCCccCHh
Confidence 999999743211000 000001245678
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||++.+..++.++|||||||++|||++ |..||...........+......... ...+..+.+++.+||+.||
T Consensus 187 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p 262 (277)
T cd05062 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNP 262 (277)
T ss_pred hcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCh
Confidence 999999998889999999999999999999 79999887777776666554332111 1233489999999999999
Q ss_pred CCcCCCCCChHHHHcC
Q 013016 391 CNRLGSKRGAADVKTH 406 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~h 406 (451)
++||+ +.|++++
T Consensus 263 ~~Rps----~~e~l~~ 274 (277)
T cd05062 263 KMRPS----FLEIISS 274 (277)
T ss_pred hhCcC----HHHHHHH
Confidence 99999 9998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.32 Aligned_cols=260 Identities=29% Similarity=0.420 Sum_probs=207.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-------HHHHHHHHHHHHHHHHCCCCCccc
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-------KKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
+|.+.+.||.|+||.||+|.+..+++ .+|+|.+....... ....+.+..|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGE---------MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCc---------eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 48889999999999999999876654 39999886432211 122345677999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+++++...+..++||||++|++|.+++... +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~ 150 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKIS 150 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEe
Confidence 999999999999999999999999998775 568999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++....... .........|+..|+
T Consensus 151 d~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y~ 177 (272)
T cd06629 151 DFGISKKSDDIY-----------------------------------------------------DNDQNMSMQGSVFWM 177 (272)
T ss_pred eccccccccccc-----------------------------------------------------cccccccccCCcccc
Confidence 999974221000 000011236788999
Q ss_pred CcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 314 SPEVASGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 314 aPE~~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|||.+.+.. ++.++|+||||+++|+|++|..||...........+.... ..++...... .+..+.++|.+||..|
T Consensus 178 ~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~ 256 (272)
T cd06629 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN-LSPVALDFLNACFTIN 256 (272)
T ss_pred CHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc-CCHHHHHHHHHHhcCC
Confidence 999987754 7899999999999999999999997665554444433322 2222222222 3348999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCc
Q 013016 390 PCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~ 409 (451)
|.+||+ ++++|.||||
T Consensus 257 p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 257 PDNRPT----ARELLQHPFI 272 (272)
T ss_pred hhhCCC----HHHHhhCCCC
Confidence 999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.41 Aligned_cols=273 Identities=25% Similarity=0.325 Sum_probs=211.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|+++++||+|.||.||+|..+++.... ...+|||.+..+.. .........+|+.+++.++|+||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-----~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-----TKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCccc-----chhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 56999999999999999999665543321 12499999875532 1223345567999999999999999999997
Q ss_pred e-CCeEEEEEeeccCCchhhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC----CCEE
Q 013016 160 A-SNFSCIVMEFCSGGDLHSLRHKQ---PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD----GHIM 231 (451)
Q Consensus 160 ~-~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~----~~~k 231 (451)
. +...+|++||.+ -+|..+++.. ....++...++.|+.||+.|+.|||++.|+||||||.||||..+ |.||
T Consensus 98 ~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 779999999994 5788777643 23568999999999999999999999999999999999999988 8999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||+++..+.+-..- .....++-|.+
T Consensus 177 IaDlGlaR~~~~plkpl----------------------------------------------------~s~d~VVVTiW 204 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPL----------------------------------------------------ASLDPVVVTIW 204 (438)
T ss_pred eecccHHHHhhcccccc----------------------------------------------------ccCCceEEEEE
Confidence 99999996544221100 01112477889
Q ss_pred ccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhcCCCCCCCCCCCCc--------
Q 013016 312 YVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPS---------NETTLRNIVKKPLTFPTQSPSSM-------- 373 (451)
Q Consensus 312 y~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~-------- 373 (451)
|+|||+++|.. |+.++|||++|||+.||+|-++.|.+.. ..+.+.+|......+....|+.+
T Consensus 205 YRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~ 284 (438)
T KOG0666|consen 205 YRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQT 284 (438)
T ss_pred ecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHH
Confidence 99999999965 8999999999999999999999997632 22445566554333333222211
Q ss_pred ------------------------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 374 ------------------------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 374 ------------------------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.++...+|+.+||+.||-+|.| ++++|+|+||.+.+.+
T Consensus 285 ~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 285 LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTEDPLP 346 (438)
T ss_pred HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhcccccccCCCC
Confidence 1224779999999999999999 9999999999997554
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=323.87 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=207.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.++||+|++|.||+|.+.... .||+|.+..... ..+.+..|+.++++++|+||+++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~----------~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNST----------KVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 69 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCc----------eEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 4478999999999999999999876543 299998864322 23566779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..++||||+++++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCcc
Confidence 99999999999999999999999876667789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .......++..|+|||+
T Consensus 150 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~ 175 (261)
T cd05072 150 ARVIEDNEY------------------------------------------------------TAREGAKFPIKWTAPEA 175 (261)
T ss_pred ceecCCCce------------------------------------------------------eccCCCccceecCCHHH
Confidence 843211000 00001245667999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|+|++ |..||...........+..... .+.. ...+.++.+++.+||+.+|++||+
T Consensus 176 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~~p~~Rp~- 250 (261)
T cd05072 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-MPRM---ENCPDELYDIMKTCWKEKAEERPT- 250 (261)
T ss_pred hccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-CCCC---CCCCHHHHHHHHHHccCCcccCcC-
Confidence 988889999999999999999998 9999988777776666655432 2211 123448999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
++++++
T Consensus 251 ---~~~i~~ 256 (261)
T cd05072 251 ---FDYLQS 256 (261)
T ss_pred ---HHHHHH
Confidence 888754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=328.26 Aligned_cols=259 Identities=26% Similarity=0.377 Sum_probs=213.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|+..++||.|+||.||+|.++.... .||+|++..... ......+..|+.+++.+.|+||+++++++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQ---------VVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYL 72 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCE---------EEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458888999999999999999876654 499999875422 234567778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++..|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 73 KGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred ECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccce
Confidence 99999999999999999998865 358999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|+..|+|||++.
T Consensus 150 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~apE~~~ 174 (277)
T cd06640 150 QLTDTQ-------------------------------------------------------IKRNTFVGTPFWMAPEVIQ 174 (277)
T ss_pred eccCCc-------------------------------------------------------cccccccCcccccCHhHhc
Confidence 221000 0011235778899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|+|||||++|+|++|+.||...........+...... . .....+..+.+|+.+||+.+|++||+
T Consensus 175 ~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~li~~~l~~~p~~Rp~---- 246 (277)
T cd06640 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---T-LTGEFSKPFKEFIDACLNKDPSFRPT---- 246 (277)
T ss_pred cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---C-CchhhhHHHHHHHHHHcccCcccCcC----
Confidence 888999999999999999999999999877665554444332211 1 11123447899999999999999999
Q ss_pred hHHHHcCCCcCCCCcc
Q 013016 400 AADVKTHPFFKGLNFA 415 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~ 415 (451)
+.+++.|+||......
T Consensus 247 ~~~il~~~~~~~~~~~ 262 (277)
T cd06640 247 AKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHHhChHhhhcchh
Confidence 9999999999986653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=329.71 Aligned_cols=259 Identities=28% Similarity=0.390 Sum_probs=204.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.++.+++ .||+|++.+..... .....+..|+++++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 70 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQ---------IVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFR 70 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCC---------EEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcc
Confidence 469999999999999999999876655 49999986543222 23345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|..+.... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 71 RKKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999999999999999888776543 348999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......|+..|+|||++.
T Consensus 149 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 149 TLAAPG-------------------------------------------------------EVYTDYVATRWYRAPELLV 173 (286)
T ss_pred eccCCc-------------------------------------------------------cccCcccceeeccCcHHhc
Confidence 321100 0001235788899999987
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC-------CC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQSP-------SS 372 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~~-------~~ 372 (451)
+. .++.++||||||+++|+|++|+.||......+....+...... .+.... ..
T Consensus 174 ~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd07846 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFP 253 (286)
T ss_pred cccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCC
Confidence 63 4688999999999999999999999876654443333321000 000000 01
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+..+.+|+.+||+.||++||+ +.+++.||||
T Consensus 254 ~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 254 KLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred CcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 12347899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.79 Aligned_cols=263 Identities=29% Similarity=0.413 Sum_probs=208.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|...++||.|++|.||+|.++.+.+ .+|+|++..... ......+.+|++++++++|+||+++++++.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 69 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGM---------IFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFL 69 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCe---------EEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Confidence 468999999999999999999977654 499999875422 234456778999999999999999999886
Q ss_pred eC--CeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 160 AS--NFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 160 ~~--~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
.. +.+|+||||++|++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred ccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeec
Confidence 43 4789999999999999887542 2455899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... ......++..|+||
T Consensus 150 g~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~~p 172 (287)
T cd06621 150 GVSGELVNS---------------------------------------------------------LAGTFTGTSFYMAP 172 (287)
T ss_pred ccccccccc---------------------------------------------------------ccccccCCccccCH
Confidence 997321100 00012567789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCCC-CCCCCC-CCcChHHHHHHHHHhccc
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-----NETTLRNIVKKPLT-FPTQSP-SSMSEYHARDLISGLLNK 388 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~-~~~~~~-~~~~~~~~~~ll~~~L~~ 388 (451)
|.+.+..++.++|||||||++|+|++|+.||.... ..+....+...... .+.... ....+..+.+||.+||..
T Consensus 173 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 252 (287)
T cd06621 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEK 252 (287)
T ss_pred HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCC
Confidence 99998889999999999999999999999998652 23333333332211 111111 112344789999999999
Q ss_pred CcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
||.+||| +.|++.||||+....
T Consensus 253 ~p~~Rpt----~~eil~~~~~~~~~~ 274 (287)
T cd06621 253 DPTRRPT----PWDMLEHPWIKAQMK 274 (287)
T ss_pred CcccCCC----HHHHHhCcccccccc
Confidence 9999999 999999999977443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.48 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=207.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH--HHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+|.+.+.||+|+||.||+|.++.+++ .||||.+..... ........+..|+.+++++.|+||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGR---------ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCc---------EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 579999999999999999999887665 399998864321 122345677789999999999999999998
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+.+. ..+++||||++|++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcC
Confidence 8763 5789999999999999988765 44889999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ .........|+..|+||
T Consensus 151 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 151 GASKRLQTICL----------------------------------------------------SGTGMKSVTGTPYWMSP 178 (265)
T ss_pred ccccccccccc----------------------------------------------------cccccccCCCCccccCh
Confidence 98743211000 00001123688899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||........+.++...... + ..+...+..+.++|.+|+. +|++||+
T Consensus 179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~i~~~l~-~p~~Rp~ 254 (265)
T cd06652 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-P--VLPPHVSDHCRDFLKRIFV-EAKLRPS 254 (265)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC-C--CCchhhCHHHHHHHHHHhc-ChhhCCC
Confidence 9998888999999999999999999999999876555555544433211 1 1122233478999999994 9999999
Q ss_pred CCCChHHHHcCCCcC
Q 013016 396 SKRGAADVKTHPFFK 410 (451)
Q Consensus 396 ~~~~~~ell~hp~~~ 410 (451)
++||++|||+.
T Consensus 255 ----~~~il~~~~~~ 265 (265)
T cd06652 255 ----ADELLRHTFVH 265 (265)
T ss_pred ----HHHHhcCcccC
Confidence 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=337.40 Aligned_cols=261 Identities=18% Similarity=0.292 Sum_probs=202.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||.|+||.||+|.+.+.... ..+..||+|++..... ......+..|+.++.++ +|+||+++++++
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~----~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKS----ASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccc----cccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 6899999999999999999986554321 2233599999874321 23345566799999999 799999999988
Q ss_pred EeC-CeEEEEEeeccCCchhhhhhhCCC----------------------------------------------------
Q 013016 159 EAS-NFSCIVMEFCSGGDLHSLRHKQPH---------------------------------------------------- 185 (451)
Q Consensus 159 ~~~-~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 185 (451)
... ..+++||||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 644 578999999999999998864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCC
Q 013016 186 -------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258 (451)
Q Consensus 186 -------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 258 (451)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------- 227 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------- 227 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-------------
Confidence 258899999999999999999999999999999999999999999999999985321100
Q ss_pred CCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHH
Q 013016 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYE 338 (451)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~e 338 (451)
.........++..|+|||++.+..++.++|||||||++|+
T Consensus 228 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~e 267 (337)
T cd05054 228 ----------------------------------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 267 (337)
T ss_pred ----------------------------------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHH
Confidence 0001112356678999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 339 MIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 339 llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
|++ |..||......+.+............ +.....++.+++.+||+.+|++||+ +.||++|
T Consensus 268 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell~~ 329 (337)
T cd05054 268 IFSLGASPYPGVQIDEEFCRRLKEGTRMRA---PEYATPEIYSIMLDCWHNNPEDRPT----FSELVEI 329 (337)
T ss_pred HHHcCCCCCCCCCccHHHHHHHhccCCCCC---CccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 998 99999875544444444333221111 1223348999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.36 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=202.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
|+...-++-||.|+-|-||+|+.++.. ||||.++.. -+.+|+-|++|+|+||+.+.|+|
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~net-----------VAVKKV~el----------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLHNET-----------VAVKKVREL----------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred HHHhhhhhhhccCcccceeeeeccCce-----------ehhHHHhhh----------hhhhHHHHHhccCcceeeEeeee
Confidence 344444567899999999999988764 999987622 22378889999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.....+|||||||..|.|.++|+.. ..+.......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999999875 55899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+..... ++.-+|+||..|||||+|
T Consensus 260 ~e~~~~--------------------------------------------------------STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 260 KELSDK--------------------------------------------------------STKMSFAGTVAWMAPEVI 283 (904)
T ss_pred Hhhhhh--------------------------------------------------------hhhhhhhhhHhhhCHHHh
Confidence 543211 222257999999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+.+.+.|+|||||||||||||||+.||...+...++--+-...+.+| .+...++.++-||+.||+-.|.+||+
T Consensus 284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp---vPstcP~GfklL~Kqcw~sKpRNRPS--- 357 (904)
T KOG4721|consen 284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP---VPSTCPDGFKLLLKQCWNSKPRNRPS--- 357 (904)
T ss_pred hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc---CcccCchHHHHHHHHHHhcCCCCCcc---
Confidence 999999999999999999999999999986544333222222222222 23445558999999999999999999
Q ss_pred ChHHHHcCC
Q 013016 399 GAADVKTHP 407 (451)
Q Consensus 399 ~~~ell~hp 407 (451)
++++|.|-
T Consensus 358 -Frqil~Hl 365 (904)
T KOG4721|consen 358 -FRQILLHL 365 (904)
T ss_pred -HHHHHHHH
Confidence 99999984
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=336.63 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=201.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.+..+++ .||||++... ........+..|+.++++++|+||+++++++.
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~---------~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGV---------KVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIR 73 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCC---------eEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence 689999999999999999999887665 3999998642 12233455667999999999999999999875
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. .+.|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 74 PPSFESFNDVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred cccccccceEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECc
Confidence 44 3689999999 4678777654 4599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++........ .........|+..|+|
T Consensus 150 fg~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~a 177 (336)
T cd07849 150 FGLARIADPEHD----------------------------------------------------HTGFLTEYVATRWYRA 177 (336)
T ss_pred ccceeecccccc----------------------------------------------------ccCCcCCcCcCCCccC
Confidence 999753211000 0001112468899999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC--------------------CCCC-----
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--------------------FPTQ----- 368 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------------~~~~----- 368 (451)
||.+.+ ..++.++|||||||++|+|++|+.||........+..+...... .+..
T Consensus 178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T cd07849 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPW 257 (336)
T ss_pred hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccH
Confidence 998765 45899999999999999999999999775544333222211000 0000
Q ss_pred --CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 369 --SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 369 --~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
..+. .+.++.+||.+||+.||++||| +.|+++||||+..
T Consensus 258 ~~~~~~-~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 258 NKLFPN-ADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred HHHhcc-cCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 0011 2337899999999999999999 9999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.30 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=206.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.++||+|+||+||+|.+..... +.+..||+|.+.... .......+..|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 45789999999999999999998643221 122359999997532 23344567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP---------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NI 222 (451)
+...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ni 155 (283)
T cd05090 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI 155 (283)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceE
Confidence 999999999999999999999885332 12478899999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
|++.++.+||+|||++....... ....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~-----------------------------------------------------~~~~ 182 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSAD-----------------------------------------------------YYRV 182 (283)
T ss_pred EEcCCCcEEeccccccccccCCc-----------------------------------------------------ceec
Confidence 99999999999999985321100 0001
Q ss_pred ccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
.....++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+...... + .+...+..+.++
T Consensus 183 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~l 258 (283)
T cd05090 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL-P---CSEDCPPRMYSL 258 (283)
T ss_pred ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-C---CCCCCCHHHHHH
Confidence 112345677999999988889999999999999999998 99999887666555555443321 1 112234489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHcC
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+.+||+.||++||+ +.+|+++
T Consensus 259 i~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 259 MTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred HHHHcccCcccCcC----HHHHHHH
Confidence 99999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=326.75 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=210.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|++|.||+|.++..++ .+|+|++..... ......+.+|+++++.+.|+||+++++.+.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGK---------IMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFY 69 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCc---------EEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeee
Confidence 368888999999999999999886655 499999876532 234456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+..++|+||+++++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 70 NNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999999987754 568999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ......|+..|+|||.+
T Consensus 149 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~~PE~~ 171 (265)
T cd06605 149 GQLVNS---------------------------------------------------------LAKTFVGTSSYMAPERI 171 (265)
T ss_pred hhhHHH---------------------------------------------------------HhhcccCChhccCHHHH
Confidence 321100 00013678889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
.+..++.++|||||||++|+|++|+.||.... ..+.+..+...... . ......+.++.++|.+||..||++|
T Consensus 172 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~p~~R 248 (265)
T cd06605 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--R-LPSGKFSPDFQDFVNLCLIKDPRER 248 (265)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--C-CChhhcCHHHHHHHHHHcCCCchhC
Confidence 99889999999999999999999999997642 22334444333211 1 1111134489999999999999999
Q ss_pred CCCCCChHHHHcCCCcCC
Q 013016 394 LGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~ 411 (451)
|+ +.+++.||||++
T Consensus 249 pt----~~~ll~~~~~~~ 262 (265)
T cd06605 249 PS----YKELLEHPFIKK 262 (265)
T ss_pred cC----HHHHhhCchhhc
Confidence 99 999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.90 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=207.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++...+ ....||+|++.... .......+..|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 679999999999999999999865421 11249999987543 2233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||+++++|.+++.... +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999999999987653 368999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... ........++..|+|||.+.
T Consensus 155 ~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 155 RLEDSEA-----------------------------------------------------TYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred ccccccc-----------------------------------------------------ceeccCCCCCccccChhhhc
Confidence 4320000 00000113467899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |..||......+....+......... ...+..+.+|+.+||+.+|++||+
T Consensus 182 ~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~--- 254 (266)
T cd05033 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPP----MDCPSALYQLMLDCWQKDRNERPT--- 254 (266)
T ss_pred cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcC---
Confidence 8889999999999999999998 99999887777776666554322111 123448999999999999999999
Q ss_pred ChHHHHcC
Q 013016 399 GAADVKTH 406 (451)
Q Consensus 399 ~~~ell~h 406 (451)
+.+|+++
T Consensus 255 -~~ei~~~ 261 (266)
T cd05033 255 -FSQIVST 261 (266)
T ss_pred -HHHHHHH
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=322.30 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=206.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||+||+|.+.+... +|+|.+..... ....+..|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~----------~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYD----------VAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVC 68 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCc----------EEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 3679999999999999999998765432 99999875422 124567799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..++||||+.+++|.+++..... .+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.+
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 69 TKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred ccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 999999999999999999999876533 6899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... ........++..|+|||++
T Consensus 148 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~~pe~~ 173 (256)
T cd05113 148 RYVLDDE------------------------------------------------------YTSSVGSKFPVRWSPPEVL 173 (256)
T ss_pred eecCCCc------------------------------------------------------eeecCCCccChhhCCHHHH
Confidence 4321100 0000012356679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |+.||......+....+..+...... ...+..+.+++.+||..||.+||+
T Consensus 174 ~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~-- 247 (256)
T cd05113 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP----HLASEKVYAIMYSCWHEKAEERPT-- 247 (256)
T ss_pred hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCCC--
Confidence 88889999999999999999998 99999887777777777665433222 223448999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.+|+.+
T Consensus 248 --~~~ll~~ 254 (256)
T cd05113 248 --FQQLLSS 254 (256)
T ss_pred --HHHHHHh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.61 Aligned_cols=261 Identities=25% Similarity=0.328 Sum_probs=202.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
++|++.+.||.|+||.||+|.+..+++ .||||++..... .......+..|+.+++.+. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~ 70 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK---------LVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVE 70 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc---------EEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeE
Confidence 469999999999999999999887665 499999865422 1223345667999999995 69999999999
Q ss_pred EeCCe-----EEEEEeeccCCchhhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCC
Q 013016 159 EASNF-----SCIVMEFCSGGDLHSLRHKQP---HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGH 229 (451)
Q Consensus 159 ~~~~~-----~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~ 229 (451)
...+. .|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 71 HVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred eecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe
Confidence 87665 8999999965 8888876542 346899999999999999999999999999999999999998 889
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++....... .......++
T Consensus 150 ~kl~dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~ 174 (295)
T cd07837 150 LKIADLGLGRAFSIPV-------------------------------------------------------KSYTHEIVT 174 (295)
T ss_pred EEEeecccceecCCCc-------------------------------------------------------cccCCcccc
Confidence 9999999974221000 000011467
Q ss_pred CCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC------------------
Q 013016 310 HEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP------------------ 370 (451)
Q Consensus 310 ~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------ 370 (451)
+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...........+
T Consensus 175 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd07837 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254 (295)
T ss_pred cCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccch
Confidence 78999998866 45789999999999999999999999887666555444332110000000
Q ss_pred -----CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcC
Q 013016 371 -----SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 371 -----~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~ 410 (451)
....+.++.+||.+||..||.+||+ +.|++.||||+
T Consensus 255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred hHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 0113347899999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.20 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=205.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|+++.+++ .||||.+.............+..|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRK---------PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCC---------EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 689999999999999999999877665 39999886543333445566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
..+..++||||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 999999999999999999988643 234589999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .......|+..|+|||.
T Consensus 153 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~aPE~ 177 (267)
T cd08228 153 GRFFSSKT-------------------------------------------------------TAAHSLVGTPYYMSPER 177 (267)
T ss_pred ceeccchh-------------------------------------------------------HHHhcCCCCccccChhh
Confidence 74321000 00012367888999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN--ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++||||||+++|+|++|+.||..... ......+.... .+... ....+..+.+++.+||..+|++||+
T Consensus 178 ~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~ 254 (267)
T cd08228 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLP-TEHYSEKLRELVSMCIYPDPDQRPD 254 (267)
T ss_pred hccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCC-hhhcCHHHHHHHHHHCCCCcccCcC
Confidence 9988899999999999999999999999975432 23333333322 11111 1123347999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+.++++
T Consensus 255 ----~~~vl~ 260 (267)
T cd08228 255 ----IGYVHQ 260 (267)
T ss_pred ----HHHHHH
Confidence 999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=326.41 Aligned_cols=258 Identities=27% Similarity=0.361 Sum_probs=199.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+...++ .||+|++..... ......+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 73 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQ---------LVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIH 73 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCc---------EEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 689999999999999999999877665 399999865421 122234567999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 74 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 74 TKETLTFVFEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred cCCeEEEEEecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 999999999999 567777665443 457889999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......++..|+|||++.
T Consensus 152 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 176 (291)
T cd07870 152 AKSIPS-------------------------------------------------------QTYSSEVVTLWYRPPDVLL 176 (291)
T ss_pred ccCCCC-------------------------------------------------------CCCCCccccccccCCceee
Confidence 211000 0001125678899999987
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCC--------------CC---------C----CCCC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPL--------------TF---------P----TQSP 370 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~--------------~~---------~----~~~~ 370 (451)
+. .++.++|||||||++|+|++|+.||...... +.+..+..... .+ + ....
T Consensus 177 ~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd07870 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWK 256 (291)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhcc
Confidence 64 4788999999999999999999999765432 22322221000 00 0 0000
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
....+.++.+++.+||..||.+||| +.|++.||||
T Consensus 257 ~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 257 RLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred ccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0112347899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=319.01 Aligned_cols=259 Identities=30% Similarity=0.513 Sum_probs=208.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||+|+||.||+|.+..+.+ .||+|++...... ......+..|+.+++.++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 70 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGE---------LMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCc---------EEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence 58899999999999999999876654 4999998765432 3456778889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..++|+||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 71 REKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999999999999998764 4488999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
........ ........|+..|+|||++.+
T Consensus 149 ~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~~~PE~~~~ 177 (264)
T cd06626 149 LKNNTTTM---------------------------------------------------GEEVQSLAGTPAYMAPEVITG 177 (264)
T ss_pred cCCCCCcc---------------------------------------------------cccccCCcCCcCccChhhccC
Confidence 32111000 000112367889999999987
Q ss_pred CC---CCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 321 GS---HGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 321 ~~---~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
.. ++.++||||||+++|+|++|+.||...... .....+.... ...+. ....+..+.+||.+||+.||.+||+
T Consensus 178 ~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~ 254 (264)
T cd06626 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPT 254 (264)
T ss_pred CCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc---ccccCHHHHHHHHHHccCCcccCCC
Confidence 66 789999999999999999999999765333 3332332221 11221 1112448899999999999999999
Q ss_pred CCCChHHHHcCCCc
Q 013016 396 SKRGAADVKTHPFF 409 (451)
Q Consensus 396 ~~~~~~ell~hp~~ 409 (451)
+.+++.|||+
T Consensus 255 ----~~~i~~~~~~ 264 (264)
T cd06626 255 ----ASELLQHPFV 264 (264)
T ss_pred ----HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.60 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=202.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.+..+++ .||||++............++.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~---------~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSR---------RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCc---------EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 689999999999999999999887665 39999997654333444567888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP---------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
+++..|+||||++|++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCE
Confidence 9999999999999999999886421 2335677889999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+|+|||++............. ..................+||+
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l-------------------------------------~~~~~~s~~s~~t~~g~~vGT~ 195 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDI-------------------------------------DVDERNICYSSMTIPGKIVGTP 195 (932)
T ss_pred EEEecCcceeccccccccccc-------------------------------------ccccccccccccccCCCCCCCC
Confidence 999999986442110000000 0000000000011122457999
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC-CCCcChHHHHHHHHHhcccC
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS-PSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~d 389 (451)
.|||||++.+..++.++|||||||++|||+||+.||............. ...+... .....+..+.+++.+||+.|
T Consensus 196 ~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 196 DYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV---ILSPIEVAPYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred CCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhh---ccChhhccccccCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999999999999998754433322211 1111111 11123348899999999999
Q ss_pred cCCcCC
Q 013016 390 PCNRLG 395 (451)
Q Consensus 390 P~~Rpt 395 (451)
|++|++
T Consensus 273 P~kR~s 278 (932)
T PRK13184 273 PAERYS 278 (932)
T ss_pred hhhCcC
Confidence 999988
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=325.80 Aligned_cols=270 Identities=36% Similarity=0.708 Sum_probs=211.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+|++.+.||.|+||.||+|.+.... +.+..||+|++....... ......+..|+.+++++ +|+||+.+++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 4889999999999999999875321 112359999997654322 22345567799999999 599999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999999999988764 45899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... ........|+..|+|||.+
T Consensus 153 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 153 KEFHEDE------------------------------------------------------VERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred eeccccc------------------------------------------------------ccccccccCCcccCChhhc
Confidence 4321100 0001124688899999998
Q ss_pred cCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 319 SGG--SHGNAVDWWAFGIFIYEMIYGRTPFAAPSN----ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 319 ~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
.+. .++.++||||||+++|+|++|..||..... .+....+......++.. .+..+.+++.+||+.||++
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ll~~~l~~~p~~ 253 (290)
T cd05613 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE-----MSALAKDIIQRLLMKDPKK 253 (290)
T ss_pred cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc-----CCHHHHHHHHHHhcCCHHH
Confidence 763 467899999999999999999999975322 23333444433333322 3348899999999999999
Q ss_pred cCCC-CCChHHHHcCCCcCCCCcccc
Q 013016 393 RLGS-KRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 393 Rpt~-~~~~~ell~hp~~~~~~~~~~ 417 (451)
|++. ...+++++.||||+.++|..+
T Consensus 254 R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 254 RLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred hcCCCCCCHHHHHcCcccccCCHHHH
Confidence 9842 233999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=320.01 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=210.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||.|+||.||+|.+..+++ .||+|++..... .......+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGK---------ILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIID 70 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCC---------EEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence 58899999999999999999877655 499999875432 23334567779999999999999999998754
Q ss_pred --CCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeccCCCCcEEEccCCCEE
Q 013016 161 --SNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLH-----MLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 161 --~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH-----~~givH~Dlkp~NIll~~~~~~k 231 (451)
....|++|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+|
T Consensus 71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence 45789999999999999988753 2356899999999999999999999 89999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++....... .......|+..
T Consensus 151 l~d~g~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 175 (265)
T cd08217 151 LGDFGLAKILGHDS-------------------------------------------------------SFAKTYVGTPY 175 (265)
T ss_pred EecccccccccCCc-------------------------------------------------------ccccccccCCC
Confidence 99999974321100 00112367889
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|+|||.+.+..++.++||||||+++|+|++|+.||...........+..+..... +...+..+.+++.+||+.+|.
T Consensus 176 ~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~l~~~p~ 251 (265)
T cd08217 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI----PYRYSSELNEVIKSMLNVDPD 251 (265)
T ss_pred ccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC----ccccCHHHHHHHHHHccCCcc
Confidence 9999999988899999999999999999999999998776666666655543211 112334899999999999999
Q ss_pred CcCCCCCChHHHHcCCCc
Q 013016 392 NRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~ 409 (451)
+||+ +.+|++|||+
T Consensus 252 ~Rp~----~~~il~~~~~ 265 (265)
T cd08217 252 KRPS----TEELLQLPLI 265 (265)
T ss_pred cCCC----HHHHhhCCCC
Confidence 9999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=328.58 Aligned_cols=257 Identities=31% Similarity=0.433 Sum_probs=209.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.+...++ .||+|++.... .......+..|+++++.++|+||+++++.+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGT---------VMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAF 72 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCc---------EEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeE
Confidence 4679999999999999999999876654 49999886542 223345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
...+.+|+||||+++++|.+++... +.+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 73 LNENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred ecCCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999999999988764 458999999999999999999997 6999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+..... .......|+..|+|||+
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~~~~~~~~aPE~ 173 (284)
T cd06620 151 SGELIN---------------------------------------------------------SIADTFVGTSTYMSPER 173 (284)
T ss_pred ccchhh---------------------------------------------------------hccCccccCcccCCHHH
Confidence 632100 00112368899999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-----------TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+.+..++.++|||||||++|+|++|+.||...... +.+..+...... .......+.++.+|+.+||
T Consensus 174 ~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l 250 (284)
T cd06620 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP---RLPSSDFPEDLRDFVDACL 250 (284)
T ss_pred HccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC---CCCchhcCHHHHHHHHHHh
Confidence 98888999999999999999999999999865442 223333322211 1111113348999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
..||.+||+ +.|+++|+||.+.
T Consensus 251 ~~dp~~Rpt----~~e~~~~~~~~~~ 272 (284)
T cd06620 251 LKDPTERPT----PQQLCAMPPFIQA 272 (284)
T ss_pred cCCcccCcC----HHHHhcCcccccc
Confidence 999999999 9999999999773
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=330.17 Aligned_cols=259 Identities=28% Similarity=0.416 Sum_probs=210.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.....||.|+||.||++.+..+.+ .||||.+.... ......+..|+.+++.++|+||+++++.+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~ 89 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGK---------QVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYL 89 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCC---------EEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHhee
Confidence 446666789999999999999876654 49999986542 233455677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++.|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 90 VGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred cCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 99999999999999999998754 358999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||.+.
T Consensus 167 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 191 (292)
T cd06658 167 QVSKE-------------------------------------------------------VPKRKSLVGTPYWMAPEVIS 191 (292)
T ss_pred hcccc-------------------------------------------------------cccCceeecCccccCHHHHc
Confidence 21100 00011236888999999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|||++|+.||........+..+......... . ....+..+.+++.+||..||.+|||
T Consensus 192 ~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~li~~~l~~~P~~Rpt---- 265 (292)
T cd06658 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-D-SHKVSSVLRGFLDLMLVREPSQRAT---- 265 (292)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-c-ccccCHHHHHHHHHHccCChhHCcC----
Confidence 888999999999999999999999999887766665555433221111 1 1123447899999999999999999
Q ss_pred hHHHHcCCCcCCCCc
Q 013016 400 AADVKTHPFFKGLNF 414 (451)
Q Consensus 400 ~~ell~hp~~~~~~~ 414 (451)
++++++||||.....
T Consensus 266 ~~~il~~~~~~~~~~ 280 (292)
T cd06658 266 AQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHhhChhhhccCC
Confidence 999999999998443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.30 Aligned_cols=249 Identities=25% Similarity=0.457 Sum_probs=195.9
Q ss_pred CCceEEeee--ccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeE
Q 013016 80 RDFDLHRRI--GAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~ 156 (451)
++|.+.+.+ |.|+||.||+|..+.+++ .+|+|++....... . |+.....+ +|+||+++++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~ 76 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQK---------LFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYY 76 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCc---------EEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEE
Confidence 567776666 999999999999887765 49999987542211 1 22222222 7999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEecc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDF 235 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Df 235 (451)
.+..++..|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 77 SVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred EEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999999998775 3699999999999999999999999999999999999999998 9999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .....|+..|+||
T Consensus 155 g~~~~~~~-----------------------------------------------------------~~~~~~~~~y~aP 175 (267)
T PHA03390 155 GLCKIIGT-----------------------------------------------------------PSCYDGTLDYFSP 175 (267)
T ss_pred ccceecCC-----------------------------------------------------------CccCCCCCcccCh
Confidence 98742210 0112578889999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++||||||+++|+|++|+.||........ ...+.... .......+ ..+..+.+||.+||+.||.+|+
T Consensus 176 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~ 253 (267)
T PHA03390 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIK-NVSKNANDFVQSMLKYNINYRL 253 (267)
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCccc-ccCHHHHHHHHHHhccChhhCC
Confidence 999988899999999999999999999999986544332 12221111 11111112 3344899999999999999999
Q ss_pred CCCCChHHHHcCCCcCC
Q 013016 395 GSKRGAADVKTHPFFKG 411 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~ 411 (451)
+. ++++|+||||+.
T Consensus 254 ~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 254 TN---YNEIIKHPFLKI 267 (267)
T ss_pred ch---HHHHhcCCcccC
Confidence 51 599999999974
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.34 Aligned_cols=258 Identities=19% Similarity=0.317 Sum_probs=207.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.+.||.|+||+||+|.+..... ......+|+|.+.... ......+..|+.++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~----~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCP----EQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCC----CCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 679999999999999999998644221 1122358999987542 233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP-----------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
..+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999999887542 23489999999999999999999999999999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.++|+|||++....... .........+
T Consensus 158 ~~kl~dfg~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 184 (288)
T cd05093 158 LVKIGDFGMSRDVYSTD-----------------------------------------------------YYRVGGHTML 184 (288)
T ss_pred cEEeccCCccccccCCc-----------------------------------------------------eeecCCCCCc
Confidence 99999999974221000 0000011245
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..+...... ...+.++.+|+.+||+
T Consensus 185 ~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~ 260 (288)
T cd05093 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP----RTCPKEVYDLMLGCWQ 260 (288)
T ss_pred cccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcc
Confidence 678999999998889999999999999999998 99999888777777777766532211 1234489999999999
Q ss_pred cCcCCcCCCCCChHHHHc
Q 013016 388 KDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~ 405 (451)
.||.+||+ +.+++.
T Consensus 261 ~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 261 REPHMRLN----IKEIHS 274 (288)
T ss_pred CChhhCCC----HHHHHH
Confidence 99999999 888753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.03 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=204.1
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||.|++|.||+|.+..+++ .||||++..... ......+..|+.++++++|+||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 69 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGE---------IVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHT 69 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCe---------EEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence 58999999999999999999877655 499999875422 2223455679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 70 ENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 999999999996 58888776543 3458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......++..|++||++.
T Consensus 149 ~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 149 AFGIPV-------------------------------------------------------NTFSNEVVTLWYRAPDVLL 173 (284)
T ss_pred hhcCCc-------------------------------------------------------cccccccccccccChHHhc
Confidence 321100 0001125678899999987
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC--------------CCCCCC----------CCcC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--------------FPTQSP----------SSMS 374 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------~~~~~~----------~~~~ 374 (451)
+. .++.++|||||||++|+|++|+.||......+....+...... +..... ....
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 64 4688999999999999999999999887766555544321100 000000 0112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 347889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=330.22 Aligned_cols=260 Identities=26% Similarity=0.347 Sum_probs=205.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||.|+||.||+|.++.+++ .+|+|.+...... ......+.+|+.+++++.||||+++++++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 73 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGE---------IVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVV 73 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCc---------EEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEE
Confidence 3679999999999999999999886655 4999999754322 22233456799999999999999999999
Q ss_pred EeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
... +..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 74 VGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecC
Confidence 877 89999999995 58988887653 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++....... .......++..|+|||
T Consensus 152 ~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~aPE 176 (293)
T cd07843 152 LAREYGSPL-------------------------------------------------------KPYTQLVVTLWYRAPE 176 (293)
T ss_pred ceeeccCCc-------------------------------------------------------cccccccccccccCch
Confidence 874322100 0001125678899999
Q ss_pred cccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--------------------------CCCC
Q 013016 317 VASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF--------------------------PTQS 369 (451)
Q Consensus 317 ~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~ 369 (451)
.+.+.. ++.++||||||+++|+|++|..||........+.++....... ....
T Consensus 177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (293)
T cd07843 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKK 256 (293)
T ss_pred hhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcc
Confidence 987654 6889999999999999999999998877666555443211100 0000
Q ss_pred CCCc-ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 370 PSSM-SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 370 ~~~~-~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.+.. .+..+.+||++||+.||++||| +.|+|.||||
T Consensus 257 ~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 257 FPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred ccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 1111 2447899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.57 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=208.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC---CCCccceeEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD---HPFLPTLYAE 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~ 157 (451)
.|++.+.||.|+||.||+|.+..+++ .||+|++.... .......+..|+.+++.+. |+||++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~ 70 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR---------VVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGS 70 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc---------EEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeee
Confidence 47888999999999999999876655 49999986542 2233455677899999986 9999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+..+...|+||||++|++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 71 YLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 99999999999999999999988653 589999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .......|+..|+|||.
T Consensus 148 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~ 172 (277)
T cd06917 148 AALLNQNS-------------------------------------------------------SKRSTFVGTPYWMAPEV 172 (277)
T ss_pred eeecCCCc-------------------------------------------------------cccccccCCcceeCHHH
Confidence 74322100 00112368889999999
Q ss_pred ccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.++ .++.++|||||||++|+|++|..||...........+.... .+ .......+.++.+++.+||+.||.+||+
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~- 248 (277)
T cd06917 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PP-RLEDNGYSKLLREFVAACLDEEPKERLS- 248 (277)
T ss_pred hccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CC-CCCcccCCHHHHHHHHHHcCCCcccCcC-
Confidence 8754 46889999999999999999999998765544443332221 11 1111123448999999999999999999
Q ss_pred CCChHHHHcCCCcCCCCc
Q 013016 397 KRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~ 414 (451)
+.+++.|+||++...
T Consensus 249 ---~~~il~~~~~~~~~~ 263 (277)
T cd06917 249 ---AEELLKSKWIKAHSK 263 (277)
T ss_pred ---HHHHhhChHhhcccc
Confidence 999999999988554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=324.79 Aligned_cols=259 Identities=21% Similarity=0.334 Sum_probs=207.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||.|+||.||+|.+...... .....+++|.+..... .....+.+|+.++++++|+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~----~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPT----KDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCC----CcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 46799999999999999999986543211 1223489999875432 2234566799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
...+..++||||+++++|.+++.... .+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999987542 2348999999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.++|+|||++........ .....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~-----------------------------------------------------~~~~~ 183 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY-----------------------------------------------------YRVGG 183 (291)
T ss_pred ccCCcEEECCCCcccccCCCce-----------------------------------------------------eecCC
Confidence 9999999999999742211000 00011
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
...|+..|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+..+..... ....+..+.+++.
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~ 259 (291)
T cd05094 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER----PRVCPKEVYDIML 259 (291)
T ss_pred CCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCC----CccCCHHHHHHHH
Confidence 2356788999999999889999999999999999999 9999988877777776655543321 1223448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.||.+||+ +.++++
T Consensus 260 ~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 260 GCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred HHcccChhhCcC----HHHHHH
Confidence 999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.12 Aligned_cols=258 Identities=17% Similarity=0.219 Sum_probs=202.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+|++.+.||+|+||.||+|.+...+.. ....||+|++.... .......+..|+.+++.++|+||+++++++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 36799999999999999999997654331 11238999986432 223345677799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
... ..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 79 LTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred cCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence 765 5779999999999999987653 35889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ ........++..|+|||++
T Consensus 157 ~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~apE~~ 183 (316)
T cd05108 157 KLLGADEK-----------------------------------------------------EYHAEGGKVPIKWMALESI 183 (316)
T ss_pred ccccCCCc-----------------------------------------------------ceeccCCccceeecChHHh
Confidence 53221000 0000011345679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |+.||.+....+.. .+.......+.. ...+.++.+++.+||..||++||+
T Consensus 184 ~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps-- 257 (316)
T cd05108 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP---PICTIDVYMIMVKCWMIDADSRPK-- 257 (316)
T ss_pred ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCCC---CCCCHHHHHHHHHHccCChhhCcC--
Confidence 99899999999999999999998 99999876655543 333333222221 223448999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.+++.+
T Consensus 258 --~~~l~~~ 264 (316)
T cd05108 258 --FRELIIE 264 (316)
T ss_pred --HHHHHHH
Confidence 8888875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.36 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=205.2
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.++||.|++|.||+|.++.+++ .||+|++..... .......+..|+.+++.++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~ 70 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE---------IVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE 70 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC---------EEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence 6778899999999999999876655 499999875432 122334566799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..|+||||+ +++|.+++.......+++..++.++.||+.||+|||+++++||||+|+||+++.++.++|+|||++...
T Consensus 71 ~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 71 NKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred CeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 9999999999 578999988765556999999999999999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
.... .......++..|+|||++.+.
T Consensus 150 ~~~~-------------------------------------------------------~~~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 150 GVPV-------------------------------------------------------RTYTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred CCCc-------------------------------------------------------cccCccccccCCCCCceeecC
Confidence 1000 000011467789999988764
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------------------CC------CCCCCcChH
Q 013016 322 -SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF------------------PT------QSPSSMSEY 376 (451)
Q Consensus 322 -~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~------------------~~------~~~~~~~~~ 376 (451)
.++.++||||||+++|+|++|+.||........+.++.+..... +. .......+.
T Consensus 175 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (283)
T cd07835 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDE 254 (283)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCH
Confidence 46889999999999999999999998876655544443321100 00 000122334
Q ss_pred HHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 377 ~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.+.++|.+||+.||.+||| ++|++.||||
T Consensus 255 ~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 255 DGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred HHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 7899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.27 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=207.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
.+++|.+.|.+|||+.||+|.+.+.+.+ ||+|.+... +....+.+.+|+.+|++|. |+|||.+++..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~---------~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKK---------YALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCce---------eeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 5699999999999999999999888543 999988644 5667788889999999996 99999999933
Q ss_pred E-e---C---CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccCCC
Q 013016 159 E-A---S---NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 159 ~-~---~---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~~~ 229 (451)
. . + -.++|.||||+||+|-|+++.....+|++.++++|+.|+++|+.+||... |||||||-+||||..+|.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 2 1 1 26789999999999999999777777999999999999999999999988 999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
.||||||.+.-.-..+. +.+. ..+++ ..+ ...-|
T Consensus 185 ~KLCDFGSatt~~~~~~------------------~~~e----~~~ve-----~eI-------------------~k~TT 218 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPT------------------SAQE----VNYVE-----EEI-------------------EKYTT 218 (738)
T ss_pred EEeCcccccccccCCCc------------------cHHH----HHHHH-----HHH-------------------HhhCC
Confidence 99999998731110000 0000 00000 000 11568
Q ss_pred CCccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 310 HEYVSPEVA---SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 310 ~~y~aPE~~---~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+.|+|||.+ .|.+++.|+|||+|||+||.|+....||+.... ..|+.+...+|... .++..+.+||+.||
T Consensus 219 p~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p---~ys~~l~~LI~~mL 291 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFP---NYSDRLKDLIRTML 291 (738)
T ss_pred ccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCc---cHHHHHHHHHHHHh
Confidence 999999997 467789999999999999999999999986433 46788888888752 34458999999999
Q ss_pred ccCcCCcCCCCCChHHHHcC
Q 013016 387 NKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~h 406 (451)
+.||++||+ +-+++.+
T Consensus 292 ~~nP~~RPn----I~Qv~~~ 307 (738)
T KOG1989|consen 292 QPNPDERPN----IYQVLEE 307 (738)
T ss_pred ccCcccCCC----HHHHHHH
Confidence 999999999 7777654
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=319.33 Aligned_cols=259 Identities=31% Similarity=0.499 Sum_probs=214.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|++|.||+|.++.+++ .||+|++...... .....+..|+.++.+++|+||+++++++.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGK---------IYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFY 69 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCc---------EEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence 368999999999999999999987655 4999998765322 34566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||.+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 70 KEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred cCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999999998765 568999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......|+..|+|||.+
T Consensus 148 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~pE~~ 172 (264)
T cd06623 148 KVLENTL-------------------------------------------------------DQCNTFVGTVTYMSPERI 172 (264)
T ss_pred eecccCC-------------------------------------------------------CcccceeecccccCHhhh
Confidence 4321100 000123578889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS---NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
.+..++.++||||||+++|+|++|+.||.... ..+....+....... ......+..+.++|.+||..+|++||+
T Consensus 173 ~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~ 249 (264)
T cd06623 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEEFSPEFRDFISACLQKDPKKRPS 249 (264)
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCcccCCHHHHHHHHHHccCChhhCCC
Confidence 88888999999999999999999999998764 334444444332211 111213448999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCC
Q 013016 396 SKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~ 413 (451)
+.++++||||+..+
T Consensus 250 ----~~~ll~~~~~~~~~ 263 (264)
T cd06623 250 ----AAELLQHPFIKKAD 263 (264)
T ss_pred ----HHHHHhCHHHHhcc
Confidence 99999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=324.81 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=206.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|++|.||+|.++.+.+ .||+|++..... .......+..|++++++++|+||+++++++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~---------~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGE---------IVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFR 70 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCc---------EEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEE
Confidence 369999999999999999999887655 499999875432 2333466778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||++++.|..+.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.
T Consensus 71 ~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 71 RKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred ECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 999999999999877666555443 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......|+..|+|||++.
T Consensus 149 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~~~PE~~~ 174 (288)
T cd07833 149 ALRARPA------------------------------------------------------SPLTDYVATRWYRAPELLV 174 (288)
T ss_pred ccCCCcc------------------------------------------------------ccccCcccccCCcCCchhc
Confidence 3221100 0111236788899999998
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCC--------CCC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQ--------SPS 371 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~--------~~~ 371 (451)
+. .++.++||||||+++|+|++|+.||......+.+..+...... ++.. ..+
T Consensus 175 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07833 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYP 254 (288)
T ss_pred CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcC
Confidence 88 7899999999999999999999999876555443332211000 0000 011
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
...+.++.+||++||..||++||+ ++++++||||
T Consensus 255 ~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 255 GKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 122448999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=318.65 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=205.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|++|.||+|.+..+. .||+|.+..... ....+..|+.++++++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~----------~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCe----------EEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 67999999999999999999876543 399999875422 2345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 99999999999999999999987655679999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||.+.
T Consensus 152 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 152 VIKEDIY------------------------------------------------------EAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred EccCCcc------------------------------------------------------cccCCCcCceeccCccccc
Confidence 4321000 0000112345799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |+.||........+..+..... .+. +...+..+.+++.+||+.||.+||+
T Consensus 178 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~li~~~l~~~P~~Rp~--- 250 (261)
T cd05068 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MPC---PPGCPKELYDIMLDCWKEDPDDRPT--- 250 (261)
T ss_pred cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCC---CCcCCHHHHHHHHHHhhcCcccCCC---
Confidence 8889999999999999999999 9999988777777766655422 111 1123348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.+|+.
T Consensus 251 -~~~l~~ 256 (261)
T cd05068 251 -FETLQW 256 (261)
T ss_pred -HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.44 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=206.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
+.++|.+.++||+|||+.||++..-.+.+ +||+|.+.... .+..+...+|++..++++|||+++++++
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~---------~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh 86 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGH---------LYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDH 86 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCccc---------chhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHH
Confidence 44789999999999999999998655544 59999997653 3456677889999999999999999987
Q ss_pred EEeC-----CeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccCC
Q 013016 158 FEAS-----NFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDG 228 (451)
Q Consensus 158 ~~~~-----~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~~ 228 (451)
...+ ...||+++|...|+|.+.+...+ +.-+++.++..|+.+|++||++||+.. ++||||||.|||+.+++
T Consensus 87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG 166 (302)
T ss_pred HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC
Confidence 6433 35899999999999999887653 345999999999999999999999999 99999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.++|.|||.+.... .+...+...-.+.++- .-..
T Consensus 167 ~~vl~D~GS~~~a~------------------i~i~~~~~a~~lQe~a----------------------------~e~C 200 (302)
T KOG2345|consen 167 LPVLMDLGSATQAP------------------IQIEGSRQALRLQEWA----------------------------EERC 200 (302)
T ss_pred ceEEEeccCccccc------------------eEeechHHHHHHHHHH----------------------------HHhC
Confidence 99999999874321 0111111111111111 1156
Q ss_pred CCCccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 309 THEYVSPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN--ETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 309 t~~y~aPE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
|..|+|||++.- ...+.++|||||||+||+|+.|..||+..-. ......+.++...+|.... .+..+.+||+
T Consensus 201 t~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~---yse~l~~lik 277 (302)
T KOG2345|consen 201 TIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSR---YSEALHQLIK 277 (302)
T ss_pred CCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCC---ccHHHHHHHH
Confidence 888999999853 4568999999999999999999999975322 2233345555666665433 5558999999
Q ss_pred HhcccCcCCcCCCCCChHHHHcC
Q 013016 384 GLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.||+.||.+||+ +.+|+.+
T Consensus 278 ~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 278 SMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HHhcCCcccCCC----HHHHHHH
Confidence 999999999999 9999863
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=329.11 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=209.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|...+.||.|+||.||+|.+...++ .||+|++..... ......+..|+.++++++|+||+++++++.
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKE---------VVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYL 72 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCe---------EEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccc
Confidence 457788899999999999999876654 499999874422 234466778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 73 KGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred cCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999999999988764 458999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||++.
T Consensus 150 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06642 150 QLTDT-------------------------------------------------------QIKRNTFVGTPFWMAPEVIK 174 (277)
T ss_pred cccCc-------------------------------------------------------chhhhcccCcccccCHHHhC
Confidence 32110 00011235788899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+...... .. ....+.++.+++.+||..+|++||+
T Consensus 175 ~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~li~~~l~~~p~~Rp~---- 246 (277)
T cd06642 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TL-EGQYSKPFKEFVEACLNKDPRFRPT---- 246 (277)
T ss_pred cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CC-CcccCHHHHHHHHHHccCCcccCcC----
Confidence 988999999999999999999999999876555544443333211 11 1123347999999999999999999
Q ss_pred hHHHHcCCCcCCCC
Q 013016 400 AADVKTHPFFKGLN 413 (451)
Q Consensus 400 ~~ell~hp~~~~~~ 413 (451)
+.+++.||||....
T Consensus 247 ~~~il~~~~~~~~~ 260 (277)
T cd06642 247 AKELLKHKFITRYT 260 (277)
T ss_pred HHHHHHhHHHHHHh
Confidence 99999999998743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=327.24 Aligned_cols=264 Identities=27% Similarity=0.365 Sum_probs=201.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.++||.|+||.||+|.++.+++ .||||++...... ......+..|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ---------IVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEIC 80 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCc---------EEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence 4789999999999999999999887655 4999998644211 11223345689999999999999999998
Q ss_pred EeCC--------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EASN--------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~~--------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
...+ ..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 81 RTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred ecccccccCCCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcE
Confidence 6554 459999999 568887776542 458999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++.......... ........++.
T Consensus 159 kl~dfg~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~ 187 (310)
T cd07865 159 KLADFGLARAFSLSKNSK---------------------------------------------------PNRYTNRVVTL 187 (310)
T ss_pred EECcCCCcccccCCcccC---------------------------------------------------CCCccCcccCc
Confidence 999999985332110000 00011235788
Q ss_pred CccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC-------------------CC--
Q 013016 311 EYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP-------------------TQ-- 368 (451)
Q Consensus 311 ~y~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-------------------~~-- 368 (451)
.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.......+ ..
T Consensus 188 ~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (310)
T cd07865 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQK 267 (310)
T ss_pred cccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccc
Confidence 899999987654 68899999999999999999999987665443333222111000 00
Q ss_pred ------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 369 ------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 369 ------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
......+..+.+||.+||..||.+||| ++|+|+||||
T Consensus 268 ~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 268 RKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 001112346789999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=326.07 Aligned_cols=264 Identities=17% Similarity=0.279 Sum_probs=208.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
....++|.+.+.||.|+||.||+|.+...... ..+..||+|++..... ......+..|+.+++++ +|+||+++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKS----DAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCC----CceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceE
Confidence 34447899999999999999999987432211 1233599999875422 23345677899999999 79999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++...+..++||||+++++|.+++.......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECC
Confidence 99999999999999999999999999875555589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++........ ........++..|+|
T Consensus 185 fg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~a 211 (302)
T cd05055 185 FGLARDIMNDSN-----------------------------------------------------YVVKGNARLPVKWMA 211 (302)
T ss_pred CcccccccCCCc-----------------------------------------------------eeecCCCCcccccCC
Confidence 999743211000 000011246678999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||.+.+..++.++|||||||++|+|++ |..||......+.+.+......... .+...+.++.+|+.+||+.+|++|
T Consensus 212 PE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~R 288 (302)
T cd05055 212 PESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA---QPEHAPAEIYDIMKTCWDADPLKR 288 (302)
T ss_pred HhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCchhC
Confidence 999999889999999999999999998 9999988766655555544322211 112234489999999999999999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|+ +.||++
T Consensus 289 pt----~~ell~ 296 (302)
T cd05055 289 PT----FKQIVQ 296 (302)
T ss_pred cC----HHHHHH
Confidence 99 888874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=322.24 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=210.4
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|...+.||.|++|.||+|.++..++ .+|+|++..... .....+.+|+.+++.+.|+||+++++++..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~ 87 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGR---------QVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLV 87 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCC---------EEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEc
Confidence 45556789999999999999876654 399998864322 223456679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.++.|+|+||+.|++|.+++.. ..+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++..
T Consensus 88 ~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 88 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred CCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999999999998876 4589999999999999999999999999999999999999999999999998632
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... ........|+..|+|||.+.+
T Consensus 165 ~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 189 (285)
T cd06648 165 VSKE-------------------------------------------------------VPRRKSLVGTPYWMAPEVISR 189 (285)
T ss_pred hccC-------------------------------------------------------CcccccccCCccccCHHHhcC
Confidence 1100 000112368889999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++|||||||++|+|++|+.||...........+.......... ....+..+.+|+.+||+.||++||+ +
T Consensus 190 ~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt----~ 263 (285)
T cd06648 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN--LHKVSPRLRSFLDRMLVRDPAQRAT----A 263 (285)
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcc--cccCCHHHHHHHHHHcccChhhCcC----H
Confidence 889999999999999999999999998877666666665543222111 1113348999999999999999999 9
Q ss_pred HHHHcCCCcCCCC
Q 013016 401 ADVKTHPFFKGLN 413 (451)
Q Consensus 401 ~ell~hp~~~~~~ 413 (451)
.++++||||++..
T Consensus 264 ~~il~~~~~~~~~ 276 (285)
T cd06648 264 AELLNHPFLAKAG 276 (285)
T ss_pred HHHccCcccccCC
Confidence 9999999999844
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.54 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=205.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|++|.||+|.++.+++. +|||.+.............+..|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~---------~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVP---------VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCce---------EEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 6799999999999999999998766553 9999887654444445567788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
.++..++||||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchh
Confidence 999999999999999999988642 235689999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .......|+..|+|||+
T Consensus 153 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~ape~ 177 (267)
T cd08229 153 GRFFSSKT-------------------------------------------------------TAAHSLVGTPYYMSPER 177 (267)
T ss_pred hhccccCC-------------------------------------------------------cccccccCCcCccCHHH
Confidence 74321100 00012368889999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN--ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++||||||+++|+|++|..||..... ......+.... .+.. .....+..+.+++.+||..||.+|||
T Consensus 178 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt 254 (267)
T cd08229 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPL-PSDHYSEELRQLVNMCINPDPEKRPD 254 (267)
T ss_pred hcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCC-CcccccHHHHHHHHHhcCCCcccCCC
Confidence 9988899999999999999999999999976433 23333333221 1111 11223448999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+.+|++
T Consensus 255 ----~~~i~~ 260 (267)
T cd08229 255 ----ITYVYD 260 (267)
T ss_pred ----HHHHHH
Confidence 887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.78 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=215.6
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
...+.+..++||+|+||+||+|...+... .+.-.+||||.++.. ...+...+|++|++++..++|||||+++|+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p----~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLP----GQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCC----CccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34678889999999999999998654431 122347999999866 344567889999999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
|.+++.+|+|+|||..|+|.++|.... ..+++..+...|+.||+.|+.||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999999999999987532 12388899999999999999999999999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
++..|||+|||+++-. |..+|+. ....+
T Consensus 638 e~l~VKIsDfGLsRdi---------------------------------YssDYYk-------------------~~~~t 665 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDI---------------------------------YSSDYYK-------------------VRGNT 665 (774)
T ss_pred cceEEEecccccchhh---------------------------------hhhhhhc-------------------ccCCc
Confidence 9999999999998521 1111111 00001
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
.-...|||||.|+.+.|+.++|||||||+|||+++ |+.||.+.++++.+..+..+.+ ++ .+...+.++.+|+.+
T Consensus 666 -~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~---~Pe~CP~~vY~LM~~ 740 (774)
T KOG1026|consen 666 -LLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS---CPENCPTEVYSLMLE 740 (774)
T ss_pred -eeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-cc---CCCCCCHHHHHHHHH
Confidence 23467999999999999999999999999999998 9999999999999999999876 22 233445589999999
Q ss_pred hcccCcCCcCCCCCChHHH
Q 013016 385 LLNKDPCNRLGSKRGAADV 403 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~el 403 (451)
||+.+|.+||+ +.||
T Consensus 741 CW~~~P~~RPs----F~eI 755 (774)
T KOG1026|consen 741 CWNENPKRRPS----FKEI 755 (774)
T ss_pred HhhcCcccCCC----HHHH
Confidence 99999999999 7766
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.01 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=207.6
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.+.||.|+||.||+|.++..... .....||+|.+..... ......+.+|+.+++.++|+||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~----~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKG----EPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCC----CcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 347899999999999999999998754311 1123499999865421 2233456679999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP--------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~ 229 (451)
+...+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence 999999999999999999999886532 234788999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++........ ........++
T Consensus 158 ~kl~dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 184 (277)
T cd05032 158 VKIGDFGMTRDIYETDY-----------------------------------------------------YRKGGKGLLP 184 (277)
T ss_pred EEECCcccchhhccCcc-----------------------------------------------------cccCCCCCcc
Confidence 99999999743211000 0001122567
Q ss_pred CCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcc
Q 013016 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 310 ~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..+.. ..+.. .+.++.+++.+||+
T Consensus 185 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~ 259 (277)
T cd05032 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPEN-----CPDKLLELMRMCWQ 259 (277)
T ss_pred ccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCC-----CCHHHHHHHHHHcC
Confidence 78999999988889999999999999999998 9999988777777666664322 22221 24489999999999
Q ss_pred cCcCCcCCCCCChHHHHc
Q 013016 388 KDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~ 405 (451)
.+|++||| +.+|+.
T Consensus 260 ~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 260 YNPKMRPT----FLEIVS 273 (277)
T ss_pred CChhhCCC----HHHHHH
Confidence 99999999 998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=324.54 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=202.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHH-HHHCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI-LKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||.||+|.++.+++ .||+|++........ ...+..|+.+ ++.++|+||+++++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~ 69 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGT---------IMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGAL 69 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCc---------EEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence 479999999999999999999887665 499999875432211 2233345554 6667899999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
..++..|+||||+ .++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+||
T Consensus 70 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 70 FREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred ecCCcEEEEhhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999 47888877643 235689999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .......|+..|+||
T Consensus 149 g~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 172 (283)
T cd06617 149 GISGYLVDS--------------------------------------------------------VAKTIDAGCKPYMAP 172 (283)
T ss_pred ccccccccc--------------------------------------------------------cccccccCCccccCh
Confidence 997421100 000113578889999
Q ss_pred ccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 316 EVASG----GSHGNAVDWWAFGIFIYEMIYGRTPFAAP-SNETTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 316 E~~~~----~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|.+.+ ..++.++|||||||++|+|++|+.||... ...+.+..+.... ...+. ...+.++.+||.+||..+
T Consensus 173 E~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~ 248 (283)
T cd06617 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA----EKFSPEFQDFVNKCLKKN 248 (283)
T ss_pred hhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc----cccCHHHHHHHHHHccCC
Confidence 98865 44688999999999999999999999753 2334444444332 11221 123448999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 390 PCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
|.+||+ +.+++.||||+....
T Consensus 249 p~~Rp~----~~~il~~~~~~~~~~ 269 (283)
T cd06617 249 YKERPN----YPELLQHPFFELHLS 269 (283)
T ss_pred hhhCcC----HHHHhcCchhhhccc
Confidence 999999 999999999999654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=326.68 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=209.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.+.++||+|+||.||+|.+..+++ .||+|++.............+..|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCc---------EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 569999999999999999999876554 49999986543333444566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcce
Confidence 9999999999995 67777765432 458999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .....|+..|+|||++.
T Consensus 164 ~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 164 LVSP-----------------------------------------------------------ANSFVGTPYWMAPEVIL 184 (307)
T ss_pred ecCC-----------------------------------------------------------CCCccCCccccCceeee
Confidence 2110 01235778899999885
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 ---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
...++.++||||||+++|+|++|+.||...........+...... . ......+..+.++|.+||+.||++||+
T Consensus 185 ~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rp~- 260 (307)
T cd06607 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--T-LSSNDWSDYFRNFVDSCLQKIPQDRPS- 260 (307)
T ss_pred ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--C-CCchhhCHHHHHHHHHHhcCChhhCcC-
Confidence 345788999999999999999999999887666655544433211 1 111123448999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
+.+|+.||||....
T Consensus 261 ---~~~il~~~~~~~~~ 274 (307)
T cd06607 261 ---SEELLKHRFVLRER 274 (307)
T ss_pred ---HHHHhcChhhcccC
Confidence 99999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.08 Aligned_cols=269 Identities=39% Similarity=0.717 Sum_probs=211.3
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+|.+.+.||.|++|.||+|.+..... .+..||||++.+..... ......+..|+.++.++ +|+||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHD------AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEecccc------CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 48899999999999999998653321 11249999997654322 23445677899999999 599999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++..|+||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999999999988654 45899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... .........|+..|+|||.+
T Consensus 153 ~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 153 KEFLAE------------------------------------------------------EEERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred cccccc------------------------------------------------------cccccccccCCccccCHHHh
Confidence 432110 00011124688899999998
Q ss_pred cCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 319 SGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSN----ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 319 ~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
.+.. .+.++||||||+++|+|++|..||..... .+....+.......+. ..+..+.++|.+||+.||++
T Consensus 179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~ 253 (288)
T cd05583 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK-----TMSAEARDFIQKLLEKDPKK 253 (288)
T ss_pred cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc-----ccCHHHHHHHHHHhcCCHhh
Confidence 7755 68899999999999999999999964322 2233334333332222 23348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcccc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
|||... +.++|+||||+.++|..+
T Consensus 254 R~t~~~-~~~~l~~~~~~~~~~~~~ 277 (288)
T cd05583 254 RLGANG-ADEIKNHPFFQGIDWDDL 277 (288)
T ss_pred ccCcch-HHHHhcCcccccCCHHHH
Confidence 998432 678899999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=324.89 Aligned_cols=262 Identities=18% Similarity=0.278 Sum_probs=208.1
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~ 156 (451)
..++|++.+.||+|+||.||+|.++..... .....+|+|++..... ......+..|+.+++++ +|+||+++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~----~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNP----NETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCC----CCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 347799999999999999999988654311 1223599999875422 23345577899999999 7999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQ--------------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NI 222 (451)
++..++.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998652 235689999999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
|++.++.+||+|||++........ ...
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-----------------------------------------------------~~~ 190 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-----------------------------------------------------YRK 190 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-----------------------------------------------------eec
Confidence 999999999999999853221000 000
Q ss_pred ccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+....... . +...+.++.+|
T Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~l 266 (293)
T cd05053 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRME---K-PQNCTQELYHL 266 (293)
T ss_pred cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC---C-CCCCCHHHHHH
Confidence 001134567999999988889999999999999999997 999998877777666665543211 1 11223489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHcC
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+.+||..||++||| +.|++++
T Consensus 267 i~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 267 MRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred HHHHcccCcccCcC----HHHHHHH
Confidence 99999999999999 9998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=327.53 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=211.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|....+||.|+||.||+|.+...++ .||+|++..... .....+.+|+.+++.+.||||+++++.+.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~ 88 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGR---------QVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYL 88 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCC---------EEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhhee
Confidence 345666689999999999999876554 399999865422 22345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 89 VGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred eCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 99999999999999999987755 458999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||++.
T Consensus 166 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 190 (297)
T cd06659 166 QISKD-------------------------------------------------------VPKRKSLVGTPYWMAPEVIS 190 (297)
T ss_pred hcccc-------------------------------------------------------cccccceecCccccCHHHHc
Confidence 21100 00011236888999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||......+.+..+........ .... ..+..+.++|.+||+.||.+||+
T Consensus 191 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~l~~~i~~~l~~~P~~Rps---- 264 (297)
T cd06659 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNAH-KISPVLRDFLERMLTREPQERAT---- 264 (297)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCc-cccC-CCCHHHHHHHHHHhcCCcccCcC----
Confidence 88899999999999999999999999988776666665544322211 1112 23348999999999999999999
Q ss_pred hHHHHcCCCcCCCCc
Q 013016 400 AADVKTHPFFKGLNF 414 (451)
Q Consensus 400 ~~ell~hp~~~~~~~ 414 (451)
+.++++||||.+.+.
T Consensus 265 ~~~ll~~~~~~~~~~ 279 (297)
T cd06659 265 AQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHhhChhhccCCC
Confidence 999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.26 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=205.0
Q ss_pred eeeccC--CeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCe
Q 013016 86 RRIGAG--DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNF 163 (451)
Q Consensus 86 ~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~ 163 (451)
.+||.| +||+||+|.+...++ .||+|++...... ....+.+..|+.+++.++|+||++++++|..+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~---------~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~ 73 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGT---------LVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCc---------EEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence 346666 999999999877665 4999998754322 2344677789999999999999999999999999
Q ss_pred EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCC
Q 013016 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243 (451)
Q Consensus 164 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 243 (451)
.|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.....
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 99999999999999998876555699999999999999999999999999999999999999999999999986521110
Q ss_pred CCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC--
Q 013016 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-- 321 (451)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 321 (451)
.... .. . .........++..|+|||++.+.
T Consensus 154 ~~~~-----------------------------------~~--------~-----~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (328)
T cd08226 154 NGQK-----------------------------------AK--------V-----VYDFPQFSTSVLPWLSPELLRQDLY 185 (328)
T ss_pred cCcc-----------------------------------cc--------c-----cccccccccCccCccChhhhcCCCC
Confidence 0000 00 0 00000011355679999999774
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC---------------------------------
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ--------------------------------- 368 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------- 368 (451)
.++.++|||||||++|+|++|+.||...................+..
T Consensus 186 ~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (328)
T cd08226 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQ 265 (328)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccc
Confidence 47899999999999999999999998876655555444332211100
Q ss_pred ---------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 369 ---------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 369 ---------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
......+..+.+|+++||+.||++||| +.|+|+||||.++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~~~ 316 (328)
T cd08226 266 TMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQVKE 316 (328)
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHHHH
Confidence 001123347899999999999999999 999999999988544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.57 Aligned_cols=260 Identities=18% Similarity=0.260 Sum_probs=208.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+.+|.+.++||.|+||.||+|.+..+.. .+.+..||+|++.... .......+..|+.++..++|+||+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4578899999999999999998765421 1123359999997542 122345577799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--------------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
...+..++++||+.+++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 9999999999999999999987532 12348889999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||++....... ......
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------------------~~~~~~ 184 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAAD-----------------------------------------------------YYKLMG 184 (283)
T ss_pred cCCCceEecccccccccccch-----------------------------------------------------heeecc
Confidence 999999999999974321100 000011
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+........ +...+..+.+|+.
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~~li~ 260 (283)
T cd05091 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC----PDDCPAWVYTLML 260 (283)
T ss_pred CccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC----CCCCCHHHHHHHH
Confidence 2246778999999988889999999999999999998 8999988877777777776654321 1223448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.+|.+||+ +.+|+.
T Consensus 261 ~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 261 ECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred HHhCCCcccCCC----HHHHHH
Confidence 999999999999 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=321.92 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=209.9
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
-|++.++||.|+||.||+|.++.++. .||||++..... ......+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~---------~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 73 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK---------VVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc---------EEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence 37888999999999999998876654 499999864422 2334567789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
+++.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 74 DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 9999999999999999998864 3589999999999999999999999999999999999999999999999998742
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.... ........|+..|+|||.+.+
T Consensus 151 ~~~~-------------------------------------------------------~~~~~~~~~~~~y~~PE~~~~ 175 (277)
T cd06641 151 LTDT-------------------------------------------------------QIKRNTFVGTPFWMAPEVIKQ 175 (277)
T ss_pred cccc-------------------------------------------------------hhhhccccCCccccChhhhcc
Confidence 2100 000012357888999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++|||||||++|+|++|..||...........+....... .....+.++.+++.+||..+|.+||+ +
T Consensus 176 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~----~ 247 (277)
T cd06641 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT----LEGNYSKPLKEFVEACLNKEPSFRPT----A 247 (277)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC----CCcccCHHHHHHHHHHccCChhhCcC----H
Confidence 888999999999999999999999998766655555544332211 11223448999999999999999999 9
Q ss_pred HHHHcCCCcCCC
Q 013016 401 ADVKTHPFFKGL 412 (451)
Q Consensus 401 ~ell~hp~~~~~ 412 (451)
.+++.||||.+.
T Consensus 248 ~~~l~~~~~~~~ 259 (277)
T cd06641 248 KELLKHKFIVRF 259 (277)
T ss_pred HHHHhCHHHhhh
Confidence 999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.54 Aligned_cols=257 Identities=20% Similarity=0.313 Sum_probs=203.4
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+.+++|++.+.||.|+||.||+|.++.++.. ..+|+|.+.... .......+..|+.++.++ +|+||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~-------~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~ 74 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLL 74 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCce-------eeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 3458899999999999999999998655432 126777765321 223345667799999999 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
+++...+..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred EEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 99999999999999999999999987542 2358899999999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++...... .
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~--------------------------------------------------------~ 178 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVY--------------------------------------------------------V 178 (303)
T ss_pred EEecCCCcEEeCccccCcccchh--------------------------------------------------------h
Confidence 99999999999999997311000 0
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......++..|+|||++.+..++.++|||||||++|+|+| |..||......+....+..... .. .+. ..+.++.+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~-~~~~~~~~ 254 (303)
T cd05088 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-LE--KPL-NCDDEVYD 254 (303)
T ss_pred hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc-CC--CCC-CCCHHHHH
Confidence 0001124567999999988888999999999999999998 9999988776666665544321 11 111 12348999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
|+.+||+.+|.+||+ +.+++.+
T Consensus 255 li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 255 LMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred HHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=321.59 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=204.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|++|.||+|.+...... .....||+|.+..... ......+..|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~----~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGD----AVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCC----CCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 6799999999999999999998762210 1122499998864421 223355777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CEE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPH-----KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIM 231 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~k 231 (451)
+.+..++||||++|++|.+++..... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 99999999999999999999876532 2589999999999999999999999999999999999998765 599
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ ........++..
T Consensus 160 l~dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 186 (277)
T cd05036 160 IADFGMARDIYRASY-----------------------------------------------------YRKGGRAMLPIK 186 (277)
T ss_pred eccCccccccCCccc-----------------------------------------------------eecCCCCCccHh
Confidence 999999853211000 000001133457
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|+|||++.+..++.++|||||||++|+|++ |..||...........+..... ..+ ...+..+.+++.+||+.|
T Consensus 187 y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~i~~cl~~~ 261 (277)
T cd05036 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP-----KGCPGPVYRIMTDCWQHT 261 (277)
T ss_pred hCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC-----CCCCHHHHHHHHHHcCCC
Confidence 999999998889999999999999999997 9999998777666655544321 111 223348999999999999
Q ss_pred cCCcCCCCCChHHHHcC
Q 013016 390 PCNRLGSKRGAADVKTH 406 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~h 406 (451)
|++||+ +.+|++|
T Consensus 262 p~~Rps----~~~vl~~ 274 (277)
T cd05036 262 PEDRPN----FATILER 274 (277)
T ss_pred cccCcC----HHHHHHH
Confidence 999999 9999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=316.55 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=207.9
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH--HHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+|+..+.||+|++|+||+|.++.+++ .|++|++..... ...+....+..|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGD---------FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCc---------EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 36778899999999999999876554 399999865321 1233456678899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~ 149 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMA 149 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999998765 45899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... ......|+..|+|||.+
T Consensus 150 ~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 150 KQVVEFS--------------------------------------------------------FAKSFKGSPYWMAPEVI 173 (258)
T ss_pred eeccccc--------------------------------------------------------cccccCCCcceeCHHHh
Confidence 4321100 01123688889999998
Q ss_pred cCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.... ++.++|+|||||++|+|++|+.||...........+.... ..+. .+ ...+..+.+|+.+||+.+|.+||+
T Consensus 174 ~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~-~~~~~~~~~li~~~l~~~p~~Rp~-- 248 (258)
T cd06632 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELPP-IP-DHLSDEAKDFILKCLQRDPSLRPT-- 248 (258)
T ss_pred cCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCCC-cC-CCcCHHHHHHHHHHhhcCcccCcC--
Confidence 8766 8999999999999999999999998766555444443311 1111 11 223448999999999999999999
Q ss_pred CChHHHHcCCCc
Q 013016 398 RGAADVKTHPFF 409 (451)
Q Consensus 398 ~~~~ell~hp~~ 409 (451)
+.+++.|||+
T Consensus 249 --~~~~l~~~~~ 258 (258)
T cd06632 249 --AAELLEHPFV 258 (258)
T ss_pred --HHHHhcCCCC
Confidence 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.47 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=209.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+..+.+ .||+|.+..... .....+..|+.+++.++||||+++++.+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~ 85 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQ---------EVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSY 85 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCC---------EEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhhee
Confidence 3789999999999999999998766554 399999864322 2235567799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..|+|+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 86 LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred eeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 9999999999999999999988653 4789999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ........|++.|+|||.+
T Consensus 163 ~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~~PE~~ 187 (293)
T cd06647 163 AQITPE-------------------------------------------------------QSKRSTMVGTPYWMAPEVV 187 (293)
T ss_pred eccccc-------------------------------------------------------ccccccccCChhhcCchhh
Confidence 422100 0001123688889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|||||||++|+|++|+.||........+..+..... +........+..+.+++.+||..+|.+||+
T Consensus 188 ~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~--- 262 (293)
T cd06647 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT--PELQNPEKLSAIFRDFLNRCLEMDVEKRGS--- 262 (293)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC--CCCCCccccCHHHHHHHHHHccCChhhCcC---
Confidence 888889999999999999999999999987655444333322211 111111122337899999999999999999
Q ss_pred ChHHHHcCCCcCCC
Q 013016 399 GAADVKTHPFFKGL 412 (451)
Q Consensus 399 ~~~ell~hp~~~~~ 412 (451)
+.+++.|+||+..
T Consensus 263 -~~~il~h~~~~~~ 275 (293)
T cd06647 263 -AKELLQHPFLKIA 275 (293)
T ss_pred -HHHHhcCHHHhcC
Confidence 9999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.55 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=199.4
Q ss_pred CceEEeeeccCCeeEEEEEEecc--ccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNN--KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.|.+.++||+|++|.||+|.++. .++ .||+|++.............+..|+.+++.++||||+++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~---------~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGK---------EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVF 71 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCC---------eEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEE
Confidence 48899999999999999999876 333 4999999864322223345566799999999999999999999
Q ss_pred EeC--CeEEEEEeeccCCchhhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc----CCC
Q 013016 159 EAS--NFSCIVMEFCSGGDLHSLRHKQP---HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS----DGH 229 (451)
Q Consensus 159 ~~~--~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~----~~~ 229 (451)
... +.+|+||||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 72 LEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred eCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce
Confidence 988 89999999995 56776664322 236899999999999999999999999999999999999999 899
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++........ .........++
T Consensus 151 ~kl~Dfg~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~ 178 (316)
T cd07842 151 VKIGDLGLARLFNAPLK----------------------------------------------------PLADLDPVVVT 178 (316)
T ss_pred EEECCCccccccCCCcc----------------------------------------------------cccccCCcccc
Confidence 99999999853221100 00011123678
Q ss_pred CCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHhcCC-----------------
Q 013016 310 HEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET---------TLRNIVKKP----------------- 362 (451)
Q Consensus 310 ~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~---------~~~~i~~~~----------------- 362 (451)
..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+..++...
T Consensus 179 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (316)
T cd07842 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEY 258 (316)
T ss_pred ccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccc
Confidence 889999988774 57899999999999999999999997644321 111111100
Q ss_pred ---------CCCCCCC----CC--CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 363 ---------LTFPTQS----PS--SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 363 ---------~~~~~~~----~~--~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..++... .. ...+.++.+++.+||+.||++||| +.|++.||||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 259 DTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred hhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 0000000 00 023337899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.72 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=204.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
++|...++||+|+||.||++.+..+++ .||+|.+...... .....+..|+.++.++. |+||+++++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~---------~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~ 72 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGAL 72 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCC---------EEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEE
Confidence 567788899999999999999887655 4999998754322 33456677899999986 99999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhh---hhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEec
Q 013016 159 EASNFSCIVMEFCSGGDLHSLR---HKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l---~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
..++..++||||+ +++|.++. .......+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 73 FREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred ecCCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEee
Confidence 9999999999998 55665543 22334669999999999999999999997 5999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .......|+..|+|
T Consensus 152 fg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~a 175 (288)
T cd06616 152 FGISGQLVDS--------------------------------------------------------IAKTRDAGCRPYMA 175 (288)
T ss_pred cchhHHhccC--------------------------------------------------------CccccccCccCccC
Confidence 9997422100 00011257888999
Q ss_pred cccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 315 PEVASGG---SHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 315 PE~~~~~---~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
||++.+. .++.++|||||||++|+|++|+.||..... .+.+.++..+.. ..+.... ...+.++.+|+.+||+.|
T Consensus 176 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~ 254 (288)
T cd06616 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE-REFSPSFVNFINLCLIKD 254 (288)
T ss_pred HHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC-CccCHHHHHHHHHHccCC
Confidence 9999876 589999999999999999999999976542 223333333322 1222111 223448999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCCCC
Q 013016 390 PCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
|++||| +++|+.||||+...
T Consensus 255 p~~Rpt----~~~i~~~~~~~~~~ 274 (288)
T cd06616 255 ESKRPK----YKELLEHPFIKDYE 274 (288)
T ss_pred hhhCcC----HHHHhcChhhhchh
Confidence 999999 99999999998844
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=316.04 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=197.4
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
++||+|+||.||+|.++.+++ .||+|.+.... .......+..|++++++++|+||+++++++...+..|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---------~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 69 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNT---------PVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 69 (252)
T ss_pred CccCcccCccEEEEEEecCCc---------eEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeE
Confidence 368999999999999876655 39999886442 2233456778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 70 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 70 IVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccc
Confidence 999999999999998654 3458999999999999999999999999999999999999999999999999974211000
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
. ........++..|+|||.+.+..++.
T Consensus 149 ~-----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ 175 (252)
T cd05084 149 Y-----------------------------------------------------ASTGGMKQIPVKWTAPEALNYGRYSS 175 (252)
T ss_pred c-----------------------------------------------------cccCCCCCCceeecCchhhcCCCCCh
Confidence 0 00000012345699999999888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
++|||||||++|+|++ |..||...........+...... + .+...+..+.+|+.+||+.||++||+ +.+++
T Consensus 176 ~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 247 (252)
T cd05084 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-P---CPELCPDAVYRLMERCWEYDPGQRPS----FSTVH 247 (252)
T ss_pred HHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-C---CcccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 9999999999999998 99999877666655555443211 1 12233448999999999999999999 88886
Q ss_pred c
Q 013016 405 T 405 (451)
Q Consensus 405 ~ 405 (451)
+
T Consensus 248 ~ 248 (252)
T cd05084 248 Q 248 (252)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.45 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=200.1
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCC
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASN 162 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~ 162 (451)
.+.+.||.|.||.||+|.++.. ....+..|+||++... ......+.+..|++.+++++||||+++++++...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccc
Confidence 4678999999999999999831 1122345999999643 22334677788999999999999999999999888
Q ss_pred eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccC
Q 013016 163 FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSN 242 (451)
Q Consensus 163 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 242 (451)
..++||||+++|+|.+++.......+++..+..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999999999999998756679999999999999999999999999999999999999999999999999975331
Q ss_pred CCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCC
Q 013016 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322 (451)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 322 (451)
.... ........+...|+|||.+.+..
T Consensus 155 ~~~~-----------------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 155 EKSK-----------------------------------------------------YKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp TSSS-----------------------------------------------------EEESTTSESGGGGS-HHHHHHSE
T ss_pred cccc-----------------------------------------------------ccccccccccccccccccccccc
Confidence 1000 00001124566799999998888
Q ss_pred CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChH
Q 013016 323 HGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401 (451)
Q Consensus 323 ~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ 401 (451)
++.++||||||+++|||++ |+.||......+....+..+..... +...+..+.++|.+||+.||.+||+ +.
T Consensus 182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~C~~~~p~~RPs----~~ 253 (259)
T PF07714_consen 182 YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI----PDNCPKDIYSLIQQCWSHDPEKRPS----FQ 253 (259)
T ss_dssp ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS----BTTSBHHHHHHHHHHT-SSGGGS------HH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccee----ccchhHHHHHHHHHHcCCChhhCcC----HH
Confidence 9999999999999999999 7899998888887777755433221 1223448999999999999999999 99
Q ss_pred HHHc
Q 013016 402 DVKT 405 (451)
Q Consensus 402 ell~ 405 (451)
+|++
T Consensus 254 ~i~~ 257 (259)
T PF07714_consen 254 EILQ 257 (259)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.07 Aligned_cols=262 Identities=19% Similarity=0.284 Sum_probs=205.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|.+.+.||+|+||.||+|.+....+. ....+..+|+|++.... .......+..|+.+++.+ +|+||++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 36799999999999999999987543221 11222359999997542 123345677799999999 79999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPH--------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
+...+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 9999999999999999999999976421 34889999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.+||+|||++........ ....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-----------------------------------------------------~~~~ 199 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-----------------------------------------------------YKKT 199 (307)
T ss_pred EcCCCcEEECCCcccccccccch-----------------------------------------------------hhcc
Confidence 99999999999999742211000 0000
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+...... ..+ ...+.++.+|+
T Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~li 275 (307)
T cd05098 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM---DKP-SNCTNELYMMM 275 (307)
T ss_pred ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCC---CCC-CcCCHHHHHHH
Confidence 01134567999999998889999999999999999998 99999877666666655544321 111 12334899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHc
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+||..+|.+||+ +.++++
T Consensus 276 ~~~l~~~p~~Rps----~~evl~ 294 (307)
T cd05098 276 RDCWHAVPSQRPT----FKQLVE 294 (307)
T ss_pred HHHcccChhhCcC----HHHHHH
Confidence 9999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.83 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=214.3
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.+..+.. .||+|++...... ......+..|+++++.++|+|++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 70 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEE 70 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCc---------EEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence 58899999999999999999876554 4999999754321 2334556779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+..++|+|++++++|.+++.... ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence 999999999999999999887754 467999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......|++.|+|||.+
T Consensus 151 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~pe~~ 175 (258)
T cd08215 151 KVLSSTV-------------------------------------------------------DLAKTVVGTPYYLSPELC 175 (258)
T ss_pred eecccCc-------------------------------------------------------ceecceeeeecccChhHh
Confidence 4321100 011123688889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++||||||+++|+|++|+.||...........+......... ...+..+.+++.+||..+|++||+
T Consensus 176 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~--- 248 (258)
T cd08215 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP----SQYSSELRNLVSSLLQKDPEERPS--- 248 (258)
T ss_pred ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcC---
Confidence 8888999999999999999999999999887777776666655432211 123448999999999999999999
Q ss_pred ChHHHHcCCCc
Q 013016 399 GAADVKTHPFF 409 (451)
Q Consensus 399 ~~~ell~hp~~ 409 (451)
+.++|+||||
T Consensus 249 -~~~ll~~~~~ 258 (258)
T cd08215 249 -IAQILQSPFI 258 (258)
T ss_pred -HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.14 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=207.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.++||.|+||.||+|.++... .+|+|++..... .....+..|+.+++.++|+||+++++++.
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~----------~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRV----------RVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCC----------cEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 57999999999999999999988733 399999876532 23345677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence 99999999999999999999987766779999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......++..|+|||.+.
T Consensus 153 ~~~~~~-------------------------------------------------------~~~~~~~~~~~~~~PE~~~ 177 (261)
T cd05148 153 LIKEDV-------------------------------------------------------YLSSDKKIPYKWTAPEAAS 177 (261)
T ss_pred hcCCcc-------------------------------------------------------ccccCCCCceEecCHHHHc
Confidence 321100 0000124566799999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |+.||......+.+..+..... .+. . ...+..+.+++.+||+.||.+|||
T Consensus 178 ~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~-~~~~~~~~~~i~~~l~~~p~~Rpt--- 250 (261)
T cd05148 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-MPC--P-AKCPQEIYKIMLECWAAEPEDRPS--- 250 (261)
T ss_pred cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-CCC--C-CCCCHHHHHHHHHHcCCCchhCcC---
Confidence 8889999999999999999998 8999988877777777765422 111 1 223448999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.+|++
T Consensus 251 -~~~l~~ 256 (261)
T cd05148 251 -FKALRE 256 (261)
T ss_pred -HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=322.19 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=209.4
Q ss_pred CCceEEeeeccCCeeEEEEEEecccccc-------CCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQ-------DRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv 152 (451)
++|++.++||+|+||.||+|.+...... .........||+|++..... ......+..|++++++++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCEe
Confidence 6899999999999999999998764422 12223345699999876532 23446677899999999999999
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP---------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
++++++..++..++|||++++++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987653 125899999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.++|+|||++....... .....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~-----------------------------------------------------~~~~~ 189 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSD-----------------------------------------------------YYRVQ 189 (296)
T ss_pred ecCCCceEEccccceeecccCc-----------------------------------------------------ceeec
Confidence 9999999999999974321100 00011
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhcC----CCCCCCCCCCCcChHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY--GRTPFAAPSNETTLRNIVKK----PLTFPTQSPSSMSEYH 377 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~ 377 (451)
....++..|+|||++.+..++.++|||||||++|+|++ |..||........+..+... ...... ..+...+.+
T Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 268 (296)
T cd05051 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYL-PRPPNCPKD 268 (296)
T ss_pred CcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccC-CCccCCCHH
Confidence 12356778999999988889999999999999999998 78899877766666655432 111111 111223448
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.+++.+||+.||.+||+ +.||++
T Consensus 269 l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 269 IYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred HHHHHHHHhccChhcCCC----HHHHHH
Confidence 999999999999999999 999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.04 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.+.||+|+||.||+|.++... .+|+|++..... ....+..|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~----------~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKI----------DVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCc----------cEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 57899999999999999999876533 299999864322 1234566999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||++|++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 70 KQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred CCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999999999987653 368999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||.+.
T Consensus 149 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~Pe~~~ 174 (256)
T cd05059 149 YVLDDQY------------------------------------------------------TSSQGTKFPVKWAPPEVFD 174 (256)
T ss_pred ecccccc------------------------------------------------------cccCCCCCCccccCHHHhc
Confidence 3210000 0000112345799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |+.||......+....+....... . +...+..+.+++.+||..+|++||+
T Consensus 175 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~li~~cl~~~p~~Rpt--- 247 (256)
T cd05059 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY---R-PKLAPTEVYTIMYSCWHEKPEDRPA--- 247 (256)
T ss_pred cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC---C-CCCCCHHHHHHHHHHhcCChhhCcC---
Confidence 8889999999999999999999 899998877776666665442211 1 1223448999999999999999999
Q ss_pred ChHHHHcC
Q 013016 399 GAADVKTH 406 (451)
Q Consensus 399 ~~~ell~h 406 (451)
+.|+++.
T Consensus 248 -~~~~l~~ 254 (256)
T cd05059 248 -FKKLLSQ 254 (256)
T ss_pred -HHHHHHH
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=314.03 Aligned_cols=250 Identities=48% Similarity=0.835 Sum_probs=210.6
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||.|+||.||+|.+...++ .+|+|++.+...........+..|+.++++++|+||+++++.+..++..|+|
T Consensus 1 lg~G~~~~v~~~~~~~~~~---------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGK---------LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCCCc---------EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999999876554 4999999877655555666788899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 247 (451)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-- 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-- 147 (250)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--
Confidence 9999999999998775 358999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcch
Q 013016 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327 (451)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 327 (451)
.......|+..|+|||.+.+..++.++
T Consensus 148 -----------------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~ 174 (250)
T cd05123 148 -----------------------------------------------------SRTNTFCGTPEYLAPEVLLGKGYGKAV 174 (250)
T ss_pred -----------------------------------------------------CcccCCcCCccccChHHhCCCCCCchh
Confidence 011123678889999999888889999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCC
Q 013016 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407 (451)
Q Consensus 328 DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp 407 (451)
|+||||+++|+|++|..||...........+......++... +..+.+++++||..||++||+.+. ++++++||
T Consensus 175 D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~ 248 (250)
T cd05123 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL-----SPEARDLISGLLQKDPTKRLGSGG-AEEIKAHP 248 (250)
T ss_pred hHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCC
Confidence 999999999999999999988777666777766544444332 348999999999999999999222 29999999
Q ss_pred Cc
Q 013016 408 FF 409 (451)
Q Consensus 408 ~~ 409 (451)
||
T Consensus 249 ~f 250 (250)
T cd05123 249 FF 250 (250)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.83 Aligned_cols=263 Identities=17% Similarity=0.275 Sum_probs=207.8
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~ 156 (451)
..++|.+.+.||+|+||.||+|.+...... ....+..||+|++.... .......+..|+.+++.+ +|+||+++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKD--KPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCC--CCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 347899999999999999999986432211 11122359999987542 223345677899999999 8999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NI 222 (451)
++...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999987642 23578889999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
|++.++.+||+|||++........ ...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~-----------------------------------------------------~~~ 195 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY-----------------------------------------------------YKK 195 (304)
T ss_pred EEcCCCcEEECCCccceecccccc-----------------------------------------------------ccc
Confidence 999999999999999853221100 000
Q ss_pred ccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+........ +...+.++.+|
T Consensus 196 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l 271 (304)
T cd05101 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK----PANCTNELYMM 271 (304)
T ss_pred ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCC----CCCCCHHHHHH
Confidence 111245678999999998889999999999999999998 8999988877777776655432211 11234489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHc
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.+||..+|.+||+ +.|+++
T Consensus 272 i~~cl~~~p~~Rps----~~e~l~ 291 (304)
T cd05101 272 MRDCWHAIPSHRPT----FKQLVE 291 (304)
T ss_pred HHHHcccChhhCCC----HHHHHH
Confidence 99999999999999 888876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=320.36 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=206.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.++||+|+||.||+|....... ...+..+|+|.+.... ......+..|+++++.++|+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLP----EQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCC----CCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 4679999999999999999997643211 1122358999887542 23345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPH-------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
...+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 999999999999999999999876432 3488999999999999999999999999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.++|+|||++....... .......
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~-----------------------------------------------------~~~~~~~ 183 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTD-----------------------------------------------------YYRVGGR 183 (280)
T ss_pred CCCCEEECCCCceeEcCCCc-----------------------------------------------------eeecCCC
Confidence 99999999999974321100 0000011
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.+..+..+..... . ...+..+.+|+.+
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~li~~ 259 (280)
T cd05092 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER---P-RTCPPEVYAIMQG 259 (280)
T ss_pred ccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCC---C-CCCCHHHHHHHHH
Confidence 245678999999999889999999999999999998 9999988777777766655532211 1 1233489999999
Q ss_pred hcccCcCCcCCCCCChHHHHc
Q 013016 385 LLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~ 405 (451)
||..||.+||+ +.+|+.
T Consensus 260 cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 260 CWQREPQQRMV----IKDIHS 276 (280)
T ss_pred HccCChhhCCC----HHHHHH
Confidence 99999999999 888864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.06 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=202.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||.|+||.||+|.++..+.. ..+++|.+.... .......+..|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~-------~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 72 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK-------MNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGAC 72 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCc-------ceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEE
Confidence 6899999999999999999988765431 126888876321 223345677799999999 799999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
...+..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 73 ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred ccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 99999999999999999999986532 1348899999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||++...... ....
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~--------------------------------------------------------~~~~ 176 (297)
T cd05089 153 GENLASKIADFGLSRGEEVY--------------------------------------------------------VKKT 176 (297)
T ss_pred CCCCeEEECCcCCCccccce--------------------------------------------------------eccC
Confidence 99999999999997311000 0000
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
...++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...+..+.+|+.
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~ 252 (297)
T cd05089 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK----PRNCDDEVYELMR 252 (297)
T ss_pred CCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCCHHHHHHHH
Confidence 0123456999999988889999999999999999997 9999998877777777665432111 1123348999999
Q ss_pred HhcccCcCCcCCCCCChHHHHcC
Q 013016 384 GLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+||+.||.+||+ ++++++.
T Consensus 253 ~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 253 QCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred HHcCCChhhCcC----HHHHHHH
Confidence 999999999999 8888643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=316.75 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=202.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.+..+.. ||+|++..... ....+..|++++++++|+||+++++.+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----------valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCce----------EEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence 679999999999999999998765532 99999975322 1245677999999999999999999875
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..++||||+++++|.+++.......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred -CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 4568999999999999999987655668999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||++.
T Consensus 151 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~PE~~~ 176 (262)
T cd05071 151 LIEDNEY------------------------------------------------------TARQGAKFPIKWTAPEAAL 176 (262)
T ss_pred ecccccc------------------------------------------------------ccccCCcccceecCHhHhc
Confidence 3221100 0000124567899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++|||||||++|+|++ |..||......+....+...... +. . ...+..+.+|+.+||+.||++||+
T Consensus 177 ~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~~--~-~~~~~~l~~li~~~l~~~p~~Rp~--- 249 (262)
T cd05071 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-PC--P-PECPESLHDLMCQCWRKEPEERPT--- 249 (262)
T ss_pred cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-CC--c-cccCHHHHHHHHHHccCCcccCCC---
Confidence 8889999999999999999999 89999887777776666554221 11 1 123348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.+++.
T Consensus 250 -~~~~~~ 255 (262)
T cd05071 250 -FEYLQA 255 (262)
T ss_pred -HHHHHH
Confidence 887763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.01 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=198.1
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~ 160 (451)
|.+.++||+|+||.||+|.++.+.+ .||+|++.+..... . ......|+.+++++. |+||+++++++.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~---------~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 69 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFD 69 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCc---------EEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEec
Confidence 6789999999999999999876655 49999987542211 1 123346888888885 9999999999998
Q ss_pred C--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 161 S--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 161 ~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. +.+++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++|++||||+|+||+++. +.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 70 RKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccc
Confidence 7 89999999995 58877776543 45899999999999999999999999999999999999999 99999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .....++..|+|||++
T Consensus 147 ~~~~~~~~--------------------------------------------------------~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 147 RGIYSKPP--------------------------------------------------------YTEYISTRWYRAPECL 170 (282)
T ss_pred cccccCCC--------------------------------------------------------cCCCCCCcccCChhHh
Confidence 43211000 0012577889999987
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC------------------CCCCCCC------CCc
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL------------------TFPTQSP------SSM 373 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------~~~~~~~------~~~ 373 (451)
.+ ..++.++|||||||++|+|++|..||...+..+.+..+..... .++.... ...
T Consensus 171 ~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd07831 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPN 250 (282)
T ss_pred hcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHccc
Confidence 54 4568899999999999999999999988766554444432110 0111000 012
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.+.++.+||.+||+.||++||+ +.+++.||||
T Consensus 251 ~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 251 ASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred ccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 2458999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.75 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=198.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+++.....||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++|+||+++++++.
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQV---------RIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDS 75 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCc---------EEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence 445556689999999999999876654 499998865422 23456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRF--SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l--~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg 236 (451)
.++..++||||+++++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999999999887642 234 88889999999999999999999999999999999986 6799999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ........|+..|+|||
T Consensus 155 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~~aPE 179 (268)
T cd06624 155 TSKRLAGI-------------------------------------------------------NPCTETFTGTLQYMAPE 179 (268)
T ss_pred hheecccC-------------------------------------------------------CCccccCCCCccccChh
Confidence 87422100 00001125788999999
Q ss_pred cccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH--hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 317 VASGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNI--VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 317 ~~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i--~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
++.+.. ++.++||||||+++|+|++|+.||........ .... ......++ ...+.++.+|+.+||+.+|.
T Consensus 180 ~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~ 254 (268)
T cd06624 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP-----ESLSAEAKNFILRCFEPDPD 254 (268)
T ss_pred hhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC-----cccCHHHHHHHHHHcCCCch
Confidence 987644 78899999999999999999999976433221 1111 11111112 22334899999999999999
Q ss_pred CcCCCCCChHHHHcCCCc
Q 013016 392 NRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~ 409 (451)
+||| +.|++.||||
T Consensus 255 ~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 255 KRAS----AHDLLQDPFL 268 (268)
T ss_pred hCCC----HHHHHhCCCC
Confidence 9999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=336.21 Aligned_cols=265 Identities=19% Similarity=0.263 Sum_probs=206.2
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~ 153 (451)
+.+..++|.+.++||+|+||.||+|++++.... .....||||++..... ....+.+..|+.++.++. |+||++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~----~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHS----QSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCC----CCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 334447799999999999999999998643211 1122499999975422 223346778999999997 999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCC------------------------------------------------
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH------------------------------------------------ 185 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------------------------------ 185 (451)
+++++...+..|+||||+++|+|.++++....
T Consensus 106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 99999999999999999999999999865321
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 013016 186 ------------------------------------------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDL 217 (451)
Q Consensus 186 ------------------------------------------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dl 217 (451)
..+++..+..++.||+.||+|||++|++||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl 265 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL 265 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence 23677888999999999999999999999999
Q ss_pred CCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccc
Q 013016 218 KPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAE 297 (451)
Q Consensus 218 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (451)
||+|||++.++.+||+|||++........
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~--------------------------------------------------- 294 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSN--------------------------------------------------- 294 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccc---------------------------------------------------
Confidence 99999999999999999999843211000
Q ss_pred cccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChH
Q 013016 298 PVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376 (451)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 376 (451)
........|+..|+|||.+.+..++.++|||||||++|||++ |..||......+.+...+......+. +...+.
T Consensus 295 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---p~~~~~ 369 (401)
T cd05107 295 --YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK---PAHASD 369 (401)
T ss_pred --cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCC---CCCCCH
Confidence 000112357788999999998889999999999999999998 89999876655554444333222211 122344
Q ss_pred HHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 377 HARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 377 ~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
++.+|+.+||..+|.+||+ +.||++
T Consensus 370 ~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 370 EIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 8999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.07 Aligned_cols=257 Identities=14% Similarity=0.168 Sum_probs=200.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||.|+||+||+|.+...++. ....+++|.+.... .......+..|+.+++.+.|+||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~ 78 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGIC 78 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 36799999999999999999998655431 01127788875331 223345666788889999999999999987
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. ....++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 79 ~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 79 P-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred C-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 5 456789999999999999987643 45899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ..........|+..|+|||.+
T Consensus 157 ~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~y~~pE~~ 183 (279)
T cd05111 157 DLLYPD-----------------------------------------------------DKKYFYSEHKTPIKWMALESI 183 (279)
T ss_pred eeccCC-----------------------------------------------------CcccccCCCCCcccccCHHHh
Confidence 432100 000011123567789999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |+.||.+.........+..+..... +...+.++.+++.+||..||++||+
T Consensus 184 ~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~c~~~~p~~Rps-- 257 (279)
T cd05111 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ----PQICTIDVYMVMVKCWMIDENVRPT-- 257 (279)
T ss_pred ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcC--
Confidence 98889999999999999999998 9999988766554444433332211 1223447899999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.|+++
T Consensus 258 --~~el~~ 263 (279)
T cd05111 258 --FKELAN 263 (279)
T ss_pred --HHHHHH
Confidence 888865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.85 Aligned_cols=265 Identities=25% Similarity=0.337 Sum_probs=211.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.+...++ .||||++..... .......+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR---------KVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRP 70 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc---------EEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcc
Confidence 58999999999999999999876554 499999875431 23344567779999999999999999999987
Q ss_pred CC-----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 161 SN-----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 161 ~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
.+ .+|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+||
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 71 PSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred cCcccccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 75 8999999995 6888888664 36999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... ........++..|+||
T Consensus 148 g~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~aP 175 (330)
T cd07834 148 GLARGVDPDEDE----------------------------------------------------KGFLTEYVVTRWYRAP 175 (330)
T ss_pred CceEeecccccc----------------------------------------------------cccccccccccCcCCc
Confidence 998533211000 0001123678889999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC------------------------
Q 013016 316 EVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP------------------------ 370 (451)
Q Consensus 316 E~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------------ 370 (451)
|++.+. .++.++||||||+++|+|++|+.||......+.+..+.......+....
T Consensus 176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 999887 7899999999999999999999999988776666555543221111000
Q ss_pred --CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 371 --SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 371 --~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
....+.++.+||.+||++||.+||+ +++++.||||+++..
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~~~ 297 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQLHD 297 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhhcc
Confidence 0112347899999999999999999 999999999998443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.04 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=204.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||.+..... .......+..|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNE---------KVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCC---------eEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 679999999999999999999876655 499999875321 2223345567999999999999999999886
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. .+.|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~D 151 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 151 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECc
Confidence 44 3589999999 57898888754 5599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++....... .......|+..|+|
T Consensus 152 fg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~a 176 (337)
T cd07858 152 FGLARTTSEKG-------------------------------------------------------DFMTEYVVTRWYRA 176 (337)
T ss_pred CccccccCCCc-------------------------------------------------------ccccccccccCccC
Confidence 99985321100 00112357888999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------------------CCCCC---
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP-----------------------LTFPT--- 367 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-----------------------~~~~~--- 367 (451)
||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.... ...+.
T Consensus 177 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (337)
T cd07858 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF 256 (337)
T ss_pred hHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH
Confidence 998865 458899999999999999999999998765433322222100 00000
Q ss_pred CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 368 ~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.......+.++.+||++||+.||++||+ ++++++||||..+..+
T Consensus 257 ~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~~~~ 300 (337)
T cd07858 257 ARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASLHDP 300 (337)
T ss_pred HHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhhcCc
Confidence 0001123347899999999999999999 9999999999985444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.84 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=206.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|++|.||+|.++.+++ .||+|++..... .......+..|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~---------~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGK---------KVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCC---------EEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 679999999999999999999887765 399999875422 2233455667999999999999999999886
Q ss_pred e----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 160 A----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 160 ~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
. ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 75 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~df 151 (334)
T cd07855 75 PPGADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151 (334)
T ss_pred ccCCCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccc
Confidence 3 35789999999 56898887654 44999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... .........|+..|+||
T Consensus 152 g~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 152 GMARGLSSSPTE---------------------------------------------------HKYFMTEYVATRWYRAP 180 (334)
T ss_pred ccceeecccCcC---------------------------------------------------CCcccccccccccccCh
Confidence 997432111000 00011123688899999
Q ss_pred ccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------------------CCCCCC--
Q 013016 316 EVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-----------------------TFPTQS-- 369 (451)
Q Consensus 316 E~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~~~-- 369 (451)
|.+.+ ..++.++|||||||++|+|++|+.||...+....+..+..... ......
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (334)
T cd07855 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWS 260 (334)
T ss_pred HHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHH
Confidence 99866 4578999999999999999999999987654433322222100 000000
Q ss_pred -CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 -PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 -~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.....+.++.++|.+||+.||.+||+ +.+++.||||++....
T Consensus 261 ~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 261 KIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQYHDP 303 (334)
T ss_pred HHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhccCC
Confidence 00113448999999999999999999 9999999999974443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.01 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=202.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|..+.+. .||+|.+..... ....+..|+.++++++|+||+++++++.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~----------~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCc----------eEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 67999999999999999999876543 399999875432 2345677999999999999999999874
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 5678999999999999999877666679999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||++.
T Consensus 151 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 151 LIEDNEY------------------------------------------------------TAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred ecCCCCc------------------------------------------------------ccccCCcccccccCHHHhc
Confidence 3211000 0001124567899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |+.||.+....+....+...... + . +...+.++.+++.+||+.+|++||+
T Consensus 177 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~-~~~~~~~~~~li~~~l~~~p~~Rp~--- 249 (260)
T cd05067 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-P--R-PDNCPEELYELMRLCWKEKPEERPT--- 249 (260)
T ss_pred cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-C--C-CCCCCHHHHHHHHHHccCChhhCCC---
Confidence 8889999999999999999999 99999887776666665444221 1 1 1223348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+++++.
T Consensus 250 -~~~l~~ 255 (260)
T cd05067 250 -FEYLRS 255 (260)
T ss_pred -HHHHHH
Confidence 888864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=316.20 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=202.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||.|+||.||+|.+..+.. +|+|.+...... ...+.+|+.++++++|+||+++++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~----------~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTK----------VAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCce----------eEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 3679999999999999999998765443 999998754321 23467799999999999999999988
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. .+..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence 5 456899999999999999998765566899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .......++..|+|||.+
T Consensus 150 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~~ 175 (260)
T cd05070 150 RLIEDNEY------------------------------------------------------TARQGAKFPIKWTAPEAA 175 (260)
T ss_pred eeccCccc------------------------------------------------------ccccCCCCCccccChHHH
Confidence 43211000 000012355679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++||||||+++|+|++ |..||......+....+...... +. +...+..+.+|+.+||..||.+|||
T Consensus 176 ~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~li~~~l~~~p~~Rpt-- 249 (260)
T cd05070 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-PC---PQDCPISLHELMLQCWKKDPEERPT-- 249 (260)
T ss_pred hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CC---CCcCCHHHHHHHHHHcccCcccCcC--
Confidence 88889999999999999999999 99999887777777766554221 11 1223348999999999999999999
Q ss_pred CChHHHH
Q 013016 398 RGAADVK 404 (451)
Q Consensus 398 ~~~~ell 404 (451)
+++++
T Consensus 250 --~~~l~ 254 (260)
T cd05070 250 --FEYLQ 254 (260)
T ss_pred --HHHHH
Confidence 88876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.98 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=202.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.+.||+|+||.||+|...+. .||+|.+.... ....+..|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----------~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLL 65 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCC-----------cEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34557899999999999999999976543 39999986432 234567799999999999999999
Q ss_pred EEEE-eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 156 AEFE-ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 156 ~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
+++. ..+..++||||+++++|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred EEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecC
Confidence 9764 556899999999999999998876555689999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .....++..|+|
T Consensus 146 fg~~~~~~~~----------------------------------------------------------~~~~~~~~~y~a 167 (256)
T cd05082 146 FGLTKEASST----------------------------------------------------------QDTGKLPVKWTA 167 (256)
T ss_pred Cccceecccc----------------------------------------------------------CCCCccceeecC
Confidence 9997421100 001134557999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+..++.++|||||||++|+|++ |+.||......+....+..+... ... ...+..+.+++.+||+.||++|
T Consensus 168 PE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05082 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAP-DGCPPVVYDVMKQCWHLDAATR 243 (256)
T ss_pred HHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCC-CCCCHHHHHHHHHHhcCChhhC
Confidence 999988889999999999999999997 99999887766666666544221 111 2234489999999999999999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|| +.++++
T Consensus 244 pt----~~~l~~ 251 (256)
T cd05082 244 PS----FLQLRE 251 (256)
T ss_pred cC----HHHHHH
Confidence 99 888864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.58 Aligned_cols=258 Identities=18% Similarity=0.294 Sum_probs=202.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.+.||+|+||.||+|.+...... .....+|+|++..... ......+..|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~----~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGR----AGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCC----CcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence 478899999999999999987543211 1223599999875432 2234567789999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQP----------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLK 218 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlk 218 (451)
.+..++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++|++|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999999999999876431 2347899999999999999999999999999999
Q ss_pred CCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccc
Q 013016 219 PENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298 (451)
Q Consensus 219 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (451)
|+|||++.++.+||+|||++........
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~---------------------------------------------------- 182 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDS---------------------------------------------------- 182 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccc----------------------------------------------------
Confidence 9999999999999999999743211000
Q ss_pred ccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHH
Q 013016 299 VAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377 (451)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 377 (451)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.... ..+. +...+.+
T Consensus 183 -~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~ 257 (290)
T cd05045 183 -YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY-RMER---PENCSEE 257 (290)
T ss_pred -hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCCC---CCCCCHH
Confidence 000011245667999999988889999999999999999998 999998877666555544332 1111 1223348
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.+|+.+||+.||++||+ +.++++
T Consensus 258 ~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 258 MYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred HHHHHHHHccCCcccCCC----HHHHHH
Confidence 999999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.15 Aligned_cols=257 Identities=32% Similarity=0.483 Sum_probs=209.5
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.+..+++ .|++|++...... ......+..|+.++++++|+||+++++.+..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGE---------LMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERD 70 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCc---------EEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEec
Confidence 47888999999999999999886555 3999999765432 3456777889999999999999999999998
Q ss_pred C--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 161 S--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 161 ~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. +..++|+||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 71 EEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred CCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence 8 89999999999999999988764 6999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .......++..|+|||.+
T Consensus 149 ~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 149 KRLGDIETG-----------------------------------------------------EGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred Eeccccccc-----------------------------------------------------ccccCCCCCccccCHhhh
Confidence 533211100 001123678889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++||||||+++|+|++|..||..... ......+..... ...... ..+..+.+|+.+||+.||.+||+
T Consensus 176 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~l~~~i~~~l~~~p~~Rp~-- 250 (260)
T cd06606 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPE-HLSEEAKDFLRKCLRRDPKKRPT-- 250 (260)
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC--CcCCCc-ccCHHHHHHHHHhCcCChhhCCC--
Confidence 888899999999999999999999999987652 223333322111 111111 22448999999999999999999
Q ss_pred CChHHHHcCCCc
Q 013016 398 RGAADVKTHPFF 409 (451)
Q Consensus 398 ~~~~ell~hp~~ 409 (451)
+.+++.||||
T Consensus 251 --~~~ll~~~~~ 260 (260)
T cd06606 251 --ADELLQHPFL 260 (260)
T ss_pred --HHHHhhCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.97 Aligned_cols=279 Identities=22% Similarity=0.292 Sum_probs=209.1
Q ss_pred CCce-EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-----------HHHHHHHHHHHHHHCC
Q 013016 80 RDFD-LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-----------KVHRAEMEKKILKMLD 147 (451)
Q Consensus 80 ~~y~-~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~ 147 (451)
++|. +.+.||.|+||+||+|.++..++ .||||++......... ....+..|+.+++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGK---------IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCC---------eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 5565 45779999999999999876655 3999998654322100 1124567999999999
Q ss_pred CCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 148 h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
|+||+++++++..+++.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC
Confidence 9999999999999999999999995 6898888654 458999999999999999999999999999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+.++|+|||++............... ... ..........
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~---------------------------------~~~--------~~~~~~~~~~ 194 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKD---------------------------------ETM--------QRREEMTSKV 194 (335)
T ss_pred CCEEECCccceeeccccccccccccc---------------------------------ccc--------cccccccccc
Confidence 99999999998543321110000000 000 0000111225
Q ss_pred cCCCccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC----------------
Q 013016 308 GTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP---------------- 370 (451)
Q Consensus 308 gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------------- 370 (451)
++..|+|||.+.+.. ++.++|||||||++|+|++|+.||......+.+..+...........+
T Consensus 195 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
T PTZ00024 195 VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK 274 (335)
T ss_pred cccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCC
Confidence 678899999987744 689999999999999999999999988776666555432111110000
Q ss_pred -------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 371 -------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 371 -------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
....+.++.++|++||+.||++||+ ++|+|.||||++....
T Consensus 275 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 275 PKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSDPLP 322 (335)
T ss_pred cccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCCCCC
Confidence 0112447899999999999999999 9999999999985443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.35 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=202.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|++|.||+|.+..... +|+|++..... ....+..|+.++++++|+||+++++++.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~----------~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK----------VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCce----------EEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 679999999999999999998866542 99998865322 2245667999999999999999999875
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 4568999999999999999987655668999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||.+.
T Consensus 151 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 151 LIEDNEY------------------------------------------------------TARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred EccCCcc------------------------------------------------------cccCCCccchhhCCHHHhc
Confidence 3211000 0000123567799999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |..||.+....+....+...... + .. ...+..+.+++.+||.+||.+||+
T Consensus 177 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~-~~~~~~~~~li~~~l~~~p~~Rp~--- 249 (260)
T cd05069 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-P--CP-QGCPESLHELMKLCWKKDPDERPT--- 249 (260)
T ss_pred cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CC-cccCHHHHHHHHHHccCCcccCcC---
Confidence 8889999999999999999999 99999987777766666554221 1 11 123348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
++++++
T Consensus 250 -~~~i~~ 255 (260)
T cd05069 250 -FEYIQS 255 (260)
T ss_pred -HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=289.14 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=214.3
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.-.++||+|.||+||+|+.+++.+ .||+|.++.... ++..-....+|+.+++.+.|.|||+++++.-.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e---------ivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhs 72 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE---------IVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc---------eEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhcc
Confidence 46667899999999999998877655 699999986532 22233445679999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
++.+-+|+||| ..+|.++.... ++.++.+.++.++.|+++||.|+|++++.||||||+|+||+.+|.+||+|||+++.
T Consensus 73 dkkltlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 73 DKKLTLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred CceeEEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence 99999999999 88999888766 45699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
+..+- +-+. .-+-|..|++|.++.|
T Consensus 151 fgipv----------------------------------------------rcys---------aevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 151 FGIPV----------------------------------------------RCYS---------AEVVTLWYRPPDVLFG 175 (292)
T ss_pred cCCce----------------------------------------------Eeee---------ceeeeeeccCcceeee
Confidence 43210 0011 1256889999999999
Q ss_pred CC-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcC-----------h------------
Q 013016 321 GS-HGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS-----------E------------ 375 (451)
Q Consensus 321 ~~-~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----------~------------ 375 (451)
.. |+...|+||.|||+.|+.. |++.|.+.+.++.+++|...........|+.+. +
T Consensus 176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l 255 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL 255 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence 66 8999999999999999987 999999999999988887754433333322211 0
Q ss_pred -HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 376 -YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 376 -~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
..-++++.++|.-+|..|.+ +++.++||||..
T Consensus 256 ns~grdllqkll~cnp~qris----aeaalqhpyf~d 288 (292)
T KOG0662|consen 256 NSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSD 288 (292)
T ss_pred cchhHHHHHHHhccCcccccC----HHHHhcCccccc
Confidence 03479999999999999999 999999999986
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=317.31 Aligned_cols=257 Identities=16% Similarity=0.216 Sum_probs=202.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||.|+||+||+|.+..++.. ....||+|++..... ......+..|+.+++.++|+||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 36799999999999999999997765432 112389999875422 23345677799999999999999999998
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.. ...+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 79 LT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence 75 45789999999999999887643 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .......++..|+|||.+
T Consensus 157 ~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 157 RLLDIDETE-----------------------------------------------------YHADGGKVPIKWMALESI 183 (279)
T ss_pred eecccccce-----------------------------------------------------eecCCCccchhhCCHHHh
Confidence 533211000 000011345679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |..||...........+..... .+. +...+.++.+++.+||+.||+.||+
T Consensus 184 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~li~~~l~~dp~~Rp~-- 257 (279)
T cd05109 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-LPQ---PPICTIDVYMIMVKCWMIDSECRPR-- 257 (279)
T ss_pred ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC---CccCCHHHHHHHHHHcCCChhhCcC--
Confidence 98889999999999999999998 9999987666555544444322 111 1123448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.+++.
T Consensus 258 --~~~l~~ 263 (279)
T cd05109 258 --FRELVD 263 (279)
T ss_pred --HHHHHH
Confidence 899884
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=309.17 Aligned_cols=253 Identities=32% Similarity=0.496 Sum_probs=209.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.+..+++ .+++|++..... .....+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 68 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGK---------EVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLK 68 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCc---------EEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 48889999999999999999876554 499999976533 344667779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..++++||++|++|.+++.... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+..
T Consensus 69 ~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 69 KDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred CCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 999999999999999999887753 4689999999999999999999999999999999999999999999999998743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
...... .....|+..|+|||.+.+
T Consensus 148 ~~~~~~--------------------------------------------------------~~~~~~~~~~~~PE~~~~ 171 (253)
T cd05122 148 LSDTKA--------------------------------------------------------RNTMVGTPYWMAPEVING 171 (253)
T ss_pred cccccc--------------------------------------------------------ccceecCCcccCHHHHcC
Confidence 211000 113467888999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++||||||+++|+|++|+.||...........+..... +........+..+.++|.+||+.||.+||| +
T Consensus 172 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~ 245 (253)
T cd05122 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP--PGLRNPEKWSDEFKDFLKKCLQKNPEKRPT----A 245 (253)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC--CCcCcccccCHHHHHHHHHHccCChhhCCC----H
Confidence 8889999999999999999999999988755554444433211 111122222448999999999999999999 9
Q ss_pred HHHHcCCC
Q 013016 401 ADVKTHPF 408 (451)
Q Consensus 401 ~ell~hp~ 408 (451)
.++++|||
T Consensus 246 ~~~l~~~~ 253 (253)
T cd05122 246 EQLLKHPF 253 (253)
T ss_pred HHHhcCCC
Confidence 99999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=313.50 Aligned_cols=255 Identities=28% Similarity=0.373 Sum_probs=205.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+..+++ .||+|.+.............+.+|+.++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGR---------VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCC---------EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 689999999999999999999886554 39999987543333444567788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
..+..++||||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccce
Confidence 999999999999999999988653 234589999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .......|+..|+|||.
T Consensus 153 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~apE~ 177 (267)
T cd08224 153 GRFFSSKT-------------------------------------------------------TAAHSLVGTPYYMSPER 177 (267)
T ss_pred eeeccCCC-------------------------------------------------------cccceecCCccccCHHH
Confidence 74221000 00012357888999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS--NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++|||||||++|+|++|+.||.... ..+....+..+.... ......+..+.++|.+||..+|++||+
T Consensus 178 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rp~ 254 (267)
T cd08224 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP---LPADHYSEELRDLVSRCINPDPEKRPD 254 (267)
T ss_pred hccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC---CChhhcCHHHHHHHHHHcCCCcccCCC
Confidence 998889999999999999999999999996543 223334443332211 111123448999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+.+|++
T Consensus 255 ----~~~il~ 260 (267)
T cd08224 255 ----ISYVLQ 260 (267)
T ss_pred ----HHHHHH
Confidence 888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.43 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=206.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||.|+||.||+|.+++.. .||||.+..... ....+..|+.++++++|+||++++++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~----------~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAV 69 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCc----------eEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeee
Confidence 3478999999999999999999976543 299999875422 23456779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+......++||||+++++|.+++....+..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 70 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred eecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcccc
Confidence 99989999999999999999999876666799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... ........++..|+|||.
T Consensus 150 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~~PE~ 175 (261)
T cd05034 150 ARLIEDDE------------------------------------------------------YTAREGAKFPIKWTAPEA 175 (261)
T ss_pred ceeccchh------------------------------------------------------hhhhhccCCCccccCHHH
Confidence 74321100 000001134567999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++|||||||++|+|++ |+.||.+......+..+..... ..+. ..+.++.+++.+||+.+|.+||+
T Consensus 176 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~ 250 (261)
T cd05034 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP-----NCPEELYDLMLQCWDKDPEERPT 250 (261)
T ss_pred hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCCHHHHHHHHHHcccCcccCCC
Confidence 998889999999999999999998 9999988777777777765432 1111 12348999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+++++.
T Consensus 251 ----~~~l~~ 256 (261)
T cd05034 251 ----FEYLQS 256 (261)
T ss_pred ----HHHHHH
Confidence 888763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=322.19 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=205.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|.+.++||+|+||.||+|......+. .......+|+|++.... .......+..|+.+++++ +|+||++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKS--RPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCc--cCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 36799999999999999999986543221 11223359999987542 223345677799999999 69999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
+...+..|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 999999999999999999999987642 245889999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.+||+|||++......... ...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------------~~~ 193 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY-----------------------------------------------------KKT 193 (314)
T ss_pred EcCCCcEEEccccccccccccccc-----------------------------------------------------ccc
Confidence 999999999999998532110000 000
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
....++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+....... .. ...+.++.+|+
T Consensus 194 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~l~~li 269 (314)
T cd05099 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMD---KP-SNCTHELYMLM 269 (314)
T ss_pred ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CC-CCCCHHHHHHH
Confidence 01124457999999998889999999999999999999 999998877777776665543211 11 12233899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHc
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+||..||++||+ +.++++
T Consensus 270 ~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 270 RECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred HHHcCCCcccCcC----HHHHHH
Confidence 9999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.33 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=202.9
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeEEE
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYAEF 158 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~ 158 (451)
|++.+.||.|+||.||+|.++.+++ .||+|++..... .......+..|+.+++++ .|+||+++++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~---------~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 70 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGR---------FVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVC 70 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCC---------EEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence 6789999999999999999876544 499999974432 122223444577776655 699999999999
Q ss_pred EeCCe-----EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 159 EASNF-----SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 159 ~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
...+. .+++|||+. ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 71 HGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEe
Confidence 88776 999999995 589888877655569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... .......++..|+
T Consensus 150 dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~ 173 (287)
T cd07838 150 DFGLARIYSFE--------------------------------------------------------MALTSVVVTLWYR 173 (287)
T ss_pred ccCcceeccCC--------------------------------------------------------ccccccccccccc
Confidence 99987432100 0001124678899
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC----------------CCCCCCC------
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT----------------FPTQSPS------ 371 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----------------~~~~~~~------ 371 (451)
|||++.+..++.++|||||||++|+|++|+.||......+.+.++...... ++.....
T Consensus 174 ~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T cd07838 174 APEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFV 253 (287)
T ss_pred ChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhh
Confidence 999999988999999999999999999999999988777766666542110 0000000
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
...+..+.++|.+||+.||.+||+ +.+++.||||
T Consensus 254 ~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 254 PEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred hhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 011236789999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.31 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=202.2
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.+.||+|+||.||+|.+..... ....||+|++..... .......+..|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 5678899999999999998765331 112499999875422 223345677899999999999999999988665
Q ss_pred Ce------EEEEEeeccCCchhhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 162 NF------SCIVMEFCSGGDLHSLRHKQP----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 162 ~~------~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
+. .++||||+++++|..++.... ...+++..++.++.||+.||.|||++|++||||||+||++++++.+|
T Consensus 74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k 153 (273)
T cd05035 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC 153 (273)
T ss_pred CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEE
Confidence 54 799999999999998875432 24589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ ........++..
T Consensus 154 l~dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 180 (273)
T cd05035 154 VADFGLSKKIYSGDY-----------------------------------------------------YRQGRIAKMPVK 180 (273)
T ss_pred ECCccceeecccccc-----------------------------------------------------ccccccccCCcc
Confidence 999999853211000 000001134567
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..+..... +...+.++.+++.+||+.||
T Consensus 181 ~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p 256 (273)
T cd05035 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ----PEDCLDELYDLMYSCWRADP 256 (273)
T ss_pred ccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCCHHHHHHHHHHcCCCh
Confidence 999999988889999999999999999999 9999988877777777665532211 12234489999999999999
Q ss_pred CCcCCCCCChHHHHcC
Q 013016 391 CNRLGSKRGAADVKTH 406 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~h 406 (451)
.+||+ +.|++++
T Consensus 257 ~~Rp~----~~e~~~~ 268 (273)
T cd05035 257 KDRPT----FTKLREV 268 (273)
T ss_pred hhCcC----HHHHHHH
Confidence 99999 8888753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.04 Aligned_cols=260 Identities=27% Similarity=0.370 Sum_probs=206.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||.|+||.||+|.+..++. .||||++.... ........+..|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGA---------KVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCc---------EEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 679999999999999999999876655 49999986432 12233445677999999999999999999987
Q ss_pred eCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
... .+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 654 469999999 8899888764 458999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......+++.|+
T Consensus 161 dfg~~~~~~~----------------------------------------------------------~~~~~~~~~~y~ 182 (343)
T cd07880 161 DFGLARQTDS----------------------------------------------------------EMTGYVVTRWYR 182 (343)
T ss_pred eccccccccc----------------------------------------------------------CccccccCCccc
Confidence 9999742110 001235788899
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC--------------------CC----
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP--------------------TQ---- 368 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------~~---- 368 (451)
|||.+.+ ..++.++|||||||++|+|++|+.||...........+.......+ ..
T Consensus 183 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (343)
T cd07880 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKD 262 (343)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcch
Confidence 9999876 4578999999999999999999999987665554444433211110 00
Q ss_pred --CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 369 --SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 369 --~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
......+..+.++|.+||+.||.+||| +.+++.||||+.....
T Consensus 263 ~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 263 FRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhhcCc
Confidence 000122337899999999999999999 9999999999986443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=311.53 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=207.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH--HHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV--LEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+|.+.+.||+|+||.||+|.+..+++ .||+|++.... .........+.+|++++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGR---------ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCC---------EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 579999999999999999999877655 49999875321 1223445677889999999999999999999
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+.+. +.+++||||+++++|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcc
Confidence 8764 5689999999999999988764 44899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ .......+.|+..|+||
T Consensus 151 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 151 GASKRIQTICM----------------------------------------------------SGTGIKSVTGTPYWMSP 178 (264)
T ss_pred ccccccccccc----------------------------------------------------cCccccccCCcccccCH
Confidence 99753211000 00000123688899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||........+.++...... ...+. ..+..+.+++.+||. +|..||+
T Consensus 179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~-~~~~~~~~~i~~~l~-~~~~r~~ 254 (264)
T cd06653 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLPD-GVSDACRDFLKQIFV-EEKRRPT 254 (264)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCCc-ccCHHHHHHHHHHhc-CcccCcc
Confidence 9999888899999999999999999999999877666655555433211 11122 233489999999999 5799999
Q ss_pred CCCChHHHHcCCCc
Q 013016 396 SKRGAADVKTHPFF 409 (451)
Q Consensus 396 ~~~~~~ell~hp~~ 409 (451)
+.+++.|||.
T Consensus 255 ----~~~~~~~~~~ 264 (264)
T cd06653 255 ----AEFLLRHPFV 264 (264)
T ss_pred ----HHHHhcCCCC
Confidence 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.31 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=214.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|++...||+|++|.||+|.+....+ .||+|++..... ....+..|+++++.++|+||+++++.+.
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGK---------EVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCc---------EEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 669999999999999999999886554 399999975432 3455667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+|+||++|++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 9999999999999999999998753 369999999999999999999999999999999999999999999999999863
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|+..|+|||.+.
T Consensus 165 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~~PE~~~ 189 (286)
T cd06614 165 QLTKE-------------------------------------------------------KSKRNSVVGTPYWMAPEVIK 189 (286)
T ss_pred hhccc-------------------------------------------------------hhhhccccCCcccCCHhHhc
Confidence 21100 00011235778899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+........ ......+..+.+||.+||+.+|.+||+
T Consensus 190 ~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt---- 263 (286)
T cd06614 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPS---- 263 (286)
T ss_pred CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--cchhhCCHHHHHHHHHHhccChhhCcC----
Confidence 88899999999999999999999999988776665555544332111 111223448999999999999999999
Q ss_pred hHHHHcCCCcCCCCc
Q 013016 400 AADVKTHPFFKGLNF 414 (451)
Q Consensus 400 ~~ell~hp~~~~~~~ 414 (451)
+.+++.|+||++..+
T Consensus 264 ~~~il~~~~~~~~~~ 278 (286)
T cd06614 264 AEELLQHPFLKKACP 278 (286)
T ss_pred HHHHhhChHhhccCc
Confidence 999999999999433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.44 Aligned_cols=267 Identities=21% Similarity=0.296 Sum_probs=203.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccc-----cCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYR-----QDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
++|++.++||+|+||.||+|.+.+... ..........||+|++..... ......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 689999999999999999998764321 001112223599999975422 2334567789999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP----------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
++++...+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999999886532 1236889999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||++....... ......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~-----------------------------------------------------~~~~~~ 189 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGD-----------------------------------------------------YYRIQG 189 (295)
T ss_pred cCCCcEEecccccccccccCc-----------------------------------------------------ceeccC
Confidence 999999999999974221000 000011
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhc---CCCCCCCCCCCCcChHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY--GRTPFAAPSNETTLRNIVK---KPLTFPTQSPSSMSEYHAR 379 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~ 379 (451)
...++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+.. ..........+...+..+.
T Consensus 190 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (295)
T cd05097 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF 269 (295)
T ss_pred cCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHH
Confidence 2245678999999998889999999999999999988 7788887766665554432 1100000111222344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+|+.+||+.||++||+ +++|++
T Consensus 270 ~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 270 KLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred HHHHHHcCCCchhCcC----HHHHHH
Confidence 9999999999999999 888864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.07 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=209.0
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcch-HHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK-EVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
+...+||+|+|-+||+|.+...+-+ ||=-.+.. .........+++..|+.+|+.|+|+||+++|+.+.+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giE---------VAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIE---------VAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccccchh---------hHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 3455799999999999999777644 33211111 1223455678899999999999999999999999765
Q ss_pred C--eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccC-CCEEEeccC
Q 013016 162 N--FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSD-GHIMLSDFD 236 (451)
Q Consensus 162 ~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg 236 (451)
. .+.+|+|++..|+|..|+++. +.++...++.|++||++||.|||++. |||||||.+||+|+.+ |.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 5 589999999999999999886 55899999999999999999999886 9999999999999966 899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|...+.. ....++|||.|||||
T Consensus 192 LAtl~r~s---------------------------------------------------------~aksvIGTPEFMAPE 214 (632)
T KOG0584|consen 192 LATLLRKS---------------------------------------------------------HAKSVIGTPEFMAPE 214 (632)
T ss_pred HHHHhhcc---------------------------------------------------------ccceeccCccccChH
Confidence 99654322 222358999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.. ..|+..+||||||++|+||+|+..||.. .+.-.+++++..|..+-... .+..+++++||.+||.. ..+|++
T Consensus 215 mYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~---kV~dPevr~fIekCl~~-~~~R~s 289 (632)
T KOG0584|consen 215 MYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS---KVKDPEVREFIEKCLAT-KSERLS 289 (632)
T ss_pred HHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh---ccCCHHHHHHHHHHhcC-chhccC
Confidence 886 6899999999999999999999999976 56677888888876432221 22234999999999999 999999
Q ss_pred CCCChHHHHcCCCcCCC
Q 013016 396 SKRGAADVKTHPFFKGL 412 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~ 412 (451)
+.|||+||||+..
T Consensus 290 ----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 290 ----AKELLKDPFFDED 302 (632)
T ss_pred ----HHHHhhChhhccc
Confidence 9999999999995
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.16 Aligned_cols=267 Identities=18% Similarity=0.276 Sum_probs=208.7
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
+.+...+|.+.+.||+|+||.||+|.+....+.. ......||+|++.... .......+..|+.+++++ +|+||++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDK--PNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCcc--CCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3344467999999999999999999875433211 1122348999887542 223456677899999999 7999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
+++++...+..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 23478899999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+|||++.++.+||+|||++.........
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------------------- 190 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY---------------------------------------------------- 190 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc----------------------------------------------------
Confidence 9999999999999999997432110000
Q ss_pred cccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHH
Q 013016 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+........ . ...+.++
T Consensus 191 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~l 265 (334)
T cd05100 191 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK---P-ANCTHEL 265 (334)
T ss_pred -ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---C-CCCCHHH
Confidence 00001134567999999999889999999999999999998 8999988877777766655432111 1 1223489
Q ss_pred HHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 379 RDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+|+.+||+.+|.+||+ +.|++++
T Consensus 266 ~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 266 YMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred HHHHHHHcccChhhCcC----HHHHHHH
Confidence 99999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=310.48 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=205.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||.|+||.||+|...+. .||+|.+..... ....+..|+.+++.++|+||++++++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~-----------~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~ 68 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQ-----------KVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGV 68 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCc-----------EEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 347899999999999999999987632 399999976532 34567779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.
T Consensus 69 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccc
Confidence 99999999999999999999999876555799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... ....++..|+|||.
T Consensus 149 ~~~~~~~~----------------------------------------------------------~~~~~~~~~~ape~ 170 (256)
T cd05039 149 AKEASQGQ----------------------------------------------------------DSGKLPVKWTAPEA 170 (256)
T ss_pred cccccccc----------------------------------------------------------ccCCCcccccCchh
Confidence 74221000 01124456999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++||||||+++|+|++ |..||......+....+..+... ... ...+.++.++|.+||..+|++||+
T Consensus 171 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~li~~~l~~~p~~Rp~- 245 (256)
T cd05039 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM---EAP-EGCPPEVYKVMKDCWELDPAKRPT- 245 (256)
T ss_pred hcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---CCc-cCCCHHHHHHHHHHhccChhhCcC-
Confidence 988889999999999999999997 99999887766666555543211 111 123448999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.||++
T Consensus 246 ---~~~l~~ 251 (256)
T cd05039 246 ---FKQLRE 251 (256)
T ss_pred ---HHHHHH
Confidence 888874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.85 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=203.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||+|+||.||+|.+..... +|+|.+.... .....+.+|+.++++++|+||+++++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~----------~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~ 69 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAV 69 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCcc----------EEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 34789999999999999999998665432 9999887542 223556779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.. ...++||||+++++|.+++.......+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.
T Consensus 70 ~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 70 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred EcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcc
Confidence 887 7889999999999999999876666789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .......++..|+|||+
T Consensus 149 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~PE~ 174 (260)
T cd05073 149 ARVIEDNEY------------------------------------------------------TAREGAKFPIKWTAPEA 174 (260)
T ss_pred eeeccCCCc------------------------------------------------------ccccCCcccccccCHhH
Confidence 743211000 00001135567999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|+|++ |..||...........+..+.. .+ .. ...+.++.+++.+||..+|++||+
T Consensus 175 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~-~~~~~~~~~~i~~~l~~~p~~Rp~- 249 (260)
T cd05073 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RP-ENCPEELYNIMMRCWKNRPEERPT- 249 (260)
T ss_pred hccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-CC--Cc-ccCCHHHHHHHHHHcccCcccCcC-
Confidence 988889999999999999999999 9999988776666655554422 11 11 123348999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.+++.
T Consensus 250 ---~~~l~~ 255 (260)
T cd05073 250 ---FEYIQS 255 (260)
T ss_pred ---HHHHHH
Confidence 887763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=311.13 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=205.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||+|.+.... ..+..||+|++....... ....+..|+.+++.++|+||+++++++...+..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 72 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLY 72 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceE
Confidence 36899999999999987641 011249999998664322 4567778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 166 IVMEFCSGGDLHSLRHKQP-------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999987752 356999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ ........++..|+|||.+
T Consensus 153 ~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 153 RDVYDDDY-----------------------------------------------------YRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred cccccccc-----------------------------------------------------cccccCCCcCccccCHHHh
Confidence 53321100 0011123577889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |..||......+....+..+.... .. ...+.++.+++.+||..||.+||+
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~li~~~l~~~p~~Rps-- 253 (262)
T cd00192 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KP-EYCPDELYELMLSCWQLDPEDRPT-- 253 (262)
T ss_pred ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CC-ccCChHHHHHHHHHccCCcccCcC--
Confidence 88889999999999999999999 699999987777777776532211 11 122348999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.|++++
T Consensus 254 --~~~l~~~ 260 (262)
T cd00192 254 --FSELVER 260 (262)
T ss_pred --HHHHHHh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.96 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=206.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|.+.+.||+|+||.||+|.+..+++ .+|+|.+.+... .......+..|+.+++++ +|+||+++++++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---------~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~ 76 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKE---------VVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVI 76 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCe---------EEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence 779999999999999999999876554 499998854321 222334566799999999 999999999988
Q ss_pred EeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
... ..+|+||||++ ++|.+++... .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g 152 (337)
T cd07852 77 KAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG 152 (337)
T ss_pred ccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 654 47899999995 6898887653 58899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++.......... .......+.|+..|+|||
T Consensus 153 ~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~y~aPE 182 (337)
T cd07852 153 LARSLSELEENP--------------------------------------------------ENPVLTDYVATRWYRAPE 182 (337)
T ss_pred chhccccccccc--------------------------------------------------cCcchhcccccccccCce
Confidence 985322110000 000111246889999999
Q ss_pred cccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC---------------------------CCCC
Q 013016 317 VASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT---------------------------FPTQ 368 (451)
Q Consensus 317 ~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---------------------------~~~~ 368 (451)
.+.+ ..++.++|||||||++|+|++|+.||......+....+...... ....
T Consensus 183 ~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (337)
T cd07852 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE 262 (337)
T ss_pred eeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh
Confidence 8865 45788999999999999999999999876655444433222110 0011
Q ss_pred CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 369 ~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
..+. .+.++.++|.+||+.||++||+ +.++++||||++....
T Consensus 263 ~~~~-~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~~~~ 304 (337)
T cd07852 263 LLPK-ASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQFHNP 304 (337)
T ss_pred hccC-CCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhhccC
Confidence 1111 3448999999999999999999 9999999999996554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.99 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCe
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNF 163 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~ 163 (451)
+.+.+|.|+ .||.++.+.+++ .||||++..... .......+..|+.+++.++|+||+++++++...+.
T Consensus 6 i~~~~~~~~--~v~~~~~~~~~~---------~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (314)
T cd08216 6 IGKCFEDLM--IVHLAKHKPTNT---------LVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73 (314)
T ss_pred hhHhhcCCc--eEEEEEecCCCC---------EEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence 344444444 455555444443 499999976522 23455678889999999999999999999999999
Q ss_pred EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCC
Q 013016 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243 (451)
Q Consensus 164 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 243 (451)
.+++|||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.....
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999999999999876556799999999999999999999999999999999999999999999999998743211
Q ss_pred CCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC--
Q 013016 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-- 321 (451)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 321 (451)
..... ...........++..|+|||++.+.
T Consensus 154 ~~~~~------------------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (314)
T cd08216 154 HGKRQ------------------------------------------------RVVHDFPKSSVKNLPWLSPEVLQQNLQ 185 (314)
T ss_pred ccccc------------------------------------------------cccccccccccccccccCHHHhcCCCC
Confidence 10000 0000111233677889999998763
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-------CCC----------------------CCCC
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-------PTQ----------------------SPSS 372 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-------~~~----------------------~~~~ 372 (451)
.++.++|||||||++|+|++|+.||..............+.... +.. ....
T Consensus 186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (314)
T cd08216 186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265 (314)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence 47899999999999999999999998765544433322211100 000 0001
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
..+.++.+|+.+||++||++||| ++++|+||||+++.
T Consensus 266 ~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~~ 302 (314)
T cd08216 266 TFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQCK 302 (314)
T ss_pred HHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhhc
Confidence 11236889999999999999999 99999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=327.51 Aligned_cols=262 Identities=19% Similarity=0.294 Sum_probs=200.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|++.+.||.|+||+||+|.+.+... ...+..||||+++... .......+..|+.++.++ +|+||++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCc----cccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 3689999999999999999998754321 1223369999997542 123345677799999999 68999999998
Q ss_pred EEeC-CeEEEEEeeccCCchhhhhhhCC----------------------------------------------------
Q 013016 158 FEAS-NFSCIVMEFCSGGDLHSLRHKQP---------------------------------------------------- 184 (451)
Q Consensus 158 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 184 (451)
+... ..+++|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 57899999999999999886432
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCC
Q 013016 185 -------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251 (451)
Q Consensus 185 -------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 251 (451)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------ 233 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------ 233 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc------
Confidence 1236788889999999999999999999999999999999999999999999974321000
Q ss_pred CCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHH
Q 013016 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWA 331 (451)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS 331 (451)
.........++..|+|||.+.+..++.++||||
T Consensus 234 -----------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 266 (343)
T cd05103 234 -----------------------------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 266 (343)
T ss_pred -----------------------------------------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHH
Confidence 000011124567799999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 332 FGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 332 lG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
|||++|+|++ |..||........+..........+. +...+.++.+++.+||..||++||+ +.||++|
T Consensus 267 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~cl~~~p~~Rps----~~eil~~ 335 (343)
T cd05103 267 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 335 (343)
T ss_pred HHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 9999999997 99999875544333333322211111 1123348999999999999999999 9999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=310.24 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=212.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|++.++||.|+||.||+|.++.+++ .+|+|.+...... ......+..|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLD 70 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC---------EEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence 58999999999999999998876654 4999998765432 2334566779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
....|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999999999886632 345899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... ......|+..|+|||.+
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~~~~~~~~Pe~~ 173 (256)
T cd08530 151 KVLKKN---------------------------------------------------------MAKTQIGTPHYMAPEVW 173 (256)
T ss_pred hhhccC---------------------------------------------------------CcccccCCccccCHHHH
Confidence 432210 00012577889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|+||||+++|+|++|+.||...+..+....+......... ...+.++.+++.+||+.+|++||+
T Consensus 174 ~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~--- 246 (256)
T cd08530 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP----PIYSQDLQNFIRSMLQVKPKLRPN--- 246 (256)
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc----hhhCHHHHHHHHHHcCCCcccCCC---
Confidence 9988999999999999999999999999988777666666554432211 123448999999999999999999
Q ss_pred ChHHHHcCCCc
Q 013016 399 GAADVKTHPFF 409 (451)
Q Consensus 399 ~~~ell~hp~~ 409 (451)
+.++++||++
T Consensus 247 -~~~~l~~p~~ 256 (256)
T cd08530 247 -CDKILASPAV 256 (256)
T ss_pred -HHHHhcCCCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=326.72 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=202.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+..+++ .||||++.+... .......+..|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGE---------KVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCc---------EEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 679999999999999999999876654 399999875421 2223345667999999999999999999987
Q ss_pred eCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
... .+|+|+||+. .+|..++. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~ 159 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 543 5699999994 56766542 348999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......|+..|+
T Consensus 160 dfg~~~~~~~----------------------------------------------------------~~~~~~~~~~y~ 181 (342)
T cd07879 160 DFGLARHADA----------------------------------------------------------EMTGYVVTRWYR 181 (342)
T ss_pred eCCCCcCCCC----------------------------------------------------------CCCCceeeeccc
Confidence 9999742110 001235788899
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------------------CCCCCC
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-----------------------TFPTQS 369 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~~~ 369 (451)
|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..... ..+...
T Consensus 182 aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (342)
T cd07879 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKD 261 (342)
T ss_pred ChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccch
Confidence 9999876 4578999999999999999999999988765554444433110 000000
Q ss_pred C---CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 P---SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ~---~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
. ....+.++.+||.+||+.||.+||+ +.+++.||||+++...
T Consensus 262 ~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 262 FSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhcccc
Confidence 0 0112347899999999999999999 9999999999996543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.66 Aligned_cols=256 Identities=19% Similarity=0.257 Sum_probs=199.4
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.++||+|+||.||+|.+...... ..+|+|.+..... .......+..|+.+++.++|+||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~-------~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCe-------eeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccC
Confidence 34678899999999999998765421 1389998865421 233456677799999999999999999987432
Q ss_pred ------CeEEEEEeeccCCchhhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 162 ------NFSCIVMEFCSGGDLHSLRHKQ----PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 162 ------~~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
...++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEE
Confidence 3579999999999999877432 234589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++........ ........+++.
T Consensus 153 l~Dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 179 (272)
T cd05075 153 VADFGLSKKIYNGDY-----------------------------------------------------YRQGRIAKMPVK 179 (272)
T ss_pred ECCCCcccccCcccc-----------------------------------------------------eecCCcccCCcc
Confidence 999999853211000 000011245677
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||.+.+..++.++|||||||++|+|++ |+.||......+....+..+..... . ...+..+.+++.+||+.||
T Consensus 180 ~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---P-PDCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred cCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC---C-CCCCHHHHHHHHHHcCCCc
Confidence 999999999889999999999999999999 8999988777776666665533211 1 1233479999999999999
Q ss_pred CCcCCCCCChHHHHcC
Q 013016 391 CNRLGSKRGAADVKTH 406 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~h 406 (451)
++||+ +.+|+++
T Consensus 256 ~~Rps----~~~l~~~ 267 (272)
T cd05075 256 KDRPS----FETLRCE 267 (272)
T ss_pred ccCcC----HHHHHHH
Confidence 99999 9998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=319.33 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=208.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|...++||+|+||+||+|.+..+++ .||+|++.............+..|+.+++.++|+||+++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNE---------VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCc---------EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 37778889999999999999876654 499999875433333445567779999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
....|+||||+ .++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~~lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 93 EHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CCEEEEEEecC-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 99999999999 467777765542 4589999999999999999999999999999999999999999999999998631
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc-
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS- 319 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~- 319 (451)
.. ......|+..|+|||++.
T Consensus 171 ~~-----------------------------------------------------------~~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 171 SS-----------------------------------------------------------PANSFVGTPYWMAPEVILA 191 (313)
T ss_pred cC-----------------------------------------------------------CCCCccccccccChhhccc
Confidence 10 001236888899999984
Q ss_pred --CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 320 --GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 320 --~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+..++.++|||||||++|+|++|..||...........+...... ... ....+..+++|+.+||+.+|.+||+
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l~~li~~~l~~~P~~Rp~-- 266 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQ-SNEWTDSFRGFVDYCLQKIPQERPA-- 266 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCC-ccccCHHHHHHHHHHccCChhhCcC--
Confidence 355788999999999999999999999887666655555443221 111 1223347999999999999999999
Q ss_pred CChHHHHcCCCcCCCC
Q 013016 398 RGAADVKTHPFFKGLN 413 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~ 413 (451)
+.+++.||||+..+
T Consensus 267 --~~~~l~~~~~~~~~ 280 (313)
T cd06633 267 --SAELLRHDFVRRDR 280 (313)
T ss_pred --HHHHhcCcccCCCc
Confidence 99999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=316.77 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=204.9
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.++||.|++|.||+|.+...++ .+|+|++.... ........+..|+.+++.++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~---------~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 70 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGE---------LVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK 70 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCe---------EEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence 6789999999999999999887654 39999998653 2233345667799999999999999999999988
Q ss_pred --CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 162 --NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 162 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+..++||||++ ++|.+++.... ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 71 GKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred CCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence 89999999995 58888876542 469999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .......++..|+|||.+.
T Consensus 149 ~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 149 PYTKRNS------------------------------------------------------ADYTNRVITLWYRPPELLL 174 (287)
T ss_pred eccCCCc------------------------------------------------------ccccccccccccCCceeeE
Confidence 3221100 0000124677899999877
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC--------------------------CC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP--------------------------SS 372 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------------------------~~ 372 (451)
+. .++.++||||||+++|+|++|+.||........+..+...........+ ..
T Consensus 175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07840 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254 (287)
T ss_pred ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcc
Confidence 63 5789999999999999999999999887766555554432111110000 01
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+..+.+++.+||+.||.+||+ +.+++.||||
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 255 LIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred cCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 12447899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=325.13 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=202.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||+|++.+... .......+.+|+.++++++|+||+++++++.
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCe---------EEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 789999999999999999999876654 499999875422 2223455667999999999999999999886
Q ss_pred eC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
.. ...|++++++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence 43 3578999988 8899887764 348999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......|+..|+
T Consensus 163 dfg~~~~~~~----------------------------------------------------------~~~~~~~~~~y~ 184 (345)
T cd07877 163 DFGLARHTDD----------------------------------------------------------EMTGYVATRWYR 184 (345)
T ss_pred cccccccccc----------------------------------------------------------cccccccCCCcc
Confidence 9999742110 001236788899
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----------------------CCCCC
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-----------------------FPTQS 369 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----------------------~~~~~ 369 (451)
|||.+.+ ..++.++|||||||++|+|++|+.||........+..+...... .+...
T Consensus 185 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (345)
T cd07877 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 264 (345)
T ss_pred CHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcc
Confidence 9999876 46788999999999999999999999876655544433321110 00000
Q ss_pred ---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 370 ---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 370 ---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.....+.++.+||.+||+.||.+||+ +.+++.||||++
T Consensus 265 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 265 FANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred hhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 00112347899999999999999999 999999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=313.15 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=205.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+|++.+.||.|+||.||+|.++..+. .+..+|+|.+..... ......+..|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3679999999999999999998764432 112499999875422 23345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 75 TKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999999999987653 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... ........++..|+|||.+
T Consensus 154 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~~pe~~ 181 (267)
T cd05066 154 RVLEDDPEA----------------------------------------------------AYTTRGGKIPIRWTAPEAI 181 (267)
T ss_pred cccccccce----------------------------------------------------eeecCCCccceeecCHhHh
Confidence 532210000 0000011235679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|++++ |..||......+....+..+.. .+. . ...+..+.+++.+||+.+|.+||+
T Consensus 182 ~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~-~~~~~~~~~li~~~l~~~p~~Rp~-- 255 (267)
T cd05066 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LPA--P-MDCPAALHQLMLDCWQKDRNERPK-- 255 (267)
T ss_pred ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CCC--C-CCCCHHHHHHHHHHcccCchhCCC--
Confidence 98889999999999999999886 9999988777666666655422 221 1 122348899999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.++++
T Consensus 256 --~~~i~~ 261 (267)
T cd05066 256 --FEQIVS 261 (267)
T ss_pred --HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.92 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=206.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|++|.||+|.+..+++ .||+|++..... .......+.+|+.+++++.|+||+++++++.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~---------~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGR---------KVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCc---------EEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 789999999999999999999987655 499999865421 2233455667999999999999999999886
Q ss_pred eCCe------EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASNF------SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~~------~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
..+. .|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence 6554 89999999 7899988875 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......++..|+
T Consensus 161 dfg~~~~~~~----------------------------------------------------------~~~~~~~~~~y~ 182 (343)
T cd07851 161 DFGLARHTDD----------------------------------------------------------EMTGYVATRWYR 182 (343)
T ss_pred cccccccccc----------------------------------------------------------cccCCccccccc
Confidence 9999742210 001235778899
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC--------------------CC---
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT--------------------QS--- 369 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~--- 369 (451)
|||.+.+ ..++.++|||||||++|+|++|+.||........+..+.......+. ..
T Consensus 183 aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (343)
T cd07851 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKD 262 (343)
T ss_pred CHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCC
Confidence 9999866 35789999999999999999999999887766655555443211110 00
Q ss_pred ---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 370 ---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 370 ---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.....+..+.+||.+||+.||.+||| +.+|+.||||++.
T Consensus 263 ~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~~ 304 (343)
T cd07851 263 FKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAEY 304 (343)
T ss_pred HHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCcccc
Confidence 00012448999999999999999999 9999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=332.22 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=213.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+.-++-.+.++||+|+||.||+|..+...... ...||+|...........+..++..|+++|++++|||||++|
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~-----~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFK-----VVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCce-----eeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 334455667799999999999999987653210 012899999864445567788899999999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
|+......++||||+|.||+|.+++...+. .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999998754 5999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++.....- .+. ...-.-...|+||
T Consensus 307 GLs~~~~~~------------------------------------------~~~-------------~~~~klPirWLAP 331 (474)
T KOG0194|consen 307 GLSRAGSQY------------------------------------------VMK-------------KFLKKLPIRWLAP 331 (474)
T ss_pred ccccCCcce------------------------------------------eec-------------cccccCcceecCh
Confidence 997422100 000 0000123569999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|.+....|+.++|||||||++||+++ |..||.+....+....+.......+... ..+.++..++.+|+..||+.||
T Consensus 332 Etl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~ 408 (474)
T KOG0194|consen 332 ETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRP 408 (474)
T ss_pred hhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhcc
Confidence 99999999999999999999999999 8999999999999999955433322221 2344889999999999999999
Q ss_pred CCCCChHHHH
Q 013016 395 GSKRGAADVK 404 (451)
Q Consensus 395 t~~~~~~ell 404 (451)
+ +.++.
T Consensus 409 t----m~~i~ 414 (474)
T KOG0194|consen 409 T----MSTIK 414 (474)
T ss_pred C----HHHHH
Confidence 9 66554
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.53 Aligned_cols=271 Identities=27% Similarity=0.362 Sum_probs=202.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.++||.|+||.||+|.++.+++. +|||++...... ........+|+++++.++|+||+++++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~---------~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRV---------VALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMA 76 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcE---------EEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhhe
Confidence 37899999999999999999998876653 999998654221 11223455699999999999999999987
Q ss_pred EeC--------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EAS--------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
... ..+++||||+ +++|...+... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 77 VERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred ecccccccccCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 543 3579999999 45677666543 3469999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+|+|||++............ .............|++
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~~ 190 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKG--------------------------------------------GGGGGTRKYTNLVVTR 190 (311)
T ss_pred EECcCccchhccCCCccccc--------------------------------------------CCcccccccccceecc
Confidence 99999998533211110000 0000011112347888
Q ss_pred CccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-------------------CCC
Q 013016 311 EYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-------------------QSP 370 (451)
Q Consensus 311 ~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------------~~~ 370 (451)
.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......... ...
T Consensus 191 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T cd07866 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP 270 (311)
T ss_pred CcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCC
Confidence 99999988764 4789999999999999999999999887766555544332111000 000
Q ss_pred C------CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 371 S------SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 371 ~------~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
. ......+.+||.+||+.||.+||| +.|++.||||
T Consensus 271 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 271 RTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred ccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 0 011237889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.54 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=204.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+..... ......||+|++..... ......+..|+.+++++.|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred HhceecccccccccccEEEEEEcccCC----CCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 689999999999999999998754210 01123599999875422 233456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP--------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
.++..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999999987432 12478889999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+||+++.++.++|+|||++........
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------------------------- 185 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADY----------------------------------------------------- 185 (288)
T ss_pred hheEecCCCceEECccccceecccCcc-----------------------------------------------------
Confidence 999999999999999998742210000
Q ss_pred cccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHH
Q 013016 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..+..... +...+.++
T Consensus 186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l 261 (288)
T cd05050 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC----PDNCPLEL 261 (288)
T ss_pred ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCCHHH
Confidence 000001134567999999998889999999999999999997 8899988777777776665543211 11233489
Q ss_pred HHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 379 RDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+|+.+||+.||.+||+ +.||++
T Consensus 262 ~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 262 YNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred HHHHHHHcccCcccCCC----HHHHHH
Confidence 99999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=307.33 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=211.1
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+|.+.+.||.|++|.||+|.++..++ .||+|.+...... ......+..|++++++++|+||+++++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD---------FVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc---------EEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence 48899999999999999999876655 3999999766432 2345678889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 71 SDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999999999999998765 5699999999999999999999999999999999999999999999999999853
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
...... ......|+..|+|||...+
T Consensus 149 ~~~~~~-------------------------------------------------------~~~~~~~~~~y~~pe~~~~ 173 (254)
T cd06627 149 LNDVSK-------------------------------------------------------DDASVVGTPYWMAPEVIEM 173 (254)
T ss_pred cCCCcc-------------------------------------------------------cccccccchhhcCHhhhcC
Confidence 221000 0112357888999999988
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
..++.++||||||+++|+|++|..||...........+....... . +...+..+.+++.+||..+|++||+ +
T Consensus 174 ~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~i~~~l~~~p~~R~~----~ 245 (254)
T cd06627 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---L-PEGISPELKDFLMQCFQKDPNLRPT----A 245 (254)
T ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---C-CCCCCHHHHHHHHHHHhCChhhCcC----H
Confidence 778999999999999999999999998766555554544322211 1 1122348999999999999999999 9
Q ss_pred HHHHcCCCc
Q 013016 401 ADVKTHPFF 409 (451)
Q Consensus 401 ~ell~hp~~ 409 (451)
.+++.||||
T Consensus 246 ~~~l~~~~~ 254 (254)
T cd06627 246 KQLLKHPWI 254 (254)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=313.29 Aligned_cols=260 Identities=18% Similarity=0.280 Sum_probs=210.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++...||.|+||.||+|+.+...+. .....||+|.+.... .......+..|+.++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~----~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcC----CCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence 6799999999999999999998654321 122359999986542 2224566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPH-------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
+.+..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 99999999999999999999876542 25899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++....... ........++..|
T Consensus 159 ~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y 184 (275)
T cd05046 159 SLLSLSKDVYNSE------------------------------------------------------YYKLRNALIPLRW 184 (275)
T ss_pred cccccccccCccc------------------------------------------------------ccccCCceeEEee
Confidence 9999874211000 0001122456779
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+|||.+.+..++.++||||||+++|+|++ |..||...........+..+....+.. ...+..+.+++.+||+.||.
T Consensus 185 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~~i~~~l~~~p~ 261 (275)
T cd05046 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP---EGCPSRLYKLMTRCWAVNPK 261 (275)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC---CCCCHHHHHHHHHHcCCCcc
Confidence 99999988888999999999999999998 899998877777777666555443321 22344899999999999999
Q ss_pred CcCCCCCChHHHHcC
Q 013016 392 NRLGSKRGAADVKTH 406 (451)
Q Consensus 392 ~Rpt~~~~~~ell~h 406 (451)
+||+ +.+++.+
T Consensus 262 ~Rp~----~~~~l~~ 272 (275)
T cd05046 262 DRPS----FSELVSA 272 (275)
T ss_pred cCCC----HHHHHHH
Confidence 9999 9998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.60 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=204.4
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+|.+.++||+|+||.||+|.+...... +++|++...... .......+..|+.++++++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAE---------ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCc---------ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 488999999999999999988755432 566665432211 112233455688999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
......++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccC
Confidence 9999999999999999999888642 3456999999999999999999999999999999999999974 679999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++....... .......|+..|+|||
T Consensus 151 ~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~~pe 175 (260)
T cd08222 151 VSRLLMGSC-------------------------------------------------------DLATTFTGTPYYMSPE 175 (260)
T ss_pred ceeecCCCc-------------------------------------------------------ccccCCCCCcCccCHH
Confidence 874321100 0011235788899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.+.+..++.++|+||||+++|+|++|..||...........+..+..... +...+.++.++|.+||..||++||+
T Consensus 176 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~- 250 (260)
T cd08222 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL----PETYSRQLNSIMQSMLNKDPSLRPS- 250 (260)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC----cchhcHHHHHHHHHHhcCChhhCcC-
Confidence 99888889999999999999999999999987766666666655432221 1233448999999999999999999
Q ss_pred CCChHHHHcCCCc
Q 013016 397 KRGAADVKTHPFF 409 (451)
Q Consensus 397 ~~~~~ell~hp~~ 409 (451)
+.|+++||||
T Consensus 251 ---~~~il~~~~~ 260 (260)
T cd08222 251 ---AAEILRNPFI 260 (260)
T ss_pred ---HHHHhhCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=309.60 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=203.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
++||+|++|.||+|.+..... ....||||.+...... .....+..|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 71 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGG------KVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLM 71 (257)
T ss_pred CcCCccCcccEEeeeEecCCC------CceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEE
Confidence 368999999999999865321 1123899999876543 456677889999999999999999999988 8999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+++++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999999999887643568999999999999999999999999999999999999999999999999985322100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
. .........++..|+|||.+.+..++.
T Consensus 152 ~----------------------------------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (257)
T cd05040 152 D----------------------------------------------------HYVMEEHLKVPFAWCAPESLRTRTFSH 179 (257)
T ss_pred c----------------------------------------------------ceecccCCCCCceecCHHHhcccCcCc
Confidence 0 000001235677899999999888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
++|||||||++|+|++ |+.||......+....+.......+. +...+..+.+++.+||+.+|++||+ +.+++
T Consensus 180 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 252 (257)
T cd05040 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER---PEACPQDIYNVMLQCWAHNPADRPT----FAALR 252 (257)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC---CccCCHHHHHHHHHHCCCCcccCCC----HHHHH
Confidence 9999999999999998 99999887777766666543222221 1223448999999999999999999 88887
Q ss_pred c
Q 013016 405 T 405 (451)
Q Consensus 405 ~ 405 (451)
.
T Consensus 253 ~ 253 (257)
T cd05040 253 E 253 (257)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=312.50 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=193.6
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
++||+|+||.||+|....... ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+...+..|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~-------~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~ 71 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMS-------KARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71 (269)
T ss_pred CcCCccCCceEEEEEEecCCC-------CeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceE
Confidence 369999999999997644321 1248888876432 2233455677999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccC
Q 013016 166 IVMEFCSGGDLHSLRHKQPH---KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSN 242 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 242 (451)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999999876532 235688889999999999999999999999999999999999999999999873211
Q ss_pred CCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC--
Q 013016 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG-- 320 (451)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 320 (451)
.. ..........++..|+|||++..
T Consensus 152 ~~-----------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05042 152 PE-----------------------------------------------------DYYITKDCHAVPLRWLAPELVEIRG 178 (269)
T ss_pred cc-----------------------------------------------------hheeccCCCCCcccccCHHHHhhcc
Confidence 00 00000011245677999998743
Q ss_pred -----CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-CCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 321 -----GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKK-PLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 321 -----~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
..++.++|||||||++|||++ |..||......+.+..+... ....+....+...+..+.+++..|+ .||++|
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 346889999999999999999 88999887766666655443 3333333333345557888999998 599999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|+ +++|++
T Consensus 258 pt----~~~v~~ 265 (269)
T cd05042 258 PT----AEEVHE 265 (269)
T ss_pred cC----HHHHHH
Confidence 99 888875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=311.38 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=205.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|...+.||+|+||.||+|.++...+. ...+|+|.+.... .......+..|++++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~------~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRK------EVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCC------ceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 6799999999999999999998754321 1249999986542 1223456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999999987643 468999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
......... .......++..|+|||++.
T Consensus 156 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 156 VLEDDPEGT----------------------------------------------------YTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred ecccccccc----------------------------------------------------eeccCCCcCceecCHHHhh
Confidence 322110000 0000112345799999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++|||||||++|+|++ |..||......+....+.... ..+. ....+..+.+++.+||..||++||+
T Consensus 184 ~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~--- 256 (268)
T cd05063 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLPA---PMDCPSAVYQLMLQCWQQDRARRPR--- 256 (268)
T ss_pred cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCCC---CCCCCHHHHHHHHHHcCCCcccCcC---
Confidence 8889999999999999999997 999998877777776665542 2221 1123348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.+|++
T Consensus 257 -~~~i~~ 262 (268)
T cd05063 257 -FVDIVN 262 (268)
T ss_pred -HHHHHH
Confidence 888874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=311.46 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=205.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+|++.+.||.|+||.||+|.++..++. +..||||++.... .......+..|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~------~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKR------EIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCC------ceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 36799999999999999999998765431 1249999987542 233446678899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++..++||||+++++|.+++.... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccc
Confidence 99999999999999999999887653 45899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........... ........++..|+|||.+
T Consensus 154 ~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~y~~PE~~ 183 (269)
T cd05065 154 RFLEDDTSDPT--------------------------------------------------YTSSLGGKIPIRWTAPEAI 183 (269)
T ss_pred cccccCccccc--------------------------------------------------cccccCCCcceeecCHhHh
Confidence 43221100000 0000000124569999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |..||......+....+.... ..+. . ...+..+.+++.+||..+|.+||+
T Consensus 184 ~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~-~~~~~~~~~li~~~l~~~p~~Rp~-- 257 (269)
T cd05065 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RLPP--P-MDCPTALHQLMLDCWQKDRNARPK-- 257 (269)
T ss_pred ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCCC--c-ccCCHHHHHHHHHHcCCChhhCcC--
Confidence 98889999999999999999886 999998877776666664432 1111 1 122348899999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+++|+.
T Consensus 258 --~~~i~~ 263 (269)
T cd05065 258 --FGQIVS 263 (269)
T ss_pred --HHHHHH
Confidence 888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=316.33 Aligned_cols=265 Identities=22% Similarity=0.313 Sum_probs=205.8
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
..+..++|.+.+.||.|++|.||+|.++.+++ .||||++...... .....+..|+.++.+. .|+||++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---------~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGH---------VMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCe---------EEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHh
Confidence 34556889999999999999999999886554 4999999754221 2233445566666666 4999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEE
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl 232 (451)
+++++......|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||
T Consensus 79 ~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 79 CYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred hheeeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEE
Confidence 999999999999999998 567777766543 468999999999999999999997 69999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++....... ......|+..|
T Consensus 157 ~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~y 180 (296)
T cd06618 157 CDFGISGRLVDSK--------------------------------------------------------AKTRSAGCAAY 180 (296)
T ss_pred CccccchhccCCC--------------------------------------------------------cccCCCCCccc
Confidence 9999874221000 00012467789
Q ss_pred cCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 313 VSPEVASGGS----HGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 313 ~aPE~~~~~~----~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+.+..+......... .....+.++.+|+.+||+
T Consensus 181 ~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 258 (296)
T cd06618 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP--PNEGFSPDFCSFVDLCLT 258 (296)
T ss_pred cCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHHHcc
Confidence 9999987653 78899999999999999999999976433 3455555544322111 111234489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.||.+||+ +++++.||||+....
T Consensus 259 ~~p~~Rp~----~~~il~~~~~~~~~~ 281 (296)
T cd06618 259 KDHRKRPK----YRELLQHPFIRRYET 281 (296)
T ss_pred CChhhCCC----HHHHhcChhhhccch
Confidence 99999999 999999999987433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.30 Aligned_cols=247 Identities=21% Similarity=0.266 Sum_probs=194.7
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l 166 (451)
+||+|+||.||+|.++.... +..+|+|++..... .....+.+..|+.+++.+.|+||+++++++. .+..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-------~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKS-------EKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCC-------ceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEE
Confidence 68999999999997653321 12599999865432 2334566778999999999999999999886 456799
Q ss_pred EEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCC
Q 013016 167 VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 246 (451)
||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 73 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 73 VMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 99999999999998764 4589999999999999999999999999999999999999999999999999843221100
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 326 (451)
. ........++..|+|||.+.+..++.+
T Consensus 151 ~----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05116 151 Y----------------------------------------------------YKAKTHGKWPVKWYAPECMNYYKFSSK 178 (257)
T ss_pred e----------------------------------------------------eeecCCCCCCccccCHhHhccCCcCch
Confidence 0 000001134578999999988888999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 327 VDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 327 ~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
+|||||||++|||++ |+.||......+....+..+.. ..+ ...+.++.+||.+||+.||++||+ +.+|.
T Consensus 179 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~l~~li~~~~~~~p~~Rp~----~~~i~ 249 (257)
T cd05116 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP-----QRCPPEMYDLMKLCWTYGVDERPG----FAVVE 249 (257)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC-----CCCCHHHHHHHHHHhccCchhCcC----HHHHH
Confidence 999999999999998 9999988777666666655432 122 123348999999999999999999 77765
Q ss_pred c
Q 013016 405 T 405 (451)
Q Consensus 405 ~ 405 (451)
.
T Consensus 250 ~ 250 (257)
T cd05116 250 L 250 (257)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=317.06 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=207.4
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|....+||+|+||.||++..+.+++ .||||.+.... ......+..|+.+++.++|+||+++++.+...
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGK---------LVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 89 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCe---------EEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC
Confidence 3444679999999999999877655 39999885432 22345577799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
++.|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 90 DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 999999999999999988754 34899999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
... ........|+..|+|||.+.+.
T Consensus 167 ~~~-------------------------------------------------------~~~~~~~~~~~~y~~pE~~~~~ 191 (292)
T cd06657 167 SKE-------------------------------------------------------VPRRKSLVGTPYWMAPELISRL 191 (292)
T ss_pred ccc-------------------------------------------------------cccccccccCccccCHHHhcCC
Confidence 100 0001123678899999999888
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChH
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ 401 (451)
.++.++||||||+++|+|++|..||...........+....... ...... .+..+.+++.+||..||.+||+ +.
T Consensus 192 ~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~~~l~~~P~~R~~----~~ 265 (292)
T cd06657 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHK-VSPSLKGFLDRLLVRDPAQRAT----AA 265 (292)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCccc-CCHHHHHHHHHHHhCCcccCcC----HH
Confidence 88999999999999999999999998776665555443332211 111112 2348899999999999999999 99
Q ss_pred HHHcCCCcCCCCc
Q 013016 402 DVKTHPFFKGLNF 414 (451)
Q Consensus 402 ell~hp~~~~~~~ 414 (451)
+++.||||.....
T Consensus 266 ~ll~~~~~~~~~~ 278 (292)
T cd06657 266 ELLKHPFLAKAGP 278 (292)
T ss_pred HHhcChHHhccCC
Confidence 9999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=308.79 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=196.5
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
++||+|+||.||+|.+..... ....+|+|.+...... .....+..|+.+++.+.|+||+++++++. .+..+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~------~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 71 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG------KEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLM 71 (257)
T ss_pred CccCccCceeEEEeEeeccCC------CcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceE
Confidence 469999999999998755431 1124999999866433 33456777999999999999999999876 45689
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+++++|.+++.... .+++..+..++.|++.||+|||.+|++|+||||+|||++.++.+||+|||++.......
T Consensus 72 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 72 LVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 9999999999999998753 68999999999999999999999999999999999999999999999999974321100
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
. .........++..|+|||.+.+..++.
T Consensus 150 ~----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~ 177 (257)
T cd05060 150 D----------------------------------------------------YYRATTAGRWPLKWYAPECINYGKFSS 177 (257)
T ss_pred c----------------------------------------------------ccccccCccccccccCHHHhcCCCCCc
Confidence 0 000000112456799999999888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
++|||||||++|+|++ |..||......+....+...... + .+...+..+.+++.+||..||.+||+ +.+|+
T Consensus 178 ~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~Rp~----~~~l~ 249 (257)
T cd05060 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P---RPEECPQEIYSIMLSCWKYRPEDRPT----FSELE 249 (257)
T ss_pred cchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHhcCChhhCcC----HHHHH
Confidence 9999999999999998 99999887776666665544321 1 11223348999999999999999999 88876
Q ss_pred c
Q 013016 405 T 405 (451)
Q Consensus 405 ~ 405 (451)
+
T Consensus 250 ~ 250 (257)
T cd05060 250 S 250 (257)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=319.43 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=208.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|...+.||+|+||.||+|.+..++. .||+|++.............+..|++++++++|+|++++++++.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~---------~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCc---------EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 348889999999999999999876554 49999987543333344566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..++||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 96 REHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred eCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9999999999995 5787776544 3458999999999999999999999999999999999999999999999999873
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .....|+..|+|||++.
T Consensus 174 ~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 174 IASP-----------------------------------------------------------ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred ccCC-----------------------------------------------------------cccccCCccccChhhhh
Confidence 2110 01235788899999974
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 ---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+..++.++|||||||++|+|++|+.||...........+......... ....+..+.+|+.+||+.+|.+||+
T Consensus 195 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt- 270 (317)
T cd06635 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQDRPT- 270 (317)
T ss_pred cCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC---CccccHHHHHHHHHHccCCcccCcC-
Confidence 356789999999999999999999999887666666666554332111 1223347999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.++++|+|+..
T Consensus 271 ---~~~il~~~~~~~ 282 (317)
T cd06635 271 ---SEELLKHMFVLR 282 (317)
T ss_pred ---HHHHHhChhhhc
Confidence 999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.75 Aligned_cols=261 Identities=27% Similarity=0.332 Sum_probs=203.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.++.+++ .||+|++..... .......+..|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGE---------LVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCc---------EEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 3789999999999999999999986654 499999975421 122234556799999999999999999998
Q ss_pred EeCC----------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 159 EASN----------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 159 ~~~~----------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
.+.. ++|+|+||+++ +|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG 153 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 7654 89999999965 777766654 34689999999999999999999999999999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++........ .......+
T Consensus 154 ~~kl~dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~ 179 (302)
T cd07864 154 QIKLADFGLARLYNSEES------------------------------------------------------RPYTNKVI 179 (302)
T ss_pred cEEeCcccccccccCCcc------------------------------------------------------ccccccee
Confidence 999999999743221100 00001245
Q ss_pred CCCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC-------------------
Q 013016 309 THEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ------------------- 368 (451)
Q Consensus 309 t~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------- 368 (451)
+..|+|||.+.+. .++.++|||||||++|+|++|+.||......+.+..+..........
T Consensus 180 ~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T cd07864 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259 (302)
T ss_pred ccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccc
Confidence 6789999988654 46889999999999999999999998876666555544321110000
Q ss_pred ------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 369 ------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 369 ------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
......+..+.++|.+||..||.+||+ +.+++.||||
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 001113458999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.01 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCceEEeeeccCCeeEEEEEEecccccc-------CCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQ-------DRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv 152 (451)
++|++.++||+|+||.||+|.+....+. ....+....+|+|++.... .......+..|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 5799999999999999999976542210 0111223469999997542 223345677899999999999999
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH---------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
++++++...+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++|++|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999998876421 24778899999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.++|+|||++....... .....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~-----------------------------------------------------~~~~~ 189 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGD-----------------------------------------------------YYRIQ 189 (296)
T ss_pred EcCCCCEEeccCcccccccCCc-----------------------------------------------------ceecc
Confidence 9999999999999974321000 00001
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhc---C---CCCCCCCCCCCcCh
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY--GRTPFAAPSNETTLRNIVK---K---PLTFPTQSPSSMSE 375 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~---~---~~~~~~~~~~~~~~ 375 (451)
....++..|+|||...++.++.++|||||||++|||++ |..||......+.+..... . ....+. +...+
T Consensus 190 ~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 266 (296)
T cd05095 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPK---PALCP 266 (296)
T ss_pred CcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCC---CCCCC
Confidence 11244677999999888889999999999999999998 7889987665554443221 1 111111 12233
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
..+.+|+.+||+.||.+||+ +.+|++
T Consensus 267 ~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 267 DSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred HHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 48999999999999999999 888764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=322.73 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=201.8
Q ss_pred CceEEeeeccCCeeEEEEEEeccc--cccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNK--YRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
+|.+.+.||.|+||.||+|.+... +. .||+|++.... ........+..|+.+++++ +|+||+++++.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~---------~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 70 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEE---------TVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDM 70 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCc---------eEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeee
Confidence 488999999999999999998765 33 49999986432 1222344566799999998 59999999987
Q ss_pred EEeC----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 158 FEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 158 ~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+... ...|+++||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 71 ~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 71 DIVFPGNFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred eeeccccCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeC
Confidence 5432 4688999998 57898888654 558999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++......... .........|+..|+
T Consensus 148 Dfg~a~~~~~~~~~---------------------------------------------------~~~~~~~~~g~~~y~ 176 (332)
T cd07857 148 DFGLARGFSENPGE---------------------------------------------------NAGFMTEYVATRWYR 176 (332)
T ss_pred cCCCceeccccccc---------------------------------------------------ccccccCcccCcccc
Confidence 99998532210000 000111347899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--------------------------C
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF--------------------------P 366 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------------------------~ 366 (451)
|||++.+ ..++.++|||||||++|+|++|+.||...+....+..++...... +
T Consensus 177 aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (332)
T cd07857 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKP 256 (332)
T ss_pred CcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcc
Confidence 9998866 468999999999999999999999998765444433332211100 0
Q ss_pred -CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 367 -TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 367 -~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
....+. .+..+.+|+.+||+.||.+||| +.+++.||||++..
T Consensus 257 ~~~~~~~-~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~~~ 299 (332)
T cd07857 257 FESIFPN-ANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAIWH 299 (332)
T ss_pred hHhhCCC-CCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhhhc
Confidence 001111 2347999999999999999999 99999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=314.55 Aligned_cols=256 Identities=29% Similarity=0.409 Sum_probs=202.6
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~ 160 (451)
|.+.+.||.|++|+||+|.+..+++ .||||.+...... .......+|+..++++. |+||+++++++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 69 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE---------LVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRE 69 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc---------EEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence 6788999999999999999877655 3999998754321 11223345888999998 9999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
++..|+||||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 70 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 70 NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 99999999999 88999988776555789999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
..... ......|+..|+|||++.+
T Consensus 149 ~~~~~--------------------------------------------------------~~~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 149 IRSRP--------------------------------------------------------PYTDYVSTRWYRAPEILLR 172 (283)
T ss_pred ccCCC--------------------------------------------------------CcCCCCCcccccCceeeec
Confidence 21100 0011357888999998854
Q ss_pred -CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-------------------CCC------CCcC
Q 013016 321 -GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-------------------QSP------SSMS 374 (451)
Q Consensus 321 -~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------------~~~------~~~~ 374 (451)
..++.++||||||+++|+|++|+.||......+.+..+......... ... ....
T Consensus 173 ~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07830 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA 252 (283)
T ss_pred CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccC
Confidence 45789999999999999999999999877665554443321111000 000 0011
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
+.++.+||++||+.||++||| +.|++.||||
T Consensus 253 ~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 253 SPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred CHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 347999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=324.82 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=201.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.+..+++ .||+|.+..... .....+..|++++++++|+||+++++++.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~---------~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~ 72 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDK---------RVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLG 72 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCc---------EEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence 689999999999999999999887665 499999865422 33455667999999999999999998765
Q ss_pred eC--------------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 160 AS--------------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 160 ~~--------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
.. ...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~ 148 (342)
T cd07854 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 44 36899999995 688887754 3589999999999999999999999999999999999998
Q ss_pred c-CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 226 S-DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 226 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
. ++.++|+|||.+......... .....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~----------------------------------------------------~~~~~ 176 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSH----------------------------------------------------KGYLS 176 (342)
T ss_pred CCCceEEECCcccceecCCcccc----------------------------------------------------ccccc
Confidence 4 567899999997432110000 00001
Q ss_pred ccccCCCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC------------------
Q 013016 305 SFVGTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF------------------ 365 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~------------------ 365 (451)
...|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+....+.......
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (342)
T cd07854 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRN 256 (342)
T ss_pred cccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh
Confidence 1257888999998755 457889999999999999999999998776655544443321100
Q ss_pred ----CCC---CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 366 ----PTQ---SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 366 ----~~~---~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
+.. ......+.++.+||.+||+.||.+||| +.+++.||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~ 306 (342)
T cd07854 257 DGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCY 306 (342)
T ss_pred cccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccc
Confidence 000 000113347899999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=315.51 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=204.1
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.+.||.|++|.||+|.+..+++ .+++|.+...... ......+..|+.++++++|+||+++++++..+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~---------~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 70 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGE---------IVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHK 70 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCc---------EEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence 5678899999999999999876654 4999998754322 23345677799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus 71 ~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 71 GDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 99999999995 58887776643 56999999999999999999999999999999999999999999999999987433
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
.... .......++..|+|||.+.+.
T Consensus 149 ~~~~-------------------------------------------------------~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 149 GSPV-------------------------------------------------------RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred CCCc-------------------------------------------------------ccccCccCcccccCcHHHhcC
Confidence 2110 000012467789999999876
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-------------------CCCCCC------CCcCh
Q 013016 322 -SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-------------------FPTQSP------SSMSE 375 (451)
Q Consensus 322 -~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-------------------~~~~~~------~~~~~ 375 (451)
.++.++||||||+++|+|++|+.||...+..+.+..+...... ++.... ....+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (283)
T cd05118 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNAS 253 (283)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhC
Confidence 6899999999999999999999999887766554444322111 000000 01123
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.++.+||.+||++||.+||+ +.+++.||||
T Consensus 254 ~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 254 PQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred HHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 47899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=309.22 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=194.8
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l 166 (451)
.||+|+||.||+|.+..... +..||+|++.... .......+..|+.++++++|+||+++++++. .+..++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~-------~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKK-------QIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCC-------ceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEE
Confidence 48999999999998753321 1239999997552 2334456778999999999999999999886 457899
Q ss_pred EEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCC
Q 013016 167 VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 246 (451)
||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus 72 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 72 VMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999999999887542 4589999999999999999999999999999999999999999999999999742211000
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 326 (451)
. ........++..|+|||++.+..++.+
T Consensus 151 ~----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05115 151 Y----------------------------------------------------YKARSAGKWPLKWYAPECINFRKFSSR 178 (257)
T ss_pred c----------------------------------------------------eeccCCCCCCcccCCHHHHccCCCCch
Confidence 0 000000123567999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 327 VDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 327 ~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+|||||||++|+|++ |..||......+....+..+.... .+...+.++.+++.+||..||++||+ +.+|++
T Consensus 179 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~c~~~~~~~Rp~----~~~i~~ 250 (257)
T cd05115 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD----CPAECPPEMYALMKDCWIYKWEDRPN----FAKVEE 250 (257)
T ss_pred hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999996 999999887777666665543211 11223448999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=312.80 Aligned_cols=259 Identities=15% Similarity=0.184 Sum_probs=204.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+.... ...+..|++|++.... .......+..|+.++++++|+||+++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 378999999999999999999987622 0012249999886432 334456677899999999999999999987
Q ss_pred Ee-CCeEEEEEeeccCCchhhhhhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 159 EA-SNFSCIVMEFCSGGDLHSLRHKQPH------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 159 ~~-~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
.. +...++++||+++++|.+++..... ..+++..++.++.||+.||+|||+++++|+||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 65 5688999999999999999876432 4589999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||+++....... ........++..
T Consensus 158 l~d~g~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 184 (280)
T cd05043 158 ITDNALSRDLFPMDY-----------------------------------------------------HCLGDNENRPVK 184 (280)
T ss_pred ECCCCCcccccCCce-----------------------------------------------------EEeCCCCCcchh
Confidence 999999843211000 000011235667
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||++.+..++.++|||||||++|++++ |+.||......+....+..+. .+.. ....+.++.+++.+||..||
T Consensus 185 y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~li~~~l~~~p 260 (280)
T cd05043 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLAQ---PINCPDELFAVMACCWALDP 260 (280)
T ss_pred ccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCCC---CCcCCHHHHHHHHHHcCCCh
Confidence 999999998889999999999999999999 999998876666555544432 2211 12234489999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
++||| +.+++.
T Consensus 261 ~~Rps----~~~~~~ 271 (280)
T cd05043 261 EERPS----FSQLVQ 271 (280)
T ss_pred hhCCC----HHHHHH
Confidence 99999 888874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.85 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=214.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
...+..+.+.||.|+||.||.|...+...... -..||||.+.+. .+.+....|.+|..+|+.++|||||+++|+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~----~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS----PIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCcc----ceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 34568889999999999999999876543211 123899988765 456677889999999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP-----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
+.+.+..+|++|||+||+|..+|+..+ ...++..+...++.||++|+.||+++++|||||...|+|++....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999998763 234889999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||+|+..... +|+.... .-.-...|
T Consensus 844 aDFGlArDiy~~---------------------------------~yyr~~~--------------------~a~lPvkW 870 (1025)
T KOG1095|consen 844 ADFGLARDIYDK---------------------------------DYYRKHG--------------------EAMLPVKW 870 (1025)
T ss_pred cccchhHhhhhc---------------------------------hheeccC--------------------ccccceec
Confidence 999999522111 0000000 00123469
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-CCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKK-PLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
||||.+..+.++.++|||||||+|||++| |..||...++.+.+..++.+ .+..|... +..+.+++..||+.+|
T Consensus 871 m~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C-----P~~ly~lM~~CW~~~p 945 (1025)
T KOG1095|consen 871 MPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC-----PEKLYQLMLQCWKHDP 945 (1025)
T ss_pred CCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC-----ChHHHHHHHHHccCCh
Confidence 99999999999999999999999999999 99999999999998866655 44444433 3377899999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
++||+ +..|++
T Consensus 946 e~RP~----F~~i~~ 956 (1025)
T KOG1095|consen 946 EDRPS----FRTIVE 956 (1025)
T ss_pred hhCcc----HHHHHh
Confidence 99999 888876
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.80 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=199.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|.+.+.||.|+||.||+|...+. .||+|++.... ....+..|+.++++++|+||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-----------~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQ-----------KVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGV 67 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCC-----------ceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 447899999999999999999864332 39999986542 22456679999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+..+ ..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 68 ~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 68 ILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 8765 479999999999999999876556689999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ......+..|+|||.
T Consensus 147 ~~~~~~~----------------------------------------------------------~~~~~~~~~y~~pe~ 168 (254)
T cd05083 147 ARVGSMG----------------------------------------------------------VDNSKLPVKWTAPEA 168 (254)
T ss_pred ceecccc----------------------------------------------------------CCCCCCCceecCHHH
Confidence 7421100 001123456999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|+|++ |+.||......+....+..+....+ . ...+..+.+++.+||+.+|.+||+
T Consensus 169 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~li~~~l~~~p~~Rp~- 243 (254)
T cd05083 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP---P-EGCPADVYVLMTSCWETEPKKRPS- 243 (254)
T ss_pred hccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCC---C-CcCCHHHHHHHHHHcCCChhhCcC-
Confidence 988889999999999999999997 9999988877766666655422111 1 123348999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+++++.
T Consensus 244 ---~~~l~~ 249 (254)
T cd05083 244 ---FHKLRE 249 (254)
T ss_pred ---HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=317.74 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=207.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|...+.||+|+||.||+|.++.+.. .+|+|.+.............+..|+++++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCc---------EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 458888999999999999999876654 49999986533233344456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence 9999999999995 68877765442 458999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .....|+..|+|||.+.
T Consensus 164 ~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 164 IMAP-----------------------------------------------------------ANXFVGTPYWMAPEVIL 184 (308)
T ss_pred eecC-----------------------------------------------------------cccccCCccccCHHHHh
Confidence 2110 01235788899999975
Q ss_pred C---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 G---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+ ..++.++|||||||++|+|++|..||...........+........ .....+..+.+||.+||..+|.+||+
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~- 260 (308)
T cd06634 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPT- 260 (308)
T ss_pred hcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc---CcccccHHHHHHHHHHhhCCcccCCC-
Confidence 3 4578899999999999999999999987666555555544332211 11223447899999999999999999
Q ss_pred CCChHHHHcCCCcCCC
Q 013016 397 KRGAADVKTHPFFKGL 412 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~ 412 (451)
+.++++|||+...
T Consensus 261 ---~~~ll~~~~~~~~ 273 (308)
T cd06634 261 ---SEVLLKHRFVLRE 273 (308)
T ss_pred ---HHHHhhCcccccc
Confidence 9999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.01 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=192.5
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||+|+||.||+|.+..... +..+|+|.+..... ......+.+|+.++++++|+||+++++++.+....+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 71 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYT-------PAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL 71 (269)
T ss_pred CcccccCCceEEEEEEcCCCC-------ceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcE
Confidence 368999999999998764321 12389998875432 122345677999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccC
Q 013016 166 IVMEFCSGGDLHSLRHKQP---HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSN 242 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 242 (451)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999999987542 2346778888999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC-
Q 013016 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG- 321 (451)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 321 (451)
... .........|+..|+|||++.+.
T Consensus 152 ~~~-----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05087 152 KED-----------------------------------------------------YYVTPDQLWVPLRWIAPELVDEVH 178 (269)
T ss_pred Ccc-----------------------------------------------------eeecCCCcCCcccccCHhHhcccc
Confidence 000 00011123577889999998642
Q ss_pred ------CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-CCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 322 ------SHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKK-PLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 322 ------~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
.++.++|||||||++|||++ |+.||......+........ ....+........+..+.+++.+|+ .+|++|
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred ccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence 35789999999999999996 99999876665554433332 2333332222234447899999998 689999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|| ++||+.
T Consensus 258 pt----~~~l~~ 265 (269)
T cd05087 258 PS----AEEVHL 265 (269)
T ss_pred CC----HHHHHH
Confidence 99 888874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.73 Aligned_cols=256 Identities=16% Similarity=0.217 Sum_probs=204.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|++.+.||+|+||.||+|.++.+++. ....+|+|++..... ......+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 6799999999999999999998755421 112489998875532 334466778999999999999999999998
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
. ...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 78999999999999999987653 348999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
........ .......++..|+|||.+.
T Consensus 158 ~~~~~~~~-----------------------------------------------------~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 158 LLDVDEKE-----------------------------------------------------YHAEGGKVPIKWMALESIL 184 (279)
T ss_pred cccCcccc-----------------------------------------------------eecCCCcccccccCHHHhh
Confidence 33210000 0000012356799999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++|||||||++|||++ |+.||......+....+..+... +. +...+.++.+++.+||..||..||+
T Consensus 185 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~l~~~p~~Rp~--- 257 (279)
T cd05057 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQ---PPICTIDVYMVLVKCWMIDAESRPT--- 257 (279)
T ss_pred cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CC---CCCCCHHHHHHHHHHcCCChhhCCC---
Confidence 8889999999999999999998 99999988777766666544321 11 1223348999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.++++
T Consensus 258 -~~~l~~ 263 (279)
T cd05057 258 -FKELIN 263 (279)
T ss_pred -HHHHHH
Confidence 887763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=329.93 Aligned_cols=245 Identities=31% Similarity=0.536 Sum_probs=202.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
...|.+...+|.|+|+.|-.|.+..+.+. +++|++.+.. ....+|+.++... +|+||+++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~---------~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v 384 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQE---------PAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDV 384 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccc---------hhheeccccc-------cccccccchhhhhcCCCcceeecce
Confidence 37799999999999999999999887765 9999998662 1222366555554 79999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE-ccCCCEEEeccC
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV-RSDGHIMLSDFD 236 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll-~~~~~~kl~Dfg 236 (451)
+.++.+.|+|||++.|+-|.+-+...+. +. ..+..|+++|+.|+.|||++|+|||||||+|||+ +..|+++|+|||
T Consensus 385 ~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 385 YEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred ecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999999988776665432 33 7788899999999999999999999999999999 588999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++..+.. -.+-+-|..|.|||
T Consensus 462 ~a~~~~~~----------------------------------------------------------~~tp~~t~~y~APE 483 (612)
T KOG0603|consen 462 FWSELERS----------------------------------------------------------CDTPALTLQYVAPE 483 (612)
T ss_pred hhhhCchh----------------------------------------------------------hcccchhhcccChh
Confidence 98543211 00125678899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++....|+.++||||||++||+||+|+.||.....+ +.+.++..+... ...+..+++||.+||++||.+|++
T Consensus 484 vl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-------~~vS~~AKdLl~~LL~~dP~~Rl~ 556 (612)
T KOG0603|consen 484 VLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-------ECVSDEAKDLLQQLLQVDPALRLG 556 (612)
T ss_pred hhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc-------cccCHHHHHHHHHhccCChhhCcC
Confidence 999999999999999999999999999999986666 555555444333 233449999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.+++.||||.+
T Consensus 557 ----~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 557 ----ADEIGAHPWFLS 568 (612)
T ss_pred ----hhhhccCcchhc
Confidence 999999999933
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.68 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=203.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|++.+.||.|+||.||+|.+.... .+|+|++...... ...+..|++++++++|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~----------~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKR----------KVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCT 69 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCC----------eEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 67999999999999999999886433 3999998754321 234667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.....|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 70 ERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999999999887643 458999999999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... ........++..|+|||.+.
T Consensus 149 ~~~~~~------------------------------------------------------~~~~~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 149 FVLDDQ------------------------------------------------------YTSSTGTKFPVKWSSPEVFS 174 (256)
T ss_pred ecccCc------------------------------------------------------ccccCCCccchhhcCHhHhc
Confidence 221000 00000113456799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
++.++.++||||||+++|+|++ |..||...........+..+...+. +...+..+.+|+.+||+.+|++||+
T Consensus 175 ~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~--- 247 (256)
T cd05112 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK----PRLASQSVYELMQHCWKERPEDRPS--- 247 (256)
T ss_pred cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC----CCCCCHHHHHHHHHHcccChhhCCC---
Confidence 8889999999999999999998 9999988777777776655422211 1223458999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.++++
T Consensus 248 -~~~~l~ 253 (256)
T cd05112 248 -FSLLLH 253 (256)
T ss_pred -HHHHHH
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=315.01 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=205.3
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.+.||.|++|.||+|....+++ .||+|++.... ........+..|+.++++++|+||+++++++...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~---------~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 70 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE 70 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc---------EEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence 6678899999999999999887655 49999998653 2233345566799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..++||||++ ++|.+++.... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...
T Consensus 71 ~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 71 RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 99999999996 69999988753 45999999999999999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
..... ......++..|+|||.+.+.
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 149 GIPLR-------------------------------------------------------TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred CCCcc-------------------------------------------------------ccCccccCcCcCChHHhcCC
Confidence 11000 00012456779999998776
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC------------------CCCC-------CCCCCcCh
Q 013016 322 -SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL------------------TFPT-------QSPSSMSE 375 (451)
Q Consensus 322 -~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------~~~~-------~~~~~~~~ 375 (451)
.++.++|||||||++|+|++|+.||......+.+.++..... .++. ...+.. +
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 252 (282)
T cd07829 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRL-D 252 (282)
T ss_pred cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccc-c
Confidence 789999999999999999999999988776655554433110 0010 001111 3
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
..+.++|.+||..||++||+ +.+++.||||
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred HHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 47999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.28 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=196.1
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l 166 (451)
.||+|+||.||+|...... .+|+|++..... ......+..|+.+++.++|+||+++++++...+..++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~----------~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69 (250)
T ss_pred ccCCCCCceEEEEEecCCc----------EEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence 6899999999999865433 399999875432 2233457779999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCC
Q 013016 167 VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 246 (451)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 70 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 147 (250)
T cd05085 70 VMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI- 147 (250)
T ss_pred EEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-
Confidence 999999999999886543 458999999999999999999999999999999999999999999999999974211000
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 326 (451)
........++..|+|||++.+..++.+
T Consensus 148 -----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 174 (250)
T cd05085 148 -----------------------------------------------------YSSSGLKQIPIKWTAPEALNYGRYSSE 174 (250)
T ss_pred -----------------------------------------------------cccCCCCCCcccccCHHHhccCCCCch
Confidence 000001134567999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 327 VDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 327 ~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||||||+++|+|++ |..||...........+...... .... ..+..+.+|+.+||+.+|++||+ +.|+++
T Consensus 175 ~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~li~~~l~~~p~~Rp~----~~~l~~ 246 (250)
T cd05085 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQ-KCPDDVYKVMQRCWDYKPENRPK----FSELQK 246 (250)
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCC-CCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 999999999999998 99999887766666666544221 1111 23348999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.00 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||.|+||.||+|.++.+++ .||+|++.+... .......+..|+.+++.+.||||++++++|.
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 79 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQ---------NVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFI 79 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCC---------EEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence 779999999999999999999887665 399998865321 1223355667999999999999999999987
Q ss_pred e-CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 A-SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. .+..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 5 56889999999 7789888764 34888999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... ......++..|+|||.+
T Consensus 156 ~~~~~----------------------------------------------------------~~~~~~~~~~y~aPE~~ 177 (328)
T cd07856 156 RIQDP----------------------------------------------------------QMTGYVSTRYYRAPEIM 177 (328)
T ss_pred cccCC----------------------------------------------------------CcCCCcccccccCceee
Confidence 42110 00123577889999998
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------------------CCCCCCCCCC
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--------------------------PLTFPTQSPS 371 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~--------------------------~~~~~~~~~~ 371 (451)
.+ ..++.++|||||||++|+|++|+.||........+..+.+. ....+.....
T Consensus 178 ~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (328)
T cd07856 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKF 257 (328)
T ss_pred eccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHc
Confidence 66 56899999999999999999999999876543322221110 0000100000
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
...+..+.++|.+||+.+|++||+ +.+++.||||....
T Consensus 258 ~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~~~ 295 (328)
T cd07856 258 KNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAPYH 295 (328)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccccc
Confidence 123348999999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=307.39 Aligned_cols=255 Identities=25% Similarity=0.321 Sum_probs=202.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.++||+|+||.||+|.+..... ....||||.+..... ....+.+..|+.+++++.|+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPEN------EKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCC------CCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 3679999999999999999998765411 011389999875532 23445677899999999999999999988
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.. +..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 75 45789999999999999987643 35899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .......++..|+|||.+
T Consensus 155 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~aPE~~ 180 (270)
T cd05056 155 RYLEDESY------------------------------------------------------YKASKGKLPIKWMAPESI 180 (270)
T ss_pred eecccccc------------------------------------------------------eecCCCCccccccChhhh
Confidence 43211000 000011345679999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |..||......+....+..+..... .. ..+..+.+++.+||..+|.+|||
T Consensus 181 ~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~li~~~l~~~P~~Rpt-- 254 (270)
T cd05056 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PP-NCPPTLYSLMTKCWAYDPSKRPR-- 254 (270)
T ss_pred ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CC-CCCHHHHHHHHHHcCCChhhCcC--
Confidence 88889999999999999999996 9999988877776666655432211 11 22348999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.+++.
T Consensus 255 --~~~~~~ 260 (270)
T cd05056 255 --FTELKA 260 (270)
T ss_pred --HHHHHH
Confidence 888775
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.45 Aligned_cols=275 Identities=27% Similarity=0.393 Sum_probs=208.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+.+|+.+..||+||||.||+|+.+-+++. ||||.|.... ......++.+|+.++.+|+|||||+++..+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~---------YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGRE---------YAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchh---------hhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 46899999999999999999999988775 9999998764 556677888999999999999999987322
Q ss_pred Ee------------------------------------------------------------------------------
Q 013016 159 EA------------------------------------------------------------------------------ 160 (451)
Q Consensus 159 ~~------------------------------------------------------------------------------ 160 (451)
.+
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 00
Q ss_pred ---------------------------------C--------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHH
Q 013016 161 ---------------------------------S--------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199 (451)
Q Consensus 161 ---------------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~q 199 (451)
+ -.+||.||||+...|.+++..+.... ....+++++++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFre 705 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFRE 705 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHH
Confidence 0 14789999999988888887764321 47789999999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccc
Q 013016 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRF 279 (451)
Q Consensus 200 il~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (451)
|++||.|+|++|||||||||.||++++++.|||+|||+|........
T Consensus 706 IlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~--------------------------------- 752 (1351)
T KOG1035|consen 706 ILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLE--------------------------------- 752 (1351)
T ss_pred HHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhh---------------------------------
Confidence 99999999999999999999999999999999999999853210000
Q ss_pred cCCccccccCCCcccccccccccccccccCCCccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHH
Q 013016 280 FGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG---SHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTL 355 (451)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~ 355 (451)
.......+. .....+......+.+||..|+|||++.+. .|+.|+||||||+|++||+. ||.. +.....+
T Consensus 753 ---~~d~~~~~~-~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL 825 (1351)
T KOG1035|consen 753 ---SIDQDLSFS-TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL 825 (1351)
T ss_pred ---hHhhccCcc-ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH
Confidence 000000000 00111122233456999999999999774 49999999999999999994 5643 3344456
Q ss_pred HHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcC
Q 013016 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 356 ~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~ 410 (451)
.++..+.++.+........+ .-..+|++||++||.+||| |.|||++.||.
T Consensus 826 ~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 826 TNLRKGSIPEPADFFDPEHP-EEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred HhcccCCCCCCcccccccch-HHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 66666666555222222233 5679999999999999999 99999999998
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=309.18 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=190.4
Q ss_pred eeccCCeeEEEEEEecccccc---------------CCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQ---------------DRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL 151 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~---------------~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI 151 (451)
+||+|+||.||+|.....+.. .........||+|++.... ......+..|+.+++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999986533211 1112222459999997543 2234556678899999999999
Q ss_pred cceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---
Q 013016 152 PTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG--- 228 (451)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~--- 228 (451)
+++++++..++..++||||+++++|..++... .+.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888654 34689999999999999999999999999999999999998654
Q ss_pred ----CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 229 ----HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 229 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
.+|++|||++..... ..
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-----------------------------------------------------------~~ 178 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-----------------------------------------------------------RE 178 (274)
T ss_pred CccceeeecCCcccccccc-----------------------------------------------------------cc
Confidence 389999998631100 00
Q ss_pred ccccCCCccCcccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
...++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+... +.......+.. ....+.+++
T Consensus 179 ~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~li 252 (274)
T cd05076 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPEP-----SCKELATLI 252 (274)
T ss_pred ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCCC-----CChHHHHHH
Confidence 1246778999998876 55799999999999999985 6999998765544322 22222222221 123789999
Q ss_pred HHhcccCcCCcCCCCCChHHHHcC
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+||+.+|++||+ +.+|+++
T Consensus 253 ~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 253 SQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred HHHcccChhhCcC----HHHHHHh
Confidence 9999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=310.51 Aligned_cols=255 Identities=19% Similarity=0.250 Sum_probs=192.6
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.+.||+|+||+||++....... ..+..||+|++..... ......+.+|+++++.++|+||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPAND-----GTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccC-----CCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4999999999999999887543211 1233599999975421 22345567799999999999999999988653
Q ss_pred --CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 162 --NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 162 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 4689999999999999998763 49999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
........ ........++..|+|||.+.
T Consensus 156 ~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 156 AVPEGHEY----------------------------------------------------YRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred ccCCcchh----------------------------------------------------hccCCCCCCCceeeCHhHhc
Confidence 32110000 00000113456699999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--H------------HHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET--T------------LRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~--~------------~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+..++.++|||||||++|+|++|..||....... . +..........+ .+...+..+.+++.+|
T Consensus 184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~c 260 (283)
T cd05080 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP---CPKNCPQEVYILMKNC 260 (283)
T ss_pred ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC---CCCCCCHHHHHHHHHH
Confidence 8889999999999999999999999986543210 0 111111111111 1223345899999999
Q ss_pred cccCcCCcCCCCCChHHHHc
Q 013016 386 LNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~ 405 (451)
|+.||++||+ +++++.
T Consensus 261 l~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 261 WETEAKFRPT----FRSLIP 276 (283)
T ss_pred hccChhhCCC----HHHHHH
Confidence 9999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=308.75 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=194.8
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEEeCCeEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~ 165 (451)
.||+|+||.||+|.++.++.. ..+|+|.+.... .......+..|+.++.++ +||||+++++++...+..|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~-------~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCe-------eEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCce
Confidence 589999999999998765432 127888886432 223345667799999999 7999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 166 IVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+|
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEE
Confidence 9999999999999987532 13478999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++...... .......++..
T Consensus 153 l~dfgl~~~~~~~--------------------------------------------------------~~~~~~~~~~~ 176 (270)
T cd05047 153 IADFGLSRGQEVY--------------------------------------------------------VKKTMGRLPVR 176 (270)
T ss_pred ECCCCCccccchh--------------------------------------------------------hhccCCCCccc
Confidence 9999987311000 00000123557
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+..+...... . .. ...+.++.+|+.+||..||
T Consensus 177 y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~--~~-~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-E--KP-LNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred cCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC-C--CC-CcCCHHHHHHHHHHcccCh
Confidence 999999988889999999999999999997 99999887776666666443211 1 11 1223489999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
.+||+ +.+++.
T Consensus 253 ~~Rps----~~~il~ 263 (270)
T cd05047 253 YERPS----FAQILV 263 (270)
T ss_pred hhCCC----HHHHHH
Confidence 99999 888874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.00 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=197.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
+.||.|+||.||+|.++..... ...+..+|+|.+.+.. .......+.+|+.+++.++|+||+++++++...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~---~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGP---GSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccC---cccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence 3689999999999988654311 1112359999886542 1233456777999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-----CEEEecc
Q 013016 166 IVMEFCSGGDLHSLRHKQP-----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-----HIMLSDF 235 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-----~~kl~Df 235 (451)
+||||+++++|.+++.... ...+++..+..++.||+.||+|||+++++|+||||+||+++.++ .++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999987532 23478999999999999999999999999999999999999887 8999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ ........++..|+||
T Consensus 156 g~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~aP 182 (269)
T cd05044 156 GLARDIYKSDY-----------------------------------------------------YRKEGEGLLPVRWMAP 182 (269)
T ss_pred ccccccccccc-----------------------------------------------------cccCcccCCCccccCH
Confidence 99742211000 0000112456789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||++|+|++ |..||......+....+..+.... .. ...+..+.+|+.+||+.+|.+||
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ---KP-ENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---Cc-ccchHHHHHHHHHHcCCCcccCC
Confidence 99998889999999999999999998 999998877666666554432111 11 12334899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ ++++++
T Consensus 259 ~----~~~i~~ 265 (269)
T cd05044 259 T----FDRIQE 265 (269)
T ss_pred C----HHHHHH
Confidence 9 888764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=303.57 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=197.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~ 165 (451)
++||.|+||.||+|.+.. .+ .||+|++...... .....+..|+.+++++.|+||+++++++...++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~---------~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 68 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NT---------EVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY 68 (251)
T ss_pred CccccCCCceEEEEEEeC-CC---------cEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeE
Confidence 369999999999999876 43 3999998765332 34456778999999999999999999999999999
Q ss_pred EEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCC
Q 013016 166 IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245 (451)
Q Consensus 166 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 245 (451)
+||||+.|++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 69 ~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 69 IVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999986643 358899999999999999999999999999999999999999999999999974221000
Q ss_pred CCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCc
Q 013016 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325 (451)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 325 (451)
. ........++..|+|||.+.+..++.
T Consensus 148 ~-----------------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~ 174 (251)
T cd05041 148 Y-----------------------------------------------------TVSDGLKQIPIKWTAPEALNYGRYTS 174 (251)
T ss_pred c-----------------------------------------------------eeccccCcceeccCChHhhccCCCCc
Confidence 0 00000112355699999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 326 AVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 326 ~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
++|||||||++|+|++ |..||...........+.... ..+ .+...+.++.+++.+||+.+|.+||+ +.|++
T Consensus 175 ~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ell 246 (251)
T cd05041 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP---APQLCPEEIYRLMLQCWAYDPENRPS----FSEIY 246 (251)
T ss_pred chhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC---CCccCCHHHHHHHHHHhccChhhCcC----HHHHH
Confidence 9999999999999999 899998876666555554432 111 11223448999999999999999999 99988
Q ss_pred c
Q 013016 405 T 405 (451)
Q Consensus 405 ~ 405 (451)
+
T Consensus 247 ~ 247 (251)
T cd05041 247 N 247 (251)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=303.74 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=206.7
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
+++.+.||.|+||.||+|.+..... ..+..||+|++..... ......+..|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 3567889999999999999876541 1123599999975532 12445677799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..++||||+++++|.+++.......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999999988754444899999999999999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
..... +. .....++..|+|||.+.+.
T Consensus 154 ~~~~~-----------------------------------------------~~-------~~~~~~~~~y~~Pe~~~~~ 179 (258)
T smart00219 154 YDDDY-----------------------------------------------YK-------KKGGKLPIRWMAPESLKDG 179 (258)
T ss_pred ccccc-----------------------------------------------cc-------cccCCCcccccChHHhccC
Confidence 21100 00 0001367789999999888
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 322 SHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
.++.++||||||+++|+|++ |..||...........+......... ...+.++.+++.+||..||++||| +
T Consensus 180 ~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt----~ 251 (258)
T smart00219 180 KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP----ENCPPEIYKLMLQCWAEDPEDRPT----F 251 (258)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC----CcCCHHHHHHHHHHCcCChhhCcC----H
Confidence 89999999999999999998 89999887777777777665432221 123448999999999999999999 9
Q ss_pred HHHHc
Q 013016 401 ADVKT 405 (451)
Q Consensus 401 ~ell~ 405 (451)
.++++
T Consensus 252 ~~ll~ 256 (258)
T smart00219 252 SELVE 256 (258)
T ss_pred HHHHh
Confidence 99885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.06 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=188.8
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l 166 (451)
.||.|+||.||+|.++..... +......+|+|++.... ....+.+..|+.+++.+.|+||+++++++..++..++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccc--cccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 689999999999987654321 01111237888875432 2334566678999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC--------EEEeccCcc
Q 013016 167 VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH--------IMLSDFDLS 238 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~--------~kl~Dfg~a 238 (451)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++
T Consensus 77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999987653 35899999999999999999999999999999999999987765 689999986
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... .....|+..|+|||++
T Consensus 156 ~~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~~ 176 (258)
T cd05078 156 ITVLP-----------------------------------------------------------KEILLERIPWVPPECI 176 (258)
T ss_pred cccCC-----------------------------------------------------------chhccccCCccCchhc
Confidence 32110 0123577889999999
Q ss_pred cCC-CCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 SGG-SHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 ~~~-~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.+. .++.++|||||||++|+|++| ..||......... .+......++... ..++.+|+.+||+.||++|||
T Consensus 177 ~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps- 249 (258)
T cd05078 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPK-----WTELANLINQCMDYEPDFRPS- 249 (258)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCC-----cHHHHHHHHHHhccChhhCCC-
Confidence 874 478999999999999999998 4666554443332 2333333333222 237999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
++++++
T Consensus 250 ---~~~il~ 255 (258)
T cd05078 250 ---FRAIIR 255 (258)
T ss_pred ---HHHHHH
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=305.25 Aligned_cols=252 Identities=17% Similarity=0.257 Sum_probs=192.0
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l 166 (451)
+||+|+||.||+|....... ...+++|.+..... ......+.+|+.+++.++||||+++++.+......|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG-------VARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC-------cceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEE
Confidence 69999999999997654332 12367777664421 2334567789999999999999999999999999999
Q ss_pred EEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 167 VMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++......
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999987642 234677888999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC----
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG---- 320 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---- 320 (451)
..........|+..|+|||++.+
T Consensus 153 -----------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (268)
T cd05086 153 -----------------------------------------------------DYIETEDDKCVPLRWLAPELVGEFHGG 179 (268)
T ss_pred -----------------------------------------------------hhhhcccCCcCcccccCchhcccccCc
Confidence 00001112367889999999753
Q ss_pred ---CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 321 ---GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 321 ---~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
..++.++|||||||++|||++ |..||......+.+..+..+. ...+........+..+.+++..|+ .+|.+||+
T Consensus 180 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~ 258 (268)
T cd05086 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRAT 258 (268)
T ss_pred cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCC
Confidence 235789999999999999997 677998777766666655442 222222222234458899999999 78999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+++|++
T Consensus 259 ----~~~i~~ 264 (268)
T cd05086 259 ----AEEVHR 264 (268)
T ss_pred ----HHHHHH
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.26 Aligned_cols=259 Identities=30% Similarity=0.477 Sum_probs=212.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+++-..+||.|.||.||.|...+++. +.|+|-+.-.... ...+..+.+|..++..++|||+|+.||+-.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGe---------llAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGE---------LLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccc---------hhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeec
Confidence 35556789999999999999887765 6999988765443 5566778889999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.+..+|.||||.||+|.+++... ...++.....+..|++.||.|||+.|||||||||+||+++.+|.+|++|||.|..
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999999998875 4477888888999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
...... . ....-....||+.|||||++.|
T Consensus 1384 i~~~~~----------------------------------------~-----------~~~el~~~~GT~~YMAPEvit~ 1412 (1509)
T KOG4645|consen 1384 IKNNAQ----------------------------------------T-----------MPGELQSMMGTPMYMAPEVITG 1412 (1509)
T ss_pred ecCchh----------------------------------------c-----------CCHHHHhhcCCchhcCchhhcc
Confidence 322100 0 0011113589999999999987
Q ss_pred C---CCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcC-CCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 321 G---SHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKK-PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 321 ~---~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
. +.+.++||||||||+.||+||+.||...++ ..++..+-.+ .+.+|.. + +.+.++||.+||+.||.+|++
T Consensus 1413 t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~----l-s~~g~dFle~Cl~~dP~~Rw~ 1487 (1509)
T KOG4645|consen 1413 TKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER----L-SSEGRDFLEHCLEQDPKMRWT 1487 (1509)
T ss_pred cccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh----h-hHhHHHHHHHHHhcCchhhhH
Confidence 4 357899999999999999999999988544 4555555444 3344443 2 338899999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.|||+|.|-+.
T Consensus 1488 ----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1488 ----ASQLLEHAFGKS 1499 (1509)
T ss_pred ----HHHHHHhhcccc
Confidence 999999999765
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.31 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=196.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|++.++||+|+||.||+|.+..... ..+..||+|.+.... .......+.+|+.+++++.|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGD-----NTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCC-----CccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 348999999999999999998643211 222359999987542 2333456788999999999999999999987
Q ss_pred eC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 AS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
.. ...++||||++|++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcc
Confidence 75 57899999999999999987653 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+......... ........|+..|+|||.
T Consensus 156 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~apE~ 183 (284)
T cd05079 156 TKAIETDKEY----------------------------------------------------YTVKDDLDSPVFWYAPEC 183 (284)
T ss_pred ccccccCccc----------------------------------------------------eeecCCCCCCccccCHHH
Confidence 7532110000 000112356778999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN--------------ETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
+.+..++.++|||||||++|+|++++.|+..... ..............+. +...+..+.+|+.
T Consensus 184 ~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~ 260 (284)
T cd05079 184 LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR---PPNCPEEVYQLMR 260 (284)
T ss_pred hccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC---CCCCCHHHHHHHH
Confidence 9888899999999999999999998776532110 1111111111111111 1223448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.||.+||+ +.++++
T Consensus 261 ~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 261 KCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred HHccCCcccCcC----HHHHHH
Confidence 999999999999 999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.58 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=221.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+-|++...||.|.+|.||+++.+.+++ ..|+||..... ...+.++.|..+++.. .|||++.+|++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~---------~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQ---------LAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCc---------eeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 569999999999999999999887765 48999887542 3345566688899887 699999999999
Q ss_pred Ee-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 159 EA-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 159 ~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
.. ++.++||||||.|||..|+++...+.++.|..+.-|++.++.||.+||.+.++|||||-.|||++.+|.|||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 53 4689999999999999999999888899999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||.+.. .+....+.++++||+.||
T Consensus 166 DFGvSaQ-------------------------------------------------------ldsT~grRnT~iGtP~WM 190 (953)
T KOG0587|consen 166 DFGVSAQ-------------------------------------------------------LDSTVGRRNTFIGTPYWM 190 (953)
T ss_pred eeeeeee-------------------------------------------------------eecccccccCcCCCcccc
Confidence 9999732 123445566789999999
Q ss_pred CcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 314 SPEVASGG-----SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 314 aPE~~~~~-----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
|||++... .|+..+|+||||++..||-.|.+|+.++.....+-.|.+.++ |...-+..+..++.+||..||.+
T Consensus 191 APEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP--PkLkrp~kWs~~FndFIs~cL~K 268 (953)
T KOG0587|consen 191 APEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKLKRPKKWSKKFNDFISTCLVK 268 (953)
T ss_pred cceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC--ccccchhhHHHHHHHHHHHHHhh
Confidence 99999653 367899999999999999999999999888777666655533 33343455666999999999999
Q ss_pred CcCCcCCCCCChHHHHcCCCcCC
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
|-++||+ ..++|+|||+++
T Consensus 269 d~e~RP~----~~~ll~hpFi~e 287 (953)
T KOG0587|consen 269 DYEQRPS----TEELLKHPFITE 287 (953)
T ss_pred ccccCcc----hhhhccCCcccc
Confidence 9999999 999999999996
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=304.42 Aligned_cols=248 Identities=20% Similarity=0.255 Sum_probs=190.2
Q ss_pred eeeccCCeeEEEEEEeccccccC---CCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCC
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQD---RGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASN 162 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~---~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~ 162 (451)
+.||+|+||.||+|......... ........+|+|++.... ......+..|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999999999865332110 111222358999886542 233445667889999999999999999999999
Q ss_pred eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC-------EEEecc
Q 013016 163 FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH-------IMLSDF 235 (451)
Q Consensus 163 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~-------~kl~Df 235 (451)
..++||||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998887654 345899999999999999999999999999999999999987664 899999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .....|+..|+||
T Consensus 157 g~~~~~~~-----------------------------------------------------------~~~~~~~~~y~aP 177 (262)
T cd05077 157 GIPITVLS-----------------------------------------------------------RQECVERIPWIAP 177 (262)
T ss_pred CCCccccC-----------------------------------------------------------cccccccccccCh
Confidence 98732110 0112577889999
Q ss_pred cccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 316 EVAS-GGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 316 E~~~-~~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|++. +..++.++|||||||++|+|+ +|..||......+. ..+......... ....++.+|+.+||+.||.+|
T Consensus 178 E~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~R 251 (262)
T cd05077 178 ECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCMLVT-----PSCKELADLMTHCMNYDPNQR 251 (262)
T ss_pred hhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccCCC-----CChHHHHHHHHHHcCCChhhC
Confidence 9987 456899999999999999998 58888876543332 222232222111 122378999999999999999
Q ss_pred CCCCCChHHHHcC
Q 013016 394 LGSKRGAADVKTH 406 (451)
Q Consensus 394 pt~~~~~~ell~h 406 (451)
|+ +.+|+++
T Consensus 252 p~----~~~il~~ 260 (262)
T cd05077 252 PF----FRAIMRD 260 (262)
T ss_pred cC----HHHHHHh
Confidence 99 9999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.63 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=209.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+...+.++||+|-||.|.+|...+.. +||||+++.... ......|..|+++|.+|+||||++++++|.
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~l----------kVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPL----------KVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCce----------EEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 34788999999999999999987633 499999987743 334577888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++.+|+|+||+++|+|.+++......-+.-.....|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||.++
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 99999999999999999999987643334556677799999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
-+- ..+........+-...|||+|.+.
T Consensus 686 ~ly-----------------------------------------------------sg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 686 NLY-----------------------------------------------------SGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred ccc-----------------------------------------------------cCCceeeecceeeeeeehhHHHHH
Confidence 211 111111112235567899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHhc---CCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY--GRTPFAAPSNETTLRNIVK---KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
-++++.++|||+||+++||+++ .+.||....+++...+... ....-.-...+...++.+.+++.+|+..|-++||
T Consensus 713 lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP 792 (807)
T KOG1094|consen 713 LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP 792 (807)
T ss_pred hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC
Confidence 9999999999999999999875 8999998888877665433 2222222233456777899999999999999999
Q ss_pred CCCCChHHHH
Q 013016 395 GSKRGAADVK 404 (451)
Q Consensus 395 t~~~~~~ell 404 (451)
+ +++|-
T Consensus 793 s----Fe~lh 798 (807)
T KOG1094|consen 793 S----FEQLH 798 (807)
T ss_pred C----HHHHH
Confidence 9 88874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.33 Aligned_cols=252 Identities=17% Similarity=0.244 Sum_probs=193.3
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE-eCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE-ASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~ 164 (451)
+.||+|+||.||+|.+..... ....+|+|.+.... .......+..|+.+++.++|+||+++++++. .++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 72 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG------QKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSP 72 (262)
T ss_pred CcccccCCceEEEEEEecCCC------ceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCc
Confidence 368999999999998754321 12359999986431 2233456677999999999999999999775 45678
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCC
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 244 (451)
++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 73 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 73 LVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999987653 34678888999999999999999999999999999999999999999999997422110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCC
Q 013016 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324 (451)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 324 (451)
... .........++..|+|||.+.+..++
T Consensus 152 ~~~---------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (262)
T cd05058 152 EYY---------------------------------------------------SVHNHTGAKLPVKWMALESLQTQKFT 180 (262)
T ss_pred cce---------------------------------------------------eecccccCcCCccccChhHhccCccc
Confidence 000 00000112456789999999888899
Q ss_pred cchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHH
Q 013016 325 NAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADV 403 (451)
Q Consensus 325 ~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~el 403 (451)
.++|||||||++|||++ |.+||......+....+..+..... +...+..+.+++.+||..+|++||+ +.+|
T Consensus 181 ~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i 252 (262)
T cd05058 181 TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ----PEYCPDPLYEVMLSCWHPKPEMRPT----FSEL 252 (262)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC----CCcCCHHHHHHHHHHcCCChhhCCC----HHHH
Confidence 99999999999999999 5677877666666665555432111 1123448999999999999999999 8888
Q ss_pred Hc
Q 013016 404 KT 405 (451)
Q Consensus 404 l~ 405 (451)
++
T Consensus 253 l~ 254 (262)
T cd05058 253 VS 254 (262)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=310.60 Aligned_cols=257 Identities=18% Similarity=0.236 Sum_probs=199.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..++.. ....+|+|++..... ......+..|+.+++.++|+||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 6799999999999999999998755431 112379998875422 222345677999999999999999999987
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.. ..++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 54 5679999999999999887643 358999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... ........++..|+|||.+.
T Consensus 158 ~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~~PE~~~ 184 (303)
T cd05110 158 LLEGDEK-----------------------------------------------------EYNADGGKMPIKWMALECIH 184 (303)
T ss_pred cccCccc-----------------------------------------------------ccccCCCccccccCCHHHhc
Confidence 3211000 00001124567899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++|||||||++|||++ |..||.+.........+..+ ..++. +...+.++.+++.+||..+|++||+
T Consensus 185 ~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~--- 257 (303)
T cd05110 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERLPQ---PPICTIDVYMVMVKCWMIDADSRPK--- 257 (303)
T ss_pred cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCC---CCCCCHHHHHHHHHHcCCChhhCcC---
Confidence 8889999999999999999997 99999876555444333332 22221 1223448999999999999999999
Q ss_pred ChHHHHcC
Q 013016 399 GAADVKTH 406 (451)
Q Consensus 399 ~~~ell~h 406 (451)
+.++++.
T Consensus 258 -~~~l~~~ 264 (303)
T cd05110 258 -FKELAAE 264 (303)
T ss_pred -HHHHHHH
Confidence 8887763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=299.57 Aligned_cols=260 Identities=24% Similarity=0.309 Sum_probs=208.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHH-HCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK-MLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~nIv~l~~~~ 158 (451)
.+.+-...||.|+||+|++..++..++ ++|||.|+.... .....++..|.+... .-++||||++||++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~---------~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGK---------LMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCc---------EEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 445566789999999999999887765 699999987644 334455666766554 45799999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhh---hCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEccCCCEEEec
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRH---KQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~---~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
..++..++.||+| ..||..+.. ......+++..+.+|....+.||.||. ...||||||||+|||++..|.+||||
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 9999999999999 788876543 333456999999999999999999999 56899999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++-.+...-+.. .-.|...|||
T Consensus 212 FGIcGqLv~SiAkT--------------------------------------------------------~daGCrpYmA 235 (361)
T KOG1006|consen 212 FGICGQLVDSIAKT--------------------------------------------------------VDAGCRPYMA 235 (361)
T ss_pred ccchHhHHHHHHhh--------------------------------------------------------hccCCccccC
Confidence 99984322111100 0168889999
Q ss_pred cccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCCCCCCCCC-CcChHHHHHHHHHhcccCc
Q 013016 315 PEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKKPLTFPTQSPS-SMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 315 PE~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dP 390 (451)
||-+.. ..|+.++||||||++|||+.||+.||...+ ..+.+..++.+.++....... -..+..+..+|..||.+|-
T Consensus 236 PERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~ 315 (361)
T KOG1006|consen 236 PERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDR 315 (361)
T ss_pred hhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhccc
Confidence 999864 458999999999999999999999999854 456677777776654433322 3355589999999999999
Q ss_pred CCcCCCCCChHHHHcCCCcCC
Q 013016 391 CNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~hp~~~~ 411 (451)
..||. ..+|+++||++-
T Consensus 316 ~~Rpk----y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 316 SDRPK----YDDLKKFPFYRM 332 (361)
T ss_pred ccCcc----hhhhhcCchhhh
Confidence 99999 999999999987
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=305.30 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=193.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|....... ..+..||+|.+.... ......+..|+++++.++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQD-----NTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcC-----CCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 579999999999999999998542111 112359999986542 233456778999999999999999999875
Q ss_pred e--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 A--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
. ...+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 4 347899999999999999987643 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+......... ........++..|+|||+
T Consensus 155 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~aPE~ 182 (284)
T cd05081 155 TKVLPQDKEY----------------------------------------------------YKVREPGESPIFWYAPES 182 (284)
T ss_pred cccccCCCcc----------------------------------------------------eeecCCCCCceEeeCHHH
Confidence 8532110000 000000123445999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---------------HHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---------------TTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
+.+..++.++|||||||++|||++|..++...... ..+..+......++. ....+.++.+|+
T Consensus 183 ~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 259 (284)
T cd05081 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA---PPGCPAEIYAIM 259 (284)
T ss_pred hccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCC---CCCCCHHHHHHH
Confidence 99888999999999999999999988776443211 011122222211111 122334899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHc
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+||..+|++||| +.||++
T Consensus 260 ~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 260 KECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred HHHccCChhhCCC----HHHHHH
Confidence 9999999999999 998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=299.79 Aligned_cols=233 Identities=28% Similarity=0.443 Sum_probs=184.9
Q ss_pred CCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEEEee
Q 013016 91 GDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEF 170 (451)
Q Consensus 91 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~ 170 (451)
|.+|.||+|.++.+++. ||+|++..... ...|...+....||||+++++++...+..|+||||
T Consensus 4 g~~~~v~~~~~~~~~~~---------~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 66 (237)
T cd05576 4 GVIDKVLLVMDTRTQQT---------FILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66 (237)
T ss_pred cccceEEEEEEccCCcE---------EEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEec
Confidence 89999999999877664 99999976421 12244445556799999999999999999999999
Q ss_pred ccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCC
Q 013016 171 CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250 (451)
Q Consensus 171 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 250 (451)
++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......
T Consensus 67 ~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------ 138 (237)
T cd05576 67 AEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------ 138 (237)
T ss_pred CCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence 9999999988765 34899999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHH
Q 013016 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWW 330 (451)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIw 330 (451)
.....++..|+|||.+.+..++.++|||
T Consensus 139 ----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 166 (237)
T cd05576 139 ----------------------------------------------------CDGEAVENMYCAPEVGGISEETEACDWW 166 (237)
T ss_pred ----------------------------------------------------cccCCcCccccCCcccCCCCCCchhhHH
Confidence 0012456679999999888889999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHHHHcCCCc
Q 013016 331 AFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFF 409 (451)
Q Consensus 331 SlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~ell~hp~~ 409 (451)
|+||++|+|++|+.|+........ . ......+ ...+..+.++|.+||+.||++|+++ ...++++++||||
T Consensus 167 slG~il~el~~g~~~~~~~~~~~~--~--~~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 167 SLGAILFELLTGKTLVECHPSGIN--T--HTTLNIP-----EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHHHHCcchhhcCchhcc--c--ccccCCc-----ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999988764321100 0 0011111 2234489999999999999999993 1225999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.29 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=203.2
Q ss_pred CceEEeeeccCCeeEEEEEEecc-ccccCCCCCCcceEEEEEcchHHH-------HHHHHHHHHHHHHHHHHH-CCCCCc
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNN-KYRQDRGHEPCCLYAMKVVNKEVL-------EKKKKVHRAEMEKKILKM-LDHPFL 151 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~nI 151 (451)
+|++.+.||+|+||.||+|.++. ..+ .+|+|.+..... ........+..|+.++.+ ++|+||
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i 71 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQN---------LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI 71 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCc---------eeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe
Confidence 47888999999999999999877 222 499998864321 122334556678887765 799999
Q ss_pred cceeEEEEeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCC
Q 013016 152 PTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 152 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~ 228 (451)
+++++++..+++.|+||||++|++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 72 VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC
Confidence 99999999999999999999999999987542 23568999999999999999999996 7899999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.++|+|||.+....... ......|
T Consensus 152 ~~~l~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~ 175 (269)
T cd08528 152 KVTITDFGLAKQKQPES--------------------------------------------------------KLTSVVG 175 (269)
T ss_pred cEEEecccceeeccccc--------------------------------------------------------ccccccC
Confidence 99999999974321100 1112368
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+......... ....+..+.+|+.+||+.
T Consensus 176 ~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~ 252 (269)
T cd08528 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP---EGMYSEDVTDVITSCLTP 252 (269)
T ss_pred cccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC---cccCCHHHHHHHHHHCCC
Confidence 88999999999888999999999999999999999999877766666666554432211 122344899999999999
Q ss_pred CcCCcCCCCCChHHHHc
Q 013016 389 DPCNRLGSKRGAADVKT 405 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~ 405 (451)
||++||+ +.|+..
T Consensus 253 ~p~~Rp~----~~e~~~ 265 (269)
T cd08528 253 DAEARPD----IIQVSA 265 (269)
T ss_pred CCccCCC----HHHHHH
Confidence 9999999 888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=299.52 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=189.9
Q ss_pred eeeccCCeeEEEEEEeccccccCCC-CCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeE
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRG-HEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~ 164 (451)
+.||+|+||.||+|.+......... ......+++|++..... ....+.+|+.++++++|+||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 3689999999999998765421000 01112378887764421 14666779999999999999999999988 778
Q ss_pred EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-------CEEEeccCc
Q 013016 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-------HIMLSDFDL 237 (451)
Q Consensus 165 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-------~~kl~Dfg~ 237 (451)
++||||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999887542 589999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+..... .....++..|+|||+
T Consensus 155 a~~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~ 175 (259)
T cd05037 155 PITVLS-----------------------------------------------------------REERVERIPWIAPEC 175 (259)
T ss_pred cccccc-----------------------------------------------------------ccccccCCCccChhh
Confidence 742210 001246677999999
Q ss_pred ccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 318 ASGG--SHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 318 ~~~~--~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
+.+. .++.++|||||||++|+|++ |..||......+....... ....+... ...+.+++.+||+.+|.+||
T Consensus 176 ~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPD-----CAELANLINQCWTYDPTKRP 249 (259)
T ss_pred hcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCC-----chHHHHHHHHHhccChhhCC
Confidence 9876 68999999999999999999 6888877654333332221 11111111 13899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ +.++++
T Consensus 250 t----~~~il~ 256 (259)
T cd05037 250 S----FRAILR 256 (259)
T ss_pred C----HHHHHH
Confidence 9 999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.06 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=200.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..... ..+..||||++...... .....+..|+.+++.+.|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-----~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCC-----CCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence 568899999999999999998754311 12235999999765332 34567788999999999999999999988
Q ss_pred e--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 A--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
. ....++||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 7 568999999999999999987654 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+......... ........++..|+|||.
T Consensus 156 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~Pe~ 183 (284)
T cd05038 156 AKVLPEDKDY----------------------------------------------------YYVKEPGESPIFWYAPEC 183 (284)
T ss_pred ccccccCCcc----------------------------------------------------eeccCCCCCcccccCcHH
Confidence 8432210000 000001134556999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE--------------TTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
+.+..++.++|||||||++|+|++|..|+...... ..+...+......+. +...+.++.+|+.
T Consensus 184 ~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~ 260 (284)
T cd05038 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR---PPSCPDEVYDLMK 260 (284)
T ss_pred HccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC---CccCCHHHHHHHH
Confidence 98888999999999999999999999998654222 122223332222221 1223348999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.+|.+||+ +.||++
T Consensus 261 ~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 261 LCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred HHhccChhhCCC----HHHHHH
Confidence 999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=301.52 Aligned_cols=259 Identities=15% Similarity=0.153 Sum_probs=185.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HH------HHHHHHHHHHHHHHHCCCCCc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KK------KKVHRAEMEKKILKMLDHPFL 151 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~------~~~~~~~~e~~~l~~l~h~nI 151 (451)
++|.+.++||+|+||+||+|.+..+.. ....+|+|+....... .. ........+...+..+.|+||
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 679999999999999999999876511 0113677764322110 00 001111223344556789999
Q ss_pred cceeEEEEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 152 PTLYAEFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 152 v~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
+++++++.... +.++++|++ ..++.+++... ...++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 99999776543 557889987 56777766553 336788899999999999999999999999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+.++|+|||+|........... ..........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~------------------------------------------------~~~~~~~~~~ 194 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIE------------------------------------------------YSKEQKDLHR 194 (294)
T ss_pred CcEEEEEcCCceeeccCCcccc------------------------------------------------cccccccccC
Confidence 9999999999853321000000 0001112246
Q ss_pred cCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHH--------HHHHhcCCCCCCCCCCCCcChHHH
Q 013016 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETT--------LRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~--------~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
||+.|+|||+..+..++.++|||||||++|||++|+.||..... ... ...+..+...++ ..+..+
T Consensus 195 gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 268 (294)
T PHA02882 195 GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIK------NANKFI 268 (294)
T ss_pred CCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccC------CCCHHH
Confidence 99999999999999999999999999999999999999987632 221 222222222111 123489
Q ss_pred HHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 379 RDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+++..|+..+|++||+ +.+|++
T Consensus 269 ~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 269 YDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred HHHHHHHHhCCCCCCCC----HHHHHH
Confidence 99999999999999999 888864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.12 Aligned_cols=269 Identities=28% Similarity=0.378 Sum_probs=209.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.-..+||+|.||.||+|+.+++++. ||+|++-.+. .....-....+|+.+|..+.|+|++.+++.|.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kk---------valkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKK---------VALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccch---------hHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 4577788999999999999999888764 8888764321 11222334567999999999999999998874
Q ss_pred e--------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 160 A--------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 160 ~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
. ...+||||.+| .-+|.-++.+. ..+|+...+++++.+++.||.|+|.+.|+|||+|++|+||+.+|.+|
T Consensus 87 tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred hccCCcccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence 3 23699999999 45777777554 35699999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||+++.+......... +....+-|.+
T Consensus 165 lADFGlar~fs~~~n~~kp---------------------------------------------------rytnrvvTLw 193 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKP---------------------------------------------------RYTNRVVTLW 193 (376)
T ss_pred eeccccccceecccccCCC---------------------------------------------------Ccccceeeee
Confidence 9999998654432221110 0112266899
Q ss_pred ccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCc-----------------
Q 013016 312 YVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM----------------- 373 (451)
Q Consensus 312 y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~----------------- 373 (451)
|++||.++|. .|+.+.|||..|||+.||+||.+.+.+..+...+..|..--..+..+.|++.
T Consensus 194 YrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~ 273 (376)
T KOG0669|consen 194 YRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKG 273 (376)
T ss_pred cCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcc
Confidence 9999999984 5899999999999999999999999998887766665442222222222111
Q ss_pred -------------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 374 -------------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 374 -------------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.++++.+|+.++|..||.+|++ ++++|+|.||...+.+
T Consensus 274 ~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 274 QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFWKDPMP 324 (376)
T ss_pred hhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhhcCCcc
Confidence 1227789999999999999999 9999999999985554
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=300.36 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=197.8
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.+.||+|+||.||+|.+..... .+..||||++..... .....+.+..|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDG------SFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCC------CceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 5678899999999999998764321 123599999975432 223355677899999999999999999988653
Q ss_pred C------eEEEEEeeccCCchhhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 162 N------FSCIVMEFCSGGDLHSLRHKQP----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 162 ~------~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
+ ..++++||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEE
Confidence 2 3478999999999988765321 22478999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++....... .........++..
T Consensus 154 l~dfg~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 180 (273)
T cd05074 154 VADFGLSKKIYSGD-----------------------------------------------------YYRQGCASKLPVK 180 (273)
T ss_pred ECcccccccccCCc-----------------------------------------------------ceecCCCccCchh
Confidence 99999974321000 0000112245667
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|++||.+.+..++.++|||||||++|+|++ |+.||......+....+........ +...+..+.+++.+||+.+|
T Consensus 181 ~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~l~~~p 256 (273)
T cd05074 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ----PPDCLEDVYELMCQCWSPEP 256 (273)
T ss_pred hcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCh
Confidence 999999988888999999999999999999 9999988776666666655432111 11233489999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
.+||+ +.+++.
T Consensus 257 ~~Rps----~~~~~~ 267 (273)
T cd05074 257 KCRPS----FQHLRD 267 (273)
T ss_pred hhCcC----HHHHHH
Confidence 99999 888875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=314.66 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=210.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC------CCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH------PFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~nIv~ 153 (451)
.+|.+....|.|-|++|.+|.+...+.. ||||||+.... ....=..|++||++|+. -|+++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~---------vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQE---------VAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCe---------eEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 5699999999999999999998766543 99999986533 33444569999999953 47999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEE
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQ-PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIM 231 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~k 231 (451)
++-.|...+|+|||||-+ ..+|.++++.. .+-.|....+..++.|+..||..|-.+||+|.||||+||||++. ..+|
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 999999999999999988 88999998765 34568999999999999999999999999999999999999965 5789
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|||||.|........ +| +.-+..
T Consensus 578 LCDfGSA~~~~enei------------------------------------------tP---------------YLVSRF 600 (752)
T KOG0670|consen 578 LCDFGSASFASENEI------------------------------------------TP---------------YLVSRF 600 (752)
T ss_pred eccCccccccccccc------------------------------------------cH---------------HHHHHh
Confidence 999999853322111 11 133456
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC-------------------
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS------------------- 372 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------------------- 372 (451)
|.|||+++|.+|+...|+||+||+||||+||+..|.+..+..++...+.....+|..+...
T Consensus 601 YRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~ 680 (752)
T KOG0670|consen 601 YRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEV 680 (752)
T ss_pred ccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEec
Confidence 9999999999999999999999999999999999999888888777766544444322100
Q ss_pred ------------------------------cC------hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 373 ------------------------------MS------EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 373 ------------------------------~~------~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.. -.++++||.+||..||++|.| +.++|.||||++
T Consensus 681 D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 681 DKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred cccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC----HHHHhcCCcccC
Confidence 00 016789999999999999999 999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=315.26 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=204.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
....+.++||.|.||.||.|......+.. ..-||||.++.... .+..+.|..|..+|+.++||||++++|+|.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge-----~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGE-----RIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCc-----ceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34556678999999999999987653211 12399999987643 334678889999999999999999999998
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+. ..+||||+++-|.|..|++.++ ..++......++.||+.||.|||+..+|||||...|||+.+..-|||+|||+++
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 65 5789999999999999998875 459999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..+....-. .....-...|||||.+.
T Consensus 540 ~~ed~~yYk------------------------------------------------------aS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 540 YLEDDAYYK------------------------------------------------------ASRGKLPIKWMAPESIN 565 (974)
T ss_pred hccccchhh------------------------------------------------------ccccccceeecCccccc
Confidence 443221110 00112345699999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
-..++.++|||.|||.|||++. |..||.+-.+.+.+..+.++. ++.|.. ++..+..|+.+||++||.+||+.
T Consensus 566 fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n-----CPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 566 FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN-----CPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC-----CChHHHHHHHHHhccCcccCCcH
Confidence 8899999999999999999987 999999988888888777764 333433 33377889999999999999993
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.56 Aligned_cols=274 Identities=22% Similarity=0.291 Sum_probs=228.2
Q ss_pred hhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHH
Q 013016 61 FAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140 (451)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~ 140 (451)
+++.+-..|.......+......|.+.||.|.||.||+|+++..+++ ...||||.++.. ...++..+|..|+
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkr------e~~VAIKTLK~G--ytekqrrdFL~EA 681 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKR------EITVAIKTLKAG--YTEKQRRDFLSEA 681 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCc------ceeEEEeeeccC--ccHHHHhhhhhhh
Confidence 44555555554444555566788999999999999999999876532 235999999866 3456678899999
Q ss_pred HHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 141 ~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
.||-++.||||++|.|+-.......||.|||++|+|+.+|+.+.+ .|++-++.-|++.|+.|++||-++|+|||||...
T Consensus 682 sIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAAR 760 (996)
T KOG0196|consen 682 SIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAAR 760 (996)
T ss_pred hhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhh
Confidence 999999999999999999999999999999999999999998864 4999999999999999999999999999999999
Q ss_pred cEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
||||+.+..+|++|||+++.+++.+...
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~---------------------------------------------------- 788 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAA---------------------------------------------------- 788 (996)
T ss_pred heeeccceEEEeccccceeecccCCCcc----------------------------------------------------
Confidence 9999999999999999997654332100
Q ss_pred cccccccc--CCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHH
Q 013016 301 ARSCSFVG--THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377 (451)
Q Consensus 301 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 377 (451)
..+.-| ...|.|||.|...+++.++||||+|+||||.++ |+.||.+.++.+.++.|..+..-+|.-. .+..
T Consensus 789 --ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmD----CP~a 862 (996)
T KOG0196|consen 789 --YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMD----CPAA 862 (996)
T ss_pred --ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCC----CcHH
Confidence 001111 256999999999999999999999999999887 9999999999999999988754333222 2337
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+-.|+..||++|-.+||. +.+|+.
T Consensus 863 L~qLMldCWqkdR~~RP~----F~qiV~ 886 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPK----FAQIVS 886 (996)
T ss_pred HHHHHHHHHHHHhhcCCC----HHHHHH
Confidence 899999999999999999 888864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=318.94 Aligned_cols=246 Identities=29% Similarity=0.463 Sum_probs=194.0
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.+...+.||+|+||.||+++++.+++ .||||.++... .....+...+|+++|++++|+|||+++++-++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~---------~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGR---------LVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEET 82 (732)
T ss_pred ceeehhhhcCCccceeeeeccccccc---------chhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCc
Confidence 46777889999999999999888876 49999999764 33445667789999999999999999987765
Q ss_pred CC------eEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc--cCC--C
Q 013016 161 SN------FSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR--SDG--H 229 (451)
Q Consensus 161 ~~------~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~--~~~--~ 229 (451)
.. ...+|||||.||||...++.-. ...+++.....++.+++.||.|||++|||||||||.||++. .+| .
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Confidence 43 6689999999999999987643 35699999999999999999999999999999999999996 445 3
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
-||+|||.|+...+ .+.-.+++||
T Consensus 163 yKLtDfG~Arel~d--------------------------------------------------------~s~~~S~vGT 186 (732)
T KOG4250|consen 163 YKLTDFGAARELDD--------------------------------------------------------NSLFTSLVGT 186 (732)
T ss_pred EeeecccccccCCC--------------------------------------------------------CCeeeeecCc
Confidence 69999999964432 1233467999
Q ss_pred CCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCC---------------C-----
Q 013016 310 HEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPL---------------T----- 364 (451)
Q Consensus 310 ~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~---------------~----- 364 (451)
+.|.+||+... +.|+..+|.|||||++|+..||..||.... ..+.+..+..++. .
T Consensus 187 ~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~l 266 (732)
T KOG4250|consen 187 EEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTL 266 (732)
T ss_pred hhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccC
Confidence 99999999984 788999999999999999999999996532 2334444433221 1
Q ss_pred -CCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 365 -FPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 365 -~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
++....+.+.. .+-..+..+|+++|.+|.
T Consensus 267 P~p~~Ls~~l~~-~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 267 PQPNHLSRGLAT-RLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCcccccHHHHh-hhhHHHHHHHhhhHHHhC
Confidence 11111111111 456889999999999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=299.71 Aligned_cols=267 Identities=28% Similarity=0.437 Sum_probs=213.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH----HHHHHHHHHHHHHHHCCCCCccce
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK----KKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.++|-++++||.|+|+.||+|.+....+ .||||+-.....+.+ ...+...+|..|.+.|.||.||++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqR---------YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQR---------YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhh---------eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 3569999999999999999999877665 599998754433332 334556779999999999999999
Q ss_pred eEEEE-eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeccCCCCcEEEcc---CC
Q 013016 155 YAEFE-ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML--GIIYRDLKPENVLVRS---DG 228 (451)
Q Consensus 155 ~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--givH~Dlkp~NIll~~---~~ 228 (451)
|++|. +.+.+|-|+|||+|.+|.=|++.. +.+++..++.|+-||+.||.||.+. -|||-||||.|||+.. -|
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 99996 556899999999999999888876 5599999999999999999999976 4999999999999964 37
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||+++.+..... ...+....+..+.|
T Consensus 611 eIKITDFGLSKIMdddSy------------------------------------------------~~vdGmeLTSQgAG 642 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSY------------------------------------------------NSVDGMELTSQGAG 642 (775)
T ss_pred eeEeeecchhhhccCCcc------------------------------------------------CcccceeeecccCc
Confidence 899999999976543222 12234455567789
Q ss_pred CCCccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HH--HHhc-CCCCCCCCCCCCcChHHHHH
Q 013016 309 THEYVSPEVASGG----SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LR--NIVK-KPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 309 t~~y~aPE~~~~~----~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~--~i~~-~~~~~~~~~~~~~~~~~~~~ 380 (451)
|.+|++||++.-+ ..+.++||||+|||+|..+.|+.||...-.... +. .|++ ..+.+|.. +...+ ++++
T Consensus 643 TYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVss-eAka 719 (775)
T KOG1151|consen 643 TYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVVSS-EAKA 719 (775)
T ss_pred eeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--CccCH-HHHH
Confidence 9999999997543 358899999999999999999999987544332 22 1222 23445543 22333 8999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
||++||++.-++|.. +.+|..||||.-
T Consensus 720 FIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 720 FIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred HHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 999999999999999 999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.20 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=208.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+....++||-|.||.||.|.|+...-. ||||.++. +...+++|..|+.+|+.++|||+|+++|+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslT---------vAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLT---------VAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeecccee---------eehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 34577889999999999999999977543 99999873 345678899999999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+..+|||+|||..|+|.+||.......++......|+.||..|++||..+++|||||...|+|+.++..||++|||++
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999999999887777888999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+++... +||.+ ..---...|.|||-+
T Consensus 413 RlMtgD------------------TYTAH------------------------------------AGAKFPIKWTAPEsL 438 (1157)
T KOG4278|consen 413 RLMTGD------------------TYTAH------------------------------------AGAKFPIKWTAPESL 438 (1157)
T ss_pred hhhcCC------------------ceecc------------------------------------cCccCcccccCcccc
Confidence 653211 01100 001224569999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.-+.++.++|||+|||+|||+.| |-.||.+.+-...+..+.++.. .-|... +..+.+|++.||+|.|.+||+
T Consensus 439 AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC-----PpkVYeLMraCW~WsPsDRPs- 512 (1157)
T KOG4278|consen 439 AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC-----PPKVYELMRACWNWSPSDRPS- 512 (1157)
T ss_pred cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC-----CHHHHHHHHHHhcCCcccCcc-
Confidence 99999999999999999999998 9999999877777666655532 223332 337889999999999999999
Q ss_pred CCChHHH
Q 013016 397 KRGAADV 403 (451)
Q Consensus 397 ~~~~~el 403 (451)
+.|+
T Consensus 513 ---Faei 516 (1157)
T KOG4278|consen 513 ---FAEI 516 (1157)
T ss_pred ---HHHH
Confidence 5554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.78 Aligned_cols=268 Identities=17% Similarity=0.232 Sum_probs=177.6
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
....++|.+.++||+|+||.||+|.+..+.. ..+..||||.+...... +.... +.++...+.++..++
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~-----e~~~~--e~l~~~~~~~~~~~~ 195 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV-----EIWMN--ERVRRACPNSCADFV 195 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh-----HHHHH--HHHHhhchhhHHHHH
Confidence 3456889999999999999999999887621 11224999987643111 11111 112222233333222
Q ss_pred EE------EEeCCeEEEEEeeccCCchhhhhhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 013016 156 AE------FEASNFSCIVMEFCSGGDLHSLRHKQPHK------------------RFSLTSARFYAAEVLVALEYLHMLG 211 (451)
Q Consensus 156 ~~------~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~g 211 (451)
.. .......+|||||+.+++|.+++...... ......+..++.||+.||+|||++|
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 22 24566899999999999999988654211 1123456789999999999999999
Q ss_pred CeeccCCCCcEEEcc-CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCC
Q 013016 212 IIYRDLKPENVLVRS-DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTP 290 (451)
Q Consensus 212 ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (451)
|+||||||+|||++. ++.+||+|||++......
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~---------------------------------------------- 309 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---------------------------------------------- 309 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccc----------------------------------------------
Confidence 999999999999996 579999999998432100
Q ss_pred CcccccccccccccccccCCCccCcccccCC----------------------CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 013016 291 NRLFVAEPVAARSCSFVGTHEYVSPEVASGG----------------------SHGNAVDWWAFGIFIYEMIYGRTPFAA 348 (451)
Q Consensus 291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DIwSlG~il~elltg~~pf~~ 348 (451)
.......++|++.|||||.+... .++.++|||||||+||||+++..++..
T Consensus 310 --------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 310 --------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred --------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch
Confidence 00111235789999999976432 234467999999999999997766432
Q ss_pred CChHHHHHHHhcC-CCCC-------CCCCC---------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 349 PSNETTLRNIVKK-PLTF-------PTQSP---------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 349 ~~~~~~~~~i~~~-~~~~-------~~~~~---------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
....+..++.. .... ..... .........+||.+||++||++||| +.++|+||||++
T Consensus 382 --~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a~e~L~Hpff~~ 455 (566)
T PLN03225 382 --NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS----AKAALAHPYFDR 455 (566)
T ss_pred --HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC----HHHHhCCcCcCC
Confidence 22222222111 0000 00000 0111224568999999999999999 999999999999
Q ss_pred CCcc
Q 013016 412 LNFA 415 (451)
Q Consensus 412 ~~~~ 415 (451)
.+..
T Consensus 456 ~~~~ 459 (566)
T PLN03225 456 EGLL 459 (566)
T ss_pred CCcc
Confidence 6664
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.70 Aligned_cols=263 Identities=20% Similarity=0.301 Sum_probs=216.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++..+.++||+|+||.||+|.|..... ..+-||||.++...... ....|.+|+.+|.+|+|+|+++|||+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 557777899999999999999986432 23459999998765432 6678999999999999999999999988
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+ ..+.||||+++.|||.+.|+......|.......++.||+.||.||..+++|||||...|||+.....|||+|||+.+
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 7 678899999999999999988767779999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.+...+. ...+++. .--...|+|||.+.
T Consensus 261 aLg~ned--------------------------------------~Yvm~p~--------------rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 261 ALGENED--------------------------------------MYVMAPQ--------------RKVPFAWCAPESLR 288 (1039)
T ss_pred ccCCCCc--------------------------------------ceEecCC--------------CcCcccccCHhHhc
Confidence 5432111 0011111 12234699999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
...++.++|||+|||+||||+| |+.||.+.....++.+|-.+.. ++. +..++.++.++++.||.++|++|||
T Consensus 289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpR---Pk~csedIY~imk~cWah~paDRpt--- 361 (1039)
T KOG0199|consen 289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPR---PKYCSEDIYQIMKNCWAHNPADRPT--- 361 (1039)
T ss_pred cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCC---CCCChHHHHHHHHHhccCCcccccc---
Confidence 9999999999999999999998 9999999999999998875432 222 1234458999999999999999999
Q ss_pred ChHHHHcCCCcCC
Q 013016 399 GAADVKTHPFFKG 411 (451)
Q Consensus 399 ~~~ell~hp~~~~ 411 (451)
+..|...-++++
T Consensus 362 -Fsair~~~~l~e 373 (1039)
T KOG0199|consen 362 -FSAIREDLVLAE 373 (1039)
T ss_pred -HHHHHHhHHHHh
Confidence 777765555554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=277.34 Aligned_cols=243 Identities=44% Similarity=0.692 Sum_probs=198.2
Q ss_pred CeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEEEeec
Q 013016 92 DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFC 171 (451)
Q Consensus 92 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 171 (451)
+||.||+|.+..+++ .+|+|++........ ...+..|++.+++++|+||+++++.+......++|||++
T Consensus 1 ~~g~v~~~~~~~~~~---------~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 69 (244)
T smart00220 1 SFGKVYLARDKKTGK---------LVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYC 69 (244)
T ss_pred CceEEEEEEECCCCc---------EEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCC
Confidence 589999999987554 399999976533221 467778999999999999999999999999999999999
Q ss_pred cCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCC
Q 013016 172 SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251 (451)
Q Consensus 172 ~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 251 (451)
++++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 70 ~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------ 141 (244)
T smart00220 70 DGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------ 141 (244)
T ss_pred CCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc------
Confidence 99899999877533 8999999999999999999999999999999999999999999999999975322110
Q ss_pred CCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHH
Q 013016 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWA 331 (451)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS 331 (451)
......|+..|++||.+.+..++.++||||
T Consensus 142 --------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~s 171 (244)
T smart00220 142 --------------------------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWS 171 (244)
T ss_pred --------------------------------------------------ccccccCCcCCCCHHHHccCCCCchhhHHH
Confidence 111236788899999998888899999999
Q ss_pred HHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 332 FGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 332 lG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
||+++++|++|..||.. .........+........... .. .+.++.+++.+||..+|++||+ +.++++||||
T Consensus 172 lG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~i~~~l~~~p~~Rp~----~~~~~~~~~~ 244 (244)
T smart00220 172 LGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE-WK-ISPEAKDLIRKLLVKDPEKRLT----AEEALQHPFF 244 (244)
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc-cc-CCHHHHHHHHHHccCCchhccC----HHHHhhCCCC
Confidence 99999999999999987 444444444443333322211 00 2338999999999999999999 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.88 Aligned_cols=275 Identities=20% Similarity=0.244 Sum_probs=188.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEecccccc-------CCCCCCcceEEEEEcchHHHHHHH-----------HHHHHH
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQ-------DRGHEPCCLYAMKVVNKEVLEKKK-----------KVHRAE 137 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~ 137 (451)
.+..++|.+.++||+|+||+||+|.+...... ......+..||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34568899999999999999999976332210 011122345999998643211111 112234
Q ss_pred HHHHHHHHCCCCCc-----cceeEEEEe--------CCeEEEEEeeccCCchhhhhhhCC--------------------
Q 013016 138 MEKKILKMLDHPFL-----PTLYAEFEA--------SNFSCIVMEFCSGGDLHSLRHKQP-------------------- 184 (451)
Q Consensus 138 ~e~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~-------------------- 184 (451)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777766554 677777643 357899999999999999886421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCc
Q 013016 185 --HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQ 262 (451)
Q Consensus 185 --~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~ 262 (451)
...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------------- 363 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------------- 363 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------------
Confidence 1224677889999999999999999999999999999999999999999999974221000
Q ss_pred ccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCC--------------------
Q 013016 263 TYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS-------------------- 322 (451)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------- 322 (451)
........+++.|+|||.+....
T Consensus 364 -------------------------------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~ 406 (507)
T PLN03224 364 -------------------------------------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWL 406 (507)
T ss_pred -------------------------------------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHh
Confidence 00000114578999999986432
Q ss_pred CC--cchhHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 323 HG--NAVDWWAFGIFIYEMIYGRT-PFAAPSNE-----------TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 323 ~~--~~~DIwSlG~il~elltg~~-pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
++ .+.||||+|||+|+|++|.. ||...... .....+......++ ..+. .+..+++|+.+||..
T Consensus 407 yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~--~~d~-~s~~~~dLi~~LL~~ 483 (507)
T PLN03224 407 YGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS--LLDR-NKEAGWDLACKLITK 483 (507)
T ss_pred cCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc--cccc-cChHHHHHHHHHhcc
Confidence 11 24799999999999999875 77542111 11111222222222 1222 234899999999998
Q ss_pred Cc---CCcCCCCCChHHHHcCCCcCC
Q 013016 389 DP---CNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 389 dP---~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+| .+|+| +.|+|+||||..
T Consensus 484 ~~~~~~~RlS----a~eaL~Hp~f~~ 505 (507)
T PLN03224 484 RDQANRGRLS----VGQALSHRFFLP 505 (507)
T ss_pred CCCCcccCCC----HHHHhCCCCcCC
Confidence 76 68999 999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.20 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.-+.-+|.|+- .|..|.+.-..++ ||+|..... ........+..+|..++..++|+||++++.+|.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~---------v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRP---------VAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCc---------eehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 57888889999998 7777777666554 999988766 445566777888999999999999999999995
Q ss_pred eC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
-. ...|+|||+| ..+|.+.+.. .++-..+..|+.|++.|++|||++||+||||||+||++..+..+||.
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~ 160 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKIL 160 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeec
Confidence 33 3689999999 7899988773 37788899999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|.... ...+..-++.|+.|+
T Consensus 161 dfg~ar~e~--------------------------------------------------------~~~~mtpyVvtRyyr 184 (369)
T KOG0665|consen 161 DFGLARTED--------------------------------------------------------TDFMMTPYVVTRYYR 184 (369)
T ss_pred cchhhcccC--------------------------------------------------------cccccCchhheeecc
Confidence 999984211 011223357889999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC---------------------------C---
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP---------------------------L--- 363 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~---------------------------~--- 363 (451)
|||++.|..|...+||||+||++.||++|+..|.+...-+.+.++.... .
T Consensus 185 apevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~ 264 (369)
T KOG0665|consen 185 APEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFS 264 (369)
T ss_pred CchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchh
Confidence 9999999889999999999999999999999998754433333322200 0
Q ss_pred -CCCCCCC------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcC
Q 013016 364 -TFPTQSP------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 364 -~~~~~~~------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~ 410 (451)
.+|+... +......+++++.+||-.||++|.+ ++++|.|||++
T Consensus 265 ~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 265 ELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK 314 (369)
T ss_pred hhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee
Confidence 1111111 1233447899999999999999999 99999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.89 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=199.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~ 157 (451)
.++|++.+++|.|-|+.|+.|....+..+ ++||+++.- ..+.+.+|+.||..|. ||||++++++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK---------~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~Di 101 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEK---------CVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDI 101 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCce---------EEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhh
Confidence 37899999999999999999987666553 899998743 2355667999999996 9999999998
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEEec
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIMLSD 234 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~D 234 (451)
..+. ....||+||+++.+...+... ++...++.++.+++.||.|+|++||+|||+||.|++|+.. -.++|+|
T Consensus 102 V~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 102 VKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred hcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeee
Confidence 8654 578999999988877765443 7888999999999999999999999999999999999965 5799999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
+|+|.+......- +-.+.+..|--
T Consensus 177 WGLAEFYHp~~eY--------------------------------------------------------nVRVASRyfKG 200 (338)
T KOG0668|consen 177 WGLAEFYHPGKEY--------------------------------------------------------NVRVASRYFKG 200 (338)
T ss_pred cchHhhcCCCcee--------------------------------------------------------eeeeehhhcCC
Confidence 9999654321110 01145566788
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhc-------------CCCCC--------------
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVK-------------KPLTF-------------- 365 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~-------------~~~~~-------------- 365 (451)
||++.. ..|+...|+|||||++..|+..+.||-. .++.+.+.+|.. -.+.+
T Consensus 201 PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk 280 (338)
T KOG0668|consen 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRK 280 (338)
T ss_pred chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccc
Confidence 999876 4589999999999999999999998754 344443333322 00000
Q ss_pred -----CCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 366 -----PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 366 -----~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.......+..+++.+|+.++|..|-.+|+| |.|++.||||..+..+
T Consensus 281 ~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 281 PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVREA 331 (338)
T ss_pred cHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHHHH
Confidence 111112233458999999999999999999 9999999999875443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.97 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=196.9
Q ss_pred ceEEeeeccCCeeE-EEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEEE
Q 013016 82 FDLHRRIGAGDIGT-VYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFE 159 (451)
Q Consensus 82 y~~~~~LG~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~ 159 (451)
|.-.+.+|.|+.|+ ||+|...+. .||||.+-... .....+|+..|+.. .|||||++|+.-.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R-----------~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~ 573 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGR-----------EVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQ 573 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCc-----------eehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeecc
Confidence 44456689999886 799987654 39999886442 34556799999887 5999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhC-CC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CC--CEEE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQ-PH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DG--HIML 232 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~-~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~--~~kl 232 (451)
+..++||+.|+| ..+|.+++... .. ........+.++.|++.||++||+.+||||||||+||||+. ++ +++|
T Consensus 574 d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 574 DRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred CCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEe
Confidence 999999999999 89999999874 11 11122455788999999999999999999999999999986 34 7899
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
.|||+|+..... ...-.+.....||-+|
T Consensus 653 SDfglsKkl~~~----------------------------------------------------~sS~~r~s~~sGt~GW 680 (903)
T KOG1027|consen 653 SDFGLSKKLAGG----------------------------------------------------KSSFSRLSGGSGTSGW 680 (903)
T ss_pred cccccccccCCC----------------------------------------------------cchhhcccCCCCcccc
Confidence 999999744321 1111223345799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+|||++....-+.++||||||||+|+.++| .-||... .+.-.+|+.+........+.. .. ++.+||.+||++||.
T Consensus 681 ~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~-d~-eA~dLI~~ml~~dP~ 756 (903)
T KOG1027|consen 681 QAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLP-DC-EAKDLISRMLNPDPQ 756 (903)
T ss_pred cCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCc-hH-HHHHHHHHhcCCCcc
Confidence 999999998888899999999999999995 9999864 333346666655443322221 11 799999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCC
Q 013016 392 NRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~ 411 (451)
.||+ |.+||.||||=.
T Consensus 757 ~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 757 LRPS----ATDVLNHPLFWD 772 (903)
T ss_pred cCCC----HHHHhCCCccCC
Confidence 9999 999999999955
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=273.32 Aligned_cols=264 Identities=24% Similarity=0.369 Sum_probs=206.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+.+..+-||.|+||.||-+++..+++. ||+|.+..- ..+-...+++.+|+++|.-++|.|++..++...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrr---------valkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQ 122 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKR---------VALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQ 122 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccc---------hhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcC
Confidence 5577788899999999999998877765 999988643 234445667788999999999999999998876
Q ss_pred eCC-----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 ASN-----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
-.. .+|+|+|++ -.+|.+++-. ...++...++-++.||++||+|||+.||.||||||.|+|++++..+||||
T Consensus 123 Pph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 123 PANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred CCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecc
Confidence 443 578999998 6678777655 35699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+++..+... ......-+-|..|+|
T Consensus 200 FGLARvee~d~------------------------------------------------------~~hMTqEVVTQYYRA 225 (449)
T KOG0664|consen 200 FGLARTWDQRD------------------------------------------------------RLNMTHEVVTQYYRA 225 (449)
T ss_pred cccccccchhh------------------------------------------------------hhhhHHHHHHHHhcc
Confidence 99985321100 000111255778999
Q ss_pred cccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-----------------------CCCCCCCC--
Q 013016 315 PEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-----------------------KPLTFPTQ-- 368 (451)
Q Consensus 315 PE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~-----------------------~~~~~~~~-- 368 (451)
||++.|.. |+.++||||+|||+.||+..+..|...+..+.+..|.. +....|..
T Consensus 226 PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v 305 (449)
T KOG0664|consen 226 PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR 305 (449)
T ss_pred HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence 99999965 89999999999999999999999988776655444432 21111110
Q ss_pred ----CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 369 ----SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 369 ----~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
..+..-..+...++..+|.+||.+|.+ ..+.+.|+++.+..+
T Consensus 306 LYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRL 351 (449)
T ss_pred eeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccce
Confidence 011122336789999999999999999 999999999998665
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=325.30 Aligned_cols=240 Identities=19% Similarity=0.239 Sum_probs=182.2
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|...+.||+|+||.||+|.++..+. .||||.+..... ....|++++++++|||||++++++.+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGM---------QFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCc---------EEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEc
Confidence 45667789999999999999876554 399999864321 11236888999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH---MLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
.+..|+||||+++|+|.++++. +++..+..|+.||+.||+||| +.+|+||||||+||+++.++..++. ||.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 9999999999999999999853 789999999999999999999 6799999999999999998888775 554
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
..... ......||..|||||+
T Consensus 829 ~~~~~-----------------------------------------------------------~~~~~~~t~~y~aPE~ 849 (968)
T PLN00113 829 PGLLC-----------------------------------------------------------TDTKCFISSAYVAPET 849 (968)
T ss_pred ccccc-----------------------------------------------------------cCCCccccccccCccc
Confidence 31100 0001257889999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCC-------CCCCCC-CCCCcChHHHHHHHHH
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-----ETTLRNIVKKP-------LTFPTQ-SPSSMSEYHARDLISG 384 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~-----~~~~~~i~~~~-------~~~~~~-~~~~~~~~~~~~ll~~ 384 (451)
+.+..++.++|||||||++|||+||+.||..... .+......... ...... ........++.+++.+
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 929 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHh
Confidence 9998999999999999999999999999854211 11111111000 000000 0000111256789999
Q ss_pred hcccCcCCcCCCCCChHHHHc
Q 013016 385 LLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~ 405 (451)
||+.||++||+ +.|+++
T Consensus 930 Cl~~~P~~RPt----~~evl~ 946 (968)
T PLN00113 930 CTATDPTARPC----ANDVLK 946 (968)
T ss_pred hCcCCchhCcC----HHHHHH
Confidence 99999999999 888875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=272.51 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=184.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++..+.+.||+|.||.||+|.|++.. ||||++... ++.....+.|+-.-..|+|+||+.+++.-.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~-----------VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGED-----------VAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred heeEEEEEecCccccceeeccccCCc-----------eEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 67899999999999999999999875 999999754 222222233443344679999999998876
Q ss_pred eCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CCeeccCCCCcEEEccC
Q 013016 160 ASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-----L---GIIYRDLKPENVLVRSD 227 (451)
Q Consensus 160 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-----~---givH~Dlkp~NIll~~~ 227 (451)
.++ .++||++|.+.|||+|||.+. .++.....+++..++.||+|||. + .|.|||||..||||..+
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 543 789999999999999999883 48999999999999999999995 2 49999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
|..-|+|+|+|......- .. .....+..+
T Consensus 353 ~~C~IADLGLAv~h~~~t--------------------------------------~~-------------idi~~N~rV 381 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDT--------------------------------------DT-------------IDIPPNPRV 381 (513)
T ss_pred CcEEEeeceeeEEecccC--------------------------------------Cc-------------ccCCCCCcc
Confidence 999999999985322110 01 111122349
Q ss_pred cCCCccCcccccCCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCC----CChHHHHHHHhcCC---CC
Q 013016 308 GTHEYVSPEVASGGS----H--GNAVDWWAFGIFIYEMIYG----------RTPFAA----PSNETTLRNIVKKP---LT 364 (451)
Q Consensus 308 gt~~y~aPE~~~~~~----~--~~~~DIwSlG~il~elltg----------~~pf~~----~~~~~~~~~i~~~~---~~ 364 (451)
||..|||||++.... + -..+||||||+|+||+.-+ +.||.+ ....+.+.+++... +.
T Consensus 382 GTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ 461 (513)
T KOG2052|consen 382 GTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPN 461 (513)
T ss_pred ceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCC
Confidence 999999999986532 2 2469999999999998753 567754 33455555555433 22
Q ss_pred CCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 365 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+|..+.....-..+.++++.||..||.-|.|
T Consensus 462 ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 462 IPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred CCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 2322222111125678999999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.80 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=174.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHH-----HHHHHHHHHHHHHCC---CC
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK-----VHRAEMEKKILKMLD---HP 149 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~---h~ 149 (451)
.+.+|...+.||+|+||.||+|.++.+... |+||.|.+++...+.. .-.+-.|++||..++ |+
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~e---------VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~ 629 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYE---------VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE 629 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceE---------EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence 456799999999999999999999887543 9999999887654332 233556999999997 99
Q ss_pred CccceeEEEEeCCeEEEEEeec-cCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 150 FLPTLYAEFEASNFSCIVMEFC-SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 150 nIv~l~~~~~~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
||++++++|++++++||+||-- +|.+|.+++... ..+++..++-|++|++.|+++||+.||||||||-+|+.++.+|
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG 707 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC
Confidence 9999999999999999999975 556888999876 4599999999999999999999999999999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
-+||+|||.+.... ..-...|+|
T Consensus 708 ~~klidfgsaa~~k---------------------------------------------------------sgpfd~f~g 730 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTK---------------------------------------------------------SGPFDVFVG 730 (772)
T ss_pred eEEEeeccchhhhc---------------------------------------------------------CCCcceeee
Confidence 99999999873211 111124799
Q ss_pred CCCccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 013016 309 THEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFA 347 (451)
Q Consensus 309 t~~y~aPE~~~~~~~-~~~~DIwSlG~il~elltg~~pf~ 347 (451)
|..|.|||++.|..| +..-|||++|++||.++..+.||.
T Consensus 731 tv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 731 TVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999888 889999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.43 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=188.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH--CCCCCcccee
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM--LDHPFLPTLY 155 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~ 155 (451)
.....++..+||+|.||.||+|.+++. +||||++..+. .+.+..|..|.+. ++|+||++++
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~-----------~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi 270 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNR-----------LVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFI 270 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCc-----------eeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhh
Confidence 345677888999999999999998874 49999998542 2344456666654 5899999999
Q ss_pred EEEEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeeccCCCCcE
Q 013016 156 AEFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM---------LGIIYRDLKPENV 222 (451)
Q Consensus 156 ~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---------~givH~Dlkp~NI 222 (451)
++-+... .++||+||.+.|+|.+||..+ .++|....+|+..|++||+|||+ ..|+|||||..||
T Consensus 271 ~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNV 347 (534)
T KOG3653|consen 271 GAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNV 347 (534)
T ss_pred chhccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccce
Confidence 9887655 899999999999999999874 48999999999999999999996 3599999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
||-.|++.-|+|||+|..+.... ....
T Consensus 348 LvK~DlTccIaDFGLAl~~~p~~----------------------------------------------------~~~d- 374 (534)
T KOG3653|consen 348 LVKNDLTCCIADFGLALRLEPGK----------------------------------------------------PQGD- 374 (534)
T ss_pred EEccCCcEEeeccceeEEecCCC----------------------------------------------------CCcc-
Confidence 99999999999999996443110 0111
Q ss_pred ccccccCCCccCcccccCCCC------CcchhHHHHHHHHHHHHhCCCCC------------C-----CCChHHHHHHHh
Q 013016 303 SCSFVGTHEYVSPEVASGGSH------GNAVDWWAFGIFIYEMIYGRTPF------------A-----APSNETTLRNIV 359 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~------~~~~DIwSlG~il~elltg~~pf------------~-----~~~~~~~~~~i~ 359 (451)
+-.-+||..|||||++.|..- -.+.||||+|.|||||+++...+ . .+.-+++-..++
T Consensus 375 ~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV 454 (534)
T KOG3653|consen 375 THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV 454 (534)
T ss_pred hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH
Confidence 111389999999999987542 23689999999999999865443 2 122333433444
Q ss_pred cC--CCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 360 KK--PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 360 ~~--~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+. .+.++..+-.-..-.-+++.+..||.+|++.|.|+
T Consensus 455 ~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 455 RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 33 34455544443334467899999999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=278.20 Aligned_cols=302 Identities=23% Similarity=0.335 Sum_probs=211.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+.|.++++||+|+|++||++.+.... .....||+|.+.... ...++..|+++|..+ .+.||+++.+++
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~------~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQD------TKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhc------cccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhh
Confidence 67999999999999999999987620 011259999997542 335577799999998 599999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~ 237 (451)
..++..++|+||+++..-.+++.. ++...++.+++.++.||.++|.+|||||||||+|+|++.. +.-.|+|||+
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence 999999999999999988888766 6789999999999999999999999999999999999854 6789999999
Q ss_pred ccccCCCCCCCCCCC--CCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccc--cccccccccccccCCCcc
Q 013016 238 SLCSNAIPAVESPAS--SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV--AEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 238 a~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~ 313 (451)
|.....-........ .+..... ...............++..+. .+..........||++|+
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~---------------~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfR 244 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPA---------------MGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFR 244 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCcc---------------ccCcccccccccccCCCCceeccCCCccceecccCCCCCCC
Confidence 963111110000000 0000000 000000000011111222222 234444555678999999
Q ss_pred CcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhc--------------CC--C------------
Q 013016 314 SPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVK--------------KP--L------------ 363 (451)
Q Consensus 314 aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~--------------~~--~------------ 363 (451)
|||++...+ .+.++||||.|+|+.-+++++.||-...++ +.+.++.. +. +
T Consensus 245 aPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~ 324 (418)
T KOG1167|consen 245 APEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPEL 324 (418)
T ss_pred chHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHH
Confidence 999998755 689999999999999999999998543221 11111110 11 0
Q ss_pred -----C-------------CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 364 -----T-------------FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 364 -----~-------------~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
. .....+.+..+..+.+|+.+||+.||.+|.| ++++|+||||.+.+...
T Consensus 325 ~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~~~~ 391 (418)
T KOG1167|consen 325 RVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEADRTE 391 (418)
T ss_pred HhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchhhhh
Confidence 0 0111122233336789999999999999999 99999999999865543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.90 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=222.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.++.++|.|+||.||+|+++.+.+ +.|+|+++... ...+.-++.|+-+++..+|+|||.+++.+.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~e---------laavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGE---------LAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCc---------hhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhh
Confidence 689999999999999999999987765 69999998653 234455666999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+.++++||||.||+|.+..+-. +++++.++..+++..+.||+|||+.|=+|||||-.|||+++.|.+|++|||.+-
T Consensus 83 r~dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchh
Confidence 999999999999999999987664 679999999999999999999999999999999999999999999999999862
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc-
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA- 318 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~- 318 (451)
... ....+..++.||+.|||||+.
T Consensus 161 qit-------------------------------------------------------ati~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 161 QIT-------------------------------------------------------ATIAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhh-------------------------------------------------------hhhhhhhcccCCccccchhHHH
Confidence 111 012334467999999999985
Q ss_pred --cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 --SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 --~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
..+.|...+|||++|+...|+-.-++|.........+..+-...+..|.......+...+.+|++.+|.++|.+||+
T Consensus 186 verkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt- 264 (829)
T KOG0576|consen 186 VERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT- 264 (829)
T ss_pred HHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC-
Confidence 34578999999999999999999999988877777766666666666655555555658999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
++.+|.|||..+
T Consensus 265 ---aeklL~h~fvs~ 276 (829)
T KOG0576|consen 265 ---AEKLLQHPFVSQ 276 (829)
T ss_pred ---hhhheeceeecc
Confidence 999999999988
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.80 Aligned_cols=252 Identities=19% Similarity=0.210 Sum_probs=205.3
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
.+..++||+|+||+||+|.|-..++. ....||+|++... ...+....+..|+-+|.++.|||++++++++...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 45567899999999999999765432 2235999999765 3345567788899999999999999999999877
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
. +.||++|+++|.|.++++..+ ..+-......|..||++||.|||++++|||||-..||||.....+|++|||+++..
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 6 889999999999999998864 45889999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
..... .-......-.+.|||=|.+...
T Consensus 849 ~~d~~-----------------------------------------------------ey~~~~gK~pikwmale~i~~~ 875 (1177)
T KOG1025|consen 849 APDEK-----------------------------------------------------EYSAPGGKVPIKWMALESIRIR 875 (1177)
T ss_pred Ccccc-----------------------------------------------------cccccccccCcHHHHHHHhhcc
Confidence 32110 0000011223569999999999
Q ss_pred CCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 322 SHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
.|+.++|||||||++||++| |..|+.+...+++-..+..+.. ++ .+.+.+.++..++.+||..|+..||+ +
T Consensus 876 ~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls---qPpiCtiDVy~~mvkCwmid~~~rp~----f 947 (1177)
T KOG1025|consen 876 KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS---QPPICTIDVYMVMVKCWMIDADSRPT----F 947 (1177)
T ss_pred CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC---CCCCccHHHHHHHHHHhccCcccCcc----H
Confidence 99999999999999999999 9999999988887666655533 22 23445568999999999999999999 5
Q ss_pred HHH
Q 013016 401 ADV 403 (451)
Q Consensus 401 ~el 403 (451)
+++
T Consensus 948 kel 950 (1177)
T KOG1025|consen 948 KEL 950 (1177)
T ss_pred HHH
Confidence 554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.54 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=205.8
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
.+..++..+.+.||+|.||.||+|..+...... ......||||........ .....+..|+++|+.+ .|+||+.+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred eechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 333355667779999999999999877544321 122345999999866433 5567788899999998 59999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC------C--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP------H--------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------~--------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
+|++...+.+++|+||+..|+|.+++...+ . ..++..+...++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 0 13889999999999999999999999999999999
Q ss_pred cEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
|||+..+..+||+|||+|+.......-..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~--------------------------------------------------- 476 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT--------------------------------------------------- 476 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe---------------------------------------------------
Confidence 99999999999999999853221111000
Q ss_pred cccccccc--CCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHhcCCC-CCCCCCCCCcCh
Q 013016 301 ARSCSFVG--THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPS-NETTLRNIVKKPL-TFPTQSPSSMSE 375 (451)
Q Consensus 301 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~-~~~~~~~i~~~~~-~~~~~~~~~~~~ 375 (451)
+. -.| ...|||||.+....|+.++||||||++|||++| |..||.+.. ..+.+..+..+.. ..|.. ..
T Consensus 477 -~~--~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~-----c~ 548 (609)
T KOG0200|consen 477 -KS--SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEH-----CS 548 (609)
T ss_pred -cC--CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCC-----CC
Confidence 00 011 234999999999899999999999999999999 999999855 5555555555543 33332 23
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
.++.++++.|++.+|++||+ +.++.
T Consensus 549 ~eiY~iM~~CW~~~p~~RP~----F~~~~ 573 (609)
T KOG0200|consen 549 DEIYDLMKSCWNADPEDRPT----FSECV 573 (609)
T ss_pred HHHHHHHHHHhCCCcccCCC----HHHHH
Confidence 48889999999999999999 55554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.45 Aligned_cols=258 Identities=16% Similarity=0.176 Sum_probs=207.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.++++...+-+|.||.||+|.|.+.... ..++-|-+|.+... ....++..+..|.-.+..+.|+|+..+.+++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 6788899999999999999988755432 22233666766544 45567788888999999999999999999885
Q ss_pred -eCCeEEEEEeeccCCchhhhhhhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 160 -ASNFSCIVMEFCSGGDLHSLRHKQP------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 160 -~~~~~~lV~E~~~ggsL~~~l~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
+....++++.++.-|+|..++...+ ...++..+...++.|++.|++|||..|+||.||...|++|++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4568899999999999999988432 233678888999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|=.+++-+-. .+.......-.....|
T Consensus 438 tDsaLSRDLFP-----------------------------------------------------~DYhcLGDnEnRPvkW 464 (563)
T KOG1024|consen 438 TDSALSRDLFP-----------------------------------------------------GDYHCLGDNENRPVKW 464 (563)
T ss_pred ccchhccccCc-----------------------------------------------------ccccccCCCCCCcccc
Confidence 99888743211 1111111112345679
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|+||.+.+..|+.++||||||++||||+| |+.|+...+..++...+..+..--.. ...++++..++..||..+|+
T Consensus 465 MslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP----~NCPDeLf~vMacCWallpe 540 (563)
T KOG1024|consen 465 MSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP----FNCPDELFTVMACCWALLPE 540 (563)
T ss_pred cCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC----CCCcHHHHHHHHHHHhcCcc
Confidence 99999999999999999999999999999 99999999999998888887532221 22445999999999999999
Q ss_pred CcCCCCCChHHHH
Q 013016 392 NRLGSKRGAADVK 404 (451)
Q Consensus 392 ~Rpt~~~~~~ell 404 (451)
+||+ .+++.
T Consensus 541 eRPs----f~Qlv 549 (563)
T KOG1024|consen 541 ERPS----FSQLV 549 (563)
T ss_pred cCCC----HHHHH
Confidence 9999 88765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=247.85 Aligned_cols=216 Identities=26% Similarity=0.354 Sum_probs=176.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++...+..||.|+||.|=+.++..++. +.|+|.+.... +.+..++..+|+.+..+. .+|.+|++||..
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~---------imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGT---------IMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCe---------EEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 556677889999999999888877665 69999998664 344456667788776665 699999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
..++..++.||.| ..||..+.... .++.+++..+-+|+..+++||.|||+ ..++|||+||+|||++.+|++|+|||
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccc
Confidence 9999999999999 78888876542 35679999999999999999999995 58999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++-.+.+.-++ +. -.|...||||
T Consensus 194 GIsG~L~dSiAk------------------------------------------------------t~--daGCkpYmaP 217 (282)
T KOG0984|consen 194 GISGYLVDSIAK------------------------------------------------------TM--DAGCKPYMAP 217 (282)
T ss_pred ccceeehhhhHH------------------------------------------------------HH--hcCCCccCCh
Confidence 997432211110 00 1577889999
Q ss_pred ccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCC
Q 013016 316 EVASG----GSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPL 363 (451)
Q Consensus 316 E~~~~----~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~ 363 (451)
|.+.. ..|+.++||||||+.++||.+++.||.. ....+.+.+++....
T Consensus 218 Eri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 218 ERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred hhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 99854 3689999999999999999999999987 456777888877643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=234.03 Aligned_cols=213 Identities=37% Similarity=0.591 Sum_probs=180.8
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIV 167 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV 167 (451)
||.|++|.||+|....+++ .+++|++....... ....+.+|+.+++.+.|++|+++++++......+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~---------~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~ 69 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69 (215)
T ss_pred CCcCCceEEEEEEecCCCc---------EEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEE
Confidence 6899999999999876444 39999998653321 345677899999999999999999999999999999
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccCcccccCCCCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~ 246 (451)
||++.|++|.+++.... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 70 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 70 MEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred EecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99999899999987642 35899999999999999999999999999999999999999 89999999999743211100
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC-CCCc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-SHGN 325 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 325 (451)
......+...|++||.+... .++.
T Consensus 149 -------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~ 173 (215)
T cd00180 149 -------------------------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSE 173 (215)
T ss_pred -------------------------------------------------------hhhcccCCCCccChhHhcccCCCCc
Confidence 01112567789999999876 7789
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 326 AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 326 ~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.|+|++|+++++| ..+.+++.+|++.||.+||+ +.++++
T Consensus 174 ~~D~~~lg~~~~~l------------------------------------~~~~~~l~~~l~~~p~~R~~----~~~l~~ 213 (215)
T cd00180 174 KSDIWSLGVILYEL------------------------------------PELKDLIRKMLQKDPEKRPS----AKEILE 213 (215)
T ss_pred hhhhHHHHHHHHHH------------------------------------HHHHHHHHHHhhCCcccCcC----HHHHhh
Confidence 99999999999999 28899999999999999999 999998
Q ss_pred CC
Q 013016 406 HP 407 (451)
Q Consensus 406 hp 407 (451)
|+
T Consensus 214 ~~ 215 (215)
T cd00180 214 HL 215 (215)
T ss_pred CC
Confidence 75
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.22 Aligned_cols=230 Identities=15% Similarity=0.204 Sum_probs=157.1
Q ss_pred HCCC-CCccceeEEE-------EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 013016 145 MLDH-PFLPTLYAEF-------EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216 (451)
Q Consensus 145 ~l~h-~nIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~D 216 (451)
.+.| .||+.++++| .....++++||++ +++|.+++... ...+++..++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3455 5788888877 2334678889988 78999999754 35599999999999999999999999999999
Q ss_pred CCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccc------cCC
Q 013016 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQT------LTP 290 (451)
Q Consensus 217 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 290 (451)
|||+||||+..|.+|++|||++........... .+. .||...... .+.
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~---------------------ki~-----DfG~a~~~~~~~~~~~~~ 159 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATT---------------------KSR-----EIGSSRREEILSERRIEK 159 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcc---------------------ccc-----ccccccccccccccchhh
Confidence 999999999989999999988753221100000 000 011000000 000
Q ss_pred CcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC
Q 013016 291 NRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370 (451)
Q Consensus 291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 370 (451)
................+||+.|||||++.+..|+.++|||||||+||||++|..|+.... ..+..+..... +....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~ 235 (793)
T PLN00181 160 LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQIL 235 (793)
T ss_pred hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhhh
Confidence 000000001111123479999999999999999999999999999999999998876422 22222222211 11110
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
. .. ....+++.+||++||.+||+ +.|+|+||||.+.
T Consensus 236 ~-~~-~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 236 L-NW-PKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred h-cC-HHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 1 11 25678999999999999999 9999999999873
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=233.57 Aligned_cols=215 Identities=40% Similarity=0.622 Sum_probs=176.9
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|.+.+.||.|++|.||+|....+.+ .+|+|.+...... .....+..|++.+++++|+|++++++++...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~---------~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~ 69 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGE---------LVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDP 69 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCc---------EEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence 5678899999999999999887544 3999999865332 2456777799999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
...++++|++.+++|.+++...... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||.+...
T Consensus 70 ~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 70 EPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred CceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 9999999999999999998875322 889999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc-cC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA-SG 320 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~ 320 (451)
.... ........++..|++||.+ ..
T Consensus 149 ~~~~------------------------------------------------------~~~~~~~~~~~~~~~pe~~~~~ 174 (225)
T smart00221 149 HRDL------------------------------------------------------AALLKTVKGTPFYLAPEVLLGG 174 (225)
T ss_pred cCcc------------------------------------------------------cccccceeccCCcCCHhHhcCC
Confidence 2110 0011123577789999998 55
Q ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHHhcCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNE-TTLRNIVKKP 362 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~-~~~~~i~~~~ 362 (451)
..++.++|||+||+++++|++|+.||.. .... .+.+.+..+.
T Consensus 175 ~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 175 KGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 6678899999999999999999999987 4444 5555565554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=240.08 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=187.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeE-E
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYA-E 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~-~ 157 (451)
+.|.|.+.||+|.||.+.+|.++.+... +++|.+.+... ...+|.+|...--.| .|.||+..|+ .
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~---------ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTR---------IVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceE---------EEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHH
Confidence 6799999999999999999999988764 99999986643 345566666554444 5899998886 6
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--CCCEEEecc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDF 235 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Df 235 (451)
|+..+.+++++||++.|+|..-+.. ..+.+...+.++.|++.||.|||++++||||||.+||||.. ..++|||||
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence 7788899999999999999875544 45889999999999999999999999999999999999963 348999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .. ...-+-.|.+|
T Consensus 168 G~t~k~g~t----------------------------V~------------------------------~~~~~~~y~~p 189 (378)
T KOG1345|consen 168 GLTRKVGTT----------------------------VK------------------------------YLEYVNNYHAP 189 (378)
T ss_pred ccccccCce----------------------------eh------------------------------hhhhhcccCCc
Confidence 997321100 00 01223459999
Q ss_pred ccccCC---C--CCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCC-CCCCCCCCCCcChHHHHHHHHHh
Q 013016 316 EVASGG---S--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNE----TTLRNIVKKP-LTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 316 E~~~~~---~--~~~~~DIwSlG~il~elltg~~pf~~~~~~----~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
|+.... . .....|||.||+|+|.+|||+.||...... -.+.++..+. ...|... ...+..+..+.++-
T Consensus 190 e~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F--~~fs~~a~r~Fkk~ 267 (378)
T KOG1345|consen 190 ELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF--NPFSEKALRLFKKS 267 (378)
T ss_pred HHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh--cccCHHHHHHHHHh
Confidence 987542 2 367899999999999999999999864322 2334444443 3333322 22344889999999
Q ss_pred cccCcCCc---CCCCCChHHHHcCCCcC
Q 013016 386 LNKDPCNR---LGSKRGAADVKTHPFFK 410 (451)
Q Consensus 386 L~~dP~~R---pt~~~~~~ell~hp~~~ 410 (451)
|++++++| .+ +....+.-|..
T Consensus 268 lt~~~~drcki~~----~kk~rk~~w~E 291 (378)
T KOG1345|consen 268 LTPRFKDRCKIWT----AKKMRKCLWKE 291 (378)
T ss_pred cCCcccccchhHH----HHHHHHHHHHH
Confidence 99999999 45 55555555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=258.95 Aligned_cols=273 Identities=37% Similarity=0.662 Sum_probs=226.4
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEEeCCeEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFEASNFSCI 166 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~l 166 (451)
+|.|+||.|++++... +...+..+|+|+..+......... ....|..++...+ ||.+|++.-.++.++..++
T Consensus 2 lg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCcCCCcchHHHHHhc------cccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 7999999999886433 234455799999988765544443 4445777888886 9999999999999999999
Q ss_pred EEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCC
Q 013016 167 VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246 (451)
Q Consensus 167 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 246 (451)
++++..||.|...+... ..+.+.....+...++.|++++|+.|++|||+|++||+++.+|.+++.|||+++..-.
T Consensus 75 ~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~--- 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK--- 149 (612)
T ss_pred hhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh---
Confidence 99999999987665543 5588899999999999999999999999999999999999999999999999853210
Q ss_pred CCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcc
Q 013016 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326 (451)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 326 (451)
.. .-|||..|||||++. ....+
T Consensus 150 --------------------------------------------------~~------~~cgt~eymApEI~~--gh~~a 171 (612)
T KOG0603|consen 150 --------------------------------------------------EK------IACGTYEYRAPEIIN--GHLSA 171 (612)
T ss_pred --------------------------------------------------hh------hcccchhhhhhHhhh--ccCCc
Confidence 00 018999999999998 46789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-CCChHHHHc
Q 013016 327 VDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKT 405 (451)
Q Consensus 327 ~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~~~~~ell~ 405 (451)
+|.||||++++||+||..||.. +.+..|....+..|...+. .+++++..++..+|.+|... .+++.|+++
T Consensus 172 ~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~-----~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 172 ADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSA-----EARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred ccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhH-----HHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 9999999999999999999987 7888888877777766554 88999999999999999986 367899999
Q ss_pred CCCcCCCCcc--cccccCCCCCCCCCCCCCCCCCCC
Q 013016 406 HPFFKGLNFA--LIRSLTPPEIPGMRRQKTMPFPDQ 439 (451)
Q Consensus 406 hp~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~ 439 (451)
|+||+.++|. ..+...+|+.|+........+.|.
T Consensus 243 h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~ 278 (612)
T KOG0603|consen 243 HEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDP 278 (612)
T ss_pred cchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCc
Confidence 9999999999 458888889999887544444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=218.73 Aligned_cols=165 Identities=18% Similarity=0.141 Sum_probs=128.9
Q ss_pred CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCC
Q 013016 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253 (451)
Q Consensus 174 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 253 (451)
|+|.+++... +..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899988764 356999999999999999999999998 999999999999999 998742210
Q ss_pred CCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHH
Q 013016 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFG 333 (451)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG 333 (451)
....||+.|||||++.+..++.++||||||
T Consensus 62 --------------------------------------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG 91 (176)
T smart00750 62 --------------------------------------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLG 91 (176)
T ss_pred --------------------------------------------------ccCCCcccccChHHhcCCCCcchhhHHHHH
Confidence 011578999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCC--CCCCcChH--HHHHHHHHhcccCcCCcCCCCCChHHHHcCCC
Q 013016 334 IFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQ--SPSSMSEY--HARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408 (451)
Q Consensus 334 ~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~--~~~~~~~~--~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~ 408 (451)
|++|||++|+.||...... ..+..+.......... ........ ++.+++.+||+.||.+||+ +.|+++|+|
T Consensus 92 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~----~~~ll~~~~ 167 (176)
T smart00750 92 ITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA----ANHYLAHCR 167 (176)
T ss_pred HHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC----HHHHHHHHH
Confidence 9999999999999765432 3344443332221111 01111121 5899999999999999999 999999998
Q ss_pred cCC
Q 013016 409 FKG 411 (451)
Q Consensus 409 ~~~ 411 (451)
+..
T Consensus 168 ~~~ 170 (176)
T smart00750 168 ALF 170 (176)
T ss_pred HHH
Confidence 764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=264.05 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=194.6
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcch---HHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK---EVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
...+.+|.|++|.|+.+......+. ++.|.++. ...........+..|..+-..+.|+||+..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~---------~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKS---------FPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCCCcc---------chhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 4567899999998877765544432 33333321 11112222222556777788889999988887776
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.....-+||||++ +|..++... +.+....+-.++.|++.||+|||+.||.|||||++|++++.+|.+||+|||.+.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcce
Confidence 66655555999999 999988775 458999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
+.... .+........++|+..|+|||++.
T Consensus 469 vf~~~---------------------------------------------------~e~~~~~~~g~~gS~pY~apE~~~ 497 (601)
T KOG0590|consen 469 VFRYP---------------------------------------------------WEKNIHESSGIVGSDPYLAPEVLT 497 (601)
T ss_pred eeccC---------------------------------------------------cchhhhhhcCcccCCcCcCccccc
Confidence 43211 111223334568999999999999
Q ss_pred CCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhc-CCCC---CCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 320 GGSHG-NAVDWWAFGIFIYEMIYGRTPFAAPSNETTL-RNIVK-KPLT---FPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 320 ~~~~~-~~~DIwSlG~il~elltg~~pf~~~~~~~~~-~~i~~-~~~~---~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
+..|+ ..+||||.|++++.|++|+.||..+...+.. ..... .... -+.... ...+...+.+|.+||++||.+|
T Consensus 498 ~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~-~~lp~~~~~~~~~~l~~~P~~R 576 (601)
T KOG0590|consen 498 GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL-SLLPRETRIIIYRMLQLDPTKR 576 (601)
T ss_pred ccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH-HhchhhHHHHHHHHccCChhhe
Confidence 99985 5799999999999999999999876554332 11111 1110 111111 1223377899999999999999
Q ss_pred CCCCCChHHHHcCCCcCCCCc
Q 013016 394 LGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~~~~ 414 (451)
.| +++|++++||+++.-
T Consensus 577 ~t----i~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 577 IT----IEQILNDEWIRSIEC 593 (601)
T ss_pred ec----HHHHhhChHhhhcce
Confidence 99 999999999999754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=226.00 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=194.8
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC----CCCccceeE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD----HPFLPTLYA 156 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~nIv~l~~ 156 (451)
+|.+.++||+|+||.||+|.+..... ..+|+|+......... ..+..|..++..+. ..++..+++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~--------~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~ 87 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKN--------KEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLD 87 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCC--------eeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEE
Confidence 79999999999999999999876541 1389999875422111 14555888888886 368999999
Q ss_pred EE-EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-----CCE
Q 013016 157 EF-EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-----GHI 230 (451)
Q Consensus 157 ~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-----~~~ 230 (451)
.+ ..+.+.|+||+++ |.+|.++......+.|+...+..|+.|++.+|++||+.|++||||||+|+++... ..+
T Consensus 88 ~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 88 HGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceE
Confidence 99 5888999999999 9999999877777889999999999999999999999999999999999999865 368
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
.|.|||+++.......... . ..+ .......+.||.
T Consensus 167 ~llDfGlar~~~~~~~~~~------------------------------------~-~~~--------~r~~~~~~rGT~ 201 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGG------------------------------------N-LRP--------PRPQKGLFRGTL 201 (322)
T ss_pred EEEecCCCccccccCCCCc------------------------------------c-ccc--------CCCCccCCCCcc
Confidence 9999999852211100000 0 000 000012357999
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
.|+++.+..+...+.+.|+||++.++.+|+.|..||...........+................+..+.++...+-+.+.
T Consensus 202 ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (322)
T KOG1164|consen 202 RYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDY 281 (322)
T ss_pred ccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCC
Confidence 99999999999999999999999999999999999977554322222222111111110122233377888888888999
Q ss_pred CCcCCCCCChHHHH
Q 013016 391 CNRLGSKRGAADVK 404 (451)
Q Consensus 391 ~~Rpt~~~~~~ell 404 (451)
..+|. ...+.
T Consensus 282 ~~~Pd----y~~~~ 291 (322)
T KOG1164|consen 282 EDKPD----YEKLA 291 (322)
T ss_pred cCCCC----HHHHH
Confidence 99999 55544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=215.28 Aligned_cols=265 Identities=37% Similarity=0.564 Sum_probs=206.0
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC-CccceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP-FLPTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-nIv~l~~~~~~ 160 (451)
|.+...||.|+||.||++.+. . .+++|.+.............+.+|+.+++.+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~---------~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---K---------LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---c---------EEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 788899999999999999987 1 3899999877554433567788899999999988 79999999988
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEeccCcc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDLS 238 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a 238 (451)
....+++++++.+++|.+++..... ..+.......++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.+
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 8889999999999999977665432 2589999999999999999999999999999999999999988 7999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
............ ........|+..|++||.+
T Consensus 150 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 150 KLLPDPGSTSSI-------------------------------------------------PALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred eecCCCCccccc-------------------------------------------------cccccccccccccCCHHHh
Confidence 422111000000 0112345899999999999
Q ss_pred cC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCC-CCCCCCCCc---ChHHHHHHHHHhcc
Q 013016 319 SG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN----ETTLRNIVKKPLT-FPTQSPSSM---SEYHARDLISGLLN 387 (451)
Q Consensus 319 ~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~---~~~~~~~ll~~~L~ 387 (451)
.+ ..+....|+||+|++++++++|..||..... ......+...... ......... ....+.+++.+++.
T Consensus 181 ~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLA 260 (384)
T ss_pred cCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHh
Confidence 88 5678999999999999999999999887663 3444444443322 121111111 11368899999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.+|..|.+ ..+...++|...
T Consensus 261 ~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 261 KDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred cCchhcCC----HHHHhhchHhhC
Confidence 99999999 888877766655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=210.30 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
-.|.+.++||+|+||..++|...-+.+ .||||.-.... ..-.+..|....+.| ..++|..+|-+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne---------~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNE---------PVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred ccceeccccccCcceeeecccccccCc---------eEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 369999999999999999998776654 49999876442 223445588888887 589999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-----CEEEe
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-----HIMLS 233 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-----~~kl~ 233 (451)
.++.+-.||+|++ |.||.|+..-. +..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+-++
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 9999999999999 99999988765 45699999999999999999999999999999999999998543 58899
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+...++......+ .....+..||..||
T Consensus 172 DFGmAK~YrDp~TkqHIP------------------------------------------------YrE~KSLsGTARYM 203 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIP------------------------------------------------YREHKSLSGTARYM 203 (449)
T ss_pred eccchhhhcCccccccCc------------------------------------------------cccccccccceeee
Confidence 999998765544433211 01122457999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA---PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
+----+|...+.+.|+=|||-|++..|-|..||.+ +...+-+.+|-..+...+......-.+.++..-++-.-..+-
T Consensus 204 SINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F 283 (449)
T KOG1165|consen 204 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDF 283 (449)
T ss_pred EeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCc
Confidence 98888898899999999999999999999999987 445666666665555444433333344466666666666666
Q ss_pred CCcCC
Q 013016 391 CNRLG 395 (451)
Q Consensus 391 ~~Rpt 395 (451)
.+-|.
T Consensus 284 ~E~PD 288 (449)
T KOG1165|consen 284 FETPD 288 (449)
T ss_pred ccCCC
Confidence 66666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=204.52 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=201.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~ 156 (451)
..+.|.++++||.|+||.+|+|.....+.+ ||||+-.+.. ....+..|..+.+.|+ ...|+.+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~---------VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~ 78 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEE---------VAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRH 78 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCce---------EEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhh
Confidence 347899999999999999999998887765 9999986542 2234555889999997 578999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEEe
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIMLS 233 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~ 233 (451)
++.+..+-.|||+++ |.||.++.+-.. ..|+..++.-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+-|+
T Consensus 79 y~~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 79 YGTEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred hccccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 999999999999999 999999887553 559999999999999999999999999999999999999743 578999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+...+.......+ ........||..|.
T Consensus 157 DFGLaKky~d~~t~~HIp------------------------------------------------yre~r~ltGTaRYA 188 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIP------------------------------------------------YREDRNLTGTARYA 188 (341)
T ss_pred eccchhhhccccccccCc------------------------------------------------cccCCccceeeeeh
Confidence 999997543322111100 00112357999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP---SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
+--...|...+...|+-|+|.+|..+.-|..||.+. +...-..+|...+...+.+....-.+.++...+.-|-..--
T Consensus 189 SinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F 268 (341)
T KOG1163|consen 189 SINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGF 268 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCC
Confidence 988888877889999999999999999999999984 33445666766666655544444455578888888888777
Q ss_pred CCcCCC
Q 013016 391 CNRLGS 396 (451)
Q Consensus 391 ~~Rpt~ 396 (451)
++-|..
T Consensus 269 ~E~Pdy 274 (341)
T KOG1163|consen 269 EEKPDY 274 (341)
T ss_pred CCCCcH
Confidence 777773
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=241.69 Aligned_cols=265 Identities=33% Similarity=0.581 Sum_probs=195.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|..++.+..|+||-||+++++.+.++ +|+|+ +++...- +- ++..-..|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqr---------fa~ki-Nkq~lil--------Rn--ilt~a~npfvv------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQR---------FAMKI-NKQNLIL--------RN--ILTFAGNPFVV------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccc---------hhhcc-cccchhh--------hc--cccccCCccee-------
Confidence 6799999999999999999999987765 89854 3331110 00 22222233322
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
|+=..+++.. +.++... +.+++|||+.||+|||+||+|.+|+.-|.+|++|||+++
T Consensus 136 --------------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 136 --------------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred --------------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhh
Confidence 2223333332 2344322 789999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.....-... .+. .+|.. +........++||+.|.|||++.
T Consensus 192 ~GLms~atn------------------l~e-------------g~I~k---------~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 192 KGLMSLATN------------------LKE-------------GHIEK---------DTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhhhhccch------------------hhh-------------cchHH---------HHHHhhhccccCCccccChhhhh
Confidence 432111100 000 00000 00111112469999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
...|+..+|.|++|+|+||.+-|+.||.+...++.+..++...+.++...+ . .+.++++++.++|..+|..|.... +
T Consensus 232 rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de-a-~p~Ea~dli~~LL~qnp~~Rlgt~-g 308 (1205)
T KOG0606|consen 232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE-A-LPPEAQDLIEQLLRQNPLCRLGTG-G 308 (1205)
T ss_pred hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc-C-CCHHHHHHHHHHHHhChHhhcccc-h
Confidence 999999999999999999999999999999999999999999998888733 2 344899999999999999998754 6
Q ss_pred hHHHHcCCCcCCCCcccccccCCCCCCCCCCCCCCCCCC
Q 013016 400 AADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 438 (451)
+-+|.+|+||+.+||..+-.+-.+++|.........|.+
T Consensus 309 a~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFD 347 (1205)
T ss_pred hhhhhhccceeecccchhhhhhccccccccccccchhhc
Confidence 889999999999999977667778999888765555554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=207.66 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=205.3
Q ss_pred hhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH
Q 013016 66 IRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145 (451)
Q Consensus 66 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~ 145 (451)
-+.+|+++..|+.+++..+.-+|.+...|..|+|+|.++. +++|++.-+.. .......|..|.-.|+.
T Consensus 176 ~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd-----------ivakil~vr~~-t~risrdfneefp~lri 243 (448)
T KOG0195|consen 176 TRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGND-----------IVAKILNVREV-TARISRDFNEEFPALRI 243 (448)
T ss_pred ccccccccccCcchhhhhhhhhhccCCCcccccccccCcc-----------hhhhhhhhhhc-chhhcchhhhhCcceee
Confidence 3567888889999999999999999999999999999875 78888875543 33445667778888999
Q ss_pred CCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEE
Q 013016 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVL 223 (451)
Q Consensus 146 l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIl 223 (451)
+.||||+.+++.|....++.+|..||+.|||+++++...+-..+..++.+++.+|++|++|||+.. |..-.|....++
T Consensus 244 fshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvm 323 (448)
T KOG0195|consen 244 FSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVM 323 (448)
T ss_pred ecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEE
Confidence 999999999999999999999999999999999999987777889999999999999999999865 555578899999
Q ss_pred EccCCCEEEe--ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 224 VRSDGHIMLS--DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 224 l~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
++++.+.+|. |--++... ++
T Consensus 324 idedltarismad~kfsfqe------------------------------------------------~g---------- 345 (448)
T KOG0195|consen 324 IDEDLTARISMADTKFSFQE------------------------------------------------VG---------- 345 (448)
T ss_pred ecchhhhheecccceeeeec------------------------------------------------cc----------
Confidence 9999876654 43332100 00
Q ss_pred cccccccCCCccCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSH---GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~---~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
..-.+.||+||.+...+- -.++|+|||+++||||.|.+.||...++.+.-.++.-+-+ ....++.+.. .+
T Consensus 346 ----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl--rv~ippgis~-hm 418 (448)
T KOG0195|consen 346 ----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL--RVHIPPGISR-HM 418 (448)
T ss_pred ----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc--cccCCCCccH-HH
Confidence 023467999999988664 3589999999999999999999999888887666654332 2223333333 88
Q ss_pred HHHHHHhcccCcCCcCC
Q 013016 379 RDLISGLLNKDPCNRLG 395 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt 395 (451)
.+|++-|++.||.+||.
T Consensus 419 ~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPK 435 (448)
T ss_pred HHHHHHHhcCCCCcCCC
Confidence 99999999999999999
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=218.56 Aligned_cols=141 Identities=26% Similarity=0.220 Sum_probs=111.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH--HHHHHHHHHHHHHHHHHHCCCCCccc-eeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRAEMEKKILKMLDHPFLPT-LYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~-l~~ 156 (451)
++|.+.+.||+|+||+||+|.++..... .+|||++..... ........+.+|+++|++++|+||+. +++
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~--------~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGT--------ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCe--------EEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 7799999999999999999988753221 479998753311 12223456788999999999999985 443
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEEccCCCEEEecc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDL-KPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dl-kp~NIll~~~~~~kl~Df 235 (451)
.+..||||||++|++|... . . .. ...++.|++.||.|||++||+|||| ||+|||++.++.++|+||
T Consensus 90 ----~~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 ----TGKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred ----cCCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 2468999999999999632 1 1 11 1467899999999999999999999 999999999999999999
Q ss_pred Cccccc
Q 013016 236 DLSLCS 241 (451)
Q Consensus 236 g~a~~~ 241 (451)
|+|...
T Consensus 157 GlA~~~ 162 (365)
T PRK09188 157 QLASVF 162 (365)
T ss_pred ccceec
Confidence 998644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=197.17 Aligned_cols=138 Identities=17% Similarity=0.188 Sum_probs=113.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHH------HHHHHHHHHHCCCCCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR------AEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~nIv~ 153 (451)
++|.+.+.||.|+||.||++... ..+ +|||+++............ +++|+..+.++.|++|..
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~-~~~----------~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTD-YGK----------YILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred CceEEEEEecCCCceEEEEEecC-CCc----------EEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 78999999999999999997553 222 9999998665444444333 578899999999999999
Q ss_pred eeEEEEeC--------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 154 LYAEFEAS--------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 154 l~~~~~~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
+.+++... +..+|||||++|.+|.++.. +++ ....+|+.+|..||+.|++|||+||+||+++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS 169 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence 99886643 35899999999999988732 333 2456999999999999999999999999999
Q ss_pred cCCCEEEeccCccc
Q 013016 226 SDGHIMLSDFDLSL 239 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~ 239 (451)
.+| ++|+|||...
T Consensus 170 ~~g-i~liDfg~~~ 182 (232)
T PRK10359 170 KNG-LRIIDLSGKR 182 (232)
T ss_pred CCC-EEEEECCCcc
Confidence 988 9999999863
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=225.38 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=179.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-HHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-KKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+|...+.||.+.|=+|.+|.+.++. |+||++.+.... .-........|++ ...++|||++.+.-+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-----------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-----------VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-----------EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 6888999999999999999887763 999999876421 1122333334555 66679999999999888
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.....|||-+|. .-+|+|-+..++- +...+.+-|+.||+.||.-+|..||+|||||.+||||+.=+-+.|+||..=+
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 888999999999 6688888877533 7788888899999999999999999999999999999998899999996421
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
. . |..++.=.+ ..|..+....+ ..|.|||-+.
T Consensus 169 P-----t--------------------------------YLPeDNPad----f~fFFDTSrRR-------tCYiAPERFv 200 (1431)
T KOG1240|consen 169 P-----T--------------------------------YLPEDNPAD----FTFFFDTSRRR-------TCYIAPERFV 200 (1431)
T ss_pred C-----c--------------------------------cCCCCCccc----ceEEEecCCce-------eeecChHhhh
Confidence 0 0 000000000 11222222211 2499999874
Q ss_pred CC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 320 GG----------S-HGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 320 ~~----------~-~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
.. . .+++-||||+||+++||++ |++||.- ..+.....+.-..+......+.+..++++|..|++
T Consensus 201 ~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~ 276 (1431)
T KOG1240|consen 201 SALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQ 276 (1431)
T ss_pred ccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHc
Confidence 31 1 3578899999999999998 8999952 11111111100000000111112268999999999
Q ss_pred cCcCCcCCCCCChHHHHcC
Q 013016 388 KDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~h 406 (451)
.||.+|.+ |++.|+-
T Consensus 277 rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 277 RDPSKRLS----AEDYLQK 291 (1431)
T ss_pred cCchhccC----HHHHHHh
Confidence 99999999 9999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=186.18 Aligned_cols=141 Identities=24% Similarity=0.248 Sum_probs=107.3
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-----------------------HHHHHHHHHH
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-----------------------KVHRAEMEKK 141 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~ 141 (451)
...||+|++|.||+|.+. +++ .||||+++........ .......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~---------~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGE---------ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC-CCC---------EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 457999999999999986 443 3999999765321110 0122345899
Q ss_pred HHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCCCC
Q 013016 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL-HMLGIIYRDLKPE 220 (451)
Q Consensus 142 ~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givH~Dlkp~ 220 (451)
++.++.++++........ .. .+|||||++|++|...... ...+++..+..++.||+.+|.+| |+.||+||||||+
T Consensus 72 ~l~~l~~~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred HHHHHHHCCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 999998887754443322 22 3899999988777654322 24689999999999999999999 6999999999999
Q ss_pred cEEEccCCCEEEeccCcccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~ 240 (451)
|||++ ++.++|+|||+|..
T Consensus 148 NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred HEEEE-CCcEEEEEcccccc
Confidence 99998 58899999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-23 Score=193.79 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=149.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC----------C
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH----------P 149 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~ 149 (451)
..+...+.||.|+++.||.+++.+++++ +|||++...........+.+.+|......+.+ -
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~---------~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~ 82 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEE---------FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHL 82 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEE---------EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH
T ss_pred eEEEEccccccCCceEEEEEEEccCCce---------EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhc
Confidence 4577788999999999999999988764 99999976554444455555555544433322 1
Q ss_pred CccceeEEE---------EeC---C-----eEEEEEeeccCCchhhhhhh---CCCC--CCCHHHHHHHHHHHHHHHHHH
Q 013016 150 FLPTLYAEF---------EAS---N-----FSCIVMEFCSGGDLHSLRHK---QPHK--RFSLTSARFYAAEVLVALEYL 207 (451)
Q Consensus 150 nIv~l~~~~---------~~~---~-----~~~lV~E~~~ggsL~~~l~~---~~~~--~l~~~~~~~i~~qil~aL~~L 207 (451)
.++.-++.. ... . ..+++|+-+ -++|.+++.. .... .+.......+..|++..+++|
T Consensus 83 r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 83 RFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp -B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence 222222222 111 1 347889988 7788876542 2111 233444566779999999999
Q ss_pred HHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccc
Q 013016 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQT 287 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (451)
|..|+||+||+|+|++++.+|.+.|+||+.....+..
T Consensus 162 h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------------------- 198 (288)
T PF14531_consen 162 HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR------------------------------------------- 198 (288)
T ss_dssp HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-------------------------------------------
T ss_pred hhcceEecccceeeEEEcCCCCEEEcChHHHeecCce-------------------------------------------
Confidence 9999999999999999999999999999875321100
Q ss_pred cCCCcccccccccccccccccCCCccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 013016 288 LTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG--------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV 359 (451)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~ 359 (451)
... -..+..|.+||.... ..++.+.|.|+||++||.|++|..||...........
T Consensus 199 --------------~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-- 261 (288)
T PF14531_consen 199 --------------YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-- 261 (288)
T ss_dssp --------------EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--
T ss_pred --------------eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--
Confidence 000 123466899997643 2368899999999999999999999986533222111
Q ss_pred cCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 360 KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
....+. ..+..++.||.++|++||.+|
T Consensus 262 ------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 111112 233389999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=178.75 Aligned_cols=141 Identities=21% Similarity=0.191 Sum_probs=109.2
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-----------------------HHHHHHHHHHHH
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-----------------------KKKVHRAEMEKK 141 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~ 141 (451)
.+.||+|++|.||+|.+. +++ .||||+++...... .........|..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~---------~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGE---------ELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCC---------EEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 467999999999999976 333 39999998652110 011223457889
Q ss_pred HHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhh-hhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCC
Q 013016 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-RHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKP 219 (451)
Q Consensus 142 ~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp 219 (451)
.+.++.|++|.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP 146 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSE 146 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCh
Confidence 99999999885554443332 4899999988765432 332 457888999999999999999999 9999999999
Q ss_pred CcEEEccCCCEEEeccCccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+|||++ ++.++|+|||++...
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhEEEE-CCCEEEEEcccceec
Confidence 999999 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=174.38 Aligned_cols=202 Identities=18% Similarity=0.179 Sum_probs=136.9
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-HHHHHHHHHHHHHHCC-CCCccceeEEEEe
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-KVHRAEMEKKILKMLD-HPFLPTLYAEFEA 160 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~ 160 (451)
.+...|+.|+||+||++...+. .++.+.+......... ....+.+|+++|+++. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~-----------k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGER-----------KFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeecCCc-----------eeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 4567899999999997765222 2665655433322111 1235778999999995 5889999986
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC-CCCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDL-KPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dl-kp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+..|++|||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 346999999999998654211 1 1357889999999999999999999 7999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
......... ..........+.++ | ...++.|+.|+...
T Consensus 141 ~~~~~~~~~-------------r~L~~rDl~~llk~----~-------------------------~~y~~~~l~~~~~~ 178 (218)
T PRK12274 141 RGNPRARWM-------------RLLAREDLRHLLKH----K-------------------------RMYCPAALTPVERR 178 (218)
T ss_pred ecCCcchHH-------------HHHHHHHHHHHHHH----H-------------------------HhcCCCCCCHHHHh
Confidence 322100000 00000011111111 1 13566788888643
Q ss_pred CC-CCC-cchhHHHHHHHHHHHHhCCCCCCCCC
Q 013016 320 GG-SHG-NAVDWWAFGIFIYEMIYGRTPFAAPS 350 (451)
Q Consensus 320 ~~-~~~-~~~DIwSlG~il~elltg~~pf~~~~ 350 (451)
-. ..+ ...+.++.|+-+|.++|+..+..+..
T Consensus 179 ~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 179 VLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 32 223 56788899999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=190.45 Aligned_cols=274 Identities=23% Similarity=0.335 Sum_probs=176.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEecccccc-------------------CC----CCCCc---ceEEEEEcchHHHHH
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQ-------------------DR----GHEPC---CLYAMKVVNKEVLEK 129 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-------------------~~----~~~~~---~~vavK~~~~~~~~~ 129 (451)
+.++++|+|..-||+|..+.||.|+....+.. +. .++++ =..|||.+-.-...+
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 34567899999999999999999987653211 00 00111 135666653221110
Q ss_pred --HHHHHHHHHHH--------------HHHHHC--------CCCCccceeEEEEe-------------------------
Q 013016 130 --KKKVHRAEMEK--------------KILKML--------DHPFLPTLYAEFEA------------------------- 160 (451)
Q Consensus 130 --~~~~~~~~~e~--------------~~l~~l--------~h~nIv~l~~~~~~------------------------- 160 (451)
....+.+.+|. ...+.+ .|||||++.++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 11111111121 111122 59999999987732
Q ss_pred --CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC--C--CEEEec
Q 013016 161 --SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD--G--HIMLSD 234 (451)
Q Consensus 161 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~--~--~~kl~D 234 (451)
+..+|+||.-+ ..+|.+++-.+. .+.....-|+.|+++|+.|||++||.|||+|.+|||+.-+ + .+.|+|
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 23789999988 679999987642 5677788899999999999999999999999999999633 3 578999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|.......-.. +..+.....-|.-.-||
T Consensus 389 FGCcLAd~~hGlql-------------------------------------------------py~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 389 FGCCLADDNHGLQL-------------------------------------------------PYESDEVDLGGNAKLMA 419 (598)
T ss_pred cceeeecccccccc-------------------------------------------------ccccccccCCCcceecc
Confidence 99985322110000 00011112256777999
Q ss_pred cccccCCC-----C-CcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhc-CCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 315 PEVASGGS-----H-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVK-KPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 315 PE~~~~~~-----~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
||+....+ . -.++|.|+.|.+.||+++...||........ .....+ ..+..+.. .+..++++|..+|
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~-----vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSR-----VPPVARQLVFDLL 494 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCccc-----CChHHHHHHHHHh
Confidence 99875422 1 3489999999999999999999987433211 111111 22223332 2338999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCC
Q 013016 387 NKDPCNRLGSKRGAADVKTHPF 408 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~ 408 (451)
+.||++|+++. .+..+|+.-.
T Consensus 495 ~r~pskRvsp~-iAANvl~LsL 515 (598)
T KOG4158|consen 495 KRDPSKRVSPN-IAANVLNLSL 515 (598)
T ss_pred cCCccccCCcc-HHHhHHHHHH
Confidence 99999999953 2455554433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=207.10 Aligned_cols=196 Identities=24% Similarity=0.369 Sum_probs=157.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC---CCCcccee
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD---HPFLPTLY 155 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~ 155 (451)
...|.|.+.||+|+||+||+|...+ ++ +||||+-+.... .++..-.+++.+|+ -+.|..+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~---------~~alK~e~P~~~------WEfYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GK---------LVALKVEKPPNP------WEFYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-Cc---------EEEEEeecCCCc------eeeeehHHHHHhhchhhhcchHHHH
Confidence 3569999999999999999998776 22 699999865433 33334455666665 34566777
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-------CC
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-------DG 228 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-------~~ 228 (451)
.++...+..+||+||.+.|+|.++++. .+.+++..++.++.||+.-|++||..+||||||||+|+||.. ..
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 777778888999999999999999984 466999999999999999999999999999999999999963 23
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
-++|+|||.+.-+.-.+. ..+-...++
T Consensus 839 ~l~lIDfG~siDm~lfp~-----------------------------------------------------~~~F~~~~~ 865 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPD-----------------------------------------------------GTKFKAVWH 865 (974)
T ss_pred ceEEEecccceeeeEcCC-----------------------------------------------------CcEEeeeec
Confidence 689999999853221111 122334588
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP 345 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~p 345 (451)
|-.+-.+|...|.+|++.+|.|.|+.+++-||.|+..
T Consensus 866 td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 866 TDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=171.87 Aligned_cols=133 Identities=20% Similarity=0.220 Sum_probs=103.7
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-----CCCCccceeEEEE
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-----DHPFLPTLYAEFE 159 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~nIv~l~~~~~ 159 (451)
...||+|+||.||. +..... .+||++..... .....+.+|+.+++.+ .||||++++++++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~----------k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e 71 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQ----------RCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE 71 (210)
T ss_pred cceecCCCceEEEE--CCCCcC----------eEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence 45799999999995 443332 57999875422 2335577899999999 5799999999998
Q ss_pred eCC---e-EEEEEee--ccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeccCCCCcEEEccC----C
Q 013016 160 ASN---F-SCIVMEF--CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL-EYLHMLGIIYRDLKPENVLVRSD----G 228 (451)
Q Consensus 160 ~~~---~-~~lV~E~--~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL-~~LH~~givH~Dlkp~NIll~~~----~ 228 (451)
++. . +.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +
T Consensus 72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 72 TDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred eCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCC
Confidence 873 4 3489999 5579999999663 36655 35688888888 89999999999999999999743 4
Q ss_pred CEEEeccCc
Q 013016 229 HIMLSDFDL 237 (451)
Q Consensus 229 ~~kl~Dfg~ 237 (451)
.++|+||+-
T Consensus 147 ~~~LiDg~G 155 (210)
T PRK10345 147 IPVVCDNIG 155 (210)
T ss_pred cEEEEECCC
Confidence 899999443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-20 Score=170.07 Aligned_cols=145 Identities=25% Similarity=0.226 Sum_probs=110.0
Q ss_pred CceEEeeeccCCeeEEEEEE-eccccccCCCCCCcceEEEEEcchHHHHH---------------------HHHHHHHHH
Q 013016 81 DFDLHRRIGAGDIGTVYLCS-LNNKYRQDRGHEPCCLYAMKVVNKEVLEK---------------------KKKVHRAEM 138 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~-~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~ 138 (451)
-|.+.+.||.|++|.||+|. +..+++ .||||+++...... ......+..
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGK---------ERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCc---------EEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 48899999999999999998 433433 49999997542100 001123567
Q ss_pred HHHHHHHCCCCC--ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-Ceec
Q 013016 139 EKKILKMLDHPF--LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG-IIYR 215 (451)
Q Consensus 139 e~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-ivH~ 215 (451)
|+.++.++.+.+ ++++++. . ..++||||+.|++|..+.... ..+....+..++.||+.+|.+||++| |+||
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 999999997533 4444442 2 358999999888887654322 34666778899999999999999999 9999
Q ss_pred cCCCCcEEEccCCCEEEeccCccccc
Q 013016 216 DLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 216 Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-21 Score=186.69 Aligned_cols=185 Identities=28% Similarity=0.411 Sum_probs=140.5
Q ss_pred CeEEEEEeeccCCchhhhhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQ-PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
.++||.|++|...+|.+++... ....-++...+.++.|+..|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3789999999999999999744 34457888999999999999999 9999999999999999999999999999743
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
....+. ..........-+||..||+||++.|
T Consensus 406 ~~~~~~-------------------------------------------------~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 406 QDKDET-------------------------------------------------VAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred cccCCc-------------------------------------------------ccchhhhhhhcccccccCCHHHHhh
Confidence 322110 0001122233489999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCC-CCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFP-TQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
..|+.++||||||+||+||+. -...|. ....+..+-.+.++.. .... + +-..|+..||...|.+||+
T Consensus 437 ~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~~d~----p-~e~~ll~~lls~~p~~RP~--- 505 (516)
T KOG1033|consen 437 QQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFLQDY----P-EEYTLLQQLLSPSPEERPS--- 505 (516)
T ss_pred hhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHhhcC----c-HHHHHHHHhcCCCcccCch---
Confidence 999999999999999999997 333333 2223334444443311 1111 1 5578999999999999998
Q ss_pred ChHHHHcCCCcC
Q 013016 399 GAADVKTHPFFK 410 (451)
Q Consensus 399 ~~~ell~hp~~~ 410 (451)
+.+.--|+|.+
T Consensus 506 -~~~~~~~~~~~ 516 (516)
T KOG1033|consen 506 -AIEVALHEFLQ 516 (516)
T ss_pred -HHHHhhhhhcC
Confidence 88888888864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=162.75 Aligned_cols=136 Identities=23% Similarity=0.272 Sum_probs=112.4
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH-----HHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-----EKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+.||+|++|.||+|.+.+. .+++|+...... ........+.+|+.++..+.|++|+....++..
T Consensus 2 ~~l~~G~~~~vy~~~~~~~-----------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGI-----------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeCCC-----------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999987433 289998653221 112223456779999999999999888877777
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+..++||||++|++|.+++.... . .+..++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+.
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 888999999999999999886531 2 7888999999999999999999999999999999 8899999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=178.06 Aligned_cols=204 Identities=21% Similarity=0.295 Sum_probs=153.4
Q ss_pred HHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eeccCCCCc
Q 013016 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGI-IYRDLKPEN 221 (451)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-vH~Dlkp~N 221 (451)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.-...++++|+.||.|||...| +|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35678999999999999999999999999999999998874 3558888899999999999999997665 999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
++++....+||+|||+........... .
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~---------------------------------------------------~- 107 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPE---------------------------------------------------A- 107 (484)
T ss_pred ceeeeeEEEEechhhhccccccccccc---------------------------------------------------c-
Confidence 999999999999999974322100000 0
Q ss_pred cccccccCCCccCcccccCCC-------CCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhc-CCCCCCCCC
Q 013016 302 RSCSFVGTHEYVSPEVASGGS-------HGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVK-KPLTFPTQS 369 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~-------~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~-~~~~~~~~~ 369 (451)
.....-...|.|||.+.+.. -+.+.||||||++++|+++...||.... ..+.+..+.. +...+....
T Consensus 108 -~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i 186 (484)
T KOG1023|consen 108 -HHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSI 186 (484)
T ss_pred -cchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcch
Confidence 00001223599999997742 3567999999999999999999997632 2345555555 221121111
Q ss_pred C-CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHH
Q 013016 370 P-SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404 (451)
Q Consensus 370 ~-~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell 404 (451)
. ......++..+++.|+..+|.+||+ ++++-
T Consensus 187 ~~~~e~~~~l~~l~~~cw~e~P~~rPs----~~~i~ 218 (484)
T KOG1023|consen 187 ELLNELPPELLLLVARCWEEIPEKRPS----IEQIR 218 (484)
T ss_pred hhhhhcchHHHHHHHHhcccChhhCcc----HHHHH
Confidence 1 1122337899999999999999999 66653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-21 Score=200.50 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=202.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
..|.+.+-||+|+|+.|-++........ .+|+|.+.... ...........|..+-+.+. |.|++.+++..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~--------~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~ 90 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPES--------SSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS 90 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcc--------eeeccCCCCCC-CccchhhhcCccccccccccccccccccCCcc
Confidence 4577788899999999988776544432 36777665432 12223344444777777776 99999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEccCC-CEEEeccC
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDG-HIMLSDFD 236 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~Dfg 236 (451)
......+++++|..|+++.+-+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||
T Consensus 91 ~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 91 SSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred CCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCch
Confidence 99999999999999999998774222225788889999999999999999 99999999999999999999 99999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc-CCCccCc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG-THEYVSP 315 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aP 315 (451)
+|...... ..........+| ++.|+||
T Consensus 171 ~At~~~~~----------------------------------------------------~g~~~~~~~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 171 LATAYRNK----------------------------------------------------NGAERSLKDRCGSSPPYGAP 198 (601)
T ss_pred hhcccccc----------------------------------------------------CCcceeeecccCCCCCCCCc
Confidence 98432210 000011112377 9999999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 316 EVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 316 E~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|...+. ......|+||.|+++.-+++|..|+........ +..+......+-...+..+.. ...+++.++|..+|..|
T Consensus 199 E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~k~l~~~~~~r 277 (601)
T KOG0590|consen 199 EHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISD-QAHDLLHKILKENPSNR 277 (601)
T ss_pred ccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCCh-hhhhcccccccCCchhc
Confidence 999885 457899999999999999999999987655442 222333322222333344444 78999999999999999
Q ss_pred CCCCCChHHHHcCCCcCC
Q 013016 394 LGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~ 411 (451)
.+ .+++..++|+..
T Consensus 278 ~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 278 LS----IEELKLDNWLSS 291 (601)
T ss_pred cc----cccccccccccc
Confidence 99 999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.6e-20 Score=190.19 Aligned_cols=265 Identities=31% Similarity=0.521 Sum_probs=197.2
Q ss_pred CCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
.+|.++...-.+.-....+||++|+.|++|...++... ..+...+...+..+..++++||...+.|+|++|.|+|+..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence 44555555544555668899999999999998888763 4677778888899999999999999999999999999999
Q ss_pred CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccc
Q 013016 227 DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306 (451)
Q Consensus 227 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (451)
+|..++.|||...............+......++ ...+.. .+..............
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~--~~~~~~----------------------~~~~l~~~~~~~~~~~ 995 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPR--RLSRSE----------------------RRPQLSADEARRKHAV 995 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccc--cccccc----------------------cccccccchhhccccc
Confidence 9999999999654333222211110000000000 000000 0000011122234467
Q ss_pred ccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+||+.|.+||.+.+...+..+|.|++|++++|.++|..||........+.++.++...++.... .-++++++++.++|
T Consensus 996 ~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~--~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 996 VGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPE--EGSYEAQDLINRLL 1073 (1205)
T ss_pred cCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCcc--ccChhhhhhhhhhh
Confidence 8999999999999999999999999999999999999999999999999999998887776433 33448999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCC-CCCCCCCCCc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRR-QKTMPFPDQK 440 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~ 440 (451)
..+|.+|..+.. +.++..|+||+.++|..+.....+++|+..+ +.+..|....
T Consensus 1074 ~~~~~qr~~a~~-~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~ 1127 (1205)
T KOG0606|consen 1074 TEEPTQRLGAKG-AAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRF 1127 (1205)
T ss_pred ccCchhccCccc-ccccccCCccCCCCccccccccCccCCCCCCCCccchhhccc
Confidence 999999999322 4589999999999999999999999999985 4554444433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=158.95 Aligned_cols=132 Identities=23% Similarity=0.278 Sum_probs=105.7
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH-----HHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-----LEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
.||+|++|.||+|.+.+. .+++|+..... ........++..|++++..+.|+++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~~~~-----------~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGL-----------KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecCCc-----------cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 389999999999986442 28999864321 11122345667799999999988766665556667
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+..++||||++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999988755311 7899999999999999999999999999999 8999999999985
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=180.44 Aligned_cols=138 Identities=23% Similarity=0.249 Sum_probs=112.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH-----HHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-----LEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
..|...++||+|+||+||+|.+.... +++|+..... ........++..|+++++.++|++|+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-----------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-----------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-----------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 34567889999999999999876543 3444322111 1122234567789999999999999988
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
+.++......++||||++|++|.+++. ....++.+++.+|.+||++|++||||||+|||+ .++.++|+|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEe
Confidence 887777778899999999999998875 356789999999999999999999999999999 688999999
Q ss_pred cCccc
Q 013016 235 FDLSL 239 (451)
Q Consensus 235 fg~a~ 239 (451)
||++.
T Consensus 471 FGla~ 475 (535)
T PRK09605 471 FGLGK 475 (535)
T ss_pred Ccccc
Confidence 99986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=158.18 Aligned_cols=136 Identities=26% Similarity=0.228 Sum_probs=104.8
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH-------------------HHHHHHHHHHHH
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK-------------------KKVHRAEMEKKI 142 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~ 142 (451)
|.+.+.||.|+||.||+|.+.. ++ .||||+++....... ........|..+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~-g~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPD-GN---------PVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred hhcCCccccCcceEEEEEEcCC-CC---------EEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 8888999999999999998753 33 399998764321000 011224568888
Q ss_pred HHHCCCCC--ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 143 LKMLDHPF--LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 143 l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
+..+.|.+ ++.+++ ....++||||++|++|.++... .....++.+|+.++.++|+.||+||||||+
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~ 154 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEF 154 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence 88888774 445544 2456899999999998765321 345678899999999999999999999999
Q ss_pred cEEEccCCCEEEeccCccc
Q 013016 221 NVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~ 239 (451)
||+++.++.++|+|||.+.
T Consensus 155 Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred cEEEcCCCcEEEEECCccc
Confidence 9999999999999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=148.90 Aligned_cols=136 Identities=26% Similarity=0.288 Sum_probs=96.0
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHH---------------------HHHHHHHHH
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVH---------------------RAEMEKKIL 143 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~e~~~l 143 (451)
.+.||+|+||+||+|.+. +++ .||||+++........... ....|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~---------~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGE---------PVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC-CCC---------EEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 467999999999999876 333 3999998754221111111 113455666
Q ss_pred HHCCCCC--ccceeEEEEeCCeEEEEEeeccCCchhh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCC
Q 013016 144 KMLDHPF--LPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKP 219 (451)
Q Consensus 144 ~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp 219 (451)
..+.+.+ +.+.+++ ...++||||++|+.+.. .+.... . ...+..++.+++.++.++|. .||+|+||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p 143 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSE 143 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCCh
Confidence 6664433 4555543 24689999998855432 121110 1 16678899999999999999 9999999999
Q ss_pred CcEEEccCCCEEEeccCccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~ 239 (451)
+||+++ ++.++|+|||.+.
T Consensus 144 ~Nili~-~~~~~liDfg~a~ 162 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAV 162 (187)
T ss_pred hhEEEE-CCcEEEEECcccc
Confidence 999999 9999999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.8e-17 Score=150.19 Aligned_cols=135 Identities=24% Similarity=0.266 Sum_probs=101.1
Q ss_pred eec-cCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH-----H-----HHHHHHHHHHHHHHHHHCCCCCc--cc
Q 013016 87 RIG-AGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-----E-----KKKKVHRAEMEKKILKMLDHPFL--PT 153 (451)
Q Consensus 87 ~LG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~-----~~~~~~~~~~e~~~l~~l~h~nI--v~ 153 (451)
.|| .|+.|+||.+...+. .++||.+..... . ......++.+|+.++.++.|++| +.
T Consensus 38 ~lg~~~g~gtv~~v~~~~~-----------~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~ 106 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTPGV-----------NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPR 106 (239)
T ss_pred eeecCCCCccEEEEEeCCc-----------eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCce
Confidence 466 788888888776532 289998854211 0 11223456779999999998885 67
Q ss_pred eeEEEEeCC----eEEEEEeeccC-CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 154 LYAEFEASN----FSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 154 l~~~~~~~~----~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
.+++..... ..++|||+++| .+|.+++.. ..+++. .+.+|+.+|.+||++||+||||||+|||++.++
T Consensus 107 pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 107 PIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred eEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC
Confidence 777654332 23699999987 689888765 235544 357899999999999999999999999999999
Q ss_pred CEEEeccCccc
Q 013016 229 HIMLSDFDLSL 239 (451)
Q Consensus 229 ~~kl~Dfg~a~ 239 (451)
.++|+|||.+.
T Consensus 180 ~v~LIDfg~~~ 190 (239)
T PRK01723 180 KFWLIDFDRGE 190 (239)
T ss_pred CEEEEECCCcc
Confidence 99999999985
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=136.46 Aligned_cols=131 Identities=24% Similarity=0.310 Sum_probs=110.7
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC--CCccceeEEEEeC
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH--PFLPTLYAEFEAS 161 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~ 161 (451)
+.+.||.|.++.||++...+. .+++|++..... ...+..|+.+++.+.| .+++++++++...
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~-----------~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~ 65 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDE-----------DYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESD 65 (155)
T ss_pred cceecccccccceEEEEecCC-----------eEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence 457899999999999998652 299999875432 3456678999999976 5899999999888
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML---GIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+..+++|||++|+++..+ +......++.+++.+|++||.. +++|+||+|+||+++..+.++++|||.+
T Consensus 66 ~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 66 GWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred CccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 899999999988877654 5567778899999999999984 7999999999999999899999999997
Q ss_pred c
Q 013016 239 L 239 (451)
Q Consensus 239 ~ 239 (451)
.
T Consensus 137 ~ 137 (155)
T cd05120 137 G 137 (155)
T ss_pred c
Confidence 5
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=156.91 Aligned_cols=261 Identities=24% Similarity=0.229 Sum_probs=188.6
Q ss_pred CceEEeeecc--CCeeEEEEEEe--ccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 81 DFDLHRRIGA--GDIGTVYLCSL--NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 81 ~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
.+.+...+|. |.+|.||.+.. .... ..+|+|.-..... .......-.+|....+++ .|+|.++.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~---------~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESP---------HKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCC---------cccccccccCCCC-CccccccccchhhcccccCccccccccC
Confidence 4778889999 99999998876 3332 2488887332211 111122223455556666 499999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeeccCCCCcEEEccC-CCE
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV----ALEYLHMLGIIYRDLKPENVLVRSD-GHI 230 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~----aL~~LH~~givH~Dlkp~NIll~~~-~~~ 230 (451)
..++..+..|+-+|+| +.+|..+.+.. +.-++...++.++.+... ||.++|..+++|-|+||+||++..+ ...
T Consensus 185 ~~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence 9999999999999999 78888876654 344888999999999999 9999999999999999999999999 789
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+++|||+............ ......-.|..
T Consensus 263 ~~~df~~v~~i~~~~~~~~--------------------------------------------------~~~~~r~~~~~ 292 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSV--------------------------------------------------FKVSKRPEGDC 292 (524)
T ss_pred ecCCcceeEEccCCccccc--------------------------------------------------eeeeecCCCCc
Confidence 9999999753322110000 00001114667
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP--SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
.|++||.+.+ -++...|||++|.++.+..+|..+.... +.+..+..+. ++.+....... .+...+..|+..
T Consensus 293 ~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip~e~~~~~s~-~l~~~~~~~~d~ 365 (524)
T KOG0601|consen 293 IYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IPLEFCEGGSS-SLRSVTSQMLDE 365 (524)
T ss_pred eEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----CchhhhcCcch-hhhhHHHHhcCc
Confidence 7999998866 6788999999999999999887766543 3333322222 23333322222 566699999999
Q ss_pred CcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+|-.|++ ++.+++|++..+...
T Consensus 366 ~~~~~~~----~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 366 DPRLRLT----AQILTALNVIHSKLF 387 (524)
T ss_pred chhhhhH----HHHHhccccccchhh
Confidence 9999999 999999999987433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.1e-15 Score=135.84 Aligned_cols=210 Identities=20% Similarity=0.252 Sum_probs=147.7
Q ss_pred HHHCCCCCccceeEEEEeCC-----eEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--Ce
Q 013016 143 LKMLDHPFLPTLYAEFEASN-----FSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLG--II 213 (451)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g--iv 213 (451)
+-.+.|-|||+++.++.+.+ ...++.||+.-|+|..+|++.+ ...+.....++|+-||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44567999999998886544 5789999999999999987643 355888899999999999999999875 99
Q ss_pred eccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcc
Q 013016 214 YRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293 (451)
Q Consensus 214 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (451)
|+++..+-|++..+|-+|+.--.... .+.+-...
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s--------------------------~h~s~~~~-------------------- 234 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDS--------------------------THPSVNST-------------------- 234 (458)
T ss_pred cCCcchhheeecCCceEEecccCccc--------------------------cchhhhhh--------------------
Confidence 99999999999999888765321110 00000000
Q ss_pred cccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhcCCCCCCCCCCCC
Q 013016 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTP-FAAPSNETTLRNIVKKPLTFPTQSPSS 372 (451)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~ 372 (451)
....+..-.|-++|.+||.-.....+-++|||+||....+|..|..- -...+..+.-..+.+........
T Consensus 235 -----~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~---- 305 (458)
T KOG1266|consen 235 -----REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENG---- 305 (458)
T ss_pred -----hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCc----
Confidence 00000011456789999976655667799999999999999887764 22222222222222222211111
Q ss_pred cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 373 ~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.-++++.+||+-.|..||+ +++++.||.+-+++--
T Consensus 306 ----lqr~~i~kcl~~eP~~rp~----ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 306 ----LQRGSITKCLEGEPNGRPD----ARLLLFHPLLFEVHSL 340 (458)
T ss_pred ----cccCcCcccccCCCCCCcc----hhhhhcCceeeecchH
Confidence 2256889999999999999 9999999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.4e-14 Score=141.73 Aligned_cols=146 Identities=21% Similarity=0.277 Sum_probs=98.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH--------------------------
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-------------------------- 131 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------- 131 (451)
.+..|. .+-||.|++|.||+|+++++. .||||+.+......-.
T Consensus 116 ~F~~fd-~~plasaSigQVh~A~l~~G~----------~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~ 184 (437)
T TIGR01982 116 LFAEFE-EKPLAAASIAQVHRARLVDGK----------EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPT 184 (437)
T ss_pred HHhhCC-CcceeeeehhheEEEEecCCC----------EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHH
Confidence 334454 357999999999999987553 3999998654211000
Q ss_pred -H----------HHHHHHHHHHHHHC----CC-CC--ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHH
Q 013016 132 -K----------VHRAEMEKKILKML----DH-PF--LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193 (451)
Q Consensus 132 -~----------~~~~~~e~~~l~~l----~h-~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~ 193 (451)
. .-++..|+..+.++ .| ++ |++++. ...+..+|||||++|++|.++......+ . ..
T Consensus 185 ~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~ 258 (437)
T TIGR01982 185 EVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG-L---DR 258 (437)
T ss_pred HHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC-C---CH
Confidence 0 00133455555544 23 33 233332 2234579999999999999876542211 2 23
Q ss_pred HHHHHHHHH-HHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 194 RFYAAEVLV-ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 194 ~~i~~qil~-aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
..++.+++. .+..+|..|++|+|+||.||+++.+|+++|+|||++..
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 456666665 47889999999999999999999999999999999753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-13 Score=137.62 Aligned_cols=112 Identities=19% Similarity=0.214 Sum_probs=91.6
Q ss_pred EEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHH
Q 013016 117 YAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196 (451)
Q Consensus 117 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i 196 (451)
|.|.+...... .......+-++-|+.++||||+++++.++..+++|||+|-+ ..|..++++. ....+.-.
T Consensus 40 vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~v~~G 109 (690)
T KOG1243|consen 40 VSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEEVCLG 109 (690)
T ss_pred eEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHHHHHH
Confidence 55555543321 33344555678899999999999999999999999999987 4566677663 46667778
Q ss_pred HHHHHHHHHHHH-HCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 197 AAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 197 ~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+.||+.||.||| +.+++|++|.-+-|+|+..|..||++|.++
T Consensus 110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 999999999998 688999999999999999999999999886
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.6e-14 Score=146.33 Aligned_cols=152 Identities=18% Similarity=0.236 Sum_probs=96.8
Q ss_pred CCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH----------------------
Q 013016 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK---------------------- 129 (451)
Q Consensus 72 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------- 129 (451)
+......+.+|+. +-||.|++|.||+|+++.+++. ||||+.+......
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~---------VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~ 181 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGRE---------VVVKVLRPDILPVIDADLALMYRLARWVERLLPDG 181 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCE---------EEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCccc
Confidence 3333445667887 7899999999999999874443 9999998553110
Q ss_pred -----H----HHHHH------HHHHHHHHHHC----CCCCccceeEEEE-eCCeEEEEEeeccCCchhhhhhhCCCC---
Q 013016 130 -----K----KKVHR------AEMEKKILKML----DHPFLPTLYAEFE-ASNFSCIVMEFCSGGDLHSLRHKQPHK--- 186 (451)
Q Consensus 130 -----~----~~~~~------~~~e~~~l~~l----~h~nIv~l~~~~~-~~~~~~lV~E~~~ggsL~~~l~~~~~~--- 186 (451)
. +.... +.+|+..+.++ .+.+.+.+-.++. -....+|||||+.|+.|.++..-...+
T Consensus 182 ~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~ 261 (537)
T PRK04750 182 RRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM 261 (537)
T ss_pred ccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH
Confidence 0 11111 23344333333 2333333333332 245678999999999998753211111
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEEeccCcccc
Q 013016 187 -RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIMLSDFDLSLC 240 (451)
Q Consensus 187 -~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl~Dfg~a~~ 240 (451)
.+....+..++.|+ ...|++|+|+||.||+++.+| +++++|||+...
T Consensus 262 ~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 262 KLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 23333344444444 358999999999999999888 999999999743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.8e-13 Score=118.59 Aligned_cols=127 Identities=23% Similarity=0.300 Sum_probs=94.3
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEeCCe
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEASNF 163 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~ 163 (451)
++.|+.|.++.||++...+. .|++|+...... ....+..|+.+++.+.+.++ ++++.+.. ..
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~-----------~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~ 65 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANK-----------KYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ET 65 (170)
T ss_pred eeecCCcccCceEEEEECCe-----------EEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC
Confidence 45689999999999986532 299999864421 12234568888888865554 45665443 34
Q ss_pred EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeccCCCCcEEEccCCCEEEeccCcc
Q 013016 164 SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGI-----IYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 164 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~gi-----vH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.++|||+++|.++.+. . . ....++.+++.+|+.||..++ +|+|++|.||+++ ++.++++|||.+
T Consensus 66 ~~lv~e~i~G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a 134 (170)
T cd05151 66 GVLITEFIEGSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA 134 (170)
T ss_pred CeEEEEecCCCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence 5799999999887643 0 1 123456889999999999885 9999999999999 778999999997
Q ss_pred c
Q 013016 239 L 239 (451)
Q Consensus 239 ~ 239 (451)
.
T Consensus 135 ~ 135 (170)
T cd05151 135 G 135 (170)
T ss_pred c
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.9e-12 Score=114.60 Aligned_cols=144 Identities=19% Similarity=0.166 Sum_probs=99.3
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----------------------HHHHHHHHHHHHHH
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----------------------KKKKVHRAEMEKKI 142 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~e~~~ 142 (451)
..||.|--+.||.|....... +...+..+|||+.+-.... ........+.|...
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~ 79 (197)
T cd05146 3 GCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHN 79 (197)
T ss_pred CccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHH
Confidence 468999999999997543100 0001124999998532110 00112223478999
Q ss_pred HHHCCC--CCccceeEEEEeCCeEEEEEeeccCCchhh-hhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeccCC
Q 013016 143 LKMLDH--PFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALEYL-HMLGIIYRDLK 218 (451)
Q Consensus 143 l~~l~h--~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~~~~i~~qil~aL~~L-H~~givH~Dlk 218 (451)
|+++.. -+++.++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |+.||||+||+
T Consensus 80 L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 80 LKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 998853 567777765 45689999996543321 2222 2355667788899999999998 89999999999
Q ss_pred CCcEEEccCCCEEEeccCcccc
Q 013016 219 PENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 219 p~NIll~~~~~~kl~Dfg~a~~ 240 (451)
+.|||+. ++.+.|+|||.+..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEE-CCcEEEEECCCcee
Confidence 9999997 57899999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-13 Score=135.57 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=178.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
.....+|..+..||.|.|+.|+.+..+. +++..|++|-..+.......... -..|+.+...+ .|.+++..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCC
Confidence 3445689999999999999999876331 22335888887665443333222 23355555555 58999998
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEEe
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIMLS 233 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~ 233 (451)
+..+......|+--|||.++++...+.. ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcc
Confidence 8888888888899999999988765422 2447888999999999999999999999999999999999986 788899
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||....+. .....+.+.-.++
T Consensus 410 ~~~~~t~~~----------------------------------------------------------~~~~~~~~~~r~~ 431 (524)
T KOG0601|consen 410 DFGCWTRLA----------------------------------------------------------FSSGVFHHIDRLY 431 (524)
T ss_pred ccccccccc----------------------------------------------------------eeccccccccccc
Confidence 999863100 0000112223344
Q ss_pred --CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 314 --SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 314 --aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+++......+..++|++|||.-+.+.++|...-..... ...+..+....... .. .++..+.+.++..++.
T Consensus 432 p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~p~~~~----~~-~~~q~~~kv~~~~~~~ 503 (524)
T KOG0601|consen 432 PIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDTPNLPG----LK-LQLQVLLKVMINPDRK 503 (524)
T ss_pred ccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccccCCCc----hH-HhhhhhhhhhcCCccc
Confidence 44444455678899999999999999998775443222 22233332221111 11 3788999999999999
Q ss_pred CcCCCCCChHHHHcCCCcC
Q 013016 392 NRLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~ 410 (451)
.|+. +.++..|.=|.
T Consensus 504 ~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 504 RRPS----AVELSLHSEFY 518 (524)
T ss_pred cchh----hhhhcccchhh
Confidence 9999 88888776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-11 Score=107.29 Aligned_cols=135 Identities=24% Similarity=0.240 Sum_probs=99.8
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcc-----hHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN-----KEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
.+++|+-+.+|.+.+.+.. +++|.=. .......-...+..+|+.++.++.--.|...+=++.+.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-----------av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~ 71 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-----------AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP 71 (204)
T ss_pred hhhCCcceeEEeeeccCcc-----------eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence 4788999999988664432 4555332 22223333445567799999988765665555556667
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+...|+|||++|..|.+++... ...++..+-.-+.-||.+||||+||+++||++..++ +.++|||++...
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 7778999999999998888765 245677788888899999999999999999998665 999999998644
Q ss_pred C
Q 013016 242 N 242 (451)
Q Consensus 242 ~ 242 (451)
+
T Consensus 142 ~ 142 (204)
T COG3642 142 D 142 (204)
T ss_pred c
Confidence 3
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-11 Score=105.49 Aligned_cols=148 Identities=24% Similarity=0.214 Sum_probs=108.8
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEE-----EcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMK-----VVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK-----~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
....|-+|+-+.|+++.+.+.. ..|| ..+.......-...+...|+.++.++.--.|.-..=+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~-----------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEA-----------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccCCce-----------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 5667889999999999876543 3444 33333333334455667799999988765665544556
Q ss_pred EeCCeEEEEEeeccC-CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CEEEec
Q 013016 159 EASNFSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIMLSD 234 (451)
Q Consensus 159 ~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl~D 234 (451)
.+...-+|+|||++| .++.+++...-...........++++|-..+.-||.++|||+||..+||++..+| .+.|+|
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEe
Confidence 666667899999966 3777877665444444444478899999999999999999999999999998765 458999
Q ss_pred cCcccccC
Q 013016 235 FDLSLCSN 242 (451)
Q Consensus 235 fg~a~~~~ 242 (451)
||++....
T Consensus 160 fgls~~s~ 167 (229)
T KOG3087|consen 160 FGLSSVSR 167 (229)
T ss_pred ecchhccc
Confidence 99986543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-12 Score=133.39 Aligned_cols=171 Identities=21% Similarity=0.310 Sum_probs=119.7
Q ss_pred HHHHHHHHHH-HCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhc
Q 013016 199 EVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLN 277 (451)
Q Consensus 199 qil~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (451)
+++.||.|+| +.++||++|.|++|.++..|.+||+.|+++......-.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~------------------------------- 155 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE------------------------------- 155 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-------------------------------
Confidence 3449999999 57899999999999999999999999998743221000
Q ss_pred cccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q 013016 278 RFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLR 356 (451)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ell-tg~~pf~~~~~~~~~~ 356 (451)
............-..-...|.|||++.+...+.++|+||+||++|.+. .|+..+...+.... .
T Consensus 156 ---------------~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~ 219 (700)
T KOG2137|consen 156 ---------------YPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-Y 219 (700)
T ss_pred ---------------cccccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch-h
Confidence 000001111111123456799999999977899999999999999999 56666655433322 2
Q ss_pred HHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccccccc
Q 013016 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420 (451)
Q Consensus 357 ~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~ 420 (451)
..................+.++++-|.++|..++..||+ +.+++.-|||+.-..+.++.+
T Consensus 220 ~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 220 SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRFL 279 (700)
T ss_pred hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchhhhhhhc
Confidence 222222222332333344459999999999999999999 999999999999666655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.9e-11 Score=109.75 Aligned_cols=139 Identities=22% Similarity=0.266 Sum_probs=104.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC--CCccceeEEEEeC--
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH--PFLPTLYAEFEAS-- 161 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~-- 161 (451)
+.||.|..+.||++...++. .+++|+....... .....+..|.++++.+.+ ..+++++.+....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~----------~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~ 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGR----------RLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV 71 (223)
T ss_pred eecCCCccceEEEEEecCCc----------ceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence 46899999999999875422 2999998754221 123456779999999876 4467788877654
Q ss_pred -CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 013016 162 -NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM------------------------------- 209 (451)
Q Consensus 162 -~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------- 209 (451)
+..++||||++|.+|.+.+.. ..+++.....++.+++.+|..||+
T Consensus 72 ~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 72 LGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred cCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 367899999999988775432 236777777788888888888873
Q ss_pred -------------------------CCCeeccCCCCcEEEcc--CCCEEEeccCccc
Q 013016 210 -------------------------LGIIYRDLKPENVLVRS--DGHIMLSDFDLSL 239 (451)
Q Consensus 210 -------------------------~givH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 239 (451)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5678999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.4e-10 Score=109.65 Aligned_cols=213 Identities=16% Similarity=0.169 Sum_probs=150.1
Q ss_pred CeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE----eCCeEEEE
Q 013016 92 DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE----ASNFSCIV 167 (451)
Q Consensus 92 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~----~~~~~~lV 167 (451)
-..+.|+|+.+-++. .|++|.+......... ....-+++++++.|.|||++.++|. .+..+++|
T Consensus 288 ~~~Ttyk~~s~~DG~---------~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvlv 355 (655)
T KOG3741|consen 288 FSITTYKATSNVDGN---------AYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLV 355 (655)
T ss_pred ccceeEeeeeccCCc---------eeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEE
Confidence 456889998877765 3999999433222221 2222467899999999999999886 34478999
Q ss_pred EeeccC-CchhhhhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 168 MEFCSG-GDLHSLRHKQP-------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 168 ~E~~~g-gsL~~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
|+|.++ ++|.++..... +...++..+|.++.||..||.++|+.|+.-+-|.+.+||++.+.+++|.
T Consensus 356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS 435 (655)
T KOG3741|consen 356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRIS 435 (655)
T ss_pred EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEe
Confidence 999876 46777544321 2347899999999999999999999999999999999999998889988
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
..|+......
T Consensus 436 ~C~i~Dvl~~---------------------------------------------------------------------- 445 (655)
T KOG3741|consen 436 GCGIMDVLQE---------------------------------------------------------------------- 445 (655)
T ss_pred cccceeeecC----------------------------------------------------------------------
Confidence 8776421110
Q ss_pred Cc-ccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SP-EVASGGSHGNAVDWWAFGIFIYEMIYGRTP-FAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aP-E~~~~~~~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
-| |-+.+ -.+-|.=.||.+++.|.||..- +........ +..|.. .++.+++++|.-+...++
T Consensus 446 d~~~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~------------~yS~D~rn~v~yl~s~~~ 510 (655)
T KOG3741|consen 446 DPTEPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITT------------TYSTDLRNVVEYLESLNF 510 (655)
T ss_pred CCCcchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhh------------hhhHHHHHHHHHHHhcCc
Confidence 01 11212 2356888999999999999654 222222222 233222 233488899999999888
Q ss_pred CCcCCCCCChHHHHcC
Q 013016 391 CNRLGSKRGAADVKTH 406 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~h 406 (451)
++ .+ +.+++.|
T Consensus 511 ~~-ks----I~~llp~ 521 (655)
T KOG3741|consen 511 RE-KS----IQDLLPM 521 (655)
T ss_pred cc-cc----HHHHHHH
Confidence 86 45 7777754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-10 Score=101.69 Aligned_cols=99 Identities=28% Similarity=0.338 Sum_probs=68.7
Q ss_pred HHHHHHHHHHHHHCCCC--CccceeEEEEeCCeEEEEEeecc--CCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHH-H
Q 013016 133 VHRAEMEKKILKMLDHP--FLPTLYAEFEASNFSCIVMEFCS--GGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY-L 207 (451)
Q Consensus 133 ~~~~~~e~~~l~~l~h~--nIv~l~~~~~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~-L 207 (451)
..+..+|.+.|.++..- ++++++++. ..+|||||+. |..+..+.... ++......++.+++..+.. +
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHH
Confidence 34467799999999765 567777553 3479999997 66665544332 2245567788888886665 5
Q ss_pred HHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
|..||+|+||++.|||++.+ .+.|+|||.+..
T Consensus 124 ~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 124 HKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 79999999999999999977 999999999853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=9.5e-10 Score=103.82 Aligned_cols=104 Identities=19% Similarity=0.080 Sum_probs=82.0
Q ss_pred HHHHHHHHHHCCCCCc--cceeEEEEe-----CCeEEEEEeeccCC-chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 013016 136 AEMEKKILKMLDHPFL--PTLYAEFEA-----SNFSCIVMEFCSGG-DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207 (451)
Q Consensus 136 ~~~e~~~l~~l~h~nI--v~l~~~~~~-----~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L 207 (451)
..+|...+.++..-+| +.++.+++. ....+||||++++. +|.+++........+......++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 5678888888855454 444556543 23578999999776 799888643334456778889999999999999
Q ss_pred HHCCCeeccCCCCcEEEcc-------CCCEEEeccCccc
Q 013016 208 HMLGIIYRDLKPENVLVRS-------DGHIMLSDFDLSL 239 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~-------~~~~kl~Dfg~a~ 239 (451)
|++||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999985 4689999999874
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.3e-08 Score=87.80 Aligned_cols=137 Identities=18% Similarity=0.221 Sum_probs=92.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHH------HHHHHHHHHC---CCCC
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA------EMEKKILKML---DHPF 150 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~e~~~l~~l---~h~n 150 (451)
++|.+.+.+-......|.+-...+.. +++|..+.+.......+..+ .+.+..+.++ ..-.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~k-----------yIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKK-----------YILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcE-----------EEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 67999999999888888877655532 99999986644333332222 1222323333 2233
Q ss_pred ccceeEEEE-----eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 151 LPTLYAEFE-----ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 151 Iv~l~~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
+..++.+.+ .....+|||||++|..|.++.. +++ .+...|..++.-||+.|++|+|.+|.|++++
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 333333332 2235679999999998877632 232 2445677889999999999999999999999
Q ss_pred cCCCEEEeccCcc
Q 013016 226 SDGHIMLSDFDLS 238 (451)
Q Consensus 226 ~~~~~kl~Dfg~a 238 (451)
.+ .++++||+..
T Consensus 170 ~~-~i~iID~~~k 181 (229)
T PF06176_consen 170 NN-GIRIIDTQGK 181 (229)
T ss_pred CC-cEEEEECccc
Confidence 54 5999999875
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.2e-08 Score=93.91 Aligned_cols=137 Identities=25% Similarity=0.266 Sum_probs=101.5
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-------------------HHHHHHHHHHHHH
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-------------------KKKVHRAEMEKKI 142 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~e~~~ 142 (451)
+.+..+||.|--+.||.|.+....+ +|||.=+-....- .-.....++|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~----------~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRK----------VAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECCCCCE----------EEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 5577899999999999999875543 8999654221110 0012234668889
Q ss_pred HHHCCCC--CccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 143 LKMLDHP--FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 143 l~~l~h~--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
|.+|.-. .+++.+++ +..++|||++.|-.|...- +.......++..|+.-+.-+-..|+||+|+++=
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSef 231 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEF 231 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchh
Confidence 9998755 67777764 5678999999987776532 234455566667777777777999999999999
Q ss_pred cEEEccCCCEEEeccCccc
Q 013016 221 NVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~ 239 (451)
||++++||.+.++||-.+.
T Consensus 232 NIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred eEEEecCCCEEEEeCcccc
Confidence 9999999999999998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.7e-08 Score=92.64 Aligned_cols=238 Identities=19% Similarity=0.253 Sum_probs=151.6
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE-----
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE----- 157 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~----- 157 (451)
..+-||+|+-+.+|..-.-.+ -+.||..+....... + .++.|... .||-+-.=+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d------------~VAKIYh~Pppa~~a--q----k~a~la~~p~~p~~~~rvaWPqa~L 76 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD------------QVAKIYHAPPPAAQA--Q----KVAELAATPDAPLLNYRVAWPQATL 76 (637)
T ss_pred CCccccCCccceeeecchhhc------------hhheeecCCCchHHH--H----HHHHhccCCCCcchhhhhcccHHHh
Confidence 456799999999995432222 355887655332211 1 23333333 56654331111
Q ss_pred -EEe-CCeEEEEEeeccCCc-hhhhhh----hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 158 -FEA-SNFSCIVMEFCSGGD-LHSLRH----KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 158 -~~~-~~~~~lV~E~~~ggs-L~~~l~----~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
... ....-+.|+.+.|.. +.+++. ++....+.|.-+.+.++.|+.+.+-||..|-+-+|+.++|+|+.+++.+
T Consensus 77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceE
Confidence 112 223678888887652 333322 2223447899999999999999999999999999999999999999999
Q ss_pred EEeccCcc-cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 231 MLSDFDLS-LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 231 kl~Dfg~a-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
.|+|=..- .+.+ ......-+|.
T Consensus 157 ~LVdsDsfqi~~n---------------------------------------------------------g~~~~cpVg~ 179 (637)
T COG4248 157 VLVDSDSFQINAN---------------------------------------------------------GTLHLCPVGV 179 (637)
T ss_pred EEEcccceeeccC---------------------------------------------------------CceEecccCc
Confidence 99974210 0000 0001112788
Q ss_pred CCccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCC-------ChHH-HH--------HHHhcCCCCCCC
Q 013016 310 HEYVSPEVAS-----GGSHGNAVDWWAFGIFIYEMIYG-RTPFAAP-------SNET-TL--------RNIVKKPLTFPT 367 (451)
Q Consensus 310 ~~y~aPE~~~-----~~~~~~~~DIwSlG~il~elltg-~~pf~~~-------~~~~-~~--------~~i~~~~~~~~~ 367 (451)
..|.+||... |..-+...|.|-||++|++||.| +-||.+. +..+ .+ .+-..+..+.|.
T Consensus 180 ~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~ 259 (637)
T COG4248 180 SEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPR 259 (637)
T ss_pred cccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCC
Confidence 9999999864 23346789999999999999986 9999752 2222 11 111112334444
Q ss_pred CCCCCcChHHHHHHHHHhcccC--cCCcCCC
Q 013016 368 QSPSSMSEYHARDLISGLLNKD--PCNRLGS 396 (451)
Q Consensus 368 ~~~~~~~~~~~~~ll~~~L~~d--P~~Rpt~ 396 (451)
.++-.+.+..+..|..+|++.- +.-|||+
T Consensus 260 ~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 260 SIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred CCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 5555556668899999999853 5689994
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=3e-08 Score=90.43 Aligned_cols=103 Identities=28% Similarity=0.294 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHCCCCC--ccceeEEEEeCC----eEEEEEeeccCC-chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 013016 135 RAEMEKKILKMLDHPF--LPTLYAEFEASN----FSCIVMEFCSGG-DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207 (451)
Q Consensus 135 ~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~----~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~L 207 (451)
+..+|...+..+..-+ .++.+++.+... ..+||+|+++|. +|.+++..... .+......++.+++..++-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence 4556777777775444 566677666532 468999999874 79998876433 66777889999999999999
Q ss_pred HHCCCeeccCCCCcEEEccCC---CEEEeccCccc
Q 013016 208 HMLGIIYRDLKPENVLVRSDG---HIMLSDFDLSL 239 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~~~---~~kl~Dfg~a~ 239 (451)
|++||+|+|+++.|||++.++ .+.|+||+.+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999999887 89999999874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.7e-08 Score=87.28 Aligned_cols=139 Identities=14% Similarity=0.101 Sum_probs=97.2
Q ss_pred ccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH---HHHHHHHHHHHHHHHHCCCCC--ccceeEEEE-eC-
Q 013016 89 GAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK---KKKVHRAEMEKKILKMLDHPF--LPTLYAEFE-AS- 161 (451)
Q Consensus 89 G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~-~~- 161 (451)
|.||-+.|+.....+. .+=||.-....... +.....+.+|...+.++..-+ ++++. ++. ..
T Consensus 27 ~rgG~SgV~r~~~~g~-----------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~ 94 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-----------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI 94 (216)
T ss_pred CCCCcceEEEEEeCCc-----------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc
Confidence 4577777877654433 26666554111111 122345667888888885433 45555 332 11
Q ss_pred ---CeEEEEEeeccC-CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC--EEEecc
Q 013016 162 ---NFSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH--IMLSDF 235 (451)
Q Consensus 162 ---~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Df 235 (451)
-..+||+|-+.| .+|.+++....-.+.+......++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 257899998843 58888876654445678888899999999999999999999999999999987777 999999
Q ss_pred Cccc
Q 013016 236 DLSL 239 (451)
Q Consensus 236 g~a~ 239 (451)
..+.
T Consensus 175 Ek~r 178 (216)
T PRK09902 175 EKSR 178 (216)
T ss_pred hccc
Confidence 8763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.3e-07 Score=82.85 Aligned_cols=134 Identities=25% Similarity=0.247 Sum_probs=93.2
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---------------------HHHHHHHHHHHHHHH
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---------------------KKVHRAEMEKKILKM 145 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~ 145 (451)
.|..|--+.||+|...... .+|+|+++.....-. ....+...|..-|++
T Consensus 55 ~istGKEA~Vy~a~~~~~~----------~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R 124 (268)
T COG1718 55 CISTGKEANVYLAETGDGR----------YVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKR 124 (268)
T ss_pred eecCCcceEEEeeccCCCc----------eEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 5667777889998764332 399999975433211 123334557777777
Q ss_pred CC--CCCccceeEEEEeCCeEEEEEeeccCCchhh--hhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCC
Q 013016 146 LD--HPFLPTLYAEFEASNFSCIVMEFCSGGDLHS--LRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPE 220 (451)
Q Consensus 146 l~--h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~--~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~ 220 (451)
+. +-.+++-+.+.. -.|||||+ |....- .|. ...+....+..+..++++.+.-|-. .|+||+||+.=
T Consensus 125 ~~eAGVrvP~Pi~~~~----nVLvMEfI-g~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy 196 (268)
T COG1718 125 AYEAGVRVPEPIAFRN----NVLVMEFI-GDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY 196 (268)
T ss_pred HHHcCCCCCCceeecC----CeEEEEec-cCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence 73 555666666553 36999999 433110 111 1223444688889999999998887 99999999999
Q ss_pred cEEEccCCCEEEeccCccc
Q 013016 221 NVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~ 239 (451)
|||+. ++.+.++|||.|.
T Consensus 197 NiL~~-~~~p~iID~~QaV 214 (268)
T COG1718 197 NILVH-DGEPYIIDVSQAV 214 (268)
T ss_pred heEEE-CCeEEEEECcccc
Confidence 99999 8899999999984
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.7e-07 Score=84.44 Aligned_cols=139 Identities=27% Similarity=0.361 Sum_probs=82.3
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC--CccceeEEEE---
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP--FLPTLYAEFE--- 159 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--nIv~l~~~~~--- 159 (451)
++.|+.|..+.||++...+ ++ +++|+.... .....+..|..+++.+... .+++++....
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~----------~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~ 65 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GR----------YVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE 65 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SE----------EEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE
T ss_pred CccCCCCCeeeEEEEEECC-cE----------EEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc
Confidence 4679999999999998776 32 999998754 2334455678888777533 3567776443
Q ss_pred eCCeEEEEEeeccCCchhh----------------hh---hhC--CCCCCCHHH---------HHHH------------H
Q 013016 160 ASNFSCIVMEFCSGGDLHS----------------LR---HKQ--PHKRFSLTS---------ARFY------------A 197 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~ 197 (451)
.....+++|++++|..+.. .+ +.. ....+.... .... .
T Consensus 66 ~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (239)
T PF01636_consen 66 FNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDL 145 (239)
T ss_dssp ETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHH
T ss_pred ccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhh
Confidence 3346799999999988776 11 111 111111100 0000 1
Q ss_pred HHHHH-HHHHHHH-------CCCeeccCCCCcEEEc-cCCCEEEeccCccc
Q 013016 198 AEVLV-ALEYLHM-------LGIIYRDLKPENVLVR-SDGHIMLSDFDLSL 239 (451)
Q Consensus 198 ~qil~-aL~~LH~-------~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 239 (451)
..+.. .+..+++ ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 146 EELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 11222 3333332 4599999999999999 66667899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4e-07 Score=93.17 Aligned_cols=153 Identities=24% Similarity=0.322 Sum_probs=94.0
Q ss_pred cCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-------------------
Q 013016 71 FGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK------------------- 131 (451)
Q Consensus 71 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------- 131 (451)
++.+....+.+|.- .-|+.++-|.||+|+++.+. .|||||.+......-.
T Consensus 117 LG~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~----------~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~ 185 (517)
T COG0661 117 LGRPIEELFSEFEP-EPIASASIAQVHRAVLKSGE----------EVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPG 185 (517)
T ss_pred hCCCHHHHHHHcCC-CchhhhhHhhheeEEecCCC----------EEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 34333344445542 46899999999999999744 3999999754321100
Q ss_pred ------------HHH------HHHHHHHHHHHC-----CCCC--ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCC
Q 013016 132 ------------KVH------RAEMEKKILKML-----DHPF--LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK 186 (451)
Q Consensus 132 ------------~~~------~~~~e~~~l~~l-----~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~ 186 (451)
..+ ++.+|..-+.++ ..++ |++++ .+-.+.-.|+|||+.|..+.+...... .
T Consensus 186 ~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~-~ 262 (517)
T COG0661 186 GRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKS-A 262 (517)
T ss_pred cccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHh-c
Confidence 000 122344444443 1233 23333 233456789999999999998753332 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 187 ~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++...+.....++. +..+-..|++|.|.+|.||+++.+|++.+.|||+..
T Consensus 263 g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 263 GIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred CCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCccee
Confidence 355333322222221 222334899999999999999999999999999963
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.56 E-value=7e-07 Score=82.52 Aligned_cols=135 Identities=13% Similarity=0.115 Sum_probs=83.8
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC--ccceeEEEEeCCe
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF--LPTLYAEFEASNF 163 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~~ 163 (451)
..||.|..+.||++. ..+ +++|+..... ....+.+|.++++.+..-+ +++++++....+.
T Consensus 7 ~~i~~G~t~~~y~~~---~~~----------~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~ 68 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGK----------WMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR 68 (226)
T ss_pred eeecCCCCcceeEec---CCC----------EEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe
Confidence 468999999999842 111 7899987532 1233566899998886444 5788888888888
Q ss_pred EEEEEeeccCCc-hhhh---------------------hhhCCCCCCCHHHHHH-HHHH----------HHHH-HHHHH-
Q 013016 164 SCIVMEFCSGGD-LHSL---------------------RHKQPHKRFSLTSARF-YAAE----------VLVA-LEYLH- 208 (451)
Q Consensus 164 ~~lV~E~~~ggs-L~~~---------------------l~~~~~~~l~~~~~~~-i~~q----------il~a-L~~LH- 208 (451)
..+|||+++|.+ +... ++..+........... +..+ +... ..+|.
T Consensus 69 ~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~ 148 (226)
T TIGR02172 69 LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE 148 (226)
T ss_pred eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence 899999998863 1111 1111111111111111 1111 1111 12222
Q ss_pred ---HCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 209 ---MLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 209 ---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
...++|+|+.|.||++++++ +.++||+.+.
T Consensus 149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 12479999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.2e-09 Score=104.72 Aligned_cols=245 Identities=18% Similarity=0.178 Sum_probs=163.4
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~ 160 (451)
|...+.+++|+++++++.+..... +...+++... .....++++|.+++||| .+..++-++.
T Consensus 244 s~~fh~fvK~altknpKkRptaek----------lL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~ 305 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEK----------LLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDG 305 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhh----------heeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCc
Confidence 566677899999999987654433 2446665432 23334788999999999 7777777888
Q ss_pred CCeEEEEEeeccCC-chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGG-DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+.+++++++.++ +....... ....+..-+...+.+.-+++|++||+.-=+|+| ||+..+ +..++.||+...
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred ccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCc
Confidence 88999999999776 22221111 112244455566778888999999988668888 777664 678899998753
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.+... ....++.+++.++|||+..
T Consensus 380 ~L~~~--------------------------------------------------------~~~~t~~~~~~~~~pev~~ 403 (829)
T KOG0576|consen 380 QLTRT--------------------------------------------------------MKPRTAIGTPEPLAPEVIQ 403 (829)
T ss_pred ccCcc--------------------------------------------------------cccccCCCCCCCCCchhhc
Confidence 22110 0233568999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
.+.+....|+|++|.-..+|--|-+|-..+... ...+-.+.-.+.......+....-.++...|+...|..|+.
T Consensus 404 ~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---- 477 (829)
T KOG0576|consen 404 ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---- 477 (829)
T ss_pred ccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc----
Confidence 999999999999998777777777775542110 00010111000000000011101125788899999999999
Q ss_pred hHHHHcCCCcCCC
Q 013016 400 AADVKTHPFFKGL 412 (451)
Q Consensus 400 ~~ell~hp~~~~~ 412 (451)
...++.|.+|.+-
T Consensus 478 ~mgacfsKvfngC 490 (829)
T KOG0576|consen 478 HMGACFSKVFNGC 490 (829)
T ss_pred hhhHHHHHHhccC
Confidence 9999999999983
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.1e-06 Score=80.36 Aligned_cols=135 Identities=19% Similarity=0.111 Sum_probs=82.7
Q ss_pred eccCCe-eEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEEeCCeEE
Q 013016 88 IGAGDI-GTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFEASNFSC 165 (451)
Q Consensus 88 LG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~ 165 (451)
|..|.+ +.||++...+ . .+.||+..... ...+..|+++++.+. +--+++++++....+..+
T Consensus 6 ~~~g~~~~~v~~~~~~~-~----------~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 68 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-P----------GLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAW 68 (244)
T ss_pred cCCCCCcCeEEEEcCCC-C----------cEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccE
Confidence 444544 7899886543 2 28899986542 233455888887774 445778888887777889
Q ss_pred EEEeeccCCchhhhh-------------------hhCCCC--CCCHH--HHHHH-----------------------HHH
Q 013016 166 IVMEFCSGGDLHSLR-------------------HKQPHK--RFSLT--SARFY-----------------------AAE 199 (451)
Q Consensus 166 lV~E~~~ggsL~~~l-------------------~~~~~~--~l~~~--~~~~i-----------------------~~q 199 (451)
+|||+++|.+|.... +..+.. ++... ..... ..+
T Consensus 69 lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (244)
T cd05150 69 LLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEE 148 (244)
T ss_pred EEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHH
Confidence 999999998776431 111111 11100 00000 111
Q ss_pred HHHHHHHH----HHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 200 VLVALEYL----HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 200 il~aL~~L----H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++..|... ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 149 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 149 LYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 11111111 12348999999999999987778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.7e-06 Score=91.87 Aligned_cols=206 Identities=22% Similarity=0.268 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHHHCCCCCccceeEEEEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 013016 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH 208 (451)
Q Consensus 133 ~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH 208 (451)
....+.|...+.++.|+|++.++.+..... ...+..|+|.+.++...+... ...+...++.+..++++||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 344455788889999999999999886543 234556788888888777765 55889999999999999999999
Q ss_pred HCCCeeccCCCC---cEEEccCCCEEEe--ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCc
Q 013016 209 MLGIIYRDLKPE---NVLVRSDGHIMLS--DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSK 283 (451)
Q Consensus 209 ~~givH~Dlkp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (451)
+..+.|.-+..+ +-.++.++.+.+. ||+.+........
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~------------------------------------- 346 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK------------------------------------- 346 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-------------------------------------
Confidence 997666666555 4444555666655 7776532221100
Q ss_pred cccccCCCcccccccccccccccccCCCccCcccccCCCCCc--chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Q 013016 284 KIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN--AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361 (451)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 361 (451)
.....-...+.++|......+.. ..|+|.+|.....+..|..+-... .....++..
T Consensus 347 -------------------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l~~ 404 (1351)
T KOG1035|consen 347 -------------------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLLDV 404 (1351)
T ss_pred -------------------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhhcc
Confidence 01113345578888877766544 469999999999999876553321 111111111
Q ss_pred CCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.......+++.+|+.-++++|+. +.+++.|+|.+.-..
T Consensus 405 -----------~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 405 -----------LSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRFPTD 442 (1351)
T ss_pred -----------ccchhhhhhhhhhcchhhhhccc----hhhhhhchhcccccc
Confidence 11114678899999999999999 999999999988333
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.2e-06 Score=90.13 Aligned_cols=84 Identities=20% Similarity=0.317 Sum_probs=57.2
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCc--cceeEEEEe
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFL--PTLYAEFEA 160 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nI--v~l~~~~~~ 160 (451)
-...|+.|.+..+|+......... ..+++|+....... .....+.+|..+++.+. |.+| ++++.++.+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~-------~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d 112 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSV-------KRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD 112 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcc-------eeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC
Confidence 356789999999999876543210 02778876533211 11235667999999985 6665 788888766
Q ss_pred C---CeEEEEEeeccCCch
Q 013016 161 S---NFSCIVMEFCSGGDL 176 (451)
Q Consensus 161 ~---~~~~lV~E~~~ggsL 176 (451)
. +..|+||||++|..+
T Consensus 113 ~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 113 ASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCcCCCceEEEEecCCccc
Confidence 4 468999999988653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.4e-06 Score=72.95 Aligned_cols=129 Identities=27% Similarity=0.332 Sum_probs=94.0
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~ 160 (451)
....+.||+|..|.||+|.+.+.. +|+|+-+.+. ....++.|+++|..+.-.++ .++|.+.++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~-----------~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGE-----------VALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCce-----------EEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh
Confidence 445678999999999999998763 8999987542 33566779999999987775 566665554
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC-CCcEEEccCCCEEEeccCccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLK-PENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlk-p~NIll~~~~~~kl~Dfg~a~ 239 (451)
++.|||+.|.+|.++-... + .+-+..++++---|-..||-|+.|. |..+++..++.+-|+||..|.
T Consensus 88 ----~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 ----FIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred ----hhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 3559999888887653221 2 2233445666555667899999986 666666667799999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=82.49 Aligned_cols=139 Identities=22% Similarity=0.249 Sum_probs=86.9
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH----------------------------HHHHHH--
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK----------------------------KKKVHR-- 135 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~-- 135 (451)
+-||.-+.|.||+|+.+++. .|||||-+...... ++..+.
T Consensus 167 ~piaaASlaQVhrA~L~~G~----------~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGE----------DVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecCCC----------EEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 46899999999999999844 39999986543211 000011
Q ss_pred ----HHHHHHH----HHHCCCCC------ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHH
Q 013016 136 ----AEMEKKI----LKMLDHPF------LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201 (451)
Q Consensus 136 ----~~~e~~~----l~~l~h~n------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil 201 (451)
+..|++- .+.+.|-+ |+++|-.+ ...-.|+||||+|..+.|+..-.. ..++...+..-+.++.
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY 313 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH
Confidence 1223322 22233444 45555322 345789999999998887643332 2366554433333322
Q ss_pred HHHHHHHHCCCeeccCCCCcEEEcc----CCCEEEeccCccc
Q 013016 202 VALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSL 239 (451)
Q Consensus 202 ~aL~~LH~~givH~Dlkp~NIll~~----~~~~kl~Dfg~a~ 239 (451)
.- -|=..|++|+|=+|.||+++. ++.+.+-|||+..
T Consensus 314 ~~--qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 314 LE--QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred HH--HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 11 122568999999999999994 5689999999974
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.2e-05 Score=68.38 Aligned_cols=128 Identities=23% Similarity=0.308 Sum_probs=90.2
Q ss_pred CCceEEeeeccCCe-eEEEEEEeccccccCCCCCCcceEEEEEcchHHH----------HH--------HHHHHHHHHHH
Q 013016 80 RDFDLHRRIGAGDI-GTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL----------EK--------KKKVHRAEMEK 140 (451)
Q Consensus 80 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~--------~~~~~~~~~e~ 140 (451)
.+++.++.||.|.- |.||++...+. .||||++..-.. .. .....-+..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-----------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-----------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-----------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 67999999999999 99999998765 399999322100 00 02334566677
Q ss_pred HHHHHCC---CCCc--cceeEEEEeC------------------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHH
Q 013016 141 KILKMLD---HPFL--PTLYAEFEAS------------------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197 (451)
Q Consensus 141 ~~l~~l~---h~nI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~ 197 (451)
+...+|+ +.++ |+.+||..-. ....||.||++... .+.. .-+
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~ 170 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDI 170 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHH
Confidence 7777764 5566 8888888322 13467777765432 1222 335
Q ss_pred HHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 198 ~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+|++-|..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 171 ~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 66888889999999999999999987 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.1e-05 Score=68.92 Aligned_cols=130 Identities=21% Similarity=0.266 Sum_probs=89.1
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-------------HHHHHHHHHHHHHHHHHCC-----
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-------------KKKKVHRAEMEKKILKMLD----- 147 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~----- 147 (451)
..||.|+.-.||.--+ +.. .+|||....... .........+|+.....+.
T Consensus 7 ~~i~~G~~R~cy~HP~--dp~----------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~ 74 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD--DPN----------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGV 74 (199)
T ss_pred cccccCCCceEEECCC--CCC----------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCC
Confidence 3589999999996322 222 799999876500 0112334445665555554
Q ss_pred -CCCccceeEEEEeCCeEEEEEeeccCC------chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 148 -HPFLPTLYAEFEASNFSCIVMEFCSGG------DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 148 -h~nIv~l~~~~~~~~~~~lV~E~~~gg------sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
+.+|.+++|+.+++.-.-+|+|.+.+. +|.+++.. +.++. . +...+-+-..||-+++|+.+||+|.
T Consensus 75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~ 147 (199)
T PF10707_consen 75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPH 147 (199)
T ss_pred cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcc
Confidence 889999999999999899999987442 57777744 33555 2 3333444456888999999999999
Q ss_pred cEEEccCC----CEEEec
Q 013016 221 NVLVRSDG----HIMLSD 234 (451)
Q Consensus 221 NIll~~~~----~~kl~D 234 (451)
||++.... .+.|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 99997442 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.6e-05 Score=71.13 Aligned_cols=96 Identities=24% Similarity=0.282 Sum_probs=77.5
Q ss_pred HHHHHHHHCCC-CCccceeEEEEeCCeEEEEEeeccCCchhhh---hhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 013016 138 MEKKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSL---RHKQPHKRFSLTSARFYAAEVLVALEYLHM---L 210 (451)
Q Consensus 138 ~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~ 210 (451)
.|.-+++.+++ +++++++|+|.. ++|.||...+++... +... ...+|..+.+|+.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 37788888876 699999999943 579999977766532 1111 236899999999999999999997 4
Q ss_pred CCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 211 givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+.-.|++++|+.++.+|++|++|.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 47789999999999999999999998763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.5e-05 Score=74.40 Aligned_cols=80 Identities=24% Similarity=0.282 Sum_probs=53.4
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--H--HHHHHHHHHHHHHHHHCC---CCCccceeEE
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--K--KKKVHRAEMEKKILKMLD---HPFLPTLYAE 157 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---h~nIv~l~~~ 157 (451)
.+.||.|.+..||++.+.++.++ ++||.-...... . .-...+...|.+.|+.+. -.++++++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~s---------vIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKS---------VIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeE---------EEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 46799999999999998654322 899985422110 0 112345556777777752 3467888876
Q ss_pred EEeCCeEEEEEeeccCCc
Q 013016 158 FEASNFSCIVMEFCSGGD 175 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggs 175 (451)
. .+..++|||++++..
T Consensus 102 D--~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 D--EELAVTVMEDLSDHK 117 (401)
T ss_pred C--CCCCEEEEecCCCcc
Confidence 4 456789999997643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.5e-05 Score=72.74 Aligned_cols=73 Identities=11% Similarity=0.166 Sum_probs=46.1
Q ss_pred eeeccCCee-EEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC---CccceeEEEEeC
Q 013016 86 RRIGAGDIG-TVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP---FLPTLYAEFEAS 161 (451)
Q Consensus 86 ~~LG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---nIv~l~~~~~~~ 161 (451)
..|+.|+.. .||+.. . . +++|+..... ....+..|.+++..+... -+.++++.....
T Consensus 3 ~~~~~gG~~n~vy~~~---~-~----------~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~ 63 (235)
T cd05155 3 EPVDSGGTDNATFRLG---D-D----------MSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG 63 (235)
T ss_pred eeccCCCcccceEEcC---C-c----------eEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCc
Confidence 456766666 599752 1 1 7889876431 223566788888887532 355666544432
Q ss_pred ---CeEEEEEeeccCCchh
Q 013016 162 ---NFSCIVMEFCSGGDLH 177 (451)
Q Consensus 162 ---~~~~lV~E~~~ggsL~ 177 (451)
+..++||++++|.++.
T Consensus 64 ~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 64 EGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred cCCCcceEEEEeecCCCCC
Confidence 2458999999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00011 Score=71.03 Aligned_cols=78 Identities=14% Similarity=0.080 Sum_probs=55.5
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC---CCccceeEEEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH---PFLPTLYAEFE 159 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~nIv~l~~~~~ 159 (451)
.-.+.||.|..+.||.....+.. +.+|+.+.. .....+..|...|+.+.. ..++++++++.
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-----------~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~ 80 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-----------PMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMT 80 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-----------EEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEec
Confidence 33567999999999988654332 777885321 112356668888888853 46889998876
Q ss_pred eC---CeEEEEEeeccCCch
Q 013016 160 AS---NFSCIVMEFCSGGDL 176 (451)
Q Consensus 160 ~~---~~~~lV~E~~~ggsL 176 (451)
.+ +..+||||+++|.++
T Consensus 81 ~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 81 HEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred cCCcCCCeEEEEeccCCEec
Confidence 43 678999999988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=7e-05 Score=69.58 Aligned_cols=75 Identities=24% Similarity=0.356 Sum_probs=47.5
Q ss_pred EeeeccCCeeEEEEEEecc-ccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEEEeCC
Q 013016 85 HRRIGAGDIGTVYLCSLNN-KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEFEASN 162 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~ 162 (451)
++.|..|-...+|++.... ..+ .|++|+..... ........|..+++.+...+ .+++++.+. +
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~---------~~vlR~~~~~~----~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~- 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQD---------AVLVRVYGNKT----ELIIDRERELRIHKLLSKHGLAPKLYATFQ-N- 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCC---------eEEEEEccCCc----cceecHHHHHHHHHHHHhCCCCCeEEEEeC-C-
Confidence 4567888888999987553 111 28899876431 11123345888888885433 455655443 2
Q ss_pred eEEEEEeeccCCch
Q 013016 163 FSCIVMEFCSGGDL 176 (451)
Q Consensus 163 ~~~lV~E~~~ggsL 176 (451)
.+||||++|.++
T Consensus 68 --~~l~e~i~G~~l 79 (235)
T cd05157 68 --GLIYEFIPGRTL 79 (235)
T ss_pred --cEEEEeeCCCcC
Confidence 389999998776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00015 Score=69.94 Aligned_cols=138 Identities=22% Similarity=0.254 Sum_probs=82.4
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC--ccceeEE-----
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF--LPTLYAE----- 157 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~----- 157 (451)
.+.|..|....+|++...+. . +++|+.... ....+..|+.++..+.+.+ +++++..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~----------~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~ 81 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-R----------YVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEY 81 (296)
T ss_pred eecccCccccceEEEEeCCC-c----------EEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence 55677888889998865432 1 899998641 1233445777777774333 4454431
Q ss_pred -EEeCCeEEEEEeeccCCchhh----h----------hhhC----CCC-----CCCHHHH--H--------HHHHHHHHH
Q 013016 158 -FEASNFSCIVMEFCSGGDLHS----L----------RHKQ----PHK-----RFSLTSA--R--------FYAAEVLVA 203 (451)
Q Consensus 158 -~~~~~~~~lV~E~~~ggsL~~----~----------l~~~----~~~-----~l~~~~~--~--------~i~~qil~a 203 (451)
...++..++|+++++|..+.. . ++.. ... ...+... . .....+..+
T Consensus 82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 161 (296)
T cd05153 82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE 161 (296)
T ss_pred eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence 234456789999999877532 0 1110 000 0011110 0 011123334
Q ss_pred HHHHHH-------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 204 LEYLHM-------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 204 L~~LH~-------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.++.. .++||+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 444443 479999999999999987777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.8e-05 Score=70.74 Aligned_cols=133 Identities=18% Similarity=0.198 Sum_probs=75.3
Q ss_pred eccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEeCCeEEE
Q 013016 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEASNFSCI 166 (451)
Q Consensus 88 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~l 166 (451)
+..|-.+.+|+....+. .+++|+...... ........|..+++.+...++ ++++..+. -++
T Consensus 4 ~~~G~tn~~y~~~~~~~-----------~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~ 65 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGI-----------SFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWL 65 (256)
T ss_pred CCCcCcCCeEEEEeCCc-----------cEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEE
Confidence 45677788888763221 188888653311 110124568888888864433 55555442 268
Q ss_pred EEeeccCCchhhh-----------------hhhCC--CCCCCHH-HHHHHHHHH---------HHHHHHHHH--------
Q 013016 167 VMEFCSGGDLHSL-----------------RHKQP--HKRFSLT-SARFYAAEV---------LVALEYLHM-------- 209 (451)
Q Consensus 167 V~E~~~ggsL~~~-----------------l~~~~--~~~l~~~-~~~~i~~qi---------l~aL~~LH~-------- 209 (451)
||||++|..+..- ++..+ ..+++.. .+..+..++ ...+..+-.
T Consensus 66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (256)
T TIGR02721 66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP 145 (256)
T ss_pred EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence 9999998765421 11111 1112221 112222111 111222221
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 2589999999999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.6e-05 Score=73.81 Aligned_cols=136 Identities=21% Similarity=0.292 Sum_probs=95.2
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH-----------------H--HHHHHHHHHH
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK-----------------K--VHRAEMEKKI 142 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------~--~~~~~~e~~~ 142 (451)
+.+.++||-|--+.||.+.+.++.. .++|+=+..+..-.. . .-...+|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~----------~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNP----------LILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecCCCCc----------hhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 7788999999999999998876543 788865433221000 0 0113457788
Q ss_pred HHHCCCCC--ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 143 LKMLDHPF--LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 143 l~~l~h~n--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
|+.|.... +++.++ .+..|+|||++.|-.|.+..+-. .+..+...+..-+--|-.+|+||+|..-=
T Consensus 164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEF 231 (465)
T KOG2268|consen 164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEF 231 (465)
T ss_pred HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchh
Confidence 88875322 455554 45679999999998887653221 22334455555566778899999999999
Q ss_pred cEEEccCCCEEEeccCccc
Q 013016 221 NVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~ 239 (451)
||++.+++.++++||-...
T Consensus 232 Nimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eeEEecCCCEEEeechHhh
Confidence 9999999999999997753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0002 Score=69.55 Aligned_cols=142 Identities=23% Similarity=0.275 Sum_probs=81.5
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC--ccceeEEE-
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF--LPTLYAEF- 158 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~- 158 (451)
...++.++.|....||++...+. + +++|+..... ....+..|.+++..|...+ +++++...
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~-~----------~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVG-R----------YILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred ceeccccCCccccceEEEEeCCC-c----------EEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 34456678888889998864322 2 8899875421 1122334666666664222 44444321
Q ss_pred -----EeCCeEEEEEeeccCCchhh-----------h---hhhCCCC---------CC-CHHH--HH----------HHH
Q 013016 159 -----EASNFSCIVMEFCSGGDLHS-----------L---RHKQPHK---------RF-SLTS--AR----------FYA 197 (451)
Q Consensus 159 -----~~~~~~~lV~E~~~ggsL~~-----------~---l~~~~~~---------~l-~~~~--~~----------~i~ 197 (451)
...+..++|+||++|.++.. . ++....+ .+ .|.. .. ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 23467899999998865421 1 1110000 00 0100 00 011
Q ss_pred HHHHHHHHHHHH-------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 198 AEVLVALEYLHM-------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 198 ~qil~aL~~LH~-------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+...++++.. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223345555542 689999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00037 Score=68.01 Aligned_cols=30 Identities=33% Similarity=0.392 Sum_probs=25.9
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.|+||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999966556899999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00035 Score=69.44 Aligned_cols=77 Identities=17% Similarity=0.223 Sum_probs=51.3
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH----HHHHHHHHHHHHHHHCC---CCCccceeE
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK----KKVHRAEMEKKILKMLD---HPFLPTLYA 156 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~---h~nIv~l~~ 156 (451)
..+.||.|....||+....+ + . ++||.-........ -...+...|...|+.+. ..++++++.
T Consensus 36 ~~~eiggGn~N~VyrV~~~~-~-s---------vVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~ 104 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS-G-S---------FVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH 104 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC-c-c---------EEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence 46789999999999988643 2 2 88998763222111 12344444666666553 357889998
Q ss_pred EEEeCCeEEEEEeeccC
Q 013016 157 EFEASNFSCIVMEFCSG 173 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~g 173 (451)
++. +..++|||++++
T Consensus 105 ~de--d~~vlvME~L~~ 119 (418)
T PLN02756 105 FDR--TMALIGMRYLEP 119 (418)
T ss_pred ECC--CCCEEEEeecCC
Confidence 887 456889999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00048 Score=67.31 Aligned_cols=77 Identities=21% Similarity=0.241 Sum_probs=49.8
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH----HHHHHHHHHHHHHHHHCC--CC-CccceeEEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK----KKKVHRAEMEKKILKMLD--HP-FLPTLYAEFE 159 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~-nIv~l~~~~~ 159 (451)
.||.|....||++.+..+++. |+||.-....... .-...+...|...|+... .| .++++|. .
T Consensus 2 EigdGnlN~VfrV~~~~g~~s---------vIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRA---------AIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEcCCCCee---------EEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 579999999999997543233 8999775443321 223445556777777653 34 4666664 3
Q ss_pred eCCeEEEEEeeccCC
Q 013016 160 ASNFSCIVMEFCSGG 174 (451)
Q Consensus 160 ~~~~~~lV~E~~~gg 174 (451)
+.+...+|||+++..
T Consensus 71 D~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 71 DTEMAVTVMEDLSHH 85 (370)
T ss_pred ccccceehHhhCccc
Confidence 455667999998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00036 Score=67.48 Aligned_cols=82 Identities=22% Similarity=0.230 Sum_probs=48.5
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEEEeCCe
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEFEASNF 163 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~ 163 (451)
++.|..|-...||++....... ....+..+++|+..... ........|..++..+...+ .+++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~---~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDA---LSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN--- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCccc---ccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC---
Confidence 3456677777899887543210 11111238899976431 12234456888888775333 4566666542
Q ss_pred EEEEEeeccCCchh
Q 013016 164 SCIVMEFCSGGDLH 177 (451)
Q Consensus 164 ~~lV~E~~~ggsL~ 177 (451)
.+|+||++|.++.
T Consensus 73 -~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -GRIEEFIPSRTLT 85 (302)
T ss_pred -CchhheeCCCcCC
Confidence 2689999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=2.6e-05 Score=86.47 Aligned_cols=233 Identities=13% Similarity=0.040 Sum_probs=142.3
Q ss_pred eEEEEEcchHHHHH--HHHHHHHHHHHHHHHHCCCCCccceeEEEE--eCCeEEEEEeeccCCchhhhhhhCCC--CCCC
Q 013016 116 LYAMKVVNKEVLEK--KKKVHRAEMEKKILKMLDHPFLPTLYAEFE--ASNFSCIVMEFCSGGDLHSLRHKQPH--KRFS 189 (451)
Q Consensus 116 ~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~~--~~l~ 189 (451)
++.+||.+.-.... +...+....|...++...|+++...+.-.. ++...+.+++|+.+|.+.+.+-+.-. ..+.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 36777765432221 111122223444555668888877665443 33467899999999999997765422 2233
Q ss_pred HHHHHHHHHHHHHHHHHHHHC-----CCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCccc
Q 013016 190 LTSARFYAAEVLVALEYLHML-----GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264 (451)
Q Consensus 190 ~~~~~~i~~qil~aL~~LH~~-----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (451)
..-+...-.+.+.+..-+|+. -.+|++||+-|.+|..+.+++++++|+.+..+.
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--------------------- 1392 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--------------------- 1392 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc---------------------
Confidence 333333334446666666642 279999999999999999999999999751110
Q ss_pred ccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 013016 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRT 344 (451)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~ 344 (451)
.....+..++++.|+.|++...-.++.++|+|..|+-+|++-.|..
T Consensus 1393 ----------------------------------~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1393 ----------------------------------VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred ----------------------------------hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence 1111223578888999999888788888999999999999988888
Q ss_pred CCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 345 PFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 345 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+|...... .++.++...-..... -+.+.++......+|-+.-..||. -...+.-+.|.-
T Consensus 1439 ~fi~flq~-~Lkgiidn~tf~sIe---~l~pgdaNve~~~~Ll~K~~~rp~----q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1439 YFIFFLQP-ALKGIIDNHTFFSIE---KLKPGDANVEALHRLLWKYMERPG----QYISLSRDHFAV 1497 (2724)
T ss_pred HHHHHHHH-HHcCccccccccccc---ccCCCcccHHHHHHHHHHhhhcch----hhhhcccccccc
Confidence 77432111 122222221111111 111113444555566666678888 666666555543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0006 Score=67.47 Aligned_cols=78 Identities=24% Similarity=0.376 Sum_probs=51.0
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH---HHHHHHHHHHHHHHHHCC--CC-CccceeEEE
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK---KKKVHRAEMEKKILKMLD--HP-FLPTLYAEF 158 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~--h~-nIv~l~~~~ 158 (451)
.+.||.|....||++.+....+. |+||.-....... .-...+...|.++|+... .| +++++|.
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~s---------vIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNIS---------VIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCce---------EEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 66899999999999997432222 8888765433221 123455566778877663 34 4666774
Q ss_pred EeCCeEEEEEeeccC
Q 013016 159 EASNFSCIVMEFCSG 173 (451)
Q Consensus 159 ~~~~~~~lV~E~~~g 173 (451)
.+.....+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 345567799998854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.002 Score=62.40 Aligned_cols=141 Identities=24% Similarity=0.299 Sum_probs=94.9
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH-----------------------HHHHHHHHHHHHH
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-----------------------EKKKKVHRAEMEK 140 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~e~ 140 (451)
|-..|..|--+.||.|....+.. +||||.+-..+ ......-+.+.|+
T Consensus 148 inGCiSTGKEANVYHat~~dG~~----------~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSE----------FAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecCCCce----------EEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 44557788888999988665543 99999842211 0111233456678
Q ss_pred HHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCC
Q 013016 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKP 219 (451)
Q Consensus 141 ~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givH~Dlkp 219 (451)
.-|.+++...|+-.--... ....|||+++ |.+=+-.- ..+...++...+..+-.|++.-+.-|. .+++||.||.-
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~Fl-Grdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFL-GRDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeec-cCCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 8888887666543222222 2357999999 44322110 111234777788888889988888776 67899999999
Q ss_pred CcEEEccCCCEEEeccCccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~ 239 (451)
=|+|+. +|.+.++|.+.+.
T Consensus 294 fN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred hhheEE-CCEEEEEEccccc
Confidence 999886 7899999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0023 Score=61.06 Aligned_cols=29 Identities=24% Similarity=0.406 Sum_probs=24.8
Q ss_pred CCeeccCCCCcEEEccCCC-EEEeccCccc
Q 013016 211 GIIYRDLKPENVLVRSDGH-IMLSDFDLSL 239 (451)
Q Consensus 211 givH~Dlkp~NIll~~~~~-~kl~Dfg~a~ 239 (451)
.++|+|++|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0026 Score=62.77 Aligned_cols=145 Identities=14% Similarity=0.149 Sum_probs=82.6
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEe
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEA 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~ 160 (451)
..-+..|..|-...+|++........ ....|++|+..... ...-....|..+++.+..-++ +++++.+..
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~-----~~~~~v~Ri~g~~t----~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~ 108 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGN-----LGRKVLVRIYGEGV----ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN 108 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCC-----CCCeEEEEEccCCC----CeeechHHHHHHHHHHHHcCCCCceEEEECC
Confidence 33344566688889999875432110 01138899886532 122223568888888865444 466666643
Q ss_pred CCeEEEEEeeccCCchhhh-----------------hhhCC--CC--CCCHHHHHHHHHHH-----------------HH
Q 013016 161 SNFSCIVMEFCSGGDLHSL-----------------RHKQP--HK--RFSLTSARFYAAEV-----------------LV 202 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~-----------------l~~~~--~~--~l~~~~~~~i~~qi-----------------l~ 202 (451)
+ .|++|++|.+|... ++... .. ...+..+..+..++ ..
T Consensus 109 -g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 -G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred -c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 2 58999988776421 11111 11 11122232332211 11
Q ss_pred HHHHHH--------HCCCeeccCCCCcEEEcc-CCCEEEeccCccc
Q 013016 203 ALEYLH--------MLGIIYRDLKPENVLVRS-DGHIMLSDFDLSL 239 (451)
Q Consensus 203 aL~~LH--------~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 239 (451)
.+..|. ...++|+|+++.|||++. ++.+.|+||..+.
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 122221 235899999999999986 4689999999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00064 Score=68.29 Aligned_cols=84 Identities=17% Similarity=0.165 Sum_probs=58.5
Q ss_pred cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC-------CCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS-------PSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 325 ~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+++|||++|.++.++.-|...+......+....+..-........ -....+....+++..|+...|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l-- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL-- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc--
Confidence 499999999999999999988876555554444433211100000 00011225678999999999999999
Q ss_pred CChHHHHcCCCcCCC
Q 013016 398 RGAADVKTHPFFKGL 412 (451)
Q Consensus 398 ~~~~ell~hp~~~~~ 412 (451)
..++.+|+-|.++
T Consensus 188 --~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 --PMELSKRCSFTEV 200 (725)
T ss_pred --hhHHhcCccHHHH
Confidence 8999999999885
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0025 Score=62.53 Aligned_cols=145 Identities=17% Similarity=0.233 Sum_probs=81.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~ 158 (451)
++..+. .|..|=...+|++...+.... ...|++|+..... ...-....|..+++.+..-++ +++++++
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~------~~~~v~Ri~g~~t----~~~IdR~~E~~il~~l~~~gl~P~~l~~~ 83 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGN------EVSVTVRLFGPNT----DYVIDRERELQAIKYLSAAGFGAKLLGVF 83 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCC------CceEEEEEecCCc----CeEechHHHHHHHHHHHhcCCCCceeEEe
Confidence 344544 454577778998875432110 0128899876431 122334568888888865555 5667666
Q ss_pred EeCCeEEEEEeeccCCchhh--h---------------hhhCC--CC-CC-CHHHHHHHHHHH-----------------
Q 013016 159 EASNFSCIVMEFCSGGDLHS--L---------------RHKQP--HK-RF-SLTSARFYAAEV----------------- 200 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~--~---------------l~~~~--~~-~l-~~~~~~~i~~qi----------------- 200 (451)
. ++ +|.+|++|..|.. + ++... .. .. -+..+.++..++
T Consensus 84 ~-~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~ 159 (330)
T PLN02421 84 G-NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETI 159 (330)
T ss_pred C-Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhccc
Confidence 3 33 5899998776532 0 11111 01 01 122333332222
Q ss_pred -----HHHHHHHH----HC----CCeeccCCCCcEEEcc-CCCEEEeccCccc
Q 013016 201 -----LVALEYLH----ML----GIIYRDLKPENVLVRS-DGHIMLSDFDLSL 239 (451)
Q Consensus 201 -----l~aL~~LH----~~----givH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 239 (451)
..-+..+. .. -++|+|+.+.|||+++ ++.++++||+.|-
T Consensus 160 ~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 160 SFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred CHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11222222 11 2799999999999985 5789999999873
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.004 Score=60.11 Aligned_cols=138 Identities=16% Similarity=0.205 Sum_probs=80.7
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC--CCccceeEEEE
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH--PFLPTLYAEFE 159 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~ 159 (451)
..++..+..|....+|.....+ + .++|. ... ............+|..+++.+.- .-+...++.|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~--~---------~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~ 93 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTG--Q---------KYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCG 93 (321)
T ss_pred CceeeeccCCcccceEEEecCC--c---------eEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccc
Confidence 4445555455555555554431 1 26777 221 11122344555668888887753 33456667776
Q ss_pred eCC--eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHH-HHHHHHHHHHHH---------------------------
Q 013016 160 ASN--FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA-AEVLVALEYLHM--------------------------- 209 (451)
Q Consensus 160 ~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~-~qil~aL~~LH~--------------------------- 209 (451)
++. ..|.||++++|..+.+.+.... ...+++ ..+...|+-||+
T Consensus 94 ~~~~g~pf~v~~~veGe~~~~~~~~~~-------~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~ 166 (321)
T COG3173 94 EGYLGTPFYVMEWVEGEVVWSALPPES-------LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEY 166 (321)
T ss_pred cCCCCCceEEEEEecceeccCcCCccc-------chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHH
Confidence 655 7799999998854433211110 001111 133333333333
Q ss_pred -----------------------C--------CCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 -----------------------L--------GIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 -----------------------~--------givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+ .++|+|+.+.||+++.++-+-+.||+.+.
T Consensus 167 ~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 167 RRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 2 48999999999999998889999999985
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.025 Score=54.81 Aligned_cols=29 Identities=24% Similarity=0.461 Sum_probs=25.6
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0021 Score=58.71 Aligned_cols=29 Identities=34% Similarity=0.599 Sum_probs=21.0
Q ss_pred CCeeccCCCCcEEE-ccCCCEEEeccCccc
Q 013016 211 GIIYRDLKPENVLV-RSDGHIMLSDFDLSL 239 (451)
Q Consensus 211 givH~Dlkp~NIll-~~~~~~kl~Dfg~a~ 239 (451)
.++|+|+.+.|||+ ..++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 788999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.009 Score=57.91 Aligned_cols=72 Identities=19% Similarity=0.282 Sum_probs=57.5
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
+..+.|++|++- |++|.-. +.-.+.++..++.+.+..++-+.. -.+=|||+.-+||||+ +|++.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 334788999986 7777532 124577888898888887777774 4689999999999999 999999999998
Q ss_pred c
Q 013016 239 L 239 (451)
Q Consensus 239 ~ 239 (451)
+
T Consensus 369 R 369 (488)
T COG5072 369 R 369 (488)
T ss_pred e
Confidence 6
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0083 Score=59.87 Aligned_cols=86 Identities=16% Similarity=0.298 Sum_probs=48.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~ 158 (451)
++..+. .|..|-...+|++........ .-....|.+++.. ......-....|..+++.+...++ .++++.+
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~---~~~~k~Vl~R~~g----~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f 122 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKD---RYPIKSVCIKKSS----TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF 122 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCC---ccccceEEEEecc----CCCceEeccHHHHHHHHHHHhCCCCCeEEEec
Confidence 344444 566688899999975433210 0000013333321 111222234558899999875554 5667766
Q ss_pred EeCCeEEEEEeeccCCchh
Q 013016 159 EASNFSCIVMEFCSGGDLH 177 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~ 177 (451)
.. ++|+||++|.+|.
T Consensus 123 ~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 123 GD----FTIQEWVEGNTMG 137 (383)
T ss_pred CC----EEEEEEeccccCC
Confidence 43 5999999988764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.03 Score=53.86 Aligned_cols=82 Identities=15% Similarity=0.163 Sum_probs=47.1
Q ss_pred ccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HHHHHHHHHHHHHHHHHC-------C------CCCccc
Q 013016 89 GAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KKKKVHRAEMEKKILKML-------D------HPFLPT 153 (451)
Q Consensus 89 G~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l-------~------h~nIv~ 153 (451)
|.|-.|.+|++......+. .+.....-+.||........ .......+.+|+.+.+.+ . ...+++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~-~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~ 80 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKG-DGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPK 80 (294)
T ss_pred CCcceeEEEEEEEEEEEcc-CCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeece
Confidence 7788899998887651110 11112234889998622211 112344566677666544 1 123566
Q ss_pred eeEEEEeCCeEEEEEeec
Q 013016 154 LYAEFEASNFSCIVMEFC 171 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~ 171 (451)
++....+.+..+||||-+
T Consensus 81 ~~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 81 CYYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEEeccCCCceeeehhhh
Confidence 666665556789999966
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.052 Score=52.67 Aligned_cols=29 Identities=10% Similarity=0.093 Sum_probs=27.2
Q ss_pred CCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 211 givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++||+|+.++|||++.++.+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.021 Score=55.74 Aligned_cols=136 Identities=24% Similarity=0.333 Sum_probs=80.6
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc------cceeE----
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL------PTLYA---- 156 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI------v~l~~---- 156 (451)
.|++ .-..||++...++. +++|+.+.. . ....+..|...+..|.-.+| ..+-|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~-----------~iLki~~~~-~----~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~ 95 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGR-----------YILKIYRPG-W----TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLE 95 (331)
T ss_pred cccc-ccCceEEEEecCCC-----------eEEEEecCC-C----CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhh
Confidence 3444 45678888766554 799999865 1 12334447777777632222 22211
Q ss_pred EEEeCCeEEEEEeeccCCchhh-h-----------h---h----hCC--C----CCCCHH----H---------HHHHHH
Q 013016 157 EFEASNFSCIVMEFCSGGDLHS-L-----------R---H----KQP--H----KRFSLT----S---------ARFYAA 198 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~-~-----------l---~----~~~--~----~~l~~~----~---------~~~i~~ 198 (451)
......+.+-|++|++|..+.. . + + ..+ . ....|. . ......
T Consensus 96 ~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a 175 (331)
T COG2334 96 ALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRA 175 (331)
T ss_pred hccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHH
Confidence 1122248899999999988872 1 0 0 011 0 011222 0 011334
Q ss_pred HHHHHHHHHHH--------CC--CeeccCCCCcEEEccCCC-EEEeccCccc
Q 013016 199 EVLVALEYLHM--------LG--IIYRDLKPENVLVRSDGH-IMLSDFDLSL 239 (451)
Q Consensus 199 qil~aL~~LH~--------~g--ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~ 239 (451)
++...++.+.+ .+ +||+|+.|+||+++.+.. +.++||+.+.
T Consensus 176 ~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 176 ALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 45555555554 23 999999999999998875 8999999874
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0089 Score=58.77 Aligned_cols=158 Identities=23% Similarity=0.260 Sum_probs=92.9
Q ss_pred hhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccC------CCCCCcceEEEEEcchHHHHHHHHHH
Q 013016 61 FAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQD------RGHEPCCLYAMKVVNKEVLEKKKKVH 134 (451)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~ 134 (451)
++.+.+..+....+....+.+|.- .-||.|+-+.||+|..+...-+. .+......+|+|+........
T Consensus 171 ~T~k~l~qa~~~~~~~eiF~efn~-~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~----- 244 (565)
T KOG1236|consen 171 FTKKKLRQAFGVKKIEEIFSEFNR-EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQ----- 244 (565)
T ss_pred HHHHHHHHHHCcCcHHHHHHhcCC-cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHH-----
Confidence 455556666655455555555543 35899999999999865332211 123334569999987653211
Q ss_pred HHHHHHHHHH------------------------------HCC----CCCccceeEEE-------------EeCCeEEEE
Q 013016 135 RAEMEKKILK------------------------------MLD----HPFLPTLYAEF-------------EASNFSCIV 167 (451)
Q Consensus 135 ~~~~e~~~l~------------------------------~l~----h~nIv~l~~~~-------------~~~~~~~lV 167 (451)
+.....||. +++ --|+.++..-| .-.....||
T Consensus 245 -ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~ 323 (565)
T KOG1236|consen 245 -IRLDLGILGFGAKLINNVPDLSWLSLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLV 323 (565)
T ss_pred -HHHHHHHHhhhhhhhhhcCccccccCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceee
Confidence 111111111 110 00111111101 111245678
Q ss_pred EeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEccCC
Q 013016 168 MEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 168 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~ 228 (451)
-+|..|.++..++... ..++...++++.-.+.||--|- -.+++|.|++|.||++..+.
T Consensus 324 E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 324 ETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred eeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 8889899998888763 3566677778777777776555 46899999999999997543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.057 Score=51.68 Aligned_cols=75 Identities=24% Similarity=0.221 Sum_probs=45.6
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeEEEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYAEFE 159 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~ 159 (451)
+-.+.++-|....+|+.... .+ .+.||+-... ....+..|.+-|+.| .--.+++++++..
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~--~~---------~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~ 82 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTD--GG---------SYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGE 82 (288)
T ss_dssp -EEEEE--SSSSEEEEEETT--S----------EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE
T ss_pred eeeEecCCCChhheEEEECC--Cc---------cEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 34557889999999988732 22 2899987622 223455577777777 3456889999998
Q ss_pred eCCeEEEEEeeccCC
Q 013016 160 ASNFSCIVMEFCSGG 174 (451)
Q Consensus 160 ~~~~~~lV~E~~~gg 174 (451)
..+..||||||++.+
T Consensus 83 ~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 83 YDDDAFLLLEFLEMG 97 (288)
T ss_dssp -SSCCEEEEE-----
T ss_pred ecCCceEEEEeecCC
Confidence 888889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.092 Score=59.26 Aligned_cols=30 Identities=33% Similarity=0.444 Sum_probs=25.9
Q ss_pred CCCeeccCCCCcEEEccCC--CEE-EeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDG--HIM-LSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~--~~k-l~Dfg~a~ 239 (451)
.++||+|+.+.|||++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.09 Score=53.55 Aligned_cols=90 Identities=18% Similarity=0.189 Sum_probs=51.1
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~ 156 (451)
..++. -++.|..|-.-.+|++........ .....+..|.+++..... ...-....|..+++.+...+| .++++
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~-~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETAN-NYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCc-cccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEE
Confidence 33455 556677787888999876532100 000001238889886432 122233457777777765554 35666
Q ss_pred EEEeCCeEEEEEeeccCCchh
Q 013016 157 EFEASNFSCIVMEFCSGGDLH 177 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~ 177 (451)
.+. + ..|.||++|.+|.
T Consensus 178 ~f~-g---g~I~efi~g~~l~ 194 (442)
T PTZ00296 178 TFS-G---GRIEEWLYGDPLR 194 (442)
T ss_pred EeC-C---CEEEEeeCCccCC
Confidence 553 2 3579999887553
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.23 Score=48.62 Aligned_cols=28 Identities=32% Similarity=0.324 Sum_probs=24.2
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 451 | ||||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-39 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-37 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-36 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-36 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-36 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-33 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-33 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-32 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-32 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-32 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-32 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-32 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-32 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-32 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-32 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-32 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-32 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-32 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-32 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-32 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-32 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-32 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-32 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-32 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-32 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-32 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-32 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-32 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-32 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-32 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-31 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-31 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-31 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-31 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-29 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-28 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-28 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-28 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-28 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-26 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-19 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 9e-04 |
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 451 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-105 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-98 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-92 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-92 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-91 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 6e-91 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-91 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-91 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-89 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-89 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-89 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-89 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-89 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-89 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 6e-88 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-84 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-76 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-75 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 5e-65 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 5e-65 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-59 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-57 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-53 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-53 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-52 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-52 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-51 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-51 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-51 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 9e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-51 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 6e-51 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-51 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-50 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-50 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-50 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-50 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-49 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-49 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-49 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-49 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-49 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-49 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-48 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-48 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-48 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 7e-48 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-48 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-47 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-36 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-47 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-47 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-47 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 9e-47 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-46 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-46 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-46 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-46 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-45 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-45 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-45 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-45 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-44 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-44 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-44 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-44 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-44 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-43 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-43 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 6e-43 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-42 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-42 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-42 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-42 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-41 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-40 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-40 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-40 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-40 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-39 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-38 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-37 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-37 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-36 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-36 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-36 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 9e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-34 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-32 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-31 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-15 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-30 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-16 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-29 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-15 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-28 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-28 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-28 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-27 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-27 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-26 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-25 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-25 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 6e-25 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-24 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-24 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-23 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-12 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-23 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-23 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-23 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-23 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-22 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-22 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-08 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-21 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-21 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-07 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 9e-21 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-09 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-20 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-20 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-08 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-09 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-20 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-20 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-20 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-20 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-19 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-19 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-19 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-19 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-19 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-19 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-19 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-19 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-07 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-19 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-19 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-19 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-07 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-19 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-18 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-17 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-17 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-07 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-17 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-17 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-16 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-16 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-04 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-16 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-16 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-16 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-16 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-16 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 9e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-15 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-15 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-15 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-15 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-15 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-15 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-15 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-14 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-14 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-14 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-14 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-14 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-14 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-14 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-14 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-14 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-14 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-14 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-14 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-14 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-13 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-13 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-13 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 1e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-13 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-13 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-13 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-13 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-13 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 7e-13 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 8e-04 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-11 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 2e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-04 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-04 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-11 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-11 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 6e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-10 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-08 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-07 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 6e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 102/357 (28%), Positives = 150/357 (42%), Gaps = 71/357 (19%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+ DF + +G G TV L + YA+K++ K + K+ K
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLA----RELATSRE-----YAIKILEKRHIIKENK 73
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
V E+ ++ LDHPF LY F+ + + G+L L++ + F T
Sbjct: 74 VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETC 131
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
RFY AE++ ALEYLH GII+RDLKPEN+L+ D HI ++DF
Sbjct: 132 TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT--------------- 176
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
+K + + AR+ SFVGT +Y
Sbjct: 177 -----------------------------AKVLSPESKQ---------ARANSFVGTAQY 198
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
VSPE+ + S + D WA G IY+++ G PF A + + I+K F P
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEK 254
Query: 373 MSEYHARDLISGLLNKDPCNRLGS--KRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427
ARDL+ LL D RLG G +K HPFF+ + + + TPP++
Sbjct: 255 FFP-KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 8e-98
Identities = 105/353 (29%), Positives = 165/353 (46%), Gaps = 72/353 (20%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
F+L + +G G G V+L ++ G + LYAMKV+ K L+ + +V
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLV------KKISGSDARQLYAMKVLKKATLKVRDRVR-T 73
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
+ME+ IL ++HPF+ L+ F+ ++++F GGDL F+ +FY
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFY 131
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
AE+ +AL++LH LGIIYRDLKPEN+L+ +GHI L+DF L S E+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL---------------SKES 176
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
+ Y+ F GT EY++PE
Sbjct: 177 IDHEKKAYS----------------------------------------FCGTVEYMAPE 196
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V + H + DWW+FG+ ++EM+ G PF + T+ I+K L P +S
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM----PQFLSP- 251
Query: 377 HARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
A+ L+ L ++P NRLG+ G ++K H FF +++ + R + PP P
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-95
Identities = 108/353 (30%), Positives = 169/353 (47%), Gaps = 77/353 (21%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+ +DF + R +G G G V+L + R YAMKV+ KE++ + K+V
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHT 53
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E+ +L ++ HPF+ ++ F+ + ++M++ GG+L S + +RF A+FY
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFY 111
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
AAEV +ALEYLH IIYRDLKPEN+L+ +GHI ++DF
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF------------------- 152
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
+K + +T + GT +Y++PE
Sbjct: 153 -------------------------AKYVPDVT--------------YTLCGTPDYIAPE 173
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V S + ++DWW+FGI IYEM+ G TPF + T I+ L F P +E
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNE- 228
Query: 377 HARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
+DL+S L+ +D RLG+ + G DVK HP+FK + + + R++ P P
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 6e-95
Identities = 102/354 (28%), Positives = 162/354 (45%), Gaps = 72/354 (20%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHR 135
+ F+L R +G G G V+ R+ G ++AMKV+ K ++ K
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQV------RKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67
Query: 136 AEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
+ E+ IL+ + HPF+ L F+ +++E+ SGG+L + F +A F
Sbjct: 68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACF 125
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y AE+ +AL +LH GIIYRDLKPEN+++ GH+ L+DF L E
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL---------------CKE 170
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+ + T+T F GT EY++P
Sbjct: 171 SIHDGTVTHT----------------------------------------FCGTIEYMAP 190
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
E+ H AVDWW+ G +Y+M+ G PF + + T+ I+K L P +++
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL----PPYLTQ 246
Query: 376 YHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
ARDL+ LL ++ +RLG+ A +V+ HPFF+ +N+ + R + PP P
Sbjct: 247 -EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP 299
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-94
Identities = 116/387 (29%), Positives = 172/387 (44%), Gaps = 76/387 (19%)
Query: 43 TSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLN 102
+ PE ++ P + + + DF + IG G G V L
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPS--DFHFLKVIGKGSFGKVLLA--- 57
Query: 103 NKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KMLDHPFLPTLYAEFEAS 161
+++ + YA+KV+ K+ + KKK+ E+ +L K + HPFL L+ F+ +
Sbjct: 58 -RHKAEE-----VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111
Query: 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221
+ V+++ +GG+L H Q + F ARFYAAE+ AL YLH L I+YRDLKPEN
Sbjct: 112 DKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169
Query: 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG 281
+L+ S GHI+L+DF L E S T T
Sbjct: 170 ILLDSQGHIVLTDFGL---------------CKENIEHNSTTST---------------- 198
Query: 282 SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY 341
F GT EY++PEV + VDWW G +YEM+Y
Sbjct: 199 ------------------------FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 342 GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401
G PF + + NI+ KPL +++ AR L+ GLL KD RLG+K
Sbjct: 235 GLPPFYSRNTAEMYDNILNKPLQL----KPNITN-SARHLLEGLLQKDRTKRLGAKDDFM 289
Query: 402 DVKTHPFFKGLNFALI--RSLTPPEIP 426
++K+H FF +N+ + + +TPP P
Sbjct: 290 EIKSHVFFSLINWDDLINKKITPPFNP 316
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 4e-94
Identities = 110/388 (28%), Positives = 166/388 (42%), Gaps = 78/388 (20%)
Query: 42 PTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSL 101
+K E S+K + + T + T FD + +G G G V L
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNT-AQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 102 NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161
YAMK+++K+ + K K++ EK+IL+ ++ PFL L F+ +
Sbjct: 63 KESGN---------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221
+ +VME+ +GG++ S H + RFS ARFYAA++++ EYLH L +IYRDLKPEN
Sbjct: 114 SNLYMVMEYVAGGEMFS--HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG 281
+L+ G+I ++DF
Sbjct: 172 LLIDQQGYIQVTDFGF-------------------------------------------- 187
Query: 282 SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY 341
+K+++ T + GT E ++PE+ + AVDWWA G+ IYEM
Sbjct: 188 AKRVKGRT--------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 342 GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGA 400
G PF A IV + F PS S +DL+ LL D R G+ K G
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVRF----PSHFSS-DLKDLLRNLLQVDLTKRFGNLKNGV 288
Query: 401 ADVKTHPFFKGLNFALI--RSLTPPEIP 426
D+K H +F ++ I R + P IP
Sbjct: 289 NDIKNHKWFATTDWIAIYQRKVEAPFIP 316
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-92
Identities = 111/353 (31%), Positives = 161/353 (45%), Gaps = 74/353 (20%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+T DFD + +G G G V L + + YAMK++ KEV+ K +V
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILV----REKATG-----RYYAMKILRKEVIIAKDEVAHT 52
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ++L+ HPFL L F+ + C VME+ +GG+L H + F+ ARFY
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFY 110
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
AE++ ALEYLH ++YRD+K EN+++ DGHI ++DF L E
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL---------------CKEG 155
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
S + T F GT EY++PE
Sbjct: 156 ISDGATMKT----------------------------------------FCGTPEYLAPE 175
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V +G AVDWW G+ +YEM+ GR PF +E I+ + + F P ++S
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSP- 230
Query: 377 HARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
A+ L++GLL KDP RLG A +V H FF +N+ + + L PP P
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-92
Identities = 99/379 (26%), Positives = 162/379 (42%), Gaps = 75/379 (19%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
K +F + R + D+++ + IG G G V L +++ R
Sbjct: 43 KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLV----RHKSTRK--- 95
Query: 114 CCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSG 173
+YAMK+++K + K+ E+ I+ + P++ L+ F+ + +VME+ G
Sbjct: 96 --VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
GDL +L ARFY AEV++AL+ +H +G I+RD+KP+N+L+ GH+ L+
Sbjct: 154 GDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293
DF + + ++ T
Sbjct: 211 DFGTCM--------------------------------------KMNKEGMVRCDTA--- 229
Query: 294 FVAEPVAARSCSFVGTHEYVSPEV----ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP 349
VGT +Y+SPEV G +G DWW+ G+F+YEM+ G TPF A
Sbjct: 230 -------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 350 SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
S T I+ + + +S+ A++LI L D RLG + G ++K H FF
Sbjct: 277 SLVGTYSKIMNHKNSLTFPDDNDISK-EAKNLICAFL-TDREVRLG-RNGVEEIKRHLFF 333
Query: 410 KGLNFA--LIRSLTPPEIP 426
K +A +R P +P
Sbjct: 334 KNDQWAWETLRDTVAPVVP 352
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-91
Identities = 112/363 (30%), Positives = 167/363 (46%), Gaps = 77/363 (21%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
++ L DF++ + IG G V + + + +YAMK++NK + K+ +
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVV---------KMKQTGQVYAMKIMNKWDMLKRGE 104
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
V E+ +L D ++ L+ F+ N+ +VME+ GGDL +L K +R
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEM 163
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
ARFY AE+++A++ +H LG ++RD+KP+N+L+ GHI L+DF L
Sbjct: 164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL------------- 210
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
+ +++L VGT +Y
Sbjct: 211 -------------------------KLRADGTVRSLVA----------------VGTPDY 229
Query: 313 VSPEV-------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPL 363
+SPE+ GS+G DWWA G+F YEM YG+TPF A S T IV K+ L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPP 423
+ P + E ARD I LL P RLG GA D +THPFF GL++ +R PP
Sbjct: 290 SLP-LVDEGVPE-EARDFIQRLLC-PPETRLGR-GGAGDFRTHPFFFGLDWDGLRDSVPP 345
Query: 424 EIP 426
P
Sbjct: 346 FTP 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 6e-91
Identities = 106/404 (26%), Positives = 167/404 (41%), Gaps = 86/404 (21%)
Query: 42 PTSKSSPENLSLKP---HRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYL 98
P + +NL SD + LT DF +HR IG G G VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG 207
Query: 99 CSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL---KMLDHPFLPTLY 155
C + D G +YAMK ++K+ ++ K+ A E+ +L D PF+ +
Sbjct: 208 CR-----KADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258
Query: 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYR 215
F + +++ +GGDLH H H FS RFYAAE+++ LE++H ++YR
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHY--HLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 216 DLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRF 275
DLKP N+L+ GH+ +SD L A + + + +
Sbjct: 317 DLKPANILLDEHGHVRISDLGL--------ACD---------FSKKKPHA---------- 349
Query: 276 LNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV-ASGGSHGNAVDWWAFGI 334
VGTH Y++PEV G ++ ++ DW++ G
Sbjct: 350 ------------------------------SVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 335 FIYEMIYGRTPFAAPSN---ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391
+++++ G +PF R + + P S S R L+ GLL +D
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSP-ELRSLLEGLLQRDVN 434
Query: 392 NRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432
RLG RGA +VK PFF+ L++ ++ + PP IP
Sbjct: 435 RRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 8e-91
Identities = 112/369 (30%), Positives = 174/369 (47%), Gaps = 85/369 (23%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
G L +DFDL R IG G V L + ++ +YAMKVV KE++ +
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLV----RLKKTD-----RIYAMKVVKKELVNDDE 51
Query: 132 KVHRAEMEKKIL-KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSL 190
+ + EK + + +HPFL L++ F+ + V+E+ +GGDL + H Q ++
Sbjct: 52 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE 109
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
ARFY+AE+ +AL YLH GIIYRDLK +NVL+ S+GHI L+D+ +
Sbjct: 110 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM------------- 156
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
E P T T F GT
Sbjct: 157 --CKEGLRPGDTTST----------------------------------------FCGTP 174
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP---------SNETTLRNIVKK 361
Y++PE+ G +G +VDWWA G+ ++EM+ GR+PF + + + I++K
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 234
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS--KRGAADVKTHPFFKGLNFALI-- 417
+ P S+S A ++ LNKDP RLG + G AD++ HPFF+ +++ ++
Sbjct: 235 QIRI----PRSLSV-KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 289
Query: 418 RSLTPPEIP 426
+ + PP P
Sbjct: 290 KQVVPPFKP 298
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 9e-91
Identities = 106/397 (26%), Positives = 172/397 (43%), Gaps = 82/397 (20%)
Query: 42 PTSKSSPENLSLKP---HRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYL 98
P ++ +L P S + ++ + + F R +G G G V+
Sbjct: 145 PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQP-MGEDWFLDFRVLGRGGFGEVFA 203
Query: 99 CSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158
C + + LYA K +NK+ L+K+K A +EKKIL + F+ +L F
Sbjct: 204 CQMKATGK---------LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254
Query: 159 EASNFSCIVMEFCSGGDL--HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
E C+VM +GGD+ H + + F A FY A+++ LE+LH IIYRD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFL 276
LKPENVL+ DG++ +SD L AVE + +++T
Sbjct: 315 LKPENVLLDDDGNVRISDLGL--------AVELK-------AGQTKTKGY---------- 349
Query: 277 NRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFI 336
GT +++PE+ G + +VD++A G+ +
Sbjct: 350 ------------------------------AGTPGFMAPELLLGEEYDFSVDYFALGVTL 379
Query: 337 YEMIYGRTPFAA----PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392
YEMI R PF A N+ + ++++ +T+ P S ++D LL KDP
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTY----PDKFSP-ASKDFCEALLQKDPEK 434
Query: 393 RLGSK-RGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
RLG + ++THP F+ +++ + LTPP +P
Sbjct: 435 RLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 1e-89
Identities = 103/359 (28%), Positives = 164/359 (45%), Gaps = 75/359 (20%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
G + + DF+ +G G G V L + + LYA+K++ K+V+ +
Sbjct: 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLS----ERKGTD-----ELYAVKILKKDVVIQDD 62
Query: 132 KVHRAEMEKKIL-KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSL 190
V +EK++L PFL L++ F+ + VME+ +GGDL + H Q RF
Sbjct: 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKE 120
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
A FYAAE+ + L +L GIIYRDLK +NV++ S+GHI ++DF +
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM------------- 167
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
E T T F GT
Sbjct: 168 --CKENIWDGVTTKT----------------------------------------FCGTP 185
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
+Y++PE+ + +G +VDWWAFG+ +YEM+ G+ PF + ++I++ + + P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----P 241
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
SMS+ A + GL+ K P RLG G D+K H FF+ +++ + + + PP P
Sbjct: 242 KSMSK-EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 2e-89
Identities = 113/403 (28%), Positives = 187/403 (46%), Gaps = 86/403 (21%)
Query: 38 SFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVY 97
+++PT+++ ++ + R + + L +DFDL R IG G V
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESG-KASSSLGLQDFDLLRVIGRGSYAKVL 69
Query: 98 LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KMLDHPFLPTLYA 156
L + ++ +YAM+VV KE++ + + + EK + + +HPFL L++
Sbjct: 70 LV----RLKKTD-----RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120
Query: 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
F+ + V+E+ +GGDL + H Q ++ ARFY+AE+ +AL YLH GIIYRD
Sbjct: 121 CFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 178
Query: 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFL 276
LK +NVL+ S+GHI L+D+ + E P T T
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGM---------------CKEGLRPGDTTST----------- 212
Query: 277 NRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFI 336
F GT Y++PE+ G +G +VDWWA G+ +
Sbjct: 213 -----------------------------FCGTPNYIAPEILRGEDYGFSVDWWALGVLM 243
Query: 337 YEMIYGRTPFAAP---------SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
+EM+ GR+PF + + + I++K + P S+S A ++ LN
Sbjct: 244 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----PRSLSV-KAASVLKSFLN 298
Query: 388 KDPCNRLGS--KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
KDP RLG + G AD++ HPFF+ +++ ++ + + PP P
Sbjct: 299 KDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 341
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-89
Identities = 106/361 (29%), Positives = 166/361 (45%), Gaps = 75/361 (20%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
++ L DF++ + IG G G V + + ++AMK++NK + K+ +
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAE 117
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
E+ +L D ++ TL+ F+ N +VM++ GGDL +L K R
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEM 176
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
ARFY AE+++A++ +H L ++RD+KP+N+L+ +GHI L+D
Sbjct: 177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD------------------ 218
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
FGS + E +S VGT +Y
Sbjct: 219 ---------------------------FGSCLK---------LMEDGTVQSSVAVGTPDY 242
Query: 313 VSPEV-----ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV--KKPLTF 365
+SPE+ G +G DWW+ G+ +YEM+YG TPF A S T I+ K+ F
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425
P + +SE +A+DLI L+ +RLG G D K HPFF G+++ IR+ P I
Sbjct: 303 P-TQVTDVSE-NAKDLIRRLICSRE-HRLGQ-NGIEDFKKHPFFSGIDWDNIRNCEAPYI 358
Query: 426 P 426
P
Sbjct: 359 P 359
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 2e-89
Identities = 99/357 (27%), Positives = 167/357 (46%), Gaps = 77/357 (21%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+ L DF LH+ +G G G V+L ++++ +A+K + K+V+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLA----EFKKTN-----QFFAIKALKKDVVLMDDD 60
Query: 133 VHRAEMEKKILKM-LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
V +EK++L + +HPFL ++ F+ VME+ +GGDL H Q +F L+
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY--HIQSCHKFDLS 118
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
A FYAAE+++ L++LH GI+YRDLK +N+L+ DGHI ++DF +
Sbjct: 119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-------------- 164
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
E ++T T F GT +
Sbjct: 165 -CKENMLGDAKTNT----------------------------------------FCGTPD 183
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
Y++PE+ G + ++VDWW+FG+ +YEM+ G++PF E +I + P
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PR 239
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
+ + A+DL+ L ++P RLG D++ HP F+ +N+ + + + PP P
Sbjct: 240 WLEK-EAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEIDPPFRP 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 3e-89
Identities = 87/365 (23%), Positives = 154/365 (42%), Gaps = 85/365 (23%)
Query: 71 FGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK 130
F + F F++ R IG G G V + N+ + +YAMK +NK+ ++
Sbjct: 6 FDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKK---------MYAMKYMNKQKCVER 56
Query: 131 KKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSL 190
+V E +I++ L+HPFL L+ F+ +V++ GGDL H Q + F
Sbjct: 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRY--HLQQNVHFKE 114
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
+ + + E+++AL+YL II+RD+KP+N+L+ GH+ ++D
Sbjct: 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD---------------- 158
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGT 309
F + + T + + GT
Sbjct: 159 -----------------------------FNIAAMLPRET------------QITTMAGT 177
Query: 310 HEYVSPEV---ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---LRNIVKKPL 363
Y++PE+ G + AVDWW+ G+ YE++ GR P+ S+ ++ + +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLT 421
T+ PS+ S+ L+ LL +P R +DV+ P+ +N+ + + L
Sbjct: 238 TY----PSAWSQ-EMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINWDAVFQKRLI 289
Query: 422 PPEIP 426
P IP
Sbjct: 290 PGFIP 294
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 7e-89
Identities = 115/414 (27%), Positives = 176/414 (42%), Gaps = 78/414 (18%)
Query: 18 TSTANSSSMSSESCSSFSRLSFELPTSKSSPENL-SLKPHRSSDFAYSAIRSATFGRKTG 76
T + E ++ ++ L ++ + S P +S + A +
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+ +F+ + +G G G V L R YAMK++ KEV+ K +V
Sbjct: 147 MN--EFEYLKLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHT 195
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ++L+ HPFL L F+ + C VME+ +GG+L H + FS ARFY
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFY 253
Query: 197 AAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
AE++ AL+YLH ++YRDLK EN+++ DGHI ++DF L E
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL---------------CKE 298
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+ T F GT EY++P
Sbjct: 299 GIKDGATMKT----------------------------------------FCGTPEYLAP 318
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
EV +G AVDWW G+ +YEM+ GR PF +E I+ + + F P ++
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----PRTLGP 374
Query: 376 YHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
A+ L+SGLL KDP RLG A ++ H FF G+ + + + L+PP P
Sbjct: 375 -EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 6e-88
Identities = 113/360 (31%), Positives = 163/360 (45%), Gaps = 76/360 (21%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
L +F+ R +G G G V L R E LYA+KV+ K+V+ +
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLA---------RVKETGDLYAVKVLKKDVILQDD 65
Query: 132 KVHRAEMEKKIL-KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSL 190
V EK+IL +HPFL L+ F+ + VMEF +GGDL + H Q +RF
Sbjct: 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDE 123
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
ARFYAAE++ AL +LH GIIYRDLK +NVL+ +GH L+DF +
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM------------- 170
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
E T T F G TP
Sbjct: 171 --CKEGICNGVTTAT-------------FCG-------TP-------------------- 188
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
+Y++PE+ +G AVDWWA G+ +YEM+ G PF A + + I+ + + P
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----P 244
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGS--KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
+ + E A ++ + K+P RLGS + G + HPFFK +++A + R + PP P
Sbjct: 245 TWLHE-DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP 303
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 2e-84
Identities = 109/423 (25%), Positives = 176/423 (41%), Gaps = 75/423 (17%)
Query: 8 EPPSDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIR 67
+ D + S + S + EL + A + +
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 68 SATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL 127
G + + DF+ +G G G V L LYA+K++ K+V+
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVV 379
Query: 128 EKKKKVHRAEMEKKILKM-LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK 186
+ V +EK++L + PFL L++ F+ + VME+ +GGDL + H Q
Sbjct: 380 IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVG 437
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
RF A FYAAE+ + L +L GIIYRDLK +NV++ S+GHI ++DF +
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM--------- 488
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
E T T F
Sbjct: 489 ------CKENIWDGVTTKT----------------------------------------F 502
Query: 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
GT +Y++PE+ + +G +VDWWAFG+ +YEM+ G+ PF + ++I++ + +
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY- 561
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPP 423
P SMS+ A + GL+ K P RLG G D+K H FF+ +++ + + + PP
Sbjct: 562 ---PKSMSK-EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
Query: 424 EIP 426
P
Sbjct: 618 YKP 620
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-76
Identities = 99/359 (27%), Positives = 145/359 (40%), Gaps = 83/359 (23%)
Query: 74 KTGLTFRDFDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
K T DFD+ R +G G G VYL NK+ + A+KV+ K LEK+
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKF----------IMALKVLFKSQLEKEGV 57
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
H+ E +I L HP + +Y F +++EF G+L+ Q H RF
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQR 115
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ + E+ AL Y H +I+RD+KPEN+L+ G + ++DF S
Sbjct: 116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-------------- 161
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
+P + T C GT +Y
Sbjct: 162 ---VHAPSLRRRT-------------------------------------MC---GTLDY 178
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
+ PE+ G +H VD W G+ YE + G PF +PS+ T R IV L F P
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF----PPF 234
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431
+S+ ++DLIS LL P RL V HP+ K + R + PP + +
Sbjct: 235 LSD-GSKDLISKLLRYHPPQRL----PLKGVMEHPWVKANS----RRVLPPVYQSTQSK 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 5e-75
Identities = 89/339 (26%), Positives = 136/339 (40%), Gaps = 79/339 (23%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
+K DF++ R +G G G VYL +K+ + A+KV+ K LEK
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKF----------ILALKVLFKAQLEKAG 51
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
H+ E +I L HP + LY F + +++E+ G ++ Q +F
Sbjct: 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR--ELQKLSKFDEQ 109
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
Y E+ AL Y H +I+RD+KPEN+L+ S G + ++DF S
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS------------- 156
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
+P S+ C GT +
Sbjct: 157 ----VHAPSSRRTD-------------------------------------LC---GTLD 172
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
Y+ PE+ G H VD W+ G+ YE + G+ PF A + + T + I + TF P
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PD 228
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
++E ARDLIS LL +P R +V HP+
Sbjct: 229 FVTE-GARDLISRLLKHNPSQRP----MLREVLEHPWIT 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 5e-65
Identities = 73/386 (18%), Positives = 124/386 (32%), Gaps = 110/386 (28%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
++ D+ + R + G + LC +NK+ YA+K K +LEKK+
Sbjct: 24 KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKF-----------YALKKYEKSLLEKKRD 72
Query: 133 V--------------HRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-- 176
+ E +I+ + + + T + I+ E+ +
Sbjct: 73 FTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132
Query: 177 ----HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIM 231
+ K + + VL + Y+H I +RD+KP N+L+ +G +
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVK 192
Query: 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPN 291
LSDF S + KKI+
Sbjct: 193 LSDFGES---------------------------------------EYMVDKKIKG---- 209
Query: 292 RLFVAEPVAARSCSFVGTHEYVSPEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAP 349
S GT+E++ PE S +G VD W+ GI +Y M Y PF+
Sbjct: 210 -----------SR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 350 SN-ETTLRNIVKKPLTFPTQSPSSMSEYH--------------ARDLISGLLNKDPCNRL 394
+ NI K + +P + D + L K+P R+
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 395 GSKRGAADVKTHPFFKGLNFALIRSL 420
S+ D H + N +R
Sbjct: 316 TSE----DALKHEWLADTNIEDLREF 337
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-65
Identities = 71/344 (20%), Positives = 118/344 (34%), Gaps = 76/344 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ +G G G V + D YA+K + ++K+ E
Sbjct: 7 DFEEIAVLGQGAFGQVVKA----RNALDS-----RYYAIKKIRH----TEEKLSTILSEV 53
Query: 141 KILKMLDHPFLPTLYAEFEASNFS-------------CIVMEFCSGGDLHSLRHKQPHKR 187
+L L+H ++ YA + I ME+C G L+ L H +
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN- 112
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247
++L AL Y+H GII+RDLKP N+ + ++ + DF L+ + +
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
S S + T S +
Sbjct: 173 LKLDSQNLPGSSDNLT-----------------------------------------SAI 191
Query: 308 GTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
GT YV+ EV G G + +D ++ GI +EMIY L+ + + FP
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFP 249
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ + + +I L++ DP R GA + +
Sbjct: 250 PDFDDNKMK-VEKKIIRLLIDHDPNKRP----GARTLLNSGWLP 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 68/390 (17%), Positives = 122/390 (31%), Gaps = 88/390 (22%)
Query: 22 NSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRD 81
+SS + + + + + +L + S + + +S + S R +
Sbjct: 7 HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPS--------RPESFFQQS 58
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F R+G G G V+ + ++D LYA+K K + +
Sbjct: 59 FQRLSRLGHGSYGEVFKV----RSKEDG-----RLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
K+ HP L +E + E C G L Y + L
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTL 167
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
+AL +LH G+++ D+KP N+ + G L D
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGD--------------------------- 200
Query: 262 QTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG ++ T A G Y++PE+ G
Sbjct: 201 ------------------FGLLVELGT------------AGAGEVQEGDPRYMAPELLQG 230
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+G A D ++ G+ I E+ P + + + L P + + +S R
Sbjct: 231 S-YGTAADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYL--PPEFTAGLSS-ELRS 283
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
++ +L DP R A + P +
Sbjct: 284 VLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 4e-57
Identities = 89/340 (26%), Positives = 140/340 (41%), Gaps = 80/340 (23%)
Query: 74 KTGLTFRDFDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
G DF + +G G VY S++ A+K+++K+ + K
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLE----------VAIKMIDKKAMYKAGM 54
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
V R + E KI L HP + LY FE SN+ +V+E C G+++ + K FS
Sbjct: 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENE 113
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
AR + +++ + YLH GI++RDL N+L+ + +I ++DF L+
Sbjct: 114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-------------- 159
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTL--TPNRLFVAEPVAARSCSFVGTH 310
T + + TL TPN
Sbjct: 160 ----------TQLKMPHEKH-------------YTLCGTPN------------------- 177
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
Y+SPE+A+ +HG D W+ G Y ++ GR PF + + TL +V P
Sbjct: 178 -YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----P 232
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
S +S A+DLI LL ++P +RL + V HPF
Sbjct: 233 SFLSI-EAKDLIHQLLRRNPADRL----SLSSVLDHPFMS 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-54
Identities = 70/370 (18%), Positives = 127/370 (34%), Gaps = 76/370 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ ++IG G G L + G Y +K +N + K++ + E
Sbjct: 25 KYVRLQKIGEGSFGKAILV-----KSTEDGR----QYVIKEINISRMSSKER-EESRREV 74
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L + HP + FE + IVM++C GGDL + Q F + ++
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+AL+++H I++RD+K +N+ + DG + L D
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD-------------------------- 168
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG ++ L + + +GT Y+SPE+
Sbjct: 169 -------------------FGIARV--LNSTVEL--------ARACIGTPYYLSPEICEN 199
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+ N D WA G +YE+ + F A S + + I+ S R
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS---FPPVSLHYSY-DLRS 255
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPE---IPGMRRQKTMPFP 437
L+S L ++P +R + F + E + + + P P
Sbjct: 256 LVSQLFKRNPRDRP----SVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIP 311
Query: 438 DQKIKSQSTA 447
++ S +
Sbjct: 312 AKRPASGQNS 321
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 78/352 (22%), Positives = 126/352 (35%), Gaps = 88/352 (25%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+ R + R +G G + + K +A K+V K +L K + +
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEV----------FAGKIVPKSLLLKPHQREKM 62
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
ME I + L H + + FE ++F +V+E C L L HK+ K + AR+Y
Sbjct: 63 SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKR-RKALTEPEARYY 120
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
++++ +YLH +I+RDLK N+ + D + + DF L+
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------------------ 162
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTL--TPNRLFVAEPVAARSCSFVGTHEYVS 314
T R + L TPN Y++
Sbjct: 163 ------TKVEYDGERK-------------KVLCGTPN--------------------YIA 183
Query: 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS 374
PEV S H VD W+ G +Y ++ G+ PF + T I K + P ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI----PKHIN 239
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
A LI +L DP R ++ FF P +P
Sbjct: 240 P-VAASLIQKMLQTDPTARP----TINELLNDEFFT-------SGYIPARLP 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 75/369 (20%), Positives = 123/369 (33%), Gaps = 89/369 (24%)
Query: 56 HRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCC 115
H + + + R + + ++IG+G V+ +E
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL----------NEKKQ 53
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP--TLYAEFEASNFSCIVMEFCSG 173
+YA+K VN E + + E L L LY + +VME C
Sbjct: 54 IYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
DL+S K K + Y +L A+ +H GI++ DLKP N L+ DG + L
Sbjct: 112 IDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLI 168
Query: 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293
DF + + ++Q T + +
Sbjct: 169 DFGI--------------------------------------------ANQMQPDTTSVV 184
Query: 294 FVAEPVAARSCSFVGTHEYVSPEV-----------ASGGSHGNAVDWWAFGIFIYEMIYG 342
S VGT Y+ PE S D W+ G +Y M YG
Sbjct: 185 KD---------SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 343 RTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401
+TPF N+ + L I+ P + +D++ L +DP R+
Sbjct: 236 KTPFQQIINQISKLHAIIDPNHEIE--FPDIPEK-DLQDVLKCCLKRDPKQRI----SIP 288
Query: 402 DVKTHPFFK 410
++ HP+ +
Sbjct: 289 ELLAHPYVQ 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 79/372 (21%), Positives = 130/372 (34%), Gaps = 82/372 (22%)
Query: 42 PTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLC-S 100
P + + A A + R + R +G G +
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISD 62
Query: 101 LNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160
+ K +A K+V K +L K + + ME I + L H + + FE
Sbjct: 63 ADTKEV----------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112
Query: 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220
++F +V+E C L L HK+ K + AR+Y ++++ +YLH +I+RDLK
Sbjct: 113 NDFVFVVLELCRRRSLLEL-HKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG 170
Query: 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFF 280
N+ + D + + DF L+ VE
Sbjct: 171 NLFLNEDLEVKIGDFGLA------TKVEYD------------------------------ 194
Query: 281 GSKKIQTL--TPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYE 338
++ + L TPN Y++PEV S H VD W+ G +Y
Sbjct: 195 -GERKKVLCGTPN--------------------YIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 339 MIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398
++ G+ PF + T I K + P ++ A LI +L DP R
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKNEYSI----PKHINP-VAASLIQKMLQTDPTARP---- 284
Query: 399 GAADVKTHPFFK 410
++ FF
Sbjct: 285 TINELLNDEFFT 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 74/345 (21%), Positives = 119/345 (34%), Gaps = 89/345 (25%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R + + ++IG+G V+ +E +YA+K VN E + + E
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL----------NEKKQIYAIKYVNLEEA-DNQTLDSYRNE 57
Query: 140 KKILKMLDHPFLP--TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
L L LY + +VME C DL+S K K + Y
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYW 114
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
+L A+ +H GI++ DLKP N L+ DG + L DF +
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGI-------------------- 153
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
+ ++Q T + + S VGT Y+ PE
Sbjct: 154 ------------------------ANQMQPDTTSVVKD---------SQVGTVNYMPPEA 180
Query: 318 -----------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTF 365
S D W+ G +Y M YG+TPF N+ + L I+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P + +D++ L +DP R+ ++ HP+ +
Sbjct: 241 E--FPDIPEK-DLQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 68/347 (19%), Positives = 123/347 (35%), Gaps = 77/347 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ + +G G G V+ K + D C YA+K + E ++ + E
Sbjct: 6 DFEPIQCLGRGGFGVVFEA----KNKVDD-----CNYAIKRIRLPNRELARE--KVMREV 54
Query: 141 KILKMLDHPFLPTLYAEFE------------ASNFSCIVMEFCSGGDLHS-LRHKQPHKR 187
K L L+HP + + + + I M+ C +L + + +
Sbjct: 55 KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247
+ ++ A+E+LH G+++RDLKP N+ D + + DF
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG----------- 163
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
L ++ Q + P AR V
Sbjct: 164 ------------------------LVTAMD--------QDEEEQTVLTPMPAYARHTGQV 191
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
GT Y+SPE G S+ + VD ++ G+ ++E++Y PF+ V+ FP
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL-KFPP 247
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414
++ +L+ P R A ++ + F+ L+F
Sbjct: 248 LFTQKYPC--EYVMVQDMLSPSPMERP----EAINIIENAVFEDLDF 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 89/344 (25%), Positives = 134/344 (38%), Gaps = 81/344 (23%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
G G + + L IG G G V + A K + K +E
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVD 51
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSL 190
+ + E +I+K LDHP + LY FE + +VME C+GG+L + HK + F
Sbjct: 52 RFKQ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRE 105
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAV 247
+ A +VL A+ Y H L + +RDLKPEN L + D + L DF L+
Sbjct: 106 SDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA--------- 156
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
F K+ + V
Sbjct: 157 ------------------------------ARFKPGKMMR-----------------TKV 169
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
GT YVSP+V G +G D W+ G+ +Y ++ G PF+AP++ + I + TFP
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE 228
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
+ ++S A LI LL K P R+ + H +F+
Sbjct: 229 KDWLNVSP-QAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-51
Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 18/221 (8%)
Query: 20 TANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTF 79
+ E SS + L++K + K G+
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGH------AEKVGIE- 54
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEM 138
+F+L + +G G G V+L R+ GH+ LYAMKV+ K +++K K
Sbjct: 55 -NFELLKVLGTGAYGKVFLV------RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 107
Query: 139 EKKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E+++L+ + PFL TL+ F+ +++++ +GG+L + H +RF+ + Y
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT--HLSQRERFTEHEVQIYV 165
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
E+++ALE+LH LGIIYRD+K EN+L+ S+GH++L+DF LS
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-37
Identities = 48/134 (35%), Positives = 72/134 (53%), Gaps = 14/134 (10%)
Query: 302 RSCSFVGTHEYVSPEVASGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL---- 355
R+ F GT EY++P++ GG H AVDWW+ G+ +YE++ G +PF + +
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNF 414
R I+K + P MS A+DLI LL KDP RLG R A ++K H FF+ +N+
Sbjct: 276 RRILKSEPPY----PQEMSA-LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330
Query: 415 ALI--RSLTPPEIP 426
+ + + P P
Sbjct: 331 DDLAAKKVPAPFKP 344
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-51
Identities = 66/340 (19%), Positives = 114/340 (33%), Gaps = 82/340 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
D+++ IG G G + + D + K ++ + + +K E
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI----RRKSDG-----KILVWKELDYGSMTEAEK-QMLVSE 55
Query: 140 KKILKMLDHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARF 195
+L+ L HP + Y + IVME+C GGDL S+ + + +
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 196 YAAEVLVALEYLH-----MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
++ +AL+ H +++RDLKP NV + ++ L DF L+
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA------------ 163
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
R T FVGT
Sbjct: 164 ---------------------------RILNHDTSFAKT----------------FVGTP 180
Query: 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
Y+SPE + S+ D W+ G +YE+ PF A S + I + P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P 237
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
S+ ++I+ +LN +R ++ +P
Sbjct: 238 YRYSD-ELNEIITRMLNLKDYHRP----SVEEILENPLIL 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-51
Identities = 84/366 (22%), Positives = 140/366 (38%), Gaps = 82/366 (22%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+T + F +G+G V+L ++ G +A+K + K +
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVK-----QRLTGKL----FALKCIKKSPAFRDSS 52
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLT 191
+ E +LK + H + TL +E++ +VM+ SGG+L + + ++
Sbjct: 53 LEN---EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEK 106
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVE 248
A +VL A++YLH GI++RDLKPEN+L + + IM++DF LS
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---------- 156
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308
+ + + T G
Sbjct: 157 -----------------------------KMEQNGIMSTA------------------CG 169
Query: 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ 368
T YV+PEV + + AVD W+ G+ Y ++ G PF + I + F +
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESP 229
Query: 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGM 428
+SE A+D I LL KDP R +HP+ G N AL R + P +
Sbjct: 230 FWDDISE-SAKDFICHLLEKDPNERY----TCEKALSHPWIDG-NTALHRDIYPSVSLQI 283
Query: 429 RRQKTM 434
++
Sbjct: 284 QKNFAK 289
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 9e-51
Identities = 82/383 (21%), Positives = 130/383 (33%), Gaps = 109/383 (28%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-- 129
G + + L IG G G V + A+K++NK + +
Sbjct: 18 GGSLLELQKKYHLKGAIGQGSYGVVRVA-----IENQTRAI----RAIKIMNKNKIRQIN 68
Query: 130 KKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL------------- 176
K V R + E +++K L HP + LY +E + C+VME C GG L
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 177 -------------------------HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG 211
+ ++ AL YLH G
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 212 IIYRDLKPENVLVRSDG--HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYS 269
I +RD+KPEN L ++ I L DF L
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGL-------------------------------- 216
Query: 270 TRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH--GNAV 327
SK+ L + + GT +V+PEV + + G
Sbjct: 217 ------------SKEFYKLNNGEYYGMT-------TKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 328 DWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387
D W+ G+ ++ ++ G PF ++ T+ ++ K L F + + +S ARDL+S LLN
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLN 316
Query: 388 KDPCNRLGSKRGAADVKTHPFFK 410
++ R A HP+
Sbjct: 317 RNVDERF----DAMRALQHPWIS 335
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 86/346 (24%), Positives = 133/346 (38%), Gaps = 78/346 (22%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
T + + R +G G G V LC G E A+KV++K +++K
Sbjct: 18 QHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-----GQE----CAVKVISKRQVKQKT 68
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
E ++LK LDHP + LY FE + +V E +GG+L KRFS
Sbjct: 69 DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEV 126
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVE 248
A +VL + Y+H I++RDLKPEN+L+ S D +I + D
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID-------------- 172
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFV 307
FG S + ++ +
Sbjct: 173 -------------------------------FGLSTHFE---ASKKMK---------DKI 189
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
GT Y++PEV G ++ D W+ G+ +Y ++ G PF + L+ + K TF
Sbjct: 190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL 248
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
+SE A+DLI +L P R+ A D H + +
Sbjct: 249 PQWKKVSE-SAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-50
Identities = 64/350 (18%), Positives = 106/350 (30%), Gaps = 103/350 (29%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
DF IG+G G V+ K+R D Y +K V +K R
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKA----KHRIDG-----KTYVIKRVKYN----NEKAER-- 53
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFS----------------CIVMEFCSGGDLHSLRH 181
E K L LDH + ++ ++ I MEFC G L
Sbjct: 54 -EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 182 KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
K+ ++ A ++ ++Y+H +I RDLKP N+ + + + D
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD------- 165
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
FG R
Sbjct: 166 --------------------------------------FGLVTSLKNDGKR--------- 178
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVK 360
GT Y+SPE S +G VD +A G+ + E+++ T F ++
Sbjct: 179 --TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRD 233
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ + + L+ LL+K P +R +++
Sbjct: 234 GII------SDIFDK-KEKTLLQKLLSKKPEDRP----NTSEILRTLTVW 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 74/409 (18%), Positives = 130/409 (31%), Gaps = 102/409 (24%)
Query: 16 RTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKT 75
+S + ++ + + ++ +++ R
Sbjct: 5 HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGR-------- 56
Query: 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR 135
+ + ++IG+G V+ +E +YA+K VN E + +
Sbjct: 57 -----IYSILKQIGSGGSSKVFQVL----------NEKKQIYAIKYVNLEEA-DNQTLDS 100
Query: 136 AEMEKKILKMLDHPFLP--TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
E L L LY + +VME C DL+S K K
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWER 157
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+ Y +L A+ +H GI++ DLKP N L+ DG + L DF +
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGI---------------- 200
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ ++Q T + + S VG Y+
Sbjct: 201 ----------------------------ANQMQPDTTSVVKD---------SQVGAVNYM 223
Query: 314 SPEVASGGS-----------HGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKK 361
PE S D W+ G +Y M YG+TPF N+ + L I+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P + +D++ L +DP R+ ++ HP+ +
Sbjct: 284 NHEIEF--PDIPEK-DLQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 325
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-50
Identities = 80/334 (23%), Positives = 128/334 (38%), Gaps = 79/334 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F R++G+G G V+L + G E +K +NK+ + + + E E +
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSS-----GLE----RVIKTINKDRS--QVPMEQIEAEIE 72
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL--HSLRHKQPHKRFSLTSARFYAAE 199
+LK LDHP + ++ FE + IVME C GG+L + + K S +
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
++ AL Y H ++++DLKPEN+L + I + DF L+
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------------ 174
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
F S + T + GT Y++PE
Sbjct: 175 ---------------------ELFKSDEHST-----------------NAAGTALYMAPE 196
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V D W+ G+ +Y ++ G PF S E + K + + ++
Sbjct: 197 VFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTP- 253
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
A DL+ +L KDP R AA V H +FK
Sbjct: 254 QAVDLLKQMLTKDPERRP----SAAQVLHHEWFK 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 84/386 (21%), Positives = 138/386 (35%), Gaps = 81/386 (20%)
Query: 45 KSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNK 104
+ + D + K G + +++G+G G V LC +K
Sbjct: 4 HHHHSSGRENLYFQGDLQAT--PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCR--DK 59
Query: 105 YRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164
A+K++ K + + E +LK+LDHP + LY FE
Sbjct: 60 VTHVE-------RAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111
Query: 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224
+VME GG+L +F+ A +VL + YLH I++RDLKPEN+L+
Sbjct: 112 YLVMECYKGGEL--FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLL 169
Query: 225 RS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG 281
S D I + D FG
Sbjct: 170 ESKEKDALIKIVD---------------------------------------------FG 184
Query: 282 -SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI 340
S + + +GT Y++PEV + D W+ G+ ++ ++
Sbjct: 185 LSAVFE---NQKKMK---------ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILL 231
Query: 341 YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400
G PF +++ LR + K TF + ++SE A+DLI +L D R+ A
Sbjct: 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIKQMLQFDSQRRI----SA 286
Query: 401 ADVKTHPFFKGLNFALIRSLTPPEIP 426
HP+ K + + P +
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLA 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 82/334 (24%), Positives = 124/334 (37%), Gaps = 77/334 (23%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+++ +G G G V C E YA+KV+NK K K E
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRIT-----QQE----YAVKVINKASA-KNKDTSTILREV 72
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++LK LDHP + L+ E S+ IV E +GG+L KRFS A +V
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIKQV 130
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
+ Y+H I++RDLKPEN+L+ S D I + DF LS
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS------------------- 171
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
F +GT Y++PEV
Sbjct: 172 --------------------TCFQQNTKMK-----------------DRIGTAYYIAPEV 194
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
G++ D W+ G+ +Y ++ G PF + L+ + F ++S+
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-D 252
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
A+DLI +L P R+ A HP+ +
Sbjct: 253 AKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 70/359 (19%), Positives = 124/359 (34%), Gaps = 89/359 (24%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +G G+ G V+ C + Y K V K + E
Sbjct: 7 YMIAEDLGRGEFGIVHRC-------VETSSKKT----YMAKFVKV----KGTDQVLVKKE 51
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT--SARFYA 197
IL + H + L+ FE+ ++ EF SG D+ + F L Y
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYV 108
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDFDLSLCSNAIPAVESPASSPE 255
+V AL++LH I + D++PEN++ ++ I + +F
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF-------------------- 148
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+R L + L EY +P
Sbjct: 149 ---------------GQARQLK---PGDNFRLL------------------FTAPEYYAP 172
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
EV A D W+ G +Y ++ G PF A +N+ + NI+ TF ++ +S
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTM 434
A D + LL K+ +R+ A++ HP+ K ++ I ++ ++
Sbjct: 233 -EAMDFVDRLLVKERKSRM----TASEALQHPWLKQKI----ERVSTKVIRTLKHRRYY 282
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-49
Identities = 48/337 (14%), Positives = 89/337 (26%), Gaps = 85/337 (25%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
L + +H +G G VY + + +KV + +
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEA----TQGDLNDAKNKQKFVLKVQKPA---NPWEFYIG 114
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL---RHKQPHKRFSLTSA 193
+ LK Y+ N S +V E S G L + P K
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-----------DGHIMLSDFDLSLCSN 242
+A +L +E +H II+ D+KP+N ++ + + L D S+
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302
P +F
Sbjct: 235 LFP--------------------------------------------KGTIFT------- 243
Query: 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKK 361
+ T + E+ S +D++ +Y M++G E + ++
Sbjct: 244 --AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398
+ + +LN C+ L S
Sbjct: 302 LPHLDMWN----------EFFHVMLNIPDCHHLPSLD 328
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-49
Identities = 83/412 (20%), Positives = 136/412 (33%), Gaps = 90/412 (21%)
Query: 8 EPPSDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIR 67
P + T + E +S +
Sbjct: 91 SKPCEPTAPVLIPGDERKRRRGYDVD------EQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 68 SATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKE 125
K +D+H +G G G V+ +R G+ +A K V
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV-------TERATGNN----FAAKFVMTP 193
Query: 126 VLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH 185
K+ V + E + + +L HP L L+ FE N ++ EF SGG+L K
Sbjct: 194 HESDKETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVAD 247
Query: 186 KRFSLT--SARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFDLSLCS 241
+ ++ A Y +V L ++H ++ DLKPEN++ + + L DF
Sbjct: 248 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF------ 301
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
L+ L+ + ++
Sbjct: 302 -----------------------------GLTAHLD---PKQSVKVT------------- 316
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361
GT E+ +PEVA G G D W+ G+ Y ++ G +PF +++ TLRN+
Sbjct: 317 -----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
+ S +SE +D I LL DP R+ HP+ N
Sbjct: 372 DWNMDDSAFSGISE-DGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGN 418
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-49
Identities = 80/376 (21%), Positives = 139/376 (36%), Gaps = 84/376 (22%)
Query: 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKK 131
K G + +D+ +G+G G V+ C ++ G + K +N K
Sbjct: 45 KQGSVYDYYDILEELGSGAFGVVHRC-------VEKATGRV----FVAKFINTPYPLDKY 93
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
V E I+ L HP L L+ FE +++EF SGG+L + + + ++
Sbjct: 94 TVKN---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMS 147
Query: 192 --SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDFDLSLCSNAIPAV 247
Y + L+++H I++ D+KPEN++ + + + DF
Sbjct: 148 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF------------ 195
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
L+ LN + ++
Sbjct: 196 -----------------------GLATKLN---PDEIVKVT------------------T 211
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
T E+ +PE+ G D WA G+ Y ++ G +PFA + TL+N+ + F
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG 427
+ SS+S A+D I LL K+P RL D HP+ KG + L +
Sbjct: 272 DAFSSVSP-EAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHSNLTSRIPSSRYNK 326
Query: 428 MRRQKTMPFPDQKIKS 443
+R++ + D
Sbjct: 327 IRQKIKEKYADWPAPQ 342
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-49
Identities = 80/354 (22%), Positives = 132/354 (37%), Gaps = 86/354 (24%)
Query: 78 TFRDF-DLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKKKVH 134
D ++ +G+G V C + + G E YA K + K L ++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKC-------RQKGTGKE----YAAKFIKKRRLSSSRRGV 50
Query: 135 RAEM---EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSL 190
E E IL+ + HP + TL+ FE +++E SGG+L L K + +
Sbjct: 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTE 107
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPA 246
A + ++L + YLH I + DLKPEN+++ + I L DF +
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI--------- 158
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
+ + + + +
Sbjct: 159 --------------------------AHKIE---AGNEFKNI------------------ 171
Query: 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
GT E+V+PE+ + G D W+ G+ Y ++ G +PF + + TL NI F
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231
Query: 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420
+ S+ SE A+D I LL KDP R+ A H + K + +R
Sbjct: 232 EEYFSNTSE-LAKDFIRRLLVKDPKRRM----TIAQSLEHSWIKAIRRRNVRGE 280
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 71/325 (21%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +++G G V L + D YA+K + + +++ R E
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV----EGLHDGHF-----YALKRILCHEQQDREEAQR---E 76
Query: 140 KKILKMLDHPFLPTLYAEFEASNFS----CIVMEFCSGGDLHSL--RHKQPHKRFSLTSA 193
+ ++ +HP + L A + +++ F G L + R K +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+ + LE +H G +RDLKP N+L+ +G +L D
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS---------------- 180
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ + L + + T Y
Sbjct: 181 --MNQACIHVEGSRQALTLQDWAAQ----------------------------RCTISYR 210
Query: 314 SPEVASGGSH---GNAVDWWAFGIFIYEMIYGRTPF-AAPSNETTLRNIVKKPLTFPTQS 369
+PE+ S SH D W+ G +Y M++G P+ ++ V+ L+ P
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP--Q 268
Query: 370 PSSMSEYHARDLISGLLNKDPCNRL 394
S L++ ++ DP R
Sbjct: 269 SPRHSS-ALWQLLNSMMTVDPHQRP 292
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-48
Identities = 82/334 (24%), Positives = 126/334 (37%), Gaps = 79/334 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+++ +G G G V C E YA+KV+NK K K E +
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRIT-----QQE----YAVKVINKASA-KNKDTSTILREVE 73
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFYAAEV 200
+LK LDHP + L+ E S+ IV E +GG+L + + KRFS A +V
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQV 130
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
+ Y+H I++RDLKPEN+L+ S D I + DF LS
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS------------------- 171
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
F +GT Y++PEV
Sbjct: 172 --------------------TCFQQNTKMK-----------------DRIGTAYYIAPEV 194
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
G++ D W+ G+ +Y ++ G PF + L+ + F ++S+
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD-D 252
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
A+DLI +L P R+ A HP+ +
Sbjct: 253 AKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 76/317 (23%), Positives = 116/317 (36%), Gaps = 71/317 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F + ++IG G VY + G A+K V L K E
Sbjct: 33 NFRIEKKIGRGQFSEVYRAA-----CLLDGV----PVALKKVQIFDLMDAKARADCIKEI 83
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFYAA 198
+LK L+HP + YA F N IV+E GDL + K+ + + Y
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ ALE++H +++RD+KP NV + + G + L D L
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG-------------------- 183
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
R F ++ AA S VGT Y+SPE
Sbjct: 184 ---------------------------------RFFSSKTTAAHSL--VGTPYYMSPERI 208
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTL-RNIVKKPLTFPTQSPSSMSEY 376
+ D W+ G +YEM ++PF N +L + I + +P SE
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE- 265
Query: 377 HARDLISGLLNKDPCNR 393
R L++ +N DP R
Sbjct: 266 ELRQLVNMCINPDPEKR 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-48
Identities = 71/339 (20%), Positives = 127/339 (37%), Gaps = 81/339 (23%)
Query: 79 FRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
F D +D+ +G G V C + G E +A K++N + L + + E
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCV-----HKTTGLE----FAAKIINTKKL-SARDFQKLE 53
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFY 196
E +I + L HP + L+ + +F +V + +GG+L + + + +S A
Sbjct: 54 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHC 110
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASS 253
++L ++ Y H GI++R+LKPEN+L+ S + L+D
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD------------------- 151
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
FG + ++ + + F GT Y
Sbjct: 152 --------------------------FGLAIEVN---DSEAWH---------GFAGTPGY 173
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
+SPEV + VD WA G+ +Y ++ G PF I +P+ +
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
++ A+ LI +L +P R+ A P+
Sbjct: 234 VTP-EAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 50/419 (11%), Positives = 100/419 (23%), Gaps = 108/419 (25%)
Query: 40 ELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLC 99
+ +S S S ++ + + G R +G D
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA 92
Query: 100 SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML------------- 146
+ Q+ G + + V + + + E L++L
Sbjct: 93 T-----DQETGES----FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 147 ------------DHPFLPTLYAEFEASNFS--CIVMEFCSGGDLHSL-----RHKQPHKR 187
+ + + + +L + H HK
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKS 202
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247
+ +V+ L LH G+++ L+P ++++ G + L+ F+ + A
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---AR 259
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
+ S P
Sbjct: 260 VVSSVSRGFEPP---------------------------------------------ELE 274
Query: 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT 367
+S + D WA G+ IY + P + I + P
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ 334
Query: 368 QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
R L+ G L +RL P ++ L R+ +P
Sbjct: 335 P---------VRALLEGFLRYPKEDRL----LPLQAMETPEYEQL-----RTELSAALP 375
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+ +T F +R +G G G V C + + +YA K + K+ ++K+K
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKG 227
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
A EK+IL+ ++ F+ +L +E + C+V+ +GGDL + F
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A FYAAE+ LE LH I+YRDLKPEN+L+ GHI +SD L+
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 47/131 (35%), Positives = 62/131 (47%), Gaps = 4/131 (3%)
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361
VGT Y++PEV + + DWWA G +YEMI G++PF + + +
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK-RGAADVKTHPFFKGLNFALI--R 418
P + S AR L S LL KDP RLG + A +VK HP FK LNF +
Sbjct: 401 VKEVPEEYSERFSP-QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459
Query: 419 SLTPPEIPGMR 429
L PP P +
Sbjct: 460 MLEPPFKPDPQ 470
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 84/433 (19%), Positives = 157/433 (36%), Gaps = 92/433 (21%)
Query: 9 PPSDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLK-PHRSSDFAYSAIR 67
+ S ++ S + L+ +P L++ P + F + +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIV- 78
Query: 68 SATFGRKTGLTFRDFDLHRR--IGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVN 123
K G + + + +G G G V+ C ++ G + A K++
Sbjct: 79 ----TAKQGAVNSFYTVSKTEILGGGRFGQVHKC-------EETATGLK----LAAKIIK 123
Query: 124 KEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ 183
++ K++V E ++ LDH L LY FE+ N +VME+ GG+L +
Sbjct: 124 TRGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRI 177
Query: 184 PHKRFSLT--SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDFDLSL 239
+ ++LT + ++ + ++H + I++ DLKPEN+L + I + DF
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF---- 233
Query: 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299
L+R +K++
Sbjct: 234 -------------------------------GLARRYK---PREKLKVN----------- 248
Query: 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV 359
GT E+++PEV + D W+ G+ Y ++ G +PF ++ TL NI+
Sbjct: 249 -------FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301
Query: 360 KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRS 419
+ +SE A++ IS LL K+ R+ A++ HP+ S
Sbjct: 302 ACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRI----SASEALKHPWLSDHKLHSRLS 356
Query: 420 LTPPEIPGMRRQK 432
+ G Q
Sbjct: 357 AQKKKNRGSDAQD 369
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 76/399 (19%), Positives = 133/399 (33%), Gaps = 88/399 (22%)
Query: 47 SPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYR 106
+ + A + +K G + R++G+G G V LC K
Sbjct: 5 HHHSSGRENLYFQGIAIN--PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCK--EKNG 60
Query: 107 QDRGHEPCCLYAMKVVNKEVL----------EKKKKVHRAEMEKKILKMLDHPFLPTLYA 156
A+KV+ K +K E +LK LDHP + L+
Sbjct: 61 HSE-------KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113
Query: 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
FE + +V EF GG+L +F A ++L + YLH I++RD
Sbjct: 114 VFEDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRD 171
Query: 217 LKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLS 273
+KPEN+L+ + +I + DF L
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGL------------------------------------ 195
Query: 274 RFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFG 333
S + +GT Y++PEV + D W+ G
Sbjct: 196 --------SSFFS---KDYKLR---------DRLGTAYYIAPEVLKK-KYNEKCDVWSCG 234
Query: 334 IFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ +Y ++ G PF +++ ++ + K F ++S+ A++LI +L D R
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD-EAKELIKLMLTYDYNKR 293
Query: 394 LGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432
A + + K + +S + +
Sbjct: 294 C----TAEEALNSRWIKKYANNINKSDQKTLCGALSNMR 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-47
Identities = 74/341 (21%), Positives = 130/341 (38%), Gaps = 83/341 (24%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKKKVHRAEM- 138
+D +G+G V C +++ G + YA K + K + ++ E
Sbjct: 13 YDTGEELGSGQFAVVKKC-------REKSTGLQ----YAAKFIKKRRTKSSRRGVSREDI 61
Query: 139 --EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ILK + HP + TL+ +E +++E +GG+L + + + A +
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAE-KESLTEEEATEF 119
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPAVESPAS 252
++L + YLH L I + DLKPEN+++ I + DF
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF----------------- 162
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
L+ ++ + + + GT E+
Sbjct: 163 ------------------GLAHKID---FGNEFKNI------------------FGTPEF 183
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
V+PE+ + G D W+ G+ Y ++ G +PF + + TL N+ F + S+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
S A+D I LL KDP R+ D HP+ K +
Sbjct: 244 TSA-LAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKD 279
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-47
Identities = 77/388 (19%), Positives = 143/388 (36%), Gaps = 84/388 (21%)
Query: 55 PHRSSDFAYSAIRSATFGRKTGLTFRDF-DLHRR-IGAGDIGTVYLCSLNNKYRQDR--G 110
H SS + + F +F L + +G G V C + G
Sbjct: 5 HHHSSGVDLG--TENLYFQSME-NFNNFYILTSKELGRGKFAVVRQC-------ISKSTG 54
Query: 111 HEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH-PFLPTLYAEFEASNFSCIVME 169
E YA K + K + E +L++ P + L+ +E ++ +++E
Sbjct: 55 QE----YAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109
Query: 170 FCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--- 226
+ +GG++ SL + + S ++L + YLH I++ DLKP+N+L+ S
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169
Query: 227 DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQ 286
G I + DF +SR + + +++
Sbjct: 170 LGDIKIVDF-----------------------------------GMSRKIG---HACELR 191
Query: 287 TLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPF 346
+ +GT EY++PE+ + A D W GI Y ++ +PF
Sbjct: 192 EI------------------MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 347 AAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406
N+ T NI + + + ++ SS+S+ A D I LL K+P R A +H
Sbjct: 234 VGEDNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRP----TAEICLSH 288
Query: 407 PFFKGLNFALIRSLTPPEIPGMRRQKTM 434
+ + +F + + ++
Sbjct: 289 SWLQQWDFENLFHPEETSSSSQTQDHSV 316
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 77/340 (22%), Positives = 126/340 (37%), Gaps = 85/340 (25%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKKKVHRAEM- 138
+D+ +G+G V C +++ G E YA K + K ++ E
Sbjct: 14 YDIGEELGSGQFAIVKKC-------REKSTGLE----YAAKFIKKRQSRASRRGVSREEI 62
Query: 139 --EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARF 195
E IL+ + H + TL+ +E +++E SGG+L L K+ S A
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATS 119
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPAVESPA 251
+ ++L + YLH I + DLKPEN+++ HI L DF L
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL-------------- 165
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
+ + + + + GT E
Sbjct: 166 ---------------------AHEIE---DGVEFKNI------------------FGTPE 183
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
+V+PE+ + G D W+ G+ Y ++ G +PF + + TL NI F + S
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
SE A+D I LL K+ RL + HP+
Sbjct: 244 HTSE-LAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 76/364 (20%), Positives = 134/364 (36%), Gaps = 82/364 (22%)
Query: 55 PHRSS-DFAYSAIRSATFGRKTGLTFRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHE 112
PH +S R + F F D +D+ +G G V C + G E
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCV-----HKTTGLE 56
Query: 113 PCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCS 172
+A K++N + L + + E E +I + L HP + L+ + +F +V + +
Sbjct: 57 ----FAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111
Query: 173 GGDL-HSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DG 228
GG+L + + + +S A ++L ++ Y H GI++R+LKPEN+L+ S
Sbjct: 112 GGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQT 287
+ L+D FG + ++
Sbjct: 169 AVKLAD---------------------------------------------FGLAIEVN- 182
Query: 288 LTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFA 347
+ + F GT Y+SPEV + VD WA G+ +Y ++ G PF
Sbjct: 183 --DSEAWH---------GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231
Query: 348 APSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407
I +P+ +++ A+ LI +L +P R+ A P
Sbjct: 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRI----TADQALKVP 286
Query: 408 FFKG 411
+
Sbjct: 287 WICN 290
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-46
Identities = 78/340 (22%), Positives = 127/340 (37%), Gaps = 85/340 (25%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVLEKKKKVHRAEM- 138
+D+ +G+G V C +++ G E YA K + K ++ E
Sbjct: 14 YDIGEELGSGQFAIVKKC-------REKSTGLE----YAAKFIKKRQSRASRRGVCREEI 62
Query: 139 --EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARF 195
E IL+ + HP + TL+ +E +++E SGG+L L K+ S A
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATS 119
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPAVESPA 251
+ ++L + YLH I + DLKPEN+++ HI L DF
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG--------------- 164
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
L+ + + + + GT E
Sbjct: 165 --------------------LAHEIE---DGVEFKNI------------------FGTPE 183
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
+V+PE+ + G D W+ G+ Y ++ G +PF + + TL NI F + S
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
SE A+D I LL K+ RL + HP+
Sbjct: 244 QTSE-LAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 7e-46
Identities = 50/408 (12%), Positives = 97/408 (23%), Gaps = 117/408 (28%)
Query: 67 RSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV 126
+ + G R +G D Q+ G + + V
Sbjct: 65 QPFRVESELGERPRTLVRGTVLGQEDPYAYLEA-----TDQETGES----FEVHVPYFTE 115
Query: 127 LEKKKKVHRAEMEKKILK----------------------MLDHPFLPTLYAEFEASNFS 164
+ + + E L+ ++ P +
Sbjct: 116 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 175
Query: 165 CIVMEF-------CSGGDLHSL--RHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYR 215
++ F + + H HK + +V+ L LH G+++
Sbjct: 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235
Query: 216 DLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRF 275
L+P ++++ G + L+ F+
Sbjct: 236 YLRPVDIVLDQRGGVFLTGFEHL------------------------------------- 258
Query: 276 LNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN-----AVDWW 330
G+ ++P A P E + + G H A D W
Sbjct: 259 --VRDGAS---AVSPIGRGFAPP------------ETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 331 AFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390
G+ IY + P + I + P R L+ G L
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP---------VRALLEGFLRYPK 352
Query: 391 CNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPD 438
+RL P ++ L R+ +P +
Sbjct: 353 EDRL----LPLQAMETPEYEQL-----RTELSAALPLYQTDGEPTREG 391
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 75/374 (20%), Positives = 143/374 (38%), Gaps = 92/374 (24%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G G C + +A+K+++K + + E LK+
Sbjct: 17 KPLGEGSFSICRKC-----VHKKSNQA----FAVKIISK------RMEANTQKEITALKL 61
Query: 146 LD-HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVAL 204
+ HP + L+ F + +VME +GG+L + K FS T A + +++ A+
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAV 119
Query: 205 EYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
++H +G+++RDLKPEN+L + I + DF
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG------------------------- 154
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321
+R ++ ++T T Y +PE+ +
Sbjct: 155 ----------FARLKP--PDNQPLKT------------------PCFTLHYAAPELLNQN 184
Query: 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-------LRNIVKKPLTFPTQSPSSMS 374
+ + D W+ G+ +Y M+ G+ PF + T ++ I K +F ++ ++S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTM 434
+ A+DLI GLL DP RL + ++ + + + + L P+I G
Sbjct: 245 Q-EAKDLIQGLLTVDPNKRL----KMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
Query: 435 PFPDQKIKSQSTAF 448
+K+ AF
Sbjct: 300 T----CVKATFHAF 309
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 54/408 (13%), Positives = 99/408 (24%), Gaps = 111/408 (27%)
Query: 43 TSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLN 102
+ + + + + + T R L + GD V+L
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV--- 81
Query: 103 NKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASN 162
+R + +A+KV + ++ R L
Sbjct: 82 --RDVERLED----FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 163 FS--------------------------CIVMEFCSGGDLHSL-----RHKQPHKRFSLT 191
S ++M S DL L +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFRGDEGIL 194
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
+ A+++ L G+++ P+N+ + DG +ML D
Sbjct: 195 ALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD----------------- 237
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
+ V R +
Sbjct: 238 ----------------------------VSA-------------LWKVGTRGPASSVPVT 256
Query: 312 YVSPEV--ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-----LRNIVKKPLT 364
Y E AS + +A++ W G+ IY + PF + V +
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
S + + ++ + LI LN D RL + P F L
Sbjct: 317 LAFGSCTPLPDF-VKTLIGRFLNFDRRRRL----LPLEAMETPEFLQL 359
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 93/416 (22%), Positives = 142/416 (34%), Gaps = 95/416 (22%)
Query: 9 PPSDATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRS 68
P + R + S+S + + ENL + D +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 69 ATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE 128
F +K +D IG G V C + GHE +A+K++
Sbjct: 90 KEFYQK-------YDPKDVIGRGVSSVVRRCV-----HRATGHE----FAVKIMEVTAER 133
Query: 129 KKKKVHRAEMEK-----KILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRH 181
+ E IL+ + HP + TL +E+S+F +V + G+L L
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 182 KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
K S R +L A+ +LH I++RDLKPEN+L+ + I LSD
Sbjct: 194 K---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD------- 243
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVA 300
FG S ++ P
Sbjct: 244 --------------------------------------FGFSCHLE---PGEKLR----- 257
Query: 301 ARSCSFVGTHEYVSPEV------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT 354
GT Y++PE+ + +G VD WA G+ ++ ++ G PF
Sbjct: 258 ----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313
Query: 355 LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
LR I++ F + S +DLIS LL DP RL A HPFF+
Sbjct: 314 LRMIMEGQYQFSSPEWDDRSS-TVKDLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-45
Identities = 86/380 (22%), Positives = 138/380 (36%), Gaps = 84/380 (22%)
Query: 38 SFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDF-DLHRRIGAGDIGTV 96
+L T +++S ++ S + DF ++ +G G V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 97 YLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156
Y C + +G YA+KV+ K E +L L HP + L
Sbjct: 70 YRC-------KQKG--TQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
FE +V+E +GG+L R + +S A ++L A+ YLH GI++RD
Sbjct: 116 IFETPTEISLVLELVTGGELFD-RIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 217 LKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLS 273
LKPEN+L + D + ++D
Sbjct: 174 LKPENLLYATPAPDAPLKIAD--------------------------------------- 194
Query: 274 RFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAF 332
FG SK ++ L + GT Y +PE+ G ++G VD W+
Sbjct: 195 ------FGLSKIVE---HQVLMK---------TVCGTPGYCAPEILRGCAYGPEVDMWSV 236
Query: 333 GIFIYEMIYGRTPFAAPSNETTL-RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391
GI Y ++ G PF + + R I+ F + +S +A+DL+ L+ DP
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL-NAKDLVRKLIVLDPK 295
Query: 392 NRLGSKRGAADVKTHPFFKG 411
RL HP+ G
Sbjct: 296 KRL----TTFQALQHPWVTG 311
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 75/355 (21%), Positives = 122/355 (34%), Gaps = 89/355 (25%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
T + +++ +G G V C + E YA+K+++
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCI-----HKPTCKE----YAVKIIDVTGGGSFS 59
Query: 132 KVHRAEMEK------KILKMLD-HPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQ 183
E+ + IL+ + HP + L +E + F +V + G+L L K
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK- 118
Query: 184 PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
S R +L + LH L I++RDLKPEN+L+ D +I L+D
Sbjct: 119 --VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD--------- 167
Query: 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAAR 302
FG S ++ P
Sbjct: 168 ------------------------------------FGFSCQLD---PGEKLR------- 181
Query: 303 SCSFVGTHEYVSPEV------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR 356
GT Y++PE+ + +G VD W+ G+ +Y ++ G PF LR
Sbjct: 182 --EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
I+ F + S+ +DL+S L P R A + HPFF+
Sbjct: 240 MIMSGNYQFGSPEWDDYSD-TVKDLVSRFLVVQPQKRY----TAEEALAHPFFQQ 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 81/372 (21%), Positives = 133/372 (35%), Gaps = 90/372 (24%)
Query: 70 TFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDR--GHEPCCLYAMKVVNKEVL 127
R + +++ IG G C + E +A+K+++K
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRC-------IHKATNME----FAVKIIDK--- 57
Query: 128 EKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK 186
K+ E +IL HP + TL ++ + +V E GG+L L K
Sbjct: 58 -SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQK 111
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH----IMLSDFDLSLCSN 242
FS A + +EYLH G+++RDLKP N+L + I + DF
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG------ 165
Query: 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302
++ L + + T
Sbjct: 166 -----------------------------FAKQLRA--ENGLLMTP-------------- 180
Query: 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---LRNIV 359
T +V+PEV + A D W+ G+ +Y M+ G TPFA ++T L I
Sbjct: 181 ----CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236
Query: 360 KKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRS 419
+ +S+S+ A+DL+S +L+ DP RL AA V HP+ +
Sbjct: 237 SGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRL----TAALVLRHPWIVHWDQLPQYQ 291
Query: 420 LTPPEIPGMRRQ 431
L + P + +
Sbjct: 292 LNRQDAPHLVKG 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-44
Identities = 59/368 (16%), Positives = 107/368 (29%), Gaps = 110/368 (29%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ L +G G V+ + G +A+KV N + V E E
Sbjct: 10 LWLLSDILGQGATANVFRG-----RHKKTGDL----FAIKVFNNISFLRPVDVQMREFE- 59
Query: 141 KILKMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
+LK L+H + L+A E + ++MEFC G L++ L +
Sbjct: 60 -VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPAVESPASS 253
+V+ + +L GI++R++KP N++ L+DF +
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA--------------- 163
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
++ +L GT EY+
Sbjct: 164 -----------------------RELEDDEQFVSL------------------YGTEEYL 182
Query: 314 SPEVASGG--------SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK---- 361
P++ +G VD W+ G+ Y G PF + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 362 ---------------PLTFPTQSP-----SSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401
P+ + P S + +++ +L D G
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD---- 298
Query: 402 DVKTHPFF 409
Sbjct: 299 QFFAETSD 306
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-44
Identities = 70/339 (20%), Positives = 131/339 (38%), Gaps = 80/339 (23%)
Query: 79 FRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
F + + L +G G V C ++ YA ++N + L + + E
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQE---------YAAMIINTKKL-SARDHQKLE 58
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL-HSLRHKQPHKRFSLTSARFY 196
E +I ++L HP + L+ ++ + +GG+L + + + +S A
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHC 115
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASS 253
++L A+ + H +G+++R+LKPEN+L+ S + L+D
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLAD------------------- 156
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
FG + +++ + + F GT Y
Sbjct: 157 --------------------------FGLAIEVEG--EQQAWF---------GFAGTPGY 179
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
+SPEV +G VD WA G+ +Y ++ G PF + I FP+ +
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 239
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
++ A+DLI+ +L +P R+ AA+ HP+
Sbjct: 240 VTP-EAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 88/355 (24%), Positives = 132/355 (37%), Gaps = 102/355 (28%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM----- 138
L IG G G V L Y ++ YAMKV++K+ L ++ R
Sbjct: 17 LKDEIGKGSYGVVKLA-----YNENDNTY----YAMKVLSKKKLIRQAGFPRRPPPRGTR 67
Query: 139 ------------------EKKILKMLDHPFLPTLYAEFEASNFSCI--VMEFCSGGDLHS 178
E ILK LDHP + L + N + V E + G +
Sbjct: 68 PAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 179 LRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ K S ARFY +++ +EYLH II+RD+KP N+LV DGHI ++DF +S
Sbjct: 128 VPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298
L+ G+ P F+A
Sbjct: 185 ----------------------------NEFKGSDALLSNTVGT-------PA--FMA-- 205
Query: 299 VAARSCSFVGTHEYVSPEVASGGS---HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355
PE S G A+D WA G+ +Y ++G+ PF
Sbjct: 206 ----------------PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
I + L FP Q + +DLI+ +L+K+P +R+ ++K HP+
Sbjct: 250 SKIKSQALEFPDQPDIAED---LKDLITRMLDKNPESRI----VVPEIKLHPWVT 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 6e-43
Identities = 59/357 (16%), Positives = 108/357 (30%), Gaps = 106/357 (29%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ L +G G V+ + G +A+KV N + V E E
Sbjct: 10 LWLLSDILGQGATANVFRG-----RHKKTGDL----FAIKVFNNISFLRPVDVQMREFE- 59
Query: 141 KILKMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
+LK L+H + L+A E + ++MEFC G L++ L +
Sbjct: 60 -VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRS----DGHIMLSDFDLSLCSNAIPAVESPASS 253
+V+ + +L GI++R++KP N++ L+DF +
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA--------------- 163
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
++ +L GT EY+
Sbjct: 164 -----------------------RELEDDEQFVSL------------------YGTEEYL 182
Query: 314 SPEVASGG--------SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK---- 361
P++ +G VD W+ G+ Y G PF + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 362 ---------------PLTFPTQSP-----SSMSEYHARDLISGLLNKDPCNRLGSKR 398
P+ + P S + +++ +L D G +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 73/371 (19%), Positives = 123/371 (33%), Gaps = 92/371 (24%)
Query: 74 KTGLTFRDFDLHRR-IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
K D+ L ++ +G G G V C ++ + A+K++ K
Sbjct: 22 KKYAVTDDYQLSKQVLGLGVNGKVLECF--HRRTGQK-------CALKLLYD-----SPK 67
Query: 133 VHRAEMEKKILKML-DHPFLPTLYAEFEASNFSC----IVMEFCSGGDLHSLRHKQPHKR 187
+ E P + + +E + I+ME GG+L S ++ +
Sbjct: 68 ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 188 FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAI 244
F+ A ++ A+++LH I +RD+KPEN+L S D + L+DF +
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA------ 178
Query: 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304
+ +QT
Sbjct: 179 ---------------------------------KETTQNALQT----------------- 188
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVK 360
T YV+PEV + + D W+ G+ +Y ++ G PF + + + R I
Sbjct: 189 -PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420
FP S +SE A+ LI LL DP RL HP+ L
Sbjct: 248 GQYGFPNPEWSEVSE-DAKQLIRLLLKTDPTERL----TITQFMNHPWINQSMVVPQTPL 302
Query: 421 TPPEIPGMRRQ 431
+ +
Sbjct: 303 HTARVLQEDKD 313
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 76/362 (20%), Positives = 129/362 (35%), Gaps = 84/362 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK----KKKVHRAE 137
+ + +G G G V + A+K++ K+ L + + V +
Sbjct: 7 YLMGDLLGEGSYGKVKEV-----LDSETLCR----RAVKILKKKKLRRIPNGEANVKK-- 55
Query: 138 MEKKILKMLDHPFLPTLY--AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
E ++L+ L H + L E +VME+C G + + P KRF + A
Sbjct: 56 -EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHG 113
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y +++ LEYLH GI+++D+KP N+L+ + G + +S +
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV------------------ 155
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+ L+ F +T S G+ + P
Sbjct: 156 -----------------AEALHPFAADDTCRT---------------SQ---GSPAFQPP 180
Query: 316 EVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM 373
E+A+G G VD W+ G+ +Y + G PF + NI K P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----PGDC 236
Query: 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF-KGLNFALIRSLTPPEIPGMRRQK 432
DL+ G+L +P R ++ H +F K A PP R +
Sbjct: 237 GP-PLSDLLKGMLEYEPAKRF----SIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWR 291
Query: 433 TM 434
+M
Sbjct: 292 SM 293
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 51/334 (15%), Positives = 104/334 (31%), Gaps = 55/334 (16%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R+ ++ I + L + + + + L + ++
Sbjct: 53 REVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP-LSSPSPMDAPSVK 111
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
+ + + I M+ C +L + + +
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ A+E+LH G+++RDLKP N+ D + + DF L
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL--------------------- 210
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
T + Q + P A VGT Y+SPE
Sbjct: 211 ----------VTAMD------------QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378
G ++ + VD ++ G+ ++E++Y F+ + V+ FP +
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNL-KFPLLFTQKYPQ--E 302
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
++ +L+ P R A D+ + F+ L
Sbjct: 303 HMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-42
Identities = 52/335 (15%), Positives = 104/335 (31%), Gaps = 65/335 (19%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+F +IG+G+ G+V+ C R D C+YA+K K + + A E
Sbjct: 11 TEFHELEKIGSGEFGSVFKC----VKRLDG-----CIYAIKRSKKPLAGSVDE-QNALRE 60
Query: 140 KKIL-KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFY 196
+ H + ++ + + I E+C+GG L + + F +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
+V L Y+H + +++ D+KP N+ + + + A V
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV--------- 171
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
++ G + G +++ E
Sbjct: 172 ------------MFKIGD-----LGHVTRISSPQ--------------VEEGDSRFLANE 200
Query: 317 VASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
V +H D +A + + P N I + + P +S+
Sbjct: 201 VLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQWHEIRQGR---LPRIPQVLSQ 254
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+L+ +++ DP R A + H
Sbjct: 255 -EFTELLKVMIHPDPERRP----SAMALVKHSVLL 284
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 80/348 (22%), Positives = 122/348 (35%), Gaps = 91/348 (26%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML- 146
+G G V C N YA+K++ K+ + +V R E ++L
Sbjct: 21 LGEGAHARVQTCI--NLITSQE-------YAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEY 206
H + L FE + +V E GG + L H + F+ A +V AL++
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 207 LHMLGIIYRDLKPENVLVRSDGH---IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
LH GI +RDLKPEN+L + + DFDL
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG------------------------- 161
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV-----A 318
+ + LTP G+ EY++PEV
Sbjct: 162 -------SGIKLNGDCSPISTPELLTP----------------CGSAEYMAPEVVEAFSE 198
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT---------------LRNIVKKPL 363
+ D W+ G+ +Y ++ G PF +I +
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
FP + + +S A+DLIS LL +D RL AA V HP+ +G
Sbjct: 259 EFPDKDWAHISC-AAKDLISKLLVRDAKQRL----SAAQVLQHPWVQG 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-42
Identities = 79/426 (18%), Positives = 134/426 (31%), Gaps = 90/426 (21%)
Query: 21 ANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFR 80
+NS S + PT P F ++S +K +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ +G G G V NK Q++ +A+K+ L+ K R E
Sbjct: 63 YKVTSQVLGLGINGKVLQIF--NKRTQEK-------FALKM-----LQDCPKARR---EV 105
Query: 141 KILKML-DHPFLPTLYAEFE----ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
++ P + + +E IVME GG+L S + + F+ A
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPAS 252
+ A++YLH + I +RD+KPEN+L S + + L+DF
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------- 209
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
++ + T T Y
Sbjct: 210 -------------------FAKE---TTSHNSLTT------------------PCYTPYY 229
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVKKPLTFPTQ 368
V+PEV + + D W+ G+ +Y ++ G PF + I FP
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGM 428
S +SE + LI LL +P R+ + HP+ L +
Sbjct: 290 EWSEVSE-EVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQSTKVPQTPLHTSRVLKE 344
Query: 429 RRQKTM 434
+++
Sbjct: 345 DKERWE 350
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 77/372 (20%), Positives = 133/372 (35%), Gaps = 88/372 (23%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++ L + IG G+ V L G E A+K+++K L + + E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA-----RHILTGRE----VAIKIIDKTQL-NPTSLQKLFREV 65
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+I+K+L+HP + L+ E ++ME+ SGG++ + H R AR ++
Sbjct: 66 RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMKEKEARSKFRQI 123
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ A++Y H I++RDLK EN+L+ +D +I ++DF S
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---------------------- 161
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
N F K+ C G Y +PE+ G
Sbjct: 162 ----------------NEFTVGGKLDA---------------FC---GAPPYAAPELFQG 187
Query: 321 -GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
G VD W+ G+ +Y ++ G PF + + +++ P MS
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI----PFYMST-DCE 242
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFK-GLNFALIRSLTPPEIPGMRRQKTMPFPD 438
+L+ L +P R + + G ++ PE+ D
Sbjct: 243 NLLKRFLVLNPIKRG----TLEQIMKDRWINAGHEEDELKPFVEPEL---------DISD 289
Query: 439 QKIKSQSTAFDY 450
QK Y
Sbjct: 290 QKRIDIMVGMGY 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 70/342 (20%), Positives = 108/342 (31%), Gaps = 88/342 (25%)
Query: 81 DFDLHRRIGAGDIGTVYL-CSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
F +G G GT+ +N+ A+K + E A+ E
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR-----------DVAVKRILPECFSF------ADRE 67
Query: 140 KKILKMLD-HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
++L+ D HP + + + F I +E C L +Q
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQE-YVEQKDFAHLGLEPITLLQ 125
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGH-----IMLSDFDLSLCSNAIPAVESPASS 253
+ L +LH L I++RDLKP N+L+ M+SDF
Sbjct: 126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF------------------ 167
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
L + L S ++ GT ++
Sbjct: 168 -----------------GLCKKLAVGRHSFSRRS-----------------GVPGTEGWI 193
Query: 314 SPEVASGGSHGN---AVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQS 369
+PE+ S N VD ++ G Y +I G PF NI+ +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLH 251
Query: 370 PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
P + AR+LI ++ DP R A V HPFF
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRP----SAKHVLKHPFFWS 289
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 72/346 (20%), Positives = 128/346 (36%), Gaps = 82/346 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEMEK 140
+DL + +G G G V L + A+K+V+ + ++ + + + E
Sbjct: 9 WDLVQTLGEGAYGEVQLA-----VNRVTEEA----VAVKIVDMKRAVDCPENIKK---EI 56
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
I KML+H + Y N + +E+CSGG+L +P A+ + ++
Sbjct: 57 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQL 114
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ + YLH +GI +RD+KPEN+L+ ++ +SDF L+ R
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA------------------TVFR 156
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
R LN+ G+ YV+PE+
Sbjct: 157 YN--------NRERLLNKMCGT-------LP--------------------YVAPELLKR 181
Query: 321 -GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHA 378
H VD W+ GI + M+ G P+ PS+ + +K +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDS-AP 238
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFF-KGLNFALIRSLTPP 423
L+ +L ++P R+ D+K ++ K L + P
Sbjct: 239 LALLHKILVENPSARI----TIPDIKKDRWYNKPLK----KGAKRP 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (384), Expect = 2e-40
Identities = 74/370 (20%), Positives = 124/370 (33%), Gaps = 102/370 (27%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+++ R+G G G V QD G + A+K +E+ K ++ R +E
Sbjct: 15 PWEMKERLGTGGFGYVLRW-----IHQDTGEQ----VAIKQCRQELSPKNRE--RWCLEI 63
Query: 141 KILKMLDHPFLPTLYAEFE------ASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSA 193
+I+K L+HP + + + ++ + ME+C GGDL L +
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSDFDLSLCSNAIPAVESP 250
R +++ AL YLH II+RDLKPEN++++ + D
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID---------------- 167
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGT 309
G +K+ L L FVGT
Sbjct: 168 -----------------------------LGYAKE---LDQGELCT---------EFVGT 186
Query: 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK-------- 361
+Y++PE+ + VD+W+FG +E I G PF V++
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 362 ------PLTFPTQSP-----SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ F + P S + + +L R F+
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNPNVGCFQ 302
Query: 411 GLNFALIRSL 420
L+ L L
Sbjct: 303 ALDSILSLKL 312
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 79/340 (23%), Positives = 132/340 (38%), Gaps = 77/340 (22%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
+ + L +G G G V + Q GH+ A+K++N++ +
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIG-----EHQLTGHK----VAVKILNRQKIRSLD 53
Query: 132 KVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
V + + E + LK+ HP + LY +VME+ SGG+L + H R
Sbjct: 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD--YICKHGRVEEM 111
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
AR ++L A++Y H +++RDLKPENVL+ + + ++DF LS
Sbjct: 112 EARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------- 158
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
N + ++T SC G+
Sbjct: 159 -------------------------NMMSDGEFLRT---------------SC---GSPN 175
Query: 312 YVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
Y +PEV SG G VD W+ G+ +Y ++ G PF ++ + + KK P
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGVFYIP 231
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
++ L+ +L DP R D++ H +FK
Sbjct: 232 EYLNR-SVATLLMHMLQVDPLKRA----TIKDIREHEWFK 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 72/347 (20%), Positives = 127/347 (36%), Gaps = 78/347 (22%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKE-VLEKKKKVHRAEMEK 140
+DL + +G G G V L + A+K+V+ + ++ + + + E
Sbjct: 9 WDLVQTLGEGAYGEVQLA-----VNRVTEEA----VAVKIVDMKRAVDCPENIKK---EI 56
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
I KML+H + Y N + +E+CSGG+L +P A+ + ++
Sbjct: 57 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQL 114
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ + YLH +GI +RD+KPEN+L+ ++ +SDF L+ R
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA------------------TVFR 156
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
R LN+ G+ YV+PE+
Sbjct: 157 YN--------NRERLLNKMCGT-------LP--------------------YVAPELLKR 181
Query: 321 -GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHA 378
H VD W+ GI + M+ G P+ PS+ + +K +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDS-AP 238
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFF-KGLNFALIRSLTPPE 424
L+ +L ++P R+ D+K ++ K L R
Sbjct: 239 LALLHKILVENPSARI----TIPDIKKDRWYNKPLKKGAKRPRVTSG 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 74/390 (18%), Positives = 116/390 (29%), Gaps = 79/390 (20%)
Query: 23 SSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDF 82
S S+SS S + L+ + + + L + + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWM 60
Query: 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI 142
R+G G G V+ + G A+K V EV + E
Sbjct: 61 THQPRVGRGSFGEVHRM-KDK----QTGF----QCAVKKVRLEVFRVE--------ELVA 103
Query: 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV 202
L P + LY + I ME GG L L + A +Y + L
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALE 161
Query: 203 ALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
LEYLH I++ D+K +NVL+ SDG L D
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCD--------------------------- 194
Query: 262 QTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG + +Q + GT +++PEV G
Sbjct: 195 ------------------FGHALCLQPDGLGK------SLLTGDYIPGTETHMAPEVVMG 230
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
VD W+ + M+ G P+ I +P + P S +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP-LTAQ 288
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
I L K+P +R A +++
Sbjct: 289 AIQEGLRKEPVHRA----SAMELRRKVGKA 314
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 68/346 (19%), Positives = 120/346 (34%), Gaps = 89/346 (25%)
Query: 72 GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK 131
G + + +G+G G V+ +++ E +K + KE + +
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTA-----VDKEKNKE----VVVKFIKKEKVLEDC 66
Query: 132 KVHRAEMEK-----KILKMLDHPFLPTLYAEFEASNFSCIVMEF-CSGGDLHSLRHKQPH 185
+ ++ K IL ++H + + FE F +VME SG DL + H
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFA--FIDRH 124
Query: 186 KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
R A + +++ A+ YL + II+RD+K EN+++ D I L DF +
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA------- 177
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
Y + + F G+
Sbjct: 178 -----------------AYLER-----GKLFYTFCGT-------IE-------------- 194
Query: 306 FVGTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
Y +PEV G G ++ W+ G+ +Y +++ PF L V+ +
Sbjct: 195 ------YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIH 242
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P +S+ L+SGLL P R + T P+
Sbjct: 243 P----PYLVSK-ELMSLVSGLLQPVPERRT----TLEKLVTDPWVT 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 69/359 (19%), Positives = 113/359 (31%), Gaps = 103/359 (28%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ +G G GTV G A+K + + A ME K
Sbjct: 17 VVSEKILGYGSSGTVVFQ----------GSFQGRPVAVKRMLID------FCDIALMEIK 60
Query: 142 ILKMLD-HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL-----RHKQPHKRFSLTSARF 195
+L D HP + Y F I +E C +L L + K +
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRS-------------DGHIMLSDFDLSLCSN 242
++ + +LH L II+RDLKP+N+LV + + I++SDF L
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL----- 174
Query: 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302
KK+ +
Sbjct: 175 ---------------------------------------CKKLD---SGQ----SSFRTN 188
Query: 303 SCSFVGTHEYVSPEVASGGSH-------GNAVDWWAFGIFIYEMI-YGRTPFAAPSNETT 354
+ GT + +PE+ ++ ++D ++ G Y ++ G+ PF +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSR 246
Query: 355 LRNIVKKPLTFPTQSPSSMSEY--HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
NI++ + A DLIS +++ DP R A V HP F
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLFWP 301
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 80/330 (24%), Positives = 135/330 (40%), Gaps = 78/330 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ + +G G G V L + A+K +++++L+K R E E
Sbjct: 11 YIIRETLGEGSFGKVKLA-----THYKTQQK----VALKFISRQLLKKSDMHMRVEREIS 61
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
LK+L HP + LY +V+E+ GG+L + KR + R + +++
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFD--YIVEKKRMTEDEGRRFFQQII 118
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261
A+EY H I++RDLKPEN+L+ + ++ ++DF LS + + +
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------NIMTDGN--------- 162
Query: 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG- 320
FL GS PN Y +PEV +G
Sbjct: 163 -------------FLKTSCGS-------PN--------------------YAAPEVINGK 182
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
G VD W+ GI +Y M+ GR PF ++ + N+ KK + P +S A+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNSCVYVMPDFLSP-GAQS 237
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
LI ++ DP R+ +++ P+F
Sbjct: 238 LIRRMIVADPMQRI----TIQEIRRDPWFN 263
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 62/331 (18%), Positives = 103/331 (31%), Gaps = 80/331 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ R + G VY + YA+K + EK + + + E
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA----QDVGSGRE-----YALKRLLSNEEEKNRAIIQ---E 75
Query: 140 KKILKML-DHPFLPTLYAEFEASNFS--------CIVMEFCSGGDLHSLRHKQPHKRFSL 190
+K L HP + + ++ E C G + L+ + S
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 191 TSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
+ + A++++H II+RDLK EN+L+ + G I L D
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD-------------- 181
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS--CSF 306
FGS + P+ + A+ A +
Sbjct: 182 -------------------------------FGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 307 VGTHEYVSPEV---ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL 363
T Y +PE+ S G D WA G +Y + + + PF + IV
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGKY 266
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394
+ P LI +L +P RL
Sbjct: 267 SIPPHDTQYTV---FHSLIRAMLQVNPEERL 294
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 82/379 (21%), Positives = 141/379 (37%), Gaps = 84/379 (22%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+ + L +G G G V + + GH+ A+K++N++ +
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVG-----KHELTGHK----VAVKILNRQKIRSLDV 59
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
V + E + LK+ HP + LY + +VME+ SGG+L + + R
Sbjct: 60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD--YICKNGRLDEKE 117
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+R ++L ++Y H +++RDLKPENVL+ + + ++DF LS + S
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------NMMSDGE 170
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
FL GS PN Y
Sbjct: 171 ----------------------FLRTSCGS-------PN--------------------Y 181
Query: 313 VSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
+PEV SG G VD W+ G+ +Y ++ G PF ++ + + KK +P
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF----DDDHVPTLFKKICDGIFYTPQ 237
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431
++ L+ +L DP R D++ H +FK + L P
Sbjct: 238 YLNP-SVISLLKHMLQVDPMKRA----TIKDIREHEWFK-------QDLPKYLFPEDPSY 285
Query: 432 KTMPFPDQKIKSQSTAFDY 450
+ D+ +K F+
Sbjct: 286 SSTMIDDEALKEVCEKFEC 304
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 72/329 (21%), Positives = 109/329 (33%), Gaps = 81/329 (24%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G G VY + A+K + + E + K L
Sbjct: 30 LGKGTYGIVYAG-RDL----SNQV----RIAIKEIP---ERDSRYSQPLHEEIALHKHLK 77
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA--RFYAAEVLVALE 205
H + F + F I ME GG L +L + FY ++L L+
Sbjct: 78 HKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 206 YLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTY 264
YLH I++RD+K +NVL+ + G + +SDF
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT--------------------------- 169
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS-- 322
SK++ + P +F GT +Y++PE+ G
Sbjct: 170 -----------------SKRLAGINPCTE-----------TFTGTLQYMAPEIIDKGPRG 201
Query: 323 HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDL 381
+G A D W+ G I EM G+ PF + + + P SMS A+
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI--PESMSA-EAKAF 258
Query: 382 ISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
I DP R A D+ F K
Sbjct: 259 ILKCFEPDPDKRA----CANDLLVDEFLK 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 62/338 (18%), Positives = 113/338 (33%), Gaps = 83/338 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R IG G TVY + E A + L K + R + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-----LDTETTVE----VAWCELQDRKL-TKSERQRFKEE 75
Query: 140 KKILKMLDHP----FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
++LK L HP F + + + +V E + G L + + K + R
Sbjct: 76 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRS 133
Query: 196 YAAEVLVALEYLH--MLGIIYRDLKPENVLV-RSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ ++L L++LH II+RDLK +N+ + G + + D
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD------------------ 175
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
G ++ + + + +GT E+
Sbjct: 176 ---------------------------LGLATLKRASFAK------------AVIGTPEF 196
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
++PE+ + +VD +AFG+ + EM P++ N + V P
Sbjct: 197 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPASFDKV 254
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+++I G + ++ R D+ H FF+
Sbjct: 255 AIP-EVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 79/348 (22%), Positives = 123/348 (35%), Gaps = 89/348 (25%)
Query: 81 DFDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
D++L IG+G V C+ + A+K +N E + E+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKE-----------KVAIKRINLEKCQTSMDELLKEI 64
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH--KQPHKRFSLTSARF- 195
+ + HP + + Y F + +VM+ SGG S+ K + S
Sbjct: 65 --QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG---SVLDIIKHIVAKGEHKSGVLD 119
Query: 196 --YAA----EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
A EVL LEYLH G I+RD+K N+L+ DG + ++DF
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG------------- 166
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
S L+ + + +FVGT
Sbjct: 167 ------------------VSAFLATGGDITRNKVRK-------------------TFVGT 189
Query: 310 HEYVSPEV-ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP---LTF 365
+++PEV + D W+FGI E+ G P+ L ++ L
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 366 PTQSPSSMSEY--HARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFK 410
Q + +Y R +IS L KDP KR AA++ H FF+
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDP-----EKRPTAAELLRHKFFQ 292
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 50 NLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDR 109
++L R+ F + + ++ + + +G+G G V L + +
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA-----FERKT 159
Query: 110 GHEPCCLYAMKVVNKEVL-----EKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164
+ A+++++K + E E +ILK L+HP + + F+A ++
Sbjct: 160 CKK----VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY- 214
Query: 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224
IV+E GG+L + +KR + + Y ++L+A++YLH GII+RDLKPENVL+
Sbjct: 215 YIVLELMEGGELFD-KVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
Query: 225 RS---DGHIMLSDFDLS 238
S D I ++DF S
Sbjct: 273 SSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 28/110 (25%), Positives = 49/110 (44%), Gaps = 9/110 (8%)
Query: 306 FVGTHEYVSPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK- 361
GT Y++PEV + AVD W+ G+ ++ + G PF+ + +L++ +
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
F + + +SE A DL+ LL DP R + HP+ +
Sbjct: 361 KYNFIPEVWAEVSE-KALDLVKKLLVVDPKARF----TTEEALRHPWLQD 405
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 17/168 (10%)
Query: 79 FRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
F D ++L IG G V C ++ G + +A+K+V+ + +
Sbjct: 22 FEDVYELCEVIGKGPFSVVRRCI-----NRETGQQ----FAVKIVDVAKFTSSPGLSTED 72
Query: 138 MEK--KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL--HSLRHKQPHKRFSLTSA 193
+++ I ML HP + L + + +V EF G DL ++ +S A
Sbjct: 73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLS 238
Y ++L AL Y H II+RD+KP VL+ S + L F ++
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF 365
VGT +++PEV +G VD W G+ ++ ++ G PF + E I+K
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKM 251
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425
+ S +SE A+DL+ +L DP R+ + HP+ K + + P +
Sbjct: 252 NPRQWSHISE-SAKDLVRRMLMLDPAERI----TVYEALNHPWLKERDRYAYKIHLPETV 306
Query: 426 PGMRRQKTM 434
+R+
Sbjct: 307 EQLRKFNAR 315
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 21/169 (12%)
Query: 79 FRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-----EKKKK 132
RD + + + +G+G G V L + + + A+K+++K +
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLA-----FERKTCKK----VAIKIISKRKFAIGSAREADP 58
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
E E +ILK L+HP + + F+A ++ IV+E GG+L + +KR +
Sbjct: 59 ALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD-KVVG-NKRLKEAT 115
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLS 238
+ Y ++L+A++YLH GII+RDLKPENVL+ S D I ++DF S
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 15/146 (10%)
Query: 306 FVGTHEYVSPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL-RNIVKK 361
GT Y++PEV + AVD W+ G+ ++ + G PF+ + +L I
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLT 421
F + + +SE A DL+ LL DP R + HP+ + +
Sbjct: 236 KYNFIPEVWAEVSE-KALDLVKKLLVVDPKARF----TTEEALRHPWLQD------EDMK 284
Query: 422 PPEIPGMRRQKTMPFPDQKIKSQSTA 447
+ + Q + ST+
Sbjct: 285 RKFQDLLSEENESTALPQVLAQPSTS 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 66/415 (15%), Positives = 115/415 (27%), Gaps = 115/415 (27%)
Query: 81 DFDLHRRIGAG--DIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
++L IG G D+ TV + ++ +N LE
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGE-----------YVTVRRIN---LEACSNEMVT 71
Query: 137 EMEK--KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
++ + K+ +HP + A F A N +V F + G L + +
Sbjct: 72 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA 131
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
+ VL AL+Y+H +G ++R +K ++L+ DG + LS S
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL-------------RSNLSM 178
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
+ R + V V ++S
Sbjct: 179 ISHGQRQRV-----------------------------------VHDFPKYSVKVLPWLS 203
Query: 315 PEVASGGSHG--NAVDWWAFGIFIYEMIYGRTPFA---------------APSNETTLRN 357
PEV G D ++ GI E+ G PF P T
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 358 IVKKPLTFPTQSPSSMSEYHA--------------------------RDLISGLLNKDPC 391
++ P++S ++ + + L ++P
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 392 NRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKSQST 446
R A+ + H FFK + +L P Q
Sbjct: 324 ARP----SASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFG 374
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 72/335 (21%), Positives = 112/335 (33%), Gaps = 83/335 (24%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+D + IG+G+ G L + A+K + + + V R E
Sbjct: 22 YDFVKDIGSGNFGVARLM-----RDKLTKEL----VAVKYIERGAA-IDENVQR---EII 68
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
+ L HP + I+ME+ SGG+L+ RFS ARF+ ++L
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLL 126
Query: 202 VALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
+ Y H + I +RDLK EN L+ + + DF S S
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHS------- 172
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
G+ P ++A V R EY
Sbjct: 173 ---------------QPKSTVGT-------PA--YIAPEVLLR-------QEYDGKIA-- 199
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL----TFPTQSPSSMSE 375
D W+ G+ +Y M+ G PF P R +++ L + P S
Sbjct: 200 --------DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE- 250
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
LIS + DP R+ ++KTH +F
Sbjct: 251 --CCHLISRIFVADPATRI----SIPEIKTHSWFL 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 60/323 (18%), Positives = 115/323 (35%), Gaps = 89/323 (27%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+++ ++ +G G G V K A+K + E ++K
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDV-----------AIKQIESE--SERKAFIV--- 50
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
E + L ++HP + LY + C+VME+ GG L++ L +P ++ A +
Sbjct: 51 ELRQLSRVNHPNIVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 198 AEVLVALEYLHML---GIIYRDLKPENVLVRSDGHIM-LSDFDLSLCSNAIPAVESPASS 253
+ + YLH + +I+RDLKP N+L+ + G ++ + DF
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT---------------- 152
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ + +T + G+ ++
Sbjct: 153 -------------------ACDIQ--------THMT---------------NNKGSAAWM 170
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFA-APSNETTLRNIVKKPL--TFPTQSP 370
+PEV G ++ D +++GI ++E+I R PF + V P
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 371 SSMSEYHARDLISGLLNKDPCNR 393
+ L++ +KDP R
Sbjct: 231 KPI-----ESLMTRCWSKDPSQR 248
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 64/323 (19%), Positives = 110/323 (34%), Gaps = 83/323 (25%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRA 136
+ D ++ +IGAG GTV+ + A+K++ ++ E+ + R
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWHGS-----------DVAVKILMEQDFHAERVNEFLR- 83
Query: 137 EMEKKILKMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSAR 194
E I+K L HP + A + N IV E+ S G L+ L ++
Sbjct: 84 --EVAIMKRLRHPNIVLFMGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 195 FYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
A +V + YLH I++R+LK N+LV + + DF LS
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-------------- 186
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
R + T S S GT E+
Sbjct: 187 -------RLKASTFLSSK----------------------------------SAAGTPEW 205
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL--TFPTQSP 370
++PEV D ++FG+ ++E+ + P+ + + + K P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 371 SSMSEYHARDLISGLLNKDPCNR 393
+ +I G +P R
Sbjct: 266 PQV-----AAIIEGCWTNEPWKR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 73/273 (26%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-EKKKKVHRAE 137
+ +RIG+G GTVY K+ D A+K++N ++ + + E
Sbjct: 23 DGQITVGQRIGSGSFGTVYKG----KWHGD--------VAVKMLNVTAPTPQQLQAFKNE 70
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
+ +L+ H + A IV ++C G L+ H K F + A
Sbjct: 71 V--GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIA 126
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
+ ++YLH II+RDLK N+ + D + + DF
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG--------------------- 165
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
L+ +R+ GS + + L+ G+ +++PEV
Sbjct: 166 --------------LATEKSRWSGSHQFEQLS------------------GSILWMAPEV 193
Query: 318 ASGGSHG---NAVDWWAFGIFIYEMIYGRTPFA 347
D +AFGI +YE++ G+ P++
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 51/328 (15%), Positives = 96/328 (29%), Gaps = 85/328 (25%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKKKKVHRA 136
F ++ IG G G VY ++ + A+++++ E ++ K R
Sbjct: 32 FEQLEIGELIGKGRFGQVYHG----RWHGE--------VAIRLIDIERDNEDQLKAFKR- 78
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E + H + + I+ C G L+S+ + R
Sbjct: 79 --EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQI 135
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
A E++ + YLH GI+++DLK +NV +G ++++DF
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFG-------------------- 174
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
L ++ L G +++PE
Sbjct: 175 ---------------LFSISGVLQAGRREDKLR---------------IQNGWLCHLAPE 204
Query: 317 V---------ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK--KPLTF 365
+ D +A G YE+ PF E + + KP
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS 264
Query: 366 PTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ D++ + R
Sbjct: 265 QIGMGKEI-----SDILLFCWAFEQEER 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 47/268 (17%), Positives = 95/268 (35%), Gaps = 58/268 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM-- 138
D +G G G + +V+ + L + + +
Sbjct: 11 DLIHGEVLGKGCFGQAIKVTHRETG--------------EVMVMKELIRFDEETQRTFLK 56
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E K+++ L+HP + + E+ GG L + ++ + +A
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAK 115
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ + YLH + II+RDL N LVR + +++++DF
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFG---------------------- 153
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
L+R + +T + +P + + VG +++PE+
Sbjct: 154 -------------LARLM------VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPF 346
+G S+ VD ++FGI + E+I
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 67/311 (21%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ ++G G + TVYL + A+K + EK++ + R E E
Sbjct: 15 IVDKLGGGGMSTVYLA---EDTILNI------KVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
L H + ++ E + +VME+ G L H S+ +A + ++L
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDG 123
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
+++ H + I++RD+KP+N+L+ S+ + + DF ++ A S S T
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK----------------ALSETSLT 167
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH 323
T +GT +Y SPE A G +
Sbjct: 168 QTN--------------------------------------HVLGTVQYFSPEQAKGEAT 189
Query: 324 GNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDLI 382
D ++ GI +YEM+ G PF + + +++I T + + ++I
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ-SLSNVI 248
Query: 383 SGLLNKDPCNR 393
KD NR
Sbjct: 249 LRATEKDKANR 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 67/318 (21%), Positives = 113/318 (35%), Gaps = 76/318 (23%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L +G G + V+L R R A+KV+ ++ R E +
Sbjct: 16 LGEILGFGGMSEVHLA---RDLRDHR------DVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 144 KMLDHPFLPTLY----AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
L+HP + +Y AE A IVME+ G L + H + A A+
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIAD 124
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
AL + H GII+RD+KP N+++ + + + DF ++ A +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA----------------RAIAD 168
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+ T ++ + +GT +Y+SPE A
Sbjct: 169 SGNSVT------------------------------------QTAAVIGTAQYLSPEQAR 192
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVKKPLTFPTQSPSSMSE 375
G S D ++ G +YE++ G PF S + +R P + +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL-- 250
Query: 376 YHARDLISGLLNKDPCNR 393
++ L K+P NR
Sbjct: 251 ---DAVVLKALAKNPENR 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 54/333 (16%), Positives = 112/333 (33%), Gaps = 94/333 (28%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-- 136
+ + ++IG G G V+ + A+K + E + ++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKG----RLV-KDKSV----VAIKSLILGDSEGETEMIEKFQ 68
Query: 137 --EMEKKILKMLDHPFLPTLYAEFEASNFS-CIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
+ E I+ L+HP + LY + +VMEF GDL+ + H +
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYG---LMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVK 124
Query: 194 RFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDG-----HIMLSDFDLSLCSNAIPA 246
++ + +EY+ I++RDL+ N+ ++S ++DF L
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL--------- 175
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
S+ + +++
Sbjct: 176 --------------------------SQQ--------SVHSVS---------------GL 186
Query: 307 VGTHEYVSPEVASGGS--HGNAVDWWAFGIFIYEMIYGRTPFA--APSNETTLRNIVKKP 362
+G ++++PE + D ++F + +Y ++ G PF + + I ++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 363 L--TFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
L T P P + R++I + DP R
Sbjct: 247 LRPTIPEDCPPRL-----RNVIELCWSGDPKKR 274
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 45/333 (13%), Positives = 97/333 (29%), Gaps = 92/333 (27%)
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--EKK 130
+ +G+ F+ + ++ G ++ +KV+ K
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGN-----------DIVVKVLKVRDWSTRKS 51
Query: 131 KKVHRAEMEKKILKMLDHPFLPTLYA---EFEASNFSCIVMEFCSGGDLHSLRHKQPHKR 187
+ + E L++ HP + + A + ++ + G L+++ H+ +
Sbjct: 52 RDFNE---ECPRLRIFSHPNVLPVLGACQSPPAPHP-TLITHWMPYGSLYNVLHEGTNFV 107
Query: 188 FSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+ A +A ++ + +LH L I L +V++ D +S
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM----------- 156
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
K
Sbjct: 157 ----------------------------------ADVKFSFQSP---------------G 167
Query: 306 FVGTHEYVSPEVASGGSHGN---AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP 362
+ +V+PE + D W+F + ++E++ PFA SN + +
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 363 L--TFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
L T P + L+ +N+DP R
Sbjct: 228 LRPTIPPGISPHV-----SKLMKICMNEDPAKR 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 26/177 (14%)
Query: 70 TFGRKTGLTFRDFDLHRR-IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE 128
K D+ + + +G G G V NK Q++ +A+K++ +
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF--NKRTQEK-------FALKML-----Q 52
Query: 129 KKKKVHRAEMEKKIL-KMLDHPFLPTLYAEFE----ASNFSCIVMEFCSGGDLHSLRHKQ 183
K R E ++ + P + + +E IVME GG+L S +
Sbjct: 53 DCPKARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109
Query: 184 PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDL 237
+ F+ A + A++YLH + I +RD+KPEN+L S + + L+DF
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 25/131 (19%), Positives = 45/131 (34%), Gaps = 12/131 (9%)
Query: 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVKKPLTFPTQSP 370
E +G + + D W+ G+ +Y ++ G PF + I FP
Sbjct: 168 KET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRR 430
S +SE + LI LL +P R+ + HP+ L + ++
Sbjct: 227 SEVSE-EVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQSTKVPQTPLHTSRV--LKE 279
Query: 431 QKTMPFPDQKI 441
K ++
Sbjct: 280 DKERWEDVKEE 290
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/285 (22%), Positives = 103/285 (36%), Gaps = 36/285 (12%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R++G G TV+L + AMKVV + A E ++LK
Sbjct: 43 RKLGWGHFSTVWLS---------WDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKS 89
Query: 146 L-----DHP---FLPTLYAEFEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
+ + P + L +F+ S C+V E G L K ++ L
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 194 RFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ +VL L+YLH II+ D+KPEN+L+ + + + A A E S
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN--------EQYIRRLAAEATEWQRS 200
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
S + + + ++K++ + L A V + T +Y
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK-VKIADLGNACWVHKHFTEDIQTRQY 259
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN 357
S EV G + D W+ +E+ G F S E R+
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 81/369 (21%), Positives = 124/369 (33%), Gaps = 130/369 (35%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK------ 140
++G G G VY K + +G + A+K + R + E
Sbjct: 28 KVGEGTYGVVY------KAKDSQGR----IVALKRI------------RLDAEDEGIPST 65
Query: 141 -----KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
+LK L HP + +L + +V EF DL + + + +
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKI 123
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y ++L + + H I++RDLKP+N+L+ SDG + L+DF L+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA----------------- 166
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE---- 311
R FG P R + THE
Sbjct: 167 ----------------------RAFGI-------PVRSY--------------THEVVTL 183
Query: 312 -YVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK--------- 360
Y +P+V G +VD W+ G EMI G+ F +++ L I
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 361 ----------KPLTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVK 404
K TF S DL+S +L DP R+ A D
Sbjct: 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI----SARDAM 299
Query: 405 THPFFKGLN 413
HP+FK L+
Sbjct: 300 NHPYFKDLD 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 9e-23
Identities = 77/368 (20%), Positives = 114/368 (30%), Gaps = 129/368 (35%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK------ 140
+IG G G VY Q+ E +A+K + R E E
Sbjct: 9 KIGEGTYGVVYKA-------QNNYGE---TFALKKI------------RLEKEDEGIPST 46
Query: 141 -----KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
ILK L H + LY +V E DL L +A+
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
+ ++L + Y H +++RDLKP+N+L+ +G + ++DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------------- 147
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE---- 311
R FG P R + THE
Sbjct: 148 ----------------------RAFGI-------PVRKY--------------THEIVTL 164
Query: 312 -YVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPS---------------NETT 354
Y +P+V G +D W+ G EM+ G F S N
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 355 LRNIVKKP---LTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKT 405
N+ + P F P + DL+S +L DP R+ A
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI----TAKQALE 280
Query: 406 HPFFKGLN 413
H +FK N
Sbjct: 281 HAYFKENN 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 19/192 (9%)
Query: 46 SSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKY 105
E L L + + G L DF+ +GAG+ G V+ S
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGE---LKDDDFEKISELGAGNGGVVFKVS----- 53
Query: 106 RQDRGHEPC-CLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFS 164
H+P + A K+++ E+ + + E ++L + P++ Y F +
Sbjct: 54 -----HKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSPYIVGFYGAFYSDGEI 106
Query: 165 CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVL 223
I ME GG L + K R + V+ L YL I++RD+KP N+L
Sbjct: 107 SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164
Query: 224 VRSDGHIMLSDF 235
V S G I L DF
Sbjct: 165 VNSRGEIKLCDF 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 22/86 (25%), Positives = 34/86 (39%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
SFVGT Y+SPE G + D W+ G+ + EM GR P P + +
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDP 390
++P G+ ++ P
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPP 274
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 61/337 (18%), Positives = 105/337 (31%), Gaps = 97/337 (28%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +LK L H + TL+ +V E+ DL ++ + + +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLF 107
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++L L Y H +++RDLKP+N+L+ G + L+DF L+
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-------------------- 147
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE-----YV 313
R P + + +E Y
Sbjct: 148 -------------------RAKSI-------PTKTY--------------DNEVVTLWYR 167
Query: 314 SPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK------------ 360
P++ G + +D W G YEM GR F + E L I +
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 361 -------KPLTFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHP 407
K +P ++ + DL++ LL + NR+ A D HP
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI----SAEDAMKHP 283
Query: 408 FFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKSQ 444
FF L + + I ++ + +
Sbjct: 284 FFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSAHH 320
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-22
Identities = 41/204 (20%), Positives = 73/204 (35%), Gaps = 20/204 (9%)
Query: 43 TSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLN 102
L + + G++ + + +G+G G+VY
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG--- 62
Query: 103 NKYRQDRGHEPCCLYAMKVVNKEVLEKKKKV---HRAEMEKKILKMLDHPFLP---TLYA 156
R A+K V K+ + ++ R ME +LK + F L
Sbjct: 63 --IRVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLD 115
Query: 157 EFEASNFSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYR 215
FE + +++E DL AR + +VL A+ + H G+++R
Sbjct: 116 WFERPDSFVLILERPEPVQDL--FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 173
Query: 216 DLKPENVLV-RSDGHIMLSDFDLS 238
D+K EN+L+ + G + L DF
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 31/135 (22%), Positives = 49/135 (36%), Gaps = 23/135 (17%)
Query: 306 FVGTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
F GT Y PE HG + W+ GI +Y+M+ G PF I++ +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPE 424
F +S + LI L P +R +++ HP+ + L P E
Sbjct: 262 F----RQRVSS-ECQHLIRWCLALRPSDRP----TFEEIQNHPWMQD-------VLLPQE 305
Query: 425 IPGMRRQKTMPFPDQ 439
+ P P +
Sbjct: 306 TAEIHLHSLSPGPSK 320
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-22
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
F +IG G G V+ ++N+ ++ + A+K+++ E E + + + E+
Sbjct: 23 LFTKLEKIGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEI-- 71
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L D P++ Y + I+ME+ GG S T E+
Sbjct: 72 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG---SALDLLEPGPLDETQIATILREI 128
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
L L+YLH I+RD+K NVL+ G + L+DF
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 8/106 (7%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+FVGT +++PEV ++ + D W+ GI E+ G P S ++ + P
Sbjct: 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKN 234
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P + S+ ++ + LNK+P R A ++ H F
Sbjct: 235 NPPTLEGNYSK-PLKEFVEACLNKEPSFRP----TAKELLKHKFIL 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 39/194 (20%), Positives = 72/194 (37%), Gaps = 20/194 (10%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEP 113
KP + G+ ++ L +G G GTV+ +R +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAG-----HRLTDRLQ- 58
Query: 114 CCLYAMKVVNKEVLEKKKKVH---RAEMEKKILKMLD----HPFLPTLYAEFEASNFSCI 166
A+KV+ + + + +E +L + HP + L FE +
Sbjct: 59 ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115
Query: 167 VMEF-CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225
V+E DL + +R + +V+ A+++ H G+++RD+K EN+L+
Sbjct: 116 VLERPLPAQDL--FDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173
Query: 226 SD-GHIMLSDFDLS 238
G L DF
Sbjct: 174 LRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 16/106 (15%)
Query: 306 FVGTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
F GT Y PE S H W+ GI +Y+M+ G PF + I++ L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF------ERDQEILEAELH 251
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
F P+ +S LI L P +R ++ P+ +
Sbjct: 252 F----PAHVSP-DCCALIRRCLAPKPSSRP----SLEEILLDPWMQ 288
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 66/333 (19%), Positives = 103/333 (30%), Gaps = 113/333 (33%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDL----HSLRHKQPHKRFSLTSAR 194
E ++K L H + LY N +V EF DL S + L +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
++ ++L L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA---------------- 155
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE--- 311
R FG P F + E
Sbjct: 156 -----------------------RAFGI-------PVNTF--------------SSEVVT 171
Query: 312 --YVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-------- 360
Y +P+V G ++D W+ G + EMI G+ F ++E L+ I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 361 -----------KPLTFPTQSPSSMSEY-----------HARDLISGLLNKDPCNRLGSKR 398
P + P + + + D + GLL +P RL
Sbjct: 232 LWPSVTKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---- 286
Query: 399 GAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431
A HP+F + G R
Sbjct: 287 SAKQALHHPWFAEYY-------HHASMGGSRSH 312
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-21
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+++ +G G G VY K + L A KV+ + E+ + +E +
Sbjct: 21 WEIVGELGDGAFGKVY------KAKNKETGA---LAAAKVIETKSEEELEDY---IVEIE 68
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
IL DHP++ L + I++EFC GG + ++ + + + + ++L
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQML 127
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
AL +LH II+RDLK NVL+ +G I L+DF
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 33/115 (28%), Positives = 46/115 (40%), Gaps = 19/115 (16%)
Query: 305 SFVGTHEYVSPEV-----ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR--- 356
SF+GT +++PEV + D W+ GI + EM P +R
Sbjct: 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLL 232
Query: 357 NIVKKPLTFPT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
I K PT +PS S RD + L+K+P R AA + HPF
Sbjct: 233 KIAKSDP--PTLLTPSKWSV-EFRDFLKIALDKNPETRP----SAAQLLEHPFVS 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 36/157 (22%), Positives = 62/157 (39%), Gaps = 15/157 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D + +G+G G V+ K + A+K + + +++ K R M+
Sbjct: 26 DLENLGEMGSGTCGQVWKM-RFRKTGH--------VIAVKQMRRSGNKEENK--RILMDL 74
Query: 141 KIL-KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++ K D P++ + F + I ME K+
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGKMTVA 132
Query: 200 VLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDF 235
++ AL YL G+I+RD+KP N+L+ G I L DF
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 22/114 (19%), Positives = 39/114 (34%), Gaps = 14/114 (12%)
Query: 304 CSFVGTHEYVSPEV-----ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRN 357
G Y++PE + + D W+ GI + E+ G+ P+ + L
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241
Query: 358 IVKK-PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
++++ P P S + + L KD R + H F K
Sbjct: 242 VLQEEPPLLPGHMGFSGD---FQSFVKDCLTKDHRKRP----KYNKLLEHSFIK 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 49/285 (17%), Positives = 87/285 (30%), Gaps = 87/285 (30%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
RD L +G G G V+ S + V K + +K E E
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGEN---------------VAVKIFSSRDEKSWFRETE 52
Query: 140 KKILKMLDHPFLPTLY-AEFEASNFS---CIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
ML H + ++ + + S ++ + G L+ S
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLR 109
Query: 196 YAAEVLVALEYLHML--------GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247
+ L +LH+ I +RDLK +N+LV+ +G ++D L++ +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-------M 162
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
S +++ + V
Sbjct: 163 HSQSTNQLDVGNNPR--------------------------------------------V 178
Query: 308 GTHEYVSPEVASGGSHGNA------VDWWAFGIFIYEMIYGRTPF 346
GT Y++PEV + VD WAFG+ ++E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 15/159 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D IG G G+V ++ Q + A+K + V EK++K + M+
Sbjct: 23 DLKDLGEIGRGAYGSVNKM-VHKPSGQ--------IMAVKRIRSTVDEKEQK--QLLMDL 71
Query: 141 KI-LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGG--DLHSLRHKQPHKRFSLTSARFYA 197
+ ++ D P++ Y I ME S + +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 198 AEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDF 235
+ AL +L L II+RD+KP N+L+ G+I L DF
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 25/113 (22%), Positives = 40/113 (35%), Gaps = 11/113 (9%)
Query: 304 CSFVGTHEYVSPEVASGGSHGNA----VDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNI 358
G Y++PE + D W+ GI +YE+ GR P+ ++ L +
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
Query: 359 VKK-PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
VK P S + ++ L KD R ++ HPF
Sbjct: 243 VKGDPPQLSNSEEREFSP-SFINFVNLCLTKDESKRP----KYKELLKHPFIL 290
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 62/308 (20%), Positives = 92/308 (29%), Gaps = 103/308 (33%)
Query: 139 EKKILKML---DHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHKQPHKRFSL 190
E +L+ L +HP + L S +V E DL + K P
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
+ + + L L++LH I++RDLKPEN+LV S G + L+DF L+
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------------ 167
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
R + L T
Sbjct: 168 ---------------------------RIYSY-------QMAL---------------TP 178
Query: 311 E-----YVSPEVASGGSHGNAVDWWAFG-IFIYEMIYGRTPFAAPS-------------- 350
Y +PEV ++ VD W+ G IF EM + F S
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIF-AEMFRRKPLFCGNSEADQLGKIFDLIGL 237
Query: 351 -NETTLRNIVKKPL-TFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAAD 402
E V P FP + P + L+ +L +P R+ A
Sbjct: 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI----SAFR 293
Query: 403 VKTHPFFK 410
H +
Sbjct: 294 ALQHSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 4e-20
Identities = 58/306 (18%), Positives = 97/306 (31%), Gaps = 97/306 (31%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +LK L H + L+ + +V EFC DL + +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLF 108
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++L L + H +++RDLKP+N+L+ +G + L++F L+
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA-------------------- 148
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE-----YV 313
R FG P R + + E Y
Sbjct: 149 -------------------RAFGI-------PVRCY--------------SAEVVTLWYR 168
Query: 314 SPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTP-FAAPS---------------NETTLR 356
P+V G ++D W+ G E+ P F E
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 357 NIVKKPL--TFPT-QSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKTHP 407
++ K P +P + +S+ RDL+ LL +P R+ A + HP
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHP 284
Query: 408 FFKGLN 413
+F
Sbjct: 285 YFSDFC 290
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 55/317 (17%), Positives = 93/317 (29%), Gaps = 99/317 (31%)
Query: 58 SSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLY 117
D + + L G G V+ L N+Y
Sbjct: 11 GVDLGTENLYFQS---------MPLQLLEVKARGRFGCVWKAQLLNEY-----------V 50
Query: 118 AMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY-AEFEASNFS---CIVMEFCSG 173
A+K+ + K+ + E E L + H + AE ++ ++ F
Sbjct: 51 AVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM----------LGIIYRDLKPENVL 223
G L S A + L YLH I +RD+K +NVL
Sbjct: 107 GSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163
Query: 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSK 283
++++ ++DF L+ F +
Sbjct: 164 LKNNLTACIADFGLA---------------------------------------LKFEAG 184
Query: 284 KIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA-----VDWWAFGIFIYE 338
K T + VGT Y++PEV G + +D +A G+ ++E
Sbjct: 185 KSAGDTHGQ--------------VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 339 MIYGRTPFAAPSNETTL 355
+ T P +E L
Sbjct: 231 LASRCTAADGPVDEYML 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 16/159 (10%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPC-CLYAMKVVNKEVLEKKKKVHRAEME 139
D + +G G G V H P + A+K + V +++K R M+
Sbjct: 8 DLEPIMELGRGAYGVVEKMR----------HVPSGQIMAVKRIRATVNSQEQK--RLLMD 55
Query: 140 KKI-LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYA 197
I ++ +D PF T Y I ME + + A
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 198 AEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDF 235
++ ALE+LH L +I+RD+KP NVL+ + G + + DF
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 12/112 (10%)
Query: 304 CSFVGTHEYVSPEVASGGSHGNA----VDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNI 358
G Y++PE + + D W+ GI + E+ R P+ + L+ +
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 359 VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
V++P P S D S L K+ R ++ HPFF
Sbjct: 227 VEEPS--PQLPADKFSA-EFVDFTSQCLKKNSKER----PTYPELMQHPFFT 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 44/173 (25%), Positives = 64/173 (36%), Gaps = 28/173 (16%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-E 137
F + L IG G G VY A+K + E +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGDE-----------VAVKAARHDPDEDISQTIENVR 54
Query: 138 MEKKILKMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E K+ ML HP + L + N C+VMEF GG L+ + KR +
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSG---KRIPPDILVNW 110
Query: 197 AAEVLVALEYLHMLG---IIYRDLKPENVLVRSDGHIM--------LSDFDLS 238
A ++ + YLH II+RDLK N+L+ ++DF L+
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK--P 362
S G + +++PEV D W++G+ ++E++ G PF +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
L P+ P L+ N DP +R
Sbjct: 233 LPIPSTCPEPF-----AKLMEDCWNPDPHSR 258
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 64/331 (19%), Positives = 96/331 (29%), Gaps = 109/331 (32%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E K+LK L H L L + +V EF + P+ + Y
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLF 131
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
+++ + + H II+RD+KPEN+LV G + L DF +
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA-------------------- 171
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE-----YV 313
R + P ++ E Y
Sbjct: 172 -------------------RTLAA-------PGEVY--------------DDEVATRWYR 191
Query: 314 SPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPSNETTLRNIVK----------- 360
+PE+ G G AVD WA G + EM G F S+ L +I+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250
Query: 361 --------KPLTFPTQSP--------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVK 404
+ P +SE DL L+ DP R A++
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSE-VVIDLAKKCLHIDPDKRP----FCAELL 305
Query: 405 THPFFKGLNFALIRSLTPPEIPGMRRQKTMP 435
H FF+ F + K
Sbjct: 306 HHDFFQMDGF-------AERFSQELQLKVQK 329
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ +IG G GTVY ++ Q A++ +N L+++ K E
Sbjct: 22 YTRFEKIGQGASGTVYTA-MDVATGQ--------EVAIRQMN---LQQQPKKELIINEIL 69
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
+++ +P + + + +VME+ +GG L + E L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECL 126
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
ALE+LH +I+RD+K +N+L+ DG + L+DF
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 35/110 (31%), Positives = 50/110 (45%), Gaps = 14/110 (12%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR---NIVKK 361
+ VGT +++PEV + ++G VD W+ GI EMI G P+ NE LR I
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATN 231
Query: 362 PLTFPT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P Q+P +S RD ++ L D R A ++ H F K
Sbjct: 232 GT--PELQNPEKLSAIF-RDFLNRCLEMDVEKRG----SAKELLQHQFLK 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 68/361 (18%), Positives = 113/361 (31%), Gaps = 128/361 (35%)
Query: 131 KKVHRAEMEK-----------KILKML---DHPFLPTLY-----AEFEASNFSCIVMEFC 171
K+V R + + +L+ L +HP + L+ + + +V E
Sbjct: 43 KRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
Query: 172 SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231
DL + K P + + ++L L++LH +++RDLKP+N+LV S G I
Sbjct: 102 DQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160
Query: 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPN 291
L+DF L+ R +
Sbjct: 161 LADFGLA---------------------------------------RIYSF-------QM 174
Query: 292 RLFVAEPVAARSCSFVGTHE-----YVSPEVASGGSHGNAVDWWAFG-IFIYEMIYGRTP 345
L T Y +PEV S+ VD W+ G IF EM +
Sbjct: 175 AL---------------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF-AEMFRRKPL 218
Query: 346 FAAPS---------------NETTLRNIVKKPL-TFPTQSPSSMSEY------HARDLIS 383
F S E V P F ++S + ++ +DL+
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 278
Query: 384 GLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKS 443
L +P R+ A +HP+F + L + P + S
Sbjct: 279 KCLTFNPAKRI----SAYSALSHPYF--------QDLERCKENLD-----SHLPPSQNTS 321
Query: 444 Q 444
+
Sbjct: 322 E 322
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
D + +IG G G V L + A+K+++ L K+++ E
Sbjct: 47 LDSYVKIGEGSTGIVCLA-REKHSGR--------QVAVKMMD---LRKQQRRELLFNEVV 94
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
I++ H + +Y + ++MEF GG L + R + VL
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVL 151
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
AL YLH G+I+RD+K +++L+ DG + LSDF
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 33/123 (26%), Positives = 56/123 (45%), Gaps = 18/123 (14%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR---NIVKK 361
S VGT +++PEV S + VD W+ GI + EM+ G P+ +++ ++ +
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRDS 256
Query: 362 PLTFPT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRG-AADVKTHPFFKGLNFALIRS 419
P P ++ +S RD + +L +DP +R A ++ HPF L
Sbjct: 257 PP--PKLKNSHKVSPVL-RDFLERMLVRDP-----QERATAQELLDHPFLL--QTGLPEC 306
Query: 420 LTP 422
L P
Sbjct: 307 LVP 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 75/417 (17%), Positives = 126/417 (30%), Gaps = 131/417 (31%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
R++G G TV+L +D AMK+V K AE E K+L+
Sbjct: 25 RKLGWGHFSTVWLA-------KD--MVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQR 71
Query: 146 L--------DHPFLP---TLYAEFEASNFS----CIVMEFCSGGDLHSLRHKQPHKRFSL 190
+ D L F + +V E G +L +L K H+ L
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPL 130
Query: 191 TSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
+ + ++L+ L+Y+H GII+ D+KPEN +++ D I
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN--------VLMEIVDSPENLIQI----- 177
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
+++ N + + + + T
Sbjct: 178 ---------------------KIADLGNACWYDEHY------------------TNSIQT 198
Query: 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN------IV---- 359
EY SPEV G G D W+ I+E+I G F + ++ I+
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258
Query: 360 -------------------------KKPLTFPTQSPSSMSEYHAR--------DLISGLL 386
L F +Y D +S +L
Sbjct: 259 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318
Query: 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKS 443
DP R A + HP+ K + P+ +P ++++
Sbjct: 319 QLDPRKRA----DAGGLVNHPWLKDTLGM--EEIRVPDRELYGSGSDIPGWFEEVRD 369
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 62/289 (21%), Positives = 91/289 (31%), Gaps = 86/289 (29%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+ L IG G G VY SL+ + A+KV + ++ E
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDERP-----------VAVKVFSFA----NRQNFINEK 56
Query: 139 EKKILKMLDHPFLPTLY-AEFEASNFS----CIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
+ +++H + + + +VME+ G L S+
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSS 113
Query: 194 RFYAAEVLVALEYLHM---------LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244
A V L YLH I +RDL NVLV++DG ++SDF LS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS------ 167
Query: 245 PAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304
LT NRL +
Sbjct: 168 -----------------------------------------MRLTGNRLVRPGEEDNAAI 186
Query: 305 SFVGTHEYVSPEVASG-------GSHGNAVDWWAFGIFIYEMIYGRTPF 346
S VGT Y++PEV G S VD +A G+ +E+ T
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 46/280 (16%), Positives = 85/280 (30%), Gaps = 87/280 (31%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+ + ++IG G G V++ + A+KV + E
Sbjct: 36 AKQIQMVKQIGKGRYGEVWMGKWRGEK-----------VAVKVFFTTEEASWFR----ET 80
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFS----CIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
E ++ H + A S ++ ++ G L+ S
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSML 137
Query: 195 FYAAEVLVALEYLHML--------GIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
A + L +LH I +RDLK +N+LV+ +G ++D L++
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------- 190
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
+F + PN +
Sbjct: 191 -------------------------------KFISDTNEVDIPPN-------------TR 206
Query: 307 VGTHEYVSPEVASGGSHGN------AVDWWAFGIFIYEMI 340
VGT Y+ PEV + N D ++FG+ ++E+
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 37/202 (18%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
R L IG G G V+ + A+K+ + +++ E
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKWRGEE-----------VAVKIFSSR----EERSWFREA 85
Query: 139 EKKILKMLDHPFLPTLY-AEFEASNFS---CIVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
E ML H + A+ + + +V ++ G L ++ ++
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMI 142
Query: 195 FYAAEVLVALEYLHM--------LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
A L +LHM I +RDLK +N+LV+ +G ++D L++
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------- 195
Query: 247 VESPASSPEAASPRSQTYTRQY 268
A+ +P + T++Y
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRY 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 63/322 (19%), Positives = 100/322 (31%), Gaps = 106/322 (32%)
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRH--KQPHKRFSLTSARFY 196
E ++LK L HP L L F +V E+C H++ H + + +
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSI 107
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
+ L A+ + H I+RD+KPEN+L+ I L DF +
Sbjct: 108 TWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA------------------ 149
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE----- 311
R P+ + E
Sbjct: 150 ---------------------RLLTG-------PSDYY--------------DDEVATRW 167
Query: 312 YVSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPSNETTLRNIVK--------- 360
Y SPE+ G + G VD WA G +F E++ G + S+ L I K
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVF-AELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 361 ----------KPLTFPTQSP--------SSMSEYHARDLISGLLNKDPCNRLGSKRGAAD 402
+ P ++S A L+ G L+ DP RL
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISY-PALGLLKGCLHMDPTERL----TCEQ 281
Query: 403 VKTHPFFKGLNFALIRSLTPPE 424
+ HP+F+ + + +
Sbjct: 282 LLHHPYFENIREIEDLAKEHDK 303
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 11/154 (7%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F R IG G G VY + + + + A+K ++ + +K E +
Sbjct: 56 FSDLREIGHGSFGAVYFA-RDVRNSE--------VVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
L+ L HP + + + +VME+C G L + K L
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGAL 164
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
L YLH +I+RD+K N+L+ G + L DF
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 28/112 (25%), Positives = 44/112 (39%), Gaps = 16/112 (14%)
Query: 305 SFVGTHEYVSPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR---NI 358
SFVGT +++PEV G + VD W+ GI E+ + P N + +I
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHI 265
Query: 359 VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ P SE + R+ + L K P +R + + H F
Sbjct: 266 AQNES--PALQSGHWSE-YFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 15/154 (9%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
FD+ ++G G G+VY + + Q + A+K V +E + E+
Sbjct: 31 FDVLEKLGEGSYGSVYKAI-HKETGQ--------IVAIKQVP---VESDLQEIIKEIS-- 76
Query: 142 ILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVL 201
I++ D P + Y + + IVME+C G + + + +K + L
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI-IRLRNKTLTEDEIATILQSTL 135
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
LEYLH + I+RD+K N+L+ ++GH L+DF
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 14/110 (12%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR---NIVKK 361
+ +GT +++PEV + D W+ GI EM G+ P+ ++ +R I
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTN 240
Query: 362 PLTFPT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
P PT + P S+ + D + L K P R A + HPF +
Sbjct: 241 PP--PTFRKPELWSD-NFTDFVKQCLVKSPEQRA----TATQLLQHPFVR 283
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 77/426 (18%), Positives = 131/426 (30%), Gaps = 147/426 (34%)
Query: 37 LSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTV 96
++ + E + P S A + S + ++G G G V
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSATSID----------RYRRITKLGEGTYGEV 50
Query: 97 YLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK-----------KILKM 145
Y K +E A+K + R E E+ +LK
Sbjct: 51 Y------KAIDTVTNE---TVAIKRI------------RLEHEEEGVPGTAIREVSLLKE 89
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L H + L + ++ ++ E+ DL K P S+ + + +++ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 206 YLHMLGIIYRDLKPENVLV-----RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ H ++RDLKP+N+L+ + + DF L+
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---------------------- 184
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE-----YVSP 315
R FG P R F THE Y P
Sbjct: 185 -----------------RAFGI-------PIRQF--------------THEIITLWYRPP 206
Query: 316 EVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPS---------------NETTLRNI 358
E+ G H +VD W+ I+ EM+ F S ++TT +
Sbjct: 207 EILLGSRHYSTSVDIWSIACIW-AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 359 VKKP---LTFPTQSPSSMSEY-------HARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
P +FP ++ DL++ +L DP R+ A + HP+
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI----SAKNALEHPY 321
Query: 409 FKGLNF 414
F +F
Sbjct: 322 FSHNDF 327
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
F+L +G G G VY + K Q L A+KV++ E+++ + E
Sbjct: 26 FELVELVGNGTYGQVYKG-RHVKTGQ--------LAAIKVMDVTGDEEEE----IKQEIN 72
Query: 142 ILKML-DHPFLPTLYAEFEASNFSC------IVMEFCSGGDLHSLRHKQPHKRFSLTSAR 194
+LK H + T Y F N +VMEFC G + L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 195 FYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ E+L L +LH +I+RD+K +NVL+ + + L DF +S
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 26/114 (22%), Positives = 42/114 (36%), Gaps = 18/114 (15%)
Query: 305 SFVGTHEYVSPEVA-----SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR--- 356
+F+GT +++PEV ++ D W+ GI EM G P + +R
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMHPMRALF 244
Query: 357 NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
I + P P S+ + I L K+ R + HPF +
Sbjct: 245 LIPRNP--APRLKSKKWSKK-FQSFIESCLVKNHSQRP----ATEQLMKHPFIR 291
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 84/400 (21%), Positives = 123/400 (30%), Gaps = 126/400 (31%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK------ 140
+G G TVY + + K N+ V KK K+ K
Sbjct: 17 FLGEGQFATVY-----------KARD-------KNTNQIVAIKKIKLGHRSEAKDGINRT 58
Query: 141 -----KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
K+L+ L HP + L F + +V +F DL + K + + +
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKA 116
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
Y L LEYLH I++RDLKP N+L+ +G + L+DF L+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------------- 159
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE---- 311
+ FGS PNR + TH+
Sbjct: 160 ----------------------KSFGS-------PNRAY--------------THQVVTR 176
Query: 312 -YVSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPS---------------NET 353
Y +PE+ G G VD WA G I E++ S E
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCIL-AELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235
Query: 354 TLRNIVKKPL--TFPTQSPSSMSEY------HARDLISGLLNKDPCNRLGSKRGAADVKT 405
++ P TF + + DLI GL +PC R+ A
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----TATQALK 291
Query: 406 HPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQKIKSQS 445
+F P + K P IK +
Sbjct: 292 MKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKR 331
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 69/334 (20%), Positives = 102/334 (30%), Gaps = 119/334 (35%)
Query: 131 KKVHRAEMEK-----------KILKMLDHPFLPTLY------AEFEASNFSCI--VMEFC 171
KKV E EK KIL++L H + L A I V +FC
Sbjct: 48 KKV-LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106
Query: 172 SGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231
DL L +F+L+ + +L L Y+H I++RD+K NVL+ DG +
Sbjct: 107 EH-DLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPN 291
L+DF L+ R F
Sbjct: 165 LADFGLA---------------------------------------RAFSL--------- 176
Query: 292 RLFVAEPVAARSCSFVGTHE-----YVSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRT 344
++ + T+ Y PE+ G G +D W G I EM
Sbjct: 177 ------AKNSQPNRY--TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM-AEMWTRSP 227
Query: 345 PFAAPSNETTLRNIVK-------------------KPLTFPTQSPSSMSEY--------H 377
+ + L I + + L + + +
Sbjct: 228 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 287
Query: 378 ARDLISGLLNKDPCNRLGSKRG-AADVKTHPFFK 410
A DLI LL DP ++R + D H FF
Sbjct: 288 ALDLIDKLLVLDP-----AQRIDSDDALNHDFFW 316
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 60/346 (17%), Positives = 115/346 (33%), Gaps = 77/346 (22%)
Query: 56 HRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCC 115
H S + T + G F + L R +G G +G VY + R
Sbjct: 10 HSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIV------- 62
Query: 116 LYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY--AEFEASNFSCIVMEFCSG 173
A+K++++ + R + E + L P + ++ E + + + M +G
Sbjct: 63 --ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY--VDMRLING 118
Query: 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233
DL ++ + + A ++ AL+ H G +RD+KPEN+LV +D L
Sbjct: 119 VDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV 176
Query: 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293
DF ++ A + T G+ + + P R
Sbjct: 177 DFGIA----------------SATTDEKLTQL-----------GNTVGT--LYYMAPER- 206
Query: 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET 353
F R+ D +A +YE + G P+
Sbjct: 207 FSESHATYRA------------------------DIYALTCVLYECLTGSPPYQGDQ--- 239
Query: 354 TLRNIVKKPLTFPTQSPSSMSE---YHARDLISGLLNKDPCNRLGS 396
+++ + PS++ +I+ + K+P +R +
Sbjct: 240 --LSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 74/371 (19%), Positives = 120/371 (32%), Gaps = 120/371 (32%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D+ L R++G G V N +E +K++ KKKK+ R E
Sbjct: 37 DYQLVRKLGRGKYSEV--FEAINI----TNNEKV---VVKILK---PVKKKKIKR---EI 81
Query: 141 KILKML-DHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
KIL+ L P + TL S +V E + D L + RFY
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM 136
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLV-RSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
E+L AL+Y H +GI++RD+KP NV++ + L D+ L+
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA------------------ 178
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
++Y+ R V + + PE
Sbjct: 179 ---EFYHPGQEYNVR-----------------------------------VASRYFKGPE 200
Query: 317 VASGGSH-GNAVDWWAFGIFIYEMIYGRTPF----------------------------- 346
+ ++D W+ G + MI+ + PF
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260
Query: 347 ---AAPSNETTLRNIVKKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAA 401
P L +K +++ +S A D + LL D +RL A
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSP-EALDFLDKLLRYDHQSRL----TAR 315
Query: 402 DVKTHPFFKGL 412
+ HP+F +
Sbjct: 316 EAMEHPYFYTV 326
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 24/163 (14%)
Query: 82 FDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-EME 139
+ L R+IG+G G +YL + A+K+ E K H +E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEE----------VAIKL------ECVKTKHPQLHIE 54
Query: 140 KKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
KI KM+ +PT+ +++ +VME G L L + ++FSL + A
Sbjct: 55 SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLAD 112
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSDFDLS 238
+++ +EY+H I+RD+KP+N L+ + + DF L+
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R R +G G G V LC + D E A+K + E + E+E
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQV---AVKSLKPESGGNHIADLKKEIE 75
Query: 140 KKILKMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFY 196
IL+ L H + + N ++MEF G L L + + +L Y
Sbjct: 76 --ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKY 131
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A ++ ++YL ++RDL NVLV S+ + + DF L+
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK--VHRAEMEKK 141
+ I G +G +YL DR + VV K ++ A E++
Sbjct: 84 VKGCIAHGGLGWIYLA-------LDRN-----VNGRPVVLKGLVHSGDAEAQAMAMAERQ 131
Query: 142 ILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
L + HP + ++ E ++ IVME+ G L + + + + A Y
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAY 187
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
E+L AL YLH +G++Y DLKPEN+++ + + L D
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 14/92 (15%), Positives = 25/92 (27%), Gaps = 12/92 (13%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
GT + +PE+ G A D + G + + L
Sbjct: 236 YLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY---------VDGLP 285
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396
+ Y L+ ++ DP R +
Sbjct: 286 EDDPVLKTYDSYGR--LLRRAIDPDPRQRFTT 315
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 14/162 (8%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R R +G G G V L + D E A+K + + + + + E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPT--NDGTGEMV---AVKALKADAGPQHRSGWKQEID 85
Query: 140 KKILKMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFY 196
IL+ L H + E + +VME+ G L L L +
Sbjct: 86 --ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLF 139
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A ++ + YLH I+RDL NVL+ +D + + DF L+
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 44/200 (22%), Positives = 76/200 (38%), Gaps = 27/200 (13%)
Query: 54 KPHRSSDFAYSAIRSATFGRKTGLTFRDFD----------LHRRIGAGDIGTVYLCSLNN 103
H D+ + F G F D D +++G G+ G+V +C +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 104 KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA--EFEAS 161
QD E A+K + E + R E +ILK L H +
Sbjct: 65 --LQDNTGEVV---AVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 162 NFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YAAEVLVALEYLHMLGIIYRDLK 218
++ME+ G L L+ + + + Y +++ +EYL I+RDL
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172
Query: 219 PENVLVRSDGHIMLSDFDLS 238
N+LV ++ + + DF L+
Sbjct: 173 TRNILVENENRVKIGDFGLT 192
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 81/376 (21%), Positives = 125/376 (33%), Gaps = 117/376 (31%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
DF L +G G G V CS +K + A+K + +K R E
Sbjct: 11 SDFQLKSLLGEGAYGVV--CSATHKPTGEI-------VAIKKIE--PFDKPLFALRTLRE 59
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHKQP----HKRFSL 190
KILK H + T++ +F I+ E DLH + Q H ++ +
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFI 118
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESP 250
Y + L A++ LH +I+RDLKP N+L+ S+ + + DF L+
Sbjct: 119 -----Y--QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA------------ 159
Query: 251 ASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310
R + T + + E VA R
Sbjct: 160 ---------------RIIDE----------SAADNSEPTGQQSGMVEFVATRW------- 187
Query: 311 EYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA----------------PSNET 353
Y +PEV + A+D W+ G + E+ R F P ++
Sbjct: 188 -YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 354 TLRNIV---------------KKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396
LR I PL FP +P DL+ +L DP R+
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK------GIDLLQRMLVFDPAKRI-- 298
Query: 397 KRGAADVKTHPFFKGL 412
A + HP+ +
Sbjct: 299 --TAKEALEHPYLQTY 312
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 67/319 (21%), Positives = 115/319 (36%), Gaps = 97/319 (30%)
Query: 131 KKVHRAEMEK----KILKMLDHPFLPTL----YAEFEASNFSCI--VMEFCSGGDLHSL- 179
KKV + + K +I++++ HP + L Y+ + + + V+E+ ++
Sbjct: 70 KKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS 128
Query: 180 -RHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ + + + + Y ++L +L Y+H +GI +RD+KP+N+L+ + L
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV------LK 182
Query: 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298
L FGS KI L V+
Sbjct: 183 LID--------------------------------------FGSAKI--LIAGEPNVSY- 201
Query: 299 VAARSCSFVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN 357
+ + Y +PE+ G ++ +D W+ G + E++ G+ F S L
Sbjct: 202 --------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 358 IVK-----------------KPLTFPTQSPSSMSEY-------HARDLISGLLNKDPCNR 393
I+K FP P S+ A DLIS LL P R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 394 LGSKRGAADVKTHPFFKGL 412
L A + HPFF L
Sbjct: 314 L----TAIEALCHPFFDEL 328
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 35/165 (21%), Positives = 69/165 (41%), Gaps = 26/165 (15%)
Query: 82 FDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-EME 139
+ + RRIG G G ++ +L N + A+K E ++ E
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQ----------VAIKF------EPRRSDAPQLRDE 55
Query: 140 KKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+ K+L +P +Y + + +V++ G L L ++FS+ + A
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAK 113
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGH-----IMLSDFDLS 238
++L ++ +H ++YRD+KP+N L+ I + DF +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 26/169 (15%), Positives = 45/169 (26%), Gaps = 20/169 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L G + A+ V+ + + + L
Sbjct: 35 LLIFHGGVPPLQFWQA------LDTALDRQV---ALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVA 203
+D P + + +V E+ GG L + P S A + A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLAAA 141
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ H G+ P V V DG ++L+ A +P
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP-------ATMPDANPQD 183
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 11/83 (13%), Positives = 22/83 (26%), Gaps = 6/83 (7%)
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM 373
P + D G +Y ++ R P + L + P P+ +
Sbjct: 172 YPATMPDANP--QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADI 228
Query: 374 SEYHARDL---ISGLLNKDPCNR 393
+ + + D R
Sbjct: 229 DRDIPFQISAVAARSVQGDGGIR 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 38/164 (23%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R +++G G+ G+V +C + QD E A+K + E + R E
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVV---AVKKLQHSTEEHLRDFER---E 61
Query: 140 KKILKMLDHPFLPTLYAEFEASNFS--CIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF- 195
+ILK L H + ++ ++ME+ G L L+ + + +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLL 117
Query: 196 -YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
Y +++ +EYL I+RDL N+LV ++ + + DF L+
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 74/399 (18%), Positives = 114/399 (28%), Gaps = 138/399 (34%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV-NKE---------- 125
L R +++ +G G G V C RG A+K++ N
Sbjct: 17 LQER-YEIVGNLGEGTFGKVVEC-----LDHARGKSQV---ALKIIRNVGKYREAARLEI 67
Query: 126 -VLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP 184
VL+K K+ E + + M D F CI E G + +
Sbjct: 68 NVLKKIKE-KDKENKFLCVLMSDW---------FNFHGHMCIAFELL-GKNTFEFLKENN 116
Query: 185 HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244
+ + L R A ++ AL +LH + + DLKPEN+L ++
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL---------------FVNSEF 161
Query: 245 PAVESPASSPEAASPR----------SQTYTRQYSTRL--SRFLNRFFGSKKIQTLTPNR 292
+ + S E S + S T+ ++ T + +R
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH----------------- 204
Query: 293 LFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE 352
Y PEV D W+ G ++E G T F N
Sbjct: 205 -------------------YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 353 TTLRNIV---------------------KKPLTFPTQSPSSMSE---------------- 375
L + K L + S
Sbjct: 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305
Query: 376 --YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
DL+ +L DP R+ A+ HPFF GL
Sbjct: 306 EHVQLFDLMRRMLEFDPAQRI----TLAEALLHPFFAGL 340
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 73/384 (19%), Positives = 131/384 (34%), Gaps = 108/384 (28%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R ++L +++G G G V ++ + A+K + + R E
Sbjct: 9 RKYELVKKLGKGAYGIV--WKSIDRRTGEV-------VAVKKIFD-AFQNSTDAQRTFRE 58
Query: 140 KKILK-MLDHPFLPTLYAEFEASNFSCI--VMEFCSGGDLHSLRHKQP----HKRFSLTS 192
IL + H + L A N + V ++ DLH++ HK++ +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVV-- 115
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
Y +++ ++YLH G+++RD+KP N+L+ ++ H+ ++DF LS I V +
Sbjct: 116 ---Y--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
+ + + T +V T Y
Sbjct: 171 LSINENTENFDDDQPILT----------------------------------DYVATRWY 196
Query: 313 VSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFA----------------APSNET- 353
+PE+ G + +D W+ G I E++ G+ F PSNE
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDV 255
Query: 354 -------------TLRNIVKKPL------------TFPTQSPSSMSEYHARDLISGLLNK 388
+L+ V+ +P + A DL+ LL
Sbjct: 256 ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315
Query: 389 DPCNRLGSKRGAADVKTHPFFKGL 412
+P R+ A D HPF
Sbjct: 316 NPNKRI----SANDALKHPFVSIF 335
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 17/164 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R ++G G+ G+V LC + D A+K + ++++ R E
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDP--LGDNTGALV---AVKQLQHSGPDQQRDFQR---E 74
Query: 140 KKILKMLDHPFLPTLYA--EFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF- 195
+ILK L F+ +VME+ G L L+ + L ++R
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLL 130
Query: 196 -YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
Y++++ +EYL ++RDL N+LV S+ H+ ++DF L+
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 75/391 (19%), Positives = 124/391 (31%), Gaps = 120/391 (30%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR- 135
L F + R++G G G V LC Q ++ YA+KVV KK R
Sbjct: 33 LNNA-FLVIRKMGDGTFGRVLLC-------QHIDNK--KYYAVKVVRN-----IKKYTRS 77
Query: 136 AEMEKKILKML------DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFS 189
A++E ILK + ++ + + +F + C++ E G L+ + + + F
Sbjct: 78 AKIEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFH 135
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
+ + Y E+L AL YL + + + DLKPEN+L+ F+ SL +
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD------PYFEKSLITVRRVTDGK 189
Query: 250 PASSPEAASPR-------SQTYTRQYSTRL--SRFLNRFFGSKKIQTLTPNRLFVAEPVA 300
S T+ Y + +R
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ------------------------- 224
Query: 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK 360
Y +PEV + D W+FG + E+ G F + L +
Sbjct: 225 -----------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES 273
Query: 361 --------------------------KPLTFPTQSPSSMSEYHAR--------------- 379
L +P + S S H +
Sbjct: 274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
D + +L DP R A++ H F +
Sbjct: 334 DFLYSILQIDPTLRP----SPAELLKHKFLE 360
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 79/406 (19%), Positives = 137/406 (33%), Gaps = 114/406 (28%)
Query: 43 TSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRD-FDLHRRIGAGDIGTVYL--C 99
+ S+K R D + AT G+ + + IG G G VY
Sbjct: 16 PVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKL 75
Query: 100 SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL----Y 155
+ + V K+VL+ K+ +R E +I++ LDH + L Y
Sbjct: 76 CDSGE---------------LVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFY 117
Query: 156 AEFEASNFSCI--VMEFCSGGDLHSL--RHKQPHKRFSLTSARFYAAEVLVALEYLHMLG 211
+ E + + V+++ ++ + + + + + + Y ++ +L Y+H G
Sbjct: 118 SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 212 IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTR 271
I +RD+KP+N+L+ D + L LC
Sbjct: 177 ICHRDIKPQNLLLDPDTAV------LKLCD------------------------------ 200
Query: 272 LSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH-GNAVDWW 330
FGS K L V S++ + Y +PE+ G + +++D W
Sbjct: 201 --------FGSAK--QLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVW 241
Query: 331 AFGIFIYEMIYGRTPFAAPSNETTLRNIVK-----------------KPLTFPTQSPSSM 373
+ G + E++ G+ F S L I+K FP
Sbjct: 242 SAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 301
Query: 374 SEY-------HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
++ A L S LL P RL + H FF L
Sbjct: 302 TKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDEL 343
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 70/394 (17%), Positives = 115/394 (29%), Gaps = 128/394 (32%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV-NKE---------- 125
L+ R +++ +G G G V C G A+K+V N +
Sbjct: 12 LSAR-YEIVDTLGEGAFGKVVEC-----IDHKAGGRHV---AVKIVKNVDRYCEAARSEI 62
Query: 126 -VLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP 184
VLE + ++ML+ FE CIV E G + +
Sbjct: 63 QVLEHLNT-TDPNSTFRCVQMLEW---------FEHHGHICIVFELL-GLSTYDFIKENG 111
Query: 185 HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAI 244
F L R A ++ ++ +LH + + DLKPEN+L + +
Sbjct: 112 FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN---------- 161
Query: 245 PAVESPASSPEAASPR-----SQTYTRQYSTRL--SRFLNRFFGSKKIQTLTPNRLFVAE 297
P ++ + + S TY ++ + L +R
Sbjct: 162 PKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH---------------------- 199
Query: 298 PVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN 357
Y +PEV D W+ G + E G T F ++ L
Sbjct: 200 --------------YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 358 IV---------------------KKPLTFPTQSPS---------SMSEY---------HA 378
+ L + S + + E+
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
DLI +L DP R+ + HPFF L
Sbjct: 306 FDLIQKMLEYDPAKRI----TLREALKHPFFDLL 335
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 14/163 (8%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ R +G G G VY EP A+K VN+ +++ E ++
Sbjct: 29 MSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEAS--VM 82
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPH-----KRFSLTSARF-- 195
K + + L + ++ME + GDL S LR +P + ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A E+ + YL+ ++RDL N +V D + + DF ++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 28/168 (16%), Positives = 55/168 (32%), Gaps = 14/168 (8%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKV--------VNKEVLEKKKKV 133
+ L + G +Y + +++K+ + ++ K
Sbjct: 44 WKLKSFQTRDNQGILYE-AAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 134 HRAEMEKKILKMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
+ KK L +PT + +V+ G L S P S S
Sbjct: 103 LQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFDLS 238
A +L ALE+LH ++ ++ EN+ V + L+ + +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 28/166 (16%)
Query: 82 FDLHRRIGAGDIGTVYLC--SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR-AEM 138
F + ++IG G+ G + L N+Y A+K LE K +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEY-----------VAIK------LEPMKSRAPQLHL 53
Query: 139 EKKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E + K L +P +Y ++ +V+E G L L + FSL + A
Sbjct: 54 EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIA 111
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGH-----IMLSDFDLS 238
+++ +EY+H +IYRD+KPEN L+ G+ I + DF L+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 75/416 (18%), Positives = 121/416 (29%), Gaps = 128/416 (30%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
++G G G VY + + + YA+K + + A E +L+ L
Sbjct: 28 KVGRGTYGHVYKA-------KRKDGKDDKDYALKQIEGTGIS-----MSACREIALLREL 75
Query: 147 DHPFLPTLYAEFEASNFSCI--VMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV---- 200
HP + +L F + + + ++ DL + + + + V
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 201 ---LVALEYLHMLGIIYRDLKPENVLVRSD----GHIMLSDFDLSLCSNAIPAVESPASS 253
L + YLH +++RDLKP N+LV + G + ++D +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA--------------- 179
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
R F S P + A V T Y
Sbjct: 180 ------------------------RLFNS-------PLKPL------ADLDPVVVTFWYR 202
Query: 314 SPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPSNETTLRNIVK--------KPL 363
+PE+ G H A+D WA G IF E++ F + N +
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIF-AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 364 TFPTQS--P--SSMSEYH------------------------------ARDLISGLLNKD 389
FP M E+ A L+ LL D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321
Query: 390 PCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPG-MRRQKTMPFPDQKIKSQ 444
P R+ + P+F +IP R T PD K +
Sbjct: 322 PIKRI----TSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKK 373
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 19/166 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVH-RAEMEKKI 142
L R +G G+ G+V L + D A+K++ +++ E
Sbjct: 27 LGRMLGKGEFGSVREAQLKQE---DGSFVKV---AVKMLKADIIASSDIEEFLREAA--C 78
Query: 143 LKMLDHPFLPTLYA------EFEASNFSCIVMEFCSGGDLHS-LR-HKQPHKRFSLTSAR 194
+K DHP + L +++ F GDLH+ L + F+L
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 195 F--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ +EYL I+RDL N ++ D + ++DF LS
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 12/159 (7%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+L R IG G G V+ + + A+K + ++ E
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSP---ENPALAV---AIKTCKNCTSDSVREKFLQEAL- 68
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
++ DHP + L + I+ME C+ G+L S L+ ++ L S YA +
Sbjct: 69 -TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQ 124
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ AL YL ++RD+ NVLV S+ + L DF LS
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 11/160 (6%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + IG+GD G V L + P A+K + E++++ E
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVP---GQRDVPV---AIKALKAGYTERQRR--DFLSE 100
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
I+ DHP + L + IV E+ G L + LR +F++
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLR 158
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
V + YL LG ++RDL NVLV S+ +SDF LS
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 68/371 (18%), Positives = 116/371 (31%), Gaps = 85/371 (22%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
++ + IG G G V +K + A+K VN+ + E R E
Sbjct: 26 DNYIIKHLIGRGSYGYV--YLAYDKNTEKN-------VAIKKVNR-MFEDLIDCKRILRE 75
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHS-LRHKQP----HKRFS 189
IL L ++ LY + IV+E DL + H +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTI 134
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVES 249
L Y +L+ ++H GII+RDLKP N L+ D + + DF L+ + S
Sbjct: 135 L-----Y--NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART------INS 181
Query: 250 PASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309
+ ++ L + LT V T
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQ------------LTS---------------HVVT 214
Query: 310 HEYVSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPSNETTLRNIVKKPL---- 363
Y +PE+ + ++D W+ G IF E++ + PL
Sbjct: 215 RWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDPTN-------RFPLFPGS 266
Query: 364 -TFPTQSPSSMSEYHARD------LISGLL---NKDPCNRLGSKRGAADVKTHPFFKGLN 413
FP + + H + +I ++ +D + +K P K +N
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 414 FALIRSLTPPE 424
+
Sbjct: 327 LKQKYPSISDD 337
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 40/159 (25%), Positives = 61/159 (38%), Gaps = 10/159 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ IGAG+ G VY L + P A+K + EK++ E
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPV---AIKTLKAGYTEKQRV--DFLGEA 97
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
I+ H + L I+ E+ G L LR K FS+
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRG 155
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++YL + ++RDL N+LV S+ +SDF LS
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + + +GAG+ G V L + A+K + EK+++ E
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLP---SKKEISV---AIKTLKVGYTEKQRR--DFLGEA 97
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
I+ DHP + L S IV E+ G L S LR +F++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRG 155
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++YL +G ++RDL N+L+ S+ +SDF L
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 41/161 (25%), Positives = 61/161 (37%), Gaps = 18/161 (11%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM-- 138
D L +IG G+ G V+ L A+K + + +A+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTL---------VAVKSCRETLPPDL----KAKFLQ 161
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
E +ILK HP + L IVME GGD + LR + + +
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMV 219
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ +EYL I+RDL N LV + +SDF +S
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 33/165 (20%), Positives = 67/165 (40%), Gaps = 23/165 (13%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F + +G+G GTVY + ++ P A+K + + K K E
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPV---AIKELREATSPKANKEILDEAY- 69
Query: 141 KILKMLDHPFLPTLYAEFEASNFSC------IVMEFCSGGDLHS-LRHKQPHKRFSLTSA 193
++ +D+P + L C ++ + G L +R + +
Sbjct: 70 -VMASVDNPHVCRLLG-------ICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYL 119
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ + YL +++RDL NVLV++ H+ ++DF L+
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-15
Identities = 48/213 (22%), Positives = 78/213 (36%), Gaps = 12/213 (5%)
Query: 27 SSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHR 86
S + E +S ++S + + R + +L R
Sbjct: 337 ERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGR 396
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
IG G G V+ Y A+K + ++ E ++
Sbjct: 397 CIGEGQFGDVHQ----GIYMSPENPAMAV--AIKTCKNCTSDSVREKFLQEAL--TMRQF 448
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALE 205
DHP + L + I+ME C+ G+L S L+ ++ L S YA ++ AL
Sbjct: 449 DHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALA 505
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
YL ++RD+ NVLV S+ + L DF LS
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 43/161 (26%), Positives = 66/161 (40%), Gaps = 16/161 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE--M 138
D L+R +G G G VY N A+K K+ K+ +
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNH---KGEKINV---AVKTCKKDCTLDNKE----KFMS 62
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
E I+K LDHP + L E I+ME G+L L + + + Y+
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKN--SLKVLTLVLYS 119
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ A+ YL + ++RD+ N+LV S + L DF LS
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 36/160 (22%), Positives = 61/160 (38%), Gaps = 17/160 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ L + +G+G G V L +Y A+K++ + + + + E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD----------VAVKMIKEGSMSEDEFF----QE 53
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
+ + L HP L Y IV E+ S G L + LR +
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCY 111
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V + +L I+RDL N LV D + +SDF ++
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 74/384 (19%), Positives = 123/384 (32%), Gaps = 133/384 (34%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +G G G V S + R A+K K VL + V A E
Sbjct: 11 SRYMDLKPLGCGGNGLV--FSAVDNDCDKR-------VAIK---KIVLTDPQSVKHALRE 58
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSC--------------IVMEFCSGGDLHSLRHKQP- 184
KI++ LDH + ++ S IV E+ DL ++ + P
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL 117
Query: 185 ---HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
H R + Y ++L L+Y+H +++RDLKP N+ + ++ D L +
Sbjct: 118 LEEHARLFM-----Y--QLLRGLKYIHSANVLHRDLKPANLFINTE------DLVLKIGD 164
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFG-SKKIQTLTPNRLFVAEPVA 300
FG ++ + ++ ++E +
Sbjct: 165 --------------------------------------FGLARIMDPHYSHKGHLSEGLV 186
Query: 301 ARSCSFVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA----------- 348
+ Y SP + ++ A+D WA G EM+ G+T FA
Sbjct: 187 TKW--------YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 349 -----PSNET-------------TLRNIVKKPLT--FPTQSPSSMSEYHARDLISGLLNK 388
E KPLT P S A D + +L
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR------EAVDFLEQILTF 292
Query: 389 DPCNRLGSKRGAADVKTHPFFKGL 412
P +RL A + +HP+
Sbjct: 293 SPMDRL----TAEEALSHPYMSIY 312
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 10/159 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D L ++G G G V + A+K + +VL + + + E
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSV---AVKCLKPDVLSQPEAMDDFIREV 72
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
+ LDH L LY +V E G L LR Q H F L + YA +
Sbjct: 73 NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQ 129
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
V + YL I+RDL N+L+ + + + DF L
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 35/171 (20%), Positives = 72/171 (42%), Gaps = 20/171 (11%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV----LEKK--KKVHR 135
+ + IG G G +YL +N+ +KV + E K ++ +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAP----CVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 136 AEMEKKILKM--LDHPFLPTLYA----EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFS 189
E +K ++ L + +P + + ++ ++M+ G DL + KRFS
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFS 150
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFDLS 238
+ + +L LEY+H ++ D+K N+L+ ++ + L D+ L+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 37/178 (20%), Positives = 72/178 (40%), Gaps = 37/178 (20%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ L ++IG+G G +YL E + +KV + ++ E K
Sbjct: 39 WVLGKKIGSGGFGLIYLA------FPTNKPEKDARHVVKV-------EYQENGPLFSELK 85
Query: 142 ILKML---------------DHPFLPTLY----AEFEASNFSCIVMEFCSGGDLHSLRHK 182
+ + D+ +P Y EF+ ++ +VME G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 183 QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFDLS 238
+ F ++ +L LEY+H ++ D+K N+L+ ++ + L+D+ LS
Sbjct: 145 --NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 21/161 (13%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
L ++G G G V++ + N R A+K + + + + E
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSPEAFL----QEA 230
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YA 197
+++K L H L LYA IV E+ S G L L+ L + A
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMA 286
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A++ + Y+ + ++RDL+ N+LV + ++DF L+
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 15/159 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D + ++G G G VY A+K + ++ +E ++ + E
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKY------SLTV---AVKTLKEDTMEVEEFL----KEA 60
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
++K + HP L L I+ EF + G+L LR + S + A +
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQ 119
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ A+EYL I+RDL N LV + + ++DF LS
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 17/160 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + IG+G G V+L NK + A+K + + + ++ + E
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK----------VAIKTIREGAMSEEDFI----EE 53
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
+++ L HP L LY C+V EF G L LR ++ F+ +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCL 111
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V + YL +I+RDL N LV + I +SDF ++
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 36/156 (23%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ +G+G+ GTV Y+ + + A+K++ E + K E ++
Sbjct: 21 EDKELGSGNFGTVKK----GYYQMKKVVKTV---AVKILKNEANDPALKDELLA-EANVM 72
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLV 202
+ LD+P++ + EA ++ +VME G L+ L+ ++ + +V +
Sbjct: 73 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSM 128
Query: 203 ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++YL ++RDL NVL+ + + +SDF LS
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 16/159 (10%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ IG G G VY +L + D C A+K +N+ + E I+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDN---DGKKIHC---AVKSLNRITDIGEVSQFLTEGI--IM 80
Query: 144 KMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YAAE 199
K HP + +L + +V+ + GDL + +R++ + T + +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQ 136
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
V ++YL ++RDL N ++ + ++DF L+
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 28/168 (16%), Positives = 60/168 (35%), Gaps = 16/168 (9%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
D + +G G ++ + HE +KV++K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEV--LLKVLDKAHRNYSESFFE---A 62
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
++ L H L Y + + +V EF G L + L+ + ++ A
Sbjct: 63 ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAK 120
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM--------LSDFDLS 238
++ A+ +L +I+ ++ +N+L+ + LSD +S
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 82 FDLHRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA-EME 139
F L R+IG+G G +YL ++ A+K+ E K H E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE----------VAIKL------ENVKTKHPQLLYE 52
Query: 140 KKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
KI ++L +P + +++ +VM+ G L L + K SL + A
Sbjct: 53 SKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLAD 110
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSDFDLS 238
+++ +E++H ++RD+KP+N L+ + + DF L+
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 17/160 (10%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+D + +G G G V +Y A+K++ + + + + + E
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD----------VAIKMIKEGSMSEDEFI----EE 69
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAA 198
K++ L H L LY I+ E+ + G L + LR + RF
Sbjct: 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCK 127
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V A+EYL ++RDL N LV G + +SDF LS
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 35/169 (20%), Positives = 59/169 (34%), Gaps = 20/169 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+G G VY L E A+K + + ++ R E +
Sbjct: 13 FMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAM--LR 66
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLV 202
L HP + L ++ +CS GDLH L + PH T L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 203 ALEYLHML-------------GIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+++H++ ++++DL NVLV ++ +SD L
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 78/376 (20%), Positives = 121/376 (32%), Gaps = 124/376 (32%)
Query: 82 FDLHRRIGAGDIGTVY--LCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
F + R G G GTV V K+V++ + +R
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGM---------------SVAIKKVIQDPRFRNRELQI 69
Query: 140 KKILKMLDHP--------FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
+ L +L HP F + + +VME+ LH ++ +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRR-DIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 192 SA--RFYAAEVLVALEYLHM--LGIIYRDLKPENVLV-RSDGHIMLSDFDLSLCSNAIPA 246
+ + +++ ++ LH+ + + +RD+KP NVLV +DG L LC
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-------TLKLCD----- 175
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
FGS K L+P+ V ++
Sbjct: 176 ---------------------------------FGSAKK--LSPSEPNV---------AY 191
Query: 307 VGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFA----------------AP 349
+ + Y +PE+ G H AVD W+ G EM+ G F P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 350 SNET-----------TLRNIVKKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396
S E L N P + F S E A DL+S LL P R+
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE--AYDLLSALLQYLPEERM-- 307
Query: 397 KRGAADVKTHPFFKGL 412
+ HP+F L
Sbjct: 308 --KPYEALCHPYFDEL 321
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 33/161 (20%), Positives = 67/161 (41%), Gaps = 21/161 (13%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
L +++GAG G V++ + N + A+K + + + + E
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMKPGSMSVEAFLA----EA 234
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YA 197
++K L H L L+A I+ EF + G L L+ + + ++
Sbjct: 235 NVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFS 290
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A++ + ++ I+RDL+ N+LV + ++DF L+
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 32/159 (20%), Positives = 64/159 (40%), Gaps = 16/159 (10%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
R IG G G VY ++ + C A+K +++ ++ + E ++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQ---AQNRIQC---AIKSLSRITEMQQVEAFLREGL--LM 76
Query: 144 KMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YAAE 199
+ L+HP + L +++ + GDL +R Q + T + +
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQ 132
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
V +EYL ++RDL N ++ + ++DF L+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 73/376 (19%), Positives = 123/376 (32%), Gaps = 118/376 (31%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + + IG+G G V C+ + A+K +++ + + RA E
Sbjct: 62 KRYQNLKPIGSGAQGIV--CAAYDAVLDRN-------VAIKKLSR-PFQNQTHAKRAYRE 111
Query: 140 KKILKMLDHPFLPTLY----AEFEASNFSCI--VMEFCSGGDLHSLRHKQPHKRFSLTSA 193
++K ++H + +L + F + VME +L + +
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERM 166
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+ ++L +++LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 211
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
R T +TP +V T Y
Sbjct: 212 ------------RTAGTS--------------FMMTP---------------YVVTRYYR 230
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA----------------PSNET---- 353
+PEV G + VD W+ G + EM+ + F P E
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 354 ---------TLRNIVKKPLT--FPTQSPSSMSEY------HARDLISGLLNKDPCNRLGS 396
FP + SE+ ARDL+S +L DP R+
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-- 348
Query: 397 KRGAADVKTHPFFKGL 412
D HP+
Sbjct: 349 --SVDDALQHPYINVW 362
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 62/320 (19%), Positives = 97/320 (30%), Gaps = 112/320 (35%)
Query: 135 RAEMEKKILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHKQP----H 185
R E KIL H + + A IV + DL+ L Q H
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDH 129
Query: 186 KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+ L Y ++L L+Y+H +++RDLKP N+L+ + + + DF L+
Sbjct: 130 ICYFL-----Y--QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA------- 175
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
R + F+ E VA R
Sbjct: 176 --------------------RVADPD-----------------HDHTGFLTEYVATRW-- 196
Query: 306 FVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA---------------- 348
Y +PE+ ++D W+ G + EM+ R F
Sbjct: 197 ------YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 349 PSNET--------------TLRNIVKKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCN 392
PS E +L + K P FP A DL+ +L +P
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS------KALDLLDKMLTFNPHK 304
Query: 393 RLGSKRGAADVKTHPFFKGL 412
R+ HP+ +
Sbjct: 305 RI----EVEQALAHPYLEQY 320
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 29/159 (18%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + +G+G GTV+ + + P +KV+ + + + M
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPE--GESIKIPV---CIKVIEDKSGRQSFQAVTDHML- 67
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
+ LDH + L S+ +V ++ G L +R + + +
Sbjct: 68 -AIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQ 123
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ + YL G+++R+L NVL++S + ++DF ++
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 34/166 (20%), Positives = 68/166 (40%), Gaps = 20/166 (12%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE--MEKK 141
L + +G G+ G+V +L + D A+K + + +++ E E
Sbjct: 38 LGKILGEGEFGSVMEGNLKQE---DGTSLKV---AVKTMKLDNSSQRE---IEEFLSEAA 88
Query: 142 ILKMLDHPFLPTLYA-----EFEASNFSCIVMEFCSGGDLHS-LRHKQPH-KRFSLTSAR 194
+K HP + L + +++ F GDLH+ L + + +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 195 F--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ ++ + +EYL ++RDL N ++R D + ++DF LS
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 20/168 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L +G G G V+L +N + L A+K + KE E ++ + E E +L
Sbjct: 45 LKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKAL-KEASESARQDFQREAE--LL 97
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF----------SLTS 192
ML H + + +V E+ GDL+ LR P + L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 193 ARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ A++V + YL L ++RDL N LV + + DF +S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 17/159 (10%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
L R+GAG G V++ N + A+K + + + + E
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTK----------VAVKSLKQGSMSPDAFL----AEA 59
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
++K L H L LYA I+ E+ G L L+ K ++ AA+
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQ 117
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ + ++ I+RDL+ N+LV ++DF L+
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 15/159 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D + ++G G G VY A+K + ++ +E ++ + E
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKY------SLTV---AVKTLKEDTMEVEEFLK----EA 267
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
++K + HP L L I+ EF + G+L LR + S + A +
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQ 326
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ A+EYL I+R+L N LV + + ++DF LS
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 32/157 (20%), Positives = 66/157 (42%), Gaps = 12/157 (7%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ IG G G VY +L + D C A+K +N+ + E I+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDN---DGKKIHC---AVKSLNRITDIGEVSQFLTEGI--IM 144
Query: 144 KMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVL 201
K HP + +L + +V+ + GDL + +R++ + ++ + +V
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVA 202
Query: 202 VALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+++L ++RDL N ++ + ++DF L+
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 72/394 (18%), Positives = 124/394 (31%), Gaps = 82/394 (20%)
Query: 13 ATTRTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFG 72
++ + A + ++ S S+ + S + + P SD+
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-------- 52
Query: 73 RKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
+++ IG G G V C +K + A+K + + V E
Sbjct: 53 -------DRYEIRHLIGTGSYGHV--CEAYDKLEKRV-------VAIKKILR-VFEDLID 95
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHS-LRHKQP-- 184
R E IL L+H + + + +V+E D R
Sbjct: 96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLT 154
Query: 185 --HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSN 242
H + L Y +LV ++Y+H GI++RDLKP N LV D + + DF L
Sbjct: 155 ELHIKTLL-----Y--NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL----- 202
Query: 243 AIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302
A + + + + + LT
Sbjct: 203 --------ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT------------- 241
Query: 303 SCSFVGTHEYVSPEVASGGSH-GNAVDWWAFG-IFIYEMIYGRTPFAAPSNETTLRNIVK 360
V T Y +PE+ + A+D W+ G IF E++ E + +
Sbjct: 242 --GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA-ELL-------NMIKENVAYHADR 291
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394
PL FP S +S + ++L
Sbjct: 292 GPL-FPGSSCFPLSPDQKAGNDFKFHTRGNRDQL 324
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 14/163 (8%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L R +G G G VY ++ D A+K + + E+ + E I+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSG-MPNDPSPLQV---AVKTLPEVCSEQDELDFLMEAL--II 87
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPH--KRFSLTSARF--YAA 198
+H + S I+ME +GGDL S LR +P + SL A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML---SDFDLS 238
++ +YL I+RD+ N L+ G + DF ++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 33/159 (20%), Positives = 67/159 (42%), Gaps = 11/159 (6%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F + +G+G GTVY + ++ P A+K + + K K E
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPV---AIKELREATSPKANKEILDEAY- 69
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAE 199
++ +D+P + L S ++ + G L +R + + + +
Sbjct: 70 -VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQ 125
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ + YL +++RDL NVLV++ H+ ++DF L+
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 21/161 (13%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
L ++G G G V++ + N R A+K + + + + E
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSPEAFL----QEA 313
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF--YA 197
+++K L H L LYA IV E+ S G L L+ L + A
Sbjct: 314 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMA 369
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
A++ + Y+ + ++RDL+ N+LV + ++DF L+
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 27/169 (15%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR- 135
+ +R +++ + IG G G V D A+K+V +K+ HR
Sbjct: 95 VAYR-YEVLKVIGKGSFGQVVKA-------YDHKVH--QHVALKMVRN-----EKRFHRQ 139
Query: 136 AEMEKKILKML-------DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF 188
A E +IL+ L + + F N C+ E S +L+ L K + F
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVI-HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGF 197
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH--IMLSDF 235
SL R +A +L L+ LH II+ DLKPEN+L++ G I + DF
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 21/169 (12%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L R +G G G V+L N + L A+K + K+ +K + E E +L
Sbjct: 19 LKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKAL-KDPTLAARKDFQREAE--LL 71
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-----------SLT 191
L H + Y + +V E+ GDL+ LR P L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 192 SARFY--AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
++ A+++ + YL ++RDL N LV ++ + + DF +S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 14/163 (8%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L R +G G G VY ++ A+K + + E+ + E I+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEAL--II 128
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPH--KRFSLTSARF--YAA 198
+H + S I++E +GGDL S LR +P + SL A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML---SDFDLS 238
++ +YL I+RD+ N L+ G + DF ++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+G G+ G+V YR + A+KV+ + + + E +I+
Sbjct: 16 IELGCGNFGSVRQ----GVYRMRKKQIDV---AIKVLKQGTEKADTE--EMMREAQIMHQ 66
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVAL 204
LD+P++ L +A +VME GG LH L K+ +++ +V + +
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 123
Query: 205 EYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+YL ++RDL NVL+ + + +SDF LS
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-13
Identities = 40/161 (24%), Positives = 61/161 (37%), Gaps = 19/161 (11%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
++ L + IG G+ G V L A+K + + + AE
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATAQA---FLAEAS 66
Query: 140 KKILKMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYA 197
++ L H L L E IV E+ + G L LR + ++
Sbjct: 67 --VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFS 123
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+V A+EYL ++RDL NVLV D +SDF L+
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 28/177 (15%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
R IG G G V+ +EP + A+K++ +E + + E ++
Sbjct: 51 YVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAA--LM 104
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-------------- 188
D+P + L C++ E+ + GDL+ LR PH
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 189 -----SLTSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L+ A A +V + YL ++RDL N LV + + ++DF LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 36/171 (21%), Positives = 66/171 (38%), Gaps = 22/171 (12%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L + +G G G V C A+K++ + + + +E++ IL
Sbjct: 31 LGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELK--IL 84
Query: 144 KMLD-HPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-----------S 189
+ H + L + +++EFC G+L + LR K+
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 190 LTSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
LT Y+ +V +E+L I+RDL N+L+ + + DF L+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 30/178 (16%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L + +G G+ G V +G A+K++ + + + +E +L
Sbjct: 27 LGKTLGEGEFGKVVKA----TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN--VL 80
Query: 144 KMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF------- 195
K ++HP + LY +++E+ G L LR + L S
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 196 --------------YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS 238
+A ++ ++YL + +++RDL N+LV ++G M +SDF LS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLS 197
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 13/153 (8%)
Query: 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML 146
+G G+ G+V YR + A+KV+ + + + E +I+ L
Sbjct: 343 ELGCGNFGSVRQ----GVYRMRKKQIDV---AIKVLKQGTEKADTEEMMREA--QIMHQL 393
Query: 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVLVALE 205
D+P++ L +A +VME GG LH L K+ +++ +V + ++
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMK 450
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
YL ++R+L NVL+ + + +SDF LS
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 27/170 (15%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR- 135
R +++ IG G G V DR + A+K++ KK
Sbjct: 52 WMDR-YEIDSLIGKGSFGQVVKA-------YDRVEQ--EWVAIKIIKN-----KKAFLNQ 96
Query: 136 AEMEKKILKML------DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFS 189
A++E ++L+++ ++ L F N C+V E S +L+ L + S
Sbjct: 97 AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVS 155
Query: 190 LTSARFYAAEVLVALEYLHM--LGIIYRDLKPENVLVRSDGH--IMLSDF 235
L R +A ++ AL +L L II+ DLKPEN+L+ + I + DF
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 41/162 (25%), Positives = 58/162 (35%), Gaps = 23/162 (14%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE--M 138
+ L + IG G+ G V L KV K + K
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGN---------------KVAVKCI---KNDATAQAFLA 235
Query: 139 EKKILKMLDHPFLPTLYAE-FEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFY 196
E ++ L H L L E IV E+ + G L LR + +
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKF 294
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ +V A+EYL ++RDL NVLV D +SDF L+
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 44/197 (22%), Positives = 85/197 (43%), Gaps = 32/197 (16%)
Query: 51 LSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRG 110
+ + R ++F I +TF + + + IG+G G V C+ + +
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTF-----TVLKRYQNLKPIGSGAQGIV--CAAYDAILERN- 52
Query: 111 HEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY----AEFEASNFSCI 166
A+K +++ + + RA E ++K ++H + L + F +
Sbjct: 53 ------VAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105
Query: 167 --VMEFCSGGDLHSLRHKQ---PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221
VME +L + + + L Y ++L +++LH GII+RDLKP N
Sbjct: 106 YIVMELM-DANLCQVIQMELDHERMSYLL-----Y--QMLCGIKHLHSAGIIHRDLKPSN 157
Query: 222 VLVRSDGHIMLSDFDLS 238
++V+SD + + DF L+
Sbjct: 158 IVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 32/144 (22%), Positives = 44/144 (30%), Gaps = 41/144 (28%)
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA----------------P 349
+V T Y +PEV G + VD W+ G + EMI G F P
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 350 SNET-------------TLRNIVKKPLT--FPTQSPSSMSEY------HARDLISGLLNK 388
E FP + SE+ ARDL+S +L
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 389 DPCNRLGSKRGAADVKTHPFFKGL 412
D R+ + HP+
Sbjct: 306 DASKRI----SVDEALQHPYINVW 325
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 25/173 (14%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ +GAG G V + + A+K++ +++ +E++ +L
Sbjct: 27 FGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELK--VL 80
Query: 144 KML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARF------ 195
L +H + L + ++ E+C GDL + LR K+ S TS
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 196 ---------YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS 238
++ +V + +L I+RDL N+L+ + G I + DF L+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 49/238 (20%), Positives = 90/238 (37%), Gaps = 30/238 (12%)
Query: 16 RTTSTANSSSMSSESCSSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKT 75
R + + SS S S + R++ L ++ +P + S++ F R
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGV-----SEYELPEDPKWEFPRD- 81
Query: 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR 135
L + +G G G V + + A+K++ + EK
Sbjct: 82 -----KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV--AVKMLKDDATEKDLSDLV 134
Query: 136 AEMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF----- 188
+EME ++KM+ H + L +++E+ S G+L LR ++P
Sbjct: 135 SEME--MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 189 ------SLTSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+T ++ +EYL I+RDL NVLV + + ++DF L+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 70/359 (19%), Positives = 114/359 (31%), Gaps = 138/359 (38%)
Query: 124 KEVLEKKKKVHRAEMEKKILKMLDHP--------FLPTLYAEFEASNFSC---------- 165
K+VL+ + +R E I+K+LDH F T E +
Sbjct: 38 KKVLQDPRYKNR---ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNN 94
Query: 166 --------------------IVMEFCSGGDLHSLRHKQPHKRFSLTSA--RFYAAEVLVA 203
++ME+ LH + S+ Y ++ A
Sbjct: 95 GVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153
Query: 204 LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQT 263
+ ++H LGI +RD+KP+N+LV S + L LC
Sbjct: 154 VGFIHSLGICHRDIKPQNLLVNSKDN------TLKLCD---------------------- 185
Query: 264 YTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSH 323
FGS K L P+ V +++ + Y +PE+ G +
Sbjct: 186 ----------------FGSAKK--LIPSEPSV---------AYICSRFYRAPELMLGATE 218
Query: 324 -GNAVDWWAFGIFIYEMIYGRTPFA----------------APSNET-----------TL 355
++D W+ G E+I G+ F+ P+ E
Sbjct: 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF 278
Query: 356 RNIVKKPLT--FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ K P +PS A DL+ +L +P R+ + HPFF L
Sbjct: 279 PTLKAKDWRKILPEGTPSL-----AIDLLEQILRYEPDLRI----NPYEAMAHPFFDHL 328
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +G+G G V CS + + A+K + + + + RA E
Sbjct: 25 AVYRDLQPVGSGAYGAV--CSAVDGRTGAK-------VAIKKLYR-PFQSELFAKRAYRE 74
Query: 140 KKILKMLDHPFLPTLY----AEFEASNFSCI--VMEFCSGGDLHSLRHKQP----HKRFS 189
++LK + H + L + +F+ VM F G DL L + +F
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL 133
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ Y ++L L Y+H GII+RDLKP N+ V D + + DF L+
Sbjct: 134 V-----Y--QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 35/150 (23%), Positives = 48/150 (32%), Gaps = 48/150 (32%)
Query: 301 ARSCS-----FVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA------ 348
AR +V T Y +PEV VD W+ G + EMI G+T F
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 349 ----------PSNET--------------TLRNIVKKPLT--FPTQSPSSMSEYHARDLI 382
P E L + KK SP A +L+
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP------LAVNLL 288
Query: 383 SGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+L D R+ A + HP+F+ L
Sbjct: 289 EKMLVLDAEQRV----TAGEALAHPYFESL 314
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ +G+G G+V C+ + R A+K +++ + R E
Sbjct: 29 ERYQNLSPVGSGAYGSV--CAAFDTKTGLR-------VAVKKLSR-PFQSIIHAKRTYRE 78
Query: 140 KKILKMLDHPFLPTLY----AEFEASNFSCI--VMEFCSGGDLHSLRHKQP----HKRFS 189
++LK + H + L F+ + V G DL+++ Q H +F
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL 137
Query: 190 LTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+ Y ++L L+Y+H II+RDLKP N+ V D + + DF L+
Sbjct: 138 I-----Y--QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 33/151 (21%), Positives = 47/151 (31%), Gaps = 50/151 (33%)
Query: 301 ARSCSFVGTHEYVS------PEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA----- 348
AR + T YV+ PE+ H VD W+ G + E++ GRT F
Sbjct: 179 ARHTADEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
Query: 349 -----------PSNET--------------TLRNIVKKPLT--FPTQSPSSMSEYHARDL 381
P E +L + K F +P A DL
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP------LAVDL 291
Query: 382 ISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ +L D R+ AA H +F
Sbjct: 292 LEKMLVLDSDKRI----TAAQALAHAYFAQY 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 46/220 (20%), Positives = 79/220 (35%), Gaps = 49/220 (22%)
Query: 32 SSFSRLSFELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAG 91
S +S+ + + + SS + + +R + AT +FD IG G
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYR---VPLVDLEEAT---------NNFDHKFLIGHG 50
Query: 92 DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR---AEMEKKILKMLDH 148
G VY L + KV K + + E+E L H
Sbjct: 51 VFGKVYKGVLRDG--------------AKVALKRRTPESSQGIEEFETEIE--TLSFCRH 94
Query: 149 PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT----------SARFYAA 198
P L +L + N ++ ++ G+L + S++ +AR
Sbjct: 95 PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---- 150
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L YLH II+RD+K N+L+ + ++DF +S
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 19/170 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L + +G G G V + + A+K++ + EK +EME ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV--AVKMLKDDATEKDLSDLVSEME--MM 94
Query: 144 KML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF-----------SL 190
KM+ H + L +++E+ S G+L LR ++P +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 191 TSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
T ++ +EYL I+RDL NVLV + + ++DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 35/169 (20%), Positives = 68/169 (40%), Gaps = 21/169 (12%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ +GAG G V + A+K++ +K+ +E+ KI+
Sbjct: 50 FGKTLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL--KIM 103
Query: 144 KMLD-HPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRF---------SLTS 192
L H + L ++ E+C GDL + LR K + ++
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 193 ARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS 238
++++V + +L I+RD+ NVL+ ++GH+ + DF L+
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLA 211
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 38/170 (22%), Positives = 63/170 (37%), Gaps = 24/170 (14%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
IG G+ G V + D A+K + + + + E+E +L
Sbjct: 29 FQDVIGEGNFGQVLKARIKK----DGLRMDA---AIKRMKEYASKDDHRDFAGELE--VL 79
Query: 144 KML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEVL 201
L HP + L E + + +E+ G+L LR + + + A L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 202 -----------VA--LEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
VA ++YL I+RDL N+LV + ++DF LS
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 29/174 (16%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK------KKV 133
+ + R I +G G V C+ + A+K V V + +
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIP--------VAIKRVFNTVSDGRTVNILSDSF 71
Query: 134 H--RAEMEKKILKMLDHPFLPTLYAEFEASNFSC-----IVMEFCSGGDLHSLRHKQPHK 186
R E ++L HP + L F +V E DL + H Q
Sbjct: 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ--- 127
Query: 187 RFSLTSA--RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
R ++ +++ +L+ L LH G+++RDL P N+L+ + I + DF+L+
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 19/170 (11%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L + +G G G V L + A+K++ + EK +EME ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV--AVKMLKSDATEKDLSDLISEME--MM 128
Query: 144 KML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPH-----------KRFSL 190
KM+ H + L +++E+ S G+L L+ ++P L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 191 TSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+S A +V +EYL I+RDL NVLV D + ++DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +G+G G+V CS +K ++ A+K +++ + + RA E
Sbjct: 24 KTYVSPTHVGSGAYGSV--CSAIDKRSGEK-------VAIKKLSR-PFQSEIFAKRAYRE 73
Query: 140 KKILKMLDHPFLPTLY----AEFEASNFSCI--VMEFCSGGDLHSLRHKQ---PHKRFSL 190
+LK + H + L NF VM F DL + + ++ +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLV 132
Query: 191 TSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
Y ++L L+Y+H G+++RDLKP N+ V D + + DF L+
Sbjct: 133 -----Y--QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 41/150 (27%), Positives = 52/150 (34%), Gaps = 48/150 (32%)
Query: 301 ARSCS-----FVGTHEYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAA------ 348
AR +V T Y +PEV H VD W+ G + EM+ G+T F
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 349 ----------PSNET--------------TLRNIVKKPLT--FPTQSPSSMSEYHARDLI 382
P E +L +K T FP SP A DL+
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASP------QAADLL 286
Query: 383 SGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+L D RL AA THPFF+
Sbjct: 287 EKMLELDVDKRL----TAAQALTHPFFEPF 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 36/178 (20%), Positives = 70/178 (39%), Gaps = 30/178 (16%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ +G+G G V + A+K++ ++ +++ +E++ ++
Sbjct: 49 FGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELK--MM 102
Query: 144 KML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFS------------ 189
L H + L S ++ E+C GDL + LR K+
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 190 ------LTSARF--YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLS 238
LT +A +V +E+L ++RDL NVLV + G ++ + DF L+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLA 219
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 60/320 (18%), Positives = 108/320 (33%), Gaps = 98/320 (30%)
Query: 39 FELPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYL 98
F++P ++ PE + R F+ ++ A+ +F +G G G VY
Sbjct: 2 FDVP-AEEDPEVHLGQLKR---FSLRELQVAS---------DNFSNKNILGRGGFGKVYK 48
Query: 99 CSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY--- 155
L + G A+K + +E + + + E+E ++ M H L L
Sbjct: 49 GRLAD------GTL----VAVKRLKEERTQGGELQFQTEVE--MISMAVHRNLLRLRGFC 96
Query: 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT-SARFY----AAEVLVALEYLH-- 208
+V + + G + S ++P + L R +A L YLH
Sbjct: 97 MT---PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---GLAYLHDH 150
Query: 209 -MLGIIYRDLKPENVLVRSDGHIMLSDFDLS-LCSNAIPAVESPASSPEAASPRSQTYTR 266
II+RD+K N+L+ + ++ DF L+ L T+
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL------------------MDYKDTHV- 191
Query: 267 QYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNA 326
+T GT +++PE S G
Sbjct: 192 --TTA----------------------------------VRGTIGHIAPEYLSTGKSSEK 215
Query: 327 VDWWAFGIFIYEMIYGRTPF 346
D + +G+ + E+I G+ F
Sbjct: 216 TDVFGYGVMLLELITGQRAF 235
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 40/206 (19%), Positives = 75/206 (36%), Gaps = 46/206 (22%)
Query: 49 ENLSLKPHRSSDFAYSAIRSAT--FGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYR 106
++L + R F++ +++ T F + + +G G G VY +NN
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNK-----MGEGGFGVVYKGYVNNT-- 55
Query: 107 QDRGHEPCCLYAMKVVNKEVLEKKKKVHR---AEMEKKILKMLDHPFLPTLY---AEFEA 160
A+K + V +++ + E++ ++ H L L ++
Sbjct: 56 ---------TVAVKKLAAMVDITTEELKQQFDQEIK--VMAKCQHENLVELLGFSSD--- 101
Query: 161 SNFSCIVMEFCSGGD----LHSLRHKQP---HKRFS--LTSARFYAAEVLVALEYLHMLG 211
+ C+V + G L L P H R +A + +LH
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------GINFLHENH 153
Query: 212 IIYRDLKPENVLVRSDGHIMLSDFDL 237
I+RD+K N+L+ +SDF L
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 7e-08
Identities = 34/203 (16%), Positives = 57/203 (28%), Gaps = 59/203 (29%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVV-----NKEVLEKKKKVHR 135
+IG G G V+ ++ A+K++ + +K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT-----------PVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 136 AEMEKKILKMLDH--------------------------PFLPTLYAEFEASNFSC---- 165
E I K L P L + + ++ S
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 166 ---------IVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYR 215
IV+EF GG + K SL +A+ ++ +L L +R
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDL---EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186
Query: 216 DLKPENVLVRSDGHIMLSDFDLS 238
DL NVL++ L
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 55/304 (18%), Positives = 104/304 (34%), Gaps = 44/304 (14%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
L + +G G G V C A+K++ + + + +E+ KIL
Sbjct: 26 LGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSEL--KIL 79
Query: 144 KMLD-HPFLPTLY-AEFEASNFSCIVMEFCSGGDLHS-LRHKQPHKRFSLTSARFYAAEV 200
+ H + L A + +++EFC G+L + LR K+ T +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR--- 136
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ +G I DLK + S S F + + E+P +
Sbjct: 137 ----QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192
Query: 261 SQ--TYTRQYSTRLSRFLNRFFGSKKI--QTLTPNRLFVAEPVAARSCSF------VGTH 310
Y+ Q + + F S+K + L + ++E + C F
Sbjct: 193 EHLICYSFQVAKGME-----FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 311 EYV------------SPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRN 357
+YV +PE + D W+FG+ ++E+ G +P+ +
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307
Query: 358 IVKK 361
+K+
Sbjct: 308 RLKE 311
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 49/275 (17%), Positives = 86/275 (31%), Gaps = 49/275 (17%)
Query: 33 SFSRLSFE-LPTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDF-------DL 84
S +R+ E +L + +R D+ S TF + + +
Sbjct: 38 SHARIGEEKARNILKYLSDLRVVQNRQKDYEGSTF---TFIGLSLYSLHRLVRSGKVDAI 94
Query: 85 HRRIGAGDIGTVYLC-SLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHR----AEME 139
+ +G G V+ C S + H+ KV K A E
Sbjct: 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 154
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+ L+ L +P +YA + ++ME +L+ +R + P +
Sbjct: 155 FRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRVRVENPDE---------VLDM 201
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
+L + + GI++ DL NVLV S+ I + DF S+
Sbjct: 202 ILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV----------EVGEEGW--- 247
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLF 294
R+ R R + +F N
Sbjct: 248 ------REILERDVRNIITYFSRTYRTEKDINSAI 276
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 64/448 (14%), Positives = 122/448 (27%), Gaps = 132/448 (29%)
Query: 3 IDSDFEPP--SDATTRTTSTANSSSMSSESC-------SSFSRLSFELPTSKSSPENL-- 51
I S FE + + S +S E + S T S E +
Sbjct: 21 ILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 52 -----SLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDI-----GTVY---- 97
L+ + F S I++ R+ + R + R D V
Sbjct: 81 KFVEEVLRI--NYKFLMSPIKTEQ--RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 98 LCSLNNKYRQDRGHEPCCLYAMKVVNK-----EVLEKKK-------KVH-----RAEMEK 140
L + R + + + K +V K K+ +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L+ML L + + + + S D HS K + S + +
Sbjct: 197 TVLEMLQ-----KLLYQIDPN--------WTSRSD-HSSNIKLR-----IHSIQAELRRL 237
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC--------SNAIPAVESPAS 252
L + Y + L ++ + V++ + F+LS C + + +
Sbjct: 238 LKSKPYENCL-LVLLN-------VQNAKAW--NAFNLS-CKILLTTRFKQVTDFLSAATT 286
Query: 253 SPEAASPRSQTYTRQYSTRL-SRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
+ + S T T L ++L+ + Q L P +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLD-----CRPQDL---------PREVLT-------- 324
Query: 312 YVSPEVAS--GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS 369
+P S S + + W ++ + N L I++ L
Sbjct: 325 -TNPRRLSIIAESIRDGLATWDN----WKHV----------NCDKLTTIIESSLN--VLE 367
Query: 370 PSSMSEYHARDLISGLLNKD---PCNRL 394
P+ + L + P L
Sbjct: 368 PAEYRKMF-DRL--SVFPPSAHIPTILL 392
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 451 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.47 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.74 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.14 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 87.89 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=506.89 Aligned_cols=273 Identities=37% Similarity=0.631 Sum_probs=243.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+.+|+++|++++|||||+++++|+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~---------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCC---------EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 679999999999999999999988776 49999999887666666788899999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 999999999999999999999875 569999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... +.......+++||+.|||||++.
T Consensus 181 ~~~~-----------------------------------------------------~~~~~~~~~~~GTp~YmAPEvl~ 207 (311)
T 4aw0_A 181 VLSP-----------------------------------------------------ESKQARANSFVGTAQYVSPELLT 207 (311)
T ss_dssp ECCT-----------------------------------------------------TTTCCCBCCCCSCGGGCCHHHHH
T ss_pred ecCC-----------------------------------------------------CCCcccccCcccCcccCCHHHHc
Confidence 4321 11122334579999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..|+.++|||||||++|+|++|+.||.+.+..+.+.++..+.+.++... +.++++||.+||++||++|||
T Consensus 208 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~dli~~lL~~dp~~R~t---- 278 (311)
T 4aw0_A 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKF-----FPKARDLVEKLLVLDATKRLG---- 278 (311)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTC-----CHHHHHHHHHHSCSSGGGSTT----
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc-----CHHHHHHHHHHccCCHhHCcC----
Confidence 99999999999999999999999999999999999999999887766533 338999999999999999999
Q ss_pred hHH------HHcCCCcCCCCcccccccCCCCC
Q 013016 400 AAD------VKTHPFFKGLNFALIRSLTPPEI 425 (451)
Q Consensus 400 ~~e------ll~hp~~~~~~~~~~~~~~~~~~ 425 (451)
++| |++||||++++|..+.+..||.+
T Consensus 279 ~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 279 CEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp SGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred hHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 665 69999999999998887777654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-65 Score=488.67 Aligned_cols=279 Identities=37% Similarity=0.694 Sum_probs=233.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||+||+|++..+. ..+..||||++.+..... .....+.+|+.+|++++|||||+++++|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 368999999999999999999875432 122369999997653322 2234567799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999999999875 56999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+.... ......+++||+.|||||++
T Consensus 174 ~~~~~-------------------------------------------------------~~~~~~~~~GT~~YmAPE~~ 198 (304)
T 3ubd_A 174 KESID-------------------------------------------------------HEKKAYSFCGTVEYMAPEVV 198 (304)
T ss_dssp EC------------------------------------------------------------CCCCSCCCCGGGCCHHHH
T ss_pred eeccC-------------------------------------------------------CCccccccccCcccCCHHHh
Confidence 53211 01122346899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC-
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK- 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~- 397 (451)
.+..|+.++|||||||++|||+||+.||.+.+..+.+..+.+....+|.. .+.++++||.+||++||++|||++
T Consensus 199 ~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~~L~~dP~~R~ta~~ 273 (304)
T 3ubd_A 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF-----LSPEAQSLLRMLFKRNPANRLGAGP 273 (304)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSSGGGSTTCST
T ss_pred ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc-----CCHHHHHHHHHHcccCHHHCCCCCc
Confidence 99999999999999999999999999999999999999999887766543 334899999999999999999953
Q ss_pred CChHHHHcCCCcCCCCcccc--cccCCCCCC
Q 013016 398 RGAADVKTHPFFKGLNFALI--RSLTPPEIP 426 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~--~~~~~~~~p 426 (451)
..++|+++||||++++|..+ +.+.||++|
T Consensus 274 ~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 274 DGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp TTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 34689999999999999755 778888887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=486.27 Aligned_cols=260 Identities=25% Similarity=0.425 Sum_probs=222.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|+++++||+|+||+||+|+++.+++ .||||++.+.... ....+.+.+|+.+|++++|||||+++++|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 92 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGR---------QYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESF 92 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCC---------EEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEE
Confidence 3789999999999999999999987765 4999999865433 23456788899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
++++.+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 93 ~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999999999998877777899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+.... ......+++||+.|||||++
T Consensus 173 ~~~~~-------------------------------------------------------~~~~~~~~~GT~~YmAPE~l 197 (350)
T 4b9d_A 173 RVLNS-------------------------------------------------------TVELARACIGTPYYLSPEIC 197 (350)
T ss_dssp SCCCH-------------------------------------------------------HHHHHHHHHSCCTTCCHHHH
T ss_pred eeecC-------------------------------------------------------CcccccccCCCccccCHHHH
Confidence 53210 01112245899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..|+.++|||||||+||||+||+.||.+.+..+.+.++..+..... + ...+.++++||.+||++||++|||
T Consensus 198 ~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~-~~~s~~~~~li~~~L~~dP~~R~s--- 270 (350)
T 4b9d_A 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---S-LHYSYDLRSLVSQLFKRNPRDRPS--- 270 (350)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C-TTSCHHHHHHHHHHTCSSGGGSCC---
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---C-ccCCHHHHHHHHHHccCChhHCcC---
Confidence 999999999999999999999999999999999999999988765322 1 223448999999999999999999
Q ss_pred ChHHHHcCCCcCC
Q 013016 399 GAADVKTHPFFKG 411 (451)
Q Consensus 399 ~~~ell~hp~~~~ 411 (451)
++|+|+||||++
T Consensus 271 -~~e~l~hp~~~~ 282 (350)
T 4b9d_A 271 -VNSILEKGFIAK 282 (350)
T ss_dssp -HHHHHTSHHHHT
T ss_pred -HHHHhcCHHhhc
Confidence 999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-63 Score=469.14 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=213.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+.+|+.++++++|||||+++++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~ 81 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQ---------KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCC---------EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 34789999999999999999999887765 499999987766555666778899999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+++.+||||||| +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 82 ~~~~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 82 IKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp EECSSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred EEECCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCC
Confidence 99999999999999 78999998775 5699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|+.... .....+.+||+.|||||+
T Consensus 159 a~~~~~--------------------------------------------------------~~~~~~~~GT~~Y~APE~ 182 (275)
T 3hyh_A 159 SNIMTD--------------------------------------------------------GNFLKTSCGSPNYAAPEV 182 (275)
T ss_dssp C-----------------------------------------------------------------------CTTSCHHH
T ss_pred CeecCC--------------------------------------------------------CCccCCeeECcccCChhh
Confidence 853211 011124589999999999
Q ss_pred ccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..| +.++|||||||++|+|+||+.||.+.+..+.+..+..+...++.. .+.++++||.+||++||++|||
T Consensus 183 ~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~~L~~dP~~R~s- 256 (275)
T 3hyh_A 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-----LSPGAAGLIKRMLIVNPLNRIS- 256 (275)
T ss_dssp HSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----SCHHHHHHHHHHSCSSGGGSCC-
T ss_pred hcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHccCChhHCcC-
Confidence 998876 689999999999999999999999998888999998887766543 3348999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
++|+|+||||+.
T Consensus 257 ---~~eil~hpw~k~ 268 (275)
T 3hyh_A 257 ---IHEIMQDDWFKV 268 (275)
T ss_dssp ---HHHHHHCHHHHT
T ss_pred ---HHHHHcCccccc
Confidence 999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=479.39 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=223.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
...|++.++||+|+||+||+|+++.+++ .||||++..... ...+.+.+|+.+|+.++|||||+++++|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~---------~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 140 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSY 140 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCC---------EEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3679999999999999999999987765 499999976532 2345567899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++++|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 141 ~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 141 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999999999976 35999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+.... ......+++||+.|||||++
T Consensus 218 ~~~~~-------------------------------------------------------~~~~~~~~~GTp~YmAPEvl 242 (346)
T 4fih_A 218 AQVSK-------------------------------------------------------EVPRRKSLVGTPYWMAPELI 242 (346)
T ss_dssp EECCS-------------------------------------------------------SSCCBCCCCSCGGGCCHHHH
T ss_pred eecCC-------------------------------------------------------CCCcccccccCcCcCCHHHH
Confidence 53321 11122356999999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..|+.++|||||||++|||++|+.||.+.+..+.+..+........ ..+.. .+.++++||.+||++||++|||
T Consensus 243 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~-~s~~~~dli~~~L~~dP~~R~t--- 317 (346)
T 4fih_A 243 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHK-VSPSLKGFLDRLLVRDPAQRAT--- 317 (346)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-SCGGG-SCHHHHHHHHHHSCSSTTTSCC---
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-Ccccc-CCHHHHHHHHHHcCCChhHCcC---
Confidence 999999999999999999999999999999888888888876543221 11222 3448999999999999999999
Q ss_pred ChHHHHcCCCcCCC
Q 013016 399 GAADVKTHPFFKGL 412 (451)
Q Consensus 399 ~~~ell~hp~~~~~ 412 (451)
+.|+|+||||++.
T Consensus 318 -a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 318 -AAELLKHPFLAKA 330 (346)
T ss_dssp -HHHHTTCGGGGGC
T ss_pred -HHHHhcCHhhcCC
Confidence 9999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=487.92 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=223.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.+.|++.++||+|+||+||+|+++.+++ .||||++..... ...+.+.+|+.+|+.++|||||+++++|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~---------~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 217 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSY 217 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCC---------EEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 3679999999999999999999988766 499999975532 2345577899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++++|||||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|
T Consensus 218 ~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 218 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999999999876 35999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... ......+++||+.|||||++
T Consensus 295 ~~~~~-------------------------------------------------------~~~~~~~~~GTp~YmAPEvl 319 (423)
T 4fie_A 295 AQVSK-------------------------------------------------------EVPRRKSLVGTPYWMAPELI 319 (423)
T ss_dssp EECCS-------------------------------------------------------SCCCBCCCEECTTTCCHHHH
T ss_pred eECCC-------------------------------------------------------CCccccccccCcCcCCHHHH
Confidence 53221 11122356999999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..|+.++|||||||++|||++|+.||.+.+..+.+..+........ ..+.. .+.++++||.+||++||++|||
T Consensus 320 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~-~s~~~~dli~~~L~~dP~~R~t--- 394 (423)
T 4fie_A 320 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHK-VSPSLKGFLDRLLVRDPAQRAT--- 394 (423)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTS-SCHHHHHHHHHHSCSSTTTSCC---
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-ccccc-CCHHHHHHHHHHcCCChhHCcC---
Confidence 999999999999999999999999999999888888888876543221 12222 3448999999999999999999
Q ss_pred ChHHHHcCCCcCCC
Q 013016 399 GAADVKTHPFFKGL 412 (451)
Q Consensus 399 ~~~ell~hp~~~~~ 412 (451)
+.|||+||||++.
T Consensus 395 -a~ell~Hp~~~~~ 407 (423)
T 4fie_A 395 -AAELLKHPFLAKA 407 (423)
T ss_dssp -HHHHTTCGGGGGC
T ss_pred -HHHHhcCHHhcCC
Confidence 9999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-60 Score=453.46 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=210.2
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe-
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA- 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~- 160 (451)
|++.++||+|+||+||+|.++.++. .||+|++...... ....+.+.+|+.++++++|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCe---------EEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 4788899999999999999987765 4999999765433 3345678889999999999999999999975
Q ss_pred ---CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEcc-CCCEEEec
Q 013016 161 ---SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRS-DGHIMLSD 234 (451)
Q Consensus 161 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~-~~~~kl~D 234 (451)
++.+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence 35789999999999999999875 56999999999999999999999999 999999999999984 79999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|+... .....+++||+.|||
T Consensus 176 FGla~~~~---------------------------------------------------------~~~~~~~~GTp~YmA 198 (290)
T 3fpq_A 176 LGLATLKR---------------------------------------------------------ASFAKAVIGTPEFMA 198 (290)
T ss_dssp TTGGGGCC---------------------------------------------------------TTSBEESCSSCCCCC
T ss_pred CcCCEeCC---------------------------------------------------------CCccCCcccCccccC
Confidence 99984211 111224689999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+ .|+.++|||||||+||||+||+.||.+..... .+..+..+..+. ... ...+.++++||.+||++||++|
T Consensus 199 PE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~-~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFD-KVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGG-GCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCC-ccCCHHHHHHHHHHccCChhHC
Confidence 998875 69999999999999999999999998765544 444454443211 111 2233489999999999999999
Q ss_pred CCCCCChHHHHcCCCcCC
Q 013016 394 LGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~ 411 (451)
|| +.|+|+||||++
T Consensus 275 ~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 275 YS----IKDLLNHAFFQE 288 (290)
T ss_dssp CC----HHHHHTSGGGC-
T ss_pred cC----HHHHhcCccccC
Confidence 99 999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-61 Score=466.09 Aligned_cols=261 Identities=26% Similarity=0.330 Sum_probs=219.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.+.|.+.++||+|+||+||+|+++.+++ .||||+++.+.. ..+|+.+++.++|||||+++++|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~---------~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~ 119 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGF---------QCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAV 119 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCC---------EEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEE
Confidence 3679999999999999999999987765 499999986422 13599999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~ 237 (451)
.+++++|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+
T Consensus 120 ~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 120 REGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999999999875 5699999999999999999999999999999999999999998 699999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|+........ ........++||+.|||||+
T Consensus 198 a~~~~~~~~~--------------------------------------------------~~~~~~~~~~GT~~YmAPE~ 227 (336)
T 4g3f_A 198 ALCLQPDGLG--------------------------------------------------KSLLTGDYIPGTETHMAPEV 227 (336)
T ss_dssp CEEC--------------------------------------------------------------CCCCCCGGGCCHHH
T ss_pred CeEccCCCcc--------------------------------------------------cceecCCccccCccccCHHH
Confidence 8643211000 00112234689999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..|+.++|||||||+||||+||+.||.+.+..+.+.++......+.. .++. .+.++.+||.+||++||.+|||
T Consensus 228 ~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~-~s~~~~~li~~~L~~dP~~R~s-- 303 (336)
T 4g3f_A 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE-IPPS-CAPLTAQAIQEGLRKEPVHRAS-- 303 (336)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG-SCTT-SCHHHHHHHHHHTCSSGGGSCC--
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh-cCcc-CCHHHHHHHHHHccCCHhHCcC--
Confidence 99999999999999999999999999999988887788888877654322 2223 3448999999999999999999
Q ss_pred CChHHH-------------HcCCCcCCCCc
Q 013016 398 RGAADV-------------KTHPFFKGLNF 414 (451)
Q Consensus 398 ~~~~el-------------l~hp~~~~~~~ 414 (451)
+.|| |+|||+++...
T Consensus 304 --a~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 304 --AMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp --HHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred --HHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9987 57999988544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=489.25 Aligned_cols=285 Identities=32% Similarity=0.602 Sum_probs=241.1
Q ss_pred CCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHH---HHHHHHCCCCC
Q 013016 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME---KKILKMLDHPF 150 (451)
Q Consensus 74 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~n 150 (451)
....++++|++.+.||+|+||+||+|+++.+++ .||||++.+..............| +.+++.++|||
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~---------~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~ 253 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTT
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCC---------EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCC
Confidence 456778999999999999999999999988765 599999988766544433444444 55566778999
Q ss_pred ccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 151 LPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 151 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
||+++++|.+.+++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+
T Consensus 254 IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCE
T ss_pred EeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCE
Confidence 999999999999999999999999999999875 569999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||+|+.... ....+++||+
T Consensus 332 KL~DFGlA~~~~~---------------------------------------------------------~~~~t~~GTp 354 (689)
T 3v5w_A 332 RISDLGLACDFSK---------------------------------------------------------KKPHASVGTH 354 (689)
T ss_dssp EECCCTTCEECSS---------------------------------------------------------CCCCSCCSCG
T ss_pred EecccceeeecCC---------------------------------------------------------CCCCCccCCc
Confidence 9999999853211 1123469999
Q ss_pred CccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 311 EYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAP---SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 311 ~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
.|||||++.+ ..|+.++|||||||+||||++|+.||.+. ...+....+......++.. .+.++++||.+||
T Consensus 355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~-----~S~~a~dLI~~lL 429 (689)
T 3v5w_A 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-----FSPELRSLLEGLL 429 (689)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHT
T ss_pred CccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc-----CCHHHHHHHHHHc
Confidence 9999999975 57999999999999999999999999763 3345566677776665543 2348999999999
Q ss_pred ccCcCCcCCC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 387 NKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 387 ~~dP~~Rpt~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
++||.+|++. ..+++||++||||++++|..+ +...||++|.....
T Consensus 430 ~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~ 477 (689)
T 3v5w_A 430 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 477 (689)
T ss_dssp CSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCS
T ss_pred cCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCC
Confidence 9999999985 456899999999999999865 78899999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-58 Score=459.38 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=219.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|+++.+++ .||||++.+... .......+.+|+.+|+.++|||||++++++.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~---------~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQ---------QVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCC---------EEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 579999999999999999999987765 499999976532 2234466778999999999999999999876
Q ss_pred e------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 A------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
. .+++||||||| +|+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+
T Consensus 124 ~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp CSSCTTTCCCEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred cccccccCCEEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEe
Confidence 4 36899999999 57899988764 569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+....... .......+++||+.||
T Consensus 201 DFGla~~~~~~~~---------------------------------------------------~~~~~~~~~~GT~~Y~ 229 (398)
T 4b99_A 201 DFGMARGLCTSPA---------------------------------------------------EHQYFMTEYVATRWYR 229 (398)
T ss_dssp CCTTCBCC----------------------------------------------------------CCCCCSSCCCCTTC
T ss_pred ecceeeecccCcc---------------------------------------------------ccccccccceeChHhc
Confidence 9999853321100 0111223569999999
Q ss_pred CcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC---------------------
Q 013016 314 SPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS--------------------- 371 (451)
Q Consensus 314 aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--------------------- 371 (451)
|||++.+. .|+.++||||+|||+|||++|+.||.+.+..+.+..|......++.....
T Consensus 230 APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (398)
T 4b99_A 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVP 309 (398)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCC
T ss_pred CHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCC
Confidence 99999885 46999999999999999999999999998888888876543322211100
Q ss_pred -----CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 372 -----SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 372 -----~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
...+.++++||.+||++||.+||| +.|+|+||||++...+
T Consensus 310 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 310 WETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHDP 354 (398)
T ss_dssp HHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCCG
T ss_pred HHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCCC
Confidence 112348999999999999999999 9999999999986544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=445.80 Aligned_cols=272 Identities=24% Similarity=0.400 Sum_probs=200.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++++.||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|++++|||||+++++|.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 73 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWL 73 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCC---------EEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCC---------EEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 679999999999999999999987765 49999997542 2233456788999999999999999999987
Q ss_pred eCC------------eEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 160 ASN------------FSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 160 ~~~------------~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
+.+ ++|||||||+||+|.+++..... ...++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 74 ~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp EEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred ecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC
Confidence 544 47999999999999999986532 23566778999999999999999999999999999999999
Q ss_pred CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccc
Q 013016 227 DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306 (451)
Q Consensus 227 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (451)
+|.+||+|||+|+........... ...........+.
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~ 190 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTV-------------------------------------------LTPMPAYARHTGQ 190 (299)
T ss_dssp TCCEEECCCCCC--------------------------------------------------------------------
T ss_pred CCcEEEccCccceecCCCcccccc-------------------------------------------ccccccccccCCc
Confidence 999999999998654321111000 0000111223356
Q ss_pred ccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 307 ~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+||+.|||||++.+..|+.++|||||||++|||++ ||...... ..+..+..... |.. .... ...+.+||.+|
T Consensus 191 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~--p~~-~~~~-~~~~~~li~~~ 263 (299)
T 4g31_A 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKF--PPL-FTQK-YPCEYVMVQDM 263 (299)
T ss_dssp -CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCC--CHH-HHHH-CHHHHHHHHHH
T ss_pred ccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCC--CCC-Cccc-CHHHHHHHHHH
Confidence 89999999999999999999999999999999996 77653222 23333333322 111 1111 22678999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
|++||++||| +.|+|+||||++++|+.
T Consensus 264 L~~dP~~Rps----~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 264 LSPSPMERPE----AINIIENAVFEDLDFPG 290 (299)
T ss_dssp TCSSGGGSCC----HHHHHTSGGGCCC----
T ss_pred cCCChhHCcC----HHHHhcCHhhCCCCCCC
Confidence 9999999999 99999999999988753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=436.70 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=207.8
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
+.+..+++.+.++||+|+||+||+|+++.+ ||||+++... ......+.+.+|+.++++++|||||++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~------------vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l 97 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHGD------------VAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLF 97 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSSE------------EEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECCc------------EEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 345568899999999999999999987643 8999987442 233456778899999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++.+ +.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|
T Consensus 98 ~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~D 175 (307)
T 3omv_A 98 MGYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGD 175 (307)
T ss_dssp EEEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECC
T ss_pred EEEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEee
Confidence 998864 56899999999999999997653 4699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|+..... .......+.+||+.|||
T Consensus 176 FGla~~~~~~-----------------------------------------------------~~~~~~~~~~GT~~ymA 202 (307)
T 3omv_A 176 FGLATVKSRW-----------------------------------------------------SGSQQVEQPTGSVLWMA 202 (307)
T ss_dssp CSSCBC-----------------------------------------------------------------CCCCTTSCC
T ss_pred ccCceecccC-----------------------------------------------------CcceeecccccCCCccC
Confidence 9998532210 01112234589999999
Q ss_pred cccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-CCCCCcChHHHHHHHHHhcccCc
Q 013016 315 PEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-QSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 315 PE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
||++.+ ..|+.++|||||||+||||+||+.||.+.+....+..++......|. ...+...+.++.+|+.+||+.||
T Consensus 203 PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP 282 (307)
T 3omv_A 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVK 282 (307)
T ss_dssp HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSS
T ss_pred HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCH
Confidence 999964 35899999999999999999999999987776665555544332221 12223345589999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
++||| +.||++
T Consensus 283 ~~RPs----~~ei~~ 293 (307)
T 3omv_A 283 EERPL----FPQILS 293 (307)
T ss_dssp TTSCC----HHHHHH
T ss_pred hHCcC----HHHHHH
Confidence 99999 887754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=437.97 Aligned_cols=265 Identities=18% Similarity=0.314 Sum_probs=217.8
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.++||+|+||+||+|.+..... ...+..||||+++... ....+.+.+|+++|++++|||||++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCP----EQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCccc----CCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 344789999999999999999999865321 1223469999997542 334567888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQ-----------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-----------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
+|.+++.+|||||||+||+|.+++... ....+++..+..|+.||+.||+|||+++||||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 999999999999999999999999764 235699999999999999999999999999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.+||+|||+|+.... .........
T Consensus 163 ~~~~~Ki~DFGla~~~~~-----------------------------------------------------~~~~~~~~~ 189 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYS-----------------------------------------------------TDYYRVGGH 189 (299)
T ss_dssp GGGCEEECCCSCHHHHTG-----------------------------------------------------GGCEEETTT
T ss_pred CCCcEEECCcccceecCC-----------------------------------------------------CCceeecCc
Confidence 999999999999853211 001111223
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
..||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+..... +...+.++.+|+.+
T Consensus 190 ~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~----p~~~~~~~~~li~~ 265 (299)
T 4asz_A 190 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR----PRTCPQEVYELMLG 265 (299)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCC----CTTCCHHHHHHHHH
T ss_pred eecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC----CccchHHHHHHHHH
Confidence 479999999999999999999999999999999999 9999999999999888888754221 12234489999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
||+.||++||| +.||+ +||++
T Consensus 266 cl~~dP~~RPs----~~~i~--~~L~~ 286 (299)
T 4asz_A 266 CWQREPHMRKN----IKGIH--TLLQN 286 (299)
T ss_dssp HTCSSGGGSCC----HHHHH--HHHHH
T ss_pred HcCCChhHCcC----HHHHH--HHHHH
Confidence 99999999999 99984 46654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=440.16 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=212.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||+|+||+||+|+++.... ...+..||||+++... ....+.+.+|+++|++++|||||+++++
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLP----EQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC-------CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCccc----CCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34789999999999999999999864321 1223469999997542 3345678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP-------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
|.+.+.+|||||||+||+|.++++... ..++++..+..|+.||+.||+|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999987642 2469999999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||+|+..... .......
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~-----------------------------------------------------~~~~~~~ 218 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYST-----------------------------------------------------DYYRVGG 218 (329)
T ss_dssp ETTTEEEECCCC--------------------------------------------------------------------
T ss_pred CCCCcEEEcccccceeccCC-----------------------------------------------------CcceecC
Confidence 99999999999998532211 0111122
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll 382 (451)
..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...+..+.+..+..+.. ..|. ..+.++.+|+
T Consensus 219 ~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~-----~~~~~~~~li 293 (329)
T 4aoj_A 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR-----ACPPEVYAIM 293 (329)
T ss_dssp -CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT-----TCCHHHHHHH
T ss_pred cccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc-----cccHHHHHHH
Confidence 3579999999999999999999999999999999999 9999999999888888877642 2222 2344899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHcC
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+||+.||++||| +.||+++
T Consensus 294 ~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 294 RGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp HHHCCSSTTTSCC----HHHHHHH
T ss_pred HHHcCcChhHCcC----HHHHHHH
Confidence 9999999999999 9998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=436.06 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=214.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
...++++.++||+|+||+||+|.+.+... ...+..||||+++... .....+.+.+|+.++++++|||||+++|+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~----~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAP----GEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCcc----CCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 44679999999999999999999864321 1223359999997542 22334678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
|.+++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999999999999996532 245899999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
|+.++.+||+|||+|+.... .......
T Consensus 178 l~~~~~~Ki~DFGlar~~~~-----------------------------------------------------~~~~~~~ 204 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYA-----------------------------------------------------ADYYKLL 204 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGG-----------------------------------------------------GGCBCSS
T ss_pred ECCCCCEEECCcccceeccC-----------------------------------------------------CCceeEe
Confidence 99999999999999853211 1111122
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
...+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+..... +...+.++.+|+
T Consensus 205 ~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----p~~~~~~~~~li 280 (308)
T 4gt4_A 205 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC----PDDCPAWVYALM 280 (308)
T ss_dssp SSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHH
T ss_pred cccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----cccchHHHHHHH
Confidence 34589999999999999999999999999999999998 8999999998888888877653221 122344899999
Q ss_pred HHhcccCcCCcCCCCCChHHHHcC
Q 013016 383 SGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 383 ~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+||+.||++||| +.||+++
T Consensus 281 ~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 281 IECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHcCCChhHCcC----HHHHHHH
Confidence 9999999999999 9998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=441.76 Aligned_cols=286 Identities=23% Similarity=0.364 Sum_probs=206.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.++||+|+||+||+|+++... ..+..||||++.+.. ....+.+|+++|+.+ +|||||+++++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQV------GPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTT------SCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccC------CCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 67999999999999999999876321 112359999987542 224566799999998 699999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~ 237 (451)
.+.+++|||||||+||+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999999999884 38999999999999999999999999999999999999977 7999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|+................ ..... ...+.............+.+||+.|||||+
T Consensus 165 a~~~~~~~~~~~~~~~~~------------------------~~~~~---~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 217 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSE------------------------AQQER---CSQNKCSICLSRRQQVAPRAGTPGFRAPEV 217 (361)
T ss_dssp CEECTTCSCGGGGGC-----------------------------------------------------CCCCGGGCCHHH
T ss_pred CcccCCcccccccccccc------------------------ccccc---cccccccccccccccccccccCccccCHHH
Confidence 965433221110000000 00000 000000000011122335689999999999
Q ss_pred ccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcC----------------------------------
Q 013016 318 ASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKK---------------------------------- 361 (451)
Q Consensus 318 ~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~---------------------------------- 361 (451)
+.+.. |+.++||||+|||+|||++|+.||.... ..+.+..|...
T Consensus 218 l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 297 (361)
T 4f9c_A 218 LTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297 (361)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHH
T ss_pred HcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHh
Confidence 98864 8999999999999999999999996544 33334333210
Q ss_pred ----CCCCC------------CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 362 ----PLTFP------------TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 362 ----~~~~~------------~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
....+ ...+.. .+.++++||.+||++||++|+| ++|+|+||||++++
T Consensus 298 ~~~~~~~~p~~~~~~~~~~~~~~~~~~-is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 298 LRGMDSSTPKLTSDIQGHATNLEGWNE-VPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKDMS 360 (361)
T ss_dssp HC----------------------CTT-CCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTTC-
T ss_pred hcccccccccccccccccccccccccc-CCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCC
Confidence 00000 011122 2348999999999999999999 99999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=465.18 Aligned_cols=265 Identities=28% Similarity=0.437 Sum_probs=231.8
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.++||+|+||+||+|.++.+++ .||||++.+.... ..+.+.+|+.+|+.++|||||+++++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~---------~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~ 222 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGN---------NFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDA 222 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45789999999999999999999988766 4999999765322 23556779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC--CCEEEecc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD--GHIMLSDF 235 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~--~~~kl~Df 235 (451)
|.+.+++|||||||.||+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 223 ~~~~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 223 FEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EECSSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEECCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999999999999988654 3569999999999999999999999999999999999999854 89999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|..... .......+||+.||||
T Consensus 302 G~a~~~~~--------------------------------------------------------~~~~~~~~GT~~y~AP 325 (573)
T 3uto_A 302 GLTAHLDP--------------------------------------------------------KQSVKVTTGTAEFAAP 325 (573)
T ss_dssp SSCEECCT--------------------------------------------------------TSEEEEECSSGGGCCH
T ss_pred cceeEccC--------------------------------------------------------CCceeeeEECccccCH
Confidence 99853321 0111235899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..|+.++|||||||+||+|++|+.||.+.+..+.+..+......++...+..+.+ ++++||++||++||.+|||
T Consensus 326 Ev~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH-HHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH-HHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999998887776655555544 8999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCCccc
Q 013016 396 SKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~ 416 (451)
+.|+|+||||+..+++.
T Consensus 405 ----~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 405 ----IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ----HHHHHHSTTTSCCCCTT
T ss_pred ----HHHHhcCcCcCCCCCCC
Confidence 99999999999977653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=437.93 Aligned_cols=289 Identities=37% Similarity=0.699 Sum_probs=245.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+..|..+++.+ +||||++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~ 90 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGD---------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCC---------EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence 344889999999999999999999987665 4999999987666666677788899999988 799999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccc
Confidence 9999999999999999999999998775 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+++.... ......+++||+.|+||
T Consensus 169 G~a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aP 193 (353)
T 3txo_A 169 GMCKEGIC-------------------------------------------------------NGVTTATFCGTPDYIAP 193 (353)
T ss_dssp TTCBCSCC----------------------------------------------------------------CCGGGCCH
T ss_pred cceeeccc-------------------------------------------------------CCccccccCCCcCeECh
Confidence 99842110 01122345899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|||++|+.||...+..+.+..+......++.. .+.++.+||++||++||.+||+
T Consensus 194 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-----LHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp HHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSSGGGSTT
T ss_pred hhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhhhCHHHccC
Confidence 99998889999999999999999999999999999999999999988776654 3338999999999999999999
Q ss_pred C--CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCC
Q 013016 396 S--KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPF 436 (451)
Q Consensus 396 ~--~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~ 436 (451)
+ ..+++|+++||||++++|..+ +...||++|...+.....+
T Consensus 269 ~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~ 313 (353)
T 3txo_A 269 SLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSN 313 (353)
T ss_dssp SGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTT
T ss_pred CcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccc
Confidence 3 122389999999999999865 7888999999876544433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=430.05 Aligned_cols=290 Identities=38% Similarity=0.679 Sum_probs=248.1
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+..|+.+++.++||||++++++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 73 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEE
Confidence 45889999999999999999999887665 499999988765555566778889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+++|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999988764 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
++.... .......++||+.|+|||+
T Consensus 152 a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 176 (337)
T 1o6l_A 152 CKEGIS-------------------------------------------------------DGATMKTFCGTPEYLAPEV 176 (337)
T ss_dssp CBCSCC-------------------------------------------------------TTCCBCCCEECGGGCCGGG
T ss_pred hhhccc-------------------------------------------------------CCCcccccccChhhCChhh
Confidence 842110 0111224589999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS- 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~- 396 (451)
+.+..++.++|||||||++|||++|+.||...+....+..+......++.. .+.++.+||.+||+.||.+||+.
T Consensus 177 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL~~dP~~R~g~~ 251 (337)
T 1o6l_A 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp GSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred hcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhhcCHHHhcCCC
Confidence 999999999999999999999999999999988888888888877666543 33489999999999999999921
Q ss_pred CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCC
Q 013016 397 KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~ 438 (451)
...+.||++||||++++|..+ +...||.+|...++....+++
T Consensus 252 ~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~ 295 (337)
T 1o6l_A 252 PSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp TTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred CCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhccc
Confidence 011999999999999999754 678899999887764444433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-55 Score=435.35 Aligned_cols=291 Identities=36% Similarity=0.701 Sum_probs=242.0
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|++.++||+|+||+||+|+++.+++ .||||++.+...........+..|..++.++ +||||++++
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~ 119 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR---------IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeE
Confidence 345789999999999999999999987765 4999999987655555666778899999876 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++|.+.+.+||||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 120 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999999988775 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+++.... ......+++||+.|+||
T Consensus 198 Gla~~~~~-------------------------------------------------------~~~~~~~~~gt~~Y~aP 222 (396)
T 4dc2_A 198 GMCKEGLR-------------------------------------------------------PGDTTSTFCGTPNYIAP 222 (396)
T ss_dssp TTCBCCCC-------------------------------------------------------TTCCBCCCCBCGGGCCH
T ss_pred ceeeeccc-------------------------------------------------------CCCccccccCCcccCCc
Confidence 99842110 01122346899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP---------SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
|++.+..++.++|||||||++|||++|+.||... ........+......+|.. .+.++++||++||
T Consensus 223 E~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL 297 (396)
T 4dc2_A 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFL 297 (396)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHT
T ss_pred hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc-----CCHHHHHHHHHHh
Confidence 9999999999999999999999999999999642 2334566677776666543 2338999999999
Q ss_pred ccCcCCcCCCC--CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCC
Q 013016 387 NKDPCNRLGSK--RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 387 ~~dP~~Rpt~~--~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~ 438 (451)
++||.+||++. .++.||++||||++++|..+ +...||++|...++....+++
T Consensus 298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd 353 (396)
T 4dc2_A 298 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353 (396)
T ss_dssp CSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSC
T ss_pred cCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcC
Confidence 99999999942 23589999999999999864 778899999988764444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=427.50 Aligned_cols=282 Identities=34% Similarity=0.714 Sum_probs=235.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|.+.+.||+|+||+||+|+++.+++ .||||++.+...........+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 344899999999999999999999987665 4999999987655555566677889998876 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEC
Confidence 9999999999999999999999998764 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+++.... .......++||+.|+||
T Consensus 163 G~a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aP 187 (345)
T 1xjd_A 163 GMCKENML-------------------------------------------------------GDAKTNTFCGTPDYIAP 187 (345)
T ss_dssp TTCBCCCC-------------------------------------------------------TTCCBCCCCSCGGGCCH
T ss_pred hhhhhccc-------------------------------------------------------CCCcccCCCCCcccCCh
Confidence 99842110 00112345899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++.. .+.++.+||.+||+.||.+||+
T Consensus 188 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL~~dp~~R~~ 262 (345)
T 1xjd_A 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEKEAKDLLVKLFVREPEKRLG 262 (345)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHSCSSGGGSBT
T ss_pred hhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc-----cCHHHHHHHHHHhcCCHhHcCC
Confidence 99999999999999999999999999999999998888888888877665543 3348999999999999999999
Q ss_pred CCCChH-HHHcCCCcCCCCcccc--cccCCCCCCCCCCCCC
Q 013016 396 SKRGAA-DVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKT 433 (451)
Q Consensus 396 ~~~~~~-ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~ 433 (451)
+. +|++||||++++|..+ +...+|.+|...++..
T Consensus 263 ----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d 299 (345)
T 1xjd_A 263 ----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 299 (345)
T ss_dssp ----TBSCGGGSGGGTTCCHHHHHTTCSCC-----------
T ss_pred ----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcch
Confidence 77 9999999999999865 6788999998876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=419.74 Aligned_cols=279 Identities=38% Similarity=0.733 Sum_probs=242.9
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||+||+|+++.+++ .||+|++.+...........+..|+.+++.++||||++++++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 74 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT 74 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEE
Confidence 45889999999999999999999887665 499999988765555556777889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 75 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 75 FQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCc
Confidence 99999999999999999999999875 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+.... ....+.+||+.|+|||+
T Consensus 153 a~~~~----------------------------------------------------------~~~~~~~gt~~y~aPE~ 174 (318)
T 1fot_A 153 AKYVP----------------------------------------------------------DVTYTLCGTPDYIAPEV 174 (318)
T ss_dssp CEECS----------------------------------------------------------SCBCCCCSCTTTCCHHH
T ss_pred ceecC----------------------------------------------------------CccccccCCccccCHhH
Confidence 84321 01123589999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||...+....+..+......++.. .+.++.+||.+||+.||.+||+..
T Consensus 175 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~lL~~dp~~R~~~~ 249 (318)
T 1fot_A 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-----FNEDVKDLLSRLITRDLSQRLGNL 249 (318)
T ss_dssp HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSCTTTCTTSS
T ss_pred hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHhccCHHHcCCCc
Confidence 999999999999999999999999999999998888999998887666543 334899999999999999999321
Q ss_pred -CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 398 -RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 398 -~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
..++||++||||++++|..+ +...+|..|...+
T Consensus 250 ~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~ 285 (318)
T 1fot_A 250 QNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 285 (318)
T ss_dssp TTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC--
T ss_pred CCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCC
Confidence 12999999999999999865 7778888888763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=431.21 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=212.8
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC-CCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH-PFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~ 155 (451)
+..++|++.++||+|+||+||+|.+....+. ..+..||||++..... ......+.+|+.+|.++.| ||||+++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~----~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKT----ATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSST----TCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcc----cCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3447899999999999999999998765432 2334699999976532 2334668889999999965 8999999
Q ss_pred EEEEe-CCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 156 AEFEA-SNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 156 ~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
++|.. ++.+|||||||+||+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99966 467999999999999999997542 245899999999999999999999999999999999
Q ss_pred cEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
|||++.++.+||+|||+|+.... +...
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~-----------------------------------------------------~~~~ 241 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYK-----------------------------------------------------DPDY 241 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTT-----------------------------------------------------CTTS
T ss_pred ceeeCCCCCEEECcchhhhhccc-----------------------------------------------------CCCc
Confidence 99999999999999999853221 1111
Q ss_pred ccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHhcCC-CCCCCCCCCCcChHH
Q 013016 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTL-RNIVKKP-LTFPTQSPSSMSEYH 377 (451)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~-~~i~~~~-~~~~~~~~~~~~~~~ 377 (451)
......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+.+ ..+..+. +..|. ..+.+
T Consensus 242 ~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~-----~~~~~ 316 (353)
T 4ase_A 242 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD-----YTTPE 316 (353)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT-----TCCHH
T ss_pred eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc-----cCCHH
Confidence 22234589999999999999999999999999999999998 99999987654444 4444442 22222 23448
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+.+|+.+||+.||++||| +.||++|
T Consensus 317 ~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 317 MYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 999999999999999999 9999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=437.47 Aligned_cols=287 Identities=35% Similarity=0.598 Sum_probs=244.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.++||+|+||+||+|+++.+++ .||+|++.+...........+..|+.++..++||||++++++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCc---------EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34789999999999999999999987655 499999987655554455557789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
|.+.+.+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999999999999999764 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
++..... ........+||+.|+|||+
T Consensus 222 a~~~~~~------------------------------------------------------~~~~~~~~~GT~~Y~APE~ 247 (437)
T 4aw2_A 222 CLKLMED------------------------------------------------------GTVQSSVAVGTPDYISPEI 247 (437)
T ss_dssp CEECCTT------------------------------------------------------SCEECCSCCSCGGGCCHHH
T ss_pred hhhcccC------------------------------------------------------CCcccccccCCcCeeChHH
Confidence 8532110 0111123589999999999
Q ss_pred cc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 318 AS-----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 318 ~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
+. +..++.++|||||||++|||++|+.||.+.+..+.+.+++... ..+|... ...+.++++||++||..+|
T Consensus 248 l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~~s~~~~dLi~~lL~~~~ 325 (437)
T 4aw2_A 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV--TDVSENAKDLIRRLICSRE 325 (437)
T ss_dssp HHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC--CCSCHHHHHHHHTTSSCGG
T ss_pred HhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc--ccCCHHHHHHHHHHhcccc
Confidence 87 4568999999999999999999999999998888888887643 3333321 1234489999999999999
Q ss_pred CC--cCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCCCC
Q 013016 391 CN--RLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTM 434 (451)
Q Consensus 391 ~~--Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~~~ 434 (451)
++ |++ ++|+++||||++++|..++...+|.+|...++...
T Consensus 326 ~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~ 367 (437)
T 4aw2_A 326 HRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDT 367 (437)
T ss_dssp GCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCC
T ss_pred cccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccch
Confidence 88 999 99999999999999999999999999998875433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-54 Score=421.80 Aligned_cols=290 Identities=35% Similarity=0.620 Sum_probs=252.4
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.....++|++.+.||+|+||.||+|.++.+++ .||||++.+...........+.+|+.+++.++||||+++
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 106 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN---------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCC---------EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 34556899999999999999999999887665 499999988766555566778889999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 107 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 99999999999999999999999999875 4599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++..... .....+||+.|+|
T Consensus 185 Fg~a~~~~~----------------------------------------------------------~~~~~~gt~~y~a 206 (350)
T 1rdq_E 185 FGFAKRVKG----------------------------------------------------------RTWTLCGTPEALA 206 (350)
T ss_dssp CTTCEECSS----------------------------------------------------------CBCCCEECGGGCC
T ss_pred cccceeccC----------------------------------------------------------CcccccCCccccC
Confidence 999853210 1123589999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++.+..++.++|||||||++|+|++|+.||...+..+.+..+..+...++.. .+.++.+||.+||+.||.+||
T Consensus 207 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----CCHHHHHHHHHHSCSCTTTCT
T ss_pred HHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHhhcCHHhcc
Confidence 999999999999999999999999999999999998889999999887766543 234899999999999999999
Q ss_pred CC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCC
Q 013016 395 GS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 395 t~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~ 438 (451)
+. ...++||++||||++++|..+ +...+|.+|....+....+++
T Consensus 282 ~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred CCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 84 445899999999999999754 788899999888764444333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=425.36 Aligned_cols=284 Identities=33% Similarity=0.649 Sum_probs=245.9
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
...++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+..|..++..+ +||||++++
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 87 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence 345899999999999999999999987655 4999999987655555667777899999887 799999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+++|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeC
Confidence 9999999999999999999999998765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+++.... .......++||+.|+||
T Consensus 166 G~a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 166 GMCKENIW-------------------------------------------------------DGVTTKTFCGTPDYIAP 190 (353)
T ss_dssp TTCBCCCC-------------------------------------------------------TTCCBCCCCSCGGGCCH
T ss_pred Cccccccc-------------------------------------------------------CCcccccccCCccccCh
Confidence 99842110 00112245899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++.. .+.++.+||.+||+.||.+||+
T Consensus 191 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS-----MSKEAVAICKGLMTKHPGKRLG 265 (353)
T ss_dssp HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSCTTSCTT
T ss_pred hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHhhcCHHHcCC
Confidence 99999999999999999999999999999999999999999999887766643 2348999999999999999996
Q ss_pred C-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 396 S-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 396 ~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
. ...+++|++||||++++|..+ +...||.+|...+.
T Consensus 266 ~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 266 CGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp CSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred CCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 3 223799999999999999865 78889999988765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=429.21 Aligned_cols=284 Identities=38% Similarity=0.669 Sum_probs=235.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHH-HHHCCCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKI-LKMLDHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~nIv~l~~~ 157 (451)
.++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+..|..+ ++.++||||++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEV---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCC---------EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCC---------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 3789999999999999999999887665 599999987754444444555666666 467899999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+.+++|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~ 185 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 185 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcc
Confidence 99999999999999999999998764 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
++.... .......++||+.|+|||+
T Consensus 186 a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 210 (373)
T 2r5t_A 186 CKENIE-------------------------------------------------------HNSTTSTFCGTPEYLAPEV 210 (373)
T ss_dssp CGGGBC-------------------------------------------------------CCCCCCSBSCCCCCCCHHH
T ss_pred cccccc-------------------------------------------------------CCCccccccCCccccCHHH
Confidence 842110 0112234689999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|||++|..||...+..+.+..+......++.. .+.++.+||.+||+.||.+||++.
T Consensus 211 ~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN-----ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSS-----SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred hCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCC-----CCHHHHHHHHHHcccCHHhCCCCC
Confidence 999999999999999999999999999999999999999998886665533 234899999999999999999977
Q ss_pred CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCC
Q 013016 398 RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKT 433 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~ 433 (451)
..+.++++||||++++|..+ +...||++|...++..
T Consensus 286 ~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d 323 (373)
T 2r5t_A 286 DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPND 323 (373)
T ss_dssp TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC---
T ss_pred CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcch
Confidence 77899999999999999865 7788999998876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=432.64 Aligned_cols=288 Identities=33% Similarity=0.588 Sum_probs=243.8
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||+|+||+||+|+++.+++ .||+|++.+...........+..|+.+++.++||||++++++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---------~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRK---------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCc---------EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 44789999999999999999999987765 499999987655554555567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
|.+.+++|||||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999998763 489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ......+.+||+.|+|||+
T Consensus 215 a~~~~~~------------------------------------------------------~~~~~~~~~gt~~Y~APE~ 240 (410)
T 3v8s_A 215 CMKMNKE------------------------------------------------------GMVRCDTAVGTPDYISPEV 240 (410)
T ss_dssp CEECCTT------------------------------------------------------SEEECCSCCSCGGGCCHHH
T ss_pred eEeeccC------------------------------------------------------CcccccCCcCCccccCHHH
Confidence 8532210 0111224589999999999
Q ss_pred ccCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 318 ASGGS----HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 318 ~~~~~----~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+.+.. ++.++|||||||+||||++|+.||.+.+..+.+.+++... ..++. ... .+.++++||.+||+.+|.
T Consensus 241 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~-~s~~~~~li~~lL~~~~~ 317 (410)
T 3v8s_A 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD--DND-ISKEAKNLICAFLTDREV 317 (410)
T ss_dssp HHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT--TCC-CCHHHHHHHHHHSSCGGG
T ss_pred hhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC--ccc-ccHHHHHHHHHHccChhh
Confidence 98765 7899999999999999999999999999888888887753 23332 122 334899999999999998
Q ss_pred C--cCCCCCChHHHHcCCCcCCCCcc--cccccCCCCCCCCCCCCCCCCCC
Q 013016 392 N--RLGSKRGAADVKTHPFFKGLNFA--LIRSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 392 ~--Rpt~~~~~~ell~hp~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~ 438 (451)
+ |++ ++||++||||++++|. ..+...+|.+|...+.....+++
T Consensus 318 rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd 364 (410)
T 3v8s_A 318 RLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 364 (410)
T ss_dssp CTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSC
T ss_pred hCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcC
Confidence 8 999 9999999999999885 56889999999988754433333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=420.51 Aligned_cols=284 Identities=37% Similarity=0.725 Sum_probs=239.1
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+..|..+++++ +||||++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 76 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDR---------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCC---------EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEE
Confidence 445889999999999999999999987665 4999999877555555667778899999988 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 77 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999998765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+++.... ........+||+.|+||
T Consensus 155 G~a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aP 179 (345)
T 3a8x_A 155 GMCKEGLR-------------------------------------------------------PGDTTSTFCGTPNYIAP 179 (345)
T ss_dssp GGCBCSCC-------------------------------------------------------TTCCBCCCCSCGGGCCH
T ss_pred cccccccC-------------------------------------------------------CCCcccccCCCccccCc
Confidence 99842110 00112245899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---------CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA---------PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
|++.+..++.++|||||||++|||++|+.||.. .........+......++.. .+.++.+||.+||
T Consensus 180 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL 254 (345)
T 3a8x_A 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-----LSVKAASVLKSFL 254 (345)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHT
T ss_pred cccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC-----CCHHHHHHHHHHh
Confidence 999999999999999999999999999999975 22344566666666655543 3348999999999
Q ss_pred ccCcCCcCCCC--CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 387 NKDPCNRLGSK--RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 387 ~~dP~~Rpt~~--~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
+.||.+||++. .++.|+++||||++++|..+ +...||..|...+.
T Consensus 255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~ 303 (345)
T 3a8x_A 255 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 303 (345)
T ss_dssp CSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTT
T ss_pred cCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 99999999942 22489999999999999754 67788888888764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=430.24 Aligned_cols=285 Identities=39% Similarity=0.638 Sum_probs=237.9
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.+.||+|+||+||+|+++.+++ .||||++.+...........+..|..++..++|+||+++++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~---------~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQ---------VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 344889999999999999999999987665 49999998766555555666788999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
+|.+.+++||||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999999997642 359999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++..... ........+||+.|+|||
T Consensus 208 la~~~~~~------------------------------------------------------~~~~~~~~~Gt~~Y~APE 233 (412)
T 2vd5_A 208 SCLKLRAD------------------------------------------------------GTVRSLVAVGTPDYLSPE 233 (412)
T ss_dssp TCEECCTT------------------------------------------------------SCEECSSCCSCGGGCCHH
T ss_pred hheeccCC------------------------------------------------------CccccceeccccCcCCHH
Confidence 98532110 001122358999999999
Q ss_pred ccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 317 VAS-------GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP--LTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 317 ~~~-------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
++. +..++.++|||||||++|||++|+.||...+..+.+.++.... ..++. .....+.++++||++||+
T Consensus 234 ~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~s~~~~dli~~lL~ 311 (412)
T 2vd5_A 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL--VDEGVPEEARDFIQRLLC 311 (412)
T ss_dssp HHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC------CCCHHHHHHHHTTSS
T ss_pred HHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc--cccCCCHHHHHHHHHHcC
Confidence 997 3568999999999999999999999999998888888887632 22222 112234489999999999
Q ss_pred cCcCCcC---CCCCChHHHHcCCCcCCCCcccccccCCCCCCCCCCCC
Q 013016 388 KDPCNRL---GSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQK 432 (451)
Q Consensus 388 ~dP~~Rp---t~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~~~~ 432 (451)
+|.+|+ + ++|+++||||++++|..++...||++|...+..
T Consensus 312 -~p~~Rlgr~~----~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~ 354 (412)
T 2vd5_A 312 -PPETRLGRGG----AGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGAT 354 (412)
T ss_dssp -CGGGCTTTTT----HHHHHTSGGGTTCCSTTSTTSCCSCCCC-----
T ss_pred -ChhhcCCCCC----HHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcc
Confidence 999985 7 999999999999999999999999999887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=434.30 Aligned_cols=293 Identities=37% Similarity=0.682 Sum_probs=240.2
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
...++|++.++||+|+||.||+|.++.+++ .||||++.+...........+..|+.+++.++||||+++++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCC---------EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 345789999999999999999999887765 49999998776555555666778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEecc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++...+.+||||||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+||
T Consensus 216 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 216 SFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccC
Confidence 999999999999999999999988765 459999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... ........+||+.|+||
T Consensus 294 G~a~~~~~-------------------------------------------------------~~~~~~~~~gt~~y~aP 318 (446)
T 4ejn_A 294 GLCKEGIK-------------------------------------------------------DGATMKTFCGTPEYLAP 318 (446)
T ss_dssp CCCCTTCC------------------------------------------------------------CCSSSCGGGCCH
T ss_pred CCceeccC-------------------------------------------------------CCcccccccCCccccCH
Confidence 99842110 00111235899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC-
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL- 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp- 394 (451)
|++.+..++.++|||||||++|+|++|+.||........+..+......++... +.++.+||.+||++||.+||
T Consensus 319 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----~~~~~~li~~~L~~dP~~R~~ 393 (446)
T 4ejn_A 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL-----GPEAKSLLSGLLKKDPKQRLG 393 (446)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS-----CHHHHHHHHHHTCSSTTTSTT
T ss_pred hhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccC-----CHHHHHHHHHHcccCHHHhCC
Confidence 999999999999999999999999999999999988888888888777665432 34899999999999999999
Q ss_pred ----CCCCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCCCccCCc
Q 013016 395 ----GSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPDQKIKSQ 444 (451)
Q Consensus 395 ----t~~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~ 444 (451)
+ ++|+++||||++++|... +...||++|...++....+.++....+
T Consensus 394 ~~~~t----~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 394 GGSED----AKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ 445 (446)
T ss_dssp CSTTT----HHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred CCCCC----HHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence 8 999999999999999754 788899999999887777777665443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=416.29 Aligned_cols=281 Identities=29% Similarity=0.590 Sum_probs=239.1
Q ss_pred CCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccc
Q 013016 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 74 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
...+.+++|.+.+.||+|+||.||+|.++.+++ .||+|++.+...........+.+|+.+++.++|||||+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~---------~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 79 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKK---------MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 344566899999999999999999999887765 49999998876666666677888999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
++++|.+.+.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~ 157 (384)
T 4fr4_A 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157 (384)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEe
Confidence 999999999999999999999999998864 569999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... .......+||+.|+
T Consensus 158 DFG~a~~~~~--------------------------------------------------------~~~~~~~~gt~~Y~ 181 (384)
T 4fr4_A 158 DFNIAAMLPR--------------------------------------------------------ETQITTMAGTKPYM 181 (384)
T ss_dssp CCTTCEECCT--------------------------------------------------------TCCBCCCCSCGGGC
T ss_pred ccceeeeccC--------------------------------------------------------CCceeccCCCcccc
Confidence 9999853211 01122458999999
Q ss_pred CcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 314 SPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAP---SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 314 aPE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|||++.+ ..++.++|||||||++|+|++|+.||... ........+......++.. .+.++.+||.+||+
T Consensus 182 aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~-----~s~~~~~li~~lL~ 256 (384)
T 4fr4_A 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA-----WSQEMVSLLKKLLE 256 (384)
T ss_dssp CGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHSC
T ss_pred CCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCc-----CCHHHHHHHHHHhc
Confidence 9999974 45899999999999999999999999753 3345556666665555543 33489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCCcccc--cccCCCCCCCCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
.||.+||+. +++|++||||++++|..+ +...||++|...
T Consensus 257 ~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 257 PNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp SSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC
T ss_pred CCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC
Confidence 999999983 789999999999999754 778888888754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=404.66 Aligned_cols=259 Identities=24% Similarity=0.430 Sum_probs=226.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+..+++ .||||++.+... .......+.+|+.+++.++||||++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 82 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGR---------EVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEV 82 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34789999999999999999999877665 499999976543 23445667789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+.+|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 83 IETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999999999998765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+..... .......+||+.|+|||+
T Consensus 161 a~~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~ 184 (328)
T 3fe3_A 161 SNEFTV--------------------------------------------------------GGKLDAFCGAPPYAAPEL 184 (328)
T ss_dssp CGGGSS--------------------------------------------------------SCGGGTTSSSGGGCCHHH
T ss_pred ceecCC--------------------------------------------------------CCccccccCCcceeCccc
Confidence 842210 011123589999999999
Q ss_pred ccCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHG-NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~-~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..+. .++|||||||++|+|++|+.||.+.+..+....+..+....|.. .+.++.+||++||+.||.+|||
T Consensus 185 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~~L~~dP~~R~t- 258 (328)
T 3fe3_A 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY-----MSTDCENLLKRFLVLNPIKRGT- 258 (328)
T ss_dssp HHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHCCSSTTTSCC-
T ss_pred ccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHCCCChhHCcC-
Confidence 9988774 79999999999999999999999999999999998887766543 2348999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
++|+++||||+...
T Consensus 259 ---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 259 ---LEQIMKDRWINAGH 272 (328)
T ss_dssp ---HHHHTTCTTTTTTC
T ss_pred ---HHHHhcCHhhcCCC
Confidence 99999999999844
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=407.69 Aligned_cols=292 Identities=34% Similarity=0.623 Sum_probs=228.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-HHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-KKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.++|++.+.||+|+||.||+|++.... ..+..||+|++.+.... .......+..|+.+++.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 378999999999999999999875221 12235999999865432 22334556779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+++|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999999998764 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .......+||+.|+|||+
T Consensus 168 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 192 (327)
T 3a62_A 168 CKESIHD-------------------------------------------------------GTVTHTFCGTIEYMAPEI 192 (327)
T ss_dssp C-----------------------------------------------------------------CTTSSCCTTSCHHH
T ss_pred ccccccC-------------------------------------------------------CccccccCCCcCccCHhh
Confidence 7421100 011123479999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||...+....+..+......++.. .+.++.+||.+||..||.+||++.
T Consensus 193 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~-----~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY-----LTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp HTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-----SCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred CcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHHHhcCHhhccCCC
Confidence 999899999999999999999999999999998888888888877665543 334899999999999999999431
Q ss_pred -CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCCCCCCCC
Q 013016 398 -RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQKTMPFPD 438 (451)
Q Consensus 398 -~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~ 438 (451)
..+.|+++||||++++|... +...+|..|...+.......+
T Consensus 268 ~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~ 311 (327)
T 3a62_A 268 PGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFD 311 (327)
T ss_dssp TTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-----------
T ss_pred CCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcc
Confidence 12899999999999999754 677788888877654443333
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=445.39 Aligned_cols=284 Identities=33% Similarity=0.649 Sum_probs=246.6
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
.+.+++|++.++||+|+||+||+|.++.+++ .||||++.+...........+..|..++..+ +|++|+.+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~---------~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l 407 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCC---------EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCc---------EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 4456899999999999999999999987765 4999999987665556667778899999887 79999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++.+.+.+||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|
T Consensus 408 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp EEECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECC
T ss_pred EEEEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEee
Confidence 99999999999999999999999999875 4599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+++.... ......+++||+.|+|
T Consensus 486 FGla~~~~~-------------------------------------------------------~~~~~~~~~GT~~Y~A 510 (674)
T 3pfq_A 486 FGMCKENIW-------------------------------------------------------DGVTTKTFCGTPDYIA 510 (674)
T ss_dssp CTTCEECCC-------------------------------------------------------TTCCBCCCCSCSSSCC
T ss_pred cceeecccc-------------------------------------------------------CCcccccccCCCcccC
Confidence 999852110 0112234689999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......++... +.++.+||++||++||++||
T Consensus 511 PE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~~li~~lL~~dP~~R~ 585 (674)
T 3pfq_A 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM-----SKEAVAICKGLMTKHPGKRL 585 (674)
T ss_dssp HHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTS-----CHHHHHHHHHHSCSSSTTCT
T ss_pred HhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccC-----CHHHHHHHHHHccCCHHHCC
Confidence 9999999999999999999999999999999999999999999999887776543 33899999999999999999
Q ss_pred CC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 395 GS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 395 t~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
++ ..+++||++||||++++|..+ +.+.||++|....
T Consensus 586 ~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~ 624 (674)
T 3pfq_A 586 GCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG 624 (674)
T ss_dssp TCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG
T ss_pred CCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC
Confidence 93 223499999999999999865 7788999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=427.38 Aligned_cols=287 Identities=34% Similarity=0.587 Sum_probs=243.9
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.+...++|.+.+.||+|+||+||+|+++.+++ .||||++.+...........+..|+.++++++||||+++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~---------~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 250 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGK---------LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 34566889999999999999999999987665 499999988766555556778889999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
++++...+.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 251 ~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEE
Confidence 999999999999999999999999887653 456999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......++||+.|
T Consensus 331 ~DFGla~~~~~~-------------------------------------------------------~~~~~~~~GT~~Y 355 (543)
T 3c4z_A 331 SDLGLAVELKAG-------------------------------------------------------QTKTKGYAGTPGF 355 (543)
T ss_dssp CCCTTCEECCTT-------------------------------------------------------CCCBCCCCSCTTT
T ss_pred eecceeeeccCC-------------------------------------------------------CcccccccCCccc
Confidence 999998532110 0112235899999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
+|||++.+..++.++|||||||++|||++|+.||.... ..+....+......++.. .+.++.+||.+||+.
T Consensus 356 ~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~lL~~ 430 (543)
T 3c4z_A 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK-----FSPASKDFCEALLQK 430 (543)
T ss_dssp SCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHSCS
T ss_pred cChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcc-----cCHHHHHHHHHhccC
Confidence 99999999999999999999999999999999998753 356667777766655533 334899999999999
Q ss_pred CcCCcCCCCC-ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 389 DPCNRLGSKR-GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 389 dP~~Rpt~~~-~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
||.+||+... .+++|++||||++++|..+ +...||++|....
T Consensus 431 dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~ 475 (543)
T 3c4z_A 431 DPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRT 475 (543)
T ss_dssp SGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSS
T ss_pred CHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccc
Confidence 9999998532 3799999999999999865 5678899987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=405.36 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=191.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.+++. .||||++..... .....+.|+..+.+++|||||++++++.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~-----------~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~ 67 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGE-----------EVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTE-----------EEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCE-----------EEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 5799999999999999999988533 399999976532 1223345666677889999999999998
Q ss_pred eCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCcEEEccC
Q 013016 160 ASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML--------GIIYRDLKPENVLVRSD 227 (451)
Q Consensus 160 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givH~Dlkp~NIll~~~ 227 (451)
+++ .+|||||||+||+|.++++.. .+++..+.+++.|++.||+|||++ +||||||||+||||+.+
T Consensus 68 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred ecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 654 689999999999999999874 489999999999999999999987 99999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+++||+|||+|+....... .........+
T Consensus 145 ~~~Ki~DFGla~~~~~~~~---------------------------------------------------~~~~~~~~~~ 173 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATD---------------------------------------------------TIDIAPNHRV 173 (303)
T ss_dssp SCEEECCCTTCEEEETTTT---------------------------------------------------EESCC-----
T ss_pred CCEEEEeCCCCccccCCCC---------------------------------------------------ceeeeccccc
Confidence 9999999999853321100 0011122358
Q ss_pred cCCCccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCCC---------------ChHHHHHHHhcCCCC--
Q 013016 308 GTHEYVSPEVASGG------SHGNAVDWWAFGIFIYEMIYGRTPFAAP---------------SNETTLRNIVKKPLT-- 364 (451)
Q Consensus 308 gt~~y~aPE~~~~~------~~~~~~DIwSlG~il~elltg~~pf~~~---------------~~~~~~~~i~~~~~~-- 364 (451)
||+.|||||++.+. .++.++|||||||+||||+||..||... ........+......
T Consensus 174 GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~ 253 (303)
T 3hmm_A 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253 (303)
T ss_dssp CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC
T ss_pred ccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCC
Confidence 99999999999764 3577999999999999999997765321 122333333333322
Q ss_pred CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 365 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+|...........+.+|+.+||+.||++||| +.||++
T Consensus 254 ~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~ 290 (303)
T 3hmm_A 254 IPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp CCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred CCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 2222222222336789999999999999999 888875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=429.31 Aligned_cols=284 Identities=36% Similarity=0.581 Sum_probs=239.2
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
....++|.+.+.||+|+||.||+|.++.+++ .||||++.+...........+..|+.+++.++||||++++
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~---------~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 250 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEE
Confidence 3556889999999999999999999987665 4999999887665555566778899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+++|+||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 251 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEec
Confidence 99999999999999999999999998765566999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... ......+||+.|+||
T Consensus 331 Gla~~~~~~--------------------------------------------------------~~~~~~~GT~~Y~AP 354 (576)
T 2acx_A 331 GLAVHVPEG--------------------------------------------------------QTIKGRVGTVGYMAP 354 (576)
T ss_dssp TTCEECCTT--------------------------------------------------------CCEECCCSCGGGCCH
T ss_pred ccceecccC--------------------------------------------------------ccccccCCCccccCH
Confidence 998532110 011134899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|++.+..++.++|||||||++|||++|+.||.... .......+......++.. .+.++++||.+||+.||.
T Consensus 355 Evl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~-----~s~~~~dLI~~lL~~dP~ 429 (576)
T 2acx_A 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER-----FSPQARSLCSQLLCKDPA 429 (576)
T ss_dssp HHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSSGG
T ss_pred HHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCcc-----CCHHHHHHHHHhccCCHH
Confidence 99999889999999999999999999999998753 344555555555444432 334899999999999999
Q ss_pred CcCCCC-CChHHHHcCCCcCCCCcccc--cccCCCCCCCCC
Q 013016 392 NRLGSK-RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMR 429 (451)
Q Consensus 392 ~Rpt~~-~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~ 429 (451)
+||+.. ..++||++||||++++|..+ +...||++|.+.
T Consensus 430 ~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 430 ERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp GSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 999321 12899999999999999865 567788888764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=409.32 Aligned_cols=264 Identities=28% Similarity=0.436 Sum_probs=227.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
++|.+.+.||+|+||+||+|.++.+++ .||+|++.+...... ...+.+.+|+.+++.++||||+++++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---------~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 82 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGL---------EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCC---------EEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence 679999999999999999999987665 499999986532211 12356778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl 232 (451)
++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 999999999999999999999998764 5699999999999999999999999999999999999998877 7999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......+||+.|
T Consensus 161 ~DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 184 (361)
T 2yab_A 161 IDFGLAHEIEDG--------------------------------------------------------VEFKNIFGTPEF 184 (361)
T ss_dssp CCCSSCEECCTT--------------------------------------------------------CCCCCCCSCGGG
T ss_pred EecCCceEcCCC--------------------------------------------------------CccccCCCCccE
Confidence 999998532210 011234799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++...+....+ ++++||.+||..||.+
T Consensus 185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~ 263 (361)
T 2yab_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRK 263 (361)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH-HHHHHHHHHSCSSTTT
T ss_pred ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH-HHHHHHHHHCCCChhH
Confidence 999999998999999999999999999999999999999999999988876665443333333 8999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||| +.|+|+||||+.+++.
T Consensus 264 R~t----~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 264 RLT----IQEALRHPWITPVDTQ 282 (361)
T ss_dssp SCC----HHHHHTSTTTSCSSHH
T ss_pred CcC----HHHHhcCcCcCCCchh
Confidence 999 9999999999987763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=410.03 Aligned_cols=260 Identities=26% Similarity=0.491 Sum_probs=225.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~---------~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQ---------EYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTE---------EEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCc---------EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 679999999999999999999887765 4999999765432 234566788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc---cCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR---SDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg 236 (451)
+.+..|+|||||.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999999999988875 4599999999999999999999999999999999999998 45789999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .......+||+.|+|||
T Consensus 159 ~a~~~~~~-------------------------------------------------------~~~~~~~~gt~~Y~APE 183 (444)
T 3soa_A 159 LAIEVEGE-------------------------------------------------------QQAWFGFAGTPGYLSPE 183 (444)
T ss_dssp SCBCCCTT-------------------------------------------------------CCBCCCSCSCGGGCCHH
T ss_pred eeEEecCC-------------------------------------------------------CceeecccCCcccCCHH
Confidence 98432210 00112347999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...++...+ ++.+||.+||+.||.+|||
T Consensus 184 ~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~Rpt- 261 (444)
T 3soa_A 184 VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP-EAKDLINKMLTINPSKRIT- 261 (444)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH-HHHHHHHHHSCSSTTTSCC-
T ss_pred HhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH-HHHHHHHHHcCCChhHCCC-
Confidence 99998999999999999999999999999999999999999999888777665555544 8999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.|+|+||||++
T Consensus 262 ---a~e~L~hp~~~~ 273 (444)
T 3soa_A 262 ---AAEALKHPWISH 273 (444)
T ss_dssp ---HHHHHHSCTTHH
T ss_pred ---HHHHhcCccccC
Confidence 999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=402.08 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=217.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|.+.+.||+|+||+||+|.+..+++ .||||++.+...........+.+|+.+++.++||||++++++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 77 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQ---------KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45889999999999999999999877765 499999987765555555678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 78 ITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp EECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence 99999999999999 88999888764 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ......+||+.|+|||+
T Consensus 155 s~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~ 178 (336)
T 3h4j_B 155 SNIMTDG--------------------------------------------------------NFLKTSCGSPNYAAPEV 178 (336)
T ss_dssp TBTTTTS--------------------------------------------------------BTTCCCTTSTTTSCGGG
T ss_pred ceeccCC--------------------------------------------------------cccccccCCcCcCCHHH
Confidence 8432110 01123479999999999
Q ss_pred ccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..+ +.++|||||||++|+|++|+.||...........+.......+ ...+.++.+||.+||+.||.+|||
T Consensus 179 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~~L~~dP~~Rpt- 252 (336)
T 3h4j_B 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP-----DFLSPGAQSLIRRMIVADPMQRIT- 252 (336)
T ss_dssp SCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC-----TTSCHHHHHHHHTTSCSSGGGSCC-
T ss_pred HcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc-----ccCCHHHHHHHHHHcCCChhHCcC-
Confidence 998776 7899999999999999999999987655444333333333332 223448999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.|+++||||+.
T Consensus 253 ---~~eil~hp~~~~ 264 (336)
T 3h4j_B 253 ---IQEIRRDPWFNV 264 (336)
T ss_dssp ---HHHHTTCHHHHT
T ss_pred ---HHHHHhChhhcc
Confidence 999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=389.01 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=218.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.++||+|+||+||+|.+..+++ .||||++..... .....+.+|+.+++.++||||++++++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDS 85 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCC---------EEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCc---------EEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEE
Confidence 34789999999999999999999877665 499999975532 223456779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+..++..|+||||++|++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 86 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999999999774 489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .......+||+.|+|||+
T Consensus 163 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 187 (297)
T 3fxz_A 163 CAQITPE-------------------------------------------------------QSKRSTMVGTPYWMAPEV 187 (297)
T ss_dssp CEECCST-------------------------------------------------------TCCBCCCCSCGGGCCHHH
T ss_pred ceecCCc-------------------------------------------------------ccccCCccCCcCccChhh
Confidence 7432210 011123479999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||...........+........ ..+...+..+.+||.+||+.||++|||
T Consensus 188 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps-- 263 (297)
T 3fxz_A 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGS-- 263 (297)
T ss_dssp HHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCC--
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--CCccccCHHHHHHHHHHccCChhHCcC--
Confidence 9999999999999999999999999999998877776666554322111 112223448999999999999999999
Q ss_pred CChHHHHcCCCcCCC
Q 013016 398 RGAADVKTHPFFKGL 412 (451)
Q Consensus 398 ~~~~ell~hp~~~~~ 412 (451)
+.|+++||||+..
T Consensus 264 --~~ell~h~~~~~~ 276 (297)
T 3fxz_A 264 --AKELLQHQFLKIA 276 (297)
T ss_dssp --HHHHTTCGGGGGC
T ss_pred --HHHHhhChhhccc
Confidence 9999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=390.94 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=210.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.+..+. .||||++..... .......+.+|+.++++++||||+++++++.
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGR----------IVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSC----------EEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCC----------EEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 78999999999999999999985432 499999976532 2333456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 9999999999995 58888776643 459999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .......||+.|+|||++.
T Consensus 168 ~~~~~~-------------------------------------------------------~~~~~~~~t~~y~aPE~~~ 192 (311)
T 3niz_A 168 AFGIPV-------------------------------------------------------RSYTHEVVTLWYRAPDVLM 192 (311)
T ss_dssp ETTSCC-------------------------------------------------------C---CCCCCCTTCCHHHHT
T ss_pred ecCCCc-------------------------------------------------------ccccCCcccCCcCCHHHhc
Confidence 322100 0011236899999999998
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC-------------------------CCc
Q 013016 320 G-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP-------------------------SSM 373 (451)
Q Consensus 320 ~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------~~~ 373 (451)
+ ..++.++|||||||++|+|++|+.||.+....+.+..+...........+ ...
T Consensus 193 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (311)
T 3niz_A 193 GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPG 272 (311)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTT
T ss_pred CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcc
Confidence 7 45899999999999999999999999987776665555432111110000 011
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.+.++.+||.+||++||++||| +.|+|+||||++++.
T Consensus 273 ~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 273 FCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCT
T ss_pred cCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCc
Confidence 2347899999999999999999 999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=396.39 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=223.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||+|++.... .....+.+|+.+++.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 71 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKK---------TYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCc---------EEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence 789999999999999999999887665 49999987442 22345677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--CCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Dfg~ 237 (451)
+.+.+|+|||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 72 SMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred cCCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 999999999999999999988654 245999999999999999999999999999999999999997 78999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .......||+.|+|||+
T Consensus 151 a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~ 174 (321)
T 1tki_A 151 ARQLKPG--------------------------------------------------------DNFRLLFTAPEYYAPEV 174 (321)
T ss_dssp CEECCTT--------------------------------------------------------CEEEEEESCGGGSCHHH
T ss_pred CeECCCC--------------------------------------------------------CccccccCChhhcCcHH
Confidence 8432110 01113478999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|..||......+.+..+......++...+....+ ++.+||.+||+.||.+|||
T Consensus 175 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp~~Rpt-- 251 (321)
T 1tki_A 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMT-- 251 (321)
T ss_dssp HTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH-HHHHHHHTTSCSSGGGSCC--
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH-HHHHHHHHHcCCChhHCcC--
Confidence 9998889999999999999999999999999999999999988877665433333333 8999999999999999999
Q ss_pred CChHHHHcCCCcCCC
Q 013016 398 RGAADVKTHPFFKGL 412 (451)
Q Consensus 398 ~~~~ell~hp~~~~~ 412 (451)
+.|+|+||||++.
T Consensus 252 --~~e~l~hp~~~~~ 264 (321)
T 1tki_A 252 --ASEALQHPWLKQK 264 (321)
T ss_dssp --HHHHHHSHHHHSC
T ss_pred --HHHHhcChhhccC
Confidence 9999999999984
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=400.71 Aligned_cols=259 Identities=26% Similarity=0.483 Sum_probs=224.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.++.+++ .||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGL---------EFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCC---------EEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 679999999999999999999887665 4999999765432 234566788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl~Dfg 236 (451)
+.+..|+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 999999999999999999988764 5599999999999999999999999999999999999998654 59999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 177 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 177 LAIEVNDS--------------------------------------------------------EAWHGFAGTPGYLSPE 200 (362)
T ss_dssp TCBCCTTC--------------------------------------------------------CSCCCSCSCTTTCCHH
T ss_pred cceEecCC--------------------------------------------------------cccccCCCCccccCHH
Confidence 98532210 0011347999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++|||||||++|+|++|+.||...+..+.+..+..+...++...+.... .++.+||.+||+.||.+||+
T Consensus 201 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~R~t- 278 (362)
T 2bdw_A 201 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT-PEAKSLIDSMLTVNPKKRIT- 278 (362)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC-HHHHHHHHHHSCSSGGGSCC-
T ss_pred HHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC-HHHHHHHHHHcCCChhhCcC-
Confidence 9999899999999999999999999999999988888888888887766654444333 48999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.|+|+||||+.
T Consensus 279 ---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 279 ---ADQALKVPWICN 290 (362)
T ss_dssp ---HHHHTTSHHHHT
T ss_pred ---HHHHhcCcccCC
Confidence 999999999976
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=394.67 Aligned_cols=264 Identities=27% Similarity=0.431 Sum_probs=224.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
++|.+.+.||+|+||.||+|.++.+++ .||+|++.+...... .....+.+|+.+++.++||||+++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 81 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGL---------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCc---------EEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 569999999999999999999987665 499999976432211 12456778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl 232 (451)
++...+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 999999999999999999999998764 5699999999999999999999999999999999999999887 8999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......+||+.|
T Consensus 160 ~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 183 (326)
T 2y0a_A 160 IDFGLAHKIDFG--------------------------------------------------------NEFKNIFGTPEF 183 (326)
T ss_dssp CCCTTCEECCTT--------------------------------------------------------SCCCCCCSCTTT
T ss_pred EECCCCeECCCC--------------------------------------------------------CccccccCCcCc
Confidence 999998532210 001124799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++....... +..+.+||.+||+.||.+
T Consensus 184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~ 262 (326)
T 2y0a_A 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAKDFIRRLLVKDPKK 262 (326)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS-CHHHHHHHHHHSCSSGGG
T ss_pred CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC-CHHHHHHHHHHccCChhh
Confidence 9999999989999999999999999999999999998888888888776655543322233 338999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||| +.|+|+||||++.++.
T Consensus 263 Rpt----~~e~l~hp~~~~~~~~ 281 (326)
T 2y0a_A 263 RMT----IQDSLQHPWIKPKDTQ 281 (326)
T ss_dssp SCC----HHHHHHSTTTSCCSHH
T ss_pred CCC----HHHHhcCCCccCCcch
Confidence 999 9999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=383.54 Aligned_cols=261 Identities=32% Similarity=0.559 Sum_probs=227.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
...+++|++.+.||+|+||+||+|.++.++. .||||++.............+.+|+.++++++||||++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCc---------EEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchh
Confidence 4556899999999999999999999887765 4999999877655555567788899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 76 GYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSC
T ss_pred heEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEec
Confidence 9999999999999999999999988765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .......|++.|+||
T Consensus 154 g~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aP 176 (279)
T 3fdn_A 154 GWSVHAPS---------------------------------------------------------SRRTDLCGTLDYLPP 176 (279)
T ss_dssp CEESCC-----------------------------------------------------------------CCCCTTCCH
T ss_pred cccccCCc---------------------------------------------------------ccccccCCCCCccCH
Confidence 98732110 011124789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++||||||+++|+|++|+.||......+....+......++.. .+.++.+||.+||+.||.+||+
T Consensus 177 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps 251 (279)
T 3fdn_A 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-----VTEGARDLISRLLKHNPSQRPM 251 (279)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT-----SCHHHHHHHHHHCCSSGGGSCC
T ss_pred hHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc-----CCHHHHHHHHHHhccChhhCCC
Confidence 99999889999999999999999999999999988888888887776655543 3348999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCC
Q 013016 396 SKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~ 413 (451)
+.||++||||++..
T Consensus 252 ----~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 252 ----LREVLEHPWITANS 265 (279)
T ss_dssp ----HHHHHHCHHHHHHC
T ss_pred ----HHHHhhCccccCCc
Confidence 99999999998843
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=403.45 Aligned_cols=276 Identities=22% Similarity=0.288 Sum_probs=219.4
Q ss_pred cCCceEEeeeccC--CeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 79 FRDFDLHRRIGAG--DIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 79 ~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
.++|++.++||+| +||+||+|.++.+++ .||||++..... .......+.+|+.+++.++|||||++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGE---------YVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCC---------EEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCC---------EEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 3789999999999 999999999987665 499999986643 2345567788999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+.+|+|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence 99999999999999999999999988766779999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
.+......... ...........+||+.|+|||
T Consensus 174 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 174 SNLSMISHGQR------------------------------------------------QRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp GCEECEETTEE------------------------------------------------CSCBCCCCTTCTTTGGGSCHH
T ss_pred cceeecccccc------------------------------------------------ccccccccccccccccccCHH
Confidence 87432110000 000011112347899999999
Q ss_pred cccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC----------------------------
Q 013016 317 VASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP---------------------------- 366 (451)
Q Consensus 317 ~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---------------------------- 366 (451)
++.+ ..++.++|||||||++|+|++|+.||.+......+..+..+.....
T Consensus 206 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (389)
T 3gni_B 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285 (389)
T ss_dssp HHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------
T ss_pred HHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccc
Confidence 9988 5789999999999999999999999988766665555544322110
Q ss_pred -------------CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 367 -------------TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 367 -------------~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
........+.++.+||.+||++||++||| +.|+|+||||+++.+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp --------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---C
T ss_pred ccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhcc
Confidence 00111223448999999999999999999 99999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=403.94 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=208.1
Q ss_pred CCcccCCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHH-HHCCCCCcc
Q 013016 75 TGLTFRDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KMLDHPFLP 152 (451)
Q Consensus 75 ~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~nIv 152 (451)
.+..+++|.+. +.||.|+||+||+|.++.+++ .||||++... ..+.+|+.++ +..+||||+
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~---------~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv 118 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC--------PKARREVELHWRASQCPHIV 118 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECS--------HHHHHHHHHHHHHTTSTTBC
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCC---------EEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcc
Confidence 34455788887 689999999999999887765 4999999643 2344577776 456899999
Q ss_pred ceeEEEEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--
Q 013016 153 TLYAEFEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-- 226 (451)
Q Consensus 153 ~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-- 226 (451)
++++++.. .+++|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 119 ~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~ 198 (400)
T 1nxk_A 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198 (400)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS
T ss_pred eEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC
Confidence 99999876 668999999999999999998765567999999999999999999999999999999999999997
Q ss_pred -CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 227 -DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 227 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
++.+||+|||++..... ......
T Consensus 199 ~~~~~kl~DFG~a~~~~~--------------------------------------------------------~~~~~~ 222 (400)
T 1nxk_A 199 PNAILKLTDFGFAKETTS--------------------------------------------------------HNSLTT 222 (400)
T ss_dssp TTCCEEECCCTTCEECC---------------------------------------------------------------
T ss_pred CCccEEEEecccccccCC--------------------------------------------------------CCcccc
Confidence 78999999999853210 001123
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE----TTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+..+...++...+.... .++.+|
T Consensus 223 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~l 301 (400)
T 1nxk_A 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS-EEVKML 301 (400)
T ss_dssp ----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC-HHHHHH
T ss_pred CCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC-HHHHHH
Confidence 47999999999999999999999999999999999999999875432 2445566666655544444433 489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
|++||+.||++||| +.|+++||||.+
T Consensus 302 i~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 302 IRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp HHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHCCCChhHCcC----HHHHhcCccccC
Confidence 99999999999999 999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=393.26 Aligned_cols=258 Identities=30% Similarity=0.482 Sum_probs=208.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++.... ..+.+.+|+.++++++||||+++++++.
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQK---------PYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCc---------EEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 679999999999999999999987665 49999997542 2345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~~~kl~Dfg 236 (451)
..+..++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999999999999999999988764 55999999999999999999999999999999999999975 8899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 197 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 220 (349)
T 2w4o_A 197 LSKIVEHQ--------------------------------------------------------VLMKTVCGTPGYCAPE 220 (349)
T ss_dssp ------------------------------------------------------------------------CGGGSCHH
T ss_pred cccccCcc--------------------------------------------------------cccccccCCCCccCHH
Confidence 98432100 0011347899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++|||||||++|+|++|+.||....... .+..+......++...+.... .++.+||.+||+.||++|||
T Consensus 221 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~Rpt 299 (349)
T 2w4o_A 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS-LNAKDLVRKLIVLDPKKRLT 299 (349)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC-HHHHHHHHTTSCSSGGGSCC
T ss_pred HhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC-HHHHHHHHHHccCChhhCcC
Confidence 9999899999999999999999999999998766554 666777766555544444433 48999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCCc
Q 013016 396 SKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~ 414 (451)
+.|+|+||||++...
T Consensus 300 ----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 300 ----TFQALQHPWVTGKAA 314 (349)
T ss_dssp ----HHHHHHSTTTTSTTC
T ss_pred ----HHHHhcCcccCCCcc
Confidence 999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=391.37 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=212.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.++.+++ .||||++...... ...+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 74 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHR 74 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCc---------EEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3789999999999999999999887665 4999999754322 2235567799999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 75 REGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp ECSSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999999999999999999998764 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
..... ..........+||+.|+|||++
T Consensus 153 ~~~~~-----------------------------------------------------~~~~~~~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 153 TVFRY-----------------------------------------------------NNRERLLNKMCGTLPYVAPELL 179 (323)
T ss_dssp EECEE-----------------------------------------------------TTEECCBCSCCSCGGGSCHHHH
T ss_pred ceecc-----------------------------------------------------CCcccccCCCccCcCccCcHHh
Confidence 43210 0001111235799999999999
Q ss_pred cCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 SGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 ~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.+..+ +.++|||||||++|+|++|+.||...... ..+..+.......+. . ...+..+.+||.+||+.||.+|||
T Consensus 180 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~li~~~L~~dP~~R~t- 255 (323)
T 3tki_A 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--W-KKIDSAPLALLHKILVENPSARIT- 255 (323)
T ss_dssp HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT--G-GGSCHHHHHHHHHHSCSSTTTSCC-
T ss_pred ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc--c-ccCCHHHHHHHHHHccCChhhCcC-
Confidence 88775 77999999999999999999999876554 333333333322221 1 123448999999999999999999
Q ss_pred CCChHHHHcCCCcCCC
Q 013016 397 KRGAADVKTHPFFKGL 412 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~ 412 (451)
+.|+++||||++.
T Consensus 256 ---~~eil~h~~~~~~ 268 (323)
T 3tki_A 256 ---IPDIKKDRWYNKP 268 (323)
T ss_dssp ---HHHHTTCTTTTCC
T ss_pred ---HHHHhhChhhccc
Confidence 9999999999873
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=396.70 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=218.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH--HHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK--KKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++........ ...+.+.+|+.+++.++||||++++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQ---------QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCC---------EEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 569999999999999999999887665 499999986543321 124567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC---EEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IML 232 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl 232 (451)
+.+.+.+|+|||||+|++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 99999999999999999998877543 2345899999999999999999999999999999999999987654 999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++....... ......+||+.|
T Consensus 175 ~Dfg~a~~~~~~~-------------------------------------------------------~~~~~~~gt~~y 199 (351)
T 3c0i_A 175 GGFGVAIQLGESG-------------------------------------------------------LVAGGRVGTPHF 199 (351)
T ss_dssp CCCTTCEECCTTS-------------------------------------------------------CBCCCCCSCGGG
T ss_pred ecCcceeEecCCC-------------------------------------------------------eeecCCcCCcCc
Confidence 9999985322100 011234799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+|||++.+..++.++|||||||++|+|++|+.||... ....+..+..+....+...+... +.++.+||.+||+.||++
T Consensus 200 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~ 277 (351)
T 3c0i_A 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHI-SESAKDLVRRMLMLDPAE 277 (351)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTS-CHHHHHHHHHHTCSSTTT
T ss_pred cCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccC-CHHHHHHHHHHCCCChhH
Confidence 9999999989999999999999999999999999874 45566677666554433222222 348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCC
Q 013016 393 RLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~ 413 (451)
||| +.|+|+||||++.+
T Consensus 278 R~s----~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 278 RIT----VYEALNHPWLKERD 294 (351)
T ss_dssp SCC----HHHHHTSHHHHTHH
T ss_pred CcC----HHHHhcChhhcCCc
Confidence 999 99999999999844
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=384.22 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=210.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||||++..... .......+.+|+.++++++||||+++++++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 71 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLH 71 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCc---------eEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEE
Confidence 689999999999999999999987665 499999975432 2233456678999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++..|+||||+. ++|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 72 SDKKLTLVFEFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9999999999995 4666655543 2569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 150 ~~~~~-------------------------------------------------------~~~~~~~~~t~~y~aPE~~~ 174 (292)
T 3o0g_A 150 AFGIP-------------------------------------------------------VRCYSAEVVTLWYRPPDVLF 174 (292)
T ss_dssp ECCSC-------------------------------------------------------CSCCCSCCSCGGGCCHHHHT
T ss_pred ecCCc-------------------------------------------------------cccccCCccccCCcChHHHc
Confidence 33210 00111237899999999998
Q ss_pred CCC-CCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHhcCCCCCCCCCC------------------------CCc
Q 013016 320 GGS-HGNAVDWWAFGIFIYEMIYGRTP-FAAPSNETTLRNIVKKPLTFPTQSP------------------------SSM 373 (451)
Q Consensus 320 ~~~-~~~~~DIwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~ 373 (451)
+.. ++.++|||||||++|+|++|..| |......+.+..+...........+ ...
T Consensus 175 ~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T 3o0g_A 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccc
Confidence 866 79999999999999999988777 5555556666665442111111100 012
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.+.++++||.+||++||++||| ++|+|+||||+++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 255 LNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred cChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 3448899999999999999999 9999999999984
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=396.54 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=225.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
+...++|++.+.||+|+||+||+|.++.+++ .||+|++...... ....+.+|+.+++.++||||++++
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~ 114 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGR---------VFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLH 114 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCC---------EEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEE
Confidence 3345789999999999999999999887665 4999999764322 234567799999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--CCCEEEe
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLS 233 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~ 233 (451)
+++.+.+.+|+||||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 115 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 115 DAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEE
Confidence 9999999999999999999999988754 345999999999999999999999999999999999999984 4789999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... ......+||+.|+
T Consensus 194 DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~ 217 (387)
T 1kob_A 194 DFGLATKLNPD--------------------------------------------------------EIVKVTTATAEFA 217 (387)
T ss_dssp CCTTCEECCTT--------------------------------------------------------SCEEEECSSGGGC
T ss_pred ecccceecCCC--------------------------------------------------------cceeeeccCCCcc
Confidence 99998532110 0011237899999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++........+ ++.+||.+||+.||.+|
T Consensus 218 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~R 296 (387)
T 1kob_A 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKR 296 (387)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH-HHHHHHHTTSCSSGGGS
T ss_pred CchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH-HHHHHHHHHcCCChhHC
Confidence 99999998999999999999999999999999999888888888888776665544444444 89999999999999999
Q ss_pred CCCCCChHHHHcCCCcCCCCc
Q 013016 394 LGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~~~~ 414 (451)
|| +.|+|+||||++...
T Consensus 297 pt----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 297 LT----VHDALEHPWLKGDHS 313 (387)
T ss_dssp CC----HHHHHTSTTTSSCCT
T ss_pred cC----HHHHhhCccccCCcc
Confidence 99 999999999998544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=408.46 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=226.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
...++|.+.+.||+|+||+||+|.+..+++ .||||++.+...........+.+|+.+++.++||||+++++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~---------~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~ 83 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGH---------KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCC---------EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 445889999999999999999999887665 49999998776555455677888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+.+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 84 VISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999998764 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 162 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 185 (476)
T 2y94_A 162 LSNMMSDG--------------------------------------------------------EFLRTSCGSPNYAAPE 185 (476)
T ss_dssp SCEECCTT--------------------------------------------------------CCBCCCCSCSTTCCHH
T ss_pred chhhcccc--------------------------------------------------------ccccccCCCcCeEChh
Confidence 98532110 0111347999999999
Q ss_pred cccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..+ +.++|||||||++|+|++|+.||........+..+..+....+.. .+.++.+||.+||+.||.+|||
T Consensus 186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~Li~~~L~~dP~~Rpt 260 (476)
T 2y94_A 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-----LNPSVISLLKHMLQVDPMKRAT 260 (476)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT-----CCHHHHHHHHHHTCSSTTTSCC
T ss_pred hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc-----CCHHHHHHHHHHcCCCchhCcC
Confidence 9998775 789999999999999999999999988888888888876655433 2348999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.|+++||||++
T Consensus 261 ----~~eil~hp~~~~ 272 (476)
T 2y94_A 261 ----IKDIREHEWFKQ 272 (476)
T ss_dssp ----HHHHHTCHHHHT
T ss_pred ----HHHHHhCHHhhh
Confidence 999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=384.46 Aligned_cols=259 Identities=33% Similarity=0.547 Sum_probs=212.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-----------------------HHHHHH
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-----------------------KKKVHR 135 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~ 135 (451)
.++|.+.+.||+|+||.||+|.+..+++ .||||++....... ....+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNT---------YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTE---------EEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCc---------EEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 4789999999999999999999877665 49999997653221 122456
Q ss_pred HHHHHHHHHHCCCCCccceeEEEEe--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 013016 136 AEMEKKILKMLDHPFLPTLYAEFEA--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGII 213 (451)
Q Consensus 136 ~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~giv 213 (451)
+.+|+.++++++||||+++++++.. .+++|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~iv 159 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKII 159 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 7889999999999999999999986 5689999999999999886543 4699999999999999999999999999
Q ss_pred eccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcc
Q 013016 214 YRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293 (451)
Q Consensus 214 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (451)
||||||+|||++.++.+||+|||++.......
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------ 191 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD------------------------------------------------ 191 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSS------------------------------------------------
T ss_pred ccCCCHHHEEECCCCCEEEecCCCcccccccc------------------------------------------------
Confidence 99999999999999999999999985322100
Q ss_pred cccccccccccccccCCCccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC
Q 013016 294 FVAEPVAARSCSFVGTHEYVSPEVASGGS---HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370 (451)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 370 (451)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+......++..
T Consensus 192 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 262 (298)
T 2zv2_A 192 -------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQ-- 262 (298)
T ss_dssp -------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSS--
T ss_pred -------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCc--
Confidence 0111247999999999998765 3788999999999999999999999887777777777665554432
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
...+.++.+||.+||+.||++||+ +.||++||||++
T Consensus 263 -~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~~ 298 (298)
T 2zv2_A 263 -PDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVTR 298 (298)
T ss_dssp -SCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHHC
T ss_pred -cccCHHHHHHHHHHhhcChhhCCC----HHHHhcCccccC
Confidence 123448999999999999999999 999999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=392.57 Aligned_cols=271 Identities=25% Similarity=0.345 Sum_probs=214.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDN---------LVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIH 70 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCc---------EEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEe
Confidence 689999999999999999999887665 499999975532 122223446899999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 71 TEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred eCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 9999999999995 69998887653 459999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~t~~y~aPE~~~ 173 (324)
T 3mtl_A 149 AKSIP-------------------------------------------------------TKTYDNEVVTLWYRPPDILL 173 (324)
T ss_dssp CC-------------------------------------------------------------------CGGGCCHHHHT
T ss_pred cccCC-------------------------------------------------------ccccccccCcccccChhhhc
Confidence 32110 00111236899999999998
Q ss_pred C-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCC-------------------------c
Q 013016 320 G-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS-------------------------M 373 (451)
Q Consensus 320 ~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------------------------~ 373 (451)
+ ..++.++|||||||++|+|++|+.||.+....+.+..+.......+...++. .
T Consensus 174 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (324)
T 3mtl_A 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPR 253 (324)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTT
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCC
Confidence 7 5689999999999999999999999999888877776655322222111111 1
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCC
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~ 422 (451)
.+.++.+||.+||++||.+||| ++|+|+||||+++..........
T Consensus 254 ~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~ 298 (324)
T 3mtl_A 254 LDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERIHKLPDT 298 (324)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTTSSSCTT
T ss_pred CCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhcccccccCCCC
Confidence 2347899999999999999999 99999999999976654443333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=376.80 Aligned_cols=265 Identities=26% Similarity=0.468 Sum_probs=228.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.++.+++ .||+|++..... .......+.+|+.++++++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGL---------EFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCc---------eEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 789999999999999999999887765 499999976543 2334566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC---EEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~Dfg 236 (451)
..+..|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 999999999999999999888765 45999999999999999999999999999999999999987655 9999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .......||+.|+|||
T Consensus 154 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 177 (284)
T 3kk8_A 154 LAIEVNDS--------------------------------------------------------EAWHGFAGTPGYLSPE 177 (284)
T ss_dssp TCEECCSS--------------------------------------------------------CBCCCSCSCGGGCCHH
T ss_pred eeEEcccC--------------------------------------------------------ccccCCCCCcCCcCch
Confidence 98432211 0111247899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++||||||+++|+|++|+.||...........+..+....+........+ ++.+||.+||+.||.+|||
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~l~~dp~~Rps- 255 (284)
T 3kk8_A 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSMLTVNPKKRIT- 255 (284)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH-HHHHHHHHHSCSSTTTSCC-
T ss_pred hhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH-HHHHHHHHHcccChhhCCC-
Confidence 99999999999999999999999999999999988888888888877666554444444 8999999999999999999
Q ss_pred CCChHHHHcCCCcCCCCcccc
Q 013016 397 KRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~~~~ 417 (451)
+.|+|+||||++......
T Consensus 256 ---~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 256 ---ADQALKVPWICNRERVAS 273 (284)
T ss_dssp ---HHHHTTSHHHHSCCCGGG
T ss_pred ---HHHHhcCccccCChhHHh
Confidence 999999999999665544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=380.44 Aligned_cols=259 Identities=34% Similarity=0.572 Sum_probs=225.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
....++|.+.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.+++.++|+||++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKF---------IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCc---------EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence 3455889999999999999999999887655 4999999876554444456778899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecc
Confidence 9999999999999999999999998765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .......|++.|+||
T Consensus 159 g~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aP 181 (284)
T 2vgo_A 159 GWSVHAPS---------------------------------------------------------LRRRTMCGTLDYLPP 181 (284)
T ss_dssp TTCEECSS---------------------------------------------------------SCBCCCCSCGGGCCH
T ss_pred cccccCcc---------------------------------------------------------cccccccCCCCcCCH
Confidence 98742211 001124789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++||||||+++|+|++|..||......+....+......++.. .+.++.+||.+||+.||.+||+
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps 256 (284)
T 2vgo_A 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF-----LSDGSKDLISKLLRYHPPQRLP 256 (284)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-----SCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCc-----CCHHHHHHHHHHhhcCHhhCCC
Confidence 99999889999999999999999999999999988888888887766555432 3348999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.++++||||+.
T Consensus 257 ----~~~ll~h~~~~~ 268 (284)
T 2vgo_A 257 ----LKGVMEHPWVKA 268 (284)
T ss_dssp ----HHHHHTCHHHHH
T ss_pred ----HHHHhhCHHHHh
Confidence 999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=383.00 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=209.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.+..+ + .||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~---------~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYG-E---------TFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIH 70 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS-C---------EEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCC-C---------EEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEc
Confidence 6899999999999999999998433 2 499999975432 2223355677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+. ++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 71 TKKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred cCCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 9999999999995 59998887653 459999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~t~~y~aPE~~~ 173 (288)
T 1ob3_A 149 AFGIP-------------------------------------------------------VRKYTHEIVTLWYRAPDVLM 173 (288)
T ss_dssp HHCC----------------------------------------------------------------CCCTTCCHHHHT
T ss_pred ccCcc-------------------------------------------------------ccccccccccccccCchhee
Confidence 32110 00111236899999999997
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC------------------------CCCCcC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ------------------------SPSSMS 374 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~~ 374 (451)
+. .++.++|||||||++|+|++|+.||......+.+..+.......... ......
T Consensus 174 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T 1ob3_A 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253 (288)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSC
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhc
Confidence 74 58999999999999999999999999988777766665421100000 000123
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
+.++.+||.+||+.||++||| +.|+|+||||++.+
T Consensus 254 ~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 254 DESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKENN 288 (288)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC--
T ss_pred CHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhcC
Confidence 448899999999999999999 99999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=395.08 Aligned_cols=269 Identities=29% Similarity=0.433 Sum_probs=220.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+... ....|++++.++ +||||+++++++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~ 85 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNM---------EFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVY 85 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCC---------EEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEE
Confidence 679999999999999999999987665 499999975421 223477888777 799999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC----CCEEEec
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD----GHIMLSD 234 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~----~~~kl~D 234 (451)
.+.+++|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 86 DDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999999988765 559999999999999999999999999999999999998543 3599999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .......+||+.|+|
T Consensus 164 fg~a~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~a 188 (342)
T 2qr7_A 164 FGFAKQLRAE-------------------------------------------------------NGLLMTPCYTANFVA 188 (342)
T ss_dssp CTTCEECBCT-------------------------------------------------------TCCBCCSSCCSSCCC
T ss_pred CCCcccCcCC-------------------------------------------------------CCceeccCCCccccC
Confidence 9998532110 011123479999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA---PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
||++.+..++.++|||||||++|+|++|..||.. ....+.+..+..+...++...+....+ ++.+||++||+.||+
T Consensus 189 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 189 PEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPH 267 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH-HHHHHHHHHTCSSTT
T ss_pred HHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH-HHHHHHHHHCCCChh
Confidence 9999887889999999999999999999999986 345667788888777766555554444 899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCCCcccccccCCCCCC
Q 013016 392 NRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p 426 (451)
+||+ +.++++||||.+.+......+.+|..|
T Consensus 268 ~R~t----~~~il~hp~~~~~~~~~~~~~~~~~~p 298 (342)
T 2qr7_A 268 QRLT----AALVLRHPWIVHWDQLPQYQLNRQDAP 298 (342)
T ss_dssp TSCC----HHHHTTSHHHHTGGGSCCSCCCCCCCH
T ss_pred HCcC----HHHHhcCCeecCccccccccCCCccch
Confidence 9999 999999999976333223334444443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.19 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=209.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH--HHHHHHHHHHHHHHHHC---CCCCccc
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK--KKKVHRAEMEKKILKML---DHPFLPT 153 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~ 153 (451)
.++|++.++||+|+||+||+|.+..+++ .||||++....... ......+.+|+.+++.+ +||||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~ 78 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGH---------FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVR 78 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCC---------EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEE
Confidence 3789999999999999999999877665 49999997432110 01112334466666655 5999999
Q ss_pred eeEEEEeCC-----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 154 LYAEFEASN-----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 154 l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
+++++.... +.++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 79 LMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EEEEEEECCSSSEEEEEEEEECC-CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred eeeeeeccCCCCceeEEEEehhh-hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 999998765 689999999 46999999887666799999999999999999999999999999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++..... .......+|
T Consensus 158 ~~kl~Dfg~a~~~~~--------------------------------------------------------~~~~~~~~g 181 (308)
T 3g33_A 158 TVKLADFGLARIYSY--------------------------------------------------------QMALTPVVV 181 (308)
T ss_dssp CEEECSCSCTTTSTT--------------------------------------------------------CCCSGGGGC
T ss_pred CEEEeeCccccccCC--------------------------------------------------------CcccCCccc
Confidence 999999999843210 001123478
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC-----------------
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS----------------- 371 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------- 371 (451)
|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.......+...++
T Consensus 182 t~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (308)
T 3g33_A 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRP 261 (308)
T ss_dssp CCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCC
T ss_pred cccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCc
Confidence 999999999999999999999999999999999999999988888777776532222111111
Q ss_pred -----CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 372 -----SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 372 -----~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
...+..+.+||.+||++||++||| +.|+|+||||++.+
T Consensus 262 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 262 VQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC----
T ss_pred HHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCCC
Confidence 123348899999999999999999 99999999999843
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=409.84 Aligned_cols=292 Identities=24% Similarity=0.333 Sum_probs=199.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++.+.. ........+.+|+.+++.++|+||+++++++.
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--C---------EEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCc---------EEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 689999999999999999999887765 49999996542 23344567788999999999999999999994
Q ss_pred e-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 A-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
. .+.+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 3 35799999998 78999988764 5699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++................ .+ ........ + .............+||+.|+|
T Consensus 200 FGla~~~~~~~~~~~~~~~~----~~------~~~~~~~~-----~-------------~~~~~~~~~~~~~~gt~~Y~a 251 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPIS----PR------EDDMNLVT-----F-------------PHTKNLKRQLTGHVVTRWYRA 251 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC-------------------------------------------------------CCCTTCC
T ss_pred cccchhccCccccccccccC----cc------cccccccc-----c-------------cccccccccccCCcccccccC
Confidence 99997543221110000000 00 00000000 0 000001112234689999999
Q ss_pred ccccc-CCCCCcchhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------HHHHHHHhcCC
Q 013016 315 PEVAS-GGSHGNAVDWWAFGIFIYEMIY-----------GRTPFAAPSN--------------------ETTLRNIVKKP 362 (451)
Q Consensus 315 PE~~~-~~~~~~~~DIwSlG~il~ellt-----------g~~pf~~~~~--------------------~~~~~~i~~~~ 362 (451)
||++. +..|+.++||||||||||||++ |+++|.+... ...+..+....
T Consensus 252 PE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~ 331 (458)
T 3rp9_A 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331 (458)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHH
T ss_pred hHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHc
Confidence 99864 5669999999999999999999 7777765431 11222221100
Q ss_pred C--------------------CCCC-------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 363 L--------------------TFPT-------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 363 ~--------------------~~~~-------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
. .++. ...+. .+.++.+||.+||.+||++||| ++|+|+||||+++++.
T Consensus 332 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLl~~mL~~dP~~R~t----~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 332 GTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA-SSADAIHLLKRMLVFNPNKRIT----INECLAHPFFKEVRIA 406 (458)
T ss_dssp CCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT-SCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTCCG
T ss_pred CCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC-CCHHHHHHHHHHhccCccccCC----HHHHhcCHhhhhcCCC
Confidence 0 0000 00111 2448999999999999999999 9999999999999887
Q ss_pred cc
Q 013016 416 LI 417 (451)
Q Consensus 416 ~~ 417 (451)
..
T Consensus 407 ~~ 408 (458)
T 3rp9_A 407 EV 408 (458)
T ss_dssp GG
T ss_pred cc
Confidence 54
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=390.87 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=210.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.+..+++ .||||++..... .......+.+|+.++++++||||+++++++.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNE---------TVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCc---------eEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 789999999999999999999887665 499999975532 2233455667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc-----cCCCEEEec
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-----SDGHIMLSD 234 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-----~~~~~kl~D 234 (451)
.++.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999999995 6999998876 4599999999999999999999999999999999999995 445699999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .......+||+.|+|
T Consensus 181 fg~a~~~~~~-------------------------------------------------------~~~~~~~~~t~~y~a 205 (329)
T 3gbz_A 181 FGLARAFGIP-------------------------------------------------------IRQFTHEIITLWYRP 205 (329)
T ss_dssp TTHHHHHC------------------------------------------------------------------CCTTCC
T ss_pred CCCccccCCc-------------------------------------------------------ccccCCCcCCccccC
Confidence 9998532110 001112368999999
Q ss_pred cccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC----------------------
Q 013016 315 PEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS---------------------- 371 (451)
Q Consensus 315 PE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---------------------- 371 (451)
||++.+.. ++.++|||||||++|+|++|+.||......+.+..+.......+...++
T Consensus 206 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
T 3gbz_A 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKR 285 (329)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHH
T ss_pred HHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhh
Confidence 99998754 8999999999999999999999999988877777765432211111110
Q ss_pred ---CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 372 ---SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 372 ---~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
...+.++.+||.+||++||.+||| +.|+|+||||++++|.
T Consensus 286 ~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 286 VLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp HHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 013458899999999999999999 9999999999998874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=377.25 Aligned_cols=262 Identities=31% Similarity=0.564 Sum_probs=198.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|.+.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.++++++||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGL---------EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCc---------eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEE
Confidence 44789999999999999999999876655 499999987655444455778889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 80 FEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp EECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred EccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 99999999999999999999998764 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ........||+.|+|||+
T Consensus 159 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~ 183 (278)
T 3cok_A 159 ATQLKMP-------------------------------------------------------HEKHYTLCGTPNYISPEI 183 (278)
T ss_dssp CEECC---------------------------------------------------------------------------
T ss_pred eeeccCC-------------------------------------------------------CCcceeccCCCCcCCcch
Confidence 7432110 001112468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||........+..+.......+ ...+.++.+||.+||+.||++||+
T Consensus 184 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps-- 256 (278)
T 3cok_A 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP-----SFLSIEAKDLIHQLLRRNPADRLS-- 256 (278)
T ss_dssp --------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC-----TTSCHHHHHHHHHHSCSSGGGSCC--
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc-----cccCHHHHHHHHHHcccCHhhCCC--
Confidence 9998899999999999999999999999988766666555544433322 223448999999999999999999
Q ss_pred CChHHHHcCCCcCCCC
Q 013016 398 RGAADVKTHPFFKGLN 413 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~ 413 (451)
+.++++||||++..
T Consensus 257 --~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 257 --LSSVLDHPFMSRNS 270 (278)
T ss_dssp --HHHHTTSTTTC---
T ss_pred --HHHHhcCccccCCC
Confidence 99999999999844
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=394.58 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=213.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-----CCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-----HPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~nIv~l 154 (451)
++|.+.++||+|+||+||+|.+..+++ .||||++.... ........|+.+++.+. |+||+++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCe---------EEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 779999999999999999999877655 49999997432 22344556899999986 9999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--------
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-------- 226 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-------- 226 (451)
++++...++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 999999998877677999999999999999999999999999999999999975
Q ss_pred -----------------CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccC
Q 013016 227 -----------------DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLT 289 (451)
Q Consensus 227 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (451)
++.+||+|||++.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---------------------------------------------- 214 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---------------------------------------------- 214 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----------------------------------------------
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC----------------------------------------------
Confidence 78999999999843211
Q ss_pred CCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC
Q 013016 290 PNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS 369 (451)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 369 (451)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.......+...
T Consensus 215 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 282 (360)
T 3llt_A 215 ------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNM 282 (360)
T ss_dssp ------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHH
T ss_pred ------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHH
Confidence 01134789999999999999999999999999999999999999998877776666554322222100
Q ss_pred ----------------------CC-------------------CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCC
Q 013016 370 ----------------------PS-------------------SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408 (451)
Q Consensus 370 ----------------------~~-------------------~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~ 408 (451)
+. ...+..+.+||.+||++||++||| +.|+|+|||
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----a~elL~hp~ 358 (360)
T 3llt_A 283 LYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS----PAELLKHKF 358 (360)
T ss_dssp HHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGG
T ss_pred HhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC----HHHHhcCcc
Confidence 00 001136789999999999999999 999999999
Q ss_pred cC
Q 013016 409 FK 410 (451)
Q Consensus 409 ~~ 410 (451)
|+
T Consensus 359 f~ 360 (360)
T 3llt_A 359 LE 360 (360)
T ss_dssp GC
T ss_pred cC
Confidence 96
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=388.54 Aligned_cols=265 Identities=26% Similarity=0.377 Sum_probs=201.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 73 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGV---------YVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIH 73 (317)
T ss_dssp --------------CEEEEEECSSSCC---------EEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCc---------EEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence 689999999999999999999876655 49999997542 1223345667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
.++..|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcC
Confidence 9999999999996 69998886532 245899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++....... ......+||+.|+||
T Consensus 153 g~~~~~~~~~-------------------------------------------------------~~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 153 GLARAFGIPV-------------------------------------------------------NTFSSEVVTLWYRAP 177 (317)
T ss_dssp SSCEETTSCC-------------------------------------------------------CCCCCCCSCCTTCCH
T ss_pred ccceecCCCc-------------------------------------------------------ccCCCCcccccccCc
Confidence 9985322100 001123789999999
Q ss_pred ccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC-------------------------
Q 013016 316 EVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS------------------------- 369 (451)
Q Consensus 316 E~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------- 369 (451)
|++.+. .++.++|||||||++|+|++|+.||.+....+.+..+.......+...
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (317)
T 2pmi_A 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQV 257 (317)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHH
T ss_pred hHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHh
Confidence 999874 589999999999999999999999999888777766654211110000
Q ss_pred ----CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 ----PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ----~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.....+.++.+||.+||+.||++||| +.|+|+||||++....
T Consensus 258 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHH 303 (317)
T ss_dssp HGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC-
T ss_pred hcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccch
Confidence 01123448999999999999999999 9999999999985554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=386.81 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=226.4
Q ss_pred CCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 80 RDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
++|.+. +.||+|+||+||+|.++.+++ .||||++...... ......+.+|+.+++.+ +||||++++++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQ---------EYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCC---------EEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 458887 889999999999999987665 4999999764322 22345677799999998 46999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CCCEEEec
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSD 234 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~~~kl~D 234 (451)
+...+..|+||||+.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999999999987766677999999999999999999999999999999999999997 78999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .......||+.|+|
T Consensus 178 fg~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~a 201 (327)
T 3lm5_A 178 FGMSRKIGHA--------------------------------------------------------CELREIMGTPEYLA 201 (327)
T ss_dssp GGGCEEC-----------------------------------------------------------------CCCGGGCC
T ss_pred CccccccCCc--------------------------------------------------------cccccccCCcCccC
Confidence 9998532110 00112479999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++.+..++.++|||||||++|+|++|+.||......+....+......++........+ .+.+||.+||+.||.+||
T Consensus 202 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~li~~~L~~dP~~Rp 280 (327)
T 3lm5_A 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVKNPEKRP 280 (327)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH-HHHHHHHHHSCSSGGGSC
T ss_pred CeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH-HHHHHHHHHcCCChhhCc
Confidence 9999999999999999999999999999999999988888888887776666555444444 899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCcccc
Q 013016 395 GSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~~~ 417 (451)
| ++++|+||||++.++...
T Consensus 281 t----~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 281 T----AEICLSHSWLQQWDFENL 299 (327)
T ss_dssp C----HHHHTTCGGGCCCCTTCC
T ss_pred C----HHHHhCCHhhcccccccc
Confidence 9 999999999999888755
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=406.33 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=208.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.+..+++ .||||++.+.. ........+.+|+.+++.++||||+++++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 130 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVF 130 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCC---------EEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4789999999999999999999887765 49999997653 2334456777899999999999999999999
Q ss_pred EeC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EAS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
... .++||||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 131 ~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 131 TPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp CSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred ccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEE
Confidence 654 467999999954 56666543 3899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++..... .......+||+.|
T Consensus 206 ~DFG~a~~~~~--------------------------------------------------------~~~~~~~~gt~~y 229 (464)
T 3ttj_A 206 LDFGLARTAGT--------------------------------------------------------SFMMTPYVVTRYY 229 (464)
T ss_dssp CCCCCC-------------------------------------------------------------CCCC----CCCTT
T ss_pred EEEEeeeecCC--------------------------------------------------------CcccCCCcccccc
Confidence 99999843211 0011234899999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC----------------------CCC-
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP----------------------TQS- 369 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------------------~~~- 369 (451)
+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..++....... ...
T Consensus 230 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (464)
T 3ttj_A 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 309 (464)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCH
T ss_pred cCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCCh
Confidence 999999999999999999999999999999999999887777666654211110 000
Q ss_pred ----CC----Cc------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 370 ----PS----SM------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 370 ----~~----~~------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
+. .. .+.++++||.+||.+||++||| ++|+|+||||+..
T Consensus 310 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 310 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVW 362 (464)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGG
T ss_pred HHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhhc
Confidence 00 00 0347899999999999999999 9999999999963
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=394.01 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=216.2
Q ss_pred CceE--EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 81 DFDL--HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 81 ~y~~--~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.|.+ .+.||+|+||.||+|.+..+++ .||+|++..... .....+.+|+.++++++||||+++++++
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~---------~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 155 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGL---------KLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAF 155 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCC---------EEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCc---------EEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3554 6789999999999999887665 499999986532 2335677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE--ccCCCEEEeccC
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--RSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll--~~~~~~kl~Dfg 236 (451)
...+.+||||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 156 ~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 156 ESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence 99999999999999999999886542 458999999999999999999999999999999999999 456789999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 235 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 258 (373)
T 2x4f_A 235 LARRYKPR--------------------------------------------------------EKLKVNFGTPEFLAPE 258 (373)
T ss_dssp SCEECCTT--------------------------------------------------------CBCCCCCSSCTTCCHH
T ss_pred CceecCCc--------------------------------------------------------cccccccCCCcEeChh
Confidence 98532210 0111236999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......++........ .++.+||.+||+.||.+||+
T Consensus 259 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~Rps- 336 (373)
T 2x4f_A 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS-EEAKEFISKLLIKEKSWRIS- 336 (373)
T ss_dssp HHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSC-HHHHHHHHTTSCSSGGGSCC-
T ss_pred hccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCC-HHHHHHHHHHcCCChhhCCC-
Confidence 9998889999999999999999999999999998888888888876655544333333 48999999999999999999
Q ss_pred CCChHHHHcCCCcCCCCcc
Q 013016 397 KRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~~ 415 (451)
+.|+|+||||++.++.
T Consensus 337 ---~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 337 ---ASEALKHPWLSDHKLH 352 (373)
T ss_dssp ---HHHHHHSHHHHCHHHH
T ss_pred ---HHHHhcCcCcCCCchh
Confidence 9999999999996554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=392.37 Aligned_cols=283 Identities=36% Similarity=0.682 Sum_probs=224.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-HHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-KKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
..++|.+.+.||+|+||+||+|++.... ..+..||||++.+.... .......+..|+.+++.+ +|+||++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence 3478999999999999999999985321 12235999999754211 112233455689999999 699999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 126 YAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred EEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeC
Confidence 9999999999999999999999998765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... ........++||+.|+||
T Consensus 204 G~a~~~~~------------------------------------------------------~~~~~~~~~~gt~~y~aP 229 (355)
T 1vzo_A 204 GLSKEFVA------------------------------------------------------DETERAYDFCGTIEYMAP 229 (355)
T ss_dssp SEEEECCG------------------------------------------------------GGGGGGCGGGSCCTTCCH
T ss_pred CCCeeccc------------------------------------------------------CCCCcccCcccCcCccCh
Confidence 99843210 001112235799999999
Q ss_pred ccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 316 EVASGG--SHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 316 E~~~~~--~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|++.+. .++.++|||||||++|+|++|+.||.... .......+......++.. .+..+.+||.+||+.|
T Consensus 230 E~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~L~~d 304 (355)
T 1vzo_A 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE-----MSALAKDLIQRLLMKD 304 (355)
T ss_dssp HHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSS
T ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc-----cCHHHHHHHHHHhhhC
Confidence 999863 47899999999999999999999997532 334455555554444432 2338999999999999
Q ss_pred cCCcC-----CCCCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 390 PCNRL-----GSKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 390 P~~Rp-----t~~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
|.+|| + ++|+++||||++++|..+ +..++|+.|..+..
T Consensus 305 P~~R~~~~~~s----~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~ 349 (355)
T 1vzo_A 305 PKKRLGCGPRD----ADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 349 (355)
T ss_dssp GGGSTTSSTTT----HHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred HHHhcCCCCCC----HHHHHcCcchhcCChhHhhhccCCCCCCCccccc
Confidence 99999 7 999999999999999754 56667777777653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=376.73 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=224.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||+|++...........+.+..|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKE---------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCc---------eEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 679999999999999999999987665 49999998765444455567788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 999999999999999999988764 459999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 164 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 188 (294)
T 2rku_A 164 KVEYD-------------------------------------------------------GERKKVLCGTPNYIAPEVLS 188 (294)
T ss_dssp ECCST-------------------------------------------------------TCCBCCCCSCCSSCCHHHHT
T ss_pred ecccC-------------------------------------------------------ccccccccCCCCcCCcchhc
Confidence 32110 00111247899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++||||||+++|+|++|+.||......+....+.......+.. .+..+.+||.+||+.||++||+
T Consensus 189 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps---- 259 (294)
T 2rku_A 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH-----INPVAASLIQKMLQTDPTARPT---- 259 (294)
T ss_dssp TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-----SCHHHHHHHHHHTCSSGGGSCC----
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccc-----cCHHHHHHHHHHcccChhhCcC----
Confidence 9889999999999999999999999999988888888877766555433 2348999999999999999999
Q ss_pred hHHHHcCCCcCCCCc
Q 013016 400 AADVKTHPFFKGLNF 414 (451)
Q Consensus 400 ~~ell~hp~~~~~~~ 414 (451)
+.|+++||||++...
T Consensus 260 ~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 260 INELLNDEFFTSGYI 274 (294)
T ss_dssp GGGGGGSHHHHTSCC
T ss_pred HHHHhhChheecCCc
Confidence 999999999998544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.86 Aligned_cols=271 Identities=30% Similarity=0.468 Sum_probs=222.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH--HHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE--KKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
++|.+.+.||+|+||+||+|.++.+++ .||+|++.+.... .......+..|+.++++++||||++++++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRA---------IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCc---------eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 679999999999999999999877765 4999999876432 23445678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC--------------------------------------CCCCCHHHHHHHHHH
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP--------------------------------------HKRFSLTSARFYAAE 199 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~q 199 (451)
+.+.+..|+||||++||+|.+++.... ...+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 999999999999999999999885210 112467888999999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEccCC--CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhc
Q 013016 200 VLVALEYLHMLGIIYRDLKPENVLVRSDG--HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLN 277 (451)
Q Consensus 200 il~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (451)
|+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------- 225 (345)
T 3hko_A 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN------------------------------- 225 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-------------------------------
T ss_pred HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc-------------------------------
Confidence 99999999999999999999999998776 899999999853211100
Q ss_pred cccCCccccccCCCcccccccccccccccccCCCccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013016 278 RFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355 (451)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 355 (451)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..
T Consensus 226 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 285 (345)
T 3hko_A 226 --------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285 (345)
T ss_dssp --------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence 00001123479999999999976 56899999999999999999999999999998888
Q ss_pred HHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 356 ~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
..+......++...... .+.++.+||.+||+.||.+||+ +.|+|+||||++..+.
T Consensus 286 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 286 SQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHCCCCTTSGGGGG-SCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSC
T ss_pred HHHHhcccccCCccccc-CCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHh
Confidence 88888776555433322 3348999999999999999999 9999999999996654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=384.85 Aligned_cols=264 Identities=27% Similarity=0.418 Sum_probs=224.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++........ .....+.+|+.+++.++||||+++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 82 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGL---------EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCe---------EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 679999999999999999999987665 499999976432211 12456778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl 232 (451)
++...+..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 999999999999999999999999764 5689999999999999999999999999999999999999888 7999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||+.|
T Consensus 161 ~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y 184 (321)
T 2a2a_A 161 IDFGLAHEIEDG--------------------------------------------------------VEFKNIFGTPEF 184 (321)
T ss_dssp CCCTTCEECCTT--------------------------------------------------------CCCCCCCSCGGG
T ss_pred ccCccceecCcc--------------------------------------------------------ccccccCCCCCc
Confidence 999998532210 001124689999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+|||++.+..++.++|||||||++|+|++|..||......+.+..+......++...... .+..+.+||.+||+.||.+
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~ 263 (321)
T 2a2a_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH-TSELAKDFIRKLLVKETRK 263 (321)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT-CCHHHHHHHHTTSCSSTTT
T ss_pred cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc-cCHHHHHHHHHHcCCChhh
Confidence 999999998999999999999999999999999999888888888887665544322222 2338999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||| +.|+++||||+.+++.
T Consensus 264 Rps----~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 264 RLT----IQEALRHPWITPVDNQ 282 (321)
T ss_dssp SCC----HHHHHHSTTTSCSSHH
T ss_pred CcC----HHHHhcCccccCCCcc
Confidence 999 9999999999997764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=384.41 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=224.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||+|++.+.........+.+.+|+.+++.++|+||+++++++.
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKE---------VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 679999999999999999999987665 49999998765444455667788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 999999999999999999988764 459999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 190 ~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~~~ 214 (335)
T 2owb_A 190 KVEYD-------------------------------------------------------GERKKVLCGTPNYIAPEVLS 214 (335)
T ss_dssp ECCST-------------------------------------------------------TCCBCCCCSCCSSCCHHHHH
T ss_pred ecccC-------------------------------------------------------cccccccCCCccccCHHHhc
Confidence 32110 00111247899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||......+.+..+......++.. .+..+.+||.+||+.||++||+
T Consensus 215 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps---- 285 (335)
T 2owb_A 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH-----INPVAASLIQKMLQTDPTARPT---- 285 (335)
T ss_dssp TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT-----SCHHHHHHHHHHTCSSGGGSCC----
T ss_pred cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc-----CCHHHHHHHHHHccCChhHCcC----
Confidence 9889999999999999999999999999988888887777766555433 2348999999999999999999
Q ss_pred hHHHHcCCCcCCCC
Q 013016 400 AADVKTHPFFKGLN 413 (451)
Q Consensus 400 ~~ell~hp~~~~~~ 413 (451)
+.|+++||||++..
T Consensus 286 ~~ell~~~~~~~~~ 299 (335)
T 2owb_A 286 INELLNDEFFTSGY 299 (335)
T ss_dssp GGGGGGSHHHHTSC
T ss_pred HHHHhcCccccCCC
Confidence 99999999999843
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=388.15 Aligned_cols=256 Identities=26% Similarity=0.488 Sum_probs=197.4
Q ss_pred CCceEE---eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCcccee
Q 013016 80 RDFDLH---RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLY 155 (451)
Q Consensus 80 ~~y~~~---~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~ 155 (451)
++|++. +.||+|+||+||+|.++.+++ .||||++.+.. .....+|+.+++.+. ||||++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~ 72 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQ---------AFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLH 72 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCC---------EEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCC---------EEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEE
Confidence 557775 789999999999999987665 49999997542 234556999999997 99999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CEEE
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HIML 232 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~kl 232 (451)
+++.+.++.|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 73 EVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEE
T ss_pred EEEEcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEE
Confidence 9999999999999999999999999875 5699999999999999999999999999999999999998766 8999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......+||+.|
T Consensus 151 ~Dfg~a~~~~~~-------------------------------------------------------~~~~~~~~~t~~y 175 (325)
T 3kn6_A 151 IDFGFARLKPPD-------------------------------------------------------NQPLKTPCFTLHY 175 (325)
T ss_dssp CCCTTCEECCC---------------------------------------------------------------------
T ss_pred eccccceecCCC-------------------------------------------------------CCcccccCCCcCc
Confidence 999998532110 0011134789999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-------NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+..+..+...++...+... +.++.+||.+|
T Consensus 176 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-s~~~~~li~~~ 254 (325)
T 3kn6_A 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV-SQEAKDLIQGL 254 (325)
T ss_dssp --------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS-CHHHHHHHHHH
T ss_pred cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC-CHHHHHHHHHH
Confidence 99999999999999999999999999999999998643 34567777776665544332233 33899999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
|+.||.+||| +.|+++||||++.
T Consensus 255 L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 255 LTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp HCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred CCCChhHCCC----HHHHhcChhhccC
Confidence 9999999999 9999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=396.45 Aligned_cols=285 Identities=23% Similarity=0.377 Sum_probs=208.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~ 157 (451)
.++|++.+.||+|+||+||+|.++.+++ .||||++.+.. ........+.+|+.+++.+. ||||++++++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGE---------VVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCC---------EEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCC---------EEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 3789999999999999999999887765 49999986542 22344566778999999997 9999999999
Q ss_pred EEeCC--eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEASN--FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+...+ .+|+|||||. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence 97554 7999999995 789998876 35899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++............. ....... ..............+||+.|+||
T Consensus 154 G~a~~~~~~~~~~~~~-----------------~~~~~~~-----------------~~~~~~~~~~~~~~~gt~~y~aP 199 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNI-----------------PLSINEN-----------------TENFDDDQPILTDYVATRWYRAP 199 (388)
T ss_dssp TTCEESSSCCCCCCCG-----------------GGCCC--------------------------------CCCGGGGCCH
T ss_pred cccccccccccccccc-----------------ccccccc-----------------ccccccccccccCCcccCCcCCH
Confidence 9986543211110000 0000000 00000011122345899999999
Q ss_pred ccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC--------------------------C
Q 013016 316 EVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT--------------------------Q 368 (451)
Q Consensus 316 E~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~ 368 (451)
|++.+ ..++.++|||||||++|||++|+.||.+.+....+..+......... .
T Consensus 200 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (388)
T 3oz6_A 200 EILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279 (388)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC----
T ss_pred HHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCC
Confidence 99987 56899999999999999999999999998887777776532111100 0
Q ss_pred C----------------CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 369 S----------------PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 369 ~----------------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
. .....+.++.+||.+||++||++||| +.|+|+||||+.....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFHNP 338 (388)
T ss_dssp -CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTCCG
T ss_pred CHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhcCC
Confidence 0 00122348999999999999999999 9999999999986544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=380.31 Aligned_cols=278 Identities=26% Similarity=0.382 Sum_probs=226.0
Q ss_pred hhhhhhhhhccCCCC-CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHH
Q 013016 61 FAYSAIRSATFGRKT-GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139 (451)
Q Consensus 61 ~~~~~~~~~~~~~~~-~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e 139 (451)
+++.+++.++..... +.....|...++||+|+||.||+|.++.+++ .||||++.... ....+.+.+|
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~---------~vavK~~~~~~---~~~~~~~~~E 92 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR---------QVAVKMMDLRK---QQRRELLFNE 92 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTT---CCSHHHHHHH
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCc---------EEEEEEEeccc---hhHHHHHHHH
Confidence 556666666532211 1111248888999999999999999886655 49999997542 2234556779
Q ss_pred HHHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 140 ~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
+.+++.++||||+++++++...+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||
T Consensus 93 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 169 (321)
T 2c30_A 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169 (321)
T ss_dssp HHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9999999999999999999999999999999999999998865 3599999999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+|||++.++.+||+|||++......
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~------------------------------------------------------- 194 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKD------------------------------------------------------- 194 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSS-------------------------------------------------------
T ss_pred HHEEECCCCcEEEeeeeeeeecccC-------------------------------------------------------
Confidence 9999999999999999997432210
Q ss_pred cccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHH
Q 013016 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 379 (451)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+......... .....+..+.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 272 (321)
T 2c30_A 195 VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK--NSHKVSPVLR 272 (321)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT--TGGGSCHHHH
T ss_pred ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC--ccccCCHHHH
Confidence 00112347999999999999989999999999999999999999999988887777777665432211 1122344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+||.+||+.||++||| +.|+++||||++...
T Consensus 273 ~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 273 DFLERMLVRDPQERAT----AQELLDHPFLLQTGL 303 (321)
T ss_dssp HHHHHHSCSSTTTSCC----HHHHHTSGGGGGCCC
T ss_pred HHHHHHccCChhhCcC----HHHHhcChhhccCCC
Confidence 9999999999999999 999999999988554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=376.73 Aligned_cols=267 Identities=24% Similarity=0.432 Sum_probs=220.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.++|.+.+.||+|+||.||+|.+..+++ .||+|++....... ......+.+|+.+++.++|+||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLC---------RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCC---------EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCc---------EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 3789999999999999999999877665 49999998765432 2345677889999999999999999999
Q ss_pred EE--eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FE--ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+. +.+..|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~df 153 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL 153 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecc
Confidence 84 456899999999665 878887766678999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ ........||+.|+||
T Consensus 154 g~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 154 GVAEALHPFAA-----------------------------------------------------DDTCRTSQGSPAFQPP 180 (305)
T ss_dssp TTCEECCTTCS-----------------------------------------------------SCEECCCCSCGGGCCH
T ss_pred ccccccCcccc-----------------------------------------------------ccccccCCCCCCCcCh
Confidence 99853221000 0111134689999999
Q ss_pred ccccCCCC--CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 316 EVASGGSH--GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 316 E~~~~~~~--~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|++.+... +.++|||||||++|+|++|+.||......+....+......++.. .+..+.+||.+||+.||.+|
T Consensus 181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~R 255 (305)
T 2wtk_C 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD-----CGPPLSDLLKGMLEYEPAKR 255 (305)
T ss_dssp HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSS-----SCHHHHHHHHHHTCSSTTTS
T ss_pred hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCc-----cCHHHHHHHHHHccCChhhC
Confidence 99987543 789999999999999999999999988888888887776554432 33489999999999999999
Q ss_pred CCCCCChHHHHcCCCcCCCCcccc
Q 013016 394 LGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
|+ +.|+++||||++......
T Consensus 256 ps----~~~ll~~~~~~~~~~~~~ 275 (305)
T 2wtk_C 256 FS----IRQIRQHSWFRKKHPPAE 275 (305)
T ss_dssp CC----HHHHHHSHHHHSCCCC-C
T ss_pred CC----HHHHhcCcccccCCCCcC
Confidence 99 999999999998655443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=389.31 Aligned_cols=276 Identities=25% Similarity=0.365 Sum_probs=216.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+..+++ .||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 93 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILER---------NVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCc---------eEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence 4789999999999999999999877665 49999997542 2233456677899999999999999999999
Q ss_pred EeCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
...+ ..|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp CSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEE
Confidence 7665 7899999995 678887753 3899999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......+||+.|
T Consensus 169 ~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 192 (371)
T 2xrw_A 169 LDFGLARTAGTS--------------------------------------------------------FMMTPYVVTRYY 192 (371)
T ss_dssp CCCCC------------------------------------------------------------------------CTT
T ss_pred EEeecccccccc--------------------------------------------------------cccCCceecCCc
Confidence 999998422100 011124789999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-------------------CC----
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT-------------------QS---- 369 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------------~~---- 369 (451)
+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......... ..
T Consensus 193 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (371)
T 2xrw_A 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 272 (371)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCH
T ss_pred cCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccch
Confidence 9999999999999999999999999999999999998887777777654322110 00
Q ss_pred --------CCC------cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCCCCC
Q 013016 370 --------PSS------MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMR 429 (451)
Q Consensus 370 --------~~~------~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p~~~ 429 (451)
.+. ..+.++++||.+||+.||.+||| ++|+|+||||+...........+|.+|...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 273 EKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPPPKIPDKQ 342 (371)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCCCCCCTTT
T ss_pred hhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCCCCCCChh
Confidence 000 01347899999999999999999 999999999998555555556666665543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=373.57 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=213.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.++. .||+|++..... ......+.+|+.++++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 90 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGL---------ERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCc---------eEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence 679999999999999999999887665 399999986532 223456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEec
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSD 234 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~D 234 (451)
+.+..|+||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 999999999999999999987543 23569999999999999999999999999999999999999 4567899999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .......||+.|+|
T Consensus 171 fg~a~~~~~~--------------------------------------------------------~~~~~~~~t~~y~a 194 (285)
T 3is5_A 171 FGLAELFKSD--------------------------------------------------------EHSTNAAGTALYMA 194 (285)
T ss_dssp CCCCCC------------------------------------------------------------------CTTGGGCC
T ss_pred eecceecCCc--------------------------------------------------------ccCcCcccccCcCC
Confidence 9998432110 01112468999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++. ..++.++|||||||++|+|++|+.||......+....+......+..... ..+.++.+||.+||+.||.+||
T Consensus 195 PE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR--PLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp HHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C--CCCHHHHHHHHHHTCSCTTTSC
T ss_pred hHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC--cCCHHHHHHHHHHccCChhhCc
Confidence 99886 46899999999999999999999999998887777776665544433221 1344899999999999999999
Q ss_pred CCCCChHHHHcCCCcCC
Q 013016 395 GSKRGAADVKTHPFFKG 411 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~ 411 (451)
+ +.|+|+||||++
T Consensus 272 s----~~e~l~hp~f~~ 284 (285)
T 3is5_A 272 S----AAQVLHHEWFKQ 284 (285)
T ss_dssp C----HHHHHTSGGGGC
T ss_pred C----HHHHhcCHHhhc
Confidence 9 999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=375.88 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=211.6
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|++.++||+|+||+||+|.+..+++ .||||++..... .......+.+|+.++++++||||+++++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 71 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQ---------IVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVF 71 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCc---------EEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhhee
Confidence 3789999999999999999999987665 499999865432 233445677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 72 RRKRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 9999999999999999999887764 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .......||+.|+|||++
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~ 174 (311)
T 4agu_A 150 RLLTGPS-------------------------------------------------------DYYDDEVATRWYRSPELL 174 (311)
T ss_dssp EECC-------------------------------------------------------------------GGGCCHHHH
T ss_pred hhccCcc-------------------------------------------------------cccCCCcCCccccChHHH
Confidence 5322100 011123789999999999
Q ss_pred cC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------------------CCCCCC--C-----C
Q 013016 319 SG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-------------------TFPTQS--P-----S 371 (451)
Q Consensus 319 ~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------------~~~~~~--~-----~ 371 (451)
.+ ..++.++|||||||++|+|++|+.||.+....+....+..... ..+... . .
T Consensus 175 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 4agu_A 175 VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254 (311)
T ss_dssp HTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHC
T ss_pred hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhc
Confidence 77 5679999999999999999999999998877766554432110 011100 0 0
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
...+.++.+||.+||++||.+||| ++|+|+||||+++.+..
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 255 PNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREIE 295 (311)
T ss_dssp TTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC---
T ss_pred ccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCHH
Confidence 123347899999999999999999 99999999999976643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=374.94 Aligned_cols=256 Identities=32% Similarity=0.506 Sum_probs=220.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||.||+|.++.+.. .||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRI---------RRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFE 76 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCc---------EEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 679999999999999999999887765 399999976532 23456777999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg 236 (451)
..+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 999999999999999999988765 459999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .......||+.|+|||
T Consensus 155 ~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aPE 178 (277)
T 3f3z_A 155 LAARFKPG--------------------------------------------------------KMMRTKVGTPYYVSPQ 178 (277)
T ss_dssp TCEECCTT--------------------------------------------------------SCBCCCCSCTTTCCHH
T ss_pred cceeccCc--------------------------------------------------------cchhccCCCCCccChH
Confidence 98432210 0111237899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+. ++.++|||||||++|+|++|+.||......+....+..+...++....... +..+.+||.+||+.||.+||+
T Consensus 179 ~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~s- 255 (277)
T 3f3z_A 179 VLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV-SPQAESLIRRLLTKSPKQRIT- 255 (277)
T ss_dssp HHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS-CHHHHHHHHHHTCSSTTTSCC-
T ss_pred Hhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC-CHHHHHHHHHHccCChhhCcC-
Confidence 98764 899999999999999999999999999888888888888766654332233 338999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.++|+||||++
T Consensus 256 ---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 256 ---SLQALEHEWFEK 267 (277)
T ss_dssp ---HHHHTTSHHHHH
T ss_pred ---HHHHhcCHHHhc
Confidence 999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=383.38 Aligned_cols=268 Identities=26% Similarity=0.342 Sum_probs=212.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH--HHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK--KKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
++|.+.+.||+|+||.||+|.+..+++ .||||++....... ......+.+|+.+++.++||||++++++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCS---------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCc---------EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 789999999999999999999887655 49999997543222 1223467789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 81 FGHKSNISLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp ECCTTCCEEEEECCS-EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred EeeCCceEEEEEcCC-CCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999999995 5888887654 34689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... ......+||+.|+|||+
T Consensus 159 a~~~~~~~-------------------------------------------------------~~~~~~~~t~~y~aPE~ 183 (346)
T 1ua2_A 159 AKSFGSPN-------------------------------------------------------RAYTHQVVTRWYRAPEL 183 (346)
T ss_dssp GSTTTSCC-------------------------------------------------------CCCCCSCCCCTTCCHHH
T ss_pred ceeccCCc-------------------------------------------------------ccCCcccccccccCchH
Confidence 85322100 01112478999999999
Q ss_pred ccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC-----------------------Cc
Q 013016 318 ASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS-----------------------SM 373 (451)
Q Consensus 318 ~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----------------------~~ 373 (451)
+.+. .++.++|||||||++|+|++|..||.+....+.+..+...........++ ..
T Consensus 184 ~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (346)
T 1ua2_A 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 263 (346)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred hhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence 9764 48999999999999999999999999988888777776532111111110 12
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccc
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
.+.++.+||.+||+.||.+||| +.|+|+||||++...+..
T Consensus 264 ~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 264 AGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCC
T ss_pred CCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCC
Confidence 2348999999999999999999 999999999999766544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=370.38 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=217.0
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.+.||+|+||.||+|.++.+++ .||||++.............+.+|+.+++.++||||+++++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 78 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGH---------KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCc---------eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 345889999999999999999999886655 49999998765555455667888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 79 VISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecc
Confidence 999999999999999999999998765 458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .......|++.|+|||
T Consensus 157 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 157 LSNMMSDG--------------------------------------------------------EFLRTSCGSPNYAAPE 180 (276)
T ss_dssp GGGCCCC---------------------------------------------------------------------CCTG
T ss_pred cccccCCC--------------------------------------------------------cceecccCCccccCHH
Confidence 97432110 0011236889999999
Q ss_pred cccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..+ +.++||||||+++|+|++|+.||...........+..+....+.. .+..+.++|.+||+.||.+||+
T Consensus 181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-----LNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchh-----cCHHHHHHHHHHccCChhhCCC
Confidence 9988765 689999999999999999999999888888877777765544432 3348999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.|+++||||++
T Consensus 256 ----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 256 ----IKDIREHEWFKQ 267 (276)
T ss_dssp ----HHHHHHSHHHHT
T ss_pred ----HHHHHhChhhcc
Confidence 999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=403.52 Aligned_cols=260 Identities=31% Similarity=0.502 Sum_probs=222.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||||++.+.... ......+.+|+.++++++||||+++++++.
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ---------EYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCC---------EEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCC---------EEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 679999999999999999999887665 4999999765432 223466778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc---cCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR---SDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg 236 (451)
..+.+|+|||||.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 999999999999999999988765 4599999999999999999999999999999999999995 45679999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 170 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 193 (486)
T 3mwu_A 170 LSTCFQQN--------------------------------------------------------TKMKDRIGTAYYIAPE 193 (486)
T ss_dssp CTTTBCCC------------------------------------------------------------CCTTGGGGCCGG
T ss_pred cCeECCCC--------------------------------------------------------CccCCCcCCCCCCCHH
Confidence 98532210 0111247999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..+...++...+.... .++++||.+||++||.+|||
T Consensus 194 ~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dp~~R~t- 270 (486)
T 3mwu_A 194 VLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS-DDAKDLIRKMLTFHPSLRIT- 270 (486)
T ss_dssp GGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC-HHHHHHHHHHTCSSTTTSCC-
T ss_pred HhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC-HHHHHHHHHHcCCChhhCcC-
Confidence 9976 58999999999999999999999999999999999998887766554444333 38999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
+.++|+||||++..
T Consensus 271 ---~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 271 ---ATQCLEHPWIQKYS 284 (486)
T ss_dssp ---HHHHHHCHHHHHTC
T ss_pred ---HHHHhcCHhhccCc
Confidence 99999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=387.33 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=204.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++..... ....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKE---------LVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCC---------EEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCc---------EEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 789999999999999999999987665 499999975422 2245667999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC--EEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH--IMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~ 237 (451)
..+.+|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 999999999999999999998764 45999999999999999999999999999999999999987765 99999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+..... .......+||+.|+|||+
T Consensus 165 a~~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~ 188 (361)
T 3uc3_A 165 SKSSVL--------------------------------------------------------HSQPKSTVGTPAYIAPEV 188 (361)
T ss_dssp C-----------------------------------------------------------------------CTTSCHHH
T ss_pred cccccc--------------------------------------------------------cCCCCCCcCCCCcCChhh
Confidence 742110 011123479999999999
Q ss_pred ccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 318 ASGGSHGNA-VDWWAFGIFIYEMIYGRTPFAAPSN----ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 318 ~~~~~~~~~-~DIwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+.+..++.+ +|||||||++|+|++|+.||..... ...+..+......++... ..+.++.+||.+||+.||.+
T Consensus 189 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~ 265 (361)
T 3uc3_A 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI---RISPECCHLISRIFVADPAT 265 (361)
T ss_dssp HHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS---CCCHHHHHHHHHHSCSCTTT
T ss_pred hcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC---CCCHHHHHHHHHHccCChhH
Confidence 988887655 8999999999999999999987543 344555555554444321 23348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCC
Q 013016 393 RLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~ 411 (451)
||| +.||++||||.+
T Consensus 266 Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 266 RIS----IPEIKTHSWFLK 280 (361)
T ss_dssp SCC----HHHHHTSHHHHT
T ss_pred CcC----HHHHHhCcchhc
Confidence 999 999999999966
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=404.26 Aligned_cols=260 Identities=30% Similarity=0.491 Sum_probs=218.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.++. .||||++.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHV---------ERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCC---------EEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCc---------EEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 679999999999999999999987665 49999998654322 23456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg 236 (451)
+.+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 999999999999999999888765 459999999999999999999999999999999999999764 459999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 185 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 208 (494)
T 3lij_A 185 LSAVFENQ--------------------------------------------------------KKMKERLGTAYYIAPE 208 (494)
T ss_dssp TCEECBTT--------------------------------------------------------BCBCCCCSCTTTCCHH
T ss_pred CCeECCCC--------------------------------------------------------ccccccCCCcCeeCHH
Confidence 98532210 0111347999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+ .++.++|||||||++|+|++|..||.+....+.+..+..+...++...+....+ .+++||.+||++||.+|||
T Consensus 209 ~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp~~R~s- 285 (494)
T 3lij_A 209 VLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE-GAKDLIKQMLQFDSQRRIS- 285 (494)
T ss_dssp HHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH-HHHHHHHHHTCSSTTTSCC-
T ss_pred HHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH-HHHHHHHHHCCCChhhCcc-
Confidence 9864 689999999999999999999999999999999999988877766554444444 8999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
+.|+|+||||++..
T Consensus 286 ---~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 286 ---AQQALEHPWIKEMC 299 (494)
T ss_dssp ---HHHHHTCHHHHHHH
T ss_pred ---HHHHhcCcccccCc
Confidence 99999999998843
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=371.40 Aligned_cols=267 Identities=26% Similarity=0.429 Sum_probs=222.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH------HHHHHHHHHHHHHHHHHHHCC-CCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV------LEKKKKVHRAEMEKKILKMLD-HPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~-h~nIv 152 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++.... .........+.+|+.+++++. ||||+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCK---------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred hccceeeeecCCCceEEEEEEEcCcCc---------eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 789999999999999999999987665 49999996432 112233456778999999995 99999
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
++++++...+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999999999999764 45999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......|++.|
T Consensus 166 ~dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 189 (298)
T 1phk_A 166 TDFGFSCQLDPG--------------------------------------------------------EKLREVCGTPSY 189 (298)
T ss_dssp CCCTTCEECCTT--------------------------------------------------------CCBCCCCSCGGG
T ss_pred ecccchhhcCCC--------------------------------------------------------cccccccCCccc
Confidence 999997432110 011123689999
Q ss_pred cCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 313 VSPEVAS------GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 313 ~aPE~~~------~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+|||++. ...++.++|||||||++|+|++|..||...........+..+...++...... .+..+.+||.+||
T Consensus 190 ~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l 268 (298)
T 1phk_A 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD-YSDTVKDLVSRFL 268 (298)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG-SCHHHHHHHHHHC
T ss_pred cCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccc-cCHHHHHHHHHHc
Confidence 9999985 45678999999999999999999999999888888888887766555433222 3448999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCCCccccc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFALIR 418 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~ 418 (451)
+.||.+||+ +.|+++||||++..+...+
T Consensus 269 ~~dp~~Rps----~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 269 VVQPQKRYT----AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp CSSGGGSCC----HHHHTTSGGGCTTC-----
T ss_pred cCCcccCCC----HHHHHhChHhhhccchhhc
Confidence 999999999 9999999999997765543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=402.78 Aligned_cols=263 Identities=28% Similarity=0.451 Sum_probs=220.8
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH----------HHHHHHHHHHHHHHHCC
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK----------KKVHRAEMEKKILKMLD 147 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~ 147 (451)
..++|.+.++||+|+||+||+|.++.+++ .||||++.+...... ...+.+.+|+.+++.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHS---------EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCC---------EEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCc---------EEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 34789999999999999999999987765 499999986543221 23456788999999999
Q ss_pred CCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 148 h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
||||+++++++.+.+++|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 999999999999999999999999999999988765 459999999999999999999999999999999999999977
Q ss_pred C---CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 228 G---HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 228 ~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+ .+||+|||++...... ....
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~--------------------------------------------------------~~~~ 206 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKD--------------------------------------------------------YKLR 206 (504)
T ss_dssp TCCSSEEECCCTTCEECCTT--------------------------------------------------------SCBC
T ss_pred CCCccEEEEECCCCEEcCCC--------------------------------------------------------Cccc
Confidence 6 6999999998532210 0111
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..+...++...+....+ ++++||++
T Consensus 207 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~ 284 (504)
T 3q5i_A 207 DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD-EAKELIKL 284 (504)
T ss_dssp CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH-HHHHHHHH
T ss_pred cccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCH-HHHHHHHH
Confidence 2479999999999875 689999999999999999999999999999999999988876655433333333 89999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
||++||.+||| +.|+|+||||++..
T Consensus 285 ~L~~dp~~R~t----~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 285 MLTYDYNKRCT----AEEALNSRWIKKYA 309 (504)
T ss_dssp HTCSSTTTSCC----HHHHHTSHHHHHTC
T ss_pred HcCCChhHCCC----HHHHhcCHhhhhch
Confidence 99999999999 99999999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=383.84 Aligned_cols=266 Identities=17% Similarity=0.269 Sum_probs=217.1
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
....++|.+.+.||+|+||+||+|.+....+ .....+..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3445789999999999999999999864322 112334569999997652 234456788899999999 89999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
++++...+.+|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998653 235899999999999999999999999999999999
Q ss_pred cEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
|||++.++.+||+|||++........ .
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~-----------------------------------------------------~ 259 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDY-----------------------------------------------------Y 259 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCT-----------------------------------------------------T
T ss_pred hEEECCCCCEEEccccCCcccCcccc-----------------------------------------------------e
Confidence 99999999999999999853321100 0
Q ss_pred ccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHH
Q 013016 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379 (451)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 379 (451)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+..+..... +...+.++.
T Consensus 260 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~ 335 (370)
T 2psq_A 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK----PANCTNELY 335 (370)
T ss_dssp CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC----CTTSCHHHH
T ss_pred ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCCHHHH
Confidence 01112357888999999999999999999999999999999 9999999888877777766542211 122344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+||.+||+.||.+||+ +.|++++
T Consensus 336 ~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 336 MMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999 9998863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=406.27 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=224.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||||++.+...........+.+|+.++++++||||+++++++.
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQ---------ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCC---------EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 679999999999999999999887665 49999997654333344566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg 236 (451)
..+.+|+|||||.|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 999999999999999999988765 559999999999999999999999999999999999999 467899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ......+||+.|+|||
T Consensus 175 ~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE 198 (484)
T 3nyv_A 175 LSTHFEAS--------------------------------------------------------KKMKDKIGTAYYIAPE 198 (484)
T ss_dssp HHHHBCCC--------------------------------------------------------CSHHHHTTGGGTCCHH
T ss_pred eeEEcccc--------------------------------------------------------cccccCCCCccccCce
Confidence 98432110 0111247999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...+.... .++++||.+||++||.+|||
T Consensus 199 ~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dp~~R~s- 275 (484)
T 3nyv_A 199 VLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS-ESAKDLIRKMLTYVPSMRIS- 275 (484)
T ss_dssp HHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC-HHHHHHHHHHTCSSGGGSCC-
T ss_pred eecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC-HHHHHHHHHHCCCChhHCcC-
Confidence 9977 68999999999999999999999999999999999998887766544443333 48999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
+.|+|+||||+...
T Consensus 276 ---~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 276 ---ARDALDHEWIQTYT 289 (484)
T ss_dssp ---HHHHHTSHHHHHHT
T ss_pred ---HHHHhhChhhcccc
Confidence 99999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=384.29 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=216.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.++++++||||+++++++.
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHR---------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCc---------eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 789999999999999999999877665 49999998765445555677888999999999999999999987
Q ss_pred eCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 160 ASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 160 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
... ..|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeec
Confidence 654 459999999999999999765 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ ........+||+.|+||
T Consensus 161 g~a~~~~~~~~----------------------------------------------------~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 161 GIARAIADSGN----------------------------------------------------SVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp SCC----------------------------------------------------------------------CCTTCCH
T ss_pred cCccccccccc----------------------------------------------------ccccccccCcCcccCCH
Confidence 99853221000 00111234799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||...........+.......+...... .+.++.+||.+||+.||.+||+
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~R~~ 267 (311)
T 3ork_A 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG-LSADLDAVVLKALAKNPENRYQ 267 (311)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT-CCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC-CCHHHHHHHHHHHhcCHhhChh
Confidence 999999999999999999999999999999999888887777766654433222222 3348999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.+++.|+|++.
T Consensus 268 ----~~~~l~~~l~~~ 279 (311)
T 3ork_A 268 ----TAAEMRADLVRV 279 (311)
T ss_dssp ----SHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHH
Confidence 999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=374.46 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=220.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGK---------LFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYE 76 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCC---------EEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence 679999999999999999999886655 499999975432 22345677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg 236 (451)
..+..|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 77 STTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 999999999999999999988764 459999999999999999999999999999999999999 778899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++..... .......||+.|+|||
T Consensus 155 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~aPE 177 (304)
T 2jam_A 155 LSKMEQN---------------------------------------------------------GIMSTACGTPGYVAPE 177 (304)
T ss_dssp TTCCCCC---------------------------------------------------------BTTHHHHSCCCBCCTT
T ss_pred cceecCC---------------------------------------------------------CccccccCCCCccChH
Confidence 9742110 0011236899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..++.++|||||||++|+|++|+.||........+..+..+...++........ .++.+||.+||+.||.+||+
T Consensus 178 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dp~~Rps- 255 (304)
T 2jam_A 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS-ESAKDFICHLLEKDPNERYT- 255 (304)
T ss_dssp TBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC-HHHHHHHHHHHCSSTTTSCC-
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC-HHHHHHHHHHcCCChhHCcC-
Confidence 9999999999999999999999999999999988888888888877665554444433 48999999999999999999
Q ss_pred CCChHHHHcCCCcCCC
Q 013016 397 KRGAADVKTHPFFKGL 412 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~ 412 (451)
+.|+++||||++.
T Consensus 256 ---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 256 ---CEKALSHPWIDGN 268 (304)
T ss_dssp ---HHHHHTSHHHHSS
T ss_pred ---HHHHhcCccccCC
Confidence 9999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=382.53 Aligned_cols=270 Identities=26% Similarity=0.335 Sum_probs=216.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.++.+++ .||||++..... .......+.+|+.+++.++||||+++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 85 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQ---------KVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEIC 85 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCC---------EEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCC---------EEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhhee
Confidence 4789999999999999999999977665 499999865432 122234566799999999999999999999
Q ss_pred Ee--------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EA--------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
.. .+.+|+||||+. ++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 86 RTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp EEC--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred eccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCE
Confidence 87 457899999995 57777766543 459999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++......... .........||+
T Consensus 164 kl~Dfg~a~~~~~~~~~---------------------------------------------------~~~~~~~~~gt~ 192 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNS---------------------------------------------------QPNRYTNRVVTL 192 (351)
T ss_dssp EECCCTTCEECCCCSSS---------------------------------------------------SCCCCCSSCSCG
T ss_pred EEccchhcccccccccc---------------------------------------------------cccccCCccccc
Confidence 99999998543211100 011112347899
Q ss_pred CccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCc----------------
Q 013016 311 EYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM---------------- 373 (451)
Q Consensus 311 ~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---------------- 373 (451)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.......+...++..
T Consensus 193 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
T 3mi9_A 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 272 (351)
T ss_dssp GGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCC
T ss_pred CccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccc
Confidence 9999999987 45799999999999999999999999998888777766654333333222221
Q ss_pred -----------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 374 -----------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 374 -----------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.+..+.+||.+||++||++||| +.|+|+||||+....+
T Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 273 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPMP 321 (351)
T ss_dssp CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSCC
T ss_pred cCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCCc
Confidence 1346899999999999999999 9999999999985553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=392.25 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=211.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC------CCCCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML------DHPFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~nIv~ 153 (451)
.+|++.++||+|+||+||+|.+..+++ .||||++.... .....+..|+.+++.+ .|+||++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~---------~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~ 163 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIH 163 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTE---------EEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCc---------EEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence 679999999999999999999887655 49999997542 2234455677777776 5789999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC--EE
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH--IM 231 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~--~k 231 (451)
+++++...+++|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 164 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 164 MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEE
T ss_pred EEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceE
Confidence 999999999999999999 579999998876677999999999999999999999999999999999999999987 99
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++..... .....+||+.
T Consensus 243 L~DFG~a~~~~~----------------------------------------------------------~~~~~~gt~~ 264 (429)
T 3kvw_A 243 VIDFGSSCYEHQ----------------------------------------------------------RVYTYIQSRF 264 (429)
T ss_dssp ECCCTTCEETTC----------------------------------------------------------CCCSSCSCGG
T ss_pred EeecccceecCC----------------------------------------------------------cccccCCCCC
Confidence 999999742210 1113478999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCC-----------------------
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQ----------------------- 368 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~----------------------- 368 (451)
|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+.......+..
T Consensus 265 y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (429)
T 3kvw_A 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTV 344 (429)
T ss_dssp GCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCE
T ss_pred ccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccc
Confidence 999999999999999999999999999999999999988877766655321100000
Q ss_pred ------------------------C-------CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 369 ------------------------S-------PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 369 ------------------------~-------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
. .....+.++.+||.+||++||++||| +.|+|+||||++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L~Hpw~~~ 414 (429)
T 3kvw_A 345 TTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQALRHPWLRR 414 (429)
T ss_dssp ECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTTC-
T ss_pred cccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHhCChhhcc
Confidence 0 00112447899999999999999999 999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=383.27 Aligned_cols=260 Identities=29% Similarity=0.469 Sum_probs=218.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH-----HHHHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-----LEKKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
++|.+.+.||.|+||.||+|.++.+++ .||||++.... .........+..|+.+++++ +||||++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGH---------EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred hhcccceEEecCCCEEEEEEEECCCCc---------EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 579999999999999999999976655 39999987542 11223345677899999998 7999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
+++++...+..|+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999998764 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... ......+||+.|+
T Consensus 243 DfG~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~ 266 (365)
T 2y7j_A 243 DFGFSCHLEPG--------------------------------------------------------EKLRELCGTPGYL 266 (365)
T ss_dssp CCTTCEECCTT--------------------------------------------------------CCBCCCCSCGGGC
T ss_pred ecCcccccCCC--------------------------------------------------------cccccCCCCCCcc
Confidence 99997432210 0112347999999
Q ss_pred CcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 314 SPEVASG------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 314 aPE~~~~------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|||++.+ ..++.++|||||||++|+|++|+.||........+..+..+...++...+... +..+.+||.+||+
T Consensus 267 aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~li~~~L~ 345 (365)
T 2y7j_A 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR-SSTVKDLISRLLQ 345 (365)
T ss_dssp CHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSS-CHHHHHHHHHHSC
T ss_pred ChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccC-CHHHHHHHHHHcC
Confidence 9999863 35788999999999999999999999998888888888777655443222222 3389999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.||++||+ +.|+|+||||++
T Consensus 346 ~dP~~Rps----~~ell~hp~f~r 365 (365)
T 2y7j_A 346 VDPEARLT----AEQALQHPFFER 365 (365)
T ss_dssp SSTTTSCC----HHHHHHSGGGCC
T ss_pred CChhHCcC----HHHHhcCcccCC
Confidence 99999999 999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=378.04 Aligned_cols=268 Identities=28% Similarity=0.432 Sum_probs=209.3
Q ss_pred CCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 80 RDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
+.|.+. +.||+|+||+||+|.+..+++ .||||++.... ......+.+|+.++.++ +||||++++++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~ 79 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQ---------EYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEF 79 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCC---------EEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCc---------EEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 679985 789999999999999876655 49999997542 22345667799999885 79999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC---EEEec
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSD 234 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~D 234 (451)
+.+.+.+|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 80 FEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999999999999999998775 45999999999999999999999999999999999999998776 99999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++.......... ..........+||+.|+|
T Consensus 158 fg~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~gt~~y~a 189 (316)
T 2ac3_A 158 FDLGSGIKLNGDCS------------------------------------------------PISTPELLTPCGSAEYMA 189 (316)
T ss_dssp TTCCC-------------------------------------------------------------------CCSGGGCC
T ss_pred ccCccccccCCccc------------------------------------------------cccccccccccCCcCccC
Confidence 99974321100000 000001112479999999
Q ss_pred cccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHhcCCCCCCCCCCCCcC
Q 013016 315 PEVASG-----GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---------------ETTLRNIVKKPLTFPTQSPSSMS 374 (451)
Q Consensus 315 PE~~~~-----~~~~~~~DIwSlG~il~elltg~~pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~ 374 (451)
||++.+ ..++.++|||||||++|+|++|+.||..... ...+..+..+...++.......
T Consensus 190 PE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~- 268 (316)
T 2ac3_A 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI- 268 (316)
T ss_dssp HHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTS-
T ss_pred hHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccC-
Confidence 999875 4578999999999999999999999987542 3355666666655543222222
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+.++.+||.+||+.||.+||| +.|+|+||||++...
T Consensus 269 ~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 269 SCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAP 304 (316)
T ss_dssp CHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC----
T ss_pred CHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCC
Confidence 338999999999999999999 999999999998543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=386.43 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=208.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCC---------EEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCC---------EEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 789999999999999999999887665 49999996542 22344566778999999999999999999997
Q ss_pred eCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
..+ .+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEE
Confidence 663 569999999 9999999876 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... .....+||+.|+
T Consensus 171 Dfg~a~~~~~----------------------------------------------------------~~~~~~~t~~y~ 192 (367)
T 1cm8_A 171 DFGLARQADS----------------------------------------------------------EMTGYVVTRWYR 192 (367)
T ss_dssp CCTTCEECCS----------------------------------------------------------SCCSSCSCGGGC
T ss_pred eeeccccccc----------------------------------------------------------ccCcCcCCCCcC
Confidence 9999843210 011247899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC-----------------------CCC
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP-----------------------TQS 369 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~~~ 369 (451)
|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+ ...
T Consensus 193 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (367)
T 1cm8_A 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 272 (367)
T ss_dssp CTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC
T ss_pred CHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCC
Confidence 9999987 6789999999999999999999999998887776666554211111 000
Q ss_pred ---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 370 ---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 370 ---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
.....+.++.+||.+||..||.+||| +.|+|+||||+++....
T Consensus 273 ~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 273 FASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTE 318 (367)
T ss_dssp GGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC---
T ss_pred HHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCCc
Confidence 00122448999999999999999999 99999999999976543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=377.20 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=200.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHH-HCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK-MLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~nIv~l~~~~ 158 (451)
++|++.++||+|+||+||+|.++.+++ .||||++.......... .....|+..+. ..+|+||+++++++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGR---------LYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSC---------EEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCe---------EEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 569999999999999999999986655 49999986543222222 23334454444 45999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+.+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceee
Confidence 9999999999999 889998887653 46999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... .......||+.|+|||++
T Consensus 205 ~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~ 228 (311)
T 3p1a_A 205 VELGTA--------------------------------------------------------GAGEVQEGDPRYMAPELL 228 (311)
T ss_dssp EECC--------------------------------------------------------------CCCCCGGGCCGGGG
T ss_pred eecccC--------------------------------------------------------CCCcccCCCccccCHhHh
Confidence 432210 011123689999999998
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+ .++.++|||||||++|||++|..|+... .....+..+... ..... ..+.++.+||.+||++||++|||
T Consensus 229 ~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~--~~~~~-~~~~~l~~li~~~L~~dP~~Rpt--- 298 (311)
T 3p1a_A 229 QG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLP--PEFTA-GLSSELRSVLVMMLEPDPKLRAT--- 298 (311)
T ss_dssp GT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCC--HHHHT-TSCHHHHHHHHHHSCSSTTTSCC---
T ss_pred cC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCC--ccccc-CCCHHHHHHHHHHcCCChhhCcC---
Confidence 86 7899999999999999999997776543 333344333221 11111 23348999999999999999999
Q ss_pred ChHHHHcCCCcCC
Q 013016 399 GAADVKTHPFFKG 411 (451)
Q Consensus 399 ~~~ell~hp~~~~ 411 (451)
+.|||+||||++
T Consensus 299 -~~ell~hp~~~~ 310 (311)
T 3p1a_A 299 -AEALLALPVLRQ 310 (311)
T ss_dssp -HHHHHTSGGGSC
T ss_pred -HHHHHhCccccC
Confidence 999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.23 Aligned_cols=287 Identities=24% Similarity=0.326 Sum_probs=207.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++.... ........+.+|+.+++.++|+||+++++++.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCc---------EEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 789999999999999999999987765 49999997542 23344567788999999999999999999997
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. +.+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cCCCCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 66 5799999999 57999998764 5599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++................ ... .+ ..............+||+.|+|
T Consensus 173 FGla~~~~~~~~~~~~~~~~--------------------------~~~-----~~--~~~~~~~~~~~~~~~gt~~Y~A 219 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLE--------------------------ENE-----EP--GPHNKNLKKQLTSHVVTRWYRA 219 (432)
T ss_dssp CTTCEEC----------------------------------------------------------------CCCCCTTCC
T ss_pred CCCccccccccccccccccc--------------------------ccc-----cc--cccccchhccccCCCCCccccC
Confidence 99986543211100000000 000 00 0000000112234689999999
Q ss_pred cccc-cCCCCCcchhHHHHHHHHHHHHhC-----------CCCCCCCC-----------------hHHHHHHHhcCCCC-
Q 013016 315 PEVA-SGGSHGNAVDWWAFGIFIYEMIYG-----------RTPFAAPS-----------------NETTLRNIVKKPLT- 364 (451)
Q Consensus 315 PE~~-~~~~~~~~~DIwSlG~il~elltg-----------~~pf~~~~-----------------~~~~~~~i~~~~~~- 364 (451)
||++ .+..++.++|||||||++|||++| .++|.+.+ ....+..+......
T Consensus 220 PE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p 299 (432)
T 3n9x_A 220 PELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299 (432)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSC
T ss_pred HHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCC
Confidence 9986 455689999999999999999984 44443322 01122222110000
Q ss_pred -------------------CCCCC-------CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccc
Q 013016 365 -------------------FPTQS-------PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 365 -------------------~~~~~-------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
.+... .+. .+.++.+||.+||++||++||| ++|+|+||||+++++...
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~~~~ 373 (432)
T 3n9x_A 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRIT----IDQALDHPYLKDVRKKKL 373 (432)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT-SCHHHHHHHHHHSCSSTTTSCC----HHHHHTCGGGTTTCCTTT
T ss_pred CHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC-CCHHHHHHHHHHhcCCcccCCC----HHHHhcChhhhhccCccc
Confidence 00000 012 3448999999999999999999 999999999999888654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=373.30 Aligned_cols=264 Identities=28% Similarity=0.453 Sum_probs=221.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
++|.+.+.||+|+||.||+|.++.+++ .||+|++........ ...+.+.+|+.++++++||||+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGK---------EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCC---------eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence 679999999999999999999987655 399999976532211 12456778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl 232 (451)
++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEE
Confidence 999999999999999999999998764 4599999999999999999999999999999999999999877 8999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......|++.|
T Consensus 154 ~dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 177 (283)
T 3bhy_A 154 IDFGIAHKIEAG--------------------------------------------------------NEFKNIFGTPEF 177 (283)
T ss_dssp CCCTTCEECC----------------------------------------------------------------CCCGGG
T ss_pred EecccceeccCC--------------------------------------------------------CcccccCCCcCc
Confidence 999998432110 001123689999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+|||++.+..++.++||||||+++|+|++|..||......+.+..+.......+...... .+..+.+||.+||+.||.+
T Consensus 178 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~ 256 (283)
T 3bhy_A 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN-TSELAKDFIRRLLVKDPKR 256 (283)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT-CCHHHHHHHHTTSCSSGGG
T ss_pred cCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc-CCHHHHHHHHHHccCCHhH
Confidence 999999998999999999999999999999999999888888888777655444322222 2338999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCcc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||+ +.|+++||||+++...
T Consensus 257 Rps----~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 257 RMT----IAQSLEHSWIKAIRRR 275 (283)
T ss_dssp SCC----HHHHHHCHHHHHHHHC
T ss_pred CcC----HHHHHhCHHHHHHHHH
Confidence 999 9999999999986544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=392.42 Aligned_cols=264 Identities=28% Similarity=0.473 Sum_probs=206.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----HHHHHHHHHHHHHHHHHCCCCCccc
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----KKKKVHRAEMEKKILKMLDHPFLPT 153 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~ 153 (451)
.++|.+.++||+|+||+||+|.++.+.+ .||||++.+.... .......+.+|+.++++++||||++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 204 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCK---------KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCc---------EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence 3789999999999999999999987765 4999999865422 1223345678999999999999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---CE
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG---HI 230 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~---~~ 230 (451)
+++++.. +..|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 205 l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 205 IKNFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp CCEEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred EEEEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceE
Confidence 9999864 5589999999999999988764 5699999999999999999999999999999999999997554 59
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... ......+||+
T Consensus 282 kl~DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~ 305 (419)
T 3i6u_A 282 KITDFGHSKILGET--------------------------------------------------------SLMRTLCGTP 305 (419)
T ss_dssp EECCSSTTTSCC-------------------------------------------------------------------C
T ss_pred EEeecccceecCCC--------------------------------------------------------ccccccCCCC
Confidence 99999998532110 1112357999
Q ss_pred CccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 311 EYVSPEVASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 311 ~y~aPE~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+..+...+....+... +..+.+||.+||
T Consensus 306 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~li~~~L 384 (419)
T 3i6u_A 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV-SEKALDLVKKLL 384 (419)
T ss_dssp TTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS-CHHHHHHHHHHS
T ss_pred CccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc-CHHHHHHHHHHc
Confidence 9999999864 56788999999999999999999999875443 334445555444332222222 338999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
+.||.+||+ +.|+|+||||++.++.
T Consensus 385 ~~dP~~Rps----~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 385 VVDPKARFT----TEEALRHPWLQDEDMK 409 (419)
T ss_dssp CSSTTTSCC----HHHHHHSGGGCCHHHH
T ss_pred cCChhHCcC----HHHHhCCcccCChhHH
Confidence 999999999 9999999999986553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=373.34 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=212.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.+..+++ .||+|++.............+.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCS---------EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCC---------eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 3779999999999999999999887665 4999998654434445567788899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
...+.+|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 9999999999999999999999875 46999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
...... .........||+.|+|||++
T Consensus 159 ~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~~ 184 (294)
T 4eqm_A 159 KALSET------------------------------------------------------SLTQTNHVLGTVQYFSPEQA 184 (294)
T ss_dssp TTC-------------------------------------------------------------------CCSSCCHHHH
T ss_pred cccccc------------------------------------------------------cccccCccccCccccCHhHh
Confidence 532110 00111234799999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..++.++|||||||++|+|++|+.||.+..........................+..+.++|.+||+.||.+||+
T Consensus 185 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~--- 261 (294)
T 4eqm_A 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--- 261 (294)
T ss_dssp HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS---
T ss_pred cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc---
Confidence 99999999999999999999999999999988777666666554332211112223448999999999999999996
Q ss_pred ChHHHHcCCCcC
Q 013016 399 GAADVKTHPFFK 410 (451)
Q Consensus 399 ~~~ell~hp~~~ 410 (451)
..+.+.+.|..
T Consensus 262 -~~~~l~~~l~~ 272 (294)
T 4eqm_A 262 -TIQEMKDDLSS 272 (294)
T ss_dssp -SHHHHHHHHHT
T ss_pred -cHHHHHHHHHH
Confidence 44445554443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=364.74 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=213.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.++.+++ .||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCc---------EEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 679999999999999999999886655 499999975432 233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 999999999999999999988654 459999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ..........|++.|+|||++.
T Consensus 154 ~~~~~-----------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~ 180 (276)
T 2yex_A 154 VFRYN-----------------------------------------------------NRERLLNKMCGTLPYVAPELLK 180 (276)
T ss_dssp ECEET-----------------------------------------------------TEECCBCCCCSCGGGCCGGGGT
T ss_pred ccCCC-----------------------------------------------------cchhcccCCccccCccChHHHh
Confidence 32100 0001112347899999999998
Q ss_pred CCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 320 GGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 320 ~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+..+ +.++|||||||++|+|++|+.||...... ..+..+.......+. ....+..+.+||.+||+.||.+|||
T Consensus 181 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps-- 255 (276)
T 2yex_A 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP---WKKIDSAPLALLHKILVENPSARIT-- 255 (276)
T ss_dssp CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT---GGGSCHHHHHHHHHHSCSSTTTSCC--
T ss_pred cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc---hhhcCHHHHHHHHHHCCCCchhCCC--
Confidence 8765 77999999999999999999999876543 334444443322211 1123448999999999999999999
Q ss_pred CChHHHHcCCCcCCC
Q 013016 398 RGAADVKTHPFFKGL 412 (451)
Q Consensus 398 ~~~~ell~hp~~~~~ 412 (451)
+.|+++||||++.
T Consensus 256 --~~~il~~~~~~~~ 268 (276)
T 2yex_A 256 --IPDIKKDRWYNKP 268 (276)
T ss_dssp --HHHHTTCTTTTCC
T ss_pred --HHHHhcCccccCh
Confidence 9999999999983
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=377.85 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=216.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.+.+.||+|+||+||+|.+..+++ .||||++.............+.+|+.++++++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCe---------EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 459999999999999999999876655 49999997543334455667888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 9999999999995 68888775432 569999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ....+||+.|+|||++.
T Consensus 203 ~~~~-----------------------------------------------------------~~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 203 IMAP-----------------------------------------------------------ANSFVGTPYWMAPEVIL 223 (348)
T ss_dssp SSSS-----------------------------------------------------------BCCCCSCGGGCCHHHHH
T ss_pred ecCC-----------------------------------------------------------CCcccCCcceeCHhhhc
Confidence 2210 11247999999999985
Q ss_pred ---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 ---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+..++.++|||||||++|||++|+.||...+....+..+........ .....+..+.+||.+||+.||++|||
T Consensus 224 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps- 299 (348)
T 1u5q_A 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPT- 299 (348)
T ss_dssp TTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCC-
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcC-
Confidence 46689999999999999999999999998887777777666543221 12233458999999999999999999
Q ss_pred CCChHHHHcCCCcCCCC
Q 013016 397 KRGAADVKTHPFFKGLN 413 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~ 413 (451)
+.+|++||||....
T Consensus 300 ---~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 300 ---SEVLLKHRFVLRER 313 (348)
T ss_dssp ---HHHHTTCHHHHSCC
T ss_pred ---HHHHhhChhhhccC
Confidence 99999999998743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=379.81 Aligned_cols=269 Identities=24% Similarity=0.406 Sum_probs=224.4
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHH--------------HHHHHHHHHH
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK--------------VHRAEMEKKI 142 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~e~~~ 142 (451)
...++|.+.+.||+|+||.||+|.+ +++ .||||++.......... ...+.+|+.+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 96 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTE---------EEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHH
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCc---------eEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHH
Confidence 3458899999999999999999998 332 49999998664332211 1677789999
Q ss_pred HHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhh------hhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeec
Q 013016 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSL------RHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYR 215 (451)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~ 215 (451)
+++++||||+++++++.+.+..|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 9999999999999999999999999999999999998 665445779999999999999999999999 999999
Q ss_pred cCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccc
Q 013016 216 DLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295 (451)
Q Consensus 216 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (451)
||||+|||++.++.+||+|||++......
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--------------------------------------------------- 205 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK--------------------------------------------------- 205 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT---------------------------------------------------
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc---------------------------------------------------
Confidence 99999999999999999999998432110
Q ss_pred cccccccccccccCCCccCcccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCC--
Q 013016 296 AEPVAARSCSFVGTHEYVSPEVASGG-SHGN-AVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSP-- 370 (451)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~-- 370 (451)
......|+..|+|||++.+. .++. ++|||||||++|+|++|+.||..... .+.+..+..+...++....
T Consensus 206 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 279 (348)
T 2pml_X 206 ------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHF 279 (348)
T ss_dssp ------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSS
T ss_pred ------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhh
Confidence 11124789999999999887 5666 99999999999999999999998776 7777777777655553211
Q ss_pred ------------CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccc
Q 013016 371 ------------SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 371 ------------~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
....+.++.+||.+||+.||.+||+ +.|+++||||++.++...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~ 334 (348)
T 2pml_X 280 LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDL 334 (348)
T ss_dssp TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHH
T ss_pred hccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHH
Confidence 0223458999999999999999999 999999999999887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=379.82 Aligned_cols=269 Identities=21% Similarity=0.360 Sum_probs=204.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.++.+++ .||||++.... .....+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCC---------EEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCc---------EEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 689999999999999999999986665 49999997542 2234466788999999999999999999986
Q ss_pred eCC---------------------------------------------------------eEEEEEeeccCCchhhhhhh
Q 013016 160 ASN---------------------------------------------------------FSCIVMEFCSGGDLHSLRHK 182 (451)
Q Consensus 160 ~~~---------------------------------------------------------~~~lV~E~~~ggsL~~~l~~ 182 (451)
+.+ +.|+|||||+|++|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 543 48999999999999999987
Q ss_pred CCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCC
Q 013016 183 QPH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRS 261 (451)
Q Consensus 183 ~~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~ 261 (451)
... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus 155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----------- 223 (332)
T 3qd2_B 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----------- 223 (332)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------------
T ss_pred ccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc-----------
Confidence 532 33567779999999999999999999999999999999999999999999998644321110000
Q ss_pred cccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 013016 262 QTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY 341 (451)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt 341 (451)
.............+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 224 --------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 271 (332)
T 3qd2_B 224 --------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271 (332)
T ss_dssp ----------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS
T ss_pred --------------------------------cccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH
Confidence 000000111223579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 342 GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 342 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
|..|+.. .......+........ . .....++.+||.+||+.||.+||| +.|+|+||||+++
T Consensus 272 ~~~~~~~--~~~~~~~~~~~~~~~~---~-~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 272 SFSTQME--RVRIITDVRNLKFPLL---F-TQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp CCCCHHH--HHHHHHHHHTTCCCHH---H-HHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred cCCChhH--HHHHHHHhhccCCCcc---c-ccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 8776532 2223333333322110 0 111237899999999999999999 9999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=383.87 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=199.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTE---------EEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCC---------EEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 789999999999999999999877665 49999996542 22334566778999999999999999999996
Q ss_pred eC------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
.. ...|+|||++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 54 5789999999 8999998865 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... .....+||+.|+
T Consensus 175 DFG~a~~~~~----------------------------------------------------------~~~~~~~t~~y~ 196 (367)
T 2fst_X 175 DFGLARHTAD----------------------------------------------------------EMTGYVATRWYR 196 (367)
T ss_dssp C-------------------------------------------------------------------------CCCTTC
T ss_pred eccccccccc----------------------------------------------------------cCCCcCcCcCcc
Confidence 9999842110 011247899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC--------------------CCCCC-
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP--------------------TQSPS- 371 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------~~~~~- 371 (451)
|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+ .....
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (367)
T 2fst_X 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 276 (367)
T ss_dssp CHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCC
T ss_pred ChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCC
Confidence 9999987 6789999999999999999999999999887776666554211110 00000
Q ss_pred -----CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 372 -----SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 372 -----~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
...+..+.+||.+||+.||.+||| +.|+|+||||++...+.
T Consensus 277 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 277 FANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCGG
T ss_pred HHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCCC
Confidence 012347899999999999999999 99999999999866544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=388.05 Aligned_cols=280 Identities=22% Similarity=0.292 Sum_probs=200.9
Q ss_pred CCceE-EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 80 RDFDL-HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+.|.+ .++||+|+||+||+|.++.... +..||||++.... ....+.+|+.+++.++||||+++++++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKD-------DKDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVF 87 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSC-------CCCEEEEECSSSS-----CCHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCC-------CeEEEEEEECCCC-----CCHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 44777 4579999999999999764321 1249999997542 123466799999999999999999999
Q ss_pred Ee--CCeEEEEEeeccCCchhhhhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE----c
Q 013016 159 EA--SNFSCIVMEFCSGGDLHSLRHKQ-------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV----R 225 (451)
Q Consensus 159 ~~--~~~~~lV~E~~~ggsL~~~l~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll----~ 225 (451)
.. ...+||||||+ +++|.+++... ....+++..++.|+.||+.||+|||++||+||||||+|||| +
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 88 LSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 166 (405)
T ss_dssp EETTTTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSST
T ss_pred ecCCCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCC
Confidence 54 67999999999 56888776532 12349999999999999999999999999999999999999 6
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.+||+|||++........ .......
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~----------------------------------------------------~~~~~~~ 194 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLK----------------------------------------------------PLADLDP 194 (405)
T ss_dssp TTTCEEECCTTCCC------------------------------------------------------------------
T ss_pred CCCcEEEEECCCceecCCCCc----------------------------------------------------ccccCCC
Confidence 778999999999853321000 0011123
Q ss_pred cccCCCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhcCCCCCCCCCCCCc--
Q 013016 306 FVGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---------ETTLRNIVKKPLTFPTQSPSSM-- 373 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~-- 373 (451)
.+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... .+.+..+.......+...+...
T Consensus 195 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 274 (405)
T 3rgf_A 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 274 (405)
T ss_dssp --CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGG
T ss_pred ceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhc
Confidence 5899999999999884 489999999999999999999999976543 2344444332211111111100
Q ss_pred -------------------------------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCC
Q 013016 374 -------------------------------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422 (451)
Q Consensus 374 -------------------------------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~ 422 (451)
.+..+.+||.+||++||.+||| +.|+|+||||++..++.......
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f~~~~~~~~~~~~~ 350 (405)
T 3rgf_A 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYFLEDPLPTSDVFAG 350 (405)
T ss_dssp STTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTSSSCCCSSTTTT
T ss_pred CcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhccCCCCccccccc
Confidence 0237899999999999999999 99999999999987776655555
Q ss_pred CCCCCC
Q 013016 423 PEIPGM 428 (451)
Q Consensus 423 ~~~p~~ 428 (451)
..+|..
T Consensus 351 ~~~~~~ 356 (405)
T 3rgf_A 351 CQIPYP 356 (405)
T ss_dssp SCCCC-
T ss_pred CCCCCC
Confidence 555543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=370.82 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=204.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
++|++.++||+|+||+||+|.+..+++ .||||++.... ...+.+|+.+++.+. |+||+++++++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~ 100 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIV 100 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCc---------EEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeee
Confidence 789999999999999999999877665 49999997432 245667999999997 99999999999
Q ss_pred Ee--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEecc
Q 013016 159 EA--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDF 235 (451)
Q Consensus 159 ~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Df 235 (451)
.. ....++||||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 101 ~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 101 KDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp ECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 88 6789999999999999998754 89999999999999999999999999999999999999777 8999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .......|+..|+||
T Consensus 176 g~a~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 199 (330)
T 3nsz_A 176 GLAEFYHPG--------------------------------------------------------QEYNVRVASRYFKGP 199 (330)
T ss_dssp TTCEECCTT--------------------------------------------------------CCCCSCCSCGGGCCH
T ss_pred CCceEcCCC--------------------------------------------------------CccccccccccccCh
Confidence 998532210 011123688999999
Q ss_pred ccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhc-------------CCCCCC--------------
Q 013016 316 EVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVK-------------KPLTFP-------------- 366 (451)
Q Consensus 316 E~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~-------------~~~~~~-------------- 366 (451)
|++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.. ......
T Consensus 200 E~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (330)
T 3nsz_A 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 279 (330)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCC
T ss_pred hhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccc
Confidence 99987 668999999999999999999999995533 2222222211 111100
Q ss_pred -----CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 367 -----TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 367 -----~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
........+.++.+||.+||++||.+||| ++|+|+||||+++..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 280 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVK 328 (330)
T ss_dssp GGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC-
T ss_pred hhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhcc
Confidence 00011113458999999999999999999 999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=378.78 Aligned_cols=267 Identities=27% Similarity=0.340 Sum_probs=214.6
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.+.||+|+||.||+|.+..+++ .||||++..... .......+.+|+.++++++||||++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 92 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGR---------IVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEV 92 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCC---------EEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCc---------eEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34789999999999999999999987665 499999865422 22334556779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 93 CKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eecCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCC
Confidence 99999999999999999998876654 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ........||+.|+|||+
T Consensus 171 ~~~~~~~-------------------------------------------------------~~~~~~~~~t~~y~aPE~ 195 (331)
T 4aaa_A 171 ARTLAAP-------------------------------------------------------GEVYDDEVATRWYRAPEL 195 (331)
T ss_dssp C-------------------------------------------------------------------CCCCCTTCCHHH
T ss_pred ceeecCC-------------------------------------------------------ccccCCCcCCccccCccc
Confidence 8432110 001112368999999999
Q ss_pred ccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------------------CCCCCCC-------
Q 013016 318 ASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-------------------TFPTQSP------- 370 (451)
Q Consensus 318 ~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-------------------~~~~~~~------- 370 (451)
+.+. .++.++|||||||++|+|++|+.||......+.+..+..... ..+....
T Consensus 196 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
T 4aaa_A 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERR 275 (331)
T ss_dssp HTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHH
T ss_pred ccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhc
Confidence 9875 689999999999999999999999998877766655542111 0110000
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
....+..+.+||.+||+.||++||| +.|||+||||+..++.
T Consensus 276 ~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 276 YPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFA 316 (331)
T ss_dssp STTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHH
T ss_pred ccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChh
Confidence 0123448999999999999999999 9999999999986654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=376.08 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=205.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC--CCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH--PFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~ 157 (451)
++|++.+.||+|+||.||+|.+..+. .||||++..... .......+.+|+.+++.++| +||++++++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~----------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQ----------IYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSC----------EEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCC----------EEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 67999999999999999999875432 499999975432 23445667889999999976 999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+++|+|||+ .+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccc
Confidence 9999999999995 589999999875 5699999999999999999999999999999999999997 78899999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .........+||+.|+|||+
T Consensus 154 a~~~~~~-----------------------------------------------------~~~~~~~~~~gt~~y~aPE~ 180 (343)
T 3dbq_A 154 ANQMQPD-----------------------------------------------------TTSVVKDSQVGTVNYMPPEA 180 (343)
T ss_dssp SCCC-----------------------------------------------------------------CCCCSSCCHHH
T ss_pred ccccCcc-----------------------------------------------------cccccCCCCcCCcCcCCHHH
Confidence 8532110 00111123479999999999
Q ss_pred ccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 318 ASG-----------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 318 ~~~-----------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+.+ ..++.++|||||||++|+|++|+.||...... ..+..+........ .+...+.++.+||.+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~ 257 (343)
T 3dbq_A 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE---FPDIPEKDLQDVLKCC 257 (343)
T ss_dssp HHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC---CCCCSCHHHHHHHHHH
T ss_pred HhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC---CcccCCHHHHHHHHHH
Confidence 865 56899999999999999999999999875443 44455544332221 1223344899999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
|+.||.+||| +.|+|+||||+.
T Consensus 258 L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 258 LKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp TCSSTTTSCC----HHHHHTSHHHHS
T ss_pred cCCChhHCCC----HHHHHhCccccc
Confidence 9999999999 999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=385.16 Aligned_cols=263 Identities=28% Similarity=0.431 Sum_probs=207.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+|.+.++||+|+||+||+|.+..+.. ||+|.+.... ....+|+.+++.++||||+++++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~----------~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~ 101 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE----------VAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFF 101 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE----------EEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe----------EEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEE
Confidence 3679999999999999999999876653 8888876432 1122589999999999999999999
Q ss_pred EeCC------eEEEEEeeccCCchhhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc-cCCCE
Q 013016 159 EASN------FSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-SDGHI 230 (451)
Q Consensus 159 ~~~~------~~~lV~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-~~~~~ 230 (451)
...+ ++|+||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp EEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred EecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcE
Confidence 6543 4899999996654433332 12235699999999999999999999999999999999999999 78999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... ......+||+
T Consensus 182 kL~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~t~ 205 (394)
T 4e7w_A 182 KLIDFGSAKILIAG--------------------------------------------------------EPNVSYICSR 205 (394)
T ss_dssp EECCCTTCEECCTT--------------------------------------------------------CCCCSSCSCG
T ss_pred EEeeCCCcccccCC--------------------------------------------------------CCCcccccCc
Confidence 99999998532110 0111347899
Q ss_pred CccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------------CCCCCC---
Q 013016 311 EYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-----------------TFPTQS--- 369 (451)
Q Consensus 311 ~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----------------~~~~~~--- 369 (451)
.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+..... .++...
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (394)
T 4e7w_A 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285 (394)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCC
T ss_pred CccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCc
Confidence 99999999875 489999999999999999999999999887777666654211 111100
Q ss_pred ----CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccccc
Q 013016 370 ----PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIR 418 (451)
Q Consensus 370 ----~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~ 418 (451)
.....+.++.+||.+||++||.+||| +.|+++||||+++.+....
T Consensus 286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCC
T ss_pred HHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhcccccc
Confidence 01113448999999999999999999 9999999999998776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=363.27 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=209.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.+.++||+|+||+||+|.+..+.. .||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---------~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCce---------EEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 459999999999999999999887665 4999999765432 334567788999999999999999999987
Q ss_pred e----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEc-cCCCEEE
Q 013016 160 A----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVR-SDGHIML 232 (451)
Q Consensus 160 ~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl 232 (451)
. ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 5 46799999999999999999875 45899999999999999999999999 99999999999998 7899999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++..... .......||+.|
T Consensus 174 ~Dfg~~~~~~~---------------------------------------------------------~~~~~~~~t~~y 196 (290)
T 1t4h_A 174 GDLGLATLKRA---------------------------------------------------------SFAKAVIGTPEF 196 (290)
T ss_dssp CCTTGGGGCCT---------------------------------------------------------TSBEESCSSCCC
T ss_pred eeCCCcccccc---------------------------------------------------------cccccccCCcCc
Confidence 99999742110 011124689999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+|||++.+ .++.++|||||||++|+|++|+.||........ ...+..+..... .+...+.++.+||.+||+.||.
T Consensus 197 ~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~ 272 (290)
T 1t4h_A 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS---FDKVAIPEVKEIIEGCIRQNKD 272 (290)
T ss_dssp CCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG---GGGCCCHHHHHHHHHHSCSSGG
T ss_pred CCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc---cCCCCCHHHHHHHHHHccCChh
Confidence 99998875 589999999999999999999999988555444 444443322111 1122234899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCC
Q 013016 392 NRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~ 411 (451)
+||| +.||++||||++
T Consensus 273 ~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 273 ERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp GSCC----HHHHHTSGGGC-
T ss_pred hCCC----HHHHhhCccccc
Confidence 9999 999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=378.45 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=211.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 95 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKV---------RVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIR 95 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCe---------EEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEe
Confidence 579999999999999999999887665 49999997432 2334466778999999999999999999997
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. ...|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~~iv~e~~-~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 96 APTIEQMKDVYIVQDLM-ETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp CSSTTTCCCEEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cCCccccceEEEEEccc-CcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEe
Confidence 65 4789999999 5699998876 3599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++........ ........+||+.|+|
T Consensus 172 fg~a~~~~~~~~----------------------------------------------------~~~~~~~~~gt~~y~a 199 (364)
T 3qyz_A 172 FGLARVADPDHD----------------------------------------------------HTGFLTEYVATRWYRA 199 (364)
T ss_dssp CTTCEECCGGGC----------------------------------------------------BCCTTCCCCSCGGGCC
T ss_pred CcceEecCCCCC----------------------------------------------------ccccccccccccCCCC
Confidence 999853221000 0011123479999999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC--------------------CCCC---
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP--------------------TQSP--- 370 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------------------~~~~--- 370 (451)
||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.......+ ....
T Consensus 200 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (364)
T 3qyz_A 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279 (364)
T ss_dssp HHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred CHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCH
Confidence 998765 4589999999999999999999999998877766666543111110 0000
Q ss_pred ---CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 371 ---SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 371 ---~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
....+.++.+||.+||++||.+||| +.|+|+||||++..
T Consensus 280 ~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 280 NRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQYY 321 (364)
T ss_dssp HHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTTC
T ss_pred HHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhcc
Confidence 0112348999999999999999999 99999999999953
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=380.50 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=207.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH-----HHHHHHHHHHHHHHHCCCCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK-----KKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++........ .....+.+|+.++++++||||+++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 94 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNK---------EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTE---------EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCc---------EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 679999999999999999999887765 499999986532211 123345569999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCC-chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 155 YAEFEASNFSCIVMEFCSGG-DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
++++.+.+.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999999999666 999988775 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... ......+||+.|+
T Consensus 173 Dfg~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y~ 196 (335)
T 3dls_A 173 DFGSAAYLERG--------------------------------------------------------KLFYTFCGTIEYC 196 (335)
T ss_dssp CCTTCEECCTT--------------------------------------------------------CCBCEECSCGGGC
T ss_pred ecccceECCCC--------------------------------------------------------CceeccCCCcccc
Confidence 99998532210 0111347999999
Q ss_pred CcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 314 SPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 314 aPE~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
|||++.+..+ +.++|||||||++|+|++|+.||..... ........+ ...+.++.+||.+||+.||.+
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~-----~~~~~~l~~li~~~L~~dP~~ 265 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP-----YLVSKELMSLVSGLLQPVPER 265 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS-----SCCCHHHHHHHHHHTCSSGGG
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC-----cccCHHHHHHHHHHccCChhh
Confidence 9999998876 8899999999999999999999976221 222222222 223448999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCC
Q 013016 393 RLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~ 411 (451)
||| +.++++||||++
T Consensus 266 Rps----~~ell~hp~~~~ 280 (335)
T 3dls_A 266 RTT----LEKLVTDPWVTQ 280 (335)
T ss_dssp SCC----HHHHHHCTTTTC
T ss_pred CcC----HHHHhcCccccC
Confidence 999 999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=381.40 Aligned_cols=263 Identities=29% Similarity=0.424 Sum_probs=216.0
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 98 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYG 98 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCc---------EEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeE
Confidence 445789999999999999999999886655 49999997542 2334466778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEecc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++..++..|+||||++|++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 99 AFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999999999999999875 4599999999999999999999985 9999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .......||+.|+||
T Consensus 177 g~~~~~~~---------------------------------------------------------~~~~~~~gt~~y~aP 199 (360)
T 3eqc_A 177 GVSGQLID---------------------------------------------------------SMANSFVGTRSYMSP 199 (360)
T ss_dssp CCCHHHHH---------------------------------------------------------HC----CCCCTTCCH
T ss_pred CCCccccc---------------------------------------------------------ccccCCCCCCCeECH
Confidence 99732100 011134789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------------------------
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI------------------------------------- 358 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i------------------------------------- 358 (451)
|++.+..++.++|||||||++|+|++|+.||......+....+
T Consensus 200 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3eqc_A 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279 (360)
T ss_dssp HHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHH
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchh
Confidence 9999999999999999999999999999999876654432221
Q ss_pred -----hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 359 -----VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 359 -----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
..... ........+.++.+||.+||++||++||| +.|+|+||||++.++..
T Consensus 280 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 280 LLDYIVNEPP---PKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp HHHHHHHSCC---CCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHSC
T ss_pred hhhHHhccCC---CCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHhh
Confidence 11111 11112223458999999999999999999 99999999999855543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=373.06 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=211.2
Q ss_pred CCceEEeeeccCCeeEEEEEEecc-ccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC------Ccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNN-KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP------FLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------nIv 152 (451)
++|++.+.||+|+||+||+|.+.. +++ .||||++.... .....+..|+.+++.++|+ +|+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~---------~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGR---------HVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTE---------EEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCc---------EEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 689999999999999999999843 333 59999997532 2345566788888888654 599
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc------
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS------ 226 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~------ 226 (451)
++++++...++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 999999998876667999999999999999999999999999999999999987
Q ss_pred -------------CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcc
Q 013016 227 -------------DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293 (451)
Q Consensus 227 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (451)
++.+||+|||++.....
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------------------------------------------- 189 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE-------------------------------------------------- 189 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS--------------------------------------------------
T ss_pred cCCccccccccccCCCceEeeCcccccCcc--------------------------------------------------
Confidence 67899999999742110
Q ss_pred cccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC------
Q 013016 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT------ 367 (451)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------ 367 (451)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.
T Consensus 190 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 261 (339)
T 1z57_A 190 --------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKT 261 (339)
T ss_dssp --------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred --------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Confidence 011247899999999999999999999999999999999999999987776655444322111110
Q ss_pred ---------------------------------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 368 ---------------------------------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 368 ---------------------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.......+.++.+||.+||+.||.+||| +.|+++||||+++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 262 RKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT----LREALKHPFFDLLKK 337 (339)
T ss_dssp SCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----HHHHTTSGGGGGGGC
T ss_pred cchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC----HHHHhcCHHHHHHhc
Confidence 0011122347889999999999999999 999999999998543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=380.74 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=208.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC--CCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD--HPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~ 157 (451)
++|.+.++||+|+||+||+|.+.. ++ .||||++..... .......+.+|+.+++++. |+||++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~---------~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQ---------IYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CC---------EEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CC---------EEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 569999999999999999998765 22 499999975532 2344567788999999996 5999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 125 ~~~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~ 200 (390)
T 2zmd_A 125 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 200 (390)
T ss_dssp EECSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred EecCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCc
Confidence 999999999999 5589999999875 4689999999999999999999999999999999999995 68999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .........+||+.|+|||+
T Consensus 201 a~~~~~~-----------------------------------------------------~~~~~~~~~~gt~~y~aPE~ 227 (390)
T 2zmd_A 201 ANQMQPD-----------------------------------------------------TTSVVKDSQVGAVNYMPPEA 227 (390)
T ss_dssp SCCC--------------------------------------------------------------CCSCCCGGGCCHHH
T ss_pred cccccCC-----------------------------------------------------CccccCCCCCcCCCccChHH
Confidence 8532110 00011123479999999999
Q ss_pred ccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 318 ASG-----------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 318 ~~~-----------~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+.+ ..++.++|||||||++|+|++|+.||..... ...+..+......... +...+.++.+||.+|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 304 (390)
T 2zmd_A 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF---PDIPEKDLQDVLKCC 304 (390)
T ss_dssp HHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC---CCCSCHHHHHHHHHH
T ss_pred hhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC---CccchHHHHHHHHHH
Confidence 875 3688999999999999999999999987543 3556666654433222 122344899999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
|+.||.+||+ +.|||+||||+...
T Consensus 305 L~~dP~~Rps----~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 305 LKRDPKQRIS----IPELLAHPYVQIQT 328 (390)
T ss_dssp TCSSTTTSCC----HHHHHTSHHHHSCC
T ss_pred cccChhhCCC----HHHHhhCcCccccC
Confidence 9999999999 99999999998743
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=372.66 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=212.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQ---------LAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCC---------eEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 789999999999999999999876655 49999986432 2234566799999998 799999999999
Q ss_pred Ee------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 EA------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~~------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
.. .+.+|+||||+.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 87 568999999999999999998766567999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ........||+.|
T Consensus 171 ~Dfg~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y 195 (326)
T 2x7f_A 171 VDFGVSAQLDRT-------------------------------------------------------VGRRNTFIGTPYW 195 (326)
T ss_dssp CCCTTTC--------------------------------------------------------------------CCGGG
T ss_pred eeCcCceecCcC-------------------------------------------------------ccccccccCCccc
Confidence 999997432110 0011134789999
Q ss_pred cCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 313 VSPEVAS-----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 313 ~aPE~~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+|||++. +..++.++|||||||++|+|++|..||...........+........ .....+..+.+||.+||.
T Consensus 196 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~ 272 (326)
T 2x7f_A 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL---KSKKWSKKFQSFIESCLV 272 (326)
T ss_dssp CCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---SCSCSCHHHHHHHHHHCC
T ss_pred cChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC---CccccCHHHHHHHHHHhc
Confidence 9999987 45689999999999999999999999998877776666655433211 122334589999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.||.+||+ +.++++||||++....
T Consensus 273 ~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 273 KNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp SSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred cChhhCCC----HHHHhhChHHhhCccc
Confidence 99999999 9999999999986553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=384.72 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|.+.+.||+|+||+||+|.++.+++ .||||++.... ....+|+++++.++|+||++++++|.
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~ 117 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFY 117 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCc---------EEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEe
Confidence 569999999999999999999987655 49999986431 12235999999999999999999985
Q ss_pred eC------CeEEEEEeeccCCchhhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCE
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRHK--QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHI 230 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~ 230 (451)
.. .++++||||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+
T Consensus 118 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 118 SSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp EEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEE
T ss_pred ccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeE
Confidence 42 25789999995 466665543 234569999999999999999999999999999999999999965 578
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||+++..... ......+||+
T Consensus 197 kl~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~t~ 220 (420)
T 1j1b_A 197 KLCDFGSAKQLVRG--------------------------------------------------------EPNVSYICSR 220 (420)
T ss_dssp EECCCTTCEECCTT--------------------------------------------------------CCCCSCCSCT
T ss_pred EeccchhhhhcccC--------------------------------------------------------CCceeeeeCC
Confidence 99999998532110 0111347899
Q ss_pred CccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------------CCCCCCC---
Q 013016 311 EYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP-----------------LTFPTQS--- 369 (451)
Q Consensus 311 ~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-----------------~~~~~~~--- 369 (451)
.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+.+++... ..++...
T Consensus 221 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~ 300 (420)
T 1j1b_A 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300 (420)
T ss_dssp TSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCC
T ss_pred CcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCC
Confidence 99999999875 68999999999999999999999999988777666655411 1111110
Q ss_pred ----CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 ----PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ----~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.....+.++.+||.+||++||.+||+ +.|+|+||||+++...
T Consensus 301 ~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDP 346 (420)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCT
T ss_pred HHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhcccccc
Confidence 01122448999999999999999999 9999999999886544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=366.37 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=215.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.++.+++ .||+|++.... ......+..|+.+++.++||||+++++++.
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGA---------LAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCC---------EEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCc---------EEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 679999999999999999999987655 49999997542 234466778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999999999999887642 459999999999999999999999999999999999999999999999999863
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... .........||+.|+|||++.
T Consensus 166 ~~~~-------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 166 KNLK-------------------------------------------------------TLQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHHH-------------------------------------------------------HHHC-----CCGGGCCHHHHH
T ss_pred cccc-------------------------------------------------------cccccccccCChhhcCCeeec
Confidence 1100 000111247899999999983
Q ss_pred -----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 320 -----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 320 -----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
+..++.++|||||||++|+|++|+.||........+..+........ ..+...+..+.+||.+||+.||.+||
T Consensus 191 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (302)
T 2j7t_A 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRP 268 (302)
T ss_dssp HHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred cccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--CCccccCHHHHHHHHHHcccChhhCC
Confidence 56789999999999999999999999999888777777766543211 12223445899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCCCcc
Q 013016 395 GSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~~~~ 415 (451)
| +.++++||||+++.+.
T Consensus 269 s----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 269 S----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp C----HHHHTTSTTTTTCCCC
T ss_pred C----HHHHhcChHHhhhccc
Confidence 9 9999999999997664
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.81 Aligned_cols=274 Identities=26% Similarity=0.346 Sum_probs=197.6
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.+.||+|+||.||+|.+..+++ .||||++..... ......+.+|+.++++++||||+++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 80 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKE---------KVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYT 80 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----C---------EEEEECCC------------------CCCCCCCTTBCCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCc---------EEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence 334789999999999999999999876654 499999976532 233456777999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHK------QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
++...+..++||||++|++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCE
Confidence 99999999999999999999998874 134569999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++.......... .........||+
T Consensus 161 kl~dfg~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~ 190 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDIT--------------------------------------------------RNKVRKTFVGTP 190 (303)
T ss_dssp EECCCHHHHHCC-----------------------------------------------------------------CCC
T ss_pred EEEeccchheeccCCCcc--------------------------------------------------chhhhcccCCCc
Confidence 999999975322110000 001112347999
Q ss_pred CccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-CCC----CCCCcChHHHHHHHHH
Q 013016 311 EYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-PTQ----SPSSMSEYHARDLISG 384 (451)
Q Consensus 311 ~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-~~~----~~~~~~~~~~~~ll~~ 384 (451)
.|+|||++.+ ..++.++|||||||++|+|++|+.||................... ... ......+.++.+||.+
T Consensus 191 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (303)
T 2vwi_A 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL 270 (303)
T ss_dssp TTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHH
T ss_pred cccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHH
Confidence 9999999876 568999999999999999999999999877666555554433221 110 1112234589999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||+.||.+||+ +.++++||||++....
T Consensus 271 ~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 271 CLQKDPEKRPT----AAELLRHKFFQKAKNK 297 (303)
T ss_dssp HCCSSGGGSCC----HHHHHTSTTC------
T ss_pred HccCChhhCcC----HHHHhhChhhhcCCCC
Confidence 99999999999 9999999999986554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=374.27 Aligned_cols=262 Identities=29% Similarity=0.487 Sum_probs=207.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----HHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----KKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++...... .......+.+|+.++++++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCK---------KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCc---------EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 679999999999999999999887665 4999999765321 12223456789999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC---EE
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH---IM 231 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~---~k 231 (451)
++++..++ .|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEE
Confidence 99987665 89999999999999988754 56999999999999999999999999999999999999987664 99
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++...... .......||+.
T Consensus 158 l~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~gt~~ 181 (322)
T 2ycf_A 158 ITDFGHSKILGET--------------------------------------------------------SLMRTLCGTPT 181 (322)
T ss_dssp ECCCTTCEECCCC--------------------------------------------------------HHHHHHHSCCT
T ss_pred EccCccceecccc--------------------------------------------------------cccccccCCcC
Confidence 9999998432100 00112468999
Q ss_pred ccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 312 YVSPEVAS---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 312 y~aPE~~~---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|+|||++. +..++.++|||||||++|+|++|..||...... .....+..+...+....+.. .+..+.+||.+||+
T Consensus 182 y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~ 260 (322)
T 2ycf_A 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE-VSEKALDLVKKLLV 260 (322)
T ss_dssp TCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT-SCHHHHHHHHHHSC
T ss_pred ccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh-cCHHHHHHHHHHcc
Confidence 99999974 456899999999999999999999999875443 33344444443332211122 23489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.||.+||+ +.++|+||||++.++
T Consensus 261 ~dP~~Rps----~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 261 VDPKARFT----TEEALRHPWLQDEDM 283 (322)
T ss_dssp SSTTTSCC----HHHHHTSGGGCCHHH
T ss_pred cCHhhCCC----HHHHhhCcCcCCHHH
Confidence 99999999 999999999998655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=372.41 Aligned_cols=275 Identities=25% Similarity=0.311 Sum_probs=213.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..+++ .||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCc---------EEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 789999999999999999999886655 49999996432 2334456678999999999999999999886
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. ...|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELM-QTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155 (353)
T ss_dssp CSCSTTCCCEEEEECCC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ccccCccceEEEEEecc-CccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEe
Confidence 54 6899999999 4799998876 3599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++............ ...........+||+.|+|
T Consensus 156 fg~a~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~gt~~y~a 190 (353)
T 2b9h_A 156 FGLARIIDESAADNSE---------------------------------------------PTGQQSGMVEFVATRWYRA 190 (353)
T ss_dssp CTTCEECC-------------------------------------------------------------CCCCCCGGGCC
T ss_pred cccccccccccccccC---------------------------------------------ccccccchhhccccccccC
Confidence 9998643211110000 0000011223579999999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC---------------------CCCC--
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP---------------------TQSP-- 370 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---------------------~~~~-- 370 (451)
||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+........ ....
T Consensus 191 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T 2b9h_A 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270 (353)
T ss_dssp HHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCC
T ss_pred CeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcc
Confidence 998765 6789999999999999999999999998876665554432110000 0000
Q ss_pred ----CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccccc
Q 013016 371 ----SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIR 418 (451)
Q Consensus 371 ----~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~ 418 (451)
....+.++.+||.+||+.||.+||| +.|+|+||||+........
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTTSS
T ss_pred hhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCcccc
Confidence 0123448899999999999999999 9999999999997765543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=376.98 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=211.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++..... .......+.+|+.+++.++||||+++++++.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGE---------KVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCC---------EEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 689999999999999999999887665 499999975432 2334566778999999999999999999998
Q ss_pred eCCeE------EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASNFS------CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~~~------~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
..+.. |+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEE
Confidence 77654 99999994 78887763 349999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... .....+||+.|+
T Consensus 187 Dfg~a~~~~~----------------------------------------------------------~~~~~~~t~~y~ 208 (371)
T 4exu_A 187 DFGLARHADA----------------------------------------------------------EMTGYVVTRWYR 208 (371)
T ss_dssp STTCC------------------------------------------------------------------CTTCCCTTS
T ss_pred ecCccccccc----------------------------------------------------------CcCCcccCcccc
Confidence 9999842210 011247899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC--------------------CCC--
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT--------------------QSP-- 370 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~~-- 370 (451)
|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.......+. ...
T Consensus 209 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (371)
T 4exu_A 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 288 (371)
T ss_dssp CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCC
T ss_pred CHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchh
Confidence 9999987 67899999999999999999999999988877766666442111100 000
Q ss_pred ----CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 371 ----SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 371 ----~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
....+.++.+||.+||++||.+||| +.|+|+||||+.+..+.
T Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 289 FTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGG
T ss_pred HHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCcc
Confidence 0112448999999999999999999 99999999999865543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=366.24 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=206.6
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
..+..++|++.++||+|+||+||+|.+.+. .||||++..... .......+.+|+.++++++||||+++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~-----------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGS-----------DVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTE-----------EEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCC-----------cEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 344558899999999999999999987543 399999975532 23345667889999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccCCCEE
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~k 231 (451)
++++...+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEE
Confidence 9999999999999999999999999876431 23899999999999999999999999 99999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++...... ........||+.
T Consensus 180 L~Dfg~a~~~~~~-------------------------------------------------------~~~~~~~~gt~~ 204 (309)
T 3p86_A 180 VCDFGLSRLKAST-------------------------------------------------------FLSSKSAAGTPE 204 (309)
T ss_dssp ECCCC------------------------------------------------------------------------CCT
T ss_pred ECCCCCCcccccc-------------------------------------------------------ccccccCCCCcc
Confidence 9999998421100 001113479999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|+|||++.+..++.++|||||||++|+|++|+.||......+....+........ . +...+.++.+||.+||+.||.
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~l~~li~~~l~~dP~ 281 (309)
T 3p86_A 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--I-PRNLNPQVAAIIEGCWTNEPW 281 (309)
T ss_dssp TSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--C-CTTSCHHHHHHHHHHTCSSGG
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--C-CccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999888777766643322211 1 122344899999999999999
Q ss_pred CcCCCCCChHHHHc
Q 013016 392 NRLGSKRGAADVKT 405 (451)
Q Consensus 392 ~Rpt~~~~~~ell~ 405 (451)
+||| +.+|++
T Consensus 282 ~Rps----~~~ll~ 291 (309)
T 3p86_A 282 KRPS----FATIMD 291 (309)
T ss_dssp GSCC----HHHHHH
T ss_pred hCcC----HHHHHH
Confidence 9999 999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=373.77 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=212.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC------ccc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF------LPT 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------Iv~ 153 (451)
++|++.+.||+|+||+||+|.++...+ ..||||++.... .....+..|+.+++.+.|++ |+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--------~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGK--------SQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTT--------EEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCc--------eEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 789999999999999999999876542 159999997542 23345667888888886655 899
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---------
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV--------- 224 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll--------- 224 (451)
+++++...++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 7778777777655679999999999999999999999999999999999999
Q ss_pred ----------ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccc
Q 013016 225 ----------RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLF 294 (451)
Q Consensus 225 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (451)
+.++.+||+|||++.....
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------------------- 194 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--------------------------------------------------- 194 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS---------------------------------------------------
T ss_pred cccccccccccCCCcEEEeecCccccccc---------------------------------------------------
Confidence 5678999999999842110
Q ss_pred ccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-------
Q 013016 295 VAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT------- 367 (451)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------- 367 (451)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.......+.
T Consensus 195 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 267 (355)
T 2eu9_A 195 -------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTR 267 (355)
T ss_dssp -------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCS
T ss_pred -------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhcc
Confidence 011247899999999999999999999999999999999999999987776655444332111111
Q ss_pred --------------------------------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 368 --------------------------------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 368 --------------------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.......+.++.+||.+||+.||++||| +.|+|+||||+++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 268 KQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT----LAEALLHPFFAGLTPE 343 (355)
T ss_dssp CGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC----HHHHTTSGGGGGCCHH
T ss_pred chhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcCCChh
Confidence 0011112347889999999999999999 9999999999998765
Q ss_pred cc
Q 013016 416 LI 417 (451)
Q Consensus 416 ~~ 417 (451)
..
T Consensus 344 ~~ 345 (355)
T 2eu9_A 344 ER 345 (355)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=368.50 Aligned_cols=265 Identities=27% Similarity=0.376 Sum_probs=212.6
Q ss_pred CCceEEeeeccCCeeEEEEEEec-cccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCcccee
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLN-NKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLY 155 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~ 155 (451)
++|.+.+.||+|+||.||+|.+. .+++ .||||++...... ......+.+|+.+++.+ .||||++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~---------~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGR---------FVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTE---------EEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCE---------EEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 78999999999999999999985 3333 5999999754221 11122344566666655 899999999
Q ss_pred EEEE-----eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 156 AEFE-----ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 156 ~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
+++. .....++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence 9987 5678999999995 699999988766679999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... .......||+
T Consensus 160 kl~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~~~ 183 (326)
T 1blx_A 160 KLADFGLARIYSFQ--------------------------------------------------------MALTSVVVTL 183 (326)
T ss_dssp EECSCCSCCCCCGG--------------------------------------------------------GGGCCCCCCC
T ss_pred EEecCcccccccCC--------------------------------------------------------CCcccccccc
Confidence 99999997422100 0111347899
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-----CCC-----------------C
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT-----FPT-----------------Q 368 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-----~~~-----------------~ 368 (451)
.|+|||++.+..++.++|||||||++|+|++|+.||........+..+...... ++. .
T Consensus 184 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 1blx_A 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 263 (326)
T ss_dssp TTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG
T ss_pred ceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhh
Confidence 999999999989999999999999999999999999998887777666542110 000 0
Q ss_pred CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 369 ~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
......+..+.+||.+||+.||.+||+ +.|+++||||++++..
T Consensus 264 ~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 264 KFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp GTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred hccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 001223448899999999999999999 9999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=378.52 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=209.7
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CC-----Ccc
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HP-----FLP 152 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----nIv 152 (451)
.++|.+.++||+|+||+||+|.+..+++ .||||++.... .....+..|+.+++.+. |+ +|+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCc---------EEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 3789999999999999999999887655 49999997542 23345566888888774 44 499
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCcEEEc--cCC
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH--MLGIIYRDLKPENVLVR--SDG 228 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--~~givH~Dlkp~NIll~--~~~ 228 (451)
++++++...++.||||||+ +++|.+++.......+++..++.++.||+.||.||| ++||+||||||+|||++ .++
T Consensus 120 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred EeeeeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 9999999999999999999 569999998876667999999999999999999999 57999999999999995 467
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++..... .....+|
T Consensus 199 ~~kL~DFG~a~~~~~----------------------------------------------------------~~~~~~~ 220 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQ----------------------------------------------------------RIYQYIQ 220 (382)
T ss_dssp CEEECCCTTCEETTC----------------------------------------------------------CCCSSCS
T ss_pred cEEEEeccCceeccc----------------------------------------------------------ccccccC
Confidence 899999999853210 0112478
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC------------------C--
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT------------------Q-- 368 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------------~-- 368 (451)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+. .
T Consensus 221 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (382)
T 2vx3_A 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTW 300 (382)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCE
T ss_pred CccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccc
Confidence 99999999999999999999999999999999999999998887777666542111100 0
Q ss_pred ---------------CCCC------------------------cChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 369 ---------------SPSS------------------------MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 369 ---------------~~~~------------------------~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
.... ....++++||.+||++||++||| +.|+|+||||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt----a~e~L~hp~f 376 (382)
T 2vx3_A 301 NLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ----PYYALQHSFF 376 (382)
T ss_dssp EECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGG
T ss_pred ccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC----HHHHhcCccc
Confidence 0000 00136899999999999999999 9999999999
Q ss_pred CCC
Q 013016 410 KGL 412 (451)
Q Consensus 410 ~~~ 412 (451)
++.
T Consensus 377 ~~~ 379 (382)
T 2vx3_A 377 KKT 379 (382)
T ss_dssp CC-
T ss_pred ccC
Confidence 984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=363.32 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=217.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.+.+.||+|+||.||+|.+..+++ .||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQK---------VVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCc---------EEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 569999999999999999999876655 499999975532 233566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccce
Confidence 99999999999999999999865 459999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 168 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 192 (303)
T 3a7i_A 168 QLTDT-------------------------------------------------------QIKRNTFVGTPFWMAPEVIK 192 (303)
T ss_dssp ECBTT-------------------------------------------------------BCCBCCCCSCGGGCCHHHHT
T ss_pred ecCcc-------------------------------------------------------ccccCccCCCcCccCHHHHh
Confidence 32210 00112347899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+........ ....+..+.+||.+||+.||.+|||
T Consensus 193 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps---- 264 (303)
T 3a7i_A 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL----EGNYSKPLKEFVEACLNKEPSFRPT---- 264 (303)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----CSSCCHHHHHHHHHHCCSSGGGSCC----
T ss_pred cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC----ccccCHHHHHHHHHHcCCChhhCcC----
Confidence 98999999999999999999999999998877777666655433211 1223448999999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
+.++++||||..
T Consensus 265 ~~~ll~~~~~~~ 276 (303)
T 3a7i_A 265 AKELLKHKFILR 276 (303)
T ss_dssp HHHHTTCHHHHH
T ss_pred HHHHhhChhhhc
Confidence 999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=361.39 Aligned_cols=253 Identities=18% Similarity=0.268 Sum_probs=204.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||+||+|.+..+++ .||||++...... ......+.+|+..+..+ +||||+++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGC---------IYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCc---------eEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 679999999999999999999886655 4999999754222 22345666789999998 899999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---------
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD--------- 227 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~--------- 227 (451)
.+.+..|+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccc
Confidence 99999999999999999999987642 2558999999999999999999999999999999999999844
Q ss_pred ----------CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccc
Q 013016 228 ----------GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAE 297 (451)
Q Consensus 228 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (451)
..+||+|||.+.....
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~------------------------------------------------------ 186 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISS------------------------------------------------------ 186 (289)
T ss_dssp ---------CCCEEECCCTTCEETTC------------------------------------------------------
T ss_pred cccccccCCceEEEEcccccccccCC------------------------------------------------------
Confidence 4799999999743211
Q ss_pred cccccccccccCCCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChH
Q 013016 298 PVAARSCSFVGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376 (451)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 376 (451)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..++... .....+..+..... +...+.
T Consensus 187 -----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~ 254 (289)
T 1x8b_A 187 -----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQGRLPRI----PQVLSQ 254 (289)
T ss_dssp -----SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHHTTCCCCC----SSCCCH
T ss_pred -----ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHHcCCCCCC----CcccCH
Confidence 0112589999999999876 4678999999999999999999887543 23344444433211 122344
Q ss_pred HHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 377 ~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
++.+||.+||+.||++||| +.|+++||||++.
T Consensus 255 ~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 255 EFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred HHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 8999999999999999999 9999999999973
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.20 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=203.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC--------CCCc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD--------HPFL 151 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~nI 151 (451)
++|.+.++||+|+||+||+|++..+++ .||||++.... .....+.+|+.+++.+. |+||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKK---------FVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCe---------EEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 679999999999999999999877655 49999997542 23455677899988885 7889
Q ss_pred cceeEEEE----eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEcc
Q 013016 152 PTLYAEFE----ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRS 226 (451)
Q Consensus 152 v~l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~ 226 (451)
+++++++. ...++|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999997 556899999999 77777777666556799999999999999999999998 9999999999999997
Q ss_pred CC-------------------------------------------------CEEEeccCcccccCCCCCCCCCCCCCCCC
Q 013016 227 DG-------------------------------------------------HIMLSDFDLSLCSNAIPAVESPASSPEAA 257 (451)
Q Consensus 227 ~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 257 (451)
++ .+||+|||++.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------- 248 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------- 248 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------------
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------------
Confidence 75 799999999843210
Q ss_pred CCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHH
Q 013016 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIY 337 (451)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ 337 (451)
.....+||+.|+|||++.+..++.++|||||||+||
T Consensus 249 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (397)
T 1wak_A 249 --------------------------------------------HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284 (397)
T ss_dssp --------------------------------------------CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred --------------------------------------------cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHH
Confidence 011237899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh------HHHHHHHhcCCCCCC------------------------CC-------------CCCCcC
Q 013016 338 EMIYGRTPFAAPSN------ETTLRNIVKKPLTFP------------------------TQ-------------SPSSMS 374 (451)
Q Consensus 338 elltg~~pf~~~~~------~~~~~~i~~~~~~~~------------------------~~-------------~~~~~~ 374 (451)
+|++|+.||..... ...+..+.......+ .. ..+...
T Consensus 285 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
T 1wak_A 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364 (397)
T ss_dssp HHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHH
T ss_pred HHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhh
Confidence 99999999986442 222222221100000 00 001112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+..+.+||.+||+.||++||| +.|||+||||++
T Consensus 365 ~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 365 AAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred HHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 336889999999999999999 999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=379.04 Aligned_cols=273 Identities=25% Similarity=0.364 Sum_probs=202.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+++ .||||++.... ........++..+..++||||+++++++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGM---------SVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp TTEEEC----------CEEEEETTTCC---------EEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 789999999999999999999887655 49999986432 22234455778888899999999999997
Q ss_pred eCC-------eEEEEEeeccCCchhhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeccCCCCcEEEcc-C
Q 013016 160 ASN-------FSCIVMEFCSGGDLHSLRHK--QPHKRFSLTSARFYAAEVLVALEYLH--MLGIIYRDLKPENVLVRS-D 227 (451)
Q Consensus 160 ~~~-------~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH--~~givH~Dlkp~NIll~~-~ 227 (451)
..+ ++++||||+.+ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||++. +
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence 643 38999999965 55444332 23456899999999999999999999 999999999999999996 8
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+.+||+|||++...... .......
T Consensus 169 ~~~kl~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~ 192 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPS--------------------------------------------------------EPNVAYI 192 (360)
T ss_dssp TEEEECCCTTCBCCCTT--------------------------------------------------------SCCCSTT
T ss_pred CcEEEeeCCCceecCCC--------------------------------------------------------CCccccc
Confidence 99999999998532211 0111347
Q ss_pred cCCCccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC-------------------
Q 013016 308 GTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT------------------- 367 (451)
Q Consensus 308 gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------------- 367 (451)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........+..+.......+.
T Consensus 193 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
T 3e3p_A 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK 272 (360)
T ss_dssp SCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCC
T ss_pred CCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccc
Confidence 899999999997755 899999999999999999999999998887777666542111000
Q ss_pred --------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCCC
Q 013016 368 --------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426 (451)
Q Consensus 368 --------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~p 426 (451)
.......+.++.+||.+||++||.+||| +.|+|+||||+++..........+.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp CCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred cCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCccccCCCCCCCC
Confidence 0001113458999999999999999999 999999999999766554433333333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=379.27 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=207.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||++.... ....+|+.+++.++||||+++++++.
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGK---------RFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCC---------EEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCC---------EEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheee
Confidence 789999999999999999999887665 49999986432 11235999999999999999999984
Q ss_pred e--------------------------------------CCeEEEEEeeccCCchhhhhhh--CCCCCCCHHHHHHHHHH
Q 013016 160 A--------------------------------------SNFSCIVMEFCSGGDLHSLRHK--QPHKRFSLTSARFYAAE 199 (451)
Q Consensus 160 ~--------------------------------------~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~q 199 (451)
. ..++++||||++ ++|.+++.. .....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 3 345899999996 688777653 23466999999999999
Q ss_pred HHHHHHHHHHCCCeeccCCCCcEEEc-cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhcc
Q 013016 200 VLVALEYLHMLGIIYRDLKPENVLVR-SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNR 278 (451)
Q Consensus 200 il~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (451)
|+.||+|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 150 i~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---------------------------------- 195 (383)
T 3eb0_A 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---------------------------------- 195 (383)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----------------------------------
T ss_pred HHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----------------------------------
Confidence 99999999999999999999999998 6889999999998532211
Q ss_pred ccCCccccccCCCcccccccccccccccccCCCccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 013016 279 FFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN 357 (451)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~ 357 (451)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+.+..
T Consensus 196 ----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 253 (383)
T 3eb0_A 196 ----------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVR 253 (383)
T ss_dssp ----------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ----------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0111347899999999998754 89999999999999999999999999888877776
Q ss_pred HhcCCC-----------------CCCCCC-------CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 358 IVKKPL-----------------TFPTQS-------PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 358 i~~~~~-----------------~~~~~~-------~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
++.... .++... .+...+.++.+||.+||++||.+||| +.|+|+||||+++.
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 254 IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----PYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGHHHH
T ss_pred HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCHHHHHHH
Confidence 654111 111110 01123447999999999999999999 99999999999854
Q ss_pred c
Q 013016 414 F 414 (451)
Q Consensus 414 ~ 414 (451)
.
T Consensus 330 ~ 330 (383)
T 3eb0_A 330 N 330 (383)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.91 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=199.8
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||+||+|.+..+++ .||||++...... ......+..+...++.++||||+++++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~ 73 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQ---------IMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYG 73 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCe---------EEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEee
Confidence 344789999999999999999999876665 4999999765322 222333444555577889999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEe
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHK--QPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~ 233 (451)
++..++..|+||||++ |+|.+++.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 74 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 74 ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp EEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred eeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999995 688877654 2345699999999999999999999998 99999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... .......||+.|+
T Consensus 153 Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~ 176 (290)
T 3fme_A 153 DFGISGYLVDD--------------------------------------------------------VAKDIDAGCKPYM 176 (290)
T ss_dssp CC-----------------------------------------------------------------------CCCCCCS
T ss_pred ecCCccccccc--------------------------------------------------------ccccccCCCcccc
Confidence 99998432110 0011236899999
Q ss_pred Ccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 314 SPEVA----SGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 314 aPE~~----~~~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
|||++ .+..++.++|||||||++|+|++|+.||.. ......+........... .....+.++.+||.+||+.
T Consensus 177 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~ 253 (290)
T 3fme_A 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PADKFSAEFVDFTSQCLKK 253 (290)
T ss_dssp CHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC---CTTTSCHHHHHHHHHHTCS
T ss_pred ChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc---ccccCCHHHHHHHHHHhhc
Confidence 99996 456689999999999999999999999986 344444454444432211 1122344899999999999
Q ss_pred CcCCcCCCCCChHHHHcCCCcCC
Q 013016 389 DPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
||++||| +.|+++||||+.
T Consensus 254 ~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 254 NSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp SGGGSCC----HHHHTTSHHHHH
T ss_pred ChhhCcC----HHHHHhCccccc
Confidence 9999999 999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=379.57 Aligned_cols=270 Identities=18% Similarity=0.255 Sum_probs=217.4
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.++||+|+||+||+|.+..... ...+..||||++.... .......+.+|+.++++++||||+++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPN----DPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCC----CCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 344789999999999999999999754321 1223359999996432 2233446777999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC---
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQP-----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG--- 228 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~--- 228 (451)
++...+..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 9999999999999999999999987643 24589999999999999999999999999999999999999655
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++..... ...........|
T Consensus 222 ~~kL~DFG~a~~~~~-----------------------------------------------------~~~~~~~~~~~~ 248 (367)
T 3l9p_A 222 VAKIGDFGMARDIYR-----------------------------------------------------AGYYRKGGCAML 248 (367)
T ss_dssp CEEECCCHHHHHHHH-----------------------------------------------------HSSCTTCCGGGS
T ss_pred eEEECCCcccccccc-----------------------------------------------------ccccccCCCcCC
Confidence 599999999842210 000111123468
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|+.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+..+...... ...+..+.+||.+||+
T Consensus 249 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~ 324 (367)
T 3l9p_A 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQ 324 (367)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTC
T ss_pred cccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcC
Confidence 899999999999999999999999999999998 99999999888888888776532221 2233489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
.||.+||+ +.+|++|.|+...+
T Consensus 325 ~dP~~Rps----~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 325 HQPEDRPN----FAIILERIEYCTQD 346 (367)
T ss_dssp SSGGGSCC----HHHHHHHHHHHHHC
T ss_pred CCHhHCcC----HHHHHHHHHHHhhC
Confidence 99999999 99999988776533
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=363.75 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=213.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++.... ....+.+|+.+++.++||||+++++++.
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQ---------IVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCC---------EEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCC---------EEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 679999999999999999999887655 49999997542 2355677999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 999999999999999999998743 3569999999999999999999999999999999999999999999999999974
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|++.|+|||++.
T Consensus 174 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~~~ 198 (314)
T 3com_A 174 QLTDT-------------------------------------------------------MAKRNTVIGTPFWMAPEVIQ 198 (314)
T ss_dssp ECBTT-------------------------------------------------------BSCBCCCCSCGGGCCHHHHS
T ss_pred hhhhh-------------------------------------------------------ccccCccCCCCCccChhhcC
Confidence 32110 00112347899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..++.++|||||||++|+|++|+.||...........+....... ...+...+..+.+||.+||+.||.+|||
T Consensus 199 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt---- 272 (314)
T 3com_A 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRAT---- 272 (314)
T ss_dssp SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCC----
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc--cCCcccCCHHHHHHHHHHccCChhhCcC----
Confidence 9889999999999999999999999999877766655554443211 1112234458999999999999999999
Q ss_pred hHHHHcCCCcCCCCcc
Q 013016 400 AADVKTHPFFKGLNFA 415 (451)
Q Consensus 400 ~~ell~hp~~~~~~~~ 415 (451)
+.++++||||++....
T Consensus 273 ~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 273 ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHTTSHHHHTCCCG
T ss_pred HHHHHhCHHHhcCCcc
Confidence 9999999999996643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=370.00 Aligned_cols=277 Identities=20% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||+||+|.+....+. ...||||++...... ......+.+|+.++++++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGS------FVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCc------ceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 37899999999999999999998765421 124999999765332 33456788899999999999999999999
Q ss_pred EeCCeE------EEEEeeccCCchhhhhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC
Q 013016 159 EASNFS------CIVMEFCSGGDLHSLRHKQP----HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG 228 (451)
Q Consensus 159 ~~~~~~------~lV~E~~~ggsL~~~l~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~ 228 (451)
...+.. ++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 99999999999999886432 22589999999999999999999999999999999999999999
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++....... .........|
T Consensus 175 ~~kl~Dfg~a~~~~~~~-----------------------------------------------------~~~~~~~~~~ 201 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGD-----------------------------------------------------YYRQGCASKL 201 (323)
T ss_dssp CEEECCCCC----------------------------------------------------------------------C
T ss_pred CEEEeeccccccccccc-----------------------------------------------------cccccccccC
Confidence 99999999985321110 0001112356
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+..+...... ...+.++.+||.+||+
T Consensus 202 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~ 277 (323)
T 3qup_A 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP----PECMEEVYDLMYQCWS 277 (323)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTC
T ss_pred cccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC----CccCHHHHHHHHHHcc
Confidence 788999999999999999999999999999999 99999998888888877766432211 1233489999999999
Q ss_pred cCcCCcCCC---CCChHHHHcCCCcCCCCcccccc
Q 013016 388 KDPCNRLGS---KRGAADVKTHPFFKGLNFALIRS 419 (451)
Q Consensus 388 ~dP~~Rpt~---~~~~~ell~hp~~~~~~~~~~~~ 419 (451)
.||.+|||+ ...+++++.|+|+....+..+..
T Consensus 278 ~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~ 312 (323)
T 3qup_A 278 ADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI 312 (323)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHC-------------
T ss_pred CChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCC
Confidence 999999994 22256778999999966654433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.26 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=213.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.+.||+|+||+||+|.+..+++ .+..||||++.... .......+.+|+.+++.++||||++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3455789999999999999999999875432 12359999997542 233446678899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+..|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 117 GVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EEECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence 9999999999999999999999998764 346999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ .........||+.|+||
T Consensus 196 g~a~~~~~~~~----------------------------------------------------~~~~~~~~~~t~~y~aP 223 (325)
T 3kul_A 196 GLSRVLEDDPD----------------------------------------------------AAYTTTGGKIPIRWTAP 223 (325)
T ss_dssp SSCEECC--------------------------------------------------------CCEECC---CCGGGSCH
T ss_pred CcccccccCcc----------------------------------------------------ceeeccCCCCcccccCH
Confidence 99854321100 00011122567789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...+..+.+||.+||..||.+||
T Consensus 224 E~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rp 299 (325)
T 3kul_A 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----PMGCPHALHQLMLDCWHKDRAQRP 299 (325)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC----CCCcCHHHHHHHHHHccCChhhCc
Confidence 99998889999999999999999999 9999999888888888776632211 122344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ +.+|++
T Consensus 300 s----~~eil~ 306 (325)
T 3kul_A 300 R----FSQIVS 306 (325)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 888875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=363.61 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=219.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.++.+++ .||||++...... ......+.+|+.++++++||||+++++++.
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---------~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ---------EYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCc---------EEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 679999999999999999999876655 4999999765322 233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg 236 (451)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred CCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999999999888764 459999999999999999999999999999999999999754 479999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .......|++.|+|||
T Consensus 170 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 193 (287)
T 2wei_A 170 LSTCFQQN--------------------------------------------------------TKMKDRIGTAYYIAPE 193 (287)
T ss_dssp GGGTBCCC--------------------------------------------------------SSCSCHHHHHTTCCHH
T ss_pred cceeecCC--------------------------------------------------------CccccccCcccccChH
Confidence 97432110 0011236888999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+ .++.++||||||+++|+|++|..||......+....+..+...++....... +.++.+||.+||+.||.+|||
T Consensus 194 ~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps- 270 (287)
T 2wei_A 194 VLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI-SDDAKDLIRKMLTFHPSLRIT- 270 (287)
T ss_dssp HHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS-CHHHHHHHHHHTCSSGGGSCC-
T ss_pred HhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc-CHHHHHHHHHHcccChhhCcC-
Confidence 9876 4899999999999999999999999998888888888877655443332333 348999999999999999999
Q ss_pred CCChHHHHcCCCcCCCCc
Q 013016 397 KRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 397 ~~~~~ell~hp~~~~~~~ 414 (451)
+.|+|+||||++..+
T Consensus 271 ---~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 271 ---ATQCLEHPWIQKYSS 285 (287)
T ss_dssp ---HHHHHHSHHHHHHCC
T ss_pred ---HHHHhcCHHHhcccc
Confidence 999999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.16 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=213.3
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|++.+.||+|+||.||+|.+..+. .||+|++...... .+.+.+|+.++++++||||++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~ 71 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLY 71 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTE----------EEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCC----------eEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEE
Confidence 345578999999999999999999987543 3999999855322 24567799999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+.+..|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 72 GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCT
T ss_pred EEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccc
Confidence 99999999999999999999999987653 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .........||+.|+||
T Consensus 151 g~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 151 GMTRFVLDD------------------------------------------------------QYTSSTGTKFPVKWASP 176 (269)
T ss_dssp TGGGGBCCH------------------------------------------------------HHHSTTSTTCCGGGCCH
T ss_pred ccccccccc------------------------------------------------------ccccccCcccccccCCH
Confidence 998432110 00011123567789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||++|+|++ |+.||......+....+........ +...+.++.+|+.+||+.||++||
T Consensus 177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----CCcCCHHHHHHHHHHccCCcccCc
Confidence 99998899999999999999999999 9999999888888888877633222 222344899999999999999999
Q ss_pred CCCCChHHHHcC
Q 013016 395 GSKRGAADVKTH 406 (451)
Q Consensus 395 t~~~~~~ell~h 406 (451)
+ +.++++|
T Consensus 253 s----~~~ll~~ 260 (269)
T 4hcu_A 253 A----FSRLLRQ 260 (269)
T ss_dssp C----HHHHHHH
T ss_pred C----HHHHHHH
Confidence 9 9999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=367.90 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=206.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++...... .....+.+|+.++++++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGD---------LFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCc---------EEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 679999999999999999999987655 4999999865322 23455678999999999999999999998
Q ss_pred eCC--eEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE----ccCCCEEE
Q 013016 160 ASN--FSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV----RSDGHIML 232 (451)
Q Consensus 160 ~~~--~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl 232 (451)
..+ +.|+||||++|++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 765 88999999999999999876532 349999999999999999999999999999999999999 77788999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||+.|
T Consensus 158 ~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 181 (319)
T 4euu_A 158 TDFGAARELEDD--------------------------------------------------------EQFVSLYGTEEY 181 (319)
T ss_dssp CCCTTCEECCTT--------------------------------------------------------CCBCCCCSCGGG
T ss_pred ccCCCceecCCC--------------------------------------------------------CceeecccCCCc
Confidence 999998532211 011124799999
Q ss_pred cCccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCCCCC---------------
Q 013016 313 VSPEVAS--------GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS----NETTLRNIVKKPLTF--------------- 365 (451)
Q Consensus 313 ~aPE~~~--------~~~~~~~~DIwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~--------------- 365 (451)
+|||++. +..++.++|||||||++|+|++|+.||.... ..+.+..+..+.+..
T Consensus 182 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 261 (319)
T 4euu_A 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261 (319)
T ss_dssp CCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEE
T ss_pred cCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCcccc
Confidence 9999986 5678999999999999999999999997532 344555555443211
Q ss_pred ----CC-CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCC
Q 013016 366 ----PT-QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHP 407 (451)
Q Consensus 366 ----~~-~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp 407 (451)
+. .......+..+.+||.+||++||++||| ++|+|+||
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred CccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 10 0111122347889999999999999999 99999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=371.64 Aligned_cols=265 Identities=19% Similarity=0.272 Sum_probs=217.4
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|.+.++||+|+||+||+|.+....+. ....+..||||++.... .......+.+|+++++++ +||||++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTT--CTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEcccccc--ccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 3347899999999999999999998654321 12233469999997652 234456778899999999 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
+++...+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998754 2459999999999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++........ ..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~-----------------------------------------------------~~ 248 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY-----------------------------------------------------YK 248 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT-----------------------------------------------------TC
T ss_pred EEEcCCCcEEEcccCcccccccccc-----------------------------------------------------cc
Confidence 9999999999999999853321100 01
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...+.++.+
T Consensus 249 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 324 (382)
T 3tt0_A 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK----PSNCTNELYM 324 (382)
T ss_dssp CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC----CSSCCHHHHH
T ss_pred cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CccCCHHHHH
Confidence 1112357888999999999999999999999999999999 9999999888888777766543221 1223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
||.+||+.||++||+ +.||+++
T Consensus 325 li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 325 MMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999 9999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=390.49 Aligned_cols=255 Identities=16% Similarity=0.188 Sum_probs=199.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHH---HHHHCCCCCcccee
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK---ILKMLDHPFLPTLY 155 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~nIv~l~ 155 (451)
.++|.+.+.||+|+||+||+|.++.+++ .||||++...........+.+.+|+. ++++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCC---------EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCc---------EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4779999999999999999999876654 49999997543333345566778984 45556899999998
Q ss_pred -------EEEEeCC-----------------eEEEEEeeccCCchhhhhhhCCC-----CCCCHHHHHHHHHHHHHHHHH
Q 013016 156 -------AEFEASN-----------------FSCIVMEFCSGGDLHSLRHKQPH-----KRFSLTSARFYAAEVLVALEY 206 (451)
Q Consensus 156 -------~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~ 206 (451)
+++...+ ..||||||+ +|+|.+++..... ..+++..++.|+.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 7776554 389999999 7899999876421 123358888999999999999
Q ss_pred HHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCcccc
Q 013016 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQ 286 (451)
Q Consensus 207 LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (451)
||++||+||||||+|||++.++.+||+|||++....
T Consensus 222 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-------------------------------------------- 257 (377)
T 3byv_A 222 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-------------------------------------------- 257 (377)
T ss_dssp HHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--------------------------------------------
T ss_pred HHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--------------------------------------------
Confidence 999999999999999999999999999999984211
Q ss_pred ccCCCcccccccccccccccccCCCccCcccccCC-----------CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013016 287 TLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG-----------SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355 (451)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 355 (451)
......+| +.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 258 --------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~ 322 (377)
T 3byv_A 258 --------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS 322 (377)
T ss_dssp --------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS
T ss_pred --------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch
Confidence 01113467 899999999887 7999999999999999999999999875544433
Q ss_pred HHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 356 ~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
..+.... . ..+.++.+||.+||+.||++||+ +.|+++||||+++...
T Consensus 323 ~~~~~~~--------~-~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 323 EWIFRSC--------K-NIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRTE 369 (377)
T ss_dssp GGGGSSC--------C-CCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHHHH
T ss_pred hhhhhhc--------c-CCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHHHH
Confidence 3333221 1 22348999999999999999999 9999999999985543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=365.22 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=210.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++.... ........+.+|+.+++.++||||+++++++.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGE---------KVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCC---------EEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 689999999999999999999887665 49999997542 22334566778999999999999999999998
Q ss_pred eCCe------EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASNF------SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~~------~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
..+. +|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 7654 599999995 788887643 49999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ......||+.|+
T Consensus 169 Dfg~~~~~~~----------------------------------------------------------~~~~~~~t~~y~ 190 (353)
T 3coi_A 169 DFGLARHADA----------------------------------------------------------EMTGYVVTRWYR 190 (353)
T ss_dssp STTCTTC------------------------------------------------------------------CCSBCCS
T ss_pred ecccccCCCC----------------------------------------------------------CccccccCcCcC
Confidence 9999742110 011237899999
Q ss_pred CcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-----------------------CCCC--
Q 013016 314 SPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPL-----------------------TFPT-- 367 (451)
Q Consensus 314 aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~-- 367 (451)
|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..... ..+.
T Consensus 191 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T 3coi_A 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 270 (353)
T ss_dssp CHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCC
T ss_pred CHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCcc
Confidence 9999987 6789999999999999999999999998877666555543110 0000
Q ss_pred -CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 368 -QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 368 -~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
.......+.++.+||.+||+.||++||| +.++|+||||+....+.
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 271 FTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPE 316 (353)
T ss_dssp TTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGG
T ss_pred HHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCcc
Confidence 0011123448999999999999999999 99999999999866543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=385.84 Aligned_cols=264 Identities=19% Similarity=0.227 Sum_probs=193.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC--CCCCcccee--
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML--DHPFLPTLY-- 155 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~nIv~l~-- 155 (451)
.+|.+.++||+|+||+||+|.+..+++ .||||++.............+..|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~ 132 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLE---------DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCc---------eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence 569999999999999999999887665 4999999876543445556666775554444 699987755
Q ss_pred -----EEEEeC-----------------CeEEEEEeeccCCchhhhhhhCCCCCCCHHHH------HHHHHHHHHHHHHH
Q 013016 156 -----AEFEAS-----------------NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA------RFYAAEVLVALEYL 207 (451)
Q Consensus 156 -----~~~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~------~~i~~qil~aL~~L 207 (451)
+++... ..+||||||++ |+|.+++.... ..+++..+ ..++.||+.||+||
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 555443 34899999997 89999997642 23455555 67789999999999
Q ss_pred HHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccc
Q 013016 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQT 287 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (451)
|++||+||||||+|||++.+|.+||+|||++.....
T Consensus 211 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------------------------------------------- 246 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-------------------------------------------- 246 (371)
T ss_dssp HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC--------------------------------------------
T ss_pred HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC--------------------------------------------
Confidence 999999999999999999999999999999843210
Q ss_pred cCCCcccccccccccccccccCCCccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH---Hhc
Q 013016 288 LTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG--GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT--LRN---IVK 360 (451)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~--~~~---i~~ 360 (451)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.. ...
T Consensus 247 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 312 (371)
T 3q60_A 247 --------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312 (371)
T ss_dssp --------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSC
T ss_pred --------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhc
Confidence 0002356799999999987 6789999999999999999999999987533211 000 001
Q ss_pred CCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccc
Q 013016 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI 417 (451)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~ 417 (451)
....+...... ..+..+.+||.+||+.||++||| +.++|+||||+++.+...
T Consensus 313 ~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 313 GTDSLAFGSCT-PLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp CCCSCCCTTSS-CCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred cccccchhhcc-CCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 11111111112 33448999999999999999999 999999999999776543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=373.42 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=203.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-----------C
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-----------H 148 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h 148 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||++..... ....+..|+.+++++. |
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCc---------EEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhcccc
Confidence 689999999999999999999876655 499999975432 2345566888888775 8
Q ss_pred CCccceeEEEEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEE
Q 013016 149 PFLPTLYAEFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVL 223 (451)
Q Consensus 149 ~nIv~l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIl 223 (451)
+||+++++++...+ ++++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 99999999998654 899999999 99999999887667799999999999999999999998 9999999999999
Q ss_pred EccC------CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccc
Q 013016 224 VRSD------GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAE 297 (451)
Q Consensus 224 l~~~------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (451)
++.+ +.+||+|||++.....
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------ 190 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE------------------------------------------------------ 190 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB------------------------------------------------------
T ss_pred EeccCCCcCcceEEEcccccccccCC------------------------------------------------------
Confidence 9543 4799999999843211
Q ss_pred cccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCCCCCCC----
Q 013016 298 PVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS------NETTLRNIVKKPLTFPT---- 367 (451)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~---- 367 (451)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..+.......+.
T Consensus 191 ----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 266 (373)
T 1q8y_A 191 ----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLR 266 (373)
T ss_dssp ----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHH
T ss_pred ----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHh
Confidence 0112368999999999999999999999999999999999999998654 22333333221111110
Q ss_pred ---------------------------------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 368 ---------------------------------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 368 ---------------------------------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
...+...+.++.+||.+||+.||.+||| +.|||+||||++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~ 340 (373)
T 1q8y_A 267 NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDT 340 (373)
T ss_dssp HCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTC
T ss_pred ccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----HHHHhhChhhhcc
Confidence 0011122347889999999999999999 9999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=370.28 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=182.3
Q ss_pred CCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 80 RDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
++|.+.+ .||+|+||+||+|.++.+++ .||||++..... .. ......++.+.|+||+++++++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~----~~---~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQ---------KCALKLLYDSPK----AR---QEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEESSHH----HH---HHHHHHHHHTTSTTBCCEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCC---------EEEEEEecCcHH----HH---HHHHHHHHhcCCCChHHHHHHH
Confidence 7899965 59999999999999987665 499999975421 11 1123346778999999999999
Q ss_pred Ee----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CCCEE
Q 013016 159 EA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIM 231 (451)
Q Consensus 159 ~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~~~k 231 (451)
.. ...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 456899999999999999998876667999999999999999999999999999999999999986 45599
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++..... .......||+.
T Consensus 172 l~Dfg~~~~~~~---------------------------------------------------------~~~~~~~~t~~ 194 (336)
T 3fhr_A 172 LTDFGFAKETTQ---------------------------------------------------------NALQTPCYTPY 194 (336)
T ss_dssp ECCCTTCEEC----------------------------------------------------------------------
T ss_pred Eeccccceeccc---------------------------------------------------------cccccCCCCcC
Confidence 999999842210 00112378999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT----LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
|+|||++.+..++.++|||||||++|+|++|+.||........ ...+......++...+.. .+.++.+||.+||+
T Consensus 195 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~ 273 (336)
T 3fhr_A 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDAKQLIRLLLK 273 (336)
T ss_dssp ---------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT-CCHHHHHHHHHHSC
T ss_pred ccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc-CCHHHHHHHHHHCC
Confidence 9999999888899999999999999999999999987654433 222333333333333333 34489999999999
Q ss_pred cCcCCcCCCCCChHHHHcCCCcCC
Q 013016 388 KDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.||.+||| +.|+|+||||++
T Consensus 274 ~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 274 TDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp SSGGGSCC----HHHHHHSHHHHT
T ss_pred CChhHCcC----HHHHhcCccccc
Confidence 99999999 999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=369.45 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=206.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH--------HHHHHHHHHHHHHHHHHHCCCCCc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL--------EKKKKVHRAEMEKKILKMLDHPFL 151 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~nI 151 (451)
++|.+.+.||+|+||.||+|.+..+. .||||++..... ........+.+|+.++++++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGI----------PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSC----------EEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cceEEeEEeccCCCEEEEEEECCCCC----------eEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 88999999999999999999876532 499999864321 122334677889999999999999
Q ss_pred cceeEEEEe-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 152 PTLYAEFEA-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 152 v~l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
+++++++.. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC
Confidence 999999954 347899999995 7888877754 346999999999999999999999999999999999999999
Q ss_pred CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccc
Q 013016 227 DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306 (451)
Q Consensus 227 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (451)
++.+||+|||++...... ......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~--------------------------------------------------------~~~~~~ 193 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD--------------------------------------------------------ANKTHY 193 (362)
T ss_dssp TCCEEECCTTC---------------------------------------------------------------------
T ss_pred CCCEEEEecCcccccccc--------------------------------------------------------ccccee
Confidence 999999999998421100 011124
Q ss_pred ccCCCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC---------------------
Q 013016 307 VGTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--------------------- 364 (451)
Q Consensus 307 ~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------------- 364 (451)
.||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+......
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (362)
T 3pg1_A 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNS 273 (362)
T ss_dssp --CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTC
T ss_pred cccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhh
Confidence 78899999999987 67899999999999999999999999998877766665431110
Q ss_pred ---CCCCC---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 365 ---FPTQS---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 365 ---~~~~~---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.+... .....+..+.+||.+||++||.+||| +.|+|+||||+++..+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 274 LSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLFDP 326 (362)
T ss_dssp CCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTCCG
T ss_pred cccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhccCc
Confidence 00000 00112347999999999999999999 9999999999996444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=359.30 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=216.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.+.||+|+||.||+|.++.+++ .||+|++..... .....+.+..|+.++++++||||+++++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRI 74 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCc---------EEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 3789999999999999999999887665 499999975432 223456677899999999999999999988
Q ss_pred Ee--CCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCcEEEccCCC
Q 013016 159 EA--SNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLG-----IIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 159 ~~--~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~ 229 (451)
.. .+..|+||||++|++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp EEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC
T ss_pred ecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC
Confidence 54 56899999999999999998753 2345999999999999999999999999 999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++...... ........|+
T Consensus 155 ~kl~dfg~~~~~~~~-------------------------------------------------------~~~~~~~~~~ 179 (279)
T 2w5a_A 155 VKLGDFGLARILNHD-------------------------------------------------------TSFAKTFVGT 179 (279)
T ss_dssp EEECCCCHHHHC----------------------------------------------------------CHHHHHHHSC
T ss_pred EEEecCchheeeccc-------------------------------------------------------cccccccCCC
Confidence 999999997432100 0001124689
Q ss_pred CCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 310 ~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..+..... +...+.++.+||.+||+.|
T Consensus 180 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~~ 255 (279)
T 2w5a_A 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI----PYRYSDELNEIITRMLNLK 255 (279)
T ss_dssp CTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----CTTSCHHHHHHHHHHTCSS
T ss_pred ccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC----CcccCHHHHHHHHHHcCCC
Confidence 999999999998899999999999999999999999999888777777777654211 1123448999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCC
Q 013016 390 PCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~ 411 (451)
|.+||+ +.||++|+|+.+
T Consensus 256 p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 256 DYHRPS----VEEILENPLILE 273 (279)
T ss_dssp GGGSCC----HHHHHTSTTCCG
T ss_pred cccCCC----HHHHHhChhhhh
Confidence 999999 999999999988
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.93 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=206.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.++.+++ .||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDK---------RVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTE---------EEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCe---------EEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 789999999999999999999987655 49999987542 334566778999999999999999999873
Q ss_pred --------------eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 160 --------------ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 160 --------------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
..+..|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 4468899999995 699998865 4589999999999999999999999999999999999997
Q ss_pred -cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 226 -SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 226 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
.++.+||+|||++........ ......
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------------~~~~~~ 182 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYS----------------------------------------------------HKGHLS 182 (320)
T ss_dssp TTTTEEEECCCTTCBCC------------------------------------------------------------CCC
T ss_pred CCCCeEEEccCccccccCCCcc----------------------------------------------------cccccc
Confidence 567999999999853221000 000111
Q ss_pred ccccCCCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC-----------------
Q 013016 305 SFVGTHEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP----------------- 366 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------------- 366 (451)
...||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+..+........
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (320)
T 2i6l_A 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN 262 (320)
T ss_dssp GGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHH
T ss_pred cccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccc
Confidence 2367899999999876 6789999999999999999999999999887776666654321110
Q ss_pred -----CCC---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 367 -----TQS---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 367 -----~~~---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
... .....+.++.+||.+||+.||.+||| +.|+|+||||+..+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 263 DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC--
T ss_pred cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCcc
Confidence 000 00123448999999999999999999 99999999999877654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=366.09 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=214.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.+.||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.++++++||||++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34789999999999999999999875321 1223359999998653 23345677889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQP----------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYR 215 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~ 215 (451)
+...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999999999999998743 1569999999999999999999999999999
Q ss_pred cCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccc
Q 013016 216 DLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFV 295 (451)
Q Consensus 216 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (451)
||||+|||++.++.+||+|||++.......
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------- 228 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------------------------------- 228 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG--------------------------------------------------
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCc--------------------------------------------------
Confidence 999999999999999999999984321100
Q ss_pred cccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcC
Q 013016 296 AEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMS 374 (451)
Q Consensus 296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 374 (451)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...
T Consensus 229 ---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 301 (343)
T 1luf_A 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC----PENC 301 (343)
T ss_dssp ---CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----CTTC
T ss_pred ---cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCC----CCCC
Confidence 0011112367889999999998899999999999999999999 9999999888888888777654221 1223
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.++.+||.+||+.||.+||+ +.++++
T Consensus 302 ~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 302 PLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 448999999999999999999 888875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=367.16 Aligned_cols=266 Identities=16% Similarity=0.264 Sum_probs=211.8
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
+.+..++|.+.+.||+|+||.||+|.+....+ ...+..||||++.... .......+.+|+.+++++ .||||++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeecccc----CCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34445789999999999999999999754321 1223459999997542 233456778899999999 8999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH---------------------KRFSLTSARFYAAEVLVALEYLHMLGI 212 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~LH~~gi 212 (451)
+++++...+..|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 193 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 99999999999999999999999999976532 248999999999999999999999999
Q ss_pred eeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCc
Q 013016 213 IYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNR 292 (451)
Q Consensus 213 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (451)
+||||||+|||++.++.+||+|||++......
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~------------------------------------------------ 225 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSD------------------------------------------------ 225 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGC------------------------------------------------
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccC------------------------------------------------
Confidence 99999999999999999999999998432110
Q ss_pred ccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCC
Q 013016 293 LFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371 (451)
Q Consensus 293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 371 (451)
..........||+.|+|||++.+..++.++|||||||++|+|+| |..||........+..++......+. +
T Consensus 226 -----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 297 (344)
T 1rjb_A 226 -----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ---P 297 (344)
T ss_dssp -----TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC---C
T ss_pred -----ccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC---C
Confidence 00011123467889999999999899999999999999999998 99999987766666665554332221 1
Q ss_pred CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 372 ~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
...+.++.+||.+||+.||.+||+ +.+|++|
T Consensus 298 ~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 298 FYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 223448999999999999999999 9999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=356.80 Aligned_cols=273 Identities=26% Similarity=0.407 Sum_probs=207.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++... ......+.+|+.++++++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSR---------YYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWL 72 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCe---------EEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHH
Confidence 679999999999999999999876655 4999999643 234466778999999999999999999886
Q ss_pred e-------------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 160 A-------------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 160 ~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
+ .+..|+||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp ECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred hhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 5 467899999999999999998643 45889999999999999999999999999999999999999
Q ss_pred CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccc
Q 013016 227 DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306 (451)
Q Consensus 227 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (451)
++.+||+|||++............. .. ............
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~------------------------------~~-----------~~~~~~~~~~~~ 190 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLD------------------------------SQ-----------NLPGSSDNLTSA 190 (303)
T ss_dssp TSCEEECCCCCCSCTTC---------------------------------------------------------------
T ss_pred CCCEEEeeCcchhhcccccchhccc------------------------------cc-----------cccccccccccC
Confidence 9999999999985432110000000 00 000001111234
Q ss_pred ccCCCccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 307 VGTHEYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAP-SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 307 ~gt~~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
.||+.|+|||++.+. .++.++|||||||++|+|++ ||... ........+......++....... +..+.+||.+
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~ 266 (303)
T 1zy4_A 191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNK-MKVEKKIIRL 266 (303)
T ss_dssp ---CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTT-SHHHHHHHHH
T ss_pred CCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccc-hHHHHHHHHH
Confidence 799999999999875 68999999999999999998 55532 233455555555555554443333 3379999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
||+.||.+||| +.++++||||+...+.
T Consensus 267 ~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 267 LIDHDPNKRPG----ARTLLNSGWLPVKHQD 293 (303)
T ss_dssp HTCSSGGGSCC----HHHHHHSSCSCCCCHH
T ss_pred HHhcCcccCcC----HHHHhCCCCcCCCChH
Confidence 99999999999 9999999999986554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=362.53 Aligned_cols=263 Identities=17% Similarity=0.277 Sum_probs=214.4
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.+.||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKG----RAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGG----CSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCc----ccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 344789999999999999999999854321 1223469999997542 2344567788999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPH----------------------KRFSLTSARFYAAEVLVALEYLHMLGIIY 214 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~qil~aL~~LH~~givH 214 (451)
++...+..|+||||++|++|.+++..... ..+++..++.++.||+.||+|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999987532 34899999999999999999999999999
Q ss_pred ccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccc
Q 013016 215 RDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLF 294 (451)
Q Consensus 215 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (451)
|||||+|||++.++.+||+|||++........
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------ 205 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS------------------------------------------------ 205 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC------------------------------------------------
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc------------------------------------------------
Confidence 99999999999999999999999853321100
Q ss_pred ccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCc
Q 013016 295 VAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM 373 (451)
Q Consensus 295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 373 (451)
........|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+........ +..
T Consensus 206 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 276 (314)
T 2ivs_A 206 -----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER----PDN 276 (314)
T ss_dssp -----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC----CTT
T ss_pred -----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCC----Ccc
Confidence 001112357788999999998889999999999999999999 9999998887777776666542211 122
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+.++.+||.+||+.||.+||+ +.+|+++
T Consensus 277 ~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 277 CSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 3448999999999999999999 9998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=370.55 Aligned_cols=261 Identities=18% Similarity=0.292 Sum_probs=207.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|.+.+.||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.++.++ +||||+++++++
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceeeceeecCCCCceEEEEEeccccc----cccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 789999999999999999999754321 1233469999997642 223346678899999999 799999999999
Q ss_pred EeCC-eEEEEEeeccCCchhhhhhhCCC----------------------------------------------------
Q 013016 159 EASN-FSCIVMEFCSGGDLHSLRHKQPH---------------------------------------------------- 185 (451)
Q Consensus 159 ~~~~-~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 185 (451)
...+ .+++||||++||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8755 59999999999999999976532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCC
Q 013016 186 ------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253 (451)
Q Consensus 186 ------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 253 (451)
..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~--------- 246 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD--------- 246 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC---------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc---------
Confidence 12899999999999999999999999999999999999999999999999998532110
Q ss_pred CCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHH
Q 013016 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFG 333 (451)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG 333 (451)
..........||+.|+|||++.+..++.++||||||
T Consensus 247 --------------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 282 (359)
T 3vhe_A 247 --------------------------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282 (359)
T ss_dssp --------------------------------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred --------------------------------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHH
Confidence 001111234688999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 334 IFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 334 ~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
|++|+|++ |..||.+....+.+...+........ +...+.++.++|.+||+.||.+||| +.||++|
T Consensus 283 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 349 (359)
T 3vhe_A 283 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 349 (359)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccCChhhCCC----HHHHHHH
Confidence 99999998 99999887655544443332221111 1223448999999999999999999 9999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=364.89 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=206.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||++.... ....+..|+.+++++ +|+||+++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNE---------YVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTE---------EEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCc---------EEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 679999999999999999999876655 49999987542 224566799999999 899999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC-----EEEe
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH-----IMLS 233 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~-----~kl~ 233 (451)
...+..|+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 75 PCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred ecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 9999999999999 99999999875 356999999999999999999999999999999999999998887 9999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++........... .........+||+.|+
T Consensus 153 DFg~a~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~y~ 184 (330)
T 2izr_A 153 DFALAKEYIDPETKKH------------------------------------------------IPYREHKSLTGTARYM 184 (330)
T ss_dssp CCTTCEESBCTTTCCB------------------------------------------------CCCCCCCCCCSCTTTC
T ss_pred EcccceeeecCCCCcc------------------------------------------------ccccccCCcCCCcccc
Confidence 9999864321111000 0001122458999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS---NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|||++.+..++.++|||||||++|+|++|+.||.... ..+.+..+.......+........+ ++.+|+.+||+.||
T Consensus 185 aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCT
T ss_pred ChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCC
Confidence 9999999999999999999999999999999998743 3344455444333222221122234 89999999999999
Q ss_pred CCcCCCCCChHHHHc
Q 013016 391 CNRLGSKRGAADVKT 405 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~ 405 (451)
.+||+ +++|++
T Consensus 264 ~~RP~----~~~l~~ 274 (330)
T 2izr_A 264 FEKPD----YDYLRK 274 (330)
T ss_dssp TCCCC----HHHHHH
T ss_pred CCCCC----HHHHHH
Confidence 99999 777765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=353.86 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=212.1
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.+.||+|+||.||+|.++.+. .||+|++...... ...+.+|+.++++++||||+++++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~ 70 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQY----------DVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYG 70 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTE----------EEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCce----------eEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34478999999999999999999887543 3999999754322 245677999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+..|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 149 (268)
T 3sxs_A 71 VCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG 149 (268)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred EEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCc
Confidence 999999999999999999999998764 2459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++....... ........||+.|+|||
T Consensus 150 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE 175 (268)
T 3sxs_A 150 MTRYVLDDQ------------------------------------------------------YVSSVGTKFPVKWSAPE 175 (268)
T ss_dssp CEEECCTTC------------------------------------------------------EEECCSCCCCGGGCCHH
T ss_pred cceecchhh------------------------------------------------------hhcccCCCcCcccCCHH
Confidence 985322110 00011225677899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++||||||+++|+|++ |+.||...........+..+...... ...+..+.+||.+||+.||.+|||
T Consensus 176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps 251 (268)
T 3sxs_A 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP----HLASDTIYQIMYSCWHELPEKRPT 251 (268)
T ss_dssp HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----TTSCHHHHHHHHHTTCSSGGGSCC
T ss_pred HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC----CcChHHHHHHHHHHcCCChhhCcC
Confidence 9998889999999999999999999 99999998888888777766543322 223448999999999999999999
Q ss_pred CCCChHHHHcC
Q 013016 396 SKRGAADVKTH 406 (451)
Q Consensus 396 ~~~~~~ell~h 406 (451)
+.|++++
T Consensus 252 ----~~~ll~~ 258 (268)
T 3sxs_A 252 ----FQQLLSS 258 (268)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 9999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=355.39 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=208.6
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+.... .||||++...... ...+.+|+.++++++|+||++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQY----------DVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTE----------EEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCC----------eEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 3378999999999999999999887543 3999999854322 2456779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+.+..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999987642 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .........||+.|+|||+
T Consensus 167 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE~ 192 (283)
T 3gen_A 167 SRYVLDD------------------------------------------------------EYTSSVGSKFPVRWSPPEV 192 (283)
T ss_dssp GGGBCCH------------------------------------------------------HHHSTTSTTSCGGGCCHHH
T ss_pred ccccccc------------------------------------------------------ccccccCCccCcccCCHHH
Confidence 8432110 0001112256788999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++||||||+++|+|++ |+.||...........+......... ...+..+.+||.+||+.||.+|||
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps- 267 (283)
T 3gen_A 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----HLASEKVYTIMYSCWHEKADERPT- 267 (283)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCC-
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC----CcCCHHHHHHHHHHccCChhHCcC-
Confidence 998899999999999999999998 99999998888888888776433222 223448999999999999999999
Q ss_pred CCChHHHHcC
Q 013016 397 KRGAADVKTH 406 (451)
Q Consensus 397 ~~~~~ell~h 406 (451)
+.++++|
T Consensus 268 ---~~~ll~~ 274 (283)
T 3gen_A 268 ---FKILLSN 274 (283)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 9999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.68 Aligned_cols=272 Identities=21% Similarity=0.288 Sum_probs=219.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.++..... ..+..||||++.... .......+.+|+.+++.++|+||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKD----EPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETT----EEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCC----CCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 37899999999999999999988742110 112259999997542 223345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQP--------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
...+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999887532 2457999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... ..........||+
T Consensus 178 kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 204 (322)
T 1p4o_A 178 KIGDFGMTRDIYET-----------------------------------------------------DYYRKGGKGLLPV 204 (322)
T ss_dssp EECCTTCCCGGGGG-----------------------------------------------------GCEEGGGSSEECG
T ss_pred EECcCccccccccc-----------------------------------------------------cccccccCCCCCC
Confidence 99999997422100 0001111236788
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
.|+|||++.+..++.++|||||||++|+|++ |..||...........+..+...... ...+..+.+||.+||+.|
T Consensus 205 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~d 280 (322)
T 1p4o_A 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYN 280 (322)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSS
T ss_pred CccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCC
Confidence 9999999998889999999999999999999 89999998888888777765432211 223448999999999999
Q ss_pred cCCcCCCCCChHHHHcC------CCcCCCCcccc
Q 013016 390 PCNRLGSKRGAADVKTH------PFFKGLNFALI 417 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~h------p~~~~~~~~~~ 417 (451)
|.+||+ +.|+++| +||+++++...
T Consensus 281 p~~Rps----~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 281 PKMRPS----FLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp GGGSCC----HHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred cccCcC----HHHHHHHHHHhhccCCcccccccc
Confidence 999999 8888876 77777666544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=350.78 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=201.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH-HHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK-KKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..++|.+.+.||+|+||.||+|.+.+. .||||++....... ....+.+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGD-----------EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTE-----------EEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCC-----------eEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 458899999999999999999997633 39999997654322 233466778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeccCCCCcEEEcc-------
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG---IIYRDLKPENVLVRS------- 226 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivH~Dlkp~NIll~~------- 226 (451)
++...+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~ 150 (271)
T 3dtc_A 74 VCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150 (271)
T ss_dssp EECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred EEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence 99999999999999999999998864 46999999999999999999999999 899999999999986
Q ss_pred -CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 227 -DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 227 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
++.+||+|||++...... ....
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~---------------------------------------------------------~~~~ 173 (271)
T 3dtc_A 151 SNKILKITDFGLAREWHRT---------------------------------------------------------TKMS 173 (271)
T ss_dssp SSCCEEECCCCC--------------------------------------------------------------------
T ss_pred cCcceEEccCCcccccccc---------------------------------------------------------cccC
Confidence 678999999998422110 0012
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
..||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.......+. +...+..+.+|+.+|
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 250 (271)
T 3dtc_A 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI---PSTCPEPFAKLMEDC 250 (271)
T ss_dssp --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC---CTTCCHHHHHHHHHH
T ss_pred CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC---CcccCHHHHHHHHHH
Confidence 36899999999999988999999999999999999999999998887777776665443332 122344899999999
Q ss_pred cccCcCCcCCCCCChHHHHcC
Q 013016 386 LNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~h 406 (451)
|+.||.+||+ +.|+++|
T Consensus 251 l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 251 WNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred hcCCcccCcC----HHHHHHH
Confidence 9999999999 9999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.76 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=202.8
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..+++|.+.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.++++++||||+++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRER---------IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCe---------EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 345899999999999999999999876655 49999998765544555677888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 999999999999999999999999865 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .........|++.|+|||
T Consensus 180 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE 205 (309)
T 2h34_A 180 IASATTDE------------------------------------------------------KLTQLGNTVGTLYYMAPE 205 (309)
T ss_dssp C----------------------------------------------------------------------CCGGGCCGG
T ss_pred cCcccccc------------------------------------------------------ccccccccCCCcCccCHH
Confidence 97432110 000111236899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC-C
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL-G 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp-t 395 (451)
++.+..++.++||||||+++|+|++|+.||......... ..+......+....+.. +.++.+||.+||+.||++|| +
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rp~s 283 (309)
T 2h34_A 206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRPGI-PVAFDAVIARGMAKNPEDRYVT 283 (309)
T ss_dssp GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGGGTSTTC-CTHHHHHHHHHTCSSGGGSCSS
T ss_pred HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCccccCCCC-CHHHHHHHHHhccCCHHHHHHh
Confidence 999988999999999999999999999999886655433 33333332222222222 33899999999999999999 7
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
++++++
T Consensus 284 ----~~~l~~ 289 (309)
T 2h34_A 284 ----CGDLSA 289 (309)
T ss_dssp ----HHHHHH
T ss_pred ----HHHHHH
Confidence 777663
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=358.29 Aligned_cols=264 Identities=17% Similarity=0.285 Sum_probs=211.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|.+.+.||+|+||.||+|.+..... ...+..||||++..... ....+.+.+|+.+++++ +||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIK----SDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccc----cchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 344789999999999999999998754211 12234699999975532 23346677899999999 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPH----------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
+++...+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999987542 2489999999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+|||++.++.+||+|||++........
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------------- 200 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSN----------------------------------------------------- 200 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT-----------------------------------------------------
T ss_pred ceEEEcCCCCEEEcccccccccccccc-----------------------------------------------------
Confidence 999999999999999999853221100
Q ss_pred cccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHH
Q 013016 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||........+............ +...+..+
T Consensus 201 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 277 (313)
T 1t46_A 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAEM 277 (313)
T ss_dssp SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC---CTTSCHHH
T ss_pred ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCC---cccCCHHH
Confidence 001112367888999999999899999999999999999999 99999887665555544443322211 12234489
Q ss_pred HHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 379 RDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
.+||.+||+.||.+||| +.|++++
T Consensus 278 ~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 278 YDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHcCCCchhCcC----HHHHHHH
Confidence 99999999999999999 9998863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=372.45 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=211.1
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.++||+|+||.||+|.++.+++ .||||++.... .......+.+|+.++++++||||++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~---------~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~ 178 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNT---------LVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLI 178 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCe---------EEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4455789999999999999999999986554 49999997542 223345677899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+.+|+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 179 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 9999999999999999999999998764 245899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++....... .........++..|+||
T Consensus 258 G~s~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 258 GMSREEADGV-----------------------------------------------------YAASGGLRQVPVKWTAP 284 (377)
T ss_dssp GGCEECTTSE-----------------------------------------------------EECCSSCCEEEGGGSCH
T ss_pred CCceecCCCc-----------------------------------------------------eeecCCCCCCCcCcCCH
Confidence 9984321100 00000112356789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||++|||++ |..||......+....+..+..... +...+..+.+||.+||+.||++||
T Consensus 285 E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC----PELCPDAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCCchhCc
Confidence 99998889999999999999999998 9999999888777766665432111 122344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
| +.+|++
T Consensus 361 s----~~~i~~ 367 (377)
T 3cbl_A 361 S----FSTIYQ 367 (377)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 888874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=361.18 Aligned_cols=258 Identities=16% Similarity=0.192 Sum_probs=204.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.+..+++. ....||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 36799999999999999999998765432 11236888886442 233456778899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++ .++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8765 789999999999999988753 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ ........||..|+|||++
T Consensus 165 ~~~~~~~~-----------------------------------------------------~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 165 KLLGAEEK-----------------------------------------------------EYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp HHHTTTCC------------------------------------------------------------CCCGGGSCHHHH
T ss_pred eEccCCcc-----------------------------------------------------cccccCCCccccccChHHh
Confidence 54321100 0011123568889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |+.||...........+..+..... +...+.++.+|+.+||+.||.+||+
T Consensus 192 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps-- 265 (327)
T 3poz_A 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----PPICTIDVYMIMVKCWMIDADSRPK-- 265 (327)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----CTTBCHHHHHHHHHHTCSCGGGSCC--
T ss_pred ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCChhhCCC--
Confidence 99999999999999999999999 9999998877776666655432211 1223448999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.+++++
T Consensus 266 --~~ell~~ 272 (327)
T 3poz_A 266 --FRELIIE 272 (327)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 9999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=351.36 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=201.9
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+..... .+..||+|++.... .......+.+|+.++++++||||++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 34789999999999999999999865432 23359999987542 23345667789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+. .+..|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 84 567899999999999999997653 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... ........|++.|+|||+
T Consensus 163 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~ 188 (281)
T 1mp8_A 163 SRYMEDST------------------------------------------------------YYKASKGKLPIKWMAPES 188 (281)
T ss_dssp ----------------------------------------------------------------------CCGGGCCHHH
T ss_pred ccccCccc------------------------------------------------------ccccccCCCcccccChhh
Confidence 85322100 000112256778999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|+|++ |..||......+....+..+..... . ...+..+.+||.+||+.||++||+
T Consensus 189 ~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~-~~~~~~l~~li~~~l~~~p~~Rps- 263 (281)
T 1mp8_A 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---P-PNCPPTLYSLMTKCWAYDPSRRPR- 263 (281)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---C-TTCCHHHHHHHHHHTCSSGGGSCC-
T ss_pred cccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---C-CCCCHHHHHHHHHHccCChhhCcC-
Confidence 998899999999999999999997 9999998888777777766542211 1 123448999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.|+++
T Consensus 264 ---~~~l~~ 269 (281)
T 1mp8_A 264 ---FTELKA 269 (281)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 998875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=354.03 Aligned_cols=255 Identities=17% Similarity=0.218 Sum_probs=203.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.+.||+|+||+||+|.++.+++. ..-....||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDY--GQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGG--GCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEeccccc--ccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 347899999999999999999998865420 00001249999997543 2334567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC--------
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH-------- 229 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~-------- 229 (451)
+...+..|+||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999998753 34899999999999999999999999999999999999998887
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++.... ......||
T Consensus 160 ~kl~Dfg~~~~~~-----------------------------------------------------------~~~~~~~~ 180 (289)
T 4fvq_A 160 IKLSDPGISITVL-----------------------------------------------------------PKDILQER 180 (289)
T ss_dssp EEECCCCSCTTTS-----------------------------------------------------------CHHHHHHT
T ss_pred eeeccCccccccc-----------------------------------------------------------CccccCCc
Confidence 9999999973211 00123678
Q ss_pred CCccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 310 HEYVSPEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 310 ~~y~aPE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
+.|+|||++.+ ..++.++|||||||++|+|++|..|+...........+.......+..... ++.+||.+||+.
T Consensus 181 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~li~~~l~~ 255 (289)
T 4fvq_A 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA-----ELANLINNCMDY 255 (289)
T ss_dssp TTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSC-----TTHHHHHHHSCS
T ss_pred CcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCH-----HHHHHHHHHcCC
Confidence 89999999987 668999999999999999999554444433333334444444444433322 789999999999
Q ss_pred CcCCcCCCCCChHHHHcC
Q 013016 389 DPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~h 406 (451)
||.+||| +.++++|
T Consensus 256 dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 256 EPDHRPS----FRAIIRD 269 (289)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred ChhHCcC----HHHHHHH
Confidence 9999999 9999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.07 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=205.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.....||+|+||.||+|.+..+++ .||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQV---------RIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCC---------EEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCe---------EEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 456666689999999999999877665 49999987542 233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-CCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-DGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~ 237 (451)
..+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999999988653 235779999999999999999999999999999999999997 89999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... ........|++.|+|||+
T Consensus 170 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~ 194 (295)
T 2clq_A 170 SKRLAGI-------------------------------------------------------NPCTETFTGTLQYMAPEI 194 (295)
T ss_dssp CEESCC------------------------------------------------------------CCCCCCGGGCCHHH
T ss_pred ccccCCC-------------------------------------------------------CCcccccCCCccccChhh
Confidence 8532110 001113468999999999
Q ss_pred ccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH--hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 318 ASGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNI--VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 318 ~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i--~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+.+.. ++.++|||||||++|+|++|+.||....... ..... .......+ ...+.++.+||.+||+.||++
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp HHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC-----TTSCHHHHHHHHHTTCSSTTT
T ss_pred hcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc-----ccCCHHHHHHHHHHccCChhh
Confidence 97654 7899999999999999999999997644332 22221 12222222 223348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCC
Q 013016 393 RLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~ 413 (451)
||+ +.++|+||||+...
T Consensus 270 Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 270 RAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp SCC----HHHHHTSGGGCC--
T ss_pred CCC----HHHHhcChhhhhcc
Confidence 999 99999999999743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=350.26 Aligned_cols=252 Identities=17% Similarity=0.290 Sum_probs=210.9
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.++.+++|.+.++||+|+||+||+|.+.+. .||||++..... .......+.+|+.++++++||||+++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~-----------~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~ 72 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGN-----------DIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPV 72 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTE-----------EEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECE
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCe-----------eEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhhe
Confidence 345668999999999999999999998633 399999976532 22334567889999999999999999
Q ss_pred eEEEEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccCCCE
Q 013016 155 YAEFEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 155 ~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~ 230 (451)
++++... +..++||||++||+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp EEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCE
T ss_pred EEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcce
Confidence 9999877 78999999999999999998876557999999999999999999999999 9999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
+|+|||++.... .....||+
T Consensus 153 ~l~~~~~~~~~~------------------------------------------------------------~~~~~~t~ 172 (271)
T 3kmu_A 153 RISMADVKFSFQ------------------------------------------------------------SPGRMYAP 172 (271)
T ss_dssp EEEGGGSCCTTS------------------------------------------------------------CTTCBSCG
T ss_pred eEEeccceeeec------------------------------------------------------------ccCccCCc
Confidence 999998863211 01236889
Q ss_pred CccCcccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 311 EYVSPEVASGGSHGN---AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~---~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
.|+|||++.+..++. ++|||||||++|+|++|+.||...........+......... +...+.++.+||.+||+
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~ 249 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI---PPGISPHVSKLMKICMN 249 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC---CTTCCHHHHHHHHHHTC
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcC
Confidence 999999998765544 799999999999999999999998888777776655433221 12234489999999999
Q ss_pred cCcCCcCCCCCChHHHHc
Q 013016 388 KDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~ 405 (451)
.||++||| +.++++
T Consensus 250 ~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 250 EDPAKRPK----FDMIVP 263 (271)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.95 Aligned_cols=257 Identities=22% Similarity=0.257 Sum_probs=202.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||+||+|.++.+. .||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----------~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGA----------KVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCC----------EEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred hccCccceeecCCCeeEEEEEECCCC----------EEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 78999999999999999999975432 49999987542 233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
..+..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999987643 23589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .........||+.|+|||+
T Consensus 186 ~~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~aPE~ 212 (321)
T 2qkw_B 186 SKKGTELD-----------------------------------------------------QTHLSTVVKGTLGYIDPEY 212 (321)
T ss_dssp CEECSSSS-----------------------------------------------------CCCCBCCCEEETTTCCHHH
T ss_pred cccccccc-----------------------------------------------------ccccccccCCCccccCHHH
Confidence 85321110 0011123468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCCC--CCCC---CCCcChHHHHHHHHHh
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT-------LRNIVKKPLTF--PTQS---PSSMSEYHARDLISGL 385 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~~~--~~~~---~~~~~~~~~~~ll~~~ 385 (451)
+.+..++.++|||||||++|+|++|+.||......+. ......+.... .... .....+..+.+++.+|
T Consensus 213 ~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 292 (321)
T 2qkw_B 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292 (321)
T ss_dssp HHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHH
T ss_pred hcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHH
Confidence 9888999999999999999999999999976433211 11111111110 0001 1111234788999999
Q ss_pred cccCcCCcCCCCCChHHHHcC
Q 013016 386 LNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~h 406 (451)
|+.||++||| +.|+++|
T Consensus 293 l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 293 LALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCCcccCcC----HHHHHHH
Confidence 9999999999 9999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=356.90 Aligned_cols=267 Identities=19% Similarity=0.294 Sum_probs=206.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||+|+||+||+|.+..+++ .||+|++... .......+.+|+.++++++||||++++++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~---------~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGE---------VMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCc---------EEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 34789999999999999999999987665 4999988543 23445667789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+++..++||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 76 LYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred EecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 999999999999999999999998753 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+............. ..............+||+.|+|||+
T Consensus 155 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~gt~~y~aPE~ 193 (310)
T 3s95_A 155 ARLMVDEKTQPEGL-----------------------------------------RSLKKPDRKKRYTVVGNPYWMAPEM 193 (310)
T ss_dssp CEECC-------------------------------------------------------------CCCCSCGGGCCHHH
T ss_pred ceeccccccccccc-----------------------------------------ccccccccccccccCCCcceeCHHH
Confidence 86433211110000 0000001112224589999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-----TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
+.+..++.++|||||||++|+|++|..||....... ......... .+.. .+..+.+|+.+||+.||++
T Consensus 194 ~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--CPPN-----CPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--CCTT-----CCTTHHHHHHHHTCSSGGG
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--CCCC-----CCHHHHHHHHHHccCChhh
Confidence 999999999999999999999999999987532211 111111111 1111 1227899999999999999
Q ss_pred cCCCCCChHHHHcCCCcCC
Q 013016 393 RLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~ 411 (451)
||+ +.+|++ |++.
T Consensus 267 Rps----~~~l~~--~L~~ 279 (310)
T 3s95_A 267 RPS----FVKLEH--WLET 279 (310)
T ss_dssp SCC----HHHHHH--HHHH
T ss_pred CcC----HHHHHH--HHHH
Confidence 999 999886 4444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.22 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=213.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.++||+|+||+||+|.++.++. .||+|++.... ...+.+.+|+.++++++||||++++++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTE---------EEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCE---------EEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34789999999999999999999987665 49999997542 234567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+||||+.|++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999999887777799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+...... .........||+.|+|||+
T Consensus 158 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE~ 183 (288)
T 3kfa_A 158 SRLMTGD------------------------------------------------------TYTAHAGAKFPIKWTAPES 183 (288)
T ss_dssp GGTSCSS------------------------------------------------------SSEEETTEEECGGGCCHHH
T ss_pred ceeccCC------------------------------------------------------ccccccCCccccCcCChhh
Confidence 8532210 0011112357788999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++||||||+++|+|++ |..||...........+........ +...+..+.+||.+||+.||.+||+
T Consensus 184 ~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps- 258 (288)
T 3kfa_A 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER----PEGCPEKVYELMRACWQWNPSDRPS- 258 (288)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC-
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC----CCCCCHHHHHHHHHHhCCChhhCcC-
Confidence 998899999999999999999999 9999998877777666655432211 1223448999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.++++
T Consensus 259 ---~~~~~~ 264 (288)
T 3kfa_A 259 ---FAEIHQ 264 (288)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=362.34 Aligned_cols=257 Identities=15% Similarity=0.175 Sum_probs=205.8
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.+..+++. ....||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 47899999999999999999998765532 11237777775332 122334556689999999999999999988
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
. .+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 6 56789999999999999998764 346899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
....... .........|+..|+|||++
T Consensus 163 ~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 163 DLLPPDD-----------------------------------------------------KQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp GGSCCCT-----------------------------------------------------TCCC-----CCTTTSCHHHH
T ss_pred cccCccc-----------------------------------------------------ccccccCCCCcccccChHHh
Confidence 5432110 00111234678899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCC-CCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.+..++.++|||||||++|+|++ |+.||......+....+..+... .+.. .+.++.+|+.+||+.||.+||+
T Consensus 190 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps- 263 (325)
T 3kex_A 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI-----CTIDVYMVMVKCWMIDENIRPT- 263 (325)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT-----BCTTTTHHHHHHTCSCTTTSCC-
T ss_pred ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc-----CcHHHHHHHHHHcCCChhhCcC-
Confidence 98899999999999999999999 99999988777777777665332 2222 2227889999999999999999
Q ss_pred CCChHHHHcC
Q 013016 397 KRGAADVKTH 406 (451)
Q Consensus 397 ~~~~~ell~h 406 (451)
+.++++|
T Consensus 264 ---~~el~~~ 270 (325)
T 3kex_A 264 ---FKELANE 270 (325)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 9999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=360.96 Aligned_cols=254 Identities=23% Similarity=0.259 Sum_probs=197.1
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||+||+|.+.+. .||||++.... ........|+.++++++||||+++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----------~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~ 85 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNE-----------YVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIG 85 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTE-----------EEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cchhhchhhheecccCceEEEEEEECCC-----------EEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcc
Confidence 3447899999999999999999987632 49999997542 22334455888999999999999999
Q ss_pred EEEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeccCCCCcE
Q 013016 157 EFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML----------GIIYRDLKPENV 222 (451)
Q Consensus 157 ~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~----------givH~Dlkp~NI 222 (451)
++.... .+|+||||+++|+|.+++... .+++..++.++.||+.||+|||+. ||+||||||+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred eeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence 998744 579999999999999999774 499999999999999999999999 999999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
|++.++.+||+|||++....... ....
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~-----------------------------------------------------~~~~ 189 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGK-----------------------------------------------------SAGD 189 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTS-----------------------------------------------------CCCC
T ss_pred EECCCCeEEEccCCccccccccc-----------------------------------------------------Cccc
Confidence 99999999999999985332110 0011
Q ss_pred ccccccCCCccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCCh----------------HHHHHHHhcC
Q 013016 303 SCSFVGTHEYVSPEVASGG-----SHGNAVDWWAFGIFIYEMIYGRTPFAAPSN----------------ETTLRNIVKK 361 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~-----~~~~~~DIwSlG~il~elltg~~pf~~~~~----------------~~~~~~i~~~ 361 (451)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ......+...
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (322)
T 3soc_A 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK 269 (322)
T ss_dssp CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS
T ss_pred cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc
Confidence 1234799999999999873 356688999999999999999999975321 2222222222
Q ss_pred CCCCC--CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 362 PLTFP--TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 362 ~~~~~--~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
..... ........+.++.+||.+||+.||++||| +.||++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 270 KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 22111 11111122335899999999999999999 888875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=363.60 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=188.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHH-HHHHCCCCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK-ILKMLDHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~nIv~l~~ 156 (451)
..++|.+.+.||+|+||.||+|.++.+++ .||||++..... ......+..|+. +++.++||||+++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQ---------IMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTE---------EEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCC---------EEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 34789999999999999999999886655 499999975422 122233444555 667789999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHK---QPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~---~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl 232 (451)
++...+..++||||+. ++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 9999999999999995 588777653 2346699999999999999999999998 9999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... .......||+.|
T Consensus 168 ~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y 191 (327)
T 3aln_A 168 CDFGISGQLVDS--------------------------------------------------------IAKTRDAGCRPY 191 (327)
T ss_dssp CCCSSSCC------------------------------------------------------------------------
T ss_pred ccCCCceecccc--------------------------------------------------------cccccCCCCccc
Confidence 999998432110 001122689999
Q ss_pred cCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCC-CCCCCCCCcChHHHHHHHHHhc
Q 013016 313 VSPEVA----SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 313 ~aPE~~----~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+|||++ .+..++.++|||||||++|+|++|+.||...... +.+..+..+... ++... ....+..+.+||.+||
T Consensus 192 ~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l 270 (327)
T 3aln_A 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE-EREFSPSFINFVNLCL 270 (327)
T ss_dssp --------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS-SCCCCHHHHHHHHHHT
T ss_pred cCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc-cccCCHHHHHHHHHHh
Confidence 999998 4566899999999999999999999999875432 233333332221 12111 1234458999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+.||.+||+ +.+|++||||.+..+
T Consensus 271 ~~dp~~Rps----~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 271 TKDESKRPK----YKELLKHPFILMYEE 294 (327)
T ss_dssp CSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred hCChhhCcC----HHHHHhChHHHHhHh
Confidence 999999999 999999999987443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=366.26 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=202.6
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.+.||+|+||.||+|+++...+ .+..||||++.... .......+.+|+.++++++||||++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSK------KEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTS------CBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCC------CceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3445789999999999999999998763211 12249999997542 233456778899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+..|+||||++|++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 113 GVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 9999999999999999999999999764 346999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... ........++..|+||
T Consensus 192 g~a~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~aP 219 (373)
T 2qol_A 192 GLGRVLEDDPEA----------------------------------------------------AYTTRGGKIPIRWTSP 219 (373)
T ss_dssp --------------------------------------------------------------------------CTTSCH
T ss_pred ccccccccCCcc----------------------------------------------------ceeccCCCcCCCccCh
Confidence 998533211000 0000112457789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||++|||++ |+.||......+....+..+..... +...+..+.+|+.+||+.||.+||
T Consensus 220 E~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RP 295 (373)
T 2qol_A 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----PMDCPAALYQLMLDCWQKDRNNRP 295 (373)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC----CTTCBHHHHHHHHHHTCSSGGGSC
T ss_pred hhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CccccHHHHHHHHHHhCcChhhCc
Confidence 99999899999999999999999998 9999999888887777765532211 112344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ +.+|++
T Consensus 296 s----~~~i~~ 302 (373)
T 2qol_A 296 K----FEQIVS 302 (373)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 888775
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=357.65 Aligned_cols=265 Identities=17% Similarity=0.273 Sum_probs=213.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+..++|.+.+.||+|+||+||+|.+....+ .....+..||||++.... .......+.+|+.+++++ +||||++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 344789999999999999999999864321 112233469999997653 233456677899999999 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPH--------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
+++...+..|+||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999999999999986532 348999999999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++........ ..
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-----------------------------------------------------~~ 214 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-----------------------------------------------------YK 214 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-----------------------------------------------------EE
T ss_pred EEEcCCCCEEEcccccccccccccc-----------------------------------------------------cc
Confidence 9999999999999999853321100 00
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...+.++.+
T Consensus 215 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 290 (334)
T 2pvf_A 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK----PANCTNELYM 290 (334)
T ss_dssp CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC----CTTCCHHHHH
T ss_pred ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCC----CccCCHHHHH
Confidence 1112357788999999988889999999999999999999 9999999888887777766542211 1223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
||.+||+.||.+||+ +.|++++
T Consensus 291 li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 291 MMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHHH
Confidence 999999999999999 9998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.55 Aligned_cols=262 Identities=16% Similarity=0.263 Sum_probs=211.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~ 156 (451)
..++|.+.+.||+|+||.||+|.+...++. .....||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKE----DAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSS----CCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcc----cchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 347899999999999999999998765432 122359999997653 223446677899999999 8999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQP------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll 224 (451)
++...+..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 9999999999999999999999987532 3458999999999999999999999999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||++...... .......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~~ 224 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMND-----------------------------------------------------SNYIVKG 224 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGC-----------------------------------------------------TTSEECS
T ss_pred CCCCeEEECccccccccccc-----------------------------------------------------cceeecC
Confidence 99999999999998432110 0001111
Q ss_pred ccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
...||+.|+|||++.+..++.++|||||||++|+|++ |..||........+..+......... +...+..+.+||.
T Consensus 225 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~ 301 (333)
T 2i1m_A 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ---PAFAPKNIYSIMQ 301 (333)
T ss_dssp SCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCC---CTTCCHHHHHHHH
T ss_pred CCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCC---CCCCCHHHHHHHH
Confidence 2367888999999999899999999999999999998 99999887666555555443322211 1223448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.||.+||+ +.||++
T Consensus 302 ~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 302 ACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHhccChhhCcC----HHHHHH
Confidence 999999999999 999886
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=349.51 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=198.2
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.++||+|+||+||+|.+... ||+|++..... .......+.+|+.++++++|+||++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~------------vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSSE------------EEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcCc------------eEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 337899999999999999999986543 89999975432 23445677889999999999999999996
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+ ..+..++||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 5 556789999999999999988654 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .........||+.|+|||+
T Consensus 167 ~~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~aPE~ 193 (289)
T 3og7_A 167 ATEKSRWS-----------------------------------------------------GSHQFEQLSGSILWMAPEV 193 (289)
T ss_dssp ----------------------------------------------------------------------CCCTTCCHHH
T ss_pred cccccccc-----------------------------------------------------ccccccccCCCccccCchh
Confidence 74221100 0011123478999999999
Q ss_pred cc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 318 AS---GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI-VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 318 ~~---~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
+. +..++.++|||||||++|+|++|+.||......+.+..+ ..+.............+..+.+||.+||+.||.+|
T Consensus 194 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 273 (289)
T 3og7_A 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273 (289)
T ss_dssp HC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhC
Confidence 87 566889999999999999999999999886665544444 34433333222233345589999999999999999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|+ +.++++
T Consensus 274 ps----~~ell~ 281 (289)
T 3og7_A 274 PS----FPRILA 281 (289)
T ss_dssp CC----HHHHHH
T ss_pred CC----HHHHHH
Confidence 99 888875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=345.99 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=211.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.+.||+|+||.||+|.+..+. .||+|++...... .+.+.+|+.+++.++||||+++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~ 70 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 70 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTE----------EEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCC----------eEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 44578999999999999999999986443 3999999865322 245677999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++...+..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 71 VCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred EEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccc
Confidence 9999999999999999999999997753 458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .........|+..|+|||
T Consensus 150 ~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE 175 (267)
T 3t9t_A 150 MTRFVLDD------------------------------------------------------QYTSSTGTKFPVKWASPE 175 (267)
T ss_dssp GGGGBCCH------------------------------------------------------HHHSTTSTTCCGGGCCHH
T ss_pred cccccccc------------------------------------------------------cccccccccccccccChh
Confidence 97432100 000011235778899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++||||||+++|+|++ |+.||......+....+..+..... +...+..+.+|+.+||+.||.+||+
T Consensus 176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps 251 (267)
T 3t9t_A 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTHVYQIMNHCWRERPEDRPA 251 (267)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC----CccCcHHHHHHHHHHccCChhhCcC
Confidence 9998889999999999999999999 9999999888888887776643221 1233448999999999999999999
Q ss_pred CCCChHHHHcC
Q 013016 396 SKRGAADVKTH 406 (451)
Q Consensus 396 ~~~~~~ell~h 406 (451)
+.+++++
T Consensus 252 ----~~~ll~~ 258 (267)
T 3t9t_A 252 ----FSRLLRQ 258 (267)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 9998863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=359.42 Aligned_cols=265 Identities=18% Similarity=0.254 Sum_probs=210.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.+.||+|+||.||+|.+..... ...+..||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPN----DPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCC----CCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 789999999999999999998653211 1122359999996432 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC---CCEE
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPH-----KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD---GHIM 231 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~---~~~k 231 (451)
..+..|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 348999999999999999999999999999999999999944 4699
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++....... .........||+.
T Consensus 184 l~Dfg~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 210 (327)
T 2yfx_A 184 IGDFGMARDIYRAS-----------------------------------------------------YYRKGGCAMLPVK 210 (327)
T ss_dssp ECCCHHHHHHHC-----------------------------------------------------------CCGGGSCGG
T ss_pred ECcccccccccccc-----------------------------------------------------ccccCCCcCCCcc
Confidence 99999974221100 0011123467889
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+...... ...+..+.+||.+||+.||
T Consensus 211 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp 286 (327)
T 2yfx_A 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQP 286 (327)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSG
T ss_pred eeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHhcCCh
Confidence 999999998899999999999999999998 99999988888777777665432221 2234489999999999999
Q ss_pred CCcCCCCCChHHHHcCCCcCC
Q 013016 391 CNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~hp~~~~ 411 (451)
.+||+ +.+|++|.|+-.
T Consensus 287 ~~Rps----~~~ll~~l~~~~ 303 (327)
T 2yfx_A 287 EDRPN----FAIILERIEYCT 303 (327)
T ss_dssp GGSCC----HHHHHHHHHHHH
T ss_pred hhCcC----HHHHHHHHHHHh
Confidence 99999 999999988655
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=353.89 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=209.9
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
..+..++|.+.+.||+|+||+||+|.++.... ..+..||||++.... .......+.+|+.++++++||||+++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~ 111 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRL 111 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 34455789999999999999999999875432 122359999997542 22334567789999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++...+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 112 EGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp EEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred EEEEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECC
Confidence 99999999999999999999999998764 35699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++......... ........||..|+|
T Consensus 191 fg~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~a 218 (333)
T 1mqb_A 191 FGLSRVLEDDPEA----------------------------------------------------TYTTSGGKIPIRWTA 218 (333)
T ss_dssp CCC---------------------------------------------------------------------CCCGGGSC
T ss_pred CCcchhhcccccc----------------------------------------------------ccccCCCCccccccC
Confidence 9998532211000 000111246778999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+..++.++|||||||++|+|++ |+.||......+....+..+..... +...+..+.+||.+||+.||.+|
T Consensus 219 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R 294 (333)
T 1mqb_A 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT----PMDCPSAIYQLMMQCWQQERARR 294 (333)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----CTTCBHHHHHHHHHHTCSSTTTS
T ss_pred chhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC----cccCCHHHHHHHHHHcCCChhhC
Confidence 999999899999999999999999999 9999998888887777766532111 12234489999999999999999
Q ss_pred CCCCCChHHHHcC
Q 013016 394 LGSKRGAADVKTH 406 (451)
Q Consensus 394 pt~~~~~~ell~h 406 (451)
|+ +.+++++
T Consensus 295 ps----~~~l~~~ 303 (333)
T 1mqb_A 295 PK----FADIVSI 303 (333)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 8888763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=370.50 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=209.3
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
+.+..++|++.++||+|+||.||+|.+++. .||||++.... ..+.+.+|+.++++++||||+++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~-----------~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~ 251 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQL 251 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTE-----------EEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEecCC-----------eEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEE
Confidence 455668899999999999999999988643 39999997542 34567789999999999999999
Q ss_pred eEEEEeCC-eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 155 YAEFEASN-FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 155 ~~~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
++++...+ .+|+||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 252 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp EEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEe
Confidence 99987665 79999999999999999987655568999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++...... .....++..|+
T Consensus 332 DfG~a~~~~~~----------------------------------------------------------~~~~~~~~~y~ 353 (450)
T 1k9a_A 332 DFGLTKEASST----------------------------------------------------------QDTGKLPVKWT 353 (450)
T ss_dssp CCTTCEECC----------------------------------------------------------------CCCTTTS
T ss_pred eCCCccccccc----------------------------------------------------------ccCCCCCccee
Confidence 99998421100 00125678899
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
|||++.+..++.++|||||||+||||++ |+.||......+....+..+.. ..+ ...+..+.+||.+||+.||.
T Consensus 354 aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p-----~~~~~~l~~li~~cl~~dp~ 428 (450)
T 1k9a_A 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-----DGCPPAVYDVMKNCWHLDAA 428 (450)
T ss_dssp CHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCC-----TTCCHHHHHHHHHHTCSSGG
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-----CcCCHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999998 9999998877777777766532 222 22344899999999999999
Q ss_pred CcCCCCCChHHHHc
Q 013016 392 NRLGSKRGAADVKT 405 (451)
Q Consensus 392 ~Rpt~~~~~~ell~ 405 (451)
+||| +.+|++
T Consensus 429 ~Rpt----~~~l~~ 438 (450)
T 1k9a_A 429 TRPT----FLQLRE 438 (450)
T ss_dssp GSCC----HHHHHH
T ss_pred HCcC----HHHHHH
Confidence 9999 888864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=360.77 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=207.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCC--CCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLD--HPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~nIv~l 154 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++........ .....+..|+.+++++. |+||+++
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNL---------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTE---------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 789999999999999999999877665 499999976532211 11234456899999996 5999999
Q ss_pred eEEEEeCCeEEEEEeeccC-CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc-cCCCEEE
Q 013016 155 YAEFEASNFSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-SDGHIML 232 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-~~~~~kl 232 (451)
++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999999999999999976 8999998764 5599999999999999999999999999999999999999 7899999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......||+.|
T Consensus 192 ~Dfg~~~~~~~~---------------------------------------------------------~~~~~~gt~~y 214 (320)
T 3a99_A 192 IDFGSGALLKDT---------------------------------------------------------VYTDFDGTRVY 214 (320)
T ss_dssp CCCTTCEECCSS---------------------------------------------------------CBCCCCSCGGG
T ss_pred eeCccccccccc---------------------------------------------------------cccCCCCCccC
Confidence 999998532210 01123689999
Q ss_pred cCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
+|||++.+..+ +.++|||||||++|+|++|+.||.... .+......++. ..+.++.+||.+||+.||.
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ-----RVSSECQHLIRWCLALRPS 283 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS-----CCCHHHHHHHHHHTCSSGG
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccc-----cCCHHHHHHHHHHccCChh
Confidence 99999987665 688999999999999999999997531 22333333222 2334899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCCCcc
Q 013016 392 NRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
+||+ +.||++||||+++-.+
T Consensus 284 ~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 284 DRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp GSCC----HHHHHTSGGGSSCCCH
T ss_pred hCcC----HHHHhcCHhhcCccCc
Confidence 9999 9999999999996554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=352.60 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=205.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC--CCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD--HPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~ 157 (451)
++|.+.+.||+|+||.||+|.+..+. .||||++..... .......+.+|+.+++++. |+||++++++
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----------~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQ----------IYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCC----------EEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCc----------EEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 67999999999999999999876432 499999965432 2334566778999999997 5999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 97 ~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred eecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence 9999999999994 589999999875 4689999999999999999999999999999999999996 58999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... .........||+.|+|||+
T Consensus 173 ~~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~aPE~ 199 (313)
T 3cek_A 173 ANQMQPDT-----------------------------------------------------TSVVKDSQVGTVNYMPPEA 199 (313)
T ss_dssp SCC-------------------------------------------------------------------CCGGGCCHHH
T ss_pred cccccCcc-----------------------------------------------------ccccccCCCCCCCcCCHHH
Confidence 85321100 0001113478999999999
Q ss_pred ccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 318 ASG-----------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 318 ~~~-----------~~~~~~~DIwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+.+ ..++.++|||||||++|+|++|+.||..... ...+..+......... +...+.++.+||.+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 276 (313)
T 3cek_A 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF---PDIPEKDLQDVLKCC 276 (313)
T ss_dssp HTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC---CCCSCHHHHHHHHHH
T ss_pred HhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC---cccchHHHHHHHHHH
Confidence 876 4678899999999999999999999987543 3444555443322211 122344899999999
Q ss_pred cccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 386 LNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
|+.||.+||+ +.|+++||||+...
T Consensus 277 l~~dp~~Rps----~~ell~h~~~~~~~ 300 (313)
T 3cek_A 277 LKRDPKQRIS----IPELLAHPYVQIQT 300 (313)
T ss_dssp TCSSTTTSCC----HHHHHTSHHHHCC-
T ss_pred ccCCcccCcC----HHHHhcCccccCCC
Confidence 9999999999 99999999999843
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.85 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=209.3
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
.++..++|.+.+.||+|+||+||+|.+..... .+..||+|++.... .......+.+|+.+++.++||||+++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~ 78 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKG------EKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKL 78 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTC------CEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCC------CcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceE
Confidence 44555889999999999999999998765431 12359999998652 22344667789999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++.+ +..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 79 IGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECC
T ss_pred EEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCc
Confidence 999875 45689999999999999987643 4589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++....... ........|++.|+|
T Consensus 157 fg~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~a 182 (281)
T 3cc6_A 157 FGLSRYIEDED------------------------------------------------------YYKASVTRLPIKWMS 182 (281)
T ss_dssp CCGGGCC---------------------------------------------------------------CCCCCGGGCC
T ss_pred cCCCccccccc------------------------------------------------------ccccccCCCCcceeC
Confidence 99985322100 000112356788999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+..++.++|||||||++|+|++ |+.||...........+........ +...+..+.+||.+||+.||.+|
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R 258 (281)
T 3cc6_A 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK----PDLCPPVLYTLMTRCWDYDPSDR 258 (281)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred chhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHccCCchhC
Confidence 999998889999999999999999998 9999988777766666655432211 12234489999999999999999
Q ss_pred CCCCCChHHHHcC
Q 013016 394 LGSKRGAADVKTH 406 (451)
Q Consensus 394 pt~~~~~~ell~h 406 (451)
|+ +.|++++
T Consensus 259 ps----~~ell~~ 267 (281)
T 3cc6_A 259 PR----FTELVCS 267 (281)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 9998864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.67 Aligned_cols=272 Identities=21% Similarity=0.261 Sum_probs=209.9
Q ss_pred CchhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHH
Q 013016 59 SDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138 (451)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~ 138 (451)
..++..++.... ++|.+.+.||+|+||+||+|.+..+. .||||++...... .....+.+
T Consensus 18 ~~~~~~~~~~~~---------~~y~~~~~lg~G~~g~V~~~~~~~~~----------~vavK~~~~~~~~--~~~~~~~~ 76 (326)
T 3uim_A 18 KRFSLRELQVAS---------DNFSNKNILGRGGFGKVYKGRLADGT----------LVAVKRLKEERTQ--GGELQFQT 76 (326)
T ss_dssp EECCTHHHHTTT---------TSSCSTTEEECCSSSEEEEECCSSSC----------CEEEEECCC-------CCCHHHH
T ss_pred ceecHHHHHHHh---------hccccceeEecCCCcEEEEEEecCCC----------EEEEEEeccccCc--hHHHHHHH
Confidence 346667777666 89999999999999999999765332 3999999865322 22335778
Q ss_pred HHHHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCe
Q 013016 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP--HKRFSLTSARFYAAEVLVALEYLHML---GII 213 (451)
Q Consensus 139 e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---giv 213 (451)
|+.+++.++||||+++++++...+..++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ ||+
T Consensus 77 e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv 156 (326)
T 3uim_A 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156 (326)
T ss_dssp HHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEE
T ss_pred HHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Confidence 9999999999999999999999999999999999999999998653 23499999999999999999999999 999
Q ss_pred eccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcc
Q 013016 214 YRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRL 293 (451)
Q Consensus 214 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (451)
||||||+|||++.++.+||+|||++......
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------------------------------------------------- 187 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYK------------------------------------------------- 187 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSS-------------------------------------------------
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCcc-------------------------------------------------
Confidence 9999999999999999999999998532211
Q ss_pred cccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHhcCCCCC---C
Q 013016 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA----PSNETTLRNIVKKPLTF---P 366 (451)
Q Consensus 294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~----~~~~~~~~~i~~~~~~~---~ 366 (451)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.. .........+....... .
T Consensus 188 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 188 -----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp -----SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred -----cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 01111234699999999999888899999999999999999999999962 11111122222211110 0
Q ss_pred C----C---CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCc
Q 013016 367 T----Q---SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 367 ~----~---~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~ 409 (451)
. . .........+.+|+.+||+.||.+||| +.||++|-+-
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~~ 308 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLEG 308 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHHT
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhcC
Confidence 0 0 001112247899999999999999999 9999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.40 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=198.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHC----CCCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKML----DHPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~nIv 152 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++........ .....+..|+.++.++ +|+||+
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRL---------QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCC---------EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCe---------EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 779999999999999999999876655 499999975432211 1223345688899888 899999
Q ss_pred ceeEEEEeCCeEEEEEee-ccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc-cCCCE
Q 013016 153 TLYAEFEASNFSCIVMEF-CSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-SDGHI 230 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-~~~~~ 230 (451)
++++++...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence 999999999999999999 7899999999874 4599999999999999999999999999999999999999 88999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++...... ......|+.
T Consensus 180 kl~dfg~~~~~~~~---------------------------------------------------------~~~~~~~~~ 202 (312)
T 2iwi_A 180 KLIDFGSGALLHDE---------------------------------------------------------PYTDFDGTR 202 (312)
T ss_dssp EECCCSSCEECCSS---------------------------------------------------------CBCCCCSCT
T ss_pred EEEEcchhhhcccC---------------------------------------------------------cccccCCcc
Confidence 99999998532210 011236899
Q ss_pred CccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 311 EYVSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 311 ~y~aPE~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
.|+|||++.+..+ +.++|||||||++|+|++|+.||... . .+......++. ..+.++.+||.+||+.|
T Consensus 203 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~----~~~~~~~~~~~-----~~~~~~~~li~~~l~~~ 271 (312)
T 2iwi_A 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--Q----EILEAELHFPA-----HVSPDCCALIRRCLAPK 271 (312)
T ss_dssp TTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--H----HHHHTCCCCCT-----TSCHHHHHHHHHHTCSS
T ss_pred cccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--H----HHhhhccCCcc-----cCCHHHHHHHHHHccCC
Confidence 9999999987666 45899999999999999999999753 1 22333333332 23348999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 390 PCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
|++||+ +.|+++||||++...
T Consensus 272 p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 272 PSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp TTTSCC----HHHHHHSTTTCC---
T ss_pred hhhCcC----HHHHhcChhhcCchh
Confidence 999999 999999999998544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=350.07 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=199.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|++.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.++++++|+||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGV---------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCC---------EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCc---------eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3789999999999999999999876655 4999999754333344556777899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
...+..++||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg 181 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 181 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecc
Confidence 9999999999999999999988652 24568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... ........|++.|+|||
T Consensus 182 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE 206 (310)
T 2wqm_A 182 LGRFFSSK-------------------------------------------------------TTAAHSLVGTPYYMSPE 206 (310)
T ss_dssp ------------------------------------------------------------------------CCSSCCHH
T ss_pred ceeeecCC-------------------------------------------------------CccccccCCCeeEeChH
Confidence 97432110 00111246899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS--NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
++.+..++.++|||||||++|+|++|+.||.... .......+...... ... ....+.++.+||.+||+.||.+||
T Consensus 207 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~l~~li~~~l~~dp~~Rp 283 (310)
T 2wqm_A 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLP-SDHYSEELRQLVNMCINPDPEKRP 283 (310)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCC-TTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCc-ccccCHHHHHHHHHHcCCChhhCC
Confidence 9999899999999999999999999999997643 23444444443322 111 123344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ +.++++
T Consensus 284 s----~~~il~ 290 (310)
T 2wqm_A 284 D----VTYVYD 290 (310)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 999885
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.52 Aligned_cols=259 Identities=18% Similarity=0.235 Sum_probs=205.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|.+.+.||+|+||.||+|.+..+++ .||||++.... ....+.+|+.+++.+ +|+||++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~ 74 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYF 74 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCc---------EEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEee
Confidence 3779999999999999999999876655 49999986432 224466799999999 79999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC-----EEE
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH-----IML 232 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~-----~kl 232 (451)
+......|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus 75 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 75 GQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred cCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 99999999999999 999999998753 45999999999999999999999999999999999999987776 999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++........... ..........||+.|
T Consensus 153 ~Dfg~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~y 184 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQH------------------------------------------------IPYREKKNLSGTARY 184 (298)
T ss_dssp CCCTTCEESBCTTTCCB------------------------------------------------CCCCCCCCCCSCTTT
T ss_pred EECcccccccccccccc------------------------------------------------ccccCccCCCCCccc
Confidence 99999864332111000 000112245799999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP---SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
+|||++.+..++.++|||||||++|+|++|+.||... .....+..+.......+........+.++.+|+.+||+.|
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCC
T ss_pred CCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999999999874 3344444443332211111111123348999999999999
Q ss_pred cCCcCCCCCChHHHHc
Q 013016 390 PCNRLGSKRGAADVKT 405 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~ 405 (451)
|++||+ +.+|++
T Consensus 265 p~~RP~----~~~l~~ 276 (298)
T 1csn_A 265 FDATPD----YDYLQG 276 (298)
T ss_dssp TTCCCC----HHHHHH
T ss_pred cccCCC----HHHHHH
Confidence 999999 888764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=355.55 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=209.6
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+.+++|.+.+.||+|+||.||+|.++.++.. ..+|+|++.... .......+.+|+.+++++ +||||++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEE-------EEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcc-------cceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 4458899999999999999999998876542 125999987532 233456678899999999 899999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
+++...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999987643 3469999999999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++..... ..
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~--------------------------------------------------------~~ 196 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEV--------------------------------------------------------YV 196 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCE--------------------------------------------------------EC
T ss_pred EEEcCCCeEEEcccCcCccccc--------------------------------------------------------cc
Confidence 9999999999999999742110 00
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+..+..... +...+.++.+
T Consensus 197 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~ 272 (327)
T 1fvr_A 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK----PLNCDDEVYD 272 (327)
T ss_dssp CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC----CTTBCHHHHH
T ss_pred cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCC----CCCCCHHHHH
Confidence 0112256788999999988889999999999999999998 9999999888887777766532111 1223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
||.+||+.||.+||+ +.+++++
T Consensus 273 li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 273 LMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHHH
Confidence 999999999999999 9999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=377.22 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=213.0
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+...+|.+.++||+|+||.||+|.++.... .||||++.... ...+.+.+|+.++++++||||++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~ 282 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLL 282 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTE---------EEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCe---------EEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEE
Confidence 3445789999999999999999999987554 49999997542 2345677899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+.+||||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 283 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred EEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeec
Confidence 99999999999999999999999998876677999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++....... ........++..|+||
T Consensus 363 G~a~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aP 388 (495)
T 1opk_A 363 GLSRLMTGDT------------------------------------------------------YTAHAGAKFPIKWTAP 388 (495)
T ss_dssp TCEECCTTCC------------------------------------------------------EECCTTCCCCGGGCCH
T ss_pred ccceeccCCc------------------------------------------------------eeecCCCcCCcceeCH
Confidence 9985322100 0001122467789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||+||||++ |..||.+....+....+..+.... . +...+.++.+||.+||+.||.+||
T Consensus 389 E~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~cl~~dP~~RP 464 (495)
T 1opk_A 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---R-PEGCPEKVYELMRACWQWNPSDRP 464 (495)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---C-CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---C-CCCCCHHHHHHHHHHcCcChhHCc
Confidence 99998889999999999999999999 999999888777766665543211 1 122344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
+ +.+|++
T Consensus 465 s----~~el~~ 471 (495)
T 1opk_A 465 S----FAEIHQ 471 (495)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 888875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=350.30 Aligned_cols=259 Identities=19% Similarity=0.281 Sum_probs=199.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.++||+|+||+||+|++..... ..+..||||++.... ......+.+|+.++++++||||++++++
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQD-----NTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCS-----SCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccC-----CCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34789999999999999999998542211 123369999997542 3344667789999999999999999999
Q ss_pred EEeC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEAS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+... .++++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 8653 56899999999999999998753 35999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ .........|+..|+||
T Consensus 159 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aP 186 (295)
T 3ugc_A 159 GLTKVLPQDKE----------------------------------------------------FFKVKEPGESPIFWYAP 186 (295)
T ss_dssp CSCC-----------------------------------------------------------------CTTCGGGGCCH
T ss_pred cccccccCCcc----------------------------------------------------eeeeccCCCCccceeCc
Confidence 99853321100 00011122567789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHhcCCCCCCCCCCCCcChHHHH
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE----------------TTLRNIVKKPLTFPTQSPSSMSEYHAR 379 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~ 379 (451)
|++.+..++.++|||||||++|+|++|..||...... .....+... ...+. +...+.++.
T Consensus 187 E~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~ 262 (295)
T 3ugc_A 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRLPR---PDGCPDEIY 262 (295)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT-CCCCC---CTTCCHHHH
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc-CcCCC---CcCcCHHHH
Confidence 9999999999999999999999999999998753221 112222222 11111 222344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||.+||+.||++||| +.||++
T Consensus 263 ~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 263 MIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp HHHHHHSCSSGGGSCC----HHHHHH
T ss_pred HHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999 888875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=352.62 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=196.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..+++|++.+.||+|+||.||+|.++.+++ .||||++...... ......+..+..+++.++||||+++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~ 91 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGH---------VIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFG 91 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCC---------EEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCe---------EEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEE
Confidence 345889999999999999999999986655 4999999765322 222233344555678889999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeccCCCCcEEEccCCCEEEecc
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML-GIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~-givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++...+..|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 92 TFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999 66666655443 35699999999999999999999995 9999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .......||+.|+||
T Consensus 170 g~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 193 (318)
T 2dyl_A 170 GISGRLVDD--------------------------------------------------------KAKDRSAGCAAYMAP 193 (318)
T ss_dssp TTC----------------------------------------------------------------------CCTTCCH
T ss_pred CCchhccCC--------------------------------------------------------ccccccCCCccccCh
Confidence 997422110 001123689999999
Q ss_pred cccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 316 EVAS-----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAP-SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 316 E~~~-----~~~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|++. +..++.++|||||||++|+|++|+.||... ...+.+..+.......... ....+.++.+||.+||+.|
T Consensus 194 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~d 271 (318)
T 2dyl_A 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG--HMGFSGDFQSFVKDCLTKD 271 (318)
T ss_dssp HHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS--SSCCCHHHHHHHHHHTCSC
T ss_pred hhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc--cCCCCHHHHHHHHHHccCC
Confidence 9995 456789999999999999999999999874 4455666666654322211 1123448999999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCCC
Q 013016 390 PCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
|.+||+ +.+|++||||++.
T Consensus 272 p~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 272 HRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp TTTSCC----HHHHTTSHHHHHH
T ss_pred hhHCcC----HHHHhhCHHHHhc
Confidence 999999 9999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.12 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=208.5
Q ss_pred ccCCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 78 TFRDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..++|.+.+ .||+|+||.||+|.+..... +..||||++.... .......+.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---C-------CEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCC-------cceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 346788877 99999999999998753221 2259999997642 2344567788999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++ ..+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 556799999999999999998654 3559999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++........ .........||+.|+|||
T Consensus 156 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE 183 (287)
T 1u59_A 156 LSKALGADDS----------------------------------------------------YYTARSAGKWPLKWYAPE 183 (287)
T ss_dssp TCEECTTCSC----------------------------------------------------EECCCCSSCCCGGGCCHH
T ss_pred ceeeeccCcc----------------------------------------------------eeeccccccccccccCHH
Confidence 9853321100 000111235788999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++|||||||++|+|++ |+.||......+....+..+..... +...+.++.+||.+||+.||.+||+
T Consensus 184 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps 259 (287)
T 1u59_A 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC----PPECPPELYALMSDCWIYKWEDRPD 259 (287)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred HhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC----CCCcCHHHHHHHHHHcCCChhhCcC
Confidence 9988889999999999999999998 9999999888887777766542211 1223448999999999999999999
Q ss_pred CCCChHHHHcC
Q 013016 396 SKRGAADVKTH 406 (451)
Q Consensus 396 ~~~~~~ell~h 406 (451)
+.++++|
T Consensus 260 ----~~~l~~~ 266 (287)
T 1u59_A 260 ----FLTVEQR 266 (287)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 9999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=373.01 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=209.5
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.++||+|+||+||+|.++.+. .||||++.... ...+.+.+|+.++++++||||++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~----------~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~ 249 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLH 249 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTE----------EEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCcc----------EEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEE
Confidence 344578999999999999999999987543 39999997542 2345677899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++. .+.+|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 250 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 250 AVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp EEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECST
T ss_pred EEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeC
Confidence 9986 667899999999999999997654446899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++...... .........++..|+||
T Consensus 329 G~a~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aP 354 (454)
T 1qcf_A 329 GLARVIEDN------------------------------------------------------EYTAREGAKFPIKWTAP 354 (454)
T ss_dssp TGGGGBCCH------------------------------------------------------HHHTTCSSSSCGGGSCH
T ss_pred CCceEcCCC------------------------------------------------------ceeccCCCcccccccCH
Confidence 998532110 00000112467789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.+..++.++|||||||+||||++ |+.||.+....+....+..+..... +...+.++.+||.+||+.||++||
T Consensus 355 E~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR----PENCPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHccCChhHCc
Confidence 99998899999999999999999999 9999999888888877776532211 122344899999999999999999
Q ss_pred CCCCChHHHHc
Q 013016 395 GSKRGAADVKT 405 (451)
Q Consensus 395 t~~~~~~ell~ 405 (451)
| +.+|++
T Consensus 431 t----~~~i~~ 437 (454)
T 1qcf_A 431 T----FEYIQS 437 (454)
T ss_dssp C----HHHHHH
T ss_pred C----HHHHHH
Confidence 9 888864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=353.45 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=207.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
++|.+.+.||+|+||+||+|.+..... ...+..||||++.... .......+.+|+.++.++ +||||+++++++
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCc----cccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 789999999999999999998754321 1233469999997653 223445677899999999 799999999998
Q ss_pred EeCC-eEEEEEeeccCCchhhhhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 159 EASN-FSCIVMEFCSGGDLHSLRHKQPH--------------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 159 ~~~~-~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
...+ .+++||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 59999999999999999987542 22889999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.+||+|||++...... ......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~ 207 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKD-----------------------------------------------------PDYVRK 207 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTC-----------------------------------------------------TTSEEE
T ss_pred ECCCCCEEECCCccccccccC-----------------------------------------------------ccceec
Confidence 999999999999998532110 001111
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHHhcCCC-CCCCCCCCCcChHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTL-RNIVKKPL-TFPTQSPSSMSEYHARD 380 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~-~~i~~~~~-~~~~~~~~~~~~~~~~~ 380 (451)
....||+.|+|||++.+..++.++|||||||++|+|++ |..||........+ ..+..+.. ..+ ...+.++.+
T Consensus 208 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~ 282 (316)
T 2xir_A 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP-----DYTTPEMYQ 282 (316)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC-----TTCCHHHHH
T ss_pred cCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC-----CCCCHHHHH
Confidence 23467889999999999899999999999999999998 99999886654443 33333321 112 223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+|.+||+.||.+||+ +.|+++|
T Consensus 283 li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 283 TMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999 9999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=346.26 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=208.6
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
+.+..++|++.+.||+|+||.||+|.+.... .||||++..... ....+.+|+.+++.++||||+++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~ 73 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRL 73 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTE----------EEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCc----------EEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceE
Confidence 3445578999999999999999999976543 399999975422 23567779999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++. .+..++||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 74 YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECC
Confidence 99886 45689999999999999998764334699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++........ .......|+..|+|
T Consensus 153 fg~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~a 178 (279)
T 1qpc_A 153 FGLARLIEDNEY------------------------------------------------------TAREGAKFPIKWTA 178 (279)
T ss_dssp CTTCEECSSSCE------------------------------------------------------ECCTTCCCCTTTSC
T ss_pred CcccccccCccc------------------------------------------------------ccccCCCCccCccC
Confidence 999853321100 00112256788999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+..++.++|||||||++|+|++ |+.||......+....+..+..... +...+.++.+|+.+||+.||++|
T Consensus 179 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R 254 (279)
T 1qpc_A 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR----PDNCPEELYQLMRLCWKERPEDR 254 (279)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC----cccccHHHHHHHHHHhccChhhC
Confidence 999988889999999999999999999 9999999888887777766532211 12234489999999999999999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|+ +.++++
T Consensus 255 ps----~~~l~~ 262 (279)
T 1qpc_A 255 PT----FDYLRS 262 (279)
T ss_dssp CC----HHHHHH
T ss_pred CC----HHHHHH
Confidence 99 888875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=354.36 Aligned_cols=257 Identities=16% Similarity=0.194 Sum_probs=203.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.+..+++. ....||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 37899999999999999999998766543 11125777765331 223345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+. .++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8765 789999999999999988753 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ ........||+.|+|||++
T Consensus 165 ~~~~~~~~-----------------------------------------------------~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3lzb_A 165 KLLGAEEK-----------------------------------------------------EYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp --------------------------------------------------------------------CCCGGGSCHHHH
T ss_pred eEccCccc-----------------------------------------------------cccccCCCccccccCHHHH
Confidence 53221100 0011123567889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |+.||......+....+........ +...+.++.+||.+||+.||.+||+
T Consensus 192 ~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps-- 265 (327)
T 3lzb_A 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----PPICTIDVYMIMRKCWMIDADSRPK-- 265 (327)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCChhHCcC--
Confidence 99999999999999999999999 9999998877777666655532211 1223448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.||++
T Consensus 266 --~~ell~ 271 (327)
T 3lzb_A 266 --FRELII 271 (327)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 999886
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.25 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=199.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH----HHHHHHHHHHHHHHHCCCCCcccee
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK----KKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
++|.+.+.||+|+||+||+|.+..+++ .||||++........ .....+.+|+.++++++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCC---------EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEcCCce---------EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 789999999999999999999987665 499999865432211 1125677899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccCCC----
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSDGH---- 229 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~~~---- 229 (451)
+++.+.. ++||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 9997665 6999999999999888654 346999999999999999999999999 999999999999988776
Q ss_pred -EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 230 -IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 230 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
+||+|||++..... ......|
T Consensus 167 ~~kl~Dfg~~~~~~~----------------------------------------------------------~~~~~~g 188 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH----------------------------------------------------------SVSGLLG 188 (287)
T ss_dssp CEEECCCTTCBCCSS----------------------------------------------------------CEECCCC
T ss_pred eEEeCCCCccccccc----------------------------------------------------------cccccCC
Confidence 99999999742110 1112478
Q ss_pred CCCccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 309 THEYVSPEVAS--GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT--LRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 309 t~~y~aPE~~~--~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
|+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+........ .. ...+..+.+||.+
T Consensus 189 ~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~l~~li~~ 265 (287)
T 4f0f_A 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT--IP-EDCPPRLRNVIEL 265 (287)
T ss_dssp CCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC--CC-TTSCHHHHHHHHH
T ss_pred CccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC--CC-cccCHHHHHHHHH
Confidence 99999999984 44578999999999999999999999987554332 333333322211 11 2234489999999
Q ss_pred hcccCcCCcCCCCCChHHHHc
Q 013016 385 LLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~ 405 (451)
||+.||.+||+ +.|+++
T Consensus 266 ~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 266 CWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhcCChhhCcC----HHHHHH
Confidence 99999999999 999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=369.73 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=209.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.++||+|+||.||+|.++.+. .||||++..... ..+.+.+|+.++++++||||+++++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----------~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 246 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTE----------EEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCc----------eEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 44478999999999999999999987653 399999985432 2345778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++.. +..|+||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 9876 678999999999999999976544569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++....... ........++..|+|||
T Consensus 326 ~a~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE 351 (452)
T 1fmk_A 326 LARLIEDNE------------------------------------------------------YTARQGAKFPIKWTAPE 351 (452)
T ss_dssp TTC--------------------------------------------------------------------CCGGGSCHH
T ss_pred cceecCCCc------------------------------------------------------eecccCCcccccccCHh
Confidence 985321100 00011125677899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++|||||||++|||++ |+.||.+....+.+..+..+..... +...+..+.+||.+||+.||++|||
T Consensus 352 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC----PPECPESLHDLMCQCWRKEPEERPT 427 (452)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHccCChhhCcC
Confidence 9998899999999999999999999 9999999888888887766532111 1223448999999999999999999
Q ss_pred CCCChHHHHc--CCCcCC
Q 013016 396 SKRGAADVKT--HPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~--hp~~~~ 411 (451)
+++|++ ..++..
T Consensus 428 ----~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 428 ----FEYLQAFLEDYFTS 441 (452)
T ss_dssp ----HHHHHHHHHTTTSC
T ss_pred ----HHHHHHHHHHHhcc
Confidence 988875 244444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=343.77 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=205.2
Q ss_pred cCCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 79 FRDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.++|.+.+ .||+|+||+||+|.+.... .+..||||++..... .......+.+|+.+++.++||||++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCC-------ceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 36799998 9999999999999664321 122599999986532 23345678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+ ..+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 9 567889999999999999999875 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .........|++.|+|||+
T Consensus 164 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~ 191 (291)
T 1xbb_A 164 SKALRADEN----------------------------------------------------YYKAQTHGKWPVKWYAPEC 191 (291)
T ss_dssp CEECCTTCS----------------------------------------------------EEEC----CCCGGGCCHHH
T ss_pred ceeeccCCC----------------------------------------------------cccccccCCCCceeeChHH
Confidence 853321100 0000111246788999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++||||||+++|+|++ |+.||......+....+..+..... +...+..+.++|.+||+.||.+||+
T Consensus 192 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps- 266 (291)
T 1xbb_A 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC----PAGCPREMYDLMNLCWTYDVENRPG- 266 (291)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSTTTSCC-
T ss_pred hccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcC-
Confidence 988889999999999999999999 9999999888777777666532211 1223448999999999999999999
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.++++
T Consensus 267 ---~~~l~~ 272 (291)
T 1xbb_A 267 ---FAAVEL 272 (291)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 888874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.06 Aligned_cols=268 Identities=16% Similarity=0.200 Sum_probs=196.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH--------HHHHHHHHHHHHHHCCCCCc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK--------KVHRAEMEKKILKMLDHPFL 151 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~nI 151 (451)
++|.+.++||+|+||+||+|.++.+... ..+..||||++......... .......|+..++.++|+||
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCC----CTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CeEEEEEEEecCCCeEEEEeeecCcccc----ccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 6799999999999999999998765321 11224999998754321111 11123345666778899999
Q ss_pred cceeEEEEeC----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc--
Q 013016 152 PTLYAEFEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR-- 225 (451)
Q Consensus 152 v~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~-- 225 (451)
+++++++... .+.||||||+ |++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 9999999765 5689999999 99999999874 35699999999999999999999999999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.+||+|||++........... ........
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~------------------------------------------------~~~~~~~~ 220 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKA------------------------------------------------YAADPKRC 220 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCC------------------------------------------------SSCCSSCC
T ss_pred CCCeEEEEECCcceecccCCcccc------------------------------------------------cccCcccc
Confidence 889999999999854321110000 00111123
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCC-CCCC-CCCCCcChHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK----KPL-TFPT-QSPSSMSEYHAR 379 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~----~~~-~~~~-~~~~~~~~~~~~ 379 (451)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ... .... .......+.++.
T Consensus 221 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (364)
T 3op5_A 221 HDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIA 300 (364)
T ss_dssp CCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHH
T ss_pred cCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHH
Confidence 5799999999999999999999999999999999999999986433222111111 000 0000 000112234899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+|+..||+.||.+||+ +.+|++
T Consensus 301 ~li~~cl~~~p~~RP~----~~~l~~ 322 (364)
T 3op5_A 301 KYMETVKLLDYTEKPL----YENLRD 322 (364)
T ss_dssp HHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHHHHHhcCCCCCCCC----HHHHHH
Confidence 9999999999999999 777664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.22 Aligned_cols=258 Identities=16% Similarity=0.219 Sum_probs=205.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE-
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF- 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~- 158 (451)
.+|++.++||+|+||+||+|.+..... ....+|+|++.... .......+.+|+.++++++||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred eehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 679999999999999999999764432 12348999987532 234456677899999999999999999986
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++..|+||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence 4556889999999999999999764 355899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .........||+.|+|||.+
T Consensus 176 ~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 204 (298)
T 3f66_A 176 RDMYDKEYY---------------------------------------------------SVHNKTGAKLPVKWMALESL 204 (298)
T ss_dssp CCCSCGGGC---------------------------------------------------BC-----CCBCGGGSCHHHH
T ss_pred ccccccchh---------------------------------------------------ccccccCCCCCccccChHHh
Confidence 533211000 00111123678899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |.+||......+....+..+...... ...+..+.+++.+||+.||.+||+
T Consensus 205 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps-- 278 (298)
T 3f66_A 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPS-- 278 (298)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcC--
Confidence 99899999999999999999999 77788877777776666665443322 223448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.|+++
T Consensus 279 --~~ell~ 284 (298)
T 3f66_A 279 --FSELVS 284 (298)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 888875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.03 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=202.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.+..... ....||||++...........+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCC------ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 689999999999999999998754321 12248999998765444556677888999999999999999999998
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+ .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 765 889999999999999887642 458999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .........||..|+|||++.
T Consensus 170 ~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 197 (291)
T 1u46_A 170 ALPQNDD----------------------------------------------------HYVMQEHRKVPFAWCAPESLK 197 (291)
T ss_dssp ECCC-CC----------------------------------------------------EEEC-----CCGGGCCHHHHH
T ss_pred ccccccc----------------------------------------------------chhhhccCCCCceeeCchhhc
Confidence 3321100 000111235778899999998
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++||||||+++|+|++ |+.||......+.+..+.......+. +...+.++.++|.+||+.||.+||+
T Consensus 198 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps--- 271 (291)
T 1u46_A 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---PEDCPQDIYNVMVQCWAHKPEDRPT--- 271 (291)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC---CcCcCHHHHHHHHHHccCCcccCcC---
Confidence 8888999999999999999999 99999998888888887765443332 1223448999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.++++
T Consensus 272 -~~~l~~ 277 (291)
T 1u46_A 272 -FVALRD 277 (291)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=363.68 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=203.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|.++.+++ .||||++..... ......+.+|+.++++++||||+++++++.
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~---------~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 77 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGD---------LFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEE 77 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCc---------EEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence 679999999999999999999987665 499999986532 223455667999999999999999999998
Q ss_pred eCC--eEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE----ccCCCEEE
Q 013016 160 ASN--FSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV----RSDGHIML 232 (451)
Q Consensus 160 ~~~--~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl 232 (451)
..+ +.|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence 765 8899999999999999987643 2349999999999999999999999999999999999999 67778999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......+||+.|
T Consensus 158 ~DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 181 (396)
T 4eut_A 158 TDFGAARELEDD--------------------------------------------------------EQFVSLYGTEEY 181 (396)
T ss_dssp CCGGGCEECCCG--------------------------------------------------------GGSSCSSSCCTT
T ss_pred ecCCCceEccCC--------------------------------------------------------CccccccCCccc
Confidence 999998532110 011134799999
Q ss_pred cCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHhcCCCCCCC-------------
Q 013016 313 VSPEVASG--------GSHGNAVDWWAFGIFIYEMIYGRTPFAA----PSNETTLRNIVKKPLTFPT------------- 367 (451)
Q Consensus 313 ~aPE~~~~--------~~~~~~~DIwSlG~il~elltg~~pf~~----~~~~~~~~~i~~~~~~~~~------------- 367 (451)
+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+.+..+..+.+....
T Consensus 182 ~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 261 (396)
T 4eut_A 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261 (396)
T ss_dssp CCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEE
T ss_pred cCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCccc
Confidence 99999865 4568899999999999999999999964 3345566666655432110
Q ss_pred -------CCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 368 -------QSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 368 -------~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.......+..+.+||.+||++||++||+ +.++++
T Consensus 262 ~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l~ 302 (396)
T 4eut_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFA 302 (396)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHH
T ss_pred CccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHHH
Confidence 0001122337889999999999999999 888743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=346.85 Aligned_cols=260 Identities=18% Similarity=0.257 Sum_probs=203.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+..... .+..||||++..... .......+.+|+.++++++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDG------TSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTS------CEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCC------ceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3789999999999999999998765321 223599999975432 233456678899999999999999999999
Q ss_pred EeCC-----eEEEEEeeccCCchhhhhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC
Q 013016 159 EASN-----FSCIVMEFCSGGDLHSLRHKQ----PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH 229 (451)
Q Consensus 159 ~~~~-----~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~ 229 (451)
...+ ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7655 459999999999999988532 2356999999999999999999999999999999999999999999
Q ss_pred EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccC
Q 013016 230 IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGT 309 (451)
Q Consensus 230 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 309 (451)
+||+|||++....... .........|+
T Consensus 186 ~kl~Dfg~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 212 (313)
T 3brb_A 186 VCVADFGLSKKIYSGD-----------------------------------------------------YYRQGRIAKMP 212 (313)
T ss_dssp EEECSCSCC---------------------------------------------------------------------CC
T ss_pred EEEeecCcceeccccc-----------------------------------------------------ccCcccccCCC
Confidence 9999999984321100 00001123577
Q ss_pred CCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 310 HEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 310 ~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
+.|+|||.+.+..++.++|||||||++|+|++ |..||...........+..+..... . ...+..+.+||.+||+.
T Consensus 213 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~l~~li~~~l~~ 288 (313)
T 3brb_A 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ---P-EDCLDELYEIMYSCWRT 288 (313)
T ss_dssp GGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---B-TTCCHHHHHHHHHTTCS
T ss_pred ccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC---C-ccccHHHHHHHHHHcCC
Confidence 88999999999999999999999999999999 9999999888887777776543211 1 12334899999999999
Q ss_pred CcCCcCCCCCChHHHHcC
Q 013016 389 DPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 389 dP~~Rpt~~~~~~ell~h 406 (451)
||.+||+ +.+|+++
T Consensus 289 dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 289 DPLDRPT----FSVLRLQ 302 (313)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 9998863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.39 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=196.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
.+|.+.+.||+|+||+||...... ++ .||||++..... ..+.+|+.+++.+ +|||||++++++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~-~~---------~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFD-NR---------DVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESS-SS---------EEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeC-Ce---------EEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 469999999999999966433322 22 499999975421 2345699999999 799999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---C--CCEEEe
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---D--GHIMLS 233 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~--~~~kl~ 233 (451)
.+.+..||||||| +|+|.+++.... ..+.+..++.++.||+.||+|||++||+||||||+|||++. + ..+||+
T Consensus 88 ~~~~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 88 KDRQFQYIAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EETTEEEEEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred ecCCEEEEEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999999999999 579999987654 33555667899999999999999999999999999999953 2 368899
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++....... .........+||+.|+
T Consensus 166 DFG~a~~~~~~~----------------------------------------------------~~~~~~~~~~gt~~y~ 193 (432)
T 3p23_A 166 DFGLCKKLAVGR----------------------------------------------------HSFSRRSGVPGTEGWI 193 (432)
T ss_dssp CTTEEECC----------------------------------------------------------------CCSCTTSC
T ss_pred cccceeeccCCC----------------------------------------------------cceeeccccCCCcCcc
Confidence 999985332100 0001112357999999
Q ss_pred CcccccC---CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 314 SPEVASG---GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 314 aPE~~~~---~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|||++.+ ..++.++|||||||++|+|++ |..||........... ...............+..+.+||.+||+.|
T Consensus 194 APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 271 (432)
T 3p23_A 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--LGACSLDCLHPEKHEDVIARELIEKMIAMD 271 (432)
T ss_dssp CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--TTCCCCTTSCTTCHHHHHHHHHHHHHSCSS
T ss_pred ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--hccCCccccCccccccHHHHHHHHHHHhCC
Confidence 9999974 557889999999999999999 9999976544443222 222222222222333446899999999999
Q ss_pred cCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 390 PCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
|.+||| +.||++||||.++.+
T Consensus 272 P~~Rps----~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 272 PQKRPS----AKHVLKHPFFWSLEK 292 (432)
T ss_dssp GGGSCC----HHHHHTSTTTCCHHH
T ss_pred HhhCCC----HHHHHhCccccChHH
Confidence 999999 999999999998665
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.63 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=201.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|++.+.||+|+||+||+|.+.+. .||||++.... ..+.+.+|+.++++++||||++++
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----------~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 80 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLL 80 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTE-----------EEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEcCC-----------EEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 34558899999999999999999987533 39999997542 345677799999999999999999
Q ss_pred EEEEeC-CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 156 AEFEAS-NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 156 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
+++... +..|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp EEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred EEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEee
Confidence 987544 5899999999999999998765434489999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++...... .....+++.|+|
T Consensus 161 fg~~~~~~~~----------------------------------------------------------~~~~~~~~~y~a 182 (278)
T 1byg_A 161 FGLTKEASST----------------------------------------------------------QDTGKLPVKWTA 182 (278)
T ss_dssp CCC----------------------------------------------------------------------CCTTTSC
T ss_pred cccccccccc----------------------------------------------------------ccCCCccccccC
Confidence 9997421100 011256788999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+..++.++||||||+++|+|++ |+.||......+....+..+.... . +...+..+.++|.+||+.||.+|
T Consensus 183 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~~l~~~p~~R 258 (278)
T 1byg_A 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---A-PDGCPPAVYEVMKNCWHLDAAMR 258 (278)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---C-CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---C-cccCCHHHHHHHHHHhcCChhhC
Confidence 999998889999999999999999998 999999887777777766553211 1 12234489999999999999999
Q ss_pred CCCCCChHHHHc
Q 013016 394 LGSKRGAADVKT 405 (451)
Q Consensus 394 pt~~~~~~ell~ 405 (451)
|+ +.|+++
T Consensus 259 ps----~~~l~~ 266 (278)
T 1byg_A 259 PS----FLQLRE 266 (278)
T ss_dssp CC----HHHHHH
T ss_pred CC----HHHHHH
Confidence 99 888875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=344.05 Aligned_cols=254 Identities=23% Similarity=0.401 Sum_probs=199.3
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.+.||+|+||+||+|.+.+. .||||++... .....+.+|+.++++++||||+++++
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~-----------~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~ 68 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAK-----------DVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYG 68 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTE-----------EEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCe-----------eEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 3457899999999999999999987643 3999999743 23356778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeeccCCCCcEEEccCCC-EE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPH-KRFSLTSARFYAAEVLVALEYLHM---LGIIYRDLKPENVLVRSDGH-IM 231 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-~~l~~~~~~~i~~qil~aL~~LH~---~givH~Dlkp~NIll~~~~~-~k 231 (451)
++. +..|+||||++|++|.+++..... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +|
T Consensus 69 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~k 146 (307)
T 2eva_A 69 ACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146 (307)
T ss_dssp BCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEE
T ss_pred EEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEE
Confidence 886 348999999999999999986532 247899999999999999999999 89999999999999998886 79
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++..... ......||+.
T Consensus 147 l~Dfg~~~~~~~----------------------------------------------------------~~~~~~gt~~ 168 (307)
T 2eva_A 147 ICDFGTACDIQT----------------------------------------------------------HMTNNKGSAA 168 (307)
T ss_dssp ECCCCC----------------------------------------------------------------------CCTT
T ss_pred Eccccccccccc----------------------------------------------------------ccccCCCCCc
Confidence 999999742110 0012368999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN--ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKD 389 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d 389 (451)
|+|||++.+..++.++|||||||++|+|++|+.||..... ......+..+.... .. ...+..+.+|+.+||+.|
T Consensus 169 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~l~~li~~~l~~d 244 (307)
T 2eva_A 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LI-KNLPKPIESLMTRCWSKD 244 (307)
T ss_dssp SSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC---CB-TTCCHHHHHHHHHHTCSS
T ss_pred eEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC---cc-cccCHHHHHHHHHHhcCC
Confidence 9999999998999999999999999999999999986433 22333333332211 11 123348999999999999
Q ss_pred cCCcCCCCCChHHHHc-----CCCcCCCCc
Q 013016 390 PCNRLGSKRGAADVKT-----HPFFKGLNF 414 (451)
Q Consensus 390 P~~Rpt~~~~~~ell~-----hp~~~~~~~ 414 (451)
|.+||| +.++++ ..++.+.+.
T Consensus 245 p~~Rps----~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 245 PSQRPS----MEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp GGGSCC----HHHHHHHHHHHGGGCCCTTS
T ss_pred hhhCcC----HHHHHHHHHHHHHhccCCCC
Confidence 999999 999887 355555443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=346.32 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=198.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||.||+|.+.... ...+..||||++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 56999999999999999999853221 1123359999998653 2334466778999999999999999999998
Q ss_pred eC--CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 160 AS--NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 160 ~~--~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
.. +.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 76 67899999999999999986543 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .........||..|+|||+
T Consensus 173 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~ 200 (302)
T 4e5w_A 173 TKAIETDKE----------------------------------------------------YYTVKDDRDSPVFWYAPEC 200 (302)
T ss_dssp CEECCTTCC----------------------------------------------------EEECCCCTTCCGGGCCHHH
T ss_pred cccccCCCc----------------------------------------------------ceeccCCCCCCccccCCee
Confidence 853321100 0011112368888999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAP--------------SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~--------------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
+.+..++.++|||||||++|+|++|..|+... .....+..........+ .+...+.++.+||.
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~ 277 (302)
T 4e5w_A 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP---CPPNCPDEVYQLMR 277 (302)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC---CCTTCCHHHHHHHH
T ss_pred ecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC---CCCCCCHHHHHHHH
Confidence 99988999999999999999999999986432 11112222222221111 11223448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHc
Q 013016 384 GLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||+.||.+||| +.++++
T Consensus 278 ~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 278 KCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp HTTCSSGGGSCC----HHHHHH
T ss_pred HHcCCCCCCCCC----HHHHHH
Confidence 999999999999 998875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=343.84 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=205.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||+|++.... ..+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCC---------EEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCe---------EEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 679999999999999999999886655 49999997542 23456999999999999999999886
Q ss_pred e----------------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 160 A----------------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 160 ~----------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
. ...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil 154 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEE
Confidence 4 456899999999999999998765667999999999999999999999999999999999999
Q ss_pred EccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccc
Q 013016 224 VRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303 (451)
Q Consensus 224 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (451)
++.++.+||+|||++....... ..
T Consensus 155 ~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------------~~ 178 (284)
T 2a19_B 155 LVDTKQVKIGDFGLVTSLKNDG--------------------------------------------------------KR 178 (284)
T ss_dssp EEETTEEEECCCTTCEESSCCS--------------------------------------------------------CC
T ss_pred EcCCCCEEECcchhheeccccc--------------------------------------------------------cc
Confidence 9999999999999975322100 01
Q ss_pred cccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHH
Q 013016 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLIS 383 (451)
Q Consensus 304 ~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~ 383 (451)
....||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+..... +...+..+.+||.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~~li~ 249 (284)
T 2a19_B 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGII-------SDIFDKKEKTLLQ 249 (284)
T ss_dssp CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTCC-------CTTSCHHHHHHHH
T ss_pred cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcccc-------cccCCHHHHHHHH
Confidence 123689999999999998899999999999999999999998753 2223333333321 1233448999999
Q ss_pred HhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 384 GLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 384 ~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+||+.||.+||+ +.|+++|.|.-.
T Consensus 250 ~~l~~dp~~Rps----~~e~l~~l~~~~ 273 (284)
T 2a19_B 250 KLLSKKPEDRPN----TSEILRTLTVWK 273 (284)
T ss_dssp HHTCSSGGGSCC----HHHHHHHHHHHT
T ss_pred HHccCChhhCcC----HHHHHHHHHHHh
Confidence 999999999999 999999877654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=344.81 Aligned_cols=235 Identities=24% Similarity=0.416 Sum_probs=188.4
Q ss_pred ccCCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHH-HHCCCCCcccee
Q 013016 78 TFRDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL-KMLDHPFLPTLY 155 (451)
Q Consensus 78 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~nIv~l~ 155 (451)
..++|.+. +.||+|+||.||+|.++.+++ .||||++... ....+|+.++ +.++||||++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~---------~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~ 77 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC--------PKARREVELHWRASQCPHIVRIV 77 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCc---------EEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHH
Confidence 44788887 779999999999999877665 4999999643 2344577777 666999999999
Q ss_pred EEEEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CC
Q 013016 156 AEFEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DG 228 (451)
Q Consensus 156 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~ 228 (451)
+++.. .+.+|+||||++|++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred hhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC
Confidence 99987 778999999999999999998876667999999999999999999999999999999999999998 78
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||++..
T Consensus 158 ~~kl~Dfg~a~~-------------------------------------------------------------------- 169 (299)
T 3m2w_A 158 ILKLTDFGFAKE-------------------------------------------------------------------- 169 (299)
T ss_dssp CEEECCCTTCEE--------------------------------------------------------------------
T ss_pred cEEEeccccccc--------------------------------------------------------------------
Confidence 999999999731
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC----CCCCCCCCCCCcChHHHHHHHHH
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK----PLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
+.+..++.++|||||||++|+|++|+.||...........+... ...++.... ...+.++.+||.+
T Consensus 170 ---------~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ 239 (299)
T 3m2w_A 170 ---------TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW-SEVSEEVKMLIRN 239 (299)
T ss_dssp ---------CTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH-TTSCHHHHHHHHH
T ss_pred ---------cccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc-ccCCHHHHHHHHH
Confidence 11245678999999999999999999999875544332222221 111111000 1234489999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
||+.||.+||| +.|+++||||++
T Consensus 240 ~l~~dP~~Rps----~~e~l~hp~~~~ 262 (299)
T 3m2w_A 240 LLKTEPTQRMT----ITEFMNHPWIMQ 262 (299)
T ss_dssp HTCSSTTTSCC----HHHHHTSHHHHT
T ss_pred HcccChhhCCC----HHHHhcChhhcc
Confidence 99999999999 999999999988
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=376.21 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=204.3
Q ss_pred cCCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 79 FRDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++.+.+ +||+|+||.||+|.++.... +..||||++.... .....+.+.+|+.++++++|||||+++++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-------~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSC-------EEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCC-------cEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35666666 89999999999998864321 2249999997542 22345677889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.. +.+|+|||||.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 405 ~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 405 CQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 976 5699999999999999998754 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+........ .........+++.|+|||+
T Consensus 483 a~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~APE~ 510 (613)
T 2ozo_A 483 SKALGADDS----------------------------------------------------YYTARSAGKWPLKWYAPEC 510 (613)
T ss_dssp TTTCC------------------------------------------------------------------CCTTSCHHH
T ss_pred cccccCCCc----------------------------------------------------eeeeccCCCCccceeCHhh
Confidence 853321000 0000111246788999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||+||||++ |+.||......+.+..+..+..... +...+.++.+||.+||+.||++||+
T Consensus 511 ~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~dP~~RPs- 585 (613)
T 2ozo_A 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC----PPECPPELYALMSDCWIYKWEDRPD- 585 (613)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSTTTSCC-
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC----CCcCCHHHHHHHHHHcCCChhHCcC-
Confidence 998899999999999999999998 9999999888888888776642211 1223448999999999999999999
Q ss_pred CCChHHHH
Q 013016 397 KRGAADVK 404 (451)
Q Consensus 397 ~~~~~ell 404 (451)
+.+|+
T Consensus 586 ---~~~l~ 590 (613)
T 2ozo_A 586 ---FLTVE 590 (613)
T ss_dssp ---HHHHH
T ss_pred ---HHHHH
Confidence 88874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.31 Aligned_cols=258 Identities=16% Similarity=0.192 Sum_probs=204.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
-.|.+.++||+|+||+||+|.+..+.+ .+..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIML 92 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred eEEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 347788999999999999999765432 12349999987532 2344567778999999999999999999998
Q ss_pred eCCeE-EEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 ASNFS-CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 ~~~~~-~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..+.. ++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 93 PPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp CSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred cCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 76655 9999999999999998764 356899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .........|++.|+|||.+
T Consensus 172 ~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 200 (298)
T 3pls_A 172 RDILDREYY---------------------------------------------------SVQQHRHARLPVKWTALESL 200 (298)
T ss_dssp CTTTTGGGG---------------------------------------------------CSCCSSCTTCGGGGSCHHHH
T ss_pred ccccCCccc---------------------------------------------------ccccCcCCCCCccccChhhh
Confidence 532210000 00111223678899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|+|++ |.+||......+....+........ +...+..+.+|+.+||+.||.+|||
T Consensus 201 ~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps-- 274 (298)
T 3pls_A 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ----PEYCPDSLYQVMQQCWEADPAVRPT-- 274 (298)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC--
T ss_pred ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC----CccchHHHHHHHHHHccCChhhCcC--
Confidence 99999999999999999999999 5555666666666666655542221 1223448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.++++
T Consensus 275 --~~~ll~ 280 (298)
T 3pls_A 275 --FRVLVG 280 (298)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 888875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=362.02 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=192.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
+.|.+.+.||+|+||+||.+.... ++ .||||++.... ...+.+|+.+++++ +||||+++++++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~-g~---------~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQ-GR---------PVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESS-SS---------EEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEEC-Ce---------EEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 446778899999999998754332 22 49999987542 23456799999876 899999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC------
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKR-----FSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD------ 227 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~-----l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~------ 227 (451)
.+.+.+||||||| +|+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred ecCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 9999999999999 579999997653211 1333567899999999999999999999999999999754
Q ss_pred -------CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 228 -------GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 228 -------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
+.+||+|||++......... ..
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~---------------------------------------------------~~ 186 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSS---------------------------------------------------FR 186 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC---------------------------------------------------------
T ss_pred cccCCCceEEEEcccccceecCCCCcc---------------------------------------------------ce
Confidence 48999999998543211000 00
Q ss_pred ccccccccCCCccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCC--C
Q 013016 301 ARSCSFVGTHEYVSPEVASG-------GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQS--P 370 (451)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~ 370 (451)
......+||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... ..+..+....+... .
T Consensus 187 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~ 264 (434)
T 2rio_A 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLH 264 (434)
T ss_dssp --------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCC
T ss_pred eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccc
Confidence 01123479999999999976 568999999999999999999 999998754443 33444433332211 1
Q ss_pred CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 371 ~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
....+.++.+||.+||+.||.+||| +.+|++||||...
T Consensus 265 ~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 265 DRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred cccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 1122347999999999999999999 9999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=374.40 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=211.9
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||.||+|.++.+. .||||++..... ..+.+.+|+.+|++++|+||+++++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----------~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 329 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTE----------EEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCc----------eEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 44577999999999999999999987654 399999985432 2346778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++.+ +.+||||||+.+|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 9876 678999999999999999976544569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
++...... .........++..|+|||
T Consensus 409 ~a~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE 434 (535)
T 2h8h_A 409 LARLIEDN------------------------------------------------------EYTARQGAKFPIKWTAPE 434 (535)
T ss_dssp STTTCCCH------------------------------------------------------HHHTTCSTTSCGGGSCHH
T ss_pred cceecCCC------------------------------------------------------ceecccCCcCcccccCHH
Confidence 98432100 000001124677899999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+..... +...+..+.+||.+||+.||++|||
T Consensus 435 ~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC----PPECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCChhHCcC
Confidence 9998899999999999999999999 9999999888888887766532111 1223448999999999999999999
Q ss_pred CCCChHHHHcC--CCcCC
Q 013016 396 SKRGAADVKTH--PFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~h--p~~~~ 411 (451)
+.+|++. .+|..
T Consensus 511 ----~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 511 ----FEYLQAFLEDYFTS 524 (535)
T ss_dssp ----HHHHHHHHHTSSCC
T ss_pred ----HHHHHHHHHHHhhc
Confidence 8888753 44443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=344.53 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=192.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH--CCCCCccceeE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM--LDHPFLPTLYA 156 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~ 156 (451)
.++|++.++||+|+||+||+|.+.+. .||||++.... ...+..|.+++.. ++||||+++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----------~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~ 69 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGE-----------NVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIA 69 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTE-----------EEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCE-----------EEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEE
Confidence 37899999999999999999987432 39999997542 1233446666666 79999999999
Q ss_pred EEEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCcEEE
Q 013016 157 EFEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH--------MLGIIYRDLKPENVLV 224 (451)
Q Consensus 157 ~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givH~Dlkp~NIll 224 (451)
++.. .+.+|+||||+++|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||+|||+
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred eeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 8754 3578999999999999999954 45999999999999999999999 9999999999999999
Q ss_pred ccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccc
Q 013016 225 RSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSC 304 (451)
Q Consensus 225 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (451)
+.++.+||+|||++......... ......
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------------~~~~~~ 175 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQ---------------------------------------------------LDVGNN 175 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTE---------------------------------------------------EECCCC
T ss_pred cCCCCEEEeeCCCeeeccccccc---------------------------------------------------cccccc
Confidence 99999999999998532211000 000112
Q ss_pred ccccCCCccCcccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHhcCCCC
Q 013016 305 SFVGTHEYVSPEVASGG------SHGNAVDWWAFGIFIYEMIYG----------RTPFAAPS----NETTLRNIVKKPLT 364 (451)
Q Consensus 305 ~~~gt~~y~aPE~~~~~------~~~~~~DIwSlG~il~elltg----------~~pf~~~~----~~~~~~~i~~~~~~ 364 (451)
...||+.|+|||++.+. .++.++|||||||++|||++| +.||.... ....+.........
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~ 255 (301)
T 3q4u_A 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255 (301)
T ss_dssp CCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred ccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCC
Confidence 34799999999999886 345799999999999999999 88886532 22333443332221
Q ss_pred ---CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 365 ---FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 365 ---~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+........+..+.+||.+||+.||++||| +.||++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred CCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 1111112223347999999999999999999 999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=341.62 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=197.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE-
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF- 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~- 158 (451)
++|++.+.||+|+||+||+|.+..+++ .||||++.... ....+..|+.+++.++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCc---------eEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 679999999999999999999876665 49999876442 223466799999999988866666555
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Df 235 (451)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecC
Confidence 6778999999999 999999987543 459999999999999999999999999999999999999 78899999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........... ..........||+.|+||
T Consensus 153 g~a~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 153 GLAKKYRDARTHQH------------------------------------------------IPYRENKNLTGTARYASI 184 (296)
T ss_dssp TTCEECBCTTTCCB------------------------------------------------CCCCCSCCCCSCGGGCCH
T ss_pred ccceeccCcccCcc------------------------------------------------CCCCcccccCCCccccch
Confidence 99854322111000 000111235799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE---TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
|++.+..++.++|||||||++|+|++|+.||...... ..+..+.......+........+.++.+||.+||+.||++
T Consensus 185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 264 (296)
T 4hgt_A 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred HHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999999999864322 2333333322222211111122348999999999999999
Q ss_pred cCCCCCChHHHHc
Q 013016 393 RLGSKRGAADVKT 405 (451)
Q Consensus 393 Rpt~~~~~~ell~ 405 (451)
||+ +.+|++
T Consensus 265 Rpt----~~~l~~ 273 (296)
T 4hgt_A 265 KPD----YSYLRQ 273 (296)
T ss_dssp CCC----HHHHHH
T ss_pred CCC----HHHHHH
Confidence 999 888875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=354.80 Aligned_cols=244 Identities=18% Similarity=0.229 Sum_probs=190.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC---CCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD---HPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~ 156 (451)
++|.+.++||+|+||+||+|.+...... ..+..||||++.... ...+..|+.+++.++ |+||+.+++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDA----KNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCccc----ccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 6799999999999999999964332111 122359999997542 234556788888886 999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-------
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQ---PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS------- 226 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~------- 226 (451)
++...+..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999998742 3456999999999999999999999999999999999999998
Q ss_pred ----CCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 227 ----DGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 227 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
++.+||+|||++...... .....
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------------------~~~~~ 241 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLF-----------------------------------------------------PKGTI 241 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGS-----------------------------------------------------CTTEE
T ss_pred cccccCCEEEeeCchhhhhhcc-----------------------------------------------------CCCce
Confidence 899999999998432100 00111
Q ss_pred ccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHH
Q 013016 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLI 382 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll 382 (451)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+. ....+..+.+++
T Consensus 242 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~ 312 (365)
T 3e7e_A 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFR----RLPHLDMWNEFF 312 (365)
T ss_dssp ECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----EECSCCT----TCSSHHHHHHHH
T ss_pred eeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----eechhcc----ccCcHHHHHHHH
Confidence 2235799999999999999999999999999999999999999965322110 0001111 112344789999
Q ss_pred HHhcccCcCCcCC
Q 013016 383 SGLLNKDPCNRLG 395 (451)
Q Consensus 383 ~~~L~~dP~~Rpt 395 (451)
.+||+.+|.+|++
T Consensus 313 ~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 313 HVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHCCCCTTCCC
T ss_pred HHHcCCCCCCcch
Confidence 9999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=350.78 Aligned_cols=265 Identities=19% Similarity=0.218 Sum_probs=194.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH--------HHHHHHHHHHHHHHHHCCCCCc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK--------KKKVHRAEMEKKILKMLDHPFL 151 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~nI 151 (451)
++|.+.+.||+|+||+||+|.+..... .+..||||++....... ......+..|+.+++.++|+||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 679999999999999999999876211 12249999987542111 1112335568889999999999
Q ss_pred cceeEEEEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 152 PTLYAEFEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 152 v~l~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
+++++++.. .+..|+||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 999999988 78999999999 999999987653 69999999999999999999999999999999999999988
Q ss_pred C--CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 228 G--HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 228 ~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
+ .+||+|||++.......... .........
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~------------------------------------------------~~~~~~~~~ 219 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHK------------------------------------------------QYQENPRKG 219 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCC------------------------------------------------CCCCCGGGC
T ss_pred CCCcEEEEeCCCceecccccccc------------------------------------------------cchhccccc
Confidence 7 99999999985432110000 000111123
Q ss_pred cccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcC-CCCCCC----CCCCCcChHHHH
Q 013016 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIVKK-PLTFPT----QSPSSMSEYHAR 379 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~-~~~~~~----~~~~~~~~~~~~ 379 (451)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........... ....+. .......+.++.
T Consensus 220 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 299 (345)
T 2v62_A 220 HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIA 299 (345)
T ss_dssp SCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHH
T ss_pred cCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHH
Confidence 479999999999999889999999999999999999999996522 22211111111 111111 001112344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+||.+||+.||++||+ +.+|++
T Consensus 300 ~li~~~l~~dp~~Rps----~~~l~~ 321 (345)
T 2v62_A 300 QFLVCAHSLAYDEKPN----YQALKK 321 (345)
T ss_dssp HHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHHHHHhhcCcccCCC----HHHHHH
Confidence 9999999999999999 888875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=353.03 Aligned_cols=264 Identities=16% Similarity=0.205 Sum_probs=200.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccc------
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPT------ 153 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~------ 153 (451)
++|.+.+.||+|+||.||+|.+..+.... ....+..||||++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~-~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCD-SGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCcccc-ccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 68999999999999999999988642100 0001224999999754 34567999999999998887
Q ss_pred ---------eeEEEEe-CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEE
Q 013016 154 ---------LYAEFEA-SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVL 223 (451)
Q Consensus 154 ---------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIl 223 (451)
+++++.. ++..|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777776 77999999999 999999998765567999999999999999999999999999999999999
Q ss_pred EccCC--CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 224 VRSDG--HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 224 l~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
++.++ .+||+|||++........... ....
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~------------------------------------------------~~~~ 223 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA------------------------------------------------YVEG 223 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCC------------------------------------------------CCTT
T ss_pred EcCCCCceEEEecCcceeeccCCCcccc------------------------------------------------cccc
Confidence 99998 999999999854321110000 0001
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHh----cCCCCCCCCC-CCCcCh
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-NETTLRNIV----KKPLTFPTQS-PSSMSE 375 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~-~~~~~~~i~----~~~~~~~~~~-~~~~~~ 375 (451)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....+.... .....+.... .....+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPS 303 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCC
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCc
Confidence 1123479999999999999899999999999999999999999998754 233222222 2222211111 001224
Q ss_pred HHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 376 YHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 376 ~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.++.+||.+||+.||.+||+ +.+|++
T Consensus 304 ~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 304 ETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 48999999999999999999 888865
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.26 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=199.9
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
|++.++||+|+||+||+|.++.... ..+..||||++.... .......+.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTND-----GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC-------CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HhhhheecCCCCeEEEEEEEccCCC-----CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 5999999999999999987653321 233469999998652 233456678899999999999999999999874
Q ss_pred --CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 162 --NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 162 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+++||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 6899999999999999999764 39999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .........||..|+|||++.
T Consensus 183 ~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 183 AVPEGHE----------------------------------------------------YYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp ECCTTCS----------------------------------------------------EEEC---CCCCGGGCCHHHHH
T ss_pred ccccccc----------------------------------------------------ccccccCCCCCceeeChHHhc
Confidence 3321100 000111236788899999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHh
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE--------------TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGL 385 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~ 385 (451)
+..++.++|||||||++|+|++|..||...... ..+..........+. +...+.++.+||.+|
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 287 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR---PDKCPAEVYHLMKNC 287 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC---CccccHHHHHHHHHH
Confidence 988999999999999999999999999754221 112222222211111 122344899999999
Q ss_pred cccCcCCcCCCCCChHHHHc
Q 013016 386 LNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 386 L~~dP~~Rpt~~~~~~ell~ 405 (451)
|+.||.+||+ +.||++
T Consensus 288 l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 288 WETEASFRPT----FENLIP 303 (318)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCCcccCcC----HHHHHH
Confidence 9999999999 999884
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=347.32 Aligned_cols=275 Identities=21% Similarity=0.248 Sum_probs=208.0
Q ss_pred CchhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH-HHHHHHHHHH
Q 013016 59 SDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-EKKKKVHRAE 137 (451)
Q Consensus 59 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~ 137 (451)
..|++.++..++...... ..|...++||+|+||+||+|.+.+. .||||++..... ........+.
T Consensus 13 ~~~~~~~l~~~~~~f~~~---~~~~~~~~lg~G~~g~Vy~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~ 78 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDER---PISVGGNKMGEGGFGVVYKGYVNNT-----------TVAVKKLAAMVDITTEELKQQFD 78 (307)
T ss_dssp EECCHHHHHHHTTTTCCS---BTTTTCCEEEECSSEEEEEEESSSC-----------EEEEEEECCCTTSCTTTHHHHHH
T ss_pred CcccHHHHHHHHcccccc---cccccCCccccCCCeEEEEEEECCc-----------eEEEEEEecccCcchHHHHHHHH
Confidence 346777888777221111 2244558999999999999987432 399999865321 1223456677
Q ss_pred HHHHHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 013016 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRD 216 (451)
Q Consensus 138 ~e~~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~D 216 (451)
+|+.+++.++||||+++++++...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 79 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 158 (307)
T 2nru_A 79 QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158 (307)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCC
Confidence 89999999999999999999999999999999999999999887432 35699999999999999999999999999999
Q ss_pred CCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccc
Q 013016 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVA 296 (451)
Q Consensus 217 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (451)
|||+|||++.++.+||+|||++.......
T Consensus 159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------- 187 (307)
T 2nru_A 159 IKSANILLDEAFTAKISDFGLARASEKFA--------------------------------------------------- 187 (307)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSCS---------------------------------------------------
T ss_pred CCHHHEEEcCCCcEEEeeccccccccccc---------------------------------------------------
Confidence 99999999999999999999985322100
Q ss_pred ccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhcCCCCC------C
Q 013016 297 EPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET----TLRNIVKKPLTF------P 366 (451)
Q Consensus 297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~------~ 366 (451)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+......+ .
T Consensus 188 --~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 188 --QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp --SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred --ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 0011123478999999998876 57899999999999999999999998754322 122222211110 0
Q ss_pred CCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 367 TQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 367 ~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
........+..+.+++.+||+.||.+||+ +.+|++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~l~~ 299 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPD----IKKVQQ 299 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 01111223347899999999999999999 999886
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=348.88 Aligned_cols=260 Identities=21% Similarity=0.314 Sum_probs=202.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+..... ..+..||||++.... ......+.+|+.++++++|+||++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 92 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGD-----NTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGV 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSS-----SCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCC-----CcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEE
Confidence 34789999999999999999998542211 123369999997552 2334567789999999999999999998
Q ss_pred EE--eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FE--ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~--~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+. ..+..|+||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 93 SYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 86 4567999999999999999987642 35999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........ .........||..|+||
T Consensus 172 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aP 199 (327)
T 3lxl_A 172 GLAKLLPLDKD----------------------------------------------------YYVVREPGQSPIFWYAP 199 (327)
T ss_dssp GGCEECCTTCS----------------------------------------------------EEECSSCCCSCGGGSCH
T ss_pred ccceecccCCc----------------------------------------------------cceeeccCCccccccCH
Confidence 99853321100 00011123688889999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE--------------TTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
|++.+..++.++|||||||++|+|++|+.||...... ..+..........+. +...+.++.+|
T Consensus 200 E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 276 (327)
T 3lxl_A 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA---PPACPAEVHEL 276 (327)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred HHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC---CCcccHHHHHH
Confidence 9999888999999999999999999999998653322 112222222211111 22234489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHc
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
|.+||+.||.+||| +.||++
T Consensus 277 i~~~l~~dP~~Rps----~~ell~ 296 (327)
T 3lxl_A 277 MKLCWAPSPQDRPS----FSALGP 296 (327)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHH
Confidence 99999999999999 888854
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=373.40 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=203.3
Q ss_pred CCceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 80 RDFDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
..+.+. ++||+|+||+||+|.+..... +..||||++..... .....+.+.+|+.++++++|||||++++++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~-------~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 439 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC 439 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSC-------EEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCc-------ceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345543 489999999999997653321 12499999976532 233456788899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.. +..++||||+++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 440 ~~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 440 EA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp ES-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred ec-CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 64 5688999999999999999765 55999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .........||+.|+|||++
T Consensus 517 ~~~~~~~~----------------------------------------------------~~~~~~~~~~t~~y~APE~~ 544 (635)
T 4fl3_A 517 KALRADEN----------------------------------------------------YYKAQTHGKWPVKWYAPECI 544 (635)
T ss_dssp HHTTC-----------------------------------------------------------------CGGGSCHHHH
T ss_pred cccccCcc----------------------------------------------------ccccccCCCCceeeeChhhh
Confidence 54321100 00011122567889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||+||||++ |+.||.+....+....+..+..... +...+.++.+||.+||+.||++||+
T Consensus 545 ~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~dP~~RPs-- 618 (635)
T 4fl3_A 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC----PAGCPREMYDLMNLCWTYDVENRPG-- 618 (635)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSTTTSCC--
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCCHhHCcC--
Confidence 99999999999999999999998 9999999988888887776643211 1223448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.+|++
T Consensus 619 --~~~l~~ 624 (635)
T 4fl3_A 619 --FAAVEL 624 (635)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 888864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=356.54 Aligned_cols=259 Identities=15% Similarity=0.210 Sum_probs=200.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
..|.+.+.||+|+||+||+|.+..... ....||+|++... ........+.+|+.++++++||||+++++++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 458999999999999999999764321 1224899998753 22344567788999999999999999999875
Q ss_pred -eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 160 -ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 160 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.++..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 161 RSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred cCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccc
Confidence 456889999999999999999764 345899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
......... .........||+.|+|||++
T Consensus 240 ~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 240 RDMYDKEFD---------------------------------------------------SVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp ---------------------------------------------------------------------CCGGGSCHHHH
T ss_pred ccccccccc---------------------------------------------------cccccCCCCCcccccChHHh
Confidence 532110000 00011123577889999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||++ |..||......+....+..+..... +...+..+.+++.+||+.||++||+
T Consensus 269 ~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~----p~~~~~~l~~li~~cl~~dp~~RPs-- 342 (373)
T 3c1x_A 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPS-- 342 (373)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcC--
Confidence 99999999999999999999999 7888988776666666666543222 1223448999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.|++++
T Consensus 343 --~~ell~~ 349 (373)
T 3c1x_A 343 --FSELVSR 349 (373)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 8888763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.00 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=199.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE-
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF- 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~- 158 (451)
++|.+.+.||+|+||.||+|.+..+++ .||||++.... ....+.+|+.+++.+.|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCc---------EEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 789999999999999999999876655 49999986542 224567799999999988866555544
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Df 235 (451)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 6778899999999 999999997543 469999999999999999999999999999999999999 48899999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........... ..........||+.|+||
T Consensus 153 g~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 153 GLAKKYRDARTHQH------------------------------------------------IPYRENKNLTGTARYASI 184 (296)
T ss_dssp TTCEECBCTTTCCB------------------------------------------------CCCCCSCCCCSCTTTCCH
T ss_pred CCcccccccccccc------------------------------------------------cccccccccccccccCCh
Confidence 99854322111000 000111235799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS---NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
|++.+..++.++|||||||++|+|++|+.||.... ....+..+.......+........+.++.+|+.+||+.||.+
T Consensus 185 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 264 (296)
T 3uzp_A 185 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 264 (296)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred hhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCc
Confidence 99999999999999999999999999999998743 223333333322222211111123348999999999999999
Q ss_pred cCCCCCChHHHHc
Q 013016 393 RLGSKRGAADVKT 405 (451)
Q Consensus 393 Rpt~~~~~~ell~ 405 (451)
||+ +.+|++
T Consensus 265 Rps----~~~l~~ 273 (296)
T 3uzp_A 265 KPD----YSYLRQ 273 (296)
T ss_dssp CCC----HHHHHH
T ss_pred CCC----HHHHHH
Confidence 999 888775
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=382.80 Aligned_cols=277 Identities=24% Similarity=0.351 Sum_probs=211.5
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|.+.++||.|+||+||+|.+..+++ .||||++.... .......+.+|+.++++++||||++++++
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~---------~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGE---------QVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTC---------CEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCc---------EEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 34789999999999999999999876655 39999987542 23345667789999999999999999998
Q ss_pred EEe------CCeEEEEEeeccCCchhhhhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCC-
Q 013016 158 FEA------SNFSCIVMEFCSGGDLHSLRHKQP-HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGH- 229 (451)
Q Consensus 158 ~~~------~~~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~- 229 (451)
+.. ++..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 765 678899999999999999998753 336999999999999999999999999999999999999997765
Q ss_pred --EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 230 --IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 230 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+||+|||++...... .......
T Consensus 161 ~~vKL~DFG~a~~~~~~--------------------------------------------------------~~~~~~~ 184 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQG--------------------------------------------------------ELCTEFV 184 (676)
T ss_dssp CEEEECSCCCCCBTTSC--------------------------------------------------------CCCCCCC
T ss_pred eeEEEcccccccccccc--------------------------------------------------------ccccccc
Confidence 999999998532210 0111347
Q ss_pred cCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---------H-----hcCCCCCCCC-----
Q 013016 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRN---------I-----VKKPLTFPTQ----- 368 (451)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~---------i-----~~~~~~~~~~----- 368 (451)
||+.|+|||++.+..++.++|||||||++|+|++|..||........... + ..+...+...
T Consensus 185 gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~ 264 (676)
T 3qa8_A 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN 264 (676)
T ss_dssp SCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSC
T ss_pred CCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCch
Confidence 89999999999999999999999999999999999999976433221110 0 1111111111
Q ss_pred CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCC
Q 013016 369 SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425 (451)
Q Consensus 369 ~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~ 425 (451)
......+..+.+||.+||++||++||| +.++++||||++++..+.......+.
T Consensus 265 ~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~~iL~~kil~~f~ 317 (676)
T 3qa8_A 265 HLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALDSILSLKLLSVMN 317 (676)
T ss_dssp CCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHHHHHCCCEEECCC
T ss_pred hhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHHHHHhcccccccc
Confidence 111224558999999999999999999 99999999999976665554433333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.96 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=181.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
.+|++.++||+|+||.||+|.+..+++ .||||++.... ......+.+|+.+++++. ||||+++++++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGR---------EYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCC---------EEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCc---------EEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 579999999999999999999877665 49999986542 233456677999999996 99999999999
Q ss_pred E--------eCCeEEEEEeeccCCchhhhhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEccC
Q 013016 159 E--------ASNFSCIVMEFCSGGDLHSLRHK-QPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVRSD 227 (451)
Q Consensus 159 ~--------~~~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~~~ 227 (451)
. ....+++||||+ +|+|.+++.. ...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 4 345689999999 5899888765 23456999999999999999999999999 9999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+.+||+|||++............. .............
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~ 211 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSA-------------------------------------------QRRALVEEEITRN 211 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC--------------------------------------------------------------
T ss_pred CCEEEecCccceeccccCcccccc-------------------------------------------cccccchhhcccc
Confidence 999999999986433211100000 0000001112347
Q ss_pred cCCCccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 308 GTHEYVSPEVA---SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 308 gt~~y~aPE~~---~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......... .....+.. ...+..+.+||.+
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~---~~~~~~~~~li~~ 284 (337)
T 3ll6_A 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYSIPPH---DTQYTVFHSLIRA 284 (337)
T ss_dssp ------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTT---CCSSGGGHHHHHH
T ss_pred CCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----CcccCCcc---cccchHHHHHHHH
Confidence 89999999998 56678999999999999999999999997654433322 22222211 1122278999999
Q ss_pred hcccCcCCcCCCCCChHHHHcC
Q 013016 385 LLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~h 406 (451)
||+.||.+||+ +.|+++|
T Consensus 285 ~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 285 MLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp HSCSSGGGSCC----HHHHHHH
T ss_pred HccCChhhCcC----HHHHHHH
Confidence 99999999999 9999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=362.70 Aligned_cols=270 Identities=19% Similarity=0.277 Sum_probs=209.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC-CCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH-PFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~ 158 (451)
++|.+.++||+|+||.||+|.+..+++ .||||++.... ....+..|+.+++.+.| ++|+.+..++
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCC---------EEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCc---------EEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 789999999999999999999876655 49999987542 22346679999999986 5566777777
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEE---ccCCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLV---RSDGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Df 235 (451)
...+..||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+||
T Consensus 73 ~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 73 VEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred eeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 8888999999999 999999997643 459999999999999999999999999999999999999 68899999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++........... .........+||+.|+||
T Consensus 151 Gla~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~Y~aP 182 (483)
T 3sv0_A 151 GLAKKYRDTSTHQH------------------------------------------------IPYRENKNLTGTARYASV 182 (483)
T ss_dssp TTCEECBCTTTCCB------------------------------------------------CCCCCCCCCCSCTTTCCH
T ss_pred CcceeccCCccccc------------------------------------------------cccccccccCCCccccCH
Confidence 99864332111000 000111245899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSN---ETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
|++.+..++.++|||||||+||+|++|+.||..... ...+..+................+.++.+||.+||+.||++
T Consensus 183 E~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~ 262 (483)
T 3sv0_A 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDD 262 (483)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTC
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhh
Confidence 999999999999999999999999999999987443 33333333322111110000122348999999999999999
Q ss_pred cCCCCCChHHHHc----------CCCcCCCCcccc
Q 013016 393 RLGSKRGAADVKT----------HPFFKGLNFALI 417 (451)
Q Consensus 393 Rpt~~~~~~ell~----------hp~~~~~~~~~~ 417 (451)
||+ +.+|++ ++|+..++|...
T Consensus 263 RPs----~~el~~~L~~l~~~~~~~~~~~~dW~~~ 293 (483)
T 3sv0_A 263 KPD----YSYLKRLFRDLFIREGFQFDYVFDWTIL 293 (483)
T ss_dssp CCC----HHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred CcC----HHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence 999 665543 789988898755
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=345.00 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=192.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH--CCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM--LDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~ 157 (451)
++|++.++||+|+||.||+|.+.+. .||||++..... .....|.+++.. ++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~-----------~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGE-----------KVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTE-----------EEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCc-----------eEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 6799999999999999999987632 499999965421 222334455444 489999999999
Q ss_pred EEeC----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeccCCCCcEEEc
Q 013016 158 FEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML--------GIIYRDLKPENVLVR 225 (451)
Q Consensus 158 ~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~--------givH~Dlkp~NIll~ 225 (451)
+... +.+|+||||+++|+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 9887 7899999999999999999764 599999999999999999999998 999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.+||+|||++......... .......
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------------------~~~~~~~ 205 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNE---------------------------------------------------VDIPPNT 205 (337)
T ss_dssp TTSCEEECCCTTCEECC------------------------------------------------------------CCS
T ss_pred CCCCEEEEeCCCceeecccccc---------------------------------------------------ccCCCCC
Confidence 9999999999998532211000 0001123
Q ss_pred cccCCCccCcccccCCCCCcc------hhHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHhcCC---
Q 013016 306 FVGTHEYVSPEVASGGSHGNA------VDWWAFGIFIYEMIYG----------RTPFAAPS----NETTLRNIVKKP--- 362 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~~~~~------~DIwSlG~il~elltg----------~~pf~~~~----~~~~~~~i~~~~--- 362 (451)
.+||+.|+|||++.+..++.. +|||||||++|||++| +.||.... ....+.......
T Consensus 206 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (337)
T 3mdy_A 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285 (337)
T ss_dssp SCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred CccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC
Confidence 479999999999988776554 9999999999999999 77776532 222333333221
Q ss_pred CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
..++........+.++.+||.+||+.||.+||| +.||++|
T Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred ccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 122222122233447899999999999999999 9999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.54 Aligned_cols=267 Identities=26% Similarity=0.326 Sum_probs=192.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+.+++|++.++||+|+||+||+|.+.+. .||||++...... ....+.|+..+..++|+||++++
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----------~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~ 73 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDER-----------PVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFI 73 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTE-----------EEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCe-----------EEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhhe
Confidence 34558999999999999999999977432 4999999754221 11112344445568999999999
Q ss_pred EEEEe-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeccCCCCc
Q 013016 156 AEFEA-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML---------GIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---------givH~Dlkp~N 221 (451)
+.+.. ...+|+||||+++|+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|
T Consensus 74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~N 150 (336)
T 3g2f_A 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150 (336)
T ss_dssp EEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGG
T ss_pred ecccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccce
Confidence 86642 33789999999999999999764 358999999999999999999999 99999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++.......... ......
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~-----------------------------------------------~~~~~~ 183 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVR-----------------------------------------------PGEEDN 183 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC------------------------------------------------------
T ss_pred EEEcCCCcEEEeeccceeecccccccC-----------------------------------------------cccccc
Confidence 999999999999999986433211100 000111
Q ss_pred cccccccCCCccCcccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----------------hHHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASG-------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPS-----------------NETTLRN 357 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwSlG~il~elltg~~pf~~~~-----------------~~~~~~~ 357 (451)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ....+..
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3g2f_A 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV 263 (336)
T ss_dssp --CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH
T ss_pred ccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHh
Confidence 1223479999999999987 345678999999999999999977763321 1122222
Q ss_pred HhcCC---CCCCCCCCC-CcChHHHHHHHHHhcccCcCCcCCCCCChHHH------HcCCCcCC
Q 013016 358 IVKKP---LTFPTQSPS-SMSEYHARDLISGLLNKDPCNRLGSKRGAADV------KTHPFFKG 411 (451)
Q Consensus 358 i~~~~---~~~~~~~~~-~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~el------l~hp~~~~ 411 (451)
..... ..++..... ...+.++.+||.+||+.||++||| +.|+ +.++|-++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 264 LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 22221 222221111 123347999999999999999999 8888 55677766
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=339.59 Aligned_cols=262 Identities=20% Similarity=0.300 Sum_probs=198.3
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|.+.+.||+|+||.||+|.+..+++ .||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH---------FYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCC---------EEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCc---------EEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3679999999999999999999876655 49999986532 23445677899999999999999999998
Q ss_pred E----eCCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 159 E----ASNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 159 ~----~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
. .....|+||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 7 335889999999999999988753 3466999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++........ .... ...........||+.|
T Consensus 176 ~dfg~~~~~~~~~~----------------------~~~~------------------------~~~~~~~~~~~gt~~y 209 (317)
T 2buj_A 176 MDLGSMNQACIHVE----------------------GSRQ------------------------ALTLQDWAAQRCTISY 209 (317)
T ss_dssp CCCSSCEESCEEEE----------------------SHHH------------------------HHHHHHHHHHHSCGGG
T ss_pred EecCcchhcccccc----------------------cccc------------------------cccccccccccCCccc
Confidence 99998742210000 0000 0000001123679999
Q ss_pred cCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcc
Q 013016 313 VSPEVASGGS---HGNAVDWWAFGIFIYEMIYGRTPFAAPS--NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLN 387 (451)
Q Consensus 313 ~aPE~~~~~~---~~~~~DIwSlG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~ 387 (451)
+|||++.+.. ++.++|||||||++|+|++|+.||.... .......+ ......+. ....+..+.+||.+||+
T Consensus 210 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~l~~li~~~l~ 285 (317)
T 2buj_A 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQLSIPQ---SPRHSSALWQLLNSMMT 285 (317)
T ss_dssp CCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC--CCC---CTTSCHHHHHHHHHHTC
T ss_pred CCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-hccCCCCc---cccCCHHHHHHHHHHhh
Confidence 9999987654 6889999999999999999999996411 11112222 22222222 12234489999999999
Q ss_pred cCcCCcCCCCCChHHHHcC
Q 013016 388 KDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 388 ~dP~~Rpt~~~~~~ell~h 406 (451)
.||.+||+ +.+++++
T Consensus 286 ~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 286 VDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred cChhhCCC----HHHHHHH
Confidence 99999999 9999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.95 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=204.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|++.+.||+|+||.||+|.++.. +|+|++..... .......+.+|+.++++++|+||++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~------------~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 95 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHGE------------VAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFM 95 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESSS------------EEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcCe------------EEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence 34458899999999999999999987642 89999975421 122234456689999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++...+..++||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+||
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeec
Confidence 99999999999999999999999987643 4699999999999999999999999999999999999998 789999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... ..........|++.|+||
T Consensus 174 g~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~g~~~y~aP 203 (319)
T 2y4i_B 174 GLFSISGVLQAG--------------------------------------------------RREDKLRIQNGWLCHLAP 203 (319)
T ss_dssp SCCC------------------------------------------------------------CCSCBCCSGGGGTSCH
T ss_pred CCcccccccccc--------------------------------------------------ccccccccCCCcccccCh
Confidence 997432110000 000111123689999999
Q ss_pred ccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 316 EVASG---------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 316 E~~~~---------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
|++.+ ..++.++|||||||++|+|++|+.||...........+..+....... . ..+.++.+|+.+||
T Consensus 204 E~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~l~~li~~~l 280 (319)
T 2y4i_B 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ--I-GMGKEISDILLFCW 280 (319)
T ss_dssp HHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC--S-SCCTTHHHHHHHHH
T ss_pred HHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc--C-CCCHHHHHHHHHHh
Confidence 99875 347889999999999999999999999988888777776654332211 1 12237999999999
Q ss_pred ccCcCCcCCCCCChHHHHc
Q 013016 387 NKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~ 405 (451)
+.||.+||| +.++++
T Consensus 281 ~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 281 AFEQEERPT----FTKLMD 295 (319)
T ss_dssp CSSTTTSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 999886
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=361.47 Aligned_cols=256 Identities=16% Similarity=0.178 Sum_probs=195.9
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC-CCcc----
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH-PFLP---- 152 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv---- 152 (451)
...+|...+.||+|+||+||+|.+..+++ .||||++...........+.+.+|+.+++.+.| .|+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~---------~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~ 146 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGE---------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCC---------ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence 33569999999999999999999887665 399999984433344445667789999999977 2211
Q ss_pred -----c------------eeEEEEe-----CCeEEEEEeeccCCchhhhhh-----hCCCCCCCHHHHHHHHHHHHHHHH
Q 013016 153 -----T------------LYAEFEA-----SNFSCIVMEFCSGGDLHSLRH-----KQPHKRFSLTSARFYAAEVLVALE 205 (451)
Q Consensus 153 -----~------------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~-----~~~~~~l~~~~~~~i~~qil~aL~ 205 (451)
. ++.++.. ....+++|+++ +++|.+++. ......+++..+..++.||+.||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 225 (413)
T 3dzo_A 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225 (413)
T ss_dssp HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence 1 1111111 22568888877 899999885 223445888899999999999999
Q ss_pred HHHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccc
Q 013016 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKI 285 (451)
Q Consensus 206 ~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (451)
|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 226 ~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------------------------------------------ 263 (413)
T 3dzo_A 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------------------------ 263 (413)
T ss_dssp HHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE------------------------------------------
T ss_pred HHHhCCcccCCcccceEEEecCCeEEEEeccceeecCC------------------------------------------
Confidence 99999999999999999999999999999999743210
Q ss_pred cccCCCcccccccccccccccccCCCccCcccc----------cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 013016 286 QTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA----------SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL 355 (451)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~ 355 (451)
.....+| +.|+|||++ .+..++.++|||||||++|+|++|+.||.........
T Consensus 264 ----------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~ 326 (413)
T 3dzo_A 264 ----------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326 (413)
T ss_dssp ----------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS
T ss_pred ----------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH
Confidence 0123478 899999999 5556888999999999999999999999876655444
Q ss_pred HHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 356 RNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 356 ~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
..+..... . .+.++.+||.+||+.||++||+ +.++++||||+++...
T Consensus 327 ~~~~~~~~--------~-~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 327 EWIFRSCK--------N-IPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRTE 373 (413)
T ss_dssp GGGGSSCC--------C-CCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHH
T ss_pred HHHHhhcc--------c-CCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHHH
Confidence 44433221 1 2348999999999999999999 9999999999986553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=365.49 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=208.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|.+.+.||+|+||+||+|.+..... .+..||||++.... .....+.+..|+.++++++||||++++++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34789999999999999999999865432 23469999987542 23344667789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+. .+..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 85 567899999999999999997653 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
+....... ........||+.|+|||+
T Consensus 538 a~~~~~~~------------------------------------------------------~~~~~~~~~t~~y~aPE~ 563 (656)
T 2j0j_A 538 SRYMEDST------------------------------------------------------YYKASKGKLPIKWMAPES 563 (656)
T ss_dssp CCSCCC----------------------------------------------------------------CCGGGCCHHH
T ss_pred CeecCCCc------------------------------------------------------ceeccCCCCCcceeCHHH
Confidence 85322110 000112256788999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCC-CCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLT-FPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
+.+..++.++|||||||++|||++ |..||.+....+.+..+..+... .+. ..+..+.+||.+||+.||.+||+
T Consensus 564 ~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~RPs 638 (656)
T 2j0j_A 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP-----NCPPTLYSLMTKCWAYDPSRRPR 638 (656)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc-----cccHHHHHHHHHHcCCChhHCcC
Confidence 998899999999999999999997 99999998888888777765432 222 23448999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+.+|++
T Consensus 639 ----~~el~~ 644 (656)
T 2j0j_A 639 ----FTELKA 644 (656)
T ss_dssp ----HHHHHH
T ss_pred ----HHHHHH
Confidence 888875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.30 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=200.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||.||+|.+.... ...+..||||++... .......+.+|+.++++++|+||++++++
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQ-----DNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTS-----SSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHceeeeeeccCCCeEEEEEEecccc-----CCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3467999999999999999999853211 112336999999754 23344667789999999999999999999
Q ss_pred EEeCC--eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 158 FEASN--FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~~--~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+...+ .+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 87654 7899999999999999998753 45999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++......... ........|+..|+||
T Consensus 190 g~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 190 GLTKVLPQDKEY----------------------------------------------------YKVKEPGESPIFWYAP 217 (326)
T ss_dssp TTCEECCSSCSE----------------------------------------------------EECSSCCSCCGGGCCH
T ss_pred cchhhccccccc----------------------------------------------------cccccCCCCceeEECc
Confidence 998543211000 0001122567789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------------H---HHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE------------T---TLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~------------~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
|++.+..++.++|||||||++|+|++|..||...... . .+...+......+. +...+.++.+
T Consensus 218 E~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ 294 (326)
T 2w1i_A 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR---PDGCPDEIYM 294 (326)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC---CCcccHHHHH
Confidence 9999888999999999999999999999998643111 0 11122222111111 1223448999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHc
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
||.+||+.||++||+ +.||++
T Consensus 295 li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 295 IMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp HHHHHSCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999 988875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=336.80 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=196.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH--CCCCCccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM--LDHPFLPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~ 157 (451)
++|.+.+.||+|+||.||+|.+.+. .||||++.... ...+..|.+++.. ++||||++++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----------~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGE-----------EVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTE-----------EEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCc-----------cEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 6799999999999999999987532 39999997542 2345568888887 789999999999
Q ss_pred EEeCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeccCCCCcEEEc
Q 013016 158 FEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH--------MLGIIYRDLKPENVLVR 225 (451)
Q Consensus 158 ~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH--------~~givH~Dlkp~NIll~ 225 (451)
+...+ ..|+||||+++|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 98876 899999999999999999763 5899999999999999999999 89999999999999999
Q ss_pred cCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccc
Q 013016 226 SDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305 (451)
Q Consensus 226 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (451)
.++.+||+|||++......... .......
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------------------~~~~~~~ 210 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDT---------------------------------------------------IDIAPNH 210 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTE---------------------------------------------------EEECCCS
T ss_pred CCCCEEEEECCCceeccccccc---------------------------------------------------ccccccc
Confidence 9999999999998432211000 0001123
Q ss_pred cccCCCccCcccccCCC------CCcchhHHHHHHHHHHHHhC----------CCCCCCCC-----hHHHHHHHhcCCCC
Q 013016 306 FVGTHEYVSPEVASGGS------HGNAVDWWAFGIFIYEMIYG----------RTPFAAPS-----NETTLRNIVKKPLT 364 (451)
Q Consensus 306 ~~gt~~y~aPE~~~~~~------~~~~~DIwSlG~il~elltg----------~~pf~~~~-----~~~~~~~i~~~~~~ 364 (451)
..||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.... .......+......
T Consensus 211 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (342)
T 1b6c_B 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 290 (342)
T ss_dssp CCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred CCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC
Confidence 47999999999998753 23689999999999999999 78887642 23333333333222
Q ss_pred --CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 365 --FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 365 --~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
++...........+.+|+.+||+.||++||| +.+|++|
T Consensus 291 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 291 PNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred CCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 1111111223347899999999999999999 9999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=350.71 Aligned_cols=246 Identities=20% Similarity=0.203 Sum_probs=186.8
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----HHHHHHHHHHHHHHHHHCC-------
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----KKKKVHRAEMEKKILKMLD------- 147 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~------- 147 (451)
++|++.++||+|+||+||+|++.+ + .||||++...... .......+.+|+.+++.++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~--~---------~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~ 88 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADH--T---------PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETT--E---------EEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred ccchheeeecccCceEEEEEEeCC--c---------eEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence 679999999999999999999833 2 4999999865321 1122355677888888875
Q ss_pred --CCCccceeEEE-----------------Ee-------------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHH
Q 013016 148 --HPFLPTLYAEF-----------------EA-------------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195 (451)
Q Consensus 148 --h~nIv~l~~~~-----------------~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~ 195 (451)
|+||+++.+++ .+ .+++|||||||++|++.+.+.. ..+++..++.
T Consensus 89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~ 165 (336)
T 2vuw_A 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKS 165 (336)
T ss_dssp SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHH
T ss_pred ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHH
Confidence 77777766654 22 6799999999999977666543 4589999999
Q ss_pred HHHHHHHHHHHHH-HCCCeeccCCCCcEEEccCC--------------------CEEEeccCcccccCCCCCCCCCCCCC
Q 013016 196 YAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDG--------------------HIMLSDFDLSLCSNAIPAVESPASSP 254 (451)
Q Consensus 196 i~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~ 254 (451)
++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|....
T Consensus 166 i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------ 233 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------ 233 (336)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE------------
T ss_pred HHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC------------
Confidence 9999999999999 99999999999999999987 89999999984221
Q ss_pred CCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHH
Q 013016 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGI 334 (451)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~ 334 (451)
....+||+.|||||++.+.. +.++||||||+
T Consensus 234 ------------------------------------------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~ 264 (336)
T 2vuw_A 234 ------------------------------------------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMK 264 (336)
T ss_dssp ------------------------------------------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHH
T ss_pred ------------------------------------------------CCcEEEeecccChhhhcCCC-ccceehhhhhC
Confidence 01237999999999998866 89999999877
Q ss_pred H-HHHHHhCCCCCCCCCh-HHHHHHHhcCCCCCCCCCCC---CcChHHHHHHHHHhcccCcCCcCCCCCChHHHH-cCCC
Q 013016 335 F-IYEMIYGRTPFAAPSN-ETTLRNIVKKPLTFPTQSPS---SMSEYHARDLISGLLNKDPCNRLGSKRGAADVK-THPF 408 (451)
Q Consensus 335 i-l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~---~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell-~hp~ 408 (451)
+ .+++++|..||..... ......+..... ....... ...+.++++||.+||++| | +.|+| +|||
T Consensus 265 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s----a~e~l~~Hp~ 334 (336)
T 2vuw_A 265 KENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S----ATDLLCQHSL 334 (336)
T ss_dssp HHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-CSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S----HHHHHHHCGG
T ss_pred CCCcccccccCCCcchhhhhHHHHhhhhhhc-cCcccchhhhhhcCHHHHHHHHHHhccC-----C----HHHHHhcCCC
Confidence 7 7788899999954211 112233332211 1111111 123448999999999987 8 99999 9999
Q ss_pred cC
Q 013016 409 FK 410 (451)
Q Consensus 409 ~~ 410 (451)
|+
T Consensus 335 f~ 336 (336)
T 2vuw_A 335 FK 336 (336)
T ss_dssp GC
T ss_pred cC
Confidence 96
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=330.46 Aligned_cols=225 Identities=15% Similarity=0.135 Sum_probs=184.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||.||+|.+..+++ .||||++.............+.+|+.++.+++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~---------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDR---------QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTE---------EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCc---------eEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 679999999999999999999987655 49999998764444455677888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+..|+||||++|++|.+++... .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence 999999999999999999998542 4566788999999999999999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
|++
T Consensus 175 ------------------------------------------------------------------------~~~----- 177 (286)
T 3uqc_A 175 ------------------------------------------------------------------------TMP----- 177 (286)
T ss_dssp ------------------------------------------------------------------------CCT-----
T ss_pred ------------------------------------------------------------------------ccC-----
Confidence 333
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLR---NIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
.++.++|||||||++|+|++|+.||.+......+. ....+....+...... .+.++.+||.+||+.||.+| |
T Consensus 178 --~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~R-s- 252 (286)
T 3uqc_A 178 --DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD-IPFQISAVAARSVQGDGGIR-S- 252 (286)
T ss_dssp --TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT-SCHHHHHHHHHHHCTTSSCC-C-
T ss_pred --CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC-CCHHHHHHHHHHcccCCccC-C-
Confidence 36889999999999999999999998765533221 1111211111111122 33489999999999999999 9
Q ss_pred CCChHHHHc
Q 013016 397 KRGAADVKT 405 (451)
Q Consensus 397 ~~~~~ell~ 405 (451)
+.|+++
T Consensus 253 ---~~el~~ 258 (286)
T 3uqc_A 253 ---ASTLLN 258 (286)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 888886
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=361.52 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=193.6
Q ss_pred CCceEEeeeccCCeeEEEEEEecc-ccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNN-KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||+||+|.+.. +++ .||||++.... .......+..|+.++++++||||+++++++
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~---------~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGR---------PVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTE---------EEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCc---------EEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 789999999999999999999875 333 49999986432 233445677899999999999999999999
Q ss_pred EeCCe-----EEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 159 EASNF-----SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 159 ~~~~~-----~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
...+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEEC
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEE
Confidence 87765 7999999999999987654 59999999999999999999999999999999999999975 99999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... ....+||+.|+
T Consensus 224 DFG~a~~~~~-----------------------------------------------------------~~~~~gt~~y~ 244 (681)
T 2pzi_A 224 DLGAVSRINS-----------------------------------------------------------FGYLYGTPGFQ 244 (681)
T ss_dssp CCTTCEETTC-----------------------------------------------------------CSCCCCCTTTS
T ss_pred ecccchhccc-----------------------------------------------------------CCccCCCcccc
Confidence 9999843210 01347999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|||++.+. ++.++|||||||++|+|++|..||...... ..+........+..+.+||.+||+.||.+|
T Consensus 245 aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 312 (681)
T 2pzi_A 245 APEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQR 312 (681)
T ss_dssp CTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------cccccccccccCHHHHHHHhhhccCChhhC
Confidence 99998775 489999999999999999999998752110 011110000112378999999999999999
Q ss_pred CCCCCChHHHHcCCCcCC
Q 013016 394 LGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~~ 411 (451)
|+ ..+.+.|+|+.-
T Consensus 313 ~~----~~~~l~~~l~~~ 326 (681)
T 2pzi_A 313 FT----TAEEMSAQLTGV 326 (681)
T ss_dssp CS----SHHHHHHHHHHH
T ss_pred CC----HHHHHHHHHHHH
Confidence 99 888899988865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.63 Aligned_cols=189 Identities=17% Similarity=0.093 Sum_probs=129.7
Q ss_pred eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH-------HHHHHHHHHHHHHHHHHHHC-CCCCccceeEEE
Q 013016 87 RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-------LEKKKKVHRAEMEKKILKML-DHPFLPTLYAEF 158 (451)
Q Consensus 87 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~ 158 (451)
.++.|+.|.+..++....++ .||+|++.+.. .......+.+.+|+++|+++ .|+||+++++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~---------~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 311 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGE---------DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG 311 (569)
T ss_dssp C-C--------CCEEEEECS---------SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE
T ss_pred ccccCCcccccccccccccc---------eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 45566666655554443333 49999997542 12334556788899999999 699999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
++++.+|||||||+|++|.+++... +++++. +|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 312 ed~~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 312 ENAQSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp ECSSEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred EECCEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccC
Confidence 9999999999999999999999875 557654 58999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+.... ......+.+||+.|||||++
T Consensus 387 r~~~~-------------------------------------------------------~~~~~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 387 VTTPQ-------------------------------------------------------DCSWPTNLVQSFFVFVNELF 411 (569)
T ss_dssp ESCC----------------------------------------------------------CCSHHHHHHHHHHHHHHC
T ss_pred eeCCC-------------------------------------------------------CCccccCceechhhccHHHh
Confidence 53221 01122346899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTP 345 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~p 345 (451)
.+ .+..++|+||+|+++++|+++..+
T Consensus 412 ~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 412 AE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------------------CCCCTTHHH
T ss_pred CC-CCCCcccccccccchhhhccccch
Confidence 87 457789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=259.11 Aligned_cols=194 Identities=17% Similarity=0.139 Sum_probs=143.6
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHH-----HHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEV-----LEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
...++||+|+||+||+|..... .+++|...... .......+.+.+|+.++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~-----------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDF-----------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECSSC-----------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEECCC-----------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4567899999999999955433 28888764322 1223335667889999999999999966666
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+...+..||||||++|++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTT
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECcc
Confidence 6677788999999999999998865 5689999999999999999999999999999998 999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
++....... ... +......+++||+.|||||+
T Consensus 476 a~~~~~~~~---------------------~~~---------------------------~~~~~~~~~~GT~~y~APEv 507 (540)
T 3en9_A 476 GKISNLDED---------------------KAV---------------------------DLIVFKKAVLSTHHEKFDEI 507 (540)
T ss_dssp CEECCCHHH---------------------HHH---------------------------HHHHHHHHHHHHCGGGHHHH
T ss_pred CEECCCccc---------------------ccc---------------------------chhhhhhhhcCCCCcCCHHH
Confidence 853321000 000 00001124689999999999
Q ss_pred ccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 013016 318 ASG--GSHGNAVDWWAFGIFIYEMIYGRTPFA 347 (451)
Q Consensus 318 ~~~--~~~~~~~DIwSlG~il~elltg~~pf~ 347 (451)
+.+ ..|+...|+|+..+-..+.+.++.+|.
T Consensus 508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 508 WERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987 557888999999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=220.68 Aligned_cols=133 Identities=20% Similarity=0.212 Sum_probs=106.1
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---------------HHHHHHHHHHHHHHHC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---------------KKVHRAEMEKKILKML 146 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l 146 (451)
|.+.+.||+|+||.||+|.+ .+++ .||||+++....... .....+.+|+.+++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~---------~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFG---------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTE---------EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred EEecCEeccCCCceEEEEEe-CCCC---------EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 55559999999999999998 4443 499999975432111 2345677899999999
Q ss_pred CCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
+ | +++.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence 9 5 666665544 56799999999999988 321 23457999999999999999999999999999999
Q ss_pred CCCEEEeccCcc
Q 013016 227 DGHIMLSDFDLS 238 (451)
Q Consensus 227 ~~~~kl~Dfg~a 238 (451)
+|.+||+|||+|
T Consensus 228 ~~~vkl~DFG~a 239 (282)
T 1zar_A 228 EEGIWIIDFPQS 239 (282)
T ss_dssp TTEEEECCCTTC
T ss_pred CCcEEEEECCCC
Confidence 999999999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=183.34 Aligned_cols=139 Identities=18% Similarity=0.176 Sum_probs=106.0
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcce--EEEEEcchHHHH---------------------HHHHHHHHHH
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCL--YAMKVVNKEVLE---------------------KKKKVHRAEM 138 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~ 138 (451)
|.+.+.||.|+||.||+|.+..+++ . ||||+++..... .......+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGK---------PVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTE---------EEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCc---------EeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 7899999999999999999844332 5 999997543211 0112235778
Q ss_pred HHHHHHHCCCCCc--cceeEEEEeCCeEEEEEeeccC-C----chhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HC
Q 013016 139 EKKILKMLDHPFL--PTLYAEFEASNFSCIVMEFCSG-G----DLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-ML 210 (451)
Q Consensus 139 e~~~l~~l~h~nI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~ 210 (451)
|+.++.++.|++| +.+++. +..+|||||+.+ | +|.++... .++..+..++.||+.||.||| ++
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999988764 444442 357899999932 3 66665432 235577899999999999999 99
Q ss_pred CCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 211 GIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 211 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
||+||||||+|||++. .++|+|||+|..
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999999998 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.6e-19 Score=171.90 Aligned_cols=138 Identities=16% Similarity=0.191 Sum_probs=99.4
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-----------------H--HHHHHHHHHHHHH
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-----------------K--KKKVHRAEMEKKI 142 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~--~~~~~~~~~e~~~ 142 (451)
|.+.+.||.|++|.||+|.+..+. .||||+++..... . ........+|...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~----------~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGK----------QKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCC----------EEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECCCCC----------EEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 999999999999999999876433 3999997532110 0 0011122456777
Q ss_pred HHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 013016 143 LKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222 (451)
Q Consensus 143 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NI 222 (451)
|.++.+.++....-+... ..+|||||+.|++|.++.. ......++.||+.+|.+||++|||||||||.||
T Consensus 167 L~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NI 236 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNI 236 (397)
T ss_dssp HHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred HHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence 777755554322211122 2379999999998876532 123567889999999999999999999999999
Q ss_pred EEccCC----------CEEEeccCccc
Q 013016 223 LVRSDG----------HIMLSDFDLSL 239 (451)
Q Consensus 223 ll~~~~----------~~kl~Dfg~a~ 239 (451)
|++.+| .+.|+||+.+.
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEeCCCCcccccccccceEEEEeCCcc
Confidence 999877 38999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-13 Score=126.78 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=110.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
..|.+...+|.|+.+.||++...+ + .+++|+...... .....+..|+.+++.+. +..++++++++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~--~---------~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGEN--E---------NLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSS--C---------EEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCC--C---------cEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 679999999999999999987542 2 299999875321 11234667999999884 67788999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM----------------------------- 209 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------- 209 (451)
...+..|+|||+++|.+|.+... +......++.++..+|..||+
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred ecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 99999999999999999977521 122345788999999999998
Q ss_pred ------------------------------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 ------------------------------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ------------------------------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999865556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=119.64 Aligned_cols=134 Identities=13% Similarity=0.075 Sum_probs=99.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC--ccceeEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF--LPTLYAE 157 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~ 157 (451)
.+|.+....+.|..+.||++....+. .+++|+.... ....+..|+.+++.+.+.+ +++++++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~----------~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~ 83 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRP----------VLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDV 83 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSC----------CEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCC----------eEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEe
Confidence 56777655556777999999754322 2999997643 1234566888888885444 5679999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG-------------------------- 211 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g-------------------------- 211 (451)
+...+..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 84 ~~~~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 84 VTEAGRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp EECSSCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred ccCCCCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 88888899999999998884 111 12 2356777888888888643
Q ss_pred --------------------------------CeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 212 --------------------------------IIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 212 --------------------------------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999974
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=120.88 Aligned_cols=140 Identities=19% Similarity=0.248 Sum_probs=105.4
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcc--hHHHHHHHHHHHHHHHHHHHHHCC--CCCccceeEEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVN--KEVLEKKKKVHRAEMEKKILKMLD--HPFLPTLYAEF 158 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~ 158 (451)
.-.+.|+.|.++.||++...+. .+++|+.. ..... .....+.+|..+++.+. +..+++++.++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~-----------~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~ 107 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQ-----------TYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALC 107 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSC-----------EEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEE
T ss_pred ceEEEcCCcccceEEEEEECCc-----------eEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEEC
Confidence 3467799999999999876542 28999886 43211 12345667999999886 45588999988
Q ss_pred EeC---CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------
Q 013016 159 EAS---NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-------------------------- 209 (451)
Q Consensus 159 ~~~---~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------- 209 (451)
.+. +..|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 108 ~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 108 EDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp CCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred CCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 776 4689999999998885421 1237888899999999999999997
Q ss_pred --------------------------------CCCeeccCCCCcEEEccCCC--EEEeccCccc
Q 013016 210 --------------------------------LGIIYRDLKPENVLVRSDGH--IMLSDFDLSL 239 (451)
Q Consensus 210 --------------------------------~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 239 (451)
.+++|+|+++.|||++.++. +.|+||+.+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999997763 6899999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=5.6e-11 Score=113.79 Aligned_cols=131 Identities=18% Similarity=0.160 Sum_probs=97.4
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCC--ccceeEEEEeCC
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPF--LPTLYAEFEASN 162 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--Iv~l~~~~~~~~ 162 (451)
+.++.|....||++. . + +++|+.... .....+..|..+++.+. +.. +++++......+
T Consensus 26 ~~~~~G~~n~v~~v~----~-~---------~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~ 86 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----R-D---------FIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE 86 (304)
T ss_dssp CEEEECSSEEEEEST----T-S---------EEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS
T ss_pred EecCCCCcceEEEEC----C-E---------EEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC
Confidence 458999999999863 1 1 899997643 23356677999998873 333 455655544333
Q ss_pred ---eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------
Q 013016 163 ---FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM------------------------------ 209 (451)
Q Consensus 163 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------ 209 (451)
..|+|||+++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 87 ~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 87 TYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 45899999999998754332 26788888889999999988886
Q ss_pred ----------------------------CCCeeccCCCCcEEEcc--CCCEEEeccCccc
Q 013016 210 ----------------------------LGIIYRDLKPENVLVRS--DGHIMLSDFDLSL 239 (451)
Q Consensus 210 ----------------------------~givH~Dlkp~NIll~~--~~~~kl~Dfg~a~ 239 (451)
..++|+|++|.||+++. .+.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4567899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.8e-07 Score=89.45 Aligned_cols=132 Identities=14% Similarity=0.115 Sum_probs=93.8
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC---CccceeEEEE-e
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP---FLPTLYAEFE-A 160 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---nIv~l~~~~~-~ 160 (451)
...++.|....||+. +.+ +++|+.... .....+..|..+|+.+.+. .+++++.++. .
T Consensus 24 v~~l~~G~~n~v~~v----g~~----------~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~ 84 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGD----------WVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS 84 (306)
T ss_dssp EEEEEECSSEEEEEE----TTT----------EEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT
T ss_pred eeecCCCcceeEEEE----CCE----------EEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC
Confidence 445789999999987 221 899996432 2345677799999998653 3677777774 4
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHML------------------------------ 210 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~------------------------------ 210 (451)
.+..|+|||+++|.+|.+..-. .++......++.++...|..||+.
T Consensus 85 ~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~ 160 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV 160 (306)
T ss_dssp TSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred CCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence 5678899999999988763211 145555555666666666666642
Q ss_pred ------------------------------CCeeccCCCCcEEEcc---CCCE-EEeccCccc
Q 013016 211 ------------------------------GIIYRDLKPENVLVRS---DGHI-MLSDFDLSL 239 (451)
Q Consensus 211 ------------------------------givH~Dlkp~NIll~~---~~~~-kl~Dfg~a~ 239 (451)
.++|+|+++.|||++. ++.+ .|+||+.+.
T Consensus 161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999997 4554 899999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.5e-07 Score=86.50 Aligned_cols=136 Identities=16% Similarity=0.100 Sum_probs=97.3
Q ss_pred ceEEeeeccCCee-EEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEE
Q 013016 82 FDLHRRIGAGDIG-TVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFE 159 (451)
Q Consensus 82 y~~~~~LG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~ 159 (451)
|... .+..|..+ .||+......... ++||+-... ....+..|...|+.+. +--+.++++++.
T Consensus 27 ~~~~-~~~~G~S~~~v~rl~~~~~~~~---------~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~ 90 (272)
T 4gkh_A 27 YRWA-RDNVGQSGATIYRLYGKPNAPE---------LFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIR 90 (272)
T ss_dssp CEEE-EEECSSSSCEEEEEECCTTCCC---------EEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CeEE-EccCCCcCCeEEEEEecCCCeE---------EEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEE
Confidence 4433 34445554 7998776554433 899987644 2345667888888874 334788999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM------------------------------ 209 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------ 209 (451)
+.+..|+|||+++|.++.+..... ......+..++...|.-||.
T Consensus 91 ~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 91 TPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp ETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred ECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 999999999999998887765432 12234566667777777774
Q ss_pred ----------------------------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 ----------------------------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ----------------------------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 027999999999999977667799999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.1e-07 Score=88.66 Aligned_cols=87 Identities=7% Similarity=0.037 Sum_probs=56.3
Q ss_pred eEEeee-ccCCeeEEEEEEecc------ccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-C--CCcc
Q 013016 83 DLHRRI-GAGDIGTVYLCSLNN------KYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-H--PFLP 152 (451)
Q Consensus 83 ~~~~~L-G~G~~g~Vy~~~~~~------~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~nIv 152 (451)
...+.| +.|....+|++.... .++ .+++|+..............+..|..+++.+. + ..++
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~---------~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP 93 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQ---------KLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVP 93 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEE---------EEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCc---------eEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCC
Confidence 345678 899999999987540 011 28899876432000000134556888888774 2 3578
Q ss_pred ceeEEEEeC---CeEEEEEeeccCCchhh
Q 013016 153 TLYAEFEAS---NFSCIVMEFCSGGDLHS 178 (451)
Q Consensus 153 ~l~~~~~~~---~~~~lV~E~~~ggsL~~ 178 (451)
+++.++.+. +..|+|||+++|..+.+
T Consensus 94 ~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 94 RVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred cEEEEccCCCccCCceEEEEecCCCChhh
Confidence 888887665 46789999998877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.4e-06 Score=86.30 Aligned_cols=80 Identities=20% Similarity=0.254 Sum_probs=48.8
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHH-HHH---HHHHHHHHHHHHHHHCCC--C-CccceeE
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL-EKK---KKVHRAEMEKKILKMLDH--P-FLPTLYA 156 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~h--~-nIv~l~~ 156 (451)
-.+.||.|..+.||++.....++. ++||....... ... ....+...|.++++.+.. + .+++++.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~---------~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~ 104 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRA---------LIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY 104 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CE---------EEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred EEEECCCCceEEEEEEEECCCCcE---------EEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence 356799999999999976543332 99998653211 011 122345668888887632 3 3556665
Q ss_pred EEEeCCeEEEEEeeccCC
Q 013016 157 EFEASNFSCIVMEFCSGG 174 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~gg 174 (451)
+ +.+..++|||+++|.
T Consensus 105 ~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 S--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp E--ETTTTEEEECCCTTS
T ss_pred E--cCCccEEEEEeCCCc
Confidence 4 345568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=5.6e-06 Score=79.78 Aligned_cols=30 Identities=20% Similarity=0.262 Sum_probs=27.4
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++||+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.7e-05 Score=71.54 Aligned_cols=77 Identities=13% Similarity=0.187 Sum_probs=58.7
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC---CCCccceeEEEE
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD---HPFLPTLYAEFE 159 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~ 159 (451)
.-.+.|+.|....+|+....+ + .++||+.... ....+..|...|+.+. ...+++++.++.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~--~---------~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~ 101 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEV--Q---------TVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGN 101 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSS--C---------EEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE
T ss_pred eeeEEeCCccceeeeEEEECC--C---------eEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEee
Confidence 345678999999999987532 2 2889998643 1345566888887773 366889999998
Q ss_pred eCCeEEEEEeeccCCch
Q 013016 160 ASNFSCIVMEFCSGGDL 176 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL 176 (451)
..+..++|||+++|..+
T Consensus 102 ~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 102 SQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CSSEEEEEEECCCCCCC
T ss_pred cCCceEEEEEeccCCCC
Confidence 88899999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=4.3e-05 Score=76.15 Aligned_cols=31 Identities=26% Similarity=0.375 Sum_probs=27.2
Q ss_pred HHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 208 H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+...++|+|+++.|||++.++ +.|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 356799999999999999776 9999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=5.9e-05 Score=71.47 Aligned_cols=133 Identities=14% Similarity=0.103 Sum_probs=75.0
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEeCCe
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEASNF 163 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~ 163 (451)
.+.|+.|....+|++ .+ +++|+..... ........|..+++.+...++ +++++.+ .+.
T Consensus 23 i~~l~gG~tN~~~~~-----~~----------~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~ 81 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GD----------LCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVD--PAT 81 (301)
T ss_dssp CEEEESCSSEEEEEE-----TT----------EEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTT
T ss_pred eeEcCCcccccccee-----ee----------EEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCC
Confidence 667899999999998 11 8999987531 111223447777776643233 5666544 333
Q ss_pred EEEEEeec-cCCchhhh------------------hhhCCC---CCCC-HHHHHHHHH--------------HHHHHHHH
Q 013016 164 SCIVMEFC-SGGDLHSL------------------RHKQPH---KRFS-LTSARFYAA--------------EVLVALEY 206 (451)
Q Consensus 164 ~~lV~E~~-~ggsL~~~------------------l~~~~~---~~l~-~~~~~~i~~--------------qil~aL~~ 206 (451)
-++|+||+ +|.+|... ++.... ..+. ...+..+.. .+...+..
T Consensus 82 ~~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 161 (301)
T 3dxq_A 82 GVMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGG 161 (301)
T ss_dssp CCEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHH
T ss_pred CEEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHH
Confidence 47899999 77665320 111110 0011 111111111 11111222
Q ss_pred HH----H----CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 207 LH----M----LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 207 LH----~----~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
|. . ..++|+|+.+.||+ ..++.+.|+||+.+.
T Consensus 162 l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 162 VRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp HHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 21 1 24899999999999 667789999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=69.24 Aligned_cols=142 Identities=20% Similarity=0.201 Sum_probs=79.5
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC--ccceeEE--
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF--LPTLYAE-- 157 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~-- 157 (451)
..-.+.|+.|....+|++...++ + +++|+..... ....+..|..+++.+...+ +++++..
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g-~----------~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~ 87 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKD-P----------LILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 87 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSC-C----------EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred ceEeeccCCCcccceEEEEeCCc-c----------EEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence 33456788898899999876433 2 8999987531 1233445666666653212 3333321
Q ss_pred ----EEeCCeEEEEEeeccCCchhh-----------h---hhhC----CCCC---CC---HHHHHH------------HH
Q 013016 158 ----FEASNFSCIVMEFCSGGDLHS-----------L---RHKQ----PHKR---FS---LTSARF------------YA 197 (451)
Q Consensus 158 ----~~~~~~~~lV~E~~~ggsL~~-----------~---l~~~----~~~~---l~---~~~~~~------------i~ 197 (451)
....+..++||++++|..+.. . ++.. .... .. |..... +.
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 233467899999998865421 0 1111 0000 11 111000 01
Q ss_pred HHHHHHHHHHHH-------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 198 AEVLVALEYLHM-------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 198 ~qil~aL~~LH~-------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..+...++.|.. .++||+|+++.|||++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 124445566653 469999999999999977656899999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00046 Score=61.34 Aligned_cols=60 Identities=13% Similarity=0.011 Sum_probs=45.4
Q ss_pred CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeccCCCCcEEEccCCCEEEec
Q 013016 174 GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 174 gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
-||.++|... +.+++++++|.++.|.+.+|.-+- .+.-..+=+.|..|+|..+|.|-+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 4788888766 467999999999999999988762 22222344457899999999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00022 Score=68.45 Aligned_cols=30 Identities=20% Similarity=0.352 Sum_probs=26.5
Q ss_pred CCCeeccCCCCcEEEccC----CCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSD----GHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 239 (451)
..++|||+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999874 689999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00017 Score=72.09 Aligned_cols=82 Identities=21% Similarity=0.267 Sum_probs=48.7
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEEEeCC
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEFEASN 162 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~ 162 (451)
-.+.|+.|....||++......... ...+..+++|+..... . ...+..|..+++.+...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~--~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPI--RNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCS--SSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEEeCCCcccceEEEEeCCCcccc--CCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 3567888999999999865321000 0001138899884310 0 022335788887775333 3677776542
Q ss_pred eEEEEEeeccCCch
Q 013016 163 FSCIVMEFCSGGDL 176 (451)
Q Consensus 163 ~~~lV~E~~~ggsL 176 (451)
.+||||++|.+|
T Consensus 148 --g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 --GRLEEYIPSRPL 159 (429)
T ss_dssp --EEEECCCCEEEC
T ss_pred --CEEEEEeCCccc
Confidence 289999987555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00026 Score=69.12 Aligned_cols=83 Identities=16% Similarity=0.203 Sum_probs=45.0
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEEEeCCe
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEFEASNF 163 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~ 163 (451)
...|+.|....+|++...+..... ....+..+++|+..... ........|..+++.+...+ .+++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~-~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANN-YNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTT-CTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEeCCcccceEEEEEeCCCCccc-ccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 456888888999999865421000 00000138899886431 11112345777777774333 45777654 22
Q ss_pred EEEEEeeccCCch
Q 013016 164 SCIVMEFCSGGDL 176 (451)
Q Consensus 164 ~~lV~E~~~ggsL 176 (451)
++||||++|.++
T Consensus 110 -~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 -GRIEEWLYGDPL 121 (369)
T ss_dssp -EEEEECCCSEEC
T ss_pred -cEEEEEecCCcC
Confidence 689999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00054 Score=64.31 Aligned_cols=80 Identities=14% Similarity=0.047 Sum_probs=55.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC---CCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH---PFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~nIv~l~~ 156 (451)
....-+..+|.|..+.||+.+..++.. |.+|+...... .....+..|...|+.+.- --++++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~----------~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~ 81 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTP----------LFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAG 81 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCE----------EEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCE----------EEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence 346678889999999999998765532 99998754321 122345678888888842 23566666
Q ss_pred EEEeCCeEEEEEeeccCCch
Q 013016 157 EFEASNFSCIVMEFCSGGDL 176 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL 176 (451)
+. ..++|||++.++..
T Consensus 82 ~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 82 WD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EE----TTEEEEECCCCCCC
T ss_pred cc----CceEEEEeecccCC
Confidence 43 24789999977653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00044 Score=67.66 Aligned_cols=149 Identities=17% Similarity=0.274 Sum_probs=84.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
+...+ +.|..|-...+|++........ ....+.-+++|+..... .....+.+|..+++.+. +.-.+++++.+
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~ 123 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPS--VGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVF 123 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCC--CSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccc--cCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEc
Confidence 44553 4677788899999986431100 00011238999874321 12344456888888774 32346777766
Q ss_pred EeCCeEEEEEeeccCCchhhh-----------------hhhCC---CCCC--CHHHHHHHHHHHHH--------------
Q 013016 159 EASNFSCIVMEFCSGGDLHSL-----------------RHKQP---HKRF--SLTSARFYAAEVLV-------------- 202 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~qil~-------------- 202 (451)
.++ +||||++|.+|..- ++... .+.. -+.++.++..++..
T Consensus 124 ~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 3feg_A 124 PEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM 199 (379)
T ss_dssp TTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred CCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence 542 99999998766421 11111 1112 24555656554422
Q ss_pred -----HHHHHHH--------CCCeeccCCCCcEEEccC----CCEEEeccCccc
Q 013016 203 -----ALEYLHM--------LGIIYRDLKPENVLVRSD----GHIMLSDFDLSL 239 (451)
Q Consensus 203 -----aL~~LH~--------~givH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 239 (451)
.+..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2344432 259999999999999876 789999999874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0013 Score=62.71 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=75.6
Q ss_pred eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCC--CccceeEE-----E
Q 013016 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHP--FLPTLYAE-----F 158 (451)
Q Consensus 86 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--nIv~l~~~-----~ 158 (451)
..|+ |....||++...++.+ +++|+.+.... ....+..|..+++.+... .+++++.. .
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~----------~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~ 96 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRR----------FVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL 96 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCC----------EEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE
T ss_pred Eeec-CcccceEEEEcCCCCE----------EEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEE
Confidence 3466 8888999886543322 89999863311 112344466676666321 24444442 2
Q ss_pred EeCCeEEEEEeeccCCchhh-----------h---hhh----CCC---CCCCHHHH----------------------HH
Q 013016 159 EASNFSCIVMEFCSGGDLHS-----------L---RHK----QPH---KRFSLTSA----------------------RF 195 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~-----------~---l~~----~~~---~~l~~~~~----------------------~~ 195 (451)
...+..++||++++|..+.. . ++. ... ..+..... ..
T Consensus 97 ~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 176 (328)
T 1zyl_A 97 NHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLK 176 (328)
T ss_dssp EETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHH
T ss_pred EECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHH
Confidence 33567789999998865421 0 111 000 11222111 01
Q ss_pred HHHHHHHHHHHH----HHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 196 YAAEVLVALEYL----HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 196 i~~qil~aL~~L----H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.+.+++..+.-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 177 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 177 ATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 111222222211 124589999999999999 5 89999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0041 Score=59.82 Aligned_cols=30 Identities=27% Similarity=0.423 Sum_probs=27.0
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 469999999999999988899999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0029 Score=63.47 Aligned_cols=76 Identities=21% Similarity=0.238 Sum_probs=48.4
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCc-cceeEEEEeCC
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFL-PTLYAEFEASN 162 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~ 162 (451)
-.+.|+.|-...+|++...+..+ .+++|+..... ........|..+++.+...++ +++++.+. +
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~---------~~vLRi~g~~~----~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~- 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQA---------KYLIRLYGPKT----DEIINREREKKISCILYNKNIAKKIYVFFT-N- 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTE---------EEEEEEECC-C----CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T-
T ss_pred EEEEcCCCeEeEEEEEEECCCCc---------eEEEEECCCCh----hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C-
Confidence 35678889999999998754212 28899875321 111122468888988865554 67787763 2
Q ss_pred eEEEEEeeccCCch
Q 013016 163 FSCIVMEFCSGGDL 176 (451)
Q Consensus 163 ~~~lV~E~~~ggsL 176 (451)
.+||||++|.+|
T Consensus 177 --G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 --GRIEEFMDGYAL 188 (458)
T ss_dssp --EEEEECCCSEEC
T ss_pred --eEEEEeeCCccC
Confidence 259999988665
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.013 Score=58.02 Aligned_cols=83 Identities=19% Similarity=0.264 Sum_probs=48.6
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEEEeCC
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEFEASN 162 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~ 162 (451)
-++.|..|-...+|++......... ...+.-+++|+..... .......+|..+++.+. +.-.+++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~--~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSL--SLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T
T ss_pred EEEEcCCCcccceEEEEeCCCcccc--cCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C
Confidence 3556778888999999875321000 0001138999875431 12223345888887774 333466776432 2
Q ss_pred eEEEEEeeccCCch
Q 013016 163 FSCIVMEFCSGGDL 176 (451)
Q Consensus 163 ~~~lV~E~~~ggsL 176 (451)
++||||++|..|
T Consensus 146 --~~I~efI~G~~l 157 (424)
T 3mes_A 146 --GRIEEFIDGEPL 157 (424)
T ss_dssp --EEEEECCCSEEC
T ss_pred --CEEEEEeCCccC
Confidence 689999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.029 Score=55.13 Aligned_cols=28 Identities=29% Similarity=0.430 Sum_probs=24.2
Q ss_pred CeeccCCCCcEEEc------cCCCEEEeccCccc
Q 013016 212 IIYRDLKPENVLVR------SDGHIMLSDFDLSL 239 (451)
Q Consensus 212 ivH~Dlkp~NIll~------~~~~~kl~Dfg~a~ 239 (451)
++|+|+.+.|||+. .++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 68999999999993 45679999999874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.74 E-value=0.26 Score=43.58 Aligned_cols=83 Identities=14% Similarity=0.104 Sum_probs=62.8
Q ss_pred CCCCccceeEEEEeCCeEEEEEeecc-CCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc
Q 013016 147 DHPFLPTLYAEFEASNFSCIVMEFCS-GGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR 225 (451)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~lV~E~~~-ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~ 225 (451)
.||+++.. .+-++.+.+.+.++.-. +-++.. + ..++....++++..|+....+++ .=+|--|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence 68888876 56677777777777643 223333 2 23788999999999998875554 348888999999999
Q ss_pred cCCCEEEeccCcc
Q 013016 226 SDGHIMLSDFDLS 238 (451)
Q Consensus 226 ~~~~~kl~Dfg~a 238 (451)
.++.+++.-.|+.
T Consensus 114 ~~~~p~i~~RGik 126 (215)
T 4ann_A 114 RDGLPIAKTRGLQ 126 (215)
T ss_dssp TTSCEEESCCEET
T ss_pred CCCCEEEEEccCc
Confidence 9999999988863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.77 Score=40.66 Aligned_cols=81 Identities=11% Similarity=0.003 Sum_probs=60.2
Q ss_pred CCCCccceeEEEEeCCeEEEEEeeccCC-chhhhhhhCCCCCCCHHHHHHHHHHHHHHHH-HHHHCCCeeccCCCCcEEE
Q 013016 147 DHPFLPTLYAEFEASNFSCIVMEFCSGG-DLHSLRHKQPHKRFSLTSARFYAAEVLVALE-YLHMLGIIYRDLKPENVLV 224 (451)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~aL~-~LH~~givH~Dlkp~NIll 224 (451)
.||++ -..+-.+++.+.+.++.-+++ ++. .+. .++....++++..|+.... ++ ..-+|--|+|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence 68888 444557778888888765333 333 232 2788899998888887666 44 445888999999999
Q ss_pred ccCCCEEEeccCc
Q 013016 225 RSDGHIMLSDFDL 237 (451)
Q Consensus 225 ~~~~~~kl~Dfg~ 237 (451)
+.++.+++...|+
T Consensus 118 ~~~~~p~i~hRGi 130 (219)
T 4ano_A 118 NRALEPFFLHVGV 130 (219)
T ss_dssp CTTCCEEESCCEE
T ss_pred eCCCcEEEEEcCC
Confidence 9999999998886
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=87.89 E-value=3 Score=39.26 Aligned_cols=137 Identities=15% Similarity=0.194 Sum_probs=74.1
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE---
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE--- 157 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~--- 157 (451)
++..++.+-.|..| ||.|.-++. .|+||-.. . ...+.+.-++...-.+.-|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gstg-vff~~td~~-----------~~VVK~s~-~-----l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E 131 (342)
T 1cja_A 70 QFKGIERSEKGTEG-LFFVETESG-----------VFIVKRST-N-----IESETFCSLLCMRLGLHAPKVRVVSSNSEE 131 (342)
T ss_dssp GEEEEEECCSTTSC-EEEEEESSC-----------EEEEECCT-T-----HHHHHHHHHHHHHHTCCCCCEEEEESSSHH
T ss_pred CeeEEEeccCCCCC-eEEEEeCCC-----------EEEEeCcH-H-----HHHHHHHHHHHHHhCCCCCCeeEEeeCcHH
Confidence 47777777777655 555554322 49999552 1 122333334444444555553222110
Q ss_pred -----------E--------EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHH--HHHHHHHHHCC----C
Q 013016 158 -----------F--------EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV--LVALEYLHMLG----I 212 (451)
Q Consensus 158 -----------~--------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qi--l~aL~~LH~~g----i 212 (451)
. ...+..+++|+|.+|..|.++-...-...+... .+.++ +-+++.+..++ +
T Consensus 132 ~~e~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl 207 (342)
T 1cja_A 132 GTNMLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPI 207 (342)
T ss_dssp HHHHHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCS
T ss_pred HHHHHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcc
Confidence 0 012356799999998777654221100113222 23332 34566666553 2
Q ss_pred ee-ccCCCCcEEEccCC-CEEEeccCccc
Q 013016 213 IY-RDLKPENVLVRSDG-HIMLSDFDLSL 239 (451)
Q Consensus 213 vH-~Dlkp~NIll~~~~-~~kl~Dfg~a~ 239 (451)
+. .--.++|||++.++ .+.++|-+.+.
T Consensus 208 ~W~n~GN~~NIL~~~~n~~~~~IDhn~af 236 (342)
T 1cja_A 208 AWTNEGNLDNIMLSERGATVVPIDSKIIP 236 (342)
T ss_dssp SSCSCCCGGGEEEESBTTCEEECSCCCCC
T ss_pred cccCCCChhheEEeCCCCeEEEEcCCccc
Confidence 11 23589999998755 48899999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 451 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-75 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-62 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-45 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-31 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-19 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 8e-75
Identities = 103/348 (29%), Positives = 147/348 (42%), Gaps = 71/348 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF + +G G TV L R YA+K++ K + K+ KV E+
Sbjct: 9 DFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++ LDHPF LY F+ + + G+L K F T RFY AE+
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEI 117
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ ALEYLH GII+RDLKPEN+L+ D HI ++DF +
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA---------------------- 155
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
++ E AR+ SFVGT +YVSPE+ +
Sbjct: 156 -------------------------------KVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
S + D WA G IY+++ G PF A + + I+K F P ARD
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFP-KARD 239
Query: 381 LISGLLNKDPCNRLGSK--RGAADVKTHPFFKGLNFALIRSLTPPEIP 426
L+ LL D RLG + G +K HPFF+ + + + TPP++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 8e-64
Identities = 97/349 (27%), Positives = 162/349 (46%), Gaps = 77/349 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF LH+ +G G G V+L ++++ +A+K + K+V+ V +EK
Sbjct: 3 DFILHKMLGKGSFGKVFLA----EFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 141 KILKM-LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
++L + +HPFL ++ F+ VME+ +GGDL +F L+ A FYAAE
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAE 111
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
+++ L++LH GI+YRDLK +N+L+ DGHI ++D
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIAD------------------------- 146
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
FG K L A++ +F GT +Y++PE+
Sbjct: 147 --------------------FGMCKENMLGD----------AKTNTFCGTPDYIAPEILL 176
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
G + ++VDWW+FG+ +YEM+ G++PF E +I +P A+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE-----AK 231
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
DL+ L ++P RLG D++ HP F+ +N+ + + + PP P
Sbjct: 232 DLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEIDPPFRP 277
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 204 bits (519), Expect = 2e-62
Identities = 79/346 (22%), Positives = 121/346 (34%), Gaps = 72/346 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+D+H +G G G V+ R +A K V K+ V + E
Sbjct: 27 HYDIHEELGTGAFGVVHRV----TERATG-----NNFAAKFVMTPHESDKETVRK---EI 74
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+ + +L HP L L+ FE N ++ EF SGG+L + H + S A Y +V
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQV 133
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L ++H ++ DLKPEN++ + L D
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG---------------------- 171
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
L+ L+ GT E+ +PEVA G
Sbjct: 172 -----------LTAHLDPKQ---------------------SVKVTTGTAEFAAPEVAEG 199
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
G D W+ G+ Y ++ G +PF +++ TLRN+ + S +SE +D
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-DGKD 258
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
I LL DP R+ HP+ N S P
Sbjct: 259 FIRKLLLADPNTRM----TIHQALEHPWLTPGNAPGRDSQIPSSRY 300
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 203 bits (518), Expect = 3e-62
Identities = 95/356 (26%), Positives = 155/356 (43%), Gaps = 75/356 (21%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
LT DF +HR IG G G VY C + + +YAMK ++K+ ++ K+ A
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLA 51
Query: 137 EMEK---KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
E+ ++ D PF+ + F + +++ +GGDLH + H FS
Sbjct: 52 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADM 109
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
RFYAAE+++ LE++H ++YRDLKP N+L+ GH+ +SD L+
Sbjct: 110 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--------------- 154
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
F KK ++A V +
Sbjct: 155 ------------------------CDFSKKKPHASVGTHGYMAPEVLQK----------- 179
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM 373
G ++ ++ DW++ G +++++ G +PF + I + LT + P S
Sbjct: 180 ------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSF 232
Query: 374 SEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIP 426
S R L+ GLL +D RLG RGA +VK PFF+ L++ ++ + PP IP
Sbjct: 233 SP-ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-61
Identities = 78/345 (22%), Positives = 122/345 (35%), Gaps = 79/345 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+++ +G G G VY L A KV++ + ++++ +E
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSV---------LAAAKVIDTK---SEEELEDYMVEI 60
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
IL DHP + L F N I++EFC+GG + ++ + + + + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQT 119
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L AL YLH II+RDLK N+L DG I L+DF
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFG------------------------ 155
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA-- 318
+S R R SF+GT +++PEV
Sbjct: 156 -----------VSAKNTRTI--------------------QRRDSFIGTPYWMAPEVVMC 184
Query: 319 ---SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
+ D W+ GI + EM P + L I K Q PS S
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ-PSRWSS 243
Query: 376 YHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSL 420
+ +D + L K+ R + + HPF + IR L
Sbjct: 244 -NFKDFLKKCLEKNVDARW----TTSQLLQHPFVTVDSNKPIREL 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-60
Identities = 68/331 (20%), Positives = 118/331 (35%), Gaps = 73/331 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D+DL + +G G G V L A+K+V+ + + + E
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAVDCPE--NIKKEI 54
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
I KML+H + Y N + +E+CSGG+L A+ + ++
Sbjct: 55 CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQL 112
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ + YLH +GI +RD+KPEN+L+ ++ +SDF L+
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA---------------------- 150
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+F GT YV+PE+
Sbjct: 151 -------------------------------TVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 321 GS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
H VD W+ GI + M+ G P+ PS+ + K+ T+ +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDS-APL 237
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
L+ +L ++P R+ D+K ++
Sbjct: 238 ALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-59
Identities = 83/335 (24%), Positives = 124/335 (37%), Gaps = 79/335 (23%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
DF++ R +G G G VYL + A+KV+ K LEK H+
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLR 54
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E +I L HP + LY F + +++E+ G ++ K +F Y
Sbjct: 55 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYI 112
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML-SDFDLSLCSNAIPAVESPASSPEA 256
E+ AL Y H +I+RD+KPEN ++L S +L +
Sbjct: 113 TELANALSYCHSKRVIHRDIKPEN--------LLLGSAGELKIAD--------------- 149
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
FG + R + GT +Y+ PE
Sbjct: 150 -----------------------FGWSVHAPSS------------RRTTLCGTLDYLPPE 174
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
+ G H VD W+ G+ YE + G+ PF A + + T + I + TFP
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG---- 230
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411
ARDLIS LL +P R +V HP+
Sbjct: 231 -ARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 6e-59
Identities = 81/365 (22%), Positives = 135/365 (36%), Gaps = 72/365 (19%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+D +G G V L L A+K + K+ LE K+ E E
Sbjct: 10 IYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEG--SMENEI 58
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+L + HP + L +E+ ++M+ SGG+L + ++ A +V
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQV 116
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L A++YLH LGI++RDLKPEN+L S D + + + +E P S
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDE----DSKIMISDFGLSKMEDPGS-------- 164
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+ GT YV+PEV +
Sbjct: 165 -----------------------------------------VLSTACGTPGYVAPEVLAQ 183
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+ AVD W+ G+ Y ++ G PF ++ I+K F + +S+ A+D
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD-SAKD 242
Query: 381 LISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPDQK 440
I L+ KDP R HP+ G + AL +++ +++ Q
Sbjct: 243 FIRHLMEKDPEKRF----TCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQA 297
Query: 441 IKSQS 445
+ +
Sbjct: 298 FNATA 302
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 189 bits (482), Expect = 6e-58
Identities = 67/339 (19%), Positives = 115/339 (33%), Gaps = 73/339 (21%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVL------EKKKK 132
+ +++ +G G V C ++ YA+K+++ E ++
Sbjct: 2 YENYEPKEILGRGVSSVVRRC----IHKPTC-----KEYAVKIIDVTGGGSFSAEEVQEL 52
Query: 133 VHRAEMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLT 191
E IL+ + HP + L +E + F +V + G+L + S
Sbjct: 53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEK 110
Query: 192 SARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
R +L + LH L I++RDLKPEN+L+ D +I L+DF S + +
Sbjct: 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
+P +P
Sbjct: 171 GTPSYLAP--------------------------------------------------EI 180
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
+ +G VD W+ G+ +Y ++ G PF LR I+ F +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
S+ +DL+S L P R A + HPFF+
Sbjct: 241 DYSD-TVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 2e-56
Identities = 71/334 (21%), Positives = 108/334 (32%), Gaps = 80/334 (23%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ F R IG G G VY R + A+K ++ + +K E
Sbjct: 15 KLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+ L+ L HP + + + +VME+C G L + K
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHG 123
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
L L YLH +I+RD+K N+L+ G + L D
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD------------------------- 158
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
FGS I + SFVGT +++PEV
Sbjct: 159 --------------------FGSASIMA--------------PANSFVGTPYWMAPEVIL 184
Query: 320 GGSHGN---AVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
G VD W+ GI E+ + P + + L +I + P SEY
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEY 242
Query: 377 HARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
R+ + L K P +R + + H F
Sbjct: 243 -FRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-56
Identities = 68/368 (18%), Positives = 122/368 (33%), Gaps = 74/368 (20%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+ + + +G G+ G V+ C Y K V K +
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRC-----VETSSKKT----YMAKFVKV----KGTDQVLVKK 50
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E IL + H + L+ FE+ ++ EF SG D+ + + Y
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVH 109
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
+V AL++LH I + D++PEN++ ++ + +
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE---------------------- 147
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
FG + N EY +PEV
Sbjct: 148 ---------------------FGQARQLKPGDNF-----------RLLFTAPEYYAPEVH 175
Query: 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378
A D W+ G +Y ++ G PF A +N+ + NI+ TF ++ +S A
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI-EA 234
Query: 379 RDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTMPFPD 438
D + LL K+ +R+ A++ HP+ K + + + R T+ D
Sbjct: 235 MDFVDRLLVKERKSRM----TASEALQHPWLKQ-KIERVSTKVIRTLKHRRYYHTLIKKD 289
Query: 439 QKIKSQST 446
+ +
Sbjct: 290 LNMVVSAA 297
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (471), Expect = 3e-56
Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 68/320 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++L +G G + V+L R A+KV+ ++ R E
Sbjct: 8 RYELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58
Query: 141 KILKMLDHPFLPTLYAEFEASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
+ L+HP + +Y EA IVME+ G L + H + A
Sbjct: 59 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
A+ AL + H GII+RD+KP N+++ + + + DF ++ ++
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA------------IADS 164
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
+ +QT +GT +Y+SPE
Sbjct: 165 GNSVTQTAA----------------------------------------VIGTAQYLSPE 184
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
A G S D ++ G +YE++ G PF S + V++ P+ +S
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA- 243
Query: 377 HARDLISGLLNKDPCNRLGS 396
++ L K+P NR +
Sbjct: 244 DLDAVVLKALAKNPENRYQT 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-56
Identities = 76/350 (21%), Positives = 128/350 (36%), Gaps = 73/350 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK---VHRAE 137
+D +G+G V C R YA K + K + ++ E
Sbjct: 11 YYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E ILK + HP + TL+ +E +++E +GG+L + + + A +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFL 119
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L + YLH L I + DLKPEN+++
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRN----------------------------- 150
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
+ + F + KI + GT E+V+PE+
Sbjct: 151 -----------VPKPRIKIIDFGLAHKIDFGN------------EFKNIFGTPEFVAPEI 187
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ G D W+ G+ Y ++ G +PF + + TL N+ F + S+ S
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA-L 246
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF--ALIRSLTPPEI 425
A+D I LL KDP R+ D HP+ K + AL + + P+
Sbjct: 247 AKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-54
Identities = 61/320 (19%), Positives = 116/320 (36%), Gaps = 74/320 (23%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
+ +RIG+G GTVY + A+K++N +++ +
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGKWHGDV------------AVKMLNVTAP-TPQQLQAFKN 53
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +L+ H + + + IV ++C G L+ H +F + A
Sbjct: 54 EVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIAR 111
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
+ ++YLH II+RDLK N+ + D + + DF
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF----------------------- 148
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
L+ +R+ GS + + G+ +++PEV
Sbjct: 149 ------------GLATVKSRWSGSHQFEQ------------------LSGSILWMAPEVI 178
Query: 319 SG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS--PSSM 373
+ D +AFGI +YE++ G+ P++ +N + +V + P S S+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 374 SEYHARDLISGLLNKDPCNR 393
+ + L++ L K R
Sbjct: 239 PK-AMKRLMAECLKKKRDER 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-54
Identities = 65/337 (19%), Positives = 115/337 (34%), Gaps = 82/337 (24%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D+++ IG G G + + D + K ++ + + +K E
Sbjct: 5 DYEVLYTIGTGSYGRCQKI----RRKSDG-----KILVWKELDYGSMTEAEK-QMLVSEV 54
Query: 141 KILKMLDHPFLPTLYAEF--EASNFSCIVMEFCSGGDLHSL--RHKQPHKRFSLTSARFY 196
+L+ L HP + Y + IVME+C GGDL S+ + + +
Sbjct: 55 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 114
Query: 197 AAEVLVALEYLHMLG-----IIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPA 251
++ +AL+ H +++RDLKP NV + ++ L D
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD----------------- 157
Query: 252 SSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311
FG +I + +FVGT
Sbjct: 158 ----------------------------FGLARILNHDTSFAK----------AFVGTPY 179
Query: 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
Y+SPE + S+ D W+ G +YE+ PF A S + I + P
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PY 236
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPF 408
S+ ++I+ +LN +R ++ +P
Sbjct: 237 RYSD-ELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-53
Identities = 62/338 (18%), Positives = 119/338 (35%), Gaps = 83/338 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R IG G TVY + A + L K ++ R + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVE---------VAWCELQDRKLTKSER-QRFKEE 58
Query: 140 KKILKMLDHPFLPTLYAEFEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
++LK L HP + Y +E++ +V E + G L + + K + R
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRS 116
Query: 196 YAAEVLVALEYLHMLG--IIYRDLKPENVLVRS-DGHIMLSDFDLSLCSNAIPAVESPAS 252
+ ++L L++LH II+RDLK +N+ + G + + D
Sbjct: 117 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD------------------ 158
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
G ++ + + + +GT E+
Sbjct: 159 ---------------------------LGLATLKRASFAK------------AVIGTPEF 179
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
++PE+ + +VD +AFG+ + EM P++ N + V + + +
Sbjct: 180 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
+ E +++I G + ++ R D+ H FF+
Sbjct: 239 IPE--VKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-52
Identities = 101/353 (28%), Positives = 150/353 (42%), Gaps = 74/353 (20%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+T DFD + +G G G V L R YAMK++ KEV+ K +V
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHT 52
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ++L+ HPFL L F+ + C VME+ +GG+L + + F+ ARFY
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFY 110
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
AE++ ALEYLH ++YRD ++ + ++ D + +
Sbjct: 111 GAEIVSALEYLHSRDVVYRD-------IKLENLMLDKDGHIKITD--------------- 148
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
FG K + +F GT EY++PE
Sbjct: 149 -----------------------FGLCKEGISDGATM----------KTFCGTPEYLAPE 175
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
V +G AVDWW G+ +YEM+ GR PF +E I+ + + FP
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE---- 231
Query: 377 HARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFKGLNFALI--RSLTPPEIP 426
A+ L++GLL KDP RLG A +V H FF +N+ + + L PP P
Sbjct: 232 -AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-50
Identities = 58/333 (17%), Positives = 116/333 (34%), Gaps = 77/333 (23%)
Query: 86 RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM 145
+ +G+G+ GTV K + A+K++ E + K E +++
Sbjct: 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALK-DELLAEANVMQQ 64
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
LD+P++ + EA ++ +VME G L+ + ++ + +V + ++
Sbjct: 65 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMK 121
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYT 265
YL ++RDL NVL+ + + +SDF LS
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLS--------------------------- 154
Query: 266 RQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGN 325
+ + + ++ +PE + +
Sbjct: 155 ------------KALRADENYYKA-------------QTHGKWPVKWYAPECINYYKFSS 189
Query: 326 AVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHARDLIS 383
D W+FG+ ++E YG+ P+ + K + + P P M DL++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-----YDLMN 244
Query: 384 GLLNKDPCNRLGSKRGAADVKT---HPFFKGLN 413
D NR G A V+ + ++ +N
Sbjct: 245 LCWTYDVENRP----GFAAVELRLRNYYYDVVN 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-50
Identities = 67/375 (17%), Positives = 124/375 (33%), Gaps = 90/375 (24%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ +G G G V ++ + +A+K++ + +A E ++
Sbjct: 16 TSQVLGLGINGKVLQI----FNKRTQ-----EKFALKML--------QDCPKARREVELH 58
Query: 144 -KMLDHPFLPTLYAEFEAS----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
+ P + + +E IVME GG+L S + + F+ A
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDFDLSLCSNAIPAVESPASSPE 255
+ A++YLH + I +RD+KPEN+L S + + L+DF + +
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------KETTS 166
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
S + YT Y V+P
Sbjct: 167 HNSLTTPCYTPYY--------------------------------------------VAP 182
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTL----RNIVKKPLTFPTQSPS 371
EV + + D W+ G+ +Y ++ G PF + I FP S
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQ 431
+SE + LI LL +P R+ + HP+ L + ++
Sbjct: 243 EVSE-EVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 432 KTMPFPDQKIKSQST 446
+ ++ + +T
Sbjct: 298 RWEDVKEEMTSALAT 312
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-49
Identities = 58/315 (18%), Positives = 97/315 (30%), Gaps = 64/315 (20%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+D L ++G G G V + + A+K + +VL + + + E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTV------SVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+ LDH L LY +V E G L K F L + YA +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQ 119
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
V + YL I+RDL N+L+ + + + DF L
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM--------------------- 158
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
R + + +PE
Sbjct: 159 ------------------RALPQNDDHYVM-------------QEHRKVPFAWCAPESLK 187
Query: 320 GGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378
+ +A D W FG+ ++EM YG+ P+ + L I K+ P P +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCPQ-DI 244
Query: 379 RDLISGLLNKDPCNR 393
+++ P +R
Sbjct: 245 YNVMVQCWAHKPEDR 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 8e-49
Identities = 64/335 (19%), Positives = 112/335 (33%), Gaps = 66/335 (19%)
Query: 61 FAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMK 120
F + A + + + IGAG+ G V + A+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG------HLKLPGKREIFVAIK 60
Query: 121 VVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLR 180
+ EK+++ E I+ DHP + L S I+ EF G L S
Sbjct: 61 TLKSGYTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 118
Query: 181 HKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240
+ +F++ + ++YL + ++RDL N+LV S+ +SDF LS
Sbjct: 119 RQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-- 175
Query: 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300
RF ++P
Sbjct: 176 -------------------------------------RFLEDDT-----------SDPTY 187
Query: 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIV 359
+ + +PE +A D W++GI ++E++ YG P+ +N+ + I
Sbjct: 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247
Query: 360 KKP-LTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ L P PS++ L+ KD +R
Sbjct: 248 QDYRLPPPMDCPSAL-----HQLMLDCWQKDRNHR 277
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 56/316 (17%), Positives = 99/316 (31%), Gaps = 76/316 (24%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+D + +G G G V +Y A+K++ + + + E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYD----------VAIKMIKEGSMSED----EFIEE 49
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
K++ L H L LY I+ E+ + G L + + RF +
Sbjct: 50 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKD 108
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
V A+EYL ++RDL N LV G + +SDF LS
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS--------------------- 147
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
R+ + + + PEV
Sbjct: 148 ------------------RYVLDDEYTSSV---------------GSKFPVRWSPPEVLM 174
Query: 320 GGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYH 377
+ D WAFG+ ++E+ G+ P+ +N T +I + L P + +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV---- 230
Query: 378 ARDLISGLLNKDPCNR 393
++ ++ R
Sbjct: 231 -YTIMYSCWHEKADER 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 8e-48
Identities = 54/308 (17%), Positives = 108/308 (35%), Gaps = 70/308 (22%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD 147
+G G+ G+V + +Q A+KV+ + +K E +I+ LD
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGT--EKADTEEMMREAQIMHQLD 67
Query: 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYL 207
+P++ L +A +VME GG LH + + +++ +V + ++YL
Sbjct: 68 NPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL 125
Query: 208 HMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQ 267
++RDL NVL+ + + +SDF LS
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLS----------------------------- 156
Query: 268 YSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAV 327
+ G+ + ++ +PE + +
Sbjct: 157 ----------KALGADDSYYTA-------------RSAGKWPLKWYAPECINFRKFSSRS 193
Query: 328 DWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHARDLISGL 385
D W++G+ ++E + YG+ P+ + I + K + P + P + L+S
Sbjct: 194 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL-----YALMSDC 248
Query: 386 LNKDPCNR 393
+R
Sbjct: 249 WIYKWEDR 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 9e-48
Identities = 50/358 (13%), Positives = 107/358 (29%), Gaps = 85/358 (23%)
Query: 59 SDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYA 118
+++ Y R + K + + + +G+G G V A
Sbjct: 16 NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVA 71
Query: 119 MKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLH 177
+K++ ++ +++ E K++ L H + L S ++ E+C GDL
Sbjct: 72 VKMLKEKADSSERE--ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 178 SLRHKQPHK---------------------RFSLTSARFYAAEVLVALEYLHMLGIIYRD 216
+ + K + +A +V +E+L ++RD
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189
Query: 217 LKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFL 276
L NVLV + + DF L+
Sbjct: 190 LAARNVLVTHGKVVKICDFGLA-------------------------------------- 211
Query: 277 NRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFI 336
R +++ + ++++PE G + D W++GI +
Sbjct: 212 ---------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 337 YEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+E+ G P+ + +++ P +E ++ D R
Sbjct: 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMD--QPFYATE-EIYIIMQSCWAFDSRKR 311
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-46
Identities = 65/352 (18%), Positives = 108/352 (30%), Gaps = 88/352 (25%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
L ++G G G V++ + N R A+K + + +
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSPE----AFLQ 61
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E +++K L H L LYA IV E+ S G L + K L AA
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ + Y+ + ++RDL+ N+LV + ++DF L+
Sbjct: 121 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-------------------- 160
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
R + ++ +PE A
Sbjct: 161 -------------------RLIEDNEYTARQ---------------GAKFPIKWTAPEAA 186
Query: 319 SGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
G D W+FGI + E+ GR P+ N L + + + P E
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE-S 242
Query: 378 ARDLISGLLNKDPCNRLGSKRGAADVKT--HPFFKGLNFALIRSLTPPEIPG 427
DL+ K+P R ++ +F S P PG
Sbjct: 243 LHDLMCQCWRKEPEERP----TFEYLQAFLEDYFT--------STEPQYQPG 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 54/316 (17%), Positives = 101/316 (31%), Gaps = 74/316 (23%)
Query: 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM 138
L R+GAG G V++ N A+K + + +
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGH----------TKVAVKSLKQGSMSPD----AFLA 57
Query: 139 EKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAA 198
E ++K L H L LYA I+ E+ G L + ++ AA
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 199 EVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAAS 258
++ + ++ I+RDL+ N+LV ++DF L+
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-------------------- 156
Query: 259 PRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318
R + ++ +PE
Sbjct: 157 -------------------RLIEDNEYTARE---------------GAKFPIKWTAPEAI 182
Query: 319 SGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377
+ G+ D W+FGI + E++ +GR P+ +N ++N+ + + P + E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPE-E 238
Query: 378 ARDLISGLLNKDPCNR 393
L+ + P +R
Sbjct: 239 LYQLMRLCWKERPEDR 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-46
Identities = 65/339 (19%), Positives = 113/339 (33%), Gaps = 89/339 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVH---RAE 137
+ + +G+G G+VY R A+K V K+ + ++ R
Sbjct: 5 QYQVGPLLGSGGFGSVYSG-----IRVSDNLP----VAIKHVEKDRISDWGELPNGTRVP 55
Query: 138 MEKKILKMLD--HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
ME +LK + + L FE + +++E + AR
Sbjct: 56 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARS 114
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLV-RSDGHIMLSDFDLSLCSNAIPAVESPASSP 254
+ +VL A+ + H G+++RD+K EN+L+ + G + L D
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID-------------------- 154
Query: 255 EAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314
FGS + T F GT Y
Sbjct: 155 -------------------------FGSGALLKDTVY------------TDFDGTRVYSP 177
Query: 315 PEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM 373
PE HG + W+ GI +Y+M+ G PF I++ + F + S
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE- 230
Query: 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ LI L P +R +++ HP+ + +
Sbjct: 231 ----CQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-45
Identities = 68/334 (20%), Positives = 109/334 (32%), Gaps = 36/334 (10%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
DF+ +GAG+ G V+ S + A K+++ E+ K ++ E
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEI--KPAIRNQIIREL 55
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++L + P++ Y F + I ME GG L + K R + V
Sbjct: 56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAV 113
Query: 201 LVALEYLH-MLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASP 259
+ L YL I++RD+KP N+LV S G I L DF +S S + SP
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSP 172
Query: 260 RSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319
+ YS + + G ++ E
Sbjct: 173 E-RLQGTHYSVQSDIWS---MGLSLVEMAVGRYPIPPP----------DAKELELMFGCQ 218
Query: 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379
YG + L IV +P P + PS + +
Sbjct: 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQ 275
Query: 380 DLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
D ++ L K+P R + H F K +
Sbjct: 276 DFVNKCLIKNPAERA----DLKQLMVHAFIKRSD 305
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 73/366 (19%), Positives = 115/366 (31%), Gaps = 103/366 (28%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++ +IG G G V+ ++R+ A+K V E EK+ A E
Sbjct: 11 KYEKLAKIGQGTFGEVFKA----RHRKTG-----QKVALKKVLME-NEKEGFPITALREI 60
Query: 141 KILKMLDHPFLPTLY--------AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
KIL++L H + L +V +FC +F+L+
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL--LSNVLVKFTLSE 118
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ +L L Y+H I++RD+K NVL+ DG + L+DF L+
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------- 164
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
R F K + V T Y
Sbjct: 165 -------------------------RAFSLAKNSQPNRY------------TNRVVTLWY 187
Query: 313 VSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
PE+ G +G +D W G + EM + + L I + + +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 372 SMSEY---------------------------HARDLISGLLNKDPCNRLGSKRGAADVK 404
++ Y +A DLI LL DP R+ + D
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDAL 303
Query: 405 THPFFK 410
H FF
Sbjct: 304 NHDFFW 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 6e-44
Identities = 52/337 (15%), Positives = 99/337 (29%), Gaps = 88/337 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + R IG G G V+ + A+K++ +E + + E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM----VAVKMLKEEASADMQA--DFQREA 67
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH--------------- 185
++ D+P + L C++ E+ + GDL+
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 186 -------KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
S A +V + YL ++RDL N LV + + ++DF LS
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298
R +
Sbjct: 188 -----------------------------------------------------RNIYSAD 194
Query: 299 VAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRN 357
+ ++ PE + D WA+G+ ++E+ YG P+ ++E +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 358 IVK-KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ L P P + +L+ +K P +R
Sbjct: 255 VRDGNILACPENCPLEL-----YNLMRLCWSKLPADR 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-43
Identities = 64/315 (20%), Positives = 108/315 (34%), Gaps = 71/315 (22%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+L R IG G G V+ P A+K + ++ + E
Sbjct: 8 RIELGRCIGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEA 59
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++ DHP + L N I+ME C+ G+L S + L S YA ++
Sbjct: 60 LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 117
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
AL YL ++RD+ NVLV S+ + L DF
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF------------------------- 152
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
LSR++ + ++ ++++PE +
Sbjct: 153 ----------GLSRYME-------------------DSTYYKASKGKLPIKWMAPESINF 183
Query: 321 GSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHA 378
+A D W FG+ ++E++ +G PF N + I + L P P ++
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 379 RDLISGLLNKDPCNR 393
L++ DP R
Sbjct: 239 YSLMTKCWAYDPSRR 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 6e-43
Identities = 52/317 (16%), Positives = 97/317 (30%), Gaps = 70/317 (22%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
+ D + ++G G G VY A+K + ++ +E +
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDTMEVE----EF 60
Query: 137 EMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFY 196
E ++K + HP L L I+ EF + G+L + + S +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120
Query: 197 AAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEA 256
A ++ A+EYL I+RDL N LV + + ++DF LS
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS------------------ 162
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
R ++ +PE
Sbjct: 163 ---------------------RLMTGDTYTAHA---------------GAKFPIKWTAPE 186
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
+ D WAFG+ ++E+ + + + +++K P E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--RPEGCPE- 243
Query: 377 HARDLISGLLNKDPCNR 393
+L+ +P +R
Sbjct: 244 KVYELMRACWQWNPSDR 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-42
Identities = 49/331 (14%), Positives = 101/331 (30%), Gaps = 80/331 (24%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ +GAG G V + + D A+K++ +++ E
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMT----VAVKMLKPSAHLTERE--ALMSEL 77
Query: 141 KILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ---------------- 183
K+L L +H + L + ++ E+C GDL + ++
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 184 PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNA 243
L ++ +V + +L I+RDL N+L+ + DF L+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA----- 192
Query: 244 IPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARS 303
R +
Sbjct: 193 ------------------------------------------------RDIKNDSNYVVK 204
Query: 304 CSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKP 362
+ ++++PE + D W++GIF++E+ G +P+ ++ ++K+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
Query: 363 LTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
SP D++ + DP R
Sbjct: 265 FRML--SPEHAPA-EMYDIMKTCWDADPLKR 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 4e-42
Identities = 64/354 (18%), Positives = 106/354 (29%), Gaps = 95/354 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ +IG G G VY N +A+K + E E + E
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG----------ETFALKKIRLEK-EDEGIPSTTIREI 51
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
ILK L H + LY +V E L +A+ + ++
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQL 109
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L + Y H +++RDLKP+N+L+ +G + ++DF L+
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI----------------- 152
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+K + A V S
Sbjct: 153 --------------------PVRKYTHEIVTLWYRAPDVLMGS----------------- 175
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH--- 377
+ +D W+ G EM+ G F S L I + T +++ +++E
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 378 ---------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
DL+S +L DP R+ A H +FK
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 69/357 (19%), Positives = 110/357 (30%), Gaps = 93/357 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F +IG G G VY R + A+K + + E + A E
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDT-ETEGVPSTAIREI 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+LK L+HP + L N +V EF DL L + Y ++
Sbjct: 53 SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L L + H +++RDLKP+N+L+ ++G I L+DF L+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------- 154
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+ + A + +
Sbjct: 155 --------------------PVRTYTHEVVTLWYRAPEI-----------------LLGC 177
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH--- 377
+ AVD W+ G EM+ R F S L I + T ++
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 378 ---------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
R L+S +L+ DP R+ A HPFF+ +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-41
Identities = 58/345 (16%), Positives = 108/345 (31%), Gaps = 74/345 (21%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ R +G G G VY + + A+K VN+ +++ E
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEAS- 75
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKR--------FSLTS 192
++K + + L + ++ME + GDL S SL+
Sbjct: 76 -VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
A E+ + YL+ ++RDL N +V D + + DF +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM--------------- 179
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
R + + +
Sbjct: 180 --------------------------------------TRDIYETDYYRKGGKGLLPVRW 201
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPLTFPTQSPS 371
+SPE G D W+FG+ ++E+ P+ SNE LR +++ L P
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK---PD 258
Query: 372 SMSEYHARDLISGLLNKDPCNRLGSKRGAADVK--THPFFKGLNF 414
+ + +L+ +P R + +K P F+ ++F
Sbjct: 259 NCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-41
Identities = 61/390 (15%), Positives = 111/390 (28%), Gaps = 101/390 (25%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ IG G G V N + A+K ++ E + R E K
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVR---------VAIKKISPF--EHQTYCQRTLREIK 58
Query: 142 ILKMLDHPFLPTLYAEFEASNFS----CIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
IL H + + A ++ G DL+ L Q S ++
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFL 115
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAA 257
++L L+Y+H +++RDLKP N+L+ + + + DF
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG--------------------- 154
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
L+R + +V T Y +PE+
Sbjct: 155 --------------LARVADP-----------------DHDHTGFLTEYVATRWYRAPEI 183
Query: 318 ASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376
+ ++D W+ G + EM+ R F L +I+ + + + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 377 H--------------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
A DL+ +L +P R+ HP+ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLE 299
Query: 411 GLNFALIRSLTPPEIPGMRRQKTMPFPDQK 440
+ +P K
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 8e-41
Identities = 56/336 (16%), Positives = 107/336 (31%), Gaps = 72/336 (21%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ L R+IG+G G +YL G E A+K+ K K + +E K
Sbjct: 9 YRLGRKIGSGSFGDIYLG-----TDIAAGEE----VAIKLECV-----KTKHPQLHIESK 54
Query: 142 ILKMLDHP-FLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
I KM+ +PT+ +++ +VME ++FSL + A ++
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQM 112
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGH---IMLSDFDLSLCSNAIPAVESPASSPEAA 257
+ +EY+H I+RD+KP+N L+ + + DF L+
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA------------------- 153
Query: 258 SPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317
+ + + P R + + GT Y S
Sbjct: 154 --------------------KKYRDARTHQHIPYR---------ENKNLTGTARYASINT 184
Query: 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK---KPLTFPTQSPSSMS 374
G D + G + G P+ T + + K ++ P +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFK 410
++ + ++ + + F +
Sbjct: 245 PSEFATYLNFCRSLRFDDKP-DYSYLRQLFRNLFHR 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-40
Identities = 46/313 (14%), Positives = 101/313 (32%), Gaps = 65/313 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+F + +G+G GTVY G + A+K + + K K E
Sbjct: 10 EFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANK--EILDEA 62
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
++ +D+P + L S ++ + G L + + ++
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI 120
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
+ YL +++RDL NVLV++ H+ ++DF L+
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA---------------------- 158
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
+L AE + ++++ E
Sbjct: 159 -------------------------------KLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+ + D W++G+ ++E++ + + + +I++K P P +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--QPPICTI-DVYM 244
Query: 381 LISGLLNKDPCNR 393
++ D +R
Sbjct: 245 IMVKCWMIDADSR 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 53/313 (16%), Positives = 92/313 (29%), Gaps = 63/313 (20%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ IGAG+ G VY L + A+K + EK++ E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLK-----TSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEA 60
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
I+ H + L I+ E+ G L ++ FS+ +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGI 119
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
++YL + ++RDL N+LV S+ +SDF LS
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS---------------------- 157
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
R T T + + +PE S
Sbjct: 158 -----------------RVLEDDPEATYT-------------TSGGKIPIRWTAPEAISY 187
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380
+A D W+FGI ++E++ + + + P +P
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--TPMDCPS-AIYQ 244
Query: 381 LISGLLNKDPCNR 393
L+ ++ R
Sbjct: 245 LMMQCWQQERARR 257
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 60/357 (16%), Positives = 109/357 (30%), Gaps = 95/357 (26%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++ +IG G GTV+ + + A+K V + + + A E
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDD-DDEGVPSSALREI 52
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+LK L H + L+ + +V EFC + + + ++
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQL 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPR 260
L L + H +++RDLKP+N+L+ +G + L++
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLAN-------------------------- 144
Query: 261 SQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320
FG + PV S V +
Sbjct: 145 -------------------FGLARA---------FGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 321 GSHGNAVDWWAFGIFIYEMIYGRTP-FAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH-- 377
+ ++D W+ G E+ P F + L+ I + T + SM++
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 378 ----------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
RDL+ LL +P R+ A + HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDF 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 54/333 (16%), Positives = 105/333 (31%), Gaps = 77/333 (23%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
L L + +G G G V L + A+K++ + EK
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR--VTKVAVKMLKSDATEKDLS--DL 65
Query: 137 EMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQ------------ 183
E +++KM+ H + L +++E+ S G+L +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 184 --PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
P ++ S A +V +EYL I+RDL NVLV D + ++DF L+
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA--- 182
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
R
Sbjct: 183 --------------------------------------------------RDIHHIDYYK 192
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK 360
++ + ++++PE + + D W+FG+ ++E+ G +P+ E + + +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
PS+ + ++ + P R
Sbjct: 253 GH---RMDKPSNCTN-ELYMMMRDCWHAVPSQR 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-38
Identities = 45/313 (14%), Positives = 102/313 (32%), Gaps = 68/313 (21%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKIL 143
+ IG G G VY +L + + A+K +N+ +V + E I+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKI------HCAVKSLNRI--TDIGEVSQFLTEGIIM 82
Query: 144 KMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLV 202
K HP + +L + +V+ + GDL + + H ++ + +V
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAK 141
Query: 203 ALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQ 262
+++L ++RDL N ++ + ++DF L+
Sbjct: 142 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------------------------ 177
Query: 263 TYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGS 322
R K+ ++ ++++ E
Sbjct: 178 ---------------RDMYDKEFDSVH------------NKTGAKLPVKWMALESLQTQK 210
Query: 323 HGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHARD 380
D W+FG+ ++E++ G P+ + +++ + L P P + +
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL-----YE 265
Query: 381 LISGLLNKDPCNR 393
++ + R
Sbjct: 266 VMLKCWHPKAEMR 278
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-38
Identities = 76/390 (19%), Positives = 126/390 (32%), Gaps = 118/390 (30%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + + IG+G G V Y A+K +++ + + RA E
Sbjct: 17 KRYQNLKPIGSGAQGIVCAA-----YDAVLDRN----VAIKKLSRP-FQNQTHAKRAYRE 66
Query: 140 KKILKMLDHPFLPTLYAEF------EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
++K ++H + +L F E +VME ++ + H+R
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER-----M 121
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASS 253
+ ++L +++LH GII+RDLKP N++V+SD + + DF L+
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 166
Query: 254 PEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313
+ S T TR Y
Sbjct: 167 --RTAGTSFMMTPYVVTR---------------------------------------YYR 185
Query: 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK------------- 360
+PEV G + VD W+ G + EM+ + F +++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 361 --------------KPLTFPTQSPSSMSEYH----------ARDLISGLLNKDPCNRLGS 396
LTFP P S+ ARDL+S +L DP R+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-- 303
Query: 397 KRGAADVKTHPFFKGLNFALIRSLTPPEIP 426
D HP+ PP+I
Sbjct: 304 --SVDDALQHPYINVWYDPAEVEAPPPQIY 331
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-37
Identities = 67/373 (17%), Positives = 116/373 (31%), Gaps = 108/373 (28%)
Query: 74 KTGLTFRD-FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK 132
KT R + + +G+G G V A+K + + + +
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRP-FQSELF 60
Query: 133 VHRAEMEKKILKMLDHPFLPTLYAEFEASNFS------CIVMEFCSGGDLHSLRHKQPHK 186
RA E ++LK + H + L F +VM F ++H+
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---- 116
Query: 187 RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPA 246
+ +F ++L L Y+H GII+RDLKP N+ V D + + DF L+
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------- 168
Query: 247 VESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSF 306
++ R + A
Sbjct: 169 --------------------------------RQADSEMTGYVVTRWYRAPE-------- 188
Query: 307 VGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP 366
+ + + VD W+ G + EMI G+T F + L+ I+K T P
Sbjct: 189 ---------VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 367 TQSPSSMSEYH--------------------------ARDLISGLLNKDPCNRLGSKRGA 400
+ + A +L+ +L D R+ A
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV----TA 295
Query: 401 ADVKTHPFFKGLN 413
+ HP+F+ L+
Sbjct: 296 GEALAHPYFESLH 308
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 2e-37
Identities = 47/322 (14%), Positives = 92/322 (28%), Gaps = 75/322 (23%)
Query: 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKK 141
+ + RRIG G G ++ + A+K + + + E +
Sbjct: 7 YKVGRRIGEGSFGVIFEG-----TNLLNNQQ----VAIKFEPR-----RSDAPQLRDEYR 52
Query: 142 ILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
K+L +P +Y + + +V++ G ++FS+ + A ++
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQM 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRS-----DGHIMLSDFDLSLCSNAIPAVESPASSPE 255
L ++ +H ++YRD+KP+N L+ I + DF
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG------------------- 151
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
+ +F + I + GT Y+S
Sbjct: 152 ----------------MVKFYRDPVTKQHIPY-------------REKKNLSGTARYMSI 182
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK----KPLTFPTQSPS 371
G D A G + G P+ T + + K T + +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 372 SMSEYHARDLISGLLNKDPCNR 393
E + N
Sbjct: 243 GFPE-EFYKYMHYARNLAFDAT 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 4e-37
Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 15/188 (7%)
Query: 74 KTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKV 133
K G + +D+ +G+G G V+ C + G + K +N K V
Sbjct: 23 KQGSVYDYYDILEELGSGAFGVVHRC-----VEKATGRV----FVAKFINTPYPLDKYTV 73
Query: 134 HRAEMEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSA 193
E I+ L HP L L+ FE +++EF SGG+L + + + S
Sbjct: 74 KN---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEV 129
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDFDLSLCSNAIPAVESPA 251
Y + L+++H I++ D+KPEN++ + + + DF L+ N V+
Sbjct: 130 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189
Query: 252 SSPEAASP 259
++ E A+P
Sbjct: 190 ATAEFAAP 197
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 110 bits (275), Expect = 2e-27
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 5/146 (3%)
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKK 361
T E+ +PE+ G D WA G+ Y ++ G +PFA + TL+N+ +
Sbjct: 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243
Query: 362 PLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLT 421
F + SS+S A+D I LL K+P RL D HP+ KG + L +
Sbjct: 244 DWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHSNLTSRIP 298
Query: 422 PPEIPGMRRQKTMPFPDQKIKSQSTA 447
+R++ + D +
Sbjct: 299 SSRYNKIRQKIKEKYADWPAPQPAIG 324
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-36
Identities = 46/329 (13%), Positives = 101/329 (30%), Gaps = 77/329 (23%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
L + +G G G V + A+K++ + + + +E K
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRT----VAVKMLKEGATHSEHRALMSE-LK 68
Query: 141 KILKMLDHPFLPTL-YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHK------------- 186
++ + H + L A + +++EFC G+L + + ++
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 187 -RFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIP 245
+L Y+ +V +E+L I+RDL N+L+ + + DF L+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------- 181
Query: 246 AVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCS 305
R +P R
Sbjct: 182 ----------------------------------------------RDIYKDPDYVRKGD 195
Query: 306 FVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLT 364
++++PE + D W+FG+ ++E+ +P+ + +K+
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+P + + + +P R
Sbjct: 256 MR--APDYTTP-EMYQTMLDCWHGEPSQR 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-36
Identities = 56/350 (16%), Positives = 103/350 (29%), Gaps = 104/350 (29%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
R L IG G G V+ + A+K+ + ++++ E E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE-----------EVAVKIFSS----REERSWFREAE 47
Query: 140 KKILKMLDHPFLPTLYAEFEASNFS----CIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
ML H + A N + +V ++ G L ++ ++
Sbjct: 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIK 104
Query: 196 YAAEVLVALEYLHM--------LGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAV 247
A L +LHM I +RDLK +N+LV+ +G ++D L
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL---------- 154
Query: 248 ESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307
+ R + T + V
Sbjct: 155 ----------AVRHDSATDTIDIAPNH-------------------------------RV 173
Query: 308 GTHEYVSPEVASGGSHGN------AVDWWAFGIFIYEMIYGRTPF--------------- 346
GT Y++PEV + D +A G+ +E+ +
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 347 AAPSNETTLRNIVKKPL--TFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394
+ PS E + + ++ L P + S + ++ + RL
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 65/340 (19%), Positives = 118/340 (34%), Gaps = 56/340 (16%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
++ IG G G V+ + ++ G A+K V + E+ + E
Sbjct: 8 QYECVAEIGEGAYGKVFKA----RDLKNGGR----FVALKRVRVQTGEEGMPL-STIREV 58
Query: 141 KILKML---DHPFLPTLYAEFEASNFS-----CIVMEFCSGGDLHSLRHKQPHKRFSLTS 192
+L+ L +HP + L+ S +V E + K P +
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTET 117
Query: 193 ARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPAS 252
+ ++L L++LH +++RDLKP+N+LV S G I L+DF L+ + A+ S
Sbjct: 118 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
+ +P Y+T + + G + LF
Sbjct: 178 TLWYRAPE-VLLQSSYATPVDLW---SVGCIFAEMFRRKPLF------------------ 215
Query: 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSS 372
G S + + I ++I P + R P + +
Sbjct: 216 ------RGSSDVDQLGK------ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 263
Query: 373 MSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412
+ +DL+ L +P R+ A +HP+F+ L
Sbjct: 264 DIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDL 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 7e-35
Identities = 62/374 (16%), Positives = 117/374 (31%), Gaps = 105/374 (28%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ +G+G G+V + G A+K +++ + R E
Sbjct: 19 RYQNLSPVGSGAYGSVCAA-----FDTKTGLR----VAVKKLSRP-FQSIIHAKRTYREL 68
Query: 141 KILKMLDHPFLPTLYAEFEASNF-----SCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
++LK + H + L F + ++ G DL+++ Q + + +F
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQF 125
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPE 255
++L L+Y+H II+RDLKP N+ V D + + DF L+ ++
Sbjct: 126 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------------- 172
Query: 256 AASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315
++ R + A +
Sbjct: 173 ---------------------------DEMTGYVATRWYRAPEIMLNWM----------- 194
Query: 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSE 375
+ VD W+ G + E++ GRT F + L+ I++ T + +S
Sbjct: 195 ------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 376 YH--------------------------ARDLISGLLNKDPCNRLGSKRGAADVKTHPFF 409
A DL+ +L D R+ AA H +F
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYF 304
Query: 410 KGLNFALIRSLTPP 423
+ + P
Sbjct: 305 AQYHDPDDEPVADP 318
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 7e-35
Identities = 67/339 (19%), Positives = 117/339 (34%), Gaps = 54/339 (15%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
D+ L R++G G V+ + +K++ K K + + E
Sbjct: 36 DYQLVRKLGRGKYSEVFEA-----INITNNEK----VVVKIL------KPVKKKKIKREI 80
Query: 141 KILKML-DHPFLPTLYAEFE--ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
KIL+ L P + TL + S +V E + D L ++ + RFY
Sbjct: 81 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYM 135
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSDFDLSLCSNAIPAVESPASSPEA 256
E+L AL+Y H +GI++RD+KP NV++ + + L D+ L+ + +S
Sbjct: 136 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195
Query: 257 ASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316
P + Y L + +A + + F G Y
Sbjct: 196 KGPELLVDYQMYDYSLD--------------MWSLGCMLASMIFRKEPFFHGHDNY---- 237
Query: 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--FPTQSPSSMS 374
+ +Y+ I P L +K +++ +S
Sbjct: 238 -----DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413
A D + LL D +RL A + HP+F +
Sbjct: 293 P-EALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVV 326
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 2e-34
Identities = 61/161 (37%), Positives = 94/161 (58%), Gaps = 11/161 (6%)
Query: 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAE 137
+ +DF + R +G G G V+L R YAMKV+ KE++ + K+V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTN 52
Query: 138 MEKKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYA 197
E+ +L ++ HPF+ ++ F+ + ++M++ GG+L SL +RF A+FYA
Sbjct: 53 DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYA 110
Query: 198 AEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
AEV +ALEYLH IIYRDLKPEN+L+ +GHI ++DF +
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 3e-27
Identities = 46/125 (36%), Positives = 68/125 (54%), Gaps = 8/125 (6%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+ GT +Y++PEV S + ++DWW+FGI IYEM+ G TPF + T I+ L
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 219
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFKGLNFA--LIRSLT 421
FP +DL+S L+ +D RLG+ + G DVK HP+FK + + L R++
Sbjct: 220 FPPFFNED-----VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274
Query: 422 PPEIP 426
P P
Sbjct: 275 TPYEP 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-33
Identities = 48/333 (14%), Positives = 101/333 (30%), Gaps = 85/333 (25%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
L + D IG G+ G V + + A+K + + + +
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKA-------RIKKDGLRMDAAIKRMKEYASKDDHR--DF 57
Query: 137 EMEKKILKML-DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH---------- 185
E ++L L HP + L E + + +E+ G+L K
Sbjct: 58 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 186 ----KRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241
S +AA+V ++YL I+RDL +I++ +
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR--------NILVGE------- 162
Query: 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301
Y +++ F L + V
Sbjct: 163 -------------------------NYVAKIADF----------------GLSRGQEVYV 181
Query: 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVK 360
+ +++ E + + D W++G+ ++E++ G TP+ + + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ + P + + DL+ + P R
Sbjct: 242 G---YRLEKPLNCDD-EVYDLMRQCWREKPYER 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-33
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEME 139
+ + +IG G GTVY G E A++ +N + KK+ + E
Sbjct: 20 KKYTRFEKIGQGASGTVYTA-----MDVATGQE----VAIRQMNLQQQPKKELIIN---E 67
Query: 140 KKILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAE 199
+++ +P + + + +VME+ +GG L + + E
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRE 124
Query: 200 VLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
L ALE+LH +I+RD+K +N+L+ DG + L+DF
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 7e-24
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 8/118 (6%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT 364
+ VGT +++PEV + ++G VD W+ GI EMI G P+ + L I T
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-T 233
Query: 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422
Q+P +S RD ++ L+ D R A ++ H F K + SLTP
Sbjct: 234 PELQNPEKLSA-IFRDFLNRCLDMDVEKRG----SAKELLQHQFLKIAKP--LSSLTP 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 70/376 (18%), Positives = 121/376 (32%), Gaps = 68/376 (18%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + IG G G VY L + L A+K V ++ K + E
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDKRFKNR-------EL 64
Query: 141 KILKMLDHPFLPTLYAEFEASN------FSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSA 193
+I++ LDH + L F +S + +V+++ RH + + +
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 194 RFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM-LSDFDLSLCSNAIPAVESPAS 252
+ Y ++ +L Y+H GI +RD+KP+N+L+ D ++ L DF + S
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 253 SPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312
S +P Y++ + + G + L +F
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWS---AGCVLAELLLGQPIF------------------ 223
Query: 313 VSPEVASGGSHGNAVD--WWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP 370
G S + + G E I P ++ + P P
Sbjct: 224 ------PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP 277
Query: 371 SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRR 430
A L S LL P RL + H FF L ++ + P
Sbjct: 278 ------EAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTP---- 323
Query: 431 QKTMPFPDQKIKSQST 446
F Q++ S
Sbjct: 324 -ALFNFTTQELSSNPP 338
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-33
Identities = 37/160 (23%), Positives = 56/160 (35%), Gaps = 17/160 (10%)
Query: 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRA 136
L ++ L + IG G+ G V L A+K + +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKND-----ATAQAF 47
Query: 137 EMEKKILKMLDHPFLPTLY-AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARF 195
E ++ L H L L E IV E+ + G L +
Sbjct: 48 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107
Query: 196 YAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235
++ +V A+EYL ++RDL NVLV D +SDF
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (172), Expect = 3e-14
Identities = 15/90 (16%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 305 SFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMI-YGRTPFAAPSNETTLRNIVKKPL 363
+ ++ +PE D W+FGI ++E+ +GR P+ + + + K
Sbjct: 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-- 216
Query: 364 TFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ +P +++ + D R
Sbjct: 217 -YKMDAPDGCPP-AVYEVMKNCWHLDAAMR 244
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 62/338 (18%), Positives = 102/338 (30%), Gaps = 50/338 (14%)
Query: 88 IGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKK--VHRAEMEKKILKM 145
+G G TVY N + + A+K + + K A E K+L+
Sbjct: 6 LGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQE 56
Query: 146 LDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALE 205
L HP + L F + +V +F ++ + + + Y L LE
Sbjct: 57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLE 114
Query: 206 YLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS-LCSNAIPAVESPASSPEAASPRSQTY 264
YLH I++RDLKP N+L+ +G + L+DF L+ + A + +P
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 265 TRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHG 324
R Y + + G + L G
Sbjct: 175 ARMYGVGVDMW---AVGCILAELLLRVPFL----------------------------PG 203
Query: 325 NAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISG 384
++ IF + + P S+ + DLI G
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD-DLLDLIQG 262
Query: 385 LLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTP 422
L +PC R+ A +F P
Sbjct: 263 LFLFNPCARI----TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 1e-32
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 42 PTSKSSPENLSLKPHRSSDFAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSL 101
+K E S+K + ++ + FD + +G G G V L
Sbjct: 4 AAAKKGSEQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV-- 60
Query: 102 NNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161
+ E YAMK+++K+ + K K++ EK+IL+ ++ PFL L F+ +
Sbjct: 61 -------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221
+ +VME+ +GG++ S + RFS ARFYAA++++ EYLH L +IYRDLKPEN
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 222 VLVRSDGHIMLSDFDLS 238
+L+ G+I ++DF +
Sbjct: 172 LLIDQQGYIQVTDFGFA 188
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 1e-24
Identities = 45/135 (33%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 295 VAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETT 354
A+ V R+ + GT E ++PE+ + AVDWWA G+ IYEM G PF A
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 355 LRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR-GAADVKTHPFFKGLN 413
IV + FP+ S +DL+ LL D R G+ + G D+K H +F +
Sbjct: 247 YEKIVSGKVRFPSHFSSD-----LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 414 FALI--RSLTPPEIP 426
+ I R + P IP
Sbjct: 302 WIAIYQRKVEAPFIP 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-32
Identities = 61/176 (34%), Positives = 105/176 (59%), Gaps = 11/176 (6%)
Query: 66 IRSATF-GRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNK 124
+R+A G + +F+L + +G G G V+L R+ GH+ LYAMKV+ K
Sbjct: 9 LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLV------RKISGHDTGKLYAMKVLKK 62
Query: 125 E-VLEKKKKVHRAEMEKKILKMLDH-PFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHK 182
+++K K E+++L+ + PFL TL+ F+ +++++ +GG+L + +
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122
Query: 183 QPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
+RF+ + Y E+++ALE+LH LGIIYRD+K EN+L+ S+GH++L+DF LS
Sbjct: 123 --RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 46/129 (35%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 303 SCSFVGTHEYVSPEVASGG--SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK 360
+ F GT EY++P++ GG H AVDWW+ G+ +YE++ G +PF + + I +
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
Query: 361 KPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-KRGAADVKTHPFFKGLNFALI-- 417
+ L P MS A+DLI LL KDP RLG R A ++K H FF+ +N+ +
Sbjct: 247 RILKSEPPYPQEMSA-LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305
Query: 418 RSLTPPEIP 426
+ + P P
Sbjct: 306 KKVPAPFKP 314
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-31
Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 15/157 (9%)
Query: 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140
+ + IG+G G V+L NK + A+K + + + ++ + E
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDK----------VAIKTIREGAMSEEDFIE----EA 51
Query: 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEV 200
+++ L HP L LY C+V EF G L Q F+ + +V
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDV 110
Query: 201 LVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237
+ YL +I+RDL N LV + I +SDF +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (166), Expect = 2e-13
Identities = 18/100 (18%), Positives = 37/100 (37%), Gaps = 3/100 (3%)
Query: 294 FVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET 353
FV + S ++ SPEV S + + D W+FG+ ++E+ + +
Sbjct: 150 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 354 TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393
+ + P S H +++ + P +R
Sbjct: 210 EVVEDISTGFRLY--KPRLAST-HVYQIMNHCWKERPEDR 246
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 3e-25
Identities = 74/428 (17%), Positives = 132/428 (30%), Gaps = 133/428 (31%)
Query: 76 GLTFRD--FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKV 133
G ++D + L R++G G TV+L K + AMK+V + K
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLA----KDMVNN-----THVAMKIVRGD----KVYT 53
Query: 134 HRAEMEKKILKMLDHPFLPTL-------------YAEFEASNFSCIVMEFCSGGDLH-SL 179
AE E K+L+ ++ + + N +VM F G+ +L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 180 RHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDLS 238
K H+ L + + ++L+ L+Y+H GII+ D+KPENV
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV---------------- 157
Query: 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298
+ + + + L A
Sbjct: 158 ------------------------------------LMEIVDSPENLIQIKIADLGNACW 181
Query: 299 VAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI 358
+ + T EY SPEV G G D W+ I+E+I G F + ++
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 359 --------------------------------------------VKKPLTFPTQSPSSMS 374
++ LT + +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEIPGMRRQKTM 434
+ D +S +L DP R A + HP+ K + + + P+ +
Sbjct: 302 K-EISDFLSPMLQLDPRKRA----DAGGLVNHPWLK--DTLGMEEIRVPDRELYGSGSDI 354
Query: 435 PFPDQKIK 442
P ++++
Sbjct: 355 PGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 7e-19
Identities = 32/215 (14%), Positives = 67/215 (31%), Gaps = 54/215 (25%)
Query: 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK--- 140
+ + +G G V+ C ++ E +K KK + +
Sbjct: 4 IGKLMGEGKESAVFNC------YSEKFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHF 53
Query: 141 ------------KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRF 188
+ L+ L +P +YA + ++ME + R
Sbjct: 54 SVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELI---------DAKELYRV 100
Query: 189 SLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVE 248
+ + +L + + GI++ DL NVLV S+ I + DF S+
Sbjct: 101 RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV--------- 150
Query: 249 SPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSK 283
E + + + + +R + ++
Sbjct: 151 ------EVGEEGWREILERDVRNIITYFSRTYRTE 179
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 451 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.05 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-64 Score=476.81 Aligned_cols=274 Identities=37% Similarity=0.622 Sum_probs=240.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+.+|++++++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 689999999999999999999987765 49999999876666666778889999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccce
Confidence 999999999999999999988765 569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... .......+.+||+.|||||++.
T Consensus 157 ~~~~~-----------------------------------------------------~~~~~~~~~~GT~~Y~APE~~~ 183 (288)
T d1uu3a_ 157 VLSPE-----------------------------------------------------SKQARANSFVGTAQYVSPELLT 183 (288)
T ss_dssp ECC---------------------------------------------------------------CCCCGGGCCHHHHH
T ss_pred ecccC-----------------------------------------------------CcccccccccCCccccCceeec
Confidence 43211 0111223458999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..|+.++|||||||++|+|++|+.||.+.+..+.+.++......++... +.++++||++||+.||.+|||
T Consensus 184 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~~li~~~L~~dP~~R~t---- 254 (288)
T d1uu3a_ 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF-----FPKARDLVEKLLVLDATKRLG---- 254 (288)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTC-----CHHHHHHHHTTSCSSGGGSTT----
T ss_pred cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccC-----CHHHHHHHHHHccCCHhHCcC----
Confidence 99999999999999999999999999999999999999998877665432 338999999999999999999
Q ss_pred hHH------HHcCCCcCCCCcccccccCCCCCC
Q 013016 400 AAD------VKTHPFFKGLNFALIRSLTPPEIP 426 (451)
Q Consensus 400 ~~e------ll~hp~~~~~~~~~~~~~~~~~~p 426 (451)
++| +++||||++++|..+....||.+|
T Consensus 255 ~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 255 CEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp SGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 665 689999999999999888888887
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-62 Score=476.49 Aligned_cols=284 Identities=38% Similarity=0.691 Sum_probs=249.5
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+++++|++++.||+|+||+||+|+++.+++ .||||++.+...........+.+|+.+|++++||||+++++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~---------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 72 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence 456899999999999999999999987765 49999999887666666777888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
+|.+.+++|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 73 ~~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 73 AFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred eeccccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 999999999999999999999998875 559999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|+.... .......++||+.|||||
T Consensus 151 ~a~~~~~-------------------------------------------------------~~~~~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 151 LCKEGIS-------------------------------------------------------DGATMKTFCGTPEYLAPE 175 (337)
T ss_dssp TCBCSCC-------------------------------------------------------TTCCBCCCEECGGGCCGG
T ss_pred ccccccc-------------------------------------------------------CCcccccceeCHHHhhhh
Confidence 9853211 011223468999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+..+.+.+|... +.++++||++||++||.+|++.
T Consensus 176 ~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL-----SPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS-----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred hccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccC-----CHHHHHHHHhhccCCchhhccc
Confidence 99999999999999999999999999999999999999999999887766543 3389999999999999999964
Q ss_pred CC-ChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 397 KR-GAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 397 ~~-~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
.+ .++|+++||||++++|..+ +.+.||.+|....+
T Consensus 251 ~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~ 288 (337)
T d1o6la_ 251 GPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 288 (337)
T ss_dssp STTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSST
T ss_pred ccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCCh
Confidence 32 2899999999999999754 67788888877654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-62 Score=460.56 Aligned_cols=257 Identities=33% Similarity=0.573 Sum_probs=229.7
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.+.||+|+||+||+|+++.+++ .||+|++.+...........+.+|+.++++++|||||+++++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~ 74 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKF---------ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 74 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCc---------EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 35889999999999999999999987765 499999988766666666778889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+.+++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 75 ~~~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 75 FHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EEECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccce
Confidence 99999999999999999999998865 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|..... ......+||+.|||||+
T Consensus 153 a~~~~~---------------------------------------------------------~~~~~~~Gt~~Y~APE~ 175 (263)
T d2j4za1 153 SVHAPS---------------------------------------------------------SRRTTLCGTLDYLPPEM 175 (263)
T ss_dssp CSCCCC---------------------------------------------------------CCCEETTEEGGGCCHHH
T ss_pred eeecCC---------------------------------------------------------CcccccCCCCcccCHHH
Confidence 843210 11123479999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+....+|.. .+.++++||.+||+.||++|||
T Consensus 176 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~~li~~~L~~dp~~R~t-- 248 (263)
T d2j4za1 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-----VTEGARDLISRLLKHNPSQRPM-- 248 (263)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-----SCHHHHHHHHHHTCSSGGGSCC--
T ss_pred HcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc-----CCHHHHHHHHHHccCCHhHCcC--
Confidence 999999999999999999999999999999998899999998887766543 3348999999999999999999
Q ss_pred CChHHHHcCCCcCC
Q 013016 398 RGAADVKTHPFFKG 411 (451)
Q Consensus 398 ~~~~ell~hp~~~~ 411 (451)
++|+|+||||++
T Consensus 249 --~~eil~hp~~~~ 260 (263)
T d2j4za1 249 --LREVLEHPWITA 260 (263)
T ss_dssp --HHHHHTCHHHHH
T ss_pred --HHHHHcCcCcCC
Confidence 999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-61 Score=464.18 Aligned_cols=278 Identities=38% Similarity=0.738 Sum_probs=243.2
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
+++|+++++||+|+||+||+|+++.+++ .||||++.+.........+.+.+|+.++++++|||||++++++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~---------~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 73 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCC---------EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE
Confidence 4789999999999999999999987665 4999999987766666677888999999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++++|+|||||.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus 74 ~~~~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 74 QDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeCCeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccc
Confidence 9999999999999999999988875 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+.... ...+.+||+.|||||++
T Consensus 152 ~~~~~----------------------------------------------------------~~~~~~Gt~~Y~APE~l 173 (316)
T d1fota_ 152 KYVPD----------------------------------------------------------VTYTLCGTPDYIAPEVV 173 (316)
T ss_dssp EECSS----------------------------------------------------------CBCCCCSCTTTCCHHHH
T ss_pred eEecc----------------------------------------------------------ccccccCcccccCHHHH
Confidence 53221 11235899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC-C
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS-K 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~-~ 397 (451)
.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++..+...++... +.++.++|.+||++||.+|++. .
T Consensus 174 ~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~~li~~~L~~dp~~R~~~~r 248 (316)
T d1fota_ 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF-----NEDVKDLLSRLITRDLSQRLGNLQ 248 (316)
T ss_dssp TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTS-----CHHHHHHHHHHTCSCTTTCTTSST
T ss_pred cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHHhhhCHHhccccch
Confidence 999999999999999999999999999999999999999998876665432 3389999999999999999732 1
Q ss_pred CChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 398 RGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 398 ~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
..+++||+||||++++|..+ +...+|.+|....
T Consensus 249 ~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~ 283 (316)
T d1fota_ 249 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQ 283 (316)
T ss_dssp TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC--
T ss_pred hhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCC
Confidence 12999999999999999854 6777888886543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-60 Score=467.69 Aligned_cols=284 Identities=35% Similarity=0.633 Sum_probs=247.5
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccce
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTL 154 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l 154 (451)
....+++|+++++||+|+||+||+|+++.+++ .||||++.+.........+.+.+|+.+|+.++|||||++
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~---------~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~ 106 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN---------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCC---------EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeec
Confidence 33456899999999999999999999987765 499999988766666667788899999999999999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++...+.+++||||+.||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|
T Consensus 107 ~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeee
Confidence 99999999999999999999999988775 4599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|+.... ...+.+||+.|||
T Consensus 185 FG~a~~~~~----------------------------------------------------------~~~~~~Gt~~Y~A 206 (350)
T d1rdqe_ 185 FGFAKRVKG----------------------------------------------------------RTWTLCGTPEALA 206 (350)
T ss_dssp CTTCEECSS----------------------------------------------------------CBCCCEECGGGCC
T ss_pred ceeeeeccc----------------------------------------------------------ccccccCccccCC
Confidence 999853221 1123589999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
||++.+..|+.++|||||||++|+|+||+.||.+.+....+.++..+...++... +.++.+||++||++||.+|+
T Consensus 207 PE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-----s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-----SSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTC-----CHHHHHHHHHHSCSCTTTCT
T ss_pred HHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccC-----CHHHHHHHHHHhhhCHHhcc
Confidence 9999999999999999999999999999999999998999999988877665432 33899999999999999995
Q ss_pred C-CCCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCCCC
Q 013016 395 G-SKRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRRQK 432 (451)
Q Consensus 395 t-~~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~~ 432 (451)
. ..+.++||++||||++++|..+ +.+.+|++|....+.
T Consensus 282 ~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~ 322 (350)
T d1rdqe_ 282 GNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPG 322 (350)
T ss_dssp TSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTT
T ss_pred ccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcc
Confidence 1 1222999999999999999754 667888899877543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-61 Score=452.70 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=212.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|+++.+++ .||||++...... ...+.+.+|+.++++++|||||++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~ 73 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---------AVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRR 73 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 789999999999999999999987765 4999999765322 23356778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 74 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 74 EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999999999999998654 569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ..........+||+.|||||++.
T Consensus 152 ~~~~-----------------------------------------------------~~~~~~~~~~~GT~~Y~APE~~~ 178 (271)
T d1nvra_ 152 VFRY-----------------------------------------------------NNRERLLNKMCGTLPYVAPELLK 178 (271)
T ss_dssp ECEE-----------------------------------------------------TTEECCBCCCCSCGGGSCTHHHH
T ss_pred eecc-----------------------------------------------------CCccccccceeeCcCccCHhHhc
Confidence 3211 00111223458999999999998
Q ss_pred CCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 320 GGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 320 ~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
+..+ +.++|||||||++|||++|+.||....... .+..+.......+. +. ..+.++.+||.+||+.||++|||
T Consensus 179 ~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~--~~-~~s~~~~~li~~~L~~dP~~R~t-- 253 (271)
T d1nvra_ 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WK-KIDSAPLALLHKILVENPSARIT-- 253 (271)
T ss_dssp CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT--GG-GSCHHHHHHHHHHSCSSTTTSCC--
T ss_pred CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc--cc-cCCHHHHHHHHHHcCCChhHCcC--
Confidence 8776 678999999999999999999998765443 33333333222111 12 23348999999999999999999
Q ss_pred CChHHHHcCCCcCC
Q 013016 398 RGAADVKTHPFFKG 411 (451)
Q Consensus 398 ~~~~ell~hp~~~~ 411 (451)
++|+|+||||++
T Consensus 254 --~~eil~hpwf~~ 265 (271)
T d1nvra_ 254 --IPDIKKDRWYNK 265 (271)
T ss_dssp --HHHHTTCTTTTC
T ss_pred --HHHHhcCHhhCc
Confidence 999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=459.69 Aligned_cols=277 Identities=34% Similarity=0.719 Sum_probs=233.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHH-HCCCCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILK-MLDHPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~nIv~l~~~~ 158 (451)
++|++.+.||+|+||+||+|.++.+++ .||||++.+...........+..|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~---------~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCC---------EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 689999999999999999999987765 49999998876555555566667777765 68999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++++|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchh
Confidence 9999999999999999999999875 55999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+..... .......+||+.|+|||++
T Consensus 151 ~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~~ 175 (320)
T d1xjda_ 151 KENMLG-------------------------------------------------------DAKTNTFCGTPDYIAPEIL 175 (320)
T ss_dssp BCCCCT-------------------------------------------------------TCCBCCCCSCGGGCCHHHH
T ss_pred hhcccc-------------------------------------------------------cccccccCCCCCcCCHHHH
Confidence 532210 1111234799999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++..+.+.++.. .+.++.+||++||++||++||+
T Consensus 176 ~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~-----~s~~~~dli~~~L~~dP~~R~s--- 247 (320)
T d1xjda_ 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEKEAKDLLVKLFVREPEKRLG--- 247 (320)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHSCSSGGGSBT---
T ss_pred cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc-----CCHHHHHHHHHhcccCCCCCcC---
Confidence 99999999999999999999999999999999999999998887665543 2348999999999999999999
Q ss_pred ChH-HHHcCCCcCCCCcccc--cccCCCCCCCCCCC
Q 013016 399 GAA-DVKTHPFFKGLNFALI--RSLTPPEIPGMRRQ 431 (451)
Q Consensus 399 ~~~-ell~hp~~~~~~~~~~--~~~~~~~~p~~~~~ 431 (451)
+. +|++||||++++|..+ +...||..|...++
T Consensus 248 -~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~ 282 (320)
T d1xjda_ 248 -VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP 282 (320)
T ss_dssp -TBSCGGGSGGGTTCCHHHHHTTCSCC---------
T ss_pred -HHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCc
Confidence 85 8999999999999754 66677888877664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=448.07 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=219.0
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|.++.+++ .||||++..... ...+.+.+|+.++++++|||||+++++|.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 87 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQ---------EVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYL 87 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCC---------EEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCC---------EEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence 579999999999999999999887665 499999976532 23456778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 99999999999999999998876 359999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... .......+||+.|||||++.
T Consensus 165 ~~~~~-------------------------------------------------------~~~~~~~~gt~~Y~aPE~~~ 189 (293)
T d1yhwa1 165 QITPE-------------------------------------------------------QSKRSTMVGTPYWMAPEVVT 189 (293)
T ss_dssp ECCST-------------------------------------------------------TCCBCCCCSCGGGCCHHHHS
T ss_pred eeccc-------------------------------------------------------cccccccccCCCccChhhhc
Confidence 33210 11122348999999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRG 399 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~ 399 (451)
+..|+.++|||||||++|+|++|+.||.+.+..+.+..+........ ..+ ...+.++++||.+||+.||.+|||
T Consensus 190 ~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~-~~~s~~~~~li~~~L~~dP~~R~s---- 263 (293)
T d1yhwa1 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNP-EKLSAIFRDFLNRCLDMDVEKRGS---- 263 (293)
T ss_dssp SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSG-GGSCHHHHHHHHHHTCSSTTTSCC----
T ss_pred CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCc-ccCCHHHHHHHHHHccCChhHCcC----
Confidence 99999999999999999999999999998888777776665432211 111 223448999999999999999999
Q ss_pred hHHHHcCCCcCC
Q 013016 400 AADVKTHPFFKG 411 (451)
Q Consensus 400 ~~ell~hp~~~~ 411 (451)
+.|+|+||||+.
T Consensus 264 ~~eil~Hp~~~~ 275 (293)
T d1yhwa1 264 AKELLQHQFLKI 275 (293)
T ss_dssp HHHHTTCGGGGG
T ss_pred HHHHhcCHhhCC
Confidence 999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-59 Score=451.64 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=213.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|++.+.||+|+||+||+|+++.+++ .||||++.+..... ....+.+|+.++++++|||||++++++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQK---------LVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCC---------EEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCC---------EEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 569999999999999999999887665 49999998664432 2355678999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc---cCCCEEEeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR---SDGHIMLSDFD 236 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg 236 (451)
+++++|||||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence 999999999999999999999764 5699999999999999999999999999999999999995 47899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|+.... .....+.+||+.|||||
T Consensus 156 ~a~~~~~--------------------------------------------------------~~~~~~~~GT~~y~APE 179 (307)
T d1a06a_ 156 LSKMEDP--------------------------------------------------------GSVLSTACGTPGYVAPE 179 (307)
T ss_dssp -------------------------------------------------------------------------CTTSCHH
T ss_pred eeEEccC--------------------------------------------------------CCeeeeeeeCccccCcH
Confidence 9853211 01112358999999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
++.+..|+.++|||||||++|+|++|+.||.+....+....+......++....+...+ ++++||.+||++||++|||
T Consensus 180 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~R~s- 257 (307)
T d1a06a_ 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD-SAKDFIRHLMEKDPEKRFT- 257 (307)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH-HHHHHHHHHSCSSGGGSCC-
T ss_pred HHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH-HHHHHHHHHccCCHhHCcC-
Confidence 99999999999999999999999999999999988899999998877766655555544 8999999999999999999
Q ss_pred CCChHHHHcCCCcCC
Q 013016 397 KRGAADVKTHPFFKG 411 (451)
Q Consensus 397 ~~~~~ell~hp~~~~ 411 (451)
+.|+|+||||++
T Consensus 258 ---~~eil~hp~~~~ 269 (307)
T d1a06a_ 258 ---CEQALQHPWIAG 269 (307)
T ss_dssp ---HHHHHHSTTTTS
T ss_pred ---HHHHhcCHhhCC
Confidence 999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.9e-59 Score=457.23 Aligned_cols=280 Identities=33% Similarity=0.607 Sum_probs=228.3
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHH---HHHHHHHCCCCCccce
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEM---EKKILKMLDHPFLPTL 154 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~nIv~l 154 (451)
++++|++.++||+|+||+||+|+++.+++ .||||++.+...........+.+ ++.+++.++|||||++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~---------~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l 72 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 72 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCC---------EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEE
Confidence 46899999999999999999999987765 49999998766544433333333 4666777789999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
+++|.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 73 ~~~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 73 SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEee
Confidence 99999999999999999999999999775 5589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|..... ......+||+.|||
T Consensus 151 FGla~~~~~---------------------------------------------------------~~~~~~~GT~~y~A 173 (364)
T d1omwa3 151 LGLACDFSK---------------------------------------------------------KKPHASVGTHGYMA 173 (364)
T ss_dssp CTTCEECSS---------------------------------------------------------SCCCSCCSCGGGCC
T ss_pred eceeeecCC---------------------------------------------------------Ccccccccccccch
Confidence 999853221 11123479999999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNET---TLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
||++.+ ..|+.++|||||||+||||+||+.||....... ....+......++. . .+.++++||.+||++||
T Consensus 174 PE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----~-~s~~~~~li~~~L~~dP 248 (364)
T d1omwa3 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----S-FSPELRSLLEGLLQRDV 248 (364)
T ss_dssp HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS----S-SCHHHHHHHHHHTCSST
T ss_pred hHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC----C-CCHHHHHHHHHHcccCH
Confidence 999975 568999999999999999999999998754332 23333333333332 2 33489999999999999
Q ss_pred CCcCCC-CCChHHHHcCCCcCCCCcccc--cccCCCCCCCCCC
Q 013016 391 CNRLGS-KRGAADVKTHPFFKGLNFALI--RSLTPPEIPGMRR 430 (451)
Q Consensus 391 ~~Rpt~-~~~~~ell~hp~~~~~~~~~~--~~~~~~~~p~~~~ 430 (451)
++|||. ...++||++||||++++|..+ +...+|.+|....
T Consensus 249 ~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~ 291 (364)
T d1omwa3 249 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291 (364)
T ss_dssp TTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-
T ss_pred HHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCC
Confidence 999994 344799999999999999754 6778888886664
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-59 Score=454.75 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=229.0
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.++||+|+||+||+|+++.+++ .||||++.+.... ..+.+.+|+.+|++++|||||+++++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~---------~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~ 91 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGN---------NFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDA 91 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTE---------EEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34789999999999999999999987765 4999999765332 34567789999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc--CCCEEEecc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS--DGHIMLSDF 235 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~--~~~~kl~Df 235 (451)
+.+++++|||||||+||+|.+++... .+.+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+||
T Consensus 92 ~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 92 FEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999999999988654 345999999999999999999999999999999999999964 578999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|...... ....+.+||+.||||
T Consensus 171 G~a~~~~~~--------------------------------------------------------~~~~~~~gT~~Y~aP 194 (350)
T d1koaa2 171 GLTAHLDPK--------------------------------------------------------QSVKVTTGTAEFAAP 194 (350)
T ss_dssp TTCEECCTT--------------------------------------------------------SCEEEECSCTTTCCH
T ss_pred chheecccc--------------------------------------------------------cccceecCcccccCH
Confidence 998533210 111235899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++......+.+ ++++||.+||+.||++|||
T Consensus 195 Ev~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH-HHHHHHHHHCCSSGGGSCC
T ss_pred HHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH-HHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999988877666544443334 8999999999999999999
Q ss_pred CCCChHHHHcCCCcCCCCccc
Q 013016 396 SKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~~~~~ 416 (451)
++|||+||||++.++..
T Consensus 274 ----~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 274 ----IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp ----HHHHHHSTTTSCTTCCS
T ss_pred ----HHHHhcCcccCCCCCCC
Confidence 99999999999876643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-59 Score=445.97 Aligned_cols=265 Identities=27% Similarity=0.428 Sum_probs=225.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHH---HHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKK---KKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
++|++.+.||+|+||+||+|+++.+++ .||||++.+...... ...+.+.+|+.+|++++|||||++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGL---------QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 569999999999999999999987765 499999976533221 12456788999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC----CEEE
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG----HIML 232 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~----~~kl 232 (451)
+|.+.+++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 999999999999999999999999775 4699999999999999999999999999999999999999776 5999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||+|...... .......||+.|
T Consensus 159 ~DfG~a~~~~~~--------------------------------------------------------~~~~~~~~t~~y 182 (293)
T d1jksa_ 159 IDFGLAHKIDFG--------------------------------------------------------NEFKNIFGTPEF 182 (293)
T ss_dssp CCCTTCEECTTS--------------------------------------------------------CBCSCCCCCGGG
T ss_pred cchhhhhhcCCC--------------------------------------------------------ccccccCCCCcc
Confidence 999998533211 111234789999
Q ss_pred cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 313 VSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 313 ~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
||||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++....+.. +.++++||++||+.||.+
T Consensus 183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~ 261 (293)
T d1jksa_ 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SALAKDFIRRLLVKDPKK 261 (293)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS-CHHHHHHHHTTSCSSGGG
T ss_pred cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC-CHHHHHHHHHHccCChhH
Confidence 9999999989999999999999999999999999999999999999888766654433333 338999999999999999
Q ss_pred cCCCCCChHHHHcCCCcCCCCccc
Q 013016 393 RLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
||| ++|+|+||||++.++..
T Consensus 262 R~s----~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 262 RMT----IQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp SCC----HHHHHHSTTTCC-----
T ss_pred CcC----HHHHhcCcccCCCChhH
Confidence 999 99999999999977653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-59 Score=445.32 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=220.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|++.++||+|+||+||+|+++.+++ .||||++.+.. ....+.+.+|++++++++|||||++++++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 79 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSV---------LAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFY 79 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCe---------EEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 469999999999999999999987765 49999997542 234566778999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++.+|||||||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 80 ~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 80 YENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 999999999999999999987654 2459999999999999999999999999999999999999999999999999984
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
.... ......+.+||+.|||||++.
T Consensus 159 ~~~~-------------------------------------------------------~~~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 159 KNTR-------------------------------------------------------TIQRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp ECHH-------------------------------------------------------HHHHHTCCCSCCTTCCHHHHT
T ss_pred ccCC-------------------------------------------------------CcccccccccccccCCHHHHh
Confidence 2110 001122458999999999984
Q ss_pred -----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 320 -----GGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 320 -----~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
+..|+.++|||||||++|||++|+.||.+.+..+.+.++..+...... .+...+.++++||.+||+.||++||
T Consensus 184 ~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~ 261 (288)
T d2jfla1 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA--QPSRWSSNFKDFLKKCLEKNVDARW 261 (288)
T ss_dssp TCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS--SGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred hcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--ccccCCHHHHHHHHHHccCChhHCc
Confidence 455789999999999999999999999998888888888876543221 1223445899999999999999999
Q ss_pred CCCCChHHHHcCCCcCCC
Q 013016 395 GSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 395 t~~~~~~ell~hp~~~~~ 412 (451)
| +.|||+||||+..
T Consensus 262 t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 262 T----TSQLLQHPFVTVD 275 (288)
T ss_dssp C----HHHHTTSGGGCCC
T ss_pred C----HHHHhcCcccCCC
Confidence 9 9999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-58 Score=451.58 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=228.1
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|+++++||+|+||+||+|+++.+++ .||||++.+.... ....+.+|+.+|++++|||||+++++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~ 94 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGR---------VFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDA 94 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34789999999999999999999887765 4999999765332 23456779999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEc--cCCCEEEecc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVR--SDGHIMLSDF 235 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~--~~~~~kl~Df 235 (451)
|.+++++|||||||+||+|.+++... ..++++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus 95 ~~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 95 FEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEECCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeec
Confidence 99999999999999999998877554 34699999999999999999999999999999999999998 5789999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|...... .......||+.||||
T Consensus 174 Gla~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aP 197 (352)
T d1koba_ 174 GLATKLNPD--------------------------------------------------------EIVKVTTATAEFAAP 197 (352)
T ss_dssp TTCEECCTT--------------------------------------------------------SCEEEECSSGGGCCH
T ss_pred ccceecCCC--------------------------------------------------------CceeeccCcccccCH
Confidence 998533210 111234799999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..|+.++|||||||++|+|+||+.||.+....+.+..+......++......+.+ ++.+||.+||++||.+|||
T Consensus 198 E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH-HHHHHHHTTSCSSGGGSCC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH-HHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999999887777665555555 8999999999999999999
Q ss_pred CCCChHHHHcCCCcCCC
Q 013016 396 SKRGAADVKTHPFFKGL 412 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~~ 412 (451)
+.|+|+||||++.
T Consensus 277 ----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 277 ----VHDALEHPWLKGD 289 (352)
T ss_dssp ----HHHHHTSTTTSSC
T ss_pred ----HHHHhcCHhhCCC
Confidence 9999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-59 Score=438.49 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=210.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|+++.+++ .||||++...... ....+.+.+|++++++++|||||++++++.
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 73 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---------ILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRII 73 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCC---------EEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 789999999999999999999987765 4999999765432 334567888999999999999999999986
Q ss_pred e--CCeEEEEEeeccCCchhhhhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeccCCCCcEEEccCCCE
Q 013016 160 A--SNFSCIVMEFCSGGDLHSLRHKQ--PHKRFSLTSARFYAAEVLVALEYLHMLG-----IIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 160 ~--~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~g-----ivH~Dlkp~NIll~~~~~~ 230 (451)
+ ++.+|||||||+||+|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v 153 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence 4 56789999999999999988643 2456999999999999999999999876 9999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||+|+..... .......+||+
T Consensus 154 kl~DFG~a~~~~~~-------------------------------------------------------~~~~~~~~gt~ 178 (269)
T d2java1 154 KLGDFGLARILNHD-------------------------------------------------------TSFAKAFVGTP 178 (269)
T ss_dssp EECCHHHHHHC------------------------------------------------------------------CCC
T ss_pred EEeeccceeecccC-------------------------------------------------------CCccccCCCCc
Confidence 99999998543210 01112358999
Q ss_pred CccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 311 EYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 311 ~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+..+..... + ...+.++.+||.+||+.||
T Consensus 179 ~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~-~~~s~~l~~li~~~L~~dp 254 (269)
T d2java1 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P-YRYSDELNEIITRMLNLKD 254 (269)
T ss_dssp SCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C-TTSCHHHHHHHHHHTCSSG
T ss_pred ccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C-cccCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999999999999888888888887754322 1 1234489999999999999
Q ss_pred CCcCCCCCChHHHHcCCCc
Q 013016 391 CNRLGSKRGAADVKTHPFF 409 (451)
Q Consensus 391 ~~Rpt~~~~~~ell~hp~~ 409 (451)
.+||| +.|||+|||+
T Consensus 255 ~~Rps----~~ell~hp~i 269 (269)
T d2java1 255 YHRPS----VEEILENPLI 269 (269)
T ss_dssp GGSCC----HHHHHTSTTC
T ss_pred hHCcC----HHHHHhCCcC
Confidence 99999 9999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-58 Score=444.05 Aligned_cols=254 Identities=25% Similarity=0.342 Sum_probs=220.6
Q ss_pred CceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 81 DFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 81 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
.|+++++||+|+||+||+|+++.+++ .||||++.+.........+.+.+|+.++++++|||||++++++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCc---------EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 49999999999999999999887765 499999986654555666778899999999999999999999999
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
++++|||||||.||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred CCEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 99999999999999998766554 5699999999999999999999999999999999999999999999999999842
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
.. .....+||+.|||||++.+
T Consensus 165 ~~-----------------------------------------------------------~~~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 165 MA-----------------------------------------------------------PANSFVGTPYWMAPEVILA 185 (309)
T ss_dssp SS-----------------------------------------------------------SBCCCCSCGGGCCHHHHTT
T ss_pred cC-----------------------------------------------------------CCCccccCccccCHHHHhc
Confidence 11 0113479999999999865
Q ss_pred ---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 321 ---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 321 ---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
..|+.++|||||||++|||++|+.||.+....+.+..+..+...... +...+.++++||.+||+.||.+|||
T Consensus 186 ~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt-- 260 (309)
T d1u5ra_ 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPT-- 260 (309)
T ss_dssp TTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC---CCCCCHHHHHHHHHHCcCChhHCcC--
Confidence 45899999999999999999999999998888888888776543322 1223448999999999999999999
Q ss_pred CChHHHHcCCCcCC
Q 013016 398 RGAADVKTHPFFKG 411 (451)
Q Consensus 398 ~~~~ell~hp~~~~ 411 (451)
++|||+||||++
T Consensus 261 --~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 261 --SEVLLKHRFVLR 272 (309)
T ss_dssp --HHHHTTCHHHHS
T ss_pred --HHHHHhCHHhcC
Confidence 999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=454.10 Aligned_cols=262 Identities=28% Similarity=0.402 Sum_probs=213.4
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|+++++||+|+||+||+|+++.+++ .||+|++++.. .......+.+|+.+|+.++|||||+++++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGL---------VMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTE---------EEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3789999999999999999999887655 59999997542 223345677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
.+++++|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 74 ~~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 74 YSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCC
Confidence 9999999999999999999999765 459999999999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|.... .....+++||+.|||||+
T Consensus 152 a~~~~---------------------------------------------------------~~~~~~~~GT~~Y~APEv 174 (322)
T d1s9ja_ 152 SGQLI---------------------------------------------------------DSMANSFVGTRSYMSPER 174 (322)
T ss_dssp CHHHH---------------------------------------------------------HHTC---CCSSCCCCHHH
T ss_pred ccccC---------------------------------------------------------CCccccccCCccccCchH
Confidence 84211 011124589999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc---CC--------------------------------
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK---KP-------------------------------- 362 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~---~~-------------------------------- 362 (451)
+.+..|+.++|||||||++|||++|+.||.+.+.......... +.
T Consensus 175 l~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (322)
T d1s9ja_ 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254 (322)
T ss_dssp HHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHH
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHH
Confidence 9999999999999999999999999999987554322111000 00
Q ss_pred ----CCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 363 ----LTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 363 ----~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
...+........+.++++||.+||++||.+||| ++|+|+||||++.++
T Consensus 255 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 255 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDA 306 (322)
T ss_dssp HHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHH
T ss_pred hhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCc
Confidence 000111122234458999999999999999999 999999999987544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=430.08 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=209.0
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe-
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA- 160 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~- 160 (451)
|++.++||+|+||+||+|.++.+++ .||+|++...... ....+.+.+|++++++++|||||++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~---------~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTV---------EVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCC---------EEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCe---------EEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 5788899999999999999987765 4999999766432 3345678889999999999999999999875
Q ss_pred ---CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeccCCCCcEEEc-cCCCEEEec
Q 013016 161 ---SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLG--IIYRDLKPENVLVR-SDGHIMLSD 234 (451)
Q Consensus 161 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~D 234 (451)
++.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence 45789999999999999999775 45999999999999999999999999 99999999999997 578999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|.... .....+.+||+.|||
T Consensus 159 FGla~~~~---------------------------------------------------------~~~~~~~~GT~~Y~a 181 (270)
T d1t4ha_ 159 LGLATLKR---------------------------------------------------------ASFAKAVIGTPEFMA 181 (270)
T ss_dssp TTGGGGCC---------------------------------------------------------TTSBEESCSSCCCCC
T ss_pred cCcceecc---------------------------------------------------------CCccCCcccCccccC
Confidence 99984211 011224589999999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 315 PEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE-TTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 315 PE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
||++.+ .++.++|||||||++|||++|+.||...... .....+..+..... . +...+.++.+||.+||++||++|
T Consensus 182 PE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--~-~~~~~~~~~~li~~~l~~dp~~R 257 (270)
T d1t4ha_ 182 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--F-DKVAIPEVKEIIEGCIRQNKDER 257 (270)
T ss_dssp GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--G-GGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--c-CccCCHHHHHHHHHHccCCHhHC
Confidence 999876 6999999999999999999999999875544 44555554432211 1 12233489999999999999999
Q ss_pred CCCCCChHHHHcCCCcC
Q 013016 394 LGSKRGAADVKTHPFFK 410 (451)
Q Consensus 394 pt~~~~~~ell~hp~~~ 410 (451)
|| ++|||+||||+
T Consensus 258 ~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 258 YS----IKDLLNHAFFQ 270 (270)
T ss_dssp CC----HHHHHTSGGGC
T ss_pred cC----HHHHhCCcccC
Confidence 99 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.1e-57 Score=429.08 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=224.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH------HHHHHHHHHHHHHHHHHCC-CCCcc
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE------KKKKVHRAEMEKKILKMLD-HPFLP 152 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~nIv 152 (451)
++|++.+.||+|+||+||+|+++.+++ .||||++.+.... .....+.+.+|+.+++++. |||||
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~---------~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCK---------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCC---------EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 789999999999999999999877655 5999999764321 2234456788999999997 99999
Q ss_pred ceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEE
Q 013016 153 TLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIML 232 (451)
Q Consensus 153 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl 232 (451)
++++++.+++++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl 151 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 151 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEE
Confidence 9999999999999999999999999999765 56999999999999999999999999999999999999999999999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||++...... ......+||+.|
T Consensus 152 ~DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~~y 175 (277)
T d1phka_ 152 TDFGFSCQLDPG--------------------------------------------------------EKLREVCGTPSY 175 (277)
T ss_dssp CCCTTCEECCTT--------------------------------------------------------CCBCCCCSCGGG
T ss_pred ccchheeEccCC--------------------------------------------------------CceeeeeccCCC
Confidence 999998543210 011234799999
Q ss_pred cCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 313 VSPEVASG------GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 313 ~aPE~~~~------~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+..+...++........+ ++++||++||
T Consensus 176 ~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L 254 (277)
T d1phka_ 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD-TVKDLVSRFL 254 (277)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCH-HHHHHHHHHC
T ss_pred CCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCH-HHHHHHHHHc
Confidence 99999863 3468899999999999999999999999998888889988877665544444444 8999999999
Q ss_pred ccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 387 NKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+.||.+||+ ++|||+||||++
T Consensus 255 ~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 255 VVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp CSSGGGSCC----HHHHTTSGGGCT
T ss_pred cCChhHCcC----HHHHHcCHHHHH
Confidence 999999999 999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=438.51 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=225.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
.+++|++.+.||+|+||+||+|.++.+++ .||||++++.... ...+.+|+++|+.++|||||+++++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~---------~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~ 69 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKK---------TYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHES 69 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCc---------EEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35889999999999999999999987765 4999999865322 2346679999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC--CCEEEecc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD--GHIMLSDF 235 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~--~~~kl~Df 235 (451)
|++++++|||||||+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 70 ~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 70 FESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEccc
Confidence 99999999999999999999998765 2469999999999999999999999999999999999999854 48999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... .......+||+.|+||
T Consensus 149 G~~~~~~~--------------------------------------------------------~~~~~~~~~t~~y~ap 172 (321)
T d1tkia_ 149 GQARQLKP--------------------------------------------------------GDNFRLLFTAPEYYAP 172 (321)
T ss_dssp TTCEECCT--------------------------------------------------------TCEEEEEESCGGGSCH
T ss_pred chhhcccc--------------------------------------------------------CCcccccccccccccc
Confidence 99853211 0111234789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|.+.+..|+.++|||||||++|+|++|+.||...+..+.+.++.+....++...++.+.+ ++++||.+||+.||.+|||
T Consensus 173 e~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH-HHHHHHHTTSCSSGGGSCC
T ss_pred hhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH-HHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999999887766544444434 8999999999999999999
Q ss_pred CCCChHHHHcCCCcCC
Q 013016 396 SKRGAADVKTHPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~hp~~~~ 411 (451)
+.|+|+||||++
T Consensus 252 ----~~eil~hp~~~~ 263 (321)
T d1tkia_ 252 ----ASEALQHPWLKQ 263 (321)
T ss_dssp ----HHHHHHSHHHHS
T ss_pred ----HHHHhcCHhhcc
Confidence 999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=425.58 Aligned_cols=265 Identities=27% Similarity=0.374 Sum_probs=214.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|.++.+++ .||||++..... .......+.+|+.++++++|||||++++++.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~ 71 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGE---------VVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIH 71 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccc
Confidence 689999999999999999999987665 499999976532 2334567788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+++++|+||||+ ++.+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 72 ~~~~~~iv~e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 72 TENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp ETTEEEEEEECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred cccceeEEEeec-CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence 999999999999 4566666666556779999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........||+.|+|||++.
T Consensus 151 ~~~~~-------------------------------------------------------~~~~~~~~gt~~y~apE~~~ 175 (298)
T d1gz8a_ 151 AFGVP-------------------------------------------------------VRTYTHEVVTLWYRAPEILL 175 (298)
T ss_dssp HHCCC-------------------------------------------------------SBCTTCCBCCCTTCCHHHHT
T ss_pred eccCC-------------------------------------------------------cccceeecccceeeehhhhc
Confidence 32211 11122347999999999987
Q ss_pred CCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCC------------------------CcC
Q 013016 320 GGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPS------------------------SMS 374 (451)
Q Consensus 320 ~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------------------------~~~ 374 (451)
... ++.++|||||||++|+|++|+.||.+.+..+.+.++............. ...
T Consensus 176 ~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T d1gz8a_ 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255 (298)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTC
T ss_pred cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCC
Confidence 766 4889999999999999999999999888777776665421111111000 112
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+.++++||++||.+||++||| ++|||+||||++++.
T Consensus 256 s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 256 DEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDVTK 291 (298)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred CHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccCCC
Confidence 347899999999999999999 999999999998744
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=428.01 Aligned_cols=262 Identities=26% Similarity=0.320 Sum_probs=209.3
Q ss_pred EEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH--HHHHHHHHHHHHHHHHCCCCCccceeEEEEeC
Q 013016 84 LHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK--KKKVHRAEMEKKILKMLDHPFLPTLYAEFEAS 161 (451)
Q Consensus 84 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~ 161 (451)
.+++||+|+||+||+|+++.+++ .||||+++...... ......+.+|+.++++++|||||++++++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQ---------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCS---------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEEEECCCCc---------EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 46789999999999999887665 49999997654322 12245678899999999999999999999999
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+++|||||||.|+++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence 999999999988877665543 356999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
... .......+||+.|||||++.+.
T Consensus 151 ~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 151 GSP-------------------------------------------------------NRAYTHQVVTRWYRAPELLFGA 175 (299)
T ss_dssp TSC-------------------------------------------------------CCCCCCSCCCCTTCCHHHHTTC
T ss_pred CCC-------------------------------------------------------cccccceecChhhccHHHHccC
Confidence 211 0111234799999999998764
Q ss_pred -CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCC-----------------------CCcChHH
Q 013016 322 -SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSP-----------------------SSMSEYH 377 (451)
Q Consensus 322 -~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------------~~~~~~~ 377 (451)
.|+.++|||||||++|||++|..||.+.+..+.+.++...........+ ....+.+
T Consensus 176 ~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 255 (299)
T d1ua2a_ 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDD 255 (299)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHH
T ss_pred CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHH
Confidence 5799999999999999999999999998888887777642111111000 0112348
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
+++||.+||+.||++||| +.|+|+||||++.+.+
T Consensus 256 ~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 256 LLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGP 289 (299)
T ss_dssp HHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCC
T ss_pred HHHHHHHHccCChhhCcC----HHHHhCCHhhCCCCCC
Confidence 999999999999999999 9999999999986554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=435.87 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=207.3
Q ss_pred ccCCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHH-CCCCCcccee
Q 013016 78 TFRDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKM-LDHPFLPTLY 155 (451)
Q Consensus 78 ~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~nIv~l~ 155 (451)
..++|.+.. .||+|+||+||+|+++.+++ .||||++.+. ..+.+|+.++.+ ++|||||+++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~ 71 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQE---------KFALKMLQDC--------PKARREVELHWRASQCPHIVRIV 71 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCC---------EEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCC---------EEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEE
Confidence 347899876 59999999999999987765 4999999743 234568888655 5899999999
Q ss_pred EEEEe----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CC
Q 013016 156 AEFEA----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DG 228 (451)
Q Consensus 156 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~ 228 (451)
++|++ ++++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++
T Consensus 72 ~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTC
T ss_pred EEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccc
Confidence 99976 468999999999999999998765667999999999999999999999999999999999999985 46
Q ss_pred CEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccccccccc
Q 013016 229 HIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVG 308 (451)
Q Consensus 229 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 308 (451)
.+||+|||+|+..... ......+|
T Consensus 152 ~~Kl~DFG~a~~~~~~--------------------------------------------------------~~~~~~~g 175 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSH--------------------------------------------------------NSLTTPCY 175 (335)
T ss_dssp CEEECCCTTCEECCCC--------------------------------------------------------CCCCCCSC
T ss_pred cccccccceeeeccCC--------------------------------------------------------CccccccC
Confidence 7999999998533211 11123479
Q ss_pred CCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----cCCCCCCCCCCCCcChHHHHHHHHH
Q 013016 309 THEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIV----KKPLTFPTQSPSSMSEYHARDLISG 384 (451)
Q Consensus 309 t~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~~ll~~ 384 (451)
|+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+.......+. .....++...... .+.++.+||++
T Consensus 176 t~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~ 254 (335)
T d2ozaa1 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKMLIRN 254 (335)
T ss_dssp CCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH-SCHHHHHHHHH
T ss_pred CcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc-CCHHHHHHHHH
Confidence 999999999999999999999999999999999999998766554443333 3333333322222 33489999999
Q ss_pred hcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 385 LLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 385 ~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
||++||++||| +.|+|+||||++
T Consensus 255 ~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 255 LLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred HccCChhHCcC----HHHHHcCHHhhC
Confidence 99999999999 999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-55 Score=419.58 Aligned_cols=279 Identities=20% Similarity=0.264 Sum_probs=215.7
Q ss_pred hhhhhhhhhccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHH
Q 013016 61 FAYSAIRSATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEK 140 (451)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~ 140 (451)
+++.++..++......+..++|++.++||+|+||+||+|.++.+++. ...||||.+.... .....+.+.+|+
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~------~~~vavK~~~~~~--~~~~~~~~~~E~ 78 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKR------EIFVAIKTLKSGY--TEKQRRDFLSEA 78 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---C------CEEEEEEECCSSC--CHHHHHHHHHHH
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCE------EEEEEEEEECccc--CHHHHHHHHHHH
Confidence 45555566654444455668899999999999999999998755421 2358999986542 233446788899
Q ss_pred HHHHHCCCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCC
Q 013016 141 KILKMLDHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPE 220 (451)
Q Consensus 141 ~~l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~ 220 (451)
.+|++++|||||++++++..++.+|+|||||+||+|.+++... .+.+++..+..++.||+.||+|||++||+||||||+
T Consensus 79 ~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157 (299)
T ss_dssp HHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred HHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccc
Confidence 9999999999999999999999999999999999999988764 345999999999999999999999999999999999
Q ss_pred cEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccc
Q 013016 221 NVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVA 300 (451)
Q Consensus 221 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (451)
||||+.++.+||+|||+++......... ..
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~--------------------------------------------------~~ 187 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDP--------------------------------------------------TY 187 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------------------------------------------------
T ss_pred eEEECCCCcEEECCcccceEccCCCCcc--------------------------------------------------ee
Confidence 9999999999999999986432110000 00
Q ss_pred ccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHH
Q 013016 301 ARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHAR 379 (451)
Q Consensus 301 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 379 (451)
.......||+.|||||++.+..++.++|||||||+||||+| |+.||.+....+.+..+..+..... +...+.++.
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~l~ 263 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP----PMDCPSALH 263 (299)
T ss_dssp --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----CTTCCHHHH
T ss_pred eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC----CccchHHHH
Confidence 11112368899999999999999999999999999999998 8999999888888888776543221 112344899
Q ss_pred HHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 380 DLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 380 ~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+|+.+||+.||++||| +.||+++
T Consensus 264 ~li~~cl~~~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPK----FGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999999 8888763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=425.68 Aligned_cols=272 Identities=16% Similarity=0.264 Sum_probs=218.1
Q ss_pred hccCCCCCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-C
Q 013016 69 ATFGRKTGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-D 147 (451)
Q Consensus 69 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 147 (451)
..+..++.+..++|++.++||+|+||+||+|+++...+. .....||+|++.... .......+.+|+.++.++ +
T Consensus 26 ~~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~ 99 (325)
T d1rjba_ 26 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT----GVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGS 99 (325)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSS----SCEEEEEEEEECC--------CHHHHHHHHHHHHHCC
T ss_pred cCCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcc----cceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcC
Confidence 333444555668899999999999999999998765432 122359999987553 233445677899999988 8
Q ss_pred CCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCC---------------------CCCCHHHHHHHHHHHHHHHHH
Q 013016 148 HPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPH---------------------KRFSLTSARFYAAEVLVALEY 206 (451)
Q Consensus 148 h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~aL~~ 206 (451)
|||||++++++.+.+.+|||||||+||+|.+++..... ..+++..++.|+.||+.||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999976532 358999999999999999999
Q ss_pred HHHCCCeeccCCCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCcccc
Q 013016 207 LHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQ 286 (451)
Q Consensus 207 LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (451)
||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~------------------------------------------ 217 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD------------------------------------------ 217 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC------------------------------------------
T ss_pred HHhCCeeeccCchhccccccCCeEEEeeccccccccCC------------------------------------------
Confidence 99999999999999999999999999999998532211
Q ss_pred ccCCCcccccccccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCC
Q 013016 287 TLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTF 365 (451)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 365 (451)
.......+..||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+....+.+++.....+
T Consensus 218 -----------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (325)
T d1rjba_ 218 -----------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 286 (325)
T ss_dssp -----------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred -----------CceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 01111223478999999999999999999999999999999998 899999877777777776654433
Q ss_pred CCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 366 PTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 366 ~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+. +...+.++.+||.+||+.||++||| ++||++|
T Consensus 287 ~~---p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 287 DQ---PFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CC---CCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 22 1223448999999999999999999 9999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=415.64 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=206.0
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|.+.++||+|+||+||+|+++.. ||||+++.... .....+.+.+|+.++++++|||||++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------------vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 71 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMG 71 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSSE------------EEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECCE------------EEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeE
Confidence 4457899999999999999999986542 99999975432 2344567888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++. .+.++||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 72 ~~~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 72 YST-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp EEC-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEe-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccc
Confidence 875 456899999999999999997653 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|...... .......+..||+.|||||
T Consensus 150 la~~~~~~-----------------------------------------------------~~~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 150 LATVKSRW-----------------------------------------------------SGSHQFEQLSGSILWMAPE 176 (276)
T ss_dssp CSCC-----------------------------------------------------------------CCCCGGGCCHH
T ss_pred ceeecccc-----------------------------------------------------CCcccccccccCcccCCHH
Confidence 98532210 0111122457999999999
Q ss_pred cccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-CCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 317 VASG---GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVK-KPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 317 ~~~~---~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
++.+ ..|+.++|||||||+||||+||+.||.+......+..+.. +.........+...+.++.+|+.+||+.||.+
T Consensus 177 ~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~ 256 (276)
T d1uwha_ 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE 256 (276)
T ss_dssp HHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhH
Confidence 9865 3479999999999999999999999998776655544443 33222212222334458999999999999999
Q ss_pred cCCCCCChHHHHcC
Q 013016 393 RLGSKRGAADVKTH 406 (451)
Q Consensus 393 Rpt~~~~~~ell~h 406 (451)
||| +.||+++
T Consensus 257 RPt----~~~il~~ 266 (276)
T d1uwha_ 257 RPL----FPQILAS 266 (276)
T ss_dssp SCC----HHHHHHH
T ss_pred CcC----HHHHHHH
Confidence 999 9999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=419.15 Aligned_cols=265 Identities=25% Similarity=0.324 Sum_probs=210.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC---CCCCccceeE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML---DHPFLPTLYA 156 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~ 156 (451)
++|+++++||+|+||+||+|++..+.. ..||||++...... ......+.+|+.+++.+ +||||+++++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~--------~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGG--------RFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTT--------EEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCC--------EEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 789999999999999999999865432 25999999754322 12223344577776655 8999999999
Q ss_pred EEEe-----CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEE
Q 013016 157 EFEA-----SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIM 231 (451)
Q Consensus 157 ~~~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~k 231 (451)
+|.. ..+++++|||+.++.+.. ........+++..++.++.||+.||+|||++|||||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eecccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCee
Confidence 9853 358899999997776654 3444456799999999999999999999999999999999999999999999
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++..... .......+||+.
T Consensus 157 l~dfg~~~~~~~--------------------------------------------------------~~~~~~~~gT~~ 180 (305)
T d1blxa_ 157 LADFGLARIYSF--------------------------------------------------------QMALTSVVVTLW 180 (305)
T ss_dssp ECSCCSCCCCCG--------------------------------------------------------GGGGCCCCCCCT
T ss_pred ecchhhhhhhcc--------------------------------------------------------cccCCCcccChh
Confidence 999999743210 011123589999
Q ss_pred ccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCC----------------------CCC
Q 013016 312 YVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFP----------------------TQS 369 (451)
Q Consensus 312 y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------------------~~~ 369 (451)
|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+........ ...
T Consensus 181 Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp TCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred hcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 9999999999999999999999999999999999999888887777654211100 000
Q ss_pred CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 370 PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 370 ~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
.....+..+++||.+||++||++||| +.|+|+||||++++.
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 11123448999999999999999999 999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-55 Score=415.81 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=213.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.+.||+|+||+||+|.+..+++ .||||++.+...........+.+|+.+++.++|||||++++++.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHR---------DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCC---------EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 679999999999999999999887765 49999998765555566677889999999999999999999997
Q ss_pred eCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 160 ASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 160 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
..+ .+|||||||+|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred eccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehh
Confidence 654 489999999999999988765 56999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|.+....... .........+||+.||||
T Consensus 156 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 156 GIARAIADSG----------------------------------------------------NSVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp TTCEECC--------------------------------------------------------------------TTCCH
T ss_pred hhhhhhcccc----------------------------------------------------ccccccccccCcccccCH
Confidence 9874322110 011122345899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
|++.+..++.++|||||||++|+|+||+.||.+.+..+.+.++.......+....+.+.+ ++.+||.+||++||.+||+
T Consensus 184 E~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA-DLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH-HHHHHHHHHTCSSGGGSCS
T ss_pred HHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH-HHHHHHHHHccCCHhHCHh
Confidence 999999999999999999999999999999999988888888888766555444444444 8999999999999999994
Q ss_pred CCCChHHHHcCCCc
Q 013016 396 SKRGAADVKTHPFF 409 (451)
Q Consensus 396 ~~~~~~ell~hp~~ 409 (451)
. ++++ .|+|.
T Consensus 263 s---a~~l-~~~l~ 272 (277)
T d1o6ya_ 263 T---AAEM-RADLV 272 (277)
T ss_dssp S---HHHH-HHHHH
T ss_pred H---HHHH-HHHHH
Confidence 1 5554 45554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=426.94 Aligned_cols=288 Identities=35% Similarity=0.670 Sum_probs=230.3
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH-HHHHHHHHHHHHHHHHHCCC-CCccce
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE-KKKKVHRAEMEKKILKMLDH-PFLPTL 154 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~nIv~l 154 (451)
..+++|++.++||+|+||+||+|.+.... ..++.||||++.+.... .....+.+.+|++++++++| |||+++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~ 94 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEe
Confidence 34588999999999999999999875432 12346999999754321 12234556679999999966 899999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
++++.+...+++||||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 95 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 95 HYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 99999999999999999999999998776 4588999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+++..... ......+..|++.|+|
T Consensus 173 FG~a~~~~~~------------------------------------------------------~~~~~~~~~g~~~~~~ 198 (322)
T d1vzoa_ 173 FGLSKEFVAD------------------------------------------------------ETERAYDFCGTIEYMA 198 (322)
T ss_dssp SSEEEECCGG------------------------------------------------------GGGGGCGGGSCCTTCC
T ss_pred ccchhhhccc------------------------------------------------------ccccccccccccccch
Confidence 9998532210 1111223479999999
Q ss_pred cccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----hcCCCCCCCCCCCCcChHHHHHHHHHhccc
Q 013016 315 PEVASGGS--HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI----VKKPLTFPTQSPSSMSEYHARDLISGLLNK 388 (451)
Q Consensus 315 PE~~~~~~--~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~ 388 (451)
||.+.+.. ++.++|||||||+||+|++|+.||.+.+.......+ ......++.. .+.++.+||.+||++
T Consensus 199 pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~-----~s~~~~~li~~~l~~ 273 (322)
T d1vzoa_ 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE-----MSALAKDLIQRLLMK 273 (322)
T ss_dssp HHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT-----SCHHHHHHHHHHTCS
T ss_pred hHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc-----CCHHHHHHHHHHccc
Confidence 99998754 688999999999999999999999876554433333 3333333332 334899999999999
Q ss_pred CcCCcCCCCC-ChHHHHcCCCcCCCCccc--ccccCCCCCCCCCCC
Q 013016 389 DPCNRLGSKR-GAADVKTHPFFKGLNFAL--IRSLTPPEIPGMRRQ 431 (451)
Q Consensus 389 dP~~Rpt~~~-~~~ell~hp~~~~~~~~~--~~~~~~~~~p~~~~~ 431 (451)
||.+||+... .++|+|+||||++++|.. .+...+|.+|+++..
T Consensus 274 dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~ 319 (322)
T d1vzoa_ 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319 (322)
T ss_dssp SGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred CHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCC
Confidence 9999996432 389999999999999864 478888999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-54 Score=413.46 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=209.7
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||+||+|.++.+++ .||||+++... ...+.+.+|+.++++++|||||++++
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSL---------TVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLG 80 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTE---------EEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCe---------EEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCc
Confidence 344789999999999999999999987765 49999997542 23356778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
+|.+++.++||||||++|+|.+++.......+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred cEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 99999999999999999999999988777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|+..... .........|++.|||||
T Consensus 161 ~a~~~~~~------------------------------------------------------~~~~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 161 LSRLMTGD------------------------------------------------------TYTAHAGAKFPIKWTAPE 186 (287)
T ss_dssp CTTTCCSS------------------------------------------------------SSEEETTEEECGGGCCHH
T ss_pred ceeecCCC------------------------------------------------------CceeeccccccccccChH
Confidence 98532210 011111236888999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..|+.++|||||||++|||++|..||.. .+.......+..+ ..++. + ...+.++.+||.+||+.||++|||
T Consensus 187 ~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~~--~-~~~~~~l~~li~~cl~~dP~~Rps 262 (287)
T d1opja_ 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER--P-EGCPEKVYELMRACWQWNPSDRPS 262 (287)
T ss_dssp HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCC--C-TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCCC--C-ccchHHHHHHHHHHcCCCHhHCcC
Confidence 99999999999999999999999997666554 4444444444433 22211 1 223448999999999999999999
Q ss_pred CCCChHHHHc
Q 013016 396 SKRGAADVKT 405 (451)
Q Consensus 396 ~~~~~~ell~ 405 (451)
+.||++
T Consensus 263 ----~~ei~~ 268 (287)
T d1opja_ 263 ----FAEIHQ 268 (287)
T ss_dssp ----HHHHHH
T ss_pred ----HHHHHH
Confidence 999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=415.34 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=208.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHH---HHHHHHHHHHHHHHCC--CCCccce
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKK---KVHRAEMEKKILKMLD--HPFLPTL 154 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~--h~nIv~l 154 (451)
++|++.++||+|+||+||+|+++.+++ .||||++.+....... ...++.+|+.++++++ |||||++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNL---------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCC---------EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 679999999999999999999987765 4999999865432211 1223456999999986 8999999
Q ss_pred eEEEEeCCeEEEEEeeccC-CchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC-CCEEE
Q 013016 155 YAEFEASNFSCIVMEFCSG-GDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD-GHIML 232 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl 232 (451)
++++.+.+..|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEE
Confidence 9999999999999999976 5777777664 569999999999999999999999999999999999999855 79999
Q ss_pred eccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCc
Q 013016 233 SDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEY 312 (451)
Q Consensus 233 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 312 (451)
+|||+|..... ....+++||+.|
T Consensus 153 ~DFG~a~~~~~---------------------------------------------------------~~~~~~~GT~~y 175 (273)
T d1xwsa_ 153 IDFGSGALLKD---------------------------------------------------------TVYTDFDGTRVY 175 (273)
T ss_dssp CCCTTCEECCS---------------------------------------------------------SCBCCCCSCGGG
T ss_pred Cccccceeccc---------------------------------------------------------ccccccccCCCc
Confidence 99999853211 111235799999
Q ss_pred cCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcC
Q 013016 313 VSPEVASGGSH-GNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPC 391 (451)
Q Consensus 313 ~aPE~~~~~~~-~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~ 391 (451)
||||++.+..+ +.++|||||||++|+|++|+.||... ..+..+...++.. .+.++++||.+||+.||+
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~-----~s~~~~~li~~~L~~dp~ 244 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR-----VSSECQHLIRWCLALRPS 244 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSC-----CCHHHHHHHHHHTCSSGG
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCC-----CCHHHHHHHHHHccCCHh
Confidence 99999987665 67899999999999999999999752 2344555444432 334899999999999999
Q ss_pred CcCCCCCChHHHHcCCCcCCCCc
Q 013016 392 NRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 392 ~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
+||| ++|+|+||||+++-.
T Consensus 245 ~R~s----~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 245 DRPT----FEEIQNHPWMQDVLL 263 (273)
T ss_dssp GSCC----HHHHHTSGGGSSCCC
T ss_pred HCcC----HHHHhcCHhhCCCCC
Confidence 9999 999999999998643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=407.16 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=205.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.++++. .||||+++.... ..+.+.+|++++++++|||||++++++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~----------~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKD----------KVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVC 69 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTE----------EEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCC----------EEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCccccccee
Confidence 368999999999999999999987543 399999975432 234677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
..++.+|+|||||++|+|.+++.... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 70 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 70 LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchh
Confidence 99999999999999999999887653 55899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
+..... .........||+.|||||++
T Consensus 149 ~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE~l 174 (263)
T d1sm2a_ 149 RFVLDD------------------------------------------------------QYTSSTGTKFPVKWASPEVF 174 (263)
T ss_dssp ----------------------------------------------------------------------CTTSCCHHHH
T ss_pred eeccCC------------------------------------------------------CceeecceecCcccCChHHh
Confidence 533211 00111124789999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..|+.++|||||||++|||+| |.+||...+..+.+..+..+..... +...+.++.+|+.+||+.||++|||
T Consensus 175 ~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~~p~~Rps-- 248 (263)
T d1sm2a_ 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----PRLASTHVYQIMNHCWKERPEDRPA-- 248 (263)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC----ccccCHHHHHHHHHHccCCHhHCcC--
Confidence 99999999999999999999999 6777777777778877777543221 2233458999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
++||++|
T Consensus 249 --~~~il~~ 255 (263)
T d1sm2a_ 249 --FSRLLRQ 255 (263)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 9999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-55 Score=412.96 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=212.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|++.++||+|+||+||+|.++.+. .||||++..... ..+.+.+|+.++++++|||||+++
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~----------~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~ 74 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLY 74 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTE----------EEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCC----------EEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEE
Confidence 344578999999999999999999987543 399999975432 234678899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
+++.+ +.+|+|||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 75 g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence 98754 56799999999999999876655556999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|+..... .........||+.||||
T Consensus 154 Gla~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~AP 179 (272)
T d1qpca_ 154 GLARLIEDN------------------------------------------------------EYTAREGAKFPIKWTAP 179 (272)
T ss_dssp TTCEECSSS------------------------------------------------------CEECCTTCCCCTTTSCH
T ss_pred cceEEccCC------------------------------------------------------ccccccccCCcccccCh
Confidence 998543211 01111234789999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
|++.++.++.++|||||||++|||+|| .+||......+.+..+..+..... +...+.++.+|+.+||+.||++||
T Consensus 180 E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR----PDNCPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----cccChHHHHHHHHHHcCCCHhHCc
Confidence 999988999999999999999999994 566666777777777766532221 122344899999999999999999
Q ss_pred CCCCChHHHHc--CCCcCC
Q 013016 395 GSKRGAADVKT--HPFFKG 411 (451)
Q Consensus 395 t~~~~~~ell~--hp~~~~ 411 (451)
| ++||++ |+||..
T Consensus 256 t----~~ei~~~L~~~fts 270 (272)
T d1qpca_ 256 T----FDYLRSVLEDFFTA 270 (272)
T ss_dssp C----HHHHHHHHHHHHHH
T ss_pred C----HHHHHHHhhhhhhc
Confidence 9 999987 777753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-54 Score=411.80 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=210.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|+++.+. .||||++..... .....+.+.+|+.+|++++|||||++++++.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~----------~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 70 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGE----------TFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIH 70 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSC----------EEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCC----------EEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecc
Confidence 68999999999999999999986432 499999976532 2334567788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.++..|+|||++.++.+..+.... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||.+.
T Consensus 71 ~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 71 TKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp CSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred cCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccce
Confidence 999999999999776666555443 669999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
..... ........|++.|+|||.+.
T Consensus 149 ~~~~~-------------------------------------------------------~~~~~~~~~~~~y~~pE~~~ 173 (286)
T d1ob3a_ 149 AFGIP-------------------------------------------------------VRKYTHEIVTLWYRAPDVLM 173 (286)
T ss_dssp HHCC----------------------------------------------------------------CCCTTCCHHHHT
T ss_pred ecccC-------------------------------------------------------ccccceecccchhhhHHHHh
Confidence 32211 11112346899999999997
Q ss_pred CC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCC------------------------CCCcC
Q 013016 320 GG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQS------------------------PSSMS 374 (451)
Q Consensus 320 ~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~ 374 (451)
+. .++.++|||||||++|||++|+.||.+.+..+.+.++........... .....
T Consensus 174 ~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T d1ob3a_ 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253 (286)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSC
T ss_pred CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccC
Confidence 65 469999999999999999999999998888777776653211111000 01122
Q ss_pred hHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCC
Q 013016 375 EYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKG 411 (451)
Q Consensus 375 ~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~ 411 (451)
+.++.+||++||++||++||| +.|+|+||||++
T Consensus 254 s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 254 DESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 348899999999999999999 999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=409.57 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=212.0
Q ss_pred ccCCceEEe-eeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 78 TFRDFDLHR-RIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
..++|.+.+ +||+|+||+||+|.++...+ +..||||++.... .....+.+.+|+.+|++++|||||++++
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---C-------CEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCC-------cEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 336788888 49999999999998765432 2359999997542 2344567888999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++.. +.+|||||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 77 VCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred eecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 9875 4689999999999999987654 3469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+|........ .........||+.|||||
T Consensus 155 la~~~~~~~~----------------------------------------------------~~~~~~~~~gt~~y~aPE 182 (285)
T d1u59a_ 155 LSKALGADDS----------------------------------------------------YYTARSAGKWPLKWYAPE 182 (285)
T ss_dssp TCEECTTCSC----------------------------------------------------EECCCCSSCCCGGGCCHH
T ss_pred hhhccccccc----------------------------------------------------ccccccccccCccccChH
Confidence 9864321110 011112346899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRL 394 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rp 394 (451)
++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+..+.. ..|. ..+.++.+||.+||+.||++||
T Consensus 183 ~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~-----~~~~~l~~li~~cl~~~p~~RP 257 (285)
T d1u59a_ 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP-----ECPPELYALMSDCWIYKWEDRP 257 (285)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT-----TCCHHHHHHHHHTTCSSGGGSC
T ss_pred HHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-----cCCHHHHHHHHHHcCCCHhHCc
Confidence 9998899999999999999999998 9999999888888888877643 2222 2344899999999999999999
Q ss_pred CCCCChHHH---HcCCCcC
Q 013016 395 GSKRGAADV---KTHPFFK 410 (451)
Q Consensus 395 t~~~~~~el---l~hp~~~ 410 (451)
| +.+| |+|+|+.
T Consensus 258 s----~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 258 D----FLTVEQRMRACYYS 272 (285)
T ss_dssp C----HHHHHHHHHHHHHH
T ss_pred C----HHHHHHHHHHHHHH
Confidence 9 7776 6777763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-54 Score=406.85 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=207.0
Q ss_pred ceEE-eeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe
Q 013016 82 FDLH-RRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA 160 (451)
Q Consensus 82 y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~ 160 (451)
+.+. ++||+|+||+||+|.++... .+..||||++..... .....+.+.+|+.+|++++|||||++++++..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred CeecCCCcccCCCeEEEEEEEccCC-------cCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 4443 46999999999999876432 123599999976532 33445678899999999999999999999965
Q ss_pred CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcccc
Q 013016 161 SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLC 240 (451)
Q Consensus 161 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 240 (451)
+ ..|||||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~-~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 E-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156 (277)
T ss_dssp S-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred C-CEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhh
Confidence 4 578999999999999998875 5599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccC
Q 013016 241 SNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASG 320 (451)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 320 (451)
...... .........||+.|||||++.+
T Consensus 157 ~~~~~~----------------------------------------------------~~~~~~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 157 LRADEN----------------------------------------------------YYKAQTHGKWPVKWYAPECINY 184 (277)
T ss_dssp CCTTCS----------------------------------------------------EEEC----CCCGGGCCHHHHHH
T ss_pred cccccc----------------------------------------------------ccccccccCCCceecCchhhcC
Confidence 321100 0111123478999999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 321 GSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 321 ~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
..++.++|||||||++|||+| |+.||.+.+..+....+..+.. ..|. ..+.++.+||.+||+.||++|||
T Consensus 185 ~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~-----~~~~~~~~li~~cl~~dp~~RPs--- 256 (277)
T d1xbba_ 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA-----GCPREMYDLMNLCWTYDVENRPG--- 256 (277)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-----TCCHHHHHHHHHHTCSSTTTSCC---
T ss_pred CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc-----ccCHHHHHHHHHHcCCCHhHCcC---
Confidence 899999999999999999998 9999999888888777776542 2222 23448999999999999999999
Q ss_pred ChHHH---HcCCCcCC
Q 013016 399 GAADV---KTHPFFKG 411 (451)
Q Consensus 399 ~~~el---l~hp~~~~ 411 (451)
+.+| |+|+|++-
T Consensus 257 -~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 257 -FAAVELRLRNYYYDV 271 (277)
T ss_dssp -HHHHHHHHHHHHHHH
T ss_pred -HHHHHHHhhCHHhhc
Confidence 8887 56766643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=400.13 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=213.5
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|+++.+. .||||++++... ..+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----------~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~ 68 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQY----------DVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVC 68 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTE----------EEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCC----------EEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 378999999999999999999986433 399999986532 234677899999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+++.+++||||+++|+|.+++.... ..+++..+++++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 69 ~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 69 TKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp CCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred eeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhh
Confidence 99999999999999999998876543 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .......||+.|+|||++
T Consensus 148 ~~~~~~~~------------------------------------------------------~~~~~~~~t~~y~aPE~~ 173 (258)
T d1k2pa_ 148 RYVLDDEY------------------------------------------------------TSSVGSKFPVRWSPPEVL 173 (258)
T ss_dssp CBCSSSSC------------------------------------------------------CCCCCSCCCGGGCCHHHH
T ss_pred eeccCCCc------------------------------------------------------eeecccCCCCCcCCcHHh
Confidence 53321100 111124789999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||+| |+.||...+..+....+..+..... +...+.++.+||.+||+.||++|||
T Consensus 174 ~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~dP~~RPt-- 247 (258)
T d1k2pa_ 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----PHLASEKVYTIMYSCWHEKADERPT-- 247 (258)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCC--
T ss_pred cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccccHHHHHHHHHHccCCHhHCcC--
Confidence 99999999999999999999998 8999999999888888877543222 2234458999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
++||++|
T Consensus 248 --~~eil~~ 254 (258)
T d1k2pa_ 248 --FKILLSN 254 (258)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 9999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=408.55 Aligned_cols=267 Identities=26% Similarity=0.320 Sum_probs=209.0
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|+++++||+|+||+||+|+++.+++ .||||++..... .......+.+|+.+|++++|+||+++++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~ 78 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQ---------KVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEIC 78 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeee
Confidence 3789999999999999999999987665 499999976533 233445677899999999999999999988
Q ss_pred Ee--------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCE
Q 013016 159 EA--------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHI 230 (451)
Q Consensus 159 ~~--------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~ 230 (451)
.. .+++|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp EC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred ecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcE
Confidence 54 4578999999977666544333 3569999999999999999999999999999999999999999999
Q ss_pred EEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCC
Q 013016 231 MLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTH 310 (451)
Q Consensus 231 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 310 (451)
||+|||++......... ......+.+||+
T Consensus 157 kl~dfg~~~~~~~~~~~---------------------------------------------------~~~~~~~~~gT~ 185 (318)
T d3blha1 157 KLADFGLARAFSLAKNS---------------------------------------------------QPNRYTNRVVTL 185 (318)
T ss_dssp EECCCTTCEECCC--------------------------------------------------------CCCCCSCCSCG
T ss_pred Eeeecceeeeccccccc---------------------------------------------------ccccccceecCH
Confidence 99999998533211000 011112347999
Q ss_pred CccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCCCCCCCc----------------
Q 013016 311 EYVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPTQSPSSM---------------- 373 (451)
Q Consensus 311 ~y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~---------------- 373 (451)
.|+|||++.+. .|+.++|||||||++|||++|+.||.+......+..+......++.......
T Consensus 186 ~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T d3blha1 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265 (318)
T ss_dssp GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCC
T ss_pred HHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccccc
Confidence 99999999875 5899999999999999999999999988877776665543322222111110
Q ss_pred -----------ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 374 -----------SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 374 -----------~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.+.++++||.+||++||++||| ++|+|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~~ 311 (318)
T d3blha1 266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSD 311 (318)
T ss_dssp BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSSS
T ss_pred ccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhccC
Confidence 1336789999999999999999 9999999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=403.28 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=209.2
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+.+++|++.+.||+|+||+||+|+++++.+ ||||++..... ..+.+.+|+.++++++|+|||++++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~----------vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEE----------EEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCE----------EEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEE
Confidence 445789999999999999999999876643 99999975532 2356778999999999999999999
Q ss_pred EEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccC
Q 013016 157 EFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFD 236 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg 236 (451)
++.+ +.+++|||||++|+|..++.......+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||
T Consensus 80 ~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 80 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccc
Confidence 9854 567899999999999998876555669999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcc
Q 013016 237 LSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPE 316 (451)
Q Consensus 237 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 316 (451)
+++..... .........||+.|+|||
T Consensus 159 la~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 159 LARLIEDN------------------------------------------------------EYTARQGAKFPIKWTAPE 184 (285)
T ss_dssp TTC--------------------------------------------------------------------CCGGGSCHH
T ss_pred hhhhccCC------------------------------------------------------CceeeccccccccccChH
Confidence 98533211 011112247899999999
Q ss_pred cccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCC
Q 013016 317 VASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLG 395 (451)
Q Consensus 317 ~~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt 395 (451)
++.+..++.++|||||||++|||++| .+|+......+.+..+..+... + ... ..+.++++||.+||+.||++||+
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-~--~~~-~~~~~l~~li~~cl~~dP~~Rps 260 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-P--CPP-ECPESLHDLMCQCWRKEPEERPT 260 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-C--CCT-TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-C--CCc-ccCHHHHHHHHHHcccCHhHCcC
Confidence 99999999999999999999999995 5555666666666666655321 1 112 23448999999999999999999
Q ss_pred CCCChHHHHc--CCCcCC
Q 013016 396 SKRGAADVKT--HPFFKG 411 (451)
Q Consensus 396 ~~~~~~ell~--hp~~~~ 411 (451)
+++|+. |+||+.
T Consensus 261 ----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 261 ----FEYLQAFLEDYFTS 274 (285)
T ss_dssp ----HHHHHHHHHTTTSC
T ss_pred ----HHHHHHHHhhhhcC
Confidence 999987 889987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=410.24 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=207.1
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|.++.+++ .||||++.+... .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~---------~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGA---------KVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCC---------EEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 689999999999999999999987665 599999976432 3345567888999999999999999999997
Q ss_pred eCC------eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 ASN------FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~~~------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
..+ ++||||||| +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccc
Confidence 665 579999999 7888887765 459999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|..... .....+||+.|+
T Consensus 164 Dfg~a~~~~~----------------------------------------------------------~~~~~~~t~~y~ 185 (346)
T d1cm8a_ 164 DFGLARQADS----------------------------------------------------------EMTGYVVTRWYR 185 (346)
T ss_dssp CCTTCEECCS----------------------------------------------------------SCCSSCSCGGGC
T ss_pred cccceeccCC----------------------------------------------------------cccccccccccc
Confidence 9999853211 111347999999
Q ss_pred CcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----------------------CCCC
Q 013016 314 SPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTF-----------------------PTQS 369 (451)
Q Consensus 314 aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~~~ 369 (451)
|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+....... ....
T Consensus 186 aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (346)
T d1cm8a_ 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 265 (346)
T ss_dssp CTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC
T ss_pred CHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccc
Confidence 99999875 46899999999999999999999999887766655544321111 0000
Q ss_pred ---CCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcc
Q 013016 370 ---PSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFA 415 (451)
Q Consensus 370 ---~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~ 415 (451)
.....+.++++||++||..||.+||| +.|||+||||+++...
T Consensus 266 ~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 266 FASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 310 (346)
T ss_dssp GGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred hHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCc
Confidence 01122348999999999999999999 9999999999997644
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=396.77 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=205.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAE 157 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~ 157 (451)
..++|++.+.||+|+||+||+|.+....+ .+..||||++.... .......+.+|+.++++++|||||+++++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34789999999999999999999865432 23358999986542 33445678889999999999999999999
Q ss_pred EEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCc
Q 013016 158 FEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDL 237 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 237 (451)
+. .+.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 86 567899999999999999876653 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccc
Q 013016 238 SLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEV 317 (451)
Q Consensus 238 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 317 (451)
|+..... .........||+.|+|||+
T Consensus 155 a~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~apE~ 180 (273)
T d1mp8a_ 155 SRYMEDS------------------------------------------------------TYYKASKGKLPIKWMAPES 180 (273)
T ss_dssp ----------------------------------------------------------------------CCGGGCCHHH
T ss_pred heeccCC------------------------------------------------------cceeccceecCcccchhhH
Confidence 8532211 0111123468999999999
Q ss_pred ccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCC
Q 013016 318 ASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGS 396 (451)
Q Consensus 318 ~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~ 396 (451)
+.+..++.++|||||||++|||++ |..||...+..+.+..+..+.... .++ ..+.++.+||.+||+.||++|||
T Consensus 181 l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~-~~~~~~~~li~~cl~~dp~~Rps- 255 (273)
T d1mp8a_ 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPP-NCPPTLYSLMTKCWAYDPSRRPR- 255 (273)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCT-TCCHHHHHHHHHHTCSSGGGSCC-
T ss_pred hccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCC-CCCHHHHHHHHHHcCCCHhHCcC-
Confidence 999999999999999999999998 899999998888888887764321 112 23448999999999999999999
Q ss_pred CCChHHHHcC
Q 013016 397 KRGAADVKTH 406 (451)
Q Consensus 397 ~~~~~ell~h 406 (451)
+.||++|
T Consensus 256 ---~~ei~~~ 262 (273)
T d1mp8a_ 256 ---FTELKAQ 262 (273)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 9999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=409.71 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=205.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
-+|...++||+|+||+||+|+++.+++ .||||++.+.. ....+|+.+|++++|+||++++++|.
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~ 83 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGE---------LVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFY 83 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC---------EEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCC---------EEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEE
Confidence 359999999999999999999987765 59999997542 12235999999999999999999985
Q ss_pred eC------CeEEEEEeeccCCchhhhhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEE
Q 013016 160 AS------NFSCIVMEFCSGGDLHSLRH-KQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIM 231 (451)
Q Consensus 160 ~~------~~~~lV~E~~~ggsL~~~l~-~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~k 231 (451)
.. .++|||||||+++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 84 ~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp EC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEE
T ss_pred ecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCcee
Confidence 43 36899999996664444432 22345699999999999999999999999999999999999999875 899
Q ss_pred EeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCC
Q 013016 232 LSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHE 311 (451)
Q Consensus 232 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 311 (451)
|+|||++...... ....+.+||+.
T Consensus 164 l~DFG~a~~~~~~--------------------------------------------------------~~~~~~~gt~~ 187 (350)
T d1q5ka_ 164 LCDFGSAKQLVRG--------------------------------------------------------EPNVSYICSRY 187 (350)
T ss_dssp ECCCTTCEECCTT--------------------------------------------------------SCCCSCCSCTT
T ss_pred EecccchhhccCC--------------------------------------------------------ccccccccccc
Confidence 9999998533210 11123479999
Q ss_pred ccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------------CCCCCC-----
Q 013016 312 YVSPEVASGG-SHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKP-----------------LTFPTQ----- 368 (451)
Q Consensus 312 y~aPE~~~~~-~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-----------------~~~~~~----- 368 (451)
|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.+..+.... ..++..
T Consensus 188 y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (350)
T d1q5ka_ 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPW 267 (350)
T ss_dssp SCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCG
T ss_pred ccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCch
Confidence 9999998764 68999999999999999999999999888777766664310 011110
Q ss_pred --CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 369 --SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 369 --~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
......+.++.+||.+||++||++||| +.|+|+||||+++..
T Consensus 268 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 268 TKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRD 311 (350)
T ss_dssp GGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGC
T ss_pred hhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccccC
Confidence 011123448999999999999999999 999999999998543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=393.85 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=203.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
+.|.+.++||+|+||+||+|.++.+.. .....||||++..... ......+.+|+.++++++|||||++++++.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 679999999999999999999876532 1123599999975432 233456788999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
+.+.+++|||||.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999998876653 569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... .........||+.|||||++.
T Consensus 159 ~~~~~~~----------------------------------------------------~~~~~~~~~gt~~Y~APE~l~ 186 (283)
T d1mqba_ 159 VLEDDPE----------------------------------------------------ATYTTSGGKIPIRWTAPEAIS 186 (283)
T ss_dssp -------------------------------------------------------------------CCCGGGSCHHHHH
T ss_pred cccCCCc----------------------------------------------------cceEeccCCCCccccCHHHHc
Confidence 4321100 001112346899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKR 398 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~ 398 (451)
+..++.++|||||||++|||++| .+|+...+..+.+..+..+... +. +...+..+.+|+.+||+.||++|||
T Consensus 187 ~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~---~~~~~~~l~~li~~cl~~~p~~RPt--- 259 (283)
T d1mqba_ 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-PT---PMDCPSAIYQLMMQCWQQERARRPK--- 259 (283)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-CC---CTTCBHHHHHHHHHHTCSSTTTSCC---
T ss_pred cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-CC---chhhHHHHHHHHHHHCcCCHhHCcC---
Confidence 99999999999999999999995 5556666666676666655322 11 1223448999999999999999999
Q ss_pred ChHHHHc
Q 013016 399 GAADVKT 405 (451)
Q Consensus 399 ~~~ell~ 405 (451)
+.||++
T Consensus 260 -~~eil~ 265 (283)
T d1mqba_ 260 -FADIVS 265 (283)
T ss_dssp -HHHHHH
T ss_pred -HHHHHH
Confidence 999876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=396.75 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=211.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|+++.+++ .||||+++... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~---------~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 71 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHE---------IVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLH 71 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC---------EEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCc---------EEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccc
Confidence 689999999999999999999987765 59999997553 23345677888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++.++|+|++.|++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.
T Consensus 72 ~~~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 72 SDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CSSEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cccceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhh
Confidence 999999999999999988877654 568999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
....... ......+++.|+|||++.
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~pe~~~ 174 (292)
T d1unla_ 150 AFGIPVR-------------------------------------------------------CYSAEVVTLWYRPPDVLF 174 (292)
T ss_dssp ECCSCCS-------------------------------------------------------CCCSCCSCGGGCCHHHHT
T ss_pred cccCCCc-------------------------------------------------------cceeeccccchhhhhHhc
Confidence 4321111 011225677899999988
Q ss_pred CCC-CCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCCCCCC------------------------CCCCCCc
Q 013016 320 GGS-HGNAVDWWAFGIFIYEMIYGRTPFAA-PSNETTLRNIVKKPLTFP------------------------TQSPSSM 373 (451)
Q Consensus 320 ~~~-~~~~~DIwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~------------------------~~~~~~~ 373 (451)
+.. ++.++|||||||++|||++|+.||.. .+..+.+..+........ .......
T Consensus 175 ~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T d1unla_ 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhcccc
Confidence 765 68999999999999999999998654 444444444432111100 0001112
Q ss_pred ChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCC
Q 013016 374 SEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGL 412 (451)
Q Consensus 374 ~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~ 412 (451)
.+..+.+||++||++||.+||| ++|||+||||++.
T Consensus 255 ~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 255 LNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred CCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 2348899999999999999999 9999999999983
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=405.01 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=206.6
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|+++++||+|+||+||+|.++.+++ .||||++.+.. .....+.+.+|+.+|+.++||||+++++++.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~---------~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~ 76 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKV---------RVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIR 76 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCS---------EEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCc---------EEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence 569999999999999999999887765 49999997542 2344566788999999999999999999997
Q ss_pred eCC-----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 ASN-----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~~-----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
... ++||||+ +.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~~~~~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 77 APTIEQMKDVYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp CSSTTTCCCEEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eccccccceEEEEEe-ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcc
Confidence 653 3556555 5599999999763 599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++........ ........+||+.|+|
T Consensus 153 fG~a~~~~~~~~----------------------------------------------------~~~~~~~~~gt~~y~a 180 (345)
T d1pmea_ 153 FGLARVADPDHD----------------------------------------------------HTGFLTEYVATRWYRA 180 (345)
T ss_dssp CTTCEECCGGGC----------------------------------------------------BCCTTCCCCSCGGGCC
T ss_pred cCceeeccCCCc----------------------------------------------------cceeeccccccceech
Confidence 999854321100 1111223479999999
Q ss_pred cccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC--------------------CCCC-----
Q 013016 315 PEVASG-GSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT--------------------FPTQ----- 368 (451)
Q Consensus 315 PE~~~~-~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------------------~~~~----- 368 (451)
||++.. ..++.++||||+||++|+|++|+.||......+........... .+..
T Consensus 181 PE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (345)
T d1pmea_ 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 260 (345)
T ss_dssp GGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred HHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCH
Confidence 999855 45789999999999999999999999887765554443321100 0000
Q ss_pred --CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCccc
Q 013016 369 --SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFAL 416 (451)
Q Consensus 369 --~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~ 416 (451)
..+. .+.++++||.+||++||.+||| +.|+|+||||++.....
T Consensus 261 ~~~~~~-~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 261 NRLFPN-ADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HHHCTT-SCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTTCCGG
T ss_pred HHhCCC-CCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccCCCCc
Confidence 0112 2337999999999999999999 99999999999865543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.1e-52 Score=402.64 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=203.9
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~ 157 (451)
.++|+++++||+|+||+||+|+++.+++ .||||++.+.. ...+.+|+.+|+.+. ||||++++++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~---------~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~ 98 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADI 98 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCC---------EEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEE
Confidence 3789999999999999999999887665 59999997542 245667999999995 9999999999
Q ss_pred EEe--CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCC-CEEEec
Q 013016 158 FEA--SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDG-HIMLSD 234 (451)
Q Consensus 158 ~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~D 234 (451)
|.. ..++|+|||||.+++|.++. +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|
T Consensus 99 ~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 99 VKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecc
Confidence 974 45799999999999997763 3499999999999999999999999999999999999999765 699999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||+|...... ......+||+.|+|
T Consensus 174 FG~a~~~~~~--------------------------------------------------------~~~~~~~~t~~y~a 197 (328)
T d3bqca1 174 WGLAEFYHPG--------------------------------------------------------QEYNVRVASRYFKG 197 (328)
T ss_dssp GGGCEECCTT--------------------------------------------------------CCCCSCCSCGGGCC
T ss_pred cccceeccCC--------------------------------------------------------CcccccccCccccC
Confidence 9998533211 01123478999999
Q ss_pred cccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhc-------------CCCC---------------
Q 013016 315 PEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNET-TLRNIVK-------------KPLT--------------- 364 (451)
Q Consensus 315 PE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~-~~~~i~~-------------~~~~--------------- 364 (451)
||.+.+.. ++.++|||||||++|+|++|+.||....... ....+.. ....
T Consensus 198 PE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (328)
T d3bqca1 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277 (328)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCC
T ss_pred cccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccccccc
Confidence 99988754 7999999999999999999999997754332 2111110 0000
Q ss_pred ----CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 365 ----FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 365 ----~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
..........+.++++||++||.+||++||| ++|+|+||||+.+.|
T Consensus 278 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 278 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCC
T ss_pred chhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCC
Confidence 0000111223448999999999999999999 999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=409.28 Aligned_cols=271 Identities=24% Similarity=0.359 Sum_probs=206.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|+++.+++ .||||++.+... .......+.+|+.++++++|||||+++++|.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~---------~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDR---------NVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTE---------EEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCC---------EEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 689999999999999999999987665 599999976543 3344567788999999999999999999995
Q ss_pred e------CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEe
Q 013016 160 A------SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLS 233 (451)
Q Consensus 160 ~------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~ 233 (451)
. .+++|+|||||.++.+ +.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~ 161 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cccccccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeee
Confidence 3 3689999999965544 4443 348999999999999999999999999999999999999999999999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||++..... .......+||+.|+
T Consensus 162 df~~~~~~~~--------------------------------------------------------~~~~~~~~~t~~y~ 185 (355)
T d2b1pa1 162 DFGLARTAGT--------------------------------------------------------SFMMTPYVVTRYYR 185 (355)
T ss_dssp CCCC-----------------------------------------------------------------------CCTTC
T ss_pred chhhhhcccc--------------------------------------------------------cccccccccccccc
Confidence 9998743211 11112347999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC----------------------CCCCC--
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLT----------------------FPTQS-- 369 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~----------------------~~~~~-- 369 (451)
|||++.+..++.++||||+||++|+|++|+.||.+.+.......+...... .....
T Consensus 186 aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (355)
T d2b1pa1 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP 265 (355)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHH
T ss_pred ChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccc
Confidence 999999999999999999999999999999999988776665555431111 00000
Q ss_pred -------CC------CcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCcccccccCCCCC
Q 013016 370 -------PS------SMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNFALIRSLTPPEI 425 (451)
Q Consensus 370 -------~~------~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~~~~~~~~~~~~ 425 (451)
.. ...+.++++||++||.+||++||| |+|||+||||++...+......+|++
T Consensus 266 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 266 KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp HHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred cccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCCcccccCCCCCC
Confidence 00 012337899999999999999999 99999999999854444444444433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=393.75 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=205.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEF 158 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~ 158 (451)
.++|++.++||+|+||+||+|.++...+ ..+.||||++.+.........+.+.+|+.++++++|||||++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4789999999999999999998765432 1234999999877666666677889999999999999999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCcc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLS 238 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a 238 (451)
.+ +..++|||||++|+|.+++.... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 75 46789999999999998776542 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccc
Q 013016 239 LCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVA 318 (451)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 318 (451)
........ .........|+..|+|||++
T Consensus 159 ~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~aPE~~ 186 (273)
T d1u46a_ 159 RALPQNDD----------------------------------------------------HYVMQEHRKVPFAWCAPESL 186 (273)
T ss_dssp EECCC-CC----------------------------------------------------EEEC-----CCGGGCCHHHH
T ss_pred hhcccCCC----------------------------------------------------cceecCccccCcccCCHHHH
Confidence 64321100 01111234678899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 319 SGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 319 ~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
.+..++.++|||||||++|||+| |+.||.+.+..+.+..+......++.. + ..+..+.+||.+||+.||++|||
T Consensus 187 ~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~-~~~~~l~~li~~cl~~dp~~RPt-- 261 (273)
T d1u46a_ 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--E-DCPQDIYNVMVQCWAHKPEDRPT-- 261 (273)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--T-TCCHHHHHHHHHHTCSSGGGSCC--
T ss_pred hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc--c-cccHHHHHHHHHHcCCChhHCcC--
Confidence 99999999999999999999998 899999999999988887765444321 2 23448999999999999999999
Q ss_pred CChHHHHc
Q 013016 398 RGAADVKT 405 (451)
Q Consensus 398 ~~~~ell~ 405 (451)
+.||++
T Consensus 262 --~~ei~~ 267 (273)
T d1u46a_ 262 --FVALRD 267 (273)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 998863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=399.32 Aligned_cols=256 Identities=16% Similarity=0.208 Sum_probs=205.7
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
.+|+++++||+|+||+||+|.+..+++. ....||+|.+.... .....+.+.+|+.++++++|||||++++++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 5799999999999999999998766532 12248888886442 3334567888999999999999999999998
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
++ ..++|+|++.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 82 ~~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 82 TS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SS-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred cC-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 75 467888889899999887765 3569999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCccccc
Q 013016 240 CSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVAS 319 (451)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 319 (451)
...... .........||+.|||||++.
T Consensus 160 ~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~APE~l~ 186 (317)
T d1xkka_ 160 LLGAEE-----------------------------------------------------KEYHAEGGKVPIKWMALESIL 186 (317)
T ss_dssp HTTTTC-----------------------------------------------------C--------CCTTTSCHHHHH
T ss_pred eccccc-----------------------------------------------------ccccccccccCccccChHHHh
Confidence 432110 111122346899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCC
Q 013016 320 GGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSK 397 (451)
Q Consensus 320 ~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~ 397 (451)
++.++.++|||||||++|||+| |..||.+.+..+....+..+.. ..+ ...+.++.+|+.+||+.||.+|||
T Consensus 187 ~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p-----~~~~~~~~~li~~cl~~dP~~RPs-- 259 (317)
T d1xkka_ 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-----PICTIDVYMIMVKCWMIDADSRPK-- 259 (317)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCC--
T ss_pred cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-----cccCHHHHHHHHHhCCCChhhCcC--
Confidence 9999999999999999999998 8999998888777777766542 222 223448999999999999999999
Q ss_pred CChHHHHcC
Q 013016 398 RGAADVKTH 406 (451)
Q Consensus 398 ~~~~ell~h 406 (451)
+.||+.|
T Consensus 260 --~~eil~~ 266 (317)
T d1xkka_ 260 --FRELIIE 266 (317)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 9999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=392.35 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=204.2
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeE
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYA 156 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~ 156 (451)
+..++|++.++||+|+||.||+|.+++. .||||++++.. ..+.+.+|++++++++||||+++++
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----------~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g 67 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG 67 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTE-----------EEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEECCe-----------EEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4568899999999999999999998643 39999997542 3356778999999999999999999
Q ss_pred EEEe-CCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEecc
Q 013016 157 EFEA-SNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDF 235 (451)
Q Consensus 157 ~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Df 235 (451)
++.+ .+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+||
T Consensus 68 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccc
Confidence 9854 567899999999999999997654456899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|++..... ......+|..|+||
T Consensus 148 g~s~~~~~----------------------------------------------------------~~~~~~~~~~y~aP 169 (262)
T d1byga_ 148 GLTKEASS----------------------------------------------------------TQDTGKLPVKWTAP 169 (262)
T ss_dssp CC----------------------------------------------------------------------CCTTTSCH
T ss_pred ccceecCC----------------------------------------------------------CCccccccccCCCh
Confidence 99843211 11123678899999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC-CCCCCCCCCcChHHHHHHHHHhcccCcCCc
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPL-TFPTQSPSSMSEYHARDLISGLLNKDPCNR 393 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R 393 (451)
|++.+..++.++|||||||++|||+| |+.||......+....+..+.. ..+. ..+.++.+||.+||+.||.+|
T Consensus 170 E~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~R 244 (262)
T d1byga_ 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-----GCPPAVYEVMKNCWHLDAAMR 244 (262)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT-----TCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-----cCCHHHHHHHHHHcccCHhHC
Confidence 99999999999999999999999998 7999998888888888776532 2222 233489999999999999999
Q ss_pred CCCCCChHHHHcC
Q 013016 394 LGSKRGAADVKTH 406 (451)
Q Consensus 394 pt~~~~~~ell~h 406 (451)
|| +.+|+++
T Consensus 245 ps----~~~l~~~ 253 (262)
T d1byga_ 245 PS----FLQLREQ 253 (262)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 9998763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=397.70 Aligned_cols=262 Identities=18% Similarity=0.272 Sum_probs=199.1
Q ss_pred cCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccceeEE
Q 013016 79 FRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLYAE 157 (451)
Q Consensus 79 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~ 157 (451)
.++|++.++||+|+||+||+|.+....+. ..+..||||++..... ......+..|..++.++ +|+||+.++++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~----~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKT----ATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSS----SCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcc----cCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 37899999999999999999998765432 2334699999975432 23344566677777666 68999999998
Q ss_pred EEeC-CeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcE
Q 013016 158 FEAS-NFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENV 222 (451)
Q Consensus 158 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NI 222 (451)
+... +.+++|||||+||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 8654 57899999999999999987542 23589999999999999999999999999999999999
Q ss_pred EEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccccccc
Q 013016 223 LVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAAR 302 (451)
Q Consensus 223 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (451)
||+.++.+||+|||+|+...... ....
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~-----------------------------------------------------~~~~ 192 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDP-----------------------------------------------------DYVR 192 (299)
T ss_dssp EECGGGCEEECC------CCSCT-----------------------------------------------------TSCC
T ss_pred eECCCCcEEEccCcchhhccccc-----------------------------------------------------cccc
Confidence 99999999999999985332111 1112
Q ss_pred ccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHH
Q 013016 303 SCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDL 381 (451)
Q Consensus 303 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 381 (451)
.....||+.|||||++.+..++.++|||||||++|||+|| ..||......+.+..++.....++ . +...+.++.+|
T Consensus 193 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~l~~l 269 (299)
T d1ywna1 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--A-PDYTTPEMYQT 269 (299)
T ss_dssp TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC--C-CTTCCHHHHHH
T ss_pred cCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC--C-CccCCHHHHHH
Confidence 2245799999999999999999999999999999999986 568887665555544443322221 1 12234489999
Q ss_pred HHHhcccCcCCcCCCCCChHHHHcC
Q 013016 382 ISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 382 l~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
+.+||+.||++||| +.||++|
T Consensus 270 i~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 270 MLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp HHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCChhHCcC----HHHHHHH
Confidence 99999999999999 9999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=392.97 Aligned_cols=266 Identities=19% Similarity=0.264 Sum_probs=211.6
Q ss_pred CCcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccc
Q 013016 75 TGLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPT 153 (451)
Q Consensus 75 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~ 153 (451)
+.+..++|++.++||+|+||.||+|++....+. ....+..||||++.+... ......+..|...+.++ +|||||+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 445558899999999999999999998765432 122334699999976532 33445677788888887 7999999
Q ss_pred eeEEEEeCCeEEEEEeeccCCchhhhhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCC
Q 013016 154 LYAEFEASNFSCIVMEFCSGGDLHSLRHKQP--------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKP 219 (451)
Q Consensus 154 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp 219 (451)
++++|.+++..++|||||.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 9999999999999999999999999997553 24589999999999999999999999999999999
Q ss_pred CcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccc
Q 013016 220 ENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPV 299 (451)
Q Consensus 220 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (451)
+|||++.++.+||+|||++...... ..
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~-----------------------------------------------------~~ 190 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHI-----------------------------------------------------DY 190 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGC-----------------------------------------------------CT
T ss_pred cceeecCCCCeEeccchhhcccccc-----------------------------------------------------cc
Confidence 9999999999999999998543211 11
Q ss_pred cccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHH
Q 013016 300 AARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHA 378 (451)
Q Consensus 300 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 378 (451)
........||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+......+..+..+..... +...+.++
T Consensus 191 ~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~----p~~~~~~l 266 (299)
T d1fgka_ 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK----PSNCTNEL 266 (299)
T ss_dssp TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC----CSSCCHHH
T ss_pred ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCC----CccchHHH
Confidence 112234578999999999999999999999999999999998 7999998888887777766532211 12234489
Q ss_pred HHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 379 RDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 379 ~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
.+||.+||+.||++||| +.||++
T Consensus 267 ~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 267 YMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHccCCHhHCcC----HHHHHH
Confidence 99999999999999999 999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-51 Score=393.24 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=213.5
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|++.++||+|+||+||+|++++... ...+..||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCcc----CCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 789999999999999999999875321 1233469999997543 2334567888999999999999999999999
Q ss_pred eCCeEEEEEeeccCCchhhhhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccC
Q 013016 160 ASNFSCIVMEFCSGGDLHSLRHKQP----------------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDL 217 (451)
Q Consensus 160 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dl 217 (451)
..+..++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999986532 234899999999999999999999999999999
Q ss_pred CCCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccc
Q 013016 218 KPENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAE 297 (451)
Q Consensus 218 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (451)
||+|||++.++.+||+|||+|+.....
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~----------------------------------------------------- 193 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA----------------------------------------------------- 193 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-----------------------------------------------------
T ss_pred cccceEECCCCcEEEccchhheeccCC-----------------------------------------------------
Confidence 999999999999999999998532211
Q ss_pred cccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHhcCCCCCCCCCCCCcChH
Q 013016 298 PVAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGR-TPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEY 376 (451)
Q Consensus 298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 376 (451)
.......+..||+.|+|||++.+..|+.++|||||||++|||++|. .||...+..+.+..+..+..... +. ..+.
T Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~---p~-~~~~ 269 (301)
T d1lufa_ 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC---PE-NCPL 269 (301)
T ss_dssp GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CT-TCCH
T ss_pred ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---Cc-cchH
Confidence 1111222357889999999999999999999999999999999985 68999888888888887754221 11 2334
Q ss_pred HHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 377 HARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 377 ~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
++.+||.+||+.||++||| +.||++
T Consensus 270 ~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 270 ELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 8999999999999999999 999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=404.58 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=207.3
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|+++++||+|+||+||+|+++.+++ .||||++.+... .......+.+|+.+|+.++|||||++++++.
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~---------~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGL---------RVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTE---------EEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 679999999999999999999887665 499999976532 2334456778999999999999999999996
Q ss_pred eC-----CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEec
Q 013016 160 AS-----NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSD 234 (451)
Q Consensus 160 ~~-----~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 234 (451)
.. ...++||+++.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccc
Confidence 43 234555666779999998865 4599999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccC
Q 013016 235 FDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVS 314 (451)
Q Consensus 235 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 314 (451)
||++.... ....+..||+.|+|
T Consensus 165 fg~a~~~~----------------------------------------------------------~~~~~~~g~~~y~a 186 (348)
T d2gfsa1 165 FGLARHTD----------------------------------------------------------DEMTGYVATRWYRA 186 (348)
T ss_dssp C----CCT----------------------------------------------------------GGGSSSCHHHHTSC
T ss_pred cchhcccC----------------------------------------------------------cccccccccccccC
Confidence 99974221 01123478999999
Q ss_pred cccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCCC--------------------CCC---
Q 013016 315 PEVASGGS-HGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNIVKKPLTFPT--------------------QSP--- 370 (451)
Q Consensus 315 PE~~~~~~-~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~~--- 370 (451)
||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......+. ...
T Consensus 187 pE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (348)
T d2gfsa1 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 266 (348)
T ss_dssp HHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCH
T ss_pred chhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcch
Confidence 99987765 589999999999999999999999988777766666543221110 000
Q ss_pred ---CCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCCc
Q 013016 371 ---SSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLNF 414 (451)
Q Consensus 371 ---~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~~ 414 (451)
....+.++++||.+||+.||.+||| +.|+|+||||++...
T Consensus 267 ~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 267 ANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCC
T ss_pred hhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCCCC
Confidence 0112348999999999999999999 999999999998543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=394.84 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=210.5
Q ss_pred cccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCcccee
Q 013016 77 LTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTLY 155 (451)
Q Consensus 77 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~ 155 (451)
+.+++|++.++||+|+||+||+|+++.++.. ..||||.+.... .....+.+.+|+++|.++ +|||||+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~-------~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~ 77 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLL 77 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEE-------EEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeE-------EEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEE
Confidence 4568999999999999999999999876532 137788875432 233456788899999998 799999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCc
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQ--------------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPEN 221 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~N 221 (451)
+++.+++.+++||||++||+|.+++... ....+++..+.+++.||+.||.|||++||+||||||+|
T Consensus 78 ~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N 157 (309)
T d1fvra_ 78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157 (309)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccce
Confidence 9999999999999999999999998754 24569999999999999999999999999999999999
Q ss_pred EEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccc
Q 013016 222 VLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAA 301 (451)
Q Consensus 222 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (451)
||++.++.+||+|||++...... .
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~--------------------------------------------------------~ 181 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVY--------------------------------------------------------V 181 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEE--------------------------------------------------------C
T ss_pred EEEcCCCceEEcccccccccccc--------------------------------------------------------c
Confidence 99999999999999998532210 0
Q ss_pred cccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHH
Q 013016 302 RSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGR-TPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARD 380 (451)
Q Consensus 302 ~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 380 (451)
......||..|+|||.+.+..++.++|||||||++|||++|. .||.+.+..+.+..+..+.... .+. ..+.++.+
T Consensus 182 ~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~---~~~-~~~~~~~~ 257 (309)
T d1fvra_ 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE---KPL-NCDDEVYD 257 (309)
T ss_dssp CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC---CCT-TBCHHHHH
T ss_pred cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCC---CCc-cCCHHHHH
Confidence 111236899999999999999999999999999999999965 6788888888888887753211 112 23348999
Q ss_pred HHHHhcccCcCCcCCCCCChHHHHcC
Q 013016 381 LISGLLNKDPCNRLGSKRGAADVKTH 406 (451)
Q Consensus 381 ll~~~L~~dP~~Rpt~~~~~~ell~h 406 (451)
||.+||+.||++||| +.||++|
T Consensus 258 li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 258 LMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHcCCChhHCcC----HHHHHHH
Confidence 999999999999999 9999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=394.76 Aligned_cols=271 Identities=21% Similarity=0.281 Sum_probs=220.7
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcccee
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLY 155 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~ 155 (451)
.+..++|.+.++||+|+||+||+|.++...+. ..+..||||+++... .......+.+|+.++++++|||||+++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~----~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKD----EPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETT----EEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccC----CCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 34458899999999999999999998653211 112249999997553 233445678899999999999999999
Q ss_pred EEEEeCCeEEEEEeeccCCchhhhhhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccC
Q 013016 156 AEFEASNFSCIVMEFCSGGDLHSLRHKQ--------PHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 156 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~ 227 (451)
+++..++..++|||||++|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9999999999999999999999987643 12347899999999999999999999999999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
+++||+|||+++..... ..........
T Consensus 170 ~~~Kl~DFGla~~~~~~-----------------------------------------------------~~~~~~~~~~ 196 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYET-----------------------------------------------------DYYRKGGKGL 196 (308)
T ss_dssp CCEEECCTTCCCGGGGG-----------------------------------------------------GCEEGGGSSE
T ss_pred ceEEEeecccceeccCC-----------------------------------------------------cceeecccee
Confidence 99999999998532210 0111222347
Q ss_pred cCCCccCcccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhc
Q 013016 308 GTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYG-RTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLL 386 (451)
Q Consensus 308 gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L 386 (451)
||+.|+|||.+.+..++.++|||||||++|||+|| +.||.+.+..+.+..+.++...... ...+..+.+||.+||
T Consensus 197 ~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p----~~~~~~l~~li~~cl 272 (308)
T d1p4oa_ 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCW 272 (308)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHT
T ss_pred cccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCc----ccchHHHHHHHHHHc
Confidence 89999999999999999999999999999999997 5889998888888888876532211 223348999999999
Q ss_pred ccCcCCcCCCCCChHHHHc------CCCcCCCC
Q 013016 387 NKDPCNRLGSKRGAADVKT------HPFFKGLN 413 (451)
Q Consensus 387 ~~dP~~Rpt~~~~~~ell~------hp~~~~~~ 413 (451)
+.||.+||| +.+|++ +|+|++++
T Consensus 273 ~~~P~~RPs----~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 273 QYNPKMRPS----FLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp CSSGGGSCC----HHHHHHHHGGGSCTTHHHHC
T ss_pred CCChhHCcC----HHHHHHHHHHhcCCCCcCCC
Confidence 999999999 999987 77776543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=390.48 Aligned_cols=264 Identities=17% Similarity=0.284 Sum_probs=214.4
Q ss_pred CcccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHC-CCCCccce
Q 013016 76 GLTFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKML-DHPFLPTL 154 (451)
Q Consensus 76 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l 154 (451)
.+..++|++.++||+|+||.||+|+++...+ ...+..||||++..... ......+.+|+.+++++ +|||||++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~----~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIK----SDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSS----TTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEecccc----CCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3444789999999999999999999865432 23445799999976532 23345677899999998 69999999
Q ss_pred eEEEEeCCeEEEEEeeccCCchhhhhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCC
Q 013016 155 YAEFEASNFSCIVMEFCSGGDLHSLRHKQP----------------HKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLK 218 (451)
Q Consensus 155 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlk 218 (451)
++++.+.+.++||||||+||+|.+++.... ...+++..+..++.||+.||+|||++|+||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999987643 2358999999999999999999999999999999
Q ss_pred CCcEEEccCCCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccc
Q 013016 219 PENVLVRSDGHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298 (451)
Q Consensus 219 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (451)
|+|||++.++.+||+|||+++......
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~----------------------------------------------------- 199 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDS----------------------------------------------------- 199 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT-----------------------------------------------------
T ss_pred cccccccccCcccccccchheeccCCC-----------------------------------------------------
Confidence 999999999999999999985332110
Q ss_pred ccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCCCCCCCCCCcChHH
Q 013016 299 VAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIY-GRTPFAAPSNETTLRNIVKKPLTFPTQSPSSMSEYH 377 (451)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 377 (451)
........+||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.+.+++........ +...+.+
T Consensus 200 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~ 276 (311)
T d1t46a_ 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS---PEHAPAE 276 (311)
T ss_dssp TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC---CTTSCHH
T ss_pred cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---cccccHH
Confidence 1111223589999999999999999999999999999999998 77778777777766666654332221 1223448
Q ss_pred HHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 378 ARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 378 ~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
+.+||.+||+.||.+||| +.||++
T Consensus 277 l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 277 MYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHcCCChhHCcC----HHHHHH
Confidence 999999999999999999 999885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=376.45 Aligned_cols=256 Identities=15% Similarity=0.197 Sum_probs=201.1
Q ss_pred eEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEEe-C
Q 013016 83 DLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFEA-S 161 (451)
Q Consensus 83 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~ 161 (451)
.+.++||+|+||+||+|++..+.. ....||||++++. ........+.+|++++++++|||||++++++.. +
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----------CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ccceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 346789999999999999875432 1235899998743 234455778899999999999999999999875 5
Q ss_pred CeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEccCCCEEEeccCccccc
Q 013016 162 NFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRSDGHIMLSDFDLSLCS 241 (451)
Q Consensus 162 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 241 (451)
+..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||+++..
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred CceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 6899999999999999988765 345788999999999999999999999999999999999999999999999998644
Q ss_pred CCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCcccccCC
Q 013016 242 NAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSPEVASGG 321 (451)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 321 (451)
....... ........||+.|+|||.+.+.
T Consensus 181 ~~~~~~~---------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 209 (311)
T d1r0pa_ 181 YDKEFDS---------------------------------------------------VHNKTGAKLPVKWMALESLQTQ 209 (311)
T ss_dssp TTTTCCC---------------------------------------------------TTCTTCSSCCGGGSCHHHHHHC
T ss_pred ccccccc---------------------------------------------------ceecccccccccccChHHHhcC
Confidence 3211100 0111123689999999999999
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCCh
Q 013016 322 SHGNAVDWWAFGIFIYEMIYGRTPFAAP-SNETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGA 400 (451)
Q Consensus 322 ~~~~~~DIwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~ 400 (451)
.++.++||||||+++|||+||..||... +..+....+..+..... +...+.++.+||.+||+.||++||+ +
T Consensus 210 ~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~----p~~~~~~l~~li~~cl~~dP~~RPs----~ 281 (311)
T d1r0pa_ 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPS----F 281 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCC----H
T ss_pred CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC----cccCcHHHHHHHHHHcCCCHhHCcC----H
Confidence 9999999999999999999977777653 34445555555543221 1233458999999999999999999 9
Q ss_pred HHHHcC
Q 013016 401 ADVKTH 406 (451)
Q Consensus 401 ~ell~h 406 (451)
.||++|
T Consensus 282 ~ei~~~ 287 (311)
T d1r0pa_ 282 SELVSR 287 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=372.13 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=190.4
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCccceeEEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLPTLYAEFE 159 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~ 159 (451)
++|.+.++||+|+||+||+|++.+. .||||++..... .....+.|+..+.+++|||||++++++.
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~-----------~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~ 67 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGE-----------EVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTE-----------EEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCE-----------EEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence 5799999999999999999987543 399999975422 1222334556667789999999999997
Q ss_pred eCC----eEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeccCCCCcEEEccC
Q 013016 160 ASN----FSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM--------LGIIYRDLKPENVLVRSD 227 (451)
Q Consensus 160 ~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~--------~givH~Dlkp~NIll~~~ 227 (451)
..+ .+|+|||||++|+|.+++++. .+++..+..++.|++.||+|||+ +||+||||||+||||+.+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~ 144 (303)
T d1vjya_ 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred eCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence 654 689999999999999999874 48999999999999999999996 599999999999999999
Q ss_pred CCEEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccc
Q 013016 228 GHIMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFV 307 (451)
Q Consensus 228 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (451)
|.+||+|||++........ .........+
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~---------------------------------------------------~~~~~~~~~~ 173 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATD---------------------------------------------------TIDIAPNHRV 173 (303)
T ss_dssp SCEEECCCTTCEEEETTTT---------------------------------------------------EECC----CC
T ss_pred CCeEEEecCccccccCCCc---------------------------------------------------ceecccccee
Confidence 9999999999853321100 0011122358
Q ss_pred cCCCccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCCC---------------ChHHHHHHHhcCCCC--
Q 013016 308 GTHEYVSPEVASGGS------HGNAVDWWAFGIFIYEMIYGRTPFAAP---------------SNETTLRNIVKKPLT-- 364 (451)
Q Consensus 308 gt~~y~aPE~~~~~~------~~~~~DIwSlG~il~elltg~~pf~~~---------------~~~~~~~~i~~~~~~-- 364 (451)
||+.|||||++.+.. ++.++|||||||+||||+||..||... ........+......
T Consensus 174 gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 253 (303)
T d1vjya_ 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 253 (303)
T ss_dssp SCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC
T ss_pred cccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCC
Confidence 999999999987643 567899999999999999998877431 112222233222221
Q ss_pred CCCCCCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHc
Q 013016 365 FPTQSPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKT 405 (451)
Q Consensus 365 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~ 405 (451)
++...........+.+|+.+||+.||++||| +.||++
T Consensus 254 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~ 290 (303)
T d1vjya_ 254 IPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred CCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 1211111112235889999999999999999 999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-47 Score=365.14 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=197.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCC-ccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPF-LPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~ 158 (451)
++|++.++||+|+||+||+|+++.+++ .||||++.... ....+..|+++++.++|+| |+.+.+++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~ 72 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCG 72 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE---------EEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCC---------EEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEE
Confidence 569999999999999999999887665 49999987542 2234667999999998776 55556666
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc---CCCEEEecc
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS---DGHIMLSDF 235 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~---~~~~kl~Df 235 (451)
.+.+..++||||+ +++|.+.+... ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+||
T Consensus 73 ~~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 73 AEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred ecCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeecc
Confidence 8888999999999 77777766544 356999999999999999999999999999999999999863 457999999
Q ss_pred CcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCccCc
Q 013016 236 DLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYVSP 315 (451)
Q Consensus 236 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 315 (451)
|+|+.......... ........++||+.||||
T Consensus 151 G~a~~~~~~~~~~~------------------------------------------------~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 151 GLAKKYRDARTHQH------------------------------------------------IPYRENKNLTGTARYASI 182 (299)
T ss_dssp SSCEECBCTTTCCB------------------------------------------------CCCCBCCSCCCCSSSCCH
T ss_pred Ccceeccccccccc------------------------------------------------eeccccCCcCCCccccCH
Confidence 99864432111000 001122346899999999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCCCCCCCCCCcChHHHHHHHHHhcccCcCC
Q 013016 316 EVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNETTLRNI---VKKPLTFPTQSPSSMSEYHARDLISGLLNKDPCN 392 (451)
Q Consensus 316 E~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~ 392 (451)
|++.+..++.++|||||||++|||++|+.||...........+ .......+........+.++.+|+.+||+.||++
T Consensus 183 E~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~ 262 (299)
T d1ckia_ 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDD 262 (299)
T ss_dssp HHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTC
T ss_pred HHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999999999999999876554432222 1111111111111123348999999999999999
Q ss_pred cCCCCCChHHHHcCCCcC
Q 013016 393 RLGSKRGAADVKTHPFFK 410 (451)
Q Consensus 393 Rpt~~~~~~ell~hp~~~ 410 (451)
||++.. +.++|+|+|.+
T Consensus 263 RP~~~~-i~~~l~~~~~~ 279 (299)
T d1ckia_ 263 KPDYSY-LRQLFRNLFHR 279 (299)
T ss_dssp CCCHHH-HHHHHHHHHHH
T ss_pred CcCHHH-HHHHHHHHHHH
Confidence 999221 23557777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-47 Score=361.90 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=200.2
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC-CCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH-PFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~ 158 (451)
++|++.++||+|+||+||+|++..+++ .||||++.... ....+..|+++++.+.| +||+.+++++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~---------~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 70 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQ---------QVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFG 70 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTE---------EEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCC---------EEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence 689999999999999999999887665 49999986542 12345568899999975 8999999999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc-----CCCEEEe
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS-----DGHIMLS 233 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~-----~~~~kl~ 233 (451)
....+.|+||||+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+
T Consensus 71 ~~~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 71 QEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ecCCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEc
Confidence 9999999999999 89999988765 346999999999999999999999999999999999999974 5789999
Q ss_pred ccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCcccccccccccccccccCCCcc
Q 013016 234 DFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEPVAARSCSFVGTHEYV 313 (451)
Q Consensus 234 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 313 (451)
|||+|+.......... ........++||+.||
T Consensus 149 DFG~a~~~~~~~~~~~------------------------------------------------~~~~~~~~~~GT~~y~ 180 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQH------------------------------------------------IPYREKKNLSGTARYM 180 (293)
T ss_dssp CCTTCEESBCTTTCCB------------------------------------------------CCCCCCCCCCSCTTTC
T ss_pred ccceeEEcccCccccc------------------------------------------------eeecccCceEEchhhc
Confidence 9999965432111000 0011223468999999
Q ss_pred CcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCCCCCCCCcChHHHHHHHHHhcccCc
Q 013016 314 SPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPS---NETTLRNIVKKPLTFPTQSPSSMSEYHARDLISGLLNKDP 390 (451)
Q Consensus 314 aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP 390 (451)
|||++.+..++.++|||||||++|||++|+.||.+.. .......+.......+........+.++.+++..|+..+|
T Consensus 181 aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred CHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999999997643 2333333332221111111111123489999999999999
Q ss_pred CCcCCCCCChHHHH
Q 013016 391 CNRLGSKRGAADVK 404 (451)
Q Consensus 391 ~~Rpt~~~~~~ell 404 (451)
++||+ .+.+.
T Consensus 261 ~~rP~----y~~l~ 270 (293)
T d1csna_ 261 DATPD----YDYLQ 270 (293)
T ss_dssp TCCCC----HHHHH
T ss_pred ccCcC----HHHHH
Confidence 99998 55543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-45 Score=361.53 Aligned_cols=259 Identities=28% Similarity=0.406 Sum_probs=192.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-----------C
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-----------H 148 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h 148 (451)
++|+++++||+|+||+||+|+++.+++ .||||++++.... .+.+.+|+.+++.++ |
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~---------~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE---------EEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCC---------EEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 359999999999999999999887765 4999999865322 244556888887764 5
Q ss_pred CCccceeEEEEeC--CeEEEEEeeccCCc-hhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeccCCCCcEEE
Q 013016 149 PFLPTLYAEFEAS--NFSCIVMEFCSGGD-LHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM-LGIIYRDLKPENVLV 224 (451)
Q Consensus 149 ~nIv~l~~~~~~~--~~~~lV~E~~~ggs-L~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givH~Dlkp~NIll 224 (451)
+||+++++++... ...++||+++..+. ............+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 7899999988643 46666666664443 3444555556779999999999999999999997 899999999999999
Q ss_pred ccCCC------EEEeccCcccccCCCCCCCCCCCCCCCCCCCCcccccccchhhhhhhccccCCccccccCCCccccccc
Q 013016 225 RSDGH------IMLSDFDLSLCSNAIPAVESPASSPEAASPRSQTYTRQYSTRLSRFLNRFFGSKKIQTLTPNRLFVAEP 298 (451)
Q Consensus 225 ~~~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (451)
+.++. ++++|||.+.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~------------------------------------------------------- 184 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE------------------------------------------------------- 184 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB-------------------------------------------------------
T ss_pred eccCcccccceeeEeeccccccccc-------------------------------------------------------
Confidence 87653 99999999743211
Q ss_pred ccccccccccCCCccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC--C--------
Q 013016 299 VAARSCSFVGTHEYVSPEVASGGSHGNAVDWWAFGIFIYEMIYGRTPFAAPSNE------TTLRNIVKK--P-------- 362 (451)
Q Consensus 299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwSlG~il~elltg~~pf~~~~~~------~~~~~i~~~--~-------- 362 (451)
.....+||+.|+|||++.+..++.++||||+||++++|++|+.||...... ..+...... .
T Consensus 185 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~ 261 (362)
T d1q8ya_ 185 ---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRN 261 (362)
T ss_dssp ---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhc
Confidence 111347999999999999999999999999999999999999999754321 111111110 0
Q ss_pred ----------C----CCCCC-------------CCCCcChHHHHHHHHHhcccCcCCcCCCCCChHHHHcCCCcCCCC
Q 013016 363 ----------L----TFPTQ-------------SPSSMSEYHARDLISGLLNKDPCNRLGSKRGAADVKTHPFFKGLN 413 (451)
Q Consensus 363 ----------~----~~~~~-------------~~~~~~~~~~~~ll~~~L~~dP~~Rpt~~~~~~ell~hp~~~~~~ 413 (451)
. ..... ......+.++.+||.+||.+||.+||| ++|||+||||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 262 GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDTL 335 (362)
T ss_dssp CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTCT
T ss_pred ccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHHhcCcccCCCC
Confidence 0 00000 001112347899999999999999999 99999999999744
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.4e-26 Score=203.23 Aligned_cols=134 Identities=21% Similarity=0.240 Sum_probs=104.3
Q ss_pred ceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHH---------------HHHHHHHHHHHHHHHHHC
Q 013016 82 FDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLE---------------KKKKVHRAEMEKKILKML 146 (451)
Q Consensus 82 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l 146 (451)
+.+.++||+|+||+||+|.+..+. .||||+++..... ..........|...+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~----------~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 71 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFG----------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 71 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTE----------EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred chhCCEeeeCcceEEEEEECCCCC----------EEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence 467899999999999999876433 3999987532211 011223345688899999
Q ss_pred CCCCccceeEEEEeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccCCCCcEEEcc
Q 013016 147 DHPFLPTLYAEFEASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHMLGIIYRDLKPENVLVRS 226 (451)
Q Consensus 147 ~h~nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givH~Dlkp~NIll~~ 226 (451)
.|.+++..+++.. .++||||+++..+.+ ++...+..++.||+.||+|||++||+||||||+|||++.
T Consensus 72 ~~~~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 72 QGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp TTSSSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred cCCCcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 9999999886532 379999998766543 445556789999999999999999999999999999996
Q ss_pred CCCEEEeccCccc
Q 013016 227 DGHIMLSDFDLSL 239 (451)
Q Consensus 227 ~~~~kl~Dfg~a~ 239 (451)
+ .++|+|||+|.
T Consensus 139 ~-~~~liDFG~a~ 150 (191)
T d1zara2 139 E-GIWIIDFPQSV 150 (191)
T ss_dssp T-EEEECCCTTCE
T ss_pred C-CEEEEECCCcc
Confidence 5 58999999984
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=2.3e-08 Score=90.87 Aligned_cols=139 Identities=15% Similarity=0.107 Sum_probs=95.9
Q ss_pred CCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeEEE
Q 013016 80 RDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYAEF 158 (451)
Q Consensus 80 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~ 158 (451)
..|++.+..+-++.+.||+....+.. ++||+...... .....+..|...++.+. +--+.+++.++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~-----------~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~ 79 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENEN-----------LYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCE-----------EEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCe-----------EEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence 67888877665666799988643332 78898865422 12234556888887764 44478889999
Q ss_pred EeCCeEEEEEeeccCCchhhhhhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------
Q 013016 159 EASNFSCIVMEFCSGGDLHSLRHKQPHKRFSLTSARFYAAEVLVALEYLHM----------------------------- 209 (451)
Q Consensus 159 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------- 209 (451)
..++..++||++++|.++.+..... .....++.++...|..||+
T Consensus 80 ~~~~~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 80 RHDGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred ecCCceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 9999999999999998876543211 1123344555555555553
Q ss_pred ------------------------------CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 ------------------------------LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ------------------------------~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999876666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.31 E-value=8.5e-07 Score=79.68 Aligned_cols=75 Identities=15% Similarity=0.065 Sum_probs=52.1
Q ss_pred eccCC-eeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCC--CCccceeEEEEeCCeE
Q 013016 88 IGAGD-IGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDH--PFLPTLYAEFEASNFS 164 (451)
Q Consensus 88 LG~G~-~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~ 164 (451)
+..|. -+.||+........ +++|+..... ...+..|...++.+.. -.+++++.+..+++..
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~----------~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~ 81 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPV----------LFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 81 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCC----------EEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred cCCcccCCeEEEEEeCCCCE----------EEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccce
Confidence 44454 36899987655432 8889876442 2335557777776643 3367889888888899
Q ss_pred EEEEeeccCCchhh
Q 013016 165 CIVMEFCSGGDLHS 178 (451)
Q Consensus 165 ~lV~E~~~ggsL~~ 178 (451)
++||++++|.++.+
T Consensus 82 ~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 82 WLLLGEVPGQDLLS 95 (255)
T ss_dssp EEEEECCSSEETTT
T ss_pred EEEEEeeecccccc
Confidence 99999998877643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=4.8e-06 Score=79.94 Aligned_cols=81 Identities=20% Similarity=0.247 Sum_probs=48.7
Q ss_pred EeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHH----HHHHHHHHHHHHHHHHCC-C--CCccceeEE
Q 013016 85 HRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEK----KKKVHRAEMEKKILKMLD-H--PFLPTLYAE 157 (451)
Q Consensus 85 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~ 157 (451)
.+.||.|....||++.+..+++. ++||.-....... .....+...|.+.|+.+. + ..+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~s---------vivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRA---------LIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CE---------EEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeE---------EEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 55789999999999987665543 8888654221111 012234455777776652 2 346677754
Q ss_pred EEeCCeEEEEEeeccCCch
Q 013016 158 FEASNFSCIVMEFCSGGDL 176 (451)
Q Consensus 158 ~~~~~~~~lV~E~~~ggsL 176 (451)
+.+..++|||++.+..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 44556899999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.47 E-value=0.00014 Score=69.43 Aligned_cols=88 Identities=20% Similarity=0.315 Sum_probs=54.4
Q ss_pred ccCCceEEeeeccCCeeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCC-CCCccceeE
Q 013016 78 TFRDFDLHRRIGAGDIGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLD-HPFLPTLYA 156 (451)
Q Consensus 78 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~ 156 (451)
..+++.+ +.|+.|-.-.+|++.........+. ...-|.+++..... ......+|..+++.+. +.-.+++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~--~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRN--EPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSS--CCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccC--CCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEE
Confidence 3345555 5788899999999987654321111 11236777765221 1223456888888775 433568888
Q ss_pred EEEeCCeEEEEEeeccCCchh
Q 013016 157 EFEASNFSCIVMEFCSGGDLH 177 (451)
Q Consensus 157 ~~~~~~~~~lV~E~~~ggsL~ 177 (451)
++.+ .+||||++|.+|.
T Consensus 113 ~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 113 IFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp EETT----EEEECCCCEEECC
T ss_pred EcCC----ceEEEEeccccCC
Confidence 7753 5899999886653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00031 Score=65.03 Aligned_cols=70 Identities=16% Similarity=0.185 Sum_probs=43.3
Q ss_pred eeEEEEEEeccccccCCCCCCcceEEEEEcchHHHHHHHHHHHHHHHHHHHHHCCCCCcc--cee-----EEEEeCCeEE
Q 013016 93 IGTVYLCSLNNKYRQDRGHEPCCLYAMKVVNKEVLEKKKKVHRAEMEKKILKMLDHPFLP--TLY-----AEFEASNFSC 165 (451)
Q Consensus 93 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~nIv--~l~-----~~~~~~~~~~ 165 (451)
--.||++...++.+ |++|+.+..... ...+..|...+..|...+|. ..+ ..+...+..+
T Consensus 35 EN~vy~v~~~dg~~----------~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~ 100 (325)
T d1zyla1 35 ENRVYQFQDEDRRR----------FVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF 100 (325)
T ss_dssp SSEEEEECCTTCCC----------EEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred cceeEEEEcCCCCE----------EEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEE
Confidence 36899998765543 999998754322 23344577777766432221 111 2335567889
Q ss_pred EEEeeccCCch
Q 013016 166 IVMEFCSGGDL 176 (451)
Q Consensus 166 lV~E~~~ggsL 176 (451)
.+++++.|..+
T Consensus 101 ~l~~~~~G~~~ 111 (325)
T d1zyla1 101 AVFPSVGGRQF 111 (325)
T ss_dssp EEEECCCCEEC
T ss_pred EEEeecCCcCC
Confidence 99999977544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.05 E-value=0.00032 Score=64.47 Aligned_cols=30 Identities=33% Similarity=0.384 Sum_probs=27.0
Q ss_pred CCCeeccCCCCcEEEccCCCEEEeccCccc
Q 013016 210 LGIIYRDLKPENVLVRSDGHIMLSDFDLSL 239 (451)
Q Consensus 210 ~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 239 (451)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999984
|